Psyllid ID: psy7384

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460---
Protein Sequence
MENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSSSSTSTATPTPRIQTPTHPTTATPTSTENFPCVPTHDSDDDDDLGEGEDNLPVTGHRVAVVEGQV
Secondary Structure (PSIPRED)
cccccccccccccHHHHHHHHHHcHHHHHHHHHHHcccccccccccccccccccccEEEEEEEccccccEEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHHHHHccccccccHHHHccccccccccccEEEEEEccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEccEEcHHcHHHHcccccccccccccccHHHcccccccccccccHHHHHHHHHHHHHHccccccccccccHHHHccccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEccccccEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHcccccEEEEEEEEEEccccccccEEEEEEEEcccccHEEcHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEccccccccccHHHcccccEccccccccHHHHEcccccccccccHHHHHHHHHHHHHHHcccccccccccHHHEEEcccccccccccccccHHHHHHHHHHHcccHcccccHHHHHcccHHcccccHHHHHHHHHHHHHHHHHHcccHHHHcccccccccccccccccccccEcccccccHHHHHHHHccccccccccccccccccccccccccccccccccccHcccccccccccccccccccccccccccccccEEEEccc
Coil and Loop (DISEMBL)
menpkdsttkvyTDEERAELAEKLDKDLDDFIAGLekrsytegwpedrwqedpagIFELIEVVGngtygqvykgrhtktgQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAfikksppgkddqLWLVMEYCgagsvtdlvkstkgqslKEEWIAFICREILRGLKylhenkvihrdikgqnvlltdnaevklvdfgvsaqldrtigrrntfigtpywmapeviacdenpdatydnrsdLWSLGITALemaesqpplcdlhpmralfliprnapprlkskkwpkKFQSFIETVLVkdyhqrpytdqllkhpfirdqpTERQARIQLKDHIDTCKKrkkerddyrysgseneeeetgvggepssiiqapgdntLRRNFQQIQKLencarssssststatptpriqtpthpttatptstenfpcvpthdsdddddlgegednlpvtgHRVAVVEGQV
Flexible Loop (DISEMBL)
menpkdsttkvytdeeRAELAEKLDKDLDDFIAGLEkrsytegwpedrwQEDPAGIFELIEVVGNGTYGQVykgrhtktgqlAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVkstkgqslkeEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDfgvsaqldrtigrrNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRnapprlkskkwpKKFQSFIETVLVKDYHQRPYTDQllkhpfirdqpterqariqlkdhidtckkrkkerddyrysgseneeeetgvggepssiiQAPGDNTLRRNFQQIQKLencarssssststatptpriqtpthpttatptstenfpcvpTHDSDDDDDLGEGednlpvtghrvavvegqv
Low Complexity Region (SEG)
MENPKDSTTKVYTDEERaelaekldkdlddFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMdvtedeeeeikleinvlkKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCkkrkkerddyrysgseneeeetgvggepssIIQAPGDNTLRRNFQQIQKLENCarssssststatptprIQtpthpttatptstENFPCVPTHdsdddddlgegedNLPVTGHRVAVVEGQV
Disordered region (IsUnstruct)
***************************LDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKV*************EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR*********************************************************************************************************************************************
Disordered Region (DISOPRED)
*****************************************************AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR*********KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHI************************************************************************************************************************V*G**
Disordered Region (DISEMBL)
*********KVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTC****************************SSIIQAPGDNTLRRNFQQIQKL**********************************ENFPCVPTHDSDDDDDLGEGEDNLPVTGHRVAVVEGQV
Disordered Region (DISPRO)
**************************************************EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK*******************************GDNTLRRNFQQIQ**************************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSSSSTSTATPTPRIQTPTHPTTATPTSTENFPCVPTHDSDDDDDLGEGEDNLPVTGHRVAVVEGQV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	463	2.2.26 [Sep-21-2011]
Q9UKE5	1360	TRAF2 and NCK-interacting	yes	N/A	0.749	0.255	0.785	1e-161
P83510	1323	Traf2 and NCK-interacting	yes	N/A	0.749	0.262	0.785	1e-161
Q9JM52	1308	Misshapen-like kinase 1 O	no	N/A	0.749	0.265	0.788	1e-155
F1LP90	1336	Misshapen-like kinase 1 O	no	N/A	0.749	0.259	0.788	1e-155
Q8N4C8	1332	Misshapen-like kinase 1 O	no	N/A	0.749	0.260	0.788	1e-155
Q23356	1096	Serine/threonine-protein	yes	N/A	0.727	0.307	0.740	1e-153
O95819	1239	Mitogen-activated protein	no	N/A	0.749	0.280	0.786	1e-148
P97820	1233	Mitogen-activated protein	no	N/A	0.747	0.280	0.774	1e-140
Q7Z2Y5	1582	Nik-related protein kinas	no	N/A	0.639	0.187	0.554	1e-104
Q9R0G8	1455	Nik-related protein kinas	no	N/A	0.671	0.213	0.529	1e-103

>sp|Q9UKE5|TNIK_HUMAN TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK PE=1 SV=1

 Score =  568 bits (1463), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 274/349 (78%), Positives = 308/349 (88%), Gaps = 2/349 (0%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVMDVT DEEEEIK EIN+LKKYS+H
Sbjct: 20  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 79

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct: 80  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 139

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 140 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct: 200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD- 350
           KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID  KK++ E+D+ 
Sbjct: 260 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDET 319

Query: 351 YRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSS 399
                   EEEE    GEPSSI+  PG++TLRR+F ++Q L N  RS +
Sbjct: 320 EYEYSGSEEEEEENDSGEPSSILNLPGESTLRRDFLRLQ-LANKERSEA 367

Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading. Phosphorylates SMAD1 on Thr-322.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus GN=Tnik PE=1 SV=2

 Score =  567 bits (1462), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 274/349 (78%), Positives = 308/349 (88%), Gaps = 2/349 (0%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVMDVT DEEEEIK EIN+LKKYS+H
Sbjct: 20  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 79

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct: 80  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 139

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 140 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct: 200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD- 350
           KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID  KK++ E+D+ 
Sbjct: 260 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDET 319

Query: 351 YRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSS 399
                   EEEE    GEPSSI+  PG++TLRR+F ++Q L N  RS +
Sbjct: 320 EYEYSGSEEEEEENDSGEPSSILNLPGESTLRRDFLRLQ-LANKERSEA 367

Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9JM52|MINK1_MOUSE Misshapen-like kinase 1 OS=Mus musculus GN=Mink1 PE=1 SV=3

 Score =  550 bits (1416), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 276/350 (78%), Positives = 310/350 (88%), Gaps = 3/350 (0%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVMDVTEDEEEEIK EIN+LKKYS+H
Sbjct: 20  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKQEINMLKKYSHH 79

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKKSPPG DDQLWLVME+CGAGSVTDLVK+TKG +LKE+ IA+ICREILR
Sbjct: 80  RNIATYYGAFIKKSPPGNDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDCIAYICREILR 139

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH +KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 140 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD RSD+WSLGITA+EMAE  PPLCD+HPMRALFLIPRN PPRLKSKKW 
Sbjct: 200 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWS 259

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD- 350
           KKF  FI+T L+K Y  RP T+QLLK PFIRDQPTERQ RIQLKDHID  +K++ E+++ 
Sbjct: 260 KKFTDFIDTCLIKTYLSRPPTEQLLKFPFIRDQPTERQVRIQLKDHIDRSRKKRGEKEET 319

Query: 351 -YRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSS 399
            Y YSGSE E++  G  GEPSSI+  PG++TLRR F ++Q+ EN + S +
Sbjct: 320 EYEYSGSEEEDDSHGEEGEPSSIMNVPGESTLRREFLRLQQ-ENKSNSEA 368

Serine/threonine kinase which acts as a negative regulator of Ras-related Rap2-mediated signal transduction to control neuronal structure and AMPA receptor trafficking. Required for normal synaptic density, dendrite complexity, as well as surface AMPA receptor expression in hippocampal neurons. Can activate the JNK and MAPK14/p38 pathways and mediates stimulation of the stress-activated protein kinase MAPK14/p38 MAPK downstream of the Raf/ERK pathway. Phosphorylates: TANC1 upon stimulation by RAP2A, MBP and SMAD1. Has an essential function in negative selection of thymocytes, perhaps by coupling NCK1 to activation of JNK1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|F1LP90|MINK1_RAT Misshapen-like kinase 1 OS=Rattus norvegicus GN=Mink1 PE=1 SV=2

 Score =  549 bits (1415), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 276/350 (78%), Positives = 310/350 (88%), Gaps = 3/350 (0%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVMDVTEDEEEEIK EIN+LKKYS+H
Sbjct: 20  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKQEINMLKKYSHH 79

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKKSPPG DDQLWLVME+CGAGSVTDLVK+TKG +LKE+ IA+ICREILR
Sbjct: 80  RNIATYYGAFIKKSPPGNDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDCIAYICREILR 139

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH +KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 140 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD RSD+WSLGITA+EMAE  PPLCD+HPMRALFLIPRN PPRLKSKKW 
Sbjct: 200 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWS 259

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD- 350
           KKF  FI+T L+K Y  RP T+QLLK PFIRDQPTERQ RIQLKDHID  +K++ E+++ 
Sbjct: 260 KKFTDFIDTCLIKTYLSRPPTEQLLKFPFIRDQPTERQVRIQLKDHIDRSRKKRGEKEET 319

Query: 351 -YRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSS 399
            Y YSGSE E++  G  GEPSSI+  PG++TLRR F ++Q+ EN + S +
Sbjct: 320 EYEYSGSEEEDDSHGEEGEPSSIMNVPGESTLRREFLRLQQ-ENKSNSEA 368

Serine/threonine kinase which acts as a negative regulator ofRas-related Rap2-mediated signal transduction to control neuronal structure and AMPA receptor trafficking. Required for normal synaptic density, dendrite complexity, as well as surface AMPA receptor expression in hippocampal neurons. Can activate the JNK and MAPK14/p38 pathways and mediates stimulation of the stress-activated protein kinase MAPK14/p38 MAPK downstream of the Raf/ERK pathway. Phosphorylates: TANC1 upon stimulation by RAP2A, MBP and SMAD1. Has an essential function in negative selection of thymocytes, perhaps by coupling NCK1 to activation of JNK1.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8N4C8|MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2

 Score =  548 bits (1413), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 276/350 (78%), Positives = 310/350 (88%), Gaps = 3/350 (0%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVMDVTEDEEEEIK EIN+LKKYS+H
Sbjct: 20  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKQEINMLKKYSHH 79

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKKSPPG DDQLWLVME+CGAGSVTDLVK+TKG +LKE+ IA+ICREILR
Sbjct: 80  RNIATYYGAFIKKSPPGNDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDCIAYICREILR 139

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH +KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 140 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD RSD+WSLGITA+EMAE  PPLCD+HPMRALFLIPRN PPRLKSKKW 
Sbjct: 200 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWS 259

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD- 350
           KKF  FI+T L+K Y  RP T+QLLK PFIRDQPTERQ RIQLKDHID  +K++ E+++ 
Sbjct: 260 KKFIDFIDTCLIKTYLSRPPTEQLLKFPFIRDQPTERQVRIQLKDHIDRSRKKRGEKEET 319

Query: 351 -YRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSS 399
            Y YSGSE E++  G  GEPSSI+  PG++TLRR F ++Q+ EN + S +
Sbjct: 320 EYEYSGSEEEDDSHGEEGEPSSIMNVPGESTLRREFLRLQQ-ENKSNSEA 368

Isoform 4 can activate the JNK pathway. Involved in the regulation of actin cytoskeleton reorganization, cell-matrix adhesion, cell-cell adhesion and cell migration.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans GN=mig-15 PE=2 SV=3

 Score =  543 bits (1398), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 260/351 (74%), Positives = 303/351 (86%), Gaps = 14/351 (3%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFELIEVVGNGTYGQVYKGRH KT QLAAIK+M++ EDEE+EIKLEIN+LKK+S+H
Sbjct: 16  DPAGIFELIEVVGNGTYGQVYKGRHVKTAQLAAIKIMNINEDEEDEIKLEINMLKKHSHH 75

Query: 112 RNIATYYGAFIKKSPP--GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           RN+ATYYGAFIKK P   GK DQLWLVME+CG+GS+TDLVK+TKG SLKEEWIA+ICREI
Sbjct: 76  RNVATYYGAFIKKLPSSTGKHDQLWLVMEFCGSGSITDLVKNTKGGSLKEEWIAYICREI 135

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           LRGL +LH++KVIHRDIKGQNVLLTD+AEVKLVDFGVSAQLD+T+GRRNTFIGTPYWMAP
Sbjct: 136 LRGLYHLHQSKVIHRDIKGQNVLLTDSAEVKLVDFGVSAQLDKTVGRRNTFIGTPYWMAP 195

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SK 288
           EVIACDE+P+ATYD+RSDLWSLGITALEMAE  PPLCD+HPMRALFLIPRN PP+LK +K
Sbjct: 196 EVIACDESPEATYDSRSDLWSLGITALEMAEGHPPLCDMHPMRALFLIPRNPPPKLKRNK 255

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKER 348
           KW KKF++FIETVLVKDYHQRPYT  LL+HPFI++QP E+  R  +K+HID  ++ KK+ 
Sbjct: 256 KWTKKFETFIETVLVKDYHQRPYTGALLRHPFIKEQPHEQTIRHSIKEHIDRNRRVKKDD 315

Query: 349 DDYRYSGSENEEEETGVGG---------EPSSIIQAPGDNTLRRNFQQIQK 390
            DY YSGSE++E      G         E SS+I  P DNTLR+ FQ++Q+
Sbjct: 316 ADYEYSGSEDDEPSPNNRGPSMGIRDDSESSSMI--PMDNTLRKGFQKLQE 364

Involved in cell migration and signal transduction. Important in several developmental processes including epidermal development, Q neuroblast migrations and muscle arm targeting. Required with ina-1/pat-3 to stabilize the commissural axons growth cone along a precise direction and are required for the cell to respond appropriately when signaling in the growth cone must change.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O95819|M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens GN=MAP4K4 PE=1 SV=2

 Score =  525 bits (1352), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 276/351 (78%), Positives = 306/351 (87%), Gaps = 4/351 (1%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVMDVTEDEEEEIKLEIN+LKKYS+H
Sbjct: 20  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH 79

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKKSPPG DDQLWLVME+CGAGS+TDLVK+TKG +LKE+WIA+I REILR
Sbjct: 80  RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILR 139

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH + VIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 140 GLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD RSDLWS GITA+EMAE  PPLCD+HPMRALFLIPRN PPRLKSKKW 
Sbjct: 200 IACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWS 259

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD- 350
           KKF SFIE  LVK+Y QRP T+QLLKHPFIRDQP ERQ RIQLKDHID  +K++ E+D+ 
Sbjct: 260 KKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDET 319

Query: 351 --YRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSS 399
                   E EEE     GEPSSI+  PG++TLRR+F ++Q+ EN  RS +
Sbjct: 320 EYEYSGSEEEEEEVPEQEGEPSSIVNVPGESTLRRDFLRLQQ-ENKERSEA 369

Serine/threonine kinase that may play a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway. Phosphorylates SMAD1 on Thr-322.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P97820|M4K4_MOUSE Mitogen-activated protein kinase kinase kinase kinase 4 OS=Mus musculus GN=Map4k4 PE=1 SV=1

 Score =  499 bits (1284), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 272/351 (77%), Positives = 302/351 (86%), Gaps = 5/351 (1%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+EVVGNGTYGQVYKGRH KT   AAIKVMDVTEDEEEEI LEIN+LKKYS+H
Sbjct: 20  DPAGIFELVEVVGNGTYGQVYKGRHVKT-VTAAIKVMDVTEDEEEEITLEINMLKKYSHH 78

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKKSPPG DDQLWLVME+CGAGS+TDLVK+TKG +LKE+WIA+I REILR
Sbjct: 79  RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILR 138

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH + VIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 139 GLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 198

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD RSDLWS GITA+EMAE  PPLCD+HPMRALFLIPRN PPRLKSKKW 
Sbjct: 199 IACDENPDATYDYRSDLWSCGITAIEMAEGGPPLCDMHPMRALFLIPRNPPPRLKSKKWS 258

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD- 350
           KKF SFIE  LVK+Y QRP T+QLLKHPFIRDQP ERQ RIQLKDHID  +K++ E+D+ 
Sbjct: 259 KKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDET 318

Query: 351 --YRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSS 399
                   E EEE     GEPSSI+  PG++TLRR+F ++Q+ EN  RS +
Sbjct: 319 EYEYSGSEEEEEEVPEQEGEPSSIVNVPGESTLRRDFLRLQQ-ENKERSEA 368

Serine/threonine kinase that may play a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway. Phosphorylates SMAD1 on Thr-322.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7Z2Y5|NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=1 SV=2

 Score =  380 bits (976), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 178/321 (55%), Positives = 229/321 (71%), Gaps = 25/321 (7%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE------------------- 92
           DP GIF L + +G GTYG++Y G H KTG   A+KVM+  +                   
Sbjct: 20  DPTGIFSLDKTIGLGTYGRIYLGLHEKTGAFTAVKVMNARKTPLPEIGRRVRVNKYQKSV 79

Query: 93  -----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD 147
                DEEE+++ E+N+L+KYS H+NI ++YGAF K SPPG+  QLW+VME C AGSVTD
Sbjct: 80  GWRYSDEEEDLRTELNLLRKYSFHKNIVSFYGAFFKLSPPGQRHQLWMVMELCAAGSVTD 139

Query: 148 LVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS 207
           +V+ T  QSLKE+WIA+ICREIL+GL +LH ++VIHRDIKGQNVLLT NAEVKLVDFGVS
Sbjct: 140 VVRMTSNQSLKEDWIAYICREILQGLAHLHAHRVIHRDIKGQNVLLTHNAEVKLVDFGVS 199

Query: 208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           AQ+ RT GRRN+FIGTPYWMAPEVI CDE+P  +YD RSD+WS+GITA+EMAE  PPLC+
Sbjct: 200 AQVSRTNGRRNSFIGTPYWMAPEVIDCDEDPRRSYDYRSDVWSVGITAIEMAEGAPPLCN 259

Query: 268 LHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
           L P+ ALF+I R + P +KS  W +KF +F+E   +K++  RP +  +L+HPF+RD   E
Sbjct: 260 LQPLEALFVILRESAPTVKSSGWSRKFHNFMEKCTIKNFLFRPTSANMLQHPFVRDIKNE 319

Query: 328 RQARIQLKDHI-DTCKKRKKE 347
           R     L  H+    KKR+K+
Sbjct: 320 RHVVESLTRHLTGIIKKRQKK 340

May phosphorylate cofilin-1 and induce actin polymerization through this process, during the late stages of embryogenesis. Involved in the TNF-alpha-induced signaling pathway.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9R0G8|NRK_MOUSE Nik-related protein kinase OS=Mus musculus GN=Nrk PE=1 SV=2

 Score =  377 bits (968), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 178/336 (52%), Positives = 235/336 (69%), Gaps = 25/336 (7%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE------------------- 92
           DP GIF L + +G GTYG+++ G H KTG L A+KVM   +                   
Sbjct: 20  DPTGIFSLDKAIGLGTYGRIFLGIHEKTGSLVAVKVMSARKTPLPEIGRRVRVNKYQKSV 79

Query: 93  -----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD 147
                DEEE+++ E+N+L+KYS H+NI T+YGAF K +PPG   QLW+VME C AGSVTD
Sbjct: 80  GWRYSDEEEDLRTELNLLRKYSFHKNIVTFYGAFFKLNPPGHQHQLWMVMELCAAGSVTD 139

Query: 148 LVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS 207
           +V+ T+ QSLKE+WIA+ICREIL+GL +LH ++VIHRDIKGQNVLLT +AEVK+VDFGVS
Sbjct: 140 VVRMTRNQSLKEDWIAYICREILQGLAHLHAHQVIHRDIKGQNVLLTHDAEVKIVDFGVS 199

Query: 208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           AQ+ RT GRRN+FIGTPYWMAPEVI CDE+P  +YD RSD+WS+GITA+EMAE  PPLC 
Sbjct: 200 AQVSRTNGRRNSFIGTPYWMAPEVIHCDEDPRCSYDYRSDVWSVGITAIEMAEGAPPLCK 259

Query: 268 LHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
           L P+ AL +I R A P++KS  W +KFQ+F+E  ++K++  RP +  +L HPF+ D   E
Sbjct: 260 LQPLEALCVILREAAPKVKSSGWSRKFQNFMENCMIKNFLFRPTSGNMLLHPFVHDIKNE 319

Query: 328 RQARIQLKDHI-DTCKKRKKERDDYRYSGSENEEEE 362
           R+    L  H+    +KR+K+     + G E  +E+
Sbjct: 320 RRVVESLTKHLTGIIQKREKKGIPVAFEGEEAAKEQ 355

May phosphorylate cofilin-1 and induce actin polymerization through this process, during the late stages of embryogenesis. Involved in the TNF-alpha-induced signaling pathway.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	463
345490152	971	PREDICTED: misshapen-like kinase 1 isofo	0.818	0.390	0.848	0.0
383851117	1312	PREDICTED: mitogen-activated protein kin	0.734	0.259	0.921	0.0
189237679	1245	PREDICTED: similar to AGAP006340-PC [Tri	0.734	0.273	0.921	0.0
328786728	1344	PREDICTED: serine/threonine-protein kina	0.734	0.252	0.918	0.0
340730093	1300	PREDICTED: mitogen-activated protein kin	0.734	0.261	0.918	0.0
195125603	1551	GI12471 [Drosophila mojavensis] gi|19391	0.734	0.219	0.912	0.0
195016041	1550	GH16388 [Drosophila grimshawi] gi|193897	0.734	0.219	0.909	0.0
340730095	1027	PREDICTED: mitogen-activated protein kin	0.734	0.331	0.918	0.0
340730091	1034	PREDICTED: mitogen-activated protein kin	0.734	0.328	0.918	0.0
380017664	983	PREDICTED: serine/threonine-protein kina	0.734	0.345	0.917	0.0

>gi|345490152|ref|XP_003426313.1| PREDICTED: misshapen-like kinase 1 isoform 2 [Nasonia vitripennis] gi|345490154|ref|XP_001599608.2| PREDICTED: misshapen-like kinase 1 isoform 1 [Nasonia vitripennis]

 Score =  654 bits (1688), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/384 (84%), Positives = 341/384 (88%), Gaps = 5/384 (1%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           +DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK+YSN
Sbjct: 22  KDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKRYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+I REIL
Sbjct: 82  HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYISREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENP+ATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPEATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FIETVLVKDYHQRPYT+QLLKHPFIRDQPTERQ RIQLKDHID CKKRK  KER
Sbjct: 262 AKKFHGFIETVLVKDYHQRPYTEQLLKHPFIRDQPTERQVRIQLKDHIDRCKKRKQEKER 321

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLENCARSSSSSTSTATPT 408
           DDYRYSGSENE++E  V GEPSSIIQAPG +TLRRNFQQIQ+    ++  S   + A   
Sbjct: 322 DDYRYSGSENEDDEPAVAGEPSSIIQAPGGDTLRRNFQQIQEGRTLSQEVSPHNAAAKDN 381

Query: 409 PRIQTPTHPTTATPTSTENFPCVP 432
            +I +    + A      N P VP
Sbjct: 382 KQIPSRAKESEA---GQHNRPSVP 402

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383851117|ref|XP_003701086.1| PREDICTED: mitogen-activated protein kinase kinase kinase kinase 4 [Megachile rotundata]

 Score =  653 bits (1684), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/342 (92%), Positives = 326/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           ++PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK+YSN
Sbjct: 22  KEPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKRYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAF+KKS PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+I REIL
Sbjct: 82  HRNIATYYGAFVKKSSPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYISREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FIETVLVKDYHQRPYT+QLLKHPFIRDQPTERQ RIQLKDHID CKKRK  KER
Sbjct: 262 AKKFHGFIETVLVKDYHQRPYTEQLLKHPFIRDQPTERQVRIQLKDHIDRCKKRKQEKER 321

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           DDYRYSGSENEE+E  + GEPSSI+QAPG +TLRRNFQQIQ+
Sbjct: 322 DDYRYSGSENEEDEPALAGEPSSIVQAPGGDTLRRNFQQIQE 363

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189237679|ref|XP_968527.2| PREDICTED: similar to AGAP006340-PC [Tribolium castaneum]

 Score =  653 bits (1684), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/342 (92%), Positives = 325/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           +DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV EDEEEEIKLEINVLKKYSN
Sbjct: 22  KDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVNEDEEEEIKLEINVLKKYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+ICREIL
Sbjct: 82  HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYICREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENP+ATYDNRSDLWSLGITALEMAESQPPLC+LHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPEATYDNRSDLWSLGITALEMAESQPPLCELHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FIETVLVKDYH RPYT+QLLKH FIRDQPTERQ RIQLKDHID CKKRK  KER
Sbjct: 262 NKKFHGFIETVLVKDYHDRPYTEQLLKHAFIRDQPTERQVRIQLKDHIDRCKKRKQEKER 321

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           +DYRYSGSENEEEE  + GEPSSI+QAPG +TLRRNFQQIQ+
Sbjct: 322 EDYRYSGSENEEEEPQIAGEPSSIVQAPGGDTLRRNFQQIQE 363

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328786728|ref|XP_396948.4| PREDICTED: serine/threonine-protein kinase mig-15 [Apis mellifera]

 Score =  651 bits (1680), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/342 (91%), Positives = 325/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           ++PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK+YSN
Sbjct: 22  KEPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKRYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAF+KKS PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+I REIL
Sbjct: 82  HRNIATYYGAFVKKSSPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYISREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FIETVLVKDYHQRPYT+QLLKHPFIRDQPTERQ RIQLKDHID CKKRK  KER
Sbjct: 262 AKKFHGFIETVLVKDYHQRPYTEQLLKHPFIRDQPTERQVRIQLKDHIDRCKKRKQEKER 321

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           DDYRYSGSENEE+E  + GE SSI+QAPG +TLRRNFQQIQ+
Sbjct: 322 DDYRYSGSENEEDEPALAGEASSIVQAPGGDTLRRNFQQIQE 363

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340730093|ref|XP_003403322.1| PREDICTED: mitogen-activated protein kinase kinase kinase kinase 4-like isoform 2 [Bombus terrestris]

 Score =  650 bits (1677), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/342 (91%), Positives = 325/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           ++PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK+YSN
Sbjct: 22  KEPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKRYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAF+KKS PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+I REIL
Sbjct: 82  HRNIATYYGAFVKKSSPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYISREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FIETVLVKDYHQRPYT+QLLKHPFIRDQPTERQ RIQLKDHID CKKRK  KER
Sbjct: 262 AKKFHGFIETVLVKDYHQRPYTEQLLKHPFIRDQPTERQVRIQLKDHIDRCKKRKQEKER 321

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           DDYRYSGSENEE+E  + GE SSI+QAPG +TLRRNFQQIQ+
Sbjct: 322 DDYRYSGSENEEDEPALAGEASSIVQAPGGDTLRRNFQQIQE 363

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195125603|ref|XP_002007267.1| GI12471 [Drosophila mojavensis] gi|193918876|gb|EDW17743.1| GI12471 [Drosophila mojavensis]

 Score =  650 bits (1677), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/342 (91%), Positives = 328/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           +DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN
Sbjct: 25  KDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 84

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+ICREIL
Sbjct: 85  HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYICREIL 144

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 145 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 204

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENP+ATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN+PPRLKSKKW
Sbjct: 205 VIACDENPEATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNSPPRLKSKKW 264

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKFQ FI+TVLVKDYHQRPYT+ LLKH FI+DQPT+RQ RIQLKDHID CKKRK  KER
Sbjct: 265 SKKFQGFIDTVLVKDYHQRPYTENLLKHAFIKDQPTDRQVRIQLKDHIDRCKKRKQEKER 324

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           +DYRYSGS+N+++E  + GEPSSIIQAPG +TLRRNFQQIQ+
Sbjct: 325 EDYRYSGSDNDDDEPQLAGEPSSIIQAPGGDTLRRNFQQIQE 366

Source: Drosophila mojavensis

Species: Drosophila mojavensis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195016041|ref|XP_001984328.1| GH16388 [Drosophila grimshawi] gi|193897810|gb|EDV96676.1| GH16388 [Drosophila grimshawi]

 Score =  649 bits (1674), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/342 (90%), Positives = 327/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           +DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN
Sbjct: 29  KDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 88

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+ICREIL
Sbjct: 89  HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYICREIL 148

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 149 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 208

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENP+ATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN+PPRLKSKKW
Sbjct: 209 VIACDENPEATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNSPPRLKSKKW 268

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FI+TVLVKDYHQRPYT+ LLKH FI+DQPT+RQ RIQLKDHID CKKRK  KER
Sbjct: 269 SKKFHGFIDTVLVKDYHQRPYTENLLKHAFIKDQPTDRQVRIQLKDHIDRCKKRKQEKER 328

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           +DYRYSGS+N+++E  + GEPSSIIQAPG +TLRRNFQQIQ+
Sbjct: 329 EDYRYSGSDNDDDEPQLAGEPSSIIQAPGGDTLRRNFQQIQE 370

Source: Drosophila grimshawi

Species: Drosophila grimshawi

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340730095|ref|XP_003403323.1| PREDICTED: mitogen-activated protein kinase kinase kinase kinase 4-like isoform 3 [Bombus terrestris]

 Score =  647 bits (1668), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/342 (91%), Positives = 325/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           ++PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK+YSN
Sbjct: 22  KEPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKRYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAF+KKS PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+I REIL
Sbjct: 82  HRNIATYYGAFVKKSSPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYISREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FIETVLVKDYHQRPYT+QLLKHPFIRDQPTERQ RIQLKDHID CKKRK  KER
Sbjct: 262 AKKFHGFIETVLVKDYHQRPYTEQLLKHPFIRDQPTERQVRIQLKDHIDRCKKRKQEKER 321

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           DDYRYSGSENEE+E  + GE SSI+QAPG +TLRRNFQQIQ+
Sbjct: 322 DDYRYSGSENEEDEPALAGEASSIVQAPGGDTLRRNFQQIQE 363

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340730091|ref|XP_003403321.1| PREDICTED: mitogen-activated protein kinase kinase kinase kinase 4-like isoform 1 [Bombus terrestris]

 Score =  646 bits (1667), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/342 (91%), Positives = 325/342 (95%), Gaps = 2/342 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           ++PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK+YSN
Sbjct: 22  KEPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKRYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAF+KKS PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+I REIL
Sbjct: 82  HRNIATYYGAFVKKSSPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYISREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK--KER 348
            KKF  FIETVLVKDYHQRPYT+QLLKHPFIRDQPTERQ RIQLKDHID CKKRK  KER
Sbjct: 262 AKKFHGFIETVLVKDYHQRPYTEQLLKHPFIRDQPTERQVRIQLKDHIDRCKKRKQEKER 321

Query: 349 DDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           DDYRYSGSENEE+E  + GE SSI+QAPG +TLRRNFQQIQ+
Sbjct: 322 DDYRYSGSENEEDEPALAGEASSIVQAPGGDTLRRNFQQIQE 363

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380017664|ref|XP_003692767.1| PREDICTED: serine/threonine-protein kinase mig-15-like [Apis florea]

 Score =  645 bits (1665), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/341 (91%), Positives = 325/341 (95%), Gaps = 1/341 (0%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           ++PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK+YSN
Sbjct: 22  KEPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKRYSN 81

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRNIATYYGAF+KKS PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+I REIL
Sbjct: 82  HRNIATYYGAFVKKSSPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYISREIL 141

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct: 142 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 201

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN PPRLKSKKW
Sbjct: 202 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNPPPRLKSKKW 261

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKE-RD 349
            KKF  FIETVLVKDYHQRPYT+QLLKHPFIRDQPTERQ RIQLKDHID CKKRK+E RD
Sbjct: 262 AKKFHGFIETVLVKDYHQRPYTEQLLKHPFIRDQPTERQVRIQLKDHIDRCKKRKQEKRD 321

Query: 350 DYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           DYRYSGSENEE+E  + GE SSI+QAPG +TLRRNFQQIQ+
Sbjct: 322 DYRYSGSENEEDEPALAGEASSIVQAPGGDTLRRNFQQIQE 362

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	463
FB|FBgn0010909	1504	msn "misshapen" [Drosophila me	0.734	0.226	0.795	1.4e-144
UNIPROTKB|Q9UKE5	1360	TNIK "TRAF2 and NCK-interactin	0.730	0.248	0.716	1.3e-130
MGI|MGI:1916264	1323	Tnik "TRAF2 and NCK interactin	0.730	0.255	0.716	1.3e-130
RGD|1561817	1354	Tnik "TRAF2 and NCK interactin	0.730	0.249	0.716	1.7e-130
UNIPROTKB|F5H5M9	1312	TNIK "TRAF2 and NCK-interactin	0.730	0.257	0.713	2.2e-130
UNIPROTKB|F5H865	1338	TNIK "TRAF2 and NCK-interactin	0.730	0.252	0.713	2.2e-130
ZFIN|ZDB-GENE-051113-320	1410	tnikb "TRAF2 and NCK interacti	0.730	0.239	0.713	1.2e-129
UNIPROTKB|K3W4V5	1321	Mink1 "Misshapen-like kinase 1	0.738	0.258	0.707	1.7e-128
ZFIN|ZDB-GENE-060526-45	1287	mink1 "misshapen-like kinase 1	0.738	0.265	0.703	1.7e-128
UNIPROTKB|E7EN19	1272	MAP4K4 "Mitogen-activated prot	0.736	0.268	0.710	2.2e-128

FB|FBgn0010909 msn "misshapen" [Drosophila melanogaster (taxid:7227)]

 Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
 Identities = 272/342 (79%), Positives = 282/342 (82%)

Query:    51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN 110
             +DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM                  KYSN
Sbjct:    26 KDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 85

Query:   111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
             HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA+ICREIL
Sbjct:    86 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAYICREIL 145

Query:   171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
             RGL YLH NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE
Sbjct:   146 RGLSYLHSNKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 205

Query:   231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
             VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN+PPRLKSKKW
Sbjct:   206 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNSPPRLKSKKW 265

Query:   291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCXXXXXXXXX 350
              KKF  FI+TVLVKDYHQRPYT+ LLKH FI+DQPT+RQ RIQLKDHID C         
Sbjct:   266 SKKFHGFIDTVLVKDYHQRPYTENLLKHGFIKDQPTDRQVRIQLKDHIDRCKKRKQEKER 325

Query:   351 XXXXXXXXXXXXXX--XXXXXXXIIQAPGDNTLRRNFQQIQK 390
                                    I+QAPG +TLRRNFQQIQ+
Sbjct:   326 EDYRYSGSDNDDDEPQLAGEHSSIVQAPGGDTLRRNFQQIQE 367

GO:0048477 "oogenesis" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=ISS;NAS

GO:0008360 "regulation of cell shape" evidence=IMP

GO:0008594 "photoreceptor cell morphogenesis" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS

GO:0007391 "dorsal closure" evidence=IGI;IMP;TAS

GO:0008349 "MAP kinase kinase kinase kinase activity" evidence=ISS;NAS

GO:0000185 "activation of MAPKKK activity" evidence=NAS

GO:0007254 "JNK cascade" evidence=IGI;ISS;NAS;IMP

GO:0046580 "negative regulation of Ras protein signal transduction" evidence=IGI

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0042656 "JUN kinase kinase kinase kinase activity" evidence=TAS

GO:0001736 "establishment of planar polarity" evidence=NAS

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007097 "nuclear migration" evidence=IMP

GO:0001748 "optic lobe placode development" evidence=IMP

GO:0046529 "imaginal disc fusion, thorax closure" evidence=IMP

GO:0016476 "regulation of embryonic cell shape" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0009611 "response to wounding" evidence=IEP

GO:0007411 "axon guidance" evidence=IMP

GO:0007476 "imaginal disc-derived wing morphogenesis" evidence=IMP

UNIPROTKB|Q9UKE5 TNIK "TRAF2 and NCK-interacting protein kinase" [Homo sapiens (taxid:9606)]

 Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
 Identities = 243/339 (71%), Positives = 271/339 (79%)

Query:    52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
             DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct:    20 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 79

Query:   112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct:    80 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 139

Query:   172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
             GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct:   140 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query:   232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
             IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct:   200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query:   292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID-TCXXXXXXXXX 350
             KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID T          
Sbjct:   260 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDET 319

Query:   351 XXXXXXXXXXXXXXXXXXXXXIIQAPGDNTLRRNFQQIQ 389
                                  I+  PG++TLRR+F ++Q
Sbjct:   320 EYEYSGSEEEEEENDSGEPSSILNLPGESTLRRDFLRLQ 358

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0055037 "recycling endosome" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0006950 "response to stress" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=IDA

GO:0005524 "ATP binding" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0031532 "actin cytoskeleton reorganization" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005856 "cytoskeleton" evidence=IDA

GO:0007256 "activation of JNKK activity" evidence=IMP;IDA

GO:0048814 "regulation of dendrite morphogenesis" evidence=IDA

GO:0007010 "cytoskeleton organization" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

MGI|MGI:1916264 Tnik "TRAF2 and NCK interacting kinase" [Mus musculus (taxid:10090)]

 Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
 Identities = 243/339 (71%), Positives = 271/339 (79%)

Query:    52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
             DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct:    20 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 79

Query:   112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct:    80 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 139

Query:   172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
             GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct:   140 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query:   232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
             IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct:   200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query:   292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID-TCXXXXXXXXX 350
             KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID T          
Sbjct:   260 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDET 319

Query:   351 XXXXXXXXXXXXXXXXXXXXXIIQAPGDNTLRRNFQQIQ 389
                                  I+  PG++TLRR+F ++Q
Sbjct:   320 EYEYSGSEEEEEENDSGEPSSILNLPGESTLRRDFLRLQ 358

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0005768 "endosome" evidence=IEA

GO:0005856 "cytoskeleton" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006950 "response to stress" evidence=ISO

GO:0007010 "cytoskeleton organization" evidence=ISO

GO:0007243 "intracellular protein kinase cascade" evidence=ISO

GO:0007256 "activation of JNKK activity" evidence=ISO

GO:0007399 "nervous system development" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048814 "regulation of dendrite morphogenesis" evidence=ISO

GO:0055037 "recycling endosome" evidence=ISO

RGD|1561817 Tnik "TRAF2 and NCK interacting kinase" [Rattus norvegicus (taxid:10116)]

 Score = 1280 (455.6 bits), Expect = 1.7e-130, P = 1.7e-130
 Identities = 243/339 (71%), Positives = 271/339 (79%)

Query:    52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
             DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct:    20 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 79

Query:   112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct:    80 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 139

Query:   172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
             GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct:   140 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query:   232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
             IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct:   200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query:   292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID-TCXXXXXXXXX 350
             KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID T          
Sbjct:   260 KKFQSFIESCLVKNHGQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDET 319

Query:   351 XXXXXXXXXXXXXXXXXXXXXIIQAPGDNTLRRNFQQIQ 389
                                  I+  PG++TLRR+F ++Q
Sbjct:   320 EYEYSGSEEEEEENDSGEPSSILNLPGESTLRRDFLRLQ 358

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA;ISO

GO:0005737 "cytoplasm" evidence=IEA;ISO

GO:0005856 "cytoskeleton" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006950 "response to stress" evidence=ISO

GO:0007010 "cytoskeleton organization" evidence=ISO

GO:0007243 "intracellular protein kinase cascade" evidence=ISO

GO:0007256 "activation of JNKK activity" evidence=IEA;ISO

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA;ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0048814 "regulation of dendrite morphogenesis" evidence=IEA;ISO

GO:0005730 "nucleolus" evidence=ISO

UNIPROTKB|F5H5M9 TNIK "TRAF2 and NCK-interacting protein kinase" [Homo sapiens (taxid:9606)]

 Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
 Identities = 242/339 (71%), Positives = 271/339 (79%)

Query:    52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
             DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct:    20 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 79

Query:   112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct:    80 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 139

Query:   172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
             GL +LH++KVIHRDIKGQNVLLT+NAEVK+VDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct:   140 GLSHLHQHKVIHRDIKGQNVLLTENAEVKIVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query:   232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
             IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct:   200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query:   292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID-TCXXXXXXXXX 350
             KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID T          
Sbjct:   260 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDET 319

Query:   351 XXXXXXXXXXXXXXXXXXXXXIIQAPGDNTLRRNFQQIQ 389
                                  I+  PG++TLRR+F ++Q
Sbjct:   320 EYEYSGSEEEEEENDSGEPSSILNLPGESTLRRDFLRLQ 358

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

UNIPROTKB|F5H865 TNIK "TRAF2 and NCK-interacting protein kinase" [Homo sapiens (taxid:9606)]

 Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
 Identities = 242/339 (71%), Positives = 271/339 (79%)

Query:    52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
             DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct:    20 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 79

Query:   112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct:    80 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 139

Query:   172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
             GL +LH++KVIHRDIKGQNVLLT+NAEVK+VDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct:   140 GLSHLHQHKVIHRDIKGQNVLLTENAEVKIVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query:   232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
             IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct:   200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query:   292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID-TCXXXXXXXXX 350
             KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID T          
Sbjct:   260 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDET 319

Query:   351 XXXXXXXXXXXXXXXXXXXXXIIQAPGDNTLRRNFQQIQ 389
                                  I+  PG++TLRR+F ++Q
Sbjct:   320 EYEYSGSEEEEEENDSGEPSSILNLPGESTLRRDFLRLQ 358

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

ZFIN|ZDB-GENE-051113-320 tnikb "TRAF2 and NCK interacting kinase b" [Danio rerio (taxid:7955)]

 Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
 Identities = 242/339 (71%), Positives = 270/339 (79%)

Query:    52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
             DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct:    20 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKAEINMLKKYSHH 79

Query:   112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG SLKEEW A+ICREILR
Sbjct:    80 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNSLKEEWTAYICREILR 139

Query:   172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
             GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct:   140 GLTHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query:   232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
             IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct:   200 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 259

Query:   292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID-TCXXXXXXXXX 350
             KKFQSFIE+ LVK+++QRP T+QL+KHPFI+D P ERQ RIQLKDHID T          
Sbjct:   260 KKFQSFIESCLVKNHNQRPSTEQLIKHPFIKDLPNERQVRIQLKDHIDRTKKKRGERDET 319

Query:   351 XXXXXXXXXXXXXXXXXXXXXIIQAPGDNTLRRNFQQIQ 389
                                  II  PG++TLRR+F ++Q
Sbjct:   320 EYEYSGSEEEEEERDIGEPSSIINIPGESTLRRDFLRLQ 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

UNIPROTKB|K3W4V5 Mink1 "Misshapen-like kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
 Identities = 244/345 (70%), Positives = 268/345 (77%)

Query:    51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN 110
             +DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+
Sbjct:     4 QDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKQEINMLKKYSH 63

Query:   111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
             HRNIATYYGAFIKKSPPG DDQLWLVME+CGAGSVTDLVK+TKG +LKE+ IA+ICREIL
Sbjct:    64 HRNIATYYGAFIKKSPPGNDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDCIAYICREIL 123

Query:   171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
             RGL +LH +KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPE
Sbjct:   124 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 183

Query:   231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
             VIACDENPDATYD RSD+WSLGITA+EMAE  PPLCD+HPMRALFLIPRN PPRLKSKKW
Sbjct:   184 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKW 243

Query:   291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCXXXXXXXXX 350
              KKF  FI+T L+K Y  RP T+QLLK PFIRDQPTERQ RIQLKDHID           
Sbjct:   244 SKKFTDFIDTCLIKTYLSRPPTEQLLKFPFIRDQPTERQVRIQLKDHIDRSRKKRGEKEE 303

Query:   351 XXXXXXXXXXXXXXXXXXX--XXIIQAPGDNTLRRNFQQIQKLEN 393
                                    I+  PG++TLRR F ++Q+ EN
Sbjct:   304 TEYEYSGSEEEDDSHGEEGEPSSIMNVPGESTLRREFLRLQQ-EN 347

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-060526-45 mink1 "misshapen-like kinase 1" [Danio rerio (taxid:7955)]

 Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
 Identities = 244/347 (70%), Positives = 269/347 (77%)

Query:    51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN 110
             +DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+
Sbjct:    19 QDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEEEEEEIKAEINMLKKYSH 78

Query:   111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
             HRNIATYYGAF+KKSPPG DDQLWLVME+CGAGSVTDLVK+TKG SLKE+WIA+ICREIL
Sbjct:    79 HRNIATYYGAFVKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNSLKEDWIAYICREIL 138

Query:   171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
             RGL +LH +KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPE
Sbjct:   139 RGLSHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 198

Query:   231 VIACDENPDATYDNR--SDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK 288
             VIACDENPD+TYD R  SD+WSLGITA+EMAE  PPLCD+HPMRALFLIPRN PP+LKSK
Sbjct:   199 VIACDENPDSTYDYRQQSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 258

Query:   289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCXXXXXXX 348
             KW KKF  FIE  LVK Y  RP T+QLLKH FIRDQPTERQ RIQLKDHID         
Sbjct:   259 KWSKKFIDFIEGCLVKSYPNRPSTEQLLKHSFIRDQPTERQVRIQLKDHIDRTRKKRGEK 318

Query:   349 XXXXXXXXXXXXXXXXXXXX--XXXIIQAPGDNTLRRNFQQIQKLEN 393
                                      I+  PG++TLRR+F ++Q+ EN
Sbjct:   319 EETEYEYSGSDEEDENRGDERESSSILNVPGESTLRRDFLRLQQ-EN 364

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|E7EN19 MAP4K4 "Mitogen-activated protein kinase kinase kinase kinase 4" [Homo sapiens (taxid:9606)]

 Score = 1260 (448.6 bits), Expect = 2.2e-128, P = 2.2e-128
 Identities = 245/345 (71%), Positives = 268/345 (77%)

Query:    52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
             DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct:    20 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH 79

Query:   112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             RNIATYYGAFIKKSPPG DDQLWLVME+CGAGS+TDLVK+TKG +LKE+WIA+I REILR
Sbjct:    80 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILR 139

Query:   172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
             GL +LH + VIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct:   140 GLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 199

Query:   232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
             IACDENPDATYD RSDLWS GITA+EMAE  PPLCD+HPMRALFLIPRN PPRLKSKKW 
Sbjct:   200 IACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWS 259

Query:   292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCXXXXXXXXXX 351
             KKF SFIE  LVK+Y QRP T+QLLKHPFIRDQP ERQ RIQLKDHID            
Sbjct:   260 KKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDET 319

Query:   352 XXXXXXXXXXXXXXXXXX---XXIIQAPGDNTLRRNFQQIQKLEN 393
                                    I+  PG++TLRR+F ++Q+ EN
Sbjct:   320 EYEYSGSEEEEEEVPEQEGEPSSIVNVPGESTLRRDFLRLQQ-EN 363

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9UKE5	TNIK_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7851	0.7494	0.2551	yes	N/A
Q23356	MIG15_CAEEL	2, ., 7, ., 1, 1, ., 1	0.7407	0.7278	0.3074	yes	N/A
P83510	TNIK_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7851	0.7494	0.2622	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	463
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	0.0
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	0.0
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-179
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-132
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-121
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-120
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-117
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-106
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-105
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-104
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-100
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-91
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-89
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-88
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-86
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-82
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-81
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-80
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-79
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-78
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-78
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-78
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-77
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-76
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-75
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-70
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-69
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-69
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-69
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-64
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-64
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-63
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-62
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-62
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-61
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-59
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-59
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-57
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-57
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-56
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-56
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-55
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-55
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-52
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-49
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-48
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-48
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-48
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-48
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-47
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-47
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-46
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-46
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-44
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-43
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-42
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-41
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-41
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-40
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-40
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-40
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-39
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-39
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-38
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-38
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-37
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-37
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-37
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-37
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-36
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-36
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-36
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-35
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-35
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-35
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-34
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-34
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-32
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-31
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-31
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-31
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-30
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-29
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-29
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-29
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-28
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-28
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-27
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-27
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-27
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-26
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-26
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-26
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-25
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-25
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-24
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-24
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-24
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-24
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-24
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-24
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-23
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-23
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-23
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-23
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-22
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-22
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-22
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-22
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-22
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-21
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-21
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-21
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-21
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-21
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-21
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-21
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-21
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-21
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-21
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-20
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-20
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-20
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-19
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-19
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-19
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-19
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-18
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-18
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-18
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-17
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-17
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-17
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-15
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-14
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-14
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-13
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	4e-04
pfam10131	620	pfam10131, PTPS_related, 6-pyruvoyl-tetrahydropter	8e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.004

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  554 bits (1429), Expect = 0.0
 Identities = 208/273 (76%), Positives = 235/273 (86%), Gaps = 3/273 (1%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DP GIFEL+EV+G GTYG+VYK RH KTGQL AIK+MD+ EDEEEEIK E N+L+KYSNH
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREI 169
            NIAT+YGAFIKK+PPG DDQLWLVME CG GSVTDLVK    KG+ LKEEWIA+I RE 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           LRGL YLHENKVIHRDIKGQN+LLT NAEVKLVDFGVSAQLD T+GRRNTFIGTPYWMAP
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-K 288
           EVIACDE PDA+YD RSD+WSLGITA+E+A+ +PPLCD+HPMRALF IPRN PP LKS +
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE 242

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            W KKF  FI   L+K+Y QRP+ ++LL+HPFI
Sbjct: 243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  526 bits (1357), Expect = 0.0
 Identities = 235/270 (87%), Positives = 253/270 (93%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+EVVGNGTYGQVYKGRH KTGQLAAIKVMDVTEDEEEEIKLEIN+LKKYS+H
Sbjct: 13  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH 72

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKKSPPG DDQLWLVME+CGAGSVTDLVK+TKG +LKE+WIA+ICREILR
Sbjct: 73  RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH +KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD RSD+WSLGITA+EMAE  PPLCD+HPMRALFLIPRN PP+LKSKKW 
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           KKF  FIE  LVK+Y  RP T+QLLKHPFI
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  502 bits (1293), Expect = e-179
 Identities = 232/270 (85%), Positives = 255/270 (94%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVMDVT DEEEEIK EIN+LKKYS+H
Sbjct: 3   DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 62

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct: 63  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 242

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           KKFQSFIE+ LVK++ QRP T+QL+KHPFI
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  382 bits (982), Expect = e-132
 Identities = 143/272 (52%), Positives = 189/272 (69%), Gaps = 14/272 (5%)

Query: 53  PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYSNH 111
           P   +ELI+ +G+GTYG VYK R   TG+L AIKV+ +   ++ E I+ EI++LK+   H
Sbjct: 1   PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRH 59

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  Y+G++++       D+LW+VMEYCG GS+ D+ + T+G  L E  IA++CRE L+
Sbjct: 60  PNIVAYFGSYLR------RDKLWIVMEYCGGGSLQDIYQVTRG-PLSELQIAYVCRETLK 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL YLHE   IHRDIKG N+LLT++ +VKL DFGVSAQL  TI +R +FIGTPYWMAPEV
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKSK- 288
            A        YD + D+W+LGITA+E+AE QPP+ DLHPMRALFLI ++   PP+LK K 
Sbjct: 173 AA--VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
           KW   F  FI+  L KD  +RP   +LL+HPF
Sbjct: 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  353 bits (907), Expect = e-121
 Identities = 138/267 (51%), Positives = 190/267 (71%), Gaps = 16/267 (5%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYSNHRNI 114
           +FE++E +G G +G+VYK RH +TG+  AIKV+ +   E+ E+I  EI +LKK   H NI
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNI 59

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             YYG+++KK      D+LW+VME+C  GS+ DL+KST  Q+L E  IA++C+E+L+GL+
Sbjct: 60  VKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLE 112

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           YLH N +IHRDIK  N+LLT + EVKL+DFG+SAQL  T   RNT +GTPYWMAPEVI  
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVING 171

Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKWPKK 293
                  YD ++D+WSLGITA+E+AE +PP  +L PM+ALF I  N PP L++ +KW  +
Sbjct: 172 KP-----YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE 226

Query: 294 FQSFIETVLVKDYHQRPYTDQLLKHPF 320
           F+ F++  L K+  +RP  +QLLKHPF
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  350 bits (900), Expect = e-120
 Identities = 141/270 (52%), Positives = 188/270 (69%), Gaps = 15/270 (5%)

Query: 53  PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR 112
           P  +F+++E +G G+YG VYK  H +TGQ+ AIKV+ V ED +E IK EI++LK+  +  
Sbjct: 1   PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-EISILKQ-CDSP 58

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I  YYG++ K      +  LW+VMEYCGAGSV+D++K T  ++L EE IA I  + L+G
Sbjct: 59  YIVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKG 111

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L+YLH NK IHRDIK  N+LL +  + KL DFGVS QL  T+ +RNT IGTP+WMAPEVI
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKWP 291
              E     Y+N++D+WSLGITA+EMAE +PP  D+HPMRA+F+IP   PP L   +KW 
Sbjct: 172 Q--EIG---YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS 226

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            +F  F++  LVKD  +RP   QLL+HPFI
Sbjct: 227 PEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  344 bits (885), Expect = e-117
 Identities = 137/269 (50%), Positives = 183/269 (68%), Gaps = 17/269 (6%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHRN 113
           +F L+E +G G++G+VYK    +T Q+ AIKV+D+ E E+  E+I+ EI  L +      
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSPY 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  YYG+F+K S      +LW++MEYCG GS  DL+K  K   L E +IAFI RE+L GL
Sbjct: 61  ITKYYGSFLKGS------KLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGL 111

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLHE   IHRDIK  N+LL++  +VKL DFGVS QL  T+ +RNTF+GTP+WMAPEVI 
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
                   YD ++D+WSLGITA+E+A+ +PPL DLHPMR LFLIP+N PP L+  K+ K 
Sbjct: 172 QSG-----YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKP 226

Query: 294 FQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           F+ F+   L KD  +RP   +LLKH FI+
Sbjct: 227 FKDFVSLCLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  316 bits (812), Expect = e-106
 Identities = 149/273 (54%), Positives = 189/273 (69%), Gaps = 4/273 (1%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DP+  +E+IE +G GTYG+V+K  + K G  AA+K++D   D +EEI+ E N+LK  S+H
Sbjct: 15  DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDH 74

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS--TKGQSLKEEWIAFICREI 169
            N+  +YG + KK      DQLWLV+E C  GSVTDLVK    +G+ ++E  IA+I  E 
Sbjct: 75  PNVVKFYGMYYKKDVK-NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L GL++LH NK IHRD+KG N+LLT    VKLVDFGVSAQL  T  RRNT +GTP+WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EVIAC++  D+TYD R D+WSLGITA+E+ +  PPL DLHPMRALF IPRN PP L   +
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253

Query: 290 -WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            W  +F  FI   L KDY +RP    LL+H FI
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  313 bits (804), Expect = e-105
 Identities = 118/273 (43%), Positives = 168/273 (61%), Gaps = 14/273 (5%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS 109
           + DP  +++ +E +G G  G+VYK     TG+  AIK M + +  +E I  EI ++K   
Sbjct: 14  EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD-C 72

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI  YY +++        D+LW+VMEY   GS+TD++       + E  IA++CRE+
Sbjct: 73  KHPNIVDYYDSYLV------GDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREV 125

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+GL+YLH   VIHRDIK  N+LL+ +  VKL DFG +AQL +   +RN+ +GTPYWMAP
Sbjct: 126 LQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SK 288
           EVI   +     Y  + D+WSLGI  +EMAE +PP     P+RALFLI     P LK  +
Sbjct: 186 EVIKRKD-----YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE 240

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           KW  +F+ F+   LVKD  +RP  ++LL+HPF+
Sbjct: 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  312 bits (800), Expect = e-104
 Identities = 143/274 (52%), Positives = 186/274 (67%), Gaps = 4/274 (1%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DP   +E+IE +G GTYG+VYK  + K G LAA+K++D   D +EEI+ E N+L+   NH
Sbjct: 19  DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH 78

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS--TKGQSLKEEWIAFICREI 169
            N+  +YG F K +      QLWLV+E C  GSVT+LVK     GQ L E  I++I    
Sbjct: 79  PNVVKFYGMFYK-ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L GL++LH N++IHRD+KG N+LLT    VKLVDFGVSAQL  T  RRNT +GTP+WMAP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-K 288
           EVIAC++  D +YD R D+WSLGITA+E+ +  PPL D+HP++ LF IPRN PP L   +
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           KW + F  FI   L+KD+  RP    LL+HPFI+
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  302 bits (774), Expect = e-100
 Identities = 119/276 (43%), Positives = 183/276 (66%), Gaps = 10/276 (3%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYS 109
            +P  I+E+I  +G+G +G+VYK +H +TG  AA K++ +  +EE E+  +EI++L +  
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC- 59

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI   Y A+        +++LW+++E+C  G++  ++     + L E  I ++CR++
Sbjct: 60  KHPNIVGLYEAYFY------ENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQM 112

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L  L +LH +KVIHRD+K  N+LLT + +VKL DFGVSA+   T+ +R+TFIGTPYWMAP
Sbjct: 113 LEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSK 288
           EV+AC+   D  YD ++D+WSLGIT +E+A+ +PP  +L+PMR L  I ++ PP L +  
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS 232

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
           KW   F  F+++ LVKD   RP   +LLKHPF+ DQ
Sbjct: 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  277 bits (710), Expect = 3e-91
 Identities = 132/277 (47%), Positives = 184/277 (66%), Gaps = 13/277 (4%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK 106
           D  + +P   FELI+ +G+GTYG VYK R+  TG+LAAIKV+ +   E+  +  +  ++ 
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60

Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H NI  Y+G+++++      D+LW+ ME+CG GS+ D+   T    L E  IA++ 
Sbjct: 61  KDCKHSNIVAYFGSYLRR------DKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVS 112

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
           RE L+GL YLH    +HRDIKG N+LLTDN  VKL DFGVSAQ+  TI +R +FIGTPYW
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPR 284
           MAPEV A +      Y+   D+W++GITA+E+AE QPP+ DLHPMRALFL+ ++   PP+
Sbjct: 173 MAPEVAAVERK--GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230

Query: 285 LKSK-KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
           LK K KW   F  F++  L K+  +RP  ++LL+HPF
Sbjct: 231 LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  273 bits (700), Expect = 1e-89
 Identities = 98/269 (36%), Positives = 144/269 (53%), Gaps = 19/269 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHRNI 114
           +E++E +G G++G+VY  R  KTG+L AIKV+   + ++  E I  EI +LKK   H NI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKK-LKHPNI 59

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
              Y  F        +D+L+LVMEYC  G + DL+K      L E+   F  R+IL  L+
Sbjct: 60  VRLYDVFED------EDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALE 111

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           YLH   ++HRD+K +N+LL ++  VKL DFG++ QLD    +  TF+GTP +MAPEV+  
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLG 170

Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--KSKKWPK 292
                  Y    D+WSLG+   E+   +PP      +  LF       P           
Sbjct: 171 KG-----YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 293 KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           + +  I  +LVKD  +R   ++ L+HPF 
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  271 bits (693), Expect = 1e-88
 Identities = 132/278 (47%), Positives = 189/278 (67%), Gaps = 15/278 (5%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVL 105
           D  + +P   +ELI+ VG+GTYG VYK R+  TG+LAA+K++ +   D+   I+ EI ++
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
           K+   H NI  Y+G+++ +      ++LW+ MEYCG GS+ D+   T    L E  IA++
Sbjct: 61  KE-CKHCNIVAYFGSYLSR------EKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYV 111

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           CRE L+GL YLH    +HRDIKG N+LLTDN +VKL DFGV+A++  TI +R +FIGTPY
Sbjct: 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PP 283
           WMAPEV A ++N    Y+   D+W++GITA+E+AE QPP+ DLHPMRALFL+ ++   PP
Sbjct: 172 WMAPEVAAVEKN--GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229

Query: 284 RLKSK-KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
           +LK K KW   F +F++  L K+  +RP  ++LL H F
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  264 bits (676), Expect = 8e-86
 Identities = 110/273 (40%), Positives = 172/273 (63%), Gaps = 17/273 (6%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLK--KYSNH 111
           +++ +E++G G YG VY+G+H  TG++ A+K+  +D  +D+  +I+ E+ +L   + S  
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  YYG+++K        +LW++MEY   GSV  L+K+     + E++I+ I RE+L 
Sbjct: 62  PNITKYYGSYLK------GPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLV 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            LKY+H+  VIHRDIK  N+L+T+   VKL DFGV+A L++   +R+TF+GTPYWMAPEV
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           I         YD ++D+WSLGIT  EMA   PP  D+   RA+ LIP++ PPRL+   + 
Sbjct: 173 IT----EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS 228

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
           K  + F+   L ++  +R   ++LLK  +I+  
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  253 bits (648), Expect = 8e-82
 Identities = 133/272 (48%), Positives = 184/272 (67%), Gaps = 18/272 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYS 109
           DP  +F  +E +G G++G+VYKG   +T ++ AIK++D+   EDE E+I+ EI VL +  
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-C 59

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +   I  YYG+++K +      +LW++MEY G GS  DL+K      L+E +IA I REI
Sbjct: 60  DSPYITRYYGSYLKGT------KLWIIMEYLGGGSALDLLKPG---PLEETYIATILREI 110

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+GL YLH  + IHRDIK  NVLL++  +VKL DFGV+ QL  T  +RNTF+GTP+WMAP
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EVI       + YD ++D+WSLGITA+E+A+ +PP  DLHPMR LFLIP+N+PP L+  +
Sbjct: 171 EVIK-----QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG-Q 224

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           + K F+ F+E  L KD   RP   +LLKH FI
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  252 bits (646), Expect = 2e-81
 Identities = 113/276 (40%), Positives = 158/276 (57%), Gaps = 22/276 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNI 114
           +ELIEV+G G    VY        +  AIK +D+ +     +E++ E+  + +  NH N+
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQ-CNHPNV 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST-KGQSLKEEWIAFICREILRGL 173
             YY +F+        D+LWLVM Y   GS+ D++KS+     L E  IA + +E+L+GL
Sbjct: 62  VKYYTSFVV------GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPYWMAP 229
           +YLH N  IHRDIK  N+LL ++  VK+ DFGVSA L    DRT   R TF+GTP WMAP
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-- 287
           EV+         YD ++D+WS GITA+E+A    P     PM+ L L  +N PP L++  
Sbjct: 176 EVM----EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231

Query: 288 --KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             KK+ K F+  I   L KD  +RP  ++LLKH F 
Sbjct: 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  249 bits (637), Expect = 3e-80
 Identities = 105/276 (38%), Positives = 152/276 (55%), Gaps = 28/276 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIK-L--EINVLKKYSNHRN 113
           +   E++G G++G VY      TG+L A+K ++++ D EEE++ L  EI +L     H N
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  YYG+   +      + L + +EY   GS++ L+K  K   L E  I    R+IL GL
Sbjct: 61  IVRYYGSERDEE----KNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTRQILEGL 114

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR--TIGRRNTFIGTPYWMAPEV 231
            YLH N ++HRDIKG N+L+  +  VKL DFG + +L    T     +  GTPYWMAPEV
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH-PMRALFLI-----PRNAPPRL 285
           I  +E     Y   +D+WSLG T +EMA  +PP  +L  PM AL+ I     P   P  L
Sbjct: 175 IRGEE-----YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 ++ + F+   L +D  +RP  D+LL+HPF+
Sbjct: 230 -----SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  246 bits (630), Expect = 3e-79
 Identities = 107/272 (39%), Positives = 151/272 (55%), Gaps = 26/272 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE---EIKLEINVLKKYSNHRN 113
           ++L +++G G +G VYKG + +TG   AIK + + + +EE    I  EI++LK    H N
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  Y G  I+ S     D L++++EY   GS+  ++K        E  +A    ++L+GL
Sbjct: 61  IVKYIG-SIETS-----DSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGL 112

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            YLHE  VIHRDIK  N+L T +  VKL DFGV+ +L+       + +GTPYWMAPEVI 
Sbjct: 113 AYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI- 171

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
             E   A+    SD+WSLG T +E+    PP  DL+PM ALF I ++  P L     P+ 
Sbjct: 172 --EMSGAS--TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL-----PEG 222

Query: 294 FQS----FIETVLVKDYHQRPYTDQLLKHPFI 321
                  F+     KD + RP   QLLKHP+I
Sbjct: 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  246 bits (628), Expect = 1e-78
 Identities = 124/282 (43%), Positives = 181/282 (64%), Gaps = 10/282 (3%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYSN 110
           DP  ++E+I  +G+G +G+VYK ++ +TG LAA KV++  +E+E E+  +EI +L    N
Sbjct: 9   DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILAT-CN 67

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H  I    GAF        D +LW+++E+C  G+V D +     + L E  I  ICR++L
Sbjct: 68  HPYIVKLLGAFYW------DGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQML 120

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
             L+YLH  K+IHRD+K  NVLLT + ++KL DFGVSA+  +T+ RR++FIGTPYWMAPE
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KK 289
           V+ C+   D  YD ++D+WSLGIT +EMA+ +PP  +L+PMR L  I ++ PP L    K
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR 331
           W  +F+ F++T L K    RP   QLL+HPF+    + R  R
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR 282

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  245 bits (628), Expect = 3e-78
 Identities = 123/312 (39%), Positives = 182/312 (58%), Gaps = 27/312 (8%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE----IKLEINVL 105
           ++DP  +F  +  +G+G++G VY  R  +T ++ AIK M  +  +  E    I  E+  L
Sbjct: 10  KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
           ++   H N   Y G +++      +   WLVMEYC  GS +D+++  K + L+E  IA I
Sbjct: 70  QQL-RHPNTIEYKGCYLR------EHTAWLVMEYC-LGSASDILEVHK-KPLQEVEIAAI 120

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           C   L+GL YLH ++ IHRDIK  N+LLT+   VKL DFG SA L   +   N+F+GTPY
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASL---VSPANSFVGTPY 176

Query: 226 WMAPEVI-ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
           WMAPEVI A DE     YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N  P 
Sbjct: 177 WMAPEVILAMDE---GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 233

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-RDQPTERQARIQLKDHIDTCKK 343
           L S  W   F++F+++ L K    RP +++LLKH F+ R++P        + D I   K 
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPT-----VIIDLIQRTKD 288

Query: 344 RKKERDDYRYSG 355
             +E D+ +Y  
Sbjct: 289 AVRELDNLQYRK 300

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  244 bits (623), Expect = 5e-78
 Identities = 128/272 (47%), Positives = 182/272 (66%), Gaps = 18/272 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYS 109
           DP  +F  +E +G G++G+V+KG   +T Q+ AIK++D+   EDE E+I+ EI VL +  
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-C 59

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +   +  YYG+++K +      +LW++MEY G GS  DL+++       E  IA + +EI
Sbjct: 60  DSPYVTKYYGSYLKGT------KLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEI 110

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+GL YLH  K IHRDIK  NVLL++  +VKL DFGV+ QL  T  +RNTF+GTP+WMAP
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EVI       + YD+++D+WSLGITA+E+A+ +PP  D+HPMR LFLIP+N PP L + +
Sbjct: 171 EVIQ-----QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL-TGE 224

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           + K F+ FI+  L KD   RP   +LLKH FI
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  240 bits (615), Expect = 6e-77
 Identities = 94/273 (34%), Positives = 157/273 (57%), Gaps = 21/273 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRN 113
           +EL+  +G+G++G VYK +H  TG++ A+K++    ++ ++ +    EI +L++  +H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRR-LSHPN 59

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I     AF  K      D L+LVMEYC  G + D +  ++G  L E+    I  +ILRGL
Sbjct: 60  IVRLIDAFEDK------DHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGL 111

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH N +IHRD+K +N+LL +N  VK+ DFG++ +L ++     TF+GTP++MAPEV+ 
Sbjct: 112 EYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW--- 290
                   Y  + D+WSLG+   E+   +PP    + +  L LI R   P L+  +    
Sbjct: 172 GGNG----YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227

Query: 291 --PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
              ++ +  I+  L KD  +RP  +++L+HP+ 
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  239 bits (611), Expect = 3e-76
 Identities = 129/272 (47%), Positives = 181/272 (66%), Gaps = 18/272 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYS 109
           DP  +F  +E +G G++G+V+KG   +T ++ AIK++D+   EDE E+I+ EI VL +  
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-C 59

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +   +  YYG+++K      D +LW++MEY G GS  DL++      L E  IA I REI
Sbjct: 60  DSPYVTKYYGSYLK------DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREI 110

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+GL YLH  K IHRDIK  NVLL+++ EVKL DFGV+ QL  T  +RNTF+GTP+WMAP
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EVI       + YD+++D+WSLGITA+E+A+ +PP  +LHPM+ LFLIP+N PP L+   
Sbjct: 171 EVIK-----QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG-N 224

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           + K  + F+E  L K+   RP   +LLKH FI
Sbjct: 225 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  236 bits (602), Expect = 7e-75
 Identities = 121/279 (43%), Positives = 180/279 (64%), Gaps = 18/279 (6%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEIN 103
           PE+ W        E+I  +G+G +G+VYK ++ +TG LAA KV+D  +E+E E+  +EI+
Sbjct: 3   PEEFW--------EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEID 54

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           +L    +H NI     AF        ++ LW+++E+C  G+V D V     + L E  I 
Sbjct: 55  ILAS-CDHPNIVKLLDAFYY------ENNLWILIEFCAGGAV-DAVMLELERPLTEPQIR 106

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
            +C++ L  L YLHENK+IHRD+K  N+L T + ++KL DFGVSA+  RTI RR++FIGT
Sbjct: 107 VVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 166

Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP 283
           PYWMAPEV+ C+ + D  YD ++D+WSLGIT +EMA+ +PP  +L+PMR L  I ++ PP
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 226

Query: 284 RL-KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            L +  +W  +F+ F++  L K+   R  T QLL+HPF+
Sbjct: 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  224 bits (572), Expect = 2e-70
 Identities = 98/272 (36%), Positives = 153/272 (56%), Gaps = 20/272 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLKKYSNHRNI 114
            E ++V+G G+ G VYK RH  TG++ A+K   +D  E+  +++  E+  L+       +
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESPYV 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
              YGAF K+       ++ +V+EY   GS+ DL+K      + E  +A+I R+IL+GL 
Sbjct: 62  VKCYGAFYKEG------EISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLD 113

Query: 175 YLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YLH +  +IHRDIK  N+L+    EVK+ DFG+S  L+ T+ + NTF+GT  +M+PE I 
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL---IPRNAPPRLKSKKW 290
            +     +Y   +D+WSLG+T LE A  + P           L   I    PP L ++++
Sbjct: 174 GE-----SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
             +F+ FI   L KD  +RP   +LL+HPFI+
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  221 bits (566), Expect = 1e-69
 Identities = 97/271 (35%), Positives = 152/271 (56%), Gaps = 20/271 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           +E+I+ +G G++G+VY  R    G+L  +K +D+   +E E E+   E+ +LKK  NH N
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           I  YY +F +K       +L +VMEY   G ++  +K  K  G+   EE I     ++  
Sbjct: 61  IIKYYESFEEK------GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            LKYLH  K++HRDIK QN+ LT N  VKL DFG+S  L  T+    T +GTPY+++PE+
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRLKSKKW 290
             C   P   Y+ +SD+WSLG    E+   + P    + +  L L I +   P + S ++
Sbjct: 175 --CQNKP---YNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKGQYPPIPS-QY 227

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             + ++ + ++L KD  +RP   Q+L+ PFI
Sbjct: 228 SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  222 bits (568), Expect = 1e-69
 Identities = 103/273 (37%), Positives = 157/273 (57%), Gaps = 17/273 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL-EINVLKKYSN 110
           DP    +    +G G+ G V       TG+  A+K MD+ + +  E+   E+ +++ Y  
Sbjct: 16  DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-Q 74

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L
Sbjct: 75  HPNIVEMYSSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVL 125

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           + L +LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR + +GTPYWMAPE
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 185

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKK 289
           VI+    P   Y    D+WSLGI  +EM + +PP  +  P++A+  I  N PP+LK   K
Sbjct: 186 VIS--RLP---YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK 240

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              + +SF++ +LV+D  QR    +LL HPF+ 
Sbjct: 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  221 bits (564), Expect = 3e-69
 Identities = 97/273 (35%), Positives = 147/273 (53%), Gaps = 23/273 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE--EIKLEINVLKKYSNHRNI 114
            E +  +G G  G V K  H  TG++ A+K + +  +E    +I  E+++L K  N   I
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSPYI 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +YGAF        +  + + MEY   GS+  ++K  +G+ + E  +  I   +L+GL 
Sbjct: 62  VGFYGAFYN------NGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLT 114

Query: 175 YLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YLHE  K+IHRD+K  N+L+    ++KL DFGVS QL  ++    TF+GT  +MAPE I 
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERI- 171

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL--CDLHPMRALFL---IPRNAPPRLKSK 288
                +  Y  +SD+WSLG++ +E+A  + P    +  P     L   I    PPRL S 
Sbjct: 172 ---QGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG 227

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           K+   FQ F+   L+KD  +RP   +LL+HPFI
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  210 bits (535), Expect = 1e-64
 Identities = 110/273 (40%), Positives = 160/273 (58%), Gaps = 17/273 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL-EINVLKKYSN 110
           DP   +   E +G G  G VY      TGQ  AIK M++ +  ++E+ + EI V+++ + 
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE-NK 74

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L
Sbjct: 75  HPNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 125

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           + L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+T +GTPYWMAPE
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK-K 289
           V+         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++  K
Sbjct: 186 VVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
               F+ F+   L  D  +R    +LL+HPF++
Sbjct: 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  207 bits (528), Expect = 1e-64
 Identities = 94/260 (36%), Positives = 129/260 (49%), Gaps = 48/260 (18%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGA 120
           +G G +G VY  R  KTG+  AIK++    +    EE+  EI +LKK  NH NI   YG 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F        ++ L+LVMEYC  GS+ DL+K      L E+ I  I  +IL GL+YLH N 
Sbjct: 60  FED------ENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNG 112

Query: 181 VIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
           +IHRD+K +N+LL  DN +VKL DFG+S  L        T +GTP +MAPEV+       
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY-- 170

Query: 240 ATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIE 299
             Y  +SD+WSLG+   E+ E                                  +  I 
Sbjct: 171 --YSEKSDIWSLGVILYELPE---------------------------------LKDLIR 195

Query: 300 TVLVKDYHQRPYTDQLLKHP 319
            +L KD  +RP   ++L+H 
Sbjct: 196 KMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  207 bits (527), Expect = 3e-63
 Identities = 122/310 (39%), Positives = 186/310 (60%), Gaps = 25/310 (8%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINV 104
           +++DP  IF  +  +G+G++G VY   ++ T ++ A+K M      T ++ ++I  E+  
Sbjct: 15  YKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKF 74

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           L++   H N   Y G ++K      +   WLVMEYC  GS +DL++  K + L+E  IA 
Sbjct: 75  LQQL-KHPNTIEYKGCYLK------EHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAA 125

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           I    L+GL YLH + +IHRDIK  N+LLT+  +VKL DFG +++        N+F+GTP
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTP 181

Query: 225 YWMAPEVI-ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP 283
           YWMAPEVI A DE     YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N  P
Sbjct: 182 YWMAPEVILAMDE---GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKK 343
            L+S +W   F+ F++  L K   +RP + +LL+H F+R    +R AR+ L D I   K 
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR---RDRPARV-LIDLIQRTKD 294

Query: 344 RKKERDDYRY 353
             +E D+ +Y
Sbjct: 295 AVRELDNLQY 304

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  204 bits (519), Expect = 4e-62
 Identities = 122/311 (39%), Positives = 183/311 (58%), Gaps = 27/311 (8%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE----IKLEINV 104
           ++EDP  +F  +  +G+G++G VY  R  +T ++ AIK M  +  +  E    I  E+  
Sbjct: 19  FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           L++   H N   Y G +++      +   WLVMEYC  GS +DL++  K + L+E  IA 
Sbjct: 79  LQRI-KHPNSIEYKGCYLR------EHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAA 129

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           I    L+GL YLH + +IHRDIK  N+LLT+  +VKL DFG ++         N+F+GTP
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS----IASPANSFVGTP 185

Query: 225 YWMAPEVI-ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP 283
           YWMAPEVI A DE     YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N  P
Sbjct: 186 YWMAPEVILAMDE---GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 242

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-RDQPTERQARIQLKDHIDTCK 342
            L+S +W   F++F+++ L K    RP +++LLKH F+ R++P        L D I   K
Sbjct: 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP-----ETVLIDLIQRTK 297

Query: 343 KRKKERDDYRY 353
              +E D+ +Y
Sbjct: 298 DAVRELDNLQY 308

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  202 bits (516), Expect = 8e-62
 Identities = 99/282 (35%), Positives = 147/282 (52%), Gaps = 26/282 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHRNI 114
              +  +G G  G V K R   TG + A+K +    + +  ++I  E+ + K       I
Sbjct: 3   IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYI 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK--EEWIAFICREILRG 172
             YYGAF+ +S       + + MEYC  GS+  + K  K +  +  E+ +  I   +L+G
Sbjct: 62  VKYYGAFLDES----SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L YLH  K+IHRDIK  N+LLT   +VKL DFGVS +L  ++    TF GT ++MAPE I
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPERI 175

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-----CDLHPMRALFLIPRNAPPRLKS 287
                    Y   SD+WSLG+T LE+A+++ P        L P+  L  I     P LK 
Sbjct: 176 Q-----GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230

Query: 288 K-----KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
           +     KW ++F+ FI+  L KD  +RP    +L+HP+I+ Q
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  201 bits (513), Expect = 2e-61
 Identities = 116/310 (37%), Positives = 181/310 (58%), Gaps = 27/310 (8%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVL 105
           ++DP  +F  +  +G+G++G VY  R  +  ++ AIK M      + ++ ++I  E+  L
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
           +K   H N   Y G +++      +   WLVMEYC  GS +DL++  K + L+E  IA +
Sbjct: 70  QKL-RHPNTIQYRGCYLR------EHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAV 120

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
               L+GL YLH + +IHRD+K  N+LL++   VKL DFG ++     +   N F+GTPY
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANXFVGTPY 176

Query: 226 WMAPEVI-ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
           WMAPEVI A DE     YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N  P 
Sbjct: 177 WMAPEVILAMDE---GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-RDQPTERQARIQLKDHIDTCKK 343
           L+S  W + F++F+++ L K    RP ++ LLKH F+ R++P        + D I   K 
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP-----PTVIMDLIQRTKD 288

Query: 344 RKKERDDYRY 353
             +E D+ +Y
Sbjct: 289 AVRELDNLQY 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  196 bits (499), Expect = 2e-59
 Identities = 109/273 (39%), Positives = 159/273 (58%), Gaps = 17/273 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL-EINVLKKYSN 110
           DP   +   E +G G  G VY      TGQ  AIK M++ +  ++E+ + EI V+++  N
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN 75

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
             NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L
Sbjct: 76  -PNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 125

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           + L +LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+T +GTPYWMAPE
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KK 289
           V+         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ ++
Sbjct: 186 VVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
               F+ F+   L  D  +R    +LL+HPF++
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  193 bits (492), Expect = 9e-59
 Identities = 95/267 (35%), Positives = 142/267 (53%), Gaps = 20/267 (7%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE------EEIKLEINVLKKYSNHRNI 114
           E++G+G++G VY+G +   G   A+K + + +D +      ++++ EI +L K   H NI
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNI 64

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y G         ++D L++ +E    GS+  L+K  K  S  E  I    R+IL GL+
Sbjct: 65  VQYLGT------EREEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLE 116

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           YLH+   +HRDIKG N+L+  N  VKL DFG++ Q+        +F G+PYWMAPEVI  
Sbjct: 117 YLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVI-- 173

Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
                  Y   +D+WSLG T LEMA  +PP   L  + A+F I R+            + 
Sbjct: 174 --AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231

Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFI 321
           + FI   L +D   RP   +LL+HPF+
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  191 bits (485), Expect = 2e-57
 Identities = 108/273 (39%), Positives = 159/273 (58%), Gaps = 17/273 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL-EINVLKKYSN 110
           DP   +   E +G G  G VY      TGQ  AI+ M++ +  ++E+ + EI V+++  N
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
             NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L
Sbjct: 77  -PNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 126

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           + L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+T +GTPYWMAPE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KK 289
           V+         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +K
Sbjct: 187 VVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
               F+ F+   L  D  +R    +LL+H F++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  190 bits (484), Expect = 3e-57
 Identities = 103/290 (35%), Positives = 160/290 (55%), Gaps = 22/290 (7%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH 111
           DP    +    +G G+ G V       +G+L A+K MD+ + +  E+     V+ +   H
Sbjct: 17  DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L+
Sbjct: 77  ENVVEMYNSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLK 127

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L  LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR + +GTPYWMAPE+
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           I+        Y    D+WSLGI  +EM + +PP  +  P++A+ +I  N PP+LK+  K 
Sbjct: 188 IS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKV 242

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ-------PTERQARIQ 333
               + F++ +LV+D  QR    +LLKHPF+          P  RQ R++
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLMRQNRMR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  188 bits (479), Expect = 2e-56
 Identities = 109/273 (39%), Positives = 160/273 (58%), Gaps = 17/273 (6%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL-EINVLKKYSN 110
           DP   +   E +G G  G V+      TGQ  AIK +++ +  ++E+ + EI V+K+  N
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN 75

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
             NI  +  +F+        D+L++VMEY   GS+TD+V  T    + E  IA +CRE L
Sbjct: 76  -PNIVNFLDSFLV------GDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECL 125

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           + L++LH N+VIHRDIK  NVLL  +  VKL DFG  AQ+     +R+T +GTPYWMAPE
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KK 289
           V+         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +K
Sbjct: 186 VVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
               F+ F+   L  D  +R    +LL+HPF++
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  187 bits (476), Expect = 5e-56
 Identities = 97/261 (37%), Positives = 152/261 (58%), Gaps = 15/261 (5%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFI 122
           +G G+ G V       TG+  A+K MD+ + +  E+     V+ +  +H N+   Y +++
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVI 182
                   D+LW+VME+   G++TD+V  T+   + EE IA +C  +LR L YLH   VI
Sbjct: 90  V------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVI 140

Query: 183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATY 242
           HRDIK  ++LLT +  +KL DFG  AQ+ + + +R + +GTPYWMAPEVI+        Y
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS-----RLPY 195

Query: 243 DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKKWPKKFQSFIETV 301
               D+WSLGI  +EM + +PP  +  P++A+  I  N PPR+K S K     + F++ +
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255

Query: 302 LVKDYHQRPYTDQLLKHPFIR 322
           LV++  QR    +LL+HPF++
Sbjct: 256 LVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  184 bits (470), Expect = 3e-55
 Identities = 91/288 (31%), Positives = 147/288 (51%), Gaps = 47/288 (16%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           +E++E +G G++G V K R    G++   K +D   +TE E++++  E+N+L++   H N
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           I  YY   I +S    +  L++VMEYC  G +  L++  K   + ++EE+I  I  ++L 
Sbjct: 61  IVRYYDRIIDRS----NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 172 GLKYLH-----ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            L   H      N V+HRD+K  N+ L  N  VKL DFG++  L        T++GTPY+
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--- 283
           M+PE +        +YD +SD+WSLG    E+       C L P       P  A     
Sbjct: 177 MSPEQLN-----HMSYDEKSDIWSLGCLIYEL-------CALSP-------PFTARNQLQ 217

Query: 284 ---RLKSKK---WPKKF----QSFIETVLVKDYHQRPYTDQLLKHPFI 321
              ++K  K    P ++       I+++L  D  +RP T++LL+ P I
Sbjct: 218 LASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  185 bits (471), Expect = 3e-55
 Identities = 96/273 (35%), Positives = 155/273 (56%), Gaps = 15/273 (5%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS 109
           Q DP  + E    +G G+ G V   R   +G+  A+K+MD+ + +  E+     V+ +  
Sbjct: 16  QGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 75

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H+N+   Y +++        ++LW++ME+   G++TD+V  T+   L EE IA +C  +
Sbjct: 76  QHQNVVEMYKSYLV------GEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESV 126

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+ L YLH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + +R + +GTPYWMAP
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SK 288
           EVI+        Y    D+WSLGI  +EM + +PP     P++A+  +  + PP+LK + 
Sbjct: 187 EVIS-----RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAH 241

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           K     + F+E +L ++  +R    +LL HPF+
Sbjct: 242 KISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  181 bits (460), Expect = 6e-54
 Identities = 103/281 (36%), Positives = 148/281 (52%), Gaps = 41/281 (14%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVM-------DVTEDEEEEIKLEINVLKKYSNHRN 113
           EV+G G YG VY G  T  GQL A+K +          E E E+++ E+++LK    H N
Sbjct: 6   EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVN 63

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  Y G  +       D+ + + ME+   GS++ ++   +   L E       ++IL G+
Sbjct: 64  IVQYLGTCLD------DNTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGV 115

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT-------FIGTPYW 226
            YLH N V+HRDIKG NV+L  N  +KL+DFG + +L   +G   T         GTPYW
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL-AWVGLHGTHSNMLKSMHGTPYW 174

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP--RNAPPR 284
           MAPEVI      ++ Y  +SD+WS+G T  EMA  +PPL  +  + A+F I   R   PR
Sbjct: 175 MAPEVIN-----ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229

Query: 285 LKSKKWPKKFQS----FIETVLVKDYHQRPYTDQLLKHPFI 321
           L     P  F +    F+ + L +D H+RP   QLL+H F+
Sbjct: 230 L-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  180 bits (457), Expect = 3e-52
 Identities = 94/392 (23%), Positives = 145/392 (36%), Gaps = 34/392 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHR 112
           + ++  +G G++G+VY  R  K     A+KV+         E E    EI +L   ++  
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
           NI   Y  F        +  L+LVMEY   GS+ DL+K    +  L E    FI  +IL 
Sbjct: 59  NIVKLYDFFQD------EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRR------NTFIGTP 224
            L+YLH   +IHRDIK +N+LL  D   VKL+DFG++  L             +T +GTP
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH---PMRALFLIPRNA 281
            +MAPEV+       A   + SD+WSLGIT  E+    PP               I    
Sbjct: 173 GYMAPEVLL--GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230

Query: 282 PPRLKSKKWPKK--------FQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQ 333
           P    +                  ++ +L KD   R  +   L H  +     +      
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 334 LKDHIDTCKKRKKERDDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQKLEN 393
           L    D+   R           S                     +              +
Sbjct: 291 LLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSS 350

Query: 394 CARSSSSSTSTATPTPRIQTPTHPTTATPTST 425
              S++SS  ++ P    ++     +++    
Sbjct: 351 LLLSTASSKRSSLPKISARSSPSSLSSSSRQQ 382

Length = 384

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  168 bits (426), Expect = 4e-49
 Identities = 97/270 (35%), Positives = 149/270 (55%), Gaps = 24/270 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHR 112
           FE++  +G G++G V+K       ++ A+K +D+++    + EE I  E  VL K  +  
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKL-DSS 59

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE--WIAFICREIL 170
            I  YY +F+ K   GK   L +VMEY   G +  L+K  +G+ L E+  W  FI  +IL
Sbjct: 60  YIIRYYESFLDK---GK---LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QIL 111

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            GL +LH  K++HRDIK  N+ L     VK+ D GV+  L       NT +GTPY+++PE
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRLKSKK 289
           +  C++ P   Y+ +SD+W+LG+   E    + P  D +   AL L I R   P + S+ 
Sbjct: 172 L--CEDKP---YNEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFPPV-SQM 224

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHP 319
           + ++    I+  L KDY QRP T QLL++P
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  166 bits (422), Expect = 4e-48
 Identities = 92/271 (33%), Positives = 145/271 (53%), Gaps = 15/271 (5%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNHRNI 114
            E+IE +G G YG V K RH  TG + A+K +   V   E++ + +++++  +  +    
Sbjct: 3   LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRG 172
            T+YGA  ++        +W+ ME     S+    K    KG ++ E+ +  I   I++ 
Sbjct: 63  VTFYGALFREG------DVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115

Query: 173 LKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           L+YLH    VIHRD+K  NVL+  N +VKL DFG+S  L  ++ +       PY MAPE 
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPY-MAPER 174

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH-PMRALFLIPRNAPPRLKSKKW 290
           I  + N    YD +SD+WSLGIT +E+A  + P      P + L  +     P+L ++K+
Sbjct: 175 INPELNQKG-YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             +FQ F+   L K+Y +RP   +LL+HPF 
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  165 bits (420), Expect = 4e-48
 Identities = 89/276 (32%), Positives = 146/276 (52%), Gaps = 31/276 (11%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEE-------EEIKLEINVLKKYSNH 111
           ++G+G++G VY G +  +G+L A+K ++   V+   +       + +  EI +LK+   H
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-H 65

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  Y G+ +        D L + +EY   GSV  L+      + +E  +    R+IL+
Sbjct: 66  ENIVQYLGSSLDA------DHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILK 117

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI------GRRNTFIGTPY 225
           GL YLH   +IHRDIKG N+L+ +   +K+ DFG+S +L+         G R +  G+ +
Sbjct: 118 GLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           WMAPEV+        +Y  ++D+WSLG   +EM   + P  D   ++A+F I  NA P +
Sbjct: 178 WMAPEVVK-----QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            S    +    F+E     D+++RP   +LLKHPF+
Sbjct: 233 PSNISSEAID-FLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  165 bits (419), Expect = 7e-48
 Identities = 90/283 (31%), Positives = 144/283 (50%), Gaps = 28/283 (9%)

Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---EEIKLEINV 104
           RWQ    G       +G GT+G+VY   +  TG+L A+K + + +++    +EI  E+ V
Sbjct: 1   RWQR---GNK-----IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKV 52

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           L+    H N+  YYG  +        +++++ MEYC  G++ +L++   G+ L E  I  
Sbjct: 53  LELL-KHPNLVKYYGVEVH------REKVYIFMEYCSGGTLEELLEH--GRILDEHVIRV 103

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR---TIGRR-NTF 220
              ++L GL YLH + ++HRDIK  N+ L  N  +KL DFG + +L     T+G    + 
Sbjct: 104 YTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163

Query: 221 IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL--CDLHPMRALFLIP 278
            GTP +MAPEVI         +   +D+WSLG   LEMA  + P    D        +  
Sbjct: 164 AGTPAYMAPEVIT--GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221

Query: 279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            + PP   S +   + + F++  L  D  +RP   +LL+HPF+
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 7e-48
 Identities = 96/271 (35%), Positives = 143/271 (52%), Gaps = 29/271 (10%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDV------TEDEEEEIKLEINVLKKYSNHRNIAT 116
           +G G +G+VY      TG+  A+K +        T+ E   ++ EI +LK   + R I  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER-IVQ 68

Query: 117 YYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
           YYG         +DD+ L + MEY   GSV D +K   G +L E       R+IL G++Y
Sbjct: 69  YYGCL-------RDDETLSIFMEYMPGGSVKDQLK-AYG-ALTETVTRKYTRQILEGVEY 119

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI----GRRNTFIGTPYWMAPEV 231
           LH N ++HRDIKG N+L      VKL DFG S +L +TI        +  GTPYWM+PEV
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMSPEV 178

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-PRLKSKKW 290
           I+ +      Y  ++D+WS+G T +EM   +PP  +   M A+F I      P+L S   
Sbjct: 179 ISGE-----GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS 233

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           P   ++F+    V++  +RP  ++LL+H F+
Sbjct: 234 PDA-RNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  164 bits (418), Expect = 3e-47
 Identities = 97/273 (35%), Positives = 149/273 (54%), Gaps = 17/273 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE--EIKLEINVLKKYSNHRNI 114
            E +  +G+GT GQVYK R  KTG + A+K M  T ++EE   I ++++V+ K  +   I
Sbjct: 17  LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYI 76

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
              YG FI  S       +++ ME   +  +  L+K  +G  + E+ +  +   I++ L 
Sbjct: 77  VKCYGYFITDS------DVFICME-LMSTCLDKLLKRIQG-PIPEDILGKMTVAIVKALH 128

Query: 175 YLHENK-VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YL E   VIHRD+K  N+LL  +  VKL DFG+S +L  +  +  +  G   +MAPE I 
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERID 187

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP--LCDLHPMRALFLIPRNAPPRLK-SKKW 290
              +P+  YD R+D+WSLGI+ +E+A  Q P   C       L  I +  PP L  ++ +
Sbjct: 188 -PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEEPPSLPPNEGF 245

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
              F SF++  L KD+ +RP   +LL+HPFIR 
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  162 bits (411), Expect = 9e-47
 Identities = 97/269 (36%), Positives = 136/269 (50%), Gaps = 24/269 (8%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAF 121
           V+G GTYG VY  R   T    AIK +   +    +   E   L  Y  HRNI  Y G+ 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRGLKYLHENK 180
            +      +    + ME    GS++ L++S  G     E+ I F  ++IL GLKYLH+N+
Sbjct: 75  SE------NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 181 VIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
           ++HRDIKG NVL+ T +  VK+ DFG S +L        TF GT  +MAPEVI  D+ P 
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI--DKGPR 186

Query: 240 ATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLI------PRNAPPRLKSKKWPK 292
             Y   +D+WSLG T +EMA  +PP  +L  P  A+F +      P   P  L ++    
Sbjct: 187 G-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP-EIPESLSAEA--- 241

Query: 293 KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             ++FI      D  +R     LL+ PF+
Sbjct: 242 --KNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 1e-46
 Identities = 84/268 (31%), Positives = 131/268 (48%), Gaps = 29/268 (10%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           +G G++G+V   R   TG+L A+KV+     +   E E    E N+L +  NH  I   +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSR-INHPFIVKLH 59

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREILRGLKYL 176
            AF        +++L+LV+EY   G   +L    S +G    EE   F   EI+  L+YL
Sbjct: 60  YAFQT------EEKLYLVLEYAPGG---ELFSHLSKEG-RFSEERARFYAAEIVLALEYL 109

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H   +I+RD+K +N+LL  +  +KL DFG++ +L     R NTF GTP ++APEV+    
Sbjct: 110 HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL--- 166

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNAPPRLKSKKWPKKFQ 295
                Y    D WSLG+   EM   +PP       + ++  I ++ P R        + +
Sbjct: 167 --GKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKD-PLRFPE-FLSPEAR 221

Query: 296 SFIETVLVKDYHQR---PYTDQLLKHPF 320
             I  +L KD  +R      +++  HPF
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  161 bits (411), Expect = 2e-46
 Identities = 81/297 (27%), Positives = 131/297 (44%), Gaps = 53/297 (17%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+  +++G G++  V   +  +T +  AIK++D    + E + + +K+E  VL + + H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 113 NIATYYGAFIKKSPPGKDD-QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            I   Y  F       +D+  L+ V+EY   G +   ++  K  SL E+   F   EIL 
Sbjct: 63  GIIKLYYTF-------QDEENLYFVLEYAPNGELLQYIR--KYGSLDEKCTRFYAAEILL 113

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT------------------ 213
            L+YLH   +IHRD+K +N+LL  +  +K+ DFG +  LD                    
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 214 --IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM 271
               R  +F+GT  +++PE++       A     SDLW+LG    +M      L    P 
Sbjct: 174 KNRRRFASFVGTAEYVSPELL---NEKPAGKS--SDLWALGCIIYQM------LTGKPPF 222

Query: 272 RAL--FLIPRNAPPRLKS--KKWPKKFQSFIETVLVKDYHQRP----YTDQLLKHPF 320
           R    +L  +       S    +P   +  IE +LV D   R       D+L  HPF
Sbjct: 223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  156 bits (396), Expect = 3e-44
 Identities = 91/270 (33%), Positives = 139/270 (51%), Gaps = 18/270 (6%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL--EINVLKKYSNHRNIATYYGA 120
           +G G +G V K  H  +G + A+K +  T DE+E+ +L  +++V+ + S+   I  +YGA
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 121 FIKKSPPGKDDQLWLVMEYCGAG--SVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
             ++         W+ ME            V       + EE +  I    ++ L YL E
Sbjct: 72  LFREG------DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 179 N-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
             K+IHRD+K  N+LL  N  +KL DFG+S QL  +I +       PY MAPE I  D +
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI--DPS 182

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRNAPPRLKS---KKWPKK 293
               YD RSD+WSLGIT  E+A  + P    + +   L  + +  PP L +   +++   
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPS 242

Query: 294 FQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
           F +FI   L+KD  +RP   +LL+HPFI+D
Sbjct: 243 FVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  153 bits (388), Expect = 2e-43
 Identities = 89/269 (33%), Positives = 143/269 (53%), Gaps = 22/269 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           F++++ +G G+YG VYK +     Q  A+K +D+   ++ E E+   EI +L   ++  N
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP-N 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS--LKEEWIAFICREILR 171
           I +Y  AF+        ++L +VMEY   G ++  +   K +   + E+ I  I  ++LR
Sbjct: 61  IISYKEAFLD------GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL+ LHE K++HRD+K  N+LL  N  VK+ D G+S  L + + +  T IGTP++MAPEV
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEV 172

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRLKSKKW 290
                     Y  +SD+WSLG    EMA   PP  +   M+ L   + R   P +    +
Sbjct: 173 WK-----GRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPP-IY 225

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHP 319
            +  Q+FI ++L      RP  D++L  P
Sbjct: 226 SQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  152 bits (387), Expect = 3e-43
 Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 40/253 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSN 110
            EL + +G G +G+VYKG        T    A+K +    +E+E EE   E +++KK S 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS- 59

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI    G   +  P      L++V EY   G + D ++   G+ L  + +  +  +I 
Sbjct: 60  HPNIVRLLGVCTQGEP------LYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIA 112

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD-------RTIGRRNTFIGT 223
           +G++YL     +HRD+  +N L+T+N  VK+ DFG+S  +        R  G+       
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK--- 169

Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLI----- 277
             WMAPE +      D  + ++SD+WS G+   E+    + P   +     L L+     
Sbjct: 170 --WMAPESLK-----DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR 222

Query: 278 ---PRNAPPRLKS 287
              P N P  L  
Sbjct: 223 LPRPENCPDELYE 235

Length = 258

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  149 bits (379), Expect = 7e-42
 Identities = 96/273 (35%), Positives = 145/273 (53%), Gaps = 20/273 (7%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE--EIKLEINVLKKYSNHRNIA 115
           E+++ +G G YG VYK  H  TG   A+K + +  DE +  +I +E+++L K +    I 
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK-AVSPYIV 62

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV-KSTKGQSLKEEWIAFICREILRGLK 174
            +YGAF  +        +++ MEY  AGS+  L       + + E+ +  I   +++GLK
Sbjct: 63  DFYGAFFIEG------AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 175 YLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +L E   +IHRD+K  NVL+  N +VKL DFGVS  L  ++ + N  IG   +MAPE I 
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIK 174

Query: 234 CDENPDA--TYDNRSDLWSLGITALEMAESQ---PPLCDLHPMRALFLIPRNAPPRLKSK 288
               P+   TY  +SD+WSLG++ LEMA  +   PP    +    L  I    PP L S 
Sbjct: 175 -SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 Q F+   L K  ++RP   QLL+HP++
Sbjct: 234 YSDDA-QDFVAKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  147 bits (373), Expect = 4e-41
 Identities = 89/271 (32%), Positives = 147/271 (54%), Gaps = 29/271 (10%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           E++G+G  G VYK  H  T ++ A+KV  +D+T + +++I  E+ +L K  +   I  +Y
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFY 65

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           GAF        ++++ +  E+   GS+ D+ +      + E  +  I   +++GL YL  
Sbjct: 66  GAFFV------ENRISICTEFMDGGSL-DVYRK-----IPEHVLGRIAVAVVKGLTYLWS 113

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
            K++HRD+K  N+L+    +VKL DFGVS QL  +I +  T++GT  +MAPE I+ ++  
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQ-- 169

Query: 239 DATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRLKSKKWP 291
              Y   SD+WSLGI+ +E+A  + P          L P++ L  I    PP L   ++ 
Sbjct: 170 ---YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +KF  FI   + K   +RP  + L+ HPFI 
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIV 257

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  146 bits (370), Expect = 9e-41
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 31/277 (11%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           +  G YG+V+  +   TG + AIKV+     + +++ +++  E ++L +  +   +  YY
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            +F  K        L+LVMEY   G +  L+++    SL E+       EI+  L+YLH 
Sbjct: 61  -SFQGKK------NLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHS 111

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ--LDRTIGRRNT------FIGTPYWMAPE 230
           N +IHRD+K  N+L+  N  +KL DFG+S    + R I   +        +GTP ++APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRLKSKK 289
           VI         +    D WSLG    E     PP     P   +F  I        +  +
Sbjct: 172 VILGQ-----GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQNILNGKIEWPEDVE 225

Query: 290 WPKKFQSFIETVLVKDYHQRPYT---DQLLKHPFIRD 323
              +    I  +LV D  +R      +++  HPF + 
Sbjct: 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  147 bits (373), Expect = 1e-40
 Identities = 83/323 (25%), Positives = 136/323 (42%), Gaps = 57/323 (17%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRNI 114
            + +   +     + K  H  T  L A+K +++    +E++KL   EI   ++   H NI
Sbjct: 5   LIGKCFEDLMIVHLAK--HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNI 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y  +FI  S      +L++V      GS  DL+K+   + L E  IAFI +++L  L 
Sbjct: 62  LPYVTSFIVDS------ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD 115

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-------YWM 227
           Y+H    IHR +K  ++LL+ + +V L     S  + +   R+      P        W+
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-- 285
           +PEV+   +N    Y+ +SD++S+GITA E+A    P  D+   + L    R   P L  
Sbjct: 176 SPEVL--QQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232

Query: 286 ------------------------------KSKKWPKKFQSFIETVLVKDYHQRPYTDQL 315
                                          ++ + + F  F+E  L +D   RP   QL
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292

Query: 316 LKHPFIRDQPTERQARI--QLKD 336
           L H F + Q   R   +   LK 
Sbjct: 293 LNHSFFK-QCKRRNTSLLDLLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  144 bits (366), Expect = 6e-40
 Identities = 86/305 (28%), Positives = 133/305 (43%), Gaps = 63/305 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +E +E +G GTYG VYK R  KTG++ A+K +   ++EEE I      EI++LK+   H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKEL-KHP 58

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREIL 170
           NI         +       +L+LV EYC      DL K    +   L    I  I  ++L
Sbjct: 59  NIVKLLDVIHTER------KLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLL 108

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTPYW 226
           RGL Y H ++++HRD+K QN+L+  +  +KL DFG    L R  G   R  T  + T ++
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFG----LARAFGIPLRTYTHEVVTLWY 164

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL---CDLHPMRALFLI------ 277
            APE++   ++    Y    D+WS+G    EM   +P      ++     LF I      
Sbjct: 165 RAPEILLGSKH----YSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGT 217

Query: 278 --------------PRNAPPRLKSKKWPKKFQSF-------IETVLVKDYHQRPYTDQLL 316
                          +   P+   K   K            +  +L  +  +R    + L
Sbjct: 218 PTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277

Query: 317 KHPFI 321
           KHP+ 
Sbjct: 278 KHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  143 bits (362), Expect = 7e-40
 Identities = 85/271 (31%), Positives = 145/271 (53%), Gaps = 21/271 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRN 113
           +E+I+ +G G++G++Y  +     +   IK +D+T+    E+E  K E+ +L K   H N
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I T++ +F       ++ +L++VMEYC  G +   +   +G    E+ I     +I  GL
Sbjct: 61  IVTFFASF------QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           K++H+ K++HRDIK QN+ L+ N  V KL DFG++ QL+ ++    T +GTPY+++PE+ 
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI- 173

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL--CDLHPMRALFLIPRNAPPRLKSKKW 290
            C   P   Y+N++D+WSLG    E+   + P    +LH +         AP    S  +
Sbjct: 174 -CQNRP---YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNF 226

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            +  +S I  +       RP    +LK PF+
Sbjct: 227 SRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  142 bits (360), Expect = 2e-39
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 32/276 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRN 113
           +  I V+G G +G+    R T+   L   K +++T   E+E +    EI +L     H N
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  YY  F+       D+ L + MEY   G++ D +   KGQ  +EE + +   +I+  +
Sbjct: 61  IIAYYNHFMD------DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            Y+H+  ++HRDIK  N+ LT    +KL DFG+S  L        T +GTPY+M+PE+  
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL-- 172

Query: 234 CDENPDATYDNRSDLWSLGITALEM--------AESQPPLCDLHPMRALFLIPRNAPPRL 285
           C       Y+ +SD+W+LG    E+        A +   L        + ++  N  P +
Sbjct: 173 CQ---GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV-------VKIVQGNYTPVV 222

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               +  +  S + ++L +D  +RP  D++L  P +
Sbjct: 223 --SVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  142 bits (361), Expect = 6e-39
 Identities = 92/305 (30%), Positives = 145/305 (47%), Gaps = 55/305 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLKKYSNHRNI 114
           FE +  +G G  G V K  H  +G + A K+  +++      +I  E+ VL +  N   I
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSPYI 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +YGAF        D ++ + ME+   GS+  ++K  K   + E  +  I   +LRGL 
Sbjct: 62  VGFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPENILGKISIAVLRGLT 113

Query: 175 YLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YL E  K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE + 
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ 171

Query: 234 CDENPDATYDNRSDLWSLGITALEMA-------------------------ESQPPLCDL 268
                   Y  +SD+WSLG++ +EMA                         E++     +
Sbjct: 172 -----GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226

Query: 269 --HPMRA---------LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
             HP  +         L  I    PP+L S  +  +FQ F++  L K+  +R    +L K
Sbjct: 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286

Query: 318 HPFIR 322
           HPFI+
Sbjct: 287 HPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  140 bits (353), Expect = 2e-38
 Identities = 96/280 (34%), Positives = 143/280 (51%), Gaps = 34/280 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV------TEDEEEEIKLEINVLKKYSN 110
           + L +++G G +G+VY      TG+  A+K +        T  E   ++ EI +LK    
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL- 62

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H  I  YYG    + P  +   L + ME+   GS+ D +KS    +L E       R+IL
Sbjct: 63  HERIVQYYGCL--RDPMER--TLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQIL 116

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI----GTPYW 226
            G+ YLH N ++HRDIKG N+L      VKL DFG S +L +TI    T +    GTPYW
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYW 175

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI---PRNA-- 281
           M+PEVI+ +      Y  ++D+WS+G T +EM   +PP  +   M A+F I   P N   
Sbjct: 176 MSPEVISGE-----GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL 230

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           PP +         + F++ + V +   RP  D+LL+H F+
Sbjct: 231 PPHVSDHC-----RDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  140 bits (354), Expect = 3e-38
 Identities = 88/290 (30%), Positives = 145/290 (50%), Gaps = 30/290 (10%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHRNIA 115
           E I  +G G  G V K +H  TG + A KV+ +       ++I  E+ ++ +      I 
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CRSPYIV 66

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
           ++YGAF+       ++ + + ME+   GS+  + K  KG  +  E +  I   ++ GL Y
Sbjct: 67  SFYGAFLN------ENNICMCMEFMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTY 118

Query: 176 LH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L+  ++++HRDIK  N+L+    ++KL DFGVS +L  +I   +TF+GT  +M+PE I  
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQG 176

Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCD--------LHPMRALFLIPR---NAPP 283
            +     Y  +SD+WSLGI+ +E+A  + P             PM  L L+ +     PP
Sbjct: 177 GK-----YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQ 333
           RL S  +P+  + F++  L+KD  +RP   QL   P            +Q
Sbjct: 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQ 281

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  138 bits (350), Expect = 4e-38
 Identities = 80/276 (28%), Positives = 142/276 (51%), Gaps = 32/276 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRN 113
           +  ++ +G G++G+    +  + G+   IK +++++    E EE + E+ VL     H N
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  Y  +F       ++  L++VM+YC  G +   + + +G    E+ I     +I   L
Sbjct: 61  IVQYQESF------EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           K++H+ K++HRDIK QN+ LT +  +KL DFG++  L+ T+    T IGTPY+++PE+  
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-- 172

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRA-------LFLIPRNAPPRL 285
           C+  P   Y+N+SD+W+LG    EM       C L H   A       L +I  + PP  
Sbjct: 173 CENRP---YNNKSDIWALGCVLYEM-------CTLKHAFEAGNMKNLVLKIIRGSYPP-- 220

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            S  +    ++ +  +  ++   RP  + +L+  FI
Sbjct: 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  138 bits (351), Expect = 5e-38
 Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 48/283 (16%)

Query: 61  EVVGNGTYGQVYKGR-HTKTGQ--LAAIKVMDVTEDEEEEIKL--EINVLKKYSNHRNIA 115
           + +G G +G+VYKG+   K G+    A+K +     EEE      E  V+KK   H N+ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGS-------VTDLVKSTKGQSLKEEWIAFICRE 168
              G   ++ P      L+LV+EY   G           +  S +  +L  + +     +
Sbjct: 60  RLLGVCTEEEP------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY--- 225
           I +G++YL   K +HRD+  +N L+ ++  VK+ DFG+S         R+ +    Y   
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS---------RDVYDDDYYRKK 164

Query: 226 --------WMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRAL-F 275
                   WMAPE +      D  + ++SD+WS G+   E+      P   L     L +
Sbjct: 165 TGGKLPIRWMAPESLK-----DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY 219

Query: 276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
           L      P  K +  P +    + +    D   RP   +L++ 
Sbjct: 220 LRKGYRLP--KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  138 bits (348), Expect = 1e-37
 Identities = 98/273 (35%), Positives = 141/273 (51%), Gaps = 30/273 (10%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDV------TEDEEEEIKLEINVLKKYSNHRNI 114
           +++G G +G+VY      TG+  A K +        T  E   ++ EI +LK    H  I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERI 66

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             YYG    ++    +  L + MEY   GSV D +K+    +L E       R+IL G+ 
Sbjct: 67  VQYYGCLRDRA----EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMS 120

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI----GTPYWMAPE 230
           YLH N ++HRDIKG N+L      VKL DFG S +L +TI    T I    GTPYWM+PE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPE 179

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI---PRNAPPRLKS 287
           VI+ +      Y  ++D+WSLG T +EM   +PP  +   M A+F I   P N  P+L S
Sbjct: 180 VISGE-----GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPS 232

Query: 288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
               +  + F+  + V +   RP  ++LL+HPF
Sbjct: 233 HI-SEHARDFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  137 bits (347), Expect = 2e-37
 Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 35/268 (13%)

Query: 58  ELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNH 111
            L + +G G +G+VYKG             A+K +  D +E + EE   E  +++K  +H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI    G   ++ P      L +VMEY   G + D ++  + + L    +     +I R
Sbjct: 61  PNIVKLLGVCTEEEP------LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-----AQLDRTIGRRNTFIGTPY- 225
           G++YL     IHRD+  +N L+ +N  VK+ DFG+S         +  G +      P  
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK-----LPIR 169

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM---AESQPPLCDLHPMRALFLIPRNAP 282
           WMAPE +      +  + ++SD+WS G+   E+    E   P      +   +L      
Sbjct: 170 WMAPESLK-----EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE-YLKKGYRL 223

Query: 283 PRLKSKKWPKKFQSFIETVLVKDYHQRP 310
           P+  +   P +    +     +D   RP
Sbjct: 224 PKPPNC--PPELYKLMLQCWAEDPEDRP 249

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  137 bits (346), Expect = 4e-37
 Identities = 88/302 (29%), Positives = 143/302 (47%), Gaps = 55/302 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRN 113
           +E++ VVG G YG V K R+  TG++ AIK    +ED+E+  K    E+ VL++   H N
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HEN 61

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I     AF +K       +L+LV EY     +  L  S  G  L  + +     ++L+ +
Sbjct: 62  IVNLKEAFRRK------GRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQLLQAI 113

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT-FIGTPYWMAPEVI 232
            Y H + +IHRDIK +N+L++++  +KL DFG +  L        T ++ T ++ APE++
Sbjct: 114 AYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP----MRALFLI----------- 277
             D N    Y    D+W++G    E+ + +P    L P    +  L+LI           
Sbjct: 174 VGDTN----YGKPVDVWAIGCIMAELLDGEP----LFPGDSDIDQLYLIQKCLGPLPPSH 225

Query: 278 -------PRNA--------PPRLKSKKWPKKFQS----FIETVLVKDYHQRPYTDQLLKH 318
                  PR A         P    +++P K  S    F++  L  D  +R   D+LL+H
Sbjct: 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285

Query: 319 PF 320
           P+
Sbjct: 286 PY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  136 bits (344), Expect = 5e-37
 Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 31/279 (11%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE-----------IKLEINVLKKYS 109
           E++G GTYG+VY   +  TG++ A+K +++                  ++ EI  LK   
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL- 65

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +H NI  Y G   + +     + L + +EY   GS+   ++       +E+ + F   ++
Sbjct: 66  DHLNIVQYLG--FETTE----EYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQV 117

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWM 227
           L GL YLH   ++HRD+K  N+L+  +   K+ DFG+S + D      +  +  G+ +WM
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI--PRNAPP-- 283
           APEVI         Y  + D+WSLG   LEM   + P  D   + A+F +   R+APP  
Sbjct: 178 APEVIHSYSQ---GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234

Query: 284 -RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             +     P     F+      +   RP   +LL+HPFI
Sbjct: 235 PDVSMNLSPVALD-FLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  136 bits (346), Expect = 6e-37
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 40/282 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE I+ +G G++G+V   RH  +G+  A+K++     V   + E +  E  +L+    H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +   YG+F       +DD  L+LVMEY   G +   ++  K     E    F   +++ 
Sbjct: 62  FLVNLYGSF-------QDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFYAAQVVL 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L+YLH   +++RD+K +N+LL  +  +K+ DFG + ++    GR  T  GTP ++APE+
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTLCGTPEYLAPEI 169

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK-KW 290
           I         Y    D W+LGI   EM    PP  D +P++    I       L+ K ++
Sbjct: 170 ILS-----KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-------LEGKVRF 217

Query: 291 PKKF----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           P  F    +  I  +L  D  +R        + +  HP+   
Sbjct: 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 1e-36
 Identities = 84/311 (27%), Positives = 129/311 (41%), Gaps = 70/311 (22%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +E I  +G GTYGQVYK R+ KTG+L A+K + + E+E+E   +    EI +L+K   H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRM-ENEKEGFPITAIREIKLLQKL-RHP 58

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--------VKSTKGQSLKEEWIAF 164
           NI       I  S       +++V EY       DL        VK T+ Q      I  
Sbjct: 59  NIVRLKE--IVTSKGKGS--IYMVFEYMD----HDLTGLLDSPEVKFTESQ------IKC 104

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
             +++L GL+YLH N ++HRDIKG N+L+ ++  +KL DFG    L R   +RN+   T 
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFG----LARPYTKRNSADYTN 160

Query: 225 -----YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-------------- 265
                ++  PE++         Y    D+WS+G    E+   +P                
Sbjct: 161 RVITLWYRPPELLLGATR----YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Query: 266 ------------CDLHPMRALFLIPRNAPPRLK---SKKWPKKFQSFIETVLVKDYHQRP 310
                           P        +    RL+              ++ +L  D  +R 
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276

Query: 311 YTDQLLKHPFI 321
             DQ L+H + 
Sbjct: 277 SADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  134 bits (339), Expect = 1e-36
 Identities = 85/268 (31%), Positives = 135/268 (50%), Gaps = 19/268 (7%)

Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRNIA 115
            + VVG G+YG+V   RH   G+   IK +++      E K    E  +L +   H NI 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIV 62

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            Y     ++S  G+D  L++VM +C  G +   +K  KG+ L E  +     +I   L+Y
Sbjct: 63  AY-----RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           LHE  ++HRD+K QNV LT    +K+ D G++  L+      +T IGTPY+M+PE+ +  
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS-- 175

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF--LIPRNAPPRLKSKKWPKK 293
              +  Y+ +SD+W+LG    EMA  +    +   M +L   +I    PP    K +  +
Sbjct: 176 ---NKPYNYKSDVWALGCCVYEMATLKHAF-NAKDMNSLVYRIIEGKLPP--MPKDYSPE 229

Query: 294 FQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               I T+L K   +RP    +L+ P+I
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (340), Expect = 2e-36
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 32/266 (12%)

Query: 58  ELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNH 111
            L + +G G +G+VYKG+      K     A+K +  D +E + EE   E  +++K  +H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+    G   ++ P      L++VMEY   G +   ++  + +    + ++F   +I R
Sbjct: 61  PNVVKLLGVCTEEEP------LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSF-ALQIAR 113

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT----PY-W 226
           G++YL     IHRD+  +N L+ +N  VK+ DFG+S    R +   + +       P  W
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYRKRGGKLPIRW 169

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIPR-NAPPR 284
           MAPE +      +  + ++SD+WS G+   E+    + P   +     L  +      P+
Sbjct: 170 MAPESLK-----EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ 224

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRP 310
             +   P +    +     +D   RP
Sbjct: 225 PPNC--PPELYDLMLQCWAEDPEDRP 248

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  134 bits (339), Expect = 2e-36
 Identities = 86/277 (31%), Positives = 135/277 (48%), Gaps = 34/277 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           +E I VVG G +G V+  R     +L  IK + V   T+DE    + E  VLK   +H N
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  YY  F++      D  L +VMEY   G++ + ++      L E+ I     +IL  L
Sbjct: 61  IIEYYENFLE------DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
            ++H   ++HRD+K QN+LL  +  V K+ DFG+S  L  +  +  T +GTP +++PE+ 
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPEL- 172

Query: 233 ACDENPDATYDNRSDLWSLGITALEM--------AESQPPLCDLHPMRALFLIPRNAPPR 284
            C+  P   Y+ +SD+W+LG    E+        A + P L  L  M   F     AP  
Sbjct: 173 -CEGKP---YNQKSDIWALGCVLYELASLKRAFEAANLPALV-LKIMSGTF-----AP-- 220

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             S ++    +  I ++L  D  +RP   Q++  P  
Sbjct: 221 -ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  134 bits (338), Expect = 3e-36
 Identities = 91/271 (33%), Positives = 141/271 (52%), Gaps = 24/271 (8%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK------KYSNHRNI 114
           +++G G +G+VY      TG+  A+K +    D +E  K E+N L+      K   H  I
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK-EVNALECEIQLLKNLRHDRI 66

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             YYG    + P  K  +L + +EY   GS+ D +K+    +L E       R+IL+G+ 
Sbjct: 67  VQYYGCL--RDPEEK--KLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVS 120

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI----GTPYWMAPE 230
           YLH N ++HRDIKG N+L      VKL DFG S ++ +TI    T I    GTPYWM+PE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPE 179

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VI+ +      Y  ++D+WS+  T +EM   +PP  +   M A+F I       +     
Sbjct: 180 VISGE-----GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV 234

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               + F++ + V++  +RP  + LL+HPF+
Sbjct: 235 SDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 1e-35
 Identities = 87/301 (28%), Positives = 144/301 (47%), Gaps = 56/301 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKL-EINVLKKYSNHRNI 114
           +++I+ +G+GT+G VY  R+ +TG+L AIK M       EE + L E+  L+K + H NI
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                 F +       D+L+ V EY   G++  L+K  KG+   E  I  I  +IL+GL 
Sbjct: 61  VKLKEVFREN------DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF---IGTPYWMAPEV 231
           ++H++   HRD+K +N+L++    VK+ DFG    L R I  R  +   + T ++ APE+
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFG----LAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA----LFLI------PRNA 281
           +    +    Y +  D+W+LG    E+   +P    L P  +    L+ I      P   
Sbjct: 170 LLRSTS----YSSPVDIWALGCIMAELYTLRP----LFPGSSEIDQLYKICSVLGTPTKQ 221

Query: 282 P----PRLKSK---KWPKKFQS---------------FIETVLVKDYHQRPYTDQLLKHP 319
                 +L SK   ++P+   +                I+ +L  D  +RP   Q L+HP
Sbjct: 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281

Query: 320 F 320
           +
Sbjct: 282 Y 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  134 bits (338), Expect = 2e-35
 Identities = 92/297 (30%), Positives = 144/297 (48%), Gaps = 48/297 (16%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHRNIA 115
           E +  +G+G  G VYK  H  TG+L A+KV+    ++    +I  EI +L+   NH N+ 
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD-VNHPNVV 135

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL-KEEWIAFICREILRGLK 174
             +  F        + ++ +++E+   GS+       +G  +  E+++A + R+IL G+ 
Sbjct: 136 KCHDMF------DHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVARQILSGIA 182

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           YLH   ++HRDIK  N+L+     VK+ DFGVS  L +T+   N+ +GT  +M+PE I  
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242

Query: 235 DENPDATYDNRS-DLWSLGITALEMAESQPPL---------------CDLHPMRALFLIP 278
           D N    YD  + D+WSLG++ LE    + P                C   P  A    P
Sbjct: 243 DLN-HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA----P 297

Query: 279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-RDQPTERQARIQL 334
             A           +F+ FI   L ++  +R    QLL+HPFI R QP + Q    L
Sbjct: 298 ATASR---------EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNL 345

Length = 353

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  131 bits (330), Expect = 5e-35
 Identities = 76/267 (28%), Positives = 136/267 (50%), Gaps = 26/267 (9%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-----DEEEEIKLEINVLKKYS 109
           G F++ + +G G +  VYK      G++ A+K + + E       ++ +K EI++LK+  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL- 59

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEE---WIAFI 165
           +H N+  Y  +FI+      +++L +V+E   AG ++ ++K  K Q  L  E   W  F+
Sbjct: 60  DHPNVIKYLASFIE------NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
             ++   L+++H  +++HRDIK  NV +T    VKL D G+           ++ +GTPY
Sbjct: 114 --QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-CDLHPMRALFL-IPRNAPP 283
           +M+PE I      +  Y+ +SD+WSLG    EMA  Q P   D   + +L   I +   P
Sbjct: 172 YMSPERIH-----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP 226

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRP 310
            L +  + ++ +  +   +  D  +RP
Sbjct: 227 PLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-34
 Identities = 85/299 (28%), Positives = 129/299 (43%), Gaps = 50/299 (16%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRN 113
           ++ +  +G GTYG VYK R   TG++ AIK + +  + E   K    EI +LK+  NH N
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS--LKEEWIAFICREILR 171
           I      F        D  L+LV E+      TDL K  K +   L E  I     ++L+
Sbjct: 60  IIKLLDVF----RHKGD--LYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQ 109

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT-FIGTPYWMAPE 230
           GL + H + ++HRD+K +N+L+     +KL DFG  A+   +  R  T ++ T ++ APE
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFG-LARSFGSPVRPYTHYVVTRWYRAPE 168

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI------------- 277
           ++      D  Y    D+WS+G    E+   +P       +  LF I             
Sbjct: 169 LLL----GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224

Query: 278 -----PRNAPPRLKSKK---WPKKFQ-------SFIETVLVKDYHQRPYTDQLLKHPFI 321
                 RN       K     PK F          +  +L  D H+R   +Q L HP+ 
Sbjct: 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  128 bits (324), Expect = 3e-34
 Identities = 85/278 (30%), Positives = 134/278 (48%), Gaps = 31/278 (11%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIK----VMDVTEDEE---EEIKLEINVLKKYSNHRN 113
           + +G G +   Y+ R  KTG L A+K    V + + ++E   E ++ EI ++ +  NH +
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPH 64

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I    GA  + S         L +E+   GSV+ L+   K  + KE  I     ++LRGL
Sbjct: 65  IIRMLGATCEDS------HFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGL 116

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAE-VKLVDFGVSAQLDRTIGRRNTF----IGTPYWMA 228
            YLHEN++IHRD+KG N+L+    + +++ DFG +A+L         F    +GT  +MA
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----NAPPR 284
           PEV+  ++     Y    D+WS+G   +EMA ++PP         L LI +       P 
Sbjct: 177 PEVLRGEQ-----YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +     P   +      L      RP + +LLKHP  R
Sbjct: 232 IPEHLSP-GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  122 bits (308), Expect = 3e-32
 Identities = 73/220 (33%), Positives = 117/220 (53%), Gaps = 22/220 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLKKYSNHRNI 114
           + ++ VVG G++G+    +H  + Q  A+K   +  +    E+ + E  +L K   H NI
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNI 60

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +  +F        D  L++VMEYC  G +   +K  +G+   E+ I     ++  G++
Sbjct: 61  VAFKESF------EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           ++HE +V+HRDIK +N+ LT N +VKL DFG +  L        T++GTPY++ PE+   
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-- 172

Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRA 273
            EN    Y+N+SD+WSLG    E       LC L HP +A
Sbjct: 173 -EN--MPYNNKSDIWSLGCILYE-------LCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  121 bits (306), Expect = 1e-31
 Identities = 68/209 (32%), Positives = 110/209 (52%), Gaps = 25/209 (11%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           +G G +G+V   +     +  A+K +     V   ++E I  E  +L++  NH  I   Y
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59

Query: 119 GAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA-FICREILRGLKYL 176
             F       KD + ++++MEYC  G +  +++  +G  L +E+ A F    ++   +YL
Sbjct: 60  RTF-------KDKKYIYMLMEYCLGGELWTILRD-RG--LFDEYTARFYIACVVLAFEYL 109

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN-TFIGTPYWMAPEVIACD 235
           H   +I+RD+K +N+LL  N  VKLVDFG + +L    G++  TF GTP ++APE+I   
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--GQKTWTFCGTPEYVAPEIIL-- 165

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPP 264
              +  YD   D WSLGI   E+   +PP
Sbjct: 166 ---NKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  121 bits (306), Expect = 6e-31
 Identities = 93/331 (28%), Positives = 137/331 (41%), Gaps = 91/331 (27%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           +EL++ +G+G YG V      +TG+  AIK + +V +D  +      EIKL    L+ + 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKL----LR-HL 56

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL---VKSTKGQSLKEEWIAFIC 166
            H NI          SP   +D +++V E       TDL   +KS   Q L ++ I +  
Sbjct: 57  RHENIIGLLDILRPPSPEDFND-VYIVTELME----TDLHKVIKS--PQPLTDDHIQYFL 109

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG--TP 224
            +ILRGLKYLH   VIHRD+K  N+L+  N ++K+ DFG    L R +       G  T 
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTE 165

Query: 225 Y----WM-APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF---- 275
           Y    W  APE++         Y    D+WS+G    E+             + LF    
Sbjct: 166 YVVTRWYRAPELLLSSSR----YTKAIDIWSVGCIFAELLT----------RKPLFPGRD 211

Query: 276 ------LI------P-----------------RNAPPRLKSKKWPKKFQS-------FIE 299
                 LI      P                 ++ P + K K   K F          +E
Sbjct: 212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK-KPLSKLFPGASPEAIDLLE 270

Query: 300 TVLVKDYHQRPYTDQLLKHPF---IRDQPTE 327
            +LV D  +R   D+ L HP+   + D   E
Sbjct: 271 KMLVFDPKKRITADEALAHPYLAQLHDPEDE 301

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  119 bits (300), Expect = 7e-31
 Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 34/278 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD-VTEDEEEEIKLEINVLKKYS--NHRN 113
           FEL+ V+G G +G+V   +   T ++ A+K M+     E+  ++  +N  +     NH  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 114 IATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDL-VKSTKGQSLKEEWIAFICREILR 171
           +   + +F       +D++ ++LV++    G   DL    ++     EE + F   EI+ 
Sbjct: 62  LVNLWYSF-------QDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVL 111

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI-GTPYWMAPE 230
            L+YLH   +IHRDIK  N+LL +   V + DF ++ ++  T     T   GTP +MAPE
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPE 169

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPP-----LCDLHPMRALFLIPRNAPPRL 285
           V+         Y    D WSLG+TA E    + P           +RA           L
Sbjct: 170 VLC-----RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV----L 220

Query: 286 KSKKWPKKFQSFIETVLVKDYHQR--PYTDQLLKHPFI 321
               W  +    I  +L +D  +R       L  HP+ 
Sbjct: 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  119 bits (299), Expect = 2e-30
 Identities = 84/296 (28%), Positives = 142/296 (47%), Gaps = 45/296 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKL-EINVLKKYSNHRN 113
           +E +  +G G+YG V+K R+ +TGQ+ AIK    +ED+   ++I L EI +LK+   H N
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPN 61

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +      F +K       +L LV EYC    + +L K+ +G  + E  I  I  + L+ +
Sbjct: 62  LVNLIEVFRRKR------KLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAV 113

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            + H++  IHRD+K +N+L+T   ++KL DFG +  L         ++ T ++ APE++ 
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQP------PLCDLHPMRALF--LIPRN----- 280
                D  Y    D+W++G    E+   QP       +  L+ +R     LIPR+     
Sbjct: 174 ----GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229

Query: 281 -----------APPRLK--SKKWPKKFQ---SFIETVLVKDYHQRPYTDQLLKHPF 320
                       P   +    K+P       SF++  L  D  +R   ++LL+HP+
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  118 bits (297), Expect = 4e-30
 Identities = 87/300 (29%), Positives = 137/300 (45%), Gaps = 53/300 (17%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRN 113
           +E + +VG G+YG V K +H +TGQ+ AIK    +ED++   K+   EI +LK+   H N
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHEN 61

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +      F +K       +L+LV E+     + DL K   G  L E  +     +ILRG+
Sbjct: 62  LVNLIEVFRRKK------RLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGI 113

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT----FIGTPYWMAP 229
           ++ H + +IHRDIK +N+L++ +  VKL DFG +    RT+         ++ T ++ AP
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA----RTLAAPGEVYTDYVATRWYRAP 169

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL---CDL----HPMRAL-FLIPRNA 281
           E++      D  Y    D+W++G    EM   +P      D+    H ++ L  LIPR+ 
Sbjct: 170 ELLV----GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225

Query: 282 ---------------------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
                                P   +  K         +  L  D   RP + QLL H F
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 9e-30
 Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 40/295 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKK--YSN 110
           +E +  +G G YG VYK R   TG+  A+K + V   EE  I L    EI +LK+     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFE 59

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI              +   L LV E+      T L K  K   L  E I  + R++L
Sbjct: 60  HPNIVRLLDVCHGPRTDRELK-LTLVFEHVDQDLATYLSKCPK-PGLPPETIKDLMRQLL 117

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RG+ +LH ++++HRD+K QN+L+T + +VK+ DFG++      +    + + T ++ APE
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPE 176

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPP 283
           V+       ++Y    D+WS+G    E+   +P          L  I            P
Sbjct: 177 VLL-----QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 284 RLKSKKW-------PKKFQSFIETV-----------LVKDYHQRPYTDQLLKHPF 320
           R  S          P+ F+SF+  +           L  + H+R    + L+HP+
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  116 bits (291), Expect = 1e-29
 Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 30/271 (11%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVM------DVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +G G++G VY  +  K      +KV+      ++  +E  +   E  +L K   H  I  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVK 66

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKE----EWIAFICREIL 170
           ++ +F+++      D   ++ EYC    +   ++  K  G++L E    EW  FI  ++L
Sbjct: 67  FHASFLER------DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FI--QLL 116

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G+ Y+H+ +++HRD+K +N+ L +N  +K+ DFGVS  L  +     TF GTPY+M+PE
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
            +         YD++SD+WSLG    EM          + +  +  I     P L  + +
Sbjct: 176 ALK-----HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL-PETY 229

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            ++  S ++++L KD   RP   ++L++PFI
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  116 bits (291), Expect = 1e-29
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 21/206 (10%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           +  G +G VY  +   TG   AIKV+     + +++   +K E  ++        +A  Y
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            +F  K      D L+LVMEY   G    L+K+  G  L E+W      E++ G++ LH+
Sbjct: 64  YSFQSK------DYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQ 115

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
             +IHRDIK +N+L+     +KL DFG+S    R       F+GTP ++APE I      
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLS----RNGLENKKFVGTPDYLAPETI--LGVG 169

Query: 239 DATYDNRSDLWSLGITALEMAESQPP 264
           D   D  SD WSLG    E     PP
Sbjct: 170 D---DKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  117 bits (294), Expect = 2e-29
 Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 32/287 (11%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATY 117
           V+G G++G+V       T +L A+KV+     + +D+ E    E  VL     H  +   
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS-LKEEWIAFICREILRGLKYL 176
           +  F  K      D+L+ VMEY   G   DL+   +      E    F   EI+ GL++L
Sbjct: 62  HSCFQTK------DRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           HE  +I+RD+K  NVLL     +K+ DFG+  +        +TF GTP ++APE+++   
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP---PRLKSKKWPKK 293
                Y    D W+LG+   EM   Q P  +      LF          PR  SK+    
Sbjct: 173 -----YGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSI 226

Query: 294 FQSFIETVLVKDYHQR----PYTDQ-LLKHPFIRDQPTERQARIQLK 335
            +SF    L K+  +R    P  +Q +  HPF R+   ++  R ++K
Sbjct: 227 LKSF----LTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIK 269

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  116 bits (292), Expect = 4e-29
 Identities = 90/318 (28%), Positives = 148/318 (46%), Gaps = 63/318 (19%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLKKYSNHRNI 114
           FE I  +G G  G V+K  H  +G + A K+  +++      +I  E+ VL +  N   I
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPYI 65

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL 
Sbjct: 66  VGFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 117

Query: 175 YLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YL E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE + 
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ 175

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL---------------------------- 265
                   Y  +SD+WS+G++ +EMA  + P+                            
Sbjct: 176 -----GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230

Query: 266 ------------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
                        D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R
Sbjct: 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAER 290

Query: 310 PYTDQLLKHPFIRDQPTE 327
               QL+ H FI+    E
Sbjct: 291 ADLKQLMVHAFIKRSEAE 308

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 9e-29
 Identities = 81/332 (24%), Positives = 134/332 (40%), Gaps = 67/332 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE+I+V+G G +G+V+  R   TGQ+ A+KV+     +  ++   ++ E ++L    +  
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-P 61

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGS-VTDLVKSTKGQSLKEEWIAFICREIL 170
            I   Y +F       +D++ L+LVMEY   G  +  L++        EE   F   E++
Sbjct: 62  WIVKLYYSF-------QDEEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELV 111

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-------------------- 210
             L  +H+   IHRDIK  N+L+  +  +KL DFG+  ++                    
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 211 ---------DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES 261
                     +   R N+ +GTP ++APEV+         Y    D WSLG+   EM   
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-----YGLECDWWSLGVILYEMLYG 226

Query: 262 QPPLCDLHPMRALFLIPRNA-----PPRLKSKKWPKKFQSFIETVLVKDYHQR-PYTDQL 315
            PP            I         PP         +    I   L+ D   R    +++
Sbjct: 227 FPPFYSDTLQETYNKIINWKESLRFPP---DPPVSPEAIDLICR-LLCDPEDRLGSFEEI 282

Query: 316 LKHPFIR----DQPTERQA--RIQLKDHIDTC 341
             HPF +    +   E +     +L   +DT 
Sbjct: 283 KSHPFFKGIDWENLRETKPPFVPELSSPLDTS 314

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  111 bits (278), Expect = 9e-28
 Identities = 76/265 (28%), Positives = 131/265 (49%), Gaps = 26/265 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHR 112
           F++ + +G G + +VY+       +  A+K + + E       ++   EI++LK+  NH 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL----KEEWIAFICRE 168
           N+  Y  +FI+      D++L +V+E   AG ++ ++K  K Q      +  W  F+  +
Sbjct: 63  NVIKYLDSFIE------DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV--Q 114

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
           +   ++++H  +V+HRDIK  NV +T    VKL D G+           ++ +GTPY+M+
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL---IPRNAPPRL 285
           PE I   EN    Y+ +SD+WSLG    EMA  Q P      M    L   I +   P L
Sbjct: 175 PERI--HEN---GYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPL 228

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRP 310
            ++ + +K +  +   +  D  QRP
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  112 bits (283), Expect = 9e-28
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 15/211 (7%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIK---LEINVLKKYSNHR 112
            ++ +  VG+G YGQV     TKTG+  AIK +          K    E+ +LK + +H 
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK-HMDHE 74

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           N+      F   S       ++LV    GA    DL    K Q L ++ I F+  +ILRG
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGA----DLNNIVKCQKLSDDHIQFLVYQILRG 130

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           LKY+H   +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIM 187

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQP 263
               +    Y+   D+WS+G    E+   + 
Sbjct: 188 LNWMH----YNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  111 bits (279), Expect = 2e-27
 Identities = 85/275 (30%), Positives = 134/275 (48%), Gaps = 35/275 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           FE +  +G GTYG VY+ R T +G++ A+K +   ++E + I +    EI +L     H 
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNL-RHP 66

Query: 113 NIATYYGAFIKKSPPGKD-DQLWLVMEYC--GAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           NI       +K+   GK  D ++LVMEYC     S+ D + +       E  +  +  ++
Sbjct: 67  NIVE-----LKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP----FSESQVKCLMLQL 117

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           LRGL+YLHEN +IHRD+K  N+LLTD   +K+ DFG++             + T ++ AP
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--NAPPRLKS 287
           E++        TY    D+W++G    E+   +P L     +  L LI +    P     
Sbjct: 178 ELLLGCT----TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP---NE 230

Query: 288 KKWPKKFQSFIETVLVKDYH--QRPYTDQLLKHPF 320
             WP     F +  LV  +   ++PY +  LKH F
Sbjct: 231 SIWP----GFSDLPLVGKFTLPKQPYNN--LKHKF 259

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  111 bits (279), Expect = 2e-27
 Identities = 89/320 (27%), Positives = 146/320 (45%), Gaps = 65/320 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLKKYSNHRNI 114
           FE I  +G G  G V K +H  +G + A K+  +++      +I  E+ VL +  N   I
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPYI 65

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +YGAF        D ++ + ME+   GS+  ++K  K   + EE +  +   +LRGL 
Sbjct: 66  VGFYGAFYS------DGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLA 117

Query: 175 YLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YL E ++++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE + 
Sbjct: 118 YLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ 175

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL---------------------------- 265
                   Y  +SD+WS+G++ +E+A  + P+                            
Sbjct: 176 -----GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230

Query: 266 --------------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYH 307
                          D  P  A+F     I    PP+L +  +   FQ F+   L+K+  
Sbjct: 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPA 290

Query: 308 QRPYTDQLLKHPFIRDQPTE 327
           +R     L+ H FI+    E
Sbjct: 291 ERADLKMLMNHTFIKRSEVE 310

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 3e-27
 Identities = 79/286 (27%), Positives = 125/286 (43%), Gaps = 45/286 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE----IKLEINVLKKYSNHR 112
           F+ I+++G G  G+V+  R   TG+L A+KV+D  E  +      +  E  +L    +H 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT-LDHP 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            + T Y +F        +  L LVM+YC  G +  L++   G+ L EE   F   E+L  
Sbjct: 62  FLPTLYASF------QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG----------------- 215
           L+YLH   +++RD+K +N+LL ++  + L DF +S Q D                     
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 216 ------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
                       R N+F+GT  ++APEVI+ D      + +  D W+LGI   EM     
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-----GHGSAVDWWTLGILLYEMLYGTT 230

Query: 264 PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
           P    +       I +       S       +  I  +LVKD  +R
Sbjct: 231 PFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  110 bits (278), Expect = 4e-27
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 28/218 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F  + V+G G +G+V    + KTG+L AIK +     +  DE E +  E  + +  ++ R
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 113 N--IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           +  +   +  F  +      D +  VMEY   G   DL+         E    F    ++
Sbjct: 61  HPFLVNLFACFQTE------DHVCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVV 111

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ----LDRTIGRRNTFIGTPYW 226
            GL+YLHENK+++RD+K  N+LL     VK+ DFG+  +     DRT    +TF GTP +
Sbjct: 112 LGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT----STFCGTPEF 167

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           +APEV+      + +Y    D W LG+   EM   + P
Sbjct: 168 LAPEVLT-----ETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 80/306 (26%), Positives = 127/306 (41%), Gaps = 45/306 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+++  VG G YGQV+  +   TG++ A+K M        +E   +  E ++L   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSE 61

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +     AF       +DD+ L+L MEY   G    L+ +  G  L E+   F   E+  
Sbjct: 62  WLVKLLYAF-------QDDEYLYLAMEYVPGGDFRTLL-NNLG-VLSEDHARFYMAEMFE 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            +  LHE   IHRD+K +N L+  +  +KL DFG+S      +   N+ +G+P +MAPEV
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG---IVTYANSVVGSPDYMAPEV 169

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLC---------DLHPMRALFLIPRNAP 282
           +         YD   D WSLG    E     PP           +L   +     P    
Sbjct: 170 LR-----GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224

Query: 283 PR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARI------QL 334
           PR  L  + W       I  ++     +    + +  HPF ++        +      +L
Sbjct: 225 PRFNLSDEAW-----DLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPEL 279

Query: 335 KDHIDT 340
           +  IDT
Sbjct: 280 ESEIDT 285

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 79/264 (29%), Positives = 125/264 (47%), Gaps = 37/264 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHR 112
            E I+ VG GT+G+V+  R   +    A+KVM + E     +E+ +  E  VLK+ S H 
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HP 61

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            I   +           D + L+++MEY   G +   ++++           F   EI+ 
Sbjct: 62  FIIRLFWTE-------HDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVC 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPE 230
            L+YLH  ++++RD+K +N+LL     +KL DFG + +L DRT     T  GTP ++APE
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPE 168

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK-K 289
           VI         ++   D W+LGI   EM    PP  D +P      I       L  K +
Sbjct: 169 VIQ-----SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-------LAGKLE 216

Query: 290 WPKKFQSF----IETVLVKDYHQR 309
           +P+    +    I+ +LV D  +R
Sbjct: 217 FPRHLDLYAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  107 bits (268), Expect = 2e-26
 Identities = 83/276 (30%), Positives = 137/276 (49%), Gaps = 29/276 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK---VMDVTEDEEEE--IKLEINVLKKYSNH 111
           F + + +G G + +VY+      G   A+K   + D+ + +     IK EI++LK+  NH
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQL-NH 61

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL----KEEWIAFICR 167
            N+  YY +FI+      D++L +V+E   AG ++ ++K  K Q      K  W  F+  
Sbjct: 62  PNVIKYYASFIE------DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-- 113

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM 227
           ++   L+++H  +V+HRDIK  NV +T    VKL D G+           ++ +GTPY+M
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLC-DLHPMRALF-LIPRNAPPRL 285
           +PE I   EN    Y+ +SD+WSLG    EMA  Q P   D   + +L   I +   P L
Sbjct: 174 SPERI--HEN---GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKH 318
            S  + ++ +  +   +  D  +RP   Y   + K 
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  107 bits (269), Expect = 5e-26
 Identities = 79/318 (24%), Positives = 129/318 (40%), Gaps = 52/318 (16%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---- 100
             +    D    +E +  +G GT+G+V+K RH KT Q+ A+K   + E+E+E   +    
Sbjct: 2   QYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-KVLMENEKEGFPITALR 60

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDD--QLWLVMEYCGAGSVTDLVK--STKGQS 156
           EI +L+    H N+         K+ P        +LV E+C      DL    S K   
Sbjct: 61  EIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH----DLAGLLSNKNVK 115

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIG 215
                I  + + +L GL Y+H NK++HRD+K  N+L+T +  +KL DFG++ A       
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175

Query: 216 RRNTFIG---TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP--------- 263
           + N +     T ++  PE++  + +    Y    D+W  G    EM    P         
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERD----YGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231

Query: 264 -----------------PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ----SFIETVL 302
                            P  D   +     +P+    ++K +  P          I+ +L
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291

Query: 303 VKDYHQRPYTDQLLKHPF 320
           V D  +R   D  L H F
Sbjct: 292 VLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  107 bits (269), Expect = 5e-26
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 14/214 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEE--EIKLEINVLKKYSNHR 112
           F++  +VG G +G+V   R   TG + A+KVM   V   +E     + E ++L   ++  
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
                Y AF  K      D L+LVMEY   G +  L+   + Q   E+   F   E++  
Sbjct: 63  IPQLQY-AFQDK------DNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLA 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF-IGTPYWMAPEV 231
           +  +H+   +HRDIK +NVL+     +KL DFG +A+L       +   +GTP ++APEV
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 232 I-ACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           +   + +   TY    D WSLG+ A EM   + P
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  106 bits (266), Expect = 5e-26
 Identities = 68/269 (25%), Positives = 124/269 (46%), Gaps = 27/269 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQ-LAAIKVMDVTEDEE-----------EEIKLEINV 104
           + ++E +G+G +G VYK R    GQ L A+K ++V                 +I  E+ +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS--TKGQSLKEEWI 162
           +K+   H NI  YY  F++      +D+L++VM+      + +   S   K Q   EE I
Sbjct: 62  IKEQLRHPNIVRYYKTFLE------NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115

Query: 163 AFICREILRGLKYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
             I  +++  L+YLH E +++HRD+   N++L ++ +V + DFG++ Q      +  + +
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV 174

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           GT  +  PE++      +  Y  ++D+W+ G    +M   QPP    + +     I    
Sbjct: 175 GTILYSCPEIVK-----NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRP 310
              L    + +     I + L  D   RP
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  106 bits (266), Expect = 6e-26
 Identities = 73/215 (33%), Positives = 111/215 (51%), Gaps = 24/215 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIK----LEINVLKKYSNHR 112
           +  IE +G GTYG VYKGR+ KTGQ+ A+K + + E EEE +      EI++LK+   H 
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRL-ESEEEGVPSTAIREISLLKEL-QHP 59

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI       +      ++ +L+L+ E+        L    KGQ +  E +     +IL+G
Sbjct: 60  NIVCLQDVLM------QESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTPYWMA 228
           + + H  +V+HRD+K QN+L+ +   +KL DFG    L R  G   R  T  + T ++ A
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFG----LARAFGIPVRVYTHEVVTLWYRA 169

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           PEV+         Y    D+WS+G    EMA  +P
Sbjct: 170 PEVLL----GSPRYSTPVDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  106 bits (266), Expect = 1e-25
 Identities = 72/260 (27%), Positives = 125/260 (48%), Gaps = 29/260 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHR 112
           FE+ E +G G++G+V   +H  TG+  AIK +   E     + + +  E ++L + S H 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HP 78

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILR 171
            I     +F        +++++ ++E+   G + T L K+ +      +   F   E++ 
Sbjct: 79  FIVNMMCSFQD------ENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVL 129

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPE 230
             +YLH   +I+RD+K +N+LL +   VK+ DFG + ++ DRT     T  GTP ++APE
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLAPE 185

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VI    +  A      D W++G+   E     PP  D  P R    I      RLK   W
Sbjct: 186 VIQSKGHGKAV-----DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG---RLKFPNW 237

Query: 291 -PKKFQSFIETVLVKDYHQR 309
              + +  ++ +L  D+ +R
Sbjct: 238 FDGRARDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score =  104 bits (260), Expect = 8e-25
 Identities = 86/317 (27%), Positives = 129/317 (40%), Gaps = 65/317 (20%)

Query: 71  VYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEIN--VLKKYSNHRNIATYYGAFIKKSPPG 128
           VY  RHT TG L  +++ D+    EE +K   N  VL  +  H NI T +  F   S   
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--- 72

Query: 129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKG 188
               LW++  +   GS   L+K+   + + E  I  I    LRGL YLH+N  IHR+IK 
Sbjct: 73  ---WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKA 129

Query: 189 QNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-------WMAPEVIACDENPDAT 241
            ++L++ +  V L        L R   +       P        W++PE++  D      
Sbjct: 130 SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY---G 186

Query: 242 YDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--------------RLK- 286
           Y+ +SD++S+GITA E+A  + P  D+   + L L     PP              R+K 
Sbjct: 187 YNVKSDIYSVGITACELATGRVPFQDMLRTQML-LQKLKGPPYSPLDITTFPCEESRMKN 245

Query: 287 -------------------------------SKKWPKKFQSFIETVLVKDYHQRPYTDQL 315
                                          SK +   FQ+ +E  L +D  +RP    L
Sbjct: 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305

Query: 316 LKHPFIRDQPTERQARI 332
           L H F +    + Q  I
Sbjct: 306 LSHAFFKQVKEQTQGSI 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 77/254 (30%), Positives = 115/254 (45%), Gaps = 23/254 (9%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATY 117
           V+G G++G+V   +H   G+  A+KV+     + + E++ I  E NVL K   H  +   
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
           + +F         D+L+ V++Y   G +   ++  +  S  E    F   EI   L YLH
Sbjct: 62  HYSFQTA------DKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH 113

Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
              +I+RD+K +N+LL     V L DFG+  +        +TF GTP ++APEV+     
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP- 172

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLC--DLHPMRALFLIPRNAPPRLKSKKWPKKFQ 295
               YD   D W LG    EM    PP    D   M    L   N P RLK        +
Sbjct: 173 ----YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL---NKPLRLKPNISVSA-R 224

Query: 296 SFIETVLVKDYHQR 309
             +E +L KD  +R
Sbjct: 225 HLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  103 bits (258), Expect = 1e-24
 Identities = 83/275 (30%), Positives = 123/275 (44%), Gaps = 37/275 (13%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G++G+V   +    G+  A+KV+     +   E++ I  E NVL K   H  +  
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + +F         ++L+ V+++   G +       + +S  E    F   EI   L YL
Sbjct: 61  LHYSF------QTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRNTFIGTPYWMAPEVI 232
           H   +++RD+K +N+LL     V L DFG+     AQ D T     TF GTP ++APEVI
Sbjct: 113 HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT----TTFCGTPEYLAPEVI 168

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLC--DLHPMRALFL-IPRNAPPRLKSKK 289
              + P   YDN  D W LG    EM    PP    D+  M    L  P    P      
Sbjct: 169 R--KQP---YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTA 223

Query: 290 WPKKFQSFIETVLVKDYHQR-PYTDQLLK---HPF 320
           W     S +E +L KD  +R    +  L+   HPF
Sbjct: 224 W-----SILEELLEKDRQRRLGAKEDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 85/286 (29%), Positives = 127/286 (44%), Gaps = 41/286 (14%)

Query: 57  FELIEVVGNGTYGQVY----KGRHTKTGQLAAIKVMDVT-----EDEEEEIKLEINVLKK 107
           FEL+ V+G G YG+V+     G H   G+L A+KV+            E  + E  VL+ 
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFIC 166
                 + T + AF        D +L L+++Y   G + T L +    +   E  +    
Sbjct: 61  VRRCPFLVTLHYAF------QTDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYI 111

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPY 225
            EI+  L +LH+  +I+RDIK +N+LL     V L DFG+S + L     R  +F GT  
Sbjct: 112 AEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----NA 281
           +MAPEVI         +D   D WSLG+   E+     P        +   I R    + 
Sbjct: 172 YMAPEVI---RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK 228

Query: 282 PPRLKSKKWPKKF----QSFIETVLVKDYHQR---PYTDQLLKHPF 320
           PP      +PK      + FI+ +L KD  +R      D++  HPF
Sbjct: 229 PP------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  104 bits (260), Expect = 2e-24
 Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 16/213 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVTEDEEEEIKLEINVLKKYSNHRN 113
           F++I+V+G G +G+V   RH  + Q+ A+K++   ++ +  +     E   +  ++N   
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104

Query: 114 IATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           I   + AF       +DD+ L++VMEY   G   DLV       + E+W  F   E++  
Sbjct: 105 IVQLHYAF-------QDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKWARFYTAEVVLA 154

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEV 231
           L  +H    IHRD+K  N+LL  +  +KL DFG   ++D   + R +T +GTP +++PEV
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           +   +  D  Y    D WS+G+   EM     P
Sbjct: 215 LK-SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  102 bits (256), Expect = 3e-24
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 19/208 (9%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEE-EEIKLEINVLKKYSNHRNIATY 117
           V+G G+Y +V      KT ++ A+KV+    V +DE+ + ++ E +V +  SNH  +   
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRGLKYL 176
           +  F  +S      +L+ V+E+   G   DL+   + Q  L EE   F   EI   L +L
Sbjct: 62  HSCFQTES------RLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           HE  +I+RD+K  NVLL     +KL D+G+  +  R     +TF GTP ++APE++  ++
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPP 264
                Y    D W+LG+   EM   + P
Sbjct: 173 -----YGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  101 bits (254), Expect = 3e-24
 Identities = 53/211 (25%), Positives = 102/211 (48%), Gaps = 17/211 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---EEIKLEINVLKKYSNHRN 113
           ++++  +G G +G V+K +  +TG+  A+K + +   E     +   EI  L+    H  
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHPY 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +      F    P G      LVMEY     ++++++  + + L E  +    R +L+G+
Sbjct: 61  VVKLLDVF----PHGSG--FVLVMEYMP-SDLSEVLRDEE-RPLPEAQVKSYMRMLLKGV 112

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF-IGTPYWMAPEVI 232
            Y+H N ++HRD+K  N+L++ +  +K+ DFG++        R  +  + T ++ APE++
Sbjct: 113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQP 263
                    YD   DLW++G    E+    P
Sbjct: 173 YGAR----KYDPGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  101 bits (255), Expect = 3e-24
 Identities = 62/186 (33%), Positives = 91/186 (48%), Gaps = 27/186 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL------EINVLKKYSN 110
           +E  + +G GTY  VYK R  +TG++ AIK + + E +E +  +      EI +L++   
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK- 60

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS--LKEEWIAFICRE 168
           H NI      F      G    + LV E+      TDL K  K +S  L    I      
Sbjct: 61  HPNIIGLLDVF------GHKSNINLVFEFME----TDLEKVIKDKSIVLTPADIKSYMLM 110

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG----TP 224
            LRGL+YLH N ++HRD+K  N+L+  +  +KL DFG    L R+ G  N  +     T 
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFG----LARSFGSPNRKMTHQVVTR 166

Query: 225 YWMAPE 230
           ++ APE
Sbjct: 167 WYRAPE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  101 bits (252), Expect = 4e-24
 Identities = 72/218 (33%), Positives = 112/218 (51%), Gaps = 31/218 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---EEEIKLEINVLKKYSNHRN 113
           F+ +E +G GTY  VYKGR+  TG++ A+K + +  +E      I+ EI+++K+   H N
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELK-HEN 59

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQ--SLKEEWIAFICREI 169
           I   +           +++L LV EY       DL K   T G   +L    +     ++
Sbjct: 60  IVRLHDVI------HTENKLMLVFEYMD----KDLKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG-RRNTF---IGTPY 225
           L+G+ + HEN+V+HRD+K QN+L+    E+KL DFG    L R  G   NTF   + T +
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFG----LARAFGIPVNTFSNEVVTLW 165

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           + AP+V+        TY    D+WS+G    EM   +P
Sbjct: 166 YRAPDVLLGSR----TYSTSIDIWSVGCIMAEMITGRP 199

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  102 bits (255), Expect = 5e-24
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 66/311 (21%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK----VMDVTEDEEEEIKLEINVLKKYSNHR 112
           ++ IE +G+G YG V     T++G+  AIK      DV    +  ++ E+ +L+ +  H 
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILR-HFKHD 64

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST------KGQSLKEEWIAFIC 166
           NI              KD  +++VM         DL++S         Q L EE I +  
Sbjct: 65  NIIAIRDILRPPGADFKD--VYVVM---------DLMESDLHHIIHSDQPLTEEHIRYFL 113

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF----IG 222
            ++LRGLKY+H   VIHRD+K  N+L+ ++ E+++ DFG++  L  +      F    + 
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 223 TPYWMAPEVI-ACDENPDATYDNRSDLWSLGITALEM---------------------AE 260
           T ++ APE++ +  E     Y    D+WS+G    EM                       
Sbjct: 174 TRWYRAPELLLSLPE-----YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228

Query: 261 SQPPL-------CDLHPMRALFLIPRNAPPRLKSKKWPKKFQ---SFIETVLVKDYHQRP 310
             P          D   +R          P   SK +PK        +  +L  D  +R 
Sbjct: 229 GSPSEEVLNRIGSDR--VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286

Query: 311 YTDQLLKHPFI 321
             +Q L+HPF+
Sbjct: 287 TVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  100 bits (252), Expect = 8e-24
 Identities = 61/201 (30%), Positives = 110/201 (54%), Gaps = 18/201 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +E +  +  GTYG VY+ R  KTG++ A+K + + E E+E   +    EIN+L K   H 
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM-EKEKEGFPITSLREINILLK-LQHP 64

Query: 113 NIATYYGAFIKKSPPGKD-DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           NI T     +K+   G + D++++VMEY     +  L+++ K   L+ E +  +  ++L 
Sbjct: 65  NIVT-----VKEVVVGSNLDKIYMVMEYV-EHDLKSLMETMKQPFLQSE-VKCLMLQLLS 117

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           G+ +LH+N ++HRD+K  N+LL +   +K+ DFG++ +    +      + T ++ APE+
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177

Query: 232 IACDENPDATYDNRSDLWSLG 252
           +         Y    D+WS+G
Sbjct: 178 LLG----AKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---EEIKLEINVLKKYSNHRN 113
           +E +E +G GTYG V+K ++ +T ++ A+K + + +D+E        EI +LK+   H+N
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKN 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR----EI 169
           I   Y           D +L LV EYC      DL K     S   +    I +    ++
Sbjct: 61  IVRLYDVLHS------DKKLTLVFEYCD----QDLKKYF--DSCNGDIDPEIVKSFMFQL 108

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+GL + H + V+HRD+K QN+L+  N E+KL DFG++      +   +  + T ++  P
Sbjct: 109 LKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168

Query: 230 EVIACDENPDAT-YDNRSDLWSLGITALEMAESQPPL 265
           +V+       A  Y    D+WS G    E+A +  PL
Sbjct: 169 DVLF-----GAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  100 bits (250), Expect = 2e-23
 Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 26/269 (9%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKL-EINVLKKYSNHRNIATY 117
           V+G G++G+V       T +  AIK +    V ED++ E  + E  VL     H  +   
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
           +  F  K      + L+ VMEY   G +   ++S+      E    F   EI+ GL++LH
Sbjct: 62  FCTFQTK------EHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH 113

Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           +  +I+RD+K  NVLL  +  +K+ DFG+  +     G+ +TF GTP ++APE++   + 
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK- 172

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPL--CDLHPMRALFLIPRNAPPRLKSKKW-PKKF 294
               Y+   D WS G+   EM   Q P    D      LF    N  P     +W  K+ 
Sbjct: 173 ----YNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSILNDRPHF--PRWISKEA 223

Query: 295 QSFIETVLVKDYHQR-PYTDQLLKHPFIR 322
           +  +  +  +D  +R      + +HPF R
Sbjct: 224 KDCLSKLFERDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  103 bits (258), Expect = 2e-23
 Identities = 78/299 (26%), Positives = 146/299 (48%), Gaps = 45/299 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQL---AAIKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
           +E+I+ +GNG +G+V+  +H +T +     AI    + E E+ ++ +E+NV+++   H+N
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKN 73

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ--SLKEEWIAFICREILR 171
           I  Y   F+ K+    + +L+++ME+C AG ++  ++        ++E  I  I R++L 
Sbjct: 74  IVRYIDRFLNKA----NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 172 GLKYLHE-------NKVIHRDIKGQNVLLTDNAE-----------------VKLVDFGVS 207
            L Y H         +V+HRD+K QN+ L+                      K+ DFG+S
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 208 AQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
               + IG     ++ +GTPY+ +PE++    +   +YD++SD+W+LG    E+   + P
Sbjct: 190 ----KNIGIESMAHSCVGTPYYWSPELLL---HETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 265 LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
               +    L    +   P L  K   K+    I+ +L     +RP   Q L +  I++
Sbjct: 243 FHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Length = 1021

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 99.9 bits (249), Expect = 2e-23
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 23/262 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---EEIKLEINVLKKYSNHRN 113
           +E +E +G GTYG+VYK R   TG+L A+K   +  DEE        EI++L+  S    
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAG--SVTDLVKSTKGQSLKEEWIAFICREILR 171
           I         +   GK   L+LV EY  +      D      G+ L  + I     ++L+
Sbjct: 63  IVRLLDVEHVEEKNGK-PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           G+ + H++ V+HRD+K QN+L+     + K+ D G+       +      I T ++ APE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--NAPPRLKSK 288
           V+         Y    D+WS+G    EM+  QP       ++ L  I +    P     +
Sbjct: 182 VLL----GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP---TEQ 234

Query: 289 KWPKKFQSFIETVLVKDYHQRP 310
            WP           ++D+H+ P
Sbjct: 235 VWP-------GVSKLRDWHEFP 249

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 20/209 (9%)

Query: 59  LIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMDVTEDEEE--EIKLEINVLKKYSNHR 112
            I+ +G G +G+V   R+      TG+  A+K ++ + +E+   + + EI +L+    H 
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HE 66

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G  + + P G+   L L+MEY  +GS+ D ++  + Q   +  + F   +I +G
Sbjct: 67  NIVKYKG--VCEKPGGRS--LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF-SSQICKG 121

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS--AQLDRTIGRRNTFIGTP-YWMAP 229
           + YL   + IHRD+  +N+L+     VK+ DFG++     D+          +P +W AP
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +       + + + SD+WS G+T  E+
Sbjct: 182 ECLR-----TSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  100 bits (251), Expect = 2e-23
 Identities = 69/249 (27%), Positives = 124/249 (49%), Gaps = 19/249 (7%)

Query: 21  AEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTG 80
           A + +K++D+F+   EK        + R  +  A  +++++V+G G +G+V   RH  + 
Sbjct: 14  ALRKNKNIDNFLNRYEKIV-----RKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ 68

Query: 81  QLAAIKVM---DVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVM 137
           ++ A+K++   ++ +  +     E   +  ++N   +   + AF        D  L++VM
Sbjct: 69  KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF------QDDKYLYMVM 122

Query: 138 EYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA 197
           EY   G   DLV       + E+W  F   E++  L  +H   +IHRD+K  N+LL  + 
Sbjct: 123 EYMPGG---DLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 179

Query: 198 EVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL 256
            +KL DFG   ++D T + R +T +GTP +++PEV+   +  D  Y    D WS+G+   
Sbjct: 180 HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK-SQGGDGYYGRECDWWSVGVFLF 238

Query: 257 EMAESQPPL 265
           EM     P 
Sbjct: 239 EMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 83/303 (27%), Positives = 131/303 (43%), Gaps = 60/303 (19%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE-----EIKLEINVLKKYSNH 111
           ++ +E +G GTYG VYK R   TG++ A+K + + E E+E      I+ EI++LK+  NH
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAIR-EISLLKEL-NH 57

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK---STKGQSLKEEWIAFICRE 168
            NI               +++L+LV E+       DL K   S+    L    I     +
Sbjct: 58  PNIVRLLDVVHS------ENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQ 107

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTP 224
           +L+G+ Y H ++V+HRD+K QN+L+     +KL DFG    L R  G   R  T  + T 
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFG----LARAFGVPVRTYTHEVVTL 163

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----- 279
           ++ APE++         Y    D+WS+G    EM   +P       +  LF I R     
Sbjct: 164 WYRAPEILL----GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP 219

Query: 280 ---------------NAPPRLKSKKWPKKFQSF-------IETVLVKDYHQRPYTDQLLK 317
                             P+   +   K   +        +  +LV D  +R      L+
Sbjct: 220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279

Query: 318 HPF 320
           HP+
Sbjct: 280 HPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 55/310 (17%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEEEIKL--EINVLKKYSNHRN 113
           +E++  +G GT+G+VYK R  KTG++ A+K ++   E +   I    EI +LKK   H N
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPN 68

Query: 114 IATYYGAFIKKSPPGKDDQ--LWLVMEYCGAGSVTDLVKSTKGQS--LKEEWIAFICREI 169
           +       +++    K  +  +++V  Y       DL    +  S  L E  I     ++
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPY----MDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD---------RTIGRRN-- 218
           L G+ YLHEN ++HRDIK  N+L+ +   +K+ DFG++   D            G R   
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL---CDLHPMRALF 275
             + T ++  PE++  +      Y    D+W +G    EM   +P L    D+  +  +F
Sbjct: 185 NLVVTRWYRPPELLLGERR----YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240

Query: 276 -----------------------LIPRNAPPRLKSKKWP--KKFQSFIETVLVKDYHQRP 310
                                      N P  L+ +      +    +  +L  D ++R 
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300

Query: 311 YTDQLLKHPF 320
                L+HP+
Sbjct: 301 TASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 76/284 (26%), Positives = 126/284 (44%), Gaps = 28/284 (9%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVT--EDEEEEIKLEINVLKKYSNHRNIAT 116
           +++G G++G+V+      T Q  AIK +  DV   +D+ E   +E  VL     H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            Y  F  K      + L+ VMEY   G +   ++S     L      F   EI+ GL++L
Sbjct: 61  LYCTFQTK------ENLFFVMEYLNGGDLMFHIQSCHKFDLPRA--TFYAAEIICGLQFL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H   +++RD+K  N+LL  +  +K+ DFG+  +      +  TF GTP ++APE++   +
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS 296
                Y+   D WS G+   EM   Q P    H    LF   R   P      +P+    
Sbjct: 173 -----YNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP-----CYPRWLTR 221

Query: 297 FIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTERQARIQLK 335
             + +LVK + + P         + +HPF R+         +++
Sbjct: 222 EAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIE 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 27/192 (14%)

Query: 143 GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV 202
            S+ D+++  +G+ L EE I  +C + L  L+ LH         K  N+LLT +  +KL 
Sbjct: 1   VSLADILEV-RGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL- 52

Query: 203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
             G  A       R       PY+MAPEVI         Y  ++D++SLGIT  E  + +
Sbjct: 53  -DGSVAFKTPEQSR-----PDPYFMAPEVIQGQS-----YTEKADIYSLGITLYEALDYE 101

Query: 263 PPLCDLHPMRALFLIPRNAPPRLKSKKWPKK--------FQSFIETVLVKDYHQRPYTDQ 314
            P  +   + A+  I  N  P    +             F+ F+     +   +R   + 
Sbjct: 102 LPYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANH 161

Query: 315 LLKHPFIRDQPT 326
            L H       T
Sbjct: 162 YLAHCRALFAET 173

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 15/214 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE+++V+G G +G+V   +   TGQ+ A+K+++    +   E    + E +VL    + R
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV-NGDRR 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I   + AF        ++ L+LVM+Y   G +  L+ S     L E+   F   E++  
Sbjct: 62  WITNLHYAF------QDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLA 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPE 230
           +  +H+   +HRDIK  NVLL  N  ++L DFG   +L  D T+ + N  +GTP +++PE
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPE 173

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           ++   E+    Y    D WSLG+   EM   + P
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 99.2 bits (247), Expect = 2e-22
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 24/281 (8%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKY 108
           + A  + +  V+G+G  G V   +    G+  A+KV+D+   +E ++   + E+  L   
Sbjct: 29  EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN- 87

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLW--LVMEYCGAGSVTDLVK--STKGQSLKEEWIAF 164
            +  +I   +  F KK P   ++ L   LV++Y  AG +   +K  +   ++ +E     
Sbjct: 88  CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT----IGRRNTF 220
           +  ++L  + ++H   +IHRDIK  N+LL  N  VKL DFG S     T    +GR  TF
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR--TF 205

Query: 221 IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL--CDLHPMRALFLIP 278
            GTPY++APE+      P   Y  ++D++SLG+   E+   + P    ++  +    L  
Sbjct: 206 CGTPYYVAPEI--WRRKP---YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260

Query: 279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHP 319
           R  P  L     P + Q  +  +L  D  +RP + +LL  P
Sbjct: 261 RYDP--LPPSISP-EMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 96.7 bits (240), Expect = 3e-22
 Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 17/208 (8%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEE-EEIKLEINVLKKYSNHRNIATY 117
           V+G G+Y +V   R  KT ++ A+KV+    V +DE+ + ++ E +V ++ SNH  +   
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
           +  F  +S      +L+ V+EY   G +  +    + + L EE   F   EI   L YLH
Sbjct: 62  HSCFQTES------RLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLH 113

Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           E  +I+RD+K  NVLL     +KL D+G+  +  R     +TF GTP ++APE++  ++ 
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED- 172

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPL 265
               Y    D W+LG+   EM   + P 
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 22/211 (10%)

Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           L++ +G+G +G V+ G   +  ++A IK +      EE+   E  V+ K S H  +   Y
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVA-IKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLY 65

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           G   ++SP      + LV E+   G ++D +++ +G    +E +  +C ++  G+ YL  
Sbjct: 66  GVCTERSP------ICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLES 118

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSA-QLDRTIGRRNTFIGTPY---WMAPEVIAC 234
           + VIHRD+  +N L+ +N  VK+ DFG++   LD    +  +  GT +   W +PEV + 
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD---DQYTSSTGTKFPVKWSSPEVFSF 175

Query: 235 DENPDATYDNRSDLWSLGITALEM-AESQPP 264
                + Y ++SD+WS G+   E+ +E + P
Sbjct: 176 -----SKYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 97.4 bits (242), Expect = 4e-22
 Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 21/250 (8%)

Query: 21  AEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTG 80
           A + +K++D+F+       Y +   + R     A  +E+++V+G G +G+V   RH  T 
Sbjct: 14  ALRKNKNIDNFLN-----RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 68

Query: 81  QLAAIKVM---DVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ-LWLV 136
           ++ A+K++   ++ +  +     E   +  ++N   +   + AF       +DD+ L++V
Sbjct: 69  KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-------QDDRYLYMV 121

Query: 137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           MEY   G   DLV       + E+W  F   E++  L  +H    IHRD+K  N+LL  +
Sbjct: 122 MEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 178

Query: 197 AEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITA 255
             +KL DFG   ++++  + R +T +GTP +++PEV+   +  D  Y    D WS+G+  
Sbjct: 179 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK-SQGGDGYYGRECDWWSVGVFL 237

Query: 256 LEMAESQPPL 265
            EM     P 
Sbjct: 238 YEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 95.6 bits (238), Expect = 5e-22
 Identities = 73/226 (32%), Positives = 112/226 (49%), Gaps = 21/226 (9%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINV 104
           W +     F++I  +G GTYGQVYK R   TG+L A+K +   ++E+E   +    EI +
Sbjct: 1   WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKI 59

Query: 105 LKKYSNHRNIATYYGAFIKKSPP---GKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           L++  NHRNI         K       KD    +LV EY     +  L++S       E+
Sbjct: 60  LRQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES-GLVHFSED 116

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--- 217
            I    +++L GL Y H+   +HRDIK  N+LL +  ++KL DFG+ A+L  +   R   
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYT 175

Query: 218 NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N  I T ++  PE++  +E     Y    D+WS G    E+   +P
Sbjct: 176 NKVI-TLWYRPPELLLGEER----YGPAIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 65/242 (26%), Positives = 108/242 (44%), Gaps = 44/242 (18%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKG------RHTKTGQLAAIKV--MDVTEDEEE 96
           P D   E P     L + +G G +GQV K          +T    A+K+   D TE +  
Sbjct: 2   PLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNET-STVAVKMLKDDATEKDLS 60

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
           ++  E+ ++K    H+NI    G   ++ P      L++V+EY   G++ D +++ +   
Sbjct: 61  DLVSEMEMMKMIGKHKNIINLLGVCTQEGP------LYVVVEYAAHGNLRDFLRARRPPG 114

Query: 157 LKEEWIAFI--------------CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV 202
                                    ++ RG+++L   K IHRD+  +NVL+T++  +K+ 
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIA 174

Query: 203 DFGVSAQLDRTIG-----RRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITAL 256
           DFG    L R I      R+ T    P  WMAPE +      D  Y ++SD+WS G+   
Sbjct: 175 DFG----LARDIHHIDYYRKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLLW 225

Query: 257 EM 258
           E+
Sbjct: 226 EI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G++G+V       T ++ AIKV+     + +D+ +    E  +L   + H  +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            +  F  K      D+L+ VMEY   G +  + +  + +   E    F   E+   L +L
Sbjct: 61  LHCCFQTK------DRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H + VI+RD+K  N+LL      KL DFG+  +         TF GTP ++APE++    
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ--- 169

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPP 264
             +  Y    D W+LG+   EM   QPP
Sbjct: 170 --ELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 76/296 (25%), Positives = 135/296 (45%), Gaps = 46/296 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK--KYSNHRNI 114
           FE++ VVG G YG V K RH +T ++ AIK    +E+ EE  +  +  LK  +     NI
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                AF ++       +L+LV EY    ++ +L++        E+  ++I  ++++ + 
Sbjct: 63  VELKEAFRRRG------KLYLVFEYV-EKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIH 114

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR-TIGRRNTFIGTPYWMAPEVIA 233
           + H+N ++HRDIK +N+L++ N  +KL DFG +  L   +      ++ T ++ +PE++ 
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI---------------- 277
                 A Y    D+WS+G    E+++ QP       +  LF I                
Sbjct: 175 -----GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229

Query: 278 --PRNAPPRLKSKKWP----KKFQSFIETVLVK--------DYHQRPYTDQLLKHP 319
             PR    R  +   P    +++   +  VL+         +   R  T+Q L HP
Sbjct: 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 69/215 (32%), Positives = 100/215 (46%), Gaps = 23/215 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVT--EDEEEEIKLEINVLKKYSNHR 112
           F  + V+G G++G+V       T +L AIK++  DV   +D+ E   +E  VL       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV-KSTKGQSLKEEWIAFICREILR 171
            +   +  F         D+L+ VMEY   G   DL+    +    KE    F   EI  
Sbjct: 62  FLTQLHSCFQTM------DRLYFVMEYVNGG---DLMYHIQQVGKFKEPHAVFYAAEIAI 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ--LDRTIGRRNTFIGTPYWMAP 229
           GL +LH   +I+RD+K  NV+L     +K+ DFG+  +        R  TF GTP ++AP
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TFCGTPDYIAP 170

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           E+IA    P   Y    D W+ G+   EM   QPP
Sbjct: 171 EIIA--YQP---YGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 75/279 (26%), Positives = 122/279 (43%), Gaps = 41/279 (14%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +++G GT+G+V   R   TG+  A+K++     + +DE      E  VL+  + H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
              +F         D+L  VMEY   G +      ++ +   E+   F   EI+  L YL
Sbjct: 60  LKYSFQTH------DRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYL 111

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEVIACD 235
           H   V++RD+K +N++L  +  +K+ DFG+  +   + G    TF GTP ++APEV+   
Sbjct: 112 HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLE-- 168

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLKSK 288
              D  Y    D W LG+   EM   + P  +    +   LI       PR   P  K  
Sbjct: 169 ---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK-- 223

Query: 289 KWPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIR 322
                  S +  +L KD  QR         ++++H F  
Sbjct: 224 -------SLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 17/209 (8%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G++G+V   RH    +  A+KV+     + + EE+ I  E NVL K   H  +  
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + +F         D+L+ V++Y   G +       + +   E    F   EI   L YL
Sbjct: 61  LHFSF------QTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H   +++RD+K +N+LL     + L DFG+  +     G  +TF GTP ++APEV+   +
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL--HK 170

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPL 265
            P   YD   D W LG    EM    PP 
Sbjct: 171 QP---YDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 20/204 (9%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIK-VMD--VTEDEEEEIKLEINVLKKYSNHRNIATYYG 119
           VG G +G V   R   TGQ  AIK +M    T    +    E+ +LK    H NI +   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSD 76

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            FI    P +D  ++ V E  G    TDL +    + L++++I +   +ILRGLKY+H  
Sbjct: 77  IFIS---PLED--IYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
            V+HRD+K  N+L+ +N ++K+ DFG++   D    +   ++ T Y+ APE++   +   
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQK-- 182

Query: 240 ATYDNRSDLWSLGITALEMAESQP 263
             YD   D+WS G    EM E +P
Sbjct: 183 --YDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 18/211 (8%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYS 109
           E P   F L   +G+G +G+V++G      ++A IK++      ++++ + E+  LK+  
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVA-IKILKSDDLLKQQDFQKEVQALKRLR 60

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +   I+ +  A      P     ++++ E    GS+   ++S +GQ L    +  +  ++
Sbjct: 61  HKHLISLF--AVCSVGEP-----VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI-GRRNTFIGTPY-WM 227
             G+ YL E   IHRD+  +N+L+ ++   K+ DFG++  +   +    +  I  PY W 
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT 171

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM 258
           APE  +       T+  +SD+WS GI   EM
Sbjct: 172 APEAAS-----HGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 74/258 (28%), Positives = 125/258 (48%), Gaps = 24/258 (9%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEE-EEIKLEINVLKKYSNHRNIATY 117
           V+G G+Y +V   R  K  Q+ A+KV+    V +DE+ + ++ E +V ++ S++  +   
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
           +  F   S      +L+LV+EY   G +  +    + + L EE   F   EI   L +LH
Sbjct: 62  HSCFQTTS------RLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLH 113

Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           E  +I+RD+K  NVLL  +  +KL D+G+  +        +TF GTP ++APE++  +E 
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE- 172

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPL------CDLHPMRALFLIPRNAPPRLKSKKWP 291
               Y    D W+LG+   EM   + P        D++    LF +    P R+  +   
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI-PRFLS 227

Query: 292 KKFQSFIETVLVKDYHQR 309
            K    ++  L KD  +R
Sbjct: 228 VKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 93.1 bits (231), Expect = 5e-21
 Identities = 75/250 (30%), Positives = 113/250 (45%), Gaps = 31/250 (12%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +++G GT+G+V   R   TG+  A+K++     + +DE      E  VL+  + H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
              AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L+YL
Sbjct: 60  LKYAFQTH------DRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 111

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H   V++RDIK +N++L  +  +K+ DFG+  +         TF GTP ++APEV+    
Sbjct: 112 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE--- 168

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLKS-- 287
             D  Y    D W LG+   EM   + P  +    R   LI       PR   P  KS  
Sbjct: 169 --DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 226

Query: 288 ----KKWPKK 293
               KK PK+
Sbjct: 227 AGLLKKDPKQ 236

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 92.6 bits (230), Expect = 5e-21
 Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 33/215 (15%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE----EEIKLEINVLKKYSNH 111
            F+ +E +G GTYG VYK R+  TG++ A+K + +  + E      I+ EI++LK+  NH
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NH 58

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK---STKGQSLKEEWIAFICRE 168
            NI               +++L+LV E+       DL K   ++    +    I     +
Sbjct: 59  PNIVKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKSYLFQ 108

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTP 224
           +L+GL + H ++V+HRD+K QN+L+     +KL DFG    L R  G   R  T  + T 
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG----LARAFGVPVRTYTHEVVTL 164

Query: 225 YWMAPEV-IACDENPDATYDNRSDLWSLGITALEM 258
           ++ APE+ + C       Y    D+WSLG    EM
Sbjct: 165 WYRAPEILLGC-----KYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 93.5 bits (232), Expect = 5e-21
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK--KYSNHRNIATYYGA 120
           VG+G YG V      +TG   AIK +      E   K     L+  K+  H N+      
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       +    +LVM + G    TDL K  K + L E+ I F+  ++L+GLKY+H   
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMG----TDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG 138

Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++ Q D  +     ++ T ++ APEVI    +   
Sbjct: 139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM---TGYVVTRWYRAPEVILNWMH--- 192

Query: 241 TYDNRSDLWSLGITALEMAESQP 263
            Y    D+WS+G    EM   +P
Sbjct: 193 -YTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 82/286 (28%), Positives = 138/286 (48%), Gaps = 35/286 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMDVTE-----DEEEEIKLEINVLKKY 108
           FEL++V+G G YG+V+  R      +G+L A+KV+            E  + E  VL+  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICR 167
                + T + AF        D +L L+++Y   G + T L +  +    KE+ +     
Sbjct: 62  RQSPFLVTLHYAF------QTDTKLHLILDYINGGELFTHLSQRER---FKEQEVQIYSG 112

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPYW 226
           EI+  L++LH+  +I+RDIK +N+LL  N  V L DFG+S +  +  + R  +F GT  +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           MAP+++      D  +D   D WS+G+   E+     P        +   I R     LK
Sbjct: 173 MAPDIVR---GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI---LK 226

Query: 287 SK-KWPKKF----QSFIETVLVKDYHQR-----PYTDQLLKHPFIR 322
           S+  +P++     +  I+ +L+KD  +R        D++ KHPF +
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 17/209 (8%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVM--DV--TEDEEEEIKLEINVLKKYSNHRNIAT 116
            V+G G++G+V   R  ++G+L A+KV+  DV   +D+ E    E  +L    NH  +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            Y  F  ++P    D+L+ VME+   G +  +    K +   E    F   EI   L +L
Sbjct: 61  LYCCF--QTP----DRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H+  +I+RD+K  NVLL      KL DFG+  +        +TF GTP ++APE++    
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ--- 169

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPL 265
             +  Y    D W++G+   EM     P 
Sbjct: 170 --EMLYGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 24/200 (12%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           E +G G +G VYKG   K     A+K     +  D + +   E  +LK+Y +H NI    
Sbjct: 1   EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLI 58

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           G  ++K P      +++VME    GS+   ++  K + L  + +  +  +   G++YL  
Sbjct: 59  GVCVQKQP------IYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLES 111

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI-----GRRNTFIGTPYWMAPEVIA 233
              IHRD+  +N L+ +N  +K+ DFG+S + +  I     G +   I    W APE + 
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---WTAPEALN 168

Query: 234 CDENPDATYDNRSDLWSLGI 253
                   Y + SD+WS GI
Sbjct: 169 Y-----GRYTSESDVWSYGI 183

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-DVTEDEEEEIKL-EINVLKKYSNHRNI 114
           ++++  +G GT+ +V K +  KTG+  AIK M    +  E+   L EI  L++ S H NI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                  +     G+   L LV E     ++ +L+K  K + L E+ +     ++L+ L 
Sbjct: 61  LRLI-EVLFDRKTGR---LALVFELM-DMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLD 114

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF---IGTPYWMAPEV 231
           ++H N + HRDIK +N+L+ D+  +KL DFG S    R I  +  +   I T ++ APE 
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC---RGIYSKPPYTEYISTRWYRAPEC 169

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQP 263
           +      D  Y  + D+W++G    E+    P
Sbjct: 170 LLT----DGYYGPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 92.7 bits (230), Expect = 8e-21
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 40/289 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKY 108
           FEL++V+G G YG+V+  R      TG+L A+KV+            E  + E NVL+  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICR 167
                + T + AF        + +L L+++Y   G + T L +     +  E+ + F   
Sbjct: 62  RQSPFLVTLHYAF------QTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSG 112

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPYW 226
           EI+  L++LH+  +++RDIK +N+LL     V L DFG+S + L     R  +F GT  +
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPR 279
           MAPE+I         +    D WSLGI   E+     P              R +     
Sbjct: 173 MAPEII----RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP 228

Query: 280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
             P  +  +      Q  +  +L KD  +R         ++ +HPF + 
Sbjct: 229 PFPSFIGPEA-----QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 92.8 bits (230), Expect = 8e-21
 Identities = 72/255 (28%), Positives = 120/255 (47%), Gaps = 24/255 (9%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +++G GT+G+V   R   +G+  A+K++     + +DE      E  VLK  + H  + +
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
              +F  K      D+L  VMEY   G +      ++ +   E+   F   EI+  L YL
Sbjct: 60  LKYSFQTK------DRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYL 111

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H  K+++RD+K +N++L  +  +K+ DFG+  +         TF GTP ++APEV+    
Sbjct: 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE--- 168

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLC--DLHPMRALFLIPRNAPPRLKSKKWPKKF 294
             D  Y    D W LG+   EM   + P    D   +  L L+     PR  S       
Sbjct: 169 --DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLS----ADA 222

Query: 295 QSFIETVLVKDYHQR 309
           +S +  +L+KD ++R
Sbjct: 223 KSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 92.3 bits (229), Expect = 9e-21
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G++G+V   +    G   A+KV+     + + E+  I  E NVL K   H  +  
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + +F  ++     ++L+ V++Y   G +       + +   E    F   E+   + YL
Sbjct: 61  LHYSF--QTA----EKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYL 112

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H   +I+RD+K +N+LL     V L DFG+  +        +TF GTP ++APEV+   +
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR--K 170

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPL 265
            P   YD   D W LG    EM    PP 
Sbjct: 171 EP---YDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 27/201 (13%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATY 117
           +L   +G G +G V  G     GQ  A+K +       +    E +V+     H N+   
Sbjct: 9   KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLR-HPNLVQL 65

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL--KEEWIAFICREILRGLKY 175
            G  ++ +P      L++V EY   GS+ D ++S +G+++    + + F   ++  G++Y
Sbjct: 66  LGVVLQGNP------LYIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGF-ALDVCEGMEY 117

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS--AQLDRTIGRRNTFIGTPY-WMAPEVI 232
           L E   +HRD+  +NVL++++   K+ DFG++  A   +  G+       P  W APE +
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK------LPVKWTAPEAL 171

Query: 233 ACDENPDATYDNRSDLWSLGI 253
              +     +  +SD+WS GI
Sbjct: 172 REKK-----FSTKSDVWSFGI 187

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 23/216 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           ++ +  +G G YG V    H  TG   AIK   ++  E +        EI +L+    H 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRTLREIKILR-RFKHE 63

Query: 113 NIATYYGAFIKKSPPGKDD--QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           NI           PP  +    +++V E       TDL K  K Q L  + I +   +IL
Sbjct: 64  NIIGILDIIR---PPSFESFNDVYIVQELME----TDLYKLIKTQHLSNDHIQYFLYQIL 116

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG---VSAQLDRTIGRRNTFIGTPYWM 227
           RGLKY+H   V+HRD+K  N+LL  N ++K+ DFG   ++       G    ++ T ++ 
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           APE++         Y    D+WS+G    EM  ++P
Sbjct: 177 APEIML----NSKGYTKAIDIWSVGCILAEMLSNRP 208

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 79/329 (24%), Positives = 136/329 (41%), Gaps = 69/329 (20%)

Query: 58  ELIEVVGNG--TYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHR 112
           EL+ V+G G      V   R+  TG+   ++ +++   T +    ++ E++V K + NH 
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHP 59

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y   FI       D++LW+V  +   GS  DL+ +     + E  IA+I + +L+ 
Sbjct: 60  NIVPYRATFIA------DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY------- 225
           L Y+H    +HR +K  ++L++ + +V L     +  +     R       P        
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF---------- 275
           W++PEV+   +N    YD +SD++S+GITA E+A    P  D+   + L           
Sbjct: 174 WLSPEVL--QQNLQG-YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230

Query: 276 ----LIP--------------------------RNAPPRLKS----KKWPKKFQSFIETV 301
                IP                          R +     S    + +   F  F+E  
Sbjct: 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQC 290

Query: 302 LVKDYHQRPYTDQLLKHPF---IRDQPTE 327
           L ++   RP    LL H F   I+ + +E
Sbjct: 291 LQRNPDARPSASTLLNHSFFKQIKRRASE 319

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F  + V+G G++G+V       T +L AIK++     + +D+ E   +E  VL       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F         D+L+ VMEY   G +   ++       KE    F   EI  G
Sbjct: 62  FLTQLHSCF------QTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVG 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ--LDRTIGRRNTFIGTPYWMAPE 230
           L +LH   +I+RD+K  NV+L     +K+ DFG+  +  +D    R  TF GTP ++APE
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR--TFCGTPDYIAPE 171

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +IA        Y    D W+ G+   EM   QPP 
Sbjct: 172 IIAYQ-----PYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 21/204 (10%)

Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYY 118
            ++ +G+G +G V+ G+      +A IK++      E++   E  V+ K S H N+   Y
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVA-IKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLY 65

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           G   K+ P      +++V EY   G + + ++  KG+ L  EW+  +C ++   ++YL  
Sbjct: 66  GVCTKQRP------IFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLES 118

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPY---WMAPEVIAC 234
           N  IHRD+  +N L+ ++  VK+ DFG++   LD    +  +  GT +   W  PEV   
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD---DQYTSSQGTKFPVKWAPPEVFD- 174

Query: 235 DENPDATYDNRSDLWSLGITALEM 258
                + + ++SD+WS G+   E+
Sbjct: 175 ----YSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 37/228 (16%)

Query: 58  ELIEVVGNGTYGQVYKG--RHTKTGQL---AAIKVMDVTE--DEEEEIKLEINVLKKYSN 110
            LI  +G G++G VY+G  +    G+     AIK ++      E  E   E +V+K+++ 
Sbjct: 9   TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------GQSLKEEWI 162
           H ++    G      P        +VME    G +   ++S +              +  
Sbjct: 69  H-HVVRLLGVVSTGQPT------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD-----RTIGRR 217
             +  EI  G+ YL   K +HRD+  +N ++ ++  VK+ DFG++  +      R  G+ 
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 218 NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE--SQP 263
              +    WMAPE +      D  +  +SD+WS G+   EMA    QP
Sbjct: 182 LLPV---RWMAPESLK-----DGVFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 90.8 bits (225), Expect = 4e-20
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 15/215 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHR 112
           FE+I+V+G G +G+V   +   T ++ A+K+++  E     E    + E NVL    + +
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GDCQ 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I T + AF        ++ L+LVM+Y   G +  L+   + + L E+   F   E++  
Sbjct: 62  WITTLHYAF------QDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLA 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPE 230
           +  +H+   +HRDIK  NVLL  N  ++L DFG   ++  D T+ + +  +GTP +++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPE 173

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           ++   E+    Y    D WSLG+   EM   + P 
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (223), Expect = 6e-20
 Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 28/207 (13%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH----RNI---- 114
           +G GT+GQVY+ R   T ++ A+KV+          K EI V KK   H    RNI    
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS---------KKEI-VAKKEVAHTIGERNILVRT 50

Query: 115 ATYYGAFIK--KSPPGKDDQLWLVMEY-CGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
                 FI   K     D  L+LV +Y  G      L K  +     E+   F   E++ 
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVL 107

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L++LH+  +++RD+K +N+LL     + L DFG+S          NTF GT  ++APEV
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           +      +  Y    D WSLG+   EM
Sbjct: 168 LL----DEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 21/219 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE---EIKLEINVLKKYS--NH 111
           +E +  +G G YG VYK R   +G   A+K + V  +E+        E+ +LK+    +H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI          S   ++ ++ LV E+      T L K      L  E I  + R+ LR
Sbjct: 62  PNIVRLMDV-CATSRTDRETKVTLVFEHVDQDLRTYLDK-VPPPGLPAETIKDLMRQFLR 119

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV----SAQLDRTIGRRNTFIGTPYWM 227
           GL +LH N ++HRD+K +N+L+T   +VKL DFG+    S Q+  T       + T ++ 
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT-----PVVVTLWYR 174

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLC 266
           APEV+       +TY    D+WS+G    EM   +P  C
Sbjct: 175 APEVLL-----QSTYATPVDMWSVGCIFAEMFRRKPLFC 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 39/212 (18%)

Query: 63  VGNGTYGQVYKGRH-TKTGQL--AAIKVM--DVTEDEEEEIKLEINVLKKYSNHRNIATY 117
           +G+G +G V KG +  K+G+    A+K +  +     ++E   E +V+ +  +H  I   
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRL 61

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
            G  + K  P     L LVME    G +   +K  K + +    +  +  ++  G+ YL 
Sbjct: 62  IG--VCKGEP-----LMLVMELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLE 112

Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-----------W 226
               +HRD+  +NVLL +  + K+ DFG+S    R +G  + +    Y           W
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMS----RALGAGSDY----YRATTAGRWPLKW 164

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            APE I         + ++SD+WS G+T  E 
Sbjct: 165 YAPECINY-----GKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 77/304 (25%), Positives = 132/304 (43%), Gaps = 49/304 (16%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL-----EINVLKKYSNH 111
           +ELI+ +G G YG V   R+ +T +   + +  +T    ++I       E+ +L+ +  H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREIL 170
           +NI   Y   I    PG  ++L+L  E   A    DL +  + GQ L +        +IL
Sbjct: 62  KNITCLYDMDIVF--PGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV----SAQLDRTIGRRNTFIGTPYW 226
            GLKY+H   V+HRD+K  N+L+  + E+K+ DFG+    S       G    ++ T ++
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PR 279
            APE++   ++    Y    D+WS+G    E+   +P       +  L  I         
Sbjct: 176 RAPEIMLSFQS----YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231

Query: 280 NAPPRLKSKKW-----------PKKFQS-----------FIETVLVKDYHQRPYTDQLLK 317
               R+ S K             K F+S            +E +L  D  +R   ++ L+
Sbjct: 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291

Query: 318 HPFI 321
           HP++
Sbjct: 292 HPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 16/214 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMDVTEDEEEEIKL----EINVLKKYSN- 110
           +E +  +G G YG+V+K R  K G +  A+K + V +  EE + L    E+ VL+     
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRHLETF 61

Query: 111 -HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H N+   +      S   ++ +L LV E+      T L K  +   +  E I  +  ++
Sbjct: 62  EHPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVPTETIKDMMFQL 119

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           LRGL +LH ++V+HRD+K QN+L+T + ++KL DFG+ A++        + + T ++ AP
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYSFQMALTSVVVTLWYRAP 178

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           EV+       ++Y    DLWS+G    EM   +P
Sbjct: 179 EVLL-----QSSYATPVDLWSVGCIFAEMFRRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 38/279 (13%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKL-EINVLKKYSNHRNIATYY 118
           +G G +G+V   +   TG++ A K +D   + + + E++ L E  +L+K S+ R I +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLA 59

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            AF  K      D L LVM     G +   + +       E    F   +I+ GL++LH+
Sbjct: 60  YAFETK------DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACD 235
            ++++RD+K +NVLL D+  V++ D G++ +L    +  GR     GTP +MAPEV+  +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----AGTPGYMAPEVLQGE 169

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK--KWPKK 293
                 YD   D ++LG T  EM   + P       R   +       R      ++P K
Sbjct: 170 V-----YDFSVDWFALGCTLYEMIAGRSPFRQ----RKEKVEKEELKRRTLEMAVEYPDK 220

Query: 294 F----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           F    +   E +L KD  +R        D++ +HP  +D
Sbjct: 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 33/278 (11%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE----EEIKLEINVLKKYSNHRNIATYY 118
           +G G +G+V   +   TG+L A K ++    ++    E   +E  +L K  + R I +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLA 59

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS--LKEEWIAFICREILRGLKYL 176
            AF  K+       L LVM     G +   + +   ++    E    F   +I+ GL++L
Sbjct: 60  YAFQTKT------DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H+ ++I+RD+K +NVLL ++  V++ D G++ +L     +   + GTP +MAPE++  +E
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--KSKKWPKKF 294
                YD   D ++LG+T  EM  ++ P       R   +  +    R+   S  +P KF
Sbjct: 174 -----YDFSVDYFALGVTLYEMIAARGPF----RARGEKVENKELKQRILNDSVTYPDKF 224

Query: 295 ----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
               +SF E +L KD  +R        D L  HP  RD
Sbjct: 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 87.4 bits (216), Expect = 5e-19
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 15/215 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHR 112
           FE+++V+G G +G+V   +     ++ A+K+++  E     E    + E +VL    N +
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-Q 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I T + AF        ++ L+LVM+Y   G +  L+   + + L E+   F   E++  
Sbjct: 62  WITTLHYAF------QDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIA 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPE 230
           +  +H+   +HRDIK  N+L+  N  ++L DFG   +L  D T+ + +  +GTP +++PE
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPE 173

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           ++   E+    Y    D WSLG+   EM   + P 
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 17/213 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F  + V+G G++G+V       T +L AIK++     + +D+ E   +E  VL       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F         D+L+ VMEY   G +   ++       KE    F   EI  G
Sbjct: 62  FLTQLHSCFQTM------DRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIG 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L +LH   +I+RD+K  NV+L     +K+ DFG+  +         TF GTP ++APE+I
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           A        Y    D W+ G+   EM   Q P 
Sbjct: 174 AYQ-----PYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 35/219 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE------IKLEINVLKKYSN 110
           ++ ++ +G G+Y  VYKGR   TGQL A+K + +   E EE      I+ E ++LK    
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL---EHEEGAPFTAIR-EASLLKDL-K 61

Query: 111 HRNIATYYGAF-IKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICR 167
           H NI T +     KK+       L LV EY      TDL +     G  L    +     
Sbjct: 62  HANIVTLHDIIHTKKT-------LTLVFEYL----DTDLKQYMDDCGGGLSMHNVRLFLF 110

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF---IGTP 224
           ++LRGL Y H+ +V+HRD+K QN+L+++  E+KL DFG++    +++  + T+   + T 
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSK-TYSNEVVTL 167

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           ++  P+V+         Y    D+W +G    EMA  +P
Sbjct: 168 WYRPPDVLLGSTE----YSTSLDMWGVGCIFYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 23/221 (10%)

Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMDVT--EDEEEEIKL 100
           +W E P       + +G G +G+V +        +      A+K++  T    E E +  
Sbjct: 29  KW-EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS 87

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           E+ ++    NH NI    GA     P      + ++ EYC  G + + ++  +   L  E
Sbjct: 88  ELKIMSHLGNHENIVNLLGACTIGGP------ILVITEYCCYGDLLNFLRRKRESFLTLE 141

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRR 217
            +     ++ +G+ +L     IHRD+  +NVLLT    VK+ DFG++  +      + + 
Sbjct: 142 DLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG 201

Query: 218 NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           N  +    WMAPE I      +  Y   SD+WS GI   E+
Sbjct: 202 NARLPVK-WMAPESIF-----NCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 86.6 bits (214), Expect = 9e-19
 Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 35/261 (13%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +++G GT+G+V   +   TG+  A+K++     V +DE      E  VL+  S H  +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
              +F         D+L  VMEY   G +      ++ +   E+   F   EI+  L YL
Sbjct: 60  LKYSF------QTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYL 111

Query: 177 H-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           H E  V++RD+K +N++L  +  +K+ DFG+  +  +      TF GTP ++APEV+   
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE-- 169

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLKSK 288
              D  Y    D W LG+   EM   + P  +    +   LI       PR   P  K  
Sbjct: 170 ---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK-- 224

Query: 289 KWPKKFQSFIETVLVKDYHQR 309
                  S +  +L KD  QR
Sbjct: 225 -------SLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 69/258 (26%), Positives = 112/258 (43%), Gaps = 58/258 (22%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE----IKLEINVLKKYSNHR 112
           FE I+V+G G +G+V   +   TG + A+K +  +E  E+E    ++ E ++L + +++ 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNP 61

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +   Y +F       +D+  L+L+MEY   G +  L+   K  +  EE   F   E + 
Sbjct: 62  WVVKLYYSF-------QDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIAETIL 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI----------------- 214
            +  +H+   IHRDIK  N+LL     +KL DFG+   L ++                  
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 215 ------------------GRRN---TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGI 253
                              RR    + +GTP ++APEV          Y+   D WSLG+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-----GYNKECDWWSLGV 227

Query: 254 TALEMAESQPPLCDLHPM 271
              EM    PP C  +P 
Sbjct: 228 IMYEMLVGYPPFCSDNPQ 245

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 19/210 (9%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVT--EDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G++G+V        G+  A+K +  DV   +D+ E   +E  VL     +  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA-FICREILRGLKY 175
            Y  F  K      + L+ VME+   G   DL+   + +   + + A F   EI+ GL++
Sbjct: 61  LYCTFQTK------EHLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQF 111

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           LH   +I+RD+K  NV+L  +  +K+ DFG+  +      R +TF GTP ++APE++   
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ-- 169

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
                 Y    D WS G+   EM   Q P 
Sbjct: 170 ---GLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 32/216 (14%)

Query: 57  FELIEVVGNGTYGQV----YKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSN 110
            + I V+G G +G+V    Y   +  TG++ A+K +  +  +      K EIN+LK    
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-Y 64

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI  Y G             L L+MEY   GS+ D +       L    +    ++I 
Sbjct: 65  HENIVKYKGC----CSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQIC 117

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD--------RTIGRRNTFIG 222
            G+ YLH    IHRD+  +NVLL ++  VK+ DFG++  +         R  G    F  
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-- 175

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              W A E +      +  +   SD+WS G+T  E+
Sbjct: 176 ---WYAVECLK-----ENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL--EINVLKKYSNHRNIATY 117
           +E +G GTY  V+KGR   T  L A+K + +  +E        E+++LK    H NI T 
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTL 69

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKY 175
           +           D  L LV EY       DL +     G  +    +     +ILRGL Y
Sbjct: 70  HDIV------HTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
            H  KV+HRD+K QN+L+ +  E+KL DFG++          +  + T ++  P+V+   
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-- 177

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQP 263
               + Y  + D+W +G    EMA  +P
Sbjct: 178 --GSSEYSTQIDMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 39/231 (16%)

Query: 61  EVVGNGTYGQVYKGRHTKTG--QLAAIKVMD--VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G +GQV K R  K G    AAIK M    ++D+  +   E+ VL K  +H NI  
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWI 162
             GA   +        L+L +EY   G++ D ++ ++                +L  + +
Sbjct: 73  LLGACEHRG------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRN 218
                ++ RG+ YL + + IHRD+  +N+L+ +N   K+ DFG+S      + +T+GR  
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
                  WMA E +       + Y   SD+WS G+   E+      P C +
Sbjct: 187 V-----RWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 76/300 (25%), Positives = 140/300 (46%), Gaps = 59/300 (19%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIK----VMDVTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           +G G YG V   ++++T +  AIK      D   D +  ++ EI +L+ + +H N+    
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLR-HLDHENVIA-- 68

Query: 119 GAFIKK--SPPGKD--DQLWLVMEYCGAGSVTDL---VKSTKGQSLKEEWIAFICREILR 171
              IK    PP ++  + +++V E       TDL   ++S+  Q+L ++   +   ++LR
Sbjct: 69  ---IKDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSS--QTLSDDHCQYFLYQLLR 119

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GLKY+H   V+HRD+K  N+LL  N ++K+ DFG++            ++ T ++ APE+
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 232 I-ACDENPDATYDNRSDLWSLGITALEMAESQP--PLCD-LHPMRAL------------- 274
           +  C E     Y    D+WS+G    E+   +P  P  D +H ++ +             
Sbjct: 180 LLNCSE-----YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234

Query: 275 FLIPRNAPPRLKS----------KKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           F+    A   ++S          + +P         +E +LV D  +R   ++ L HP++
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 84.4 bits (208), Expect = 4e-18
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 15/209 (7%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL--EINVLKKYSNH 111
           A  +E +E +G G+Y  VYKG+    G+L A+KV+ + E+E        E ++LK    H
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KH 62

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI   +     K      + L LV EY        + K   G  L  E +     ++LR
Sbjct: 63  ANIVLLHDIIHTK------ETLTLVFEYVHTDLCQYMDKHPGG--LHPENVKLFLFQLLR 114

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL Y+H+  ++HRD+K QN+L++D  E+KL DFG++          +  + T ++  P+V
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAE 260
           +         Y    D+W +G   +EM +
Sbjct: 175 LL----GSTEYSTCLDMWGVGCIFVEMIQ 199

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 33/227 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE I+++ NG YG VY  RH +T Q  A+K ++    +  ++ +++ +E ++L  ++ + 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENP 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            + + + +F  K        L +VMEY   G    L+K+    +L  +       E +  
Sbjct: 62  FVVSMFCSFETKR------HLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLA 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS--AQLDRTIGRRNTFI--------- 221
           L+YLH   ++HRD+K  N+L+T    +KL DFG+S    +  T       I         
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 222 ----GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
               GTP ++APEVI         Y    D W++GI   E      P
Sbjct: 174 KQVCGTPEYIAPEVIL-----RQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 70/219 (31%), Positives = 104/219 (47%), Gaps = 32/219 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIK----LEINVLKKYSNHR 112
           +E +E +G GTYG VYK R   T +  A+K + + E E+E +      EI++LK+   H 
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEM-QHG 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK---STKGQSLKEEWIAFICREI 169
           NI               + +L+LV EY       DL K   S+   +     I     +I
Sbjct: 62  NIVRLQDVV------HSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTP 224
           LRG+ Y H ++V+HRD+K QN+L+      +KL DFG    L R  G   R  T  + T 
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG----LARAFGIPVRTFTHEVVTL 167

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           ++ APE++         Y    D+WS+G    EM   +P
Sbjct: 168 WYRAPEILLGSR----HYSTPVDIWSVGCIFAEMVNQKP 202

Length = 294

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 84.5 bits (210), Expect = 4e-18
 Identities = 82/349 (23%), Positives = 146/349 (41%), Gaps = 80/349 (22%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEEEIKL--EINVLKKYSNHRN 113
           +E+++ +G G YG V+K    +T ++ A+K + D   +  +  +   EI  L++  +H N
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68

Query: 114 IATYYGAFIK-----KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
           I       +K     K+   KD  ++LV EY      TDL    +   L++    +I  +
Sbjct: 69  I-------VKLLNVIKAENDKD--IYLVFEYME----TDLHAVIRANILEDVHKRYIMYQ 115

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT--------- 219
           +L+ LKY+H   VIHRD+K  N+LL  +  VKL DFG    L R++              
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG----LARSLSELEENPENPVLTD 171

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM--------------------- 258
           ++ T ++ APE++         Y    D+WS+G    EM                     
Sbjct: 172 YVATRWYRAPEILLGSTR----YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227

Query: 259 AESQPPLCDLHPMRALFLIP--RNAPPRLKS------KKWPKKFQSFIETVLVKDYHQRP 310
               P   D+  +++ F      + P R +        K        ++ +LV + ++R 
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287

Query: 311 YTDQLLKHPFIRD--QPTE-----RQARIQLKDHIDTCKKRKKERDDYR 352
             ++ L+HP++     P++         I L D++      K    +YR
Sbjct: 288 TAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNV------KLSVAEYR 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 84.6 bits (209), Expect = 5e-18
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 16/199 (8%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRNIATYYG 119
           VG+G YG V      +TG+  AIK +      E   K    E+ +LK +  H N+     
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK-HMQHENVIGLLD 81

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            F       +    +LVM Y      TDL K   G  L E+ + ++  ++L GLKY+H  
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYM----QTDLQK-IMGHPLSEDKVQYLVYQMLCGLKYIHSA 136

Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
            +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APEVI    +  
Sbjct: 137 GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVILNWMH-- 191

Query: 240 ATYDNRSDLWSLGITALEM 258
             Y+   D+WS+G    EM
Sbjct: 192 --YNQTVDIWSVGCIMAEM 208

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 63/239 (26%), Positives = 113/239 (47%), Gaps = 36/239 (15%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-------HTKTGQLAAIKVM--DVTEDEE 95
           PED   E       L + +G G +GQV             K     A+K++  D TE + 
Sbjct: 5   PEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDL 64

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
            ++  E+ ++K    H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 65  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 118

Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         +E + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 119 GMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKI 178

Query: 202 VDFGVSAQLDRTIGRRNTFIG--TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 7e-18
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMDVTEDEE--EEIKLEINVLKKYSN 110
            E I+V+G+G +G VYKG     G+      AIKV+      +  +EI  E  V+    +
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-D 67

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H ++    G  +         Q+ L+ +    G + D V++ K   +  +++   C +I 
Sbjct: 68  HPHVVRLLGICLSS-------QVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIA 119

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMA 228
           +G+ YL E +++HRD+  +NVL+     VK+ DFG++  LD      +   G  P  WMA
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEM 258
            E I         Y ++SD+WS G+T  E+
Sbjct: 180 LESILHRI-----YTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 84.3 bits (208), Expect = 8e-18
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRNIATYYG 119
           VG+G YG V     T+  Q  A+K +     +         E+ +LK +  H N+     
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK-HMKHENVIGLLD 81

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            F   +     ++++LV    GA    DL    K Q L +E + F+  ++LRGLKY+H  
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGA----DLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
            +IHRD+K  NV + ++ E++++DFG++ Q D  +     ++ T ++ APE++    +  
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM---TGYVATRWYRAPEIMLNWMH-- 192

Query: 240 ATYDNRSDLWSLGITALEM 258
             Y+   D+WS+G    E+
Sbjct: 193 --YNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 39/224 (17%)

Query: 59  LIEVVGNGTYGQVYKG--RHTKTGQ---LAAIKVM-DVTEDE-EEEIKLEINVLKKYSNH 111
           L   +G G +G+V+ G   H +      L A+K + +   ++  ++ + E  +L  +  H
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QH 67

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS------------TKGQSLKE 159
            NI  +YG   +  PP       +V EY   G +   ++S            +    L  
Sbjct: 68  ENIVKFYGVCTEGDPP------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---D--RTI 214
             +  I  +I  G+ YL     +HRD+  +N L+  +  VK+ DFG+S  +   D  R  
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181

Query: 215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           G     I    WM PE I         +   SD+WS G+   E+
Sbjct: 182 GHTMLPI---RWMPPESIMY-----RKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)

Query: 60  IEVVGNGTYGQVY---KGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           ++V+G G++G+V+   K      GQL A+KV+    +   +    K+E ++L +  NH  
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPF 59

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   + AF      GK   L+L++++   G +    + +K     EE + F   E+   L
Sbjct: 60  IVKLHYAF---QTEGK---LYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            +LH   +I+RD+K +N+LL +   +KL DFG+S +      +  +F GT  +MAPEV+ 
Sbjct: 112 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV- 170

Query: 234 CDENPDATYDNRSDLWSLGITALEM 258
              N    +   +D WS G+   EM
Sbjct: 171 ---NRRG-HTQSADWWSFGVLMFEM 191

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 19/205 (9%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL--EINVLKKYSNHRNIATYYGA 120
           +G GTY  V+KGR   T  L A+K + +  +E        E+++LK    H NI T +  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDI 71

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHE 178
                    +  L LV EY      +DL +     G  +    +     ++LRGL Y H+
Sbjct: 72  I------HTERCLTLVFEYLD----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
            K++HRD+K QN+L+ +  E+KL DFG++          +  + T ++  P+V+      
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL----G 177

Query: 239 DATYDNRSDLWSLGITALEMAESQP 263
              Y    D+W +G    EMA  +P
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 62/244 (25%), Positives = 114/244 (46%), Gaps = 16/244 (6%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK--KYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +          K     L+  K+  H N+      
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 194

Query: 241 TYDNRSDLWSLGITALEMAESQ---PPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSF 297
            Y+   D+WS+G    E+   +   P    +  ++ +  +       L  K   +  +++
Sbjct: 195 -YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253

Query: 298 IETV 301
           I+++
Sbjct: 254 IQSL 257

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 71/253 (28%), Positives = 109/253 (43%), Gaps = 53/253 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVTEDEE-EEIKLEINVLKKYSNHR 112
           FE ++V+G G +G+V   +   TG + A+K++   D+ E E+   I+ E ++L +     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +  +Y    K++       L+L+ME+   G +  L+   K  +L EE   F   E +  
Sbjct: 63  VVKMFYSFQDKRN-------LYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLA 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD---RTIGRRN----------- 218
           +  +H+   IHRDIK  N+LL     VKL DFG+   L    RT   RN           
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 219 ---------------------TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALE 257
                                + +GTP ++APEV          Y+   D WSLG+   E
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-----QTGYNKLCDWWSLGVIMYE 228

Query: 258 MAESQPPLCDLHP 270
           M    PP C   P
Sbjct: 229 MLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 30/286 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKL-EINVLKKYSNHR 112
           F    V+G G +G+V   +   TG++ A K ++   + + + E + L E  +L+K ++  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   Y    K       D L LV+     G +   + +      +EE   F   EIL G
Sbjct: 62  VVNLAYAYETK-------DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAP 229
           L+ LH    ++RD+K +N+LL D   +++ D G++ ++   +   GR    +GT  +MAP
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAP 170

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKS 287
           EV+      +  Y    D W LG    EM E Q P            + R       + S
Sbjct: 171 EVLN-----NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS 225

Query: 288 KKWPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRDQPTER 328
            K+ ++ +S  + +L KD  QR         ++ +HPF R+   +R
Sbjct: 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 22/225 (9%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVTEDEEEEIKL--EINVLK 106
           DP+ +  + +V+G G +G+V +GR    G+     AIK +     +++ +    E +++ 
Sbjct: 2   DPSYVT-IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMG 60

Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           ++  H NI    G   K  P      + ++ EY   GS+   ++   G+      +  + 
Sbjct: 61  QFD-HPNIIRLEGVVTKSRP------VMIITEYMENGSLDKFLRENDGK-FTVGQLVGML 112

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY 225
           R I  G+KYL E   +HRD+  +N+L+  N   K+ DFG+S +L+ +     T  G  P 
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172

Query: 226 -WMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
            W APE IA  +     + + SD+WS GI   E M+  + P  D+
Sbjct: 173 RWTAPEAIAYRK-----FTSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHRNIAT 116
           E++G G +G+V+KG       +A   V    ED  +E+K+    E  +LK+Y +H NI  
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVA---VKTCKEDLPQELKIKFLSEARILKQY-DHPNIVK 56

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   ++ P      +++VME    G     ++  K   LK + +     +   G+ YL
Sbjct: 57  LIGVCTQRQP------IYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYL 109

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEVIACD 235
                IHRD+  +N L+ +N  +K+ DFG+S Q D  I   +     P  W APE +   
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY- 168

Query: 236 ENPDATYDNRSDLWSLGITALE 257
                 Y + SD+WS GI   E
Sbjct: 169 ----GRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 74/253 (29%), Positives = 111/253 (43%), Gaps = 53/253 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVTEDEE-EEIKLEINVLKKYSNHR 112
           FE ++V+G G +G+V   +   TG + A+K++   D+ E E+   I+ E ++L +  +  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +  +Y +F  K        L+L+ME+   G +  L+   K  +L EE   F   E +  
Sbjct: 63  VVKMFY-SFQDKL------NLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLA 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD---RTIGRRN---------TF 220
           +  +H+   IHRDIK  N+LL     VKL DFG+   L    RT   RN         TF
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173

Query: 221 -----------------------IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALE 257
                                  +GTP ++APEV          Y+   D WSLG+   E
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-----QTGYNKLCDWWSLGVIMYE 228

Query: 258 MAESQPPLCDLHP 270
           M    PP C   P
Sbjct: 229 MLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 39/231 (16%)

Query: 61  EVVGNGTYGQVYKGRHTKTG--QLAAIKVMD--VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G +GQV +    K G    AAIK++    +E++  +   E+ VL K  +H NI  
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWI 162
             GA   +        L++ +EY   G++ D ++ ++                +L  + +
Sbjct: 68  LLGACENRG------YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRN 218
                ++  G++YL E + IHRD+  +NVL+ +N   K+ DFG+S      + +T+GR  
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
                  WMA E +       + Y  +SD+WS G+   E+      P C +
Sbjct: 182 V-----RWMAIESLNY-----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 55/237 (23%)

Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLA-----AIKVMDVTEDEEEEIKL--EINVLKKYSNH 111
           L + +G G +G+V K    +    A     A+K++       E   L  E N+LK+  NH
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG----------------- 154
            ++   YGA  +  P        L++EY   GS+   ++ ++                  
Sbjct: 63  PHVIKLYGACSQDGPL------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 155 -----QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-- 207
                ++L    +     +I RG++YL E K++HRD+  +NVL+ +  ++K+ DFG+S  
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 208 -----AQLDRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                + + R+ GR       P  WMA E +      D  Y  +SD+WS G+   E+
Sbjct: 177 VYEEDSYVKRSKGR------IPVKWMAIESLF-----DHIYTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFI 122
           +G G YG+VY+G   K     A+K +     E EE   E  V+K+   H N+    G   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 72

Query: 123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVI 182
           ++ P       +++ E+   G++ D ++    Q +    + ++  +I   ++YL +   I
Sbjct: 73  REPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126

Query: 183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEVIACDENPDAT 241
           HRD+  +N L+ +N  VK+ DFG+S  +       +     P  W APE +A +      
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-----K 181

Query: 242 YDNRSDLWSLGITALEMA 259
           +  +SD+W+ G+   E+A
Sbjct: 182 FSIKSDVWAFGVLLWEIA 199

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 7e-17
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 22/215 (10%)

Query: 60  IEVVGNGTYGQVYKGRHTK---TGQLAAIKVMD-----VTEDEEEEIKLEINVLKKYSNH 111
           ++V+G G YG+V++ R      TG++ A+KV+        + +    K E N+L+    H
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KH 59

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             I     AF          +L+L++EY   G +   +   +     E+   F   EI  
Sbjct: 60  PFIVDLIYAF------QTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISL 111

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L++LH+  +I+RD+K +N+LL     VKL DFG+  +        +TF GT  +MAPE+
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLC 266
           +    +  A      D WSLG    +M    PP  
Sbjct: 172 LMRSGHGKAV-----DWWSLGALMYDMLTGAPPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL--EINVLKKYSNHRNIATY 117
           ++ +G GTY  VYKGR   T  L A+K + +  +E        E+++LK    H NI T 
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTL 69

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKY 175
           +           +  L LV EY       DL +     G S+    +     ++LRGL Y
Sbjct: 70  HDII------HTEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
            H  KV+HRD+K QN+L+ +  E+KL DFG++          +  + T ++  P+++   
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQP 263
            +    Y  + D+W +G    EM+  +P
Sbjct: 180 TD----YSTQIDMWGVGCIFYEMSTGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 25/166 (15%)

Query: 56  IFELIEVVGNGTYGQVYKGR--HTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYS 109
            +E+   +G GTYG+VYK +  + K G+  AIK     +++   I      EI +L++  
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV------KSTKGQSLKEEWIA 163
            H N+ +    F++      D  ++L+ +Y       DL       +  K  S+    + 
Sbjct: 61  -HENVVSLVEVFLEH----ADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVK 111

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE----VKLVDFG 205
            +  +IL G+ YLH N V+HRD+K  N+L+         VK+ D G
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 81.2 bits (200), Expect = 2e-16
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 24/204 (11%)

Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW------IAFICREILRGLKYLHENKVIH 183
           DD+L L+MEY   GS  DL K  K Q LKE        +  +  +I+  L  +H  K++H
Sbjct: 137 DDKLLLIMEY---GSGGDLNKQIK-QRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMH 192

Query: 184 RDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIACDENPDAT 241
           RD+K  N+ L     +KL DFG S Q   ++     ++F GTPY++APE+          
Sbjct: 193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE-----RKR 247

Query: 242 YDNRSDLWSLGITALEMAESQPPL---CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFI 298
           Y  ++D+WSLG+   E+     P         M+ +     +  P   S       ++ +
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVS----SGMKALL 303

Query: 299 ETVLVKDYHQRPYTDQLLKHPFIR 322
           + +L K+   RP T QLL   F++
Sbjct: 304 DPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 58  ELIEVVGNGTYGQVYKG-----RHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSN 110
            L+  +G+G +G+VY+G              A+K +    +E +E +  +E  ++ K+ N
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-N 67

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-----SLKEEWIAFI 165
           H+NI    G   ++ P       ++++E    G +   ++  + +     SL  + + F 
Sbjct: 68  HQNIVRLIGVSFERLP------RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDRT-IGRRNTFI 221
            R++ +G KYL EN  IHRDI  +N LLT        K+ DFG++  + R    R+    
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 222 GTPY-WMAPEVIACDENPDATYDNRSDLWSLGI 253
             P  WM PE        D  + +++D+WS G+
Sbjct: 182 MLPIKWMPPEAFL-----DGIFTSKTDVWSFGV 209

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           E P    +L++ +G G +G+V+ G +       AIK +       E    E N++K+  +
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
            R +  Y  A + + P      ++++ EY   GS+ D +K+ +G  L    +  +  +I 
Sbjct: 61  PRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI---GTPY-- 225
            G+ ++     IHRD++  N+L+++    K+ DFG    L R I   N +    G  +  
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFG----LARLI-EDNEYTAREGAKFPI 167

Query: 226 -WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            W APE I        T+  +SD+WS GI   E+
Sbjct: 168 KWTAPEAINY-----GTFTIKSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 24/219 (10%)

Query: 61  EVVGNGTYGQVYKGRHTKTG---QLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIA 115
           EV+G G +G+V +GR    G      AIK +    TE +  +   E +++ ++ +H NI 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNII 68

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
              G   K  P      + ++ E+   G++   ++   GQ    + +  + R I  G+KY
Sbjct: 69  HLEGVVTKSRP------VMIITEFMENGALDSFLRQNDGQFTVIQLVGML-RGIAAGMKY 121

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY---WMAPE 230
           L E   +HRD+  +N+L+  N   K+ DFG+S  L  D +     + +G      W APE
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 231 VIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
            IA  +     + + SD+WS GI   E M+  + P  D+
Sbjct: 182 AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 28/211 (13%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           E P    +L   +G G +G+V+ G    T ++A +K +       E    E  ++KK  +
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVA-VKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
            + +  Y  A   +  P     +++V EY   GS+ D +KS +G+ L+   +  +  +I 
Sbjct: 61  DKLVQLY--AVCSEEEP-----IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY----- 225
            G+ YL     IHRD+  +N+L+ +N   K+ DFG    L R I        T       
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFG----LARLIEDD---EYTAREGAKF 166

Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGI 253
              W APE           +  +SD+WS GI
Sbjct: 167 PIKWTAPEAANY-----GRFTIKSDVWSFGI 192

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 39/231 (16%)

Query: 61  EVVGNGTYGQVYKGRHTKTG--QLAAIKVMD--VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G +GQV K R  K G    AAIK M    ++D+  +   E+ VL K  +H NI  
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWI 162
             GA   +        L+L +EY   G++ D ++ ++                +L  + +
Sbjct: 61  LLGACEHRG------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRN 218
                ++ RG+ YL + + IHRD+  +N+L+ +N   K+ DFG+S      + +T+GR  
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
                  WMA E +       + Y   SD+WS G+   E+      P C +
Sbjct: 175 V-----RWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 22/217 (10%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIA 115
           +V+G G +G+V++G     G+     AIK +    TE + ++   E +++ ++S H NI 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNII 69

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
              G   K  P        ++ EY   G++   ++   G+    + +  + R I  G+KY
Sbjct: 70  RLEGVVTKFKP------AMIITEYMENGALDKYLRDHDGEFSSYQLVGML-RGIAAGMKY 122

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGT-PY-WMAPEVI 232
           L +   +HRD+  +N+L+  N E K+ DFG+S  L D   G   T  G  P  W APE I
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 233 ACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
           A  +     + + SD+WS GI   E M+  + P  D+
Sbjct: 183 AYRK-----FTSASDVWSFGIVMWEVMSFGERPYWDM 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 18/206 (8%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMDV-TEDEEEEIKLEINVLKKYSNHRN 113
            L   +G G +G VY+G +          A+K     T     E  L+   + +  +H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I    G          ++ +W+VME    G +   ++  K  SL    +     ++   L
Sbjct: 69  IVKLIGVI-------TENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTAL 120

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEVI 232
            YL   + +HRDI  +NVL++    VKL DFG+S  L+     + +    P  WMAPE I
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Query: 233 ACDENPDATYDNRSDLWSLGITALEM 258
                  A     SD+W  G+   E+
Sbjct: 181 NFRRFTSA-----SDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 66/241 (27%), Positives = 120/241 (49%), Gaps = 40/241 (16%)

Query: 45  PED-RWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVM--DVTED 93
           PED RW E P     L + +G G +GQV         K +  +  ++A +K++  D TE 
Sbjct: 8   PEDPRW-EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVA-VKMLKSDATEK 65

Query: 94  EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK 153
           +  ++  E+ ++K    H+NI    GA  +  P      L++++EY   G++ + +++ +
Sbjct: 66  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARR 119

Query: 154 GQSLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEV 199
              ++         EE ++F        ++ RG++YL   K IHRD+  +NVL+T++  +
Sbjct: 120 PPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 179

Query: 200 KLVDFGVSAQLDRTIGRRNTFIG--TPYWMAPEVIACDENPDATYDNRSDLWSLGITALE 257
           K+ DFG++  +      + T  G     WMAPE +      D  Y ++SD+WS G+   E
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWE 234

Query: 258 M 258
           +
Sbjct: 235 I 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 21/209 (10%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYSNHRNIATYY 118
           +E +G G+Y  VYKG     GQL A+KV+ + TE+      +    L K   H NI   +
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREILRGLKYL 176
                K      + L  V EY      TDL +        L    +     ++LRGL Y+
Sbjct: 70  DIIHTK------ETLTFVFEYMH----TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI--AC 234
           H   ++HRD+K QN+L++   E+KL DFG++          ++ + T ++  P+V+  A 
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179

Query: 235 DENPDATYDNRSDLWSLGITALEMAESQP 263
           D      Y +  D+W  G   +EM + QP
Sbjct: 180 D------YSSALDIWGAGCIFIEMLQGQP 202

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 21/215 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKL-EINVLKKYSNHR 112
           F    V+G G +G+V   +   TG++ A K ++   + + + E + L E  +L+K  N R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSR 60

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            + +   A+  K      D L LV+     G +   +        +E    F   EI  G
Sbjct: 61  FVVSLAYAYETK------DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPE 230
           L+ LH+ ++++RD+K +N+LL D+  +++ D G++  +   +TI  R   +GT  +MAPE
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPE 171

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           V+      +  Y    D W+LG    EM   Q P 
Sbjct: 172 VVK-----NERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 50/235 (21%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---------------EINVLKK 107
           +G GTYG+V K   T TG++ AIK + + E   +  K                E+ ++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFIC 166
              H NI      +++       D + LVM+   +    DL K    +  L E  +  I 
Sbjct: 77  I-KHENIMGLVDVYVEG------DFINLVMDIMAS----DLKKVVDRKIRLTESQVKCIL 125

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-----------DRTIG 215
            +IL GL  LH+   +HRD+   N+ +      K+ DFG++ +            D T+ 
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 216 RRNTF---IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE--SQPPL 265
           RR      + T ++ APE++   E     Y    D+WS+G      AE  +  PL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAE----KYHFAVDMWSVGCI---FAELLTGKPL 233

Length = 335

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.0 bits (189), Expect = 6e-16
 Identities = 70/259 (27%), Positives = 109/259 (42%), Gaps = 38/259 (14%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYY 118
           E +G G +G+V+ GR        A+K    T   D + +   E  +LK+YS H NI    
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLI 59

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           G   +K P      +++VME    G     ++ T+G  LK + +  +      G++YL  
Sbjct: 60  GVCTQKQP------IYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLES 112

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD-----RTIGRRNTFIGTPYWMAPEVIA 233
              IHRD+  +N L+T+   +K+ DFG+S + +      T G +   +    W APE + 
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---WTAPEALN 169

Query: 234 CDENPDATYDNRSDLWSLGITALEM----AESQPPLCDLHPMRAL-----FLIPRNAPP- 283
                   Y + SD+WS GI   E     A     L +     A+        P   P  
Sbjct: 170 Y-----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDA 224

Query: 284 --RLKSKKW---PKKFQSF 297
             RL  + W   P +  SF
Sbjct: 225 VYRLMERCWEYDPGQRPSF 243

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 27/209 (12%)

Query: 61  EVVGNGTYGQVYKGR-HTKTGQL--AAIKVM--DVTEDEEEEIKLEINVLKKYSNHRNIA 115
           + +G+G++G V +G   T  G++   A+K +  D   D  ++   E  ++    +H N+ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLI 59

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
             YG  +          L +V E    GS+ D ++           +     +I  G++Y
Sbjct: 60  RLYGVVL-------THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY------WMAP 229
           L   + IHRD+  +N+LL  + +VK+ DFG+   L +     + ++   +      W AP
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN---EDHYVMEEHLKVPFAWCAP 169

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +        T+ + SD+W  G+T  EM
Sbjct: 170 ESLR-----TRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 15/209 (7%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           E P    +LI+ +GNG +G+V+ G      ++A +K +       E    E  ++KK  +
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVA-VKTLKPGTMSPESFLEEAQIMKKLRH 60

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
            + +  Y  A + + P      +++V EY   GS+ D +K  +G++LK   +  +  ++ 
Sbjct: 61  DKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAP 229
            G+ Y+     IHRD++  N+L+ D    K+ DFG++  + D     R        W AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E           +  +SD+WS GI   E+
Sbjct: 173 EAALY-----GRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 70/281 (24%), Positives = 111/281 (39%), Gaps = 71/281 (25%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DV-TEDEEEEIKLEINVLKKYSNHR 112
           F  I+ +G G +G+V   R   T  L A+K +   DV   ++   +K E ++L +  N  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +  YY +F  K      D L+ VM+Y   G +  L+   +    +E+   F   E+   
Sbjct: 63  VVKLYY-SFQDK------DNLYFVMDYIPGGDMMSLL--IRLGIFEEDLARFYIAELTCA 113

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG--------------------------- 205
           ++ +H+   IHRDIK  N+L+  +  +KL DFG                           
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173

Query: 206 ------VSAQLDRTIGRRN----------TFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
                 +     + + RR           + +GTP ++APEV+         Y    D W
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-----RTGYTQLCDWW 228

Query: 250 SLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           S+G+   EM   QPP          FL    A  +LK   W
Sbjct: 229 SVGVILYEMLVGQPP----------FLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 60  IEVVGNGTYGQVYKGRHT----KTGQLAAIKVMD-VTEDEEEEIKLEINVLKKYSNHRNI 114
           I+ +G G +G V   R+      TG++ A+K +   T +   + + EI +LK    H NI
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNI 67

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y G             L LVMEY   GS+ D ++  + + L    +     +I +G++
Sbjct: 68  VKYKGVCYSAGRRN----LRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGME 122

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAPEV 231
           YL   + +HRD+  +N+L+     VK+ DFG++  L  D+   +      +P +W APE 
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182

Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           +      ++ +   SD+WS G+   E+
Sbjct: 183 LT-----ESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 45/271 (16%)

Query: 65  NGTYGQVYKGRHTKTGQL---AAIKVMDVTEDEEEEIKLEINVLKKYSNHRN-IATYYGA 120
           +G +G+V   +H  T +L     IK  +          +E  V +   ++ N I  YY  
Sbjct: 26  DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSV 78

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
              K        +  +M+Y   G + DL+K  K   L E  +  I R+++  L  LH++ 
Sbjct: 79  TTLK------GHVL-IMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALNDLHKHN 129

Query: 181 VIHRDIKGQNVLLTDN-AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
           +IH DIK +NVL       + L D+G    L + IG  + + GT  + +PE I       
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYG----LCKIIGTPSCYDGTLDYFSPEKIKGH---- 181

Query: 240 ATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF--------LIPRNAPPRLKSKKWP 291
             YD   D W++G+   E+      L   HP +           L+ R        K   
Sbjct: 182 -NYDVSFDWWAVGVLTYEL------LTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234

Query: 292 KKFQSFIETVLVKDYHQRPYT-DQLLKHPFI 321
           K    F++++L  + + R    ++++KHPF+
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 35/231 (15%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS 109
           E P      +E +G G +G+VYKG       +L+A  V   T  E  E K++    ++  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 110 -----NHRNIATYYGAFIKKSP--------PGKDDQLWLVM----EYCGAGSVTDLVKST 152
                 H NI    G   K+ P           D   +LV        GA S  + VKS 
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS- 119

Query: 153 KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV-----S 207
              SL       I  +I  G++YL  +  +HRD+  +N L+ +   VK+ DFG+     S
Sbjct: 120 ---SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           A   R   +    +    WM PE I         +   SD+WS G+   E+
Sbjct: 177 ADYYRVQSKSLLPV---RWMPPEAILY-----GKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 23/204 (11%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYG 119
           ++ +G+G +G V+ G+     ++A IK ++     EE+   E  V+ K S H  +   YG
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKVA-IKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYG 66

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
              ++ P      L++V E+   G + + ++  +G+ L ++ +  +C+++  G++YL  N
Sbjct: 67  VCTQQKP------LYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN 119

Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY---WMAPEVIAC 234
             IHRD+  +N L++    VK+ DFG++  +  D          G  +   W  PEV   
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS----GAKFPVKWSPPEVFNF 175

Query: 235 DENPDATYDNRSDLWSLGITALEM 258
            +     Y ++SD+WS G+   E+
Sbjct: 176 SK-----YSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 83/338 (24%), Positives = 144/338 (42%), Gaps = 55/338 (16%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEEEIKL--EINVLKKYSNHRN 113
           +++ EV+G G+YG V     T TG+  AIK + DV E   +  ++  EI +L+    H +
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPD 60

Query: 114 IATYYGAFIKKS--PPGKDD--QLWLVMEYCGAGSVTDLVKSTKGQS-LKEEWIAFICRE 168
           I       IK    PP + +   +++V E       +DL +  K    L  E   F   +
Sbjct: 61  IVE-----IKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQ 111

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRR--NTFIGTPY 225
           +LR LKY+H   V HRD+K +N+L   + ++K+ DFG++    + T        ++ T +
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP------- 278
           + APE+        + Y    D+WS+G    E+   +P     + +  L LI        
Sbjct: 172 YRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228

Query: 279 -------------------RNAPPRLKSKKWPK---KFQSFIETVLVKDYHQRPYTDQLL 316
                              R   P   S+K+P         +E +L  D   RP  ++ L
Sbjct: 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288

Query: 317 KHPFIRDQPT-ERQARIQLKDHID-TCKKRKKERDDYR 352
             P+ +     ER+   Q    ++   ++R+  ++D R
Sbjct: 289 ADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVR 326

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 36/221 (16%)

Query: 63  VGNGTYGQVYKGR-------HTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNHRN 113
           +G G +GQV                   A+K++  D T+ +  ++  E+ ++K    H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS---------LKEEWIAF 164
           I    GA  +  P      L++++EY   G++ + +++ +            L EE + F
Sbjct: 80  IINLLGACTQDGP------LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133

Query: 165 -----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
                   ++ RG++YL   K IHRD+  +NVL+T++  +K+ DFG++  +      + T
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 220 FIG--TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 194 TNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 29/271 (10%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYY 118
           +G G++G+V + R   T ++ A+K +     V+  E      E  VL + +    +    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-- 58

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
             F  +SP    ++L+LV+ +   G +   ++  +          F   E+L  L+ LH+
Sbjct: 59  -KFSFQSP----EKLYLVLAFINGGELFHHLQ--REGRFDLSRARFYTAELLCALENLHK 111

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
             VI+RD+K +N+LL     + L DFG+     +   + NTF GTP ++APE++      
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL----- 166

Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCD--LHPM-RALFLIPRNAPPRLKSKKWPKKFQ 295
              Y    D W+LG+   EM    PP  D  ++ M R +   P   P            +
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDA-----K 221

Query: 296 SFIETVLVKDYHQR---PYTDQLLKHPFIRD 323
             +  +L +D  +R       ++  HPF   
Sbjct: 222 DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 62/242 (25%), Positives = 115/242 (47%), Gaps = 42/242 (17%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR----------HTKTGQLAAIKVM--DVTE 92
           P D   E P     L + +G G +GQV +             T T    A+K++  + T+
Sbjct: 2   PLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVT---VAVKMLKDNATD 58

Query: 93  DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST 152
            +  ++  E+ ++K    H+NI    G   ++ P      L++++EY   G++ + +++ 
Sbjct: 59  KDLADLISEMELMKLIGKHKNIINLLGVCTQEGP------LYVIVEYAAKGNLREFLRAR 112

Query: 153 K---------GQSLKEEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE 198
           +            + EE ++F        ++ RG++YL   + IHRD+  +NVL+T++  
Sbjct: 113 RPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV 172

Query: 199 VKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITAL 256
           +K+ DFG++  +      + T  G  P  WMAPE +      D  Y ++SD+WS GI   
Sbjct: 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGILMW 227

Query: 257 EM 258
           E+
Sbjct: 228 EI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 15/198 (7%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFI 122
           +G G +G+V+ G    T ++A IK +       E    E  V+KK  + + +  Y  A +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY--AVV 70

Query: 123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVI 182
            + P      +++V EY   GS+ D +K   G+ L+   +  +  +I  G+ Y+     +
Sbjct: 71  SEEP------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 183 HRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVIACDENPDAT 241
           HRD++  N+L+ +N   K+ DFG++  + D     R        W APE           
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-----GR 179

Query: 242 YDNRSDLWSLGITALEMA 259
           +  +SD+WS GI   E+ 
Sbjct: 180 FTIKSDVWSFGILLTELT 197

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 22/233 (9%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL-EINVLKKYSNHRNIATYYGAF 121
           +G G+ G V+    +   +  A+K + +T+ +  +  L EI ++++  +H NI   Y   
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVL 71

Query: 122 IKKSPPGKDD--------QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
                   +D         +++V EY      TDL    +   L EE       ++LRGL
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYME----TDLANVLEQGPLSEEHARLFMYQLLRGL 127

Query: 174 KYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTI---GRRNTFIGTPYWMAP 229
           KY+H   V+HRD+K  NV + T++  +K+ DFG++  +D      G  +  + T ++ +P
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP 282
            ++    N    Y    D+W+ G    EM   +P     H +  + LI  + P
Sbjct: 188 RLLLSPNN----YTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 14/209 (6%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           E P    +L++ +G G +G+V+ G +  + ++A +K +       +    E N++K   +
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVA-VKTLKPGTMSVQAFLEEANLMKTLQH 60

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
            + +  Y  A + K  P     ++++ EY   GS+ D +KS +G  +    +     +I 
Sbjct: 61  DKLVRLY--AVVTKEEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAP 229
            G+ Y+     IHRD++  NVL++++   K+ DFG++  + D     R        W AP
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I        ++  +SD+WS GI   E+
Sbjct: 174 EAINF-----GSFTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 21/202 (10%)

Query: 63  VGNGTYGQVYKGRHT-KTGQL-AAIKVMDVTEDE--EEEIKLEINVLKKYSNHRNIATYY 118
           +G+G +G V KG +  +  Q+  AIKV+    ++   +E+  E  ++ +  N   I    
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY-IVRMI 61

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           G         + + L LVME    G +   +   K + +    +  +  ++  G+KYL  
Sbjct: 62  GVC-------EAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEG 113

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACD 235
              +HRD+  +NVLL +    K+ DFG+S  L  D +  +  +    P  W APE I   
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 236 ENPDATYDNRSDLWSLGITALE 257
           +     + +RSD+WS GIT  E
Sbjct: 174 K-----FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 15/197 (7%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFI 122
           +G G +G+V+ G    T ++A IK +       E    E  ++KK  + + +  Y  A +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVA-IKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLY--AVV 70

Query: 123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVI 182
            + P      +++V E+ G GS+ D +K   G+ LK   +  +  +I  G+ Y+     I
Sbjct: 71  SEEP------IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124

Query: 183 HRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVIACDENPDAT 241
           HRD++  N+L+ DN   K+ DFG++  + D     R        W APE           
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-----GR 179

Query: 242 YDNRSDLWSLGITALEM 258
           +  +SD+WS GI   E+
Sbjct: 180 FTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 65/267 (24%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVT-EDEEEEIKLEINVLKKYSNH 111
           +F  I+ +G G +G+V   R   T  L A+K +   DV   ++   +K E ++L +  N 
Sbjct: 2   MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE 61

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             +  YY +F  K      D L+ VM+Y   G +  L+   +     E+   F   E+  
Sbjct: 62  WVVRLYY-SFQDK------DNLYFVMDYIPGGDMMSLL--IRMGIFPEDLARFYIAELTC 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA----------------------- 208
            ++ +H+   IHRDIK  N+L+  +  +KL DFG+                         
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172

Query: 209 ------------------QLDRTIGRR------NTFIGTPYWMAPEVIACDENPDATYDN 244
                              L+R   R+      ++ +GTP ++APEV+         Y  
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-----RTGYTQ 227

Query: 245 RSDLWSLGITALEMAESQPPLCDLHPM 271
             D WS+G+   EM   QPP     P+
Sbjct: 228 LCDWWSVGVILYEMLVGQPPFLAQTPL 254

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 21/219 (9%)

Query: 53  PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR 112
           P   ++L  ++GNG++G VY+     T +  AIK   V +D + + + E+ ++K   NH 
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKNR-ELLIMKNL-NHI 119

Query: 113 NIA----TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFIC 166
           NI      YY    KK+   K+  L +VME+    +V   +K  +    +L    +    
Sbjct: 120 NIIFLKDYYYTECFKKNE--KNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFLVKLYS 176

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAE-VKLVDFGVSAQLDRTIGRRN-TFIGTP 224
            ++ R L Y+H   + HRD+K QN+L+  N   +KL DFG +  L    G+R+ ++I + 
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSR 234

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           ++ APE++    N    Y    DLWSLG    EM    P
Sbjct: 235 FYRAPELMLGATN----YTTHIDLWSLGCIIAEMILGYP 269

Length = 440

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 26/222 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQL--AAIKVMD----VTEDEEEEIKLEINVLKKYSN 110
           F  I  +G G++G+V    + K       AIK  +    + + + + +  E  +L  Y N
Sbjct: 32  FNFIRTLGTGSFGRVILATY-KNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN-YIN 89

Query: 111 HRNIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           H      YG+F       KD+  L+LV+E+   G     ++  K      +   F   +I
Sbjct: 90  HPFCVNLYGSF-------KDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQI 140

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           +   +YL    +++RD+K +N+LL  +  +K+ DFG +  +D    R  T  GTP ++AP
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAP 197

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM 271
           E++      +  +   +D W+LGI   E+    PP     P+
Sbjct: 198 EILL-----NVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 15/211 (7%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKY 108
           W+ D   I +L+  +G G +G+V++G    T  +A   +   T D ++ +  E  ++KK 
Sbjct: 1   WEIDRTSI-QLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA-EAQIMKKL 58

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
             H  +   Y     + P      +++V E    GS+ + ++   G++LK   +  +  +
Sbjct: 59  -RHPKLIQLYAVCTLEEP------IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQ 111

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WM 227
           +  G+ YL     IHRD+  +NVL+ +N   K+ DFG++  +   I         P  W 
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM 258
           APE    +      +  +SD+WS GI   E+
Sbjct: 172 APEAALYNR-----FSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 29/208 (13%)

Query: 59  LIEVVGNGTYGQV----YKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNI 114
            ++ +G G +G V    ++G++       AIK++      E+E   E  V+ K S H  +
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKL 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
              YG   K+ P      +++V EY   G + + ++   G+  +   +  +C+++  G+ 
Sbjct: 62  VQLYGVCTKQRP------IYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMA 114

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPY---WMAPE 230
           YL   + IHRD+  +N L+ D   VK+ DFG+S   LD       + +G+ +   W  PE
Sbjct: 115 YLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPE 171

Query: 231 VIACDENPDATYDNRSDLWSLGITALEM 258
           V+       + + ++SD+W+ G+   E+
Sbjct: 172 VLLY-----SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 29/209 (13%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVM-----DVTEDEEEEIKLEINVLKKYSNHRNI 114
           ++ +G+G  G V     T TGQ  AIK +     +VT  +    +L   VL K  NH+NI
Sbjct: 21  LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL---VLMKLVNHKNI 77

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                 F  +    +   ++LVME   A ++  +++      L  E ++++  ++L G+K
Sbjct: 78  IGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----MDLDHERMSYLLYQMLCGIK 132

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-----YWMAP 229
           +LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP     Y+ AP
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYVVTRYYRAP 186

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           EVI         Y    D+WS+G    EM
Sbjct: 187 EVIL-----GMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 22/216 (10%)

Query: 62  VVGNGTYGQVYKGRHTKTGQ---LAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIAT 116
           V+G G +G+V  GR    G+     AIK +    TE +  +   E +++ ++ +H NI  
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIH 69

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++   GQ    + +  + R I  G+KYL
Sbjct: 70  LEGVVTKSKP------VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML-RGIASGMKYL 122

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W APE IA
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
             +     + + SD+WS GI   E M+  + P  ++
Sbjct: 183 YRK-----FTSASDVWSYGIVMWEVMSYGERPYWEM 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 23/216 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKL-EINVLKKYSNHR 112
           F    V+G G +G+V   +   TG++ A K ++   + + + E + L E  +L+K ++  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            ++  Y    K       D L LV+     G +   + +       E+   F   E+  G
Sbjct: 62  VVSLAYAYETK-------DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAP 229
           L+ L   ++++RD+K +N+LL D   +++ D G++ Q+   +   GR    +GT  +MAP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAP 170

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           EVI      +  Y    D W LG    EM + Q P 
Sbjct: 171 EVIN-----NEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKL-EINVLKKYSNHR 112
           F    V+G G +G+V   +   TG++ A K ++   + + + E + L E  +L+K  N R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSR 60

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            + +   A+  K      D L LV+     G +   + +       EE   F   EI  G
Sbjct: 61  FVVSLAYAYETK------DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAP 229
           L+ LH  ++++RD+K +N+LL D   +++ D G++ ++   +   GR    +GT  +MAP
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           EV+   +N   T+    D W LG    EM E + P
Sbjct: 171 EVV---KNERYTFS--PDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 27/219 (12%)

Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMDVTEDEEE--EIKLEINVLKKYSNHRN 113
           I  +G G +G+V    Y      TG+  A+K +          ++K EI +L+    H N
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HEN 67

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRG 172
           I  Y G           + + L+ME+  +GS+ + +   K + +LK++    +  +I +G
Sbjct: 68  IVKYKGI----CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKG 121

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV--SAQLDRTIGRRNTFIGTP-YWMAP 229
           + YL   + +HRD+  +NVL+    +VK+ DFG+  + + D+        + +P +W AP
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM-----AESQP 263
           E +       + +   SD+WS G+T  E+     +ES P
Sbjct: 182 ECLI-----QSKFYIASDVWSFGVTLYELLTYCDSESSP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 87/283 (30%)

Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKG-----RHTKTGQLAAIKVMDV--TEDEEEEIKL 100
           +W E P    +L + +G G +G+V +        + + +  A+K++    T  E + +  
Sbjct: 1   KW-EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMT 59

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS--------- 151
           E+ +L    +H N+    GA  K   P     L +++EYC  G++++ ++S         
Sbjct: 60  ELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEYCKFGNLSNYLRSKRECFSPYR 114

Query: 152 TKGQSLKEEWIAFICR-------------------------------------------- 167
            K    +E       +                                            
Sbjct: 115 NKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLED 174

Query: 168 ------EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR----- 216
                 ++ RG+++L   K IHRD+  +N+LL++N  VK+ DFG    L R I +     
Sbjct: 175 LISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG----LARDIYKDPDYV 230

Query: 217 RNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           R      P  WMAPE I      D  Y  +SD+WS G+   E+
Sbjct: 231 RKGDARLPLKWMAPESIF-----DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYY 118
           +G G +G+V   +   TG++ A K +D      +  E+   LE  +L+K ++   +   Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            AF  K+       L LVM     G +   + +   + L+ E +     +I  G+ +LH 
Sbjct: 61  -AFESKT------HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD--RTIGRRNTFIGTPYWMAPEVIACDE 236
             +++RD+K +NVLL D    +L D G++ +L   +TI +R    GT  +MAPE++    
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILK--- 167

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCD 267
             +  Y    D +++G +  EM   + P  D
Sbjct: 168 --EEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 63/264 (23%), Positives = 121/264 (45%), Gaps = 39/264 (14%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN---IA 115
           ++G G +G+VY  R   TG++ A+K +D   +   + E + L   ++    +  +   I 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
               AF   +P    D+L  +++    G +      ++     E+ + F   EI+ GL++
Sbjct: 61  CMTYAF--HTP----DKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYATEIILGLEH 112

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           +H   V++RD+K  N+LL ++  V++ D G++    +   + +  +GT  +MAPEV+   
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVL--- 167

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL-----CDLHPMRALFL-----IPRNAPPRL 285
                 YD+ +D +SLG    ++     P       D H +  + L     +P +  P L
Sbjct: 168 -QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPEL 226

Query: 286 KSKKWPKKFQSFIETVLVKDYHQR 309
           K         S +E +L +D  +R
Sbjct: 227 K---------SLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 72.2 bits (177), Expect = 8e-14
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           I ++IL GL+YLH  ++IHRD+K +N+ + D  +V + D G +AQ            GT 
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTV 220

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE------SQPPLCDLHPMRALFLIP 278
              APEV+A D+     Y++++D+WS GI   EM          PP      +++     
Sbjct: 221 ETNAPEVLARDK-----YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 279 RNAPPRLKSKKWPKKFQSFIETVLVKDY------HQRPYT 312
                 LK    P++F     + LV+ +       ++PYT
Sbjct: 276 LKIISTLKVH--PEEFPRDPGSRLVRGFIEYASLERQPYT 313

Length = 357

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 31/216 (14%)

Query: 60  IEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHR 112
           I  +G G +G+V+  +           L  +K +  T+DE    E + E+++ +K S H+
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HK 68

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG-------QSLKEEWIAFI 165
           N+    G   +  P       ++++EY   G +   +++TK          L  +    +
Sbjct: 69  NVVRLLGLCREAEP------HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGT 223
           C +I  G+ +L   + +HRD+  +N L++   EVK+    +S  +        RN  I  
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-- 180

Query: 224 PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           P  W+APE +  D+     +  +SD+WS G+   E+
Sbjct: 181 PLRWLAPEAVQEDD-----FSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 21/204 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNHRNI 114
            +L++ +G G +G V  G +   G   A+K +  D T    +    E +V+ +   H N+
Sbjct: 8   LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA---QAFLAEASVMTQL-RHSNL 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               G  +++        L++V EY   GS+ D ++S     L  + +     ++   ++
Sbjct: 62  VQLLGVIVEEK-----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           YL  N  +HRD+  +NVL++++   K+ DFG++ +   T   ++T      W APE +  
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR- 172

Query: 235 DENPDATYDNRSDLWSLGITALEM 258
               +  +  +SD+WS GI   E+
Sbjct: 173 ----EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 60/206 (29%), Positives = 82/206 (39%), Gaps = 54/206 (26%)

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA-QLDRTIGRRNTFIGT 223
           I R +LR ++YLHEN++IHRDIK +N+ +    +V L DFG +   +D    +   + GT
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246

Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL---------CD------- 267
               APE++A D      Y    D+WS GI   EMA     L         CD       
Sbjct: 247 IATNAPELLARD-----PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301

Query: 268 ------LHPMRALFLIPRNAPPRLK----------SKK------W------PKKFQSFIE 299
                  HP       P +A   L           S+K      W      P   +  I 
Sbjct: 302 IIRRSGTHPNE----FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLIC 357

Query: 300 TVLVKDYHQRPYTDQLLKHPFIRDQP 325
            +L  D H RP  + LL     +D P
Sbjct: 358 KMLAFDAHHRPSAEALLDFAAFQDIP 383

Length = 391

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 71/291 (24%), Positives = 113/291 (38%), Gaps = 75/291 (25%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DV-TEDEEEEIKLEINVLKKYSNH 111
           +F  I+ +G G +G+V       T  L A+K +   DV   ++   +K E ++L +  N 
Sbjct: 2   MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             +  YY +F  K      D L+ VM+Y   G +  L+   + +   E    F   E+  
Sbjct: 62  WVVKLYY-SFQDK------DNLYFVMDYIPGGDMMSLL--IRMEVFPEVLARFYIAELTL 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--------------------- 210
            ++ +H+   IHRDIK  N+L+  +  +KL DFG+                         
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 211 --------------DR--TIGRR----------NTFIGTPYWMAPEVIACDENPDATYDN 244
                         DR  T+ +R          ++ +GTP ++APEV+         Y  
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-----RKGYTQ 227

Query: 245 RSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ 295
             D WS+G+   EM   QPP          FL P     +LK   W     
Sbjct: 228 LCDWWSVGVILFEMLVGQPP----------FLAPTPTETQLKVINWENTLH 268

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 59/271 (21%)

Query: 31  FIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKG-----RHTKTGQLAAI 85
            + GL + S+         ++D    F L + +G G +G VYK      +  K G+    
Sbjct: 120 PLEGLFRPSFK--------KDD----FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK 167

Query: 86  KVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV 145
           K    TE    EI +   V +   N  + A +   F++     K+D+ WLV  Y G  ++
Sbjct: 168 KA---TEYGAVEIWMNERVRRACPN--SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTL 222

Query: 146 TDLVKST------------------KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIK 187
            DL++S                   KG   + + I  I R+IL  L  LH   ++HRD+K
Sbjct: 223 ADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282

Query: 188 GQNVLLTDNA-EVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPE-VIACDENPDA---- 240
            QN++ ++ +   K++D G +A L   I      F+  P + APE  I   + P A    
Sbjct: 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 342

Query: 241 ------------TYDNRSDLWSLGITALEMA 259
                          +R D++S G+  L+MA
Sbjct: 343 VATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373

Length = 566

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMD--VTEDEEEEIKLEINVLKKYSN 110
           F+ I+V+G+G +G VYKG     G+      AIK +    +    +EI  E  V+    +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 67

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           + ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I 
Sbjct: 68  NPHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIA 119

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMA 228
           +G+ YL E +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEM 258
            E I         Y ++SD+WS G+T  E+
Sbjct: 180 LESIL-----HRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 75/293 (25%), Positives = 126/293 (43%), Gaps = 50/293 (17%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQL---AAIKVMDVTEDEEEEIKL--EIN 103
           E       L+  +G G++G VY+G  R    G+     A+K ++ +    E I+   E +
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS------- 156
           V+K ++ H ++    G   K  P        +VME    G +   ++S + ++       
Sbjct: 62  VMKGFTCH-HVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNPGRP 114

Query: 157 ---LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT 213
              L+E  +  +  EI  G+ YL+  K +HRD+  +N ++  +  VK+ DFG++  +  T
Sbjct: 115 PPTLQE--MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Query: 214 IGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHP 270
              R    G  P  WMAPE +      D  +   SD+WS G+   E+   ++ P   L  
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227

Query: 271 MRALFLI--------PRNAPPRLKSKK---W---PKKFQSFIETV--LVKDYH 307
            + L  +        P N P R+       W   PK   +F+E V  L  D H
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 23/220 (10%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQL----AAIKVMDVTEDEEEEIKLEINVLKKYS-NHRNI 114
           ++++G+G +G V+KG     G       AIK +      +   ++  ++L   S +H  I
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               G       PG    L LV +    GS+ D V+  +  SL  + +   C +I +G+ 
Sbjct: 72  VRLLGIC-----PGA--SLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMY 123

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF--IGTPY-WMAPEV 231
           YL E++++HR++  +N+LL  ++ V++ DFGV A L     ++  +    TP  WMA E 
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGV-ADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 232 IACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHP 270
           I         Y ++SD+WS G+T  E M+    P   + P
Sbjct: 183 ILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 25/204 (12%)

Query: 63  VGNGTYGQVYKG--RHTKTGQLAAIKVMDVTEDEE---EEIKLEINVLKKYSNHRNIATY 117
           +G+G +G V KG  +  K+ +  A+K++    ++    +E+  E NV+++  N       
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN------- 55

Query: 118 YGAFIKKSPPGKDDQLW-LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
              +I +     + + W LVME    G +   ++  K + + E+ I  +  ++  G+KYL
Sbjct: 56  --PYIVRMIGICEAESWMLVMELAELGPLNKFLQ--KNKHVTEKNITELVHQVSMGMKYL 111

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIA 233
            E   +HRD+  +NVLL      K+ DFG+S  L  D    +  T    P  W APE + 
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 234 CDENPDATYDNRSDLWSLGITALE 257
             +     + ++SD+WS G+   E
Sbjct: 172 YYK-----FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 27/204 (13%)

Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           L E++G G +G V +G +T  GQ  A+K +  DVT     E   E  V+ K  +H+N+  
Sbjct: 10  LGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQAFLE---ETAVMTKL-HHKNLVR 63

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE--EWIAFICREILRGLK 174
             G  +          L++VME    G++ + ++ T+G++L    + + F   ++  G++
Sbjct: 64  LLGVILHNG-------LYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQF-SLDVAEGME 114

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           YL   K++HRD+  +N+L++++   K+ DFG+ A++   +G  N+ +    W APE +  
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGL-ARVGS-MGVDNSKLPVK-WTAPEALK- 170

Query: 235 DENPDATYDNRSDLWSLGITALEM 258
                  + ++SD+WS G+   E+
Sbjct: 171 ----HKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 64/262 (24%), Positives = 107/262 (40%), Gaps = 67/262 (25%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHR 112
           F  ++V+G G +G+V   +   TG++ A+K +  +E    D+   +K E +VL + S+  
Sbjct: 3   FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSP 61

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            + + Y +F       +D Q L+L+ME+   G +  ++   K  +  E+   F   E + 
Sbjct: 62  WVVSLYYSF-------QDAQYLYLIMEFLPGGDLMTML--IKYDTFSEDVTRFYMAECVL 112

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT------------------ 213
            ++ +H+   IHRDIK  N+L+     +KL DFG+S    +                   
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 214 IGRRNTF-----------------------------IGTPYWMAPEVIACDENPDATYDN 244
           I  RN+                              +GTP ++APE+          Y  
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-----QQGYGQ 227

Query: 245 RSDLWSLGITALEMAESQPPLC 266
             D WSLG    E     PP C
Sbjct: 228 ECDWWSLGAIMFECLIGWPPFC 249

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 13/206 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEIN--VLKKYSNHRNI 114
           ++ ++ +G+G  G V     T  G   A+K +      +   K      VL K  NH+NI
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
            +    F  +    +   ++LVME   A ++  ++       L  E ++++  ++L G+K
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIK 137

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +LH   +IHRD+K  N+++  +  +K++DFG+ A+   T      ++ T Y+ APEVI  
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVIL- 195

Query: 235 DENPDATYDNRSDLWSLGITALEMAE 260
                  Y    D+WS+G    E+ +
Sbjct: 196 ----GMGYKENVDIWSVGCIMGELVK 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 21/164 (12%)

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           VL K  NH+NI +    F  +    +   ++LVME   A ++  +++      L  E ++
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMS 122

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
           ++  ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ T
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMT 176

Query: 224 P-----YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           P     Y+ APEVI         Y    D+WS+G    EM   +
Sbjct: 177 PYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK--YSNHRN 113
             E    +G G +G V+     + G+  A+K M          K     LK   +  H N
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60

Query: 114 IATYYGAFIKKSPPGKD--DQLWLVMEYCGAGSVTDLVKS-TKGQSLKEEWIAFICREIL 170
           +     A     PP  D  +++++V E       +DL K     Q L  + +     +IL
Sbjct: 61  V---LSALDILQPPHIDPFEEIYVVTELMQ----SDLHKIIVSPQPLSSDHVKVFLYQIL 113

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF--IGTPYWMA 228
           RGLKYLH   ++HRDIK  N+L+  N  +K+ DFG+ A+++     ++    + T Y+ A
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL-ARVEEPDESKHMTQEVVTQYYRA 172

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEM 258
           PE++    +    Y +  D+WS+G    E+
Sbjct: 173 PEILMGSRH----YTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 69/287 (24%), Positives = 128/287 (44%), Gaps = 52/287 (18%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVLKKYSNHRNIATYY 118
           ++G G +G+VY  R   TG++ A+K +D     ++ IK+   E   L +      ++T  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLD-----KKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 119 GAFIK------KSPPGKDDQLWLVMEYCGAGSVTDL-VKSTKGQSLKEEWIAFICREILR 171
             FI        +P    D+L  +++    G   DL    ++     E  + F   EI+ 
Sbjct: 56  CPFIVCMSYAFHTP----DKLSFILDLMNGG---DLHYHLSQHGVFSEAEMRFYAAEIIL 108

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL+++H   V++RD+K  N+LL ++  V++ D G++   D +  + +  +GT  +MAPEV
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEV 166

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL----------CDLHPMRALFLIPRNA 281
           +         YD+ +D +SLG    ++     P            D   +     +P + 
Sbjct: 167 LQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRD 323
            P L+         S +E +L +D ++R         ++ +HPF R 
Sbjct: 223 SPELR---------SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 14/163 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F +++ +  G +G+VY GR     +L A+KV+     + ++   +++ E + L    +  
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +  YY            + ++LVMEY   G V  L+         EE       E+   
Sbjct: 66  IVHLYYSL-------QSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALA 116

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTI 214
           L YLH + +IHRD+K  N+L+++   +KL DFG+S   L+R +
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL 159

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 49/160 (30%), Positives = 82/160 (51%), Gaps = 21/160 (13%)

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           VL K  NH+NI      F  +    +   +++VME   A ++  +++      L  E ++
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMS 129

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
           ++  ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ T
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMT 183

Query: 224 P-----YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           P     Y+ APEVI         Y    D+WS+G    EM
Sbjct: 184 PYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 26/209 (12%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLA----AIKVMDVTEDEEEEIKLEINVLKKYS-NHRNI 114
           ++V+G+G +G VYKG     G+      AIK+++ T   +  ++     L   S +H ++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK---GQSLKEEWIAFICREILR 171
               G  +  +       + LV +    G + D V   K   G  L   W    C +I +
Sbjct: 72  VRLLGVCLSPT-------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW----CVQIAK 120

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP--YWMAP 229
           G+ YL E +++HRD+  +NVL+     VK+ DFG++  L+      N   G     WMA 
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I   +     + ++SD+WS G+T  E+
Sbjct: 181 ECIHYRK-----FTHQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 18/218 (8%)

Query: 59  LIEVVGNGTYGQVYKGRHTKTGQL--AAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           L + +G G +G V +G+  +   +   A+K M +   T  E E+   E   +K++ +H N
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPN 61

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKG---QSLKEEWIAFICREI 169
           +    G  ++           +++ +   G +   L+ S  G   Q L  + +     +I
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY-WM 227
             G++YL     IHRD+  +N +L +N  V + DFG+S ++ +    R+      P  W+
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMA-ESQPP 264
           A E +A     D  Y  +SD+WS G+T  E+A   Q P
Sbjct: 182 AIESLA-----DRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 20/216 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSN 110
            +L +++G G +G V +G+ ++   +    A+K M +   T  E EE   E   +K +  
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD- 59

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD--LVKSTKGQSLK---EEWIAFI 165
           H N+    G   + S   K  +  +++ +   G +    L     G   K   +  + F+
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT-P 224
             +I  G++YL     IHRD+  +N +L ++  V + DFG+S ++      R   I   P
Sbjct: 120 V-DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 225 Y-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
             W+A E +A     D  Y ++SD+W+ G+T  E+A
Sbjct: 179 VKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 63/270 (23%), Positives = 117/270 (43%), Gaps = 36/270 (13%)

Query: 63  VGNGTYGQVYKGRHTK-----TG-QLAAIKVMDVTEDEEEEIKL--EINVLKKYSNHRNI 114
           +G+G +G+VY+G  T      +G    A+K +     ++E+ +   E +++  + NH NI
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF-----ICREI 169
               G  +   P       +++ME    G +   ++  + +      +       IC ++
Sbjct: 62  VKLLGVCLLNEP------QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAE-----VKLVDFGVSAQLDRTIGRRNTFIG-- 222
            +G  YL +   IHRD+  +N L+++        VK+ DFG++  + ++   R    G  
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRNA 281
              WMAPE +      D  +  +SD+WS G+   E +   Q P   L+    L  +   A
Sbjct: 176 PVRWMAPESLL-----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV--TA 228

Query: 282 PPRLKS-KKWPKKFQSFIETVLVKDYHQRP 310
             RL+  +  P K    +     +D  +RP
Sbjct: 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 43/238 (18%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRH-----TKTGQLAAIKVM--DVTEDEEEEIKLEIN 103
           E P    E +  +G G +G+V++ R       +   + A+K++  + + D + + + E  
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQS----- 156
           ++ ++ +H NI    G      P      + L+ EY   G + + ++  S + Q      
Sbjct: 61  LMAEF-DHPNIVKLLGVCAVGKP------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113

Query: 157 -------------LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVD 203
                        L       I +++  G+ YL E K +HRD+  +N L+ +N  VK+ D
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 173

Query: 204 FGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           FG+S  +   D      N  I    WM PE I         Y   SD+W+ G+   E+
Sbjct: 174 FGLSRNIYSADYYKASENDAIPI-RWMPPESIFY-----NRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 15/209 (7%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSN 110
           E P    +L + +G G +G+V+   + K  ++A +K M       E    E NV+K   +
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVA-VKTMKPGSMSVEAFLAEANVMKTLQH 60

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
            + +  +  A + K P      ++++ E+   GS+ D +KS +G       +     +I 
Sbjct: 61  DKLVKLH--AVVTKEP------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAP 229
            G+ ++ +   IHRD++  N+L++ +   K+ DFG++  + D     R        W AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I        ++  +SD+WS GI  +E+
Sbjct: 173 EAINF-----GSFTIKSDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 61/270 (22%), Positives = 112/270 (41%), Gaps = 46/270 (17%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTG----QLAAIKVM-DVTEDEE-EEIKLEINV 104
           E P      +E +G   +G++YKG     G    QL AIK + D+   ++  E + E ++
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV--------------- 149
           + +  +H NI    G   ++ P      + ++ EY   G + + +               
Sbjct: 61  MAEL-HHPNIVCLLGVVTQEQP------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 150 KSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ 209
             T   SL       I  +I  G++YL  +  +H+D+  +N+L+ +   VK+ D G+S +
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 210 L---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE------ 260
           +   D    +  + +    WM PE I         + + SD+WS G+   E+        
Sbjct: 174 IYSADYYRVQPKSLLPI-RWMPPEAIMY-----GKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Query: 261 ---SQPPLCDLHPMRALFLIPRNAPPRLKS 287
              S   + ++   R L     + PPR+ S
Sbjct: 228 YGFSNQEVIEMVRKRQLLPCSEDCPPRMYS 257

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 24/221 (10%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQL---AAIKVMD-VTEDEEEEIKLEINVLKKYSNHRNIAT 116
            V+G G +G VY G    +       A+K ++ +T+ EE E  L+  ++ K  +H N+ +
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 117 YYGAFIKK--SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             G  +    SP        +V+ Y   G + + ++S       ++ I F   ++ +G++
Sbjct: 61  LLGICLPSEGSP-------LVVLPYMKHGDLRNFIRSETHNPTVKDLIGF-GLQVAKGME 112

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIG--RRNTFIGTPY-WMAPE 230
           YL   K +HRD+  +N +L ++  VK+ DFG++    D+       +T    P  WMA E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 231 VIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHP 270
            +         +  +SD+WS G+   E M    PP  D+  
Sbjct: 173 SLQTQ-----KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 20/214 (9%)

Query: 63  VGNGTYGQVYKG---RHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS-NHRNIATYY 118
           +GNG +G+V  G   R     ++  +K +  +   +E++     V      NH N+    
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG---QSLKEEWIAFICREILRGLKY 175
           G  I+  P        LV+E+C  G + + ++S +G   Q  +++ +  +  E+  GL +
Sbjct: 62  GQCIESIP------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT--IGRRNTFIGTPYWMAPEVIA 233
           LH+   IH D+  +N  LT +  VK+ D+G++ +         ++       W+APE++ 
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 234 CDENPDATYD--NRSDLWSLGITALEMAE--SQP 263
                    D   +S++WSLG+T  E+     QP
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 63  VGNGTYGQVYKG-----RHTKTGQLAAIKVMDVTEDEEEEIKL--EINVLKKYSNHRNIA 115
           +G G++G VY+G        +     AIK ++      E I+   E +V+K+++ H ++ 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 72

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF--------ICR 167
              G   +  P        ++ME    G +   ++S + +       A         +  
Sbjct: 73  RLLGVVSQGQPT------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG--TPY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 187 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 21/169 (12%)

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEY--CGAGSVTDLVKSTKGQSLK 158
           EI++LK  S HR I     A+  KS       + +VM    C   +  D         L 
Sbjct: 136 EIDILKTIS-HRAIINLIHAYRWKS------TVCMVMPKYKCDLFTYVDRS-----GPLP 183

Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN 218
            E    I R +L  L YLH   +IHRD+K +N+ L +     L DFG + +LD       
Sbjct: 184 LEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243

Query: 219 TF--IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
            +   GT    +PE++A D      Y  ++D+WS G+   EM+     L
Sbjct: 244 CYGWSGTLETNSPELLALD-----PYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 60/273 (21%), Positives = 109/273 (39%), Gaps = 39/273 (14%)

Query: 64  GNGTYGQVYKGRHTKTGQLAA----------IKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
           G GT+  +YKG       L            +KV+     +        +++ + S H++
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS-HKH 62

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +   YG  ++       D+  +V EY   G +   +   K  ++   W   + +++   L
Sbjct: 63  LVKLYGVCVR-------DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASAL 114

Query: 174 KYLHENKVIHRDIKGQNVLLT---DNAE----VKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            YL + K++H ++ G+N+L+     N      +KL D G+      T+  R   +    W
Sbjct: 115 HYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----ITVLSREERVERIPW 170

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRAL-FLIPRNAPPR 284
           +APE   C  N  A+    +D WS G T LE+ +  + PL  L       F   ++   R
Sbjct: 171 IAPE---CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH---R 224

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
           L      +   + I      D  +RP    +L+
Sbjct: 225 LPMPDCAELA-NLINQCWTYDPTKRPSFRAILR 256

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)

Query: 63  VGNGTYGQVYKGRHT--KTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGA 120
           VG GTYG VYK +    K  +  A+K ++ T       + EI +L++   H N+      
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLREL-KHPNVIALQKV 66

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-------STKGQSLKEEWIAFICREILRGL 173
           F+  S    D ++WL+ +Y     +  ++K       + K   L    +  +  +IL G+
Sbjct: 67  FLSHS----DRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 174 KYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLD---RTIGRRNTFIGTPYW 226
            YLH N V+HRD+K  N+L+     +   VK+ D G +   +   + +   +  + T ++
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
            APE++    +    Y    D+W++G    E+  S+P
Sbjct: 182 RAPELLLGARH----YTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYY- 118
           ++V+G+G +G VYKG     G+   I V      E    K    +L +      + + Y 
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71

Query: 119 ----GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               G  +  +       + LV +    G + D V+  K + +  + +   C +I +G+ 
Sbjct: 72  CRLLGICLTST-------VQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMS 123

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVI 232
           YL E +++HRD+  +NVL+     VK+ DFG++  LD      +   G  P  WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 233 ACDENPDATYDNRSDLWSLGITALEM 258
                    + ++SD+WS G+T  E+
Sbjct: 184 L-----HRRFTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 62/261 (23%)

Query: 51  EDPAGIFELIEVVGNGTYGQVY------------KGRHTKTGQ--LAAIKVM--DVTEDE 94
           E P     L E +G G +G+V+            +G     GQ  L A+K++  DVT+  
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60

Query: 95  EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV--------- 145
             +   EI ++ +   + NI    G  +       DD L ++ EY   G +         
Sbjct: 61  RNDFLKEIKIMSRL-KNPNIIRLLGVCVS------DDPLCMITEYMENGDLNQFLSQREI 113

Query: 146 -TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF 204
            +    +    S+    + ++  +I  G+KYL     +HRD+  +N L+ ++  +K+ DF
Sbjct: 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173

Query: 205 GVSAQLDRTIGRRNTFIGTPY-----------WMAPEVIACDENPDATYDNRSDLWSLGI 253
           G+S         RN + G  Y           WMA E I         +   SD+W+ G+
Sbjct: 174 GMS---------RNLYSGDYYRIQGRAVLPIRWMAWESILL-----GKFTTASDVWAFGV 219

Query: 254 TALEMAESQPPLCDLHPMRAL 274
           T  EM      LC   P   L
Sbjct: 220 TLWEMFT----LCKEQPYSLL 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 19/221 (8%)

Query: 57  FELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSN 110
           F L  ++G G +G V + +      + Q  A+K++     +  + EE   E   +K++ +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-D 59

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQ---SLKEEWIAFIC 166
           H N+    G  ++    G+     +++ +   G + T L+ S  G+   +L  + +    
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY 225
            +I  G++YL     IHRD+  +N +L +N  V + DFG+S ++      R+      P 
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 226 -WMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPP 264
            W+A E +A     D  Y   SD+W+ G+T  E M   Q P
Sbjct: 180 KWLALESLA-----DNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 7/93 (7%)

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY 225
           ++ RG+++L   K IHRD+  +N+LL++N  VK+ DFG++  +  D    R+ +      
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           WMAPE I      D  Y  +SD+WS G+   E+
Sbjct: 242 WMAPESIF-----DKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 53/241 (21%), Positives = 102/241 (42%), Gaps = 50/241 (20%)

Query: 57  FELIEVVGNGTYGQVYKG--RHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS----- 109
             L +++  GT+G+++ G     K G+   + V  V +   E   +++ +L + S     
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE---IQVTLLLQESCLLYG 64

Query: 110 -NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV------TDLVKSTKGQSLKEEWI 162
            +H+NI       I+   P       ++  Y   G++        L ++   Q+L  + +
Sbjct: 65  LSHQNILPILHVCIEDGEPPF-----VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL------------ 210
             +  +I  G+ YLH+  VIH+DI  +N ++ +  +VK+ D  +S  L            
Sbjct: 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179

Query: 211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLH 269
           +R +           WMA E +      +  Y + SD+WS G+   E+    Q P  ++ 
Sbjct: 180 NRPVK----------WMALESLV-----NKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224

Query: 270 P 270
           P
Sbjct: 225 P 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 33/216 (15%)

Query: 63  VGNGTYGQVYKGR-----HTKTGQLAAIKVM-DVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +G G +G+V+          +   L A+K + D +++  ++   E  +L     H +I  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVK 71

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVT--------DLVKSTKGQ---SLKEEWIAFI 165
           +YG  ++  P      L +V EY   G +         D V   +G     L +  +  I
Sbjct: 72  FYGVCVEGDP------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR---NTFIG 222
            ++I  G+ YL     +HRD+  +N L+ +N  VK+ DFG+S  +  T   R   +T + 
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              WM PE I   +     +   SD+WSLG+   E+
Sbjct: 186 I-RWMPPESIMYRK-----FTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 31/219 (14%)

Query: 63  VGNGTYGQVYK-----GRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATY 117
           VG GTYG VYK     G+  +   L  I+   ++     EI L +  LK    H N+ + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIAL-LRELK----HPNVISL 63

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAG--SVTDLVKSTKGQ----SLKEEWIAFICREILR 171
              F+  +    D ++WL+ +Y       +    +++K       L    +  +  +IL 
Sbjct: 64  QKVFLSHA----DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 172 GLKYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLD---RTIGRRNTFIGTP 224
           G+ YLH N V+HRD+K  N+L+     +   VK+ D G +   +   + +   +  + T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           ++ APE++    +    Y    D+W++G    E+  S+P
Sbjct: 180 WYRAPELLLGARH----YTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 7/93 (7%)

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY 225
           ++ +G+++L   K IHRD+  +N+LL++N  VK+ DFG++  +  D    R+        
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           WMAPE I      D  Y  +SD+WS G+   E+
Sbjct: 247 WMAPETIF-----DRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 37/224 (16%)

Query: 59  LIEVVGNGTYGQVYKGRHTKTG-----QLAAIKVM-DVTEDE-EEEIKLEINVLKKYSNH 111
            +E +G   +G+VYKG    T      Q  AIK + D  E    EE K E  +++    H
Sbjct: 9   FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA-MMRSRLQH 67

Query: 112 RNIATYYGAFIKKSP--------PGKDDQLWLVME--YCGAGSVTD--LVKSTKGQSLKE 159
            NI    G   K+ P           D   +LVM   +   GS  D   VKST    L+ 
Sbjct: 68  PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST----LEP 123

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV-----SAQLDRTI 214
                I  +I  G+++L  + V+H+D+  +NVL+ D   VK+ D G+     +A   + +
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183

Query: 215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           G  N+ +    WM+PE I         +   SD+WS G+   E+
Sbjct: 184 G--NSLLPI-RWMSPEAIMY-----GKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.2 bits (151), Expect = 4e-10
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 27/199 (13%)

Query: 79  TGQLAAIKVM--DVTEDEEEEIKL--EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW 134
           TG   AIK++  D  E+E +  +   E  +  +   H NI     A +          L+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIV----ALLDSGEAP-PGLLF 55

Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
            V EY    ++ +++ +  G     E    +  ++L  L   H   ++HRD+K QN++++
Sbjct: 56  AVFEYVPGRTLREVL-AADGALPAGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVS 113

Query: 195 ---DNAEVKLVDFGVSAQL------DR-TIGRRNTFIGTPYWMAPEVIACDENPDATYDN 244
                   K++DFG+   L      D  T+ R    +GTP + APE +   E        
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR-GEPVTP---- 168

Query: 245 RSDLWSLGITALEMAESQP 263
            SDL++ G+  LE    Q 
Sbjct: 169 NSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.5 bits (146), Expect = 7e-10
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 43/199 (21%)

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGT 223
           I +++L  ++Y+H+ K+IHRDIK +N+ L  + ++ L DFG +   ++        ++GT
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331

Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-----HPMRALFLI- 277
               +PE++A D      Y   +D+WS G+  L+M       C +      P + L  I 
Sbjct: 332 VATNSPEILAGD-----GYCEITDIWSCGLILLDMLSHD--FCPIGDGGGKPGKQLLKII 384

Query: 278 -----------------------------PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQ 308
                                          + PP +++   P  F+  +  +L  D+H 
Sbjct: 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHL 444

Query: 309 RPYTDQLLKHPFIRDQPTE 327
           RP   +LL  P    +  E
Sbjct: 445 RPGAAELLALPLFSAEEEE 463

Length = 501

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 52/210 (24%)

Query: 82  LAAIKVM--DVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEY 139
           L A+KV+  D +++  E+   E+ +L + S   NIA   G          D  L ++MEY
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNIARLLGVCTV------DPPLCMIMEY 100

Query: 140 CGAGSVTDL-------VKSTKGQSLKEEWIAF-----ICREILRGLKYLHENKVIHRDIK 187
              G   DL       V  T G +   + ++F     +  +I  G++YL     +HRD+ 
Sbjct: 101 MENG---DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157

Query: 188 GQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-----------WMAPEVIACDE 236
            +N L+  N  +K+ DFG+S         RN +    Y           WMA E +   +
Sbjct: 158 TRNCLVGKNYTIKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208

Query: 237 NPDATYDNRSDLWSLGITALEM---AESQP 263
                +  +SD+W+ G+T  E+      QP
Sbjct: 209 -----FTTKSDVWAFGVTLWEILTLCREQP 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 42/225 (18%)

Query: 63  VGNGTYGQVYKGRHTKTGQLAA---IKVMDVTEDEEEEIK-LEINVLKKYSNHRNIATYY 118
           +GNG +G+V  G    +G   A   +K + V+   +E++K LE     +   H N+    
Sbjct: 3   IGNGWFGKVILGE-VNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST-KGQSLKEEWIAF--ICREILRGLKY 175
           G   + +P        LVME+C  G +   ++S  K + +  +      +  EI  GL +
Sbjct: 62  GQCTEVTP------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-------YWMA 228
           LH+N  IH D+  +N LLT +  VK+ D+G+S         +  +  TP        W+A
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH-----NKYKEDYYVTPDQLWVPLRWIA 170

Query: 229 PEVIACDENPDATYDN--------RSDLWSLGITALEMAE--SQP 263
           PE++      D  + N         S++WSLG+T  E+ E  SQP
Sbjct: 171 PELV------DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 36/219 (16%)

Query: 63  VGNGTYGQV-----YKGRHTKTGQLAAIKVM-DVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +G G +G+V     Y    TK   L A+K + D T    ++ + E  +L     H +I  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVK 71

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS--------TKGQSLKEE------WI 162
           +YG        G  D L +V EY   G +   +++          GQ  + +       +
Sbjct: 72  FYGVC------GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR---NT 219
             I  +I  G+ YL     +HRD+  +N L+  N  VK+ DFG+S  +  T   R   +T
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +    WM PE I   +     +   SD+WS G+   E+
Sbjct: 186 MLPI-RWMPPESIMYRK-----FTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 15/97 (15%)

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI--GTPY 225
           ++ +G+ +L     IHRD+  +NVLLTD    K+ DFG    L R I   + ++  G   
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFG----LARDIMNDSNYVVKGNAR 275

Query: 226 ----WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
               WMAPE I      D  Y  +SD+WS GI   E+
Sbjct: 276 LPVKWMAPESIF-----DCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 31/230 (13%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAI-------KVMDVTEDEEEEIKLEINVLKKYSNHRN 113
           E +G GT+ +++KG   + G    +       KV+D +     E   E   +    +H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +   YG  +       D+ + +V EY   GS+ D         +   W   + +++   L
Sbjct: 61  LVLNYGVCV-----CGDESI-MVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWAL 113

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAE--------VKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            +L +  + H ++  +NVLL    +        +KL D G+S     T+  +   +    
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIP 169

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRAL 274
           W+ PE   C ENP       +D WS G T  E+ +    PL  L   + L
Sbjct: 170 WVPPE---CIENPQ-NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 52/282 (18%)

Query: 63  VGNGTYGQVYKGRHT-----KTGQLAAIKVM-DVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +G G +G+V+          +   L A+K + + +E   ++ + E  +L     H++I  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVR 71

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS----------TKGQSLKE---EWIA 163
           +YG   +  P      L +V EY   G +   ++S           +  +  +     + 
Sbjct: 72  FYGVCTEGRP------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT----IGRRNT 219
            I  +I  G+ YL     +HRD+  +N L+     VK+ DFG+S  +  T    +G R  
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLI- 277
                 WM PE I   +     +   SD+WS G+   E+    + P   L    A+  I 
Sbjct: 186 L--PIRWMPPESILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238

Query: 278 -------PRNAPPR---LKSKKWPKKFQSFIETVLVKDYHQR 309
                  PR  PP    +    W ++ Q   + +++KD H R
Sbjct: 239 QGRELERPRTCPPEVYAIMQGCWQREPQ---QRMVIKDIHSR 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 24/162 (14%)

Query: 100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
           LEI    KYS+ +       A  K S   +   L L  +     +  DL+  T       
Sbjct: 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNL-LSDDGSEGLTTLDLLSFT------- 243

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGR 216
                   ++ RG+++L     +HRD+  +NVLL     VK+ DFG++  +      + +
Sbjct: 244 -------YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +TF+    WMAPE I      D  Y   SD+WS GI   E+
Sbjct: 297 GSTFLPVK-WMAPESIF-----DNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 24/145 (16%)

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT---IGRRNTFIGTP 224
           ++  G+++L     +HRD+  +NVL+ +   VK+ DFG++  + R    I + +TF+   
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIP----- 278
            WMAPE I      +  Y   SD+WS GI   E+      P  +L PM   F        
Sbjct: 307 -WMAPESIF-----NNLYTTLSDVWSFGILLWEIFTLGGTPYPEL-PMNEQFYNAIKRGY 359

Query: 279 RNAPPRLKS--------KKWPKKFQ 295
           R A P   S        K W +KF+
Sbjct: 360 RMAKPAHASDEIYEIMQKCWEEKFE 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 30/240 (12%)

Query: 62  VVGNGTYGQVYKG---RHTKTGQLAAIKVM-DVTEDEEEEIKL-EINVLKKYSNHRNIAT 116
           ++G G +G++ +G     +K     AI  +     D++    L E   L ++ +H NI  
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVR 70

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   + +       + +V EY   G++   ++  +GQ +  + +  +   +  G+KYL
Sbjct: 71  LEGVITRGN------TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML-PGLASGMKYL 123

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP--YWMAPEVIAC 234
            E   +H+ +    VL+  +   K+  F    Q D++     T  G     W APE I  
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 235 DENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHP---MRAL---FLI--PRNAPPRL 285
                  + + SD+WS GI   E M+  + P  D+     ++A+   F +  PRN P  L
Sbjct: 183 HH-----FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 58/264 (21%), Positives = 99/264 (37%), Gaps = 78/264 (29%)

Query: 53  PAGIFELIEVVGNGTYGQVY--------------------KGRHTKTGQLAAIKVM--DV 90
           P G     E +G G +G+V+                    KGR      L A+K++  D 
Sbjct: 3   PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL----LVAVKILRPDA 58

Query: 91  TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
            ++   +   E+ +L +  +  NI    G  +       +D L ++ EY   G +   + 
Sbjct: 59  NKNARNDFLKEVKILSRLKD-PNIIRLLGVCVD------EDPLCMITEYMENGDLNQFLS 111

Query: 151 S-----------------TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           S                     ++    +  +  +I  G+KYL     +HRD+  +N L+
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171

Query: 194 TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-----------WMAPEVIACDENPDATY 242
            +N  +K+ DFG+S         RN + G  Y           WMA E I         +
Sbjct: 172 GENLTIKIADFGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECILM-----GKF 217

Query: 243 DNRSDLWSLGITALEM---AESQP 263
              SD+W+ G+T  E+    + QP
Sbjct: 218 TTASDVWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 7/100 (7%)

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS--AQLDRTIGRRNT 219
           +  + R++L  + Y+H   +IHRDIK +NVL+    ++ L DFG +  A+   +      
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
             GT    APEV+A D      Y    D+WS G+   E A
Sbjct: 322 IAGTVDTNAPEVLAGD-----PYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 41/232 (17%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIA- 115
           +++I ++G G  G+VY        +  A+K   + ED  E   L+    K++     IA 
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLK----KRFLREAKIAA 57

Query: 116 --TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWI------AF-- 164
              + G     S     D ++  M Y    ++  L+KS   + SL +E        AF  
Sbjct: 58  DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA--------QLDRTIGR 216
           I  +I   ++Y+H   V+HRD+K  N+LL    EV ++D+G +          LD  +  
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 217 RNTF----------IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           RN            +GTP +MAPE +      ++T     D+++LG+   +M
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST-----DIYALGVILYQM 224

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 23/215 (10%)

Query: 63  VGNGTYGQVYKGR-HTKTGQLAAI--KVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYG 119
           +GNG +G+V     +T TG    +  ++      +E+   L+     +   H NI    G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK-----GQSLKEEWIAFICREILRGLK 174
             ++  P        LV EYC  G +   +   +      Q L  + +A  C EI  G+ 
Sbjct: 63  QCVEAIP------YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMA--C-EIAAGVT 113

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV--SAQLDRTIGRRNTFIGTPYWMAPEVI 232
           ++H++  +H D+  +N  LT +  VK+ D+G+  S   +  I   +       W+APE++
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173

Query: 233 ACDENPDATYDNR--SDLWSLGITALEMAE--SQP 263
                   T +    S++W+LG+T  E+ E  +QP
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 37/157 (23%)

Query: 130 DDQLWLVMEYCGAGSVTDLVKS--TKGQSLKEEW-------IAFICREILRGLKYLHENK 180
            D L ++ EY   G +   +     +  + K +        + F+  +I  G+KYL    
Sbjct: 91  SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN 150

Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-----------WMAP 229
            +HRD+  +N L+  N  +K+ DFG+S         RN + G  Y           WM+ 
Sbjct: 151 FVHRDLATRNCLVGKNYTIKIADFGMS---------RNLYSGDYYRIQGRAVLPIRWMSW 201

Query: 230 EVIACDENPDATYDNRSDLWSLGITALE---MAESQP 263
           E I         +   SD+W+ G+T  E   + + QP
Sbjct: 202 ESILL-----GKFTTASDVWAFGVTLWEILTLCKEQP 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 15/97 (15%)

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI--GTPY 225
           ++ +G+ +L     IHRD+  +N+LLT     K+ DFG    L R I   + ++  G   
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFG----LARDIRNDSNYVVKGNAR 277

Query: 226 ----WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
               WMAPE I      +  Y   SD+WS GI   E+
Sbjct: 278 LPVKWMAPESIF-----NCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 20/49 (40%), Positives = 35/49 (71%)

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL 210
           I  + R++L GL+ LH   ++HRDIK +N+L+T + +VK++DFG +  +
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359

Length = 507

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 71/295 (24%), Positives = 122/295 (41%), Gaps = 59/295 (20%)

Query: 61  EVVGNGTYGQVY----KGRHTKTGQLAAIKVMDVTEDEEEEIKLE------------INV 104
           +++G G +G VY       H    Q     V  +   E E I +E            I +
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQA----VAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 105 LKKYSN--HRNIATYYG-AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG-----QS 156
            K   N  H  I  YYG    K+    +    ++++E         LV++TK      + 
Sbjct: 74  WKNIHNIDHLGIPKYYGCGSFKRC---RMYYRFILLE--------KLVENTKEIFKRIKC 122

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA-------Q 209
             ++ I  I +++L  L+Y+HE+ + H DIK +N+++  N    ++D+G+++        
Sbjct: 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKH 182

Query: 210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL- 268
           ++ +  +++   GT Y+        D +  A    R DL SLG   L+ A  + P     
Sbjct: 183 IEYSKEQKDLHRGTLYYA-----GLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237

Query: 269 ------HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
                 H  +  F I R    ++K K   K    FIE V    Y ++P  D L+K
Sbjct: 238 HNGNLIHAAKCDF-IKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291

Length = 294

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 35/144 (24%), Positives = 59/144 (40%), Gaps = 24/144 (16%)

Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ 189
           +D ++LV+++   G +   +  +K  ++ EE +     E++  L  LH   ++ RD+   
Sbjct: 57  EDSVFLVLQHAEGGKLWSHI--SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPN 114

Query: 190 NVLLTDNAEVKLVDFG----VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNR 245
           N+LL D   ++L  F     V    D              + APEV    E  +A     
Sbjct: 115 NILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN-------MYCAPEVGGISEETEAC---- 163

Query: 246 SDLWSLG------ITALEMAESQP 263
            D WSLG      +T   + E  P
Sbjct: 164 -DWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 33/132 (25%), Positives = 58/132 (43%), Gaps = 18/132 (13%)

Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           +V E+   G +   ++  KG+ +   W   + +++   L YL +  ++H ++  +N+LL 
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGR-VPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151

Query: 195 -----DNAE--VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDAT-YDNRS 246
                +     +KL D GVS     T   R   +    W+APE +     P        +
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSF----TALSREERVERIPWIAPECV-----PGGNSLSTAA 202

Query: 247 DLWSLGITALEM 258
           D WS G T LE+
Sbjct: 203 DKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 35/227 (15%)

Query: 61  EVVGNGTYGQVYKGR--------HTKTGQLAAIKV-MDVTEDEEEEIKL---EINVLKKY 108
           E +G GT  Q+Y G                  IKV + V +    +I L   E   + + 
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
            +H++I   YG  ++      D +  +V E+   G + DL    K   L   W   + ++
Sbjct: 61  VSHKHIVLLYGVCVR------DVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQ 113

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAE-------VKLVDFGVSAQLDRTIGRRNTFI 221
           +   L YL +  ++H ++  +N+LL            +KL D G+      T+  R   +
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVLSRQECV 169

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA-ESQPPLCD 267
               W+APE +   +N        +D WS G T  E+    + PL D
Sbjct: 170 ERIPWIAPECVEDSKNLSIA----ADKWSFGTTLWEICYNGEIPLKD 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.0 bits (97), Expect = 4e-04
 Identities = 23/73 (31%), Positives = 40/73 (54%), Gaps = 7/73 (9%)

Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           +VMEY     + DL+ S   + L+      + REI R +  LH   +IH D+   N++L+
Sbjct: 76  IVMEYIEGEPLKDLINSNGMEELE------LSREIGRLVGKLHSAGIIHGDLTTSNMILS 129

Query: 195 DNAEVKLVDFGVS 207
              ++ L+DFG++
Sbjct: 130 GG-KIYLIDFGLA 141

Length = 211

>gnl|CDD|220591 pfam10131, PTPS_related, 6-pyruvoyl-tetrahydropterin synthase related domain; membrane protein

 Score = 41.6 bits (98), Expect = 8e-04
 Identities = 25/92 (27%), Positives = 38/92 (41%), Gaps = 8/92 (8%)

Query: 31  FIAGLEKRSYTEGWPEDRWQEDPA--GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM 88
           +I  L  +    GW    WQ  P    I  L   + NG YG ++  R+ + G L A+   
Sbjct: 351 YIPILSGKPTLYGW---AWQGAPTSRNIVLLNTALENGYYGYMFD-RNVEMGALTAVIRK 406

Query: 89  DVTEDEEEEIK-LEINVLKK-YSNHRNIATYY 118
           D+     E  K ++ +  K  Y  +  I  YY
Sbjct: 407 DLITKSSETFKAIDQSAAKSGYVLYTEIGDYY 438

This domain is found in various bacterial hypothetical membrane proteins, as well as in tetratricopeptide TPR_2 repeat protein. The exact function of the domain has not, as yet, been established. Length = 620

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.5 bits (93), Expect = 0.003
 Identities = 17/71 (23%), Positives = 35/71 (49%), Gaps = 11/71 (15%)

Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           +VMEY G   + D+++              + R++   +  LH+  ++H D+   N ++ 
Sbjct: 413 IVMEYIGGKDLKDVLEGNPE----------LVRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462

Query: 195 DNAEVKLVDFG 205
           D+  + L+DFG
Sbjct: 463 DD-RLYLIDFG 472

Length = 535

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 18/83 (21%)

Query: 129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF---ICREILRGLKYLHE--NKV-I 182
            D   +L+ME+             +G++L E        I  ++   L  LH+    V  
Sbjct: 64  SDGWSYLLMEWI------------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 183 HRDIKGQNVLLTDNAEVKLVDFG 205
           H D+   N+L+ D   + ++D+ 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 11/49 (22%), Positives = 27/49 (55%)

Query: 156 SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF 204
            L  E    I  +IL  ++  +   ++H D+   N+L+T++ ++ ++D+
Sbjct: 198 RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246

Length = 304

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	463
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0593|consensus	396		100.0
KOG0581|consensus	364		100.0
KOG0598|consensus	357		100.0
KOG0661|consensus	538		100.0
KOG0616|consensus	355		100.0
KOG0592|consensus	604		100.0
KOG0595|consensus	429		100.0
KOG0605|consensus	550		100.0
KOG0600|consensus	560		100.0
KOG0659|consensus	318		100.0
KOG0033|consensus	355		100.0
KOG0663|consensus	419		100.0
KOG0578|consensus	550		100.0
KOG0201|consensus	467		100.0
KOG0583|consensus	370		100.0
KOG0574|consensus	502		100.0
KOG0591|consensus	375		100.0
KOG0582|consensus	516		100.0
KOG0579|consensus	1187		100.0
KOG0198|consensus	313		100.0
KOG0588|consensus	786		100.0
KOG0587|consensus	953		100.0
KOG0694|consensus	694		100.0
KOG0660|consensus	359		100.0
KOG0610|consensus	459		100.0
KOG0599|consensus	411		100.0
KOG0597|consensus	808		100.0
KOG0032|consensus	382		100.0
KOG0667|consensus	586		100.0
KOG0611|consensus	668		100.0
KOG0585|consensus	576		100.0
KOG0577|consensus	948		100.0
KOG0594|consensus	323		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0580|consensus	281		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0658|consensus	364		100.0
KOG0192|consensus	362		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0604|consensus	400		100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0589|consensus	426		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0690|consensus	516		100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG4717|consensus	864		100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG4279|consensus	1226		100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0612|consensus	1317		100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0607|consensus	463		100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG1989|consensus	738		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0662|consensus	292		100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0584|consensus	632		100.0
KOG0197|consensus	468		100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0596|consensus	677		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG2345|consensus	302		100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0193|consensus	678		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0986|consensus	591		100.0
KOG4236|consensus	888		100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0671|consensus	415		100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0586|consensus	596		100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0666|consensus	438		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4721|consensus	904		100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0696|consensus	683		100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0614|consensus	732		100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0983|consensus	391		100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0669|consensus	376		100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0603|consensus	612		100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG4645|consensus	1509		100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0608|consensus	1034		100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0670|consensus	752		100.0
KOG0668|consensus	338		100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG1290|consensus	590		100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0194|consensus	474		100.0
KOG0695|consensus	593		100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1151|consensus	775		100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1035|consensus	1351		100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1187|consensus	361		100.0
KOG1026|consensus	774		100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4250|consensus	732		100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0576|consensus	829		100.0
KOG1006|consensus	361		100.0
KOG1095|consensus	1025		100.0
KOG0665|consensus	369		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664|consensus	449		100.0
KOG4257|consensus	974		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027|consensus	903		100.0
KOG0199|consensus	1039		100.0
KOG4278|consensus	1157		100.0
KOG1094|consensus	807		100.0
KOG0196|consensus	996		100.0
KOG0984|consensus	282		100.0
KOG1167|consensus	418		100.0
KOG2052|consensus	513		100.0
KOG1152|consensus	772		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200|consensus	609		100.0
KOG3653|consensus	534		100.0
KOG1025|consensus	1177		100.0
KOG1345|consensus	378		100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024|consensus	563		99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164|consensus	322		99.95
KOG0590|consensus	601		99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG1163|consensus	341		99.93
KOG0603|consensus	612		99.93
KOG1165|consensus	449		99.93
KOG0606|consensus	1205		99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG4158|consensus	598		99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG0195|consensus	448		99.9
KOG1240|consensus	1431		99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1033|consensus	516		99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG1166|consensus	974		99.84
KOG0590|consensus	601		99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG1023|consensus	484		99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.73
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG0601|consensus	524		99.67
KOG0606|consensus	1205		99.62
KOG1243|consensus	690		99.59
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.54
KOG0601|consensus	524		99.53
KOG1266|consensus	458		99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.51
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.32
KOG3087|consensus	229		99.29
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.26
KOG3741|consensus	655		99.25
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
KOG2137|consensus	700		99.15
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
COG4248	637	Uncharacterized protein with protein kinase and he	99.1
KOG1235|consensus	538		99.08
KOG0576|consensus	829		99.05
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
PRK09902	216	hypothetical protein; Provisional	98.78
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.65
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.63
PF01636	239	APH: Phosphotransferase enzyme family This family	98.61
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
KOG1035|consensus	1351		98.46
PLN02876	822	acyl-CoA dehydrogenase	98.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.23
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.18
KOG1826|consensus	2724		98.15
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.11
KOG2268|consensus	465		98.08
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.03
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.02
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.97
PRK10593	297	hypothetical protein; Provisional	97.97
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.95
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.91
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.86
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.8
KOG2270|consensus	520		97.71
PRK05231	319	homoserine kinase; Provisional	97.68
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.46
PLN02236	344	choline kinase	97.46
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.42
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.32
PTZ00384	383	choline kinase; Provisional	97.25
KOG1093|consensus	725		97.15
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.09
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.98
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.96
PLN02756	418	S-methyl-5-thioribose kinase	96.93
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.9
KOG1236|consensus	565		96.87
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.8
PRK12396	409	5-methylribose kinase; Reviewed	96.79
PTZ00296	442	choline kinase; Provisional	96.66
COG2334	331	Putative homoserine kinase type II (protein kinase	96.6
PRK11768	325	serine/threonine protein kinase; Provisional	96.57
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.5
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.03
PRK06148	1013	hypothetical protein; Provisional	96.02

>KOG0615|consensus

Probab=100.00  E-value=8.8e-62  Score=459.12  Aligned_cols=261  Identities=30%  Similarity=0.507  Sum_probs=225.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--------chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      +...|.+.+.||+|+||.|-+|..+.+|+.||||++....        .....+.+|+++|++| +|||||+++++|   
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f---  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFF---  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeee---
Confidence            4567999999999999999999999999999999996321        2334567999999999 899999999999   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC---CcEEE
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN---AEVKL  201 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~---~~vkL  201 (463)
                         +..+..|+||||++||+|++.+-..+  .+.+...+.+++||+.||.|||++||+||||||+|||++.+   ..+||
T Consensus       246 ---~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  246 ---EVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             ---ecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence               56678899999999999999997655  68899999999999999999999999999999999999876   78999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh-hhhcccCC
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR-ALFLIPRN  280 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~-~~~~i~~~  280 (463)
                      +|||+|+..+ ....+.++||||.|.|||++....  ...|..++||||+||+||.+|+|.+||.+..... ...+|..+
T Consensus       321 tDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg--~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G  397 (475)
T KOG0615|consen  321 TDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKG--VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG  397 (475)
T ss_pred             cccchhhccc-cceehhhhcCCccccChhheecCC--eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence            9999999887 346678899999999999998532  2334458999999999999999999998765544 55566665


Q ss_pred             CCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         281 APPR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       281 ~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ....  .....+++++++||++||..||++|||++|+|+||||++.+
T Consensus       398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            5433  34467899999999999999999999999999999998754

>KOG0575|consensus

Probab=100.00  E-value=3.9e-59  Score=461.81  Aligned_cols=254  Identities=30%  Similarity=0.555  Sum_probs=234.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..+|+..+.||+|+|+.||.+++..+|+.||+|++..    .....+.+.+||++.+.| +|||||+++++|      ++
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~F------ED   89 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFF------ED   89 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEe------ec
Confidence            3679999999999999999999999999999999975    566778899999999999 899999999999      77


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+++|||+|+|..++|..+++.++  .++|.+++.+++||+.||.|||+++|+|||||..|||++++.+|||+|||||+.
T Consensus        90 s~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   90 SNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             CCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeee
Confidence            799999999999999999998554  799999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      +........+.||||.|+|||++.     ...++..+||||+|||||.||+|+|||...+-.+++..|..+....+  ..
T Consensus       168 le~~~Erk~TlCGTPNYIAPEVl~-----k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P--~~  240 (592)
T KOG0575|consen  168 LEYDGERKKTLCGTPNYIAPEVLN-----KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP--SH  240 (592)
T ss_pred             ecCcccccceecCCCcccChhHhc-----cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc--cc
Confidence            988777888999999999999998     67789999999999999999999999998888888888766654332  37


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ++.++++||.+||+.||.+|||++++|.|+||+.
T Consensus       241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  241 LSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             cCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            8999999999999999999999999999999954

>KOG0593|consensus

Probab=100.00  E-value=5.3e-59  Score=424.23  Aligned_cols=255  Identities=30%  Similarity=0.531  Sum_probs=222.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|+.+.++|+|+||+||+|+++.||+.||||++..+.++   .+-..+||++|+++ +|+|+|.++++|      ....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVF------rrkr   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVF------RRKR   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHH------Hhcc
Confidence            4699999999999999999999999999999999755442   45667999999999 899999999999      5568


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .++||||||+..-|.++- ... ..++...++.|+.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+.
T Consensus        75 klhLVFE~~dhTvL~eLe-~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   75 KLHLVFEYCDHTVLHELE-RYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             eeEEEeeecchHHHHHHH-hcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            999999999985554444 333 368999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA----------  281 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  281 (463)
                      .....++.++.|.||+|||.+.+    ...|+.++||||+||++.||++|.+.|.+.++.++++.|....          
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvG----DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVG----DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcc----cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence            77777888999999999999986    4789999999999999999999999999999999988652211          


Q ss_pred             ----------------CCC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         282 ----------------PPR---LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       282 ----------------~~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                                      .+.   ...+.++.-+.+|++.||..||.+|++++|+|.|+||.
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence                            011   11235567889999999999999999999999999993

>KOG0581|consensus

Probab=100.00  E-value=7.8e-58  Score=429.45  Aligned_cols=254  Identities=39%  Similarity=0.674  Sum_probs=230.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEee--cCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC-e
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD--VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD-Q  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~-~  132 (463)
                      ..+.++.||+|..|+||+|+++.|++.+|+|++.  ......+++.+|+++|+.. +|||||.+|++|..      +. .
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~------~~~~  152 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYS------NGEE  152 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEe------CCce
Confidence            5778899999999999999999999999999995  4455678899999999999 89999999999954      34 6


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ++|+||||+||+|.++++..+  .++|..+..++++|++||.|||+ ++||||||||+||||+..|.|||||||.++.+.
T Consensus       153 isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            999999999999999998664  69999999999999999999995 999999999999999999999999999999887


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----CchhhhhcccCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-----HPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~  286 (463)
                      +.  ..++++||..|||||.+.     +..|+.++||||||+.+.||.+|+.||...     ...+.+..|..+.+|.+.
T Consensus       231 nS--~a~tfvGT~~YMsPERi~-----g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP  303 (364)
T KOG0581|consen  231 NS--IANTFVGTSAYMSPERIS-----GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP  303 (364)
T ss_pred             hh--hcccccccccccChhhhc-----CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC
Confidence            65  568899999999999998     678999999999999999999999999764     556667778888888887


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ...|++++++||..||++||.+|||+.|+++|||++...
T Consensus       304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            778999999999999999999999999999999998543

>KOG0598|consensus

Probab=100.00  E-value=1.7e-57  Score=427.15  Aligned_cols=263  Identities=30%  Similarity=0.532  Sum_probs=236.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...|+++++||+|+||+||+++.+.+++.+|+|+++.    ...+.+....|..+|.++ +||.||+++..|      ++
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysF------Qt   96 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSF------QT   96 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEec------cc
Confidence            4579999999999999999999999999999999963    234567788999999998 899999999999      77


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+++|||+||+.||.|+..|++..  .++|..++.|+..|+.||.|||++|||||||||+|||++.+|+++|+||||++.
T Consensus        97 ~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            799999999999999999998655  699999999999999999999999999999999999999999999999999997


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .-.......++|||+.|||||++.     ...|+.++|+||||+++|+|++|.+||.+.+....+..|.....+ ..+..
T Consensus       175 ~~~~~~~t~tfcGT~eYmAPEil~-----~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-~~p~~  248 (357)
T KOG0598|consen  175 DLKDGDATRTFCGTPEYMAPEILL-----GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-LPPGY  248 (357)
T ss_pred             cccCCCccccccCCccccChHHHh-----cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC-CCCcc
Confidence            655555667789999999999998     678999999999999999999999999999988888888776632 33446


Q ss_pred             CCHHHHHHHHHhhhcCCCCCC----CHHHHhcCccccCCchhHHHH
Q psy7384         290 WPKKFQSFIETVLVKDYHQRP----YTDQLLKHPFIRDQPTERQAR  331 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rp----t~~e~l~hp~~~~~~~~~~~~  331 (463)
                      ++.++++||+++|..||.+|.    ++.++-+||||....++....
T Consensus       249 ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~  294 (357)
T KOG0598|consen  249 LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLA  294 (357)
T ss_pred             CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHh
Confidence            899999999999999999995    799999999999888765443

>KOG0661|consensus

Probab=100.00  E-value=1.7e-57  Score=437.02  Aligned_cols=261  Identities=28%  Similarity=0.454  Sum_probs=227.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHH--HHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE--IKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .+.++|.++++||.|+||.||+|+.+.+|..||||.|+..-...++  -.+|+..|+++..|||||++.+++.+     .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d-----~   81 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD-----N   81 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc-----c
Confidence            4567899999999999999999999999999999999754433333  35899999999559999999999953     2


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      +..+|+|||||+. +|+++++.+ +..|++..++.|+.||++||+|+|.+|++||||||+||||..+..|||+|||+|+.
T Consensus        82 ~~~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   82 DRILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             CceEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence            2399999999987 999999987 67899999999999999999999999999999999999999889999999999998


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--------  281 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  281 (463)
                      +... ..++.++.|.||+|||+++.    ...|+.++|||++|||++|+.+-++.|.|.++.+++++|-...        
T Consensus       160 v~Sk-pPYTeYVSTRWYRAPEvLLr----s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  160 VRSK-PPYTEYVSTRWYRAPEVLLR----SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             cccC-CCcchhhhcccccchHHhhh----ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            8765 45688999999999999984    6789999999999999999999999999999999988642110        


Q ss_pred             -------------CCCC-------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 -------------PPRL-------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 -------------~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                   .+..       .-+.++.++.++|.+||.+||++||||+|+|+||||+..
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence                         1111       113578899999999999999999999999999999854

>KOG0616|consensus

Probab=100.00  E-value=2.2e-55  Score=399.72  Aligned_cols=256  Identities=29%  Similarity=0.513  Sum_probs=231.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..|++++.||.|+||.|.+++++.+|..+|+|+++..    ....+...+|..+|+.+ .||.++++++.|      .+.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~------~d~  116 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTF------KDN  116 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEee------ccC
Confidence            4699999999999999999999999999999999743    23456677899999999 799999999999      666


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||++||.|+.+++..+  .+++..++.|+.||+.||+|||+++|++|||||+|||++.+|.+||+|||+|+.+
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            89999999999999999998765  7999999999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...   ..+.||||.|+|||++.     ...|+.++|.|||||++|||++|.+||.+.++...+.+|..+....  +..+
T Consensus       195 ~~r---T~TlCGTPeYLAPEii~-----sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f--P~~f  264 (355)
T KOG0616|consen  195 SGR---TWTLCGTPEYLAPEIIQ-----SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF--PSYF  264 (355)
T ss_pred             cCc---EEEecCCccccChHHhh-----cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC--Cccc
Confidence            643   47789999999999998     7889999999999999999999999999999999988887776532  3478


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchhHH
Q psy7384         291 PKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTERQ  329 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~~~  329 (463)
                      +.++++||+++|+.|-.+|.     ..+++.+||||....+...
T Consensus       265 s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  265 SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence            89999999999999999993     5789999999998776543

>KOG0592|consensus

Probab=100.00  E-value=1.3e-55  Score=430.02  Aligned_cols=260  Identities=32%  Similarity=0.552  Sum_probs=232.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..+|++.+.||+|+|++|++|+++.+++.||||++..    .....+.+.+|-.+|..|.+||.|++|+..|      ++
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF------QD  145 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF------QD  145 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe------ec
Confidence            4579999999999999999999999999999999863    2344566778999999999999999999999      67


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      +..+|+|+||+++|+|.++|+..+  .|++..++.|+.||+.||+|||++|||||||||+|||++.++++||+|||.|+.
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            789999999999999999998764  899999999999999999999999999999999999999999999999999987


Q ss_pred             ccccc-------------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc
Q psy7384         210 LDRTI-------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL  276 (463)
Q Consensus       210 ~~~~~-------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~  276 (463)
                      +....             ....+++||-.|.+||+|.     ....+..+|+|+||||||+|+.|.+||.+.++..++.+
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-----~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk  298 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-----DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK  298 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhc-----CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            74321             1125689999999999998     66778899999999999999999999999999888888


Q ss_pred             ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhH
Q psy7384         277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER  328 (463)
Q Consensus       277 i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  328 (463)
                      |......  ..+.+++.+++||+++|..||.+|+|++||.+||||....++.
T Consensus       299 I~~l~y~--fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  299 IQALDYE--FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHhccc--CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            7665443  2347889999999999999999999999999999999887765

>KOG0595|consensus

Probab=100.00  E-value=1.4e-54  Score=410.84  Aligned_cols=260  Identities=32%  Similarity=0.597  Sum_probs=227.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...+.|.+.+.||+|+||+||+|+++.++..||||.+...   ....+.+..||.+|+.+ +|||||.+++++      +
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~------~   79 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCI------E   79 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEE------e
Confidence            4456799999999999999999999999999999999643   44566778999999999 799999999999      5


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC------CcEEEE
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN------AEVKLV  202 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~------~~vkL~  202 (463)
                      ..+.+|||||||.||+|.++++.++  .+++..++.++.||+.||++||+++||||||||.||||+..      -.+||+
T Consensus        80 ~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   80 DDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence            6689999999999999999998765  79999999999999999999999999999999999999764      468999


Q ss_pred             ecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC
Q psy7384         203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       203 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      |||+|+.+... ....+.||+|.|||||++.     ...|+.|+|+||+|+|+|+|++|++||...+..+.+..+..+..
T Consensus       158 DFGfAR~L~~~-~~a~tlcGSplYMAPEV~~-----~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~  231 (429)
T KOG0595|consen  158 DFGFARFLQPG-SMAETLCGSPLYMAPEVIM-----SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE  231 (429)
T ss_pred             ccchhhhCCch-hHHHHhhCCccccCHHHHH-----hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc
Confidence            99999998754 3446689999999999998     68899999999999999999999999998887777665544432


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         283 -PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       283 -~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                       .......++....+|+..+|..++..|.+..+-+.|+++...+.
T Consensus       232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  232 IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence             22233455667779999999999999999999999999986653

>KOG0605|consensus

Probab=100.00  E-value=7.4e-55  Score=425.10  Aligned_cols=261  Identities=29%  Similarity=0.536  Sum_probs=229.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..+.|++++.||+|+||.||+|+.+.||.++|+|+++.+    ..+.+.++.|-.+|... ++|+||+||-.|      +
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsF------Q  211 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSF------Q  211 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEe------c
Confidence            456799999999999999999999999999999999743    34567788899999985 899999999999      7


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +.+++||||||++||++..+|....  .|++.+++.|+.+++.||..||+.|||||||||+|+||+..|++||+||||+.
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            7799999999999999999997655  79999999999999999999999999999999999999999999999999986


Q ss_pred             ccccc-----------------------cC------------------------ccccccCCccccccceeccCCCCCCC
Q psy7384         209 QLDRT-----------------------IG------------------------RRNTFIGTPYWMAPEVIACDENPDAT  241 (463)
Q Consensus       209 ~~~~~-----------------------~~------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~  241 (463)
                      -+...                       ..                        .....+|||.|||||++.     +..
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-----~kg  364 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-----GKG  364 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-----cCC
Confidence            43210                       00                        012258999999999999     667


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHh
Q psy7384         242 YDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLL  316 (463)
Q Consensus       242 ~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l  316 (463)
                      |+..+|+||||||+||||.|.|||++.++.+++.+|.+..  ...+....++++++|||.+||+ ||++|.-   ++||.
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            9999999999999999999999999999999998876543  3444556778999999999999 9999974   99999


Q ss_pred             cCccccCCchhH
Q psy7384         317 KHPFIRDQPTER  328 (463)
Q Consensus       317 ~hp~~~~~~~~~  328 (463)
                      +||||+...++.
T Consensus       444 ~HPfF~~v~W~~  455 (550)
T KOG0605|consen  444 KHPFFKGVDWDH  455 (550)
T ss_pred             cCCccccCCcch
Confidence            999999877764

>KOG0600|consensus

Probab=100.00  E-value=1.9e-54  Score=418.77  Aligned_cols=270  Identities=29%  Similarity=0.484  Sum_probs=230.5

Q ss_pred             CCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeeccccc
Q psy7384          46 EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFI  122 (463)
Q Consensus        46 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~  122 (463)
                      ...|..-....|+.+++||+|+||.||+|++..+|+.||+|.+....   ....-..+||.||++| +||||++|.++..
T Consensus       108 ~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt  186 (560)
T KOG0600|consen  108 LHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVT  186 (560)
T ss_pred             cccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEE
Confidence            34677777888999999999999999999999999999999997543   3345677999999999 8999999999986


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEE
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV  202 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~  202 (463)
                      .+    ....+|||||||++ +|.-++.. ..-.|++.+++.|++||++||.|||++||+|||||.+||||+++|.+||+
T Consensus       187 ~~----~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  187 SK----LSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             ec----CCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEec
Confidence            53    34689999999987 88887764 34479999999999999999999999999999999999999999999999


Q ss_pred             ecccccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC
Q psy7384         203 DFGVSAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       203 DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      |||||++++.... ..+..+-|.||+|||.|++    ...|+.++|+||+||||.||++|++.|.+.++.+++..|..-.
T Consensus       261 DFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG----~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc  336 (560)
T KOG0600|consen  261 DFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG----ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC  336 (560)
T ss_pred             cccceeeccCCCCcccccceEEeeccChHHhcC----CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence            9999998765443 3677889999999999997    5779999999999999999999999999999988876542211


Q ss_pred             ------------CC-------C--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         282 ------------PP-------R--------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       282 ------------~~-------~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                                  .|       .        .....++..+.+|+..||..||.+|.||.++|+|+||+..+.
T Consensus       337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~  408 (560)
T KOG0600|consen  337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL  408 (560)
T ss_pred             CCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence                        00       0        001356788999999999999999999999999999965443

>KOG0659|consensus

Probab=100.00  E-value=1.7e-54  Score=388.55  Aligned_cols=260  Identities=26%  Similarity=0.414  Sum_probs=226.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .+|..++.||+|+||.||+|++..+|+.||||.+......   .....+||+.|+.+ +|+||+.++++|      ...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F------~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF------PHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc------cCCC
Confidence            3688999999999999999999999999999999755332   56778999999999 799999999999      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+.||+||++. +|...++... ..++..+++.|+.+++.||+|||++.|+||||||+|+||+++|.+||+|||+|+.+.
T Consensus        75 ~l~lVfEfm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   75 NLSLVFEFMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             ceEEEEEeccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            99999999975 9999998644 479999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA----------  281 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  281 (463)
                      .........+-|.||+|||.+.+    ...|+..+||||.|||++||+-|.|.|.|.++.+++..|.+..          
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfG----sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFG----SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             CCCcccccceeeeeccChHHhcc----chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence            77666666689999999999986    6789999999999999999999999999999999886542210          


Q ss_pred             ------------CCC----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         282 ------------PPR----LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       282 ------------~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                                  .|.    ......++++.+|+.+||..||.+|+|+.|+|+|+||+..+..
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence                        000    0123446788999999999999999999999999999876543

>KOG0033|consensus

Probab=100.00  E-value=6.2e-56  Score=393.08  Aligned_cols=258  Identities=25%  Similarity=0.430  Sum_probs=228.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +.+.|++-+.||+|.|+.|+++.+..+|+.+|+|+++.   .....+++.+|+.|.+.| +|||||++++.+      .+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti------~~   81 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI------QE   81 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhh------cc
Confidence            45569999999999999999999999999999999863   345678899999999999 899999999998      66


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEeccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGV  206 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGl  206 (463)
                      ....|||+|+++|++|..-|-.+  ..++|..+..+++||++||.|||.+||||||+||+|+|+.+   ..-+||+|||+
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccce
Confidence            78999999999999997655433  36889999999999999999999999999999999999954   34699999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC--C
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--R  284 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~  284 (463)
                      |..+. .......++|||.|||||++.     ..+|+..+|||+.|||||.||.|.+||.+.+..+.+..|..+...  .
T Consensus       160 Ai~l~-~g~~~~G~~GtP~fmaPEvvr-----kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  160 AIEVN-DGEAWHGFAGTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS  233 (355)
T ss_pred             EEEeC-CccccccccCCCcccCHHHhh-----cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC
Confidence            99888 445667789999999999998     788999999999999999999999999999988888888776542  2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ...+.+++++++||++||..||.+|.|+.|+|+|||+.+..
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            33467789999999999999999999999999999998754

>KOG0663|consensus

Probab=100.00  E-value=1.6e-54  Score=399.72  Aligned_cols=262  Identities=27%  Similarity=0.454  Sum_probs=228.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..|+.+..|++|+||.||+|+++.|++.||+|.++.....   .-...+||.+|.++ +|||||.+-.+.+-.    +-+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~----~~d  150 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGS----NMD  150 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEecc----ccc
Confidence            5699999999999999999999999999999999755432   23457999999999 799999999988643    346


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|||||||+. +|..++...+ +++...+++.++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||+|+.++
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            79999999987 9999998766 579999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-------CC-
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-------PP-  283 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------~~-  283 (463)
                      .....++..+-|.||+|||.+.+    ...|+.++||||+|||+.||++++|.|.|.+..+++.+|.+..       .+ 
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG----~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLG----AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcC----CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            88888888899999999999986    6789999999999999999999999999999988876542110       00 


Q ss_pred             ----------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         284 ----------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       284 ----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                                            .+....+++...+|++.+|..||.+|.||+|+|+|.||.+.+.+
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                                  00111245788999999999999999999999999999986644

>KOG0578|consensus

Probab=100.00  E-value=4.8e-54  Score=422.48  Aligned_cols=258  Identities=44%  Similarity=0.798  Sum_probs=238.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++...|....+||+|+.|.||.|+...+++.||||.+.... ...+-+.+|+.+|+.+ +|+|||.+++.|+..     
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~-----  342 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG-----  342 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc-----
Confidence            456667999999999999999999999999999999998654 4456778999999999 899999999999643     


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                       +.+|+||||++||+|.|++...   .++|.+++.|++++|.||+|||.+||+|||||.+|||++.+|.+||+|||++.+
T Consensus       343 -deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaq  418 (550)
T KOG0578|consen  343 -DELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ  418 (550)
T ss_pred             -ceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeec
Confidence             7899999999999999999765   499999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-CC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SK  288 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~  288 (463)
                      +......+.+.+|||.|||||++.     ...|++++||||||++++||+.|.|||-..++...+++|..+..+.+. ..
T Consensus       419 i~~~~~KR~TmVGTPYWMAPEVvt-----rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~  493 (550)
T KOG0578|consen  419 ISEEQSKRSTMVGTPYWMAPEVVT-----RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPE  493 (550)
T ss_pred             cccccCccccccCCCCccchhhhh-----hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcc
Confidence            988877888899999999999997     778999999999999999999999999999999999999888777765 46


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .++.++++|+.+||+.|+.+|+++.|||+||||..
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            88999999999999999999999999999999954

>KOG0201|consensus

Probab=100.00  E-value=6.1e-54  Score=409.36  Aligned_cols=257  Identities=52%  Similarity=0.962  Sum_probs=239.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +....|..++.||+|+||.||+|.+..+++.||||+++..  ....++++.|+.+|..+ +++||.++|+.|+..     
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g-----   83 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKG-----   83 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeec-----
Confidence            3445688889999999999999999999999999999864  45567899999999999 899999999999653     


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                       ..++++||||.||++.++++...  .+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++.+
T Consensus        84 -~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   84 -TKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             -ccHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeee
Confidence             68999999999999999997544  558899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      +........+++|||.|||||++.     ...|+.++||||||++.|||++|.|||.+.+++..++.|.+..+|.+.. .
T Consensus       161 l~~~~~rr~tfvGTPfwMAPEVI~-----~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~  234 (467)
T KOG0201|consen  161 LTNTVKRRKTFVGTPFWMAPEVIK-----QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-D  234 (467)
T ss_pred             eechhhccccccccccccchhhhc-----cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-c
Confidence            988877779999999999999998     6789999999999999999999999999999999999999999998887 9


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      |++.+++||..||.+||+.||+|.++|+|+|++.
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            9999999999999999999999999999999986

>KOG0583|consensus

Probab=100.00  E-value=3.7e-53  Score=419.57  Aligned_cols=258  Identities=31%  Similarity=0.524  Sum_probs=224.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-----c-chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-----E-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-----~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ...+.|++.+.||+|+||+|++|.+..+|..||+|++...     . ...+.+.+|+.+++.+..||||+++++++    
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence            3456899999999999999999999999999999987642     1 23567778999999995599999999999    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-CcEEEEec
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDF  204 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-~~vkL~DF  204 (463)
                        .....+|+|||||.||+|++++...  ..+.|..++.+++||+.||+|||++||+||||||+|||++.+ +++||+||
T Consensus        90 --~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   90 --ATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             --ecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence              5557799999999999999999873  379999999999999999999999999999999999999999 99999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATY-DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      |++...........+.|||+.|+|||++.+.    ..| +.++||||+||+||.|++|..||.+.+.......|..+...
T Consensus       166 G~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~----~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~  241 (370)
T KOG0583|consen  166 GLSAISPGEDGLLKTFCGSPAYAAPEVLSGK----GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK  241 (370)
T ss_pred             ccccccCCCCCcccCCCCCcccCCHHHhCCC----CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc
Confidence            9999885334556788999999999999842    215 47899999999999999999999998777777776665443


Q ss_pred             CCCCCCC-CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         284 RLKSKKW-PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       284 ~~~~~~~-~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ...  .+ +.++++||.+||..||.+|+|+.+++.||||+.
T Consensus       242 ~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 IPS--YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            322  33 899999999999999999999999999999985

>KOG0574|consensus

Probab=100.00  E-value=1.4e-54  Score=394.51  Aligned_cols=278  Identities=42%  Similarity=0.855  Sum_probs=251.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +..-|.++++||+|+||.||+|.++.+|..+|||.+... .+.+++..||.+++++ +.|+||++|+.|.      .+..
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC-~S~yVVKYYGSYF------K~sD  102 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQC-KSKYVVKYYGSYF------KHSD  102 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHc-CCchhhhhhhhhc------cCCc
Confidence            445689999999999999999999999999999998765 5678889999999999 8999999999995      4468


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|||||||..|++.|+++.++ ..|++.++..+++..+.||+|||...-||||||..|||++-+|+.||+|||.|.++..
T Consensus       103 LWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            999999999999999998654 5899999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-CCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKKWP  291 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~  291 (463)
                      ....+++.+|||.|||||++.     ...|+.++||||||++..||..|+|||.+.+++..++.|+...+|.+. +..|+
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~-----EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS  256 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIE-----EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWS  256 (502)
T ss_pred             hHHhhCccccCcccccHHHHH-----HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhh
Confidence            888889999999999999998     678999999999999999999999999999999999999999888775 46899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhHHHHHHhHHhHHHHHHh
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKR  344 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~  344 (463)
                      +++.+||+.||.++|++|-|+-++++|||+++.+...-.+..+.+.++...++
T Consensus       257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~e~~~~~  309 (502)
T KOG0574|consen  257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQEKAILG  309 (502)
T ss_pred             hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999998776655555555555544433

>KOG0591|consensus

Probab=100.00  E-value=7.4e-55  Score=393.43  Aligned_cols=248  Identities=31%  Similarity=0.544  Sum_probs=222.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEee---cCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..|+|+++||+|+||.||++++..+|..+|.|.+.   .+....+.+..|+.+|++| +|||||++++.-..    ++..
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~----~~~e   93 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFI----EDNE   93 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhh----ccch
Confidence            35999999999999999999999999999999886   3445567888999999999 89999999993322    3344


Q ss_pred             eEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhc--CC--ceecCCCCCceEEccCCcEEEEecc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHE--NK--VIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~--~g--ivHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                      -++||||||.+|+|..+++..+  ...++|..+++++.|+|.||.+||+  ..  |+||||||.||+|+.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            5999999999999999998643  4579999999999999999999999  45  9999999999999999999999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      +++.+........+++|||.||+||++.     ...|+.++||||+||++|||+.-++||++.+-.....+|..+..+..
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~-----~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~  248 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIH-----ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL  248 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHh-----cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC
Confidence            9999988877788899999999999998     78899999999999999999999999999987777788887766666


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCH
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYT  312 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~  312 (463)
                      ....+|..+..+|..|+.+||..||+.
T Consensus       249 p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  249 PDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            667889999999999999999999984

>KOG0582|consensus

Probab=100.00  E-value=3.3e-51  Score=390.81  Aligned_cols=262  Identities=42%  Similarity=0.724  Sum_probs=231.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .+.|++.+.||.|.-++||+|+...++.+||||+++..  ....+.+.+|+..+..+ +||||++++..|..      +.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv------~~   97 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV------DS   97 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe------cc
Confidence            45799999999999999999999999999999999754  34467899999999998 89999999999954      47


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||.||.+|++.++++..-...++|..++.|+++++.||.|||.+|-||||||+.||||+.+|.|||+|||.+..+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999999999998877789999999999999999999999999999999999999999999999999876654


Q ss_pred             cccCc----cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC--
Q psy7384         212 RTIGR----RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--  285 (463)
Q Consensus       212 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--  285 (463)
                      ....+    .++++||+.|||||+++..   ...|+.|+||||||++..||.+|..||....+++.+.....+.+|.+  
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~---~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQ---LHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhc---ccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            32221    2667999999999997654   56799999999999999999999999999999998877777766522  


Q ss_pred             ------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         286 ------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       286 ------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                            ....++..++.+|..||.+||.+|||++++|+|+||+...
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence                  2346678899999999999999999999999999998643

>KOG0579|consensus

Probab=100.00  E-value=1.1e-52  Score=413.65  Aligned_cols=269  Identities=41%  Similarity=0.841  Sum_probs=245.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec-CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.+-|+|+..||.|+||+||+|..+.++...|.|+|.. .....+++.-||.||..+ +||+||+|+++|.      .++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy------~en  102 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYY------FEN  102 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHh------ccC
Confidence            34457899999999999999999999999999999974 445678889999999999 8999999999994      457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .++|+.|||.||-...++.... ..|++.++..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+....
T Consensus       103 kLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch
Confidence            9999999999999988887655 479999999999999999999999999999999999999999999999999998877


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKW  290 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~  290 (463)
                      .......+++|||+|||||++.|.+....+|+.++||||||++|.||..+.||....+++..+..|....+|.+ .+..|
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~W  261 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHW  261 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchh
Confidence            66667788999999999999999888899999999999999999999999999999999999999988877765 45789


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhHH
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQ  329 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  329 (463)
                      +..|.||+++||.+||..||++.++|+||||++.+....
T Consensus       262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~  300 (1187)
T KOG0579|consen  262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKM  300 (1187)
T ss_pred             hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchH
Confidence            999999999999999999999999999999998776543

>KOG0198|consensus

Probab=100.00  E-value=2.6e-52  Score=398.35  Aligned_cols=259  Identities=35%  Similarity=0.641  Sum_probs=219.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch-HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE-EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      .|...+.||+|+||.||++.+..+|..+|||.+...... .+.+.+|+.+|.++ +|||||++++.....   +. ..++
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~---~~-~~~~   92 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSR---EN-DEYN   92 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccc---cC-eeeE
Confidence            477889999999999999999999999999998754222 46688999999999 599999999975322   11 3799


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEeccccccccc-
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDR-  212 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~~~~~-  212 (463)
                      ++|||+.+|+|.+++...++ .+++..++.+.+||++||.|||++|||||||||+||||+. ++.+||+|||++..... 
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999999998776 7999999999999999999999999999999999999999 79999999999987763 


Q ss_pred             --ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCchhhhhcccCCCCCCCCCCC
Q psy7384         213 --TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD-LHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       213 --~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                        .........||+.|||||++..    +.....++|||||||++.||+||.+||.+ ......+..+.........+..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~----g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~  247 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRN----GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS  247 (313)
T ss_pred             cccccccccccCCccccCchhhcC----CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc
Confidence              1122345789999999999973    11223589999999999999999999988 5555656666555422244557


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++.++++||.+||..+|++||||+++|+|||.+..
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence            89999999999999999999999999999999754

>KOG0588|consensus

Probab=100.00  E-value=2e-52  Score=415.68  Aligned_cols=255  Identities=29%  Similarity=0.494  Sum_probs=226.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +.-|-|++.+.||.|+-|.|.+|++..||+.+|||++..    .......+.+||.+|+.+ .||||+++|+++      
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVw------   81 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVW------   81 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeee------
Confidence            344679999999999999999999999999999999963    344567889999999988 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ++..++|||+||++||.|++++..++  ++++.+++.+++||+.|+.|||..+|+||||||+|+||+..++|||+|||+|
T Consensus        82 e~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   82 ENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             ccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeecccee
Confidence            67789999999999999999997665  7999999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATY-DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      ...... ....+.||+|.|.|||++.+     ..| +.++||||+|||||.||+|+.||.+.+-...+.++.++.+.  .
T Consensus       160 sLe~~g-klLeTSCGSPHYA~PEIV~G-----~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--M  231 (786)
T KOG0588|consen  160 SLEVPG-KLLETSCGSPHYAAPEIVSG-----RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--M  231 (786)
T ss_pred             ecccCC-ccccccCCCcccCCchhhcC-----CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--C
Confidence            754332 34456799999999999984     444 57899999999999999999999987777777777777653  2


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +..++.++++||.+||.+||.+|.|.+||++|||+..
T Consensus       232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence            3689999999999999999999999999999999974

>KOG0587|consensus

Probab=100.00  E-value=1.3e-51  Score=421.01  Aligned_cols=310  Identities=79%  Similarity=1.287  Sum_probs=286.8

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++.+.|+|++.||.|.+|.||+++.+.+++.+|+||+....+..+++..|.++|+.+..|||++.+|++|..... ..
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~-~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP-GN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC-CC
Confidence            35667789999999999999999999999999999999998888889999999999999999999999999987665 67


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ++.+|||||||.||+..|+++...+..+.|..+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||++.+
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            79999999999999999999998888999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-CC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SK  288 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~  288 (463)
                      ++......++.+|||.|||||++.+++.....|+..+|+||||++..||.-|.|||++..+...++.|+++.+|.+. +.
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence            99998999999999999999999999998999999999999999999999999999999999999999999999887 68


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhHHHHHHhHHhHHHHH--HhhhcccccccCCCCCcc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCK--KRKKERDDYRYSGSENEE  360 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~--~~~k~~~~~~~~~~~~~~  360 (463)
                      .|+++|.+||..||.+|..+||+..++|.|||+++...+.+....++++++...  +-.+++.++.+.+++.+.
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~~e~qir~~ik~~~~~~r~~k~~~e~~e~e~~gs~e~~  326 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQPNERQVRIQIKDHIDRSRKKRGEKEETEYEYSGSEEEE  326 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCcccccccHHHHHHHHHHHHhhccchhhhccCcceeccCccccc
Confidence            999999999999999999999999999999999998888888888888877665  444555556665554433

>KOG0694|consensus

Probab=100.00  E-value=3.8e-52  Score=416.59  Aligned_cols=267  Identities=28%  Similarity=0.475  Sum_probs=235.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...|.++++||+|+||+|+++..+.+++++|||++++    ..++.+....|-+|+....+||.++.++.+|      +.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f------QT  440 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF------QT  440 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc------cc
Confidence            3579999999999999999999999999999999974    4567788889999999887899999999999      67


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+++|+||||+.||++..+.+.   ..+++..++.|+..|+.||+|||++||||||||.+|||+|..|++||+|||+++.
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence            7899999999999995444432   3699999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .-.......++||||.|||||++.     ...|+.++|+|||||+|||||.|..||.+.+..+....|....+..  +..
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~-----e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y--P~~  590 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLT-----EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY--PRF  590 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhc-----cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCc
Confidence            654445668899999999999998     7889999999999999999999999999999888888776665432  346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchhHHHHHHhHH
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTERQARIQLKD  336 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~~~~~~~~~~  336 (463)
                      ++.++.++++++|.++|++|.-     +++|..||||+...+.......++.
T Consensus       591 ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P  642 (694)
T KOG0694|consen  591 LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP  642 (694)
T ss_pred             ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence            7899999999999999999975     6899999999998877655554443

>KOG0660|consensus

Probab=100.00  E-value=2.4e-52  Score=390.88  Aligned_cols=262  Identities=28%  Similarity=0.489  Sum_probs=222.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...+|..++.||+|+||.|+.|.++.+|+.||||.+..   .....++..+|+++|+.+ +|+||+.+++++... ..+.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~-~~~~   97 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPP-SRDK   97 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccc-cccc
Confidence            34567778999999999999999999999999998862   334456778999999999 799999999999762 2245


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      -+.+|+|+|+|+ .+|..+++...  .|++..++.++.||+.||+|+|+-||+||||||.|+|++.++.+||+|||+|+.
T Consensus        98 f~DvYiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   98 FNDVYLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cceeEEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence            578999999994 58999987644  599999999999999999999999999999999999999999999999999998


Q ss_pred             ccc--ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC------
Q psy7384         210 LDR--TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA------  281 (463)
Q Consensus       210 ~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------  281 (463)
                      .+.  ....++.++.|.||+|||++..    ...|+.++||||+|||++||++|++.|.|.+...++..|....      
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~----~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLN----SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhc----cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            864  2344577899999999999974    6789999999999999999999999999988777765432211      


Q ss_pred             ----------------CCCC-------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 ----------------PPRL-------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 ----------------~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                      .+..       ..+..++.+.+|+++||..||.+|+|++|+|.||||..
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence                            0011       12466789999999999999999999999999999973

>KOG0610|consensus

Probab=100.00  E-value=8.9e-52  Score=391.80  Aligned_cols=261  Identities=29%  Similarity=0.439  Sum_probs=234.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..|++++.||.|.-|+||+|+...++..+|+|++...    .....+++.|-+||..+ +||.+..||..|      +.+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~f------et~  149 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASF------ETD  149 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhhee------ecc
Confidence            4688999999999999999999999999999999743    34456777899999999 899999999999      777


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..|||||||.||+|..+++.+.+..+++..++.|+..++.||+|||-+|||+|||||+||||.++|+|.|+||.|+...
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999986433


Q ss_pred             cc-----------------------------------c---------------------cCccccccCCccccccceecc
Q psy7384         211 DR-----------------------------------T---------------------IGRRNTFIGTPYWMAPEVIAC  234 (463)
Q Consensus       211 ~~-----------------------------------~---------------------~~~~~~~~gt~~y~aPE~l~~  234 (463)
                      ..                                   .                     ....+.++||-+|+|||++. 
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~-  308 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR-  308 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee-
Confidence            10                                   0                     01234578999999999998 


Q ss_pred             CCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---
Q psy7384         235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPY---  311 (463)
Q Consensus       235 ~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---  311 (463)
                          +...+.++|+|+||+++||||+|..||.|.+..+++.+|..........+.++..++|||+++|.+||.+|..   
T Consensus       309 ----G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r  384 (459)
T KOG0610|consen  309 ----GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR  384 (459)
T ss_pred             ----cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc
Confidence                5678889999999999999999999999999999999998887766666788899999999999999999998   


Q ss_pred             -HHHHhcCccccCCchh
Q psy7384         312 -TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       312 -~~e~l~hp~~~~~~~~  327 (463)
                       |.||.+||||....+.
T Consensus       385 GA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  385 GAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             chHHhhcCccccCCChh
Confidence             9999999999987665

>KOG0599|consensus

Probab=100.00  E-value=7.2e-53  Score=378.88  Aligned_cols=258  Identities=28%  Similarity=0.491  Sum_probs=225.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-----c----hHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-----D----EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----~----~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      .|+-.+.||.|..++|.+|.++.+|..+|+|++....     .    -.+.-..|+.+|+++..||||+++.++|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            4666689999999999999999999999999996321     1    1234467999999999999999999999     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                       +.+..+++|+|.|..|.|+|++...-  .+++...+.|++|+++|+.|||.++||||||||+|||++++.++||+|||+
T Consensus        93 -es~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   93 -ESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             -cCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence             67789999999999999999997654  799999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCC-CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDE-NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-  284 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-  284 (463)
                      ++++... ......||||+|+|||.+.+.. .....|+..+|+|++|||||.||.|.+||.....+-.+..|..+.... 
T Consensus       170 a~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  170 ACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             eeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            9998764 4456789999999999998743 235678999999999999999999999999888887777777665532 


Q ss_pred             -CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         285 -LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       285 -~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                       .....++...++||.+||+.||.+|.|++|+|.||||.
T Consensus       249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence             22346678999999999999999999999999999994

>KOG0597|consensus

Probab=100.00  E-value=5.8e-52  Score=404.89  Aligned_cols=252  Identities=33%  Similarity=0.605  Sum_probs=227.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.   ..+.+.+.+|+++++.+ +|||||.++++|      +...
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esf------Et~~   74 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESF------ETSA   74 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhh------cccc
Confidence            4689999999999999999999999999999999744   34456788999999999 899999999999      6778


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ++|+|.|||.| +|+.++....  .++|+.++.++.+++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+.+.
T Consensus        75 ~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   75 HLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             eEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            99999999988 9999997655  79999999999999999999999999999999999999999999999999999987


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ......+...|||.|||||++.     ++.|+..+|+||||||+|||++|+|||+..+-......|.......  +...+
T Consensus       152 ~~t~vltsikGtPlYmAPElv~-----e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~--p~~~S  224 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVE-----EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP--PSTAS  224 (808)
T ss_pred             cCceeeeeccCcccccCHHHHc-----CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC--ccccc
Confidence            7666667778999999999998     7899999999999999999999999999887777777665554322  33788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..+..|++.+|.+||.+|.|-.+++.|||.+.
T Consensus       225 ~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  225 SSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence            99999999999999999999999999999874

>KOG0032|consensus

Probab=100.00  E-value=1.2e-50  Score=401.53  Aligned_cols=260  Identities=32%  Similarity=0.541  Sum_probs=232.0

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      .......|++.+.||+|.||.||+|+++.+|+.+|+|++....    .....+.+|+.+|+.+..|||||.++++|    
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----  105 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----  105 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            3456678999999999999999999999999999999997432    24578999999999996699999999999    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc----CCcEEE
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKL  201 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~----~~~vkL  201 (463)
                        +....+|+|||+|.||.|++.+...   .+++.++..+++||++|++|||+.||+||||||+|+|+..    ++.+|+
T Consensus       106 --e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  106 --EDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             --EcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEE
Confidence              5667999999999999999999876   3999999999999999999999999999999999999954    357999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      +|||++..... .......+||+.|+|||++.     ...|+..+||||+||++|.|++|.+||.+.+.......+....
T Consensus       181 ~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~-----~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~  254 (382)
T KOG0032|consen  181 IDFGLAKFIKP-GERLHTIVGTPEYVAPEVLG-----GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD  254 (382)
T ss_pred             eeCCCceEccC-CceEeeecCCccccCchhhc-----CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence            99999998876 45667889999999999997     5789999999999999999999999999999888888777665


Q ss_pred             C--CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 P--PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 ~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .  .....+.++..+++||+.||..||.+|+|+.++|+|||+...
T Consensus       255 ~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  255 FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            4  233345678999999999999999999999999999999864

>KOG0667|consensus

Probab=100.00  E-value=4.2e-51  Score=408.97  Aligned_cols=258  Identities=31%  Similarity=0.475  Sum_probs=223.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC-----CceeeecccccccCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-----RNIATYYGAFIKKSP  126 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h-----~nIv~l~~~~~~~~~  126 (463)
                      ....+|+|++.||+|+||+|.+|.+..|++.||||+++.......+...|+.+|..+.+|     -|||+++++|.    
T Consensus       183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~----  258 (586)
T KOG0667|consen  183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY----  258 (586)
T ss_pred             eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc----
Confidence            345689999999999999999999999999999999998888888889999999999644     48999999995    


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC--CcEEEEec
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN--AEVKLVDF  204 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~--~~vkL~DF  204 (463)
                        ..+++|||+|+++- +|+++++.++...++...++.+++||+.||.+||+.||||+|||||||||.+-  ..|||+||
T Consensus       259 --fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  259 --FRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             --cccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence              44899999999965 99999999998899999999999999999999999999999999999999753  47999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---  281 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---  281 (463)
                      |.|++.....   ..++.+..|+|||+|+     +..|+.++||||||||++||++|.|.|.|.+..+++..|....   
T Consensus       336 GSSc~~~q~v---ytYiQSRfYRAPEVIL-----GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P  407 (586)
T KOG0667|consen  336 GSSCFESQRV---YTYIQSRFYRAPEVIL-----GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP  407 (586)
T ss_pred             ccccccCCcc---eeeeeccccccchhhc-----cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence            9999887654   3778999999999999     7899999999999999999999999999998888775421100   


Q ss_pred             ---------------------------------------------------CC-CCC-----CC-CCCHHHHHHHHHhhh
Q psy7384         282 ---------------------------------------------------PP-RLK-----SK-KWPKKFQSFIETVLV  303 (463)
Q Consensus       282 ---------------------------------------------------~~-~~~-----~~-~~~~~~~~li~~~L~  303 (463)
                                                                         .| ...     .. .-...+.+||++||.
T Consensus       408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~  487 (586)
T KOG0667|consen  408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE  487 (586)
T ss_pred             CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence                                                               00 000     00 123468999999999


Q ss_pred             cCCCCCCCHHHHhcCccccCC
Q psy7384         304 KDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       304 ~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      +||.+|+|+.|+|+||||+..
T Consensus       488 ~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  488 WDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             cCchhcCCHHHHhcCcccccc
Confidence            999999999999999999853

>KOG0611|consensus

Probab=100.00  E-value=2.1e-50  Score=380.14  Aligned_cols=253  Identities=29%  Similarity=0.501  Sum_probs=226.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...-+|++.+.||+|+||+|-+|++...|+.||||.|+.+    ..+.-.+.+||+||..| +||||+.+|++|      
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVF------  122 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVF------  122 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhh------
Confidence            3446899999999999999999999999999999999743    34456788999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ++.+.++|||||..+|.|+|++.+++  .|++.+++.+++||..|+.|||.++++|||||.+|||++.|+++||+|||++
T Consensus       123 ENkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  123 ENKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             cCCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchh
Confidence            67789999999999999999998766  7999999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATY-DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      ..+... ....++||+|.|.+||++.+     .+| ++.+|.|||||+||.|..|..||.+.+....+.+|.++..... 
T Consensus       201 Nly~~~-kfLqTFCGSPLYASPEIvNG-----~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-  273 (668)
T KOG0611|consen  201 NLYADK-KFLQTFCGSPLYASPEIVNG-----TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-  273 (668)
T ss_pred             hhhccc-cHHHHhcCCcccCCccccCC-----CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-
Confidence            766543 45678999999999999984     444 5679999999999999999999999999888888888766433 


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                        .-+..+.-||++||.+||.+|.|++++.+|=|+.
T Consensus       274 --~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  274 --ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             --CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence              4566889999999999999999999999998875

>KOG0585|consensus

Probab=100.00  E-value=4.6e-51  Score=392.16  Aligned_cols=263  Identities=30%  Similarity=0.476  Sum_probs=222.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---------------chHHHHHHHHHHHHHhcCCCceeeec
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---------------DEEEEIKLEINVLKKYSNHRNIATYY  118 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~Ei~~l~~l~~h~nIv~l~  118 (463)
                      -+.|++++.||+|.||+|.+|++..+++.||||++....               ...+.+.+||.+|+++ .|||||+|+
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence            467999999999999999999999999999999986321               1236788999999999 899999999


Q ss_pred             ccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc
Q psy7384         119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE  198 (463)
Q Consensus       119 ~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~  198 (463)
                      ++.-+    -..+.+|||+|||..|.+...-.  ....+++.+++.|++.++.||.|||.+|||||||||+|+||+++|+
T Consensus       175 EvLDD----P~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDD----PESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecC----cccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            99743    34579999999999988754321  1123999999999999999999999999999999999999999999


Q ss_pred             EEEEecccccccccc-----cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q psy7384         199 VKLVDFGVSAQLDRT-----IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA  273 (463)
Q Consensus       199 vkL~DFGla~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  273 (463)
                      |||+|||.+......     .......+|||.|+|||.+..... ....+.+.||||+||+||.|+.|+.||.+....+.
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~-~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS-FSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC-ccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            999999998765221     111223589999999999875322 23446789999999999999999999999999999


Q ss_pred             hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       274 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ..+|..........+.+.+.+++||.+||.+||.+|.++.++..|||....
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            988888776666666788999999999999999999999999999999854

>KOG0577|consensus

Probab=100.00  E-value=3.3e-51  Score=400.89  Aligned_cols=258  Identities=40%  Similarity=0.784  Sum_probs=232.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +...|.=++.||.|+||-||-|++..+...||||.+..+    .....++..|+.+|+++ +|||+|.+-++|+..    
T Consensus        24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre----   98 (948)
T KOG0577|consen   24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE----   98 (948)
T ss_pred             HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc----
Confidence            333455668899999999999999999999999999743    34457888999999999 899999999999653    


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        ...|||||||-| +-.|++.-.+ .++.+.+|..|+.+.+.||+|||+++.||||||..|||+++.|.|||+|||.|.
T Consensus        99 --~TaWLVMEYClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAs  174 (948)
T KOG0577|consen   99 --HTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSAS  174 (948)
T ss_pred             --chHHHHHHHHhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchh
Confidence              578999999965 8888887554 479999999999999999999999999999999999999999999999999987


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ....    .++++|||.|||||+|+...  .+.|+-++||||||+++.||...+||+...+.+..++-|..+..|.+...
T Consensus       175 i~~P----AnsFvGTPywMAPEVILAMD--EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~  248 (948)
T KOG0577|consen  175 IMAP----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN  248 (948)
T ss_pred             hcCc----hhcccCCccccchhHheecc--ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCc
Confidence            7654    37899999999999997532  67899999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .|++.|..||..||.+-|..|||.+++|.|+|+....
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            9999999999999999999999999999999997543

>KOG0594|consensus

Probab=100.00  E-value=1.6e-50  Score=379.91  Aligned_cols=265  Identities=29%  Similarity=0.459  Sum_probs=223.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCc-eeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRN-IATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~n-Iv~l~~~~~~~~~~~~~  130 (463)
                      ..|+.+++||+|+||+||+|+.+.+|+.||+|.+....+   ......+|+.+|+.+ +|+| ||.+++++......+..
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccccc
Confidence            357888999999999999999999999999999986654   345678999999999 7999 99999999654332334


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKG--QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+++||||++- +|..++.....  ..++...++.+++||+.||+|||++||+||||||.||||+++|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence            589999999975 99999987653  367888999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-------
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-------  281 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------  281 (463)
                      ...-.....+..++|.||+|||++.+    ...|+..+||||+|||++||+++++.|.+.++.+++..|.+..       
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlG----s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLG----STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcC----CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            77755555677889999999999985    4579999999999999999999999999999988876542110       


Q ss_pred             -------------CCCCC-C-------CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         282 -------------PPRLK-S-------KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       282 -------------~~~~~-~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                                   .+... .       +..+....+++.+||+.+|.+|.|++.+|.||||....
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                         00000 0       12234789999999999999999999999999998654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-49  Score=382.29  Aligned_cols=252  Identities=29%  Similarity=0.455  Sum_probs=217.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +|++++.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++.+ +||||+++++++      .+.+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~------~~~~   74 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTE------HDQR   74 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhh------ccCC
Confidence            5999999999999999999999999999999986432    2345678899999999 899999999988      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+|+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            8999999999999999997644  68999999999999999999999999999999999999999999999999988764


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ..   ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+......  ....++
T Consensus       153 ~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~  222 (291)
T cd05612         153 DR---TWTLCGTPEYLAPEVIQ-----SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE--FPRHLD  222 (291)
T ss_pred             CC---cccccCChhhcCHHHHc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC--CCccCC
Confidence            32   23457999999999987     566889999999999999999999999887766655555443321  223568


Q ss_pred             HHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCch
Q psy7384         292 KKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPT  326 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~  326 (463)
                      ..+++||++||..||.+|++     ++++++||||....+
T Consensus       223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            89999999999999999995     999999999986543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5e-49  Score=388.95  Aligned_cols=253  Identities=25%  Similarity=0.466  Sum_probs=219.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .+.|++.+.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+|+.+ +||||+++++++      ..
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~------~~   89 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSF------QD   89 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEE------Ec
Confidence            356999999999999999999999999999999986432    3345678899999999 899999999998      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            579999999999999999997543  688999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .....   ...+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+.......+......  .+..
T Consensus       168 ~~~~~---~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~p~~  237 (329)
T PTZ00263        168 VPDRT---FTLCGTPEYLAPEVIQ-----SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK--FPNW  237 (329)
T ss_pred             cCCCc---ceecCChhhcCHHHHc-----CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC--CCCC
Confidence            64322   3457999999999997     556789999999999999999999999888776666655544322  2235


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQP  325 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~  325 (463)
                      ++..+++||.+||+.||.+|++     ++++++||||.+..
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            7889999999999999999987     79999999998644

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-48  Score=375.13  Aligned_cols=271  Identities=86%  Similarity=1.378  Sum_probs=233.1

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +++.++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++++.+|+||+++++.+.........
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35667899999999999999999999999999999999876666778889999999987799999999998765433345


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+|+||||+||++++++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            67999999999999999998766567899999999999999999999999999999999999999999999999998876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...........|++.|+|||++.........++.++|||||||++|+|++|..||...........+............+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            54434445567999999999987543334578889999999999999999999998776666655554444444455578


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      +..+.+||.+||..+|.+|||+++++.||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0580|consensus

Probab=100.00  E-value=5.6e-50  Score=354.56  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=227.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      -+.|++.+.||+|-||.||+|+.+.++-.||+|++..++    ....++.+|+++-..| +||||+++|++|      -+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~f------hd   93 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYF------HD   93 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhhe------ec
Confidence            456999999999999999999999999999999996543    3346788999999999 899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+||++||...|+|+..+...+...+++.....|++|++.||.|||.++||||||||+|+|++..+.+||+|||-+..
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            58999999999999999999977777899999999999999999999999999999999999999999999999998765


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ..  .+.+.+.|||..|.+||...     +..++..+|+|++|++.||++.|.+||...+..+++..|...... + +..
T Consensus       174 ~p--~~kR~tlcgt~dyl~pEmv~-----~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-~-p~~  244 (281)
T KOG0580|consen  174 AP--SNKRKTLCGTLDYLPPEMVE-----GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-F-PST  244 (281)
T ss_pred             cC--CCCceeeecccccCCHhhcC-----CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-C-Ccc
Confidence            54  45678889999999999997     678999999999999999999999999988877777766544332 2 268


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ++.+++|||.+||.++|.+|.+..|++.|||+..
T Consensus       245 is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  245 ISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             cChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            8999999999999999999999999999999853

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.2e-49  Score=387.86  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=213.5

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+|+.+ +||||+++++++      ...+.+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~------~~~~~~~lv   73 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSF------QTHDRLCFV   73 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEE------EcCCEEEEE
Confidence            4699999999999999999999999998742    23345677899999999 899999999998      556799999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          74 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence            99999999999987543  6899999999999999999999999999999999999999999999999998764333333


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     ...++.++|||||||++|||++|..||.+.+.......+.....  .....++.++.+
T Consensus       152 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~  224 (323)
T cd05571         152 MKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RFPRTLSPEAKS  224 (323)
T ss_pred             ccceecCccccChhhhc-----CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence            34567999999999987     56789999999999999999999999988766555544433322  123468899999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         297 FIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       297 li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      ||++||..||.+||     ++.++++||||....+
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             HHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999999999     8999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-48  Score=378.41  Aligned_cols=254  Identities=25%  Similarity=0.435  Sum_probs=210.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|++++.||.|+||.||+|++..++..||+|++....  .....+.+|+.+++.+ +||||+++++++      ...+.
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~------~~~~~   77 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDII------HTERC   77 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEE------cCCCe
Confidence            46999999999999999999999999999999986432  2345677899999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        78 ~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          78 LTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             EEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            9999999985 8999886543 3578999999999999999999999999999999999999999999999999876544


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN------------  280 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------  280 (463)
                      .........+++.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..+.+..+...            
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLG----STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             CCccccCceecccccChHHhcC----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence            3333344578999999999863    356888999999999999999999999876654443221110            


Q ss_pred             ---------CCCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 ---------APPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 ---------~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                               ..+.       .....++.++++||++||+.||.+|||++|+|+||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                     0000       0113567899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-48  Score=377.07  Aligned_cols=258  Identities=25%  Similarity=0.387  Sum_probs=214.9

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      |++.+.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.++..+ +|+||+++++++      ...+.
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~------~~~~~   74 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAY------ETKDA   74 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEE------ccCCe
Confidence            889999999999999999999999999999986432    2234567899999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +++||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++.....
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999999999999888765555789999999999999999999999999999999999999999999999999876543


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh---hcccCCCCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---FLIPRNAPPRLKSKK  289 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~  289 (463)
                      . ......+||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.......   ...... ........
T Consensus       155 ~-~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~  227 (285)
T cd05631         155 G-ETVRGRVGTVGYMAPEVIN-----NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-DQEEYSEK  227 (285)
T ss_pred             C-CeecCCCCCCCccCHhhhc-----CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-ccccCCcc
Confidence            2 1223457999999999997     567899999999999999999999999875543221   111111 11123346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchhH
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTER  328 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~~  328 (463)
                      ++.++.+||++||+.||.+||+     ++++++||||.+..+..
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR  271 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence            7899999999999999999997     89999999998765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-48  Score=389.57  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=214.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||+||+|++..+++.||+|++...    ......+..|+.++..+ +|+||+++++.+      ....
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~------~~~~   74 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSF------QDKL   74 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEE------ecCC
Confidence            599999999999999999999999999999999643    22345677899999999 899999999998      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||++||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            8999999999999999997543  68999999999999999999999999999999999999999999999999987543


Q ss_pred             cccC-----------------------------------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHH
Q psy7384         212 RTIG-----------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL  256 (463)
Q Consensus       212 ~~~~-----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~  256 (463)
                      ....                                   .....+||+.|+|||++.     +..++.++|||||||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~~DvwSlGvil~  227 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-----QTGYNKLCDWWSLGVIMY  227 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-----CCCCCCchhhhhhHHHHH
Confidence            2100                                   012457999999999997     567889999999999999


Q ss_pred             HHHhCCCCCCCCCchhhhhcccCCC--CCCCCCCCCCHHHHHHHHHhhhcCCC---CCCCHHHHhcCccccCCchh
Q psy7384         257 EMAESQPPLCDLHPMRALFLIPRNA--PPRLKSKKWPKKFQSFIETVLVKDYH---QRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       257 ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~---~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      ||++|.+||.+.+.......+....  ........+++++++||.+|+. +|.   .||+++|+++||||....++
T Consensus       228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         228 EMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            9999999998887766665554322  1111223578899999999875 444   46899999999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-48  Score=380.29  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=209.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .++|++++.||+|+||.||+|++..+++.||+|++....  .....+.+|+.+++.+ +||||+++++++      ...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~------~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDII------HTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEE------ecCC
Confidence            357999999999999999999999999999999986432  2234667899999999 899999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          77 TLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             eEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            8999999996 58888776543 368899999999999999999999999999999999999999999999999987654


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh-hcc---cCCCC-----
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL-FLI---PRNAP-----  282 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~-~~i---~~~~~-----  282 (463)
                      .........+||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+..+.... ..+   .....     
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLG----STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence            33333345678999999999863    345788999999999999999999999876443211 110   00000     


Q ss_pred             -----CC-----------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         283 -----PR-----------------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       283 -----~~-----------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                           +.                 .....+++.+++||.+||+.||.+|||++|+|+||||.+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                 00                 00112456899999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.3e-48  Score=372.87  Aligned_cols=270  Identities=87%  Similarity=1.405  Sum_probs=233.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .+.+.|++.+.||.|+||.||+|++..+++.+|+|++.........+..|+.+++++.+|+||+++++.+......+..+
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            45568999999999999999999999999999999998766666778899999999878999999999987554444567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            89999999999999999987666678999999999999999999999999999999999999999999999999987665


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ..........|++.|+|||++.........++.++|||||||++|+|++|.+||....+......+.....+......++
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS  252 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence            43333455679999999999864433356788899999999999999999999988776666655555555555556789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      .++.+||.+||..||.+|||+.++|+||||
T Consensus       253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0658|consensus

Probab=100.00  E-value=1.4e-49  Score=372.96  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=215.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      .|+-.+++|.|+||.||+|....+++.||||.+-.+..   .-.+|+.+|+.+ +|||||++..+|...... +.-...|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l-~HpNIV~L~~~f~~~~~~-d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKL-DHPNIVRLLYFFSSSTES-DEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhc-CCcCeeeEEEEEEecCCC-chhHHHH
Confidence            58899999999999999999999999999998753322   334789999988 899999999999765422 2345679


Q ss_pred             EEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-CcEEEEeccccccccc
Q psy7384         136 VMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQLDR  212 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-~~vkL~DFGla~~~~~  212 (463)
                      ||||++. +|.++++..  .+..++...++-|..||++||.|||+.||+||||||.|||||.+ |.+||||||.|+.+..
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9999976 899988742  24578888999999999999999999999999999999999865 9999999999998865


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN------------  280 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------  280 (463)
                      . ....++..|..|+|||.+.+    ...|+.++||||.||+++||+-|++.|.|.+..+++..|.+.            
T Consensus       179 ~-epniSYicSRyYRaPELifg----a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  179 G-EPNISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             C-CCceeEEEeccccCHHHHcC----ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            4 33367889999999999986    577999999999999999999999999999888777543111            


Q ss_pred             -------CCC--------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 -------APP--------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 -------~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                             ..+        .......++++.+|+.++|..+|.+|.++-|+|.||||.+
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde  311 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE  311 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence                   011        1233466889999999999999999999999999999964

>KOG0192|consensus

Probab=100.00  E-value=2.5e-48  Score=381.85  Aligned_cols=250  Identities=29%  Similarity=0.514  Sum_probs=213.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcE-EEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~-vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...+.+.||.|+||+||+|.+.  |.. ||+|++.....   ....+.+|+.+|.++ +|||||+++|++..      ..
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~------~~  112 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTS------PP  112 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC------CC
Confidence            3556677999999999999987  555 99999974332   256899999999999 89999999999943      23


Q ss_pred             -eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC-ceecCCCCCceEEccCC-cEEEEeccccc
Q psy7384         132 -QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK-VIHRDIKGQNVLLTDNA-EVKLVDFGVSA  208 (463)
Q Consensus       132 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDLkp~NILl~~~~-~vkL~DFGla~  208 (463)
                       .++|||||+++|+|.+++.......++...+..++.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence             6999999999999999998754558999999999999999999999999 99999999999999997 99999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .........+...||+.|||||++...   ...|+.++||||||++||||+||..||.+.........+.........+.
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            776543334446899999999999743   45799999999999999999999999999998666666654444333344


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+++.+..|+..||..||.+||++.+++.
T Consensus       270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            58999999999999999999999999865

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-48  Score=384.19  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=217.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.|++++.||+|+||.||+|++..+++.||+|++...    ......+..|+.++..+ +||||+++++++      ...
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~------~~~   73 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAF------QDD   73 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEE------EcC
Confidence            3699999999999999999999999999999999743    23345677899999999 799999999998      456


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..||||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          74 EYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            79999999999999999997543  6899999999999999999999999999999999999999999999999999766


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC----CC--
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP----PR--  284 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----~~--  284 (463)
                      ..   .....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+.......+.....    +.  
T Consensus       152 ~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  223 (333)
T cd05600         152 VT---YANSVVGSPDYMAPEVLR-----GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD  223 (333)
T ss_pred             cc---ccCCcccCccccChhHhc-----CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence            43   224567999999999987     45788999999999999999999999988776555443322111    11  


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      .....++.++.+||.+||..+|.+||+++++++||||.+...
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            111356899999999999999999999999999999987544

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-48  Score=384.69  Aligned_cols=256  Identities=23%  Similarity=0.416  Sum_probs=219.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCC-cEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ...+.|++++.||+|+||.||+|.+..++ ..||+|++...    ......+.+|+.++..+ +||||+++++++     
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~-----  100 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSF-----  100 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEE-----
Confidence            34567999999999999999999977655 68999998632    23445678899999999 899999999999     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                       ...+.+|+||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       101 -~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        101 -KDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             -EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence             45578999999999999999997654  689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      +......   ....+||+.|+|||++.     +..++.++|||||||++|+|++|.+||.+.+.......+......  .
T Consensus       178 a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--~  247 (340)
T PTZ00426        178 AKVVDTR---TYTLCGTPEYIAPEILL-----NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--F  247 (340)
T ss_pred             CeecCCC---cceecCChhhcCHHHHh-----CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--C
Confidence            9876432   24567999999999997     556788999999999999999999999888776655555444322  2


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      +..+++.+++||++||..||.+|+     +++++++||||.+..+
T Consensus       248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            346788999999999999999995     8999999999987554

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.9e-48  Score=374.10  Aligned_cols=253  Identities=28%  Similarity=0.486  Sum_probs=208.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...   ......+.+|+.+++.+ +|+||+++++++      ...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAF------RRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhE------ecCC
Confidence            3699999999999999999999999999999998643   22345678899999999 899999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.++.|..+...  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          74 KLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            89999999998777655432  2368999999999999999999999999999999999999999999999999998764


Q ss_pred             cccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC----------
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN----------  280 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------  280 (463)
                      .... ......|++.|+|||++.     +..++.++|||||||++|+|++|++||.+.+.......+...          
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLL-----GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK  226 (287)
T ss_pred             ccccccccccccccccCCcHHHc-----CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence            3221 223457899999999987     456889999999999999999999999876654433221110          


Q ss_pred             -----------CCCCC---------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 -----------APPRL---------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 -----------~~~~~---------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                 ..+..         ....++.++++||++||..||.+|||++++|+||||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                       00000         012367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-48  Score=388.45  Aligned_cols=256  Identities=27%  Similarity=0.480  Sum_probs=215.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||+|++..+|+.||||++...    ......+.+|+.+|+.+ +|+||++++++|      ...+
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~------~~~~   74 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSF------QDEN   74 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEE------EcCC
Confidence            599999999999999999999999999999999743    23345677899999999 899999999999      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||+.+|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999999999997543  68999999999999999999999999999999999999999999999999987543


Q ss_pred             cccC--------------------------------------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHH
Q psy7384         212 RTIG--------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGI  253 (463)
Q Consensus       212 ~~~~--------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~  253 (463)
                      ....                                      .....+||+.|+|||++.     ...++.++|||||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~  227 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-----QTGYNKECDWWSLGV  227 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-----CCCCCCeeeeecchh
Confidence            2110                                      011346999999999987     567899999999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHhcCccccCCch
Q psy7384         254 TALEMAESQPPLCDLHPMRALFLIPRNAP--PRLKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPT  326 (463)
Q Consensus       254 il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~~  326 (463)
                      ++|+|++|.+||.+.+.......+.....  .......+++++++||.+||. +|.+|++   ++++++||||....+
T Consensus       228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999988877665554433221  112223578999999999996 9999997   999999999987543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-48  Score=379.89  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=211.2

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ||+|+||.||+|++..+++.||+|++...    ......+..|+.+|..+ +||||+++++++      ...+.+|+|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~~~~lv~e   73 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSF------QSPEKLYLVLA   73 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEE------ecCCeEEEEEc
Confidence            79999999999999999999999998632    23445677899999999 899999999998      45579999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccc
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN  218 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  218 (463)
                      |+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        74 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  151 (312)
T cd05585          74 FINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN  151 (312)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence            999999999997543  689999999999999999999999999999999999999999999999999876543333344


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFI  298 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  298 (463)
                      ..+||+.|+|||++.     +..++.++|||||||++|+|++|.+||.+.+.......+.....  .....++..+++||
T Consensus       152 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li  224 (312)
T cd05585         152 TFCGTPEYLAPELLL-----GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL--RFPDGFDRDAKDLL  224 (312)
T ss_pred             cccCCcccCCHHHHc-----CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--CCCCcCCHHHHHHH
Confidence            567999999999997     56788999999999999999999999988776665555444322  22346889999999


Q ss_pred             HHhhhcCCCCCC---CHHHHhcCccccCC
Q psy7384         299 ETVLVKDYHQRP---YTDQLLKHPFIRDQ  324 (463)
Q Consensus       299 ~~~L~~dp~~Rp---t~~e~l~hp~~~~~  324 (463)
                      .+||..||.+||   ++.++|+||||.+.
T Consensus       225 ~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            999999999997   58999999999865

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-48  Score=386.28  Aligned_cols=258  Identities=29%  Similarity=0.488  Sum_probs=220.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||.||+|++..+|+.||+|++...    ......+..|+.++..+ +|+||+++++++      ...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~   73 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSF------QDE   73 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhhe------ecC
Confidence            3699999999999999999999999999999999743    24456778899999999 799999999998      556


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          74 EHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             CeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            7999999999999999999765  46899999999999999999999999999999999999999999999999998876


Q ss_pred             cccc-----------------------------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy7384         211 DRTI-----------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES  261 (463)
Q Consensus       211 ~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g  261 (463)
                      ....                             .......||+.|+|||++.     ...++.++|||||||++|+|++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-----GTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc-----CCCCCCceeeEecchhhhhhccC
Confidence            5432                             1233457999999999997     55789999999999999999999


Q ss_pred             CCCCCCCCchhhhhcccC--CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHhcCccccCCchh
Q psy7384         262 QPPLCDLHPMRALFLIPR--NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPY-TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       262 ~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~e~l~hp~~~~~~~~  327 (463)
                      ..||.+.........+..  ..........+++++.+||.+||. ||.+|++ ++++++||||....+.
T Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence            999988876665555444  222222233478999999999997 9999999 9999999999875443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9e-48  Score=387.62  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=212.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||+||+|++..+++.||+|++...    ......+.+|+.+++.+ +|+||+++++++      ...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~------~~~~   74 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSF------QDKD   74 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEE------ecCC
Confidence            489999999999999999999999999999999643    23345678899999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          75 NLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence            8999999999999999997544  68999999999999999999999999999999999999999999999999975431


Q ss_pred             ccc-----------------------------------------------CccccccCCccccccceeccCCCCCCCCCc
Q psy7384         212 RTI-----------------------------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDN  244 (463)
Q Consensus       212 ~~~-----------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~  244 (463)
                      ...                                               ......+||+.|+|||++.     ...++.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~  227 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-----RKGYTQ  227 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-----CCCCCC
Confidence            100                                               0012357999999999987     566889


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC--CCCCCCCCCCCHHHHHHHHHhhhc--CCCCCCCHHHHhcCcc
Q psy7384         245 RSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSKKWPKKFQSFIETVLVK--DYHQRPYTDQLLKHPF  320 (463)
Q Consensus       245 ~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~~e~l~hp~  320 (463)
                      ++|||||||++|||++|.+||...+.......+...  .........++.++++||.+||..  ++..|++++++++|||
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~  307 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF  307 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence            999999999999999999999887665554443321  111222335789999999996654  4455999999999999


Q ss_pred             ccCCch
Q psy7384         321 IRDQPT  326 (463)
Q Consensus       321 ~~~~~~  326 (463)
                      |++..+
T Consensus       308 f~~~~~  313 (381)
T cd05626         308 FSEVDF  313 (381)
T ss_pred             cCCCCh
Confidence            986543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-47  Score=378.37  Aligned_cols=250  Identities=30%  Similarity=0.463  Sum_probs=212.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+|..||+|++...    ......+.+|+.+++.+ +||||++++++|      ...+.+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~------~~~~~~~lv   73 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAF------QTHDRLCFV   73 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEE------ecCCEEEEE
Confidence            4799999999999999999999999998642    23345667899999999 899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        74 ~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          74 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence            99999999998886543  6899999999999999999999999999999999999999999999999998754332223


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     ...++.++|||||||++|+|++|..||...+.......+......  ....+++++++
T Consensus       152 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~  224 (323)
T cd05595         152 MKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKS  224 (323)
T ss_pred             cccccCCcCcCCccccc-----CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHH
Confidence            34567999999999997     567889999999999999999999999877666555444333221  23467899999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         297 FIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       297 li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      ||.+||..||.+|+     ++.++++||||....+
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             HHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999999998     8999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.8e-48  Score=378.98  Aligned_cols=251  Identities=27%  Similarity=0.459  Sum_probs=214.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|+++.+++.||+|++...    ......+..|+.++..+.+||||+++++++      ...+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~------~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF------QTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE------EcCCEEEEE
Confidence            4799999999999999999999999998632    234456678888888776899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~  152 (320)
T cd05590          75 MEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT  152 (320)
T ss_pred             EcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence            99999999999887544  6899999999999999999999999999999999999999999999999998764333233


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+.......+......  ....++.++++
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~  225 (320)
T cd05590         153 TSTFCGTPDYIAPEILQ-----EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLSQDAVD  225 (320)
T ss_pred             ccccccCccccCHHHHc-----CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHH
Confidence            34567999999999987     567889999999999999999999999888776666555443322  23357899999


Q ss_pred             HHHHhhhcCCCCCCCH------HHHhcCccccCCch
Q psy7384         297 FIETVLVKDYHQRPYT------DQLLKHPFIRDQPT  326 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~------~e~l~hp~~~~~~~  326 (463)
                      ||++||..||.+|+++      +++++||||....+
T Consensus       226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            9999999999999998      99999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.6e-48  Score=379.94  Aligned_cols=250  Identities=28%  Similarity=0.479  Sum_probs=212.9

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+++.+ +||||+++++++      ...+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~------~~~~~~~lv   73 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSF------QTKDRLCFV   73 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEE------EcCCEEEEE
Confidence            4689999999999999999999999999642    23445677899999999 899999999998      556799999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        74 ~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~  151 (328)
T cd05593          74 MEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT  151 (328)
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence            99999999999886543  6899999999999999999999999999999999999999999999999998764333333


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+.......+......  ....++.++.+
T Consensus       152 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~  224 (328)
T cd05593         152 MKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKS  224 (328)
T ss_pred             cccccCCcCccChhhhc-----CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc--CCCCCCHHHHH
Confidence            34567999999999987     566889999999999999999999999887666555544333221  23467899999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         297 FIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       297 li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      ||++||..||.+|+     ++.++++||||....+
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999997     8999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0604|consensus

Probab=100.00  E-value=2.5e-49  Score=360.31  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=218.0

Q ss_pred             CceEEE-eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          55 GIFELI-EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        55 ~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      +.|.+. ++||-|-.|.|..|.++.||+.+|+|++.-    ....++|++.....+.|||||.++++|....  .....+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~--~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSY--QGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhc--cCceee
Confidence            345543 689999999999999999999999999843    3456788888888889999999999995432  445788


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEeccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQL  210 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGla~~~  210 (463)
                      .+|||.++||.|+..++.++...++|.++..|++||+.|+.|||+++|.||||||+|+|++.   |..+||+|||+|+..
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            99999999999999999999889999999999999999999999999999999999999964   567999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh----hhcccCCC--CCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA----LFLIPRNA--PPR  284 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~--~~~  284 (463)
                      .. .....+.|-||.|.|||++.     ...|+..+|+||+|||+|.||||.|||+...-...    -.+|..+.  .|.
T Consensus       215 ~~-~~~L~TPc~TPyYvaPevlg-----~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  215 QE-PGDLMTPCFTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             CC-CccccCCcccccccCHHHhC-----chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            54 34456779999999999997     56799999999999999999999999987654222    12233332  333


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .....+|+.++++|+.+|..+|.+|.|++++++|||+...
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            3445667899999999999999999999999999999853

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-47  Score=385.08  Aligned_cols=262  Identities=27%  Similarity=0.459  Sum_probs=219.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .+.|++.+.||+|+||.||+|++..+++.||+|++...    ......+..|+.+++.+ +||||+++++++      ..
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~------~~  114 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAF------QD  114 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEE------ec
Confidence            35799999999999999999999999999999998632    22334567899999998 899999999998      55


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.||+|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            67899999999999999998653   488999999999999999999999999999999999999999999999999876


Q ss_pred             cccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCC
Q psy7384         210 LDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLK  286 (463)
Q Consensus       210 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~  286 (463)
                      ...... .....+||+.|+|||++..... ...++.++|||||||++|+|++|.+||.+.+....+..+.....  ....
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD  270 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCC-CCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence            643221 2245679999999999864221 34578999999999999999999999998877666665544322  1122


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCCch
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~  326 (463)
                      ...++.++++||.+||..+|.+  |++++++++||||++..+
T Consensus       271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            2357899999999999999988  999999999999987544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.4e-47  Score=376.18  Aligned_cols=256  Identities=29%  Similarity=0.431  Sum_probs=215.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||+|++..+++.||+|++...    ......+..|+.++..+..|++|+++++++      ...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~------~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF------QTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE------EcCC
Confidence            389999999999999999999999999999998642    234456778899998885456788999888      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            8999999999999999987543  68899999999999999999999999999999999999999999999999987543


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .........+||+.|+|||++.     ...++.++|||||||++|+|++|++||.+......+..+......  ....++
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~  225 (324)
T cd05587         153 FGGKTTRTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLS  225 (324)
T ss_pred             CCCCceeeecCCccccChhhhc-----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCC
Confidence            2223334567999999999997     566889999999999999999999999887776666555443322  234678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH-----HHHhcCccccCCch
Q psy7384         292 KKFQSFIETVLVKDYHQRPYT-----DQLLKHPFIRDQPT  326 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~~~  326 (463)
                      .++.+||.+||..||.+|+++     +++++||||....+
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999999999986     89999999986544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-47  Score=387.27  Aligned_cols=256  Identities=26%  Similarity=0.459  Sum_probs=213.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+++.+ +|+||+++++.|      ...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~------~~~~   74 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSF------QDKD   74 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEE------EeCC
Confidence            589999999999999999999999999999998643    23345678899999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|||||||.+|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          75 NLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence            8999999999999999997543  68999999999999999999999999999999999999999999999999975321


Q ss_pred             ccc-----------------------------------------------CccccccCCccccccceeccCCCCCCCCCc
Q psy7384         212 RTI-----------------------------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDN  244 (463)
Q Consensus       212 ~~~-----------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~  244 (463)
                      ...                                               ......+||+.|+|||++.     ...|+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~  227 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-----RTGYTQ  227 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-----CCCCCC
Confidence            000                                               0012357999999999997     567889


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHhcCc
Q psy7384         245 RSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHP  319 (463)
Q Consensus       245 ~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp  319 (463)
                      ++|||||||++|||++|.+||.+.+.......+....  ........+++++.+||.+|+ .+|.+|++   ++++++||
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp  306 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP  306 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence            9999999999999999999998877666554443321  112223467899999999976 59999987   99999999


Q ss_pred             cccCCch
Q psy7384         320 FIRDQPT  326 (463)
Q Consensus       320 ~~~~~~~  326 (463)
                      ||.....
T Consensus       307 ~f~~~~~  313 (382)
T cd05625         307 FFKTIDF  313 (382)
T ss_pred             CcCCcCh
Confidence            9986543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-48  Score=386.97  Aligned_cols=256  Identities=25%  Similarity=0.438  Sum_probs=211.6

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||+|++..+|+.||||++...    ......+.+|+.+++.+ +||||++++++|      ...+
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~------~~~~   74 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSF------QDAQ   74 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEE------EcCC
Confidence            599999999999999999999999999999998642    22345678899999998 899999999999      4567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||+.||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            8999999999999999997543  68999999999999999999999999999999999999999999999999986331


Q ss_pred             cccC-----------------------------------------------ccccccCCccccccceeccCCCCCCCCCc
Q psy7384         212 RTIG-----------------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDN  244 (463)
Q Consensus       212 ~~~~-----------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~  244 (463)
                      ....                                               .....+||+.|+|||++.     ...++.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~  227 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-----QQGYGQ  227 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-----cCCCCC
Confidence            1000                                               001247999999999987     567899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHhcCc
Q psy7384         245 RSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKSKKWPKKFQSFIETVLVKDYHQR---PYTDQLLKHP  319 (463)
Q Consensus       245 ~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~hp  319 (463)
                      ++|||||||++|||++|.+||.+......+..+....  ........++.++++||.+||. +|.+|   +++.++++||
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp  306 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP  306 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence            9999999999999999999998877655554443221  1111223578899999999997 67665   5999999999


Q ss_pred             cccCCch
Q psy7384         320 FIRDQPT  326 (463)
Q Consensus       320 ~~~~~~~  326 (463)
                      ||....+
T Consensus       307 ~~~~~~~  313 (377)
T cd05629         307 FFRGVDW  313 (377)
T ss_pred             CcCCCCH
Confidence            9986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0589|consensus

Probab=100.00  E-value=1.5e-48  Score=381.66  Aligned_cols=256  Identities=33%  Similarity=0.585  Sum_probs=232.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.|++++++|+|+||.+++++++..+..+++|.+...   .........|+.++.++ .|||||.+++.|+.     ++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~-----~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEE-----DGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhc-----CCc
Confidence            4699999999999999999999999999999999743   33445778999999998 89999999999953     233


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .++|||+||+||+|.+.+...++..++++.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+.+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            49999999999999999999888899999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .......+.+|||.||.||++.     +..|+.++|||||||++|||++-+++|...+.......|.+.. ....+..++
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~-----d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys  231 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILS-----DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYS  231 (426)
T ss_pred             CchhhhheecCCCcccCHHHhC-----CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCcccc
Confidence            7766677889999999999998     7899999999999999999999999999998888888877776 344556889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      .+++.+|+.||..+|..||++.++|.+|.+.
T Consensus       232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  232 SELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            9999999999999999999999999998875

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.5e-48  Score=386.84  Aligned_cols=255  Identities=26%  Similarity=0.460  Sum_probs=213.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+|+.+ +|+||+++++.|      ...+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~------~~~~   74 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSF------QDKD   74 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEE------EcCC
Confidence            599999999999999999999999999999998632    22345678899999999 899999999999      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence            9999999999999999997543  68899999999999999999999999999999999999999999999999975321


Q ss_pred             cc-------------------------------------------cCccccccCCccccccceeccCCCCCCCCCcchhH
Q psy7384         212 RT-------------------------------------------IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDL  248 (463)
Q Consensus       212 ~~-------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~Di  248 (463)
                      ..                                           .......+||+.|+|||++.     ...++.++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di  227 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-----RTGYTQLCDW  227 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-----CCCCCcceee
Confidence            00                                           00012357999999999997     5678899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCCCCCCCCCHHHHHHHHHhhhcCCCCCC---CHHHHhcCccccC
Q psy7384         249 WSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKHPFIRD  323 (463)
Q Consensus       249 wSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~  323 (463)
                      |||||++|+|++|+.||.+.........+....  ........++.++.+||.+|+ .+|.+|+   +++++++||||..
T Consensus       228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999999999999998877665544433221  111223467899999999976 5999999   9999999999986


Q ss_pred             Cc
Q psy7384         324 QP  325 (463)
Q Consensus       324 ~~  325 (463)
                      ..
T Consensus       307 ~~  308 (376)
T cd05598         307 ID  308 (376)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0690|consensus

Probab=100.00  E-value=7.4e-49  Score=360.62  Aligned_cols=265  Identities=28%  Similarity=0.466  Sum_probs=231.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..+.|+++++||+|+||+|.+|+.+.+|+++|+|+++.    ..+....-..|-++|+.. +||.+..+.-.|      +
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF------Q  238 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF------Q  238 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh------c
Confidence            34678999999999999999999999999999999863    334445566788999999 899999998888      6


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+++|+||||+.||.|+-.+.+.+  .+++...+.+...|+.||.|||+++||+||||.+|+|++.+|++||+|||+++
T Consensus       239 t~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch
Confidence            7789999999999999998886544  79999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .--.......++||||.|+|||++.     ...|+.++|+|.+||++|||+||+.||+..+.......|......  .+.
T Consensus       317 E~I~~g~t~kTFCGTPEYLAPEVle-----DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k--FPr  389 (516)
T KOG0690|consen  317 EEIKYGDTTKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK--FPR  389 (516)
T ss_pred             hcccccceeccccCChhhcCchhhc-----cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc--CCc
Confidence            6655555668899999999999997     778999999999999999999999999998887777666554332  234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchhHHHHHH
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTERQARIQ  333 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~~~~~~~  333 (463)
                      .++++++.|+..+|.+||.+|.     .+.|+..|+||....+.......
T Consensus       390 ~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kk  439 (516)
T KOG0690|consen  390 TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKK  439 (516)
T ss_pred             cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhc
Confidence            7889999999999999999996     48999999999988776654443

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-47  Score=374.92  Aligned_cols=251  Identities=28%  Similarity=0.479  Sum_probs=210.9

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+++.||+|++...    ......+..|..++..+.+||||+++++++      ...+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~------~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF------QTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE------EcCCEEEEE
Confidence            4699999999999999999999999998643    233445566777777666899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  152 (316)
T cd05592          75 MEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK  152 (316)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence            99999999999987544  6899999999999999999999999999999999999999999999999999765433333


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+....+  .....++.++.+
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~  225 (316)
T cd05592         153 ASTFCGTPDYIAPEILK-----GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP--HFPRWISKEAKD  225 (316)
T ss_pred             cccccCCccccCHHHHc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence            45568999999999987     55688999999999999999999999988777665555443322  123457889999


Q ss_pred             HHHHhhhcCCCCCCCH-HHHhcCccccCCch
Q psy7384         297 FIETVLVKDYHQRPYT-DQLLKHPFIRDQPT  326 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~-~e~l~hp~~~~~~~  326 (463)
                      ||.+||..||.+||++ .++++||||....+
T Consensus       226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         226 CLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             HHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence            9999999999999986 58889999986543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-47  Score=376.69  Aligned_cols=251  Identities=27%  Similarity=0.435  Sum_probs=214.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+++.||+|++...    ......+..|+.++..+.+||||++++++|      ...+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~------~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF------QTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE------EcCCeEEEE
Confidence            4699999999999999999999999998642    233455677888888776899999999999      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          75 MEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence            99999999999886543  6899999999999999999999999999999999999999999999999998765433333


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     ...++.++|||||||++|+|++|++||...+....+..+......  .+..++.++.+
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~  225 (321)
T cd05591         153 TTTFCGTPDYIAPEILQ-----ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--YPVWLSKEAVS  225 (321)
T ss_pred             ccccccCccccCHHHHc-----CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHH
Confidence            44567999999999987     567889999999999999999999999988877666665544322  22357889999


Q ss_pred             HHHHhhhcCCCCCC-------CHHHHhcCccccCCch
Q psy7384         297 FIETVLVKDYHQRP-------YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       297 li~~~L~~dp~~Rp-------t~~e~l~hp~~~~~~~  326 (463)
                      ||.+||..||.+|+       +++++++||||....+
T Consensus       226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            99999999999999       9999999999976544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-47  Score=375.77  Aligned_cols=257  Identities=28%  Similarity=0.423  Sum_probs=217.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||+|++..+++.||+|++...    ......+..|..++..+..|++|+++++++      ...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~------~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF------QTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE------ecCC
Confidence            388999999999999999999999999999998743    223345667888888776789999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            8999999999999999986544  68999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .........+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+.......+......  .+..++
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s  225 (323)
T cd05616         153 WDGVTTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMS  225 (323)
T ss_pred             CCCCccccCCCChhhcCHHHhc-----CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCcCC
Confidence            3223334567999999999997     567899999999999999999999999888776666655443322  234678


Q ss_pred             HHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchh
Q psy7384         292 KKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~  327 (463)
                      .++.+||.+||+.||.+|++     ..++++||||....+.
T Consensus       226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999999999999998     4899999999875543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-47  Score=376.29  Aligned_cols=261  Identities=25%  Similarity=0.432  Sum_probs=209.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|++..+|..||||++...   ......+.+|+.+++.+ +||||+++++++..... .....
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~-~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-REFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCC-CCCce
Confidence            599999999999999999999999999999998632   23345678899999999 89999999998854321 22346


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          79 IYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            899999995 68999886543  689999999999999999999999999999999999999999999999999876532


Q ss_pred             ccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcc------------
Q psy7384         213 TIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI------------  277 (463)
Q Consensus       213 ~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i------------  277 (463)
                      ...   .....+||+.|+|||++...   ...++.++|||||||++|+|++|++||.+.+....+..+            
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhcc---ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            211   12345799999999998631   256888999999999999999999999776543322110            


Q ss_pred             ---------------cCCCCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         278 ---------------PRNAPP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       278 ---------------~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                     ......  ....+..+..+.+||.+||..||.+|||++++|+||||...
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                           000000  01113467889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.6e-47  Score=374.90  Aligned_cols=252  Identities=29%  Similarity=0.498  Sum_probs=213.1

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHH---HhcCCCceeeecccccccCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLK---KYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~---~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      |++++.||+|+||.||+|.+..+|+.||||++...    ......+.+|+.++.   .+ +||||+++++++      ..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~------~~   73 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACF------QT   73 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEE------Ec
Confidence            78899999999999999999999999999999643    233456667776654   44 799999999998      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.+++|..++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        74 ~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          74 EDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             CCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            5799999999999999988754   3589999999999999999999999999999999999999999999999999875


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ...........+|++.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+......  ....
T Consensus       151 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--~p~~  223 (324)
T cd05589         151 GMGFGDRTSTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRF  223 (324)
T ss_pred             CCCCCCcccccccCccccCHhHhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCC
Confidence            433333345568999999999987     567889999999999999999999999887766655555443322  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQP  325 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  325 (463)
                      ++..+.+||.+||..||.+||     ++.++++||||.+..
T Consensus       224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            789999999999999999999     799999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.5e-47  Score=380.61  Aligned_cols=260  Identities=26%  Similarity=0.473  Sum_probs=215.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...    ......+..|+.+++.+ +||||+++++++      ..
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~------~~  114 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAF------QD  114 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEE------Ec
Confidence            45799999999999999999999999999999998632    22344577889999888 899999999998      55


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.+|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            67899999999999999999643   488999999999999999999999999999999999999999999999999987


Q ss_pred             cccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCC
Q psy7384         210 LDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLK  286 (463)
Q Consensus       210 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~  286 (463)
                      ...... .....+||+.|+|||++..... ...++.++|||||||++|+|++|.+||.+.+....+..+.....  ....
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  270 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE  270 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCC-CCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence            643221 2245679999999999864211 23478899999999999999999999988877666655544321  1122


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~  324 (463)
                      ...++..+++||..||..++.+  |++++++++||||+..
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            2357899999999999865544  8999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-47  Score=362.60  Aligned_cols=270  Identities=77%  Similarity=1.320  Sum_probs=230.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...++|++.+.||+|+||.||+|.+..+++.+++|++.........+.+|+.+++++..|+||+++++.+..........
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            34578999999999999999999999899999999998776667788999999999877999999999987653323456


Q ss_pred             eEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+|+||||+++++|.+++....  ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            7899999999999999987644  45789999999999999999999999999999999999999999999999999877


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC-C
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-K  288 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~  288 (463)
                      ............|+..|+|||++.........++.++|||||||++|+|++|.+||...........+.....+.... .
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  242 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE  242 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchh
Confidence            654444445567899999999986544445667889999999999999999999998776666666655554444333 3


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      .++..+++||.+||..||.+|||++++++|||+
T Consensus       243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.1e-47  Score=368.20  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=208.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcC-CCcEEEEEEeecCc---chHHHHHHHHHHHHHhc--CCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTK-TGQLAAIKVMDVTE---DEEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +|++++.||+|+||.||+|++.. +|..||+|++....   .....+.+|+.+++.+.  +||||+++++++..... ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~-~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-DR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC-CC
Confidence            69999999999999999999864 46889999986432   22345667888777663  69999999998853211 23


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            467999999997 5899999766555789999999999999999999999999999999999999999999999999976


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC-------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-------  282 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------  282 (463)
                      .... .......||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+......+..+.....       
T Consensus       160 ~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         160 YSFQ-MALTSVVVTLWYRAPEVLL-----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             ccCC-cccccccccccccChHHHh-----CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            6433 2234557899999999986     55688899999999999999999999988776555443321100       


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         283 ------------------PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       283 ------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                        .....+.++..+++||.+||+.||++|||+.++|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              000013467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-47  Score=373.86  Aligned_cols=250  Identities=26%  Similarity=0.444  Sum_probs=210.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|+++.+|..||+|++...    ......+..|+.++..+.+||||+++++++      ...+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~------~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF------QTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE------EeCCEEEEE
Confidence            4799999999999999999999999999743    234456677888887766899999999999      455799999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        75 ~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05620          75 MEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR  152 (316)
T ss_pred             ECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence            99999999999987543  6889999999999999999999999999999999999999999999999998754322233


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+.......+....+ . ....++.++++
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~  225 (316)
T cd05620         153 ASTFCGTPDYIAPEILQ-----GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-H-YPRWITKESKD  225 (316)
T ss_pred             eeccCCCcCccCHHHHc-----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C-CCCCCCHHHHH
Confidence            45567999999999997     56788999999999999999999999988776555544433222 1 12357889999


Q ss_pred             HHHHhhhcCCCCCCCH-HHHhcCccccCCc
Q psy7384         297 FIETVLVKDYHQRPYT-DQLLKHPFIRDQP  325 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~-~e~l~hp~~~~~~  325 (463)
                      ||.+||..||.+|+++ +++++||||....
T Consensus       226 li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         226 ILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            9999999999999997 6899999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-47  Score=381.48  Aligned_cols=257  Identities=27%  Similarity=0.457  Sum_probs=215.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||+|++..+++.||+|++...    ......+..|+.++..+ +|+||+++++.+      ...+
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~------~~~~   74 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSF------QDKR   74 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEE------EcCC
Confidence            589999999999999999999999999999999632    23445678899999999 899999999998      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            9999999999999999997543  68999999999999999999999999999999999999999999999999987543


Q ss_pred             ccc-----------------------------------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHH
Q psy7384         212 RTI-----------------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL  256 (463)
Q Consensus       212 ~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~  256 (463)
                      ...                                   ......+||+.|+|||++.     +..++.++|||||||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~~~~~DiwSlGvily  227 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-----QTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-----CCCCCCcceeccccceee
Confidence            210                                   0012357999999999987     567889999999999999


Q ss_pred             HHHhCCCCCCCCCchhhhhcccCCCC--CCCCCCCCCHHHHHHHHHhhhcCCCCCC---CHHHHhcCccccCCchh
Q psy7384         257 EMAESQPPLCDLHPMRALFLIPRNAP--PRLKSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       257 ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~~~~  327 (463)
                      +|++|.+||.+.+.......+.....  .......+++++++||.+|+ .||.+|+   +++++++||||.+..+.
T Consensus       228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         228 EMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             ecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            99999999988877666555443211  11122347889999999977 4999998   58999999999876554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-47  Score=379.82  Aligned_cols=256  Identities=32%  Similarity=0.495  Sum_probs=209.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...|++++.||+|+||.||+|++..+|+.||||++....  .....+.+|+.+++.+ +|+||+++++++      ...+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~  145 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMF------DHNG  145 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEe------ccCC
Confidence            356899999999999999999999999999999986432  2346788999999999 899999999998      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+|+|.+..      ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus       146 ~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            899999999999986532      35678888999999999999999999999999999999999999999999998765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh---hhcccCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA---LFLIPRNAPPRLKSK  288 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~---~~~i~~~~~~~~~~~  288 (463)
                      .........+||..|+|||++......+..++.++|||||||++|+|++|+.||........   ...+.... ......
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~  298 (353)
T PLN00034        220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPA  298 (353)
T ss_pred             cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCC
Confidence            44333455689999999999854322234456789999999999999999999974332211   11111111 122234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .++.++++||.+||..||.+|||+.|+|+||||..
T Consensus       299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            67889999999999999999999999999999975

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.9e-47  Score=372.58  Aligned_cols=252  Identities=26%  Similarity=0.474  Sum_probs=211.5

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+++.||+|++...    .........|..++..+.+||||+++++++      ...+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~------~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF------QTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE------EeCCEEEEE
Confidence            4799999999999999999999999998743    233455667888887766899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05619          75 MEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK  152 (316)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence            99999999999997543  6889999999999999999999999999999999999999999999999998754322233


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+....+ . ....++.++++
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~~~  225 (316)
T cd05619         153 TCTFCGTPDYIAPEILL-----GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-C-YPRWLTREAKD  225 (316)
T ss_pred             eeeecCCccccCHHHHc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C-CCccCCHHHHH
Confidence            34567999999999987     56788999999999999999999999988776555544433322 1 22357889999


Q ss_pred             HHHHhhhcCCCCCCCHH-HHhcCccccCCchh
Q psy7384         297 FIETVLVKDYHQRPYTD-QLLKHPFIRDQPTE  327 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~~-e~l~hp~~~~~~~~  327 (463)
                      ||.+||..||.+||++. ++++||||.+..+.
T Consensus       226 li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         226 ILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             HHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence            99999999999999996 89999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-47  Score=377.31  Aligned_cols=262  Identities=29%  Similarity=0.434  Sum_probs=218.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++.+.||+|+||.||+|++..+|+.||+|++....    .....+..|+.+++.+ +|+||+++++++      ...+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~------~~~~   74 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAF------QDKD   74 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEE------ecCC
Confidence            5999999999999999999999999999999997432    2445677888888887 899999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            8999999999999999997653 369999999999999999999999999999999999999999999999999998764


Q ss_pred             cccC-ccccccCCccccccceeccCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCCC
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENP-DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLKS  287 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~  287 (463)
                      .... .....+||+.|+|||++...... ...++.++|||||||++|+|++|..||...+....+..+.....  .....
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  233 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED  233 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence            3221 12334799999999998643221 45678899999999999999999999988776665554433221  11223


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      ..++..+.+||..||. +|.+|||++++++||||.....
T Consensus       234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence            4678999999999998 9999999999999999986543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.9e-47  Score=375.42  Aligned_cols=252  Identities=29%  Similarity=0.460  Sum_probs=207.3

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+++.||+|++...    ......+..|+.++..+.+||||++++++|      ...+.+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~------~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF------QTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE------EcCCEEEEE
Confidence            4799999999999999999999999999742    223456778999999987899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+++|+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        75 ~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  152 (329)
T cd05588          75 IEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT  152 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence            99999999999886543  6999999999999999999999999999999999999999999999999998753322233


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--------hhhhhcccCCCCCCCCCC
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--------MRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~  288 (463)
                      ....+||+.|+|||++.     +..++.++|||||||++|+|++|+.||.....        .............. .+.
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~  226 (329)
T cd05588         153 TSTFCGTPNYIAPEILR-----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-IPR  226 (329)
T ss_pred             cccccCCccccCHHHHc-----CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-CCC
Confidence            34568999999999987     56788999999999999999999999963211        11111111111111 234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCC------HHHHhcCccccCCch
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPY------TDQLLKHPFIRDQPT  326 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt------~~e~l~hp~~~~~~~  326 (463)
                      .++..+.+||++||..||.+|++      ++++++||||.+..+
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            67889999999999999999987      789999999976543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-46  Score=372.18  Aligned_cols=255  Identities=33%  Similarity=0.575  Sum_probs=212.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .++|++++.||+|+||.||+|++..+|..+|+|++....  .....+.+|+.+|+.+ +||||+++++++      ...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~   76 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAF------YSDG   76 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEE------EECC
Confidence            457999999999999999999999999999999987542  3346788999999999 899999999998      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      .+++||||+++|+|.+++....  .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          77 EISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            8999999999999999997644  589999999999999999999986 6999999999999999999999999998766


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc--------------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL--------------  276 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~--------------  276 (463)
                      ...  ......|++.|+|||++.     +..++.++|||||||++|+|++|+.||...........              
T Consensus       155 ~~~--~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         155 IDS--MANSFVGTRSYMSPERLQ-----GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             ccc--ccccCCCCcCcCCHhHhc-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence            432  224457999999999987     56688999999999999999999999965443221110              


Q ss_pred             --------------------------------ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         277 --------------------------------IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       277 --------------------------------i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                                      +.....+......++.++++||.+||..||++|||++++++||||...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                            001111222223567899999999999999999999999999999743

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.1e-47  Score=388.31  Aligned_cols=261  Identities=28%  Similarity=0.409  Sum_probs=209.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC--CCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP--GKD  130 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~--~~~  130 (463)
                      ..++|++++.||+|+||.||+|.+..+++.||||++....   ....+|+.+|+.+ +|+||++++++|......  ...
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCc
Confidence            4567999999999999999999999999999999885432   2345799999999 899999999887543211  222


Q ss_pred             CeEEEEEecCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEecccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKS--TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVS  207 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla  207 (463)
                      ..+++||||+.+ +|.+++..  .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            357899999975 77777653  2345789999999999999999999999999999999999998654 7999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC------
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA------  281 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------  281 (463)
                      +.+.... .....+||+.|+|||++.+    ...|+.++|||||||++|+|++|.+||.+.+....+..+....      
T Consensus       219 ~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        219 KNLLAGQ-RSVSYICSRFYRAPELMLG----ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             hhccCCC-CcccCCCCcCccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            8764332 2244678999999999863    3468999999999999999999999998877655444332100      


Q ss_pred             -------------CCC--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -------------PPR--------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -------------~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                   .+.        ..+...++++++||.+||..||.+|||+.|+|+||||.+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                         000        012246789999999999999999999999999999964

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6e-47  Score=374.56  Aligned_cols=257  Identities=29%  Similarity=0.444  Sum_probs=210.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .|++++.||+|+||.||+|++.   .+++.||+|++...     ......+..|+.+++.+.+|+||+++++++      
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~------   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF------   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE------
Confidence            3899999999999999999864   47899999998632     123456778999999997799999999998      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+|+||||+.+|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            55678999999999999999987544  6899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh---hh-hcccCCCC
Q psy7384         208 AQLDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---AL-FLIPRNAP  282 (463)
Q Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---~~-~~i~~~~~  282 (463)
                      +...... ......+||+.|+|||++.+    ...++.++|||||||++|+|++|..||.......   .+ ..+....+
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  228 (332)
T cd05614         153 KEFLSEEKERTYSFCGTIEYMAPEIIRG----KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP  228 (332)
T ss_pred             ccccccCCCccccccCCccccCHHHhcC----CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC
Confidence            7653322 22234679999999999863    2347889999999999999999999996543221   11 11222111


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                        .....++..+++||.+||..||.+||     +++++++||||.+...
T Consensus       229 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         229 --PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence              12346789999999999999999999     8899999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-47  Score=375.88  Aligned_cols=249  Identities=28%  Similarity=0.466  Sum_probs=210.7

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+|+.||+|++...    ......+..|+.+++.+ +||||+++++++      ...+.+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~------~~~~~~~lv   73 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSF------QTHDRLCFV   73 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEE------EcCCEEEEE
Confidence            4699999999999999999999999999642    22345667889999988 899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      |||+.+|+|.+++....  .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus        74 ~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          74 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            99999999999886543  68999999999999999999997 8999999999999999999999999999875433323


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                      .....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+......  ....++.++.
T Consensus       152 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~  224 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAK  224 (325)
T ss_pred             ccccccCCcccCCHHHHc-----cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHH
Confidence            334567999999999987     567889999999999999999999999887665555544333221  2346789999


Q ss_pred             HHHHHhhhcCCCCCC-----CHHHHhcCccccCCc
Q psy7384         296 SFIETVLVKDYHQRP-----YTDQLLKHPFIRDQP  325 (463)
Q Consensus       296 ~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  325 (463)
                      +||++||..||.+|+     ++.++++||||....
T Consensus       225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999997     999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.6e-47  Score=372.43  Aligned_cols=249  Identities=29%  Similarity=0.461  Sum_probs=207.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHH-HHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVL-KKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l-~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +.||+|+||+||+|++..+|+.||+|++....    .....+..|+.++ +.+ +||||+++++.+      ...+.+|+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~------~~~~~~~l   73 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSF------QTADKLYF   73 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEE------EeCCEEEE
Confidence            47999999999999999999999999986431    2234455565544 555 899999999998      45578999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        74 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          74 VLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             EEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            999999999999987543  689999999999999999999999999999999999999999999999999875433333


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                      .....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+.......+.....  .....++..+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  224 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLR-----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSAR  224 (323)
T ss_pred             ccccccCChhhcChhhhc-----CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence            334567999999999987     56688999999999999999999999988766555554443322  12345789999


Q ss_pred             HHHHHhhhcCCCCCCCH----HHHhcCccccCCc
Q psy7384         296 SFIETVLVKDYHQRPYT----DQLLKHPFIRDQP  325 (463)
Q Consensus       296 ~li~~~L~~dp~~Rpt~----~e~l~hp~~~~~~  325 (463)
                      +||.+||..||.+||++    .++++||||....
T Consensus       225 ~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         225 HLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             HHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999999987    6999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.2e-47  Score=372.22  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=210.7

Q ss_pred             eeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          61 EVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +.||+|+||.||+|++.   .+++.||+|++...     ......+..|+.+|+.+ +||||++++++|      ..++.
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~------~~~~~   74 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAF------QTGGK   74 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEE------ecCCe
Confidence            68999999999999864   46889999998642     22334567899999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+.+++|.+++....  .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          75 LYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             EEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            999999999999999997544  688999999999999999999999999999999999999999999999999875433


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      ........+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+....+..+.....  .....+++
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~  225 (323)
T cd05584         153 EGTVTHTFCGTIEYMAPEILM-----RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTP  225 (323)
T ss_pred             CCCcccccCCCccccChhhcc-----CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCH
Confidence            333334567999999999987     45678899999999999999999999988777666655544432  12346788


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCc
Q psy7384         293 KFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQP  325 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  325 (463)
                      .+.+||.+||..||.+||     +++++++||||....
T Consensus       226 ~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999999999     899999999998644

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-46  Score=369.40  Aligned_cols=263  Identities=26%  Similarity=0.428  Sum_probs=214.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +|++++.||+|+||.||++++..+++.||+|++...    ......+..|+.++..+ +|+||++++++|      ...+
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~   74 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAF------QDEN   74 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEE------ecCC
Confidence            599999999999999999999999999999998632    22345577889999888 899999999999      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            9999999999999999997532 368999999999999999999999999999999999999999999999999987654


Q ss_pred             cccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC---CCCCC
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP---PRLKS  287 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~  287 (463)
                      .... .....+||+.|+|||++.........++.++|||||||++|+|++|+.||.+.+..+....+.....   .....
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  233 (331)
T cd05597         154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV  233 (331)
T ss_pred             CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence            3222 1223469999999999864332245678899999999999999999999988766555444432211   11112


Q ss_pred             CCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCCch
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~  326 (463)
                      ..++..+++||++||..++++  |++++++++||||....+
T Consensus       234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            357899999999999765444  789999999999987543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.4e-47  Score=371.72  Aligned_cols=250  Identities=29%  Similarity=0.458  Sum_probs=212.5

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||+||+|++..++..||+|++...    ......+..|+.++..+.+||||+++++++      ...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~------~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF------QTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE------EcCCEEEEE
Confidence            4799999999999999999999999998743    233456678888888886899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.||+|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  152 (318)
T cd05570          75 MEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT  152 (318)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence            99999999999887543  6899999999999999999999999999999999999999999999999998754332233


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+|++.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+.....  .....++..+.+
T Consensus       153 ~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~  225 (318)
T cd05570         153 TSTFCGTPDYIAPEILS-----YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--RYPRWLSKEAKS  225 (318)
T ss_pred             ccceecCccccCHHHhc-----CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCHHHHH
Confidence            34567999999999997     56788999999999999999999999988776655554443322  123467899999


Q ss_pred             HHHHhhhcCCCCCCCH-----HHHhcCccccCCc
Q psy7384         297 FIETVLVKDYHQRPYT-----DQLLKHPFIRDQP  325 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~~  325 (463)
                      ||++||..||.+||++     .++++||||....
T Consensus       226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999999     9999999998754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-46  Score=377.68  Aligned_cols=262  Identities=26%  Similarity=0.448  Sum_probs=216.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+++.+ +||||+++++++      ..
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~------~~  114 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAF------QD  114 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------Ec
Confidence            46799999999999999999999999999999998632    22334567888888888 899999999998      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||++||+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            57899999999999999998653   488999999999999999999999999999999999999999999999999987


Q ss_pred             ccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCC
Q psy7384         210 LDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLK  286 (463)
Q Consensus       210 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~  286 (463)
                      ..... ......+||+.|+|||++..... ...++.++|||||||++|+|++|.+||.+.+.......+.....  ....
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD  270 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCC-CccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence            64322 12245679999999999864311 23478999999999999999999999998877666665544321  2222


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCCch
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~  326 (463)
                      ...++..+++||..||..++.+  |++++++++|+||.+...
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            3468999999999999854443  789999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4717|consensus

Probab=100.00  E-value=2.1e-47  Score=369.07  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=226.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+.+-|.+.+.||+|-|++|-+|++.-+|..||||++..+.   .....+..|++.|+.+ .|||||+||++.      .
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEVi------D   87 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVI------D   87 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehh------c
Confidence            46788999999999999999999999999999999997543   3456788999999888 899999999998      5


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE-ccCCcEEEEecccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVS  207 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl-~~~~~vkL~DFGla  207 (463)
                      ....+|||+|+-++|+|+|+|-... ..+.|..+++|+.||+.||.|||+..+|||||||+||++ ..-|-|||.|||++
T Consensus        88 TQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   88 TQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccc
Confidence            6679999999999999999997654 369999999999999999999999999999999999976 56789999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      ..+... ...++.||+..|-|||++++     ..|+ +++||||||||||.|.||++||...++.+++-.|......  .
T Consensus       167 Nkf~PG-~kL~TsCGSLAYSAPEILLG-----DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--v  238 (864)
T KOG4717|consen  167 NKFQPG-KKLTTSCGSLAYSAPEILLG-----DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--V  238 (864)
T ss_pred             ccCCCc-chhhcccchhhccCchhhhc-----CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--C
Confidence            877654 44577899999999999994     4454 6799999999999999999999999999998888766543  2


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +..++.++++||..||..||.+|.+.++|..|+|++.
T Consensus       239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence            3467889999999999999999999999999999984

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.5e-46  Score=367.74  Aligned_cols=263  Identities=24%  Similarity=0.419  Sum_probs=215.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||++++..+++.+|+|++...    ......+..|+.++..+ +|+||+++++++      ...+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~   74 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAF------QDEN   74 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEE------ecCC
Confidence            599999999999999999999999999999998632    22334567788888888 899999999998      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            9999999999999999997543 368999999999999999999999999999999999999999999999999987653


Q ss_pred             cccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC---CCC
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR---LKS  287 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~  287 (463)
                      .... .....+||+.|+|||++.........++.++|||||||++|+|++|+.||...+....+..+.......   ...
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  233 (332)
T cd05623         154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV  233 (332)
T ss_pred             cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence            3221 223457999999999986433334568889999999999999999999999887766666554432111   112


Q ss_pred             CCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCCch
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~  326 (463)
                      ..++.++++||++||..++.+  |++++++++||||....+
T Consensus       234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            357899999999999765554  689999999999986543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-46  Score=369.09  Aligned_cols=255  Identities=28%  Similarity=0.437  Sum_probs=214.9

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      |++.+.||+|+||.||+|+++.+|+.||+|++...    ......+..|+.++..+.+|++|+++++++      ...+.
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~------~~~~~   75 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF------QTVDR   75 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE------ecCCE
Confidence            78899999999999999999999999999998642    233455677888888886678888999888      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999999999986543  689999999999999999999999999999999999999999999999999876433


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      ........+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.........+......  ....++.
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~  226 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIA-----YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLSK  226 (323)
T ss_pred             CCccccCccCCccccCHHHHc-----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccCCH
Confidence            322334567999999999987     556889999999999999999999999888776655555443321  2345788


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCch
Q psy7384         293 KFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPT  326 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~  326 (463)
                      ++.+|+.+||..+|.+|++     .+++++||||....+
T Consensus       227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         227 EAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             HHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            9999999999999999997     579999999986543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.9e-46  Score=361.76  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=208.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhc--CCCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +|++.+.||+|+||+||+|++..+|+.||+|.+....   .....+.+|+.+++.+.  +||||+++++++..... ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~-~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT-DRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC-CCC
Confidence            4899999999999999999999999999999986432   22335567777777653  69999999998854321 234


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+++||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            578999999985 8999887665556899999999999999999999999999999999999999999999999998766


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC----------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN----------  280 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------  280 (463)
                      .... ......||+.|+|||++.     +..++.++|||||||++|+|++|.+||.+......+..+...          
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         159 SCQM-ALTPVVVTLWYRAPEVLL-----QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cCcc-cCCCccccccccCchHhh-----CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            4322 223456899999999987     566889999999999999999999999876654433222110          


Q ss_pred             --------CCC-------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 --------APP-------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 --------~~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                              ...       ....+.++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                    000       00113567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-46  Score=371.89  Aligned_cols=252  Identities=30%  Similarity=0.480  Sum_probs=206.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+++.||+|++...    ......+..|+.++.++.+||||+++++++      ...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~------~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF------QTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE------EeCCEEEEE
Confidence            4799999999999999999999999999742    233456778888888877899999999998      455799999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        75 ~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~  152 (329)
T cd05618          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  152 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence            99999999998886543  6899999999999999999999999999999999999999999999999998754332233


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--------hhhhhcccCCCCCCCCCC
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--------MRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~  288 (463)
                      ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.....        ...+.......... .+.
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~p~  226 (329)
T cd05618         153 TSTFCGTPNYIAPEILR-----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-IPR  226 (329)
T ss_pred             cccccCCccccCHHHHc-----CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-CCC
Confidence            34567999999999997     56788899999999999999999999953211        11111111111111 234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCC------HHHHhcCccccCCch
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPY------TDQLLKHPFIRDQPT  326 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt------~~e~l~hp~~~~~~~  326 (463)
                      .++..+.+||++||..||.+|++      ++++++||||.+..+
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            67889999999999999999998      589999999987544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-46  Score=362.37  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=213.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.+ +|+||+++++.+      ...+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~   73 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAY------ETKD   73 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeee------cCCC
Confidence            3899999999999999999999999999999986432    1234567899999999 899999999998      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            89999999999999998876555579999999999999999999999999999999999999999999999999987654


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcc---cCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI---PRNAPPRLKSK  288 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i---~~~~~~~~~~~  288 (463)
                      ... .....+|++.|+|||++.     ...++.++||||+||++|+|++|..||.+.........+   ..... .....
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  226 (285)
T cd05605         154 EGE-TIRGRVGTVGYMAPEVVK-----NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-EEYSE  226 (285)
T ss_pred             CCC-ccccccCCCCccCcHHhc-----CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-cccCc
Confidence            322 223457899999999986     566888999999999999999999999876543322111   11111 12234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      .++..+.+||.+||..||.+||     +++++++||||....+
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence            5788999999999999999999     8999999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-46  Score=370.12  Aligned_cols=250  Identities=28%  Similarity=0.460  Sum_probs=207.6

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHH-HHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINV-LKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~-l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +.||+|+||+||+|++..+++.||+|++....    .....+..|+.. ++.+ +|+||+++++++      ...+.+|+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~------~~~~~~~l   73 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSF------QTADKLYF   73 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEE------EcCCeEEE
Confidence            47999999999999999999999999986432    223344455544 4555 899999999998      45578999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+.+|+|.+++....  .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        74 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          74 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            999999999999997543  688999999999999999999999999999999999999999999999999876543333


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                      .....+||+.|+|||++.     +..++.++|||||||++|+|++|.+||.+.+....+..+.....  ...+.++..+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  224 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLH-----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSAR  224 (325)
T ss_pred             CcccccCCccccCHHHHc-----CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHH
Confidence            345567999999999987     56788999999999999999999999988776665555443322  22346889999


Q ss_pred             HHHHHhhhcCCCCCCCHH----HHhcCccccCCch
Q psy7384         296 SFIETVLVKDYHQRPYTD----QLLKHPFIRDQPT  326 (463)
Q Consensus       296 ~li~~~L~~dp~~Rpt~~----e~l~hp~~~~~~~  326 (463)
                      ++|.+||+.||.+|+++.    ++++|+||....+
T Consensus       225 ~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         225 HLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             HHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            999999999999999865    8999999976544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3e-46  Score=360.72  Aligned_cols=249  Identities=29%  Similarity=0.452  Sum_probs=206.1

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ||+|+||+||+|.+..+|+.||+|++....    .....+..|+.+++.+ +|+||+++++++      .....+|+|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~------~~~~~~~lv~e   73 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAF------QTKTDLCLVMT   73 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEE------cCCCeEEEEEe
Confidence            799999999999999999999999986432    1234567899999999 899999999998      45578999999


Q ss_pred             cCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         139 YCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       139 ~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |+++|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus        74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc
Confidence            99999999887542  2346899999999999999999999999999999999999999999999999998766544333


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh----hhcccCCCCCCCCCCCCCH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA----LFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  292 (463)
                      .....||+.|+|||++.     ...++.++|||||||++|+|++|+.||........    ...+...  +......++.
T Consensus       154 ~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  226 (280)
T cd05608         154 TKGYAGTPGFMAPELLQ-----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSP  226 (280)
T ss_pred             ccccCCCcCccCHHHhc-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCH
Confidence            34567999999999997     56788899999999999999999999976543211    1111111  1122346789


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCc
Q psy7384         293 KFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQP  325 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  325 (463)
                      .+.+|+.+||+.||.+||     +++++++||||+...
T Consensus       227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence            999999999999999999     899999999997644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-47  Score=373.59  Aligned_cols=250  Identities=28%  Similarity=0.436  Sum_probs=207.8

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhc--CCCceeeecccccccCCCCCCCeEEEE
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      ||+|+||+||+|++..+|+.||+|++....    ........|..++..+.  +||||+++++++      ...+.+|+|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~------~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF------QTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE------ecCCeEEEE
Confidence            799999999999999999999999986321    22234455777777664  799999999998      555789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          75 TDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             EcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            99999999999887543  6899999999999999999999999999999999999999999999999998764333333


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.........+..... .+....+++++++
T Consensus       153 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~  227 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLD----EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-RFPKNVLSDEGRQ  227 (330)
T ss_pred             ccCccCCccccCHHHHcC----CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-CCCCccCCHHHHH
Confidence            455689999999999863    34578899999999999999999999988766555554433322 2333457899999


Q ss_pred             HHHHhhhcCCCCCC----CHHHHhcCccccCCc
Q psy7384         297 FIETVLVKDYHQRP----YTDQLLKHPFIRDQP  325 (463)
Q Consensus       297 li~~~L~~dp~~Rp----t~~e~l~hp~~~~~~  325 (463)
                      ||++||..||.+||    +++++++||||.+..
T Consensus       228 li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            99999999999998    799999999998654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.6e-46  Score=372.25  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=208.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++.+.||+|+||.||+|++..+|..||+|++...   ......+.+|+.+++.+ +||||+++++++........
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence            456899999999999999999999999999999998632   23455677899999999 89999999999865432233


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+.+ +|.+.+..    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            3568999999976 56666532    488899999999999999999999999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC----------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----------  279 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~----------  279 (463)
                      .... .......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+..          
T Consensus       173 ~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         173 ACTN-FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             cccC-ccCCCCcccCCCCCchhcc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            5432 2223457899999999997     56788999999999999999999999987654332211100          


Q ss_pred             ------------CC--CC----------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 ------------NA--PP----------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 ------------~~--~~----------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                  ..  .+                .......++.+++||.+||..||.+|||++|+|+||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                        00  00                0011123578999999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-46  Score=378.87  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|++++.||+|+||.||+|++..+++.||+|...     ...+.+|+.+|+.+ +||||++++++|.      .....
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-~HpnIv~~~~~~~------~~~~~  158 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPSIIQLKGTFT------YNKFT  158 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-CCCCCCCEeEEEE------ECCee
Confidence            357999999999999999999999999999999753     34567899999999 8999999999984      45789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      ++|||++. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            99999995 68888886543  6889999999999999999999999999999999999999999999999998754321


Q ss_pred             -cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-------hhhhcccC------
Q psy7384         214 -IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPR------  279 (463)
Q Consensus       214 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-------~~~~~i~~------  279 (463)
                       .......+||+.|+|||++.     ...|+.++|||||||++|+|++|..||......       ..+..+..      
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLA-----RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             cccccccccCccCCCChhhhc-----CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence             22234568999999999987     567899999999999999999999887543211       01100000      


Q ss_pred             --------------------CC--CCCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 --------------------NA--PPRL-----KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 --------------------~~--~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                          ..  .+..     ....++.++.+||.+||+.||.+|||++|+|+||||.+.
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                                00  0000     001345689999999999999999999999999999764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.5e-46  Score=365.32  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=210.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|.+++.||+|+||.||+|++..++..||+|.+....  .....+.+|+.+++.+ +|+||+++++++      ..++.
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~~   78 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIV------HTDKS   78 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEE------eeCCe
Confidence            46999999999999999999999999999999986432  2334567899999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          79 LTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            9999999975 8888876543 3588999999999999999999999999999999999999999999999999876544


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN------------  280 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------  280 (463)
                      .........+++.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..+.+..+.+.            
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLG----SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI  232 (309)
T ss_pred             CccccccccccccccCCHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence            3333344578999999999863    346788999999999999999999999876554332221100            


Q ss_pred             ---------CCCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         281 ---------APPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       281 ---------~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                               ..+.       .....++.++++||.+||..||.+|||++|+|+||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence                     0000       0113568899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.2e-46  Score=385.99  Aligned_cols=254  Identities=20%  Similarity=0.359  Sum_probs=202.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc-----CCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS-----NHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~-----~h~nIv~l~~~~~~~~~~~  128 (463)
                      .++|++++.||+|+||+||+|.+..+++.||||++............|+.+++.+.     +|.+|++++++|.     .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~-----~  202 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ-----N  202 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE-----c
Confidence            47899999999999999999999999999999999754444556677888888772     2345888888874     2


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCC----------
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNA----------  197 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~----------  197 (463)
                      ...++|||||++ |++|.+++....  .+++..++.|+.||+.||.|||+ .|||||||||+|||++.++          
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            336799999998 678988886543  68999999999999999999998 5999999999999998665          


Q ss_pred             ------cEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch
Q psy7384         198 ------EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM  271 (463)
Q Consensus       198 ------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  271 (463)
                            .+||+|||++.....   .....+||+.|+|||++.     +..|+.++|||||||++|||++|++||.+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVL-----GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhh-----cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                  499999998764332   234568999999999997     567899999999999999999999999877654


Q ss_pred             hhhhcccCCC--------------------------CCCC--------------CCCCCCHHHHHHHHHhhhcCCCCCCC
Q psy7384         272 RALFLIPRNA--------------------------PPRL--------------KSKKWPKKFQSFIETVLVKDYHQRPY  311 (463)
Q Consensus       272 ~~~~~i~~~~--------------------------~~~~--------------~~~~~~~~~~~li~~~L~~dp~~Rpt  311 (463)
                      +.+..+....                          .+..              .....++.+.+||.+||.+||.+|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            4332211100                          0000              00012356789999999999999999


Q ss_pred             HHHHhcCccccC
Q psy7384         312 TDQLLKHPFIRD  323 (463)
Q Consensus       312 ~~e~l~hp~~~~  323 (463)
                      ++|+|+||||..
T Consensus       432 a~e~L~Hp~~~~  443 (467)
T PTZ00284        432 ARQMTTHPYVLK  443 (467)
T ss_pred             HHHHhcCccccc
Confidence            999999999975

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.9e-46  Score=368.61  Aligned_cols=251  Identities=29%  Similarity=0.442  Sum_probs=207.6

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||+||+|++..+|+.||+|++...    ......+..|..++.+..+||||+++++++      ...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~------~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF------QTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE------ecCCEEEEE
Confidence            4699999999999999999999999998643    223345556665544433899999999998      455799999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          75 LDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence            99999999998886543  6899999999999999999999999999999999999999999999999998754333333


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||...+.......+.....  ...+..+..+.+
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  225 (325)
T cd05604         153 TTTFCGTPEYLAPEVIR-----KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAWS  225 (325)
T ss_pred             cccccCChhhCCHHHHc-----CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHHH
Confidence            34567999999999987     56788899999999999999999999988776655554443322  123457889999


Q ss_pred             HHHHhhhcCCCCCCCH----HHHhcCccccCCch
Q psy7384         297 FIETVLVKDYHQRPYT----DQLLKHPFIRDQPT  326 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~----~e~l~hp~~~~~~~  326 (463)
                      +|.+||..+|.+||++    .++++||||....+
T Consensus       226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             HHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999999876    69999999986543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-45  Score=365.42  Aligned_cols=263  Identities=25%  Similarity=0.415  Sum_probs=214.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +|++++.||+|+||.||++++..+++.||+|++...    ......+..|+.++..+ +|+||+++++++      ...+
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~------~~~~   74 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAF------QDEN   74 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEE------EcCC
Confidence            699999999999999999999999999999998642    22334567788888888 899999999998      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999999997643 368999999999999999999999999999999999999999999999999987664


Q ss_pred             cccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC-CC--CCC
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-PR--LKS  287 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~--~~~  287 (463)
                      .... .....+||+.|+|||++.........++.++|||||||++|+|++|+.||...+....+..+..... ..  ...
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  233 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI  233 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence            3322 1233579999999999864322225678899999999999999999999988776665554433221 11  111


Q ss_pred             CCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCCch
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~  326 (463)
                      ..+++++++||.+||..++.+  |++++++++||||....+
T Consensus       234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            346899999999999976654  579999999999986543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4279|consensus

Probab=100.00  E-value=1.3e-46  Score=374.25  Aligned_cols=252  Identities=36%  Similarity=0.598  Sum_probs=218.7

Q ss_pred             eeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecC
Q psy7384          62 VVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYC  140 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~  140 (463)
                      +||+|+||+||-|+|..+...+|||-+... ....+-+..||.+.+.| +|.|||+++|.+      ..++++-|.||-+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~------senGf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSV------SENGFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhcc------CCCCeEEEEeecC
Confidence            799999999999999999999999999743 34456778899999999 899999999998      6667999999999


Q ss_pred             CCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc-cCCcEEEEecccccccccccCcc
Q psy7384         141 GAGSVTDLVKSTKGQSL--KEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRR  217 (463)
Q Consensus       141 ~ggsL~~~l~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~  217 (463)
                      +||+|.++++...+ ++  +|..+..|.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++.+.....-.
T Consensus       655 PGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            99999999987654 56  7888999999999999999999999999999999996 47899999999999887666556


Q ss_pred             ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-chhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         218 NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH-PMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       218 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      .++.||..|||||++...   ...|+.++|||||||++.||.||+|||.... +...++++.........+..++.+++.
T Consensus       734 ETFTGTLQYMAPEvIDqG---~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~  810 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQG---PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKN  810 (1226)
T ss_pred             cccccchhhhChHhhccC---CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHH
Confidence            678899999999999754   5679999999999999999999999997654 455566654443333345577889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         297 FIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ||.+|+.++|..||++.++|..||++..
T Consensus       811 FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  811 FILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHcCCCcccCccHHHhccCcccccC
Confidence            9999999999999999999999999754

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-45  Score=356.34  Aligned_cols=271  Identities=55%  Similarity=0.962  Sum_probs=223.6

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .....++|++.+.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++.+.+|+||+++++++..... ..
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   91 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV-KN   91 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc-CC
Confidence            34566789999999999999999999999999999999875545556788899999999779999999998754321 34


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .+.+|+||||+++++|.+++...  ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            46899999999999999987642  2346889999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-C
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-K  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~  286 (463)
                      ..............|++.|+|||++.........++.++|||||||++|+|++|..||........+..+.....+.. .
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            876543333344579999999999864332245688899999999999999999999988776555544433332222 2


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ...++..+.+||.+||+.||.+|||+.++++|+||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            34567899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.2e-46  Score=367.48  Aligned_cols=255  Identities=33%  Similarity=0.588  Sum_probs=211.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++....  .....+.+|+++++.+ +|+||++++++|.      ..+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~------~~~   76 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFY------SDG   76 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEE------ECC
Confidence            467999999999999999999999999999999987542  3346788999999999 7999999999994      457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      .+|+||||+.+|+|.+++...+  .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            8999999999999999997644  588999999999999999999975 7999999999999999999999999998765


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc--------------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL--------------  276 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~--------------  276 (463)
                      ...  ......|++.|+|||++.     +..++.++|||||||++|+|++|+.||...........              
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (333)
T cd06650         155 IDS--MANSFVGTRSYMSPERLQ-----GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET  227 (333)
T ss_pred             hhh--ccccCCCCccccCHHHhc-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence            432  123457999999999987     55688899999999999999999999965433221110              


Q ss_pred             ------------------------------ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         277 ------------------------------IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       277 ------------------------------i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                                    +.....+......++.++++||.+||..||++|||++|++.||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                          111111222223467899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.7e-46  Score=368.19  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=209.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..+++.||+|++...    ......+..|+.++.++.+|+||+++++++      ...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~------~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF------QTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE------EeCCEEEEE
Confidence            4799999999999999999999999999743    233456778999999887899999999998      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  152 (327)
T cd05617          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT  152 (327)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence            99999999999886543  6999999999999999999999999999999999999999999999999998754332233


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc------hhhhhcccCCCCCCCCCCCC
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP------MRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.....      .............. .+..+
T Consensus       153 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~  226 (327)
T cd05617         153 TSTFCGTPNYIAPEILR-----GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-IPRFL  226 (327)
T ss_pred             eecccCCcccCCHHHHC-----CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-CCCCC
Confidence            34568999999999987     56788999999999999999999999954321      11222222222222 23467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCC------HHHHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRPY------TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt------~~e~l~hp~~~~~~~~  327 (463)
                      +..+.++|.+||..||.+|++      ++++++||||....+.
T Consensus       227 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         227 SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            889999999999999999998      5799999999876543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-46  Score=369.65  Aligned_cols=249  Identities=26%  Similarity=0.447  Sum_probs=211.2

Q ss_pred             eeeeeeCCeEEEEEEEc---CCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          61 EVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      +.||+|+||.||++++.   .+|+.||+|++....   .....+..|+.+|+++ +||||+++++++      ...+.+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~------~~~~~~~   74 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAF------QTEGKLY   74 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEE------EcCCEEE
Confidence            68999999999999863   578999999997432   2334567899999999 899999999998      4557999


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          75 LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            999999999999998654  368999999999999999999999999999999999999999999999999987664433


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHH
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF  294 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  294 (463)
                      ......+||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+.......+......  ....++..+
T Consensus       153 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--~p~~~~~~~  225 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MPQFLSPEA  225 (318)
T ss_pred             CceecccCChhhcCHHHHc-----CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHH
Confidence            3344567999999999987     456788999999999999999999999887776666555443321  234578899


Q ss_pred             HHHHHHhhhcCCCCCCC-----HHHHhcCccccCCc
Q psy7384         295 QSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQP  325 (463)
Q Consensus       295 ~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~  325 (463)
                      .+||++||+.||.+||+     ++++++||||....
T Consensus       226 ~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            99999999999999999     78899999998754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-46  Score=357.54  Aligned_cols=265  Identities=45%  Similarity=0.903  Sum_probs=225.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.++|++++.||.|+||.||+|.+..++..+|+|++.... .....+..|+.+++++ +|+||+++++.+      ....
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~   75 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAY------FYEN   75 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEE------ecCC
Confidence            4567999999999999999999998899999999987543 3445778899999999 799999999998      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            8999999999999999987543 368999999999999999999999999999999999999999999999999987665


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKW  290 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~  290 (463)
                      ..........+++.|+|||++.........++.++|||||||++|+|++|.+||.+......+..+.....+.. ....+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW  234 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC
Confidence            44333445678999999999864433345678899999999999999999999988776665555554443332 23468


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      +.++.+||.+||..+|.+||+++++++||||.+..
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            89999999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0612|consensus

Probab=100.00  E-value=1.7e-47  Score=399.16  Aligned_cols=264  Identities=28%  Similarity=0.466  Sum_probs=230.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...|+|+++||+|+||.|.+++++.++++||+|+++.    .......|..|-.+|.-- +.+-|+.++-+|      ++
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAF------QD  146 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAF------QD  146 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHh------cC
Confidence            4579999999999999999999999999999999863    334455666666676655 789999999999      78


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ++++|+||||+.||+|..++....  .+++.++++|+..|+.||+-||++|+|||||||+||||+..|++||+|||.+..
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence            899999999999999999997654  799999999999999999999999999999999999999999999999999888


Q ss_pred             cccc-cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCC
Q psy7384         210 LDRT-IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLK  286 (463)
Q Consensus       210 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~  286 (463)
                      ++.. .-.....+|||.|++||++.......+.|+..||+||+||++|||++|..||+..+-..++-+|.....  ..+.
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~  304 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD  304 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence            7743 334566789999999999976555458899999999999999999999999999999999998877632  2223


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCC---HHHHhcCccccCCchh
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~~~  327 (463)
                      ...+|.++++||.++|+ +|..|..   ++++.+||||.+..|.
T Consensus       305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence            35689999999999876 6888888   9999999999998874

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-45  Score=363.79  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=205.5

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHH-HHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEIN-VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~-~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +.||+|+||.||+|++..+|+.||+|++....    .....+..|+. +++.+ +||||+++++++      ...+.+|+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~------~~~~~~~l   73 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSF------QTAEKLYF   73 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEE------EcCCEEEE
Confidence            47999999999999999999999999986432    22344555655 45566 899999999998      45578999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+++|+|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        74 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          74 VLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             EEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            999999999998886543  688999999999999999999999999999999999999999999999999875433323


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                      .....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+.......+.....  ......+..+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  224 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLR-----KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL--QLPGGKTVAAC  224 (321)
T ss_pred             ccccccCCcccCCHHHhc-----CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHH
Confidence            334567999999999986     56688999999999999999999999988766555544443322  22346788999


Q ss_pred             HHHHHhhhcCCCCCCCH----HHHhcCccccCCc
Q psy7384         296 SFIETVLVKDYHQRPYT----DQLLKHPFIRDQP  325 (463)
Q Consensus       296 ~li~~~L~~dp~~Rpt~----~e~l~hp~~~~~~  325 (463)
                      ++|.+||..||.+|+++    .++++|+||....
T Consensus       225 ~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         225 DLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             HHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            99999999999999875    5999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-45  Score=380.11  Aligned_cols=266  Identities=27%  Similarity=0.439  Sum_probs=220.9

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ....++|++.+.||+|+||+||+|++..+|+.||||++...   ......+.+|+.++..+ +|+||+++++.+......
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceeccccc
Confidence            34567999999999999999999999999999999998643   33445677899999998 899999999887543211


Q ss_pred             --CCCCeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEe
Q psy7384         128 --GKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       128 --~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~D  203 (463)
                        .....+++||||+.+|+|.+++....  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence              11124789999999999999987532  34689999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC
Q psy7384         204 FGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       204 FGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      ||+++.+....  ......+||+.|+|||++.     ...|+.++|||||||++|+|++|..||.+.+....+..+....
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~  261 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-----RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR  261 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            99987654321  1224467999999999997     5678999999999999999999999998877655555444433


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .. .....+++++.+||.+||..||.+||++.++++|||+..
T Consensus       262 ~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        262 YD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            32 234568899999999999999999999999999999864

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.8e-45  Score=353.98  Aligned_cols=271  Identities=53%  Similarity=0.950  Sum_probs=224.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ....++|++.+.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++++.+||||+++++++..... ...
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~-~~~   96 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK-LVG   96 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc-cCC
Confidence            3456789999999999999999999999999999999976555567788899999998789999999999864321 223


Q ss_pred             CeEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +..|+||||+.+++|.+++...  ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            5789999999999999988642  23468999999999999999999999999999999999999999999999999988


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KS  287 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~  287 (463)
                      .............|+..|+|||++.........++.++|||||||++|+|++|++||........+..+.....+.. ..
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  256 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP  256 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcc
Confidence            76543323344578999999999864322233478899999999999999999999988776666655544433322 23


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ..++..+.+||.+||..+|.+||++.++++||||+
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            45778999999999999999999999999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0607|consensus

Probab=100.00  E-value=8.3e-47  Score=346.46  Aligned_cols=262  Identities=26%  Similarity=0.451  Sum_probs=215.3

Q ss_pred             CceEEE-eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELI-EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +-|++. +.||+|+|+.|--|....+|..||||++.... ....++.+|++++.....|+||++|+++|      +++..
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF------Edd~~  150 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF------EDDTR  150 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh------cccce
Confidence            345543 58999999999999999999999999997553 45678899999999999999999999999      77789


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC---cEEEEecccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA---EVKLVDFGVSAQ  209 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~---~vkL~DFGla~~  209 (463)
                      +|||||.+.||+|...|..++  .+++.++..+.+.|+.||+|||.+||.||||||+|||..+..   -||||||.+...
T Consensus       151 FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            999999999999999998776  699999999999999999999999999999999999996543   489999999765


Q ss_pred             cccc-------cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc------------
Q psy7384         210 LDRT-------IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP------------  270 (463)
Q Consensus       210 ~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~------------  270 (463)
                      +...       .....+.+|+..|||||+...-......|+.++|.||||||||.||+|.+||.|.-.            
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            4221       122345689999999999754333356799999999999999999999999954311            


Q ss_pred             ---hhhhhcccCCCC--CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         271 ---MRALFLIPRNAP--PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       271 ---~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                         ...+..|..+..  |.-....++.++++||..+|..|+.+|.++.++++|||++..
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence               111223433332  222234568899999999999999999999999999999754

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-45  Score=369.78  Aligned_cols=259  Identities=23%  Similarity=0.401  Sum_probs=209.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.+ +||||+++++++........
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence            356899999999999999999999999999999998642   23345677899999998 89999999998864432233


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+.+ +|.+++..    .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            4578999999975 77777643    478899999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC-------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-------  282 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------  282 (463)
                      ..... ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.+....+..+.....       
T Consensus       176 ~~~~~-~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         176 AGTSF-MMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cCCCC-cccCCcccCCcCCHHHHh-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            64332 223457999999999997     56788999999999999999999999987765444332211000       


Q ss_pred             --------------C------------C-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         283 --------------P------------R-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       283 --------------~------------~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                    +            .       ......+..+++||.+||..||.+|||++++|+||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                          0            0       001123467899999999999999999999999999953

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-45  Score=369.18  Aligned_cols=259  Identities=24%  Similarity=0.406  Sum_probs=208.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.+ +||||+++++++........
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence            456899999999999999999999999999999998643   23345677899999999 89999999999865433234


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....|+||||+.+ +|.+.+..    .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence            4578999999976 67666643    488899999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC----------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----------  279 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~----------  279 (463)
                      ..... ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.........+..          
T Consensus       169 ~~~~~-~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         169 AGTSF-MMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             CCCcc-ccCCccccCCccCHHHHc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            64332 224457999999999987     56788999999999999999999999987654333211100          


Q ss_pred             ------------CC-------CC-----------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 ------------NA-------PP-----------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 ------------~~-------~~-----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                  ..       .+           .......+..+++||.+||..||.+|||++|+|+||||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                        00       00           0011223567899999999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG1989|consensus

Probab=100.00  E-value=1.3e-45  Score=380.58  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=216.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec-CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ....-+++|.+.|.+|||+.||+|++...|..||+|++-. +......+.+||.+|+.|.+|+|||.+++..........
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            3445678999999999999999999998889999998754 445567889999999999999999999994322221112


Q ss_pred             -CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEccCCcEEEEeccc
Q psy7384         130 -DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       130 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                       .-.++|.||||.||.|-|++..+....|++.++.+|+.++++|+.+||...  |||||||-|||||+.+|..||||||.
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence             346789999999999999999777667999999999999999999999998  99999999999999999999999999


Q ss_pred             ccccccccCcc---------ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcc
Q psy7384         207 SAQLDRTIGRR---------NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI  277 (463)
Q Consensus       207 a~~~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i  277 (463)
                      |+..-......         -...-|+.|+|||.+...  .+..+++|+|||+|||+||-|+....||.+......+   
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly--sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl---  267 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY--SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL---  267 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh--cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---
Confidence            87543221100         112368999999998543  3678999999999999999999999999877554443   


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       .+.......+.+++.+++||+.||+.||++||++.|++.+
T Consensus       268 -ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  268 -NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence             4444444446889999999999999999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.5e-46  Score=366.86  Aligned_cols=255  Identities=24%  Similarity=0.447  Sum_probs=204.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+|+.+|..+.+||||+++++++.   
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---   81 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---   81 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec---
Confidence            4568999999999999999999853     345789999986432  334578899999999978999999999884   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhC----------------------------------------------------
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTK----------------------------------------------------  153 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------  153 (463)
                        .....+|+||||+++|+|.+++....                                                    
T Consensus        82 --~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          82 --KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             --CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence              23357899999999999999987532                                                    


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC--ccccccCC
Q psy7384         154 --------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGT  223 (463)
Q Consensus       154 --------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt  223 (463)
                              ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  ......++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                    12477888999999999999999999999999999999999999999999999986532211  11233466


Q ss_pred             ccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhh
Q psy7384         224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVL  302 (463)
Q Consensus       224 ~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  302 (463)
                      +.|+|||++.     ...++.++|||||||++|||++ |.+||.+......+...............+++.+.+||.+||
T Consensus       240 ~~y~aPE~~~-----~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  314 (338)
T cd05102         240 LKWMAPESIF-----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW  314 (338)
T ss_pred             ccccCcHHhh-----cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            7899999987     5678999999999999999997 999998765433332222222222234467889999999999


Q ss_pred             hcCCCCCCCHHHHhc
Q psy7384         303 VKDYHQRPYTDQLLK  317 (463)
Q Consensus       303 ~~dp~~Rpt~~e~l~  317 (463)
                      ..||.+|||+.++++
T Consensus       315 ~~dp~~RPs~~el~~  329 (338)
T cd05102         315 QGDPKERPTFSALVE  329 (338)
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.2e-45  Score=354.65  Aligned_cols=269  Identities=45%  Similarity=0.860  Sum_probs=223.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .+.+.|++++.||.|+||.||+|++..++..+|+|++.... .....+..|+.+++.+ +|+||+++++.+      ..+
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~   81 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAF------YWD   81 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEE------EeC
Confidence            34567999999999999999999999999999999987543 3456778899999999 799999999998      345


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.+++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            78999999999999988876543 36899999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LKSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~  289 (463)
                      ...........+++.|+|||++.........++.++|||||||++|+|++|.+||...+.......+.....+. .....
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK  240 (292)
T ss_pred             cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence            44333334567899999999986433334567889999999999999999999998776655544443333222 23456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhH
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER  328 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  328 (463)
                      ++.++.+||.+||..+|.+||+++++++||||......+
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            788999999999999999999999999999998654443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-46  Score=369.29  Aligned_cols=258  Identities=25%  Similarity=0.450  Sum_probs=209.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||.|+||.||+|.+..+++.||+|++....   .....+.+|+.+|+.+ +|+||++++++|.........
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccccc
Confidence            346999999999999999999999999999999986432   2335567899999999 899999999998644322333


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|++||++ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence            5689999998 6799888753   35999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---C------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---A------  281 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---~------  281 (463)
                      ...   ....+||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+....+..+...   .      
T Consensus       169 ~~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         169 DDE---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             CCC---cCCccccccccCchHhcC----CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            543   245679999999999863    356888999999999999999999999776544333221100   0      


Q ss_pred             -------------CCCCC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -------------PPRLK-------SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -------------~~~~~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                   .+...       ....++.+.+||.+||..||.+|||+.|+|+||||..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                         00000       1234667899999999999999999999999999974

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-45  Score=348.27  Aligned_cols=252  Identities=35%  Similarity=0.642  Sum_probs=214.3

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc------hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED------EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.....      ....+.+|+.+++++ +||||+++++++      ..
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~   75 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCL------RD   75 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEE------cc
Confidence            48899999999999999999999999999999864321      234678899999999 899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.+++|.+++....  .+++..++.++.||+.||.|||+.||+||||+|+||++++++.++|+|||++..
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            579999999999999999997654  688999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         210 LDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       210 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      .......   .....|+..|+|||++.     +..++.++|||||||++|+|++|++||...+.......+.........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  228 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVIS-----GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL  228 (263)
T ss_pred             ccccccccccccCCCcCccccCcceec-----cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCC
Confidence            5432111   12346888999999997     455889999999999999999999999887666655554443333333


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ...++..+.+||.+||..+|.+|||+.++++|+||
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            45678999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.6e-45  Score=345.60  Aligned_cols=254  Identities=31%  Similarity=0.586  Sum_probs=217.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .|++++.||.|+||.||++.+..+++.||+|.+....   .....+.+|+.+++++ +|+||+++++.+.     ..+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWE-----GEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeec-----CCCCE
Confidence            3899999999999999999999999999999986432   3345678899999999 8999999998873     23457


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+.+++|.+++.......+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            89999999999999999876656789999999999999999999999999999999999999999999999999987654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........+++.|+|||++.     ...++.++|||||||++|+|++|..||...+.......+.....+. ....+++
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  228 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFS-----NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP-MPKDYSP  228 (257)
T ss_pred             cCCccccccCCcCccChhHhc-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-CccccCH
Confidence            433344567899999999987     5668889999999999999999999998776655554444443322 2346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      .+.+||.+||+.||.+|||+.++++||||
T Consensus       229 ~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         229 ELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-45  Score=378.40  Aligned_cols=257  Identities=24%  Similarity=0.434  Sum_probs=217.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCC-CcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKT-GQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+|+.+|..+ +|||||++++.|      ...+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~------~~~~  138 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDF------KSDD  138 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEE------EECC
Confidence            34599999999999999999998877 7888888775443 3345677899999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+||||||+.||+|.+++...  ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            999999999999999988642  234689999999999999999999999999999999999999999999999999987


Q ss_pred             cccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         210 LDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       210 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      +.....  .....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+....+..+...... ...
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~  292 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWE-----RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFP  292 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhC-----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCC
Confidence            653321  234567999999999987     567899999999999999999999999887766655555443332 223


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..++.++++||.+||..||++||++++++.|+|+..
T Consensus       293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            467889999999999999999999999999999964

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-45  Score=352.82  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=205.6

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ||+|+||.||++++..+|+.||+|.+....    .....+..|+++++.+ +||||+++++.+      .....+|+|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~------~~~~~~~lv~e   73 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAF------ESKTHLCLVMS   73 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEE------ecCCeEEEEEe
Confidence            799999999999999999999999986321    2234456799999999 899999999998      45578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccc
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN  218 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  218 (463)
                      |+.|++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ...
T Consensus        74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~  152 (277)
T cd05607          74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TIT  152 (277)
T ss_pred             cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eee
Confidence            9999999998876665578999999999999999999999999999999999999999999999999987664321 223


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch----hhhhcccCCCCCCCCCCCCCHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM----RALFLIPRNAPPRLKSKKWPKKF  294 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~  294 (463)
                      ...|++.|+|||++.     ...++.++|||||||++|+|++|..||.+....    ......... ........++.++
T Consensus       153 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  226 (277)
T cd05607         153 QRAGTNGYMAPEILK-----EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-EVKFEHQNFTEES  226 (277)
T ss_pred             ccCCCCCccCHHHHc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-ccccccccCCHHH
Confidence            456899999999987     455889999999999999999999999764332    111112111 1122234678999


Q ss_pred             HHHHHHhhhcCCCCCCCH----HHHhcCccccCCch
Q psy7384         295 QSFIETVLVKDYHQRPYT----DQLLKHPFIRDQPT  326 (463)
Q Consensus       295 ~~li~~~L~~dp~~Rpt~----~e~l~hp~~~~~~~  326 (463)
                      ++||.+||+.||.+||++    ++++.||||....+
T Consensus       227 ~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         227 KDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             HHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence            999999999999999999    77889999976443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.1e-45  Score=391.73  Aligned_cols=263  Identities=28%  Similarity=0.560  Sum_probs=216.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...++|++++.||+|+||+||+|++..++..||+|++...   ......+..|+.+|+.| +|||||+++++|..    .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~d----e   84 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLN----K   84 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEe----c
Confidence            3456899999999999999999999999999999998643   33456788999999999 89999999998854    2


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcC-------CceecCCCCCceEEcc----
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHEN-------KVIHRDIKGQNVLLTD----  195 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~-------givHrDLkp~NILl~~----  195 (463)
                      ....+||||||+.+|+|.++|....  ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.    
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            3467999999999999999997532  24699999999999999999999984       4999999999999964    


Q ss_pred             -------------CCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy7384         196 -------------NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ  262 (463)
Q Consensus       196 -------------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~  262 (463)
                                   .+.+||+|||++..+.... .....+||+.|+|||++...   ...++.++||||||||||+|++|.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge---~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHE---TKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhcc---CCCCCchhHHHHHHHHHHHHHHCC
Confidence                         2358999999998664322 22345799999999998632   345788999999999999999999


Q ss_pred             CCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         263 PPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       263 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .||........+....... +.+.....+.++.+||..||..+|.+||++.|+|.|+||...
T Consensus       241 ~PF~~~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        241 TPFHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCCCcCCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            9998766655544333322 223334578899999999999999999999999999999754

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-45  Score=369.37  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=208.9

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++++.||+|+||.||+|.+..+|+.||+|.+...   ......+.+|+.+|+.+ +|+||+++++++..... .....+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~   79 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHI-DPFEEI   79 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCc-cccceE
Confidence            78899999999999999999999999999998643   22345778899999999 89999999999854311 111378


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            99999997 4788877543  36899999999999999999999999999999999999999999999999999865432


Q ss_pred             c-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-------------
Q psy7384         214 I-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-------------  279 (463)
Q Consensus       214 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-------------  279 (463)
                      . .......+++.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+....+..+..             
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMG----SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcC----CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            2 12234468999999999863    34578899999999999999999999987765544332211             


Q ss_pred             ----------C--CCCC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 ----------N--APPR-----LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 ----------~--~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                .  ..+.     ......++++.+||.+||..||.+|||+.|+|+||||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                      0  0000     1123457899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4e-45  Score=356.43  Aligned_cols=257  Identities=25%  Similarity=0.441  Sum_probs=210.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|++.+.||.|+||.||+|++..++..||+|.+....  .....+.+|+.+++.+ +|+||+++++++      ...+.
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~------~~~~~   78 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDII------HTEKS   78 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEE------ecCCe
Confidence            46999999999999999999999999999999986432  2344677899999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          79 LTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             EEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            999999997 48988886543 3688999999999999999999999999999999999999999999999999876543


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-------------  279 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-------------  279 (463)
                      .........+++.|+|||++..    ...++.++|||||||++|+|++|++||.+.+.......+..             
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             CCCcccccceeecccCcHHHhC----CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence            3333344567899999999863    34578899999999999999999999987654333221100             


Q ss_pred             --------CCCCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 --------NAPPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 --------~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                              ...+.       .....+++.+++||.+||..||.+|||++++|+||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                    00010       0113567899999999999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.4e-45  Score=352.88  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=212.0

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....    .....+.+|+.+++.+ +|+||+++++.+      ...+.
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~------~~~~~   74 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAY------ETKDA   74 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEE------ecCCE
Confidence            788899999999999999999999999999986432    1234567899999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            99999999999999998766555799999999999999999999999999999999999999999999999999876543


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---hhhhcccCCCCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM---RALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~  289 (463)
                      .. ......|++.|+|||++.     ...++.++|||||||++|+|++|.+||......   .....+..... ......
T Consensus       155 ~~-~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~  227 (285)
T cd05630         155 GQ-TIKGRVGTVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-EEYSEK  227 (285)
T ss_pred             Cc-cccCCCCCccccChHHHc-----CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-hhcCcc
Confidence            22 223457999999999987     566889999999999999999999999765432   11111111111 122346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCch
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPT  326 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~  326 (463)
                      ++.++++||.+||+.||.+|||     ++|+++||||.....
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence            7889999999999999999999     999999999976433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.1e-44  Score=344.17  Aligned_cols=252  Identities=34%  Similarity=0.592  Sum_probs=218.7

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++.+.||+|+||.||+|.+..++..|++|.+..   .......+.+|+.+++.+ +||||+++++.+      ...+..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~   74 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESF------LDKGKL   74 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeee------ccCCEE
Confidence            8899999999999999999999999999999864   334566788899999999 899999999998      445789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            99999999999999998765567999999999999999999999999999999999999999999999999998876554


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                      ........|++.|+|||++.     ...++.++|+|||||++|+|++|..||...+.......+.....+... ..++..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCE-----DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-QMYSQQ  228 (256)
T ss_pred             cchhhccccCccccCHHHhc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-cccCHH
Confidence            33334557899999999987     456788999999999999999999999877766555555444433322 267889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      +.++|.+||+.+|++||++.+++.|||+
T Consensus       229 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         229 LAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5e-45  Score=352.39  Aligned_cols=254  Identities=30%  Similarity=0.503  Sum_probs=208.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .|++++.||+|+||.||+|++..++..||+|.+....   .....+.+|+.+++.+ +||||+++++++      ...+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~   73 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVL------MQESR   73 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEE------eeCCe
Confidence            3899999999999999999999999999999986432   2346778899999999 799999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      +|+||||+. ++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus        74 ~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          74 LYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             EEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            999999997 58888886543 3568999999999999999999999999999999999999999999999999987664


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-----------  280 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  280 (463)
                      ..........+++.|+|||++..    ...++.++|||||||++|+|++|++||.+.........+...           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLG----SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             CCcccccCCcccccccChHHhcC----CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence            43333344567899999998863    345788999999999999999999999876544332211000           


Q ss_pred             ----------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 ----------------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 ----------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                      .........+++++++||.+||..||.+|||+.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                            00001123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-45  Score=350.28  Aligned_cols=257  Identities=53%  Similarity=0.991  Sum_probs=222.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|++.+.||.|+||.||+|.+..++..||+|++....  .....+.+|+.+++.+ +|+||+++++.+.      .+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFL------KGSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEE------ECCe
Confidence            36899999999999999999999999999999987542  3445778899999999 7999999999984      4478


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+|+||+.+++|.+++...   .+++..++.++.||+.||.|||+++|+|+||+|+||++++++.++|+|||+++.+..
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            99999999999999998754   689999999999999999999999999999999999999999999999999988765


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........+++.|+|||++.     +..++.++|||||||++|+|++|.+||...+.......+.....+......++.
T Consensus       151 ~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEVIK-----QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSK  225 (274)
T ss_pred             cccccccccCCccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCH
Confidence            444445567899999999997     445889999999999999999999999877766665555555554444444888


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      .+.++|.+||..+|++|||++++++||||.+...
T Consensus       226 ~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.7e-45  Score=351.82  Aligned_cols=261  Identities=44%  Similarity=0.864  Sum_probs=219.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      .|++.+.||+|+||.||+|.+..++..+++|.+.... .....+.+|+.+++.+ +|+||+++++.+.      ..+..|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~------~~~~~~   78 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFY------YENNLW   78 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEe------eCCEEE
Confidence            3788899999999999999999999999999986543 3456778899999999 8999999999984      457899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+.+++|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            9999999999998876432 368999999999999999999999999999999999999999999999999987654433


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CCCCCCCHH
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LKSKKWPKK  293 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~  293 (463)
                      .......+++.|+|||++.........++.++|||||||++|+|++|.+||...+.......+.....+. .....++.+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE  237 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence            3334567899999999986444335667889999999999999999999998877666555544333222 223468899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      +++||.+||..||.+||+++++++||||...
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            9999999999999999999999999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.9e-45  Score=347.42  Aligned_cols=257  Identities=49%  Similarity=0.950  Sum_probs=213.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ +||||+++++.+.      ..+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~------~~~   79 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYL------SRE   79 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEE------eCC
Confidence            3457999999999999999999999999999999987443 3445678899999999 8999999999984      447


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            8999999999999999986543  68999999999999999999999999999999999999999999999999998765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCC-CCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRL-KSK  288 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~-~~~  288 (463)
                      ..........|++.|+|||.+....  ...++.++|||||||++|+|++|.+||....+......+.....  +.. ...
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEK--NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT  235 (267)
T ss_pred             ccccccCccccCccccCHhHccccc--CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccc
Confidence            4333334567899999999885321  34577899999999999999999999976655444433322211  111 123


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF  320 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  320 (463)
                      .++..+.+||++||..+|.+|||++++|+|+|
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            57889999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.8e-45  Score=351.04  Aligned_cols=258  Identities=27%  Similarity=0.422  Sum_probs=214.4

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      |++.+.||+|+||+||+|.+..+++.+|+|++....    .....+.+|+.+|+.+ +|+||+.+++.+      ..++.
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~------~~~~~   74 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAY------ETKDA   74 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEE------ecCCE
Confidence            788899999999999999999999999999986432    2234567899999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            99999999999999988765555799999999999999999999999999999999999999999999999999876543


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKSKKW  290 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~  290 (463)
                      . .......|++.|+|||++.     ...++.++|+|||||++|+|++|..||.+.........+....  ........+
T Consensus       155 ~-~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd05632         155 G-ESIRGRVGTVGYMAPEVLN-----NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF  228 (285)
T ss_pred             C-CcccCCCCCcCccChHHhc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccC
Confidence            2 1223457999999999987     5668889999999999999999999998765543322221111  111223467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~  327 (463)
                      +.++.+|+..||..||.+||+     ++++++|+||.+....
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence            889999999999999999999     8999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-45  Score=349.02  Aligned_cols=252  Identities=40%  Similarity=0.703  Sum_probs=208.6

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHH---HHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE---IKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++++.||+|+||+||+|++..+++.||+|++.........   ..+|+.+++.+ +|+||+++++++.      .....
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~------~~~~~   73 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQ------DDNYL   73 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEE------ESSEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccc------ccccc
Confidence            89999999999999999999999999999999866544333   34599999999 8999999999994      45789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      ++||||+.+++|.+++....  .+++..+..++.||++||.+||++||+|+||||+|||++.++.++|+|||++......
T Consensus        74 ~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~  151 (260)
T PF00069_consen   74 YIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN  151 (260)
T ss_dssp             EEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred             cccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999998433  6899999999999999999999999999999999999999999999999998764333


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc---ccCCCCC--CCCCC
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL---IPRNAPP--RLKSK  288 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~---i~~~~~~--~~~~~  288 (463)
                      ........+++.|+|||++..    ...++.++||||||+++|+|++|..||...........   .......  .....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQ----GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR  227 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTT----TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT
T ss_pred             ccccccccccccccccccccc----cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc
Confidence            344456679999999999851    46788999999999999999999999987732222221   1111000  00011


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ..+..+.++|.+||+.||.+||++.++++||||
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            223799999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0662|consensus

Probab=100.00  E-value=1.2e-45  Score=313.60  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=214.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .|+-.++||+|+||+||+|++..+++.||+|.++...++   .....+||-+|+.+ +|.|||+++++.      ..++.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvl------hsdkk   75 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVL------HSDKK   75 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhh------ccCce
Confidence            477779999999999999999999999999999866544   35778999999999 899999999998      56689


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +-+|+|||.. +|..+.....+ .+..+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++.++-
T Consensus        76 ltlvfe~cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   76 LTLVFEFCDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             eEEeHHHhhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            9999999965 78888776553 689999999999999999999999999999999999999999999999999998876


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCC-------CCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRN-------APPR  284 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-------~~~~  284 (463)
                      ...-....+-|.||++|.++.+    ..-|+.+.|+||.|||+.|+.. |+|.|.+.+-.+++..|-+.       ..|.
T Consensus       154 pvrcysaevvtlwyrppdvlfg----akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             ceEeeeceeeeeeccCcceeee----eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence            6544556678999999999986    4668999999999999999986 78888887766666543211       0000


Q ss_pred             C-----------C--C-------CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         285 L-----------K--S-------KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       285 ~-----------~--~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .           .  .       +.+...-++|++++|..+|.+|.+++++|+||||.+.
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            0           0  0       1223456789999999999999999999999999864

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.7e-45  Score=356.26  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=194.7

Q ss_pred             eeeeeeCCeEEEEEEEc--CCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          61 EVVGNGTYGQVYKGRHT--KTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++||+|+||.||+|+++  .+++.||+|.+.... ....+.+|+.+|+.+ +||||++++++|..    .....+|+|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~~~lv~e   80 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLREL-KHPNVISLQKVFLS----HADRKVWLLFD   80 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhc-CCCCCcceeeeEec----CCCcEEEEEEe
Confidence            68999999999999975  467899999986542 234577899999999 89999999999854    23467899999


Q ss_pred             cCCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE----ccCCcEEEEecccc
Q psy7384         139 YCGAGSVTDLVKSTK-------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL----TDNAEVKLVDFGVS  207 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl----~~~~~vkL~DFGla  207 (463)
                      |+.+ +|.+++....       ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9965 8888876422       2358999999999999999999999999999999999999    45678999999999


Q ss_pred             cccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh---------hhh
Q psy7384         208 AQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---------ALF  275 (463)
Q Consensus       208 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---------~~~  275 (463)
                      +.......   .....+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.......         .+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  235 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcC----CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence            87643221   2234578999999999863    3458899999999999999999999996543210         000


Q ss_pred             cc---cC-------------------------CCCC--------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy7384         276 LI---PR-------------------------NAPP--------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHP  319 (463)
Q Consensus       276 ~i---~~-------------------------~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  319 (463)
                      .+   ..                         ....        .......+..+.+||.+||+.||.+|||++|+|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            00   00                         0000        000112356789999999999999999999999999


Q ss_pred             cc
Q psy7384         320 FI  321 (463)
Q Consensus       320 ~~  321 (463)
                      ||
T Consensus       316 ~f  317 (317)
T cd07868         316 YF  317 (317)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.4e-45  Score=358.90  Aligned_cols=255  Identities=27%  Similarity=0.494  Sum_probs=203.3

Q ss_pred             EEeeeeee--CCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          59 LIEVVGNG--TYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        59 ~~~~LG~G--~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ++++||+|  +|++||++.++.+|+.||+|++....   .....+.+|+.+++.+ +||||++++++|.      .++..
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~------~~~~~   74 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFI------ADNEL   74 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEE------ECCEE
Confidence            56889999  68899999999999999999997532   3345677899999998 8999999999994      45789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+......
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            99999999999999997655556899999999999999999999999999999999999999999999999865433211


Q ss_pred             cC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC---
Q psy7384         214 IG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP---  283 (463)
Q Consensus       214 ~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---  283 (463)
                      ..       ......++..|+|||++...   ...|+.++|||||||++|+|++|..||.................+   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  231 (327)
T ss_pred             cccccccccccccccceecccChHHhhcc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence            00       01223567789999998632   246889999999999999999999999765433222111110000   


Q ss_pred             -----------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         284 -----------------------------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       284 -----------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                                                               ......+++.+++||.+||+.||++|||++++++||||.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                                                     001123567899999999999999999999999999997


Q ss_pred             C
Q psy7384         323 D  323 (463)
Q Consensus       323 ~  323 (463)
                      +
T Consensus       312 ~  312 (327)
T cd08227         312 Q  312 (327)
T ss_pred             h
Confidence            5

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.1e-44  Score=350.68  Aligned_cols=257  Identities=42%  Similarity=0.757  Sum_probs=216.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +...+|++++.||+|+||.||+|++..++..||+|.+.... .....+.+|+.+++.+ +|+||+++++.|.      ..
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~------~~   89 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYL------VG   89 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEE------eC
Confidence            44568999999999999999999999999999999987533 3456778899999998 8999999999984      44


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...|+||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            6899999999999999998643   4789999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LKSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~  289 (463)
                      ...........|++.|+|||.+.     ...++.++|||||||++|+|++|++||...........+.....+. .....
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK  241 (296)
T ss_pred             cccccccCcccCCccccCHHHHc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence            44333334457899999999986     4567889999999999999999999998776655444333322222 22346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ++..+.+||.+||..+|.+|||+.++++||||..
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            7889999999999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-44  Score=348.83  Aligned_cols=255  Identities=42%  Similarity=0.730  Sum_probs=217.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..+|++++.||.|+||.||+|.+..+|+.||+|.+... ......+.+|+.+++.+ +|+||+++++.+      ...+.
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~~~~   90 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSF------LVGDE   90 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeE------ecCce
Confidence            35799999999999999999999999999999998643 33456778899999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+.+++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            99999999999999988643   589999999999999999999999999999999999999999999999999876654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LKSKKWP  291 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~  291 (463)
                      .........+++.|+|||.+.     ...++.++|||||||++|+|++|..||.+.+.......+.....+. .....++
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS  242 (296)
T ss_pred             ccccCCCcCCCccccCcchhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCC
Confidence            433334457899999999986     4567889999999999999999999998877665554443332222 2334678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..+.+||.+||..||.+|||+.++++||||..
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~  274 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL  274 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence            89999999999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.1e-44  Score=350.91  Aligned_cols=258  Identities=42%  Similarity=0.754  Sum_probs=218.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +...+|++++.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +|+||+++++.+      ...
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~------~~~   88 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSY------LVG   88 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEE------ecC
Confidence            44568999999999999999999999999999999987533 3445678899999998 899999999998      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..|+||||+++++|.+++...   .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            7899999999999999998643   5889999999999999999999999999999999999999999999999998766


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LKSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~  289 (463)
                      ...........+++.|+|||.+.     ...++.++|+|||||++|+|++|.+||.+.+.......+.....+. .....
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER  240 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence            44333334457899999999986     5567889999999999999999999998776655544443332222 23346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++..+++||.+||..+|++||+++++++||||...
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence            78899999999999999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.3e-44  Score=347.20  Aligned_cols=249  Identities=33%  Similarity=0.582  Sum_probs=208.3

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|++++.||+|+||.||+|++..++..||+|++...  ......+.+|+.+++++ +||||+++++.+.      ..+..
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~------~~~~~   74 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFF------VENRI   74 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE------ECCEE
Confidence            588999999999999999999999999999998654  23345688999999999 8999999999994      45789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      ++||||+++++|..+.      .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          75 SICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             EEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            9999999999986542      4788899999999999999999999999999999999999999999999998766432


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-------hhhhcccCCCCCCCC
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNAPPRLK  286 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~  286 (463)
                        .....+|+..|+|||++.     +..++.++|||||||++|+|++|..||......       .....+.....+...
T Consensus       149 --~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (279)
T cd06619         149 --IAKTYVGTNAYMAPERIS-----GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP  221 (279)
T ss_pred             --cccCCCCChhhcCceeec-----CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC
Confidence              224457999999999997     556889999999999999999999999653321       111222222233333


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ...++.++.+||.+||..+|.+||+++++++||||...
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            44578899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=353.14  Aligned_cols=258  Identities=32%  Similarity=0.509  Sum_probs=218.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+..|++++..+ +|+||+++++.+      ....
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~   74 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASF------QTET   74 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeee------ecCC
Confidence            5999999999999999999999999999999987543    2345678899999999 799999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.+++|.+++.......+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            89999999999999999986655679999999999999999999999999999999999999999999999999987543


Q ss_pred             cccC-----------------------------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy7384         212 RTIG-----------------------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ  262 (463)
Q Consensus       212 ~~~~-----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~  262 (463)
                      ....                             ......|+..|+|||++.     +..++.++|||||||++|+|++|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-----GDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-----CCCCCchHHHHHHHHHHHHHhhCC
Confidence            2110                             112346889999999987     456788999999999999999999


Q ss_pred             CCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC----HHHHhcCccccCCc
Q psy7384         263 PPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPY----TDQLLKHPFIRDQP  325 (463)
Q Consensus       263 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~~~  325 (463)
                      .||.+.+....+..+.............+..+++||.+||..||.+|||    ++++|+||||+...
T Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         230 TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             CCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            9998877766665554433332333347899999999999999999999    99999999997643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.1e-45  Score=347.37  Aligned_cols=256  Identities=50%  Similarity=0.955  Sum_probs=212.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ +||||+++++.+      ...+.
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~------~~~~~   80 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSY------LRRDK   80 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEE------EeCCE
Confidence            357899999999999999999999999999999987543 2345677899999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+++++|.+++....  .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            999999999999999987544  689999999999999999999999999999999999999999999999999876654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCCC-CCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRL-KSKK  289 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~-~~~~  289 (463)
                      .........|+..|+|||++....  ...++.++|+|||||++|+|++|.+||................  ++.. ....
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVER--KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK  236 (267)
T ss_pred             cccccccccCcccccChhhhcccc--CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence            433345567999999999974211  3457889999999999999999999997665544433322221  1111 1235


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPF  320 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  320 (463)
                      ++..+.+||.+||..+|++|||++++++|||
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            7889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0584|consensus

Probab=100.00  E-value=9.4e-46  Score=367.39  Aligned_cols=257  Identities=31%  Similarity=0.569  Sum_probs=219.9

Q ss_pred             CCCCce-EEEeeeeeeCCeEEEEEEEcCCCcEEE---EEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          52 DPAGIF-ELIEVVGNGTYGQVYKGRHTKTGQLAA---IKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        52 ~~~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~va---iK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ++.++| ++..+||+|+|-+||+|.|..+|..||   +|+-+..+  ...+++..|+.+|+.| +|+|||++|+.+... 
T Consensus        36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~-  113 (632)
T KOG0584|consen   36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDT-  113 (632)
T ss_pred             CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecC-
Confidence            455666 577899999999999999999999888   34433333  4458899999999999 899999999999753 


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC--CceecCCCCCceEEcc-CCcEEEE
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN--KVIHRDIKGQNVLLTD-NAEVKLV  202 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--givHrDLkp~NILl~~-~~~vkL~  202 (463)
                         ....+.+|.|++..|+|+.|+++.+  .++...++.|++||+.||.|||++  -|||||||.+||+|+. .|.|||+
T Consensus       114 ---~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  114 ---DNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             ---CCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence               3467999999999999999998766  688899999999999999999998  4999999999999975 5899999


Q ss_pred             ecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hhhhhcccCCC
Q psy7384         203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIPRNA  281 (463)
Q Consensus       203 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~  281 (463)
                      |+|||+.+.....  ...+|||.|||||++      ...|++.+||||||+++.||.|+..||..-.. .+.+.++..+.
T Consensus       189 DLGLAtl~r~s~a--ksvIGTPEFMAPEmY------EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi  260 (632)
T KOG0584|consen  189 DLGLATLLRKSHA--KSVIGTPEFMAPEMY------EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI  260 (632)
T ss_pred             chhHHHHhhcccc--ceeccCccccChHHH------hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC
Confidence            9999998876433  447899999999998      57799999999999999999999999966554 45555666777


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .|.-...--.+++++||.+||.. ...|+|+.|||+||||...
T Consensus       261 KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  261 KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            66655555578999999999999 9999999999999999864

>KOG0197|consensus

Probab=100.00  E-value=2.3e-45  Score=360.38  Aligned_cols=249  Identities=24%  Similarity=0.439  Sum_probs=215.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ...+++++.||+|-||.||+|.+..+ ..||+|.+....-..+.+.+|+++|++| +|+|||++++++.      .++-+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~------~~~pi  276 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCT------KQEPI  276 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEe------cCCce
Confidence            34567889999999999999998743 3699999987767778888999999999 8999999999994      44579


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      ||||||+..|+|.++++...+..+...+...++.|||+|++||+++++|||||-..||||+++..+||+|||||+.....
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            99999999999999999867778999999999999999999999999999999999999999999999999999955432


Q ss_pred             cCc-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         214 IGR-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       214 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ... .....-...|.|||.+.     ...++.++|||||||+||||+| |+.||.+.+..+.+..+.++... ..+..+|
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~-----~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl-p~P~~CP  430 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALN-----YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL-PRPEGCP  430 (468)
T ss_pred             ceeecCCCCCCceecCHHHHh-----hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC-CCCCCCC
Confidence            211 11111244699999998     5679999999999999999998 89999999999999888777653 3455799


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHh
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLL  316 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l  316 (463)
                      +++.+++..||..+|++|||++.+.
T Consensus       431 ~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  431 DEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHH
Confidence            9999999999999999999999654

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-44  Score=341.13  Aligned_cols=254  Identities=54%  Similarity=0.995  Sum_probs=217.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|++.+.||+|+||.||+|++..++..+++|.+..... ...+.+|+.+++.+ +|+||+++++.+.      .....
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~------~~~~~   73 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-DSPYIVKYYGSYF------KNTDL   73 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-CCCcEeeeeeeee------cCCcE
Confidence            3569999999999999999999998899999999875533 67889999999999 8999999999984      44789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+++||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999999999986533 46899999999999999999999999999999999999999999999999998877554


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCCCCH
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKWPK  292 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~  292 (463)
                      ........++..|+|||++.     +..++.++||||||||+|+|++|++||...........+........ ....++.
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQ-----EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSP  227 (256)
T ss_pred             ccccccccCCccccCHHHHh-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCH
Confidence            33334456889999999986     45688899999999999999999999987766555544433332222 2345778


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      .+.+||.+||..||.+|||+.++|.||||
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0596|consensus

Probab=100.00  E-value=4.2e-45  Score=356.64  Aligned_cols=265  Identities=23%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEee---cCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...+..|+++++||.||.+.||++.....+ .+|+|.+.   .+......+.+||..|.+|..|.+||+||++-+     
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----  430 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----  430 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----
Confidence            345678999999999999999999876544 45555443   233445678999999999999999999999874     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                       .++.+|+||||=+. +|..+|+.... ..+.-.++.|.+|||.|+.++|.+||||.||||.|+|+- .|.+||+|||+|
T Consensus       431 -~d~~lYmvmE~Gd~-DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA  506 (677)
T KOG0596|consen  431 -TDGYLYMVMECGDI-DLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIA  506 (677)
T ss_pred             -cCceEEEEeecccc-cHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechh
Confidence             35899999998654 99999986653 344448999999999999999999999999999999995 678999999999


Q ss_pred             cccccccC--ccccccCCccccccceeccCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhccc
Q psy7384         208 AQLDRTIG--RRNTFIGTPYWMAPEVIACDENP------DATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIP  278 (463)
Q Consensus       208 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~------~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~  278 (463)
                      ..+.....  .....+||+.||+||.+......      .-..+.++||||||||||+|+.|++||...... ..+..|.
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~  586 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT  586 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence            87754322  23456899999999999754322      223578999999999999999999999765532 2233332


Q ss_pred             CCCCCCCCCCCC--CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         279 RNAPPRLKSKKW--PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       279 ~~~~~~~~~~~~--~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      .. ...+..+.+  ..++.++++.||.+||++||++.++|+|||++-.+.
T Consensus       587 ~P-~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i  635 (677)
T KOG0596|consen  587 DP-NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI  635 (677)
T ss_pred             CC-CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence            22 111122222  224999999999999999999999999999986443

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-44  Score=348.54  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=204.3

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|++..+|..||+|.+....   .....+.+|+.+++.+ +|+||+++++++      .....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~------~~~~~   73 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVL------HSDKK   73 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHh------ccCCc
Confidence            4899999999999999999999999999999986432   2235677899999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+|+||+.+ +|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        74 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          74 LTLVFEYCDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             eEEEEecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            9999999975 7888776533 3689999999999999999999999999999999999999999999999999886654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCchhhhhccc-------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD-LHPMRALFLIP-------------  278 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~-------------  278 (463)
                      .........+++.|+|||++.+    ...++.++|||||||++|+|++|..||.. .+....+..+.             
T Consensus       152 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07839         152 PVRCYSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG  227 (284)
T ss_pred             CCCCcCCCccccCCcChHHHhC----CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence            3333344568899999999863    34578899999999999999999888643 33222211110             


Q ss_pred             -----CCC-CC--------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         279 -----RNA-PP--------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       279 -----~~~-~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                           ... .+        ....+.+++++++||.+||..||.+|||++++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                 000 00        00123567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG2345|consensus

Probab=100.00  E-value=1.2e-44  Score=322.04  Aligned_cols=262  Identities=27%  Similarity=0.399  Sum_probs=215.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..+||.+.+.||+|||+.||+++...++..+|+|.+... ..+.+...+|++..+++ +||||+++++..+.... ....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~-D~~~   96 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEK-DGKH   96 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhc-cCce
Confidence            457999999999999999999999999999999888644 46778889999999999 89999999998876532 2346


Q ss_pred             eEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEccCCcEEEEecccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ..||+++|...|+|.+.+...+  +..+++.++..|+.+|++||++||+..  ++||||||.|||+++.+.++|.|||.+
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            7999999999999999987654  457999999999999999999999998  999999999999999999999999998


Q ss_pred             ccccccc---------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hhhh-hc
Q psy7384         208 AQLDRTI---------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRAL-FL  276 (463)
Q Consensus       208 ~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~~-~~  276 (463)
                      +...-..         ........|..|+|||.+....  ....+.++|||||||+||+|+.|..||...-. -..+ ..
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~--~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS--HCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheeccc--CcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            7653211         1122345789999999997643  56789999999999999999999999953211 1111 12


Q ss_pred             ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       277 i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.......+....+++.+.+||++||+.||.+||++.+++.+
T Consensus       255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            223233334445689999999999999999999999999874

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.9e-44  Score=346.06  Aligned_cols=257  Identities=49%  Similarity=0.898  Sum_probs=218.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..|+.++.||.|+||.||+|.+..++..||+|++....  .....+.+|+.+++.+ +|+||+++++.+      .....
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~   76 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSY------LKGTK   76 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE------EECCE
Confidence            45888999999999999999999999999999987543  3456788899999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++...   .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            99999999999999998642   588999999999999999999999999999999999999999999999999876654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........++..|+|||++.     ...++.++|+|||||++|+|++|.+||.+.........+.....+. ....++.
T Consensus       154 ~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  227 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEVIQ-----QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT-LTGEFSK  227 (277)
T ss_pred             CccccccccCcccccCHhHhc-----cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC-CchhhhH
Confidence            333334456888999999986     4567889999999999999999999998877666555544333332 2335678


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      .+.+||.+||..+|.+||+++++++|+||.+...+
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            89999999999999999999999999999876554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.5e-44  Score=346.49  Aligned_cols=254  Identities=30%  Similarity=0.522  Sum_probs=209.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++....   ...+.+.+|+.+++.+ +|+||+++++++      ....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~------~~~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVF------RRKR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEE------eeCC
Confidence            36999999999999999999999999999999886432   2335677899999999 799999999998      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+++||||+++++|..++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus        74 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          74 KLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             EEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecC
Confidence            899999999998888776543  368999999999999999999999999999999999999999999999999998765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-----------  280 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  280 (463)
                      ..........++..|+|||++.+    ...++.++|||||||++|+|++|.+||.+....+....+...           
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVG----DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             CCcccccCcccccccCCHHHHhC----CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            44333344568899999999863    345788999999999999999999999877654433321100           


Q ss_pred             ----------CCCCC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 ----------APPRL--------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 ----------~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                ..+..        ....++..+.+||.+||..+|++|||+.|++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                      00000        013467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.8e-44  Score=339.00  Aligned_cols=253  Identities=29%  Similarity=0.570  Sum_probs=217.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||++++..+|+.||+|.+...   ......+.+|+.+++++ +|+||+++++.+      ...+.
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~   73 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESF------EENGN   73 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeee------cCCCe
Confidence            489999999999999999999999999999998642   33446788999999999 899999999998      55579


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            99999999999999999765555689999999999999999999999999999999999999999999999999876654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........|++.|+|||++.     +..++.++|+|||||++|+|++|..||...........+.....+. ....++.
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  227 (256)
T cd08218         154 TVELARTCIGTPYYLSPEICE-----NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP-VSSHYSY  227 (256)
T ss_pred             chhhhhhccCCccccCHHHhC-----CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC-CcccCCH
Confidence            333333456889999999986     4567889999999999999999999998776655555544444332 2346788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ++.++|.+||+.+|.+||++.++++||||
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         228 DLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.2e-44  Score=345.72  Aligned_cols=253  Identities=28%  Similarity=0.508  Sum_probs=217.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++.+.||+|+||.||++.+..+++.||+|++...    ......+.+|+++++++ +||||+++++.+      ...+
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~   74 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSF------QDDS   74 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEE------EcCC
Confidence            599999999999999999999999999999998643    23456778899999999 799999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++....
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            8999999999999999997653  68999999999999999999999999999999999999999999999999988765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ..   ....+|++.|+|||.+.     ...++.++||||||+++|+|++|..||...........+......  ....++
T Consensus       153 ~~---~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  222 (290)
T cd05580         153 GR---TYTLCGTPEYLAPEIIL-----SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR--FPSFFS  222 (290)
T ss_pred             CC---CCCCCCCccccChhhhc-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc--CCccCC
Confidence            43   23457899999999986     456788999999999999999999999877655444444333221  233568


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         292 KKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      ..++++|.+||..||.+|+     +++++++||||....+.
T Consensus       223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence            9999999999999999999     99999999999876544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1e-43  Score=337.83  Aligned_cols=253  Identities=30%  Similarity=0.549  Sum_probs=219.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++++.||.|+||.||.+++..++..+++|.+...   ......+.+|+.+++++ +|+||+++++++      ...+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~------~~~~~   73 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHF------MDDNT   73 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEE------ecCCe
Confidence            489999999999999999999999999999988643   34456778999999999 899999999999      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +++||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus        74 ~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            99999999999999999876555789999999999999999999999999999999999999999999999999887654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........|++.|+|||++.     +..++.++|||||||++|+|++|..||......+....+....... ....++.
T Consensus       154 ~~~~~~~~~~~~~y~ape~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  227 (256)
T cd08221         154 EYSMAETVVGTPYYMSPELCQ-----GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSS  227 (256)
T ss_pred             ccccccccCCCccccCHhhcC-----CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCH
Confidence            433334567899999999987     4557888999999999999999999998877666665554443332 2356789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ++.++|.+||..+|.+||++.++++|+|+
T Consensus       228 ~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         228 ELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.7e-44  Score=349.09  Aligned_cols=253  Identities=34%  Similarity=0.582  Sum_probs=209.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|++.+.||+|+||.||++.+..++..+|+|.+....  .....+.+|+++++++ +||||++++++|      ..++.+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~~~   74 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAF------YSDGEI   74 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------eeCCEE
Confidence            5999999999999999999999999999999986432  2345678899999999 899999999999      455799


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      |+||||+++++|.+++....  .+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus        75 ~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             EEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            99999999999999997653  68999999999999999999997 6999999999999999999999999999876533


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc--------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP--------------  278 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~--------------  278 (463)
                      .  .....+|++.|+|||++.     +..++.++|||||||++|+|++|..||...........+.              
T Consensus       153 ~--~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         153 S--MANSFVGTRSYMSPERLQ-----GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             c--ccccCCCCcCccChhHhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccc
Confidence            2  124457899999999986     4567889999999999999999999996544322221111              


Q ss_pred             ----------------------CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         279 ----------------------RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       279 ----------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                            ....+......++.++++||.+||..+|++|||+.++++||||.+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                                  1111122223467889999999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.6e-44  Score=345.01  Aligned_cols=253  Identities=27%  Similarity=0.465  Sum_probs=209.7

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++++.||.|+||.||+|++..+|..||||.+....   .....+.+|+++++++ +||||+++++++      ...+..
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~~~   74 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVI------HTENKL   74 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhc------ccCCcE
Confidence            889999999999999999999999999999886432   2335788899999999 899999999998      455789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+. ++|.+++.......+++..++.++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999996 58999887666667899999999999999999999999999999999999999999999999998766543


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC-----------
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-----------  282 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----------  282 (463)
                      ........+++.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+.......+.....           
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLG----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             ccccccccccccccCCeEEec----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            333344567889999998863    34467889999999999999999999987665443332211000           


Q ss_pred             ---------CC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         283 ---------PR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       283 ---------~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                               +.       .....++.+++++|.+||+.||.+|||++++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                     00       0013467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-44  Score=362.18  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=205.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEc--CCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHT--KTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ....+|++++.||+|+||.||+|...  .++..||+|.+...    ....+|+.+|+.+ +||||++++++|      ..
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-~h~~iv~~~~~~------~~  157 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-SHRAIINLIHAY------RW  157 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-CCCCccceeeeE------ee
Confidence            34567999999999999999999764  34678999988543    2346899999999 899999999998      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+|||++. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            578999999996 5888888433  3689999999999999999999999999999999999999999999999999976


Q ss_pred             cccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh---hhhcccC-----
Q psy7384         210 LDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---ALFLIPR-----  279 (463)
Q Consensus       210 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---~~~~i~~-----  279 (463)
                      ......  ......||+.|+|||++.     ...|+.++|||||||++|+|++|..||.+.....   .+..+..     
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~  309 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLA-----LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH  309 (392)
T ss_pred             cCcccccccccccccccCccCHhHhc-----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence            643321  123457999999999997     5668899999999999999999999997654321   1110000     


Q ss_pred             ---------------------CC------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         280 ---------------------NA------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       280 ---------------------~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                                           ..      +..+....++.++++||.+||..||.+|||+.++|+||||...+.
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             ccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence                                 00      000111245678999999999999999999999999999986543

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-44  Score=339.41  Aligned_cols=257  Identities=54%  Similarity=0.997  Sum_probs=216.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .++|++.+.||.|+||.||+|.+..++..+|+|++.... .....+.+|+.+++.+ +||||+++++.+      ...+.
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~------~~~~~   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSY------LRRDK   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEE------EeCCE
Confidence            357999999999999999999999999999999987543 3456788999999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|++|||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999999987642 3689999999999999999999999999999999999999999999999999887655


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCC-CCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPR-LKSKK  289 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~-~~~~~  289 (463)
                      .........++..|+|||.+....  ...++.++|||||||++|+|++|.+||.+.+.......+....  .+. .....
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVER--KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK  231 (262)
T ss_pred             hhhccccccCCccccCchhhcccc--cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence            433445567899999999986321  1367889999999999999999999998877665554443331  111 12235


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPF  320 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  320 (463)
                      ++.++++||++||..+|..|||+.+++.|+|
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            6788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-44  Score=342.14  Aligned_cols=258  Identities=42%  Similarity=0.848  Sum_probs=219.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhc--CCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++.+.||+|+||.||+|.+..++..||+|.+...  ......+.+|+.+++.+.  .||||+++++.+      ....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~------~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY------LKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee------eeCC
Confidence            488889999999999999999999999999998643  344567889999999984  399999999998      3457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.+++|.+++...   .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            899999999999999998643   68999999999999999999999999999999999999999999999999988775


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ..........|+..|+|||.+..    +..++.++|+|||||++|+|++|.+||.+.........+.....+......++
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITE----GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS  228 (277)
T ss_pred             CCccccccccCCcceeCHHHhcc----CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCC
Confidence            54433445578999999998853    34578899999999999999999999988766655555444444444444578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      .++.+|+.+||..||.+||++.+++.|+||++...
T Consensus       229 ~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            89999999999999999999999999999986543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0193|consensus

Probab=100.00  E-value=6.5e-45  Score=359.24  Aligned_cols=259  Identities=29%  Similarity=0.503  Sum_probs=219.1

Q ss_pred             CCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeeccc
Q psy7384          44 WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGA  120 (463)
Q Consensus        44 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~  120 (463)
                      +....| +...+...+...||+|+||+||+|+|..   .||||++..   +....+.|++|+.+|++- +|.||+-+.|+
T Consensus       382 ~s~~~W-eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~  456 (678)
T KOG0193|consen  382 DSLEEW-EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGA  456 (678)
T ss_pred             cccccc-ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehh
Confidence            444444 5666778899999999999999999974   499999974   445678899999999999 89999999999


Q ss_pred             ccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEE
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK  200 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vk  200 (463)
                      +..       ..+.||.-+|+|.+|+.+++... ..|.....+.|++||++|+.|||.++|||||||..||++.++++||
T Consensus       457 ~~~-------p~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  457 CMN-------PPLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             hcC-------CceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEE
Confidence            953       34499999999999999998654 4688999999999999999999999999999999999999999999


Q ss_pred             EEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc
Q psy7384         201 LVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       201 L~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  278 (463)
                      |+||||+.....-.  .......|...|||||+++...  ..+|++.+|||||||++|||++|..||........++.+.
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd--~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG  606 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQD--DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG  606 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcc--cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec
Confidence            99999987653221  1123345788899999998433  6789999999999999999999999999777777788887


Q ss_pred             CC---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         279 RN---APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       279 ~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ++   .........+++++++|+..||..++++||.+.+||.
T Consensus       607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            77   3333445678899999999999999999999999876

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.9e-44  Score=346.94  Aligned_cols=258  Identities=27%  Similarity=0.421  Sum_probs=212.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc------hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED------EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+.....      ....+..|+.+++.+ +|+||+++++++      ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~------~~   73 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVF------GH   73 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhhee------ec
Confidence            48899999999999999999999999999999874422      244567899999999 799999999999      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+ +++|.+++.... ..+++..++.++.||++||.|||++||+|+||||+|||++.++.++|+|||++..
T Consensus        74 ~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          74 KSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             CCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            57899999999 889999997543 3689999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--------  281 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  281 (463)
                      ............+++.|+|||.+..    ...++.++|||||||++|+|++|.+||.+.++...+..+....        
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         152 FGSPNRKMTHQVVTRWYRAPELLFG----ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW  227 (298)
T ss_pred             ccCCCccccccccceeeeCHHHHhC----CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence            6554333344467889999998852    3457889999999999999999999998766544332221100        


Q ss_pred             ------------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         282 ------------------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       282 ------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                                        .........+..+.+||.+||.++|++|||+.+++.|+||++.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                              000011345678999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-43  Score=339.05  Aligned_cols=255  Identities=44%  Similarity=0.757  Sum_probs=215.6

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|++.+.||.|+||+||+|.+..++..+|+|++....  .....+.+|+.+++.+ +|+||+++++.+      ...+..
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~   74 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSF------VVGDEL   74 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEE------eeCCEE
Confidence            5999999999999999999998899999999986432  3457788999999998 899999999988      445789


Q ss_pred             EEEEecCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKG-QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      |+||||+.+++|.+++..... ..+++..++.++.||+.||.|||+.||+||||+|+||++++++.++|+|||++..+..
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            999999999999999976543 4689999999999999999999999999999999999999999999999999876654


Q ss_pred             ccCc----cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC-
Q psy7384         213 TIGR----RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-  287 (463)
Q Consensus       213 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-  287 (463)
                      ....    .....|+..|+|||++..    ...++.++|+|||||++|+|++|..||...+.......+.....+.... 
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~----~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQ----VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG  230 (267)
T ss_pred             CccccccccccccCChhhcChHHHcc----ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCc
Confidence            3221    234468999999999863    2367889999999999999999999998776655554443333322221 


Q ss_pred             ---CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         288 ---KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       288 ---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                         ..++..+.+||.+||..||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               3567899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-44  Score=357.15  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=198.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      ..|++++.||+|+||.||+|++..++..||+|+....     ....|+.+++.+ +|+||+++++++.      ..+..|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~------~~~~~~  133 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-NHPSVIRMKDTLV------SGAITC  133 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-CCCCCcChhheEE------eCCeeE
Confidence            4699999999999999999999999999999985432     234689999999 8999999999984      457889


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       134 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             EEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            9999996 58888886533 46899999999999999999999999999999999999999999999999998754322 


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCch---------hhhhcccC---CC
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP-LCDLHPM---------RALFLIPR---NA  281 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~P-f~~~~~~---------~~~~~i~~---~~  281 (463)
                      .......||+.|+|||++.     ...++.++|||||||++|||+++..| |......         ..+..+..   ..
T Consensus       211 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~  285 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLA-----RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH  285 (357)
T ss_pred             cccccccccccccCCeecC-----CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence            1223457999999999997     56789999999999999999985444 4332111         00000000   00


Q ss_pred             C-----------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 P-----------------------------PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 ~-----------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +                             .......++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            0                             00111245677888999999999999999999999999975

>KOG0986|consensus

Probab=100.00  E-value=2.9e-45  Score=350.09  Aligned_cols=266  Identities=27%  Similarity=0.405  Sum_probs=224.5

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      +....+.|..-++||+|+||.|+-|+.+.||+.+|+|.+...    ........+|-.+|.++ +.+.||.+--+|    
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAf----  254 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAF----  254 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeee----
Confidence            344556799999999999999999999999999999987532    23345567899999999 799999999999    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                        +..+.+||||..|.||+|.-.|...++..+++..++.|+.+|+.||.+||+.+||+|||||+|||+|+.|+|.|+|+|
T Consensus       255 --eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  255 --ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             --cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccc
Confidence              666899999999999999988888777789999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh---hhcccCCCC
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA---LFLIPRNAP  282 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~---~~~i~~~~~  282 (463)
                      ||..+.... .....+||.+|||||++.     +..|+.+.|.|||||+||||+.|+.||........   +....... 
T Consensus       333 LAvei~~g~-~~~~rvGT~GYMAPEvl~-----ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-  405 (591)
T KOG0986|consen  333 LAVEIPEGK-PIRGRVGTVGYMAPEVLQ-----NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-  405 (591)
T ss_pred             eEEecCCCC-ccccccCcccccCHHHHc-----CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-
Confidence            999876543 334458999999999998     66799999999999999999999999965433222   22211222 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchhHH
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTERQ  329 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~~~  329 (463)
                      +...+..+++++++|.+.+|.+||.+|..     ++++.+||||++..+.+.
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence            22234789999999999999999999965     679999999998777654

>KOG4236|consensus

Probab=100.00  E-value=2.2e-45  Score=355.91  Aligned_cols=258  Identities=28%  Similarity=0.513  Sum_probs=222.4

Q ss_pred             CCCceEEE--eeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          53 PAGIFELI--EVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        53 ~~~~y~~~--~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +..-|+|.  +.||.|-||+||-|+++.+|+.||||+|.+   .......+++|+.||+.+ .||.||.+-..|      
T Consensus       560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~------  632 (888)
T KOG4236|consen  560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMF------  632 (888)
T ss_pred             HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEee------
Confidence            34455553  799999999999999999999999999963   345668899999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC---CcEEEEec
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN---AEVKLVDF  204 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~---~~vkL~DF  204 (463)
                      +..+.+|+|||.+.| +..++|.......|++...+.++.||+.||.|||-+||+|+||||+|||+.+.   -.+|||||
T Consensus       633 ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  633 ETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             cCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence            666899999999965 66666666666689999999999999999999999999999999999999654   46999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      |+|+.+.+.. .+.+.+|||.|+|||+++     +..|+.+-||||+|||+|.-|.|..||....+.....+...--.|.
T Consensus       712 GfARiIgEks-FRrsVVGTPAYLaPEVLr-----nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp  785 (888)
T KOG4236|consen  712 GFARIIGEKS-FRRSVVGTPAYLAPEVLR-----NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPP  785 (888)
T ss_pred             cceeecchhh-hhhhhcCCccccCHHHHh-----hccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCC
Confidence            9999998653 445678999999999998     7889999999999999999999999997766655444443444455


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .....++.++.+||..+|+..-.+|.++++.|.|||+++-
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            5567889999999999999999999999999999999864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.8e-44  Score=346.82  Aligned_cols=261  Identities=26%  Similarity=0.409  Sum_probs=209.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....   .....+.+|+.+++.+.+|+||+++++++..... .....
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-~~~~~   80 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK-NGKPS   80 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC-CCCce
Confidence            5999999999999999999999999999999886432   2235678899999999767999999998854321 11234


Q ss_pred             EEEEEecCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEeccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK---GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSA  208 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~  208 (463)
                      .|+||||+.+ +|.+++....   ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999986 8888876543   236899999999999999999999999999999999999998 8899999999987


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-------
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-------  281 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------  281 (463)
                      .............+++.|+|||++..    ...++.++|||||||++|+|++|.+||.+.++...+..+....       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLG----STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhC----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            66443333344467889999998863    3457889999999999999999999998876655443221100       


Q ss_pred             ------------CC-------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         282 ------------PP-------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       282 ------------~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                                  .+       ....+.++.++.+||.+||..||.+||++++++.||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                        00       001135788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-43  Score=339.82  Aligned_cols=251  Identities=35%  Similarity=0.675  Sum_probs=211.3

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc----------hHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED----------EEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      +|.+...||+|+||.||+|.+..++..+|+|.+.....          ..+.+.+|+.+++++ +||||+++++++    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSS----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEE----
Confidence            36778999999999999999998999999998864321          124677899999999 899999999998    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                        ...+..++||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||+|+||++++++.++|+|||
T Consensus        76 --~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          76 --LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             --EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccC
Confidence              44578999999999999999997643  68899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccc------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         206 VSAQLDRTI------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       206 la~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      +++......      .......|+..|+|||.+.     ...++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  226 (267)
T cd06628         152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK-----QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE  226 (267)
T ss_pred             CCcccccccccCCccccccccCCCcCccChhHhc-----cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence            987664211      1112346889999999986     55678899999999999999999999988766655554444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       280 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ...+.. ...++..+.++|++||+.||.+||++.++++||||
T Consensus       227 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 NASPEI-PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cCCCcC-CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            333222 34678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0671|consensus

Probab=100.00  E-value=1.8e-45  Score=345.88  Aligned_cols=259  Identities=22%  Similarity=0.371  Sum_probs=216.5

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-----ceeeecccccccC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-----NIATYYGAFIKKS  125 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-----nIv~l~~~~~~~~  125 (463)
                      +...++|+++..||+|+||.|..|.+..++..||||+++....-.+....|+++|+++..+.     -+|.+.++|    
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF----  160 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF----  160 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence            34478999999999999999999999999999999999877777788889999999995332     488888888    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc----------
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD----------  195 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~----------  195 (463)
                        +-.+++|||+|.+ |-|++|++...+..+++...++.|++||+++++|||+.+++|.||||+|||+.+          
T Consensus       161 --dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  161 --DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             --hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence              6668999999998 569999999888889999999999999999999999999999999999999842          


Q ss_pred             ----------CCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7384         196 ----------NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL  265 (463)
Q Consensus       196 ----------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  265 (463)
                                +..|+|+|||.|+...+..   +..+.|..|+|||+++     +-+++.++||||+||||+||++|...|
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViL-----gLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVIL-----GLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchhee-----ccCcCCccCceeeeeEEEEeeccceec
Confidence                      2358999999998776543   6678999999999999     678999999999999999999999999


Q ss_pred             CCCCchhhh---hcccCCCCCCCCC-----------------------------------------CCCCHHHHHHHHHh
Q psy7384         266 CDLHPMRAL---FLIPRNAPPRLKS-----------------------------------------KKWPKKFQSFIETV  301 (463)
Q Consensus       266 ~~~~~~~~~---~~i~~~~~~~~~~-----------------------------------------~~~~~~~~~li~~~  301 (463)
                      +..++.+.+   ..|....+.....                                         +.--..+.+||++|
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            877655532   2222211100000                                         00012578999999


Q ss_pred             hhcCCCCCCCHHHHhcCccccCC
Q psy7384         302 LVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       302 L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      |..||.+|+|+.|+|.||||+..
T Consensus       390 L~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  390 LEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HccCccccccHHHHhcCHHhhcC
Confidence            99999999999999999999753

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-43  Score=338.82  Aligned_cols=254  Identities=34%  Similarity=0.620  Sum_probs=208.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc------chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .|++.+.||+|+||.||+|.+..++..||+|++....      .....+.+|+.+++.+ +|+||+++++.+..    ..
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~   77 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRD----RA   77 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEc----CC
Confidence            4888999999999999999999999999999886331      2235678899999999 79999999998743    22


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...++++|||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            468899999999999999997544  588999999999999999999999999999999999999999999999999876


Q ss_pred             ccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         210 LDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       210 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      +....   .......++..|+|||++.     ...++.++|||||||++|+|++|.+||...........+.........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVIS-----GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL  230 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhC-----CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCC
Confidence            53211   1112345889999999986     456788999999999999999999999877655555443332222222


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ...+++.+++|| +||..+|.+||+++++++||||+
T Consensus       231 ~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         231 PSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             chhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            345678899999 67778999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-44  Score=345.74  Aligned_cols=253  Identities=52%  Similarity=0.941  Sum_probs=214.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+....  .....+.+|+.+++++ +|+||+++++.+      ...+.
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~   76 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSY------LKGTK   76 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccc------ccCCc
Confidence            35788899999999999999999999999999987432  3445788999999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++..   ..+++..++.++.||+.||.|||++||+|+||+|+||++++++.++|+|||++..+..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            9999999999999998854   3588999999999999999999999999999999999999999999999999877654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........|+..|+|||++.     ...++.++|+|||||++|+|++|..||...........+.....+.. ...++.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  227 (277)
T cd06642         154 TQIKRNTFVGTPFWMAPEVIK-----QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL-EGQYSK  227 (277)
T ss_pred             cchhhhcccCcccccCHHHhC-----cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCC-CcccCH
Confidence            333333456889999999987     45678899999999999999999999987665555544433333322 235678


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .+.++|.+||..+|.+||++.++++||||..
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         228 PFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            9999999999999999999999999999964

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-44  Score=365.10  Aligned_cols=252  Identities=22%  Similarity=0.324  Sum_probs=201.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ....|.+.+.||+|+||.||+|.+..+++.||||....     ..+.+|+.+|+++ +|+|||++++++.      ..+.
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L-~HpnIv~l~~~~~------~~~~  234 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRL-SHPAVLALLDVRV------VGGL  234 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHC-CCCCCCcEEEEEE------ECCE
Confidence            35579999999999999999999999999999996432     3456899999999 8999999999984      4478


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|||||++. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       235 ~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        235 TCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            999999995 58888886543 3689999999999999999999999999999999999999999999999999976543


Q ss_pred             ccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-------hhhhhcccCC-C-
Q psy7384         213 TIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-------MRALFLIPRN-A-  281 (463)
Q Consensus       213 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~-~-  281 (463)
                      ...  .....+||+.|+|||++.     +..++.++|||||||+||||++|..|+.....       ...+..+... . 
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~-----~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLA-----GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV  387 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHc-----CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence            211  123457999999999997     56689999999999999999998766533211       0111111000 0 


Q ss_pred             -------------------------CCCCCC------CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -------------------------PPRLKS------KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -------------------------~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                               .+....      ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                     000000      134568999999999999999999999999999964

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-43  Score=336.90  Aligned_cols=254  Identities=34%  Similarity=0.624  Sum_probs=210.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc------chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .|++.+.||+|+||.||+|++..+|..||+|.+....      .....+.+|+.+++++ +|+||+++++++..    ..
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~   77 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRD----PM   77 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEecc----CC
Confidence            5899999999999999999999999999999885321      2245678899999999 89999999998742    12


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+++++|.+++....  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            357899999999999999987543  578999999999999999999999999999999999999999999999999876


Q ss_pred             ccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         210 LDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       210 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      .....   .......|+..|+|||++.     +..++.++|||||||++|+|++|+.||...........+.........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVIS-----GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL  230 (265)
T ss_pred             cccccccccccccCCCCccccChhhhc-----CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCC
Confidence            53211   1223346889999999986     456788999999999999999999999877655555444333222223


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ....+..+.++|.+||. +|++||+++++++|||+.
T Consensus       231 ~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         231 PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            44667889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.3e-43  Score=340.39  Aligned_cols=261  Identities=35%  Similarity=0.622  Sum_probs=211.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|++.+.||+|+||.||+|++..+|+.||+|.+....  .....+..|+.++.+..+||||+++++.+      ...+..
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~------~~~~~~   75 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL------FREGDV   75 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE------ecCCcE
Confidence            5899999999999999999999999999999987542  23445666777655555899999999998      345689


Q ss_pred             EEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      |+||||++ |+|.+++...  ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999997 5888887653  234689999999999999999999997 9999999999999999999999999998866


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-chhhhhcccCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH-PMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .... ......|+..|+|||++.+... ...++.++|+|||||++|+|++|..||.... ....+..+.....+......
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         155 VDSV-AKTIDAGCKPYMAPERINPELN-QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             cccc-ccccccCCccccChhhcCCccc-ccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence            4322 1233468899999998864211 2557889999999999999999999996532 23333333333344444456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ++.++.+||.+||..+|.+||+++++++||||....
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            889999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0586|consensus

Probab=100.00  E-value=1.8e-44  Score=357.93  Aligned_cols=257  Identities=27%  Similarity=0.475  Sum_probs=220.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---HHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...+.|.+++.||+|.|+.|.+|++..++..||||+++.+..+   ...+.+|+++|+.+ +|||||+++.+.      +
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~------~  125 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVI------E  125 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeee------e
Confidence            3456799999999999999999999999999999999865433   34578999999999 899999999998      5


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||||+.+|.+++++....  .+.+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++.
T Consensus       126 t~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  126 TEATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             ecceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccce
Confidence            5689999999999999999997665  57779999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      +++.. ....++||++.|.|||++.+    ...-++.+|+||+|++||.|++|.+||.+.+-...-.....+...  .+-
T Consensus       204 ~~~~~-~~lqt~cgsppyAaPEl~~g----~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~  276 (596)
T KOG0586|consen  204 FFDYG-LMLQTFCGSPPYAAPELFNG----KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPF  276 (596)
T ss_pred             eeccc-ccccccCCCCCccChHhhcC----cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccc
Confidence            88743 45577899999999999985    334467899999999999999999999887655444333333221  122


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .++.++.++|+++|..+|.+|++++++..|.|+...
T Consensus       277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence            467789999999999999999999999999998743

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-43  Score=341.49  Aligned_cols=254  Identities=23%  Similarity=0.444  Sum_probs=210.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|.+..+|..||+|++....   .....+.+|+.+++.+ +|+||+++++++      .....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~~   73 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVF------PHGSG   73 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEE------ecCCe
Confidence            4899999999999999999999999999999987432   3356788999999999 799999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus        74 ~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          74 FVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             eEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            99999999 999999987544 4699999999999999999999999999999999999999999999999999887654


Q ss_pred             ccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC----------
Q psy7384         213 TIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA----------  281 (463)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  281 (463)
                      ... ......|+..|+|||.+..    ...++.++|||||||++|+|++|.+||.+..+...+..+....          
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYG----ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             CCCCccccccCcccccCceeeec----cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence            321 2334578999999999863    3456889999999999999999999997766544332211100          


Q ss_pred             -----------CCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         282 -----------PPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       282 -----------~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                                 .+.       ......+..+.+||.+||..+|.+|||++++|+||||.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                       000       01124568999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0666|consensus

Probab=100.00  E-value=9.1e-45  Score=332.02  Aligned_cols=260  Identities=26%  Similarity=0.471  Sum_probs=207.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCc----EEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .|++++.||+|+||.||+|..++++.    .+|||.++...   .......+|+.+++.+ +||||+.+..+|+.     
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~-----   98 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLS-----   98 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhc-----
Confidence            48999999999999999997665543    78999987542   2335667999999999 89999999999974     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC----CcEEE
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTK---GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN----AEVKL  201 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~----~~vkL  201 (463)
                      .+..++|++||++. +|+.+|+...   ...++...++.|+.||+.|+.|||++=|+||||||.||||..+    |.|||
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence            35799999999988 8999887543   3468899999999999999999999999999999999999877    99999


Q ss_pred             EecccccccccccCcc---ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-------
Q psy7384         202 VDFGVSAQLDRTIGRR---NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------  271 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-------  271 (463)
                      +|||+++.+.......   ...+-|.||+|||.+++    ...|+.++|||++|||+.|||+..|.|.+....       
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG----a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG----ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcc----cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            9999999887654332   34568999999999986    567999999999999999999999999654211       


Q ss_pred             --hhh---hcccCCC----------CCCC-------C---------------CCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q psy7384         272 --RAL---FLIPRNA----------PPRL-------K---------------SKKWPKKFQSFIETVLVKDYHQRPYTDQ  314 (463)
Q Consensus       272 --~~~---~~i~~~~----------~~~~-------~---------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e  314 (463)
                        +++   +.+....          .|..       .               ...-++...+|+.+||+.||.+|.|+++
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q  333 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ  333 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence              111   1111100          0000       0               0112345788999999999999999999


Q ss_pred             HhcCccccCCch
Q psy7384         315 LLKHPFIRDQPT  326 (463)
Q Consensus       315 ~l~hp~~~~~~~  326 (463)
                      +|+|+||++.+.
T Consensus       334 Aleh~yF~~d~l  345 (438)
T KOG0666|consen  334 ALEHPYFTEDPL  345 (438)
T ss_pred             HhcccccccCCC
Confidence            999999987643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.9e-44  Score=357.34  Aligned_cols=255  Identities=24%  Similarity=0.430  Sum_probs=205.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCC-----cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTG-----QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      -..++|++.+.||+|+||.||+|++...|     ..||+|++....  .....+.+|+.+++.+.+|+||+++++++   
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~---  111 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC---  111 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe---
Confidence            44567999999999999999999875443     579999986432  33456788999999987799999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhC---------------------------------------------------
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTK---------------------------------------------------  153 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------  153 (463)
                         ...+.+|+||||+.+|+|.+++....                                                   
T Consensus       112 ---~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         112 ---THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             ---cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence               45578999999999999999986431                                                   


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC-
Q psy7384         154 -----------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG-  215 (463)
Q Consensus       154 -----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-  215 (463)
                                       ...+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++....... 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                             12477888999999999999999999999999999999999999999999999876543211 


Q ss_pred             -ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         216 -RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       216 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                       ......+++.|+|||++.     ...++.++|||||||++|+|++ |..||.........................+.+
T Consensus       269 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (374)
T cd05106         269 VVKGNARLPVKWMAPESIF-----DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE  343 (374)
T ss_pred             eeccCCCCccceeCHHHhc-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence             111223566799999986     5678999999999999999997 999998765544443333332222233456889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +.++|.+||+.||.+|||++++++
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.6e-44  Score=343.91  Aligned_cols=253  Identities=30%  Similarity=0.508  Sum_probs=209.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....   ...+.+.+|+++++.+ +||||+++++++      ...+.
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~   74 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVF------RRKKR   74 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhc------ccCCe
Confidence            6999999999999999999999899999999875332   2345677899999999 899999999999      45678


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.++....  ..+++..++.++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            99999999999888877543  2589999999999999999999999999999999999999999999999999887654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-------------  279 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-------------  279 (463)
                      .........++..|+|||++.+    ...++.++|||||||++|+|++|.+||...........+..             
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVG----DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             CccccCcccceeeccCcHHhcc----ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            4333445678999999999863    34577889999999999999999999976654332221110             


Q ss_pred             --------CCCCC--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         280 --------NAPPR--------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       280 --------~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                              ...+.        ...+.++..+.+||.+||..+|.+||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                    00000        0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-43  Score=347.10  Aligned_cols=250  Identities=25%  Similarity=0.423  Sum_probs=193.7

Q ss_pred             eeeeeeCCeEEEEEEEcC--CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          61 EVVGNGTYGQVYKGRHTK--TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      .+||+|+||.||+|++..  ++..||+|.+.... ....+.+|+.+|+.+ +||||+++++++..    .....+|+|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLREL-KHPNVIALQKVFLS----HSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhC-CCCCeeeEEEEEec----cCCCeEEEEEe
Confidence            689999999999999754  56789999886443 234677899999999 89999999998854    23468899999


Q ss_pred             cCCCCCHHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE----ccCCcEEEEecccc
Q psy7384         139 YCGAGSVTDLVKST-------KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL----TDNAEVKLVDFGVS  207 (463)
Q Consensus       139 ~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl----~~~~~vkL~DFGla  207 (463)
                      |+.+ +|.+++...       ....+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9875 788877532       12358899999999999999999999999999999999999    45678999999999


Q ss_pred             cccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh---------hh
Q psy7384         208 AQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA---------LF  275 (463)
Q Consensus       208 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~---------~~  275 (463)
                      +.......   ......||+.|+|||++.+    ...++.++|||||||++|+|++|.+||........         +.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD  235 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcC----CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence            87643321   2234578999999999863    34578899999999999999999999965332100         00


Q ss_pred             ---cccC-------------------------CCC--------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy7384         276 ---LIPR-------------------------NAP--------PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHP  319 (463)
Q Consensus       276 ---~i~~-------------------------~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  319 (463)
                         ....                         ...        ........+..+.+||.+||..||.+|||++|+|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp  315 (317)
T cd07867         236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP  315 (317)
T ss_pred             HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence               0000                         000        0000112356788999999999999999999999999


Q ss_pred             cc
Q psy7384         320 FI  321 (463)
Q Consensus       320 ~~  321 (463)
                      ||
T Consensus       316 ~f  317 (317)
T cd07867         316 YF  317 (317)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4721|consensus

Probab=100.00  E-value=9.6e-45  Score=354.25  Aligned_cols=237  Identities=29%  Similarity=0.536  Sum_probs=211.6

Q ss_pred             EEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      -++-||.|+.|-||+|+..  ++.||||.++      +.-..+|+-|++| +|+||+.+.++|      .....+|||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkL-kH~NII~FkGVC------tqsPcyCIiME  192 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKL-KHPNIITFKGVC------TQSPCYCIIME  192 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhc-cCcceeeEeeee------cCCceeEEeee
Confidence            3577999999999999865  6789999764      2223578889999 899999999999      44578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccc
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN  218 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  218 (463)
                      ||..|-|..+|+...  .++......|.++|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++..... ....
T Consensus       193 fCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkM  269 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKM  269 (904)
T ss_pred             ccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhh
Confidence            999999999997654  7889999999999999999999999999999999999999999999999999887665 4557


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFI  298 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  298 (463)
                      .++||..|||||+|.     +.+.++++|||||||+|||||||..||.+......++-+..+...-+.+..+|+.|+-||
T Consensus       270 SFaGTVaWMAPEvIr-----nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIR-----NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             hhhhhHhhhCHHHhh-----cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence            789999999999998     778899999999999999999999999998888888777666665666778999999999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q psy7384         299 ETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       299 ~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.||+-.|..||++.++|.|
T Consensus       345 Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  345 KQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHhcCCCCCccHHHHHHH
Confidence            99999999999999999998

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-43  Score=345.71  Aligned_cols=261  Identities=28%  Similarity=0.472  Sum_probs=211.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ...|++.+.||+|+||.||+|.+..+|..||+|.+.....   ....+.+|+.+++++ +|+||+++++++..    ...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~   80 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVG----KHL   80 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEec----CCC
Confidence            4569999999999999999999999999999999864322   223456899999999 89999999999853    223


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          81 DSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             CeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            578999999975 8888887543 46899999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--------  282 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------  282 (463)
                      ...........+++.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+....+..+.....        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLG----CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CCccCCCCcccccccccChhhhcC----CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence            543333333456888999999863    34578899999999999999999999987766554432211000        


Q ss_pred             ----------CCC----------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         283 ----------PRL----------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       283 ----------~~~----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                                ...          .....++.+.+||.+||..||.+|||+++++.||||.+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                      000          0123578899999999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.1e-43  Score=336.36  Aligned_cols=251  Identities=37%  Similarity=0.670  Sum_probs=208.6

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------hHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +|++.+.||.|+||.||+|.+ .+|+.+|+|.+.....       ....+.+|+.+|+.+ +|+||+++++++      .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~   72 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTC------L   72 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEe------e
Confidence            378889999999999999986 4788999998864321       234578899999999 899999999998      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+..|+||||+.+++|.+++....  .+++..+..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++.
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          73 DDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence            5579999999999999999997543  58899999999999999999999999999999999999999999999999987


Q ss_pred             ccccc------cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-C
Q psy7384         209 QLDRT------IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-A  281 (463)
Q Consensus       209 ~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~  281 (463)
                      .....      ........|+..|+|||++.     ...++.++|||||||++|+|++|..||...+.......+... .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (265)
T cd06631         151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN-----ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG  225 (265)
T ss_pred             hhhhccccccccccccccCCCccccChhhhc-----CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence            65321      11123456899999999987     556788999999999999999999999876655444333322 1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ........++.++.+||.+||..+|.+||++.++++||||
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1122344688999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-43  Score=335.32  Aligned_cols=250  Identities=28%  Similarity=0.539  Sum_probs=214.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...  ....+.+.+|+.+++.+ +|+||+++++.+      ...+.+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESF------EADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEE------EECCEE
Confidence            489999999999999999999999999999998643  33456778899999999 899999999998      455799


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||+++++.++|+|||++......
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            99999999999999987666667899999999999999999999999999999999999999999999999998776544


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                      ........|++.|+|||++.     ...++.++|+||||+++|+|++|..||...+.......+...... .....++..
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  227 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWE-----NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYE  227 (255)
T ss_pred             ccccccccCCccccCHHHHc-----cCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHH
Confidence            33334567899999999986     456888999999999999999999999877665555544433332 233467889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.+||.+||+.||.+|||+.+++.-
T Consensus       228 ~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         228 LRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHhCCcccCCCHHHHhhc
Confidence            9999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.9e-44  Score=339.83  Aligned_cols=253  Identities=37%  Similarity=0.661  Sum_probs=213.3

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|++.+.||.|+||.||+|.+..+++.+|+|.+....  .....+.+|+.+++.+ +||||+++++.+      ...+.+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~~~   74 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAF------YNNGDI   74 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheee------ecCCEE
Confidence            5888899999999999999999999999999987542  3456788999999999 699999999998      444799


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      |+||||+.+++|.+++.... ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999999997653 478999999999999999999999 9999999999999999999999999999876643


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----chhhhhcccCCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH-----PMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~~  287 (463)
                      ....  ...++..|+|||.+.     +..++.++|||||||++|+|++|..||....     .......+.....+....
T Consensus       154 ~~~~--~~~~~~~y~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (265)
T cd06605         154 SLAK--TFVGTSSYMAPERIQ-----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS  226 (265)
T ss_pred             HHhh--cccCChhccCHHHHc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh
Confidence            3221  267899999999986     4578899999999999999999999996542     222222333333333333


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..++.++.+||.+||..||.+|||+.+++.||||+.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            348899999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.8e-43  Score=342.21  Aligned_cols=259  Identities=42%  Similarity=0.812  Sum_probs=218.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ++..+|++.+.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++.+ +||||+++++++.     
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~-----   85 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYL-----   85 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEE-----
Confidence            44567999999999999999999999999999999986322    2335678899999999 8999999999984     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                       ..+..|+||||+. |+|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||++++++.++|+|||++
T Consensus        86 -~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          86 -REHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             -eCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcc
Confidence             4468999999997 47777775433 36899999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ......    ....+++.|+|||++....  ...++.++||||||+++|+|++|.+||.+.+.......+.....+....
T Consensus       163 ~~~~~~----~~~~~~~~y~aPE~~~~~~--~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (307)
T cd06607         163 SLVSPA----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS  236 (307)
T ss_pred             eecCCC----CCccCCccccCceeeeccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCc
Confidence            765432    3456889999999985321  3557889999999999999999999998877766666655555555555


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ..++..+++||.+||..+|.+||++.+++.||||....
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            67899999999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-43  Score=341.89  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=203.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.+....  .....+.+|+.+++.+ +|+||+++++++      ...+.
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~~   77 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDII------HTKKT   77 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEE------ecCCe
Confidence            46999999999999999999999899999999986432  2234567899999999 899999999998      45579


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+ +|.+++..... .+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        78 ~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          78 LTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EEEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            9999999985 99998875443 689999999999999999999999999999999999999999999999999876533


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhcc---cCCC-------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLI---PRNA-------  281 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i---~~~~-------  281 (463)
                      .........++..|+|||++.+    ...++.++|||||||++|+|++|.+||.+.... +.+..+   ....       
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLG----STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             CCccccccccccccCCcHHhhc----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence            2222233457889999998863    345788999999999999999999999765421 111100   0000       


Q ss_pred             -----------C----CC---CCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         282 -----------P----PR---LKSKKWP--KKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       282 -----------~----~~---~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                 .    ..   .....++  ..+.++|.+||..+|.+|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                       0    00   0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0696|consensus

Probab=100.00  E-value=5.1e-45  Score=344.49  Aligned_cols=269  Identities=28%  Similarity=0.432  Sum_probs=229.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...|.++.+||+|+||+|.+|..+.+.+++|||+++.+    .++.+.-..|-++|....+-|.+++++.+|      +.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF------QT  421 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF------QT  421 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh------hh
Confidence            35688999999999999999999999999999998642    344445556777777665778999999999      56


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      -+.+|+||||+.||+|.-.++..+  .+.|..+..|+..|+-||-|||++|||+||||.+|||++.+|++||+|||+++.
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence            689999999999999998887665  688999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .--......++||||.|+|||++.     -++|+.++|+||+||+|||||.|++||.+.+..+....|......  .++.
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~-----YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs--yPKs  572 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS--YPKS  572 (683)
T ss_pred             cccCCcceeeecCCCcccccceEE-----ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--Cccc
Confidence            543334457789999999999998     578999999999999999999999999999888887777655432  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCH-----HHHhcCccccCCchhHHHHHHhHHh
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYT-----DQLLKHPFIRDQPTERQARIQLKDH  337 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~~~~~~~~~~~~~~  337 (463)
                      ++.++.++.+.+|.+.|.+|..+     .++-.||||+...++...+.+++..
T Consensus       573 lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPP  625 (683)
T KOG0696|consen  573 LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPP  625 (683)
T ss_pred             ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCC
Confidence            88999999999999999999653     6788999999988887666555443

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.3e-43  Score=334.33  Aligned_cols=255  Identities=33%  Similarity=0.618  Sum_probs=215.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++++.||.|+||.||+|.+..+|..||+|++...   ......+..|+.+++.+ +|+||+++++.+..    .....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~~~   75 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIID----RSNQT   75 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeec----CCCCE
Confidence            489999999999999999999999999999998643   33456678899999999 89999999997753    23467


Q ss_pred             EEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhh-----cCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLH-----ENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH-----~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                      .|++|||+.+++|.+++....  ...+++..++.++.||+.||.|||     +.+|+|+||||+||++++++.+||+|||
T Consensus        76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence            899999999999999997642  347899999999999999999999     9999999999999999999999999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ++..............+++.|+|||++.     ...++.++|+||||+++|+|++|..||...........+.....+ .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~  229 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLN-----HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-R  229 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhc-----CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC-C
Confidence            9987765433234557899999999987     455788999999999999999999999877654444444333332 2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ....++..+.+++.+||..+|.+|||+.++++|||+
T Consensus       230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            345678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.8e-44  Score=346.43  Aligned_cols=257  Identities=38%  Similarity=0.732  Sum_probs=215.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ...|.....||+|+||.||++.+..++..||||.+.... .....+.+|+.+++.+ +|+||+++++.+      ...+.
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~------~~~~~   93 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSY------LVGDE   93 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHhe------ecCCe
Confidence            345666788999999999999999999999999986432 3445678999999998 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++.....
T Consensus        94 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658          94 LWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             EEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99999999999999988542   588999999999999999999999999999999999999999999999999876644


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKWP  291 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~  291 (463)
                      .........|+..|+|||.+.     ...++.++|||||||++|+|++|..||........+..+.....+.. .....+
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVIS-----RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVS  245 (292)
T ss_pred             ccccCceeecCccccCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccC
Confidence            433334567899999999986     55678899999999999999999999987766555444333222221 223567


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ..+.+||.+||..||.+|||++++++||||....
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence            8999999999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-43  Score=340.81  Aligned_cols=259  Identities=35%  Similarity=0.568  Sum_probs=212.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      +|++++.||+|+||.||+|++..+|..||+|.+...  ......+.+|+.+++++ +|+||+++++.+      ...+.+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~~~   74 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAF------FIEGAV   74 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhhe------ecCCeE
Confidence            589999999999999999999999999999988643  23346788899999999 899999999998      445799


Q ss_pred             EEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      |+||||+++++|..++.... ...+++..+..++.||+.||.|||+ +||+|+||||+|||++.++.+||+|||++..+.
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999999999999887532 2368999999999999999999996 699999999999999999999999999987654


Q ss_pred             cccCccccccCCccccccceeccCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh---hcccCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDEN-PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---FLIPRNAPPRLKS  287 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~---~~i~~~~~~~~~~  287 (463)
                      ...  .....+++.|+|||++..... ....++.++|||||||++|+|++|..||.........   ..+.....+. ..
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  231 (286)
T cd06622         155 ASL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-LP  231 (286)
T ss_pred             CCc--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-CC
Confidence            322  233468889999999854221 2345688999999999999999999999765443322   2222222222 23


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ..++.++.+||.+||..+|.+||+++++++||||...
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            3588999999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.7e-43  Score=332.89  Aligned_cols=252  Identities=31%  Similarity=0.501  Sum_probs=214.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+...   ......+.+|+.+|+.+ +|+||+++++.+      ...+.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~~   73 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENF------LEDKA   73 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeE------ecCCE
Confidence            489999999999999999999999999999998643   23456788999999999 899999999988      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-CcEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-~~vkL~DFGla~~~~  211 (463)
                      .++||||+++++|.+++....+..+++..++.++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            9999999999999999987665678999999999999999999999999999999999999754 468999999988765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ... ......|+..|+|||.+.     ...++.++||||||+++|+|++|..||.+.+.......+...... .....++
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  226 (256)
T cd08220         154 SKS-KAYTVVGTPCYISPELCE-----GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYS  226 (256)
T ss_pred             CCc-cccccccCCcccCchhcc-----CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-CCCCCcC
Confidence            432 223356899999999986     456788999999999999999999999877665555444333322 2234578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ..++++|.+||..+|.+|||++++++||||
T Consensus       227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         227 PDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.5e-43  Score=338.53  Aligned_cols=254  Identities=50%  Similarity=0.904  Sum_probs=215.4

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .-|++++.||.|+||.||+|.+..++..||+|++....  .....+.+|+.++..+ +|+||+++++.+      ..++.
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~~~~   76 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSY------LKDTK   76 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEE------EeCCe
Confidence            35888999999999999999999899999999986433  3345778899999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++...   .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..
T Consensus        77 ~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999999999999998642   588999999999999999999999999999999999999999999999999876654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........++..|+|||.+.     ...++.++|+|||||++|+|++|..||...........+.....+. ....++.
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  227 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT-LEGNYSK  227 (277)
T ss_pred             chhhhccccCCccccChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC-CCcccCH
Confidence            332334457899999999986     4567788999999999999999999998776655555444333322 2345788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++.++|.+||..+|.+||++.++++||||.+.
T Consensus       228 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         228 PLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.4e-43  Score=341.63  Aligned_cols=258  Identities=43%  Similarity=0.770  Sum_probs=217.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +..++|++.+.||+|+||.||++.+..++..||+|.+... ......+.+|+.+++.+ +||||+++++.+      ...
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~------~~~   88 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSY------LVG   88 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhhee------eeC
Confidence            3456899999999999999999999889999999998643 33456778899999999 799999999998      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..|+|+||+++++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            7899999999999999998653   4788999999999999999999999999999999999999999999999998766


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~  289 (463)
                      ...........|++.|+|||.+.     ...++.++|+|||||++|+|++|..||...+.......+.....+.. ....
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK  240 (293)
T ss_pred             cccccccccccCChhhcCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence            54433334457899999999986     45678899999999999999999999987766555444333222222 2345


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++..+++||.+||..+|.+||++++++.|+||...
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence            67889999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.1e-43  Score=341.29  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=213.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++++.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.+++.+ +||||+++++.+      ...+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~   74 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSF------ETKR   74 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEE------ecCC
Confidence            5899999999999999999999999999999986432    2345677899999998 899999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||++|++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            8999999999999999997654  68999999999999999999999999999999999999999999999999876321


Q ss_pred             ccc---------------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc
Q psy7384         212 RTI---------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL  276 (463)
Q Consensus       212 ~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~  276 (463)
                      ...               .......++..|+|||.+.     ...++.++|+|||||++|+|++|..||.+....+....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~  227 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-----RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ  227 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhcc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            000               0011245788999999986     45688999999999999999999999987766555554


Q ss_pred             ccCCCCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHhcCccccCCchh
Q psy7384         277 IPRNAPPR-LKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       277 i~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~~~  327 (463)
                      +....... .....++.++.+||.+||..+|.+||+   +.++|+||||......
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         228 VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            43332211 122367899999999999999999998   7999999999875544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.2e-43  Score=354.76  Aligned_cols=256  Identities=23%  Similarity=0.415  Sum_probs=205.6

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEE-----cCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRH-----TKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|++.+.||+|+||.||+|++     ..++..||+|++...  ....+.+.+|+.+|..+.+||||+++++++   
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~---  108 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC---  108 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee---
Confidence            3456799999999999999999974     345678999998643  234457788999999987799999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------------------------------------------
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------------------------------------------  154 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------  154 (463)
                         ...+..|+|||||++|+|.+++.....                                                  
T Consensus       109 ---~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         109 ---TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             ---ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence               455789999999999999999865321                                                  


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         155 -----------------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       155 -----------------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                                             ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                   246788899999999999999999999999999999999999999999999998664


Q ss_pred             cccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         212 RTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       212 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .....  .....++..|+|||++.     ...++.++|||||||++|+|++ |.+||.+.....................
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  340 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE  340 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhc-----CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC
Confidence            32211  11233566799999987     5678999999999999999998 8999977654443333322222222234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..+.++++||.+||+.||++|||+.++++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-43  Score=333.20  Aligned_cols=252  Identities=37%  Similarity=0.664  Sum_probs=212.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc------chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +|+..+.||+|+||+||+|.+..++..|++|.+....      .....+.+|+.+++.+ +|+||+++++.+      ..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~------~~   73 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTE------RE   73 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeE------ec
Confidence            4777899999999999999999899999999986432      2446788999999999 899999999988      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+++++|.+++....  .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          74 EDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCcccee
Confidence            578999999999999999997543  588999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ..... ......|+..|++||.+..    ...++.++|+|||||++|+|++|.+||...........+............
T Consensus       152 ~~~~~-~~~~~~~~~~y~~pe~~~~----~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (258)
T cd06632         152 VVEFS-FAKSFKGSPYWMAPEVIAQ----QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH  226 (258)
T ss_pred             ccccc-cccccCCCcceeCHHHhcC----CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCC
Confidence            64332 2244568999999999862    123788999999999999999999999877655555544432222233456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ++..+++||.+||..+|.+||++++++.||||
T Consensus       227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         227 LSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            78999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.2e-43  Score=333.46  Aligned_cols=253  Identities=31%  Similarity=0.610  Sum_probs=215.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+...   ......+.+|+.+++.+ +|+||+++++.+      ...+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~------~~~~~   73 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASF------QENGR   73 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhhee------ccCCe
Confidence            489999999999999999999999999999998643   23456778999999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~~~~  211 (463)
                      .|+|+||+.+++|.+++.......+++..+..++.||+.||.|||+.+|+|+||||+||++++++ .+||+|||++....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            99999999999999999776555689999999999999999999999999999999999998875 46999999988765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ..........|++.|+|||++.     ...++.++|+|||||++|+|++|..||...+.......+...... .....++
T Consensus       154 ~~~~~~~~~~~~~~~~ape~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  227 (257)
T cd08225         154 DSMELAYTCVGTPYYLSPEICQ-----NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFS  227 (257)
T ss_pred             CCcccccccCCCccccCHHHHc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCC
Confidence            4433333456899999999886     456888999999999999999999999876655554444333222 2234678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ..+.++|.+||..+|.+|||+.++++||||
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         228 RDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.9e-43  Score=335.18  Aligned_cols=250  Identities=27%  Similarity=0.479  Sum_probs=212.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++.+.||.|+||.||+|.+..++..||+|++....    ...+.+.+|+++++++ +||||+++++.+      ...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~   73 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSF------QDEE   73 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhh------cCCC
Confidence            3899999999999999999999999999999996432    3456788999999999 899999999998      5567


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.|++|.+++...  ..+++..+..++.||++||.|||++||+|+||+|+||++++++.++|+|||++....
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          74 NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            899999999999999999765  368999999999999999999999999999999999999999999999999987664


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--hhhhhcccCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--MRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~  289 (463)
                      ... ......|+..|+|||++.     ...++.++|+|||||++|+|++|..||.....  ...+...... ........
T Consensus       152 ~~~-~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  224 (258)
T cd05578         152 PDT-LTTSTSGTPGYMAPEVLC-----RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPAT  224 (258)
T ss_pred             CCc-cccccCCChhhcCHHHHc-----ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCccc
Confidence            332 223456889999999987     44578899999999999999999999987663  2222222221 22233346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCH--HHHhcCccc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYT--DQLLKHPFI  321 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~--~e~l~hp~~  321 (463)
                      ++..+.++|.+||..||.+||++  +++++||||
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            88999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-42  Score=337.45  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=203.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +.|.+++.||+|+||.||+|.+..+|..||+|++....  .....+.+|+.+++.+ +|+||+++++++      ...+.
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~------~~~~~   77 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDII------HTKET   77 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEE------ecCCe
Confidence            56999999999999999999999999999999986432  2234667899999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++....
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            999999996 57777765433 3578888999999999999999999999999999999999999999999999876543


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh-hhcc--------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-LFLI--------------  277 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i--------------  277 (463)
                      .........+++.|+|||++.+    ...++.++|||||||++|+|++|..||.+...... +..+              
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLG----ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCCCCccccccccCCceeec----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence            3333344567999999999863    24577889999999999999999999976543211 1100              


Q ss_pred             ----cCC-------CCCC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         278 ----PRN-------APPR-----LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       278 ----~~~-------~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                          ...       ..+.     ......+..+.+||.+||..||.+|||++|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                000       0000     0001225689999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.5e-43  Score=350.64  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=207.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++...   ......+.+|+.+++.+ +|+||++++++|........
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence            356799999999999999999999999999999998632   23345677899999999 89999999999864432233


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....|+||||+.+ +|.+.+..    .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            4568999999965 88887753    288999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---------  280 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------  280 (463)
                      ..... ......+++.|+|||++.     ...++.++|||||||++|+|++|+.||...+.......+...         
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         168 AGTSF-MMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             CCCCC-CCCCCcccccccCHHHHh-----CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            65432 223456889999999987     567889999999999999999999999766543322111000         


Q ss_pred             -------------C----------------CCC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         281 -------------A----------------PPR---LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       281 -------------~----------------~~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                                   .                .+.   ......++.+++||.+||..||.+|||+.|+|+||||.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                         0                000   00113456789999999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-42  Score=335.69  Aligned_cols=259  Identities=37%  Similarity=0.638  Sum_probs=211.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|++....  .....+.+|+++++.+ +||||++++++|..    ...+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~   75 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLD----ESSSS   75 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEc----cCCCe
Confidence            35899999999999999999999999999999987543  2456788999999999 89999999998853    23457


Q ss_pred             EEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +|+||||+++++|.+++...  ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            89999999999999987642  2346889999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-----hhhhhcccCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-----MRALFLIPRNAPPRL  285 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~  285 (463)
                      .....  ....++..|+|||.+.     ...++.++|||||||++|+|++|..||.....     .+....+.....+..
T Consensus       156 ~~~~~--~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd06621         156 VNSLA--GTFTGTSFYMAPERIQ-----GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL  228 (287)
T ss_pred             ccccc--ccccCCccccCHHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence            43221  2346788999999986     56788899999999999999999999976522     122222211111111


Q ss_pred             -----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         286 -----KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       286 -----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                           ....+++.+.+||.+||..+|.+|||+.|++.||||.+..
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                 1134678999999999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-43  Score=343.12  Aligned_cols=255  Identities=36%  Similarity=0.720  Sum_probs=214.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      .|+....||+|+||.||+|.+..++..||+|.+... ......+.+|+.++..+ +||||+++++.+      ...+..|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~------~~~~~~~   94 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSY------LVGEELW   94 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhhe------eeCCeEE
Confidence            356667899999999999999999999999998643 23455678899999999 899999999998      4457899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+++++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            99999999999998754   258899999999999999999999999999999999999999999999999987665443


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CCCCCCCHH
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LKSKKWPKK  293 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~  293 (463)
                      .......|+..|+|||++.     ...++.++|||||||++|+|++|..||........+..+....... .....++..
T Consensus       172 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVIS-----RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPV  246 (297)
T ss_pred             ccccceecCccccCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHH
Confidence            3334567999999999986     4567889999999999999999999998776665555443332222 223467889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      +.++|.+||..+|.+||+++++++||||.+..
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            99999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-43  Score=349.67  Aligned_cols=257  Identities=23%  Similarity=0.413  Sum_probs=206.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .+.++|++.+.||+|+||.||+|++..     +++.||+|++....  .....+..|+.++.++.+|+||+++++++.  
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~--   81 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT--   81 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe--
Confidence            455689999999999999999997543     45789999986432  234567789999999977999999999885  


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------------------------------------------
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------------------------------------------  154 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------  154 (463)
                         .....+++||||+.+++|.+++.....                                                  
T Consensus        82 ---~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (337)
T cd05054          82 ---KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE  158 (337)
T ss_pred             ---cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence               234678999999999999999864321                                                  


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC--ccccccCC
Q psy7384         155 ---------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGT  223 (463)
Q Consensus       155 ---------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt  223 (463)
                               ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....  ......++
T Consensus       159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                     2578889999999999999999999999999999999999999999999999987643211  12233467


Q ss_pred             ccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhh
Q psy7384         224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVL  302 (463)
Q Consensus       224 ~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L  302 (463)
                      ..|+|||++.     ...++.++|||||||++|+|++ |..||.+....+.+...............++.++.+++.+||
T Consensus       239 ~~y~aPE~~~-----~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl  313 (337)
T cd05054         239 LKWMAPESIF-----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCW  313 (337)
T ss_pred             ccccCcHHhc-----CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence            7899999987     5678999999999999999998 999998755433332222221222223467889999999999


Q ss_pred             hcCCCCCCCHHHHhcC
Q psy7384         303 VKDYHQRPYTDQLLKH  318 (463)
Q Consensus       303 ~~dp~~Rpt~~e~l~h  318 (463)
                      +.+|.+||+++++++|
T Consensus       314 ~~~p~~RPs~~ell~~  329 (337)
T cd05054         314 HNNPEDRPTFSELVEI  329 (337)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.6e-43  Score=338.26  Aligned_cols=255  Identities=39%  Similarity=0.751  Sum_probs=215.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..|...+.||+|++|.||++.+..++..+++|.+.... .....+.+|+.+++.+ +|+||+++++.+.      ..+..
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~------~~~~~   91 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYL------VGDEL   91 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEE------cCCeE
Confidence            35667789999999999999999999999999886433 3345678899999999 8999999999884      45789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+|+||+.+++|.+++..   ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus        92 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            999999999999999876   25889999999999999999999999999999999999999999999999988765443


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-CCCCCH
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKKWPK  292 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  292 (463)
                      ........|++.|+|||.+.     ...++.++|||||||++|+|++|..||...+.......+.....+... ...++.
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEVIS-----RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP  243 (285)
T ss_pred             CcccccccCCccccCHHHhc-----CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCH
Confidence            33334457899999999986     456888999999999999999999999887766555554444332222 223788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .+.+||.+||..+|.+|||+.++++||||...
T Consensus       244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence            99999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.1e-43  Score=333.73  Aligned_cols=252  Identities=31%  Similarity=0.532  Sum_probs=208.2

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-------chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      |+..+.||+|+||.||++.+..++..||+|++....       .....+.+|+.+++++ +|+||+++++++      ..
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~   74 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGAT------CE   74 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhcee------cc
Confidence            778899999999999999999999999999986432       1346788999999999 899999999998      55


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEeccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSA  208 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~  208 (463)
                      .+.+++||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+|+||+|+||+++.++ .+||+|||++.
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            678999999999999999997544  688999999999999999999999999999999999998765 59999999987


Q ss_pred             ccccccC----ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh---cccCCC
Q psy7384         209 QLDRTIG----RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF---LIPRNA  281 (463)
Q Consensus       209 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~---~i~~~~  281 (463)
                      .......    ......|+..|+|||++.     ...++.++|+|||||++|+|++|..||..........   .+....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  227 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLR-----GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT  227 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC
Confidence            7653311    112346888999999986     4567889999999999999999999996544322221   111112


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ........++..+.++|.+||..+|.+|||+.++++||||+
T Consensus       228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            22223345788999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-42  Score=331.68  Aligned_cols=254  Identities=38%  Similarity=0.678  Sum_probs=217.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|++.+.||.|+||.||+|.+..+++.||+|++....  .....+.+|+.++..+ +|+||+++++.+      ...+..
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~   74 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAF------YKEGEI   74 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEE------ccCCeE
Confidence            4899999999999999999999999999999987554  3467788999999999 799999999998      445789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      |+||||+.+++|.+++...  ..+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999999999765  368999999999999999999999 9999999999999999999999999999887755


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---chhhhhcccCCCCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH---PMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .........++..|+|||.+.     ...++.++|+||||+++|+|++|..||....   .......+.....+......
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQ-----GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEE  227 (264)
T ss_pred             CCCcccceeecccccCHhhhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCccc
Confidence            443333557889999999986     4578889999999999999999999997764   23333333333333333333


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ++..+.++|.+||..+|.+||++.++++||||+.
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence            8899999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.8e-43  Score=339.89  Aligned_cols=257  Identities=27%  Similarity=0.441  Sum_probs=209.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....   .....+.+|+.+++.+ +|+||+++++++      ...+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVV------HSEK   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEE------ecCC
Confidence            46999999999999999999999999999999986432   2345678899999999 899999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEeccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQL  210 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~~~  210 (463)
                      ..|+||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++...
T Consensus        75 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         75 RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            9999999996 48888886655555788999999999999999999999999999999999985 567999999999765


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC---CC------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR---NA------  281 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~------  281 (463)
                      ...........+++.|+|||++.+    ...++.++|||||||++|+|++|.+||........+..+..   ..      
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLG----SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP  229 (294)
T ss_pred             CCCccccccCceeecccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            433333344567899999998863    34578899999999999999999999987665444432211   00      


Q ss_pred             -----------CCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -----------PPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -----------~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                 .+.       ...+.+++.+.++|.+||+.+|.+||+++++++||||.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence                       000       012356788999999999999999999999999999975

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.7e-43  Score=338.38  Aligned_cols=244  Identities=18%  Similarity=0.280  Sum_probs=201.7

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch----HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE----EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      ..||+|++|.||+|.+  +|+.||+|.+......    .+.+.+|+.+|+++ +||||+++++++....  .....+++|
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~--~~~~~~~lv  100 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIV--DDLPRLSLI  100 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecc--cCCCceEEE
Confidence            5789999999999987  5889999998754332    35667999999999 8999999999985411  123578999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      |||+.+|+|.+++...+  .+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+.... 
T Consensus       101 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        101 LEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             EEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999999997643  68888999999999999999998 499999999999999999999999999988654321 


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                        ...+|+..|+|||++...   ...++.++|||||||++|||++|..||.+.+.......+.........+..++..++
T Consensus       178 --~~~~~~~~y~aPE~~~~~---~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~  252 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDI---FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK  252 (283)
T ss_pred             --ccccCcccccCHHHhhhc---cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence              334689999999998631   256899999999999999999999999887766655554333222222336789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy7384         296 SFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       296 ~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +||.+||+.||++|||++++++
T Consensus       253 ~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        253 CIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHHhcCCcccCcCHHHHHH
Confidence            9999999999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.1e-43  Score=342.06  Aligned_cols=251  Identities=22%  Similarity=0.387  Sum_probs=199.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcC----------------CCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCcee
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTK----------------TGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIA  115 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv  115 (463)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++...  ......+.+|+.+|.++ +||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence            4679999999999999999998642                3447999998753  23345788999999999 899999


Q ss_pred             eecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHhhhhc
Q psy7384         116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG-----------------QSLKEEWIAFICREILRGLKYLHE  178 (463)
Q Consensus       116 ~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~~l~~~~~~~i~~qil~aL~~LH~  178 (463)
                      ++++++.      ..+..|+||||+.+|+|.+++.....                 ..+++..+..++.||+.||.|||+
T Consensus        83 ~~~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          83 RLLGVCV------DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             EEEEEEe------cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            9999984      44679999999999999999865321                 236778889999999999999999


Q ss_pred             CCceecCCCCCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHH
Q psy7384         179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL  256 (463)
Q Consensus       179 ~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~  256 (463)
                      +||+||||||+|||++.++.+||+|||+++.+.....  ......++..|+|||++.     ...++.++|||||||++|
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~  231 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-----MGKFTTASDVWAFGVTLW  231 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-----cCCCCchhhhHHHHHHHH
Confidence            9999999999999999999999999999876533211  112234578899999987     556899999999999999


Q ss_pred             HHHh--CCCCCCCCCchhhhhcccC------CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy7384         257 EMAE--SQPPLCDLHPMRALFLIPR------NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLL  316 (463)
Q Consensus       257 ell~--g~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  316 (463)
                      +|++  +..||.+.+....+..+..      ..........++..+.+||.+||..||.+|||++++.
T Consensus       232 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             HHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            9986  6678877665444322110      0111112346788999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=337.66  Aligned_cols=253  Identities=28%  Similarity=0.471  Sum_probs=208.6

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++.+.||.|++|.||+|.+..+|..||+|++....   .....+.+|+.+++.+ +|+||+++++++      ...+..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~------~~~~~~   73 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVV------HSENKL   73 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhhee------ccCCeE
Confidence            678899999999999999999999999999987442   2235678899999999 799999999998      445799


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+. ++|.+++.......+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++......
T Consensus        74 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          74 YLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             EEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence            99999995 58999987665456899999999999999999999999999999999999999999999999998765433


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-------------
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-------------  280 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------------  280 (463)
                      ........+++.|+|||++..    ...++.++|||||||++|+|++|.+||...+....+..+...             
T Consensus       153 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         153 VRTYTHEVVTLWYRAPEILLG----SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             ccccCccccccCCCCCceeec----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence            322334467889999998863    345688999999999999999999999877654433221110             


Q ss_pred             ------------C--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 ------------A--PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 ------------~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                  .  ........++..+.++|.+||+.+|.+|||+++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                        0  0001124567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-42  Score=332.41  Aligned_cols=250  Identities=22%  Similarity=0.404  Sum_probs=210.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      ..|.+.+.||+|+||.||+|.+..++..||+|++.........+.+|+++++.+ +|+||+++++++      ...+.++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~~   78 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC------TREPPFY   78 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEE------cCCCCcE
Confidence            458999999999999999999999999999999876655667888999999999 899999999998      4457889


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+.+++|.+++.......+++..++.++.|+++||.|||++||+||||||+|||+++++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            99999999999999977655678999999999999999999999999999999999999999999999999987664322


Q ss_pred             Cc-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         215 GR-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .. .....++..|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+..... ......++.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  232 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-MERPEGCPP  232 (263)
T ss_pred             eeccCCCCCccccCCHHHhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCH
Confidence            11 11123456799999886     5668889999999999999998 9999987665544444433222 223456789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ++.++|.+||..+|++|||+.++++
T Consensus       233 ~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         233 KVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-42  Score=330.96  Aligned_cols=255  Identities=33%  Similarity=0.620  Sum_probs=211.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.....   ....+..|+.+++.+ +|+||+++++.+      ...+.
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~------~~~~~   73 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVE------VHREK   73 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeE------ecCCE
Confidence            58999999999999999999998999999999875544   567788999999999 899999999987      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +++|+||+.+++|.+++....  .+++..++.++.|++.||.|||+.||+|+||+|+||++++++.+||+|||++.....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          74 VYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             EEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            999999999999999997543  578899999999999999999999999999999999999999999999999887644


Q ss_pred             ccCcc----ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhcccCCCCCCC-C
Q psy7384         213 TIGRR----NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRNAPPRL-K  286 (463)
Q Consensus       213 ~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~-~  286 (463)
                      .....    ....+++.|+|||++....  ...++.++|||||||++|+|++|..||...... .....+.....+.. .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  229 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD  229 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence            32221    1346788999999987421  234788999999999999999999999765332 22222222222222 2


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ...++..+.+||.+||+.+|.+|||+++++.|||+
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            23458899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0614|consensus

Probab=100.00  E-value=6.3e-45  Score=351.60  Aligned_cols=265  Identities=25%  Similarity=0.427  Sum_probs=236.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEee----cCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~----~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .++++..||-|+||.|-++........+|+|+++    ......+.+..|-++|..+ +.|.||++|..|      .+..
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTf------rd~k  493 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTF------RDSK  493 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHh------ccch
Confidence            4678899999999999999877655568998886    3445667888999999999 699999999999      6778


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ++|++||-|-||.|+.++..++  .+.+..++.|+..+++|++|||++|||+|||||+|+|++.+|-+||.|||+|+++.
T Consensus       494 yvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999999999997655  79999999999999999999999999999999999999999999999999999987


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .. ....++||||.|.|||+++     +...+.++|.||||+++||||+|.|||.+.+++.++..|..+...-..+..++
T Consensus       572 ~g-~KTwTFcGTpEYVAPEIIL-----nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~  645 (732)
T KOG0614|consen  572 SG-RKTWTFCGTPEYVAPEIIL-----NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRIT  645 (732)
T ss_pred             cC-CceeeecCCcccccchhhh-----ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccc
Confidence            65 4456789999999999998     67789999999999999999999999999999999999998887666667899


Q ss_pred             HHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchhHHHHHHhH
Q psy7384         292 KKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTERQARIQLK  335 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~~~~~~~~~  335 (463)
                      ..+.+||+++-..+|.+|..     +.+|-+|.||....++......|.
T Consensus       646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~  694 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLP  694 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCC
Confidence            99999999999999999975     899999999998777765444443

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.1e-43  Score=333.31  Aligned_cols=247  Identities=28%  Similarity=0.464  Sum_probs=207.9

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ||.|+||.||+|++..+++.+|+|++....    .....+.+|+.+++.+ +|+||+++++.+      ..++.+|+|||
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~~lv~e   73 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTF------KDKKYIYMLME   73 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeE------EcCCccEEEEe
Confidence            699999999999999999999999986432    3446788999999999 899999999998      45578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccc
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN  218 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  218 (463)
                      |+.+++|.+++....  .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        74 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~  150 (262)
T cd05572          74 YCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTW  150 (262)
T ss_pred             cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccc
Confidence            999999999997543  58999999999999999999999999999999999999999999999999998765432 223


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--chhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH--PMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ...|++.|++||.+.     ...++.++|+|||||++|+|++|..||....  .......+.........+..+++++.+
T Consensus       151 ~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (262)
T cd05572         151 TFCGTPEYVAPEIIL-----NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKD  225 (262)
T ss_pred             cccCCcCccChhHhc-----CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHH
Confidence            457899999999986     4567889999999999999999999997766  434444333222222223345889999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHhcCccccCC
Q psy7384         297 FIETVLVKDYHQRPY-----TDQLLKHPFIRDQ  324 (463)
Q Consensus       297 li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  324 (463)
                      ||.+||..+|.+||+     ++|+++||||.+.
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            999999999999999     9999999999754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.3e-43  Score=338.24  Aligned_cols=259  Identities=46%  Similarity=0.874  Sum_probs=221.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +..+.|++.+.||+|+||.||+|.+..++..|++|++.........+.+|+.+++.+ +|+||+++++.+.      ..+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~~~   88 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYL------VGD   88 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEE------ECC
Confidence            345569999999999999999999998899999999986555567788999999999 8999999999984      347


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+|+||+.+++|.+++.... ..++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          89 ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            8999999999999999998654 368999999999999999999999999999999999999999999999999987655


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC-CCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW  290 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~  290 (463)
                      ..........++..|++||++.     +..++.++|+|||||++|+|++|..||...........+.....+.... ..+
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIK-----RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW  242 (286)
T ss_pred             cchhhhccccCCcccCCHhHhc-----CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence            4333334456889999999986     4567889999999999999999999998776665555443333333222 348


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +..+++||.+||+.+|.+|||+.+++.|+||..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            899999999999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.5e-43  Score=336.50  Aligned_cols=253  Identities=27%  Similarity=0.440  Sum_probs=203.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      |++++.||+|+||.||+|.+..++..||+|++...  ........+|+.++.++.+|+||+++++++..    ...+.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD----RKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec----CCCCcEE
Confidence            67899999999999999999999999999998643  22233445788899988679999999999843    2226899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++.......
T Consensus        77 lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          77 LVFELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EEEecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            99999975 8888876543 36899999999999999999999999999999999999999 999999999998764332


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC---------------
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR---------------  279 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~---------------  279 (463)
                       ......+++.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+..+....+..               
T Consensus       154 -~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 -PYTEYISTRWYRAPECLLT----DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             -CcCCCCCCcccCChhHhhc----CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence             2234568999999998753    34568899999999999999999999987665433221110               


Q ss_pred             C--C---CCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         280 N--A---PPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       280 ~--~---~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      .  .   .+.       .....++..+.+||.+||..+|.+|||++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0  0   000       0012467899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-43  Score=336.94  Aligned_cols=254  Identities=30%  Similarity=0.530  Sum_probs=208.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...   ......+.+|+.+++.+ +|+||+++++++.      ..+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFR------RKG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEE------ECC
Confidence            3699999999999999999999999999999988643   23346788999999999 7999999999994      457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.++.|..+....  ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....
T Consensus        74 ~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          74 RLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             EEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            899999999987776655432  358999999999999999999999999999999999999999999999999988765


Q ss_pred             cccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-----------
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-----------  279 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-----------  279 (463)
                      .... ......++..|+|||++..    ...++.++||||||+++|+|++|.+||.+......+..+..           
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVG----DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE  227 (288)
T ss_pred             CCccccccCcccccCCcCCchhcC----CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence            4432 3344678999999999873    22678899999999999999999999977654433221100           


Q ss_pred             ---------C-CCCC---------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         280 ---------N-APPR---------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       280 ---------~-~~~~---------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                               . ..+.         .....++.++.+||++||..+|++|||++++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                     0 0000         0112347889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.6e-42  Score=338.70  Aligned_cols=265  Identities=41%  Similarity=0.772  Sum_probs=220.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +..+.|...+.||+|+||.||+|++..+|..||+|++....    .....+..|+.+++.+ +|+||+++++++      
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------   90 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCY------   90 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEE------
Confidence            33445777789999999999999999999999999986432    2335677899999999 899999999998      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+..|+||||+. |+|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          91 LKEHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EeCCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCC
Confidence            44578999999996 57888776433 36899999999999999999999999999999999999999999999999988


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      .....    .....|+..|+|||++....  ...++.++|||||||++|+|++|.+||...+.......+.....+....
T Consensus       169 ~~~~~----~~~~~~~~~y~aPE~~~~~~--~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
T cd06633         169 SKSSP----ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQS  242 (313)
T ss_pred             cccCC----CCCccccccccChhhccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            64322    24457899999999985211  3457889999999999999999999998887766666655555555555


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhHHHH
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR  331 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  331 (463)
                      ..++..+++||.+||+.+|.+||++.+++.||||......+...
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~~  286 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLI  286 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHHHH
Confidence            67888999999999999999999999999999999876555443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-42  Score=333.35  Aligned_cols=254  Identities=31%  Similarity=0.581  Sum_probs=208.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-----------hHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-----------EEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+.....           ..+.+..|+.+++.+ +|+||+++++++   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~---   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFE---   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEe---
Confidence            48889999999999999999998999999998853211           124567899999999 899999999988   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                         ...+.+++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+||
T Consensus        78 ---~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          78 ---TTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             ---ccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeec
Confidence               4557899999999999999999765  36899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-
Q psy7384         205 GVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-  281 (463)
Q Consensus       205 Gla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-  281 (463)
                      |++........  ......|+..|+|||++...   ...++.++|+||||+++|+|++|..||........+..+.... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  229 (272)
T cd06629         153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY---SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS  229 (272)
T ss_pred             cccccccccccccccccccCCccccCHHHhccc---cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc
Confidence            99876543211  12334688999999998632   1347889999999999999999999997665554443322211 


Q ss_pred             ---CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         282 ---PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       282 ---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                         .+......++..+.+||.+||..+|.+|||++++|+||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence               1112224568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.9e-43  Score=339.66  Aligned_cols=256  Identities=26%  Similarity=0.456  Sum_probs=208.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.|++.+.||.|+||.||+|.+..+++.+|+|.+.....   ....+.+|+.+++++ +||||+++++++...    ..+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~----~~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGS----NLD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEec----CCC
Confidence            358999999999999999999999999999999874322   233567899999999 799999999988532    237


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++....
T Consensus        80 ~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          80 KIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             cEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            89999999975 9999887644 368999999999999999999999999999999999999999999999999988765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-----------  280 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  280 (463)
                      ..........+++.|+|||++.+    ...++.++|||||||++|+|++|.+||........+..+...           
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLG----AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CCccccccccccccccCchhhcC----CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence            54333344568899999999863    234678899999999999999999999876654433221100           


Q ss_pred             ---------------C----CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 ---------------A----PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 ---------------~----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                     .    ...+....+++.+.+||++||+.+|++|||+.|+|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                           0    0001111158889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-42  Score=334.88  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=206.1

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ||+|+||+||+|.+..+|+.||+|++...    ......+..|+.+|+.+ +||||+++++.+      ...+.+|+|||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~~lv~e   73 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAF------ETKDDLCLVMT   73 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEE------ecCCeEEEEEe
Confidence            69999999999999999999999998642    12234556899999999 799999999998      45578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccc
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN  218 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  218 (463)
                      |+++++|.+++.......+++..+..++.||+.||.|||++||+||||+|+||++++++.++|+|||++...... ....
T Consensus        74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~  152 (277)
T cd05577          74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIK  152 (277)
T ss_pred             cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Cccc
Confidence            999999999998766557999999999999999999999999999999999999999999999999998765432 2223


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---hhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM---RALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                      ...++..|+|||++.     +..++.++|||||||++|+|++|+.||......   ..+....... +......+++.+.
T Consensus       153 ~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  226 (277)
T cd05577         153 GRAGTPGYMAPEVLQ-----GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM-AVEYPDKFSPEAK  226 (277)
T ss_pred             cccCCCCcCCHHHhc-----CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc-cccCCccCCHHHH
Confidence            456888999999986     445888999999999999999999999765431   1111111111 1223346789999


Q ss_pred             HHHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         296 SFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       296 ~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      +||.+||+.||.+||     ++.++++||||.+..+
T Consensus       227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             HHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence            999999999999999     8999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-42  Score=335.02  Aligned_cols=254  Identities=27%  Similarity=0.463  Sum_probs=207.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      +|++.+.||.|++|.||+|++..+|..||+|++....  .....+.+|+.+++.+ +|+||+++++.+      ...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVI------HTENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeE------eeCCcE
Confidence            4899999999999999999999999999999987542  2345677899999999 899999999998      445789


Q ss_pred             EEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      |+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++.....
T Consensus        74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            999999985 8888886543 24689999999999999999999999999999999999999999999999999876644


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN------------  280 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------  280 (463)
                      .........++..|++||++..    ...++.++|||||||++|+|++|.+||.+.+..+....+...            
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLG----SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             CccccccccccccccChHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence            3333344567899999998863    345788999999999999999999999876654433221100            


Q ss_pred             --------CCCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 --------APPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 --------~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                              ..+.       ...+..+..++++|.+||+.||.+||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                    0000       0012457789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-43  Score=337.80  Aligned_cols=253  Identities=33%  Similarity=0.580  Sum_probs=211.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..|++++.||+|+||+||++.+..+|..||+|++...  ......+.+|+.+++.+ +||||+++++.+      ...+.
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~~   77 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAF------LNENN   77 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeE------ecCCE
Confidence            4689999999999999999999999999999988643  23456788999999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      +|+||||+++++|.+++...+  .+++..++.++.|++.||.|||+ +||+||||||+||++++++.++|+|||++....
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999999999999999987543  68999999999999999999997 699999999999999999999999999986553


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-----------hhhhcccCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-----------RALFLIPRN  280 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-----------~~~~~i~~~  280 (463)
                      ...  ....+|+..|+|||++.     ...++.++|||||||++|+|++|..||......           .....+...
T Consensus       156 ~~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd06620         156 NSI--ADTFVGTSTYMSPERIQ-----GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE  228 (284)
T ss_pred             hhc--cCccccCcccCCHHHHc-----cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence            221  23457899999999986     457888999999999999999999999765432           112222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..+......++..+.+||.+||..||.+|||++++++|+||..
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            2333333347789999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-42  Score=332.61  Aligned_cols=244  Identities=24%  Similarity=0.400  Sum_probs=197.5

Q ss_pred             eEEEeee--eeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          57 FELIEVV--GNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        57 y~~~~~L--G~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      |++.+.+  |.|+||.||+++++.++..+|+|++.......    .|+.....+.+|+||+++++.|      ...+.+|
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~------~~~~~~~   85 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSV------TTLKGHV   85 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEE------ecCCeeE
Confidence            5555555  99999999999999999999999986432211    1233333333799999999999      4457899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEecccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSAQLDRT  213 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~  213 (463)
                      +||||+++++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++......
T Consensus        86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9999999999999997654  789999999999999999999999999999999999999888 9999999998766432


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh----hhhcccCCCCCCCCCCC
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR----ALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~  289 (463)
                          ....|+..|+|||++.     ...++.++|||||||++|+|++|..||.......    .+....  .........
T Consensus       164 ----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (267)
T PHA03390        164 ----SCYDGTLDYFSPEKIK-----GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKN  232 (267)
T ss_pred             ----ccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccc
Confidence                3346899999999997     5667889999999999999999999997544322    111111  111122346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCC-HHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPY-TDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt-~~e~l~hp~~~~  323 (463)
                      ++..+++||.+||+.+|.+|++ ++++|+||||.+
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            8899999999999999999996 699999999963

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.8e-43  Score=336.47  Aligned_cols=251  Identities=22%  Similarity=0.411  Sum_probs=208.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCC-----cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTG-----QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +.|++.+.||+|+||.||+|.+...+     ..||+|.+....  .....+.+|+.++..+ +||||+++++++      
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~------   77 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVC------   77 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEE------
Confidence            36899999999999999999976555     679999986432  2345688999999999 899999999998      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKG--------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL  193 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl  193 (463)
                      ......|++|||+++++|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~  157 (283)
T cd05048          78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV  157 (283)
T ss_pred             cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence            445688999999999999999975421              357889999999999999999999999999999999999


Q ss_pred             ccCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy7384         194 TDNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHP  270 (463)
Q Consensus       194 ~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~  270 (463)
                      ++++.++|+|||++.......  .......+++.|+|||.+.     ...++.++|||||||++|||++ |..||.+...
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-----YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhc-----cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999987653221  1123345688999999986     5668899999999999999998 9999988777


Q ss_pred             hhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         271 MRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       271 ~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+....+.....+ .....++.++.+|+.+||+.||.+||++.+++++
T Consensus       233 ~~~~~~i~~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         233 QEVIEMIRSRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHcCCcC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6665555443332 2345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=344.42  Aligned_cols=261  Identities=27%  Similarity=0.472  Sum_probs=207.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..++|++.+.||+|+||.||+|++..+|..||+|.+...  ......+.+|+.+++.+ +|+||+++++++..... ...
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~   80 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSF-ESF   80 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccc-ccc
Confidence            356799999999999999999999999999999998632  22345677899999999 79999999998754321 233


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...|+|+||+.+ +|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            568999999975 88877754   35899999999999999999999999999999999999999999999999998765


Q ss_pred             ccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc---CC----
Q psy7384         211 DRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP---RN----  280 (463)
Q Consensus       211 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~---~~----  280 (463)
                      .....   .....+|++.|+|||++..    ...++.++|||||||++|+|++|++||.+.+.......+.   ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            43221   1123578999999998752    3457889999999999999999999997654322211100   00    


Q ss_pred             ----------------CC--CC----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 ----------------AP--PR----LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 ----------------~~--~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                      .+  ..    ...+..+.++.+||.+||+.+|.+|||+.++++||||..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence                            00  00    001245778999999999999999999999999999974

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-42  Score=331.30  Aligned_cols=252  Identities=27%  Similarity=0.490  Sum_probs=208.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++.+.||+|+||.||+|++..+++.||||.+..    .......+.+|+.+++.+ +||||+++++.+.      ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~~   74 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFI------ED   74 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEE------EC
Confidence            469999999999999999999999999999998753    223345678899999999 8999999999984      44


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +..++||||+++++|.+++....  ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccce
Confidence            78999999999999999886432  3458899999999999999999999999999999999999999999999999988


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--hhhhhcccCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--MRALFLIPRNAPPRLK  286 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~  286 (463)
                      .............|++.|+|||.+.     ...++.++|+|||||++|+|++|..||.....  ......+.....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIH-----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP  229 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhc-----cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC
Confidence            7654333334457899999999987     45678899999999999999999999965432  2223333333333333


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...++..+.++|.+||..+|.+||++.++++.
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            44677899999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=328.82  Aligned_cols=253  Identities=33%  Similarity=0.637  Sum_probs=212.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC------cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT------EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .|++.+.||+|+||.||+|++..++..||+|.+...      ......+.+|+.+++++ +|+||+++++.+..    ..
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~----~~   77 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRD----PE   77 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEc----CC
Confidence            589999999999999999999999999999987532      22345778899999999 89999999998743    22


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+++||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            357899999999999999987544  588999999999999999999999999999999999999999999999999876


Q ss_pred             ccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         210 LDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       210 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      .....   .......|+..|+|||++.     +..++.++|+|||||++|+|++|++||.+.........+.........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  230 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVIS-----GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML  230 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhc-----CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCC
Confidence            54211   1123456899999999987     456788999999999999999999999887666655555443333344


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      +..+++.+.++|.+||. +|.+||++.+++.|||.
T Consensus       231 p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         231 PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            56788999999999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-42  Score=331.44  Aligned_cols=249  Identities=19%  Similarity=0.342  Sum_probs=205.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..|++.+.||+|+||.||+|.+.   ..+..||+|++....  .....+.+|+.+++.+ +||||+++++++      ..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~   77 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVI------TR   77 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEE------ec
Confidence            46999999999999999999875   346689999987542  3345778899999998 899999999998      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+..
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            578999999999999999987543 3689999999999999999999999999999999999999999999999998765


Q ss_pred             cccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         210 LDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       210 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ...... ......++..|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+...... ...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~~~  230 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQ-----YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-PAP  230 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHh-----hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-CCC
Confidence            422111 111223567899999986     5678899999999999999775 99999887776655555443322 234


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..++..+.+++.+||..+|.+||+++++++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            568899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=330.72  Aligned_cols=247  Identities=30%  Similarity=0.505  Sum_probs=203.1

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||.|+||.||+|.+..+|+.||+|++....    .....+..|..++....+|+||+++++++      ...+.+|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~------~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF------QSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE------EcCCeEEEE
Confidence            57999999999999999999999999986432    12233455655555555899999999999      455789999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+++|.+++....  .+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....    
T Consensus        76 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          76 MEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            99999999999997644  689999999999999999999999999999999999999999999999999875433    


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCCCCCCCHHH
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLKSKKWPKKF  294 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~  294 (463)
                      .....|+..|+|||.+.     +..++.++||||||+++|+|++|.+||...+.......+.....  +......++..+
T Consensus       150 ~~~~~~~~~y~~pe~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (260)
T cd05611         150 NKKFVGTPDYLAPETIL-----GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA  224 (260)
T ss_pred             cccCCCCcCccChhhhc-----CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence            23456889999999987     34578899999999999999999999987766554443322221  122233578999


Q ss_pred             HHHHHHhhhcCCCCCC---CHHHHhcCccccCC
Q psy7384         295 QSFIETVLVKDYHQRP---YTDQLLKHPFIRDQ  324 (463)
Q Consensus       295 ~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~  324 (463)
                      .++|.+||..+|++||   +++|+++||||.+.
T Consensus       225 ~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         225 VDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            9999999999999999   55899999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.4e-42  Score=326.59  Aligned_cols=253  Identities=36%  Similarity=0.653  Sum_probs=217.3

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||.|+||.||++.+..++..||+|++....   .....+..|+++++.+ +|+|++++++.+.      ..+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~------~~~~   73 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFE------EKGK   73 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEe------cCCE
Confidence            4899999999999999999999999999999987542   3556788999999999 7999999999984      4479


Q ss_pred             EEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      .++||||+++++|.+++....  ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence            999999999999999998653  357999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...........|++.|+|||.+.     ...++.++|+||+|+++|+|++|..||...........+....... ....+
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  227 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQ-----NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQY  227 (258)
T ss_pred             ccCcceecceeeeecccChhHhc-----cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC-CCCCC
Confidence            55433334557899999999886     4567889999999999999999999997776555544443333322 23367


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      +..+.++|.+||..+|.+|||+.++|+||||
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.4e-42  Score=329.08  Aligned_cols=251  Identities=36%  Similarity=0.558  Sum_probs=203.3

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ...||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.+ +|+||+++++++      ...+..++|||
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~~~~~~lv~e   85 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSD------SENGFFKIFME   85 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeee------ccCCEEEEEEe
Confidence            368999999999999999999999999886443 3456788999999999 899999999998      45578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEecccccccccccC
Q psy7384         139 YCGAGSVTDLVKSTKGQSL--KEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~  215 (463)
                      |+.+++|.+++..... .+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++........
T Consensus        86 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          86 QVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             cCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999999975432 34  78889999999999999999999999999999999976 67999999999876543322


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh-hhcccCCCCCCCCCCCCCHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-LFLIPRNAPPRLKSKKWPKKF  294 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  294 (463)
                      ......|++.|+|||++...   ...++.++||||||+++|+|++|.+||........ ................+++++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKG---PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA  241 (268)
T ss_pred             ccccCCCCccccChhhhccc---cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence            23344689999999998632   23478899999999999999999999975433221 211111111112234577899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         295 QSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       295 ~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ++|+.+||..+|.+|||+.+++.||||
T Consensus       242 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         242 KNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0983|consensus

Probab=100.00  E-value=1.1e-43  Score=319.82  Aligned_cols=258  Identities=34%  Similarity=0.581  Sum_probs=216.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..+++..||.|+.|+|++++.+.+|...|||.+..+.  .+.+++...+.++.+..+.|+||+.+++|+..      ..+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n------~dV  166 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN------TDV  166 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC------chH
Confidence            4577899999999999999999999999999997543  44567777888777765689999999999643      577


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      ++.||.|.. -+..+++..+ .+++|..+-++...++.||.||.. +||+|||+||+|||+++.|++||||||++..+-.
T Consensus       167 ~IcMelMs~-C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  167 FICMELMST-CAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            899999852 4444555444 479999999999999999999986 5999999999999999999999999999987754


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCchhhhhcccCCCCCCCCCC-CC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD-LHPMRALFLIPRNAPPRLKSK-KW  290 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~-~~  290 (463)
                      ... .+.-.|.+.|||||.+....  ...|+-++||||||+.|+||.||..||.+ ..+.+.+-.+....+|.+... .+
T Consensus       245 SkA-htrsAGC~~YMaPERidp~~--~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF  321 (391)
T KOG0983|consen  245 SKA-HTRSAGCAAYMAPERIDPPD--KPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF  321 (391)
T ss_pred             ccc-cccccCCccccCccccCCCC--CCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence            322 23346999999999997543  57899999999999999999999999977 456777777777777766653 49


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++.|++|+..||.+|+.+||...++|+|||+..-
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            9999999999999999999999999999999753

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.1e-42  Score=328.72  Aligned_cols=250  Identities=23%  Similarity=0.425  Sum_probs=209.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .+.|+++++||+|+||.||+|.+. ++..||+|.+.......+.+.+|+.+++.+ +|+||+++++.+      ...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~   76 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVV------TKEEPI   76 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEE------cCCCCc
Confidence            457999999999999999999864 556799998876555567888999999999 899999999988      455788


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+.+++|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999999999999998766567889999999999999999999999999999999999999999999999999876432


Q ss_pred             cC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         214 IG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       214 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .. ......++..|+|||++.     ...++.++|||||||++|+|++ |..||...........+...... .....++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  230 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAIN-----FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-PRMENCP  230 (261)
T ss_pred             ceeccCCCccceecCCHHHhc-----cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCC
Confidence            21 112234567899999986     4567889999999999999998 99999887666655555443322 2234678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .++.++|.+||..+|++||+++++++
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         231 DELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-42  Score=343.75  Aligned_cols=261  Identities=24%  Similarity=0.424  Sum_probs=209.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++.+.||+|+||+||+|++..++..||||.+...   ......+.+|+.+++.+ +|+||+++++++..... ...
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~-~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHR-EAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccc-ccc
Confidence            45799999999999999999999999999999988642   23345667899999999 89999999998754321 122


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+. ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            46899999996 6898888654  36999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcc-------------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------------  277 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i-------------  277 (463)
                      ...........++..|+|||.+..    ...++.++|||||||++|+|++|.+||.+.+.......+             
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLN----CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             CCCcccccccccccCccChHHHhc----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            543233345578999999999863    234788999999999999999999999765432211100             


Q ss_pred             --------------cCCCCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         278 --------------PRNAPP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       278 --------------~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                    ......  ....+.++.++.+||.+||+.+|.+|||++++++||||..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                          000000  0112457889999999999999999999999999999964

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4e-42  Score=328.57  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=207.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...++|++.+.||+|+||.||+|++..++ .||+|++.........+.+|+.+++.+ +|+||+++++.+.       .+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-------~~   73 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-------EE   73 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEEC-------CC
Confidence            34567999999999999999999887654 599999976555566788999999999 7999999998762       24


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.+|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            57999999999999999986555568899999999999999999999999999999999999999999999999997664


Q ss_pred             cccCc-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         212 RTIGR-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       212 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ..... .....++..|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+...... .....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  227 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPE  227 (262)
T ss_pred             ccccccccCCcccceecCHhHhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-CCccc
Confidence            33211 12234567899999886     5668899999999999999999 89999877665555544333222 22346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ++..+.+||.+||..+|.+||++.++++
T Consensus       228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         228 CPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-42  Score=336.42  Aligned_cols=258  Identities=34%  Similarity=0.594  Sum_probs=206.6

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|+..+.||+|+||.||++.+..++..+|+|.+....  .....+.+|+.++.++.+|+||+++++++.      ..+..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~------~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF------REGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe------cCCcE
Confidence            4667789999999999999999999999999986432  345577889999999966999999999883      44688


Q ss_pred             EEEEecCCCCCHHHHHH---hhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         134 WLVMEYCGAGSVTDLVK---STKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~---~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      +++|||+.. +|.++..   ......+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++..
T Consensus        79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            999999864 6655433   2334579999999999999999999997 4999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hhhhhcccCCCCCCCCC-
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIPRNAPPRLKS-  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~-  287 (463)
                      ..... ......|++.|+|||++....  ...++.++|||||||++|+|++|++||..... ...+..+.....+.... 
T Consensus       158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd06616         158 LVDSI-AKTRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS  234 (288)
T ss_pred             hccCC-ccccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence            54322 123346899999999986321  13688899999999999999999999976542 22233333333322222 


Q ss_pred             --CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         288 --KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       288 --~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                        ..++.++.+||.+||..+|.+|||++++++||||..
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence              347889999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.7e-42  Score=326.60  Aligned_cols=248  Identities=23%  Similarity=0.423  Sum_probs=207.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      ..|++.+.||+|+||.||++.++. +..+|+|.+.........+.+|+.+|+.+ +||||+++++++      ...+..|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVC------TQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEE------ccCCCEE
Confidence            358999999999999999998754 56799998876555567888999999999 899999999998      4557899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+++|+|.+++....+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        76 iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999999999999875432 58899999999999999999999999999999999999999999999999987653221


Q ss_pred             Cc-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         215 GR-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .. .....++..|+|||++.     ...++.++|||||||++|+|++ |++||...+.......+.....+ ......+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~  228 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFN-----FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-YRPKLASM  228 (256)
T ss_pred             eeccCCCCCchhhCChhhcc-----cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-CCCCCCCH
Confidence            11 12223556899999986     4568889999999999999999 99999887776666665554332 22345678


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+.+||.+||..+|.+||+++++++
T Consensus       229 ~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         229 TVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-43  Score=365.31  Aligned_cols=260  Identities=22%  Similarity=0.379  Sum_probs=194.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCC-cEEEEE------------------EeecCcchHHHHHHHHHHHHHhcCCCc
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTG-QLAAIK------------------VMDVTEDEEEEIKLEINVLKKYSNHRN  113 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vaiK------------------~~~~~~~~~~~~~~Ei~~l~~l~~h~n  113 (463)
                      +.++|++++.||+|+||+||+|..+... ..+++|                  .+.........+.+|+.+|+++ +|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCC
Confidence            3468999999999999999998765332 222222                  2222223345678999999999 8999


Q ss_pred             eeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCc
Q psy7384         114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK---GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQN  190 (463)
Q Consensus       114 Iv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~N  190 (463)
                      |+++++++      ...+..|+|+|++.+ +|.+++....   ........++.|+.||+.||.|||++||+||||||+|
T Consensus       225 Iv~l~~~~------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N  297 (501)
T PHA03210        225 ILKIEEIL------RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN  297 (501)
T ss_pred             cCcEeEEE------EECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            99999998      455789999999964 7777765422   1123466788899999999999999999999999999


Q ss_pred             eEEccCCcEEEEecccccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCC
Q psy7384         191 VLLTDNAEVKLVDFGVSAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP-LCDL  268 (463)
Q Consensus       191 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~P-f~~~  268 (463)
                      ||++.++.+||+|||++..+..... .....+||+.|+|||++.     +..|+.++|||||||++|||++|..+ |.+.
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~ell~~~~~p~~~~  372 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA-----GDGYCEITDIWSCGLILLDMLSHDFCPIGDG  372 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc-----CCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence            9999999999999999987654322 223467999999999997     56789999999999999999998754 4322


Q ss_pred             C--chhhhhcccCC------------------------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy7384         269 H--PMRALFLIPRN------------------------------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLL  316 (463)
Q Consensus       269 ~--~~~~~~~i~~~------------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  316 (463)
                      .  ....+..+...                              .........++..+.++|.+||..||.+|||+.|+|
T Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL  452 (501)
T PHA03210        373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL  452 (501)
T ss_pred             CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence            1  11111111000                              000011124567888999999999999999999999


Q ss_pred             cCccccCCc
Q psy7384         317 KHPFIRDQP  325 (463)
Q Consensus       317 ~hp~~~~~~  325 (463)
                      +||||....
T Consensus       453 ~hp~f~~~~  461 (501)
T PHA03210        453 ALPLFSAEE  461 (501)
T ss_pred             hChhhhcCC
Confidence            999998654

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.7e-42  Score=327.38  Aligned_cols=251  Identities=22%  Similarity=0.427  Sum_probs=209.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...+.|+++++||+|+||.||+|.+. +++.||+|.+.........+.+|+.+++++ +|+||+++++++.       .+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-------~~   73 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVT-------QE   73 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-------cC
Confidence            34567999999999999999999864 567899999987666677889999999999 7999999998862       24


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.+++|.+++....+..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++....
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            68999999999999999977666678999999999999999999999999999999999999999999999999987665


Q ss_pred             ccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         212 RTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       212 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ... .......++..|+|||++.     ...++.++|||||||++|+|++ |++||.+.+.......+...... .....
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  227 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-PRPDN  227 (260)
T ss_pred             CCCcccccCCcccccccCHHHhc-----cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-CCCCC
Confidence            221 1112334667899999986     5568889999999999999999 99999877765555444333222 22345


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+.++.++|.+||..+|.+|||++++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         228 CPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.7e-42  Score=347.58  Aligned_cols=256  Identities=23%  Similarity=0.402  Sum_probs=204.9

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +...++|.+.+.||+|+||.||+|.+...     +..||+|++....  ...+.+.+|+.+|.++..||||+++++++  
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~--  110 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC--  110 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE--
Confidence            34567899999999999999999987533     3469999986432  23457889999999995599999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------------------------------------------------
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------------------------------------------  153 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------  153 (463)
                          ...+.+|||||||.+|+|.+++....                                                  
T Consensus       111 ----~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         111 ----TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             ----ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence                45578999999999999999886432                                                  


Q ss_pred             --------------------------------------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCC
Q psy7384         154 --------------------------------------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ  189 (463)
Q Consensus       154 --------------------------------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~  189 (463)
                                                                  ...+++..+..++.||+.||.|||++||+||||||+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~  266 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR  266 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence                                                        124778888999999999999999999999999999


Q ss_pred             ceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy7384         190 NVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLC  266 (463)
Q Consensus       190 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~  266 (463)
                      |||++.++.+||+|||+++.......  ......+++.|+|||++.     ...++.++|||||||++|+|++ |..||.
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-----DNLYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc-----CCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence            99999999999999999876543221  122335678899999986     5668899999999999999997 999997


Q ss_pred             CCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         267 DLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       267 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .......................++..+.++|.+||..||++|||+.++.+
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            754433333222222222234567899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.7e-42  Score=331.25  Aligned_cols=249  Identities=23%  Similarity=0.411  Sum_probs=197.8

Q ss_pred             eeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHh--cCCCceeeecccccccCCCCCCCeEEE
Q psy7384          62 VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKY--SNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l--~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      .||+|+||.||++.+..+++.+|+|.+....    ........|..+++.+  .+|+||+.+++.+      ...+..|+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF------HTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE------ecCCeEEE
Confidence            4899999999999999999999999886432    1122334444443332  2699999999998      44578999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+.+|+|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        75 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-  151 (279)
T cd05633          75 ILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (279)
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence            999999999999887544  68999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh--hhhcccCCCCCCCCCCCCCHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR--ALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~  293 (463)
                       .....|++.|+|||.+..    +..++.++|||||||++|+|++|..||.......  ......... .......++.+
T Consensus       152 -~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  225 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQK----GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV-NVELPDSFSPE  225 (279)
T ss_pred             -ccCcCCCcCccCHHHhcC----CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC-CcCCccccCHH
Confidence             233469999999998752    3457889999999999999999999997543222  111111111 11223467899


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCc
Q psy7384         294 FQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQP  325 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  325 (463)
                      +++||.+||..||.+|+     ++.++++||||+...
T Consensus       226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            99999999999999999     699999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3e-42  Score=328.49  Aligned_cols=248  Identities=29%  Similarity=0.493  Sum_probs=208.7

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ||.|+||.||+|++..+|+.+|+|++....    .....+.+|+.+++++ +|+||+++++.+      ......|+|||
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~------~~~~~~~lv~e   73 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSF------QGKKNLYLVME   73 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHhe------ecCcEEEEEEe
Confidence            689999999999999999999999986432    3456788899999999 799999999988      45578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC---
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---  215 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---  215 (463)
                      |+.+++|.+++....  .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........   
T Consensus        74 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          74 YLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            999999999997654  689999999999999999999999999999999999999999999999999875533211   


Q ss_pred             -----ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         216 -----RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       216 -----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                           ......++..|++||.+.     ...++.++||||||+++|+|++|..||...........+............+
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVIL-----GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV  226 (265)
T ss_pred             ccccccccCcccCccccCHHHhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence                 223456888999999987     4457889999999999999999999998777665555444433322222235


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCH---HHHhcCccccCC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYT---DQLLKHPFIRDQ  324 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~---~e~l~hp~~~~~  324 (463)
                      +..+.+||.+||+.+|.+|||+   .++|+||||.+.
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             CHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            8999999999999999999999   999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-42  Score=331.31  Aligned_cols=250  Identities=22%  Similarity=0.415  Sum_probs=212.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ...|++.+.||.|+||.||+|.+.. +..+|+|++..... ....+..|+.+++.+ +|+||+++++++      ...+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVC------SVGEP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeE------ecCCC
Confidence            4469999999999999999999887 88999999875544 456788999999999 899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .++||||+.+++|.+++....+..+++..+..++.||+.||.|||++||+|+||||+|||+++++.+||+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999999999876666789999999999999999999999999999999999999999999999999877644


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .........++..|+|||++.     ...++.++|||||||++|+|++ |..||.+.+.......+...... .....++
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  230 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAAS-----HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-PCPAKCP  230 (261)
T ss_pred             ccccccCCCCceEecCHHHHc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-CCCCCCC
Confidence            322223334677899999986     4568889999999999999998 89999887766665555433222 2335778


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +.+.++|.+||..||.+|||+.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.2e-42  Score=331.45  Aligned_cols=251  Identities=30%  Similarity=0.549  Sum_probs=212.6

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +|++.+.||+|+||.||+|.+..+|..||+|++...    ......+.+|+.+++++.+|+||+++++++      ...+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~------~~~~   75 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF------QDEE   75 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh------cCCc
Confidence            599999999999999999999999999999998642    233466788999999994499999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..++||||+.+++|.+++....  .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            8999999999999999997654  69999999999999999999999999999999999999999999999999987664


Q ss_pred             ccc--------------------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch
Q psy7384         212 RTI--------------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM  271 (463)
Q Consensus       212 ~~~--------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  271 (463)
                      ...                    .......++..|+|||++.     ...++.++|||||||++++|++|..||......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-----EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhC-----CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            332                    1223346789999999986     455788999999999999999999999877654


Q ss_pred             hhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHhcCccc
Q psy7384         272 RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT----DQLLKHPFI  321 (463)
Q Consensus       272 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~e~l~hp~~  321 (463)
                      .....+.....  .....+++.+.+||.+||+.+|.+||++    +++++||||
T Consensus       229 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         229 LTFQKILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHHhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44433322111  2234668899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0669|consensus

Probab=100.00  E-value=2.1e-44  Score=320.96  Aligned_cols=267  Identities=27%  Similarity=0.465  Sum_probs=217.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC--
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG--  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~--  128 (463)
                      .+.|+-..+||+|.||.||+|+.+++|+.||+|++-.   .........+|+.+|..+ +|+|++.++++|.....+.  
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence            4568888999999999999999999999999987643   223345667899999999 8999999999997665432  


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||.+|+. +|.-++...+ ..++..+++.+++++++||.|+|++.|+|||+|++|+||+.+|.+||+|||+++
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            33569999999987 8888886543 468999999999999999999999999999999999999999999999999997


Q ss_pred             ccccc----cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-----
Q psy7384         209 QLDRT----IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-----  279 (463)
Q Consensus       209 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-----  279 (463)
                      .+...    ...++..+-|.+|++||.+.+    ...|+++.|||..|||+.||.++.+.|.+.+...++..|..     
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG----~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLG----DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhc----ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            66422    123455677999999999986    56799999999999999999999999999887776654311     


Q ss_pred             --CCCCC--------------C------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         280 --NAPPR--------------L------------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       280 --~~~~~--------------~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                        ...|.              .            .+-.-++++.+|+.++|..||.+|++++++|+|.||...+..
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence              00000              0            000124578899999999999999999999999999876655

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.4e-42  Score=341.25  Aligned_cols=262  Identities=23%  Similarity=0.418  Sum_probs=207.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCC-----
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP-----  126 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~-----  126 (463)
                      ..++|++.+.||.|+||.||+|.+..+|..||+|.+.... .....+.+|+.+++.+ +||||+++++++.....     
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccc
Confidence            4578999999999999999999999999999999986443 3456678899999999 89999999988754311     


Q ss_pred             ---CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc-cCCcEEEE
Q psy7384         127 ---PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLV  202 (463)
Q Consensus       127 ---~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~-~~~~vkL~  202 (463)
                         .......|+||||+. ++|.+++..   ..+++..++.++.||++||.|||++||+||||||+||+++ .++.+||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence               011246899999997 488888753   2588999999999999999999999999999999999997 45678999


Q ss_pred             ecccccccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         203 DFGVSAQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       203 DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      |||++..+.....   ......++..|+|||++..    ...++.++|||||||++|+|++|..||.+.++......+..
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhC----ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999876543211   1122357889999998753    34578899999999999999999999987665443332211


Q ss_pred             CC------------------------CCC----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 NA------------------------PPR----LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 ~~------------------------~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..                        ...    .....++.++.+||.+||+.||.+|||++++++||||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            10                        000    011356788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=336.72  Aligned_cols=256  Identities=24%  Similarity=0.435  Sum_probs=203.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcC--CCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTK--TGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+....    .....+.+|+.++..+ +||||+++++++..    ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLE----HA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeC----CC
Confidence            48999999999999999999988  89999999987532    3345677899999999 89999999999853    22


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc----CCcEEEE
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTK---GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLV  202 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~----~~~vkL~  202 (463)
                      ...+|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||++||+||||||+|||++.    ++.+||+
T Consensus        76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            3689999999975 7777775432   236899999999999999999999999999999999999998    8999999


Q ss_pred             ecccccccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh-------
Q psy7384         203 DFGVSAQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR-------  272 (463)
Q Consensus       203 DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~-------  272 (463)
                      |||++........   .....++++.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.....       
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~  230 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ  230 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence            9999886643322   1234568899999998863    3457889999999999999999999997654322       


Q ss_pred             --hhhc----------------------------ccCCCCCC-----CC--CCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q psy7384         273 --ALFL----------------------------IPRNAPPR-----LK--SKKWPKKFQSFIETVLVKDYHQRPYTDQL  315 (463)
Q Consensus       273 --~~~~----------------------------i~~~~~~~-----~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  315 (463)
                        .+..                            ......+.     ..  ....+..+.++|.+||..||.+|||+.|+
T Consensus       231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei  310 (316)
T cd07842         231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA  310 (316)
T ss_pred             HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence              0000                            00000000     00  01456789999999999999999999999


Q ss_pred             hcCccc
Q psy7384         316 LKHPFI  321 (463)
Q Consensus       316 l~hp~~  321 (463)
                      ++||||
T Consensus       311 l~~~~f  316 (316)
T cd07842         311 LEHPYF  316 (316)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-41  Score=322.36  Aligned_cols=254  Identities=38%  Similarity=0.696  Sum_probs=214.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|++|.||+|.+..++..|++|++....   .....+.+|+.+++++ +|+||+++++.+...    ....
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~~~   75 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDE----EKNT   75 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecC----CCCe
Confidence            3788899999999999999999999999999987554   3567888999999999 799999999998432    1268


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +++|+||+.+++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999999999997654  789999999999999999999999999999999999999999999999999887765


Q ss_pred             ccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-chhhhhcccCCCCCCCCCCC
Q psy7384         213 TIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH-PMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       213 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ...  ......++..|++||.+.     ...++.++||||||+++|+|++|..||.... .......+............
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIR-----GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH  228 (260)
T ss_pred             ccccccccCCCCCccccCHhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcc
Confidence            432  123456899999999986     4458889999999999999999999997765 22333333322222233456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ++..+++||.+||..+|.+||++.++++||||
T Consensus       229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             cCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            68999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-42  Score=332.13  Aligned_cols=250  Identities=24%  Similarity=0.415  Sum_probs=208.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +.|.+.+.||+|+||.||+|.+..     ++..||+|++.....  ....+.+|+++|+.+ +|+||+++++++      
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------   77 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVC------   77 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEE------
Confidence            468999999999999999998753     357899999865433  356888999999999 899999999998      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTK------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD  195 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~  195 (463)
                      ......|+||||+.+++|.+++....            ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~  157 (280)
T cd05049          78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence            44478999999999999999997543            235788899999999999999999999999999999999999


Q ss_pred             CCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy7384         196 NAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMR  272 (463)
Q Consensus       196 ~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~  272 (463)
                      ++.+||+|||++.......  .......+++.|+|||++.     ...++.++|||||||++|+|++ |..||.+.....
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-----YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhc-----cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999987543221  1112334678899999987     5678899999999999999998 999998877666


Q ss_pred             hhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         273 ALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       273 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....+....... ....++..+.+||.+||..||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         233 VIECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            555554443322 33468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.4e-42  Score=330.90  Aligned_cols=260  Identities=22%  Similarity=0.406  Sum_probs=208.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|++.+.||+|+||.||+|.++.     .+..||+|.+.....  ....+.+|+.+++.+ +|+||+++++++   
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~---   78 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVV---   78 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE---
Confidence            345689999999999999999997652     345899998864432  334567899999999 899999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                         ...+..|+||||+.+|+|.+++.....        ..++...+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        79 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~  155 (288)
T cd05061          79 ---SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             ---cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence               444688999999999999999975331        234667889999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q psy7384         197 AEVKLVDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRA  273 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~  273 (463)
                      +.++|+|||+++........  .....++..|+|||.+.     ...++.++|||||||++|+|++ |.+||.+....+.
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-----~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~  230 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV  230 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhc-----cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999998755322111  12224567899999986     5668899999999999999998 7999987766554


Q ss_pred             hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc------CccccCC
Q psy7384         274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK------HPFIRDQ  324 (463)
Q Consensus       274 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~------hp~~~~~  324 (463)
                      ...+....... .....+..++++|.+||+.||.+|||+.++++      ||||...
T Consensus       231 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         231 LKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            44443332222 23356789999999999999999999999986      8998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-42  Score=341.00  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=209.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||.||+|.+..+|..||+|++....   .....+.+|+.+|+.+ +|+||+++++++........
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccc
Confidence            4567999999999999999999999999999999985322   2235677899999999 89999999999864432222


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+++||||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            34679999999 6799888864   3589999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--------  281 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  281 (463)
                      ....   .....+++.|+|||++..    ...++.++|+|||||++|+|++|.+||.+.........+....        
T Consensus       168 ~~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         168 TDSE---MTGYVVTRWYRAPEVILN----WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccC---ccccccCCcccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            6432   234467899999999863    2457889999999999999999999998765433322211100        


Q ss_pred             -------------------CC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -------------------PP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -------------------~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                         ..  .......+..+.++|.+||..||.+|||+.+++.||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence                               00  0012356778999999999999999999999999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=322.72  Aligned_cols=251  Identities=39%  Similarity=0.722  Sum_probs=216.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....   .....+.+|++++.++ +|+||+++++++      ...+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~   73 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSI------ETSDS   73 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEE------EeCCE
Confidence            4889999999999999999999999999999987554   3556788999999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          74 LYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             EEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            99999999999999999765  3689999999999999999999999999999999999999999999999999987765


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .........++..|+|||.+.     ...++.++||||||+++|+|++|..||...........+.....+. ....++.
T Consensus       152 ~~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  225 (254)
T cd06627         152 VSKDDASVVGTPYWMAPEVIE-----MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-LPEGISP  225 (254)
T ss_pred             CcccccccccchhhcCHhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC-CCCCCCH
Confidence            443334457899999999986     3447889999999999999999999998776655555443333322 3346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      .+.++|.+||..+|++|||+.++++||||
T Consensus       226 ~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         226 ELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-41  Score=321.14  Aligned_cols=251  Identities=54%  Similarity=1.023  Sum_probs=214.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      .|++.+.||+|+||.||++.+..++..+++|++..... ....+.+|+.+++.+ +|+||+++++.+      ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSY------LKKDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEE------ecCCeEE
Confidence            38889999999999999999998999999999975543 567888999999999 799999999998      4447899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +++||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++.......
T Consensus        74 l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999999999987653 468999999999999999999999999999999999999999999999999987765432


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-CCCCCHH
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKKWPKK  293 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~  293 (463)
                      . .....++..|++||.+.     ...++.++||||||+++|+|++|..||...+.......+.....+... ...++..
T Consensus       153 ~-~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (253)
T cd05122         153 A-RNTMVGTPYWMAPEVIN-----GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE  226 (253)
T ss_pred             c-ccceecCCcccCHHHHc-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHH
Confidence            2 34557899999999986     445788999999999999999999999877555554444333332222 2335889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKHPF  320 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~hp~  320 (463)
                      +.++|.+||+.||.+|||+.++++|||
T Consensus       227 ~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.9e-42  Score=335.37  Aligned_cols=261  Identities=28%  Similarity=0.464  Sum_probs=204.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCC--CC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP--PG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~--~~  128 (463)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.+++++ +||||+++++++.....  ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence            456999999999999999999999999999999886432   2234556899999999 89999999998754321  12


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .....|+||||+.+ +|.+++.... ..+++..++.++.||++||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence            23567999999975 8888876543 368999999999999999999999999999999999999999999999999987


Q ss_pred             ccccccC----ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC---CC
Q psy7384         209 QLDRTIG----RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR---NA  281 (463)
Q Consensus       209 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~  281 (463)
                      .......    ......++..|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+.......+..   ..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcC----CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            6643221    1123467889999998863    34467899999999999999999999977654332211100   00


Q ss_pred             C------------------C---------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         282 P------------------P---------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       282 ~------------------~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      +                  +         .......+..+.+||.+||..||.+|||++++|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            0                  0         00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.8e-42  Score=341.55  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=209.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++.+.||+|+||.||+|.+..+|..||+|++....   .....+.+|+.+|+.+ +||||++++++|....  ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~--~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPG--ADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccC--CCC
Confidence            357999999999999999999999999999999986432   3345677899999999 7999999999885432  234


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            67899999996 58988886543  5899999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCc----cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-------
Q psy7384         211 DRTIGR----RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-------  279 (463)
Q Consensus       211 ~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-------  279 (463)
                      ......    ....+|+..|+|||++..    ...++.++|||||||++|+|++|++||.+.+....+..+..       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLS----LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcC----CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            432211    123478999999999863    34578899999999999999999999977654332211100       


Q ss_pred             ----------------CCC--CCC----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 ----------------NAP--PRL----KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 ----------------~~~--~~~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                      ...  ...    .....+.++.+||.+||+.+|.+|||+++++.||||..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence                            000  000    11346789999999999999999999999999999964

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=324.63  Aligned_cols=251  Identities=22%  Similarity=0.392  Sum_probs=209.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..+.|++.+.||+|+||.||+|.+. +++.||+|.+.........+.+|+.+++++ +|+||+++++++      ...+.
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~   75 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVC------TLEEP   75 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEE------ecCCC
Confidence            3456999999999999999999875 457899999876655567788999999999 799999999988      44568


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++....+..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            89999999999999999766555789999999999999999999999999999999999999999999999999887653


Q ss_pred             ccCc-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         213 TIGR-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       213 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      .... ......+..|+|||++.     ...++.++|||||||++|+|++ |+.||.+.........+...... .....+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  229 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAAL-----YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-PCPPGC  229 (261)
T ss_pred             CcccccCCCcCceeccCccccc-----cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCcC
Confidence            2111 11112345799999986     5668889999999999999999 99999887766655555443222 233467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +..+.++|.+||+.+|.+||+++++++
T Consensus       230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         230 PKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-41  Score=325.02  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=207.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++.+.||+|+||.||+|.+..+ ..+|+|.+.........+.+|+.+++.+ +|+||+++++++.       .+.
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-------~~~   74 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-------EEP   74 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-------CCC
Confidence            446799999999999999999987655 4589998876555567788999999999 8999999998872       245


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            79999999999999999865555688999999999999999999999999999999999999999999999999976543


Q ss_pred             ccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         213 TIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ... ......++..|+|||++.     ...++.++|||||||++|+|++ |.+||.+..+......+...... .....+
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-PCPQGC  228 (260)
T ss_pred             CcccccCCCccchhhCCHHHhc-----cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCccc
Confidence            211 112234567899999886     5668889999999999999999 99999887766655554443222 223467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +..+++||++||..||.+||+++++++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.6e-42  Score=328.77  Aligned_cols=253  Identities=22%  Similarity=0.389  Sum_probs=205.3

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|++....  .....+.+|+.+++.+ +|+||+++++++    
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVV----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE----
Confidence            45679999999999999999998652     35679999886432  2345678899999998 899999999998    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA  197 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~  197 (463)
                        ......++||||+.+++|.+++.....        ..++...+..++.|++.||.|||+.||+||||||+|||+++++
T Consensus        79 --~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          79 --SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             --cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC
Confidence              455789999999999999999875331        2356788899999999999999999999999999999999999


Q ss_pred             cEEEEecccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q psy7384         198 EVKLVDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRAL  274 (463)
Q Consensus       198 ~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~  274 (463)
                      .++|+|||+++........  .....+++.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.......
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~  231 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL  231 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh-----cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999998765332111  11234578899999987     5668899999999999999999 79999887766555


Q ss_pred             hcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         275 FLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       275 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..+.....+ .....++..+++||.+||+.||.+|||+.+++++
T Consensus       232 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         232 RFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            444333322 2234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.5e-41  Score=333.74  Aligned_cols=259  Identities=41%  Similarity=0.784  Sum_probs=217.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ++...|+..+.||+|+||.||++++..++..+|+|++....    .....+.+|+.+++.+ +|+||+++++++      
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------   94 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCY------   94 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEE------
Confidence            44456888999999999999999999999999999986432    2335678899999999 899999999998      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+..|+||||+.| +|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++
T Consensus        95 ~~~~~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635          95 LREHTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             eeCCeEEEEEeCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCc
Confidence            445688999999975 7877776433 36899999999999999999999999999999999999999999999999988


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ......    ....|++.|+|||++....  ...++.++|||||||++|+|++|.+||...........+.....+....
T Consensus       173 ~~~~~~----~~~~~~~~y~aPE~~~~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  246 (317)
T cd06635         173 SIASPA----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS  246 (317)
T ss_pred             cccCCc----ccccCCccccChhhhhcCC--CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCC
Confidence            654332    3457899999999975311  3457889999999999999999999998877666666655555444555


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ..++..+++||.+||+.+|.+||++.++++|+|+....
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            67889999999999999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0603|consensus

Probab=100.00  E-value=4.7e-43  Score=349.60  Aligned_cols=247  Identities=25%  Similarity=0.361  Sum_probs=211.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +...|++...+|.|+|+.|..|.+..+++..++|++...   ..+..+|+.++....+||||+++++++      .+..+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~------~~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVY------EDGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeeccee------cCCce
Confidence            466799999999999999999999999999999999755   334456777777777999999999999      66789


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE-ccCCcEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl-~~~~~vkL~DFGla~~~~  211 (463)
                      .|+|||++.|+.|.+.+...+  .+ ..++..|+.||+.|+.|||++|||||||||+|||+ ++.++++|+|||.++...
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~--~~-~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP--EF-CSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc--hh-HHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999999999988886544  23 37788899999999999999999999999999999 689999999999998876


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhcccCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~  290 (463)
                      ..   ..+.+-|..|.|||++.     ...|+++|||||||++||+||+|+.||...... +....+.....    ...+
T Consensus       468 ~~---~~tp~~t~~y~APEvl~-----~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~----s~~v  535 (612)
T KOG0603|consen  468 RS---CDTPALTLQYVAPEVLA-----IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF----SECV  535 (612)
T ss_pred             hh---hcccchhhcccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc----cccc
Confidence            54   34557789999999998     678999999999999999999999999765554 33333332222    2688


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      |+.+++||+.||+.||.+|+++++++.||||..
T Consensus       536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  536 SDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             CHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence            999999999999999999999999999999943

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.5e-42  Score=328.59  Aligned_cols=250  Identities=28%  Similarity=0.498  Sum_probs=207.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++.+.||+|+||.||+|++..++..+|+|.+...    ......+.+|+.+++.+ +|+||+++++.+.      ..+
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~------~~~   75 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFI------EDN   75 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeE------eCC
Confidence            588999999999999999999999999999987632    22345778899999999 8999999999984      457


Q ss_pred             eEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ..++||||+.+++|.+++...  ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  155 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  155 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence            899999999999999998742  234689999999999999999999999999999999999999999999999999877


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch--hhhhcccCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM--RALFLIPRNAPPRLKS  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~  287 (463)
                      ............|+..|+|||.+.     ...++.++|+||||+++|+|++|..||.+....  .....+.....+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~ape~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd08229         156 FSSKTTAAHSLVGTPYYMSPERIH-----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS  230 (267)
T ss_pred             cccCCcccccccCCcCccCHHHhc-----CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCc
Confidence            654333334457899999999986     456788999999999999999999999754332  2222232333333344


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..++..+++||.+||..||.+|||+.++++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            567889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-42  Score=335.21  Aligned_cols=254  Identities=38%  Similarity=0.738  Sum_probs=212.4

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      |+...+||+|+||.||++.+..+|..||+|.+.... .....+.+|+.+++.+ +|+||+++++.+      ...+..|+
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~~~~~~l   94 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSY------LVGDELWV   94 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEE------EeCCEEEE
Confidence            445578999999999999999999999999886432 3455678899999998 899999999998      45579999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+++++|.+++...   .+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus        95 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~  171 (292)
T cd06657          95 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  171 (292)
T ss_pred             EEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence            99999999999987542   488999999999999999999999999999999999999999999999999876644333


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCCCCHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKWPKKF  294 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~  294 (463)
                      ......|++.|+|||.+.     ...++.++|+|||||++|+|++|.+||.+.........+....+... ....++..+
T Consensus       172 ~~~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (292)
T cd06657         172 RRKSLVGTPYWMAPELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL  246 (292)
T ss_pred             cccccccCccccCHHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHH
Confidence            334457899999999886     45678899999999999999999999987766554443333322222 224578899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       295 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .++|.+||..+|.+||++.+++.||||....
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            9999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.9e-42  Score=365.55  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=203.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++.++||+|+||.||+|++..+|+.||+|++....    .....+.+|+.++..+ +||||+++++++      ...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~------~d~   74 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSIC------SDG   74 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEE------eeC
Confidence            57999999999999999999999999999999986431    2345688899999999 899999999998      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEE
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK---------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL  201 (463)
                      +..|+||||++||+|.+++....         ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKL  154 (932)
T PRK13184         75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVI  154 (932)
T ss_pred             CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEE
Confidence            78999999999999999986421         123556778899999999999999999999999999999999999999


Q ss_pred             Eecccccccccc------------------cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q psy7384         202 VDFGVSAQLDRT------------------IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP  263 (463)
Q Consensus       202 ~DFGla~~~~~~------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~  263 (463)
                      +|||++......                  .......+||+.|+|||++.     +..++.++|||||||++|+|++|..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-----g~~~S~kSDIWSLGVILyELLTG~~  229 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-----GVPASESTDIYALGVILYQMLTLSF  229 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-----CCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            999999765211                  01112357999999999987     5678899999999999999999999


Q ss_pred             CCCCCCchhhhhcccCCCCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         264 PLCDLHPMRALFLIPRNAPPR-LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       264 Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ||................+.. .....++..+.+++.+||..||.+|++..+.+.+
T Consensus       230 PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        230 PYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             CCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            997754433322211111111 1224678899999999999999999887665543

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-41  Score=324.30  Aligned_cols=251  Identities=28%  Similarity=0.509  Sum_probs=208.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...    ......+.+|+.+++++ +|+||+++++.+.      ..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~------~~   74 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFI------EN   74 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeee------cC
Confidence            4699999999999999999999999999999988532    22356788999999999 8999999999994      45


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +..++||||+.+++|.+++....  ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceee
Confidence            78999999999999999986532  3458899999999999999999999999999999999999999999999999987


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--hhhhhcccCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--MRALFLIPRNAPPRLK  286 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~  286 (463)
                      .............+++.|+|||.+.     ...++.++|||||||++|+|++|..||.....  ......+.....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIH-----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP  229 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhc-----cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC
Confidence            6654333334457899999999986     55688899999999999999999999965432  1222222233333333


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...++..+.++|.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3467889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8e-42  Score=333.51  Aligned_cols=254  Identities=24%  Similarity=0.422  Sum_probs=207.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++....  ...+.+.+|+.+++++.+|+||+++++.+    
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC----  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE----
Confidence            3457999999999999999999863     345689999886432  33457889999999996799999999998    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                        ...+..|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus       109 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         109 --TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             --ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence              445689999999999999999976554458999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCC
Q psy7384         206 VSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       206 la~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      ++........  ......++..|+|||.+.     ...++.++|||||||++|+|++ |.+||.+...............
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~  261 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY  261 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhc-----cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence            9876543211  112234677899999987     5668889999999999999998 9999987665544433322222


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ........+..+.+|+.+||..+|.+|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            22233456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.4e-42  Score=325.64  Aligned_cols=250  Identities=24%  Similarity=0.437  Sum_probs=207.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+.........+.+|+.+++++ +|+||+++++.+.       ...
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-------~~~   74 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVS-------EEP   74 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEEC-------CCC
Confidence            3457999999999999999999865 556799999876555567789999999999 8999999998872       245


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+||++++++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            79999999999999999865555689999999999999999999999999999999999999999999999999876543


Q ss_pred             ccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         213 TIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ... ......++..|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+...... ......
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-PCPQDC  228 (260)
T ss_pred             cccccccCCCCCccccChHHHh-----cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCcC
Confidence            211 112223566899999886     5568889999999999999999 99999887766655555443222 223467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +..+.+||.+||..+|.+|||++++++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.3e-42  Score=340.20  Aligned_cols=258  Identities=22%  Similarity=0.344  Sum_probs=207.2

Q ss_pred             CCCceEE-EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchH---------------HHHHHHHHHHHHhcCCCceee
Q psy7384          53 PAGIFEL-IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---------------EEIKLEINVLKKYSNHRNIAT  116 (463)
Q Consensus        53 ~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~Ei~~l~~l~~h~nIv~  116 (463)
                      ..++|.. .+.||.|+||+||+|.+..+++.||+|++.......               ..+.+|+.+++.+ +|+||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceee
Confidence            4567764 577999999999999999999999999986432211               2467899999999 8999999


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +++++      ...+..|+||||+. |+|.+++....  .+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus        85 ~~~~~------~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         85 LVDVY------VEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK  155 (335)
T ss_pred             eeEEE------ecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC
Confidence            99998      44578999999997 58999886543  58999999999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccc--------------cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy7384         197 AEVKLVDFGVSAQLD--------------RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ  262 (463)
Q Consensus       197 ~~vkL~DFGla~~~~--------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~  262 (463)
                      +.++|+|||++....              ..........+++.|+|||++.+    ...++.++|||||||++|+|++|.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG----AEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc----CCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999987654              11112223457889999999863    334688999999999999999999


Q ss_pred             CCCCCCCchhhhhcccC---CCC---------------------CC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy7384         263 PPLCDLHPMRALFLIPR---NAP---------------------PR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLL  316 (463)
Q Consensus       263 ~Pf~~~~~~~~~~~i~~---~~~---------------------~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  316 (463)
                      +||.+.++...+..+..   ...                     ..  ......+..+.+||.+||..+|.+|||++++|
T Consensus       232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l  311 (335)
T PTZ00024        232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL  311 (335)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence            99988766554332211   000                     00  00124578899999999999999999999999


Q ss_pred             cCccccCC
Q psy7384         317 KHPFIRDQ  324 (463)
Q Consensus       317 ~hp~~~~~  324 (463)
                      .||||+..
T Consensus       312 ~~~~~~~~  319 (335)
T PTZ00024        312 KHEYFKSD  319 (335)
T ss_pred             cCcccCCC
Confidence            99999754

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-41  Score=324.43  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      ++|++++.||+|+||.||+|.+.. +..+|+|.+.........+.+|+.+++++ +||||+++++++      ...+..|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVC------TKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEE------ccCCCcE
Confidence            469999999999999999998754 44699998876555567788999999999 799999999998      4446789


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+.+|+|.+++..... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......
T Consensus        76 lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            99999999999999976443 68999999999999999999999999999999999999999999999999987553321


Q ss_pred             C-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         215 G-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      . ......++..|++||++.     ...++.++|||||||++|+|++ |..||...+.......+...... ......+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  228 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLL-----YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-YRPHLASE  228 (256)
T ss_pred             eeecCCCccChhhCCHHHHh-----cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-CCCCCCCH
Confidence            1 111223566799999986     4568889999999999999998 99999877765555544443332 22345688


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+++++.+||..+|.+|||+.+++.+
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-42  Score=325.01  Aligned_cols=248  Identities=23%  Similarity=0.434  Sum_probs=205.6

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +|++.+.||+|+||.||+|.+. ++..+|+|++.........+.+|+.+++.+ +|+||+++++++      ...+..|+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~~l   76 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVC------TKQRPIFI   76 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEE------cCCCceEE
Confidence            5889999999999999999876 466899999875555556788899999999 899999999998      45578999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||+++.......
T Consensus        77 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            9999999999999975443 689999999999999999999999999999999999999999999999999876543211


Q ss_pred             c-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         216 R-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       216 ~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                      . .....++..|+|||.+.     ...++.++|||||||++|+|++ |.+||....+......+...... .....++..
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  229 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFD-----YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-YRPKLAPTE  229 (256)
T ss_pred             cccCCCCCCccccCHHHhc-----cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHH
Confidence            1 11112345799999987     5668889999999999999999 89999877666655554433222 223467899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.+++.+||..+|.+|||+.++++.
T Consensus       230 ~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         230 VYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.4e-42  Score=340.19  Aligned_cols=256  Identities=24%  Similarity=0.430  Sum_probs=202.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||++....  .....+.+|+.+|.++.+|+||+++++++.   
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---   81 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---   81 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee---
Confidence            3467999999999999999999853     457899999997532  334567889999999977899999999874   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCC---------------------------------------------------
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKG---------------------------------------------------  154 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------  154 (463)
                        .....+++||||+.+|+|.+++.....                                                   
T Consensus        82 --~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          82 --KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             --cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence              233578999999999999999865321                                                   


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC--ccc
Q psy7384         155 --------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRN  218 (463)
Q Consensus       155 --------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~  218 (463)
                                    ..++...+..++.||++||.|||++||+||||||+|||++.++.+||+|||++........  ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          2367778889999999999999999999999999999999999999999999876532211  112


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSF  297 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  297 (463)
                      ...++..|+|||++.     ...++.++|||||||++|+|++ |..||.+.......................++++.++
T Consensus       240 ~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (343)
T cd05103         240 DARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT  314 (343)
T ss_pred             CCCCCcceECcHHhc-----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            233567899999986     5678899999999999999997 9999976543322222111111111223467899999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q psy7384         298 IETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       298 i~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +..||..||.+|||+.++++|
T Consensus       315 ~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         315 MLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-41  Score=333.07  Aligned_cols=261  Identities=27%  Similarity=0.479  Sum_probs=206.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCC--C
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP--G  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~--~  128 (463)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++....   .....+.+|+++++.+ +|+||+++++++......  .
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence            357999999999999999999999999999999885322   2234567899999999 899999999987543221  2


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||||+.+ +|...+... ...+++..++.++.||++||.|||++||+|+||||+|||+++++.++|+|||++.
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence            34578999999975 677766543 3369999999999999999999999999999999999999999999999999987


Q ss_pred             ccccccC-----------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcc
Q psy7384         209 QLDRTIG-----------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI  277 (463)
Q Consensus       209 ~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i  277 (463)
                      .......           ......+++.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+.......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG----ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhC----CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            6543211           1123457889999998863    345788999999999999999999999876655433221


Q ss_pred             cCC--------------------------CCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         278 PRN--------------------------APPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       278 ~~~--------------------------~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ...                          ..+..  ....++..+.+||.+||..||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            110                          00000  012345688999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.7e-41  Score=332.13  Aligned_cols=259  Identities=41%  Similarity=0.783  Sum_probs=216.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .+...|+..+.||+|+||.||+|++..++..+|+|.+...    ......+.+|+.+++.+ +|+||+++++++.     
T Consensus        12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----   85 (308)
T cd06634          12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYL-----   85 (308)
T ss_pred             CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEE-----
Confidence            3455688889999999999999999999999999988632    22345677899999999 8999999999984     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                       .....|+||||+. |+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus        86 -~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  162 (308)
T cd06634          86 -REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA  162 (308)
T ss_pred             -cCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccc
Confidence             4478999999996 58887775433 35899999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ......    ....+++.|+|||++....  ...++.++|||||||++|+|++|..||.+.........+.....+....
T Consensus       163 ~~~~~~----~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (308)
T cd06634         163 SIMAPA----NXFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS  236 (308)
T ss_pred             eeecCc----ccccCCccccCHHHHhhcc--cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCc
Confidence            765432    3456899999999975321  3457789999999999999999999998776665555555555555555


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ..++..+.+||++||..+|.+||+++++++|||+....
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            67889999999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.2e-42  Score=338.71  Aligned_cols=253  Identities=30%  Similarity=0.506  Sum_probs=199.0

Q ss_pred             eeeeee--CCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNG--TYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G--~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      ..||.|  +||+||+|++..+|+.||+|++....   ...+.+.+|+.+++.+ +||||++++++|      ...+..|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~------~~~~~~~~   76 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVF------TTGSWLWV   76 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeE------ecCCceEE
Confidence            456666  99999999999999999999987432   2346678888888888 899999999999      45578999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus        77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            99999999999999876555689999999999999999999999999999999999999999999999986543221111


Q ss_pred             cc-------ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC------
Q psy7384         216 RR-------NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP------  282 (463)
Q Consensus       216 ~~-------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------  282 (463)
                      ..       ....++..|+|||++...   ...++.++|||||||++|+|++|.+||.+.........+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQD---LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             cccccccccccccCccCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence            00       112345679999998632   24578899999999999999999999977654333221111100      


Q ss_pred             ---------------------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         283 ---------------------------------------PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       283 ---------------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                                             .......++..+.+||++||+.||++|||++++|+||||..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                                   00011235678999999999999999999999999999953

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-41  Score=326.23  Aligned_cols=254  Identities=22%  Similarity=0.372  Sum_probs=203.4

Q ss_pred             EEEeeeeeeCCeEEEEEEEcCCCc--EEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          58 ELIEVVGNGTYGQVYKGRHTKTGQ--LAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~~~~~--~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .+.+.||+|+||.||+|++..++.  .+|+|.+...   ......+..|+.+++.+ +|+||+++++.+...........
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence            466899999999999999887765  5899988643   34456778899999999 89999999997654322122346


Q ss_pred             EEEEEecCCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKST----KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .++||||+.+|+|.+++...    ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            79999999999999987532    22358899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         209 QLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ........  .....+++.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+...... .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~  234 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLA-----DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL-K  234 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHcc-----CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-C
Confidence            76432211  12234677899999987     5678899999999999999999 89999877665544444333322 2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ....++..+.++|.+||..||.+|||+++++++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            234678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-41  Score=338.28  Aligned_cols=258  Identities=26%  Similarity=0.444  Sum_probs=207.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....   .....+.+|+.+++++ +|+||+++++++.........
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeeccccccc
Confidence            357999999999999999999999999999999986432   2245677899999999 899999999988543222333


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...|++++++ +++|.+++...   .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            5678999987 77998888643   5899999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC----------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN----------  280 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------  280 (463)
                      ...   .....+++.|+|||++..    ...++.++|||||||++|+|++|.+||........+..+...          
T Consensus       171 ~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         171 DDE---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccc---ccccccCCCccCHHHHhC----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            432   234578999999998862    345788999999999999999999999765543322211000          


Q ss_pred             ---------------CCCC----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 ---------------APPR----LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 ---------------~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                     ..+.    ......+..+.+||.+||..||.+||++.+++.||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence                           0000    001235778999999999999999999999999999974

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-41  Score=328.55  Aligned_cols=250  Identities=21%  Similarity=0.413  Sum_probs=204.6

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEc----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .|++.+.||+|+||.||+|.+.    .++..+|+|.+....  .....+.+|+.+++.+ +||||+++++++      ..
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~------~~   78 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVV------TQ   78 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEE------ec
Confidence            5899999999999999999863    356789999986432  2335788899999999 899999999998      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTK---------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT  194 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~  194 (463)
                      .+..|+||||+.+++|.+++....               ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~  158 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence            568999999999999999986432               12478888999999999999999999999999999999999


Q ss_pred             cCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCch
Q psy7384         195 DNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPM  271 (463)
Q Consensus       195 ~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~  271 (463)
                      .++.+||+|||+++......  .......++..|+|||++.     ...++.++|||||||++|+|++ |.+||.+....
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-----YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ  233 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhc-----cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999997653221  1123334677899999986     4568899999999999999998 99999887765


Q ss_pred             hhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         272 RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       272 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .....+...... .....++..+.+++.+||+.||.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         234 EVIEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            555444333322 2334678999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4645|consensus

Probab=100.00  E-value=3.8e-44  Score=378.51  Aligned_cols=258  Identities=31%  Similarity=0.580  Sum_probs=221.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .-+|+-...||.|.||.||-|.+..+|...|+|-+.....   ....+.+|+.+|..+ +|||+|++|++-++      .
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvH------R 1306 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVH------R 1306 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeec------H
Confidence            3456667899999999999999999999999998864333   345677899999999 89999999999744      4


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..+|.||||+||+|.+++....  ..++...+.+..|+++|+.|||++|||||||||+||+++.+|.+|++|||.|..+
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence            68999999999999999997543  5778888899999999999999999999999999999999999999999999887


Q ss_pred             cccc----CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CchhhhhcccCCCCCCC
Q psy7384         211 DRTI----GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRL  285 (463)
Q Consensus       211 ~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~  285 (463)
                      ....    +.....+||+.|||||++.+..  +.....+.|||||||++.||+||+.||... ++...++.+..+..|..
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~--~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTK--GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccc--cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence            5442    2345678999999999998653  345677899999999999999999999765 45667787777777666


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +.. ++.+-++||..||..||++|.++.|+|.|.|-..
T Consensus      1463 P~~-ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1463 PER-LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             chh-hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            554 9999999999999999999999999999998753

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-41  Score=327.38  Aligned_cols=251  Identities=24%  Similarity=0.444  Sum_probs=205.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +.|++.+.||+|+||.||+|.+..     ++..||+|.+....  .....+.+|+.+++.+ +|+||+++++++.     
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----   79 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEc-----
Confidence            569999999999999999999987     67889999886432  2345688899999999 8999999999884     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC---cE
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKG-----QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA---EV  199 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~---~v  199 (463)
                       ..+..|+||||+.|++|.+++.....     ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+
T Consensus        80 -~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          80 -ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             -cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence             44678999999999999999976542     2588999999999999999999999999999999999998654   59


Q ss_pred             EEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhc
Q psy7384         200 KLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFL  276 (463)
Q Consensus       200 kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~  276 (463)
                      ||+|||+++.+.....  .......+..|+|||++.     ...++.++|||||||++|+|++ |..||.+.........
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~  233 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL-----DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF  233 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHh-----cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999886632211  111223456799999987     5668999999999999999997 9999988766555444


Q ss_pred             ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       277 i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +....... ....++..+.+|+.+||..+|++||++.++++|
T Consensus       234 ~~~~~~~~-~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         234 VTGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            43332222 234678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-41  Score=331.87  Aligned_cols=264  Identities=28%  Similarity=0.472  Sum_probs=209.1

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCC-
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP-  126 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~-  126 (463)
                      +...+.|++.+.||+|+||.||+|.++.+|+.||+|++...   ......+.+|+.+++.+ +||||+++++++..... 
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchh
Confidence            34456799999999999999999999999999999998643   22345677899999999 89999999998854320 


Q ss_pred             ---CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEe
Q psy7384         127 ---PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       127 ---~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~D  203 (463)
                         ......+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++++++.+||+|
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence               0123489999999986 777777643 33689999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC--
Q psy7384         204 FGVSAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--  280 (463)
Q Consensus       204 FGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--  280 (463)
                      ||++........ ......++..|+|||++..    ...++.++|||||||++|+|++|++||...+....+..+...  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999876644321 1223356788999998853    345678999999999999999999999876554433221110  


Q ss_pred             -CCC-------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 -APP-------------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 -~~~-------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                       ..+                         ......++..+.+||.+||..||.+||++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence             000                         00112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-41  Score=337.74  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|.+.+.||+|+||.||+|++..+|..||+|.+...   ......+.+|+.+++.+ +|+||+++++++.........
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCC
Confidence            35799999999999999999999999999999998642   22335677899999999 899999999998644322333


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+.. +|..++.    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            567999999964 7766552    25889999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---------  281 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  281 (463)
                      ...   .....+++.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+....+..+....         
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         168 DAE---MTGYVVTRWYRAPEVILN----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCC---CCCceeeecccChhhhcC----ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            432   234568899999999863    2457889999999999999999999998766443332211100         


Q ss_pred             -------------CCCC-------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -------------PPRL-------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -------------~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                   .+..       ..+..+..+.+||.+||+.||.+||++++++.||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence                         0000       01246778999999999999999999999999999964

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-42  Score=337.75  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=211.4

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||.|+||.||+|++..+|..||+|.+...   ....+.+.+|+.+++.+ +|+||+++++++..... .....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSP-EDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCc-ccccc
Confidence            589999999999999999999989999999988643   23456788899999999 79999999999854321 12247


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+.+ +|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        79 ~~lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          79 VYIVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             eEEEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            8999999974 8888886543  799999999999999999999999999999999999999999999999999987654


Q ss_pred             cc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC-------
Q psy7384         213 TI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-------  282 (463)
Q Consensus       213 ~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------  282 (463)
                      ..   .......+++.|+|||++..    ...++.++|+|||||++|+|++|.+||.+.+....+..+.....       
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLS----SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             cccccccccccccccCcCCceeeec----ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            42   12344568999999999973    22688899999999999999999999987765443332211000       


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         283 ----------------------PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       283 ----------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                            ........+..+.+||.+||+++|.+|||+++++.||||..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                                  00011346788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-41  Score=322.25  Aligned_cols=243  Identities=25%  Similarity=0.419  Sum_probs=199.2

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      +.||+|+||.||+|++..+++.+|+|.+...  ......+.+|+++++.+ +|+||+++++++      ...+..|+|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVC------TQKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE------cCCCCeEEEEe
Confidence            4689999999999999999999999987533  33456788999999999 899999999998      44578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCcc-
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-  217 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-  217 (463)
                      |+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... 
T Consensus        74 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          74 LVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             eccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            999999999986533 358899999999999999999999999999999999999999999999999987543221110 


Q ss_pred             -ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         218 -NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       218 -~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                       ....++..|+|||.+.     ...++.++|||||||++|+|++ |.+||...........+...... .....++..+.
T Consensus       153 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  226 (252)
T cd05084         153 GGMKQIPVKWTAPEALN-----YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-PCPELCPDAVY  226 (252)
T ss_pred             CCCCCCceeecCchhhc-----CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-CCcccCCHHHH
Confidence             1112345699999986     5568889999999999999997 99999776655544444333222 23446788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy7384         296 SFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       296 ~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +||.+||..+|++|||+.++++
T Consensus       227 ~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         227 RLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-41  Score=324.41  Aligned_cols=252  Identities=28%  Similarity=0.557  Sum_probs=208.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec------CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV------TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +|.+.+.||+|+||.||++++..++..+++|++..      .......+..|+.+++.+ +||||+++++.+.      .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~   73 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFL------E   73 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHh------c
Confidence            58999999999999999999988777677766542      223344567889999999 8999999999984      4


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ....++||||+.+++|.+++...  ....+++..++.++.|++.||.|||++||+|+||+|+||++++ +.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCce
Confidence            46789999999999999988652  2346899999999999999999999999999999999999975 56999999998


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ..............|++.|+|||.+.     ...++.++|+||||+++|+|++|..||...........+.....+. ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  226 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALK-----HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS-LP  226 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC-Cc
Confidence            76644333334456889999999886     4567888999999999999999999998766655555544443333 23


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ..++.++.++|.+||..+|.+||++.++++||||
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            4678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=326.10  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=206.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCC-----cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTG-----QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      .++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .....+.+|+.+|+.+ +|+||+++++++     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~-----   78 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVV-----   78 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEE-----
Confidence            457999999999999999999986543     789999986443  3345678899999998 899999999998     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTK--------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE  198 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~  198 (463)
                       ......|+||||+.+|+|.+++....        ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        79 -~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~  157 (277)
T cd05032          79 -STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             -cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC
Confidence             44578999999999999999997533        124678889999999999999999999999999999999999999


Q ss_pred             EEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q psy7384         199 VKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALF  275 (463)
Q Consensus       199 vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~  275 (463)
                      +||+|||+++.+.....  ......++..|+|||.+.     ...++.++|||||||++|+|++ |.+||.+.+......
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  232 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK  232 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHh-----cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence            99999999876543211  122345678899999986     5568889999999999999998 999998777666555


Q ss_pred             cccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       276 ~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+...... .....++..+.+||.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         233 FVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            54433322 223457899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.9e-41  Score=325.51  Aligned_cols=250  Identities=24%  Similarity=0.428  Sum_probs=198.5

Q ss_pred             eeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHh--cCCCceeeecccccccCCCCCCCeEEE
Q psy7384          62 VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKY--SNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l--~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      .||+|+||.||+|++..+++.||+|++....    ........|..+++.+  ..||||+.+++.+      ...+.+|+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF------HTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee------ecCCEEEE
Confidence            4899999999999999999999999986432    1122233343333322  2799999999998      45578999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+.||+|.+++....  .+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++......  
T Consensus        75 v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--  150 (278)
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence            999999999999886543  6899999999999999999999999999999999999999999999999998765432  


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh--hhcccCCCCCCCCCCCCCHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA--LFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~  293 (463)
                      .....+|+..|+|||++..    +..++.++||||+||++|+|++|..||.+......  .........+. ....++..
T Consensus       151 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~  225 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPE  225 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC-CCCcCCHH
Confidence            2234579999999999863    33578899999999999999999999976632221  11111111222 22356899


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         294 FQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      +.++|.+||..+|.+||     ++.++++||||.+..+
T Consensus       226 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             HHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence            99999999999999999     9999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-41  Score=338.47  Aligned_cols=259  Identities=27%  Similarity=0.449  Sum_probs=210.8

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++.+.||+|+||.||+|++..++..||+|++...   ......+.+|+.+++.+ +|+||+++++++........
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence            456799999999999999999999999999999998642   22345677899999999 89999999998854322122


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....|+|+||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            34589999999 5699999864   3589999999999999999999999999999999999999999999999999887


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC-------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-------  282 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------  282 (463)
                      ....   .....++..|+|||++..    ...++.++|||||||++|+|++|+.||.+......+..+.....       
T Consensus       168 ~~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         168 TDDE---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccc---ccCCcccccccCHHHHhC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            6433   244578999999999863    23578899999999999999999999987665544332211100       


Q ss_pred             --------------------CC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         283 --------------------PR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       283 --------------------~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                          ..  .....++..+.+||.+||..+|.+|||+.++++||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~  303 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE  303 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence                                00  001245789999999999999999999999999999974

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-41  Score=334.25  Aligned_cols=249  Identities=24%  Similarity=0.417  Sum_probs=202.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcE----EEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQL----AAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+|++.+.||+|+||.||+|++..++..    ||+|++...  ......+.+|+.+++.+ +||||+++++++..     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~-----   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT-----   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC-----
Confidence            4699999999999999999998766654    899998643  23456788899999999 89999999998842     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        +..++|+||+.+|+|.+++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 --~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          81 --STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             --CCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence              35789999999999999997643 358888999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCcc--ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         209 QLDRTIGRR--NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      .........  ....++..|+|||++.     ...++.++|||||||++|||++ |..||.+.........+..... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~  231 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LP  231 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhc-----cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC-CC
Confidence            765332211  1223466899999987     5678899999999999999997 9999987665443322222221 12


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ....++..+.+++.+||..+|.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.2e-41  Score=320.14  Aligned_cols=251  Identities=35%  Similarity=0.589  Sum_probs=213.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...   ......+.+|+.+++.+ +|+||+++++++.      ....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~~~~   73 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFL------DGNK   73 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhc------cCCE
Confidence            489999999999999999999999999999998643   33455677899999999 7999999999984      4478


Q ss_pred             EEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      .|+||||+.+++|.+++....  ...+++..+..++.||+.||.|||++|++|+||+|.||++++++.+||+|||++...
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            999999999999999986532  346899999999999999999999999999999999999999999999999998776


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...  ......+++.|++||.+.     ...++.++|+||||+++|+|++|+.||...+.......+.....+... ..+
T Consensus       154 ~~~--~~~~~~~~~~~~~Pe~~~-----~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~  225 (256)
T cd08530         154 KKN--MAKTQIGTPHYMAPEVWK-----GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP-PIY  225 (256)
T ss_pred             ccC--CcccccCCccccCHHHHC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc-hhh
Confidence            544  223346889999999986     566788999999999999999999999877765554444444433332 367


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      +.+++++|.+||..+|++|||+.++++||++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            8899999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-41  Score=328.75  Aligned_cols=255  Identities=24%  Similarity=0.439  Sum_probs=208.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|++.+.||+|+||.||++.+...     ...+|+|++....  .....+.+|+.+++++.+|+||+++++++   
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---   85 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---   85 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---
Confidence            3456799999999999999999998643     3689999986432  23456788999999986799999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCc
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKST--------------KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQN  190 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~N  190 (463)
                         ...+.+++||||+.+|+|.+++...              ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus        86 ---~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          86 ---TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             ---cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence               4457899999999999999999653              23468899999999999999999999999999999999


Q ss_pred             eEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy7384         191 VLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCD  267 (463)
Q Consensus       191 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~  267 (463)
                      ||++.++.+||+|||+++.+.....  ......++..|+|||++.     ...++.++|||||||++|+|++ |..||.+
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-----cCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence            9999999999999999986643211  112223456799999986     5678899999999999999997 9999988


Q ss_pred             CCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         268 LHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       268 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ....+....+....... .....+..+.+||.+||..||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         238 IPVEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            76655555444333222 234668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=321.46  Aligned_cols=252  Identities=24%  Similarity=0.428  Sum_probs=210.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...++|++.+.||+|+||.||+|.+. .+..+|+|.+.........+.+|+.+++.+ +|+||+++++++      ....
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~   74 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVC------SEEE   74 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeee------ecCC
Confidence            34567999999999999999999975 457799999986666677889999999999 799999999998      4446


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..++||||+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++..+.
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            78999999999999999987665678999999999999999999999999999999999999999999999999987664


Q ss_pred             cccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .... ......++..|+|||.+.     +..++.++|||||||++|+|++ |+.||.+......+..+...... .....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  228 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAAN-----YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-PRPPN  228 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhc-----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Confidence            3211 111223456899999987     5568889999999999999998 99999887766555555443221 22335


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+.++.+++.+||..+|.+||+++++++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            5889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.1e-41  Score=329.63  Aligned_cols=251  Identities=25%  Similarity=0.452  Sum_probs=204.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc--EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ--LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.|++.+.||+|+||.||+|++..++.  .+++|.+...  ......+.+|+.++.++.+||||+++++++      ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~------~~~   75 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC------ENR   75 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE------ccC
Confidence            359999999999999999999887764  4688887632  233457888999999997799999999998      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +.+|+||||+.+++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence            68999999999999999997532              1248889999999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q psy7384         197 AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALF  275 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~  275 (463)
                      +.+||+|||++........ ......+..|+|||++.     ...++.++|||||||++|+|++ |..||.+........
T Consensus       156 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~  229 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLN-----YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE  229 (297)
T ss_pred             CeEEECCcCCCccccceec-cCCCCcCccccCchhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999864332111 11122355799999986     5668899999999999999997 999998877666555


Q ss_pred             cccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       276 ~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+....... ....++..+.+||.+||..+|.+|||++++++.
T Consensus       230 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         230 KLPQGYRME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            554433222 234678999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-41  Score=331.84  Aligned_cols=250  Identities=27%  Similarity=0.475  Sum_probs=202.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcE--EEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQL--AAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .|++.+.||+|+||.||+|.+..++..  +|+|.+...  ......+.+|+.++.++.+|+||+++++++      ...+
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~------~~~~   81 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC------EHRG   81 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE------CCCC
Confidence            599999999999999999999877754  567766532  234457888999999997899999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA  197 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~  197 (463)
                      .+|+||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            8999999999999999997542              13578999999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhc
Q psy7384         198 EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFL  276 (463)
Q Consensus       198 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~  276 (463)
                      .+||+|||++....... ......++..|+|||++.     ...++.++|||||||++|+|++ |.+||.+....+....
T Consensus       162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  235 (303)
T cd05088         162 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  235 (303)
T ss_pred             cEEeCccccCcccchhh-hcccCCCcccccCHHHHh-----ccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            99999999986432211 112223466799999886     4568889999999999999998 9999987766554444


Q ss_pred             ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       277 i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +....... ....++..+.+||.+||..+|.+||++++++.+
T Consensus       236 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         236 LPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HhcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43322211 223567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-41  Score=327.58  Aligned_cols=250  Identities=23%  Similarity=0.423  Sum_probs=206.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..|.+.+.||+|+||.||++.+.     .++..+|+|.+... ......+.+|+.+++++ +|+||+++++++      .
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~   77 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVC------V   77 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE------e
Confidence            35899999999999999999863     34567899988643 33456788999999999 799999999998      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTK-----------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA  197 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~  197 (463)
                      ..+.+|+||||+.+++|.+++....           ...+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            4578999999999999999997543           12489999999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q psy7384         198 EVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRAL  274 (463)
Q Consensus       198 ~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~  274 (463)
                      .+||+|||++........  ......++..|+|||++.     ...++.++|||||||++|+|++ |.+||.........
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~  232 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-----YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  232 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999876543211  112234577899999986     5678889999999999999998 99999887766655


Q ss_pred             hcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         275 FLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       275 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..+....... ....++.++.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         233 ECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5555444332 23457889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=327.06  Aligned_cols=252  Identities=28%  Similarity=0.495  Sum_probs=208.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+....   .....+.+|+.+++.+ +|+||+++++++      ...+..
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~   73 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVF------RHKGDL   73 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhh------ccCCCE
Confidence            677899999999999999999999999999986432   2356778899999999 799999999998      445789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        74 ~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          74 YLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             EEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            999999975 8888887643 46899999999999999999999999999999999999999999999999998777554


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC------------
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA------------  281 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------  281 (463)
                      ........++..|+|||.+..    ...++.++|||||||++|+|++|++||...+..+.+..+....            
T Consensus       152 ~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         152 VRPYTHYVVTRWYRAPELLLG----DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             cccccCccCcccccCcHHHhc----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence            323344568889999999863    2368889999999999999999999998776654433221100            


Q ss_pred             --------------CC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         282 --------------PP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       282 --------------~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                    ..  ....+.++.++.+||.+||..||.+||++.++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                          00  00112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-41  Score=326.98  Aligned_cols=257  Identities=30%  Similarity=0.480  Sum_probs=209.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      |++.+.||.|+||.||+|++.   .+|..||+|++...     ....+.+.+|+.+++.+.+|+||+++++.+      +
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~------~   75 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF------Q   75 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe------e
Confidence            889999999999999999875   47899999998642     123456788999999997799999999998      5


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .+..+|+||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++.
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            5578999999999999999997543  68899999999999999999999999999999999999999999999999987


Q ss_pred             cccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh----hcccCCCCC
Q psy7384         209 QLDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL----FLIPRNAPP  283 (463)
Q Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~  283 (463)
                      ...... .......|+..|+|||.+...   ...++.++|||||||++|+|++|..||.........    ..+..... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-  229 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGG---DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-  229 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCC---CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-
Confidence            654321 122345689999999998632   235678899999999999999999999643322211    11111111 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                       .....++..+.+|+.+||..||.+||     ++++++.||||....+
T Consensus       230 -~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         230 -PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             -CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence             12345788999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=322.69  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=206.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ++|++.+.||+|+||.||+|.+..+   ...||+|++....  .....+.+|+.+++.+ +|+||+++++.+      ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~   76 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVV------TK   76 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEE------ec
Confidence            4699999999999999999998654   4579999986432  3345778899999999 899999999988      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..++||||+.+++|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            5789999999999999999976443 689999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccc--cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         210 LDRTIGRRN--TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       210 ~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      .........  ...++..|+|||.+.     ...++.++|||||||++|+|++ |..||...........+...... ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~  229 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIA-----YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-PP  229 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhc-----cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CC
Confidence            752221111  123467899999987     4568889999999999999998 99999777665555544433221 22


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...++..+.+|+.+||+.+|++||++.+++++
T Consensus       230 ~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            34678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.7e-41  Score=320.46  Aligned_cols=245  Identities=23%  Similarity=0.416  Sum_probs=204.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      ..|++.+.||+|+||.||++...  |..+|+|.+... .....+.+|+.+++.+ +|+||+++++++.     ...+..|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~~~   76 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIV-----EEKGGLY   76 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhC-CCCCeeeEEEEEE-----cCCCceE
Confidence            36899999999999999999764  778999998644 3456788999999999 8999999999764     3346789


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+.+++|.+++.......+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999999999987665568899999999999999999999999999999999999999999999999987654322


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                         ....++..|+|||++.     ...++.++|||||||++|+|++ |++||...........+.....+ .....++..
T Consensus       157 ---~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  227 (256)
T cd05082         157 ---DTGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGCPPV  227 (256)
T ss_pred             ---CCCccceeecCHHHHc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHH
Confidence               2234567899999986     5568889999999999999997 99999876655544444333222 233567899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +.++|.+||..+|++|||+.++++
T Consensus       228 ~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         228 VYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=324.88  Aligned_cols=253  Identities=30%  Similarity=0.513  Sum_probs=206.2

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      |++.+.||+|+||.||+|.+..+++.||||.+.....  ......+|+..++++.+|+||+++++++      ...+..|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~------~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF------RENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh------hcCCcEE
Confidence            6788999999999999999998999999999864322  2334457899999994499999999999      4467899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+ +|+|.+++....+..+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            999999 7799998876655578999999999999999999999999999999999999999999999999988665432


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC--------------
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--------------  280 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------------  280 (463)
                       ......++..|+|||++..    ...++.++|+||||+++|+|++|.+||......+....+...              
T Consensus       154 -~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLR----STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             -CcCCCCCcccccCceeeec----CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence             2234568899999999863    345788999999999999999999999776654443221110              


Q ss_pred             -------CC-----C--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         281 -------AP-----P--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       281 -------~~-----~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                             ..     .  .......+..+.+||++||..+|.+|||++|++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                   00     0  00011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-41  Score=330.10  Aligned_cols=255  Identities=24%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcC-------CCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeeccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTK-------TGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFI  122 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~  122 (463)
                      ...++|.+.+.||+|+||.||+|++..       ++..+|+|++...  ......+..|+.+++.+.+|+||+++++++ 
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-   93 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-
Confidence            345689999999999999999998743       2357999998743  233456788999999997799999999998 


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCC
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKG  188 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp  188 (463)
                           ...+.+|+||||+.+|+|.+++.....              ..++...++.++.||+.||+|||++||+||||||
T Consensus        94 -----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          94 -----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             -----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence                 445789999999999999999976432              2478889999999999999999999999999999


Q ss_pred             CceEEccCCcEEEEecccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPL  265 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf  265 (463)
                      +|||++.++.+||+|||++.........  .....+++.|+|||++.     +..++.++|||||||++|+|++ |.+||
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~~g~~p~  243 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTLGGSPY  243 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc-----cCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999998765432111  11123456899999987     5668899999999999999998 89999


Q ss_pred             CCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         266 CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       266 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+.........+...... .....++.++++||.+||..+|.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         244 PGVPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CcCCHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            776654444333333222 2334678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-41  Score=323.02  Aligned_cols=255  Identities=22%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      |++.+.||+|+||.||+|.+..+   +..||+|++....   .....+.+|+.+++.+ +|+||+++++++.........
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence            57789999999999999987653   4789999987432   3345788899999999 899999999987544322333


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK----GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                      ...++||||+.+|+|..++....    ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence            46899999999999999886532    23689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         207 SAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       207 a~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ++........  .....++..|+|||++.     ...++.++|||||||++|||++ |.+||.+....+....+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  234 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL  234 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            8865432211  11223467899999986     5678899999999999999999 99999887766655554444332


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      . ....++..+.++|.+||..||.+|||+.+++++
T Consensus       235 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 K-QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             C-CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 244678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.8e-41  Score=329.75  Aligned_cols=255  Identities=23%  Similarity=0.414  Sum_probs=206.1

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcC-------CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTK-------TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAF  121 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~  121 (463)
                      ....++|.+.+.||+|+||.||+|++..       ....+|+|++....  .....+..|+.+++.+.+||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3445689999999999999999998642       34579999987432  33456788999999986799999999998


Q ss_pred             cccCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                            ...+.+|+||||+.+|+|.+++....              ...++...+..++.||+.||.|||++||+|||||
T Consensus        88 ------~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  161 (314)
T cd05099          88 ------TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA  161 (314)
T ss_pred             ------ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence                  44568999999999999999997643              1347888999999999999999999999999999


Q ss_pred             CCceEEccCCcEEEEecccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPP  264 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~P  264 (463)
                      |+|||++.++.+||+|||+++........  .....++..|+|||++.     ...++.++|||||||++|+|++ |..|
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~~g~~p  236 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGILMWEIFTLGGSP  236 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc-----cCCcCccchhhHHHHHHHHHHhCCCCC
Confidence            99999999999999999999765432111  11123446799999986     5668899999999999999999 8999


Q ss_pred             CCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         265 LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       265 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      |.+.........+....... ....++.++++||.+||..+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         237 YPGIPVEELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCCCCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            98776655555444333222 23467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-41  Score=324.62  Aligned_cols=247  Identities=32%  Similarity=0.561  Sum_probs=199.9

Q ss_pred             EEEeeeeeeCCeEEEEEEEc----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          58 ELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++.+.||.|+||.||+|.+.    ..+..|+||++....  .....+.+|++.++++ +||||+++++++.      ..+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~------~~~   74 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCI------ENE   74 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEE------SSS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccc------ccc
Confidence            46789999999999999988    345689999996432  3467889999999999 8999999999995      235


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+++||||+.+|+|.+++.......++...+..|+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++....
T Consensus        75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            69999999999999999998755679999999999999999999999999999999999999999999999999988762


Q ss_pred             ccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         212 RTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       212 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ...  .......+...|+|||.+.     ...++.++||||||+++|||++ |..||.+.........+...... ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~  228 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLK-----DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL-PIPD  228 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHH-----HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-TSBT
T ss_pred             cccccccccccccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccc-eecc
Confidence            211  1122334677899999997     4558999999999999999999 78999888776655555444332 2345


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .++..+.++|..||..+|.+|||+.++++
T Consensus       229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             TSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             chhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            78999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8.6e-41  Score=325.10  Aligned_cols=264  Identities=35%  Similarity=0.587  Sum_probs=210.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..+.|++.+.||+|+||.||+|.+..++..||+|.+....  .....+..|+.++.+..+|+||+++++.+      ...
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~------~~~   86 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF------ITD   86 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee------ecC
Confidence            3467999999999999999999999889999999997442  23455667887777775799999999998      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||++++++.+||+|||++..
T Consensus        87 ~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          87 SDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             CeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            78999999985 47888776543 378999999999999999999997 6999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hhhhhcccCCCCCCCC-C
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIPRNAPPRLK-S  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~~~-~  287 (463)
                      +..... .....++..|+|||.+..... ...++.++|||||||++|+|++|+.||..... .+.+..+.....+... .
T Consensus       165 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06618         165 LVDSKA-KTRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN  242 (296)
T ss_pred             ccCCCc-ccCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence            643322 223457889999999863211 24578899999999999999999999976433 2223222222222222 2


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      ..++.++.+||.+||..||.+||++++++.||||.....
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            247889999999999999999999999999999986443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=325.71  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=205.5

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhc--CCCceeeecccccccCCCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      |++.+.||+|+||.||+|++..++..||+|++.....   ....+.+|+.+++++.  +|+||+++++++..... ....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~-~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT-DREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC-CCCc
Confidence            7889999999999999999998899999999974322   2345667888777763  59999999999854321 1223


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .++++|||+.+ +|.+++.......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            48999999975 89998876554568999999999999999999999999999999999999999999999999987764


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA----------  281 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  281 (463)
                      .... .....++..|+|||++.     ...++.++|||||||++|+|++|.+||.+.+..+.+..+....          
T Consensus       159 ~~~~-~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         159 FEMA-LTSVVVTLWYRAPEVLL-----QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             CCcc-cccccccccccChHHhc-----cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            4321 23345788999999987     4567889999999999999999999998876654433221100          


Q ss_pred             --------CC-------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         282 --------PP-------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       282 --------~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                              .+       ....+..+..+.+||.+||+.||.+||+++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                    00       00012345778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.4e-41  Score=331.65  Aligned_cols=248  Identities=29%  Similarity=0.485  Sum_probs=196.4

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCC
Q psy7384          67 TYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAG  143 (463)
Q Consensus        67 ~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~gg  143 (463)
                      ++|.||.+++..+++.||+|++...   ......+..|+.+++.+ +|+||+++++++.      ..+..|++|||+.+|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~------~~~~~~~~~e~~~~~   84 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFI------VDSELYVVSPLMAYG   84 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheee------cCCeEEEEEeccCCC
Confidence            4455666666778999999998643   34456788999999999 7999999999984      457899999999999


Q ss_pred             CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC-------c
Q psy7384         144 SVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG-------R  216 (463)
Q Consensus       144 sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-------~  216 (463)
                      +|.+++.......+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||.+........       .
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            999999876556789999999999999999999999999999999999999999999999998865532111       1


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---------------
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---------------  281 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------------  281 (463)
                      .....++..|+|||++...   ...|+.++|||||||++|+|++|..||................               
T Consensus       165 ~~~~~~~~~y~aPE~~~~~---~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQN---LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             cccccccccccCHHHhcCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            1234577889999998632   2458889999999999999999999998765433221110000               


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 -----------------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 -----------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                       ........++.++.+||.+||..||.+|||++++|+||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                             0000112334678999999999999999999999999999743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-41  Score=319.25  Aligned_cols=245  Identities=25%  Similarity=0.471  Sum_probs=207.2

Q ss_pred             eeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCcch--HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTEDE--EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +.||+|+||.||+|.+...   +..||+|++......  ...+.+|+.+++.+ +|+||+++++++      .....+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVC------TEEEPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeee------cCCCceEE
Confidence            4789999999999999866   889999999754433  57888999999999 699999999998      44578999


Q ss_pred             EEecCCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         136 VMEYCGAGSVTDLVKSTK-------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ||||+.+++|.+++....       ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence            999999999999998652       2478999999999999999999999999999999999999999999999999998


Q ss_pred             cccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         209 QLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ......  .......+++.|+|||.+.     ...++.++|||||||++|+|++ |..||...........+..... ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~  227 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLK-----DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-LP  227 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhc-----cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC
Confidence            765432  1223446788999999986     4478899999999999999999 6999988866655555544322 22


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ....++.++.++|.+||..+|.+|||+++++++
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            344668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-41  Score=317.85  Aligned_cols=246  Identities=22%  Similarity=0.396  Sum_probs=207.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .+.|++.+.||.|+||.||+|...  |+.||+|.+.........+.+|+.+++.+ +|+||+++++++      ...+..
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~   75 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVV------LQGNPL   75 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEE------cCCCCe
Confidence            346899999999999999999865  78899999976655567888999999999 799999999998      345789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+.+++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999999998766557899999999999999999999999999999999999999999999999998876432


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .   ....++..|+|||.+.     ...++.++|||||||++|+|++ |..||...........+...... .....+++
T Consensus       156 ~---~~~~~~~~~~ape~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  226 (256)
T cd05039         156 Q---DSGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM-EAPEGCPP  226 (256)
T ss_pred             c---ccCCCcccccCchhhc-----CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCccCCCH
Confidence            2   1233466799999986     4567889999999999999997 99999877655544444333222 22346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+.++|.+||..+|.+|||++++++
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.8e-41  Score=323.12  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=197.3

Q ss_pred             Cce-EEEeeeeeeCCeEEEEEE----EcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIF-ELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y-~~~~~LG~G~fg~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ++| ++++.||+|+||+||++.    ...++..||+|++....  .....+.+|+.+|+++ +||||+++++++..    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----   77 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSE----   77 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec----
Confidence            345 999999999999998865    33567899999987543  2456778899999999 89999999998743    


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .....+|+||||+.+++|.+++...   .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccc
Confidence            2335789999999999999999653   4899999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhc-------
Q psy7384         208 AQLDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFL-------  276 (463)
Q Consensus       208 ~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~-------  276 (463)
                      .........   .....++..|+|||++.     ...++.++|||||||++|+|++|..||...... .....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLK-----ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT  229 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhc-----ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence            866432211   11224567799999986     456888999999999999999999998543221 00000       


Q ss_pred             ------ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         277 ------IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       277 ------i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                            .............++..+.+++.+||..+|++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  00000111123457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.1e-41  Score=335.58  Aligned_cols=259  Identities=25%  Similarity=0.460  Sum_probs=208.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++.+.||+|+||.||+|.+..+|..+|+|.+..   .......+.+|+.+++++.+|+||+++++++..    ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~----~~   80 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA----EN   80 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc----CC
Confidence            34679999999999999999999998999999998753   223345667899999999679999999998743    22


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+.+ +|.+++...   .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          81 DKDIYLVFEYMET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             CceEEEEeccccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            3578999999974 998888643   678889999999999999999999999999999999999999999999999876


Q ss_pred             ccccc-----CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC----
Q psy7384         210 LDRTI-----GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN----  280 (463)
Q Consensus       210 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~----  280 (463)
                      .....     .......|++.|+|||++..    ...++.++|||||||++|+|++|++||.+.........+...    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLG----STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeec----cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            54322     12234568999999998863    345778899999999999999999999776544332211000    


Q ss_pred             -------------------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 -------------------------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 -------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                               .......+.++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence                                     0011112346889999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-41  Score=325.92  Aligned_cols=250  Identities=24%  Similarity=0.412  Sum_probs=206.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCcc-hHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTED-EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +.|.+.+.||+|+||.||+|++..     ++..+++|.+..... ....+.+|+.+++++ +|+||+++++++      .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~   77 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVC------G   77 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEE------c
Confidence            469999999999999999998643     456789998864433 345788999999999 899999999998      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT  194 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~  194 (463)
                      ..+..++||||+.+++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~  157 (291)
T cd05094          78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG  157 (291)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence            5578999999999999999997543              13478999999999999999999999999999999999999


Q ss_pred             cCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCch
Q psy7384         195 DNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPM  271 (463)
Q Consensus       195 ~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~  271 (463)
                      .++.++|+|||++.......  .......++..|+|||++.     ...++.++|||||||++|+|++ |..||......
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  232 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-----YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT  232 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999987654321  1122345678899999987     5668889999999999999998 99999877766


Q ss_pred             hhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         272 RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       272 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....+.....+. ....++..+.+||.+||..+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         233 EVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            5555444433322 23457889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0608|consensus

Probab=100.00  E-value=9.6e-42  Score=336.68  Aligned_cols=257  Identities=26%  Similarity=0.452  Sum_probs=216.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      -|..++.||-|+||.|.+++...|..+||+|.+++.    ......++.|-.||... +.+-||+||-.|      ++.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySF------QDkd  702 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSF------QDKD  702 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEe------ccCC
Confidence            478899999999999999999999999999998643    34456677888999887 899999999999      6778


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||+|+.||++..+|-+.+  .|.|..++.|+..+..|+++.|.+|+|||||||+|||||.+|+|||+||||++-+.
T Consensus       703 nLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999999999987655  79999999999999999999999999999999999999999999999999986431


Q ss_pred             ---------ccc---------------------------------CccccccCCccccccceeccCCCCCCCCCcchhHH
Q psy7384         212 ---------RTI---------------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW  249 (463)
Q Consensus       212 ---------~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~Diw  249 (463)
                               ...                                 -.....+||+.|+|||+|.     ...|+..||+|
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-----r~g~~q~cdww  855 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-----RTGYTQLCDWW  855 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-----ccCccccchhh
Confidence                     000                                 0112357999999999998     77899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHhcCccccCC
Q psy7384         250 SLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQ  324 (463)
Q Consensus       250 SlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~  324 (463)
                      |.|||||||+.|++||-...+..+.+++.+-..  .......++.++.++|.+ |+.+++.|..   ++|+..||||+..
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~k-Lc~sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQK-LCCSADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHH-HhcChhhhhcccchhhhhcCcccccc
Confidence            999999999999999988888777666543321  122345789999999998 5667888864   7889999999876


Q ss_pred             chh
Q psy7384         325 PTE  327 (463)
Q Consensus       325 ~~~  327 (463)
                      .+.
T Consensus       935 Dfs  937 (1034)
T KOG0608|consen  935 DFS  937 (1034)
T ss_pred             chH
Confidence            543

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-41  Score=323.67  Aligned_cols=254  Identities=30%  Similarity=0.489  Sum_probs=206.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++.+.||.|+||.||+|.+..+|+.+|+|++...   ......+.+|+.+++.+ +|+||+++++++...    ..+..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~~~~   75 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSK----GKGSI   75 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecC----CCCcE
Confidence            78899999999999999999999999999999754   23345678899999999 799999999998432    13789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+|||+++++.++|+|||++......
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          76 YMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             EEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            999999975 8988886543 36899999999999999999999999999999999999999999999999998876543


Q ss_pred             cC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-------CC--
Q psy7384         214 IG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-------PP--  283 (463)
Q Consensus       214 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------~~--  283 (463)
                      .. ......++..|+|||.+.+    ...++.++|||||||++|+|++|.+||........+..+....       .+  
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLG----ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             CcccccccccccccCCceeeEc----cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            21 1233457889999998763    3457889999999999999999999998766544332221100       00  


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         284 --------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       284 --------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                                          .......+..+.++|.+||..+|.+||+++++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                                00011137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1e-40  Score=318.19  Aligned_cols=251  Identities=21%  Similarity=0.386  Sum_probs=207.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...++|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.+ +|+||+++++.+.      . .
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~-~   73 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT------K-E   73 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEc------C-C
Confidence            45678999999999999999999864 456799998876555567888999999999 8999999999873      3 5


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|+||||+.+++|.+++.......++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            78999999999999999987655678888999999999999999999999999999999999999999999999987654


Q ss_pred             cccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         212 RTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .... ......++..|+|||++.     ...++.++|+|||||++|+|++ |.+||.+.+.......+...... .....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  227 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAIN-----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-PRPEN  227 (260)
T ss_pred             CCCcccccCCcccccccCHhHhc-----cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-CCccc
Confidence            3211 112234567799999986     4568889999999999999998 99999887666555544433222 22346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+.++.+++.+||..+|.+||++.++++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            7889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.2e-41  Score=322.68  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=202.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc----EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+|++++.||+|+||+||+|++..+|.    .||+|++...  ......+.+|+.++..+ +|+||+++++.+..     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-----   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-----   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-----
Confidence            469999999999999999999887776    4899998643  33456788899999998 89999999998842     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        ...+++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++
T Consensus        81 --~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          81 --STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             --CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence              35789999999999999987543 368999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         209 QLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ........  .....+++.|+|||.+.     ...++.++|||||||++|||++ |.+||...........+...... .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~  231 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESIL-----HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-P  231 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C
Confidence            76432211  11123467899999986     5668899999999999999998 99999776554433333332222 2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....++..+.++|.+||..||++||++.+++.
T Consensus       232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            23467889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.2e-41  Score=338.59  Aligned_cols=256  Identities=23%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|.+.+.||+|+||.||+|++.     .+++.||+|++....  .....+.+|+.+|.++..||||+++++++   
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~---  110 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC---  110 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE---
Confidence            44557899999999999999999864     345689999997542  22346788999999994499999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------------------------------------------
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------------------------------------------  154 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------  154 (463)
                         ...+.+|+||||+.+|+|.+++...+.                                                  
T Consensus       111 ---~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         111 ---TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             ---ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence               444689999999999999999975321                                                  


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCC
Q psy7384         155 ----------------------------------------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKG  188 (463)
Q Consensus       155 ----------------------------------------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp  188 (463)
                                                                    ..+++..+..++.||+.||.|||++||+||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                          1356777889999999999999999999999999


Q ss_pred             CceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPL  265 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf  265 (463)
                      +|||++.++.+||+|||+++.......  ......+++.|+|||++.     ...++.++|||||||++|||++ |..||
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-----NNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc-----CCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999876532211  122345788899999987     4568889999999999999998 89999


Q ss_pred             CCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         266 CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       266 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ......+.................++.++.+||.+||..+|.+||++++|++.
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77655444333222221112234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.6e-41  Score=331.42  Aligned_cols=258  Identities=26%  Similarity=0.441  Sum_probs=205.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCC--CcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKT--GQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~--~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +|++.+.||+|+||.||++++..+  +..||+|.+...   ......+.+|+.+++++.+|+||+++++.+....  ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP--GNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc--ccC
Confidence            489999999999999999999888  899999998642   2234567789999999967999999998754221  233


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|++|||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            56899999986 5899888643  36899999999999999999999999999999999999999999999999999765


Q ss_pred             ccccC----ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-------
Q psy7384         211 DRTIG----RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-------  279 (463)
Q Consensus       211 ~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-------  279 (463)
                      .....    ......|++.|+|||++..    ...++.++|||||||++|+|++|.+||...+....+..+..       
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLS----FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            43211    1233578999999998753    34678899999999999999999999976553322211000       


Q ss_pred             --------------------CCCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         280 --------------------NAPP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       280 --------------------~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                                          ....  .......+..+.+||.+||+.||.+|||+.+++.||||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~  296 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA  296 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence                                0000  011234578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.5e-41  Score=329.71  Aligned_cols=254  Identities=29%  Similarity=0.492  Sum_probs=206.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||.|+||.||+|.+..+|..||+|++...   ......+..|+.+++.+ +||||++++++|..     .
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-----~   81 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFIS-----P   81 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEec-----C
Confidence            466899999999999999999999999999999987532   23356778899999999 89999999998842     2


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....|+||||+ +++|.+++..   ..+++..+..++.||++||.|||++||+||||+|.|||++.++.++|+|||++..
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            35789999999 5689888863   2578888999999999999999999999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc-------------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-------------  276 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~-------------  276 (463)
                      ....   .....+++.|+|||++..    ...++.++|||||||++|+|++|.+||...........             
T Consensus       158 ~~~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         158 QDPQ---MTGYVSTRYYRAPEIMLT----WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             cCCC---cCCCcccccccCceeeec----cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            5432   234567889999998752    34688899999999999999999999976554221110             


Q ss_pred             --------------ccCCC--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         277 --------------IPRNA--PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       277 --------------i~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                    .....  +.....+.++..+.++|.+||+.+|++|||+++++.||||..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~  293 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP  293 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence                          00000  000111356789999999999999999999999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.2e-41  Score=325.66  Aligned_cols=250  Identities=23%  Similarity=0.390  Sum_probs=205.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .|++.+.||+|+||.||+|.+..+     +..||+|++.....  ....+..|+.++..+ +||||+++++++      .
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~------~   78 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVV------T   78 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEE------c
Confidence            478889999999999999987643     57899999974432  245678899999988 899999999998      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT  194 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~  194 (463)
                      ..+..++++||+.+++|.+++....              ...+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF  158 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence            4467899999999999999985321              12478888999999999999999999999999999999999


Q ss_pred             cCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCch
Q psy7384         195 DNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPM  271 (463)
Q Consensus       195 ~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~  271 (463)
                      +++.+||+|||+++.......  ......+++.|+|||++.     ...++.++|||||||++|||++ |.+||.+....
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  233 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-----YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  233 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHh-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999876533211  122334678999999986     4568889999999999999998 89999887776


Q ss_pred             hhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         272 RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       272 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .....+...... .....++..+.+|+..||+.+|.+||++++++..
T Consensus       234 ~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         234 DVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            666555444332 2345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0670|consensus

Probab=100.00  E-value=1.6e-42  Score=335.80  Aligned_cols=267  Identities=25%  Similarity=0.403  Sum_probs=219.8

Q ss_pred             CCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc-----CCCceeee
Q psy7384          43 GWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS-----NHRNIATY  117 (463)
Q Consensus        43 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~-----~h~nIv~l  117 (463)
                      ||....+.+...++|.+....|+|-||+|.+|.+..-|..||||||..+....+.=..|+++|++|.     +--|+++|
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            4444455556678999999999999999999999999999999999988777788889999999995     23489999


Q ss_pred             cccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       118 ~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +..|.      ..+++|||||-+. .+|+++++..+ +-.|....++.|+.|++.||..|..+||+|.||||+||||++.
T Consensus       500 ~r~F~------hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  500 FRHFK------HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHhh------hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence            99994      4589999999985 49999998755 3468899999999999999999999999999999999999865


Q ss_pred             -CcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q psy7384         197 -AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF  275 (463)
Q Consensus       197 -~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  275 (463)
                       ..+||||||.|......  ..+.+.-+..|+|||+++     +..|+...|+||+||+||||.||+..|.|.++...+.
T Consensus       573 k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiL-----G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr  645 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIIL-----GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR  645 (752)
T ss_pred             cceeeeccCccccccccc--cccHHHHHHhccCcceee-----cCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence             56899999999876542  335556788899999999     7889999999999999999999999999988776653


Q ss_pred             cccC--------------------------------------------CCCC-C-C-----CCCCC-------CHHHHHH
Q psy7384         276 LIPR--------------------------------------------NAPP-R-L-----KSKKW-------PKKFQSF  297 (463)
Q Consensus       276 ~i~~--------------------------------------------~~~~-~-~-----~~~~~-------~~~~~~l  297 (463)
                      ....                                            ...| . +     ..+.+       -..+++|
T Consensus       646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL  725 (752)
T KOG0670|consen  646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL  725 (752)
T ss_pred             HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence            2100                                            0000 0 0     00011       2368899


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         298 IETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       298 i~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +.+||..||.+|.|+.|+|+||||+.
T Consensus       726 Ldkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  726 LDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHHhccChhhcCCHHHHhcCCcccC
Confidence            99999999999999999999999974

>KOG0668|consensus

Probab=100.00  E-value=2.8e-42  Score=303.48  Aligned_cols=252  Identities=23%  Similarity=0.418  Sum_probs=210.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      +.|++++++|+|-|+.||.|.+..+++.++||+++.  -..+.+.+|+.+|+.|..||||++++++..+.    ......
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp----~Sktpa  111 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP----ESKTPS  111 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc----cccCch
Confidence            469999999999999999999999999999999864  34678899999999998899999999998653    346778


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEecccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~  213 (463)
                      ||+||+.+.+...+..     .++..+++.++.||+.||.|||++||+|||+||.|+||+. ...++|+|+|+|.+....
T Consensus       112 LiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9999999977776654     5888999999999999999999999999999999999985 457999999999887654


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCchhhhhcccCC------------
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-CDLHPMRALFLIPRN------------  280 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf-~~~~~~~~~~~i~~~------------  280 (463)
                       ...+..+.+..|.-||.+..    -..|+.+-|+|||||+|+.|+..+-|| .|.++.+++.+|...            
T Consensus       187 -~eYnVRVASRyfKGPELLVd----y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  187 -KEYNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             -ceeeeeeehhhcCCchheee----chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence             45567788999999999974    567899999999999999999998887 566665555332110            


Q ss_pred             ----CCC-------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         281 ----APP-------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       281 ----~~~-------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                          .++                   .....-.++++.|||.++|..|-..|+||.|++.||||.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence                000                   011123468999999999999999999999999999995

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-40  Score=325.13  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=208.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEc-------CCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeeccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFI  122 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~  122 (463)
                      ....+|++.+.||+|+||.||+|++.       ..+..||+|.+...  ......+.+|+.+++.+.+||||+++++.+ 
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-   90 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-   90 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE-
Confidence            44568999999999999999999753       23457999988643  334567889999999987799999999998 


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCC
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKG  188 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp  188 (463)
                           ......|+||||+.+|+|.+++.....              ..++...+..++.||+.||.|||++||+||||||
T Consensus        91 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp  165 (304)
T cd05101          91 -----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA  165 (304)
T ss_pred             -----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence                 445788999999999999999976431              2467788999999999999999999999999999


Q ss_pred             CceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPL  265 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf  265 (463)
                      +|||++.++.+||+|||+++.......  ......+++.|+|||++.     +..++.++|||||||++|+|++ |..||
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999986643221  112234567899999986     5668899999999999999998 88999


Q ss_pred             CCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         266 CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       266 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+.+.......+...... .....++..+++||.+||..+|.+|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         241 PGIPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ccCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            877666655554433322 2334678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.3e-41  Score=325.22  Aligned_cols=251  Identities=23%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCC----------------cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceee
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTG----------------QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIAT  116 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~----------------~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~  116 (463)
                      ++|++++.||+|+||.||+|.+..++                ..||+|.+....  .....+.+|+++++.+ +|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~   83 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIAR   83 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeE
Confidence            57999999999999999999876544                458999987443  3456788999999999 8999999


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK---------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                      +++++      ..++..++||||+.+++|.+++....         ...+++..++.++.||+.||.|||++||+|||||
T Consensus        84 ~~~~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          84 LLGVC------TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             EEEEE------ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            99998      44478999999999999999997643         1258899999999999999999999999999999


Q ss_pred             CCceEEccCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh--CCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE--SQP  263 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~--g~~  263 (463)
                      |+||+++.++.++|+|||++.......  .......+++.|+|||++.     ...++.++|||||||++|+|++  |..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~~~~~~~  232 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-----LGKFTTKSDVWAFGVTLWEILTLCREQ  232 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-----cCCCCccchhhhhHHHHHHHHhcCCCC
Confidence            999999999999999999987653221  1123345678899999987     4568899999999999999998  788


Q ss_pred             CCCCCCchhhhhcccCC------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         264 PLCDLHPMRALFLIPRN------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       264 Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ||........+..+...      .........++.++.+||.+||+.||.+|||+.++++
T Consensus       233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            98776655544332211      1111123456789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1290|consensus

Probab=100.00  E-value=5.1e-41  Score=323.78  Aligned_cols=273  Identities=26%  Similarity=0.454  Sum_probs=216.5

Q ss_pred             CCCCCCcCCCCC-CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC-------Cce
Q psy7384          43 GWPEDRWQEDPA-GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-------RNI  114 (463)
Q Consensus        43 ~~~~~~~~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h-------~nI  114 (463)
                      ||.+.+..+.+. ++|.++++||.|-|++||+|.|..+.+.||+|+.+..+.-.+....||++|+++..+       ..|
T Consensus        65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V  144 (590)
T KOG1290|consen   65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCV  144 (590)
T ss_pred             CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence            466677777787 899999999999999999999999999999999988777788889999999998643       379


Q ss_pred             eeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEE
Q psy7384         115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLL  193 (463)
Q Consensus       115 v~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl  193 (463)
                      |+|++.|....+  ...++|+|+|++ |-+|..+|.....+.++...++.|++|||.||.|||. +||||.||||+|||+
T Consensus       145 V~LlD~FkhsGp--NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  145 VQLLDHFKHSGP--NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeccceecCC--CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            999999987653  457999999999 5599999998888899999999999999999999997 599999999999998


Q ss_pred             ccC-----------------------------------------------------------------------------
Q psy7384         194 TDN-----------------------------------------------------------------------------  196 (463)
Q Consensus       194 ~~~-----------------------------------------------------------------------------  196 (463)
                      ..+                                                                             
T Consensus       222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~  301 (590)
T KOG1290|consen  222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE  301 (590)
T ss_pred             eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence            400                                                                             


Q ss_pred             --------------------------------------------------------------------------------
Q psy7384         197 --------------------------------------------------------------------------------  196 (463)
Q Consensus       197 --------------------------------------------------------------------------------  196 (463)
                                                                                                      
T Consensus       302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~  381 (590)
T KOG1290|consen  302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN  381 (590)
T ss_pred             ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence                                                                                            


Q ss_pred             ---------CcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7384         197 ---------AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD  267 (463)
Q Consensus       197 ---------~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  267 (463)
                               ..|||+|||-|+.....   .+.-+.|..|+||||+.     +..|+..+||||++|+++||+||...|..
T Consensus       382 p~~~~~~~di~vKIaDlGNACW~~kh---FT~DIQTRQYRapEVll-----GsgY~~~ADiWS~AC~~FELaTGDyLFeP  453 (590)
T KOG1290|consen  382 PDIPLPECDIRVKIADLGNACWVHKH---FTEDIQTRQYRAPEVLL-----GSGYSTSADIWSTACMAFELATGDYLFEP  453 (590)
T ss_pred             CCCCCCccceeEEEeeccchhhhhhh---hchhhhhhhccCcceee-----cCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence                     01566666666554322   23446789999999999     78899999999999999999999998843


Q ss_pred             CCc------hhhhhc-------cc----------------CCCCCCC-CCC------------CCC----HHHHHHHHHh
Q psy7384         268 LHP------MRALFL-------IP----------------RNAPPRL-KSK------------KWP----KKFQSFIETV  301 (463)
Q Consensus       268 ~~~------~~~~~~-------i~----------------~~~~~~~-~~~------------~~~----~~~~~li~~~  301 (463)
                      .+-      .+-+..       ++                ++....+ ..+            .|+    .++.+||.-|
T Consensus       454 hsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~Pm  533 (590)
T KOG1290|consen  454 HSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPM  533 (590)
T ss_pred             CCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHH
Confidence            211      111110       00                0000000 001            333    3578899999


Q ss_pred             hhcCCCCCCCHHHHhcCccccCCch
Q psy7384         302 LVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       302 L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      |+.+|++||||.++|+|||+...+.
T Consensus       534 Lef~PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  534 LEFDPEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             HhcCccccccHHHHhcCccccCCCC
Confidence            9999999999999999999986543

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.5e-41  Score=323.35  Aligned_cols=250  Identities=23%  Similarity=0.392  Sum_probs=204.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+|.+.++||+|+||.||++...     .++..+|+|.+... ......+.+|+++++.+ +|+||+++++++      .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~   77 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVC------T   77 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEE------e
Confidence            35888999999999999999753     34668999987643 34456788999999999 899999999988      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKG-------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD  195 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~  195 (463)
                      ..+..++||||+.+++|.+++.....             ..+++..++.++.||+.||+|||++||+||||||+|||+++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~  157 (280)
T cd05092          78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ  157 (280)
T ss_pred             cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence            44678999999999999999976432             24788999999999999999999999999999999999999


Q ss_pred             CCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy7384         196 NAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMR  272 (463)
Q Consensus       196 ~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~  272 (463)
                      ++.+||+|||++........  ......+++.|+|||++.     ...++.++|||||||++|+|++ |.+||.......
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  232 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-----YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE  232 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc-----cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence            99999999999875532211  112234577899999987     5668899999999999999998 999998777666


Q ss_pred             hhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         273 ALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       273 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....+...... .....++..+.+||.+||+.||.+||++++++.
T Consensus       233 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         233 AIECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            55555444332 223467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-41  Score=321.90  Aligned_cols=252  Identities=29%  Similarity=0.514  Sum_probs=207.6

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      |++.+.||+|+||.||+|++..+++.||+|++...   ......+..|+.+++.+ +|+||+++++++      ...+..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~------~~~~~~   73 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVI------HTERKL   73 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhh------hcCCce
Confidence            67789999999999999999999999999998754   33346677899999999 799999999998      445789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      ++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||++++++.++|+|||++......
T Consensus        74 ~~v~e~~~~-~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          74 YLVFEYCDM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             EEEecCcCc-CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            999999984 8999998653 36899999999999999999999999999999999999999999999999998876544


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC--------------
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--------------  279 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~--------------  279 (463)
                      ........++..|+|||.+..    ...++.++|||||||++|+|++|.+||........+..+..              
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07829         152 LRTYTHEVVTLWYRAPEILLG----SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT  227 (282)
T ss_pred             ccccCccccCcCcCChHHhcC----CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence            333344557888999999863    23678899999999999999999999977654433222110              


Q ss_pred             ------CCCCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         280 ------NAPPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       280 ------~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                            ...+.       ...+..+..+.++|.+||..||.+||+++++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                  00000       1112347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.1e-40  Score=357.21  Aligned_cols=145  Identities=30%  Similarity=0.530  Sum_probs=130.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|+++++||+|+||.||+|++..+++.||||++....    .....+..|+.++..+ +|+||+++++++      ...
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~------~~~   76 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSL------QSA   76 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEE------EEC
Confidence            46999999999999999999999999999999986432    2346678899999888 899999999888      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +.+||||||+.|++|.+++....  .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus        77 ~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          77 NNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            78999999999999999997543  68899999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-40  Score=317.65  Aligned_cols=240  Identities=24%  Similarity=0.400  Sum_probs=198.0

Q ss_pred             eeeeeCCeEEEEEEE--cCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          62 VVGNGTYGQVYKGRH--TKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~--~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      .||+|+||.||+|.+  ..++..+|+|++....   .....+..|+.+++.+ +|+||+++++++.       .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-------~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-------AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-------CCCcEEE
Confidence            689999999999965  4567899999986432   2346788899999999 8999999999872       2467999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      |||+.+|+|.+++....  .+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++.........
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          74 MELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            99999999999996543  6899999999999999999999999999999999999999999999999998766433221


Q ss_pred             ---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         217 ---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       217 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                         .....++..|+|||.+.     ...++.++|||||||++|||++ |.+||.+.........+.....+. ....++.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~  225 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME-CPQRCPP  225 (257)
T ss_pred             eeecCCCCCCccccCHhHhc-----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCCH
Confidence               11223457899999886     4568889999999999999998 999998877666555554443322 3346889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ++++||.+||+.||.+||++++|..
T Consensus       226 ~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         226 EMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHHHHHhccCchhCcCHHHHHH
Confidence            9999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-40  Score=321.27  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=200.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc----EEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +.|++++.||+|+||+||+|.+..++.    .+++|.+....  .....+..|+.++..+ +||||+++++++.      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~------   79 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP------   79 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC------
Confidence            468999999999999999999987776    46777775332  2335667788888888 8999999999872      


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                       ....++|+||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 -~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          80 -GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             -CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence             245789999999999999997543 368999999999999999999999999999999999999999999999999997


Q ss_pred             ccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         209 QLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      .......  ......++..|+|||++.     ...++.++|||||||++|||++ |..||.+.........+..+..+ .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~-----~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~  231 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESIL-----FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL-A  231 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhc-----cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C
Confidence            6532211  122345677899999986     5568899999999999999998 99999887655443333332222 2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....++..+.+++.+||..||++|||+.++++
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            23356788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-40  Score=315.82  Aligned_cols=248  Identities=27%  Similarity=0.466  Sum_probs=207.6

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCC----cEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTG----QLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +++.+.||.|+||.||+|.+...+    ..||+|++.....  ....+..|+.+++.+ +|+||+++++.+.      ..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~~   73 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCT------EE   73 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEc------CC
Confidence            356789999999999999998766    8899999975543  467888999999999 8999999999984      44


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..|+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++...
T Consensus        74 ~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       74 EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceec
Confidence            78999999999999999997655433899999999999999999999999999999999999999999999999998766


Q ss_pred             ccccCccc-cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         211 DRTIGRRN-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       211 ~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ........ ...+++.|+|||.+.     ...++.++|||||||++|+|++ |.+||...+.......+....... ...
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~  227 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLK-----DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP-KPE  227 (258)
T ss_pred             ccccccccccCCCcccccChHHhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCC
Confidence            54311111 123678999999985     5678899999999999999998 899998766655555544443332 233


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..+.++.+++.+||..+|.+|||+.++++
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      228 NCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             cCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            57899999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-40  Score=329.21  Aligned_cols=255  Identities=23%  Similarity=0.396  Sum_probs=206.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC-------CcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeeccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT-------GQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFI  122 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~  122 (463)
                      ....+|++.+.||+|+||.||+|++...       +..||+|++...  ......+.+|+.+++++.+|+||+++++++ 
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-   87 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC-   87 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE-
Confidence            3445799999999999999999986432       236899988643  233567889999999997799999999998 


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCC
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKG  188 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp  188 (463)
                           ...+.+|+||||+.+|+|.+++....              ...++...+..++.||+.||.|||++||+||||||
T Consensus        88 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          88 -----TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             -----ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence                 44568999999999999999997542              12467788899999999999999999999999999


Q ss_pred             CceEEccCCcEEEEecccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPL  265 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf  265 (463)
                      +|||++.++.+||+|||+++........  .....++..|+|||++.     ...++.++|||||||++|+|++ |..||
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc-----cCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999998765432211  11223456799999987     5678889999999999999998 89999


Q ss_pred             CCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         266 CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       266 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+.+.......+...... .....++..+.+||.+||..+|.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         238 PGIPVEELFKLLKEGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            887766655544433322 2234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=314.43  Aligned_cols=243  Identities=33%  Similarity=0.533  Sum_probs=206.3

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ||.|+||.||++.+..+++.+|+|++....    .....+..|+.+++.+ +|+||+++++.+      ...+.+|+|||
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~~~v~e   73 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAF------QTEEKLYLVLE   73 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHe------ecCCeeEEEEe
Confidence            699999999999999889999999986432    2455788899999999 799999999998      55679999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccc
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN  218 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  218 (463)
                      |+.+++|.+++....  .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...........
T Consensus        74 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~  151 (250)
T cd05123          74 YAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN  151 (250)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence            999999999997654  589999999999999999999999999999999999999999999999999877654322334


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFI  298 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li  298 (463)
                      ...++..|++||.+.     ...++.++|+||||+++|+|++|..||...........+....  .......+..+.+||
T Consensus       152 ~~~~~~~~~~Pe~~~-----~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i  224 (250)
T cd05123         152 TFCGTPEYLAPEVLL-----GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LRFPEFLSPEARDLI  224 (250)
T ss_pred             CCcCCccccChHHhC-----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHH
Confidence            556889999999986     4457888999999999999999999997766544444443322  122335588999999


Q ss_pred             HHhhhcCCCCCCCH---HHHhcCccc
Q psy7384         299 ETVLVKDYHQRPYT---DQLLKHPFI  321 (463)
Q Consensus       299 ~~~L~~dp~~Rpt~---~e~l~hp~~  321 (463)
                      ++||..||.+||++   +++++||||
T Consensus       225 ~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         225 SGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            99999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-40  Score=318.59  Aligned_cols=249  Identities=24%  Similarity=0.425  Sum_probs=203.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc---EEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ++|++.+.||+|+||.||+|++..++.   .+|+|.+....  .....+.+|+.+++.+ +||||+++++++      ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~   76 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVV------TK   76 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE------ec
Confidence            469999999999999999999875543   79999886432  3346788899999999 899999999998      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            578999999999999999997543 3588999999999999999999999999999999999999999999999999886


Q ss_pred             cccccCcc---ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         210 LDRTIGRR---NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       210 ~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ........   ....++..|+|||.+.     ...++.++|+|||||++|+|++ |..||.+.........+..... ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~  229 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LP  229 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhc-----cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CC
Confidence            64322111   1122356799999986     4568899999999999999886 9999987765554444443322 12


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....++..+.+++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         230 APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            23457889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=315.73  Aligned_cols=241  Identities=23%  Similarity=0.384  Sum_probs=198.7

Q ss_pred             eeeeeeCCeEEEEEEEcCCC---cEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTG---QLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +.||+|+||.||+|.+..++   ..+|+|.+.....  ....+.+|+.+++.+ +|+||+++++++.       .+..++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-------~~~~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-------GEPLML   72 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-------CCceEE
Confidence            47999999999999876554   7899999875543  456788999999999 8999999999873       246899


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+.+|+|.+++....  .+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||+++.......
T Consensus        73 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          73 VMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            999999999999997554  689999999999999999999999999999999999999999999999999887643322


Q ss_pred             cccc---ccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         216 RRNT---FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       216 ~~~~---~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ....   ..++..|+|||.+.     ...++.++|||||||++|+|++ |.+||......+....+..... ......++
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  224 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECIN-----YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-LPRPEECP  224 (257)
T ss_pred             ccccccCccccccccCHHHhc-----CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-CCCCCCCC
Confidence            1111   12345799999886     5668889999999999999998 9999987766554444433322 23345678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..++++|.+||..+|++||++.++++
T Consensus       225 ~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         225 QEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            89999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-40  Score=319.41  Aligned_cols=252  Identities=20%  Similarity=0.434  Sum_probs=207.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ..|++++.||+|+||.||+|+++.+     .+.|++|.+.....  ....+.+|+.+++++ +|+||+++++.+      
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------   77 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLC------   77 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEE------
Confidence            4689999999999999999997643     46799998865433  356788999999999 899999999988      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEE
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKG-------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK  200 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vk  200 (463)
                      ...+..|+||||+++|+|.+++.....       ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence            445788999999999999999976542       2589999999999999999999999999999999999999999999


Q ss_pred             EEecccccccccc-cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhccc
Q psy7384         201 LVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       201 L~DFGla~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~  278 (463)
                      |+|||++...... ........++..|+|||.+.     ...++.++|||||||++|+|++ |..||.+.........+.
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~  232 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ-----EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ  232 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence            9999998654321 11223345677899999886     4557788999999999999998 889998776666555554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...........++..+.++|.+||..+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            3333333345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.6e-40  Score=314.34  Aligned_cols=248  Identities=23%  Similarity=0.410  Sum_probs=205.3

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      .|++.+.||+|+||.||+|.+. .+..+|+|++.........+.+|+++++.+ +||||+++++++      ......|+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~~~   76 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVC------TERSPICL   76 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEE------ccCCceEE
Confidence            6899999999999999999875 467899999876555567788999999999 899999999998      44568899


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999999999987543 3578999999999999999999999999999999999999999999999999875532211


Q ss_pred             -ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         216 -RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       216 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                       ......++..|+|||++.     ...++.++|||||||++|+|++ |.+||...........+...... ......+..
T Consensus       156 ~~~~~~~~~~~~~aPe~~~-----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  229 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFS-----FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL-YKPRLASQS  229 (256)
T ss_pred             cccCCCccchhhcCHhHhc-----cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC-CCCCCCCHH
Confidence             112223567899999986     4568889999999999999998 99999876655555444333222 223456889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.+|+.+||..+|.+|||+++++++
T Consensus       230 ~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         230 VYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=324.41  Aligned_cols=252  Identities=22%  Similarity=0.358  Sum_probs=200.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCC--------------cEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeee
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTG--------------QLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATY  117 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--------------~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l  117 (463)
                      .++|++.+.||+|+||.||+|++..++              ..||+|++...  ......+.+|+++++++ +|+||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence            457999999999999999999875432              35899998643  23345788999999999 89999999


Q ss_pred             cccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG----------QSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       118 ~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                      ++++      ...+..++||||+.+++|.+++.....          ..+++..+..++.||+.||.|||++||+|||||
T Consensus        83 ~~~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  156 (295)
T cd05097          83 LGVC------VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA  156 (295)
T ss_pred             EEEE------cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence            9998      445788999999999999999864321          136788899999999999999999999999999


Q ss_pred             CCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh--CCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE--SQP  263 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~--g~~  263 (463)
                      |+|||+++++.+||+|||++........  ......++..|+|||++.     ...++.++|||||||++|+|++  |..
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlG~~l~el~~~~~~~  231 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-----LGKFTTASDVWAFGVTLWEMFTLCKEQ  231 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc-----cCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999876532211  112234567899999987     5668899999999999999988  678


Q ss_pred             CCCCCCchhhhhcccC------CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         264 PLCDLHPMRALFLIPR------NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       264 Pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ||...+.......+..      ..........+++.+.+||.+||..||.+||+++++++
T Consensus       232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         232 PYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8887665444332211      11111123456889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.6e-40  Score=322.13  Aligned_cols=249  Identities=26%  Similarity=0.454  Sum_probs=202.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .....+.+|+.+++.+ +||||+++++.+      .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~   73 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGAC------S   73 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEE------e
Confidence            37889999999999999998753     23578889886433  2345788899999999 899999999998      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCC
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTK----------------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDI  186 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDL  186 (463)
                      ..+..|+||||+.+++|.+++....                      ...+++..+..++.|++.||.|||++||+||||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di  153 (290)
T cd05045          74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL  153 (290)
T ss_pred             cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence            5577899999999999999986432                      124788899999999999999999999999999


Q ss_pred             CCCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy7384         187 KGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQP  263 (463)
Q Consensus       187 kp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~  263 (463)
                      ||+|||+++++.+||+|||+++.......  ......++..|+|||.+.     ...++.++|||||||++|+|++ |..
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~  228 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-----DHIYTTQSDVWSFGVLLWEIVTLGGN  228 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-----cCCcchHhHHHHHHHHHHHHHhcCCC
Confidence            99999999999999999999876533211  112234567899999886     5668899999999999999998 999


Q ss_pred             CCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         264 PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       264 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ||.+.........+...... .....++.++.+||.+||+.+|.+||++.++++
T Consensus       229 p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         229 PYPGIAPERLFNLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCCCHHHHHHHHhCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99877665544443333222 223467889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.9e-40  Score=315.47  Aligned_cols=244  Identities=23%  Similarity=0.419  Sum_probs=201.8

Q ss_pred             eeeeeeCCeEEEEEEEcC-CCc--EEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTK-TGQ--LAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +.||+|+||.||+|.+.. .+.  .||+|.+.....  ....+.+|+.+++++ +|+||+++++.+.      . ...++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~-~~~~~   72 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVL------T-HPLMM   72 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEc------C-CeEEE
Confidence            468999999999999865 333  689999875443  456788999999999 8999999999983      3 68999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      ||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.....
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            99999999999999765434689999999999999999999999999999999999999999999999999887644211


Q ss_pred             c---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         216 R---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       216 ~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .   .....++..|+|||++.     ...++.++|||||||++|+|++ |..||...+..+....+.............+
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~-----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLR-----TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACP  227 (257)
T ss_pred             ceecccCCCCCceecCHHHhc-----ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCC
Confidence            1   11235678899999986     5668889999999999999998 9999987766665554443222222334678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..+.+++.+||..+|++||++.++++
T Consensus       228 ~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         228 QDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            89999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.3e-40  Score=315.57  Aligned_cols=241  Identities=25%  Similarity=0.411  Sum_probs=196.8

Q ss_pred             eeeeeCCeEEEEEEEc--CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEE
Q psy7384          62 VVGNGTYGQVYKGRHT--KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      .||+|+||.||+|.+.  ..+..||+|++....  ...+.+.+|+.+++++ +|+||+++++++.       .+..++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-------~~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-------AEALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-------CCCeEEEE
Confidence            4899999999999875  445679999986443  2345688999999999 8999999999872       24689999


Q ss_pred             ecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc-
Q psy7384         138 EYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-  216 (463)
Q Consensus       138 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-  216 (463)
                      ||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... 
T Consensus        74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            9999999999987533 36899999999999999999999999999999999999999999999999998765432211 


Q ss_pred             --cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         217 --RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       217 --~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                        .....++..|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+.....+ ......+.+
T Consensus       153 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  226 (257)
T cd05115         153 KARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-DCPAECPPE  226 (257)
T ss_pred             eccCCCCCCcccCCHHHHc-----cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-CCCCCCCHH
Confidence              11122357899999986     4568889999999999999996 99999887776655544443332 233467889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +.++|.+||..+|++||++.++++
T Consensus       227 l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         227 MYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.8e-40  Score=320.05  Aligned_cols=251  Identities=21%  Similarity=0.406  Sum_probs=204.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      .++|++++.||+|+||.||+|.+..     ++..||+|++....  .....+.+|+.++..+ +||||+++++++     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~-----   77 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVC-----   77 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEE-----
Confidence            3569999999999999999998753     57889999986443  2345688899999999 899999999998     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCC--------------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCC
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------------QSLKEEWIAFICREILRGLKYLHENKVIHRDI  186 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDL  186 (463)
                       ..++..|+||||+.+|+|.+++.....                    ..+++..+..++.||+.||.|||++||+||||
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl  156 (288)
T cd05050          78 -AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL  156 (288)
T ss_pred             -cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence             445688999999999999999975321                    24778889999999999999999999999999


Q ss_pred             CCCceEEccCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy7384         187 KGQNVLLTDNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQP  263 (463)
Q Consensus       187 kp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~  263 (463)
                      ||+|||++.++.++|+|||++.......  .......++..|+|||++.     ...++.++|||||||++|+|++ |..
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~~~~~~  231 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIFSYGMQ  231 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh-----cCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999987653221  1112223566799999986     5678899999999999999997 889


Q ss_pred             CCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         264 PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       264 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ||.+....+....+...... .....++.++.+||.+||+.+|.+|||+.|+++
T Consensus       232 p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         232 PYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99877766655544333322 223457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-40  Score=315.11  Aligned_cols=249  Identities=24%  Similarity=0.409  Sum_probs=204.4

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc---EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..|+..+.||+|+||.||+|.+..++.   .+|+|.+...  ......+..|+.+++.+ +|+||+++++++      ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~   77 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVV------TK   77 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEE------cc
Confidence            468899999999999999999876654   7999988644  23356788899999999 899999999998      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..|+||||+.+++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence            578999999999999999987543 4688999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCccc---cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         210 LDRTIGRRN---TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       210 ~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      .........   ....+..|+|||++.     ...++.++|||||||++|+|++ |..||...+.......+.... ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~  230 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIA-----YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP  230 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhh-----cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC
Confidence            643221111   112345799999986     4568899999999999999997 999998776665555554332 222


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....++..+.+|+.+||..+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            23457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-40  Score=322.53  Aligned_cols=252  Identities=20%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcC----------------CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCcee
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTK----------------TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIA  115 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv  115 (463)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|++....  .....+.+|+.+++.+ +|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence            4579999999999999999986542                34578999987432  3346788999999999 899999


Q ss_pred             eecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCC
Q psy7384         116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG---------QSLKEEWIAFICREILRGLKYLHENKVIHRDI  186 (463)
Q Consensus       116 ~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~l~~~~~~~i~~qil~aL~~LH~~givHrDL  186 (463)
                      ++++++      ...+..|+||||+.+++|.+++.....         ..+++..+..++.||+.||+|||++||+||||
T Consensus        83 ~~~~~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl  156 (296)
T cd05095          83 RLLAVC------ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL  156 (296)
T ss_pred             eEEEEE------ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence            999998      444678999999999999999875431         23677889999999999999999999999999


Q ss_pred             CCCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh--CC
Q psy7384         187 KGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE--SQ  262 (463)
Q Consensus       187 kp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~--g~  262 (463)
                      ||+|||++.++.++|+|||+++.+.....  ......+++.|++||+..     ...++.++|||||||++|||++  |.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~DiwSlG~~l~el~~~~~~  231 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-----LGKFTTASDVWAFGVTLWEILTLCKE  231 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-----cCCccchhhhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999876533211  112233467899999876     4568899999999999999998  78


Q ss_pred             CCCCCCCchhhhhcccC------CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         263 PPLCDLHPMRALFLIPR------NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       263 ~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .||...+..+.......      ..........++..+.+|+.+||..||.+||++.++++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         232 QPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             CCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            99977665443322110      01111223457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.9e-40  Score=319.99  Aligned_cols=258  Identities=30%  Similarity=0.460  Sum_probs=206.8

Q ss_pred             eEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      |++.+.||+|+||.||++++.   .++..||+|++...     ......+.+|+.++.++.+|+||+++++.+      .
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~------~   75 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF------Q   75 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee------e
Confidence            889999999999999999864   45788999998632     123356778999999997799999999998      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||||+.+|+|.+++...  ..+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++.
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            557899999999999999998654  368899999999999999999999999999999999999999999999999987


Q ss_pred             ccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh----hhcccCCCCC
Q psy7384         209 QLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA----LFLIPRNAPP  283 (463)
Q Consensus       209 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~  283 (463)
                      ....... ......|+..|+|||.+...   ...++.++||||||+++|+|++|..||........    ...+..... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  229 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGG---SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP-  229 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCC---CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC-
Confidence            6543221 12334689999999998632   22367889999999999999999999964332211    111111111 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHhcCccccCCchh
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~~~  327 (463)
                       .....++..+.+||.+||+.||++|||   +.++|+||||+...+.
T Consensus       230 -~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         230 -PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             -CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence             123457789999999999999999998   5778999999876554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=317.08  Aligned_cols=244  Identities=27%  Similarity=0.481  Sum_probs=197.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCc--EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQ--LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|++..++.  .+|+|.+...  ......+.+|+.++.++.+||||+++++++      ...+.+|+|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~------~~~~~~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC------EHRGYLYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE------ecCCCceEE
Confidence            368999999999999988775  4688887632  334567889999999997899999999998      445678999


Q ss_pred             EecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEE
Q psy7384         137 MEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV  202 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~  202 (463)
                      |||+.+|+|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99999999999997532              1247889999999999999999999999999999999999999999999


Q ss_pred             ecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCC
Q psy7384         203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       203 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      |||++........ ......+..|+|||++.     ...++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus       155 dfgl~~~~~~~~~-~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  228 (270)
T cd05047         155 DFGLSRGQEVYVK-KTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  228 (270)
T ss_pred             CCCCccccchhhh-ccCCCCccccCChHHHc-----cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC
Confidence            9999864322111 11223456799999986     5668889999999999999997 999998776655554443332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ... ....++.++.+|+.+||..+|.+|||++++++
T Consensus       229 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCC-CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            222 22356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.3e-40  Score=315.30  Aligned_cols=250  Identities=26%  Similarity=0.506  Sum_probs=206.2

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcC-CCcEEEEEEeecC-----------cchHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTK-TGQLAAIKVMDVT-----------EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~-~~~~vaiK~~~~~-----------~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+...           ......+..|+.++.+..+|+||+++++.+   
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~---   78 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF---   78 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE---
Confidence            7889999999999999999987 6789999987522           122345667888887655899999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEE
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL  201 (463)
                         ...+..|+||||+++++|.+++...  ....+++..++.++.|++.||.|||+ .||+|+||+|.|||++.++.++|
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence               4557999999999999999988642  33468999999999999999999996 78999999999999999999999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      +|||++....... ......|+..|++||.+.     ...++.++||||||+++|+|++|.+||...........+....
T Consensus       156 ~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (269)
T cd08528         156 TDFGLAKQKQPES-KLTSVVGTILYSCPEIVK-----NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV  229 (269)
T ss_pred             ecccceeeccccc-ccccccCcccCcChhhhc-----CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence            9999987765432 334557899999999987     4567889999999999999999999997766555444443333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ........++..+.+||.+||..||++||++.|+..+
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3333334678899999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-40  Score=315.82  Aligned_cols=249  Identities=25%  Similarity=0.458  Sum_probs=204.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc---EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +.|++.+.||+|+||.||+|.+..+++   .||+|++...  ......+..|+.+++.+ +||||+++++++      ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~------~~   76 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVV------TK   76 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEE------CC
Confidence            358999999999999999999887665   6999998643  33456788999999999 899999999998      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence            578899999999999999987543 3688999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCc--ccccc---CCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         210 LDRTIGR--RNTFI---GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       210 ~~~~~~~--~~~~~---gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      .......  .....   .+..|+|||.+.     ...++.++|||||||++|||++ |..||...+.......+..... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~-  229 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR-  229 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhc-----cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence            5432111  11111   245799999987     5678889999999999999886 9999987766555554433222 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ......++..+.+++.+||..+|.+||++++++.
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1223467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.3e-40  Score=311.72  Aligned_cols=229  Identities=19%  Similarity=0.237  Sum_probs=187.6

Q ss_pred             eCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCH
Q psy7384          66 GTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV  145 (463)
Q Consensus        66 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL  145 (463)
                      |.||.||+|++..+++.||+|.+....    ....|...+... .||||+++++.+      ...+..|+||||+.||+|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~-~~~~i~~~~~~~------~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPH-CVPNMVCLHKYI------VSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhc-CCCceeehhhhe------ecCCeEEEEEecCCCCCH
Confidence            899999999999999999999986542    223444444455 699999999998      455789999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccccccCCcc
Q psy7384         146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY  225 (463)
Q Consensus       146 ~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~  225 (463)
                      .+++....  .+++..+..++.||++||.|||++||+||||||+||+++.++.++|+|||++.......   ....++..
T Consensus        73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~  147 (237)
T cd05576          73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENM  147 (237)
T ss_pred             HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCcc
Confidence            99987654  58999999999999999999999999999999999999999999999999876654322   23456788


Q ss_pred             ccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy7384         226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKD  305 (463)
Q Consensus       226 y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~d  305 (463)
                      |+|||.+.     ...++.++|+||+||++|+|++|..||........     .... ...+..++..+++||.+||+.|
T Consensus       148 y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~li~~~l~~d  216 (237)
T cd05576         148 YCAPEVGG-----ISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----THTT-LNIPEWVSEEARSLLQQLLQFN  216 (237)
T ss_pred             ccCCcccC-----CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----cccc-cCCcccCCHHHHHHHHHHccCC
Confidence            99999886     45678899999999999999999998754322110     0000 1122357889999999999999


Q ss_pred             CCCCCCH-----HHHhcCccc
Q psy7384         306 YHQRPYT-----DQLLKHPFI  321 (463)
Q Consensus       306 p~~Rpt~-----~e~l~hp~~  321 (463)
                      |.+|+++     +++++||||
T Consensus       217 p~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         217 PTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHHhcCCCccchHHHHcCCCC
Confidence            9999985     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0194|consensus

Probab=100.00  E-value=4e-41  Score=335.41  Aligned_cols=251  Identities=29%  Similarity=0.488  Sum_probs=213.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCc---E-EEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQ---L-AAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~-vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ...-.+.++||+|+||.||+|+.+..+.   . ||+|....    ......++.+|.++++.+ +|||||++||+...  
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~--  232 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVL--  232 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--
Confidence            3445667999999999999999775432   3 89998873    345677889999999998 89999999999854  


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                          ..-+|||||+|.||+|.++++..+. .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||
T Consensus       233 ----~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 ----EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             ----CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence                4679999999999999999987654 69999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      +++............--...|+|||.+.     ...|+.++|||||||++||+++ |..||.+....+....|.......
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~-----~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~  382 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLN-----TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM  382 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhc-----cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence            9876642211111112456899999997     6689999999999999999999 888999999998888886666655


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..+...+.++..++.+|+..+|+.|||+.++.+
T Consensus       383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            666688899999999999999999999998854

>KOG0695|consensus

Probab=100.00  E-value=4.9e-41  Score=310.18  Aligned_cols=262  Identities=28%  Similarity=0.454  Sum_probs=218.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .-+.|.++++||+|+|++|.+++.+.+.+.+|+|+++.    ...+..-++.|-.+....++||.+|-++.+|      +
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf------q  321 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF------Q  321 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh------c
Confidence            34579999999999999999999999999999999862    3445566778888888888999999999999      6


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .+..+++|.||+.||+|.-.++..+  .++++.++.+...|+.||.|||++|||+||||.+|+|++..|++||+|+|+++
T Consensus       322 tesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  322 TESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             ccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence            6789999999999999977776554  69999999999999999999999999999999999999999999999999988


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-------CCchhhhhcccCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD-------LHPMRALFLIPRNA  281 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-------~~~~~~~~~i~~~~  281 (463)
                      .--.......++||||.|+|||+++     +..|+.++|+|+|||+++||+.|+.||.-       .+..+.++++.-..
T Consensus       400 e~l~~gd~tstfcgtpnyiapeilr-----geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  400 EGLGPGDTTSTFCGTPNYIAPEILR-----GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             cCCCCCcccccccCCCcccchhhhc-----ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence            6655555567899999999999998     77899999999999999999999999932       22233334332222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHhcCccccCCchhH
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPY------TDQLLKHPFIRDQPTER  328 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~e~l~hp~~~~~~~~~  328 (463)
                      .... +..++-.+..+++..|++||.+|..      ..++..|+||+...++.
T Consensus       475 qiri-prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  475 QIRI-PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             cccc-cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence            2111 2244556778999999999999854      68999999998766653

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-40  Score=316.82  Aligned_cols=251  Identities=25%  Similarity=0.460  Sum_probs=197.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEE----cCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRH----TKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .|++++.||+|+||.||+|..    ..++..||+|.+.... .....+.+|+.+++.+ +||||+++++++..    ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~   79 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYS----AGR   79 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEcc----CCC
Confidence            689999999999999999973    4578899999986443 3356788999999999 89999999997643    233


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            57899999999999999997543 35889999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh--------------
Q psy7384         211 DRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA--------------  273 (463)
Q Consensus       211 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~--------------  273 (463)
                      ......   .....++..|+|||++.     +..++.++|||||||++|||++|..++........              
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY  233 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhc-----cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence            432211   01112345699999986     55688899999999999999998777543221100              


Q ss_pred             -hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         274 -LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       274 -~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                       +..+............++..+.+||.+||..+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             00011111111223467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.2e-40  Score=312.83  Aligned_cols=243  Identities=21%  Similarity=0.421  Sum_probs=202.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      +.|++.+.||+|+||.||++.  .+++.||+|.+... .....+.+|+.+++.+ +||||+++++++..       +..|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-------~~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-VTAQAFLEETAVMTKL-HHKNLVRLLGVILH-------NGLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-chHHHHHHHHHHHHhC-CCCCcCeEEEEEcC-------CCcE
Confidence            469999999999999999986  46788999998654 2346788999999999 89999999998742       3479


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            99999999999999987655568999999999999999999999999999999999999999999999999987643221


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHH
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  293 (463)
                         .....+..|+|||.+.     ...++.++|||||||++|+|++ |.+||...+.......+....... ....++..
T Consensus       155 ---~~~~~~~~y~~pe~~~-----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  225 (254)
T cd05083         155 ---DNSKLPVKWTAPEALK-----HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME-PPEGCPAD  225 (254)
T ss_pred             ---CCCCCCceecCHHHhc-----cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC-CCCcCCHH
Confidence               2223466899999886     5668889999999999999997 999998776655544444433222 23467899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +.+||.+||..+|.+||++++++.
T Consensus       226 ~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         226 VYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.6e-40  Score=316.51  Aligned_cols=252  Identities=21%  Similarity=0.361  Sum_probs=205.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcC----CCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTK----TGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .++|++.+.||+|+||.||+|.+..    ++..|++|++...  ......+.+|+.+++++ +|+||+++++++..    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----   79 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIE----   79 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec----
Confidence            4579999999999999999999876    3578999988643  33456778899999999 89999999998742    


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCC------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEE
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKG------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL  201 (463)
                       .....++++||+.+++|.+++.....      ..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||
T Consensus        80 -~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          80 -DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             -CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence             24678999999999999999876432      45899999999999999999999999999999999999999999999


Q ss_pred             EecccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhccc
Q psy7384         202 VDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       202 ~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~  278 (463)
                      +|||+++.+......  .....++..|+|||++.     ...++.++|||||||++|+|++ |.+||...........+.
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  233 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLV-----NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK  233 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHh-----cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            999999765322111  12234567899999986     5668899999999999999998 999998776655444333


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...... ....+++++.+++.+||..||++|||+.++++
T Consensus       234 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         234 DGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             cCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            332222 23456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-40  Score=319.16  Aligned_cols=251  Identities=22%  Similarity=0.410  Sum_probs=198.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEE----cCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRH----TKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~----~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .|++++.||+|+||.||+|+.    ..++..||+|.+...  ......+.+|+.+++.+ .|+||+++++++...    .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~   79 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTED----G   79 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecC----C
Confidence            478999999999999999984    456889999998643  23346788999999999 899999999988432    2


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....++||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            357899999999999999986543 3588999999999999999999999999999999999999999999999999886


Q ss_pred             cccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--------------hh
Q psy7384         210 LDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--------------MR  272 (463)
Q Consensus       210 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--------------~~  272 (463)
                      +.....   ......++..|+|||++.     +..++.++|||||||++|+|+++..|+.....              ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~-----~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLI-----QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhc-----cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            643221   112345677899999986     55688899999999999999998776532110              00


Q ss_pred             h-hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         273 A-LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       273 ~-~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      . ...+.... .......++..+.+||.+||+.+|.+|||+++++++
T Consensus       234 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         234 RLVRVLEEGK-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHHcCc-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            0 00011111 111234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.7e-40  Score=314.13  Aligned_cols=249  Identities=23%  Similarity=0.411  Sum_probs=192.6

Q ss_pred             eeeeeeCCeEEEEEEEcC--CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTK--TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|....  ....+|+|.+....  .....+.+|+.+++.+ +|+||+++++.+      ......|+|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~------~~~~~~~lv   73 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQC------IESIPYLLV   73 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEE------CCCCceEEE
Confidence            368999999999997543  34568888775432  2345677899999988 899999999998      445789999


Q ss_pred             EecCCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         137 MEYCGAGSVTDLVKSTKG---QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |||+.+|+|.+++.....   ....+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence            999999999999976442   23467788999999999999999999999999999999999999999999998654221


Q ss_pred             c--CccccccCCccccccceeccCC--CCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC----
Q psy7384         214 I--GRRNTFIGTPYWMAPEVIACDE--NPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR----  284 (463)
Q Consensus       214 ~--~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~----  284 (463)
                      .  .......++..|+|||++....  .....++.++|||||||++|+|++ |.+||....+...+..+.......    
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP  233 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence            1  1112334677899999975321  113467889999999999999999 889998776655544433332211    


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....++..+.+++..|+ .||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            123467888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.6e-40  Score=313.20  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=203.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .+|.+.+.||+|+||.||+|.+...   ...||+|......  ...+.+.+|+.+++.+ +|+||+++++++..      
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~------   78 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE------   78 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC------
Confidence            4689999999999999999987654   3468999886443  3456788999999999 79999999998732      


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                       +..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence             45789999999999999997543 3589999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCc-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         210 LDRTIGR-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       210 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ....... .....++..|+|||.+.     ...++.++|||||||++|+|++ |..||.+.........+...... ...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~  230 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-PMP  230 (270)
T ss_pred             cccccceecCCCCccccccChhhhc-----cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-CCC
Confidence            5433111 11223456799999886     4568889999999999999986 99999887766555544443332 233


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..++..+.++|.+||..+|.+|||+.+++..
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1151|consensus

Probab=100.00  E-value=8.5e-41  Score=318.31  Aligned_cols=260  Identities=23%  Similarity=0.395  Sum_probs=214.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch--------HHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE--------EEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      .++|-++.+||+|+|+.||+|-|....++||+|+-..+...        .+...+|..|.+.| +||.||++|++|..  
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfsl--  538 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSL--  538 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeee--
Confidence            57899999999999999999999999999999998654332        23456799999999 89999999999964  


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC--CceecCCCCCceEEcc---CCcEE
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN--KVIHRDIKGQNVLLTD---NAEVK  200 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--givHrDLkp~NILl~~---~~~vk  200 (463)
                         +.+.+|-|+|||+|.+|.-+++..+  .+++.+++.|+.||+.||.||...  -|||-||||.|||+.+   -|.+|
T Consensus       539 ---DtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  539 ---DTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ---ccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence               3468899999999999999997665  799999999999999999999986  5999999999999954   47799


Q ss_pred             EEecccccccccccCc-------cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q psy7384         201 LVDFGVSAQLDRTIGR-------RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA  273 (463)
Q Consensus       201 L~DFGla~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  273 (463)
                      |+|||+++.++.....       ..-..||.||++||.+.-... ...++.++||||+|||+|..+.|+-||........
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgke-PPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd  692 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKE-PPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD  692 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCC-CCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence            9999999988654322       233579999999999864322 35678899999999999999999999966433222


Q ss_pred             h---hcccCCCC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         274 L---FLIPRNAP-PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       274 ~---~~i~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      +   ..|..... ..+..+.++.++++||++||..--+.|..+.++..||||.
T Consensus       693 ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  693 ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            2   22333222 2334567899999999999999999999999999999995

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=308.73  Aligned_cols=242  Identities=25%  Similarity=0.404  Sum_probs=199.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++||+|+||.||+|.+.. ++.||+|++.....  ....+.+|+.+++++ +|+||+++++++      ......|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~------~~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVC------VQKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEE------ecCCCeEEEEE
Confidence            479999999999999877 99999999875433  456788999999999 899999999998      44578999999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCcc-
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-  217 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-  217 (463)
                      |+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......... 
T Consensus        73 ~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          73 LVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence            999999999987543 368899999999999999999999999999999999999999999999999987654221111 


Q ss_pred             -ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         218 -NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       218 -~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                       ....++..|+|||.+.     ...++.++|||||||++|+|++ |..||...........+.... ........+.++.
T Consensus       152 ~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  225 (251)
T cd05041         152 DGLKQIPIKWTAPEALN-----YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMPAPQLCPEEIY  225 (251)
T ss_pred             cccCcceeccCChHhhc-----cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCCCCccCCHHHH
Confidence             1122356799999986     4568899999999999999998 899998776555444443322 1222346788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q psy7384         296 SFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       296 ~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +|+.+||..+|.+|||++++++
T Consensus       226 ~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         226 RLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-39  Score=312.26  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=191.9

Q ss_pred             eeeeeeCCeEEEEEEEc--CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHT--KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||+|.+.  .++..+|+|.+....  .....+.+|+.+++.+ +||||+++++.+      .....+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQC------TEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEE------cCCCCcEEE
Confidence            36899999999999864  345679999886543  2335678899999999 899999999988      444678999


Q ss_pred             EecCCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         137 MEYCGAGSVTDLVKSTKG---QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |||+++|+|.+++.....   ...++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            999999999999975432   24567778889999999999999999999999999999999999999999998654322


Q ss_pred             cC--ccccccCCccccccceeccCCCC--CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC----
Q psy7384         214 IG--RRNTFIGTPYWMAPEVIACDENP--DATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR----  284 (463)
Q Consensus       214 ~~--~~~~~~gt~~y~aPE~l~~~~~~--~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~----  284 (463)
                      ..  ......++..|+|||++......  ...++.++|||||||++|+|++ |..||......+............    
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP  233 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence            11  11234578889999998532110  1246789999999999999996 999997766554433222221111    


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ......++.+.+++..|+ .+|.+|||+++++.
T Consensus       234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            112246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1035|consensus

Probab=100.00  E-value=8.3e-41  Score=351.79  Aligned_cols=261  Identities=29%  Similarity=0.517  Sum_probs=205.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCC------
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP------  126 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~------  126 (463)
                      ..|+.++.||+||||.||+++++-+|+.||||.|...  ......+.+|+.+|.+| +|||||+++.+++....      
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccccc
Confidence            4578899999999999999999999999999999866  44556788999999999 89999999998863100      


Q ss_pred             ----------------------------------------------C---------------------------------
Q psy7384         127 ----------------------------------------------P---------------------------------  127 (463)
Q Consensus       127 ----------------------------------------------~---------------------------------  127 (463)
                                                                    .                                 
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                          0                                 


Q ss_pred             --------------------C--------CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC
Q psy7384         128 --------------------G--------KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN  179 (463)
Q Consensus       128 --------------------~--------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~  179 (463)
                                          .        ..-.+||=||||+..+|++++....... ....++++++||++||.|+|++
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC
Confidence                                0        0024799999999988888887654221 4678899999999999999999


Q ss_pred             CceecCCCCCceEEccCCcEEEEecccccccc------------------cccCccccccCCccccccceeccCCCCCCC
Q psy7384         180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD------------------RTIGRRNTFIGTPYWMAPEVIACDENPDAT  241 (463)
Q Consensus       180 givHrDLkp~NILl~~~~~vkL~DFGla~~~~------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  241 (463)
                      |||||||||.||++++++.|||+|||+|+...                  ......+..+||..|+|||++....  ...
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~--~~~  794 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS--SNK  794 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--ccc
Confidence            99999999999999999999999999998721                  0112345678999999999997532  247


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCC-CCchhhhhcccCCCCCCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         242 YDNRSDLWSLGITALEMAESQPPLCD-LHPMRALFLIPRNAPPRL---KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       242 ~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      |+.|+||||||+||+||+.   ||.- ......+..+.....|..   ..+.. +.-..+|++||+.||++||||.|+|+
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            9999999999999999975   3632 222333444444433333   22222 35578999999999999999999999


Q ss_pred             CccccC
Q psy7384         318 HPFIRD  323 (463)
Q Consensus       318 hp~~~~  323 (463)
                      +.||..
T Consensus       871 s~llpp  876 (1351)
T KOG1035|consen  871 SELLPP  876 (1351)
T ss_pred             ccCCCc
Confidence            999973

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-39  Score=308.41  Aligned_cols=242  Identities=26%  Similarity=0.409  Sum_probs=197.8

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++||+|+||.||+|... ++..+|+|++....  .....+.+|+.+++.+ +||||+++++++      ...+..++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVC------TQRQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEE------ecCCccEEEEE
Confidence            46899999999999854 67889999986432  2344678899999999 899999999998      44568899999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCcc-
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-  217 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-  217 (463)
                      |+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... 
T Consensus        73 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          73 LVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence            999999999987543 357899999999999999999999999999999999999999999999999987654322111 


Q ss_pred             ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHH
Q psy7384         218 NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS  296 (463)
Q Consensus       218 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  296 (463)
                      ....++..|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+...... .....++..+.+
T Consensus       152 ~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  225 (250)
T cd05085         152 GLKQIPIKWTAPEALN-----YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-SCPQKCPDDVYK  225 (250)
T ss_pred             CCCCCcccccCHHHhc-----cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence            1123456799999986     4568889999999999999998 99999877665554444333222 223467899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q psy7384         297 FIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       297 li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      |+.+||..+|.+||++.++++
T Consensus       226 li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         226 VMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1187|consensus

Probab=100.00  E-value=5.2e-40  Score=324.96  Aligned_cols=249  Identities=31%  Similarity=0.492  Sum_probs=195.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch-HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC-eE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE-EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD-QL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~-~~  133 (463)
                      .|.-...||+|+||.||+|.... |..||||.+...... ..+|.+|+.+|.++ +|||+|+|+|+|..      .+ ..
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e------~~~~~  147 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLE------GGEHR  147 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEec------CCceE
Confidence            45556899999999999998654 489999988765554 66799999999999 69999999999953      34 69


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC---ceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK---VIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +||+||+.+|+|.+.+.......+++....+|+.+++.||+|||...   |||||||++|||+|.+...||+|||+|+..
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            99999999999999998655337899999999999999999999854   999999999999999999999999999655


Q ss_pred             ccccCccccc-cCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---chhhhh----c-----c
Q psy7384         211 DRTIGRRNTF-IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH---PMRALF----L-----I  277 (463)
Q Consensus       211 ~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---~~~~~~----~-----i  277 (463)
                      .......... .||.+|+|||++.     .+..+.++|||||||+|.||++|+.+.....   ......    .     +
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~-----~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~  302 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYAS-----TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL  302 (361)
T ss_pred             CccccceeeecCCCCccCChhhhc-----cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence            4311111222 7999999999997     5678999999999999999999998876432   111111    1     1


Q ss_pred             cCCCCCCCCCCCCC--HH---HHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         278 PRNAPPRLKSKKWP--KK---FQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       278 ~~~~~~~~~~~~~~--~~---~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....+.+....++  .+   +..+..+|+..+|..||++.|+++
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11122232212233  23   556788999999999999998643

>KOG1026|consensus

Probab=100.00  E-value=9e-41  Score=343.22  Aligned_cols=251  Identities=24%  Similarity=0.425  Sum_probs=215.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .+...-++.+.||+|+||+||+|+...-     ...||||.++....  ..++|++|+++|..| +|||||+|+|+|   
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC---  558 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVC---  558 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEE---
Confidence            3445567889999999999999986432     35799999974433  568999999999999 899999999999   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------CC----CCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceE
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------QS----LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL  192 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~----l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NIL  192 (463)
                         ..++-+|+|+|||..|+|.++|..+.+        ..    |+..+...|+.||+.|+.||-++.+|||||-..|.|
T Consensus       559 ---~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 ---REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL  635 (774)
T ss_pred             ---ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence               566889999999999999999986542        23    889999999999999999999999999999999999


Q ss_pred             EccCCcEEEEecccccccccccCcc--ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy7384         193 LTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLH  269 (463)
Q Consensus       193 l~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~  269 (463)
                      |.++..|||+|||+++.+.......  ....-...||+||.|.     -..|+.++||||+||+|||+++ |+.||++.+
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-----y~kFTteSDVWs~GVvLWEIFsyG~QPy~glS  710 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-----YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS  710 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-----cCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence            9999999999999998765432111  0112356899999999     5779999999999999999987 999999999


Q ss_pred             chhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q psy7384         270 PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQL  315 (463)
Q Consensus       270 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  315 (463)
                      +.+.+..|..+.. -..+..+|.++.+|+..||+.+|.+||++.||
T Consensus       711 n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  711 NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            9999999877766 45567899999999999999999999999997

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=313.04  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=204.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCc----EEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .++|++.+.||+|+||.||+|.+..+|.    .+|+|.+....  .....+.+|+.+++++ +|+||+++++++..    
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec----
Confidence            4579999999999999999999877665    58999886543  2346778899999999 89999999998842    


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                         ...++||||+.+|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 ---~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 ---SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             ---CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccc
Confidence               578999999999999999976433 5899999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccc--cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         208 AQLDRTIGRRN--TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       208 ~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      +..........  ...++..|+|||.+.     ...++.++|+|||||++|+|++ |..||.+....+....+..... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~  230 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESIL-----HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-L  230 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhh-----cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-C
Confidence            87653321111  112356799999886     5668889999999999999998 9999988766554444433322 2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....++..+.+++.+||..+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            223456789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-39  Score=310.69  Aligned_cols=245  Identities=21%  Similarity=0.403  Sum_probs=194.1

Q ss_pred             eeeeeeCCeEEEEEEEcCC---CcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +.||+|+||.||+|.+...   +..||+|.+...  ......+.+|+.+++.+ +||||+++++++.     ..++..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICL-----PSEGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEee-----cCCCCcEE
Confidence            4689999999999987543   457999988532  23356777899999998 8999999999764     23356899


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc-
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI-  214 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-  214 (463)
                      ||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          75 VLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999999999997543 346778888999999999999999999999999999999999999999999987653211 


Q ss_pred             ---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         215 ---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       215 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                         .......++..|+|||.+.     ...++.++|||||||++|||++ |.+||...+.......+.....+. ....+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  227 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL-QPEYC  227 (262)
T ss_pred             eeecccccCcCCccccChhHhc-----cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-CCCcC
Confidence               1112234677899999986     4568889999999999999999 577787666555444433332222 23456


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +..+.+++.+||..+|++||++.++++.
T Consensus       228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         228 PDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.1e-40  Score=313.69  Aligned_cols=244  Identities=25%  Similarity=0.472  Sum_probs=198.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCC------cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          61 EVVGNGTYGQVYKGRHTKTG------QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +.||+|+||.||+|++....      ..+|+|.+....  .....+.+|+.+++.+ +||||+++++++      ...+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~   73 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVC------LLNEP   73 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeee------cCCCC
Confidence            36899999999999986543      679999876432  3456788899999999 899999999998      34467


Q ss_pred             EEEEEecCCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-----cEEEE
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK-----GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-----EVKLV  202 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-----~vkL~  202 (463)
                      .|+||||+.+++|.+++....     ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++     .++|+
T Consensus        74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEEC
Confidence            999999999999999997532     23478899999999999999999999999999999999999877     89999


Q ss_pred             eccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccC
Q psy7384         203 DFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       203 DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~  279 (463)
                      |||++.......  .......++..|+|||++.     ...++.++|||||||++|+|++ |..||...........+..
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  228 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL-----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA  228 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHc-----cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc
Confidence            999987653221  1112234578899999987     5668899999999999999998 9999987766555544433


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       280 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .... .....++..+.+||.+||..+|.+||+++++++
T Consensus       229 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         229 GGRL-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             CCcc-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3222 223467889999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-39  Score=310.24  Aligned_cols=238  Identities=22%  Similarity=0.410  Sum_probs=191.7

Q ss_pred             eeeeeeCCeEEEEEEEcCCC----------cEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          61 EVVGNGTYGQVYKGRHTKTG----------QLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.||+|+||.||+|.+..++          ..+++|++.........+.+|+.+++.+ +|+||+++++++.      . 
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~-   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCV------R-   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEe------c-
Confidence            46899999999999998776          3578888765544467888999999999 8999999999884      2 


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-------cEEEEe
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-------EVKLVD  203 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-------~vkL~D  203 (463)
                      ...++||||+.+|+|.+++..... .++...+..++.||+.||+|||++||+||||||+|||++.++       .+||+|
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence            467999999999999999976443 688999999999999999999999999999999999999887       799999


Q ss_pred             cccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCC
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      ||++.....    .....++..|+|||++...   ...++.++|||||||++|+|++ |..||................ 
T Consensus       152 fg~a~~~~~----~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-  223 (259)
T cd05037         152 PGIPITVLS----REERVERIPWIAPECIRNG---QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-  223 (259)
T ss_pred             CCccccccc----ccccccCCCccChhhhcCC---CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-
Confidence            999886543    1234577889999998632   1368899999999999999999 588886664332222111111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                        .........+.+||.+||..+|.+|||+.++++
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 --RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence              111122378999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.7e-40  Score=315.08  Aligned_cols=239  Identities=22%  Similarity=0.415  Sum_probs=190.2

Q ss_pred             eeeeeeCCeEEEEEEEcCCCc-------EEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQ-------LAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~-------~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +.||.|+||.||+|.+...+.       .+|+|.+.... .....+..|+.+++.+ +||||+++++++.      ....
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~------~~~~   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCV------CGDE   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEE------eCCC
Confidence            468999999999999866543       38888875432 2345677888999988 8999999999984      3467


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc--------EEEEec
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE--------VKLVDF  204 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~--------vkL~DF  204 (463)
                      .++||||+.+|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.        ++++||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            8999999999999999975443 6889999999999999999999999999999999999987654        699999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchhhhhcccCCCCC
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      |++......    ....+++.|+|||++..    ...++.++|||||||++|+|++| .+||...............  .
T Consensus       153 g~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~--~  222 (258)
T cd05078         153 GISITVLPK----EILLERIPWVPPECIEN----PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR--H  222 (258)
T ss_pred             ccccccCCc----hhccccCCccCchhccC----CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc--c
Confidence            988655322    33568889999999863    34578899999999999999998 5777665554433222111  1


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      . .....+.++.+||.+||+.||++|||++++++.
T Consensus       223 ~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         223 Q-LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             c-CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            1 122345789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-39  Score=310.43  Aligned_cols=239  Identities=21%  Similarity=0.366  Sum_probs=187.1

Q ss_pred             eeeeeeCCeEEEEEEEcCC------------CcEEEEEEeecCcc-hHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          61 EVVGNGTYGQVYKGRHTKT------------GQLAAIKVMDVTED-EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~------------~~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +.||+|+||.||+|+....            ...||+|.+..... ....+..|+.++..+ +||||+++++++.     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~-----   74 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCV-----   74 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-----
Confidence            4689999999999985322            23588888764432 334667788888888 8999999999984     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc-------EE
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE-------VK  200 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~-------vk  200 (463)
                       .....++||||+.+|+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.       ++
T Consensus        75 -~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          75 -RDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             -cCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence             4467899999999999988876433 36899999999999999999999999999999999999986654       89


Q ss_pred             EEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCchhhhhcccC
Q psy7384         201 LVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA-ESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       201 L~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell-~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      ++|||++......    ....++..|+|||++..    ...++.++|||||||++|+|+ .|..||.......... +..
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~  223 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECVED----SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE  223 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh
Confidence            9999998655322    33468889999998852    356888999999999999997 5889987654333221 111


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       280 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...  ......+.++.+||.+||+.||.+||++.+|+++
T Consensus       224 ~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         224 GQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             cCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            111  1112345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=314.42  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=189.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCcchH--H----------HHHHHHHHHHHhcCCCceee
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTEDEE--E----------EIKLEINVLKKYSNHRNIAT  116 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~--~----------~~~~Ei~~l~~l~~h~nIv~  116 (463)
                      ...++|++.+.||+|+||.||+|.+..+   +..+|+|+........  +          ....+...+..+ .|+||++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCc
Confidence            4557899999999999999999998877   6678888754322111  0          111222334445 7999999


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +++++....  ......+++||++.. ++.+++....  ..++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus        88 ~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         88 YYGCGSFKR--CRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN  162 (294)
T ss_pred             EEEeeeEec--CCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence            998764321  111245788888754 6777765432  46788899999999999999999999999999999999999


Q ss_pred             CcEEEEeccccccccccc-------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7384         197 AEVKLVDFGVSAQLDRTI-------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH  269 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  269 (463)
                      +.++|+|||+++.+....       .......||+.|+|||++.     +..++.++|||||||++|+|++|.+||.+..
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-----~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-----GACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999998663211       1123346999999999987     5678999999999999999999999998774


Q ss_pred             chhhh---------hcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         270 PMRAL---------FLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       270 ~~~~~---------~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....         ..+..   .......+++.+.++++.|+..+|.+||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        238 HNGNLIHAAKCDFIKRLHE---GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             cchHHHHHhHHHHHHHhhh---hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            32221         11211   12223456889999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.9e-39  Score=310.09  Aligned_cols=255  Identities=20%  Similarity=0.361  Sum_probs=201.4

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcC---CCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      |++.+.||+|+||.||+|.+..   ++..||+|++...   ....+.+.+|+.+++.+ +||||+++++++.........
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence            6778999999999999998653   5788999998643   23455678899999999 899999999987543221222


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK----GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                      ...++++||+.+|+|.+++....    ...++...++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence            34589999999999998875322    22578899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         207 SAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       207 a~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ++.......  ......+++.|++||.+.     ...++.++|||||||++|+|++ |.+||.+.........+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  234 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLA-----DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL  234 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHh-----cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            886543211  112234567899999986     5667889999999999999999 89999877665544433333222


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       .....++..+.+++.+||..+|.+||++.+++.+
T Consensus       235 -~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 -KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             2224577899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4250|consensus

Probab=100.00  E-value=2.6e-40  Score=332.52  Aligned_cols=208  Identities=32%  Similarity=0.532  Sum_probs=177.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +-|..-+.||+|+||.||+++++.+|+.||||.++.  .....+..-+|+++|+++ +|+|||+++++-......-....
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccccc
Confidence            456777999999999999999999999999999974  344567788999999999 79999999998643211111356


Q ss_pred             EEEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc--CC--cEEEEecccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD--NA--EVKLVDFGVS  207 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~--~~--~vkL~DFGla  207 (463)
                      ..+|||||.||+|+..+.... ...|++.++..++..+..||.|||++||+||||||.||++-.  +|  ..||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            689999999999999997643 357999999999999999999999999999999999999842  23  4699999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL  268 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  268 (463)
                      +.+++.. ...+++||+.|++||++-.    ...|+..+|.|||||++|++.||..||...
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~----q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYER----QKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhh----ccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            9998764 6788899999999999862    377899999999999999999999999543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-39  Score=311.13  Aligned_cols=238  Identities=21%  Similarity=0.364  Sum_probs=185.8

Q ss_pred             eeeeeCCeEEEEEEEcCC------------------------CcEEEEEEeecCcc-hHHHHHHHHHHHHHhcCCCceee
Q psy7384          62 VVGNGTYGQVYKGRHTKT------------------------GQLAAIKVMDVTED-EEEEIKLEINVLKKYSNHRNIAT  116 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~~~------------------------~~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~h~nIv~  116 (463)
                      .||+|+||.||+|....+                        ...||+|++..... ....+..|+.+++.+ +||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence            689999999999975322                        23588888864332 234567788888888 8999999


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +++++.      .....|+||||+++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus        81 ~~~~~~------~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          81 VHGVCV------RGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEE------eCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence            999984      4468899999999999999886533 368899999999999999999999999999999999999764


Q ss_pred             C-------cEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHH-HhCCCCCCCC
Q psy7384         197 A-------EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDL  268 (463)
Q Consensus       197 ~-------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~el-l~g~~Pf~~~  268 (463)
                      +       .+||+|||++......    ....++..|+|||.+..    ...++.++|||||||++||| ++|..||.+.
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPG----GNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             CcccCccceeeecCCccccccccc----cccccCCcccCchhhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            3       4899999987644322    23357888999998863    35678999999999999998 4799999776


Q ss_pred             CchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         269 HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       269 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ........+.....   .....+..+.++|.+||..+|.+|||+.++|++
T Consensus       226 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         226 TPSEKERFYEKKHR---LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ChHHHHHHHHhccC---CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            55433222111111   112345689999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-39  Score=314.50  Aligned_cols=249  Identities=24%  Similarity=0.404  Sum_probs=200.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc----EEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +.|++.+.||+|+||.||+|.+..+|.    .+|+|.+.....  ....+.+|+.+++.+ +||||+++++.+..     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~-----   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcC-----
Confidence            468899999999999999999887776    468888764332  234677899999999 89999999998842     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        ...++|+||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 --~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          81 --PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             --CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence              34679999999999999987543 358899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         209 QLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ........  .....++..|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+..... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~  231 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIH-----YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-LP  231 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhc-----cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC
Confidence            66432221  12234567899999986     5668899999999999999997 9999977654333322222221 12


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ....++..+.+++.+||..+|++||+++++++.
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         232 QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            234567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.1e-39  Score=338.09  Aligned_cols=266  Identities=23%  Similarity=0.329  Sum_probs=183.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCC----CcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKT----GQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .+.|++.+.||+|+||.||+|++..+    +..||+|.+...... +....+  .++.. .+.++..++..+........
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~-~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRA-CPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhh-chhhHHHHHHhhhccccccc
Confidence            45799999999999999999999988    899999987533221 111111  12222 24444444444332211245


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCC------------------CCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCce
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQ------------------SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNV  191 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NI  191 (463)
                      ...++|||||+.+++|.+++......                  ......+..++.||+.||.|||++||+||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            57899999999999999998753210                  112345678999999999999999999999999999


Q ss_pred             EEcc-CCcEEEEeccccccccccc-CccccccCCccccccceeccCCCC-----------------CCCCCcchhHHHHH
Q psy7384         192 LLTD-NAEVKLVDFGVSAQLDRTI-GRRNTFIGTPYWMAPEVIACDENP-----------------DATYDNRSDLWSLG  252 (463)
Q Consensus       192 Ll~~-~~~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~-----------------~~~~~~~~DiwSlG  252 (463)
                      |++. ++.+||+|||+++.+.... .....+++++.|+|||.+......                 ...++.++||||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9985 6899999999998654321 223456899999999976432211                 11345677999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhhhhcccCC-----------CCCCC---------CCCCCCHHHHHHHHHhhhcCCCCCCCH
Q psy7384         253 ITALEMAESQPPLCDLHPMRALFLIPRN-----------APPRL---------KSKKWPKKFQSFIETVLVKDYHQRPYT  312 (463)
Q Consensus       253 ~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------~~~~~---------~~~~~~~~~~~li~~~L~~dp~~Rpt~  312 (463)
                      ||||||+++..++..  ....+..+...           .....         .........++||.+||+.||.+|||+
T Consensus       367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            999999997665432  11111111000           00000         001123356699999999999999999


Q ss_pred             HHHhcCccccCCc
Q psy7384         313 DQLLKHPFIRDQP  325 (463)
Q Consensus       313 ~e~l~hp~~~~~~  325 (463)
                      .++|+||||....
T Consensus       445 ~e~L~Hpff~~~~  457 (566)
T PLN03225        445 KAALAHPYFDREG  457 (566)
T ss_pred             HHHhCCcCcCCCC
Confidence            9999999998543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-39  Score=310.68  Aligned_cols=252  Identities=24%  Similarity=0.454  Sum_probs=201.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcC----CCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTK----TGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +.|++.+.||+|+||.||+|++..    ++..+|+|++.....  ....+.+|+.+++.+ .|+||+++++++..    .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~----~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEK----P   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeec----C
Confidence            358888999999999999998653    478999999976555  367889999999999 89999999998743    2


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .....++||||+.+++|.+++..... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            24678999999999999999976442 58999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh-------------
Q psy7384         209 QLDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR-------------  272 (463)
Q Consensus       209 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~-------------  272 (463)
                      ........   .....++..|++||.+.     ...++.++|||||||++|+|++|..||.......             
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLR-----TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV  232 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHc-----cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence            76532111   11223456799999886     4568889999999999999999999986532211             


Q ss_pred             -hhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         273 -ALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       273 -~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                       .+...............++.++.+|+.+||..+|.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             011111111111223456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=305.46  Aligned_cols=249  Identities=19%  Similarity=0.351  Sum_probs=191.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCC--cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTG--QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~--~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      +.||+|+||.||++.....+  ..+++|.+....  .....+.+|+.+++.+ +||||+++++.+.      .....|+|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~------~~~~~~lv   73 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCV------EAIPYLLV   73 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEec------CCCccEEE
Confidence            36999999999999764433  356677765432  3456788899999988 8999999999984      44688999


Q ss_pred             EecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc-
Q psy7384         137 MEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-  213 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  213 (463)
                      |||+.+|+|.+++....  ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++...... 
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence            99999999999997543  234677788899999999999999999999999999999999999999999997643211 


Q ss_pred             -cCccccccCCccccccceeccCCC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC----C
Q psy7384         214 -IGRRNTFIGTPYWMAPEVIACDEN--PDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR----L  285 (463)
Q Consensus       214 -~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~----~  285 (463)
                       .......+++..|+|||++.....  ....++.++|||||||++|||++ |.+||....+.+.+..+.......    .
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ  233 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence             111234568899999999853211  12356789999999999999996 578897776655554433222111    1


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....+++.+.+++..|| .+|.+||+++++++
T Consensus       234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            12357889999999999 67999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0576|consensus

Probab=100.00  E-value=8.2e-41  Score=332.57  Aligned_cols=263  Identities=50%  Similarity=0.966  Sum_probs=236.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++..+|+++..+|.|+||.||+|+++.+++..|+|+++... .+..-++.||-+++.. +|||||.+++.|..      
T Consensus        11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr------   83 (829)
T KOG0576|consen   11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLR------   83 (829)
T ss_pred             cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhh------
Confidence            366778999999999999999999999999999999998654 4456778899999999 89999999999964      


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.++++||||.||+|.|+..-..  ++++.++...++..+.||+|||++|-+|||||-.|||+++.|.+||+|||.+.+
T Consensus        84 ~dklwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   84 RDKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             hcCcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhh
Confidence            378999999999999999876444  799999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCC-C
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRL-K  286 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~-~  286 (463)
                      +......+..++|||.|||||+..-..  .+.|...+|||++|+...|+-.-++|..+..+++.++......+  +.+ .
T Consensus       162 itati~KrksfiGtpywmapEvaaver--kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD  239 (829)
T KOG0576|consen  162 ITATIAKRKSFIGTPYWMAPEVAAVER--KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD  239 (829)
T ss_pred             hhhhhhhhhcccCCccccchhHHHHHh--cccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC
Confidence            988888889999999999999975332  67899999999999999999999999999999999888766543  222 2


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ...|++.|-+|++.+|.++|++|||++.+|.|||+...
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            46899999999999999999999999999999999865

>KOG1006|consensus

Probab=100.00  E-value=7.6e-41  Score=300.41  Aligned_cols=257  Identities=35%  Similarity=0.559  Sum_probs=213.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..+-+..||.|+||+|++-.++.+|+..|||.++...  .+..++..|.....+-.+.||||++||+..      .++..
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F------~EGdc  138 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF------SEGDC  138 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh------cCCce
Confidence            3455678999999999999999999999999997543  455678889988888889999999999984      45788


Q ss_pred             EEEEecCCCCCHHHHH---HhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         134 WLVMEYCGAGSVTDLV---KSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l---~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      |+.||+|.- +|..+.   ...+...++|..+-.|....+.||.||.. ..|||||+||+|||++..|.|||||||++.+
T Consensus       139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            999999964 665443   33344578999888999999999999986 5999999999999999999999999999988


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hhhhhcccCCCCCCCCC-
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIPRNAPPRLKS-  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~-  287 (463)
                      +..... .+...|...|||||.+...   ...|+-++||||||++|||+.||..|+.+.+. .+++..+..+.+|.+.. 
T Consensus       218 Lv~SiA-kT~daGCrpYmAPERi~p~---~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~  293 (361)
T KOG1006|consen  218 LVDSIA-KTVDAGCRPYMAPERIDPS---DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD  293 (361)
T ss_pred             HHHHHH-hhhccCCccccChhccCCc---cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence            765432 2445789999999999754   34699999999999999999999999977654 45555565665554433 


Q ss_pred             ---CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         288 ---KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       288 ---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                         -.++..+..||..||.+|-+.||...+++++||++.
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence               247889999999999999999999999999999974

>KOG1095|consensus

Probab=100.00  E-value=6.4e-39  Score=340.66  Aligned_cols=252  Identities=23%  Similarity=0.457  Sum_probs=213.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCC-Cc----EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKT-GQ----LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~----~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ....-++.+.||+|+||.||.|..... |.    .||+|.+...  .....+|.+|..+|.++ +|||||+++|+++.  
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~--  766 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD--  766 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--
Confidence            344678999999999999999987543 32    4899988643  55678899999999999 89999999999964  


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEE
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTK-----GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK  200 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vk  200 (463)
                          ....+|++|||+||+|..+|++.+     ...++..++..++.+|+.|+.||+++++|||||-..|+||+....||
T Consensus       767 ----~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  767 ----SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             ----CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence                367899999999999999998763     34689999999999999999999999999999999999999999999


Q ss_pred             EEeccccccccccc-Cccccc-cCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcc
Q psy7384         201 LVDFGVSAQLDRTI-GRRNTF-IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLI  277 (463)
Q Consensus       201 L~DFGla~~~~~~~-~~~~~~-~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i  277 (463)
                      |+|||+|+.+.... ...... .-...|||||.+.     .+.++.++|||||||+|||+++ |..||.+.++.+.+...
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~-----d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~  917 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK-----DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV  917 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHh-----hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence            99999999543221 111111 2345799999998     6889999999999999999999 89999999998888766


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..+. .-..+.++|+.+.+++..||..+|++||++..|++
T Consensus       918 ~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  918 LEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            5665 33455689999999999999999999999999988

>KOG0665|consensus

Probab=100.00  E-value=1.6e-39  Score=299.25  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=212.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...+|.-++.+|.|.- .|.-|-|..+++.||+|.+...   ....+...+|...+..+ +|+||++++.+|......+.
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence            3457999999999999 8889999999999999887532   23346677899999998 89999999999987655555


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....|+||||+.. +|...+..    .+.-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+.
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence            6778999999976 88888762    477888999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--------  281 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  281 (463)
                      .+.. -..+.++.|..|+|||++.     +..|.+.+||||+|||+.||++|+..|.|....++..++....        
T Consensus       168 e~~~-~~mtpyVvtRyyrapevil-----~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  168 EDTD-FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             cCcc-cccCchhheeeccCchhee-----ccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            6654 3456778999999999998     4559999999999999999999999999887766654321110        


Q ss_pred             -------------------------CCC------CC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         282 -------------------------PPR------LK-SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       282 -------------------------~~~------~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                                               .++      .. .+.-...+++++.+||..||++|.+++++|+||||+
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                     000      00 012234688999999999999999999999999996

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.3e-37  Score=313.02  Aligned_cols=269  Identities=20%  Similarity=0.301  Sum_probs=189.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEc----------------CCCcEEEEEEeecCcch-H--------------HHHHHHH
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHT----------------KTGQLAAIKVMDVTEDE-E--------------EEIKLEI  102 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~----------------~~~~~vaiK~~~~~~~~-~--------------~~~~~Ei  102 (463)
                      .+.|++.++||+|+||+||+|.+.                ..++.||||.+...... .              +....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            567999999999999999999752                23567999998643211 1              2223467


Q ss_pred             HHHHHhcCCCc-----eeeecccccccCCC--CCCCeEEEEEecCCCCCHHHHHHhhCC---------------------
Q psy7384         103 NVLKKYSNHRN-----IATYYGAFIKKSPP--GKDDQLWLVMEYCGAGSVTDLVKSTKG---------------------  154 (463)
Q Consensus       103 ~~l~~l~~h~n-----Iv~l~~~~~~~~~~--~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------  154 (463)
                      .++.++ +|.+     +++++++|......  ...+..+|||||+.+++|.+++....+                     
T Consensus       224 ~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777 4544     36677766432110  123568999999999999999874321                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc-cccccCCcccccccee
Q psy7384         155 -QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTPYWMAPEVI  232 (463)
Q Consensus       155 -~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l  232 (463)
                       ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......... .....+|+.|+|||.+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence             12356678899999999999999999999999999999999999999999998765432111 1112358899999998


Q ss_pred             ccCCCCC-----------------CCCCcchhHHHHHHHHHHHHhCCC-CCCCCCchhhh-----------hcccCCCCC
Q psy7384         233 ACDENPD-----------------ATYDNRSDLWSLGITALEMAESQP-PLCDLHPMRAL-----------FLIPRNAPP  283 (463)
Q Consensus       233 ~~~~~~~-----------------~~~~~~~DiwSlG~il~ell~g~~-Pf~~~~~~~~~-----------~~i~~~~~~  283 (463)
                      .......                 ......+||||+|||+|+|++|.. ||.+.......           ..+......
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            6321100                 011234799999999999999975 77543211111           111111221


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCC---CCCCCHHHHhcCccccC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDY---HQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp---~~Rpt~~e~l~hp~~~~  323 (463)
                      ....+..++..++||.+||..+|   .+|+|++|+|+||||..
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            22234668899999999999866   68999999999999964

>KOG0664|consensus

Probab=100.00  E-value=9.6e-40  Score=294.21  Aligned_cols=254  Identities=24%  Similarity=0.437  Sum_probs=206.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      +.||-|+||+||.+.|..+|+.||+|.+..-.   ...+.+.+|+++|..+ +|.|++..+++...... ..-..+|+|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~-dfFqEiYV~T  136 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANP-SFFQELYVLT  136 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCc-hHHHHHHHHH
Confidence            79999999999999999999999999886332   2356788999999999 89999999998743321 1113578899


Q ss_pred             ecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC-c
Q psy7384         138 EYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG-R  216 (463)
Q Consensus       138 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~  216 (463)
                      |++.. +|..+|-  ..+.++...++-++.||+.||+|||+.||.||||||.|+|+++|+.+||||||+++..+.... .
T Consensus       137 ELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h  213 (449)
T KOG0664|consen  137 ELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN  213 (449)
T ss_pred             HHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence            98865 7777764  345799999999999999999999999999999999999999999999999999998765432 2


Q ss_pred             cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc------------------
Q psy7384         217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP------------------  278 (463)
Q Consensus       217 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~------------------  278 (463)
                      ++..+-|..|+|||++++    ...|+.++||||+|||+.|||..+..|...++.+++..|.                  
T Consensus       214 MTqEVVTQYYRAPEiLMG----aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELLMG----ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hHHHHHHHHhccHHHhhc----chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            344567899999999986    6779999999999999999999999998888877765431                  


Q ss_pred             -----CCCC--CCCC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         279 -----RNAP--PRLK-------SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       279 -----~~~~--~~~~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                           +...  |...       ...-..+...++..+|..||.+|.+.++++.|++..+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence                 1111  1111       0122347788999999999999999999999999864

>KOG4257|consensus

Probab=100.00  E-value=2.1e-37  Score=305.67  Aligned_cols=244  Identities=26%  Similarity=0.474  Sum_probs=208.0

Q ss_pred             EEeeeeeeCCeEEEEEEEcCC--C--cEEEEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKT--G--QLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~--~--~~vaiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +.++||.|-||.||.|.....  |  --||||..+.  +.++.+.|..|..+++.+ +|||||+++|++..       .-
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e-------~P  464 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE-------QP  464 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec-------cc
Confidence            456899999999999986533  3  3588898864  455678899999999999 89999999999953       57


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|||||++.-|.|+.+++..+ ..|+...+..++.||+.||.|||++++|||||-..||||.+...|||+|||+++.++.
T Consensus       465 ~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            899999999999999998765 4789999999999999999999999999999999999999999999999999998875


Q ss_pred             ccCcccc-ccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         213 TIGRRNT-FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       213 ~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ......+ ..-..-|||||.+.     -..++.++|||.|||++||++. |.-||.+..+.+.+-.+.++... +.++.+
T Consensus       544 ~~yYkaS~~kLPIKWmaPESIN-----fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl-P~P~nC  617 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESIN-----FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL-PCPPNC  617 (974)
T ss_pred             cchhhccccccceeecCccccc-----hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC-CCCCCC
Confidence            4322222 12345699999997     6778999999999999999876 99999999888888777666543 456689


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      |+.+..|..+||..+|.+||++.++..
T Consensus       618 Pp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  618 PPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             ChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            999999999999999999999988754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-36  Score=285.13  Aligned_cols=240  Identities=40%  Similarity=0.688  Sum_probs=200.5

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecCcch--HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCC
Q psy7384          67 TYGQVYKGRHTKTGQLAAIKVMDVTEDE--EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS  144 (463)
Q Consensus        67 ~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggs  144 (463)
                      +||.||+|.+..+|..+|+|++......  ...+.+|+..++++ +|+||+++++.+.      .....+++|||+.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~------~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFE------DEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhhee------eCCEEEEEEeCCCCCC
Confidence            5899999999988999999998754322  57888999999999 8999999999984      4478999999999999


Q ss_pred             HHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccccccCCc
Q psy7384         145 VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP  224 (463)
Q Consensus       145 L~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~  224 (463)
                      |.+++....  .++...+..++.+++.+|.|||+.||+|+||+|.||++++++.++|+|||++....... ......++.
T Consensus        74 L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  150 (244)
T smart00220       74 LFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP  150 (244)
T ss_pred             HHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence            999997644  38899999999999999999999999999999999999999999999999988765432 234456889


Q ss_pred             cccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC--CCHHHHHHHHHhh
Q psy7384         225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK--WPKKFQSFIETVL  302 (463)
Q Consensus       225 ~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~li~~~L  302 (463)
                      .|++||.+.     ...++.++||||||+++|+|++|..||........................  ++..+.+++.+||
T Consensus       151 ~~~~pE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  225 (244)
T smart00220      151 EYMAPEVLL-----GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLL  225 (244)
T ss_pred             CCCCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHc
Confidence            999999986     456788999999999999999999999773333333332222222222212  7889999999999


Q ss_pred             hcCCCCCCCHHHHhcCccc
Q psy7384         303 VKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       303 ~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ..+|++||++.++++||||
T Consensus       226 ~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      226 VKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             cCCchhccCHHHHhhCCCC
Confidence            9999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027|consensus

Probab=100.00  E-value=5.7e-38  Score=319.84  Aligned_cols=248  Identities=27%  Similarity=0.393  Sum_probs=192.8

Q ss_pred             EeeeeeeCCeE-EEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          60 IEVVGNGTYGQ-VYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        60 ~~~LG~G~fg~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      .+.+|.|+-|+ ||+|...  |+.||||.+..  .....+++||..|+....|||||++|+.-      .+...+||..|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E------~d~qF~YIalE  583 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSE------QDRQFLYIALE  583 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeec------cCCceEEEEeh
Confidence            35789999986 8999764  78999998743  33456789999999998999999999886      66689999999


Q ss_pred             cCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---C--CcEEEEecccccccc
Q psy7384         139 YCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---N--AEVKLVDFGVSAQLD  211 (463)
Q Consensus       139 ~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~--~~vkL~DFGla~~~~  211 (463)
                      +|.. +|.|++...  ..........+.++.|+++||++||+.+||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            9977 999999873  1111222456788999999999999999999999999999975   2  468999999999886


Q ss_pred             ccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchhhhhcccCCCCCCC-C
Q psy7384         212 RTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIPRNAPPRL-K  286 (463)
Q Consensus       212 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~-~  286 (463)
                      ...   ....+..||.+|+|||++.     ....+.++|||||||++|+.++| ..||.+.-..+.  .|..+...-. .
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~-----~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLR-----EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHh-----ccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeee
Confidence            432   2234567999999999998     44456689999999999998886 999965433222  2222221111 1


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .+.-..++.+||.+||..+|..||+|.++|.||||-+..
T Consensus       736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence            111112899999999999999999999999999997643

>KOG0199|consensus

Probab=100.00  E-value=1.4e-37  Score=310.42  Aligned_cols=250  Identities=22%  Similarity=0.391  Sum_probs=213.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCC-Cc--EEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKT-GQ--LAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~~--~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+..++.++||+|+||+|++|.|+.. |+  .||||++....  ....+|.+|+.+|.+| .|+|+|+|||+.+.     
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-----  182 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-----  182 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-----
Confidence            45567789999999999999999754 33  58999997432  2567899999999999 89999999999864     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        ..+.+|||++..|+|.+.|.......|....+..|+.||+.||.||.++++|||||-..|||+-.-..|||+||||.+
T Consensus       183 --qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  183 --QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             --chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence              467899999999999999987566678889999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCcccccc----CCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         209 QLDRTIGRRNTFI----GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       209 ~~~~~~~~~~~~~----gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      .+......+ .+.    -...|+|||.|.     ...++.++|||++||++|||++ |..||.|......+.+|... ..
T Consensus       261 aLg~ned~Y-vm~p~rkvPfAWCaPEsLr-----h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-er  333 (1039)
T KOG0199|consen  261 ALGENEDMY-VMAPQRKVPFAWCAPESLR-----HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ER  333 (1039)
T ss_pred             ccCCCCcce-EecCCCcCcccccCHhHhc-----cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-cc
Confidence            886543222 111    234699999998     6778999999999999999998 78999999999999888733 33


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      -...+.+++++.+++..||..+|..|||+..|...
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            44567899999999999999999999999988643

>KOG4278|consensus

Probab=100.00  E-value=5e-36  Score=295.62  Aligned_cols=246  Identities=23%  Similarity=0.423  Sum_probs=212.8

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      ..+..+||-|-||.||.|.|++-.-.||||.++.+.-..++|..|..+|+.+ +|||+|+|+++|.      .+.-+|||
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT------~EpPFYIi  341 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT------HEPPFYII  341 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhc------cCCCeEEE
Confidence            4566799999999999999999888999999988777889999999999999 8999999999994      44679999


Q ss_pred             EecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCc
Q psy7384         137 MEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR  216 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~  216 (463)
                      .|||..|+|.|+++++....++.-.+.+++-||..|+.||..+++|||||-..|.||.++..||++||||++.+..... 
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-  420 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-  420 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-
Confidence            9999999999999998888888888999999999999999999999999999999999999999999999998865432 


Q ss_pred             cccccC---CccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         217 RNTFIG---TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       217 ~~~~~g---t~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                       +.-.|   ..-|.|||.+.+     ..++.++|||+|||+|||+.| |..||.+.+....+..+. ....-..+..|++
T Consensus       421 -TAHAGAKFPIKWTAPEsLAy-----NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  421 -TAHAGAKFPIKWTAPESLAY-----NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPP  493 (1157)
T ss_pred             -ecccCccCcccccCcccccc-----cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCH
Confidence             11122   456999999984     467889999999999999987 899998876655544443 3333344568999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+..|++.||+++|..||++.|+-+
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHHH
Confidence            9999999999999999999999844

>KOG1094|consensus

Probab=100.00  E-value=4.4e-37  Score=301.73  Aligned_cols=254  Identities=23%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +-+.....+.++||+|-||.|.+|+-. .+..||+|+++...  ....+|..||++|.+| +|||||.++++|+.     
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~-----  606 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQ-----  606 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeec-----
Confidence            344566788999999999999999853 46899999997543  3457899999999999 89999999999954     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                       ++-+++|+||++.|+|.+++..+....+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++
T Consensus       607 -DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  607 -DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             -CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence             4689999999999999999988754444556667799999999999999999999999999999999999999999998


Q ss_pred             ccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCCchhhhhcc---cCCC
Q psy7384         209 QLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA--ESQPPLCDLHPMRALFLI---PRNA  281 (463)
Q Consensus       209 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell--~g~~Pf~~~~~~~~~~~i---~~~~  281 (463)
                      .+.....  .....+-...|||||.+.     .+.++.++|+|+||+++||++  +...||...++.+.....   ....
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsil-----lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~  760 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESIL-----LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ  760 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHH-----hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC
Confidence            6643321  112234567899999998     678999999999999999975  578899887766554331   1111


Q ss_pred             C---CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         282 P---PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       282 ~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .   ....+.-++..+.+++.+|+..+-.+||+++++-.
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            1   12334578899999999999999999999999843

>KOG0196|consensus

Probab=100.00  E-value=2e-37  Score=313.08  Aligned_cols=249  Identities=27%  Similarity=0.461  Sum_probs=216.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCC---cEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTG---QLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..+|.++||.|.||.|++|+.+..|   ..||||.++..  .....+|..|..||-++ +||||++|-|+.      ...
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVV------Tks  702 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVV------TKS  702 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEE------ecC
Confidence            4578899999999999999988776   46999999853  45667899999999999 899999999998      444


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      .-+.||.|||++|+|..+|+.+.++ |+..++..+++.|+.|++||-++|+|||||-..||||+.+-.+|++|||+++.+
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence            6789999999999999999987764 888899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCcccc-ccC--CccccccceeccCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         211 DRTIGRRNT-FIG--TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA-ESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       211 ~~~~~~~~~-~~g--t~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell-~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      .+......+ .-|  ...|.|||.|.     -..++.++||||+|++|||.+ .|..||.+.++.+.+..|..+... +.
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa-----~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL-Pp  855 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL-PP  855 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhh-----hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC-CC
Confidence            665433222 222  35799999998     567899999999999999955 599999999999999888666442 33


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +-.+|..+.+|+..||++|-.+||.+.||+++
T Consensus       856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            45789999999999999999999999999874

>KOG0984|consensus

Probab=100.00  E-value=1e-36  Score=264.53  Aligned_cols=233  Identities=30%  Similarity=0.555  Sum_probs=195.1

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +...+...-+..||+|+||.|-+.++..+|...|+|.+..  +....+++.+|+.+..+....|.+|.+|+.+      .
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~------~  115 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL------F  115 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh------h
Confidence            4445556667899999999999999999999999999963  4455667788999988888999999999988      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEecc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKS--TKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                      .+..+++.||.|.. ||..+.+.  .++..++|.-+-+|+..++.||.|||++ .|||||+||+||||+.+|++||||||
T Consensus       116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence            55789999999964 77666543  3456899999999999999999999986 89999999999999999999999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCchhhhhcccCCCCCC
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD-LHPMRALFLIPRNAPPR  284 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~  284 (463)
                      ++..+...... +...|...|||||.+....+ ...|+-++||||||+++.||.+++.||.. .++.+++.++.....|.
T Consensus       195 IsG~L~dSiAk-t~daGCkpYmaPEri~~e~n-~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  195 ISGYLVDSIAK-TMDAGCKPYMAPERINPELN-QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             cceeehhhhHH-HHhcCCCccCChhhcCcccC-cccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence            99887654322 33468889999999976554 34899999999999999999999999954 57888888888888887


Q ss_pred             CCCCCCCH
Q psy7384         285 LKSKKWPK  292 (463)
Q Consensus       285 ~~~~~~~~  292 (463)
                      +....++.
T Consensus       273 Lp~~~FS~  280 (282)
T KOG0984|consen  273 LPADTFSP  280 (282)
T ss_pred             CcccccCC
Confidence            77666554

>KOG1167|consensus

Probab=100.00  E-value=4.1e-36  Score=286.43  Aligned_cols=254  Identities=27%  Similarity=0.449  Sum_probs=202.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcC---CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .|.++.+||+|+|++||++.+..   .++.||+|.+..... ...+.+|+++|..+..+.||+++.+++      ..++.
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~------rnnd~  109 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCF------RNNDQ  109 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhh------ccCCe
Confidence            48899999999999999999887   788999999976533 456889999999999999999999999      77789


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~~~~  211 (463)
                      ..+||||+++-...++..     .++...++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|...+
T Consensus       110 v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             eEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999999888886     3778899999999999999999999999999999999975 5678999999987221


Q ss_pred             ccc--------------------------------------------CccccccCCccccccceeccCCCCCCCCCcchh
Q psy7384         212 RTI--------------------------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSD  247 (463)
Q Consensus       212 ~~~--------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~D  247 (463)
                      ...                                            .......||++|+|||++..    ....+.++|
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k----~~~QttaiD  260 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR----CPRQTTAID  260 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh----ccCcCCccc
Confidence            000                                            00112369999999999985    455678899


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCC-chhhhhc---------------------ccC--------------------CC----
Q psy7384         248 LWSLGITALEMAESQPPLCDLH-PMRALFL---------------------IPR--------------------NA----  281 (463)
Q Consensus       248 iwSlG~il~ell~g~~Pf~~~~-~~~~~~~---------------------i~~--------------------~~----  281 (463)
                      |||.|||+.-+++++.||.... +...+..                     +..                    ..    
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999999984321 1111100                     000                    00    


Q ss_pred             ----CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         282 ----PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       282 ----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                          ......+.++..+.+|+.+||..||.+|.|++++|+||||.+..
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence                00111234456889999999999999999999999999998543

>KOG2052|consensus

Probab=100.00  E-value=1.6e-35  Score=283.31  Aligned_cols=280  Identities=26%  Similarity=0.444  Sum_probs=209.6

Q ss_pred             hhhHHHHHHhhccccccCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHH
Q psy7384          25 DKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINV  104 (463)
Q Consensus        25 ~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~  104 (463)
                      +.-|.+++..+.......|.|.- .+....+...+++.||+|.||.||+|.|.  |+.||||+|...  ++..+.+|.++
T Consensus       182 ~stl~Dll~~~~tSGSGSGlplL-VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEI  256 (513)
T KOG2052|consen  182 DSTLKDLLDDLETSGSGSGLPLL-VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEI  256 (513)
T ss_pred             CccHHHHHHhhccCCCCCCchhH-hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHH
Confidence            45577778777766665665543 34556778899999999999999999997  888999999654  34567777777


Q ss_pred             HHH-hcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC----
Q psy7384         105 LKK-YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN----  179 (463)
Q Consensus       105 l~~-l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----  179 (463)
                      .+. +.+|+||+.++++-....  ....++|||.+|.+.|||+|+|.+.   .++...+.+++..++.||+|||..    
T Consensus       257 YqTvmLRHENILgFIaaD~~~~--gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GT  331 (513)
T KOG2052|consen  257 YQTVMLRHENILGFIAADNKDN--GSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGT  331 (513)
T ss_pred             HHHHHhccchhhhhhhccccCC--CceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcC
Confidence            664 338999999998764432  5567899999999999999999863   699999999999999999999952    


Q ss_pred             ----CceecCCCCCceEEccCCcEEEEeccccccccccc----CccccccCCccccccceeccCCCCCCCCC-cchhHHH
Q psy7384         180 ----KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI----GRRNTFIGTPYWMAPEVIACDENPDATYD-NRSDLWS  250 (463)
Q Consensus       180 ----givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~-~~~DiwS  250 (463)
                          .|.|||||..||||..++.+.|+|+|||.......    ...+..+||..|||||++...-+..---+ ..+||||
T Consensus       332 qgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa  411 (513)
T KOG2052|consen  332 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA  411 (513)
T ss_pred             CCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence                59999999999999999999999999997665432    23466799999999999964211111111 3589999


Q ss_pred             HHHHHHHHHhC----------CCCCCCCCch----hhhhcccC--CCCCCCCCCCCC-----HHHHHHHHHhhhcCCCCC
Q psy7384         251 LGITALEMAES----------QPPLCDLHPM----RALFLIPR--NAPPRLKSKKWP-----KKFQSFIETVLVKDYHQR  309 (463)
Q Consensus       251 lG~il~ell~g----------~~Pf~~~~~~----~~~~~i~~--~~~~~~~~~~~~-----~~~~~li~~~L~~dp~~R  309 (463)
                      ||.++||++..          ++||++.-+.    +.+..+.-  ...|.+ +..|.     ..+-.+++.||..||..|
T Consensus       412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i-pnrW~s~~~l~~m~klMkeCW~~Np~aR  490 (513)
T KOG2052|consen  412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI-PNRWKSDPALRVMAKLMKECWYANPAAR  490 (513)
T ss_pred             HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCC-CcccccCHHHHHHHHHHHHhhcCCchhh
Confidence            99999999753          5788764332    33333211  111111 11232     245668999999999999


Q ss_pred             CCHHHH
Q psy7384         310 PYTDQL  315 (463)
Q Consensus       310 pt~~e~  315 (463)
                      .|+-.+
T Consensus       491 ltALri  496 (513)
T KOG2052|consen  491 LTALRI  496 (513)
T ss_pred             hHHHHH
Confidence            888665

>KOG1152|consensus

Probab=100.00  E-value=1.2e-35  Score=291.39  Aligned_cols=206  Identities=27%  Similarity=0.466  Sum_probs=175.6

Q ss_pred             CcCCCCCCc--eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---------HHHHHHHHHHHHHhc--CCCce
Q psy7384          48 RWQEDPAGI--FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---------EEEIKLEINVLKKYS--NHRNI  114 (463)
Q Consensus        48 ~~~~~~~~~--y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~Ei~~l~~l~--~h~nI  114 (463)
                      .|.....+.  |..++.||+|+||.|++|.++.+...|+||.|.+..--         ...+-.||.||..+.  .|+||
T Consensus       552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            455545554  99999999999999999999999999999998643322         223346999999983  29999


Q ss_pred             eeecccccccCCCCCCCeEEEEEecC-CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE
Q psy7384         115 ATYYGAFIKKSPPGKDDQLWLVMEYC-GAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL  193 (463)
Q Consensus       115 v~l~~~~~~~~~~~~~~~~~lV~E~~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl  193 (463)
                      ++++++|      ++++++||+||-- +|-+|+++|....  .++|.+++.|++|++.|+++||+.||||||||-+|+.+
T Consensus       632 lKlLdfF------Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv  703 (772)
T KOG1152|consen  632 LKLLDFF------EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV  703 (772)
T ss_pred             hhhhhee------ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEE
Confidence            9999999      7789999999976 4668999998665  69999999999999999999999999999999999999


Q ss_pred             ccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7384         194 TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD  267 (463)
Q Consensus       194 ~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  267 (463)
                      +.+|.+||+|||.+.....  +....++||..|.|||++.+.    ...+..-|||+||++||.++....||+.
T Consensus       704 d~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~----~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGE----KYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCC----ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999999999877653  455678999999999999853    3335668999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=325.16  Aligned_cols=238  Identities=18%  Similarity=0.317  Sum_probs=183.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      .|...+.||+|+||.||+|++..+|..||+|.+......   ...|+++++++ +|||||++++++.      ..+..|+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l-~HpnIv~~~~~~~------~~~~~~l  760 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKL-QHPNIVKLIGLCR------SEKGAYL  760 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhC-CCCCcceEEEEEE------cCCCCEE
Confidence            455667999999999999999999999999998643221   23468889998 8999999999994      4467899


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh---cCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH---ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      ||||+++|+|.++++     .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......
T Consensus       761 v~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        761 IHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            999999999999995     3788899999999999999999   6799999999999999988887775 665543322


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhh---c--ccCC-----C
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALF---L--IPRN-----A  281 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~---~--i~~~-----~  281 (463)
                      .    ....||+.|+|||++.     ...|+.++|||||||++|||++|+.||...... ....   .  ....     .
T Consensus       835 ~----~~~~~t~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (968)
T PLN00113        835 D----TKCFISSAYVAPETRE-----TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI  905 (968)
T ss_pred             C----CCccccccccCccccc-----CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence            1    2336889999999987     567899999999999999999999998532111 0000   0  0000     0


Q ss_pred             CCCCCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         282 PPRLKS-----KKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       282 ~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+....     .....++.+++.+||..||.+|||+.|+++.
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            011100     0112356789999999999999999999763

>KOG0200|consensus

Probab=100.00  E-value=1.4e-33  Score=298.15  Aligned_cols=252  Identities=25%  Similarity=0.466  Sum_probs=203.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcC-------CCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTK-------TGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ...++.+.||+|.||.|++|.-..       ....||||.+...  ..+.+.+..|+++|+.+..|+||+.+++++.   
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t---  372 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT---  372 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec---
Confidence            334777899999999999997431       1346999998643  3457788999999999999999999999994   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhC------C--------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCce
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTK------G--------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNV  191 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~------~--------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NI  191 (463)
                         ..+.+++|+||+..|+|.++++..+      .        ..++..++..++.||+.|++||++.++|||||-..||
T Consensus       373 ---~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 ---QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             ---cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence               3578999999999999999998765      0        1388999999999999999999999999999999999


Q ss_pred             EEccCCcEEEEecccccccccccCcc-ccccC--CccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy7384         192 LLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIG--TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCD  267 (463)
Q Consensus       192 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~g--t~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~  267 (463)
                      |+..+..+||+|||+|+......... ..-.|  ...|||||.+.     ...|+.++||||||++|||+++ |..||.+
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-----~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-----DRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-----cCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999998543321111 11122  33499999997     5789999999999999999998 8899988


Q ss_pred             CCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         268 LHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       268 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ......+....+.......+..+++++.++++.||..+|.+||++.++..
T Consensus       525 ~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  525 IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            65333333333333333445577999999999999999999999999865

>KOG3653|consensus

Probab=100.00  E-value=2.7e-34  Score=276.77  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=184.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHH--HhcCCCceeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK--KYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~--~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..+++++||+|.||.||+|...  ++.||||++...  ..+.+++|-+|..  .+ +|+||++++++-....  .....+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m-~h~nIl~Fi~~ekr~t--~~~~ey  283 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGM-KHENILQFIGAEKRGT--ADRMEY  283 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHH--HHHHHHhHHHHHhccCc-cchhHHHhhchhccCC--ccccce
Confidence            4578899999999999999764  699999999643  3455666655554  44 8999999998864332  224589


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc---------CCceecCCCCCceEEccCCcEEEEec
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE---------NKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                      +||+||.+.|+|.++++.+   .+++....+|+..|+.||+|||+         ..|+|||||..||||.+++++.|+||
T Consensus       284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999999865   58999999999999999999996         36999999999999999999999999


Q ss_pred             ccccccccc--cCccccccCCccccccceeccCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCc----------
Q psy7384         205 GVSAQLDRT--IGRRNTFIGTPYWMAPEVIACDENPD-ATYDNRSDLWSLGITALEMAESQPPLC-DLHP----------  270 (463)
Q Consensus       205 Gla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~-~~~~----------  270 (463)
                      |+|..+...  .+.....+||..|||||++-+.-+-. ...-.+.||||+|.+||||++...-+. +..+          
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999887533  22334478999999999997543222 122246899999999999998654332 1111          


Q ss_pred             -----hhhhhc--ccCCCCCCCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q psy7384         271 -----MRALFL--IPRNAPPRLKS----KKWPKKFQSFIETVLVKDYHQRPYTDQL  315 (463)
Q Consensus       271 -----~~~~~~--i~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~  315 (463)
                           .+.+..  +.....|.+..    ..-..-+++.+..||..|++.|.|+.=+
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                 111111  11111121111    1113467889999999999999987643

>KOG1025|consensus

Probab=100.00  E-value=1.4e-33  Score=286.31  Aligned_cols=246  Identities=26%  Similarity=0.401  Sum_probs=206.8

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCc----EEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .+..++||+|+||+||+|.+...|+    .||||++....  ....++..|.-+|.++ +|||+++|++++..       
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~-------  769 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCML-------  769 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhccc-------
Confidence            4556899999999999999976654    68999886443  4467888999999999 89999999999964       


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+-||++|+++|.|.|+++..+. .+..++...|+.||++||.|||.+++|||||-..||||..-.++||.|||+++.+
T Consensus       770 s~~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  770 STLQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             chHHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            358899999999999999987654 6888999999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccccC--CccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIG--TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       211 ~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ...........|  .+-|||=|.+.     ...|+.++|||||||++||++| |..|+.+..-.+.-..+..+.. -..+
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~-----~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP  922 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIR-----IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP  922 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhh-----ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC
Confidence            665444443333  45699999998     7789999999999999999988 8889988766554444333333 4455


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +.++.++..++.+||..|+..||+++++..
T Consensus       923 piCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  923 PICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            688999999999999999999999998753

>KOG1345|consensus

Probab=100.00  E-value=2.8e-34  Score=258.82  Aligned_cols=247  Identities=19%  Similarity=0.351  Sum_probs=197.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +..+.|.|.+.||+|.||.+.+|+++.++..+++|.+........+|.+|..---.|+.|.||+.-|++..     +..+
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-----qt~d   95 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-----QTSD   95 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-----hcCc
Confidence            34567999999999999999999999999999999999888888999999877667778999999998754     5557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc--cCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT--DNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~--~~~~vkL~DFGla~~  209 (463)
                      .+++++||++-|+|..-+..   ..+.|...+.++.|+++||.|||++++||||||.+||||-  +...|||||||+.+.
T Consensus        96 ~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence            99999999999999887754   3588999999999999999999999999999999999993  456899999999877


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh----cccCCCCCC-
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF----LIPRNAPPR-  284 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~-  284 (463)
                      .+......   --+..|.+||++.-..+......+.+|+|.||+|+|.+|+|.+||....-.+.-+    .......+. 
T Consensus       173 ~g~tV~~~---~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  173 VGTTVKYL---EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             cCceehhh---hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence            65443222   2355699999876544445556788999999999999999999996443322221    111111111 


Q ss_pred             -CCCCCCCHHHHHHHHHhhhcCCCCC
Q psy7384         285 -LKSKKWPKKFQSFIETVLVKDYHQR  309 (463)
Q Consensus       285 -~~~~~~~~~~~~li~~~L~~dp~~R  309 (463)
                       .....+++.+..+.++-|..+++.|
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCccccc
Confidence             1224678889999999999999988

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.7e-31  Score=243.85  Aligned_cols=212  Identities=43%  Similarity=0.752  Sum_probs=184.8

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecC
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYC  140 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~  140 (463)
                      ||+|++|.||++.+..+++.+++|++.....  ....+.+|+..++.+ .|++|+++++++.      .....+++|||+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~------~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFE------DENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeee------cCCeEEEEEecC
Confidence            6899999999999988899999999976544  357889999999999 7999999999984      447899999999


Q ss_pred             CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEecccccccccccCcccc
Q psy7384         141 GAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDRTIGRRNT  219 (463)
Q Consensus       141 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~  219 (463)
                      .+++|.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+............
T Consensus        74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            9999999997642 35889999999999999999999999999999999999998 899999999998876543222334


Q ss_pred             ccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHH
Q psy7384         220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIE  299 (463)
Q Consensus       220 ~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  299 (463)
                      ..+...|++||.+..    ...++.+.|+|++|+++++|                                 ..+.+++.
T Consensus       153 ~~~~~~~~~pe~~~~----~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~  195 (215)
T cd00180         153 IVGTPAYMAPEVLLG----KGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIR  195 (215)
T ss_pred             ccCCCCccChhHhcc----cCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHH
Confidence            568889999999862    12678889999999999999                                 57999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCc
Q psy7384         300 TVLVKDYHQRPYTDQLLKHP  319 (463)
Q Consensus       300 ~~L~~dp~~Rpt~~e~l~hp  319 (463)
                      .||..+|.+||+++++++|+
T Consensus       196 ~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         196 KMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHhhCCcccCcCHHHHhhCC
Confidence            99999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.1e-30  Score=239.32  Aligned_cols=206  Identities=38%  Similarity=0.679  Sum_probs=174.9

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.....  ....+.+|+..++.+ +|+||+++++.+.      .....+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~------~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFE------DPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeee------cCCceE
Confidence            5678999999999999999998899999999975433  467888999999999 8999999999883      446899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +++||+.+++|.+++..... .+++..+..++.|++.+|.+||+++++|+||+|.||+++.++.++|+|||++.......
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             EEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            99999999999999976542 17899999999999999999999999999999999999999999999999988765432


Q ss_pred             -CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCchhhh
Q psy7384         215 -GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD-LHPMRAL  274 (463)
Q Consensus       215 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~  274 (463)
                       .......++..|++||.+.    ....++.++|+|+||+++|+|++|+.||.. .++...+
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~  210 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLL----GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL  210 (225)
T ss_pred             cccccceeccCCcCCHhHhc----CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence             1223456888999999984    156677799999999999999999999977 4444333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.3e-31  Score=293.63  Aligned_cols=204  Identities=16%  Similarity=0.214  Sum_probs=147.9

Q ss_pred             CC-CceeeecccccccCCCC-CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         110 NH-RNIATYYGAFIKKSPPG-KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       110 ~h-~nIv~l~~~~~~~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                      .| +||+++++.|....... ....++++|||+ +++|.+++... ...+++..++.+++||++||.|||++||+|||||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            45 68888888873332211 234678889987 55999999743 3469999999999999999999999999999999


Q ss_pred             CCceEEcc-------------------CCcEEEEeccccccccccc----------------CccccccCCcccccccee
Q psy7384         188 GQNVLLTD-------------------NAEVKLVDFGVSAQLDRTI----------------GRRNTFIGTPYWMAPEVI  232 (463)
Q Consensus       188 p~NILl~~-------------------~~~vkL~DFGla~~~~~~~----------------~~~~~~~gt~~y~aPE~l  232 (463)
                      |+||||+.                   ++.+||+|||+++......                ......+||++|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999964                   3456666666665321100                001124689999999998


Q ss_pred             ccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH
Q psy7384         233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT  312 (463)
Q Consensus       233 ~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  312 (463)
                      .     ...|+.++|||||||+||||++|.+||......  +..+.....+...... .....+++.+||..+|.+||++
T Consensus       188 ~-----~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        188 N-----GSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHRVLPPQILLN-WPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             c-----cCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHhhcChhhhhc-CHHHHHHHHHhCCCChhhCcCh
Confidence            7     567899999999999999999999987543211  1111111111111112 3456789999999999999999


Q ss_pred             HHHhcCccccC
Q psy7384         313 DQLLKHPFIRD  323 (463)
Q Consensus       313 ~e~l~hp~~~~  323 (463)
                      .|+|+||||..
T Consensus       260 ~eil~h~~~~~  270 (793)
T PLN00181        260 SELLQSEFINE  270 (793)
T ss_pred             HHHhhchhhhh
Confidence            99999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=8.9e-30  Score=228.19  Aligned_cols=161  Identities=28%  Similarity=0.406  Sum_probs=129.0

Q ss_pred             CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccccccC
Q psy7384         143 GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG  222 (463)
Q Consensus       143 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g  222 (463)
                      |+|.+++...+ ..+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||++.......     ..|
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g   66 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRV   66 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCC
Confidence            68999997543 46999999999999999999999999      999999999999999  99987765422     268


Q ss_pred             CccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh-cccCCCCCC-----CCCCCCCH--HH
Q psy7384         223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNAPPR-----LKSKKWPK--KF  294 (463)
Q Consensus       223 t~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~-~i~~~~~~~-----~~~~~~~~--~~  294 (463)
                      |+.|+|||++.     +..|+.++|||||||++|||++|..||.......... .+.......     .....++.  .+
T Consensus        67 ~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (176)
T smart00750       67 DPYFMAPEVIQ-----GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF  141 (176)
T ss_pred             cccccChHHhc-----CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence            99999999997     5678899999999999999999999997654433221 111111111     01122333  69


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         295 QSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       295 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ++||.+||..+|.+||++.++++|+|+.
T Consensus       142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      142 ADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            9999999999999999999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024|consensus

Probab=99.95  E-value=1.4e-28  Score=232.00  Aligned_cols=251  Identities=20%  Similarity=0.334  Sum_probs=200.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCC-----cEEEEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTG-----QLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vaiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .|+++..++-+|+||.||+|.+.+..     +.|-+|.+..  ++-....+..|-..|..+ .|||+..+.++..     
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~i-----  357 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSI-----  357 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEe-----
Confidence            45777889999999999999876543     2344566542  233345566777788888 6999999999986     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhC------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEE
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTK------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL  201 (463)
                      ++....++++.+..-|+|..++...+      .+.++..++..++.|++.|++|||++||||.||-..|.+|++.-.+||
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence            45578899999999999999998433      345778888899999999999999999999999999999999999999


Q ss_pred             EecccccccccccCcc--ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhccc
Q psy7384         202 VDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~  278 (463)
                      +|=.+++.+-......  ...-....||+||.+.     +..|+.++|+|||||+||||+| |+.|+.+.++.+...-+.
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-----n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-----NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHh-----hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            9999988664321110  0011345699999998     6789999999999999999988 899999988887766555


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+... ..+-++|+++..++..||...|++||+.+|+..
T Consensus       513 dGyRl-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  513 DGYRL-AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cccee-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            54432 234589999999999999999999999999854

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.8e-27  Score=234.19  Aligned_cols=164  Identities=18%  Similarity=0.187  Sum_probs=130.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcC-CCcEEEEEEeecC------cchHHHHHHHHHHHHHhcCCCceee-ecccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTK-TGQLAAIKVMDVT------EDEEEEIKLEINVLKKYSNHRNIAT-YYGAFIK  123 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~Ei~~l~~l~~h~nIv~-l~~~~~~  123 (463)
                      ...+.|.+.+.||+|+||+||+|++.. ++..+|||++...      ......+.+|+.+|+.+ +|+||++ +++ +  
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~-~--   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA-T--   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE-c--
Confidence            346789999999999999999999876 6788899986522      12345688999999999 7999985 443 2  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCC-CCCceEEccCCcEEEE
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDI-KGQNVLLTDNAEVKLV  202 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDL-kp~NILl~~~~~vkL~  202 (463)
                             +..||||||++|++|... .  .   ..   ...++.|+++||.|||++||+|||| ||+|||++.++.+||+
T Consensus        91 -------~~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         91 -------GKDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             -------CCcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEE
Confidence                   357999999999999632 1  1   11   1467899999999999999999999 9999999999999999


Q ss_pred             ecccccccccccC--------ccccccCCccccccceeccC
Q psy7384         203 DFGVSAQLDRTIG--------RRNTFIGTPYWMAPEVIACD  235 (463)
Q Consensus       203 DFGla~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~  235 (463)
                      |||+|+.+.....        .....++++.|+|||.+...
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999987654321        11345688899999998653

>KOG1164|consensus

Probab=99.95  E-value=1.4e-26  Score=227.67  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=194.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCC-cEEEEEEeecCcc-hHHHHHHHHHHHHHhcC---CCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMDVTED-EEEEIKLEINVLKKYSN---HRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~---h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +|++.+.||+|+||.||+|.+..++ ..+|+|+...... ....+..|+.++..+..   -.++..+++...     ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-----~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-----STE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-----CCC
Confidence            7999999999999999999988775 6788998764322 22278889999998852   358888888763     134


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-----CcEEEEecc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-----AEVKLVDFG  205 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-----~~vkL~DFG  205 (463)
                      ..-|+||+.+ |.+|.++........++...+..++.|++.+|.+||+.|++||||||+|+++...     ..+.|.|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            6789999998 6799999877666789999999999999999999999999999999999999754     469999999


Q ss_pred             ccc--cccccc------C-c-cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q psy7384         206 VSA--QLDRTI------G-R-RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF  275 (463)
Q Consensus       206 la~--~~~~~~------~-~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  275 (463)
                      +++  ..-...      . . ...+.||..|+++....     +...+.+.|+||++.++.+|+.|..||.+........
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-----~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~  247 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-----GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS  247 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhC-----CCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence            998  321111      1 1 23456999999999877     6678889999999999999999999997665433222


Q ss_pred             cccCC---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         276 LIPRN---APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       276 ~i~~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+...   ..........+.++..+...+-..+...+|....+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22111   11111223456788888888888888999988877553

>KOG0590|consensus

Probab=99.95  E-value=1.6e-28  Score=256.83  Aligned_cols=252  Identities=27%  Similarity=0.380  Sum_probs=191.9

Q ss_pred             EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchH---HHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          58 ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEE---EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~---~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .....+|.|++|.|+.+........++.|.+..    .....   ..+..|.-+-..+ .|+||+..+..+..      .
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~------~  393 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQE------I  393 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhh------c
Confidence            466899999999999888877766666665431    11111   1133444455566 79999988888743      3


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...+-+||||++ +|+.++...  ..++..++..+++||+.||+|||++||.|||||++|+|++.+|.+||+|||.+...
T Consensus       394 ~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  394 DGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             ccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence            445555999999 999999765  25888899999999999999999999999999999999999999999999998766


Q ss_pred             cccc----CccccccCCccccccceeccCCCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCchhhhh-cccC-----
Q psy7384         211 DRTI----GRRNTFIGTPYWMAPEVIACDENPDATYDN-RSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPR-----  279 (463)
Q Consensus       211 ~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~-~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~-~i~~-----  279 (463)
                      ....    ......+|+..|+|||++.     ...|++ .+||||.|+|++.|.+|+.||.-....+..+ ....     
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~-----~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~  545 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLT-----GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN  545 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCccccc-----ccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence            4332    2345678999999999997     555654 5899999999999999999995544333221 1100     


Q ss_pred             -CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 -NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 -~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                       ...+......++.+.+.+|.+||++||.+|.|+++|++.+||+..
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence             011112223567788999999999999999999999999999754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=6.2e-26  Score=220.68  Aligned_cols=255  Identities=35%  Similarity=0.546  Sum_probs=200.6

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc----hHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED----EEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~  131 (463)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....    ....+.+|+.++..+ .|+ +|+++++.+.      ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~------~~~   71 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQ------DEG   71 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEe------cCC
Confidence            788999999999999999987   7789998864322    366788999999999 566 7999999993      334


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKG-QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~~  209 (463)
                      ..+++++++.+++|.+++..... ..+....+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++..
T Consensus        72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            58999999999999977764432 2688999999999999999999999999999999999999888 799999999886


Q ss_pred             cccccC------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc----hhhhhcccC
Q psy7384         210 LDRTIG------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP----MRALFLIPR  279 (463)
Q Consensus       210 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~----~~~~~~i~~  279 (463)
                      ......      .....+|+..|++||.+....  ...+....|+||+|++++++++|..||.....    ......+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  229 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE  229 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence            544322      235678999999999987310  04678889999999999999999999876653    222222222


Q ss_pred             CCCC-C--CCCCCC----CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 NAPP-R--LKSKKW----PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 ~~~~-~--~~~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ...+ .  ......    ...+.+++..++..+|..|.+..+...++|...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            2211 1  111111    257899999999999999999999999866653

>KOG1163|consensus

Probab=99.93  E-value=1.1e-25  Score=200.27  Aligned_cols=247  Identities=20%  Similarity=0.326  Sum_probs=193.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..+.|+++++||.|+||.+|+|....+|..||||+-... .....+..|..+...|..-..|..+..++      .+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~------~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYG------TEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhc------ccccc
Confidence            467899999999999999999999999999999986533 34456777888888886667777777776      44567


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEecccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQ  209 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGla~~  209 (463)
                      -.+||+++ |-+|.+++.-+.. .++...+.-++-|++.-|+|+|.+++|||||||+|+|..-   ...+.|+|||+|+.
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence            89999998 6699999876553 6889999999999999999999999999999999999854   34689999999987


Q ss_pred             ccccc-------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh---hcc--
Q psy7384         210 LDRTI-------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---FLI--  277 (463)
Q Consensus       210 ~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~---~~i--  277 (463)
                      .....       .......||..|.+--...     +...+...|+-|+|.+|..+.-|..||.+.......   ..|  
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~-----g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E  238 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHL-----GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE  238 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhh-----hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence            64321       1223457999998865544     445567789999999999999999999886544332   222  


Q ss_pred             -cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q psy7384         278 -PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTD  313 (463)
Q Consensus       278 -~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  313 (463)
                       ....+....-..+|.++.-.+..|-..--++-|...
T Consensus       239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence             222333444568899999999999887777777644

>KOG0603|consensus

Probab=99.93  E-value=1.4e-27  Score=239.01  Aligned_cols=242  Identities=25%  Similarity=0.386  Sum_probs=196.8

Q ss_pred             eeeeeCCeEEEEEEE---cCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          62 VVGNGTYGQVYKGRH---TKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~---~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      .+|+|+||.|++++.   ...|..+|+|+.....   ........|..++..+..||.+|+++-.|      +.+...++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf------qt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF------QTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee------ccccchhH
Confidence            379999999998763   3457788988875321   11224456777888886699999999999      66789999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      +++|..||.|...+....  .+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-..  
T Consensus        75 ~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--  150 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--  150 (612)
T ss_pred             hhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh--
Confidence            999999999988775443  6788889999999999999999999999999999999999999999999998865433  


Q ss_pred             ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHH
Q psy7384         216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ  295 (463)
Q Consensus       216 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  295 (463)
                        ...|||..|||||++.       ....++|.||||+++++|++|..||.+    +....|......  .+...+..++
T Consensus       151 --~~~cgt~eymApEI~~-------gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~--~p~~l~~~a~  215 (612)
T KOG0603|consen  151 --KIACGTYEYRAPEIIN-------GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE--MPRELSAEAR  215 (612)
T ss_pred             --hhcccchhhhhhHhhh-------ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC--CchhhhHHHH
Confidence              2229999999999986       356678999999999999999999987    455555554332  2335677899


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHhcCccccCCchhH
Q psy7384         296 SFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTER  328 (463)
Q Consensus       296 ~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~~  328 (463)
                      +++..++..+|.+|.-     +.++++|+||+...+..
T Consensus       216 ~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  216 SLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             HHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence            9999999999999964     68999999998766543

>KOG1165|consensus

Probab=99.93  E-value=3.6e-25  Score=205.33  Aligned_cols=248  Identities=20%  Similarity=0.335  Sum_probs=195.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .+-.|++.++||+|+||+.+.|.+.-+++.||||.-... .+..++..|.+..+.|...++|...|-+.      ++..+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFG------qeG~~   98 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFG------QEGKY   98 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeec------cccch
Confidence            345799999999999999999999999999999975432 44567888999999887889998887665      45566


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-----CCcEEEEecccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-----NAEVKLVDFGVS  207 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-----~~~vkL~DFGla  207 (463)
                      -.||||++ |-+|.|++.-+.. .|+...+..++.|++.-++|+|++.+|+|||||+|+||..     ...|.|+|||+|
T Consensus        99 NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            78999998 6699998876653 6999999999999999999999999999999999999953     346899999999


Q ss_pred             ccccccc-------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---hhhhhcc
Q psy7384         208 AQLDRTI-------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP---MRALFLI  277 (463)
Q Consensus       208 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~---~~~~~~i  277 (463)
                      +......       ....+..||..||+---.+     +...+.+.|+-|||.++..+|-|..||.+...   .+.+.+|
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl-----GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHL-----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccc-----cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            9875432       2334567999999966555     56677889999999999999999999987532   2333344


Q ss_pred             cCCC---CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q psy7384         278 PRNA---PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQ  314 (463)
Q Consensus       278 ~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  314 (463)
                      ....   +.......+|.++...++..-..+-.+-|..+-
T Consensus       252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy  291 (449)
T KOG1165|consen  252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY  291 (449)
T ss_pred             ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence            3222   222233567888888888777777666666553

>KOG0606|consensus

Probab=99.92  E-value=2.2e-25  Score=233.36  Aligned_cols=224  Identities=29%  Similarity=0.466  Sum_probs=172.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ...|+.++.|..|+||-||+++++.+.+.+|+|+-+ .    ..      ||      .||..+-+            ..
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q----~l------il------Rnilt~a~------------np  132 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-Q----NL------IL------RNILTFAG------------NP  132 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-c----ch------hh------hccccccC------------Cc
Confidence            467999999999999999999999999999996521 1    01      11      12333222            23


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      +.|      |+-..+++..+  .++.        +++.+++|||+.||+|||+||+|++|+.-|++|+.|||+++..-..
T Consensus       133 fvv------gDc~tllk~~g--~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  133 FVV------GDCATLLKNIG--PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             cee------chhhhhcccCC--CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence            333      45566665544  3432        2388999999999999999999999999999999999997643211


Q ss_pred             cC---------------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc
Q psy7384         214 IG---------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       214 ~~---------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  278 (463)
                      ..               .....||||.|+|||++.     ...|+..+|+|++|+|+||++.|..||.+..+.+.+..+.
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil-----rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi  271 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL-----RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  271 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhh-----hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence            00               112358999999999998     7889999999999999999999999999998888776655


Q ss_pred             CCCCCC-CCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHhcCccccCCchh
Q psy7384         279 RNAPPR-LKSKKWPKKFQSFIETVLVKDYHQR---PYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       279 ~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~hp~~~~~~~~  327 (463)
                      ...... ......+.+++++|.++|..+|..|   ..+-++.+|+||+...+.
T Consensus       272 sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  272 SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            443322 1245678899999999999999999   468889999999987776

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=2.7e-24  Score=203.16  Aligned_cols=244  Identities=21%  Similarity=0.267  Sum_probs=152.2

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcC---------CCceeeeccccc
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSN---------HRNIATYYGAFI  122 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~---------h~nIv~l~~~~~  122 (463)
                      .+...+.||.|+|+.||.+.+..||+.+|+|++....    ...+.+++|.-....+..         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4677899999999999999999999999999986332    234455555433322211         222333333222


Q ss_pred             ccCC------CCCCC-----eEEEEEecCCCCCHHHHHHh---hCCC--CCCHHHHHHHHHHHHHHHhhhhcCCceecCC
Q psy7384         123 KKSP------PGKDD-----QLWLVMEYCGAGSVTDLVKS---TKGQ--SLKEEWIAFICREILRGLKYLHENKVIHRDI  186 (463)
Q Consensus       123 ~~~~------~~~~~-----~~~lV~E~~~ggsL~~~l~~---~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDL  186 (463)
                      ....      .....     ..+++|+-+. ++|.+++..   ....  .+.......+..|++..+++||+.||+|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            1100      01111     3478888885 488887653   2211  1112222345689999999999999999999


Q ss_pred             CCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCC---CCCCCCcchhHHHHHHHHHHHHhCCC
Q psy7384         187 KGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN---PDATYDNRSDLWSLGITALEMAESQP  263 (463)
Q Consensus       187 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~~~~~~DiwSlG~il~ell~g~~  263 (463)
                      +|+|++++.+|.++|+||+.....+....   ....+..|.+||.......   ....++.+.|.|+||+++|.|.||..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999998766554321   1345577999998753210   13467889999999999999999999


Q ss_pred             CCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q psy7384         264 PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR  309 (463)
Q Consensus       264 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  309 (463)
                      ||............     ..... .+|+.+++||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~~-----f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEWD-----FSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGGG-----GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccccccc-----chhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99766544333211     11222 688999999999999999987

>KOG4158|consensus

Probab=99.91  E-value=2.4e-24  Score=204.08  Aligned_cols=209  Identities=22%  Similarity=0.332  Sum_probs=152.1

Q ss_pred             cCCCceeeecccccccCC---------------------CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHH
Q psy7384         109 SNHRNIATYYGAFIKKSP---------------------PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR  167 (463)
Q Consensus       109 ~~h~nIv~l~~~~~~~~~---------------------~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~  167 (463)
                      .+|||||++..+|.+...                     ......+|+||..... +|+.++-.+.   .+....+-++.
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~la  348 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILA  348 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHH
Confidence            479999999999975421                     1345689999998876 9999987653   56667788899


Q ss_pred             HHHHHHhhhhcCCceecCCCCCceEEc--cCC--cEEEEecccccccccc------cCccccccCCccccccceeccCCC
Q psy7384         168 EILRGLKYLHENKVIHRDIKGQNVLLT--DNA--EVKLVDFGVSAQLDRT------IGRRNTFIGTPYWMAPEVIACDEN  237 (463)
Q Consensus       168 qil~aL~~LH~~givHrDLkp~NILl~--~~~--~vkL~DFGla~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~  237 (463)
                      |+++|+.|||.+||.|||||.+||||.  +++  .+.|+|||++---+..      .......-|.-.-||||+....+.
T Consensus       349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            999999999999999999999999983  444  4789999976322210      011122347778999999875444


Q ss_pred             CCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---H
Q psy7384         238 PDATYD-NRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT---D  313 (463)
Q Consensus       238 ~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~---~  313 (463)
                      +....+ .++|.|+.|.+.||++....||++...+.......+.......+..++..++++|..+|+.||++|+++   .
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence            444333 468999999999999999999988544332222222222223345788999999999999999999984   4


Q ss_pred             HHhcCccc
Q psy7384         314 QLLKHPFI  321 (463)
Q Consensus       314 e~l~hp~~  321 (463)
                      .+|+-..+
T Consensus       509 Nvl~LsLw  516 (598)
T KOG4158|consen  509 NVLNLSLW  516 (598)
T ss_pred             hHHHHHHh
Confidence            44544333

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2.6e-24  Score=197.51  Aligned_cols=175  Identities=14%  Similarity=0.165  Sum_probs=131.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHH----H------HHHHHHHHHHhcCCCceeeecccccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE----E------IKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~----~------~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      .++|++++.||.|+||.||++.+  ++..+|+|++........    .      +.+|+..+.++ .|++|..+.+.+..
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~  106 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL  106 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence            45799999999999999999755  466799999963322222    2      57899999999 89999999888653


Q ss_pred             cCCC--CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEE
Q psy7384         124 KSPP--GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       124 ~~~~--~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL  201 (463)
                      ....  ......+|||||++|.+|.++..      +++    ..+.+|+.+|..||+.||+|||+||+||+++.+| ++|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            2110  11356899999999999988742      333    2456999999999999999999999999999988 999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHH
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA  259 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell  259 (463)
                      +|||...........            ..++.     ...|+.++|+||||+++..+.
T Consensus       176 iDfg~~~~~~e~~a~------------d~~vl-----er~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAK------------DRIDL-----ERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhH------------HHHHH-----HhHhcccccccceeEeehHHH
Confidence            999987655322110            00222     344667899999999877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=5.6e-24  Score=192.73  Aligned_cols=139  Identities=19%  Similarity=0.280  Sum_probs=108.1

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---h------------------------HHHHHHHHHHHHHhcCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---E------------------------EEEIKLEINVLKKYSNHR  112 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~------------------------~~~~~~Ei~~l~~l~~h~  112 (463)
                      .+.||+|+||.||+|.+. +|+.||+|+++....   .                        ......|+.+|.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence            468999999999999986 899999999964321   1                        11223599999999 577


Q ss_pred             ceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhh-hcCCceecCCCCCce
Q psy7384         113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL-HENKVIHRDIKGQNV  191 (463)
Q Consensus       113 nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givHrDLkp~NI  191 (463)
                      +|........        ...+|||||++|++|...+...  ..+++..+..++.||+.+|.|| |+.||+||||||+||
T Consensus        80 ~v~~p~~~~~--------~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NI  149 (190)
T cd05147          80 GIPCPEPILL--------KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNL  149 (190)
T ss_pred             CCCCCcEEEe--------cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            7643322211        1238999999998776554322  3688999999999999999999 799999999999999


Q ss_pred             EEccCCcEEEEecccccccc
Q psy7384         192 LLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       192 Ll~~~~~vkL~DFGla~~~~  211 (463)
                      |++ ++.++|+|||+|...+
T Consensus       150 li~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         150 LYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EEE-CCcEEEEEccccccCC
Confidence            998 5789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.6e-23  Score=188.28  Aligned_cols=187  Identities=13%  Similarity=0.080  Sum_probs=141.6

Q ss_pred             EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHH-----HHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          58 ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE-----EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .+...|++|+||+|+++..  .+..++.+.+........     .+.+|+++|++|.+|++|.+++++.          .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----------~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----------G   72 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----------C
Confidence            4568999999999998865  577788777764443222     5789999999996678899998853          5


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCC-CCCceEEccCCcEEEEecccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDI-KGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDL-kp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .|++|||+.|.+|...+..        . ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||++....
T Consensus        73 ~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             EEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            6999999999998654321        1 1357889999999999999999999 7999999999999999999998655


Q ss_pred             cccCc-------------cccccCCccccccceeccCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7384         212 RTIGR-------------RNTFIGTPYWMAPEVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLH  269 (463)
Q Consensus       212 ~~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~  269 (463)
                      .....             ..-...++.|++|+.....    ...+ ...+.++.|+-+|.|+|+..++.+..
T Consensus       144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l----~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL----KRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh----ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            43210             0112357788888765421    1222 45688899999999999999875543

>KOG0195|consensus

Probab=99.90  E-value=2.6e-24  Score=194.56  Aligned_cols=282  Identities=20%  Similarity=0.331  Sum_probs=210.2

Q ss_pred             HHHHHHHHhhhhhHH------HHHHhhccccccCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEe
Q psy7384          15 EERAELAEKLDKDLD------DFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM   88 (463)
Q Consensus        15 ~~~~~~~~~~~~~l~------~~~~~l~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~   88 (463)
                      +-..+++++.++++.      .++.+++.+...  -+..+......+...++.+|.+.-.|..|+|++..+.  ++.|++
T Consensus       146 ~~l~e~aek~gq~~nripfkdt~wkgtktr~rd--atlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil  221 (448)
T KOG0195|consen  146 NTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRD--ATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGND--IVAKIL  221 (448)
T ss_pred             HHHHHHHHHhCCCCCcccccccccccccccccc--cccccccCcchhhhhhhhhhccCCCcccccccccCcc--hhhhhh
Confidence            344556777776663      333343332221  1223333333445667889999999999999998554  555666


Q ss_pred             e---cCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHH
Q psy7384          89 D---VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI  165 (463)
Q Consensus        89 ~---~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i  165 (463)
                      .   .+.....+|..|.-.|+-+ .||||+.++++|      ....++.++..|++.|+|+.++....+...+..++.++
T Consensus       222 ~vr~~t~risrdfneefp~lrif-shpnilpvlgac------nsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~f  294 (448)
T KOG0195|consen  222 NVREVTARISRDFNEEFPALRIF-SHPNILPVLGAC------NSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRF  294 (448)
T ss_pred             hhhhcchhhcchhhhhCcceeee-cCCchhhhhhhc------cCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHH
Confidence            4   3334456777888888888 799999999999      55679999999999999999998877666788889999


Q ss_pred             HHHHHHHHhhhhcCC--ceecCCCCCceEEccCCcEEEE--ecccccccccccCccccccCCccccccceeccCCCCCCC
Q psy7384         166 CREILRGLKYLHENK--VIHRDIKGQNVLLTDNAEVKLV--DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDAT  241 (463)
Q Consensus       166 ~~qil~aL~~LH~~g--ivHrDLkp~NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  241 (463)
                      +..|+.|++|||+..  |.--.|....++|+++.+.+|.  |--++.+.       ....-.|.||+||.+...+  ...
T Consensus       295 aldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-------~gr~y~pawmspealqrkp--ed~  365 (448)
T KOG0195|consen  295 ALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------VGRAYSPAWMSPEALQRKP--EDL  365 (448)
T ss_pred             HHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-------cccccCcccCCHHHHhcCc--hhc
Confidence            999999999999974  4445789999999988766554  44433222       2234578999999997432  222


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy7384         242 YDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLL  316 (463)
Q Consensus       242 ~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  316 (463)
                      .-.++|+|||++++|||.|...||.+.++++.-.+|.-.......++.++..+..|++-|+..||.+||.++.++
T Consensus       366 n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  366 NIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             chhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            346799999999999999999999999998877666554444445668899999999999999999999988764

>KOG1240|consensus

Probab=99.90  E-value=1.4e-24  Score=227.61  Aligned_cols=246  Identities=20%  Similarity=0.251  Sum_probs=177.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHH---HHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEE---EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~---~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .|...+.||.+.|=+|.+|++.+ | +|+||++-...  -...   +...|++ . .+.+|||++++.-+.      ..+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~-~l~~~pn~lPfqk~~------~t~   93 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-F-ALMKAPNCLPFQKVL------VTD   93 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-H-HhhcCCcccchHHHH------Hhh
Confidence            58888999999999999998764 3 48899885432  2223   3334444 2 333899999998886      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...|||-+|+.+ +|+|.+..+.  .+...+.+.|+.||+.||.-+|..||+|||||.+||||+.-.-+.|+||..-+..
T Consensus        94 kAAylvRqyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   94 KAAYLVRQYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHHHHHHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc
Confidence            678999999977 9999997765  6888889999999999999999999999999999999999888999999865432


Q ss_pred             c---cccCccccccCC----ccccccceeccCC------CCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhc
Q psy7384         211 D---RTIGRRNTFIGT----PYWMAPEVIACDE------NPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFL  276 (463)
Q Consensus       211 ~---~~~~~~~~~~gt----~~y~aPE~l~~~~------~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~  276 (463)
                      .   ......+.+..|    ..|+|||.+....      ......+++.||||+||+++||++ |+|||.-    .++..
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~a  246 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLA  246 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHh
Confidence            1   111222222222    3699999986411      111126788999999999999987 6888831    11111


Q ss_pred             ccCCC--CC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         277 IPRNA--PP-RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       277 i~~~~--~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..++.  .+ .....--+..++.+|..|++.||.+|.+|++.|+-
T Consensus       247 Yr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  247 YRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11110  00 00011113368999999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=4.4e-23  Score=187.29  Aligned_cols=139  Identities=19%  Similarity=0.302  Sum_probs=109.8

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---------------------------HHHHHHHHHHHHHhcCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---------------------------EEEIKLEINVLKKYSNHR  112 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~Ei~~l~~l~~h~  112 (463)
                      .+.||+|+||.||+|.+. +|+.||||+++.....                           ...+..|...+.++ .|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence            478999999999999987 8999999998743210                           12235788999998 688


Q ss_pred             ceeeecccccccCCCCCCCeEEEEEecCCCCCHHHH-HHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCc
Q psy7384         113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL-VKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQN  190 (463)
Q Consensus       113 nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~N  190 (463)
                      +|.....+..        ...||||||++|+++... +..   ..++...+..++.|++.+|.+||+ +||+||||||+|
T Consensus        80 ~i~~p~~~~~--------~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          80 GVPVPEPILL--------KKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             CCCCceEEEe--------cCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            8744333321        124899999998865443 332   257888999999999999999999 999999999999


Q ss_pred             eEEccCCcEEEEeccccccccc
Q psy7384         191 VLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       191 ILl~~~~~vkL~DFGla~~~~~  212 (463)
                      ||++ ++.++|+|||++..+..
T Consensus       149 Ill~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEEE-CCCEEEEEcccceecCC
Confidence            9998 88999999999976643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=2.6e-21  Score=177.04  Aligned_cols=136  Identities=21%  Similarity=0.386  Sum_probs=105.7

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhc----CCCceeeecccccccCCCCCCCeEE-
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYS----NHRNIATYYGAFIKKSPPGKDDQLW-  134 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~----~h~nIv~l~~~~~~~~~~~~~~~~~-  134 (463)
                      +.||+|+||.||.  +..++.. +||++... ......+.+|+.+++.+.    .||||+++++++...   ...+.++ 
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~---~g~g~v~~   81 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD---CGTGYVYD   81 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC---CCCeEEEE
Confidence            7999999999995  6666665 68888643 334567899999999994    479999999999643   1123434 


Q ss_pred             EEEec--CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH-hhhhcCCceecCCCCCceEEcc----CCcEEEEecccc
Q psy7384         135 LVMEY--CGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL-KYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVS  207 (463)
Q Consensus       135 lV~E~--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL-~~LH~~givHrDLkp~NILl~~----~~~vkL~DFGla  207 (463)
                      +||||  +.+|+|.+++...   .+++.  ..+++|++.++ +|||+++|+||||||+|||++.    ++.++|+||+-+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  5579999999653   35555  35678888777 9999999999999999999974    347999995533

>KOG1033|consensus

Probab=99.86  E-value=8.5e-23  Score=201.14  Aligned_cols=255  Identities=20%  Similarity=0.314  Sum_probs=173.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeec-----ccccccC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYY-----GAFIKKS  125 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~-----~~~~~~~  125 (463)
                      ..+.+.+..+..+++.++..+-..+   ...++-+...... .......+++-.+.....|++.+..-     .......
T Consensus       244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~  323 (516)
T KOG1033|consen  244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN  323 (516)
T ss_pred             ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence            4455666677777777766554333   2233333333333 33344556666666664454443322     1112222


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                      ......++||.|++|...+|.+++..+. ....+...+..++.|+..|++|   +|.+|+|+||.||+...+..+||+||
T Consensus       324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhh
Confidence            2223346899999999999999997443 4456777889999999999999   99999999999999999999999999


Q ss_pred             cccccccccc------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcc
Q psy7384         205 GVSAQLDRTI------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLI  277 (463)
Q Consensus       205 Gla~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i  277 (463)
                      |+........      ...+..+||.+||+||.+.     +..|+.++||||||+||+||+. -...|+...   ++..+
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-----g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~  472 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR-----GQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDI  472 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHh-----hhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhh
Confidence            9988765433      2345568999999999998     7889999999999999999987 333343222   22222


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ..+..|....... ++-.+|+.+||...|.+||++.+.--|.|.
T Consensus       473 r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 RDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2233221111122 244589999999999999977777666664

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=5.7e-21  Score=178.92  Aligned_cols=144  Identities=19%  Similarity=0.226  Sum_probs=111.8

Q ss_pred             ceEEEeeeeeeCCeEEEEEE-EcCCCcEEEEEEeecCcc-------------------------hHHHHHHHHHHHHHhc
Q psy7384          56 IFELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMDVTED-------------------------EEEEIKLEINVLKKYS  109 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~-~~~~~~~vaiK~~~~~~~-------------------------~~~~~~~Ei~~l~~l~  109 (463)
                      -|++.+.||+|+||.||+|. +..+|+.||+|++.....                         ....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999999998 667899999999874321                         0123568999999993


Q ss_pred             CCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC-ceecCCCC
Q psy7384         110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK-VIHRDIKG  188 (463)
Q Consensus       110 ~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDLkp  188 (463)
                       +. ++.+...+..       ...||||||+.|++|..+....  ..+....+..++.||+.+|.+||++| |+||||||
T Consensus       109 -~~-~i~~p~~~~~-------~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp  177 (237)
T smart00090      109 -EA-GVPVPKPIAW-------RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE  177 (237)
T ss_pred             -hc-CCCCCeeeEe-------cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence             42 3333233211       2358999999998887654322  24666677899999999999999999 99999999


Q ss_pred             CceEEccCCcEEEEecccccccc
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      +|||++ ++.++|+|||++....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999998 8899999999987554

>KOG1166|consensus

Probab=99.84  E-value=5.6e-21  Score=204.26  Aligned_cols=196  Identities=26%  Similarity=0.356  Sum_probs=152.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHh--cCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKY--SNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l--~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..+..|.|-+.||+|+||+||+|.+.. |+.||+|+-.......-.+-  .+++.+|  .--+-|+.+..+++      .
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~--~q~~~RLk~~~~~~~~~~~~a~~------~  765 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC--LQVMERLKPQMLPSIMHISSAHV------F  765 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh--HHHHHhhchhhhcchHHHHHHHc------c
Confidence            446789999999999999999999877 99999998653322211111  1112222  11345666666653      3


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-------CCcEEEE
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-------NAEVKLV  202 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-------~~~vkL~  202 (463)
                      .+.-+||+||.+.|+|.|++...  ..+++..+..+..|+|..|++||.++|||+||||+|+||..       +.-++|+
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             CCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            36779999999999999999844  47899999999999999999999999999999999999942       3459999


Q ss_pred             ecccccccc--cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q psy7384         203 DFGVSAQLD--RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP  263 (463)
Q Consensus       203 DFGla~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~  263 (463)
                      |||.+--+.  .........++|-.+-.+|...     +..+++.+|.|.|+.++|.||.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~-----grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE-----GRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhc-----CCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999876442  2223445678899999999987     7889999999999999999999864

>KOG0590|consensus

Probab=99.82  E-value=2.2e-21  Score=203.24  Aligned_cols=260  Identities=22%  Similarity=0.331  Sum_probs=204.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCC-CcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKT-GQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...|.+.+.||+|+|+.|-.+....+ ...+|.|.+....   .....+..|..+-..+.+|.|++.+++..      ..
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~------~~   92 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS------SS   92 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc------CC
Confidence            55699999999999999999887543 4567777776443   33345555777777775699999999988      55


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh-cCCceecCCCCCceEEccCC-cEEEEecccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH-ENKVIHRDIKGQNVLLTDNA-EVKLVDFGVS  207 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDLkp~NILl~~~~-~vkL~DFGla  207 (463)
                      .+..+++++|..|+++++.+........+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|
T Consensus        93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence            678999999999999999884222225667778899999999999999 99999999999999999999 9999999999


Q ss_pred             ccccc-cc--CccccccC-CccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc-ccCC--
Q psy7384         208 AQLDR-TI--GRRNTFIG-TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRN--  280 (463)
Q Consensus       208 ~~~~~-~~--~~~~~~~g-t~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~-i~~~--  280 (463)
                      ..+.. ..  ......+| ++.|+|||....    .....+..|+||+|+++..|++|..|+.........+. ....  
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~----~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~  248 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSG----KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG  248 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccc----hhhcCCCcccccccccccccccCCCCccccccccccceeeccccc
Confidence            87755 21  22344678 999999999873    23456779999999999999999999866544433321 1111  


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .........++....+++.++|..+|..|.+.+++-.++|+..
T Consensus       249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            1123344567788999999999999999999999999999976

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.1e-19  Score=166.27  Aligned_cols=136  Identities=20%  Similarity=0.240  Sum_probs=107.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-----------------------hHHHHHHHHHHHHHhcCCCc
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-----------------------EEEEIKLEINVLKKYSNHRN  113 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~Ei~~l~~l~~h~n  113 (463)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.....                       .......|+.++..+ .|.+
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence            778899999999999999874 799999998764321                       112356788888888 5664


Q ss_pred             --eeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCce
Q psy7384         114 --IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNV  191 (463)
Q Consensus       114 --Iv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NI  191 (463)
                        +...++.          ...++||||++|++|.++...        .....++.+|+.++.++|+.||+||||||+||
T Consensus        95 i~v~~~~~~----------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni  156 (198)
T cd05144          95 FPVPKPIDW----------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI  156 (198)
T ss_pred             CCCCceeec----------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence              3333322          345899999999998765421        33567889999999999999999999999999


Q ss_pred             EEccCCcEEEEeccccccccc
Q psy7384         192 LLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       192 Ll~~~~~vkL~DFGla~~~~~  212 (463)
                      +++.++.++|+|||++...+.
T Consensus       157 ll~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEcCCCcEEEEECCccccCCC
Confidence            999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.7e-19  Score=165.18  Aligned_cols=133  Identities=24%  Similarity=0.373  Sum_probs=108.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---------hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---------EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.||+|++|.||+|.+  .|..+++|+......         ....+.+|+.++..+ .|++|.....++.      ..+
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~------~~~   72 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFV------DPE   72 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEE------eCC
Confidence            6799999999999987  567788997643211         123567899999998 6888866655552      235


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ..++||||++|++|.+++....     . ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus        73 ~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         73 NFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            6789999999999999986432     2 7788999999999999999999999999999998 78899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=8.6e-19  Score=160.28  Aligned_cols=130  Identities=23%  Similarity=0.352  Sum_probs=101.2

Q ss_pred             eeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---c------hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          62 VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---D------EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .||+|+||.||+|.+  .|..+++|......   .      ....+.+|++++..+ .|+++......+.      ..+.
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~------~~~~   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDV------DPDN   71 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEE------ECCC
Confidence            489999999999984  46778998864221   1      125567899999998 5766543333332      1245


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      .++||||++|++|.+++.....         .++.|++.+|.+||+.||+|+|++|.|||++ ++.++++|||++...
T Consensus        72 ~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        72 KTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            6899999999999998754220         7889999999999999999999999999998 889999999988654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.1e-18  Score=181.05  Aligned_cols=136  Identities=20%  Similarity=0.261  Sum_probs=106.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEe--ecCc-------chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTE-------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~--~~~~-------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ..|...+.||+|+||.||++.+....  +++|+.  ....       .....+.+|++++..+ +|++|+..+.++.   
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~---  406 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDV---  406 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEE---
Confidence            34567899999999999999875443  333332  1111       1134577899999999 7999887665553   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                         .....++||||++|++|.+++.          ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||
T Consensus       407 ---~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        407 ---DPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             ---eCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence               2245789999999999999885          246789999999999999999999999999999 67889999999


Q ss_pred             ccccc
Q psy7384         206 VSAQL  210 (463)
Q Consensus       206 la~~~  210 (463)
                      +++..
T Consensus       473 la~~~  477 (535)
T PRK09605        473 LGKYS  477 (535)
T ss_pred             ccccC
Confidence            98654

>KOG1023|consensus

Probab=99.75  E-value=2.3e-18  Score=172.95  Aligned_cols=204  Identities=22%  Similarity=0.435  Sum_probs=153.5

Q ss_pred             HHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCc-eec
Q psy7384         106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKV-IHR  184 (463)
Q Consensus       106 ~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-vHr  184 (463)
                      +.+ .|.|+.++++.+..      ....++|.+||..|+|.|.+.. ....++..-...+++.|+.||.|||.-.| .|+
T Consensus         2 ~~l-~h~n~~~f~g~~~~------~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg   73 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVD------GPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHG   73 (484)
T ss_pred             ccc-chhhhhhheeeEec------CCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeee
Confidence            345 79999999999964      3789999999999999999986 33467777788899999999999998866 999


Q ss_pred             CCCCCceEEccCCcEEEEeccccccccc--ccCccccccCCccccccceeccCCCCC--CCCCcchhHHHHHHHHHHHHh
Q psy7384         185 DIKGQNVLLTDNAEVKLVDFGVSAQLDR--TIGRRNTFIGTPYWMAPEVIACDENPD--ATYDNRSDLWSLGITALEMAE  260 (463)
Q Consensus       185 DLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~--~~~~~~~DiwSlG~il~ell~  260 (463)
                      .|+..|.+++....+||.|||+......  .........-...|.|||.+.......  ...+.+.||||+|+|+||+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            9999999999999999999999776532  111111112345699999998642211  125677999999999999999


Q ss_pred             CCCCCCCCCc----hhhhhcccCCCC----CCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         261 SQPPLCDLHP----MRALFLIPRNAP----PRLKS-KKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       261 g~~Pf~~~~~----~~~~~~i~~~~~----~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...||.....    .+.+..+.....    |.... ...++++..+++.||..+|..||+++++-.
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9999965322    223333333121    22211 145567999999999999999999998754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=5.6e-18  Score=153.28  Aligned_cols=136  Identities=21%  Similarity=0.309  Sum_probs=96.8

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchH---HH----------------------HHHHHHHHHHhcCC-Cc
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---EE----------------------IKLEINVLKKYSNH-RN  113 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~----------------------~~~Ei~~l~~l~~h-~n  113 (463)
                      .+.||+|+||.||+|.+. +|+.||||++.......   ..                      ...|...+..+..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            468999999999999876 78999999986432111   11                      12455555555211 12


Q ss_pred             eeeecccccccCCCCCCCeEEEEEecCCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCce
Q psy7384         114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNV  191 (463)
Q Consensus       114 Iv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NI  191 (463)
                      +.+.++.          ...++||||+.++.+.. .+....   . ...++.++.+++.++.++|. .||+||||||+||
T Consensus        81 ~~~~~~~----------~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Ni  146 (187)
T cd05119          81 VPKPIDL----------NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNI  146 (187)
T ss_pred             CCceEec----------CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhE
Confidence            3333332          24589999999854422 222111   1 15678899999999999999 9999999999999


Q ss_pred             EEccCCcEEEEecccccccc
Q psy7384         192 LLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       192 Ll~~~~~vkL~DFGla~~~~  211 (463)
                      +++ ++.++|+|||.+....
T Consensus       147 li~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EEE-CCcEEEEECccccccc
Confidence            999 8899999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=2.6e-17  Score=142.48  Aligned_cols=133  Identities=18%  Similarity=0.262  Sum_probs=109.4

Q ss_pred             EEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC-CceeeecccccccCCCCCCCeEEEEE
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-RNIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      +++.||.|.++.||++....  ..+++|.+..... ...+..|+.+++.+..+ .++.+++..+      ...+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~------~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASG------ESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEc------CCCCccEEEE
Confidence            35789999999999998754  6799999865443 56788999999999544 5888888776      3346799999


Q ss_pred             ecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC---CceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         138 EYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN---KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       138 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ||+.|+.+..+         +......++.+++.+|++||..   +++|+||+|+|||+++.+.++++|||+++.
T Consensus        73 e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99998777544         3455677889999999999985   799999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.73  E-value=4.4e-17  Score=165.85  Aligned_cols=178  Identities=16%  Similarity=0.257  Sum_probs=126.4

Q ss_pred             CCCCCCcccccChHHHHHHHHhhhhhHHHHHHhhccccccCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCc
Q psy7384           2 ENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ   81 (463)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~   81 (463)
                      .+++|.+.++..++.+..+.+.++..+++.+..++.                       +.||.|++|+||+|+.+ +|+
T Consensus        87 ~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd~-----------------------~plasaSigQVh~A~l~-~G~  142 (437)
T TIGR01982        87 SLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFEE-----------------------KPLAAASIAQVHRARLV-DGK  142 (437)
T ss_pred             HHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCCC-----------------------cceeeeehhheEEEEec-CCC
Confidence            456889999888888888899999888888776543                       68999999999999864 789


Q ss_pred             EEEEEEeecCcchH-----------------------------------------HHHHHHHHHHHHhc---CCCceeee
Q psy7384          82 LAAIKVMDVTEDEE-----------------------------------------EEIKLEINVLKKYS---NHRNIATY  117 (463)
Q Consensus        82 ~vaiK~~~~~~~~~-----------------------------------------~~~~~Ei~~l~~l~---~h~nIv~l  117 (463)
                      .||||+........                                         -++.+|...+.++.   .|.+-+.+
T Consensus       143 ~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~v  222 (437)
T TIGR01982       143 EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYV  222 (437)
T ss_pred             EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEe
Confidence            99999975321000                                         01233444444432   22222333


Q ss_pred             cccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH-HHhhhhcCCceecCCCCCceEEccC
Q psy7384         118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR-GLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       118 ~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~-aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      -.++.     +.....+|||||++|++|.++...... ...   ...++.+++. .+..+|..|++|+|+||.||+++.+
T Consensus       223 P~v~~-----~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~  293 (437)
T TIGR01982       223 PEVYW-----DRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKD  293 (437)
T ss_pred             CCEeh-----hhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCC
Confidence            33332     122456899999999999988754221 122   2345556655 4678899999999999999999999


Q ss_pred             CcEEEEeccccccccc
Q psy7384         197 AEVKLVDFGVSAQLDR  212 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~  212 (463)
                      +.++|+|||++..++.
T Consensus       294 g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       294 GKIIALDFGIVGRLSE  309 (437)
T ss_pred             CcEEEEeCCCeeECCH
Confidence            9999999999877653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.72  E-value=1.4e-17  Score=171.47  Aligned_cols=175  Identities=15%  Similarity=0.216  Sum_probs=120.9

Q ss_pred             CCCCCcccccChHHHHHHHHhhhhhHHHHHHhhccccccCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcE
Q psy7384           3 NPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL   82 (463)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~   82 (463)
                      .++|.+.++..++.+..+...++..+++++..+                      +. +.||.|++|+||+|+.+.+|+.
T Consensus        90 ~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~f----------------------d~-~PlasaSiaQVh~A~l~~~G~~  146 (537)
T PRK04750         90 LLQDRVPPFDGALARAIIEKALGGPVEEWFDDF----------------------DI-KPLASASIAQVHFARLKDNGRE  146 (537)
T ss_pred             HHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhc----------------------Ch-hhhcCCCccEEEEEEECCCCCE
Confidence            467888888888888888888888888877663                      33 7899999999999999888999


Q ss_pred             EEEEEeecCcc-----------------------------------hHHHHHH------HHHHHHHhc---CCCceeeec
Q psy7384          83 AAIKVMDVTED-----------------------------------EEEEIKL------EINVLKKYS---NHRNIATYY  118 (463)
Q Consensus        83 vaiK~~~~~~~-----------------------------------~~~~~~~------Ei~~l~~l~---~h~nIv~l~  118 (463)
                      ||||+++....                                   ....+.+      |...+.++.   .+.+.+.+-
T Consensus       147 VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP  226 (537)
T PRK04750        147 VVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVP  226 (537)
T ss_pred             EEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecc
Confidence            99999863310                                   0111222      333333321   122223322


Q ss_pred             ccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCC----CCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc
Q psy7384         119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ----SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT  194 (463)
Q Consensus       119 ~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~  194 (463)
                      .+|.     +-....+|||||+.|+.|.++..-...+    .+.+..+..++.|++       ..|++|+|+||.||+++
T Consensus       227 ~v~~-----d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~  294 (537)
T PRK04750        227 EVYW-----DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVS  294 (537)
T ss_pred             eeec-----ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEe
Confidence            3321     2234568999999999998753211111    244555556666665       48999999999999999


Q ss_pred             cCC----cEEEEeccccccccc
Q psy7384         195 DNA----EVKLVDFGVSAQLDR  212 (463)
Q Consensus       195 ~~~----~vkL~DFGla~~~~~  212 (463)
                      .++    .++++|||++..++.
T Consensus       295 ~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        295 YDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             cCCCCCCeEEEEecceEEECCH
Confidence            888    999999999987754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.4e-16  Score=149.51  Aligned_cols=137  Identities=19%  Similarity=0.233  Sum_probs=102.8

Q ss_pred             eeee-eeCCeEEEEEEEcCCCcEEEEEEeecC--------------cchHHHHHHHHHHHHHhcCCCce--eeecccccc
Q psy7384          61 EVVG-NGTYGQVYKGRHTKTGQLAAIKVMDVT--------------EDEEEEIKLEINVLKKYSNHRNI--ATYYGAFIK  123 (463)
Q Consensus        61 ~~LG-~G~fg~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~Ei~~l~~l~~h~nI--v~l~~~~~~  123 (463)
                      ..|| .|+.|+||.+...  +..+++|.+...              ......+.+|+.++..+ .|++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence            5677 8888888888764  677888877421              12235678899999999 68775  566665432


Q ss_pred             cCCCCCCCeEEEEEecCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEE
Q psy7384         124 KSPPGKDDQLWLVMEYCGA-GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV  202 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~  202 (463)
                      ..  ......++|||+++| .+|.+++...   .+++.    .+.||+.+|.+||++||+||||||+|||++.++.++|+
T Consensus       114 ~~--~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        114 RH--GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             ec--CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence            11  111234699999997 6899888542   35544    35789999999999999999999999999988899999


Q ss_pred             ecccccc
Q psy7384         203 DFGVSAQ  209 (463)
Q Consensus       203 DFGla~~  209 (463)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998754

>KOG0601|consensus

Probab=99.67  E-value=1.1e-16  Score=161.13  Aligned_cols=256  Identities=21%  Similarity=0.222  Sum_probs=194.7

Q ss_pred             CCCCceEEEeeeee--eCCeEEEEEEE--cCCCcEEEEEEeec--C-cchHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGN--GTYGQVYKGRH--TKTGQLAAIKVMDV--T-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~--G~fg~V~~~~~--~~~~~~vaiK~~~~--~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .+...+.+...+|.  |.+|.||.+..  ..++..+|+|.-..  . ......-.+|....+++..|+|.++.+..+   
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~---  187 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW---  187 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc---
Confidence            34566788899999  99999999998  78889999987331  1 122233346676777777899999988887   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH----HHhhhhcCCceecCCCCCceEEccC-CcE
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR----GLKYLHENKVIHRDIKGQNVLLTDN-AEV  199 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~----aL~~LH~~givHrDLkp~NILl~~~-~~v  199 (463)
                         +..+..|+-+|+|. .+|..+..... ..+++..++.++.+..+    ||.++|+.+|+|-|+||.||++..+ ..+
T Consensus       188 ---e~~~~lfiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  188 ---EGSGILFIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             ---ccCCcceeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccccee
Confidence               56688999999996 68888876543 35889999999999999    9999999999999999999999998 889


Q ss_pred             EEEecccccccccccCcccc-----ccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh
Q psy7384         200 KLVDFGVSAQLDRTIGRRNT-----FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL  274 (463)
Q Consensus       200 kL~DFGla~~~~~~~~~~~~-----~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  274 (463)
                      +++|||+...+....-....     ..|..-|++||++.      .-++...|+|++|.++.+-.++..++...- ....
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~------~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-~~~W  335 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN------GLATFASDIFSLGEVILEAILGSHLPSVGK-NSSW  335 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc------cccchHhhhcchhhhhHhhHhhcccccCCC-CCCc
Confidence            99999999887654311111     25777899999984      568889999999999999888866552220 0111


Q ss_pred             hcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         275 FLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       275 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ..+.....+...-...+.++...+..|++.+|..|++++.+++|+++.
T Consensus       336 ~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  336 SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            111111122222223455666799999999999999999999999986

>KOG0606|consensus

Probab=99.62  E-value=2.1e-16  Score=166.60  Aligned_cols=261  Identities=22%  Similarity=0.335  Sum_probs=198.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc----hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED----EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..+.+++.+-.|+++.++.+.-..+|...++|+......    +.+.+..+-.++-.- .+|-++...-.+      -..
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~------~~r  876 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF------PCR  876 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC------CCC
Confidence            457788899999999999998888887777776543211    111222222222111 345555544443      233


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...+||++|+.+++|...++...  ..+++-++.++..+..+++|||...+.|+|++|.|+|+..+++.++.|||+....
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence            67899999999999999997655  5677778888899999999999999999999999999999999999999843322


Q ss_pred             ccc-------------------------------cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHH
Q psy7384         211 DRT-------------------------------IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA  259 (463)
Q Consensus       211 ~~~-------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell  259 (463)
                      .-.                               ........||+.|.+||.+.     +......+|+|++|+++++.+
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-----g~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-----GRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-----cccCCCcchhhhhhhhhhhhh
Confidence            100                               01123356899999999998     556677899999999999999


Q ss_pred             hCCCCCCCCCchhhhhcccCCCCCCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHH---HHhcCccccCCchhHH
Q psy7384         260 ESQPPLCDLHPMRALFLIPRNAPPRL-KSKKWPKKFQSFIETVLVKDYHQRPYTD---QLLKHPFIRDQPTERQ  329 (463)
Q Consensus       260 ~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~---e~l~hp~~~~~~~~~~  329 (463)
                      +|.+||....+.+....|.....+.. -....+.++++++..+|..+|.+|..+.   ++-.|+||+...++..
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence            99999999888888777666544333 3356688999999999999999998877   8999999998877643

>KOG1243|consensus

Probab=99.59  E-value=5.8e-14  Score=142.82  Aligned_cols=183  Identities=20%  Similarity=0.290  Sum_probs=139.0

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      |++ ...+-++.+.+..|..+.++.+|.+...+.... ....+.+.++.|+.+ +||||+++++.+      +.++.+||
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~------e~~~~~yl   86 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTT------EEEGTLYL   86 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhh------cccCceEE
Confidence            555 444445554333566678889999988875544 345577888999999 899999999999      56679999


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh-cCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      |+|-+.  .|..++++     +....+...+.||+.||.||| +.+++|++|.-.-|+|+..|..||++|.++.......
T Consensus        87 vTErV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   87 VTERVR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN  159 (690)
T ss_pred             Eeeccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence            999986  67777765     446777888999999999997 6799999999999999999999999999987655433


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES  261 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g  261 (463)
                      .......---.|..|+.+...       +-..|.|-|||++++++.|
T Consensus       160 ~~~~~~~~~~s~~~P~~~~~s-------~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  160 APAKSLYLIESFDDPEEIDPS-------EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccccchhhhcccChhhcCcc-------ccchhhhhHHHHHHHHhCc
Confidence            222222233346777765421       1347999999999999988

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.54  E-value=3.8e-14  Score=125.90  Aligned_cols=128  Identities=16%  Similarity=0.138  Sum_probs=96.1

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCce-eeecccccccCCCCCCCeEEEEEe
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNI-ATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nI-v~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++.|+.|.++.||+++..  +..|++|+..........+..|+.+++.+. +.++ .+++...      .  ...++|||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~-~~~~~P~~~~~~------~--~~~~lv~e   71 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAA-EAGIGPKLYYFD------P--ETGVLITE   71 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHH-HhCCCCceEEEe------C--CCCeEEEE
Confidence            478899999999999864  778999997654333345678999999884 4344 3444433      1  23479999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCc-----eecCCCCCceEEccCCcEEEEecccccc
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKV-----IHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-----vHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      |++|.++.+..       .   ....++.+++.+|+.||..++     +|+|++|.|||++ ++.++++|||.+..
T Consensus        72 ~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          72 FIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99998875430       1   113456899999999999985     9999999999998 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.53  E-value=1.5e-14  Score=145.83  Aligned_cols=257  Identities=20%  Similarity=0.254  Sum_probs=188.0

Q ss_pred             CCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEc-CCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeeccc
Q psy7384          45 PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-KTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGA  120 (463)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~  120 (463)
                      ...+|.....++|.++..||.|.|+.|+.+... .++..|++|.....   ......-..|+.+...+.-|.+++.++..
T Consensus       255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence            344566667788999999999999999998755 66778888876422   11222223566666667679999998888


Q ss_pred             ccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-CcE
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEV  199 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-~~v  199 (463)
                      +      ...+..|+-.|||+++++...+...  ..+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..
T Consensus       335 W------~~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~  406 (524)
T KOG0601|consen  335 W------SQLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFS  406 (524)
T ss_pred             c------cccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhh
Confidence            7      4446778999999999887766332  257888889999999999999999999999999999999876 788


Q ss_pred             EEEecccccccccccCccccccCCcccc-ccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc
Q psy7384         200 KLVDFGVSAQLDRTIGRRNTFIGTPYWM-APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       200 kL~DFGla~~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  278 (463)
                      ++.|||+.+.+.-..   ......-+++ ..|++..    ...+..++|++|||.-+++.++|.+.-...   .....+.
T Consensus       407 ~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e----~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~  476 (524)
T KOG0601|consen  407 KLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLE----DYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIR  476 (524)
T ss_pred             hccccccccccceec---ccccccccccccchhhcc----ccccccccccccccccccccccCcccCccc---ccceeee
Confidence            999999986532211   2223344455 3565543    566778899999999999999987642221   1222232


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      .+..+...  .....++.+.+.++..++..|+.+.++..|.=|
T Consensus       477 ~~~~p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  477 SGDTPNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             cccccCCC--chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            33222222  333788999999999999999999999888655

>KOG1266|consensus

Probab=99.52  E-value=4.3e-14  Score=131.98  Aligned_cols=211  Identities=21%  Similarity=0.283  Sum_probs=146.9

Q ss_pred             HHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcC--C
Q psy7384         105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHEN--K  180 (463)
Q Consensus       105 l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~--g  180 (463)
                      |..+ .|.|||+++.++..... ++.....++.||++.|+|..+|++.+  ...+.....++|+-||+.||.|||+.  -
T Consensus       121 llql-vHsnlvkfH~yw~d~K~-~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  121 LLQL-VHSNLVKFHKYWTDKKY-EEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHH-HHHHHHHHHHhhccccc-ccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3344 59999999998865432 34567889999999999999998754  34678888899999999999999997  5


Q ss_pred             ceecCCCCCceEEccCCcEEEEecccccccc----cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHH
Q psy7384         181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD----RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL  256 (463)
Q Consensus       181 ivHrDLkp~NILl~~~~~vkL~DFGla~~~~----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~  256 (463)
                      |+|+++..+-|++..+|-||+.--.-.....    ..........+-++|.+||.=.     ....+.++|||+||....
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-----~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-----TTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-----ccccccchhhhhhhHHHH
Confidence            9999999999999999988876322111100    0001112234678899999643     344566799999999999


Q ss_pred             HHHhCCCC-CCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         257 EMAESQPP-LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       257 ell~g~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      +|..|..- -...+.......+.+.... .    -...-+++|.+||+..|..||++.+++-||.+-+....
T Consensus       274 emailEiq~tnseS~~~~ee~ia~~i~~-l----en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl  340 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKVEVEENIANVIIG-L----ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL  340 (458)
T ss_pred             HHHHheeccCCCcceeehhhhhhhheee-c----cCccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence            99887653 2222221111111111110 0    01123468999999999999999999999998766544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.51  E-value=1.8e-13  Score=123.18  Aligned_cols=138  Identities=22%  Similarity=0.265  Sum_probs=100.5

Q ss_pred             EeeeeeeCCeEEEEEEEcC------CCcEEEEEEeecCc-----------------------chHHHHH----HHHHHHH
Q psy7384          60 IEVVGNGTYGQVYKGRHTK------TGQLAAIKVMDVTE-----------------------DEEEEIK----LEINVLK  106 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~-----------------------~~~~~~~----~Ei~~l~  106 (463)
                      ...||.|--+.||.|....      .+..+|||+.+...                       .....+.    +|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3679999999999998653      35789999975210                       1122233    7999999


Q ss_pred             HhcCC-CceeeecccccccCCCCCCCeEEEEEecCCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHhhh-hcCCcee
Q psy7384         107 KYSNH-RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREILRGLKYL-HENKVIH  183 (463)
Q Consensus       107 ~l~~h-~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givH  183 (463)
                      ++... -++...+++          ...+|||||+.++.+.. .++.   ..+++..+..++.+++.+|..| |..||||
T Consensus        82 rl~~~Gv~vP~pi~~----------~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVH  148 (197)
T cd05146          82 RMQKAGIPCPEVVVL----------KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVH  148 (197)
T ss_pred             HHHHcCCCCCeEEEe----------cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            88533 345555544          25689999998754422 2322   1355666778889999999999 8999999


Q ss_pred             cCCCCCceEEccCCcEEEEecccccccc
Q psy7384         184 RDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       184 rDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      +||++.|||+. ++.+.|+|||.+...+
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999999996 5679999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.32  E-value=2.5e-12  Score=131.89  Aligned_cols=174  Identities=18%  Similarity=0.323  Sum_probs=122.9

Q ss_pred             CCCCCCcccccChHHHHHHHHhhhhhHHHHHHhhccccccCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCc
Q psy7384           2 ENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ   81 (463)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~   81 (463)
                      .++||.++.....+.++.+.++++..+++++...+.                       ..|+.++-|+||+|+.+ +|+
T Consensus        95 ~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~-----------------------~PiAsASIaQVH~A~L~-sG~  150 (517)
T COG0661          95 AKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFEP-----------------------EPIASASIAQVHRAVLK-SGE  150 (517)
T ss_pred             HHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-----------------------CchhhhhHhhheeEEec-CCC
Confidence            467899999999999999999999999999988765                       68999999999999975 499


Q ss_pred             EEEEEEeecCcch-----------------------------------------HHHHHHHHHHHHHhc----CCCceee
Q psy7384          82 LAAIKVMDVTEDE-----------------------------------------EEEIKLEINVLKKYS----NHRNIAT  116 (463)
Q Consensus        82 ~vaiK~~~~~~~~-----------------------------------------~~~~~~Ei~~l~~l~----~h~nIv~  116 (463)
                      .||||+.+..-..                                         +-++.+|...+.++.    +.++| .
T Consensus       151 ~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~  229 (517)
T COG0661         151 EVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDV-Y  229 (517)
T ss_pred             EEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCe-E
Confidence            9999996422100                                         011233444333332    22322 2


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHH-----HHHHHHHHHHHhhhhcCCceecCCCCCce
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWI-----AFICREILRGLKYLHENKVIHRDIKGQNV  191 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~-----~~i~~qil~aL~~LH~~givHrDLkp~NI  191 (463)
                      +-.+|.     +-...-+|+|||+.|..+.++..-.. ..++...+     ..+++|++.       .|++|.|.+|.||
T Consensus       230 VP~V~w-----e~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~-------dgffHaDpHpGNi  296 (517)
T COG0661         230 VPKVYW-----EYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGNI  296 (517)
T ss_pred             eceeeh-----hccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHh-------cCccccCCCccce
Confidence            223332     22356689999999999988853222 23443333     334444443       8999999999999


Q ss_pred             EEccCCcEEEEecccccccccc
Q psy7384         192 LLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       192 Ll~~~~~vkL~DFGla~~~~~~  213 (463)
                      +++.+|.+.+.|||+...++..
T Consensus       297 ~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         297 LVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             EEecCCcEEEEcCcceecCCHH
Confidence            9999999999999998877543

>KOG3087|consensus

Probab=99.29  E-value=3.1e-11  Score=104.76  Aligned_cols=142  Identities=27%  Similarity=0.360  Sum_probs=102.5

Q ss_pred             EEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---------cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---------EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .+..|-+|+-+.|+++.+.  |+.+.||.-...         +-...+.++|.+.|.++. --.|.-..-+|.      +
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~------D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFI------D   81 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEE------e
Confidence            5688999999999999765  787788764211         122456678999998873 323322222221      2


Q ss_pred             CCeEEEEEecCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC---cEEEEecc
Q psy7384         130 DDQLWLVMEYCGA-GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA---EVKLVDFG  205 (463)
Q Consensus       130 ~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~---~vkL~DFG  205 (463)
                      ...-.|+|||++| .++.+++...-...........++++|-+.|.-||..+|||+||..+||++..++   .+.|+|||
T Consensus        82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeec
Confidence            2355799999987 4788888765543444444578999999999999999999999999999996544   45899999


Q ss_pred             cccc
Q psy7384         206 VSAQ  209 (463)
Q Consensus       206 la~~  209 (463)
                      ++..
T Consensus       162 ls~~  165 (229)
T KOG3087|consen  162 LSSV  165 (229)
T ss_pred             chhc
Confidence            8743

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=2.4e-11  Score=112.62  Aligned_cols=142  Identities=16%  Similarity=0.175  Sum_probs=102.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCC-CceeeecccccccCCCCCCCeEEEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNH-RNIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      +.|+.|.++.||++.... |..+++|+......  ....+..|..+++.+..+ .++.+++.+....   ...+..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~---~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP---SVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC---CccCCceEEE
Confidence            678999999999998643 67899999765433  355778999999998432 2345565554211   1123678999


Q ss_pred             ecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc---------------------------------------
Q psy7384         138 EYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE---------------------------------------  178 (463)
Q Consensus       138 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------------------  178 (463)
                      ||++|.+|.+.+..   ..+++.....++.+++.+|..||+                                       
T Consensus        80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            99999888765421   135666666677777777777763                                       


Q ss_pred             -----------------CCceecCCCCCceEEcc--CCcEEEEecccccc
Q psy7384         179 -----------------NKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQ  209 (463)
Q Consensus       179 -----------------~givHrDLkp~NILl~~--~~~vkL~DFGla~~  209 (463)
                                       ..++|+|++|.|||++.  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             34699999999999988  66789999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=4e-11  Score=104.65  Aligned_cols=128  Identities=22%  Similarity=0.339  Sum_probs=92.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---------chHHHHHHHHHHHHHhcCCCce--eeecccccccCCCCC
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---------DEEEEIKLEINVLKKYSNHRNI--ATYYGAFIKKSPPGK  129 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~Ei~~l~~l~~h~nI--v~l~~~~~~~~~~~~  129 (463)
                      ..+++|+-+.++.+.+.  |..+++|.-....         -......+|..+|.++. --.|  ..++++.        
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD--------   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVD--------   70 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEc--------
Confidence            46789999999999764  4456666542111         11234567888888873 3233  2333332        


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+...|+|||++|..|.+++...         ...+++.+-.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            24668999999999999888654         134667777778889999999999999999997655 99999999864

>KOG3741|consensus

Probab=99.25  E-value=3.7e-10  Score=112.08  Aligned_cols=220  Identities=16%  Similarity=0.234  Sum_probs=160.7

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecCcchHH-HHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCC-CCHH
Q psy7384          69 GQVYKGRHTKTGQLAAIKVMDVTEDEEE-EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGA-GSVT  146 (463)
Q Consensus        69 g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~g-gsL~  146 (463)
                      .+.|+|....+|..|++|.+...+.... ....-+++++++ .|.|||++.++|....  -.+..++||++|.++ ++|.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~t--F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYT--FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhc--cCcceEEEEEecCCCCchHH
Confidence            5689999999999999999854332221 223446788898 7999999999997443  345789999999975 6888


Q ss_pred             HHHHhhC-------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         147 DLVKSTK-------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       147 ~~l~~~~-------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      ++.-...             +...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|+...+...
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            8764322             234778999999999999999999999999999999999998888999888876555433


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP-LCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      .            .  |-+..        -.+-|.=.||.++..|.||..- +........  .      .......++.
T Consensus       447 ~------------~--~~le~--------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~------~~~I~~~yS~  496 (655)
T KOG3741|consen  447 P------------T--EPLES--------QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--H------LTRITTTYST  496 (655)
T ss_pred             C------------C--cchhH--------HhhhhHHHHHHHHHHHhhcccccccccchHHH--H------HHHhhhhhhH
Confidence            1            0  11211        1235999999999999999542 111111111  0      1122335678


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC---cccc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKH---PFIR  322 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~h---p~~~  322 (463)
                      +++++|..+...+++. -++.+++.|   .||.
T Consensus       497 D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~  528 (655)
T KOG3741|consen  497 DLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFT  528 (655)
T ss_pred             HHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHH
Confidence            9999999999999886 689999887   5564

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=1.6e-10  Score=103.82  Aligned_cols=126  Identities=26%  Similarity=0.352  Sum_probs=81.8

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCc---------------------------chHHHHHHHHHHHHHhcCC-Cceeeecccc
Q psy7384          70 QVYKGRHTKTGQLAAIKVMDVTE---------------------------DEEEEIKLEINVLKKYSNH-RNIATYYGAF  121 (463)
Q Consensus        70 ~V~~~~~~~~~~~vaiK~~~~~~---------------------------~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~  121 (463)
                      .||.|.. ..|..+|+|+.....                           ......++|.+.|.++... -++.+.+++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899986 457799999975210                           0123456899999998432 1455555443


Q ss_pred             cccCCCCCCCeEEEEEecCC--CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhh-hhcCCceecCCCCCceEEccCCc
Q psy7384         122 IKKSPPGKDDQLWLVMEYCG--AGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY-LHENKVIHRDIKGQNVLLTDNAE  198 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~-LH~~givHrDLkp~NILl~~~~~  198 (463)
                                ..+|||||++  |..+..+....    ++......++.+++..+.. +|..||+|+||.+.|||++++ .
T Consensus        80 ----------~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 ----------RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             ----------TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C
T ss_pred             ----------CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e
Confidence                      3479999998  76665554322    2234456778888885555 589999999999999999877 8


Q ss_pred             EEEEecccccccc
Q psy7384         199 VKLVDFGVSAQLD  211 (463)
Q Consensus       199 vkL~DFGla~~~~  211 (463)
                      +.|+|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137|consensus

Probab=99.15  E-value=1.8e-11  Score=125.37  Aligned_cols=152  Identities=23%  Similarity=0.330  Sum_probs=113.8

Q ss_pred             HHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEecccccccccccC---------ccccccCCccccccceeccCCC
Q psy7384         168 EILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---------RRNTFIGTPYWMAPEVIACDEN  237 (463)
Q Consensus       168 qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~  237 (463)
                      +++.|+.|+|.. ++||+.|.|++|.++.++.+||+.|+++........         ......-...|.|||++.    
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~----  182 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL----  182 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc----
Confidence            444999999976 899999999999999999999999998754433111         011122456799999998    


Q ss_pred             CCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCchhhhh--cccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q psy7384         238 PDATYDNRSDLWSLGITALEMA-ESQPPLCDLHPMRALF--LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQ  314 (463)
Q Consensus       238 ~~~~~~~~~DiwSlG~il~ell-~g~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  314 (463)
                       ....+.++|+||+||++|.+. .|+..|...+......  ....+....-....+++++++=+.++|..++..||++.+
T Consensus       183 -~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  183 -GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             -cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence             455678899999999999998 6677665443222211  111122222334678999999999999999999999999


Q ss_pred             HhcCccccCC
Q psy7384         315 LLKHPFIRDQ  324 (463)
Q Consensus       315 ~l~hp~~~~~  324 (463)
                      ++.-|||.+.
T Consensus       262 l~~~~ff~D~  271 (700)
T KOG2137|consen  262 LLSIPFFSDP  271 (700)
T ss_pred             hhcccccCCc
Confidence            9999999864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.12  E-value=2.5e-10  Score=105.45  Aligned_cols=136  Identities=18%  Similarity=0.251  Sum_probs=101.4

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-----------------------chHHHHHHHHHHHHHhcCC-C
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-----------------------DEEEEIKLEINVLKKYSNH-R  112 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~Ei~~l~~l~~h-~  112 (463)
                      +.+..+||-|--|.||.|.+. .|..+|+|+-+...                       ......++|.++|..|..+ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456789999999999999875 68899999854211                       1124567899999998322 2


Q ss_pred             ceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceE
Q psy7384         113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL  192 (463)
Q Consensus       113 nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NIL  192 (463)
                      .|.+.++          .+...+||||++|-.|..+-       +.......++..|++-+.-+-..||||+|+.+-|||
T Consensus       172 ~VP~P~~----------~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIl  234 (304)
T COG0478         172 KVPKPIA----------WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNIL  234 (304)
T ss_pred             CCCCccc----------cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEE
Confidence            3444443          36889999999997765432       234445566677777777777999999999999999


Q ss_pred             EccCCcEEEEeccccccc
Q psy7384         193 LTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       193 l~~~~~vkL~DFGla~~~  210 (463)
                      ++++|.+.++||--+...
T Consensus       235 V~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         235 VTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EecCCCEEEEeCcccccC
Confidence            999999999999866443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=1.3e-09  Score=103.54  Aligned_cols=134  Identities=12%  Similarity=0.071  Sum_probs=90.9

Q ss_pred             EEEEEEcCCCcEEEEEEeecCc------------chHHHHHHHHHHHHHhcCCCcee--eecccccccCCCCCCCeEEEE
Q psy7384          71 VYKGRHTKTGQLAAIKVMDVTE------------DEEEEIKLEINVLKKYSNHRNIA--TYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        71 V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~Ei~~l~~l~~h~nIv--~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      |+++..  .|+.|.||......            .....+.+|...+.++. .-+|.  ..+.++..... ......+||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~-~~~~~s~LV  113 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSN-PATRTSFII  113 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCC-CccceeEEE
Confidence            445433  35667777653221            11124678888888773 32332  22223321110 112467899


Q ss_pred             EecCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-------CCcEEEEeccccc
Q psy7384         137 MEYCGAG-SVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-------NAEVKLVDFGVSA  208 (463)
Q Consensus       137 ~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-------~~~vkL~DFGla~  208 (463)
                      ||++++- +|.+++........+......++++++..+.-||..||+|+||++.|||++.       +..+.|+||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999886 8999986432234566778899999999999999999999999999999975       4689999999764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.10  E-value=5e-09  Score=101.71  Aligned_cols=247  Identities=11%  Similarity=0.166  Sum_probs=157.8

Q ss_pred             EEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceee----ecccccccCCCCCCCeEE
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT----YYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~----l~~~~~~~~~~~~~~~~~  134 (463)
                      ..+.||+|+-+.+|-.-..  +.. +.|+.....-..+.  ..+.+|.....||-+-.    -..... ..  .....+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~-G~--~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLH-GG--RRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchh--hch-hheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhh-CC--CccceeE
Confidence            4478999999999976433  222 34776544332222  22344555445654322    111111 10  2223488


Q ss_pred             EEEecCCCC-CHHHHHHh----hCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         135 LVMEYCGAG-SVTDLVKS----TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       135 lV~E~~~gg-sL~~~l~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ++|..+.|. .+.+++..    .......+..+.+.++.|+.+.+-||..|.+-+|+.++|+|+++++.|.|+|=..-. 
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq-  165 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ-  165 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee-
Confidence            999998874 23333321    112246677889999999999999999999999999999999999999999855322 


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCc-------hhhh-------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHP-------MRAL-------  274 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~-------~~~~-------  274 (463)
                      +........+.+|.+.|.+||.-....-.+..-+...|.|.||++++++|.| +.||.+...       .++.       
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            2223344556789999999998653222244556778999999999999987 999976422       1110       


Q ss_pred             hcccCC-----CCCCCCCCCCCHHHHHHHHHhhhc--CCCCCCCHHH
Q psy7384         275 FLIPRN-----APPRLKSKKWPKKFQSFIETVLVK--DYHQRPYTDQ  314 (463)
Q Consensus       275 ~~i~~~-----~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~~e  314 (463)
                      +.-...     .+..+...-+++.++.|..+|+..  ++.-|||++.
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            000011     111222334578899999999885  3567999875

>KOG1235|consensus

Probab=99.08  E-value=1.1e-09  Score=112.23  Aligned_cols=177  Identities=18%  Similarity=0.239  Sum_probs=117.9

Q ss_pred             CCCCCcccccChHHHHHHHHhhhhhHHHHHHhhccccccCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcE
Q psy7384           3 NPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL   82 (463)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~   82 (463)
                      .++|...+...+|..+-+.+++++.+++++.....                       +.||..+.|+||+|+.+. |+.
T Consensus       132 ~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~-----------------------~piaaASlaQVhrA~L~~-G~~  187 (538)
T KOG1235|consen  132 ELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDE-----------------------EPIAAASLAQVHRARLKN-GED  187 (538)
T ss_pred             HHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCc-----------------------chhhhcchhheEEEEecC-CCE
Confidence            46788888888888888999999999999988655                       789999999999999765 999


Q ss_pred             EEEEEeecCcc--------------------------------hHH------HHHHHHH----HHHHhcCCCc---eeee
Q psy7384          83 AAIKVMDVTED--------------------------------EEE------EIKLEIN----VLKKYSNHRN---IATY  117 (463)
Q Consensus        83 vaiK~~~~~~~--------------------------------~~~------~~~~Ei~----~l~~l~~h~n---Iv~l  117 (463)
                      ||||+-+..-.                                -.+      ++.+|.+    +.+.+ .|-+   -|.+
T Consensus       188 VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f-~~~~~~~~V~V  266 (538)
T KOG1235|consen  188 VAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENF-KDFSLLTYVLV  266 (538)
T ss_pred             EEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHH-HhcccccceeC
Confidence            99999531110                                001      1222222    22333 3444   1222


Q ss_pred             cccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc--
Q psy7384         118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD--  195 (463)
Q Consensus       118 ~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~--  195 (463)
                      -.+|.     .-...-+|+||||+|..+.|+-.-.+ ..++...+...+.++..-+  |-..|++|+|-+|.||++..  
T Consensus       267 P~Vy~-----~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~q--If~~GffHaDPHPGNilv~~~~  338 (538)
T KOG1235|consen  267 PKVYW-----DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQ--IFKTGFFHADPHPGNILVRPNP  338 (538)
T ss_pred             Ceehh-----hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHH--HHhcCCccCCCCCCcEEEecCC
Confidence            23332     22246789999999988877643222 2355554444332222211  22368999999999999984  


Q ss_pred             --CCcEEEEeccccccccc
Q psy7384         196 --NAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       196 --~~~vkL~DFGla~~~~~  212 (463)
                        ++.+.+.|||+...+..
T Consensus       339 ~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  339 EGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCCccEEEEcccccccccH
Confidence              67899999999877654

>KOG0576|consensus

Probab=99.05  E-value=2.9e-11  Score=122.47  Aligned_cols=250  Identities=30%  Similarity=0.406  Sum_probs=183.2

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCc-eeeecccccccCCCC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN-IATYYGAFIKKSPPG  128 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~n-Iv~l~~~~~~~~~~~  128 (463)
                      ..+....|....-+++|+++++++.+...+...+ .+++...    .....++++|.++ +||| .+..++.+      +
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~-n~P~~~v~~~~d~------~  304 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKV-NNPNPVVRYLEDY------D  304 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHc-cCCCCcccccccC------C
Confidence            3455666888889999999999999987766555 7776543    4556788999999 8999 66666665      6


Q ss_pred             CCCeEEEEEecCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         129 KDDQLWLVMEYCGAG-SVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       129 ~~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .++..+++|+++.++ +-....... ...+.+-+...+++.-++++++||+.-=+|+|    ||+..+ +..+..||+..
T Consensus       305 ~E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~  378 (829)
T KOG0576|consen  305 GEDYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVP  378 (829)
T ss_pred             cccccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCC
Confidence            668899999999887 222211110 11244455666788888999999998888999    888765 67999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-CCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-PPRLK  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~  286 (463)
                      ..+.... ..++..+++.++|||+..     ...+....|.|++|+--.+|.-|.+|-..  +......+.... .+.+.
T Consensus       379 ~~L~~~~-~~~t~~~~~~~~~pev~~-----~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~  450 (829)
T KOG0576|consen  379 PQLTRTM-KPRTAIGTPEPLAPEVIQ-----ENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLT  450 (829)
T ss_pred             cccCccc-ccccCCCCCCCCCchhhc-----ccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccc
Confidence            8887654 346678999999999987     56788889999999988888888888544  333333332222 11111


Q ss_pred             C-CCCCHHHHH-HHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         287 S-KKWPKKFQS-FIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       287 ~-~~~~~~~~~-li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      . ..|+..+.+ +...|+..-|..|+....++.|.+|...+
T Consensus       451 ~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  451 DKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             hhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            1 344444444 88999999999999999999999887543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.86  E-value=3.8e-08  Score=89.33  Aligned_cols=140  Identities=23%  Similarity=0.238  Sum_probs=90.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHH----------HHHHHHHHHHHhc--CCCceeeeccccc
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE----------EIKLEINVLKKYS--NHRNIATYYGAFI  122 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~Ei~~l~~l~--~h~nIv~l~~~~~  122 (463)
                      +.|++++.+-......|.+..-  .|+.+++|.........+          ...+.+..+.++.  .-..+..++-+..
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            4688999998888888888753  467889998753221111          1223344333331  1223333333322


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEE
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV  202 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~  202 (463)
                      .... .-....+|||||++|..|.++..      +++    .+...|.++|.-||+.|++|+|.+|.|+++++++ ++++
T Consensus       109 kk~~-~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI  176 (229)
T PF06176_consen  109 KKIF-RYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII  176 (229)
T ss_pred             eeec-cceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence            2211 12245679999999988876642      333    2445677889999999999999999999998655 9999


Q ss_pred             eccccc
Q psy7384         203 DFGVSA  208 (463)
Q Consensus       203 DFGla~  208 (463)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=3e-08  Score=91.07  Aligned_cols=110  Identities=17%  Similarity=0.219  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHHHHhcCCCc--eeeecccccccCCCCCCCeEEEEEecCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy7384          95 EEEIKLEINVLKKYSNHRN--IATYYGAFIKKSPPGKDDQLWLVMEYCGAG-SVTDLVKSTKGQSLKEEWIAFICREILR  171 (463)
Q Consensus        95 ~~~~~~Ei~~l~~l~~h~n--Iv~l~~~~~~~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~  171 (463)
                      .....+|...+..|. .-+  +.+.+++.....  ......+||+|++++. +|.+++.....  .+......++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~--~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLR-EAGIPTPEPVAYGERRK--GGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcC--CCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHH
Confidence            345677887777763 222  334444433221  1124668999999884 79999876432  566777889999999


Q ss_pred             HHhhhhcCCceecCCCCCceEEccCC---cEEEEecccccc
Q psy7384         172 GLKYLHENKVIHRDIKGQNVLLTDNA---EVKLVDFGVSAQ  209 (463)
Q Consensus       172 aL~~LH~~givHrDLkp~NILl~~~~---~vkL~DFGla~~  209 (463)
                      .+.-||..||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       130 ~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  130 LIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999999998887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.78  E-value=1.3e-07  Score=85.57  Aligned_cols=141  Identities=14%  Similarity=0.093  Sum_probs=99.2

Q ss_pred             eeeCCeEEEEEEEcCCCcEEEEEEeec----C---cchHHHHHHHHHHHHHhcCCCc--eeeecccccccCCCCCCCeEE
Q psy7384          64 GNGTYGQVYKGRHTKTGQLAAIKVMDV----T---EDEEEEIKLEINVLKKYSNHRN--IATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        64 G~G~fg~V~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~Ei~~l~~l~~h~n--Iv~l~~~~~~~~~~~~~~~~~  134 (463)
                      |+||.|-|++....  |..+=+|.-..    +   ......+.+|...|..+. .-+  +.+....-..+.  ...-..+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~-~~GvPVP~pvf~~~~k~--~~~~rA~  101 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELE-RAGVIVPKIVFGEAVKI--EGEWRAL  101 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHH-HcCCCCCccceeeeecc--CCceEEE
Confidence            56888889987643  33566665430    0   235678889999998884 322  333331111111  2234578


Q ss_pred             EEEecCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc--EEEEecccccc
Q psy7384         135 LVMEYCGA-GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE--VKLVDFGVSAQ  209 (463)
Q Consensus       135 lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~--vkL~DFGla~~  209 (463)
                      ||+|-+.| .+|.+++....-...++.....++.+|+..|.-||+.|+.|+|+-+.|||++.++.  ++++||.-++.
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            99997764 58888886543334567777889999999999999999999999999999986667  99999996543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.65  E-value=1.4e-07  Score=81.95  Aligned_cols=132  Identities=17%  Similarity=0.238  Sum_probs=96.0

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCce-eeecccccccCCCCCCCeEEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNI-ATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nI-v~l~~~~~~~~~~~~~~~~~l  135 (463)
                      -++.+.||+|++|.||+|.+.  |..+|+|+-.. +.....+..|.++|..+ .-.++ .++|.+          +..++
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-ds~r~~l~kEakiLeil-~g~~~~p~vy~y----------g~~~i   89 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-DSPRRNLEKEAKILEIL-AGEGVTPEVYFY----------GEDFI   89 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecC-CcchhhHHHHHHHHHHh-hhcCCCceEEEe----------chhhh
Confidence            356789999999999999886  66899997654 35677888999999988 44444 334433          34567


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC-CCceEEccCCcEEEEecccccccc
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIK-GQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk-p~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .|||+.|-.|.++...     .+    +.-+..+++.---|-..||-|..|. |.-++|.+++.+.|+||.-|+...
T Consensus        90 ~me~i~G~~L~~~~~~-----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          90 RMEYIDGRPLGKLEIG-----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhhhhcCcchhhhhhc-----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            7999999888776532     11    2334566777666778899999994 655555566699999999887443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.64  E-value=4.1e-07  Score=83.61  Aligned_cols=139  Identities=20%  Similarity=0.304  Sum_probs=93.6

Q ss_pred             EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHH-------------------------HHHHHHHHHHHhc-CC
Q psy7384          58 ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE-------------------------EIKLEINVLKKYS-NH  111 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------------------~~~~Ei~~l~~l~-~h  111 (463)
                      .+...|..|--+.||+|.. ..+..+|+|++.......+                         -...|...|+++. .+
T Consensus        51 ~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG  129 (268)
T COG1718          51 ELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG  129 (268)
T ss_pred             eeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence            3556888888899999975 5688999999863321111                         1124555555553 12


Q ss_pred             CceeeecccccccCCCCCCCeEEEEEecCCCCCH-HHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCC
Q psy7384         112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQ  189 (463)
Q Consensus       112 ~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~  189 (463)
                      -.+.+.+.+.          .-.|||||+....+ .-.|+.   ..+...++..+..++++.+.-|-. .|+||+||..-
T Consensus       130 VrvP~Pi~~~----------~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEy  196 (268)
T COG1718         130 VRVPEPIAFR----------NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEY  196 (268)
T ss_pred             CCCCCceeec----------CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhh
Confidence            2333333333          45899999965311 111111   123444678888999999998877 89999999999


Q ss_pred             ceEEccCCcEEEEecccccccc
Q psy7384         190 NVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       190 NILl~~~~~vkL~DFGla~~~~  211 (463)
                      |||+. ++.+.|+|||-|....
T Consensus       197 NiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         197 NILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             heEEE-CCeEEEEECccccccC
Confidence            99998 8889999999886654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.63  E-value=5.2e-07  Score=84.01  Aligned_cols=134  Identities=16%  Similarity=0.213  Sum_probs=79.9

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCCeEEEEEec
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDDQLWLVMEY  139 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~~~~lV~E~  139 (463)
                      ..||+|..+.||+.    .|..+++|+.... .....+.+|.+++..+.... .+.+.+++.      +..+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~------~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLV------EDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEE------ecCCeeeeeeee
Confidence            68899999999984    2445778887643 34456788999998884221 134445444      334567899999


Q ss_pred             CCCCC-HHHHH---------------------Hhh--CCCCCCHH----------------HHHHHHHHHHHHHhhhhcC
Q psy7384         140 CGAGS-VTDLV---------------------KST--KGQSLKEE----------------WIAFICREILRGLKYLHEN  179 (463)
Q Consensus       140 ~~ggs-L~~~l---------------------~~~--~~~~l~~~----------------~~~~i~~qil~aL~~LH~~  179 (463)
                      ++|.+ +...+                     +..  ....+...                ..+..+...+..+.  -..
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~--~~~  153 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP--DTS  153 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC--CCC
Confidence            99963 11111                     000  00011100                11111111111110  012


Q ss_pred             CceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       180 givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .++|+|++|.||++++++ +.|+||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            578999999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.61  E-value=5.1e-07  Score=84.03  Aligned_cols=143  Identities=18%  Similarity=0.266  Sum_probs=84.1

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC-CceeeecccccccCCCCCCCeEEEEEe
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-RNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++.|+.|..+.||++....  ..+++|+.... .....+..|..+++.+..+ ..+.+++......   ......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~---~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD---EFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET---EETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc---cccccceEEEE
Confidence            4789999999999998764  47889987544 4567788899998888544 2244555432111   23346899999


Q ss_pred             cCCCCCHHH----------------HHHh---h--CCCCCCHHH------HHHH---------------HHHHHH-HHhh
Q psy7384         139 YCGAGSVTD----------------LVKS---T--KGQSLKEEW------IAFI---------------CREILR-GLKY  175 (463)
Q Consensus       139 ~~~ggsL~~----------------~l~~---~--~~~~l~~~~------~~~i---------------~~qil~-aL~~  175 (463)
                      +++|..+..                .+..   .  ....+....      ...+               ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999988877                1111   1  000111000      0000               011122 2333


Q ss_pred             hh-------cCCceecCCCCCceEEc-cCCcEEEEeccccc
Q psy7384         176 LH-------ENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSA  208 (463)
Q Consensus       176 LH-------~~givHrDLkp~NILl~-~~~~vkL~DFGla~  208 (463)
                      ++       ...++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            33       35699999999999999 66777899999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=1.5e-06  Score=82.01  Aligned_cols=137  Identities=15%  Similarity=0.124  Sum_probs=82.4

Q ss_pred             eeeeeCC-eEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecC
Q psy7384          62 VVGNGTY-GQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYC  140 (463)
Q Consensus        62 ~LG~G~f-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~  140 (463)
                      .|-.|.. +.||++...  +..+.+|+.....  ...+.+|+.+++.+..+--+.+++++.      ...+..++|||++
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~------~~~~~~~lv~e~i   74 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYG------SDDGRAWLLTSAV   74 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEE------ecCCccEEEEEee
Confidence            4445555 789999643  3567888875432  345678999999886554455666655      2224679999999


Q ss_pred             CCCCHHHHHH-------------------hhCC--CCCCHH------HHHHH-------------------HHHHHHHHh
Q psy7384         141 GAGSVTDLVK-------------------STKG--QSLKEE------WIAFI-------------------CREILRGLK  174 (463)
Q Consensus       141 ~ggsL~~~l~-------------------~~~~--~~l~~~------~~~~i-------------------~~qil~aL~  174 (463)
                      +|.+|.....                   ....  ..+...      .....                   ..+++.-|.
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            9987764320                   0000  011100      00000                   111111111


Q ss_pred             h----hhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         175 Y----LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       175 ~----LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .    .....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            1    122458999999999999988778999999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035|consensus

Probab=98.46  E-value=7.1e-07  Score=96.90  Aligned_cols=208  Identities=22%  Similarity=0.300  Sum_probs=143.0

Q ss_pred             HHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC-eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHh
Q psy7384          96 EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD-QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK  174 (463)
Q Consensus        96 ~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~  174 (463)
                      .....|+..+.++ .|+|++.++.+...+-   ..+ ...+..|+|..-++...+....  ..+...++.+..++++||.
T Consensus       227 ~~~E~e~~~l~k~-~~~n~~~~~~~~le~~---~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~  300 (1351)
T KOG1035|consen  227 QTTEIELESLSKI-AHDNLGGYFVYGLERL---FRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLA  300 (1351)
T ss_pred             HHHHHHHHHHHhh-ccccccceeEEeehhh---cchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHH
Confidence            3445577777888 7999999998876542   222 3345667888989999887665  6788889999999999999


Q ss_pred             hhhcCCceecCCCCC---ceEEccCCcEEEE--ecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHH
Q psy7384         175 YLHENKVIHRDIKGQ---NVLLTDNAEVKLV--DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW  249 (463)
Q Consensus       175 ~LH~~givHrDLkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~Diw  249 (463)
                      |+|+....|.-|...   +-.++..+.+.+.  ||+.+..+..... .........|.++|....+   ........|+|
T Consensus       301 ~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~---~~~~~r~~dL~  376 (1351)
T KOG1035|consen  301 YLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKEN---TAKKSRLTDLW  376 (1351)
T ss_pred             HHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccc---cchhhhhhHHH
Confidence            999996665555444   3344455666666  8888776654322 2223456667888877632   22333447999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         250 SLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       250 SlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++|..+..+..|..+-...   .        ....+..........+++.+|+.-+.++|+.+.+++.|+|....
T Consensus       377 ~lgll~~~~~~~~~i~~~~---~--------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKS---A--------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             HHHHHHhhhhhcCcccccc---c--------chhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            9999999998876542110   0        00111111222267889999999999999999999999998743

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.4e-05  Score=88.43  Aligned_cols=83  Identities=13%  Similarity=0.233  Sum_probs=56.0

Q ss_pred             EeeeeeeCCeEEEEEEEcCCC--cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCce--eeecccccccCCCCCCCeE
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTG--QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNI--ATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~--~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nI--v~l~~~~~~~~~~~~~~~~  133 (463)
                      ++.|+.|.++.+|+......+  ..+++|+.....  .....+.+|..+|+.+..|.+|  .+++.++...   ...+..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~---~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA---SVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC---CcCCCc
Confidence            478899999999998765432  357777764322  2345788999999999546654  6666655321   112467


Q ss_pred             EEEEecCCCCCH
Q psy7384         134 WLVMEYCGAGSV  145 (463)
Q Consensus       134 ~lV~E~~~ggsL  145 (463)
                      |+||||++|..+
T Consensus       120 flVME~v~G~~~  131 (822)
T PLN02876        120 FYIMEYLEGRIF  131 (822)
T ss_pred             eEEEEecCCccc
Confidence            899999998653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.23  E-value=9.3e-06  Score=76.15  Aligned_cols=77  Identities=14%  Similarity=0.180  Sum_probs=45.8

Q ss_pred             eeeeeeCCe-EEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC--ceeeecccccccCCCCCCCeEEEEE
Q psy7384          61 EVVGNGTYG-QVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR--NIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        61 ~~LG~G~fg-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~--nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      +.|+.|+.. .||+..     ..+++|+... ......+.+|.++|..+..+-  -+.++++...   ..+.....|+||
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~---~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGE---PGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCC---CccCCCcceEEE
Confidence            567767766 589862     2466787543 234557889999999884331  2223232221   001123458999


Q ss_pred             ecCCCCCHH
Q psy7384         138 EYCGAGSVT  146 (463)
Q Consensus       138 E~~~ggsL~  146 (463)
                      ++++|.++.
T Consensus        74 ~~i~G~~l~   82 (235)
T cd05155          74 RWLEGETAT   82 (235)
T ss_pred             EeecCCCCC
Confidence            999997763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.18  E-value=2e-05  Score=73.78  Aligned_cols=76  Identities=14%  Similarity=0.197  Sum_probs=49.6

Q ss_pred             EeeeeeeCCeEEEEEEEcC-CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEe
Q psy7384          60 IEVVGNGTYGQVYKGRHTK-TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++.|..|-...||++.... .+..|++|+........-...+|+.++..+..+.-..+++..+      .    -.+|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~------~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF------Q----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe------C----CcEEEE
Confidence            4677888889999997543 3567888977543222234457888888885443344444433      1    148999


Q ss_pred             cCCCCCH
Q psy7384         139 YCGAGSV  145 (463)
Q Consensus       139 ~~~ggsL  145 (463)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1826|consensus

Probab=98.15  E-value=1.2e-06  Score=97.16  Aligned_cols=212  Identities=12%  Similarity=0.063  Sum_probs=142.3

Q ss_pred             HHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhh
Q psy7384         100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLH  177 (463)
Q Consensus       100 ~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH  177 (463)
                      .|...++.. .|+++...+.-..    +......|.+++|+.+|.+++.+-..-  ...+.+.-+....++.+.+..-+|
T Consensus      1278 ~e~de~~~~-~h~~~~~~p~rI~----ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1278 SERDELREA-KHYLTEVDPLRIP----PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             hhhhhhhhh-hceeeecccccCC----CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            444455555 6998887766543    245567899999999999999885422  223434434444445477777777


Q ss_pred             cC-----CceecCCCCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHH
Q psy7384         178 EN-----KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG  252 (463)
Q Consensus       178 ~~-----givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG  252 (463)
                      +.     -.+|++||+-|.+|..+..+|++++|+.+............++++.|+.|++..     .-.++.++|+|..|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-----~ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-----EIKFTKRSDILRRS 1427 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-----HHhhhhHHHHHHHH
Confidence            64     278999999999999999999999999985544444556678899999999886     56677789999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         253 ITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       253 ~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      +-+|++..|..+|-....... ..+..+......+...|.++-.....+|-+.-..||.-...+..+.|.
T Consensus      1428 ~~ly~rs~~n~~fi~flq~~L-kgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIFFLQPAL-KGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHhcccHHHHHHHHHHH-cCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            999999999988733222111 111122111111222233444444455555556778777777776665

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.11  E-value=5.1e-05  Score=68.38  Aligned_cols=131  Identities=24%  Similarity=0.354  Sum_probs=91.4

Q ss_pred             CceEEEeeeeeeCC-eEEEEEEEcCCCcEEEEEEee---cCc-------------------chHHHHHHHHHHHHHhc--
Q psy7384          55 GIFELIEVVGNGTY-GQVYKGRHTKTGQLAAIKVMD---VTE-------------------DEEEEIKLEINVLKKYS--  109 (463)
Q Consensus        55 ~~y~~~~~LG~G~f-g~V~~~~~~~~~~~vaiK~~~---~~~-------------------~~~~~~~~Ei~~l~~l~--  109 (463)
                      ..++.++.||.|+- |.||+++..  |+.+|+|++.   ...                   .....+..|.+..-+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57999999999999 999999754  7899999942   100                   01124556776655553  


Q ss_pred             CCCce--eeecccccccC------------CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhh
Q psy7384         110 NHRNI--ATYYGAFIKKS------------PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY  175 (463)
Q Consensus       110 ~h~nI--v~l~~~~~~~~------------~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~  175 (463)
                      ++.++  |+++|+.....            .........||.||+....           .+...    -+.+|++-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence            44556  99999875431            0012234568999887633           12332    34677888889


Q ss_pred             hhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       176 LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      +|..||+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999999987     2489999954

>KOG2268|consensus

Probab=98.08  E-value=3.6e-06  Score=80.01  Aligned_cols=133  Identities=14%  Similarity=0.222  Sum_probs=95.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch-----------------------HHHHHHHHHHHHHhcCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE-----------------------EEEIKLEINVLKKYSNHR  112 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~Ei~~l~~l~~h~  112 (463)
                      -|.+...||-|--+-||.+-+. .|...++|+-++....                       .-...+|...|+.|..|-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4668899999999999999864 5788888875422110                       122346888888875443


Q ss_pred             c-eeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCce
Q psy7384         113 N-IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNV  191 (463)
Q Consensus       113 n-Iv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NI  191 (463)
                      . |.+.+          +.+..++|||++.|..|....+-        ..+..+...++.-|.-|..+|+||+|..--||
T Consensus       172 fpVPkpi----------D~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNi  233 (465)
T KOG2268|consen  172 FPVPKPI----------DHNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNI  233 (465)
T ss_pred             CCCCCcc----------cccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchhee
Confidence            2 22222          33688999999999887665432        12334555666667778889999999999999


Q ss_pred             EEccCCcEEEEecccc
Q psy7384         192 LLTDNAEVKLVDFGVS  207 (463)
Q Consensus       192 Ll~~~~~vkL~DFGla  207 (463)
                      +|.+++.++++||--.
T Consensus       234 mv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  234 MVKDDDKIVVIDFPQM  249 (465)
T ss_pred             EEecCCCEEEeechHh
Confidence            9999999999999754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.03  E-value=1.4e-05  Score=72.10  Aligned_cols=103  Identities=22%  Similarity=0.235  Sum_probs=79.7

Q ss_pred             HHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHhhhh
Q psy7384          99 KLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS-TKGQSLKEEWIAFICREILRGLKYLH  177 (463)
Q Consensus        99 ~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~~LH  177 (463)
                      ..|.-+|+.+...+++.+++|.|          ..++|.||...+++...... ......++....+|+.++++.+.+|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            35777888885557999999998          23678999987766432100 01113578888999999999999999


Q ss_pred             c---CCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         178 E---NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       178 ~---~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .   ..+.-.|++++|+-|++++++|++|...+...+
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            7   458888999999999999999999999776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.02  E-value=2.1e-05  Score=74.78  Aligned_cols=135  Identities=16%  Similarity=0.216  Sum_probs=76.5

Q ss_pred             eeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchH-HHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecC
Q psy7384          62 VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYC  140 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~  140 (463)
                      .+..|-.+.+|+..  .++..+++|+........ -...+|..+++.+..+.-..+++...          .-++||||+
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----------~~~~v~e~i   70 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----------EHWLLVEWL   70 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----------CCEEEEEec
Confidence            34567788899886  346678888754332221 24578899999885442223333332          126899999


Q ss_pred             CCCCHHH--------------HHHh---hC--CCCCCH-HHHHHHHHHH------------HHHHhhhh-----cCCcee
Q psy7384         141 GAGSVTD--------------LVKS---TK--GQSLKE-EWIAFICREI------------LRGLKYLH-----ENKVIH  183 (463)
Q Consensus       141 ~ggsL~~--------------~l~~---~~--~~~l~~-~~~~~i~~qi------------l~aL~~LH-----~~givH  183 (463)
                      +|..+..              .+.+   ..  ...+.. ..+..+..++            +..+....     ...++|
T Consensus        71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H  150 (256)
T TIGR02721        71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH  150 (256)
T ss_pred             cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence            9876531              1111   11  111111 1122222122            11111110     125899


Q ss_pred             cCCCCCceEEccCCcEEEEecccccc
Q psy7384         184 RDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       184 rDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      +|+.|.|||+++++ +.|+||+.+..
T Consensus       151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       151 MDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCcCcEEEeCCC-CEEEeccccCc
Confidence            99999999999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.97  E-value=6.3e-05  Score=73.04  Aligned_cols=145  Identities=14%  Similarity=0.131  Sum_probs=83.6

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCCeEEEEEe
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++.|..|....+|+....  +..+++|+...  .....+..|+.++..+..+- .+.+++............+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            467888888899998643  34688898754  33456778888888884331 23444332100000022356789999


Q ss_pred             cCCCCCHHH----HH----------Hhh-CCCC------CCHHHHHH------------HHHHHHHHHhhhhc-------
Q psy7384         139 YCGAGSVTD----LV----------KST-KGQS------LKEEWIAF------------ICREILRGLKYLHE-------  178 (463)
Q Consensus       139 ~~~ggsL~~----~l----------~~~-~~~~------l~~~~~~~------------i~~qil~aL~~LH~-------  178 (463)
                      |++|..+..    .+          +.. ....      ........            ....+..++.++..       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876521    11          000 0000      00000000            11112233444432       


Q ss_pred             CCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       179 ~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .+++|+|++|.|||+++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999988778999999763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.97  E-value=0.00012  Score=71.18  Aligned_cols=80  Identities=15%  Similarity=0.142  Sum_probs=55.4

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC--CceeeecccccccCCCCCCCeEEEEE
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH--RNIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h--~nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      .+.||.|..+.||+.... ++ .+.+|..+. ......+..|...|+.+..+  -.+.++++++...   ...+..+|||
T Consensus        19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~---~~~g~~~LVm   92 (297)
T PRK10593         19 VECISEQPYAALWALYDS-QG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE---QSPGPDVLLL   92 (297)
T ss_pred             eeecCCccceeEEEEEcC-CC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC---CcCCCeEEEE
Confidence            478999999999998643 23 466677432 22345888999999988544  2566777665321   2235689999


Q ss_pred             ecCCCCCH
Q psy7384         138 EYCGAGSV  145 (463)
Q Consensus       138 E~~~ggsL  145 (463)
                      |+++|+++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.95  E-value=5.2e-05  Score=73.85  Aligned_cols=76  Identities=17%  Similarity=0.197  Sum_probs=49.9

Q ss_pred             eeeeeeCCeEEEEEEEcC------CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          61 EVVGNGTYGQVYKGRHTK------TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      +.|..|-...||++....      .++.+++|+............+|..++..+..+--..+++..+      .    -.
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~------~----~~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF------P----NG   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe------C----CC
Confidence            566667777899987543      2578889997654444456678888888885443334445444      1    13


Q ss_pred             EEEecCCCCCHH
Q psy7384         135 LVMEYCGAGSVT  146 (463)
Q Consensus       135 lV~E~~~ggsL~  146 (463)
                      +|+||++|..+.
T Consensus        74 ~v~e~i~G~~l~   85 (302)
T cd05156          74 RIEEFIPSRTLT   85 (302)
T ss_pred             chhheeCCCcCC
Confidence            589999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.91  E-value=0.00024  Score=64.48  Aligned_cols=127  Identities=21%  Similarity=0.352  Sum_probs=88.1

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-----------------chHHHHHHHHHHHHHhc-----CCCceeeec
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-----------------DEEEEIKLEINVLKKYS-----NHRNIATYY  118 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~Ei~~l~~l~-----~h~nIv~l~  118 (463)
                      ..||+|+.=.||.--   ...-..||++....                 ....+..+|+.....+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            689999998888743   23346778876443                 22455666776665552     378899999


Q ss_pred             ccccccCCCCCCCeEEEEEecCCC------CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceE
Q psy7384         119 GAFIKKSPPGKDDQLWLVMEYCGA------GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL  192 (463)
Q Consensus       119 ~~~~~~~~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NIL  192 (463)
                      |+.      +.+--..+|+|.+..      -+|.+++...   .+++ .   +...+-+-.+||-+.+|+.+||+|.||+
T Consensus        84 G~v------eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   84 GFV------ETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIV  150 (199)
T ss_pred             EEE------ecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEE
Confidence            998      555677899997742      3688888543   3554 2   3344455567889999999999999999


Q ss_pred             EccC---C-cEEEEe
Q psy7384         193 LTDN---A-EVKLVD  203 (463)
Q Consensus       193 l~~~---~-~vkL~D  203 (463)
                      +...   . .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9542   2 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.86  E-value=0.00016  Score=72.60  Aligned_cols=77  Identities=17%  Similarity=0.172  Sum_probs=53.5

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeec-----C---cchHHHHHHHHHHHHHhcCC--CceeeecccccccCCCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-----T---EDEEEEIKLEINVLKKYSNH--RNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~-----~---~~~~~~~~~Ei~~l~~l~~h--~nIv~l~~~~~~~~~~~~  129 (463)
                      .+.||.|.+..||++.+...++.++||.-..     .   .........|.+.|+.+..+  .++.+++.+-        
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--------  102 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--------  102 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--------
Confidence            3789999999999999864435788997431     1   12345677788888876543  3466666553        


Q ss_pred             CCeEEEEEecCCCCC
Q psy7384         130 DDQLWLVMEYCGAGS  144 (463)
Q Consensus       130 ~~~~~lV~E~~~ggs  144 (463)
                      .+..++||||+++..
T Consensus       103 ~~~~~lVME~L~~~~  117 (401)
T PRK09550        103 EELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCCEEEEecCCCcc
Confidence            245789999998744

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.80  E-value=0.00024  Score=69.45  Aligned_cols=147  Identities=16%  Similarity=0.214  Sum_probs=82.0

Q ss_pred             EEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC-CceeeecccccccCCCCCCCeEEEEE
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-RNIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      .++.++.|....+|++.. .+| .+++|+..... ....+..|++++..|..+ -.+.+++............+..+++|
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            357788888889999864 344 57788765421 234556677777777322 12334333211000012245679999


Q ss_pred             ecCCCCCHH----H-------HH---Hh-hCCC--C----CC-HHHH----H----------HHHHHHHHHHhhhh----
Q psy7384         138 EYCGAGSVT----D-------LV---KS-TKGQ--S----LK-EEWI----A----------FICREILRGLKYLH----  177 (463)
Q Consensus       138 E~~~ggsL~----~-------~l---~~-~~~~--~----l~-~~~~----~----------~i~~qil~aL~~LH----  177 (463)
                      ||++|..+.    +       .+   +. ....  .    .. ....    .          .....+...++++.    
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999985531    1       11   10 0100  0    00 0000    0          00112233444443    


Q ss_pred             ---cCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         178 ---ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       178 ---~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                         ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               3689999999999999988877999999753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270|consensus

Probab=97.71  E-value=0.00073  Score=65.75  Aligned_cols=141  Identities=21%  Similarity=0.330  Sum_probs=95.5

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-----------------------chHH----HHHHHHHHHHHhc
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-----------------------DEEE----EIKLEINVLKKYS  109 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~----~~~~Ei~~l~~l~  109 (463)
                      -+|...|..|--+.||.|.. .+|..+|||+.+.+-                       ...+    -...|++.|.++ 
T Consensus       146 ~~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-  223 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-  223 (520)
T ss_pred             eecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-
Confidence            35668899999999999974 568889999975210                       1111    123577777777 


Q ss_pred             CCCceeeecccccccCCCCCCCeEEEEEecCCCCCH-HHHHHhhCCCCCCHHHHHHHHHHHHHHHhhh-hcCCceecCCC
Q psy7384         110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRGLKYL-HENKVIHRDIK  187 (463)
Q Consensus       110 ~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givHrDLk  187 (463)
                      +...| ++-.-.+.       ...+|||+|+..-.. .-.|   +...++...+..+-.|++.-+.-| |.+++||.||.
T Consensus       224 ~~aGI-P~PePIlL-------k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLS  292 (520)
T KOG2270|consen  224 NNAGI-PCPEPILL-------KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLS  292 (520)
T ss_pred             HhcCC-CCCCceee-------ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchh
Confidence            34443 22222211       356899999963211 1122   223577777888888888888877 56799999999


Q ss_pred             CCceEEccCCcEEEEecccccccc
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      --|+|+ .+|.+.|+|.+-+...+
T Consensus       293 EfN~Ly-hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  293 EFNLLY-HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             hhhheE-ECCEEEEEEccccccCC
Confidence            999999 56789999999775544

>PRK05231 homoserine kinase; Provisional

Probab=97.68  E-value=0.00072  Score=66.41  Aligned_cols=144  Identities=12%  Similarity=0.167  Sum_probs=76.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC-CceeeecccccccCCCCCCCeEEEEEec
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-RNIATYYGAFIKKSPPGKDDQLWLVMEY  139 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~~~~~~~~~~~~~~lV~E~  139 (463)
                      +.|+.|....+|+.... .| .+++|++.  ......+..|+.++..|..+ -.+.+.+............+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            56777888899998743 34 58889875  22344555667777766322 1122222110000000123567999999


Q ss_pred             CCCCCHH-----------HHHHh----hCCC------CCCHHH----H-----------HHHHHH-HHHHHhhhh-----
Q psy7384         140 CGAGSVT-----------DLVKS----TKGQ------SLKEEW----I-----------AFICRE-ILRGLKYLH-----  177 (463)
Q Consensus       140 ~~ggsL~-----------~~l~~----~~~~------~l~~~~----~-----------~~i~~q-il~aL~~LH-----  177 (463)
                      ++|..+.           ..+..    ....      ......    .           ...+.+ +...+..+.     
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            9987431           11110    0000      000000    0           011111 111222222     


Q ss_pred             --cCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         178 --ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       178 --~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        ..++||+|++|.|||++.+...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              2489999999999999876666899999764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.46  E-value=0.0011  Score=65.34  Aligned_cols=149  Identities=15%  Similarity=0.218  Sum_probs=81.6

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      |........++.. |..|-...+|++.....   +..|++|+........-...+|..+++.+..+.--.++++.+    
T Consensus         9 w~~~~~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~----   83 (330)
T PLN02421          9 WSDLDDSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF----   83 (330)
T ss_pred             cccCCcCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe----
Confidence            4433334455544 44488888999865432   237888987543333334467888888885432224555554    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHH--------------HHHh---hC--CC--CCCHHHHHHHHHHH---------------
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTD--------------LVKS---TK--GQ--SLKEEWIAFICREI---------------  169 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~--------------~l~~---~~--~~--~l~~~~~~~i~~qi---------------  169 (463)
                        .   . .+|.+|++|.+|..              .++.   ..  ..  .--...+..++.++               
T Consensus        84 --~---~-G~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~  157 (330)
T PLN02421         84 --G---N-GMIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYE  157 (330)
T ss_pred             --C---C-cEeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhc
Confidence              1   1 15889988765521              1111   01  00  00112222222221               


Q ss_pred             -------HHHHh----hhhcC----CceecCCCCCceEEcc-CCcEEEEeccccc
Q psy7384         170 -------LRGLK----YLHEN----KVIHRDIKGQNVLLTD-NAEVKLVDFGVSA  208 (463)
Q Consensus       170 -------l~aL~----~LH~~----givHrDLkp~NILl~~-~~~vkL~DFGla~  208 (463)
                             ..-+.    ++...    -++|.||.+.|||+++ ++.++++||+.|.
T Consensus       158 ~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        158 TISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             ccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence                   11111    12222    2799999999999974 5789999999874

>PLN02236 choline kinase

Probab=97.46  E-value=0.0011  Score=65.82  Aligned_cols=141  Identities=14%  Similarity=0.211  Sum_probs=81.7

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcC----CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTK----TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..+ ..|-.|-...+|++....    .++.|++|+........-....|..+++.+..+.--.++++.+      ..   
T Consensus        39 ~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~------~~---  108 (344)
T PLN02236         39 LQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF------PN---  108 (344)
T ss_pred             EEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE------CC---
Confidence            444 455558888999987532    2467889987543333233467888888885443334555555      11   


Q ss_pred             EEEEEecCCCCCHHHH--------------HH---hhC--CC--CCCHHHHHHHHHHHH-----------------HHHh
Q psy7384         133 LWLVMEYCGAGSVTDL--------------VK---STK--GQ--SLKEEWIAFICREIL-----------------RGLK  174 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~--------------l~---~~~--~~--~l~~~~~~~i~~qil-----------------~aL~  174 (463)
                       ..|.||+++.+|...              +.   ...  ..  ......+..++.++.                 ..+.
T Consensus       109 -g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~  187 (344)
T PLN02236        109 -GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN  187 (344)
T ss_pred             -ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence             258999987665311              11   001  00  111222333322221                 1111


Q ss_pred             h--------hhcCCceecCCCCCceEEcc-CCcEEEEeccccc
Q psy7384         175 Y--------LHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSA  208 (463)
Q Consensus       175 ~--------LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~  208 (463)
                      .        .+...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1        22346899999999999976 4689999999764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.42  E-value=0.00097  Score=64.06  Aligned_cols=30  Identities=20%  Similarity=0.479  Sum_probs=25.2

Q ss_pred             CceecCCCCCceEEccCCc-EEEEecccccc
Q psy7384         180 KVIHRDIKGQNVLLTDNAE-VKLVDFGVSAQ  209 (463)
Q Consensus       180 givHrDLkp~NILl~~~~~-vkL~DFGla~~  209 (463)
                      .++|+|++|.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999987454 57999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.32  E-value=0.0024  Score=62.92  Aligned_cols=73  Identities=18%  Similarity=0.195  Sum_probs=47.6

Q ss_pred             eeeeeCCeEEEEEEEcCCCcEEEEEEee----c-C---cchHHHHHHHHHHHHHhcCC-C-ceeeecccccccCCCCCCC
Q psy7384          62 VVGNGTYGQVYKGRHTKTGQLAAIKVMD----V-T---EDEEEEIKLEINVLKKYSNH-R-NIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        62 ~LG~G~fg~V~~~~~~~~~~~vaiK~~~----~-~---~~~~~~~~~Ei~~l~~l~~h-~-nIv~l~~~~~~~~~~~~~~  131 (463)
                      .||.|....||++.+...++-++||.-.    . .   .-...+...|...|+..... | .+.++|.+        +.+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--------D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--------DTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--------ccc
Confidence            5799999999999975444678888642    1 1   23345666788888765332 3 34445543        235


Q ss_pred             eEEEEEecCCC
Q psy7384         132 QLWLVMEYCGA  142 (463)
Q Consensus       132 ~~~lV~E~~~g  142 (463)
                      ...+|||+++.
T Consensus        74 ~~~~vMEdL~~   84 (370)
T TIGR01767        74 MAVTVMEDLSH   84 (370)
T ss_pred             cceehHhhCcc
Confidence            66799999964

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PTZ00384 choline kinase; Provisional

Probab=97.25  E-value=0.0037  Score=62.76  Aligned_cols=87  Identities=17%  Similarity=0.261  Sum_probs=51.3

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCC-CcE-----EEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeeccccc
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKT-GQL-----AAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFI  122 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~  122 (463)
                      |........++ +.|..|-...+|++..... +..     |.+++........-...+|+.+++.+..+.-=.++++.+ 
T Consensus        45 w~~~~~~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-  122 (383)
T PTZ00384         45 WNNVNPEFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-  122 (383)
T ss_pred             cccCCcccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec-
Confidence            43333334455 4555588899999975432 122     444432222122223467899999986555556777776 


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHH
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVT  146 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~  146 (463)
                               .-++|.||++|.+|.
T Consensus       123 ---------~~g~l~efIeGr~l~  137 (383)
T PTZ00384        123 ---------GDFTIQEWVEGNTMG  137 (383)
T ss_pred             ---------CCEEEEEEeccccCC
Confidence                     236999999987763

>KOG1093|consensus

Probab=97.15  E-value=0.00073  Score=68.31  Aligned_cols=163  Identities=25%  Similarity=0.303  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhh
Q psy7384          96 EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY  175 (463)
Q Consensus        96 ~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~  175 (463)
                      ..+.-...+++.+ .|+|...++++-.     .......+|||++. .+|.|++....   +-..       +++     
T Consensus        27 ~~ilgr~~~lktl-~~~~l~~yl~~~r-----~~~~r~IVV~e~~~-~Sled~~~~~~---l~~~-------s~~-----   84 (725)
T KOG1093|consen   27 IQILGRFQYLKSL-QHDNLCQYLDFSR-----GKHERVIVVMEHYT-MSLEDILKTGN---LKDE-------SLL-----   84 (725)
T ss_pred             HHHhhhhHHHHhh-cCccceeeEeeec-----CccceEEEEehhhc-cchHHHHHhcc---cchh-------hhc-----
Confidence            3445567788888 7999999998764     33456899999995 59999987644   1111       111     


Q ss_pred             hhcCCceecCCCCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHH
Q psy7384         176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITA  255 (463)
Q Consensus       176 LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il  255 (463)
                        .+|+.|-     |       .++++| -++.                 |. |-.          ..+++||||+|.|+
T Consensus        85 --~~~~~~~-----~-------~~~~td-~~~t-----------------~~-~~~----------~~pKsdVwsl~~i~  121 (725)
T KOG1093|consen   85 --AHGVLHL-----N-------IIYITD-HFLT-----------------KY-PSP----------IGPKSDVWSLGFII  121 (725)
T ss_pred             --cccccee-----h-------hhhccc-cccc-----------------cC-CCC----------CCcchhhhhHHHHH
Confidence              2222222     1       233333 1110                 00 111          11478999999999


Q ss_pred             HHHHhCCCCCCCCCchhhhhcccCCCCCC----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         256 LEMAESQPPLCDLHPMRALFLIPRNAPPR----------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       256 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .++.-|...+......+.+..+..-....          .....++..+.++...|+...|..||...++.+++-|++
T Consensus       122 ~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e  199 (725)
T KOG1093|consen  122 LELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE  199 (725)
T ss_pred             HHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence            99999987775554444433222111100          011234566788999999999999999999999999875

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.09  E-value=0.00095  Score=61.38  Aligned_cols=120  Identities=18%  Similarity=0.141  Sum_probs=61.9

Q ss_pred             CcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHH-------HH---
Q psy7384          80 GQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-------LV---  149 (463)
Q Consensus        80 ~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~-------~l---  149 (463)
                      ++.|++++........-....|..+++.+..+-.-.++++.+.      .    .+|.||+.|.+|..       .+   
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~------~----g~v~e~i~g~~l~~~~~~~~~~~~~i   71 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFE------N----GRVEEFIEGRTLSPEDFRNPEILKRI   71 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEET------T----EEEEE--SSEE--CGGGGSHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcC------C----CcEEEEecccccChhhccChHHHHHH
Confidence            3568888887665566677889999998865544466666651      1    35779997765411       11   


Q ss_pred             ----H---hhCC----CC-CCHHHHHHH----------------------HHHHHHHHhhhh--------cCCceecCCC
Q psy7384         150 ----K---STKG----QS-LKEEWIAFI----------------------CREILRGLKYLH--------ENKVIHRDIK  187 (463)
Q Consensus       150 ----~---~~~~----~~-l~~~~~~~i----------------------~~qil~aL~~LH--------~~givHrDLk  187 (463)
                          .   ....    .. .-...+..+                      +..+..-+..+.        ..-++|.||.
T Consensus        72 A~~l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~  151 (211)
T PF01633_consen   72 AKLLAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLN  151 (211)
T ss_dssp             HHHHHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--S
T ss_pred             HHHHHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCc
Confidence                0   0000    00 000111111                      111122222221        1358999999


Q ss_pred             CCceEE-ccCCcEEEEecccccc
Q psy7384         188 GQNVLL-TDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       188 p~NILl-~~~~~vkL~DFGla~~  209 (463)
                      +.|||+ +.++.++|+||..|..
T Consensus       152 ~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  152 PGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GGGEEETSSSSCEEE--GTT-EE
T ss_pred             cccEEeccCCCeEEEecHHHHhh
Confidence            999999 8889999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.98  E-value=0.01  Score=57.89  Aligned_cols=28  Identities=36%  Similarity=0.554  Sum_probs=24.9

Q ss_pred             CCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       179 ~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .+++|+|+++.|||++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            58999999999999987 67899999965

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.96  E-value=0.0083  Score=58.65  Aligned_cols=29  Identities=10%  Similarity=0.267  Sum_probs=26.8

Q ss_pred             CceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       180 givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +++|+|+.+.|||++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999999764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.93  E-value=0.012  Score=59.10  Aligned_cols=73  Identities=21%  Similarity=0.201  Sum_probs=49.6

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEee-----cCc---chHHHHHHHHHHHHHhcCC--CceeeecccccccCCCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMD-----VTE---DEEEEIKLEINVLKKYSNH--RNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~-----~~~---~~~~~~~~Ei~~l~~l~~h--~nIv~l~~~~~~~~~~~~  129 (463)
                      .+.||.|....||+..+.  +..++||.-.     ...   ....+...|...|+.+..+  .++.+++.++.       
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-------  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-------  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-------
Confidence            578999999999999863  4458888754     121   1344555667777665322  46777777652       


Q ss_pred             CCeEEEEEecCCC
Q psy7384         130 DDQLWLVMEYCGA  142 (463)
Q Consensus       130 ~~~~~lV~E~~~g  142 (463)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             456889999977

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.90  E-value=0.0099  Score=57.80  Aligned_cols=31  Identities=13%  Similarity=0.320  Sum_probs=27.8

Q ss_pred             CceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       180 givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      .++|+|+++.||++++++-+-++||+++..-
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            4899999999999999988999999987543

>KOG1236|consensus

Probab=96.87  E-value=0.0078  Score=59.55  Aligned_cols=63  Identities=25%  Similarity=0.252  Sum_probs=44.4

Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhh-hcCCceecCCCCCceEEccC
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL-HENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givHrDLkp~NILl~~~  196 (463)
                      ....|+-+|..|.++..+++...   .+++..+.++.-...||.-+ --.+++|.|++|.||++.-+
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ccceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            34567888999988888886543   55555666655555554433 34699999999999999543

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.80  E-value=0.0064  Score=55.28  Aligned_cols=115  Identities=16%  Similarity=0.159  Sum_probs=72.1

Q ss_pred             eCCeEEEEEEEcCCCcEEEEEEeecCcc-hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCC
Q psy7384          66 GTYGQVYKGRHTKTGQLAAIKVMDVTED-EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS  144 (463)
Q Consensus        66 G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggs  144 (463)
                      |+-++...+..+- |-.+..|+....-. ....+.++..++.++  | .|+++..        ...-.+.+++|+|-.- 
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Arm--h-GilrL~N--------Dn~~~yGvIlE~Cy~~-  139 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARM--H-GILRLKN--------DNNYKYGVILERCYKI-  139 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHh--h-heeEeec--------CCCceeEEEEeeccCc-
Confidence            3444444444332 54444444433322 345567888888876  3 7888763        2345678999998421 


Q ss_pred             HHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc--CCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         145 VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE--NKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       145 L~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                                .-..    ..++.-=+.+|.-.|+  .+.+|+|-.|+|||.+..|.+||.|=+..
T Consensus       140 ----------~i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  140 ----------KINF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ----------ccch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                      1111    1122222466777884  47999999999999999999999998753

The function of this family is unknown.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.79  E-value=0.008  Score=60.07  Aligned_cols=75  Identities=16%  Similarity=0.190  Sum_probs=50.3

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEee----cC---cchHHHHHHHHHHHHHhcCC-C-ceeeecccccccCCCCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VT---EDEEEEIKLEINVLKKYSNH-R-NIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~----~~---~~~~~~~~~Ei~~l~~l~~h-~-nIv~l~~~~~~~~~~~~~  130 (463)
                      .+.||.|.-..||++.+...++-|+||.-.    ..   .-...+...|.+.|+.+... | .+.++|.+        +.
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--------D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--------DS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--------Cc
Confidence            578999999999999985435668888642    11   23356677788888876432 3 34555543        23


Q ss_pred             CeEEEEEecCCC
Q psy7384         131 DQLWLVMEYCGA  142 (463)
Q Consensus       131 ~~~~lV~E~~~g  142 (463)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            566899999964

>PTZ00296 choline kinase; Provisional

Probab=96.66  E-value=0.016  Score=59.39  Aligned_cols=85  Identities=14%  Similarity=0.146  Sum_probs=52.5

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCC--------CcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCce-eeecc
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKT--------GQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNI-ATYYG  119 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nI-v~l~~  119 (463)
                      |........ -++.|..|-.-.+|++.....        ++.|.+++.-......-....|..+++.+..+ +| .++++
T Consensus       100 W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~-gi~P~l~~  177 (442)
T PTZ00296        100 WRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKY-RIAPQLLN  177 (442)
T ss_pred             cccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHC-CCCCceEE
Confidence            443333344 456777788888999875422        46788888754433333456788888887533 34 35555


Q ss_pred             cccccCCCCCCCeEEEEEecCCCCCH
Q psy7384         120 AFIKKSPPGKDDQLWLVMEYCGAGSV  145 (463)
Q Consensus       120 ~~~~~~~~~~~~~~~lV~E~~~ggsL  145 (463)
                      .+          .-+.|.||++|-+|
T Consensus       178 ~f----------~gg~I~efi~g~~l  193 (442)
T PTZ00296        178 TF----------SGGRIEEWLYGDPL  193 (442)
T ss_pred             Ee----------CCCEEEEeeCCccC
Confidence            55          12567899988644

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.60  E-value=0.041  Score=54.02  Aligned_cols=142  Identities=16%  Similarity=0.256  Sum_probs=83.8

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceee-----ecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT-----YYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~-----l~~~~~~~~~~~~~~~~~l  135 (463)
                      ..|.+ .-..||+.... +|+. ++|+.... ....++.-|+..|..|..+.--|.     +-|..+..-  ....+.+-
T Consensus        32 ~~l~s-~eN~~f~~~~~-~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~--~~~~r~a~  105 (331)
T COG2334          32 RGLNS-EENSNFRVQTE-DGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEAL--SGGPRPAA  105 (331)
T ss_pred             ccccc-ccCceEEEEec-CCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhc--cCCceeEE
Confidence            34454 55678998754 3444 88998876 677788889999988864422222     222221111  11138889


Q ss_pred             EEecCCCCCHHH-----HHHh-----------hCCCC---------CCHH----H---------HHHHHHHHHHHHhhhh
Q psy7384         136 VMEYCGAGSVTD-----LVKS-----------TKGQS---------LKEE----W---------IAFICREILRGLKYLH  177 (463)
Q Consensus       136 V~E~~~ggsL~~-----~l~~-----------~~~~~---------l~~~----~---------~~~i~~qil~aL~~LH  177 (463)
                      |++|++|..+..     .+..           .++.+         ....    .         -.....++...++.+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            999999987762     1100           00000         0010    0         0112334444444444


Q ss_pred             c--------CC--ceecCCCCCceEEccCCc-EEEEeccccc
Q psy7384         178 E--------NK--VIHRDIKGQNVLLTDNAE-VKLVDFGVSA  208 (463)
Q Consensus       178 ~--------~g--ivHrDLkp~NILl~~~~~-vkL~DFGla~  208 (463)
                      +        .+  |||+|+.|.||+++.+.. +.++||+-+.
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3        34  999999999999998874 8999999653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.57  E-value=0.047  Score=53.78  Aligned_cols=76  Identities=9%  Similarity=0.049  Sum_probs=45.3

Q ss_pred             eCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccC-CCCCCCeEEEEEecCCCC
Q psy7384          66 GTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKS-PPGKDDQLWLVMEYCGAG  143 (463)
Q Consensus        66 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~-~~~~~~~~~lV~E~~~gg  143 (463)
                      +.-..||+... .+|..+++|+.+........+..|+..+..|..+. .|+.....  ... ....++..+.|+++++|.
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~--~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAF--NGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccC--CCCEEEEECCEEEEEEeeeCCC
Confidence            44457898864 44667999988644445677788888888775321 12222110  000 001235678899999876


Q ss_pred             C
Q psy7384         144 S  144 (463)
Q Consensus       144 s  144 (463)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.50  E-value=0.019  Score=55.33  Aligned_cols=76  Identities=24%  Similarity=0.274  Sum_probs=45.2

Q ss_pred             EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc--CCCceeeecccccccCCCCCCCeEEE
Q psy7384          58 ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +-.+.|+-|....+|+..  .+++.+-+|+-.  ......+..|..-|+.|.  .--.+.+.+.+...      .+..||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~------~~~~fL   89 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY------DDDAFL   89 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-------SSCCEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee------cCCceE
Confidence            345788989999999986  567788889876  333456778888888873  23345566666522      234599


Q ss_pred             EEecCCCC
Q psy7384         136 VMEYCGAG  143 (463)
Q Consensus       136 V~E~~~gg  143 (463)
                      ||||++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.03  E-value=0.016  Score=56.60  Aligned_cols=73  Identities=21%  Similarity=0.296  Sum_probs=56.2

Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEecccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      +..+.|++|++- |++|. .++     .-..+++..++.+.+..++-+..+ .+-||||...||||+ +|+|-|+||-++
T Consensus       297 e~~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         297 ETLYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             CceEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence            335778888875 44442 232     234667788888888888877765 789999999999999 999999999999


Q ss_pred             cc
Q psy7384         208 AQ  209 (463)
Q Consensus       208 ~~  209 (463)
                      +.
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            84

>PRK06148 hypothetical protein; Provisional

Probab=96.02  E-value=0.058  Score=61.22  Aligned_cols=146  Identities=15%  Similarity=0.283  Sum_probs=79.2

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC------Cceeeec-ccccccC-CCCCCCe
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH------RNIATYY-GAFIKKS-PPGKDDQ  132 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h------~nIv~l~-~~~~~~~-~~~~~~~  132 (463)
                      +.|+ |..-.+|+... .+|..+++|+.+.. .....+..|...|..|..+      |.+++.. +.+.... ......+
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~-~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPS-EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCc-cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            5665 45677888864 45678999998754 2334455566666655432      2333322 1111000 0011225


Q ss_pred             EEEEEecCCCCCHHHH-------HHh--------------hCC----CCCC-----------------HHHHHHHHHHHH
Q psy7384         133 LWLVMEYCGAGSVTDL-------VKS--------------TKG----QSLK-----------------EEWIAFICREIL  170 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~-------l~~--------------~~~----~~l~-----------------~~~~~~i~~qil  170 (463)
                      .+.+|+|++|..|.+.       +..              ...    ..+.                 ....+.++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            7789999999877551       100              000    0000                 011122333333


Q ss_pred             HHHh-----hhh--cCCceecCCCCCceEEccCC--cEE-EEecccccc
Q psy7384         171 RGLK-----YLH--ENKVIHRDIKGQNVLLTDNA--EVK-LVDFGVSAQ  209 (463)
Q Consensus       171 ~aL~-----~LH--~~givHrDLkp~NILl~~~~--~vk-L~DFGla~~  209 (463)
                      +.+.     .|.  ..++||+|+++.|||++.++  .+. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3322     122  25799999999999998775  454 999997653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	463
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-142
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-64
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-61
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-60
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-60
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-60
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-59
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-59
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-58
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-58
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-57
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-57
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-57
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-55
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-49
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-48
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-48
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-48
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-48
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-47
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-47
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-45
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-45
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-45
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-45
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-45
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-45
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-44
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-43
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-42
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-42
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-31
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-30
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-29
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-29
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-29
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-28
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-26
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-26
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-26
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-26
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-26
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-26
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-26
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-26
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-25
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-25
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-25
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-25
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-24
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-23
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-22
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-22
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-21
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-21
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-21
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-20
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-20
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-20
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-20
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-20
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-20
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-19
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-19
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-19
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-19
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-19
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-19
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-19
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-18
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-18
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-18
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-18
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-18
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-18
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-18
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-18
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-18
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-18
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-18
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-18
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-18
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-18
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-18
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-18
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-18
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-18
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-18
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-18
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-18
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-18
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-18
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-18
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-18
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-18
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-18
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-18
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-18
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-18
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-18
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-18
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-18
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-18
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-18
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-18
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-18
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-18
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-18
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-18
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-18
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-18
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-18
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-18
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-18
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-18
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-18
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-18
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-18
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-18
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-17
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-17
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-17
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-17
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-17
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-17
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-17
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-17
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-17
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-17
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-17
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-17
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-17
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-17
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-17
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-17
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-17
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-17
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-17
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-17
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-17
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-17
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-17
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-17
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-17
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-17
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-17
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-17
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-17
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-17
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-17
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-17
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-17
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-17
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-17
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-17
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-17
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-17
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-17
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-17
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-17
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-17
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-17
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-16
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-16
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-16
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-16
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-16
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-16
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-16
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-16
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-16
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-16
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-16
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-15
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-15
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-15
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-15
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-15
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-15
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-15
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-15
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-15
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-15
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-15
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-15
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-15
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-15
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-12
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
3soa_A	444	Full-Length Human Camkii Length = 444		3e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-10
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-09
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-08

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  500 bits (1287), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 233/288 (80%), Positives = 255/288 (88%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVM                  KYS+H
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH 80
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
           RNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREILR
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAPEV
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKKW 
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260
Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID 339
           KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHID 308

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  241 bits (614), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 122/278 (43%), Positives = 168/278 (60%), Gaps = 15/278 (5%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           ED   + P  +F+++E +G G+YG VYK  H +TGQ+ AIK +                 
Sbjct: 20  EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQ 79
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
              S H  +  YYG++ K +       LW+VMEYCGAGSV+D+++  + ++L E+ IA I
Sbjct: 80  QCDSPH--VVKYYGSYFKNT------DLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATI 130
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            +  L+GL+YLH  + IHRDIK  N+LL      KL DFGV+ QL   + +RN  IGTP+
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF 190
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           WMAPEVI      +  Y+  +D+WSLGITA+EMAE +PP  D+HPMRA+F+IP N PP  
Sbjct: 191 WMAPEVIQ-----EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF 245
Query: 286 -KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
            K + W   F  F++  LVK   QR    QLL+HPF+R
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  231 bits (589), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 121/284 (42%), Positives = 172/284 (60%), Gaps = 16/284 (5%)
Query: 39  SYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-XXXXXXXXX 97
           ++  G+     + DP  +F  ++ +G G++G+VYKG    T ++ AIK++          
Sbjct: 3   AHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIE 62
Query: 98  XXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL 157
                       +   I  Y+G+++K +      +LW++MEY G GS  DL+K      L
Sbjct: 63  DIQQEITVLSQCDSPYITRYFGSYLKST------KLWIIMEYLGGGSALDLLKPG---PL 113
Query: 158 KEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR 217
           +E +IA I REIL+GL YLH  + IHRDIK  NVLL++  +VKL DFGV+ QL  T  +R
Sbjct: 114 EETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 173
Query: 218 NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI 277
           N F+GTP+WMAPEVI       + YD ++D+WSLGITA+E+A+ +PP  DLHPMR LFLI
Sbjct: 174 NXFVGTPFWMAPEVIK-----QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228
Query: 278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           P+N+PP L+ +   K F+ F+E  L KD   RP   +LLKH FI
Sbjct: 229 PKNSPPTLEGQH-SKPFKEFVEACLNKDPRFRPTAKELLKHKFI 271

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  230 bits (587), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 119/271 (43%), Positives = 166/271 (61%), Gaps = 16/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-XXXXXXXXXXXXXXXXXXKYSN 110
           DP  +F  +E +G G++G+V+KG   +T Q+ AIK++                      +
Sbjct: 20  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 79
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
              +  YYG+++K S      +LW++MEY G GS  DL+++       E  IA + +EIL
Sbjct: 80  SSYVTKYYGSYLKGS------KLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEIL 130
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           +GL YLH  K IHRDIK  NVLL++  +VKL DFGV+ QL  T  +RNTF+GTP+WMAPE
Sbjct: 131 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 190
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VI       + YD+++D+WSLGITA+E+A+ +PP  D+HPMR LFLIP+N PP L    +
Sbjct: 191 VIQ-----QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVG-DF 244
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            K F+ FI+  L KD   RP   +LLKH FI
Sbjct: 245 TKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  229 bits (583), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 119/271 (43%), Positives = 166/271 (61%), Gaps = 16/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-XXXXXXXXXXXXXXXXXXKYSN 110
           DP  +F  +E +G G++G+V+KG   +T ++ AIK++                      +
Sbjct: 24  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 83
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
              +  YYG+++K      D +LW++MEY G GS  DL++      L E  IA I REIL
Sbjct: 84  SPYVTKYYGSYLK------DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREIL 134
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           +GL YLH  K IHRDIK  NVLL+++ EVKL DFGV+ QL  T  +RNTF+GTP+WMAPE
Sbjct: 135 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 194
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VI       + YD+++D+WSLGITA+E+A  +PP  +LHPM+ LFLIP+N PP L+   +
Sbjct: 195 VIK-----QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG-NY 248
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            K  + F+E  L K+   RP   +LLKH FI
Sbjct: 249 SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  228 bits (582), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 119/271 (43%), Positives = 166/271 (61%), Gaps = 16/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-XXXXXXXXXXXXXXXXXXKYSN 110
           DP  +F  +E +G G++G+V+KG   +T ++ AIK++                      +
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
              +  YYG+++K      D +LW++MEY G GS  DL++      L E  IA I REIL
Sbjct: 64  SPYVTKYYGSYLK------DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREIL 114
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           +GL YLH  K IHRDIK  NVLL+++ EVKL DFGV+ QL  T  +RNTF+GTP+WMAPE
Sbjct: 115 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 174
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VI       + YD+++D+WSLGITA+E+A  +PP  +LHPM+ LFLIP+N PP L+   +
Sbjct: 175 VIK-----QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG-NY 228
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            K  + F+E  L K+   RP   +LLKH FI
Sbjct: 229 SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  227 bits (578), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 118/273 (43%), Positives = 166/273 (60%), Gaps = 16/273 (5%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-XXXXXXXXXXXXXXXXXXKY 108
           + DP  +F  +E +G G++G+V+KG   +T ++ AIK++                     
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 76
Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
            +   +  YYG+++K      D +LW++MEY G GS  DL++      L E  IA I RE
Sbjct: 77  CDSPYVTKYYGSYLK------DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILRE 127
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
           IL+GL YLH  K IHRDIK  NVLL+++ EVKL DFGV+ QL  T  +RN F+GTP+WMA
Sbjct: 128 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 187
Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK 288
           PEVI       + YD+++D+WSLGITA+E+A  +PP  +LHPM+ LFLIP+N PP L+  
Sbjct: 188 PEVIK-----QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG- 241
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            + K  + F+E  L K+   RP   +LLKH FI
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  226 bits (577), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 118/271 (43%), Positives = 165/271 (60%), Gaps = 16/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-XXXXXXXXXXXXXXXXXXKYSN 110
           DP  +F  +E +G G++G+V+KG   +T ++ AIK++                      +
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
              +  YYG+++K      D +LW++MEY G GS  DL++      L E  IA I REIL
Sbjct: 64  SPYVTKYYGSYLK------DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREIL 114
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           +GL YLH  K IHRDIK  NVLL+++ EVKL DFGV+ QL  T  +RN F+GTP+WMAPE
Sbjct: 115 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 174
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           VI       + YD+++D+WSLGITA+E+A  +PP  +LHPM+ LFLIP+N PP L+   +
Sbjct: 175 VIK-----QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG-NY 228
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            K  + F+E  L K+   RP   +LLKH FI
Sbjct: 229 SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 111/271 (40%), Positives = 164/271 (60%), Gaps = 8/271 (2%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           +P   +E+I  +G+G +G+VYK ++ +T  LAA KV+                     +H
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI     AF        ++ LW+++E+C  G+V D V     + L E  I  +C++ L 
Sbjct: 94  PNIVKLLDAFYY------ENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLD 146
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L YLH+NK+IHRD+K  N+L T + ++KL DFGVSA+  RTI RR++FIGTPYWMAPEV
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 206
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKW 290
           + C+ + D  YD ++D+WSLGIT +EMAE +PP  +L+PMR L  I ++ PP L +  +W
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
              F+ F++  L K+   R  T QLL+HPF+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  221 bits (564), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 110/271 (40%), Positives = 163/271 (60%), Gaps = 8/271 (2%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           +P   +E+I  +G+G +G+VYK ++ +T  LAA KV+                     +H
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI     AF        ++ LW+++E+C  G+V D V     + L E  I  +C++ L 
Sbjct: 94  PNIVKLLDAFYY------ENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLD 146
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L YLH+NK+IHRD+K  N+L T + ++KL DFGVSA+  R I RR++FIGTPYWMAPEV
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEV 206
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKW 290
           + C+ + D  YD ++D+WSLGIT +EMAE +PP  +L+PMR L  I ++ PP L +  +W
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
              F+ F++  L K+   R  T QLL+HPF+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  221 bits (562), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 110/271 (40%), Positives = 162/271 (59%), Gaps = 8/271 (2%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           +P   +E+I  +G+G +G+VYK ++ +T  LAA KV+                     +H
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI     AF        ++ LW+++E+C  G+V D V     + L E  I  +C++ L 
Sbjct: 94  PNIVKLLDAFYY------ENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLD 146
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L YLH+NK+IHRD+K  N+L T + ++KL DFGVSA+  R I RR+ FIGTPYWMAPEV
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEV 206
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKW 290
           + C+ + D  YD ++D+WSLGIT +EMAE +PP  +L+PMR L  I ++ PP L +  +W
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
              F+ F++  L K+   R  T QLL+HPF+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  220 bits (560), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 168/281 (59%), Gaps = 8/281 (2%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP  ++E++  +G+G +G+VYK ++ +TG LAA KV+                     +H
Sbjct: 16  DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH 75
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             I    GA+        D +LW+++E+C  G+V D +     + L E  I  +CR++L 
Sbjct: 76  PYIVKLLGAYYH------DGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L +LH  ++IHRD+K  NVL+T   +++L DFGVSA+  +T+ +R++FIGTPYWMAPEV
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           + C+   D  YD ++D+WSLGIT +EMA+ +PP  +L+PMR L  I ++ PP L +  KW
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR 331
             +F+ F++  L K+   RP   QLL+HPF+    + +  R
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  220 bits (560), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 107/281 (38%), Positives = 168/281 (59%), Gaps = 8/281 (2%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP  ++E++  +G+G +G+VYK ++ +TG LAA KV+                     +H
Sbjct: 8   DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH 67
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             I    GA+        D +LW+++E+C  G+V D +     + L E  I  +CR++L 
Sbjct: 68  PYIVKLLGAYYH------DGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLE 120
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L +LH  ++IHRD+K  NVL+T   +++L DFGVSA+  +T+ +R++FIGTPYWMAPEV
Sbjct: 121 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 180
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           + C+   D  YD ++D+WSLGIT +EMA+ +PP  +L+PMR L  I ++ PP L +  KW
Sbjct: 181 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 240
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR 331
             +F+ F++  L K+   RP   QLL+HPF+    + +  R
Sbjct: 241 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 281

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 103/272 (37%), Positives = 147/272 (54%), Gaps = 15/272 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP   +   E +G G  G VY      TGQ  AI+ M                  + + +
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L+
Sbjct: 77  PNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+T +GTPYWMAPEV
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           +         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +K 
Sbjct: 188 VT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              F+ F+   L  D  +R    +LL+H F++
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 146/272 (53%), Gaps = 15/272 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP   +   E +G G  G VY      TGQ  AI+ M                  + + +
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L+
Sbjct: 77  PNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+  +GTPYWMAPEV
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV 187
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           +         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +K 
Sbjct: 188 VT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              F+ F+   L  D  +R    +LL+H F++
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 146/272 (53%), Gaps = 15/272 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP   +   E +G G  G VY      TGQ  AI+ M                  + + +
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L+
Sbjct: 77  PNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+  +GTPYWMAPEV
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEV 187
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           +         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +K 
Sbjct: 188 VT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              F+ F+   L  D  +R    +LL+H F++
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 147/272 (54%), Gaps = 15/272 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP   +   E +G G  G VY      TGQ  AI+ M                  + + +
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 77
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L+
Sbjct: 78  PNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L++LH N+VIHR+IK  N+LL  +  VKL DFG  AQ+     +R+T +GTPYWMAPEV
Sbjct: 129 ALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 188
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           +         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +K 
Sbjct: 189 VT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 243
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              F+ F+   L  D  +R    +L++H F++
Sbjct: 244 SAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  189 bits (479), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 146/272 (53%), Gaps = 15/272 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP   +   E +G G  G VY      TGQ  AI+ M                  + + +
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 77
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE L+
Sbjct: 78  PNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+  +GTPYWMAPEV
Sbjct: 129 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV 188
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           +         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +K 
Sbjct: 189 VT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 243
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              F+ F+   L  D  +R    +L++H F++
Sbjct: 244 SAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 106/282 (37%), Positives = 163/282 (57%), Gaps = 20/282 (7%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY 108
           +++DP  +F  +  +G+G++G VY  R  +  ++ AIK M                  ++
Sbjct: 48  FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107
Query: 109 SN---HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
                H N   Y G +++      +   WLVMEYC  GS +DL++  K + L+E  IA +
Sbjct: 108 LQKLRHPNTIQYRGCYLR------EHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAV 159
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
               L+GL YLH + +IHRD+K  N+LL++   VKL DFG ++     +   N F+GTPY
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANXFVGTPY 215
Query: 226 WMAPEVI-ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
           WMAPEVI A DE     YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N  P 
Sbjct: 216 WMAPEVILAMDE---GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 272
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-RDQP 325
           L+S  W + F++F+++ L K    RP ++ LLKH F+ R++P
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 106/282 (37%), Positives = 163/282 (57%), Gaps = 20/282 (7%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY 108
           +++DP  +F  +  +G+G++G VY  R  +  ++ AIK M                  ++
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 109 SN---HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
                H N   Y G ++++         WLVMEYC  GS +DL++  K + L+E  IA +
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTA------WLVMEYC-LGSASDLLEVHK-KPLQEVEIAAV 120
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
               L+GL YLH + +IHRD+K  N+LL++   VKL DFG ++     +   N F+GTPY
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANXFVGTPY 176
Query: 226 WMAPEVI-ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
           WMAPEVI A DE     YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N  P 
Sbjct: 177 WMAPEVILAMDE---GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-RDQP 325
           L+S  W + F++F+++ L K    RP ++ LLKH F+ R++P
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP    +    +G G+ G V       +G+L A+K M                  +   H
Sbjct: 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 207
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L+
Sbjct: 208 ENVVEMYNSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQ 258
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L  LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR   +GTPYWMAPE+
Sbjct: 259 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 318
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           I+        Y    D+WSLGI  +EM + +PP  +  P++A+ +I  N PPRLK+  K 
Sbjct: 319 IS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 373
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               + F++ +LV+D  QR    +LLKHPF+
Sbjct: 374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP    +    +G G+ G V       +G+L A+K M                  +   H
Sbjct: 71  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 130
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L+
Sbjct: 131 ENVVEMYNSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQ 181
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L  LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR   +GTPYWMAPE+
Sbjct: 182 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 241
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           I+        Y    D+WSLGI  +EM + +PP  +  P++A+ +I  N PPRLK+  K 
Sbjct: 242 IS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 296
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               + F++ +LV+D  QR    +LLKHPF+
Sbjct: 297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP    +    +G G+ G V       +G+L A+K M                  +   H
Sbjct: 26  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 85
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L+
Sbjct: 86  ENVVEMYNSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQ 136
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L  LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR   +GTPYWMAPE+
Sbjct: 137 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 196
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           I+        Y    D+WSLGI  +EM + +PP  +  P++A+ +I  N PPRLK+  K 
Sbjct: 197 IS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 251
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               + F++ +LV+D  QR    +LLKHPF+
Sbjct: 252 SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP    +    +G G+ G V       +G+L A+K M                  +   H
Sbjct: 28  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 87
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L+
Sbjct: 88  ENVVEMYNSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQ 138
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L  LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR   +GTPYWMAPE+
Sbjct: 139 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 198
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           I+        Y    D+WSLGI  +EM + +PP  +  P++A+ +I  N PPRLK+  K 
Sbjct: 199 IS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 253
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               + F++ +LV+D  QR    +LLKHPF+
Sbjct: 254 SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP    +    +G G+ G V       +G+L A+K M                  +   H
Sbjct: 17  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L+
Sbjct: 77  ENVVEMYNSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQ 127
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L  LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR   +GTPYWMAPE+
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 187
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           I+        Y    D+WSLGI  +EM + +PP  +  P++A+ +I  N PPRLK+  K 
Sbjct: 188 IS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 242
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               + F++ +LV+D  QR    +LLKHPF+
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP    +    +G G+ G V       +G+L A+K M                  +   H
Sbjct: 21  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 80
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+   Y +++        D+LW+VME+   G++TD+V  T+   + EE IA +C  +L+
Sbjct: 81  ENVVEMYNSYLV------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQ 131
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L  LH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + RR   +GTPYWMAPE+
Sbjct: 132 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 191
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKW 290
           I+        Y    D+WSLGI  +EM + +PP  +  P++A+ +I  N PPRLK+  K 
Sbjct: 192 IS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 246
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
               + F++ +LV+D  QR    +LLKHPF+
Sbjct: 247 SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  175 bits (444), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 146/273 (53%), Gaps = 15/273 (5%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q DP  + +    +G G+ G V   R   +G+  A+K+M                  +  
Sbjct: 40  QGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H N+   Y +++        ++LW++ME+   G++TD+V   +   L EE IA +C  +
Sbjct: 100 QHFNVVEMYKSYLV------GEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAV 150
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+ L YLH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + +R   +GTPYWMAP
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAP 210
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SK 288
           EVI+      + Y    D+WSLGI  +EM + +PP     P++A+  +  + PP+LK S 
Sbjct: 211 EVIS-----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSH 265
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           K     + F+E +LV+D  +R    +LL HPF+
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 141/261 (54%), Gaps = 15/261 (5%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G G+ G V       TG+  A+K M                  +  +H N+   Y +++
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVI 182
                   D+LW+VME+   G++TD+V  T+   + EE IA +C  +LR L YLH   VI
Sbjct: 113 V------GDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVI 163
Query: 183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATY 242
           HRDIK  ++LLT +  +KL DFG  AQ+ + + +R   +GTPYWMAPEVI+        Y
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS-----RLPY 218
Query: 243 DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKWPKKFQSFIETV 301
               D+WSLGI  +EM + +PP  +  P++A+  I  + PPR+K   K     + F++ +
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLM 278
Query: 302 LVKDYHQRPYTDQLLKHPFIR 322
           LV++  QR    +LL HPF++
Sbjct: 279 LVREPSQRATAQELLGHPFLK 299

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/286 (37%), Positives = 147/286 (51%), Gaps = 30/286 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIA 115
           +EL EV+G+G    V         +  AIK +                      +H NI 
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST------KGQSLKEEWIAFICREI 169
           +YY +F+ K      D+LWLVM+    GSV D++K        K   L E  IA I RE+
Sbjct: 77  SYYTSFVVK------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGR-RNTFIGTP 224
           L GL+YLH+N  IHRD+K  N+LL ++  V++ DFGVSA L    D T  + R TF+GTP
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
            WMAPEV+         YD ++D+WS GITA+E+A    P     PM+ L L  +N PP 
Sbjct: 191 CWMAPEVMEQVRG----YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 285 LKS--------KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           L++        KK+ K F+  I   L KD  +RP   +LL+H F +
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/286 (37%), Positives = 147/286 (51%), Gaps = 30/286 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIA 115
           +EL EV+G+G    V         +  AIK +                      +H NI 
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST------KGQSLKEEWIAFICREI 169
           +YY +F+ K      D+LWLVM+    GSV D++K        K   L E  IA I RE+
Sbjct: 72  SYYTSFVVK------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGR-RNTFIGTP 224
           L GL+YLH+N  IHRD+K  N+LL ++  V++ DFGVSA L    D T  + R TF+GTP
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
            WMAPEV+         YD ++D+WS GITA+E+A    P     PM+ L L  +N PP 
Sbjct: 186 CWMAPEVMEQVRG----YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 241
Query: 285 LKS--------KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           L++        KK+ K F+  I   L KD  +RP   +LL+H F +
Sbjct: 242 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 140/277 (50%), Gaps = 14/277 (5%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAF 121
           V+G GTYG VY GR        AIK +                  K+  H+NI  Y G+F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK--EEWIAFICREILRGLKYLHEN 179
                  ++  + + ME    GS++ L++S  G  LK  E+ I F  ++IL GLKYLH+N
Sbjct: 89  ------SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 180 KVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
           +++HRDIKG NVL+ T +  +K+ DFG S +L        TF GT  +MAPE+I  D+ P
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII--DKGP 199
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRLKSKKWPKKFQSF 297
              Y   +D+WSLG T +EMA  +PP  +L  P  A+F +          +    + ++F
Sbjct: 200 RG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQL 334
           I      D  +R   + LL   F++    +++ + +L
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAF 121
           V+G GTYG VY GR        AIK +                  K+  H+NI  Y G+F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK--EEWIAFICREILRGLKYLHEN 179
                  ++  + + ME    GS++ L++S  G  LK  E+ I F  ++IL GLKYLH+N
Sbjct: 75  ------SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 180 KVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
           +++HRDIKG NVL+ T +  +K+ DFG S +L        TF GT  +MAPE+I  D+ P
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII--DKGP 185
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRLKSKKWPKKFQSF 297
              Y   +D+WSLG T +EMA  +PP  +L  P  A+F +          +    + ++F
Sbjct: 186 RG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIR 322
           I      D  +R   + LL   F++
Sbjct: 245 ILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 138/277 (49%), Gaps = 21/277 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 87  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 138
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 139 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 195
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF----LIPRNAPPRLKSKKW 290
                  Y  +SD+WS+G++ +EMA  + P+       A+F     I    PP+L S  +
Sbjct: 196 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVF 251
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
             +FQ F+   L+K+  +R    QL+ H FI+    E
Sbjct: 252 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 288

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 140/283 (49%), Gaps = 27/283 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 68  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 119
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 176
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLC------DLHPMRALF----LIPRNAPPR 284
                  Y  +SD+WS+G++ +EMA  + P+       D  P  A+F     I    PP+
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPK 232
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
           L S  +  +FQ F+   L+K+  +R    QL+ H FI+    E
Sbjct: 233 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 275

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 17/273 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 71  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 122
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL   +   N F+GT  +M+PE +  
Sbjct: 123 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA--NEFVGTRSYMSPERLQ- 179
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
                  Y  +SD+WS+G++ +EMA  + P   +     L  I    PP+L S  +  +F
Sbjct: 180 ----GTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEF 235
Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
           Q F+   L+K+  +R    QL+ H FI+    E
Sbjct: 236 QDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 268

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 136/289 (47%), Gaps = 24/289 (8%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXX- 103
           PE  W      + +L E+ G G YG V K  H  +GQ+ A+K +                
Sbjct: 13  PEQHWDFTAEDLKDLGEI-GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 104 -XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAG--SVTDLVKSTKGQSLKEE 160
               + S+   I  +YGA  ++         W+ ME            V S     + EE
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREG------DCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 161 WIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
            +  I    ++ L +L EN K+IHRDIK  N+LL  +  +KL DFG+S QL  +I +   
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD 185
Query: 220 FIGTPYWMAPEVIACDENPDAT---YDNRSDLWSLGITALEMAESQPPLCDLHPM-RALF 275
               PY MAPE I    +P A+   YD RSD+WSLGIT  E+A  + P    + +   L 
Sbjct: 186 AGCRPY-MAPERI----DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240
Query: 276 LIPRNAPPRLKS---KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            + +  PP+L +   +++   F +F+   L KD  +RP   +LLKHPFI
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 141/285 (49%), Gaps = 25/285 (8%)
Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXK 107
           R+Q +   +  L E+ G+GT GQV+K R  KTG + A+K M                   
Sbjct: 19  RYQAEINDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 108 YSNHRN--IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
             +H    I   +G FI  +       +++ ME    G+  + +K      + E  +  +
Sbjct: 78  LKSHDCPYIVQCFGTFITNT------DVFIAMEL--MGTCAEKLKKRMQGPIPERILGKM 129
Query: 166 CREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIG 222
              I++ L YL E + VIHRD+K  N+LL +  ++KL DFG+S +L  D+   R     G
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AG 186
Query: 223 TPYWMAPEVIACDENPDAT---YDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIP 278
              +MAPE I   + PD T   YD R+D+WSLGI+ +E+A  Q P  +       L  + 
Sbjct: 187 CAAYMAPERI---DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243
Query: 279 RNAPPRLKSK-KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +  PP L     +   FQSF++  L KD+ +RP  ++LL+H FI+
Sbjct: 244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 132/266 (49%), Gaps = 18/266 (6%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN--HRNIATY 117
           ++ +G G++G+    + T+ G+   IK +                    +N  H NI  Y
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
             +F       ++  L++VM+YC  G +   + + KG   +E+ I     +I   LK++H
Sbjct: 89  RESF------EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           + K++HRDIK QN+ LT +  V+L DFG++  L+ T+      IGTPY+++PE+  C+  
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI--CENK 200
Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL--IPRNAPPRLKSKKWPKKFQ 295
           P   Y+N+SD+W+LG    E+   +    +   M+ L L  I  + PP   S  +    +
Sbjct: 201 P---YNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPP--VSLHYSYDLR 254
Query: 296 SFIETVLVKDYHQRPYTDQLLKHPFI 321
           S +  +  ++   RP  + +L+  FI
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFI 280

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 59/315 (18%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 130 GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 181
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 182 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 238
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL----------------------------- 265
                  Y  +SD+WS+G++ +EMA  + P+                             
Sbjct: 239 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 294
Query: 266 ---------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
                     D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R   
Sbjct: 295 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADL 354
Query: 313 DQLLKHPFIRDQPTE 327
            QL+ H FI+    E
Sbjct: 355 KQLMVHAFIKRSDAE 369

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 59/315 (18%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 95  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 146
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 203
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL----------------------------- 265
                  Y  +SD+WS+G++ +EMA  + P+                             
Sbjct: 204 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259
Query: 266 ---------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
                     D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R   
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319
Query: 313 DQLLKHPFIRDQPTE 327
            QL+ H FI+    E
Sbjct: 320 KQLMVHAFIKRSDAE 334

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 59/315 (18%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 68  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 119
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 176
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL----------------------------- 265
                  Y  +SD+WS+G++ +EMA  + P+                             
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 266 ---------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
                     D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 313 DQLLKHPFIRDQPTE 327
            QL+ H FI+    E
Sbjct: 293 KQLMVHAFIKRSDAE 307

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 59/315 (18%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 68  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 119
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 176
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL----------------------------- 265
                  Y  +SD+WS+G++ +EMA  + P+                             
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 266 ---------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
                     D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 313 DQLLKHPFIRDQPTE 327
            QL+ H FI+    E
Sbjct: 293 KQLMVHAFIKRSDAE 307

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 59/315 (18%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 68  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 119
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 176
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL----------------------------- 265
                  Y  +SD+WS+G++ +EMA  + P+                             
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 266 ---------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
                     D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 313 DQLLKHPFIRDQPTE 327
            QL+ H FI+    E
Sbjct: 293 KQLMVHAFIKRSDAE 307

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 140/315 (44%), Gaps = 59/315 (18%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V+K  H  +G + A K++                   +  N   I 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL Y
Sbjct: 68  GFYGAFYS------DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 119
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E +K++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +M+PE +  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ- 176
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL----------------------------- 265
                  Y  +SD+WS+G++ +EMA  + P+                             
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 266 ---------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
                     D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 313 DQLLKHPFIRDQPTE 327
            QL+ H FI+    E
Sbjct: 293 KQLMVHAFIKRSDAE 307

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 129/271 (47%), Gaps = 15/271 (5%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXX--XXKYSNHRNI 114
            E I  +G G YG V K RH  +GQ+ A+K +                    +  +    
Sbjct: 53  LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 112
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRG 172
            T+YGA  ++        +W+ ME     S+    K    KGQ++ E+ +  I   I++ 
Sbjct: 113 VTFYGALFREG------DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165
Query: 173 LKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           L++LH    VIHRD+K  NVL+    +VK+ DFG+S  L  ++ +       PY MAPE 
Sbjct: 166 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPY-MAPER 224
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRLKSKKW 290
           I  + N    Y  +SD+WSLGIT +E+A  + P      P + L  +     P+L + K+
Sbjct: 225 INPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 283
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             +F  F    L K+  +RP   +L++HPF 
Sbjct: 284 SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 25/277 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMX--XXXXXXXXXXXXXXXXXKYSNHRNI 114
           +E++  +G G+YG+  K R    G++   K +                    +   H NI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG----QSLKEEWIAFICREIL 170
             YY   I ++    +  L++VMEYC  G +  ++  TKG    Q L EE++  +  ++ 
Sbjct: 68  VRYYDRIIDRT----NTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLT 121
Query: 171 RGLKYLHE-----NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
             LK  H      + V+HRD+K  NV L     VKL DFG++  L+       TF+GTPY
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           +M+PE     +    +Y+ +SD+WSLG    E+    PP       + L    R    R 
Sbjct: 182 YMSPE-----QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFRR 235
Query: 286 KSKKWPKKFQSFIETVL-VKDYHQRPYTDQLLKHPFI 321
              ++  +    I  +L +KDYH RP  +++L++P I
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYH-RPSVEEILENPLI 271

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 129/271 (47%), Gaps = 15/271 (5%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXX--XXKYSNHRNI 114
            E I  +G G YG V K RH  +GQ+ A+K +                    +  +    
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRG 172
            T+YGA  ++        +W+ ME     S+    K    KGQ++ E+ +  I   I++ 
Sbjct: 69  VTFYGALFREG------DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 173 LKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           L++LH    VIHRD+K  NVL+    +VK+ DFG+S  L   +  ++   G   +MAPE 
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPER 180
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRLKSKKW 290
           I  + N    Y  +SD+WSLGIT +E+A  + P      P + L  +     P+L + K+
Sbjct: 181 INPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             +F  F    L K+  +RP   +L++HPF 
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 86/319 (26%), Positives = 137/319 (42%), Gaps = 63/319 (19%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIA 115
           FE I  +G G  G V K +H  +G + A K++                   +  N   I 
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YGAF        D ++ + ME+   GS+  ++K  K   + EE +  +   +LRGL Y
Sbjct: 78  GFYGAFYS------DGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAY 129
Query: 176 LHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           L E ++++HRD+K  N+L+    E+KL DFGVS QL  ++   N+F+GT  +MAPE +  
Sbjct: 130 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMAPERLQ- 186
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL----------------------------- 265
                  Y  +SD+WS+G++ +E+A  + P+                             
Sbjct: 187 ----GTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 242
Query: 266 -------------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQ 308
                         D  P  A+F     I    PP+L +  +   FQ F+   L+K+  +
Sbjct: 243 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 302
Query: 309 RPYTDQLLKHPFIRDQPTE 327
           R     L  H FI+    E
Sbjct: 303 RADLKMLTNHTFIKRSEVE 321

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 25/277 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMX--XXXXXXXXXXXXXXXXXKYSNHRNI 114
           +E++  +G G+YG+  K R    G++   K +                    +   H NI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG----QSLKEEWIAFICREIL 170
             YY   I ++    +  L++VMEYC  G +  ++  TKG    Q L EE++  +  ++ 
Sbjct: 68  VRYYDRIIDRT----NTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLT 121
Query: 171 RGLKYLHE-----NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
             LK  H      + V+HRD+K  NV L     VKL DFG++  L+        F+GTPY
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY 181
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           +M+PE     +    +Y+ +SD+WSLG    E+    PP       + L    R    R 
Sbjct: 182 YMSPE-----QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFRR 235
Query: 286 KSKKWPKKFQSFIETVL-VKDYHQRPYTDQLLKHPFI 321
              ++  +    I  +L +KDYH RP  +++L++P I
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYH-RPSVEEILENPLI 271

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 25/277 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMX--XXXXXXXXXXXXXXXXXKYSNHRNI 114
           +E++  +G G+YG+  K R    G++   K +                    +   H NI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG----QSLKEEWIAFICREIL 170
             YY   I ++    +  L++VMEYC  G +  ++  TKG    Q L EE++  +  ++ 
Sbjct: 68  VRYYDRIIDRT----NTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLT 121
Query: 171 RGLKYLHE-----NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
             LK  H      + V+HRD+K  NV L     VKL DFG++  L+        F+GTPY
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY 181
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           +M+PE     +    +Y+ +SD+WSLG    E+    PP       + L    R    R 
Sbjct: 182 YMSPE-----QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFRR 235
Query: 286 KSKKWPKKFQSFIETVL-VKDYHQRPYTDQLLKHPFI 321
              ++  +    I  +L +KDYH RP  +++L++P I
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYH-RPSVEEILENPLI 271

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 127/271 (46%), Gaps = 15/271 (5%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXX--XXKYSNHRNI 114
            E I  +G G YG V K RH  +GQ+ A+K +                    +  +    
Sbjct: 36  LEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFT 95
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRG 172
            T+YGA  ++        +W+  E     S+    K    KGQ++ E+ +  I   I++ 
Sbjct: 96  VTFYGALFREG------DVWICXELXDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 148
Query: 173 LKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           L++LH    VIHRD+K  NVL+    +VK  DFG+S  L   +  ++   G   + APE 
Sbjct: 149 LEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA-KDIDAGCKPYXAPER 207
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRLKSKKW 290
           I  + N    Y  +SD+WSLGIT +E+A  + P      P + L  +     P+L + K+
Sbjct: 208 INPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 266
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             +F  F    L K+  +RP   +L +HPF 
Sbjct: 267 SAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 133/285 (46%), Gaps = 26/285 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+ IE++G+G +GQV+K +H   G+   IK +                     +H NI  
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL----DHVNIVH 68
Query: 117 YYGAF----------IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           Y G +           K S   K   L++ ME+C  G++   ++  +G+ L +     + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            +I +G+ Y+H  K+I+RD+K  N+ L D  +VK+ DFG+   L +  G+R    GT  +
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRXRSKGTLRY 187
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           M+PE I+  +     Y    DL++LG+   E+      +CD     + F    +    + 
Sbjct: 188 MSPEQISSQD-----YGKEVDLYALGLILAELLH----VCDTAFETSKFFT--DLRDGII 236
Query: 287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR 331
           S  + KK ++ ++ +L K    RP T ++L+   +  +  E+  R
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTG---QLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRN 113
           F + + +G G + +VY+      G    L  +++                   K  NH N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL----KEEWIAFICREI 169
           +  YY +FI+      D++L +V+E   AG ++ ++K  K Q      +  W  F+  ++
Sbjct: 94  VIKYYASFIE------DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QL 145
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
              L+++H  +V+HRDIK  NV +T    VKL D G+           ++ +GTPY+M+P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           E I   EN    Y+ +SD+WSLG    EMA  Q P 
Sbjct: 206 ERI--HEN---GYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 133/298 (44%), Gaps = 39/298 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+ IE++G+G +GQV+K +H   G+   I+ +                     +H NI  
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKL----DHVNIVH 69
Query: 117 YYGAF-----------------------IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK 153
           Y G +                        K S   K   L++ ME+C  G++   ++  +
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 154 GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT 213
           G+ L +     +  +I +G+ Y+H  K+IHRD+K  N+ L D  +VK+ DFG+   L + 
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL-KN 188
Query: 214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA 273
            G+R    GT  +M+PE I+  +     Y    DL++LG+   E+      +CD     +
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQD-----YGKEVDLYALGLILAELLH----VCDTAFETS 239
Query: 274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR 331
            F    +    + S  + KK ++ ++ +L K    RP T ++L+   +  +  E+  R
Sbjct: 240 KFFT--DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 295

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           EV+G G +GQ  K  H +TG++  +K +                  +   H N+  + G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
             K      D +L  + EY   G++  ++KS   Q    + ++F  ++I  G+ YLH   
Sbjct: 76  LYK------DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMAYLHSMN 128
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----------------DRTIGRRNTFIGTP 224
           +IHRD+   N L+ +N  V + DFG++  +                DR   +R T +G P
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK--KRYTVVGNP 186
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           YWMAPE+I        +YD + D++S GI   E+
Sbjct: 187 YWMAPEMIN-----GRSYDEKVDVFSFGIVLCEI 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRN 113
           A  FE I V+G G +GQV K R+    +  AIK +                     NH+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 114 IATYYGAFIKK-------SPPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFI 165
           +  YY A++++       +   K   L++ MEYC  G++ DL+ S    Q   E W  F 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF- 122
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI----------- 214
            R+IL  L Y+H   +IHRD+K  N+ + ++  VK+ DFG++  + R++           
Sbjct: 123 -RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 215 GRRNTF---IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           G  +     IGT  ++A EV+    +    Y+ + D++SLGI   EM
Sbjct: 182 GSSDNLTSAIGTAMYVATEVL----DGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 24/287 (8%)
Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX--XXXXXXKYSNHRN 113
           +++ ++ +G+G YG+V   R   T    AIK++                    K  +H N
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y  F  K         +LVME    G + D +         E   A I +++L G+
Sbjct: 98  IMKLYDFFEDKR------NYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGV 149
Query: 174 KYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            YLH++ ++HRD+K +N+LL     +A +K+VDFG+SA  +    +    +GT Y++APE
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPE 208
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+         YD + D+WS+G+    +    PP         L  + +       S +W
Sbjct: 209 VLR------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK-GKYTFDSPEW 261
Query: 291 ---PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQL 334
               +  +  I+ +L  D  +R    Q L+HP+I++  +++++ I+L
Sbjct: 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIEL 308

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 52  DPAGI--FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXX----XXXXXXXX 105
           DP G+  F+L+ V+G G+Y +V   R  KT ++ A+KV+                     
Sbjct: 4   DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
            + SNH  +   +  F  +S      +L+ V+EY   G +  +    + + L EE   F 
Sbjct: 64  EQASNHPFLVGLHSCFQTES------RLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFY 115
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
             EI   L YLHE  +I+RD+K  NVLL     +KL D+G+  +  R     + F GTP 
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPN 175
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           ++APE++  ++     Y    D W+LG+   EM   + P 
Sbjct: 176 YIAPEILRGED-----YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 117/274 (42%), Gaps = 23/274 (8%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX---------XXXXXXXXXXKYSNH 111
           +V+G G    V +  H  TG   A+K+M                           + + H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I T   ++   S       ++LV +    G + D +  T+  +L E+    I R +L 
Sbjct: 160 PHIITLIDSYESSS------FMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLE 211
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            + +LH N ++HRD+K +N+LL DN +++L DFG S  L+     R    GTP ++APE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCGTPGYLAPEI 270
Query: 232 IACD-ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           + C  +     Y    DLW+ G+    +    PP      +  L +I      +  S +W
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI-MEGQYQFSSPEW 329
Query: 291 PKK---FQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             +    +  I  +L  D   R   +Q L+HPF 
Sbjct: 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX---XXXXXXKYSNHRN 113
           +++++V+G G +G+V   RH  + ++ A+K++                      ++N   
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 136
Query: 114 IATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +   + AF       +DD+ L++VMEY   G   DLV       + E+W  F   E++  
Sbjct: 137 VVQLFCAF-------QDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWAKFYTAEVVLA 186
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEV 231
           L  +H   +IHRD+K  N+LL  +  +KL DFG   ++D T +   +T +GTP +++PEV
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +   +  D  Y    D WS+G+   EM     P 
Sbjct: 247 LKS-QGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX---XXXXXKYSNHRNIATYY 118
           V+G G++G+V   +   TGQ  A+KV+                     K  +H NI   Y
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
             F  K         +LV E    G + D + S K     E   A I R++L G+ Y+H+
Sbjct: 93  EFFEDKG------YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK 144
Query: 179 NKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           NK++HRD+K +N+LL   + +A ++++DFG+S   + +   ++  IGT Y++APEV+   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVLH-- 201
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
                TYD + D+WS G+    +    PP 
Sbjct: 202 ----GTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX---XXXXXKYSNHRNIATYY 118
           V+G G++G+V   +   TGQ  A+KV+                     K  +H NI   Y
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
             F  K         +LV E    G + D + S K     E   A I R++L G+ Y+H+
Sbjct: 99  EFFEDKG------YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK 150
Query: 179 NKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           NK++HRD+K +N+LL   + +A ++++DFG+S   + +   ++  IGT Y++APEV+   
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVL--- 206
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
                TYD + D+WS G+    +    PP 
Sbjct: 207 ---HGTYDEKCDVWSTGVILYILLSGCPPF 233

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX---XXXXXXKYSNHRN 113
           +E+++V+G G +G+V   RH  T ++ A+K++                      ++N   
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 114 IATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +   + AF       +DD+ L++VMEY   G   DLV       + E+W  F   E++  
Sbjct: 131 VVQLFYAF-------QDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLA 180
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEV 231
           L  +H    IHRD+K  N+LL  +  +KL DFG   ++++  + R +T +GTP +++PEV
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +   +  D  Y    D WS+G+   EM     P 
Sbjct: 241 LKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX---XXXXXXKYSNHRN 113
           +E+++V+G G +G+V   RH  T ++ A+K++                      ++N   
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 114 IATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +   + AF       +DD+ L++VMEY   G   DLV       + E+W  F   E++  
Sbjct: 136 VVQLFYAF-------QDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLA 185
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEV 231
           L  +H    IHRD+K  N+LL  +  +KL DFG   ++++  + R +T +GTP +++PEV
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +   +  D  Y    D WS+G+   EM     P 
Sbjct: 246 LKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX---XXXXXKYSNHRNIATYY 118
           V+G G++G+V   +   TGQ  A+KV+                     K  +H NI   Y
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
             F  K         +LV E    G + D + S K     E   A I R++L G+ Y+H+
Sbjct: 116 EFFEDKG------YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK 167
Query: 179 NKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           NK++HRD+K +N+LL   + +A ++++DFG+S   + +   ++  IGT Y++APEV+   
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVL--- 223
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
                TYD + D+WS G+    +    PP 
Sbjct: 224 ---HGTYDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX---XXXXXKYSNHRNIATYY 118
           V+G G++G+V   +   TGQ  A+KV+                     K  +H NI   Y
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
             F  K         +LV E    G + D + S K     E   A I R++L G+ Y+H+
Sbjct: 117 EFFEDKG------YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK 168
Query: 179 NKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           NK++HRD+K +N+LL   + +A ++++DFG+S   + +   ++  IGT Y++APEV+   
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVL--- 224
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
                TYD + D+WS G+    +    PP 
Sbjct: 225 ---HGTYDEKCDVWSTGVILYILLSGCPPF 251

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX---XXXXXXKYSNHRN 113
           +E+++V+G G +G+V   RH  T ++ A+K++                      ++N   
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 114 IATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +   + AF       +DD+ L++VMEY   G   DLV       + E+W  F   E++  
Sbjct: 136 VVQLFYAF-------QDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLA 185
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEV 231
           L  +H    IHRD+K  N+LL  +  +KL DFG   ++++  + R +T +GTP +++PEV
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +   +  D  Y    D WS+G+   EM     P 
Sbjct: 246 LKS-QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXX----XXXXXXXXXKYSNHR 112
           F+L+ V+G G+Y +V   R  KT ++ A++V+                      + SNH 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F  +S      +L+ V+EY   G +  +    + + L EE   F   EI   
Sbjct: 114 FLVGLHSCFQTES------RLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA 165
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L YLHE  +I+RD+K  NVLL     +KL D+G+  +  R     +TF GTP ++APE++
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
             ++     Y    D W+LG+   EM   + P 
Sbjct: 226 RGED-----YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX---XXXXXKYSNHRNIATYY 118
           V+G G++G+V   +   TGQ  A+KV+                     K  +H NI   Y
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
             F  K         +LV E    G + D + S K     E   A I R++L G+ Y H+
Sbjct: 93  EFFEDKG------YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYXHK 144
Query: 179 NKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           NK++HRD+K +N+LL   + +A ++++DFG+S   + +   ++  IGT Y++APEV+   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK-IGTAYYIAPEVLH-- 201
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
                TYD + D+WS G+    +    PP 
Sbjct: 202 ----GTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 22/271 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F  +EV+G+G + +V+  +   TG+L A+K +                  K   H NI T
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
               +   +        +LVM+    G + D +      + K+   + + +++L  +KYL
Sbjct: 71  LEDIYESTT------HYYLVMQLVSGGELFDRILERGVYTEKDA--SLVIQQVLSAVKYL 122
Query: 177 HENKVIHRDIKGQNVL-LT--DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           HEN ++HRD+K +N+L LT  +N+++ + DFG+S       G  +T  GTP ++APEV+A
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLA 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
             + P   Y    D WS+G+    +    PP  +      LF   +      +S  W   
Sbjct: 181 --QKP---YSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDI 234
Query: 294 FQS---FIETVLVKDYHQRPYTDQLLKHPFI 321
            +S   FI  +L KD ++R   ++ L HP+I
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXX----XXXXXXXXXKYSNHR 112
           F+L+ V+G G+Y +V   R  KT ++ A+KV+                      + SNH 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F  +S      +L+ V+EY   G +  +    + + L EE   F   EI   
Sbjct: 67  FLVGLHSCFQTES------RLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA 118
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L YLHE  +I+RD+K  NVLL     +KL D+G+  +  R     + F GTP ++APE++
Sbjct: 119 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
             ++     Y    D W+LG+   EM   + P 
Sbjct: 179 RGED-----YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRN 113
           A  FE I V+G G +GQV K R+    +  AIK +                     NH+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 114 IATYYGAFIKK-------SPPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFI 165
           +  YY A++++       +   K   L++ MEYC   ++ DL+ S    Q   E W  F 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF- 122
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI----------- 214
            R+IL  L Y+H   +IHRD+K  N+ + ++  VK+ DFG++  + R++           
Sbjct: 123 -RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 215 GRRNTF---IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           G  +     IGT  ++A EV+    +    Y+ + D++SLGI   EM
Sbjct: 182 GSSDNLTSAIGTAMYVATEVL----DGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 96  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 146
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 204
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 205 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 255
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 256 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXX----XXXXXXXXXKYSNHR 112
           F+L+ V+G G+Y +V   R  KT ++ A+KV+                      + SNH 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F  +S      +L+ V+EY   G +  +    + + L EE   F   EI   
Sbjct: 82  FLVGLHSCFQTES------RLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA 133
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L YLHE  +I+RD+K  NVLL     +KL D+G+  +  R     + F GTP ++APE++
Sbjct: 134 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 193
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
             ++     Y    D W+LG+   EM   + P 
Sbjct: 194 RGED-----YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 109/253 (43%), Gaps = 29/253 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F+ ++++G GT+G+V   R   TG+  A+K++                  +    + H  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L
Sbjct: 70  LTALKYAF------QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 121
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   V++RDIK +N++L  +  +K+ DFG+  +         TF GTP ++APEV+ 
Sbjct: 122 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 181
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLK 286
                D  Y    D W LG+   EM   + P  +    R   LI       PR   P  K
Sbjct: 182 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 236
Query: 287 S------KKWPKK 293
           S      KK PK+
Sbjct: 237 SLLAGLLKKDPKQ 249

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 109/253 (43%), Gaps = 29/253 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F+ ++++G GT+G+V   R   TG+  A+K++                  +    + H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L
Sbjct: 67  LTALKYAF------QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   V++RDIK +N++L  +  +K+ DFG+  +         TF GTP ++APEV+ 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLK 286
                D  Y    D W LG+   EM   + P  +    R   LI       PR   P  K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 287 S------KKWPKK 293
           S      KK PK+
Sbjct: 234 SLLAGLLKKDPKQ 246

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN----HR 112
           FEL +++G G++G+V+     KT Q  AIK +                  +  +    H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F  K      + L+ VMEY   G +   ++S     L      F   EI+ G
Sbjct: 80  FLTHMFCTFQTK------ENLFFVMEYLNGGDLMYHIQSCHKFDLSRA--TFYAAEIILG 131
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L++LH   +++RD+K  N+LL  +  +K+ DFG+  +      + N F GTP ++APE++
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
              +     Y++  D WS G+   EM   Q P 
Sbjct: 192 LGQK-----YNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 87  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 137
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 138 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 195
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 196 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 246
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 247 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXX--XXXXXXXXXXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  AIK++                    K  NH 
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+L+MEY   G V D + +      KE    F  R+I+  
Sbjct: 72  NIVKLFEVI------ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF--RQIVSA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           ++Y H+ +++HRD+K +N+LL  +  +K+ DFG S +     G+ +TF G+P + APE+ 
Sbjct: 124 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDTFCGSPPYAAPELF 182
Query: 233 ACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
              +     YD    D+WSLG+    +     P 
Sbjct: 183 QGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 109/253 (43%), Gaps = 29/253 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F+ ++++G GT+G+V   R   TG+  A+K++                  +    + H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L
Sbjct: 67  LTALKYAF------QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   V++RDIK +N++L  +  +K+ DFG+  +         TF GTP ++APEV+ 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLK 286
                D  Y    D W LG+   EM   + P  +    R   LI       PR   P  K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 287 S------KKWPKK 293
           S      KK PK+
Sbjct: 234 SLLAGLLKKDPKQ 246

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 71  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 121
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR+T  GT  ++ PE+I
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMI 179
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 180 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 230
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 231 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 27/217 (12%)
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 76  HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 127
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+ T  GTP ++APE
Sbjct: 128 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE 187
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V++        +    D+WS+G     +   +PP  +   ++  +L       R+K  ++
Sbjct: 188 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL-------RIKKNEY 234
Query: 291 --PKKFQ----SFIETVLVKDYHQRPYTDQLLKHPFI 321
             PK       S I+ +L  D   RP  ++LL   F 
Sbjct: 235 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 271

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 75  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 183
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 184 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 234
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 235 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 27/217 (12%)
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 80  HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 131
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+ T  GTP ++APE
Sbjct: 132 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE 191
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V++        +    D+WS+G     +   +PP  +   ++  +L       R+K  ++
Sbjct: 192 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL-------RIKKNEY 238
Query: 291 --PKKFQ----SFIETVLVKDYHQRPYTDQLLKHPFI 321
             PK       S I+ +L  D   RP  ++LL   F 
Sbjct: 239 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 275

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 27/217 (12%)
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 76  HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 127
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+ T  GTP ++APE
Sbjct: 128 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE 187
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V++        +    D+WS+G     +   +PP  +   ++  +L       R+K  ++
Sbjct: 188 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL-------RIKKNEY 234
Query: 291 --PKKFQ----SFIETVLVKDYHQRPYTDQLLKHPFI 321
             PK       S I+ +L  D   RP  ++LL   F 
Sbjct: 235 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 271

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 73  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 181
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 182 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 232
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 233 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           F++   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   YG F   +      +++L++EY   G+V   ++  K     E+  A    E+   L
Sbjct: 74  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQ--KLSRFDEQRTATYITELANAL 125
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            Y H  +VIHRDIK +N+LL  N E+K+ DFG S     +  RR+T  GT  ++ PE+I 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMIE 183
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                   +D + DLWSLG+   E     PP 
Sbjct: 184 -----GRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 29/291 (9%)
Query: 35  LEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXX 94
           L +R  ++ W      E P G   + + +G+G++G VYKG+      +  + V       
Sbjct: 14  LGRRDSSDDW------EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 67
Query: 95  XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--ST 152
                       K + H NI  + G   K        QL +V ++C   S+   +    T
Sbjct: 68  LQAFKNEVGVLRK-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIET 119
Query: 153 KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR 212
           K + +K   +  I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++ +  R
Sbjct: 120 KFEMIK---LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 176
Query: 213 TIGRRN--TFIGTPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
             G        G+  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++
Sbjct: 177 WSGSHQFEQLSGSILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNIN 233
Query: 270 PM-RALFLIPRN--APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
              + +F++ R   +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 234 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 284

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 29/291 (9%)
Query: 35  LEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXX 94
           L +R  ++ W      E P G   + + +G+G++G VYKG+      +  + V       
Sbjct: 22  LGRRDSSDDW------EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 75
Query: 95  XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--ST 152
                       K + H NI  + G   K        QL +V ++C   S+   +    T
Sbjct: 76  LQAFKNEVGVLRK-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIET 127
Query: 153 KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR 212
           K + +K   +  I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++ +  R
Sbjct: 128 KFEMIK---LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSR 184
Query: 213 TIGRRN--TFIGTPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
             G        G+  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++
Sbjct: 185 WSGSHQFEQLSGSILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNIN 241
Query: 270 PM-RALFLIPRN--APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
              + +F++ R   +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 242 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 69  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 119
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 120 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 177
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 178 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 228
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 229 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 126/279 (45%), Gaps = 17/279 (6%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           E++G G +GQV+K   T TG   A K++                     +H N+   Y A
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F  K      + + LVMEY   G + D +        + + I F+ ++I  G++++H+  
Sbjct: 155 FESK------NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFM-KQICEGIRHMHQMY 207
Query: 181 VIHRDIKGQNVLLT--DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
           ++H D+K +N+L    D  ++K++DFG++ +       +  F GTP ++APEV+  D   
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVS 266
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL--FLIPRNAPPRLKSKKWPKKFQS 296
             T     D+WS+G+ A  +     P    +    L   L  R      + +   ++ + 
Sbjct: 267 FPT-----DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE 321
Query: 297 FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLK 335
           FI  +L+K+   R    + LKHP++ D     +   Q K
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 74  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 124
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 182
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 183 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 233
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 234 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G V  +L K +K     E+  A    E+   
Sbjct: 75  ILRLYGYFHDAT------RVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 183
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 184 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 234
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 235 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 24/279 (8%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D W E P G   + + +G+G++G VYKG+      +  + V                   
Sbjct: 1   DDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWIAF 164
           K + H NI  + G   K        QL +V ++C   S+     +  TK + +K   +  
Sbjct: 60  K-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LID 108
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFIG 222
           I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++ +  R  G        G
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 168
Query: 223 TPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRN 280
           +  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++   + +F++ R 
Sbjct: 169 SILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225
Query: 281 --APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
             +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 73  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 181
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 182 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 232
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 233 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 96  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 146
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR+   GT  ++ PE+I
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDDLCGTLDYLPPEMI 204
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 205 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 255
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 256 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 20/277 (7%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D W E P G   + + +G+G++G VYKG+      +  + V                   
Sbjct: 17  DDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K + H NI  + G   K        QL +V ++C   S+   + +++ +   ++ I  I 
Sbjct: 76  K-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHASETKFEMKKLID-IA 126
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFIGTP 224
           R+  RG+ YLH   +IHRD+K  N+ L ++  VK+ DFG++ +  R  G        G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 225 YWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNA- 281
            WMAPEVI   D NP   Y  +SD+++ GI   E+   Q P  +++    +  ++ R + 
Sbjct: 187 LWMAPEVIRMQDSNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243
Query: 282 PPRLKSKK--WPKKFQSFIETVLVKDYHQRPYTDQLL 316
            P L   +   PK+ +  +   L K   +RP   ++L
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 71  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 121
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS--RRTTLSGTLDYLPPEMI 179
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 180 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 230
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 231 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 75  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE I
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEXI 183
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 184 E-----GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 234
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 235 -----TEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           F++   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   YG F   +      +++L++EY   G+V   ++  K     E+  A    E+   L
Sbjct: 74  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQ--KLSRFDEQRTATYITELANAL 125
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            Y H  +VIHRDIK +N+LL  N E+K+ DFG S     +  RR T  GT  ++ PE+I 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIE 183
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                   +D + DLWSLG+   E     PP 
Sbjct: 184 -----GRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX--XXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  A+K++                    K  NH 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LVMEY   G V D + +      KE    F  R+I+  
Sbjct: 74  NIVKLFEVI------ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF--RQIVSA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T G + +TF G+P + APE+
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPEL 183
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 184 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX--XXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  A+K++                    K  NH 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LVMEY   G V D + +      KE    F  R+I+  
Sbjct: 74  NIVKLFEVI------ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF--RQIVSA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T G + +TF G+P + APE+
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPEL 183
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 184 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 108/253 (42%), Gaps = 29/253 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F+ ++++G GT+G+V   R   TG+  A+K++                  +    + H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L
Sbjct: 67  LTALKYAF------QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   V++RDIK +N++L  +  +K+ DFG+  +          F GTP ++APEV+ 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLK 286
                D  Y    D W LG+   EM   + P  +    R   LI       PR   P  K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 287 S------KKWPKK 293
           S      KK PK+
Sbjct: 234 SLLAGLLKKDPKQ 246

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G+G++G VYKG+      +  +KV+                  K + H NI  + G   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRK-TRHVNILLFMGYMT 102
Query: 123 KKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           K       D L +V ++C   S+     V+ TK Q  +   +  I R+  +G+ YLH   
Sbjct: 103 K-------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDYLHAKN 152
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF--IGTPYWMAPEVIAC-DEN 237
           +IHRD+K  N+ L +   VK+ DFG++    R  G +      G+  WMAPEVI   D N
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRN-APPRLKS--KKWPKK 293
           P   +  +SD++S GI   E+   + P   ++   + +F++ R  A P L    K  PK 
Sbjct: 213 P---FSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269
Query: 294 FQSFIETVLVKDYHQRPYTDQLL 316
            +  +   + K   +RP   Q+L
Sbjct: 270 MKRLVADCVKKVKEERPLFPQIL 292

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 108/253 (42%), Gaps = 29/253 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F+ ++++G GT+G+V   R   TG+  A+K++                  +    + H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L
Sbjct: 67  LTALKYAF------QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   V++RDIK +N++L  +  +K+ DFG+  +          F GTP ++APEV+ 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLK 286
                D  Y    D W LG+   EM   + P  +    R   LI       PR   P  K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 287 S------KKWPKK 293
           S      KK PK+
Sbjct: 234 SLLAGLLKKDPKQ 246

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 108/253 (42%), Gaps = 29/253 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F+ ++++G GT+G+V   R   TG+  A+K++                  +    + H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L
Sbjct: 67  LTALKYAF------QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 118
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   V++RDIK +N++L  +  +K+ DFG+  +          F GTP ++APEV+ 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLK 286
                D  Y    D W LG+   EM   + P  +    R   LI       PR   P  K
Sbjct: 179 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 287 S------KKWPKK 293
           S      KK PK+
Sbjct: 234 SLLAGLLKKDPKQ 246

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 16/254 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--XXXXXXXXXXXXXXXXXXKYSNHRNI 114
           +E+IE +GNG YG V   R   TGQ  AIK +                    K+  H NI
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 115
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                      P G+   +++V++   +  +  ++ S+  Q L  E + +   ++LRGLK
Sbjct: 116 IAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSS--QPLTLEHVRYFLYQLLRGLK 172
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF----IGTPYWMAPE 230
           Y+H  +VIHRD+K  N+L+ +N E+K+ DFG++  L  +      F    + T ++ APE
Sbjct: 173 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQ---PPLCDLHPMRALFLIPRNAPPRLKS 287
           ++         Y    DLWS+G    EM   +   P    +H ++ + ++     P +  
Sbjct: 233 LMLSLHE----YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288
Query: 288 KKWPKKFQSFIETV 301
               ++ +++I+++
Sbjct: 289 AVGAERVRAYIQSL 302

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 108/253 (42%), Gaps = 29/253 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F+ ++++G GT+G+V   R   TG+  A+K++                  +    + H  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     AF         D+L  VMEY   G +      ++ +   EE   F   EI+  L
Sbjct: 72  LTALKYAF------QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSAL 123
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   V++RDIK +N++L  +  +K+ DFG+  +          F GTP ++APEV+ 
Sbjct: 124 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 183
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRLK 286
                D  Y    D W LG+   EM   + P  +    R   LI       PR   P  K
Sbjct: 184 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 238
Query: 287 S------KKWPKK 293
           S      KK PK+
Sbjct: 239 SLLAGLLKKDPKQ 251

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY----SNHR 112
           FE I V+G G++G+V   R  +TG L A+KV+                  +      NH 
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F  ++P    D+L+ VME+   G +  +    K +   E    F   EI+  
Sbjct: 85  FLTQLFCCF--QTP----DRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISA 136
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L +LH+  +I+RD+K  NVLL      KL DFG+  +         TF GTP ++APE++
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                 +  Y    D W++G+   EM     P 
Sbjct: 197 Q-----EMLYGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXX--XXXXXXXXXXXXXXXKYSNHRNI 114
           +E+IE +GNG YG V   R   TGQ  AIK +                    K+  H NI
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 116
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                      P G+   +++V++   +  +  ++ S+  Q L  E + +   ++LRGLK
Sbjct: 117 IAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSS--QPLTLEHVRYFLYQLLRGLK 173
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF----IGTPYWMAPE 230
           Y+H  +VIHRD+K  N+L+ +N E+K+ DFG++  L  +      F    + T ++ APE
Sbjct: 174 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 231 VIACDENPDATYDNRSDLWSLGITALEM 258
           ++         Y    DLWS+G    EM
Sbjct: 234 LMLSLHE----YTQAIDLWSVGCIFGEM 257

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXX--XXXXXXXXXXXXXKYSNHR 112
           G + L + +G G + +V   RH  TG+  A+K++                    K  NH 
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LVMEY   G V D + +      KE    F  R+I+  
Sbjct: 75  NIVKLFEVI------ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF--RQIVSA 126
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T+G + +TF G+P + APE+
Sbjct: 127 VQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF--TVGNKLDTFCGSPPYAAPEL 184
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 185 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXX--XXXXXXXXXXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  AIK++                    K  NH 
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+L+MEY   G V D + +      KE    F  R+I+  
Sbjct: 75  NIVKLFEVI------ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF--RQIVSA 126
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           ++Y H+ +++HRD+K +N+LL  +  +K+ DFG S +     G+ + F G P + APE+ 
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFCGAPPYAAPELF 185
Query: 233 ACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
              +     YD    D+WSLG+    +     P 
Sbjct: 186 QGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 100 HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 151
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+    GTP ++APE
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V++        +    D+WS+G     +   +PP  +   ++  +L       R+K  ++
Sbjct: 212 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL-------RIKKNEY 258
Query: 291 --PKKFQ----SFIETVLVKDYHQRPYTDQLLKHPFI 321
             PK       S I+ +L  D   RP  ++LL   F 
Sbjct: 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  +   + A+KV+                  +  +H    N
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 67  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 117
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 175
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 176 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 226
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 227 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 20/277 (7%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D W E P G   + + +G+G++G VYKG+      +  + V                   
Sbjct: 17  DDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K + H NI  + G     + P    QL +V ++C   S+   + +++ +   ++ I  I 
Sbjct: 76  K-TRHVNILLFMGY---STAP----QLAIVTQWCEGSSLYHHLHASETKFEMKKLID-IA 126
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFIGTP 224
           R+  RG+ YLH   +IHRD+K  N+ L ++  VK+ DFG++ +  R  G        G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 225 YWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNA- 281
            WMAPEVI   D NP   Y  +SD+++ GI   E+   Q P  +++    +  ++ R + 
Sbjct: 187 LWMAPEVIRMQDSNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243
Query: 282 PPRLKSKK--WPKKFQSFIETVLVKDYHQRPYTDQLL 316
            P L   +   PK+ +  +   L K   +RP   ++L
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R   +  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDST------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  KVIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-----CDLHP--MRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP       D +    R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 98  HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 149
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+    GTP ++APE
Sbjct: 150 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 209
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V++        +    D+WS+G     +   +PP  +   ++  +L       R+K  ++
Sbjct: 210 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL-------RIKKNEY 256
Query: 291 --PKKFQ----SFIETVLVKDYHQRPYTDQLLKHPFI 321
             PK       S I+ +L  D   RP  ++LL   F 
Sbjct: 257 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 293

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTELCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 132/291 (45%), Gaps = 29/291 (9%)
Query: 35  LEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXX 94
           L +R  ++ W      E P G   + + +G+G++G VYKG+      +  + V       
Sbjct: 21  LGRRDSSDDW------EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 74
Query: 95  XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--ST 152
                       K + H NI  + G   K        QL +V ++C   S+   +    T
Sbjct: 75  LQAFKNEVGVLRK-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIET 126
Query: 153 KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR 212
           K + +K   +  I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R
Sbjct: 127 KFEMIK---LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 183
Query: 213 TIGRRN--TFIGTPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
             G        G+  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++
Sbjct: 184 WSGSHQFEQLSGSILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNIN 240
Query: 270 PM-RALFLIPRN--APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
              + +F++ R   +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 241 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 291

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX--XXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  A+K++                    K  NH 
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LVMEY   G V D + +      KE    F  R+I+  
Sbjct: 67  NIVKLFEVI------ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF--RQIVSA 118
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T G + +TF G+P + APE+
Sbjct: 119 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPEL 176
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 177 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 72  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 122
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ +FG S     +  RR T  GT  ++ PE+I
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEMI 180
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 181 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 231
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 232 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 132/291 (45%), Gaps = 29/291 (9%)
Query: 35  LEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXX 94
           L +R  ++ W      E P G   + + +G+G++G VYKG+      +  + V       
Sbjct: 22  LGRRDSSDDW------EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 75
Query: 95  XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--ST 152
                       K + H NI  + G   K        QL +V ++C   S+   +    T
Sbjct: 76  LQAFKNEVGVLRK-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIET 127
Query: 153 KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR 212
           K + +K   +  I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R
Sbjct: 128 KFEMIK---LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 184
Query: 213 TIGRRN--TFIGTPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
             G        G+  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++
Sbjct: 185 WSGSHQFEQLSGSILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNIN 241
Query: 270 PM-RALFLIPRN--APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
              + +F++ R   +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 242 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 73  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR+   GT  ++ PE+I
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDDLCGTLDYLPPEMI 181
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 182 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 232
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 233 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX--XXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  A++++                    K  NH 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LVMEY   G V D + +      KE    F  R+I+  
Sbjct: 74  NIVKLFEVI------ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF--RQIVSA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T G + +TF G+P + APE+
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPEL 183
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 184 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 74  HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 125
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+    GTP ++APE
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V++        +    D+WS+G     +   +PP  +   ++  +L       R+K  ++
Sbjct: 186 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL-------RIKKNEY 232
Query: 291 --PKKFQ----SFIETVLVKDYHQRPYTDQLLKHPFI 321
             PK       S I+ +L  D   RP  ++LL   F 
Sbjct: 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 24/280 (8%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
            D W E P G   + + +G+G++G VYKG+      +  + V                  
Sbjct: 2   SDDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWIA 163
            K + H NI  + G   K        QL +V ++C   S+     +  TK + +K   + 
Sbjct: 61  RK-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LI 109
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFI 221
            I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R  G        
Sbjct: 110 DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 222 GTPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPR 279
           G+  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++   + +F++ R
Sbjct: 170 GSILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 226
Query: 280 N--APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
              +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 227 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 266

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 24/280 (8%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
            D W E P G   + + +G+G++G VYKG+      +  + V                  
Sbjct: 5   SDDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWIA 163
            K + H NI  + G   K        QL +V ++C   S+     +  TK + +K   + 
Sbjct: 64  RK-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LI 112
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFI 221
            I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R  G        
Sbjct: 113 DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 222 GTPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPR 279
           G+  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++   + +F++ R
Sbjct: 173 GSILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 229
Query: 280 N--APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
              +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 230 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     F+ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA---GFVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     F+ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA---GFVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 24/280 (8%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
            D W E P G   + + +G+G++G VYKG+      +  + V                  
Sbjct: 5   SDDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWIA 163
            K + H NI  + G   K        QL +V ++C   S+     +  TK + +K   + 
Sbjct: 64  RK-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LI 112
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFI 221
            I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R  G        
Sbjct: 113 DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 222 GTPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPR 279
           G+  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++   + +F++ R
Sbjct: 173 GSILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 229
Query: 280 N--APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
              +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 230 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 24/279 (8%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D W E P G   + + +G+G++G VYKG+      +  + V                   
Sbjct: 1   DDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWIAF 164
           K + H NI  + G   K        QL +V ++C   S+     +  TK + +K   +  
Sbjct: 60  K-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LID 108
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFIG 222
           I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R  G        G
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 223 TPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRN 280
           +  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++   + +F++ R 
Sbjct: 169 SILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225
Query: 281 --APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
             +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 72  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 122
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMI 180
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 181 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 231
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 232 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN----HR 112
           F L +++G G++G+V+     KT Q  AIK +                  +  +    H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F  K      + L+ VMEY   G +   ++S     L      F   EI+ G
Sbjct: 79  FLTHMFCTFQTK------ENLFFVMEYLNGGDLMYHIQSCHKFDLSRA--TFYAAEIILG 130
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L++LH   +++RD+K  N+LL  +  +K+ DFG+  +      + N F GTP ++APE++
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
              +     Y++  D WS G+   EM   Q P 
Sbjct: 191 LGQK-----YNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 73  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ +FG S     +  RR T  GT  ++ PE+I
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEMI 181
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 182 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 232
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 233 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 26/282 (9%)
Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
           ++EL EV+G G +  V +  + +TGQ  A+K++                  + S      
Sbjct: 25  VYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYC-GAGSVTDLVKSTKGQSLKEEWIA-FICRE 168
           H +I      +        D  L++V E+  GA    ++VK      +  E +A    R+
Sbjct: 85  HPHIVELLETY------SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           IL  L+Y H+N +IHRD+K +NVLL    ++A VKL DFGV+ QL  +       +GTP+
Sbjct: 139 ILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPH 198
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           +MAPEV+  +      Y    D+W  G+    +     P         LF        ++
Sbjct: 199 FMAPEVVKRE-----PYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKM 251
Query: 286 KSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
             ++W    +S    +  +L+ D  +R    + L HP+++++
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 20/277 (7%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D W E P G   + + +G+G++G VYKG+      +  + V                   
Sbjct: 5   DDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 63
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K + H NI  + G   K        QL +V ++C   S+   + +++ +   ++ I  I 
Sbjct: 64  K-TRHVNILLFMGYSTKP-------QLAIVTQWCEGSSLYHHLHASETKFEMKKLID-IA 114
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFIGTP 224
           R+  RG+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R  G        G+ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 225 YWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNA- 281
            WMAPEVI   D NP   Y  +SD+++ GI   E+   Q P  +++    +  ++ R + 
Sbjct: 175 LWMAPEVIRMQDSNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 231
Query: 282 PPRLKSKK--WPKKFQSFIETVLVKDYHQRPYTDQLL 316
            P L   +   PK+ +  +   L K   +RP   ++L
Sbjct: 232 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 268

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     F+ T ++ APE++    +   
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA---GFVATRWYRAPEIMLNWMH--- 195
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 196 -YNQTVDIWSVGCIMAEL 212

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTXLCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 75  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMI 183
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 184 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 234
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 235 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 71  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 121
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMI 179
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 180 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 230
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 231 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 73  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLDYLPPEMI 181
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 182 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 232
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 233 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX---XXXXXXXXXXXKYSNHRNIATYYG 119
           +G G + + Y+     T ++ A KV+                     K  ++ ++  ++G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            F        DD +++V+E C   S+ +L K  K  ++ E    +  R+ ++G++YLH N
Sbjct: 110 FF------EDDDFVYVVLEICRRRSLLELHKRRK--AVTEPEARYFMRQTIQGVQYLHNN 161
Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
           +VIHRD+K  N+ L D+ +VK+ DFG++ +++    R+ T  GTP ++APEV+ C +   
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL-CKKG-- 218
Query: 240 ATYDNRSDLWSLGITALEMAESQPPL 265
             +    D+WSLG     +   +PP 
Sbjct: 219 --HSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 70  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMI 178
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 179 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 229
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 230 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G+V  +L K +K     E+  A    E+   
Sbjct: 73  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMI 181
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 182 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 232
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 233 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           FE+   +G G +G VY  R  ++  + A+KV+                  +  +H    N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRG 172
           I   YG F   +      +++L++EY   G V  +L K +K     E+  A    E+   
Sbjct: 75  ILRLYGYFHDAT------RVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR    GT  ++ PE+I
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLXGTLDYLPPEMI 183
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 184 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 234
Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +  I  +L  +  QRP   ++L+HP+I
Sbjct: 235 -----TEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 24/279 (8%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D W E P G   + + +G+G++G VYKG+      +  + V                   
Sbjct: 1   DDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWIAF 164
           K + H NI  + G     + P    QL +V ++C   S+     +  TK + +K   +  
Sbjct: 60  K-TRHVNILLFMGY---STAP----QLAIVTQWCEGSSLYHHLHIIETKFEMIK---LID 108
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN--TFIG 222
           I R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R  G        G
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 223 TPYWMAPEVIAC-DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRN 280
           +  WMAPEVI   D+NP   Y  +SD+++ GI   E+   Q P  +++   + +F++ R 
Sbjct: 169 SILWMAPEVIRMQDKNP---YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225
Query: 281 --APPRLKSKK-WPKKFQSFIETVLVKDYHQRPYTDQLL 316
             +P   K +   PK  +  +   L K   +RP   Q+L
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX--XXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  A+K++                    K  NH 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LVMEY   G V D + +      KE    F  R+I+  
Sbjct: 74  NIVKLFEVI------ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF--RQIVSA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T G + + F G P + APE+
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPEL 183
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 184 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNAMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 155
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 156 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 209
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 210 -YNQTVDIWSVGCIMAEL 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 205
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 206 -YNQTVDIWSVGCIMAEL 222

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX--XXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  A++++                    K  NH 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LVMEY   G V D + +      KE    F  R+I+  
Sbjct: 74  NIVKLFEVI------ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF--RQIVSA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T G + + F G+P + APE+
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGSPPYAAPEL 183
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 184 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNV 191
           ++ L++EY   G +  L      + + E  +  + ++IL G+ YLH+N ++H D+K QN+
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 192 LLTDN---AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDL 248
           LL+      ++K+VDFG+S ++      R   +GTP ++APE++  D    AT     D+
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELRE-IMGTPEYLAPEILNYDPITTAT-----DM 216
Query: 249 WSLGITALEMAESQPPLCDLHPMRALFLIPR-NAPPRLKSKKWPKKFQS-FIETVLVKDY 306
           W++GI A  +     P            I + N     ++     +  + FI+++LVK+ 
Sbjct: 217 WNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNP 276
Query: 307 HQRPYTDQLLKHPFIRD-------QPTERQARIQLKDH 337
            +RP  +  L H +++         P E  +  Q +DH
Sbjct: 277 EKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDH 314

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 218
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 219 -YNQTVDIWSVGCIMAEL 235

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 195
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 196 -YNQTVDIWSVGCIMAEL 212

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 82
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 140
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR  T  GTP ++APE+I 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEYLAPEIIL 197
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 198 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 219
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 220 -YNQTVDIWSVGCIMAEL 236

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXX---XXXXKYSNHRN 113
           ++ ++ +G+G YG+V   +   TG   AIK++                     K  +H N
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 82
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y  F  K         +LVME    G + D +     Q   E   A I +++L G 
Sbjct: 83  IMKLYEFFEDKR------NYYLVMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGT 134
Query: 174 KYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            YLH++ ++HRD+K +N+LL   + +A +K+VDFG+SA  +   G+    +GT Y++APE
Sbjct: 135 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE-VGGKMKERLGTAYYIAPE 193
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           V+         YD + D+WS G+    +    PP 
Sbjct: 194 VLR------KKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX---XXXXXKYSNHRN 113
           ++ ++ +G+G YG+V   +   TG   AIK++                     K  +H N
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y  F  K         +LVME    G + D +     Q   E   A I +++L G 
Sbjct: 66  IMKLYEFFEDKR------NYYLVMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGT 117
Query: 174 KYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            YLH++ ++HRD+K +N+LL   + +A +K+VDFG+SA  +   G+    +GT Y++APE
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE-VGGKMKERLGTAYYIAPE 176
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA----PPRLK 286
           V+         YD + D+WS G+    +    PP         L  + +      PP   
Sbjct: 177 VLR------KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPP--- 227
Query: 287 SKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
              W +   + +  ++ +L  +  +R   ++ L HP+I
Sbjct: 228 --DWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 22/278 (7%)
Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM-XXXXXXXXXXXXXXXXXXKYS 109
           ED   IFE  E +G G + +V       TG+L A+K +                   +  
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI       I +SP    + L+LVM+    G + D +      + K+   + + R++
Sbjct: 78  KHENIVALED--IYESP----NHLYLVMQLVSGGELFDRIVEKGFYTEKD--ASTLIRQV 129
Query: 170 LRGLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
           L  + YLH   ++HRD+K +N+L     + +++ + DFG+S +++      +T  GTP +
Sbjct: 130 LDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLS-KMEGKGDVMSTACGTPGY 188
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           +APEV+A  + P   Y    D WS+G+ A  +    PP  D +  + LF     A     
Sbjct: 189 VAPEVLA--QKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDSK-LFEQILKAEYEFD 242
Query: 287 SKKW---PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           S  W       + FI  ++ KD ++R   +Q  +HP+I
Sbjct: 243 SPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + +++E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 152 IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 205
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 206 -YNQTVDIWSVGCIMAEL 222

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + +++E+K++DFG+    D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX---XXXXXXXXXXXKYSNHRNIATYYG 119
           +G G + + Y+     T ++ A KV+                     K  ++ ++  ++G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            F        DD +++V+E C   S+ +L K  K  ++ E    +  R+ ++G++YLH N
Sbjct: 110 FF------EDDDFVYVVLEICRRRSLLELHKRRK--AVTEPEARYFMRQTIQGVQYLHNN 161
Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
           +VIHRD+K  N+ L D+ +VK+ DFG++ +++    R+    GTP ++APEV+ C +   
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL-CKKG-- 218
Query: 240 ATYDNRSDLWSLGITALEMAESQPPL 265
             +    D+WSLG     +   +PP 
Sbjct: 219 --HSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR  T  GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + +++E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 148 IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 201
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 202 -YNQTVDIWSVGCIMAEL 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V      +  Q  A+K +                    K+  H N+      
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F   +      +++LV    GA    DL    K Q+L +E + F+  ++LRGLKY+H   
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGA----DLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  NV + +++E++++DFG++ Q D  +     ++ T ++ APE++    +   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMH--- 205
Query: 241 TYDNRSDLWSLGITALEMAESQ 262
            Y+   D+WS+G    E+ + +
Sbjct: 206 -YNQTVDIWSVGCIMAELLQGK 226

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 24/242 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE ++++G GT+G+V   +   TG+  A+K++                  +    S H  
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 212
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     +F         D+L  VMEY   G +      ++ +   E+   F   EI+  L
Sbjct: 213 LTALKYSF------QTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 264
Query: 174 KYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
            YLH E  V++RD+K +N++L  +  +K+ DFG+  +  +      TF GTP ++APEV+
Sbjct: 265 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 324
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRL 285
                 D  Y    D W LG+   EM   + P  +    +   LI       PR   P  
Sbjct: 325 E-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 379
Query: 286 KS 287
           KS
Sbjct: 380 KS 381

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           ++V+E    G + D V   K   LKE        ++L  ++YLHEN +IHRD+K +NVLL
Sbjct: 96  YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 153
Query: 194 TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWS 250
           +   E   +K+ DFG S  L  T   R T  GTP ++APEV+       A Y+   D WS
Sbjct: 154 SSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWS 210
Query: 251 LGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYH 307
           LG+         PP  +     +L     +       + W    +K    ++ +LV D  
Sbjct: 211 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 270
Query: 308 QRPYTDQLLKHPFIRDQPTERQ 329
            R  T++ L+HP+++D+  +R+
Sbjct: 271 ARFTTEEALRHPWLQDEDMKRK 292

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           ++V+E    G + D V   K   LKE        ++L  ++YLHEN +IHRD+K +NVLL
Sbjct: 90  YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 194 TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWS 250
           +   E   +K+ DFG S  L  T   R T  GTP ++APEV+       A Y+   D WS
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWS 204
Query: 251 LGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYH 307
           LG+         PP  +     +L     +       + W    +K    ++ +LV D  
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 308 QRPYTDQLLKHPFIRDQPTERQ 329
            R  T++ L+HP+++D+  +R+
Sbjct: 265 ARFTTEEALRHPWLQDEDMKRK 286

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 201
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 202 -YNQTVDIWSVGCIMAEL 218

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 205
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 206 -YNQTVDIWSVGCIMAEL 222

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
            +LV +    G + D +  T+  +L E+    I R +L  +  LH+  ++HRD+K +N+L
Sbjct: 99  FFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156
Query: 193 LTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD-ATYDNRSDLWSL 251
           L D+  +KL DFG S QLD     R+   GTP ++APE+I C  N +   Y    D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLRSV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 252 GITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW---PKKFQSFIETVLVKDYHQ 308
           G+    +    PP      M  L +I  +   +  S +W       +  +   LV    +
Sbjct: 216 GVIMYTLLAGSPPFWHRKQMLMLRMI-MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 274
Query: 309 RPYTDQLLKHPFIRDQPTE 327
           R   ++ L HPF +    E
Sbjct: 275 RYTAEEALAHPFFQQYVVE 293

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           ++V+E    G + D V   K   LKE        ++L  ++YLHEN +IHRD+K +NVLL
Sbjct: 89  YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 146
Query: 194 TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWS 250
           +   E   +K+ DFG S  L  T   R T  GTP ++APEV+       A Y+   D WS
Sbjct: 147 SSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWS 203
Query: 251 LGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYH 307
           LG+         PP  +     +L     +       + W    +K    ++ +LV D  
Sbjct: 204 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 263
Query: 308 QRPYTDQLLKHPFIRDQPTERQ 329
            R  T++ L+HP+++D+  +R+
Sbjct: 264 ARFTTEEALRHPWLQDEDMKRK 285

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 204
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 205 -YNQTVDIWSVGCIMAEL 221

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 145 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 198
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 199 -YNQTVDIWSVGCIMAEL 215

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX---XXXXXXXXXXXKYSNHRNIATYYG 119
           +G G + + Y+     T ++ A KV+                     K  ++ ++  ++G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            F        DD +++V+E C   S+ +L K  K  ++ E    +  R+ ++G++YLH N
Sbjct: 110 FF------EDDDFVYVVLEICRRRSLLELHKRRK--AVTEPEARYFMRQTIQGVQYLHNN 161
Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
           +VIHRD+K  N+ L D+ +VK+ DFG++ +++    R+    GTP ++APEV+ C +   
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL-CKKG-- 218
Query: 240 ATYDNRSDLWSLGITALEMAESQPPL 265
             +    D+WSLG     +   +PP 
Sbjct: 219 --HSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 201
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 202 -YNQTVDIWSVGCIMAEL 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           ++V+E    G + D V   K   LKE        ++L  ++YLHEN +IHRD+K +NVLL
Sbjct: 90  YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 194 TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWS 250
           +   E   +K+ DFG S  L  T   R T  GTP ++APEV+       A Y+   D WS
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWS 204
Query: 251 LGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYH 307
           LG+         PP  +     +L     +       + W    +K    ++ +LV D  
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 308 QRPYTDQLLKHPFIRDQPTERQ 329
            R  T++ L+HP+++D+  +R+
Sbjct: 265 ARFTTEEALRHPWLQDEDMKRK 286

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 206
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 207 -YNQTVDIWSVGCIMAEL 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 211
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 212 -YNQTVDIWSVGCIMAEL 228

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           ++V+E    G + D V   K   LKE        ++L  ++YLHEN +IHRD+K +NVLL
Sbjct: 90  YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 194 TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWS 250
           +   E   +K+ DFG S  L  T   R T  GTP ++APEV+       A Y+   D WS
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWS 204
Query: 251 LGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYH 307
           LG+         PP  +     +L     +       + W    +K    ++ +LV D  
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 308 QRPYTDQLLKHPFIRDQPTERQ 329
            R  T++ L+HP+++D+  +R+
Sbjct: 265 ARFTTEEALRHPWLQDEDMKRK 286

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX---XXXXXXXXXXXKYSNHRNIATYYG 119
           +G G + + Y+     T ++ A KV+                     K  ++ ++  ++G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            F        DD +++V+E C   S+ +L K  K  ++ E    +  R+ ++G++YLH N
Sbjct: 94  FF------EDDDFVYVVLEICRRRSLLELHKRRK--AVTEPEARYFMRQTIQGVQYLHNN 145
Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
           +VIHRD+K  N+ L D+ +VK+ DFG++ +++    R+    GTP ++APEV+ C +   
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL-CKKG-- 202
Query: 240 ATYDNRSDLWSLGITALEMAESQPPL 265
             +    D+WSLG     +   +PP 
Sbjct: 203 --HSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           ++V+E    G + D V   K   LKE        ++L  ++YLHEN +IHRD+K +NVLL
Sbjct: 215 YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272
Query: 194 TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWS 250
           +   E   +K+ DFG S  L  T   R T  GTP ++APEV+       A Y+   D WS
Sbjct: 273 SSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWS 329
Query: 251 LGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYH 307
           LG+         PP  +     +L     +       + W    +K    ++ +LV D  
Sbjct: 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
Query: 308 QRPYTDQLLKHPFIRDQPTERQ 329
            R  T++ L+HP+++D+  +R+
Sbjct: 390 ARFTTEEALRHPWLQDEDMKRK 411

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           ++V+E    G + D V   K   LKE        ++L  ++YLHEN +IHRD+K +NVLL
Sbjct: 229 YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 286
Query: 194 TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWS 250
           +   E   +K+ DFG S  L  T   R T  GTP ++APEV+       A Y+   D WS
Sbjct: 287 SSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWS 343
Query: 251 LGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYH 307
           LG+         PP  +     +L     +       + W    +K    ++ +LV D  
Sbjct: 344 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 403
Query: 308 QRPYTDQLLKHPFIRDQPTERQ 329
            R  T++ L+HP+++D+  +R+
Sbjct: 404 ARFTTEEALRHPWLQDEDMKRK 425

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 222
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 223 -YNQTVDIWSVGCIMAEL 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 204
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 205 -YNQTVDIWSVGCIMAEL 221

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 205
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 206 -YNQTVDIWSVGCIMAEL 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 196
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 197 -YNQTVDIWSVGCIMAEL 213

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 195
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 196 -YNQTVDIWSVGCIMAEL 212

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 24/242 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE ++++G GT+G+V   +   TG+  A+K++                  +    S H  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     +F         D+L  VMEY   G +      ++ +   E+   F   EI+  L
Sbjct: 210 LTALKYSF------QTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 174 KYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
            YLH E  V++RD+K +N++L  +  +K+ DFG+  +  +      TF GTP ++APEV+
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRL 285
                 D  Y    D W LG+   EM   + P  +    +   LI       PR   P  
Sbjct: 322 E-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376
Query: 286 KS 287
           KS
Sbjct: 377 KS 378

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 211
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 212 -YNQTVDIWSVGCIMAEL 228

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 211
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 212 -YNQTVDIWSVGCIMAEL 228

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 204
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 205 -YNQTVDIWSVGCIMAEL 221

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 201
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 202 -YNQTVDIWSVGCIMAEL 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 218
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 219 -YNQTVDIWSVGCIMAEL 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 196
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 197 -YNQTVDIWSVGCIMAEL 213

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 157 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 210
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 211 -YNQTVDIWSVGCIMAEL 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 219
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 220 -YNQTVDIWSVGCIMAEL 236

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIA 115
           F+ +E +GNGTY  VYKG +  TG   A+K V                   K   H NI 
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRG 172
             Y           +++L LV E+        +   T G +   L+   + +   ++L+G
Sbjct: 67  RLYDVI------HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L + HENK++HRD+K QN+L+    ++KL DFG++      +   ++ + T ++ AP+V+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQP 263
                   TY    D+WS G    EM   +P
Sbjct: 181 MGSR----TYSTSIDIWSCGCILAEMITGKP 207

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 144 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 197
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 198 -YNQTVDIWSVGCIMAEL 214

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 131/314 (41%), Gaps = 43/314 (13%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHR 112
            ++  ++ VG+G YG V      +TG   AIK +                    K+  H 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           N+      F            +LVM + G    TDL K  K + L E+ I F+  ++L+G
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L+Y+H   +IHRD+K  N+ + ++ E+K++DFG++ Q D  +      + T ++ APEVI
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---XGXVVTRWYRAPEVI 197
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--NAPP-----RL 285
                    Y    D+WS+G    EM   +        +  L  I +    PP     RL
Sbjct: 198 LN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253
Query: 286 KS-------KKWP----KKFQS-----------FIETVLVKDYHQRPYTDQLLKHPFIRD 323
           +S       K  P    K F S            +E +LV D  QR    + L HP+   
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
Query: 324 -QPTERQARIQLKD 336
              TE + ++Q  D
Sbjct: 314 LHDTEDEPQVQKYD 327

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 157 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 210
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 211 -YNQTVDIWSVGCIMAEL 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 17/274 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           +EL E++G G   +V+  R  +  +  A+KV+                  + +   NH  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y     ++P G     ++VMEY    ++ D+V  T+G    +  I  I  +  + L
Sbjct: 74  IVAVYDTGEAETPAGP--LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQAL 129
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRTIGRRNTFIGTPYWMAPE 230
            + H+N +IHRD+K  N+L++    VK+VDFG++   A    ++ +    IGT  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
               D     + D RSD++SLG    E+   +PP     P+   +   R    PP  + +
Sbjct: 190 QARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                  + +   L K+   R  T   ++   +R
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXX---XXXKYSNHRN 113
           F+++  +G G++G+V+  R    G+  A+KV+                         H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   +G F          Q++++M+Y   G +  L++  K Q        F   E+   L
Sbjct: 68  IIRMWGTFQDAQ------QIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLAL 119
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVI 232
           +YLH   +I+RD+K +N+LL  N  +K+ DFG +  + D T        GTP ++APEV+
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----XLCGTPDYIAPEVV 175
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA 273
           +        Y+   D WS GI   EM     P  D + M+ 
Sbjct: 176 ST-----KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +K+ DFG++    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V      +  Q  A+K +                    K+  H N+      
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F   +      +++LV    GA    DL    K Q+L +E + F+  ++LRGLKY+H   
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGA----DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  NV + +++E++++DFG++ Q D  +     ++ T ++ APE++    +   
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMH--- 205
Query: 241 TYDNRSDLWSLGITALEMAESQ 262
            Y+   D+WS+G    E+ + +
Sbjct: 206 -YNQTVDIWSVGCIMAELLQGK 226

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
            +LV +    G + D +  T+  +L E+    I R +L  +  LH+  ++HRD+K +N+L
Sbjct: 99  FFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156
Query: 193 LTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD-ATYDNRSDLWSL 251
           L D+  +KL DFG S QLD     R    GTP ++APE+I C  N +   Y    D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 252 GITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW---PKKFQSFIETVLVKDYHQ 308
           G+    +    PP      M  L +I  +   +  S +W       +  +   LV    +
Sbjct: 216 GVIMYTLLAGSPPFWHRKQMLMLRMI-MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 274
Query: 309 RPYTDQLLKHPFIRDQPTE 327
           R   ++ L HPF +    E
Sbjct: 275 RYTAEEALAHPFFQQYVVE 293

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++     T      ++ T ++ APE++    +   
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVATRWYRAPEIMLNWMH--- 206
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 207 -YNQTVDIWSVGCIMAEL 223

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++     T      ++ T ++ APE++    +   
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVATRWYRAPEIMLNWMH--- 206
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 207 -YNQTVDIWSVGCIMAEL 223

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++     T      ++ T ++ APE++    +   
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVATRWYRAPEIMLNWMH--- 206
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 207 -YNQTVDIWSVGCIMAEL 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           +G+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 204
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 205 -YNQTVDIWSVGCIMAEL 221

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V      +  Q  A+K +                    K+  H N+      
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F   +      +++LV    GA    DL    K Q+L +E + F+  ++LRGLKY+H   
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGA----DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  NV + ++ E++++DFG++ Q D  +     ++ T ++ APE++    +   
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMH--- 197
Query: 241 TYDNRSDLWSLGITALEMAESQ 262
            Y+   D+WS+G    E+ + +
Sbjct: 198 -YNQTVDIWSVGCIMAELLQGK 218

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 19/221 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           + DP+  FEL++V+G G++G+V+  R      +G L A+KV+                  
Sbjct: 24  KADPSH-FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 107 KYS--NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
             +  NH  +   + AF        + +L+L++++   G +    + +K     EE + F
Sbjct: 83  ILADVNHPFVVKLHYAF------QTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKF 134
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
              E+  GL +LH   +I+RD+K +N+LL +   +KL DFG+S +      +  +F GT 
Sbjct: 135 YLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTV 194
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
            +MAPEV+         + + +D WS G+   EM     P 
Sbjct: 195 EYMAPEVVNRQ-----GHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGYVATRWYRAPEIMLNWMH--- 222
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 223 -YNQTVDIWSVGCIMAEL 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 8/194 (4%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
            +LV +    G + D +  T+  +L E+    I R +L  +  LH+  ++HRD+K +N+L
Sbjct: 86  FFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 143
Query: 193 LTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD-ATYDNRSDLWSL 251
           L D+  +KL DFG S QLD     R    GTP ++APE+I C  N +   Y    D+WS 
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 202
Query: 252 GITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW---PKKFQSFIETVLVKDYHQ 308
           G+    +    PP      M  L +I  +   +  S +W       +  +   LV    +
Sbjct: 203 GVIMYTLLAGSPPFWHRKQMLMLRMI-MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 261
Query: 309 RPYTDQLLKHPFIR 322
           R   ++ L HPF +
Sbjct: 262 RYTAEEALAHPFFQ 275

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX--XXXXXKYSNHR 112
           G + L++ +G G + +V   RH  TG+  A+K++                    K  NH 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +           +  L+LV EY   G V D + +      KE    F  R+I+  
Sbjct: 74  NIVKLFEVI------ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF--RQIVSA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEV 231
           ++Y H+  ++HRD+K +N+LL  +  +K+ DFG S +   T G + + F G P + APE+
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPEL 183
Query: 232 IACDENPDATYDN-RSDLWSLGITALEMAESQPPL 265
               +     YD    D+WSLG+    +     P 
Sbjct: 184 FQGKK-----YDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/331 (25%), Positives = 130/331 (39%), Gaps = 52/331 (15%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIK--VMXXXXXXXXXXXXXXXXXXKYS 109
           D    +E +  +G GT+G+V+K RH KTGQ  A+K  +M                  +  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 110 NHRNIATYYGAFIKKSPPGK--DDQLWLVMEYCG---AGSVTD-LVKSTKGQSLKEEWIA 163
            H N+         K+ P       ++LV ++C    AG +++ LVK T  +      I 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE------IK 128
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNT 219
            + + +L GL Y+H NK++HRD+K  NVL+T +  +KL DFG++       +    R   
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP- 278
            + T ++  PE++  + +    Y    DLW  G    EM    P +        L LI  
Sbjct: 189 RVVTLWYRPPELLLGERD----YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 279 -----------------------------RNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
                                        R    RLK+          I+ +LV D  QR
Sbjct: 245 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 304
Query: 310 PYTDQLLKHPFIRDQPTERQARIQLKDHIDT 340
             +D  L H F    P     +  L  H+ +
Sbjct: 305 IDSDDALNHDFFWSDPMPSDLKGMLSTHLTS 335

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 23/239 (9%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           E +G G++G V++     +     I +                   K   H NI  + GA
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLV-KSTKGQSLKEEWIAFICREILRGLKYLHEN 179
             +  PP     L +V EY   GS+  L+ KS   + L E     +  ++ +G+ YLH  
Sbjct: 103 VTQ--PP----NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 180 K--VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
              ++HR++K  N+L+     VK+ DFG+S     T     +  GTP WMAPEV+     
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR---- 212
Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---------FLIPRNAPPRLKS 287
            D   + +SD++S G+   E+A  Q P  +L+P + +           IPRN  P++ +
Sbjct: 213 -DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +      + T ++ APE++    +   
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGXVATRWYRAPEIMLNWMH--- 219
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 220 -YNQTVDIWSVGCIMAEL 236

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 125/325 (38%), Gaps = 66/325 (20%)
Query: 54  AGIFELIEVVGNG--TYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYS 109
            G +EL+ V+G G      V   R+  TG+   ++   +                  K  
Sbjct: 8   GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 67
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           NH NI  Y   FI       D++LW+V  +   GS  DL+ +     + E  IA+I + +
Sbjct: 68  NHPNIVPYRATFIA------DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 121
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---- 225
           L+ L Y+H    +HR +K  ++L++ + +V L     +  +     R+      P     
Sbjct: 122 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 181
Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL------ 276
              W++PEV+   +N    YD +SD++S+GITA E+A    P  D+ P   + L      
Sbjct: 182 VLPWLSPEVL--QQNLQG-YDAKSDIYSVGITACELANGHVPFKDM-PATQMLLEKLNGT 237
Query: 277 -----------------------------------IPR----NAPPRLKSKKWPKKFQSF 297
                                               PR    ++P     + +   F  F
Sbjct: 238 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 297
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIR 322
           +E  L ++   RP    LL H F +
Sbjct: 298 VEQCLQRNPDARPSASTLLNHSFFK 322

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K   L ++ + F+  +ILRGLKY+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++    +   
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 195
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 196 -YNQTVDIWSVGCIMAEL 212

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++D+G++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 89
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 147
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 204
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 205 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 57  FELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRN 113
           FEL++V+G G YG+V+  R      TG+L A+KV+                  K + H  
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA---------KTTEHTR 106
Query: 114 IATYYGAFIKKSPP--------GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
                   I++SP           + +L L+++Y   G +      ++ +   E  +   
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIY 164
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGT 223
             EI+  L++LH+  +I+RDIK +N+LL  N  V L DFG+S +   D T  R   F GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGT 223
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLC 266
             +MAP+++      D+ +D   D WSLG+   E+     P  
Sbjct: 224 IEYMAPDIV---RGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 89
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 147
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 204
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 205 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 24/280 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           F++  ++G G++  VY+     TG   AIK++                  K      H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y  F         + ++LV+E C  G +   +K+ + +   E        +I+ G+
Sbjct: 73  ILELYNYF------EDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGM 125
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            YLH + ++HRD+   N+LLT N  +K+ DFG++ QL     +  T  GTP +++PE+  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL---CDLHPMRALFLIPRNAPPRLKSKKW 290
                 + +   SD+WSLG     +   +PP       + +  + L     P  L  +  
Sbjct: 186 -----RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA- 239
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-RDQPTERQ 329
               +  I  +L ++   R     +L HPF+ R+  T+ +
Sbjct: 240 ----KDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSK 275

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 15/217 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           FE I  +G G++G+V   +H +TG   A+K++                  +       A 
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQ----AV 99
Query: 117 YYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +   +K     KD+  L++V+EY   G +   ++        E    F   +I+   +Y
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEY 157
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           LH   +I+RD+K +N+L+     +K+ DFG +    R  GR     GTP ++APE+I   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPEIILSK 214
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                 Y+   D W+LG+   EMA   PP     P++
Sbjct: 215 -----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +++ DFG++    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/331 (25%), Positives = 130/331 (39%), Gaps = 52/331 (15%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIK--VMXXXXXXXXXXXXXXXXXXKYS 109
           D    +E +  +G GT+G+V+K RH KTGQ  A+K  +M                  +  
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 110 NHRNIATYYGAFIKKSPPGK--DDQLWLVMEYCG---AGSVTD-LVKSTKGQSLKEEWIA 163
            H N+         K+ P       ++LV ++C    AG +++ LVK T  +      I 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE------IK 127
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNT 219
            + + +L GL Y+H NK++HRD+K  NVL+T +  +KL DFG++       +    R   
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP- 278
            + T ++  PE++  + +    Y    DLW  G    EM    P +        L LI  
Sbjct: 188 RVVTLWYRPPELLLGERD----YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 279 -----------------------------RNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
                                        R    RLK+          I+ +LV D  QR
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303
Query: 310 PYTDQLLKHPFIRDQPTERQARIQLKDHIDT 340
             +D  L H F    P     +  L  H+ +
Sbjct: 304 IDSDDALNHDFFWSDPMPSDLKGMLSTHLTS 334

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNI 114
           ++ +  VG+G YG V      K+G   A+K +                    K+  H N+
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 112
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                 F   +   + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLK
Sbjct: 113 IGLLDVFTPATSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLK 168
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           Y+H   +IHRD+K  N+ + ++ E+K++DFG++   D  +     ++ T ++ APE++  
Sbjct: 169 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLN 225
Query: 235 DENPDATYDNRSDLWSLGITALEM 258
             +    Y+   D+WS+G    E+
Sbjct: 226 WMH----YNMTVDIWSVGCIMAEL 245

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 117
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 175
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 232
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 233 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 83
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 141
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+ +   +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 142 EYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 198
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 199 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 232

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DFG++   D  +      + T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 54  AGIFELIEVVGNG--TYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYS 109
            G +EL+ V+G G      V   R+  TG+   ++   +                  K  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           NH NI  Y   FI       D++LW+V  +   GS  DL+ +     + E  IA+I + +
Sbjct: 84  NHPNIVPYRATFIA------DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---- 225
           L+ L Y+H    +HR +K  ++L++ + +V L     +  +     R+      P     
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL 268
              W++PEV+   +N    YD +SD++S+GITA E+A    P  D+
Sbjct: 198 VLPWLSPEVL--QQNLQG-YDAKSDIYSVGITACELANGHVPFKDM 240

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE ++++G GT+G+V   +   TG+  A+K++                  +    S H  
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     +F         D+L  VMEY   G +      ++ +   E+   F   EI+  L
Sbjct: 72  LTALKYSF------QTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 123
Query: 174 KYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
            YLH E  V++RD+K +N++L  +  +K+ DFG+  +  +       F GTP ++APEV+
Sbjct: 124 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 183
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRL 285
                 D  Y    D W LG+   EM   + P  +    +   LI       PR   P  
Sbjct: 184 E-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 238
Query: 286 KS------KKWPKK 293
           KS      KK PK+
Sbjct: 239 KSLLSGLLKKDPKQ 252

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 17/274 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           +EL E++G G   +V+  R  +  +  A+KV+                  + +   NH  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y     ++P G     ++VMEY    ++ D+V  T+G    +  I  I  +  + L
Sbjct: 74  IVAVYATGEAETPAGP--LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQAL 129
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRTIGRRNTFIGTPYWMAPE 230
            + H+N +IHRD+K  N++++    VK++DFG++   A    ++ +    IGT  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
               D     + D RSD++SLG    E+   +PP     P+   +   R    PP  + +
Sbjct: 190 QARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                  + +   L K+   R  T   ++   +R
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE ++++G GT+G+V   +   TG+  A+K++                  +    S H  
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 70
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     +F         D+L  VMEY   G +      ++ +   E+   F   EI+  L
Sbjct: 71  LTALKYSF------QTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 122
Query: 174 KYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
            YLH E  V++RD+K +N++L  +  +K+ DFG+  +  +       F GTP ++APEV+
Sbjct: 123 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRL 285
                 D  Y    D W LG+   EM   + P  +    +   LI       PR   P  
Sbjct: 183 E-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 237
Query: 286 KS------KKWPKK 293
           KS      KK PK+
Sbjct: 238 KSLLSGLLKKDPKQ 251

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIA 115
           F+L  ++G G YG V    H  TG++ AIK +                   K+  H NI 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 116 TYYGAFIKKSPPGKD-DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
           T +   I++    ++ ++++++ E       TDL +    Q L ++ I +   + LR +K
Sbjct: 73  TIFN--IQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN----------TFIGTP 224
            LH + VIHRD+K  N+L+  N ++K+ DFG++  +D +    +           F+ T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           ++ APEV+       A Y    D+WS G    E+   +P
Sbjct: 187 WYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE ++++G GT+G+V   +   TG+  A+K++                  +    S H  
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +     +F         D+L  VMEY   G +      ++ +   E+   F   EI+  L
Sbjct: 70  LTALKYSF------QTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSAL 121
Query: 174 KYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
            YLH E  V++RD+K +N++L  +  +K+ DFG+  +  +       F GTP ++APEV+
Sbjct: 122 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------PRNAPPRL 285
                 D  Y    D W LG+   EM   + P  +    +   LI       PR   P  
Sbjct: 182 E-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 236
Query: 286 KS------KKWPKK 293
           KS      KK PK+
Sbjct: 237 KSLLSGLLKKDPKQ 250

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +    K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +    K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 17/274 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           +EL E++G G   +V+  R  +  +  A+KV+                  + +   NH  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y     ++P G     ++VMEY    ++ D+V  T+G    +  I  I  +  + L
Sbjct: 74  IVAVYDTGEAETPAGP--LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQAL 129
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRTIGRRNTFIGTPYWMAPE 230
            + H+N +IHRD+K  N++++    VK++DFG++   A    ++ +    IGT  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
               D     + D RSD++SLG    E+   +PP     P+   +   R    PP  + +
Sbjct: 190 QARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                  + +   L K+   R  T   ++   +R
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           FE I+ +G G++G+V   +H +TG   A+K++                     N + I  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +    K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +K+ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++DF ++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 23/239 (9%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           E +G G++G V++     +     I +                   K   H NI  + GA
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLV-KSTKGQSLKEEWIAFICREILRGLKYLHEN 179
             +  PP     L +V EY   GS+  L+ KS   + L E     +  ++ +G+ YLH  
Sbjct: 103 VTQ--PP----NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 180 K--VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
              ++HRD+K  N+L+     VK+ DFG+S              GTP WMAPEV+     
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLR---- 212
Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---------FLIPRNAPPRLKS 287
            D   + +SD++S G+   E+A  Q P  +L+P + +           IPRN  P++ +
Sbjct: 213 -DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE+++V+G G +G+V   +     ++ A+K++                        + + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I T + AF        D+ L+LVM+Y   G +  L+   + + L EE   F   E++  +
Sbjct: 136 ITTLHYAF------QDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAI 188
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
             +H+   +HRDIK  N+L+  N  ++L DFG   +L  D T+ + +  +GTP +++PE+
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEI 247
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +   E     Y    D WSLG+   EM   + P 
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRN 113
           A  FE I V+G G +GQV K R+    +  AIK +                     NH+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASL-NHQY 63
Query: 114 IATYYGAFIKK-------SPPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFI 165
           +  YY A++++       +   K   L++  EYC   ++ DL+ S    Q   E W  F 
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF- 122
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI----------- 214
            R+IL  L Y+H   +IHR++K  N+ + ++  VK+ DFG++  + R++           
Sbjct: 123 -RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 215 GRRNTF---IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALE 257
           G  +     IGT  ++A EV+    +    Y+ + D +SLGI   E
Sbjct: 182 GSSDNLTSAIGTAXYVATEVL----DGTGHYNEKIDXYSLGIIFFE 223

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 17/274 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           +EL E++G G   +V+  R  +  +  A+KV+                  + +   NH  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y     ++P G     ++VMEY    ++ D+V  T+G    +  I  I  +  + L
Sbjct: 74  IVAVYDTGEAETPAGP--LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQAL 129
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRTIGRRNTFIGTPYWMAPE 230
            + H+N +IHRD+K  N++++    VK++DFG++   A    ++ +    IGT  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
               D     + D RSD++SLG    E+   +PP     P+   +   R    PP  + +
Sbjct: 190 QARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                  + +   L K+   R  T   ++   +R
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLAGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLXGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 17/274 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           +EL E++G G   +V+  R  +  +  A+KV+                  + +   NH  
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y     ++P G     ++VMEY    ++ D+V  T+G    +  I  I  +  + L
Sbjct: 91  IVAVYDTGEAETPAGP--LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQAL 146
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRTIGRRNTFIGTPYWMAPE 230
            + H+N +IHRD+K  N++++    VK++DFG++   A    ++ +    IGT  +++PE
Sbjct: 147 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
               D     + D RSD++SLG    E+   +PP     P+   +   R    PP  + +
Sbjct: 207 QARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 261
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                  + +   L K+   R  T   ++   +R
Sbjct: 262 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 295

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 91
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 149
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 150 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 206
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 207 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 240

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++ FG++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 133/286 (46%), Gaps = 28/286 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           QED    +E+ E +G+G +  V K R   TG+  A K +                  +  
Sbjct: 7   QEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 66
Query: 110 N------HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           N      H NI T +  F  K+       + L++E    G + D +   + +SL E+   
Sbjct: 67  NILREIRHPNIITLHDIFENKT------DVVLILELVSGGELFDFL--AEKESLTEDEAT 118
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D    N  +KL+DFG++ +++     +N 
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFL 276
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L +     +  +  
Sbjct: 179 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 232
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +  +      S    +  + FI  +LVKD  +R    Q L+H +I+
Sbjct: 233 VNYDFDEEYFSNT-SELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 130/283 (45%), Gaps = 24/283 (8%)
Query: 48  RWQ--EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           RW+  ED   I++  +V+G G + +V      +T +L AIK +                 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 106 XKYS-NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
             +   H NI      +           L+L+M+    G + D +   KG   + +    
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRI-VEKGFYTERDASRL 121
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVL---LTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           I  ++L  +KYLH+  ++HRD+K +N+L   L +++++ + DFG+S +++      +T  
Sbjct: 122 IF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTAC 179
Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           GTP ++APEV+A  + P   Y    D WS+G+ A  +    PP  D +  + LF     A
Sbjct: 180 GTPGYVAPEVLA--QKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKA 233
Query: 282 PPRLKSKKW---PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                S  W       + FI  ++ KD  +R   +Q L+HP+I
Sbjct: 234 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 97
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 212
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 213 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 31/280 (11%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRNIAT 116
             V+G G +G+V+  +   TG+L A K +                  K     + R I +
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS--LKEEWIAFICREILRGLK 174
              AF  K+       L LVM     G +   + +    +   +E    F   +I+ GL+
Sbjct: 250 LAYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +LH+  +I+RD+K +NVLL D+  V++ D G++ +L     +   + GTP +MAPE++  
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--KSKKWPK 292
           +E     YD   D ++LG+T  EM  ++ P       R   +  +    R+  ++  +P 
Sbjct: 364 EE-----YDFSVDYFALGVTLYEMIAARGPF----RARGEKVENKELKQRVLEQAVTYPD 414
Query: 293 KF----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           KF    + F E +L KD  +R        D L  HP  RD
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 31/280 (11%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRNIAT 116
             V+G G +G+V+  +   TG+L A K +                  K     + R I +
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLK 174
              AF  K+       L LVM     G +   + +        +E    F   +I+ GL+
Sbjct: 250 LAYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +LH+  +I+RD+K +NVLL D+  V++ D G++ +L     +   + GTP +MAPE++  
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--KSKKWPK 292
           +E     YD   D ++LG+T  EM  ++ P       R   +  +    R+  ++  +P 
Sbjct: 364 EE-----YDFSVDYFALGVTLYEMIAARGPF----RARGEKVENKELKQRVLEQAVTYPD 414
Query: 293 KF----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           KF    + F E +L KD  +R        D L  HP  RD
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFAEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 31/280 (11%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRNIAT 116
             V+G G +G+V+  +   TG+L A K +                  K     + R I +
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLK 174
              AF  K+       L LVM     G +   + +        +E    F   +I+ GL+
Sbjct: 250 LAYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +LH+  +I+RD+K +NVLL D+  V++ D G++ +L     +   + GTP +MAPE++  
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--KSKKWPK 292
           +E     YD   D ++LG+T  EM  ++ P       R   +  +    R+  ++  +P 
Sbjct: 364 EE-----YDFSVDYFALGVTLYEMIAARGPF----RARGEKVENKELKQRVLEQAVTYPD 414
Query: 293 KF----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           KF    + F E +L KD  +R        D L  HP  RD
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 130/283 (45%), Gaps = 24/283 (8%)
Query: 48  RWQ--EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           RW+  ED   I++  +V+G G + +V      +T +L AIK +                 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 106 XKYS-NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
             +   H NI      +           L+L+M+    G + D +   KG   + +    
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRI-VEKGFYTERDASRL 121
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVL---LTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           I  ++L  +KYLH+  ++HRD+K +N+L   L +++++ + DFG+S +++      +T  
Sbjct: 122 IF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTAC 179
Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           GTP ++APEV+A  + P   Y    D WS+G+ A  +    PP  D +  + LF     A
Sbjct: 180 GTPGYVAPEVLA--QKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKA 233
Query: 282 PPRLKSKKW---PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                S  W       + FI  ++ KD  +R   +Q L+HP+I
Sbjct: 234 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++D G++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 130/283 (45%), Gaps = 24/283 (8%)
Query: 48  RWQ--EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           RW+  ED   I++  +V+G G + +V      +T +L AIK +                 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 106 XKYS-NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
             +   H NI      +           L+L+M+    G + D +   KG   + +    
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRI-VEKGFYTERDASRL 121
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVL---LTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           I  ++L  +KYLH+  ++HRD+K +N+L   L +++++ + DFG+S +++      +T  
Sbjct: 122 IF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTAC 179
Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           GTP ++APEV+A  + P   Y    D WS+G+ A  +    PP  D +  + LF     A
Sbjct: 180 GTPGYVAPEVLA--QKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKA 233
Query: 282 PPRLKSKKW---PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                S  W       + FI  ++ KD  +R   +Q L+HP+I
Sbjct: 234 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 31/280 (11%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRNIAT 116
             V+G G +G+V+  +   TG+L A K +                  K     + R I +
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLK 174
              AF  K+       L LVM     G +   + +        +E    F   +I+ GL+
Sbjct: 250 LAYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +LH+  +I+RD+K +NVLL D+  V++ D G++ +L     +   + GTP +MAPE++  
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--KSKKWPK 292
           +E     YD   D ++LG+T  EM  ++ P       R   +  +    R+  ++  +P 
Sbjct: 364 EE-----YDFSVDYFALGVTLYEMIAARGPF----RARGEKVENKELKQRVLEQAVTYPD 414
Query: 293 KF----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           KF    + F E +L KD  +R        D L  HP  RD
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 117
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 175
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPEIIL 232
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 233 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX--XXXXXX 106
           +Q   A  + ++ ++G G++G+V K +   T Q  A+KV+                    
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  +H NI   +      S        ++V E    G + D +   K +   E   A I 
Sbjct: 76  KKLDHPNIMKLFEILEDSSS------FYIVGELYTGGELFDEI--IKRKRFSEHDAARII 127
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
           +++  G+ Y+H++ ++HRD+K +N+LL     + ++K++DFG+S    +    ++  IGT
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGT 186
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
            Y++APEV+        TYD + D+WS G+    +    PP 
Sbjct: 187 AYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 130/283 (45%), Gaps = 24/283 (8%)
Query: 48  RWQ--EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           RW+  ED   I++  +V+G G + +V      +T +L AIK +                 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 106 XKYS-NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
             +   H NI      +           L+L+M+    G + D +   KG   + +    
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRI-VEKGFYTERDASRL 121
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVL---LTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           I  ++L  +KYLH+  ++HRD+K +N+L   L +++++ + DFG+S +++      +T  
Sbjct: 122 IF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTAC 179
Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           GTP ++APEV+A  + P   Y    D WS+G+ A  +    PP  D +  + LF     A
Sbjct: 180 GTPGYVAPEVLA--QKP---YSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKA 233
Query: 282 PPRLKSKKW---PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                S  W       + FI  ++ KD  +R   +Q L+HP+I
Sbjct: 234 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           F+++  +G G +G VY  R  +   + A+KV+                  +  +H    N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y  F  +       +++L++E+   G +   ++  K     E+  A    E+   L
Sbjct: 76  ILRMYNYFHDRK------RIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADAL 127
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            Y HE KVIHRDIK +N+L+    E+K+ DFG S        RR    GT  ++ PE+I 
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRXMCGTLDYLPPEMIE 185
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                  T+D + DLW  G+   E     PP 
Sbjct: 186 -----GKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIA 115
           F+L  ++G G YG V    H  TG++ AIK +                   K+  H NI 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 116 TYYGAFIKKSPPGKD-DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
           T +   I++    ++ ++++++ E       TDL +    Q L ++ I +   + LR +K
Sbjct: 73  TIFN--IQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN----------TFIGTP 224
            LH + VIHRD+K  N+L+  N ++K+ DFG++  +D +    +           ++ T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           ++ APEV+       A Y    D+WS G    E+   +P
Sbjct: 187 WYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX--XXXXXXXXXXX 106
           +Q   A  + ++ ++G G++G+V K +   T Q  A+KV+                    
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  +H NI   +      S        ++V E    G + D +   K +   E   A I 
Sbjct: 76  KKLDHPNIMKLFEILEDSSS------FYIVGELYTGGELFDEI--IKRKRFSEHDAARII 127
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
           +++  G+ Y+H++ ++HRD+K +N+LL     + ++K++DFG+S    +    ++  IGT
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGT 186
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
            Y++APEV+        TYD + D+WS G+    +    PP 
Sbjct: 187 AYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++D G++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 132/285 (46%), Gaps = 28/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q+     +++ E +G+G +  V K R   TG   A K +                  +  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 110 N------HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           +      H N+ T +  +  ++       + L++E    G + D +   + +SL EE   
Sbjct: 67  SILRQVLHHNVITLHDVYENRT------DVVLILELVSGGELFDFL--AQKESLSEEEAT 118
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  K+ H D+K +N++L D       +KL+DFG++ +++  +  +N 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFL 276
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D     +  +  
Sbjct: 179 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +      S+   +  + FI  +LVK+  +R    + L+HP+I
Sbjct: 233 VSYDFDEEFFSQT-SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 17/213 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXX----XXKYSNHR 112
           F  ++V+G G++G+V   RH       A+KV+                      K   H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   + +F         D+L+ V++Y   G +       + +   E    F   EI   
Sbjct: 100 FLVGLHFSF------QTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASA 151
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L YLH   +++RD+K +N+LL     + L DFG+  +        +TF GTP ++APEV+
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                    YD   D W LG    EM    PP 
Sbjct: 212 H-----KQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX--XXXXXXXXXXX 106
           +Q   A  + ++ ++G G++G+V K +   T Q  A+KV+                    
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  +H NI   +      S        ++V E    G + D +   K +   E   A I 
Sbjct: 76  KKLDHPNIMKLFEILEDSSS------FYIVGELYTGGELFDEI--IKRKRFSEHDAARII 127
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
           +++  G+ Y+H++ ++HRD+K +N+LL     + ++K++DFG+S    +    ++  IGT
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGT 186
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
            Y++APEV+        TYD + D+WS G+    +    PP 
Sbjct: 187 AYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                          +++L+LV E+     + D + ++    +    I     ++L+GL 
Sbjct: 68  VKLLDVI------HTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV-IA 233
           + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+ + 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMA 259
           C       Y    D+WSLG    EM 
Sbjct: 181 CK-----YYSTAVDIWSLGCIFAEMV 201

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 117
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 175
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  G   T  GTP ++APE+I 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGATWTLCGTPEYLAPEIIL 232
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 233 SK-----GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 132/285 (46%), Gaps = 28/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q+     +++ E +G+G +  V K R   TG   A K +                  +  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 110 N------HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           +      H N+ T +  +  ++       + L++E    G + D +   + +SL EE   
Sbjct: 67  SILRQVLHHNVITLHDVYENRT------DVVLILELVSGGELFDFL--AQKESLSEEEAT 118
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  K+ H D+K +N++L D       +KL+DFG++ +++  +  +N 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFL 276
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D     +  +  
Sbjct: 179 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +      S+   +  + FI  +LVK+  +R    + L+HP+I
Sbjct: 233 VSYDFDEEFFSQT-SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+++     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIII 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 120/274 (43%), Gaps = 17/274 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           +EL E++G G   +V+  R  +  +  A+KV+                  + +   NH  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y     ++P G     ++VMEY    ++ D+V  T+G    +  I  I  +  + L
Sbjct: 74  IVAVYDTGEAETPAGP--LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQAL 129
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRTIGRRNTFIGTPYWMAPE 230
            + H+N +IHRD+K  N++++    VK++DFG++   A    ++ +    IGT  +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
               D     + D RSD++SLG    E+   +PP     P    +   R    PP  + +
Sbjct: 190 QARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHE 244
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                  + +   L K+   R  T   ++   +R
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V     TKTG   A+K +                    K+  H N+      
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F       + + ++LV    GA    DL    K Q L ++ + F+  +ILRGLKY+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           +IHRD+K  N+ + ++ E+K++D G++   D  +     ++ T ++ APE++    +   
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM---TGYVATRWYRAPEIMLNWMH--- 199
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    E+
Sbjct: 200 -YNQTVDIWSVGCIMAEL 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                          +++L+LV E+     + D + ++    +    I     ++L+GL 
Sbjct: 67  VKLLDVI------HTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV-IA 233
           + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+ + 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMA 259
           C       Y    D+WSLG    EM 
Sbjct: 180 CK-----YYSTAVDIWSLGCIFAEMV 200

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 26/282 (9%)
Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
           ++EL EV+G G +  V +  + +TGQ  A+K++                  + S      
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYC-GAGSVTDLVKSTKGQSLKEEWIA-FICRE 168
           H +I      +        D  L++V E+  GA    ++VK      +  E +A    R+
Sbjct: 85  HPHIVELLETY------SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           IL  L+Y H+N +IHRD+K   VLL    ++A VKL  FGV+ QL  +       +GTP+
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           +MAPEV+  +      Y    D+W  G+    +     P         LF        ++
Sbjct: 199 FMAPEVVKRE-----PYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKM 251
Query: 286 KSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
             ++W    +S    +  +L+ D  +R    + L HP+++++
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 13/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F  + V+G G++G+V       T +L AIK++                  +     +   
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +       S     D+L+ VMEY   G +   ++       KE    F   EI  GL +L
Sbjct: 81  FLTQL--HSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISIGLFFL 136
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ--LDRTIGRRNTFIGTPYWMAPEVIAC 234
           H+  +I+RD+K  NV+L     +K+ DFG+  +  +D    R   F GTP ++APE+IA 
Sbjct: 137 HKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRE--FCGTPDYIAPEIIAY 194
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL 265
                  Y    D W+ G+   EM   QPP 
Sbjct: 195 -----QPYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 26/282 (9%)
Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
           ++EL EV+G G +  V +  + +TGQ  A+K++                  + S      
Sbjct: 27  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 86
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYC-GAGSVTDLVKSTKGQSLKEEWIA-FICRE 168
           H +I      +        D  L++V E+  GA    ++VK      +  E +A    R+
Sbjct: 87  HPHIVELLETY------SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 140
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           IL  L+Y H+N +IHRD+K   VLL    ++A VKL  FGV+ QL  +       +GTP+
Sbjct: 141 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 200
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           +MAPEV+  +      Y    D+W  G+    +     P         LF        ++
Sbjct: 201 FMAPEVVKRE-----PYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKM 253
Query: 286 KSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
             ++W    +S    +  +L+ D  +R    + L HP+++++
Sbjct: 254 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 295

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEYLAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   +MA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQ 245

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 125/316 (39%), Gaps = 52/316 (16%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIK--VMXXXXXXXXXXXXXXXXXXKYS 109
           D    +E +  +G GT+G+V+K RH KTGQ  A+K  +M                  +  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 110 NHRNIATYYGAFIKKSPPGK--DDQLWLVMEYCG---AGSVTD-LVKSTKGQSLKEEWIA 163
            H N+         K+ P       ++LV ++C    AG +++ LVK T  +      I 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE------IK 128
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNT 219
            + + +L GL Y+H NK++HRD+K  NVL+T +  +KL DFG++       +    R   
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP- 278
            + T ++  PE++  + +    Y    DLW  G    EM    P +        L LI  
Sbjct: 189 RVVTLWYRPPELLLGERD----YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 279 -----------------------------RNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
                                        R    RLK+          I+ +LV D  QR
Sbjct: 245 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 304
Query: 310 PYTDQLLKHPFIRDQP 325
             +D  L H F    P
Sbjct: 305 IDSDDALNHDFFWSDP 320

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRH---TKTGQLAAIKV----MXXXXXXXXXXXXXXXXXXKYS 109
           FEL+ V+G G YG+V++ R      TG++ A+KV    M                  +  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H  I     AF          +L+L++EY   G +   ++  +     E+   F   EI
Sbjct: 79  KHPFIVDLIYAF------QTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEI 130
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
              L +LH+  +I+RD+K +N++L     VKL DFG+  +        +TF GT  +MAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           E++       + ++   D WSLG    +M    PP 
Sbjct: 191 EILM-----RSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIK--VMXXXXXXXXXXXXXXXXXXKYS 109
           D    +E +  +G GT+G+V+K RH KTGQ  A+K  +M                  +  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 110 NHRNIATYYGAFIKKSPPGK--DDQLWLVMEYCG---AGSVTD-LVKSTKGQSLKEEWIA 163
            H N+         K+ P       ++LV ++C    AG +++ LVK T  +      I 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE------IK 128
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNT 219
            + + +L GL Y+H NK++HRD+K  NVL+T +  +KL DFG++       +    R   
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
            + T ++  PE++  + +    Y    DLW  G    EM    P
Sbjct: 189 RVVTLWYRPPELLLGERD----YGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 11/213 (5%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE+I+V+G G +G+V   +   T ++ A+K++                        + + 
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   + AF        ++ L+LVM+Y   G +  L+   + + L E+   F   E++  +
Sbjct: 136 ITALHYAF------QDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAI 188
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVI 232
             +H+   +HRDIK  NVLL  N  ++L DFG   ++ D    + +  +GTP +++PE++
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
              E+    Y    D WSLG+   EM   + P 
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXX--XXXXXXXXXXXXXKYSNHRNI 114
           +E I  +G G+YG V+K R+  TGQ+ AIK                      K   H N+
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                 F +K       +L LV EYC    + +L +  +G  + E  +  I  + L+ + 
Sbjct: 65  VNLLEVFRRKR------RLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVN 116
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           + H++  IHRD+K +N+L+T ++ +KL DFG +  L       +  + T ++ +PE++  
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV- 175
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQP 263
               D  Y    D+W++G    E+    P
Sbjct: 176 ---GDTQYGPPVDVWAIGCVFAELLSGVP 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 14/217 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +E +  +G G YG VYK R   +G   A+K +                  + +  R +  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 117 YYGAFIKK-------SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +    + +       S   ++ ++ LV E+      T L K+     L  E I  + R+ 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-PGLPAETIKDLMRQF 129
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           LRGL +LH N ++HRD+K +N+L+T    VKL DFG++      +      + T ++ AP
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWYRAP 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLC 266
           EV+       +TY    D+WS+G    EM   +P  C
Sbjct: 189 EVLL-----QSTYATPVDMWSVGCIFAEMFRRKPLFC 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 132/285 (46%), Gaps = 28/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q+     +++ E +G+G +  V K R   TG   A K +                  +  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 110 N------HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           +      H NI T +  +  ++       + L++E    G + D +   + +SL EE   
Sbjct: 67  SILRQVLHPNIITLHDVYENRT------DVVLILELVSGGELFDFL--AQKESLSEEEAT 118
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  K+ H D+K +N++L D       +KL+DFG++ +++  +  +N 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFL 276
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D     +  +  
Sbjct: 179 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +      S+   +  + FI  +LVK+  +R    + L+HP+I
Sbjct: 233 VSYDFDEEFFSQT-SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 11/213 (5%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           FE+I+V+G G +G+V   +   T ++ A+K++                        + + 
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   + AF        ++ L+LVM+Y   G +  L+   + + L E+   F   E++  +
Sbjct: 152 ITALHYAF------QDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAI 204
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVI 232
             +H+   +HRDIK  NVLL  N  ++L DFG   ++ D    + +  +GTP +++PE++
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
              E+    Y    D WSLG+   EM   + P 
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 131/285 (45%), Gaps = 28/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q+     +++ E +G+G +  V K R   TG   A K +                  +  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 110 N------HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           +      H N+ T +  +  ++       + L++E    G + D +   + +SL EE   
Sbjct: 67  SILRQVLHHNVITLHDVYENRT------DVVLILELVSGGELFDFL--AQKESLSEEEAT 118
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  K+ H D+K +N++L D       +KL+DFG++ +++  +  +N 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFL 276
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D     +  +  
Sbjct: 179 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +      S    +  + FI  +LVK+  +R    + L+HP+I
Sbjct: 233 VSYDFDEEFFSHT-SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 132/285 (46%), Gaps = 28/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q+     +++ E +G+G +  V K R   TG   A K +                  +  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 110 N------HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           +      H N+ T +  +  ++       + L++E    G + D +   + +SL EE   
Sbjct: 67  SILRQVLHHNVITLHDVYENRT------DVVLILELVSGGELFDFL--AQKESLSEEEAT 118
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  K+ H D+K +N++L D       +KL+DFG++ +++  +  +N 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFL 276
           F GTP ++APE++  +  P       +D+WS+G IT + ++ + P L D     +  +  
Sbjct: 179 F-GTPEFVAPEIVNYE--PLGL---EADMWSIGVITYILLSGASPFLGDTKQETLANITS 232
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +      S    +  + FI  +LVK+  +R    + L+HP+I
Sbjct: 233 VSYDFDEEFFSHT-SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V      ++G+  AIK +                    K+  H N+      
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F   S        +LVM +      TDL K   G    EE I ++  ++L+GLKY+H   
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQ----TDLQK-IMGMEFSEEKIQYLVYQMLKGLKYIHSAG 164
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           V+HRD+K  N+ + ++ E+K++DFG++   D        ++ T ++ APEVI    +   
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVVTRWYRAPEVILSWMH--- 218
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    EM
Sbjct: 219 -YNQTVDIWSVGCIMAEM 235

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP  +APE+I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWXLCGTPEALAPEIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           +E +E +G GTYG V+K ++ +T ++ A+K   +                  K   H+NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
              +           D +L LV E+C    +     S  G  L  E +     ++L+GL 
Sbjct: 64  VRLHDVL------HSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLLKGLG 115
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           + H   V+HRD+K QN+L+  N E+KL DFG++      +   +  + T ++  P+V+  
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL 265
            +     Y    D+WS G    E+A +  PL
Sbjct: 176 AK----LYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 132/285 (46%), Gaps = 28/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q+     +++ E +G+G +  V K R   TG   A K +                  +  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 110 N------HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           +      H N+ T +  +  ++       + L++E    G + D +   + +SL EE   
Sbjct: 67  SILRQVLHHNVITLHDVYENRT------DVVLILELVSGGELFDFL--AQKESLSEEEAT 118
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  K+ H D+K +N++L D       +KL+DFG++ +++  +  +N 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFL 276
           F GTP ++APE++  +  P       +D+WS+G IT + ++ + P L D     +  +  
Sbjct: 179 F-GTPEFVAPEIVNYE--PLGL---EADMWSIGVITYILLSGASPFLGDTKQETLANITS 232
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +      S    +  + FI  +LVK+  +R    + L+HP+I
Sbjct: 233 VSYDFDEEFFSHT-SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIA 115
           F+L  ++G G YG V    H  TG++ AIK +                   K+  H NI 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 116 TYYGAFIKKSPPGKD-DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
           T +   I++    ++ ++++++ E       TDL +    Q L ++ I +   + LR +K
Sbjct: 73  TIFN--IQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN----------TFIGTP 224
            LH + VIHRD+K  N+L+  N ++K+ DFG++  +D +    +            + T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           ++ APEV+       A Y    D+WS G    E+   +P
Sbjct: 187 WYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 11  WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 66  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 178 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 212

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNI-- 114
           F+ I+ +G G++G+V   +H ++G   A+K++                     N + I  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL------NEKRILQ 96
Query: 115 ATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           A  +   +K     KD+  L++VMEY   G +   ++        E    F   +I+   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +YLH   +I+RD+K +N+L+     +++ DFG +    R  GR     GTP ++AP +I 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPAIIL 211
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                   Y+   D W+LG+   EMA   PP     P++
Sbjct: 212 S-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 12  WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 66
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 67  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 118
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 179 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 87
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR--KIGSFDETCTRFYTAEIVSAL 145
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N+F+GT  +++PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 206 LT-----EKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 9   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 63
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 64  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 176 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 210

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y  A +V  + +  S   Q+L 
Sbjct: 66  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLP 120
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 178
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 179 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 13  WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 67
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 68  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 179
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 180 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVY---KGRHTKTGQLAAIKVMXXXXXXXXXXXXXX 102
           E   + DP+  FEL++V+G G++G+V+   K   +   QL A+KV+              
Sbjct: 16  EGHEKADPSQ-FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK 74
Query: 103 XXXXKYS--NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                    NH  I   + AF        + +L+L++++   G +    + +K     EE
Sbjct: 75  MERDILVEVNHPFIVKLHYAF------QTEGKLYLILDFLRGGDL--FTRLSKEVMFTEE 126
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF 220
            + F   E+   L +LH   +I+RD+K +N+LL +   +KL DFG+S +      +  +F
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 221 IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
            GT  +MAPEV+         +   +D WS G+   EM     P 
Sbjct: 187 CGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMX--XXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           VG+G YG V      ++G+  AIK +                    K+  H N+      
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F   S        +LVM +      TDL K   G    EE I ++  ++L+GLKY+H   
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQ----TDLQK-IMGLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDA 240
           V+HRD+K  N+ + ++ E+K++DFG++   D        ++ T ++ APEVI    +   
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVVTRWYRAPEVILSWMH--- 200
Query: 241 TYDNRSDLWSLGITALEM 258
            Y+   D+WS+G    EM
Sbjct: 201 -YNQTVDIWSVGCIMAEM 217

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 41/288 (14%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXX---XXXXXXXKYSNH 111
           G + L + +G GT+G+V  G+H  TG   A+K++                     K   H
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y      S P     +++VMEY   G + D +   K   L E+    + ++IL 
Sbjct: 76  PHIIKLYQVI---STPS---DIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILS 127
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           G+ Y H + V+HRD+K +NVLL  +   K+ DFG+S  +      R +  G+P + APEV
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS-CGSPNYAAPEV 186
Query: 232 IA--CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           I+      P+       D+WS G+    +     P  D H                    
Sbjct: 187 ISGRLYAGPEV------DIWSSGVILYALLCGTLPFDDDH-------------------- 220
Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDH 337
            P  F+   + +     +  P    LLKH  ++  P +R     +++H
Sbjct: 221 VPTLFKKICDGIFYTPQYLNPSVISLLKH-MLQVDPMKRATIKDIREH 267

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 3   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 57
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 58  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 170 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 204

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 66  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 120
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 178
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 179 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 221

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 13/215 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXX-----XXXXXXXXXXXXXXXXKYSNH 111
           +E +  +G G YG VYK R   +G   A+K +                       +   H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+          S   ++ ++ LV E+      T L K+     L  E I  + R+ LR
Sbjct: 66  PNVVRLMDV-CATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-PGLPAETIKDLMRQFLR 123
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH N ++HRD+K +N+L+T    VKL DFG++      +   +  + T ++ APEV
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLWYRAPEV 182
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLC 266
           +       +TY    D+WS+G    EM   +P  C
Sbjct: 183 LL-----QSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 66  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 120
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 178
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 179 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 221

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 8   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 63  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 175 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 9   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 63
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 64  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 175
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 176 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 210

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 66  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 120
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 178
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 179 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 221

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 5   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 59
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 60  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 111
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 112 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 171
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 172 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 22  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 78
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 79  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 133
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 134 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 191
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 192 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 234

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXX-----XXXXXXXXXXXXXXXXKYSNH 111
           +E +  +G G YG VYK R   +G   A+K +                       +   H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+          S   ++ ++ LV E+      T L K+     L  E I  + R+ LR
Sbjct: 66  PNVVRLMDV-CATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-PGLPAETIKDLMRQFLR 123
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH N ++HRD+K +N+L+T    VKL DFG++      +      + T ++ APEV
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-TLWYRAPEV 182
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLC 266
           +       +TY    D+WS+G    EM   +P  C
Sbjct: 183 LL-----QSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 72  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 232 IACDENPDATYDNRSDLWSLGITALEMA 259
           +   +     Y    D+WSLG    EM 
Sbjct: 182 LLGXKY----YSTAVDIWSLGCIFAEMV 205

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 232 IACDENPDATYDNRSDLWSLGITALEMA 259
           +   +     Y    D+WSLG    EM 
Sbjct: 175 LLGXK----YYSTAVDIWSLGCIFAEMV 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 69  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 178
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 179 LLGCK-----YYSTAVDIWSLGCIFAEMV 202

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 4   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 58
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 59  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 110
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 111 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 171 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 205

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR---N 113
           F++   +G G +G VY  R  +   + A+KV+                  +  +H    N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y  F  +       +++L++E+   G +   ++  K     E+  A    E+   L
Sbjct: 77  ILRMYNYFHDRK------RIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADAL 128
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            Y HE KVIHRDIK +N+L+    E+K+ DFG S        RR    GT  ++ PE+I 
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRXMCGTLDYLPPEMIE 186
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                  T+D + DLW  G+   E     PP 
Sbjct: 187 -----GKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                          +++L+LV E+     + D + ++    +    I     ++L+GL 
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV-IA 233
           + H ++V+HRD+K +N+L+     +KL DFG++      +      + T ++ APE+ + 
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 234 CDENPDATYDNRSDLWSLGITALEMA 259
           C       Y    D+WSLG    EM 
Sbjct: 178 CK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 5/192 (2%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ 189
           +D L++V E    G V + V + K   L E+   F  +++++G++YLH  K+IHRDIK  
Sbjct: 110 EDHLYMVFELVNQGPVME-VPTLK--PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 190 NVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
           N+L+ ++  +K+ DFGVS +   +    +  +GTP +MAPE ++  E          D+W
Sbjct: 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS--ETRKIFSGKALDVW 224
Query: 250 SLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
           ++G+T       Q P  D   M     I   A          +  +  I  +L K+   R
Sbjct: 225 AMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284
Query: 310 PYTDQLLKHPFI 321
               ++  HP++
Sbjct: 285 IVVPEIKLHPWV 296

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 3   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 57
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 58  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 170 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 64
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 122
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 123 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 183 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 72  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 182 LLGCK-----YYSTAVDIWSLGCIFAEMV 205

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 84
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 142
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N+F+GT  +++PE+
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 203 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 19/239 (7%)
Query: 32  IAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVY---KGRHTKTGQLAAIKVM 88
           +  +++ + T    E   + DP+  FEL++V+G G++G+V+   K   +   QL A+KV+
Sbjct: 3   MGSIKEIAITHHVKEGHEKADPSQ-FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 61
Query: 89  XXXXXXXXXXXXXXXXXXKYS--NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVT 146
                                  NH  I   + AF        + +L+L++++   G + 
Sbjct: 62  KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF------QTEGKLYLILDFLRGGDL- 114
Query: 147 DLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV 206
              + +K     EE + F   E+   L +LH   +I+RD+K +N+LL +   +KL DFG+
Sbjct: 115 -FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL 173
Query: 207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           S +      +  +F GT  +MAPEV+         +   +D WS G+   EM     P 
Sbjct: 174 SKESIDHEKKAYSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 65
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 123
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 124 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 184 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 131/279 (46%), Gaps = 28/279 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN------ 110
           +E+ E +G+G +  V K R   TG+  A K +                  +  N      
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI T +  F  K+       + L++E    G + D +   + +SL E+      ++IL
Sbjct: 67  HPNIITLHDIFENKT------DVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQIL 118
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            G+ YLH  ++ H D+K +N++L D    N  +KL+DFG++ +++     +N F GTP +
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEF 177
Query: 227 MAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFLIPRNAPP 283
           +APE++  +  P       +D+WS+G IT + ++ + P L +     +  +  +  +   
Sbjct: 178 VAPEIVNYE--PLGL---EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232
Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              S    +  + FI  +LVKD  +R    Q L+H +I+
Sbjct: 233 EYFSNT-SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G +G+V+ G    HTK     A+K +            
Sbjct: 3   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 57
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 58  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 170 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 19/239 (7%)
Query: 32  IAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVY---KGRHTKTGQLAAIKVM 88
           +  +++ + T    E   + DP+  FEL++V+G G++G+V+   K   +   QL A+KV+
Sbjct: 2   MGSIKEIAITHHVKEGHEKADPSQ-FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 89  XXXXXXXXXXXXXXXXXXKYS--NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVT 146
                                  NH  I   + AF        + +L+L++++   G + 
Sbjct: 61  KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF------QTEGKLYLILDFLRGGDL- 113
Query: 147 DLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV 206
              + +K     EE + F   E+   L +LH   +I+RD+K +N+LL +   +KL DFG+
Sbjct: 114 -FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           S +      +  +F GT  +MAPEV+         +   +D WS G+   EM     P 
Sbjct: 173 SKESIDHEKKAYSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRH---TKTGQLAAIKV----MXXXXXXXXXXXXXXXXXXKYS 109
           FEL+ V+G G YG+V++ R      TG++ A+KV    M                  +  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H  I     AF          +L+L++EY   G +   ++  +     E+   F   EI
Sbjct: 79  KHPFIVDLIYAF------QTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEI 130
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
              L +LH+  +I+RD+K +N++L     VKL DFG+  +        + F GT  +MAP
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           E++       + ++   D WSLG    +M    PP 
Sbjct: 191 EILM-----RSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 64  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 174 LLGCK-----YYSTAVDIWSLGCIFAEMV 197

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 88
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 146
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N+F+GT  +++PE+
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 207 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 28/279 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN------ 110
           +E+ E +G+G +  V K R   TG+  A K +                  +  N      
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI T +  F  K+       + L++E    G + D +   + +SL E+      ++IL
Sbjct: 88  HPNIITLHDIFENKT------DVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQIL 139
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            G+ YLH  ++ H D+K +N++L D    N  +KL+DFG++ +++     +N F GTP +
Sbjct: 140 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEF 198
Query: 227 MAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL--HPMRALFLIPRNAPP 283
           +APE++  +  P       +D+WS+G IT + ++ + P L +     +  +  +  +   
Sbjct: 199 VAPEIVNYE--PLGL---EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 253
Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              S    +  + FI  +LVKD  +R    Q L+H +I+
Sbjct: 254 EYFSNT-SELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 43  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 99
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 100 IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 154
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 212
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 213 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 255

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXX-----XXXXXXXXXXXXXXXXKYSNH 111
           +E +  +G G YG VYK R   +G   A+K +                       +   H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+          S   ++ ++ LV E+      T L K+     L  E I  + R+ LR
Sbjct: 66  PNVVRLMDV-CATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-PGLPAETIKDLMRQFLR 123
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +LH N ++HRD+K +N+L+T    VKL DFG++      +      + T ++ APEV
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRAPEV 182
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLC 266
           +       +TY    D+WS+G    EM   +P  C
Sbjct: 183 LL-----QSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 14  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 70
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 71  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 125
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 126 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 183
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 184 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 226

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 37  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 93
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 94  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 148
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 149 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 206
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 207 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 249

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 63
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 121
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 182 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 45  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 101
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 102 IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 156
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 157 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 214
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 215 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 257

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 64  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 174 LLGCK-----YYSTAVDIWSLGCIFAEMV 197

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 62
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 120
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 121 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 181 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 47  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 103
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 104 IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 158
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 159 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 216
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 217 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 259

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 66  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 176 LLGCK-----YYSTAVDIWSLGCIFAEMV 199

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 88  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 144
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 145 IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 199
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 200 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 257
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 258 NVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 300

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 67  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 177 LLGCK-----YYSTAVDIWSLGCIFAEMV 200

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 69
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 127
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 128 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 188 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 64  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 174 LLGCK-----YYSTAVDIWSLGCIFAEMV 197

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 68  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 178 LLGCK-----YYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 67  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 177 LLGCK-----YYSTAVDIWSLGCIFAEMV 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 47/296 (15%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           E +G G+Y +  +  H  T    A+KV+                  +Y  H NI T    
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILL---RYGQHPNIITLKDV 89
Query: 121 FIKKSPPGKDD--QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           +        DD   ++LV E    G + D  K  + +   E   +F+   I + ++YLH 
Sbjct: 90  Y--------DDGKHVYLVTELMRGGELLD--KILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 179 NKVIHRDIKGQNVLLTDNAE----VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
             V+HRD+K  N+L  D +     +++ DFG + QL    G   T   T  ++APEV+  
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK- 198
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
                  YD   D+WSLGI    M     P  +          P + P  + ++    KF
Sbjct: 199 ----RQGYDEGCDIWSLGILLYTMLAGYTPFAN---------GPSDTPEEILTRIGSGKF 245
Query: 295 --------------QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKD 336
                         +  +  +L  D HQR    Q+L+HP++  +    Q+++  +D
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQD 301

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 64  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 174 LLGCK-----YYSTAVDIWSLGCIFAEMV 197

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 87
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 145
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 206 LT-----EKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 66  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 176 LLGCK-----YYSTAVDIWSLGCIFAEMV 199

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 47/296 (15%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           E +G G+Y +  +  H  T    A+KV+                  +Y  H NI T    
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILL---RYGQHPNIITLKDV 89
Query: 121 FIKKSPPGKDD--QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
           +        DD   ++LV E    G + D  K  + +   E   +F+   I + ++YLH 
Sbjct: 90  Y--------DDGKHVYLVTELMRGGELLD--KILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 179 NKVIHRDIKGQNVLLTDNAE----VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
             V+HRD+K  N+L  D +     +++ DFG + QL    G   T   T  ++APEV+  
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK- 198
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
                  YD   D+WSLGI    M     P  +          P + P  + ++    KF
Sbjct: 199 ----RQGYDEGCDIWSLGILLYTMLAGYTPFAN---------GPSDTPEEILTRIGSGKF 245
Query: 295 --------------QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKD 336
                         +  +  +L  D HQR    Q+L+HP++  +    Q+++  +D
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQD 301

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 85
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 143
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 204 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 45/312 (14%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK--VMXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           +E + +VG G+YG V K R+  TG++ AIK  +                   K   H N+
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                   KK       + +LV E+     + DL     G  L  + +     +I+ G+ 
Sbjct: 87  VNLLEVCKKKK------RWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIG 138
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           + H + +IHRDIK +N+L++ +  VKL DFG +  L       +  + T ++ APE++  
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV- 197
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL---CDL----HPMRALF-LIPRNAP---- 282
               D  Y    D+W++G    EM   +P      D+    H M  L  LIPR+      
Sbjct: 198 ---GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 283 ---------PRLK-----SKKWPKKFQSFIETV---LVKDYHQRPYTDQLLKHPFIR-DQ 324
                    P +K      +++PK  +  I+     L  D  +RP+  +LL H F + D 
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
Query: 325 PTERQAR-IQLK 335
             ER ++ +QLK
Sbjct: 315 FAERFSQELQLK 326

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 68  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 178 LLGCK-----YYSTAVDIWSLGCIFAEMV 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 66  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 176 LLGCK-----YYSTAVDIWSLGCIFAEMV 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 69  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 179 LLGCK-----YYSTAVDIWSLGCIFAEMV 202

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 84
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 142
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 203 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 68  VKLLDVI------HTENKLYLVFEFLS----MDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K +N+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 178 LLGCK-----YYSTAVDIWSLGCIFAEMV 201

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 85
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 143
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 204 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 85
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 143
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 204 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 87
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 145
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 206 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 132/303 (43%), Gaps = 40/303 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +++ E +G G +G V++     TG   A K +                      H  +  
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + AF        D+++ ++ E+   G + + V     +  ++E + ++ R++ +GL ++
Sbjct: 219 LHDAF------EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM-RQVCKGLCHM 271
Query: 177 HENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           HEN  +H D+K +N++ T   + E+KL+DFG++A LD     + T  GT  + APEV   
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEV--A 328
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW---- 290
           +  P   Y   +D+WS+G+ +  +     P    +    L    RN    +KS  W    
Sbjct: 329 EGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETL----RN----VKSCDWNMDD 377
Query: 291 ------PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-------RDQPTERQARIQLKDH 337
                  +  + FI  +L+ D + R    Q L+HP++       RD         +++D 
Sbjct: 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 437
Query: 338 IDT 340
           I T
Sbjct: 438 IKT 440

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 68  VKLLDVI------HTENKLYLVFEHVD----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 178 LLGCK-----YYSTAVDIWSLGCIFAEMV 201

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 87
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 145
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 206 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 87
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 145
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 206 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 66  VKLLDVI------HTENKLYLVFEFLS----MDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K +N+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 176 LLGCK-----YYSTAVDIWSLGCIFAEMV 199

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 88
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 146
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 207 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           +E +E +G GTYG V+K ++ +T ++ A+K   +                  K   H+NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
              +           D +L LV E+C    +     S  G  L  E +     ++L+GL 
Sbjct: 64  VRLHDVL------HSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLLKGLG 115
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           + H   V+HRD+K QN+L+  N E+KL +FG++      +   +  + T ++  P+V+  
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPL 265
            +     Y    D+WS G    E+A +  PL
Sbjct: 176 AK----LYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKG 188
           +DD  +LVMEY    ++++ ++S    S+ +  I F   +IL G+K+ H+ +++HRDIK 
Sbjct: 82  EDDCYYLVMEYIEGPTLSEYIESHGPLSV-DTAINF-TNQILDGIKHAHDMRIVHRDIKP 139
Query: 189 QNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSD 247
           QN+L+  N  +K+ DFG++  L  T + + N  +GT  + +PE        +AT D  +D
Sbjct: 140 QNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE----QAKGEAT-DECTD 194
Query: 248 LWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS---KKWPKKFQSFIETVLVK 304
           ++S+GI   EM   +PP      +       +++ P + +   K  P+   + I     K
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEK 254
Query: 305 DYHQRPYTDQLLK 317
           D   R  T Q +K
Sbjct: 255 DKANRYKTIQEMK 267

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 14/216 (6%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX-XXXXXXXXXXXKYSNHRNIATY 117
           L +++G G    V++GRH KTG L AIKV                    K  NH+NI   
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    + +   K     L+ME+C  GS+ T L + +    L E     + R+++ G+ +L
Sbjct: 73  FAIEEETTTRHK----VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 177 HENKVIHRDIKGQNVLLT---DNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV- 231
            EN ++HR+IK  N++     D   V KL DFG + +L+    +  +  GT  ++ P++ 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMY 187
Query: 232 --IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                 ++    Y    DLWS+G+T    A    P 
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 18/227 (7%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           E R Q D    FE+++V+G G + +V   +  +TGQ+ A+K+M                 
Sbjct: 55  EVRLQRDD---FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 106 XKY---SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWI 162
                  + R I   + AF        ++ L+LVMEY   G +  L+ S  G+ +  E  
Sbjct: 112 RDVLVNGDRRWITQLHFAF------QDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMA 164
Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTF 220
            F   EI+  +  +H    +HRDIK  N+LL     ++L DFG   +L  D T+ R    
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVA 223
Query: 221 IGTPYWMAPEVIAC--DENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +GTP +++PE++          +Y    D W+LG+ A EM   Q P 
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 132/303 (43%), Gaps = 40/303 (13%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +++ E +G G +G V++     TG   A K +                      H  +  
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + AF        D+++ ++ E+   G + + V     +  ++E + ++ R++ +GL ++
Sbjct: 113 LHDAF------EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM-RQVCKGLCHM 165
Query: 177 HENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           HEN  +H D+K +N++ T   + E+KL+DFG++A LD     + T  GT  + APEV   
Sbjct: 166 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEV--A 222
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW---- 290
           +  P   Y   +D+WS+G+ +  +     P    +    L    RN    +KS  W    
Sbjct: 223 EGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETL----RN----VKSCDWNMDD 271
Query: 291 ------PKKFQSFIETVLVKDYHQRPYTDQLLKHPFI-------RDQPTERQARIQLKDH 337
                  +  + FI  +L+ D + R    Q L+HP++       RD         +++D 
Sbjct: 272 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 331
Query: 338 IDT 340
           I T
Sbjct: 332 IKT 334

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXX---XXXXXXXXKYSNHRN 113
           F+  +++G G++  V   R   T +  AIK++                        +H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
               Y  F        D++L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 99  FVKLYFCF------QDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 150
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 151 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 211 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 10  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 66
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 67  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 121
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 122 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 179
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 180 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 222

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 66  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 120
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 178
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 179 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 221

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 90
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 148
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 149 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 209 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 66  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 120
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 178
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 179 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 221

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                          +++L+LV E+     +   + ++    +    I     ++L+GL 
Sbjct: 68  VKLLDVI------HTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV-IA 233
           + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+ + 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMA 259
           C       Y    D+WSLG    EM 
Sbjct: 181 CK-----YYSTAVDIWSLGCIFAEMV 201

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++  V   R   T +  AIK++                    +  R++ +
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 87
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 145
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 206 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 28  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 84
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 85  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 139
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 140 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 197
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 198 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 240

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 38/297 (12%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXX-XXXXXXXKYSNHRNIATYYG 119
           E++G G Y +V      + G+  A+K++                   +   ++NI     
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
            F        D + +LV E    GS+  L    K +   E   + + R++   L +LH  
Sbjct: 79  FF------EDDTRFYLVFEKLQGGSI--LAHIQKQKHFNEREASRVVRDVAAALDFLHTK 130
Query: 180 KVIHRDIKGQNVLLTDNAEV---KLVDF--GVSAQLDR-----TIGRRNTFIGTPYWMAP 229
            + HRD+K +N+L     +V   K+ DF  G   +L+      T     T  G+  +MAP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPP---------------LCDLHPMRAL 274
           EV+    +    YD R DLWSLG+    M    PP               +C +   + L
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK-L 249
Query: 275 FLIPRNAPPRLKSKKWP---KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
           F   +        K W     + +  I  +LV+D  QR    Q+L+HP+++ Q  E+
Sbjct: 250 FESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEK 306

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                          +++L+LV E+     +   + ++    +    I     ++L+GL 
Sbjct: 64  VKLLDVI------HTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV-IA 233
           + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+ + 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 234 CDENPDATYDNRSDLWSLGITALEMA 259
           C       Y    D+WSLG    EM 
Sbjct: 177 CK-----YYSTAVDIWSLGCIFAEMV 197

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 17  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 73
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 74  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 128
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 129 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 186
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 187 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 229

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 21  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 77
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 78  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 132
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 133 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 190
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 191 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 233

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 13  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 69
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 70  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 124
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 125 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 182
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 183 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 21  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 77
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 78  IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 132
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 133 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 190
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 191 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 233

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 67  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K +N+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 177 LLGCK-----YYSTAVDIWSLGCIFAEMV 200

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 43  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 99
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F        +  L LV++Y    +V  + +  S   Q+L 
Sbjct: 100 IM----RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 154
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 212
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 213 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXX 100
           W ED W E P    +L+E +G G  G+V+ G    HTK     A+K +            
Sbjct: 3   WWEDAW-EVPRETLKLVERLGAGQAGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLA 57
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L   
Sbjct: 58  EANLMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG 169
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                 W APE I        T+  +SD+WS GI   E+ 
Sbjct: 170 AKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+K   +                  K  NH NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 66  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K +N+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 176 LLGCK-----YYSTAVDIWSLGCIFAEMV 199

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+    +                  K  NH NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 65  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 175 LLGCK-----YYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F+ +E +G GTYG VYK R+  TG++ A+    +                  K  NH NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI---CREILR 171
                          +++L+LV E+       DL K     +L    +  I     ++L+
Sbjct: 64  VKLLDVI------HTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 232 -IACDENPDATYDNRSDLWSLGITALEMA 259
            + C       Y    D+WSLG    EM 
Sbjct: 174 LLGCK-----YYSTAVDIWSLGCIFAEMV 197

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN---H 111
           G +++++ +G G++G+V    HT TGQ  A+K++                   Y     H
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y     K      D++ +V+EY G      +V+  K   + E+      ++I+ 
Sbjct: 64  PHIIKLYDVIKSK------DEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIIS 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTPYWMAPE 230
            ++Y H +K++HRD+K +N+LL ++  VK+ DFG+S  +  T G    T  G+P + APE
Sbjct: 115 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPE 172
Query: 231 VIACD--ENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           VI+      P+       D+WS G+    M   + P  D
Sbjct: 173 VISGKLYAGPEV------DVWSCGVILYVMLCRRLPFDD 205

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMXXXXX-----XXXXXXXXXXXXXKYSN 110
           +E +  +G G YG+V+K R  K G +  A+K +                       +   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H N+   +      S   ++ +L LV E+      T L K  +   +  E I  +  ++L
Sbjct: 73  HPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVPTETIKDMMFQLL 130
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL +LH ++V+HRD+K QN+L+T + ++KL DFG++      +   +  + T ++ APE
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           V+       ++Y    DLWS+G    EM   +P
Sbjct: 190 VLL-----QSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 120/270 (44%), Gaps = 26/270 (9%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX-XXXXXXXXXXXKYSNHRNIATYYGAF 121
           +G+G +G V+      +G    IK +                   K  +H NI   +  F
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHEN 179
                      +++VME C  G + + + S   +G++L E ++A + ++++  L Y H  
Sbjct: 90  ------EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 180 KVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
            V+H+D+K +N+L  D   ++ +K++DFG+ A+L ++        GT  +MAPEV     
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGL-AELFKSDEHSTNAAGTALYMAPEVF---- 198
Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCDLH----PMRALFLIPRNAPPRLKSKKWPK 292
             D T+  + D+WS G+    +     P           +A +  P  A   ++ +    
Sbjct: 199 KRDVTF--KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA---VECRPLTP 253
Query: 293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +    ++ +L KD  +RP   Q+L H + +
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F+  +++G G++      R   T +  AIK++                    +  R++ +
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYV------TRERDVMS 85
Query: 117 Y--YGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
              +  F+K     +DD+ L+  + Y   G +   ++  K  S  E    F   EI+  L
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 143
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           +YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N F+GT  +++PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      + +    SDLW+LG    ++    PP 
Sbjct: 204 LT-----EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 116/274 (42%), Gaps = 22/274 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           + L   +G G++G+V       T    A K +                  K  +H NI  
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            Y  F        +  ++LVME C  G + + V     +  +E   A I +++L  + Y 
Sbjct: 88  LYETF------EDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYC 139
Query: 177 HENKVIHRDIKGQNVL-LTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           H+  V HRD+K +N L LTD  ++ +KL+DFG++A+       R T +GTPY+++P+V+ 
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-TKVGTPYYVSPQVL- 197
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW--- 290
                +  Y    D WS G+    +    PP         +  I R        K W   
Sbjct: 198 -----EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI-REGTFTFPEKDWLNV 251
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
             + +S I  +L K   QR  + Q L+H +   Q
Sbjct: 252 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 285

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 116/274 (42%), Gaps = 22/274 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           + L   +G G++G+V       T    A K +                  K  +H NI  
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            Y  F        +  ++LVME C  G + + V     +  +E   A I +++L  + Y 
Sbjct: 71  LYETF------EDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYC 122
Query: 177 HENKVIHRDIKGQNVL-LTDNAE--VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           H+  V HRD+K +N L LTD+ +  +KL+DFG++A+       R T +GTPY+++P+V+ 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-TKVGTPYYVSPQVL- 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW--- 290
                +  Y    D WS G+    +    PP         +  I R        K W   
Sbjct: 181 -----EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI-REGTFTFPEKDWLNV 234
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
             + +S I  +L K   QR  + Q L+H +   Q
Sbjct: 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMXXXXX-----XXXXXXXXXXXXXKYSN 110
           +E +  +G G YG+V+K R  K G +  A+K +                       +   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H N+   +      S   ++ +L LV E+      T L K  +   +  E I  +  ++L
Sbjct: 73  HPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVPTETIKDMMFQLL 130
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL +LH ++V+HRD+K QN+L+T + ++KL DFG++      +   +  + T ++ APE
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           V+       ++Y    DLWS+G    EM   +P
Sbjct: 190 VLL-----QSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN---H 111
           G +++++ +G G++G+V    HT TGQ  A+K++                   Y     H
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y     K      D++ +V+EY G      +V+  K   + E+      ++I+ 
Sbjct: 68  PHIIKLYDVIKSK------DEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIIS 118
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTPYWMAPE 230
            ++Y H +K++HRD+K +N+LL ++  VK+ DFG+S  +  T G    T  G+P + APE
Sbjct: 119 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPE 176
Query: 231 VIACD--ENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           VI+      P+       D+WS G+    M   + P  D
Sbjct: 177 VISGKLYAGPEV------DVWSCGVILYVMLCRRLPFDD 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN---H 111
           G +++++ +G G++G+V    HT TGQ  A+K++                   Y     H
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y     K      D++ +V+EY G      +V+  K   + E+      ++I+ 
Sbjct: 73  PHIIKLYDVIKSK------DEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIIS 123
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTPYWMAPE 230
            ++Y H +K++HRD+K +N+LL ++  VK+ DFG+S  +  T G    T  G+P + APE
Sbjct: 124 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPE 181
Query: 231 VIACD--ENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           VI+      P+       D+WS G+    M   + P  D
Sbjct: 182 VISGKLYAGPEV------DVWSCGVILYVMLCRRLPFDD 214

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN---H 111
           G +++++ +G G++G+V    HT TGQ  A+K++                   Y     H
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y     K      D++ +V+EY G      +V+  K   + E+      ++I+ 
Sbjct: 74  PHIIKLYDVIKSK------DEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIIS 124
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTPYWMAPE 230
            ++Y H +K++HRD+K +N+LL ++  VK+ DFG+S  +  T G    T  G+P + APE
Sbjct: 125 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPE 182
Query: 231 VIACD--ENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           VI+      P+       D+WS G+    M   + P  D
Sbjct: 183 VISGKLYAGPEV------DVWSCGVILYVMLCRRLPFDD 215

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX-XXXXXXXXXXXKYSNHRNIATY 117
           L +++G G    V++GRH KTG L AIKV                    K  NH+NI   
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    + +   K     L+ME+C  GS+ T L + +    L E     + R+++ G+ +L
Sbjct: 73  FAIEEETTTRHK----VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 177 HENKVIHRDIKGQNVLLT---DNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV- 231
            EN ++HR+IK  N++     D   V KL DFG + +L+    +     GT  ++ P++ 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVXLYGTEEYLHPDMY 187
Query: 232 --IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                 ++    Y    DLWS+G+T    A    P 
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 66/121 (54%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL   +++K+ DFG
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFG 171
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 172 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 227
Query: 263 P 263
           P
Sbjct: 228 P 228

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMXXXXX-----XXXXXXXXXXXXXKYSN 110
           +E +  +G G YG+V+K R  K G +  A+K +                       +   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H N+   +      S   ++ +L LV E+      T L K  +   +  E I  +  ++L
Sbjct: 73  HPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVPTETIKDMMFQLL 130
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL +LH ++V+HRD+K QN+L+T + ++KL DFG++      +   +  + T ++ APE
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPE 189
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           V+       ++Y    DLWS+G    EM   +P
Sbjct: 190 VLL-----QSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXK---YSNHRN 113
           FE+   +G G +G VY  R  K+  + A+KV+                  +   + +H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y  F  +       +++L++EY   G +   ++  K  +  E+  A I  E+   L
Sbjct: 85  ILRLYNYFYDRR------RIYLILEYAPRGELYKELQ--KSCTFDEQRTATIMEELADAL 136
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            Y H  KVIHRDIK +N+LL    E+K+ DFG S        RR T  GT  ++ PE+I 
Sbjct: 137 MYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSL--RRKTMCGTLDYLPPEMIE 194
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL 265
                   ++ + DLW +G+   E+    PP 
Sbjct: 195 -----GRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 18/227 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +            
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLK 158
                 +  +H NI      F           L LV++Y    +V  + +  S   Q+L 
Sbjct: 66  IM----RKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV-PETVYRVARHYSRAKQTLP 120
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRR 217
             ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R  G  
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEP 178
Query: 218 N-TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           N + I + Y+ APE+I    +    Y +  D+WS G    E+   QP
Sbjct: 179 NVSXICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQP 221

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 70/134 (52%), Gaps = 11/134 (8%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           ++LV    GA    DL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+L
Sbjct: 121 VYLVTHLMGA----DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 176
Query: 193 LTDNAEVKLVDFGVSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
           L    ++K+ DFG++   D      G    ++ T ++ APE++   +     Y    D+W
Sbjct: 177 LNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIW 232
Query: 250 SLGITALEMAESQP 263
           S+G    EM  ++P
Sbjct: 233 SVGCILAEMLSNRP 246

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 13/210 (6%)
Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHR 112
            G +E+ E +G G +G V +  H  TG+  AIK                     K  NH 
Sbjct: 14  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
           N+ +             +D   L MEYC  G +   +   +    LKE  I  +  +I  
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEV---KLVDFGVSAQLDRTIGRRNT-FIGTPYWM 227
            L+YLHEN++IHRD+K +N++L    +    K++D G + +LD+  G   T F+GT  ++
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYL 191
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE 257
           APE++         Y    D WS G  A E
Sbjct: 192 APELLE-----QKKYTVTVDYWSFGTLAFE 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +  P       +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE--PLGL---EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 171
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 172 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 227
Query: 263 P 263
           P
Sbjct: 228 P 228

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 13/210 (6%)
Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHR 112
            G +E+ E +G G +G V +  H  TG+  AIK                     K  NH 
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
           N+ +             +D   L MEYC  G +   +   +    LKE  I  +  +I  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEV---KLVDFGVSAQLDRTIGRRNT-FIGTPYWM 227
            L+YLHEN++IHRD+K +N++L    +    K++D G + +LD+  G   T F+GT  ++
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYL 190
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE 257
           APE++         Y    D WS G  A E
Sbjct: 191 APELLE-----QKKYTVTVDYWSFGTLAFE 215

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 130 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 189
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 190 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 245
Query: 263 P 263
           P
Sbjct: 246 P 246

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 115 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 174
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 175 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 230
Query: 263 P 263
           P
Sbjct: 231 P 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 116 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 175
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 176 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 231
Query: 263 P 263
           P
Sbjct: 232 P 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 107 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 166
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 167 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 222
Query: 263 P 263
           P
Sbjct: 223 P 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 229
Query: 263 P 263
           P
Sbjct: 230 P 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 171
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 172 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 227
Query: 263 P 263
           P
Sbjct: 228 P 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 108 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 167
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 168 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 223
Query: 263 P 263
           P
Sbjct: 224 P 224

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 108 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 167
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 168 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 223
Query: 263 P 263
           P
Sbjct: 224 P 224

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 229
Query: 263 P 263
           P
Sbjct: 230 P 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 169
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 225
Query: 263 P 263
           P
Sbjct: 226 P 226

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 114 TDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 229
Query: 263 P 263
           P
Sbjct: 230 P 230

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 65  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 116
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 177 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 118 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 177
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 178 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 233
Query: 263 P 263
           P
Sbjct: 234 P 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 169
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 225
Query: 263 P 263
           P
Sbjct: 226 P 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 173
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 229
Query: 263 P 263
           P
Sbjct: 230 P 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 173
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 229
Query: 263 P 263
           P
Sbjct: 230 P 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 169
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 225
Query: 263 P 263
           P
Sbjct: 226 P 226

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 65  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 116
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 177 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 169
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 225
Query: 263 P 263
           P
Sbjct: 226 P 226

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     +NT  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDYYKNTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFG 169
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G    ++ T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 225
Query: 263 P 263
           P
Sbjct: 226 P 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN---HRN 113
           FE++  +G G++G+V   +   T ++ A+K M                  +      H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +   + +F        ++ +++V++    G +   ++  +    KEE +     E++  L
Sbjct: 77  LVNLWYSF------QDEEDMFMVVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMAL 128
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            YL   ++IHRD+K  N+LL ++  V + DF ++A L R   +  T  GT  +MAPE+ +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFS 187
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             +   A Y    D WSLG+TA E+   + P
Sbjct: 188 SRKG--AGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G G++    K  H K+ Q  A+K++                  +   H NI   +  F 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE--GHPNIVKLHEVF- 75
Query: 123 KKSPPGKDDQL--WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
                   DQL  +LVME    G + + +K  K +   E   ++I R+++  + ++H+  
Sbjct: 76  -------HDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 181 VIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTP----YWMAPEVIA 233
           V+HRD+K +N+L T   DN E+K++DFG +    R     N  + TP    ++ APE++ 
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFA----RLKPPDNQPLKTPCFTLHYAAPELL- 181
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL 265
            ++N    YD   DLWSLG+    M   Q P 
Sbjct: 182 -NQN---GYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPAFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXXXXX 103
           D W E P    +L+E +G G +G+V+ G    HTK     A+K +               
Sbjct: 1   DEW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLAEAN 55
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              +  + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L    + 
Sbjct: 56  LMKQLQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTINKLL 107
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIG 222
            +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R     
Sbjct: 108 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 167
Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              W APE I        T+  +SD+WS GI   E+ 
Sbjct: 168 PIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIV 199

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI T  GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXK 107
           +W  DP+ +   ++ +G+G +G V+ G      ++A IK +                  K
Sbjct: 4   KWVIDPSEL-TFVQEIGSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIEEAEVMMK 61
Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
            S H  +   YG  ++++P      + LV E+   G ++D +++ +G    E  +  +C 
Sbjct: 62  LS-HPKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLG-MCL 113
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIGTPY- 225
           ++  G+ YL E  VIHRD+  +N L+ +N  +K+ DFG++   LD    +  +  GT + 
Sbjct: 114 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFP 170
Query: 226 --WMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPP 264
             W +PEV +      + Y ++SD+WS G+   E+ +E + P
Sbjct: 171 VKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIP 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXK 107
           +W  DP+ +   ++ +G+G +G V+ G      ++A IK +                  K
Sbjct: 2   KWVIDPSEL-TFVQEIGSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIEEAEVMMK 59
Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
            S H  +   YG  ++++P      + LV E+   G ++D +++ +G    E  +  +C 
Sbjct: 60  LS-HPKLVQLYGVCLEQAP------ICLVTEFMEHGCLSDYLRTQRGLFAAETLLG-MCL 111
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIGTPY- 225
           ++  G+ YL E  VIHRD+  +N L+ +N  +K+ DFG++   LD    +  +  GT + 
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFP 168
Query: 226 --WMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPP 264
             W +PEV +      + Y ++SD+WS G+   E+ +E + P
Sbjct: 169 VKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIP 205

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 16/225 (7%)
Query: 35  LEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXX 94
           L+   Y    PE  +Q+     F+ +  +G+G+YG+V+K R  + G+L A+K        
Sbjct: 41  LQSPGYDPSRPESFFQQS----FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK---RSMSP 93
Query: 95  XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
                       +  +H  +  +      +    +   L+L  E CG  S+    ++  G
Sbjct: 94  FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAW-G 151
Query: 155 QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI 214
            SL E  +    R+ L  L +LH   ++H D+K  N+ L      KL DFG+  +L  T 
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TA 210
Query: 215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           G      G P +MAPE++        +Y   +D++SLG+T LE+A
Sbjct: 211 GAGEVQEGDPRYMAPELL------QGSYGTAADVFSLGLTILEVA 249

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 26/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIR 322
            N     +         + FI  +LVKD  +R      L+HP+I+
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 26/285 (9%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L++E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIR 322
            N     +         + FI  +LVKD  +R      L+HP+I+
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 26/291 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX------XX 103
           QE+    ++  E +G+G +  V K R   TG   A K +                     
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H N+ T +  +  K+       + L+ E    G + D +   + +SL EE   
Sbjct: 66  SILKEIQHPNVITLHEVYENKT------DVILIGELVAGGELFDFL--AEKESLTEEEAT 117
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTD----NAEVKLVDFGVSAQLDRTIGRRNT 219
              ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D     +N 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIP 278
           F GTP ++APE++  +          +D+WS+G IT + ++ + P L D        +  
Sbjct: 178 F-GTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 279 RNAPPRLKSKKWPKKF-QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            N     +         + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 64/121 (52%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G     + T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 174 LARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 229
Query: 263 P 263
           P
Sbjct: 230 P 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 64/121 (52%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+LL    ++K+ DFG
Sbjct: 115 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 174
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G     + T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 175 LARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 230
Query: 263 P 263
           P
Sbjct: 231 P 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 71  PEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 130
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 184
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 298

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 9/209 (4%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F  + V+G G++G+V       T +L A+K++                  +         
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +       S     D+L+ VMEY   G +   ++       KE    F   EI  GL +L
Sbjct: 403 FLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFL 458
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
               +I+RD+K  NV+L     +K+ DFG+  +          F GTP ++APE+IA   
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ- 517
Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPL 265
                Y    D W+ G+   EM   Q P 
Sbjct: 518 ----PYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 9/209 (4%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F  + V+G G++G+V       T +L A+K++                  +         
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +       S     D+L+ VMEY   G +   ++       KE    F   EI  GL +L
Sbjct: 82  FLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFL 137
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
               +I+RD+K  NV+L     +K+ DFG+  +          F GTP ++APE+IA   
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ- 196
Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPL 265
                Y    D W+ G+   EM   Q P 
Sbjct: 197 ----PYGKSVDWWAFGVLLYEMLAGQAPF 221

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           +V+G G  G+V +  H +TGQ  A+K++                  + S   +I      
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW----QASGGPHIVCILDV 71
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           + +    GK   L ++ME    G +   ++    Q+  E   A I R+I   +++LH + 
Sbjct: 72  Y-ENMHHGKR-CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 129
Query: 181 VIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           + HRD+K +N+L T    +A +KL DFG + +   T     T   TPY++APEV+  ++ 
Sbjct: 130 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPCYTPYYVAPEVLGPEK- 186
Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCD-----LHP-MRALFLIPRNAPPRLKSKKWP 291
               YD   D+WSLG+    +    PP        + P M+    + +   P  +  +  
Sbjct: 187 ----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 242
Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +  I  +L  D  +R    Q + HP+I
Sbjct: 243 EDAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 64/121 (52%), Gaps = 7/121 (5%)
Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
           TDL K  K Q L  + I +   +ILRGLKY+H   V+HRD+K  N+L+    ++K+ DFG
Sbjct: 130 TDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFG 189
Query: 206 VSAQLD---RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           ++   D      G     + T ++ APE++   +     Y    D+WS+G    EM  ++
Sbjct: 190 LARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG----YTKSIDIWSVGCILAEMLSNR 245
Query: 263 P 263
           P
Sbjct: 246 P 246

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN---H 111
           G + + E +G G++G+V    H KT Q  A+K +                   Y     H
Sbjct: 9   GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y      +       + +V+EY G G + D +   K  +  E    F  ++I+ 
Sbjct: 69  PHIIKLYDVITTPT------DIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFF--QQIIC 119
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTPYWMAPE 230
            ++Y H +K++HRD+K +N+LL DN  VK+ DFG+S  +  T G    T  G+P + APE
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPE 177
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           VI    N         D+WS GI    M   + P  D
Sbjct: 178 VI----NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---XXXXXXXXXXXXXXXXXXKYSNH 111
           G + L + +G GT+G+V  G H  TG   A+K++                     K   H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y      S P      ++VMEY   G + D +   K   ++E     + ++IL 
Sbjct: 71  PHIIKLYQVI---STP---TDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILS 122
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            + Y H + V+HRD+K +NVLL  +   K+ DFG+S  +      R++  G+P + APEV
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS-CGSPNYAAPEV 181
Query: 232 IA--CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
           I+      P+       D+WS G+    +     P  D H
Sbjct: 182 ISGRLYAGPEV------DIWSCGVILYALLCGTLPFDDEH 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + I  +G G +G V   R+      TG L A+K +                  K  +  
Sbjct: 9   LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSD 68
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I  Y G       PG+  +L LVMEY  +G + D ++  + + L    +     +I +G
Sbjct: 69  FIVKYRGV---SYGPGRP-ELRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKG 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-----YWM 227
           ++YL   + +HRD+  +N+L+   A VK+ DFG++  L   + +    +  P     +W 
Sbjct: 124 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDXXVVREPGQSPIFWY 181
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM 258
           APE ++     D  +  +SD+WS G+   E+
Sbjct: 182 APESLS-----DNIFSRQSDVWSFGVVLYEL 207

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 22/270 (8%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           +V+G G  G+V +  H +TGQ  A+K++                  + S   +I      
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW----QASGGPHIVCILDV 90
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           + +    GK   L ++ME    G +   ++    Q+  E   A I R+I   +++LH + 
Sbjct: 91  Y-ENMHHGKR-CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148
Query: 181 VIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           + HRD+K +N+L T    +A +KL DFG + +  +   +   +  TPY++APEV+  ++ 
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVAPEVLGPEK- 205
Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCD-----LHP-MRALFLIPRNAPPRLKSKKWP 291
               YD   D+WSLG+    +    PP        + P M+    + +   P  +  +  
Sbjct: 206 ----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261
Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +  +  I  +L  D  +R    Q + HP+I
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP+ +   ++ +G+G +G V+ G      ++A IK +                  K S H
Sbjct: 5   DPSEL-TFVQEIGSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIEEAEVMMKLS-H 61
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             +   YG  ++++P      + LV E+   G ++D +++ +G    E  +  +C ++  
Sbjct: 62  PKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCE 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIGTPY---WM 227
           G+ YL E  VIHRD+  +N L+ +N  +K+ DFG++   LD    +  +  GT +   W 
Sbjct: 115 GMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWA 171
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM-AESQPP 264
           +PEV +      + Y ++SD+WS G+   E+ +E + P
Sbjct: 172 SPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 14  PEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 73
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 127
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 128 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 187
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 188 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 241

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 28/268 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
            E+ EVVG G +G V K +     +   + +                      NH NI  
Sbjct: 11  IEVEEVVGRGAFGVVCKAK----WRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK 66
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI-CREILRGLKY 175
            YGA +        + + LVMEY   GS+ +++   +         A   C +  +G+ Y
Sbjct: 67  LYGACL--------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 176 LHE---NKVIHRDIKGQNVLLTDNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           LH      +IHRD+K  N+LL     V K+ DFG +  +   +       G+  WMAPEV
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 175
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH--PMRALFLIPRNAPPRLKSKK 289
                   + Y  + D++S GI   E+   + P  ++     R ++ +     P L  K 
Sbjct: 176 FE-----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL-IKN 229
Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLK 317
            PK  +S +     KD  QRP  ++++K
Sbjct: 230 LPKPIESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 12  PEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 71
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 125
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 126 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKI 185
Query: 202 VDFGVSAQLDRTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 186 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 239

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---XXXXXXXXXXXXXXXXXXKYSNH 111
           G + L + +G GT+G+V  G H  TG   A+K++                     K   H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I   Y      S P      ++VMEY   G + D +   K   ++E     + ++IL 
Sbjct: 71  PHIIKLYQVI---STP---TDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILS 122
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            + Y H + V+HRD+K +NVLL  +   K+ DFG+S  +      R T  G+P + APEV
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEV 181
Query: 232 IA--CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
           I+      P+       D+WS G+    +     P  D H
Sbjct: 182 ISGRLYAGPEV------DIWSCGVILYALLCGTLPFDDEH 215

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 17  PEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 76
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 130
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 131 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 190
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 191 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 244

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 28/268 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
            E+ EVVG G +G V K +     +   + +                      NH NI  
Sbjct: 10  IEVEEVVGRGAFGVVCKAK----WRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK 65
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI-CREILRGLKY 175
            YGA +        + + LVMEY   GS+ +++   +         A   C +  +G+ Y
Sbjct: 66  LYGACL--------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 176 LHE---NKVIHRDIKGQNVLLTDNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           LH      +IHRD+K  N+LL     V K+ DFG +  +   +       G+  WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH--PMRALFLIPRNAPPRLKSKK 289
                   + Y  + D++S GI   E+   + P  ++     R ++ +     P L  K 
Sbjct: 175 FE-----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL-IKN 228
Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLK 317
            PK  +S +     KD  QRP  ++++K
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 15/216 (6%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXX 103
           W +D W E P    +L++ +G G +G+V+ G +  + ++A +K +               
Sbjct: 3   WDKDAW-EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVA-VKTLKPGTMSVQAFLEEAN 60
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K   H  +   Y    ++ P      ++++ EY   GS+ D +KS +G  +    + 
Sbjct: 61  LM-KTLQHDKLVRLYAVVTREEP------IYIITEYMAKGSLLDFLKSDEGGKVLLPKLI 113
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIG 222
               +I  G+ Y+     IHRD++  NVL++++   K+ DFG++  + D     R     
Sbjct: 114 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 173
Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              W APE I         +  +SD+WS GI   E+
Sbjct: 174 PIKWTAPEAINF-----GCFTIKSDVWSFGILLYEI 204

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 123/290 (42%), Gaps = 45/290 (15%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +EL++ +G+G +G     R  ++ +L A+K +                  +   H NI  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH-RSLRHPNIVR 79
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    +  +       L +VMEY   G + + +         E+   F  ++++ G+ Y 
Sbjct: 80  FKEVILTPT------HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYC 131
Query: 177 HENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H  +V HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 190
Query: 235 DENPDATYDNR-SDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
            E     YD + +D+WS G+T   M     P  D                     + PK 
Sbjct: 191 KE-----YDGKVADVWSCGVTLYVMLVGAYPFED--------------------PEEPKN 225
Query: 294 FQSFIETVL-----VKDY-HQRPYTDQLLKHPFIRDQPTERQARIQLKDH 337
           F+  I  +L     + DY H  P    L+   F+ D P +R +  ++++H
Sbjct: 226 FRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD-PAKRISIPEIRNH 274

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 51  EDPAGIFE-----LIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXX 101
           +DP  IFE      I  +G G +G V   R+      TG L A+K +             
Sbjct: 3   QDPT-IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 61
Query: 102 XXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
                K  +   I  Y G       PG+   L LVMEY  +G + D ++  + + L    
Sbjct: 62  EIQILKALHSDFIVKYRGV---SYGPGRQS-LRLVMEYLPSGCLRDFLQRHRAR-LDASR 116
Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           +     +I +G++YL   + +HRD+  +N+L+   A VK+ DFG++  L   + +    +
Sbjct: 117 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVV 174
Query: 222 GTP-----YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             P     +W APE ++     D  +  +SD+WS G+   E+
Sbjct: 175 REPGQSPIFWYAPESLS-----DNIFSRQSDVWSFGVVLYEL 211

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 108/275 (39%), Gaps = 33/275 (12%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMX----XXXXXXXXXXXXXXXXXKYSNHR 112
             L E++G G +G+VY  R    G   A+K                            H 
Sbjct: 9   LTLEEIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI    G  +K      +  L LVME+   G +    +   G+ +  + +     +I RG
Sbjct: 67  NIIALRGVCLK------EPNLCLVMEFARGGPLN---RVLSGKRIPPDILVNWAVQIARG 117
Query: 173 LKYLHENKV---IHRDIKGQNVLLTDNAE--------VKLVDFGVSAQLDRTIGRRNTFI 221
           + YLH+  +   IHRD+K  N+L+    E        +K+ DFG++ +  RT   + +  
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAA 175
Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           G   WMAPEVI       + +   SD+WS G+   E+   + P   +  +   + +  N 
Sbjct: 176 GAYAWMAPEVIRA-----SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230
Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLL 316
                    P+ F   +E     D H RP    +L
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 51  EDPAGIFE-----LIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXX 101
           +DP  IFE      I  +G G +G V   R+      TG L A+K +             
Sbjct: 2   QDPT-IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 102 XXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
                K  +   I  Y G       PG+   L LVMEY  +G + D ++  + + L    
Sbjct: 61  EIQILKALHSDFIVKYRGV---SYGPGRQS-LRLVMEYLPSGCLRDFLQRHRAR-LDASR 115
Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           +     +I +G++YL   + +HRD+  +N+L+   A VK+ DFG++  L   + +    +
Sbjct: 116 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVV 173
Query: 222 GTP-----YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             P     +W APE ++     D  +  +SD+WS G+   E+
Sbjct: 174 REPGQSPIFWYAPESLS-----DNIFSRQSDVWSFGVVLYEL 210

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP+ +   ++ +G+G +G V+ G      ++A IK +                  K S H
Sbjct: 3   DPSEL-TFVQEIGSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIEEAEVMMKLS-H 59
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             +   YG  ++++P      + LV E+   G ++D +++ +G    E  +  +C ++  
Sbjct: 60  PKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCE 112
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIGTPY---WM 227
           G+ YL E  VIHRD+  +N L+ +N  +K+ DFG++   LD    +  +  GT +   W 
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWA 169
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM-AESQPP 264
           +PEV +      + Y ++SD+WS G+   E+ +E + P
Sbjct: 170 SPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIP 202

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           ++ +G GTY  VYKG+   T  L A+K +                   K   H NI T +
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYL 176
                      +  L LV EY       DL +     G  +    +     ++LRGL Y 
Sbjct: 67  DII------HTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
           H  KV+HRD+K QN+L+ +  E+KL DFG++          +  + T ++  P+++    
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176
Query: 237 NPDATYDNRSDLWSLGITALEMAESQP 263
           +    Y  + D+W +G    EMA  +P
Sbjct: 177 D----YSTQIDMWGVGCIFYEMATGRP 199

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP+ +   ++ +G+G +G V+ G      ++A IK +                  K S H
Sbjct: 5   DPSEL-TFVQEIGSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIEEAEVMMKLS-H 61
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             +   YG  ++++P      + LV E+   G ++D +++ +G    E  +  +C ++  
Sbjct: 62  PKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCE 114
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIGTPY---WM 227
           G+ YL E  VIHRD+  +N L+ +N  +K+ DFG++   LD    +  +  GT +   W 
Sbjct: 115 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWA 171
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM-AESQPP 264
           +PEV +      + Y ++SD+WS G+   E+ +E + P
Sbjct: 172 SPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS------------- 109
           +G+G YG+V   +        AIKV+                  K+              
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +H NI   +  F  K         +LV E+   G + + +         E   A I ++I
Sbjct: 104 DHPNIIKLFDVFEDKK------YFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQI 155
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDN---AEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
           L G+ YLH++ ++HRDIK +N+LL +      +K+VDFG+S+   +    R+  +GT Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR-LGTAYY 214
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           +APEV+         Y+ + D+WS G+    +    PP    +    +  + +       
Sbjct: 215 IAPEVLK------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-GKYYFD 267
Query: 287 SKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              W     + +  I+ +L  DY++R   ++ L   +I+
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/281 (21%), Positives = 129/281 (45%), Gaps = 19/281 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           ++++E +G+G +G V++     TG++   K +                     +H  +  
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + AF  K       ++ L++E+   G + D + +   +  + E I ++ R+   GLK++
Sbjct: 113 LHDAFEDKY------EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM-RQACEGLKHM 165
Query: 177 HENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           HE+ ++H DIK +N++      + VK++DFG++ +L+     + T   T  + APE++  
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIV-- 222
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLC---DLHPMRALFLIPRNAPPRLKSKKWP 291
           D  P   Y   +D+W++G+    +     P     DL  ++ +            S   P
Sbjct: 223 DREPVGFY---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARI 332
           +  + FI+ +L K+  +R      L+HP+++   +   +RI
Sbjct: 280 EA-KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 51  EDPAGIFE-----LIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXX 101
           +DP  IFE      I  +G G +G V   R+      TG L A+K +             
Sbjct: 15  QDPT-IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 73
Query: 102 XXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
                K  +   I  Y G       PG+   L LVMEY  +G + D ++  + + L    
Sbjct: 74  EIQILKALHSDFIVKYRGV---SYGPGRQS-LRLVMEYLPSGCLRDFLQRHRAR-LDASR 128
Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           +     +I +G++YL   + +HRD+  +N+L+   A VK+ DFG++  L   + +    +
Sbjct: 129 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVV 186
Query: 222 GTP-----YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             P     +W APE ++     D  +  +SD+WS G+   E+
Sbjct: 187 REPGQSPIFWYAPESLS-----DNIFSRQSDVWSFGVVLYEL 223

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +++
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
            +L+EV   G +G V+K +     +  A+K+                       H NI  
Sbjct: 26  LQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQ 82
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           + GA  +K     D  LWL+  +   GS++D +K+     +    +  I   + RGL YL
Sbjct: 83  FIGA--EKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYL 137
Query: 177 HEN----------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD--RTIGRRNTFIGTP 224
           HE+           + HRDIK +NVLL +N    + DFG++ + +  ++ G  +  +GT 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            +MAPEV+    N       R D++++G+   E+A
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXX 103
           W +   ++  +  FE+   +G G    VY+ +   T +  A+KV+               
Sbjct: 42  WIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-------------- 87
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPG---------KDDQLWLVMEYCGAGSVTDLVKSTKG 154
              K  + + + T  G  ++ S P             ++ LV+E    G + D +     
Sbjct: 88  ---KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY 144
Query: 155 QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLD 211
            S ++   A   ++IL  + YLHEN ++HRD+K +N+L      +A +K+ DFG+S  ++
Sbjct: 145 YSERDA--ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 212 RTIGRRNTFIGTPYWMAPEVI-ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP 270
             +  + T  GTP + APE++  C   P+       D+WS+GI    +     P  D   
Sbjct: 203 HQVLMK-TVCGTPGYCAPEILRGCAYGPEV------DMWSVGIITYILLCGFEPFYDERG 255
Query: 271 MRALFLIPRNAPPRLKSKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
            + +F    N      S  W +     +  +  ++V D  +R  T Q L+HP++
Sbjct: 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           DP+ +   ++ +G+G +G V+ G      ++A IK +                  K S H
Sbjct: 25  DPSEL-TFVQEIGSGQFGLVHLGYWLNKDKVA-IKTIKEGSMSEDDFIEEAEVMMKLS-H 81
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             +   YG  ++++P      + LV E+   G ++D +++ +G    E  +  +C ++  
Sbjct: 82  PKLVQLYGVCLEQAP------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCE 134
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIGTPY---WM 227
           G+ YL E  VIHRD+  +N L+ +N  +K+ DFG++   LD    +  +  GT +   W 
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWA 191
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM-AESQPP 264
           +PEV +      + Y ++SD+WS G+   E+ +E + P
Sbjct: 192 SPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIP 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 51  EDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXK 107
           E P    +L+E +G G +G+V+ G    HTK     A+K +                  +
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV----AVKSLKQGSMSPDAFLAEANLMKQ 60
Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
             + R +  Y  A + + P      ++++ EY   GS+ D +K+  G  L    +  +  
Sbjct: 61  LQHQRLVRLY--AVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 112
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYW 226
           +I  G+ ++ E   IHR+++  N+L++D    K+ DFG++  + D     R        W
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            APE I        T+  +SD+WS GI   E+ 
Sbjct: 173 TAPEAINY-----GTFTIKSDVWSFGILLTEIV 200

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 123/290 (42%), Gaps = 45/290 (15%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +EL++ +G+G +G     R  ++ +L A+K +                  +   H NI  
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH-RSLRHPNIVR 78
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    +  +       L +VMEY   G + + +         E+   F  ++++ G+ Y 
Sbjct: 79  FKEVILTPT------HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYC 130
Query: 177 HENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H  +V HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 189
Query: 235 DENPDATYDNR-SDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
            E     YD + +D+WS G+T   M     P  D                     + PK 
Sbjct: 190 KE-----YDGKVADVWSCGVTLYVMLVGAYPFED--------------------PEEPKN 224
Query: 294 FQSFIETVL-----VKDY-HQRPYTDQLLKHPFIRDQPTERQARIQLKDH 337
           F+  I  +L     + DY H  P    L+   F+ D P +R +  ++++H
Sbjct: 225 FRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD-PAKRISIPEIRNH 273

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 7   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 64
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       ++++E+   G++ D ++    Q +    + ++ 
Sbjct: 65  KEIKHPNLVQLLGVCTREPP------FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 178
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 179 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 207

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 99/247 (40%), Gaps = 60/247 (24%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX-----XXXXXXXXXXXKYSNH 111
           + L   +G G+YG V      +T  + AIK+M                       K  +H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 112 RNIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTD----LVKSTKGQSL--------- 157
            NIA  Y  +       +D+Q + LVME C  G + D     +  + G+           
Sbjct: 88  PNIARLYEVY-------EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 158 -------------------------KEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
                                    +E+ I+ I R+I   L YLH   + HRDIK +N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 193 LTDNA--EVKLVDFGVSAQLDRTIGRR----NTFIGTPYWMAPEVIACDENPDATYDNRS 246
            + N   E+KLVDFG+S +  +          T  GTPY++APEV+      + +Y  + 
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL---NTTNESYGPKC 257
Query: 247 DLWSLGI 253
           D WS G+
Sbjct: 258 DAWSAGV 264

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A      +       L  E ++++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +A +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G+   EM
Sbjct: 187 VTRYYRAPEVILG-----MGYKENVDIWSVGVIMGEM 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A      +       L  E ++++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +A +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G+   EM
Sbjct: 187 VTRYYRAPEVILG-----MGYKENVDIWSVGVIMGEM 218

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 11  DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 68
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       ++++E+   G++ D ++    Q +    + ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPP------FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 183 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 211

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 4   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 61
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       ++++E+   G++ D ++    Q +    + ++ 
Sbjct: 62  KEIKHPNLVQLLGVCTREPP------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 115
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 176 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 204

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 63  VGNGTYGQVYKGRHTKTG-QLAAIKVMXXXXXXXXXXX-XXXXXXXKYSNHRNIATYYGA 120
           +G G++  VYKG  T+T  ++A  ++                    K   H NI  +Y +
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK--EEWIAFICREILRGLKYLHE 178
           + + +  GK   + LV E   +G++   +K  K   +K    W    CR+IL+GL++LH 
Sbjct: 94  W-ESTVKGKK-CIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW----CRQILKGLQFLHT 147
Query: 179 NK--VIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
               +IHRD+K  N+ +T     VK+ D G++     +  +    IGTP + APE     
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFXAPEXY--- 202
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNAPPRLKSKKWPKKF 294
              +  YD   D+++ G   LE A S+ P  +      ++  +     P    K    + 
Sbjct: 203 ---EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
           +  IE  + ++  +R     LL H F +++
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++VMEY   G + D +K   G+ L+  
Sbjct: 63  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVMEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 164 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 217
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 218 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 277
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 278 TEPTQRMTITEFMNHPWI 295

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 15/222 (6%)
Query: 40  YTEGWPE-DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXX 98
           Y +G P  D+W+ +   I  +   +G G YG+VY+G   K     A+K +          
Sbjct: 11  YFQGSPNYDKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 69
Query: 99  XXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK 158
                   K   H N+    G   ++ P       +++ E+   G++ D ++    Q + 
Sbjct: 70  LKEAAVM-KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVN 122
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN 218
              + ++  +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +
Sbjct: 123 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 182
Query: 219 TFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                P  W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 183 AGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 219

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V+EY   GS+ D +K   G+ L+  
Sbjct: 63  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 45/290 (15%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +EL++ +G G +G     R  +  +L A+K +                  +   H NI  
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH-RSLRHPNIVR 79
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    +  +       L +VMEY   G + + +         E+   F  ++++ G+ Y 
Sbjct: 80  FKEVILTPT------HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYA 131
Query: 177 HENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H  +V HRD+K +N LL  +    +K+ DFG S +      +  + +GTP ++APEV+  
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYS-KASVLHSQPKSAVGTPAYIAPEVLLK 190
Query: 235 DENPDATYDNR-SDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
            E     YD + +D+WS G+T   M     P  D                     + PK 
Sbjct: 191 KE-----YDGKVADVWSCGVTLYVMLVGAYPFED--------------------PEEPKN 225
Query: 294 FQSFIETVL-----VKDY-HQRPYTDQLLKHPFIRDQPTERQARIQLKDH 337
           F+  I  +L     + DY H  P    L+   F+ D P +R +  ++++H
Sbjct: 226 FRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD-PAKRISIPEIRNH 274

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 156 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 209
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 210 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 269
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 270 TEPTQRMTITEFMNHPWI 287

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V+EY   GS+ D +K   G+ L+  
Sbjct: 63  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 11  DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 68
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 182
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 183 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 211

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 6   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 63
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       ++++E+   G++ D ++    Q +    + ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPP------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 178 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 6   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 63
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       ++++E+   G++ D ++    Q +    + ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPP------FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 178 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 206

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++ Y   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVAYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 154 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 207
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 208 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 267
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 268 TEPTQRMTITEFMNHPWI 285

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 18/189 (9%)
Query: 135 LVMEYCGAGSVTDLVKST-KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL 193
           LVME  G+G   DL     +   L E   ++I R+++  + YL    +IHRDIK +N+++
Sbjct: 106 LVMEKHGSG--LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163
Query: 194 TDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
            ++  +KL+DFG +A L+R  G+   TF GT  + APEV+    NP        ++WSLG
Sbjct: 164 AEDFTIKLIDFGSAAYLER--GKLFYTFCGTIEYCAPEVLMG--NP--YRGPELEMWSLG 217
Query: 253 ITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
           +T   +   + P C+L       +     PP L S    K+  S +  +L     +R   
Sbjct: 218 VTLYTLVFEENPFCELEETVEAAI----HPPYLVS----KELMSLVSGLLQPVPERRTTL 269
Query: 313 DQLLKHPFI 321
           ++L+  P++
Sbjct: 270 EKLVTDPWV 278

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 155 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 208
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 209 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 268
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 269 TEPTQRMTITEFMNHPWI 286

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 148 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 201
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 261
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 262 TEPTQRMTITEFMNHPWI 279

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 150 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 203
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 264 TEPTQRMTITEFMNHPWI 281

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 150 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 203
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 204 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 264 TEPTQRMTITEFMNHPWI 281

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 194 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 247
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 308 TEPTQRMTITEFMNHPWI 325

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 149 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 202
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 203 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 262
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 263 TEPTQRMTITEFMNHPWI 280

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D+W
Sbjct: 200 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMW 253
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 254 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 313
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 314 TEPTQRMTITEFMNHPWI 331

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           ++ +E VG GTYG VYK + ++ G++ A+K   +                  K  +H NI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
            +             +  L LV E+        L ++  G  L++  I     ++LRG+ 
Sbjct: 82  VSLIDVI------HSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVA 133
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           + H+++++HRD+K QN+L+  +  +KL DFG++      +      + T ++ AP+V+  
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQP 263
            +     Y    D+WS+G    EM   +P
Sbjct: 194 SKK----YSTSVDIWSIGCIFAEMITGKP 218

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 11  DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 68
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 183 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 211

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           ++ +E VG GTYG VYK + ++ G++ A+K   +                  K  +H NI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
            +             +  L LV E+        L ++  G  L++  I     ++LRG+ 
Sbjct: 82  VSLIDVI------HSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVA 133
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           + H+++++HRD+K QN+L+  +  +KL DFG++      +      + T ++ AP+V+  
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQP 263
            +     Y    D+WS+G    EM   +P
Sbjct: 194 SKK----YSTSVDIWSIGCIFAEMITGKP 218

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 67  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 118
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 179 RRE----FHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 10  DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 67
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 68  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 121
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 182 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 210

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMX--XXXXXX 95
           PED   E P     L + +G G +GQV             K     A+K++         
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 96  XXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                          H+NI    GA  +  P      L++++ Y   G++ + +++ +  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVGYASKGNLREYLRARRPP 138
Query: 156 SLK---------EEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            ++         EE + F        ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  ++     + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEI 252

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           +D W E P    +LI+ +GNG +G+V+ G      ++A IK +                 
Sbjct: 1   KDVW-EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVA-IKTLKPGTMSPESFLEEAQIM 58
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
            K  + + +  Y  A + + P      +++V EY   GS+ D +K  +G++LK   +  +
Sbjct: 59  KKLKHDKLVQLY--AVVSEEP------IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTP 224
             ++  G+ Y+     IHRD++  N+L+ +    K+ DFG++  + D     R       
Sbjct: 111 AAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPI 170
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            W APE           +  +SD+WS GI   E+ 
Sbjct: 171 KWTAPEAALY-----GRFTIKSDVWSFGILLTELV 200

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 63  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 4   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 61
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 62  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 115
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK 175
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 176 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 6   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 63
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 117
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 178 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 6   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 63
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 117
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 178 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 11  DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 68
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 122
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 183 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 211

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 63  EAQVMKKIRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A      +       L  E ++++ 
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 219

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 8   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 65
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 180 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 208

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 6   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 63
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 178 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 206

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 8   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 65
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 180 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXX-XXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 11  DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 68
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 183 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 211

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 6   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 63
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 178 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 206

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)
Query: 56  IFELIE-VVGNGTYGQVYKGRHTKTGQLAAIKVMXXX-XXXXXXXXXXXXXXXKYSNHRN 113
           +++L E V+G G + +V    +  T Q  A+K++                   +   HRN
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +              ++D+ +LV E    GS+   +   K +   E   + + +++   L
Sbjct: 73  VLE------LIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASAL 124
Query: 174 KYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDR-------TIGRRNTFIGT 223
            +LH   + HRD+K +N+L       + VK+ DFG+ + +         +     T  G+
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRA--- 273
             +MAPEV+       + YD R DLWSLG+    +    PP        C      A   
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 274 ----LFLIPRNAPPRLKSKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
               LF   +        K W       +  I  +LV+D  QR    Q+L+HP+++
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 63  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVCEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 2   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 59
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 60  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMNKGSLLDFLKGETGKYLRLP 111
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 112 QLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 171
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 172 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 16/216 (7%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXX-XXXXXXXXXX 103
           P+D+W  +   +  L E +G G +G+V+ GR      L A+K                  
Sbjct: 105 PKDKWVLNHEDLV-LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEA 163
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K  +H NI    G   +K P      +++VME    G     ++ T+G  L+ + + 
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP------IYIVMELVQGGDFLTFLR-TEGARLRVKTLL 216
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIG 222
            +  +   G++YL     IHRD+  +N L+T+   +K+ DFG+S  + D           
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQ 276
Query: 223 TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALE 257
            P  W APE +         Y + SD+WS GI   E
Sbjct: 277 VPVKWTAPEALNY-----GRYSSESDVWSFGILLWE 307

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGHR------REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 16/216 (7%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXX-XXXXXXXXXX 103
           P+D+W  +   +  L E +G G +G+V+ GR      L A+K                  
Sbjct: 105 PKDKWVLNHEDLV-LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEA 163
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
              K  +H NI    G   +K P      +++VME    G     ++ T+G  L+ + + 
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP------IYIVMELVQGGDFLTFLR-TEGARLRVKTLL 216
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-AQLDRTIGRRNTFIG 222
            +  +   G++YL     IHRD+  +N L+T+   +K+ DFG+S  + D           
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ 276
Query: 223 TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALE 257
            P  W APE +         Y + SD+WS GI   E
Sbjct: 277 VPVKWTAPEALNY-----GRYSSESDVWSFGILLWE 307

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 171 TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 228
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 229 EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 341 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 374

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 254 TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 311
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 312 EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGETGKYLRLP 363
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 364 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 424 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 457

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGHR------REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A      +       L  E ++++ 
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 219

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 171 TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 228
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 229 EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 341 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 374

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A      +       L  E ++++ 
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLL 125
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 126 YQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG----LARTAG--TSFMMTPYV 179
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 180 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 212

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A      +       L  E ++++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +A +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 187 VTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEM 218

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 61  EVVGNGTYGQVYKGRHTKTG--QLAAIKVMXXXXXX--XXXXXXXXXXXXKYSNHRNIAT 116
           +V+G G +GQV K R  K G    AAIK M                    K  +H NI  
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWI 162
             GA   +        L+L +EY   G++ D ++ ++                +L  + +
Sbjct: 91  LLGACEHRG------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRN 218
                ++ RG+ YL + + IHRD+  +N+L+ +N   K+ DFG+S      + +T+GR  
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
                  WMA E +       + Y   SD+WS G+   E+      P C +
Sbjct: 205 V-----RWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 45/290 (15%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +EL++ +G+G +G     R  ++ +L A+K +                  +   H NI  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH-RSLRHPNIVR 79
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    +  +       L +VMEY   G + + +         E+   F  ++++ G+ Y 
Sbjct: 80  FKEVILTPT------HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYC 131
Query: 177 HENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H  +V HRD+K +N LL  +    +K+  FG S         ++T +GTP ++APEV+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVLLK 190
Query: 235 DENPDATYDNR-SDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
            E     YD + +D+WS G+T   M     P  D                     + PK 
Sbjct: 191 KE-----YDGKVADVWSCGVTLYVMLVGAYPFED--------------------PEEPKN 225
Query: 294 FQSFIETVL-----VKDY-HQRPYTDQLLKHPFIRDQPTERQARIQLKDH 337
           F+  I  +L     + DY H  P    L+   F+ D P +R +  ++++H
Sbjct: 226 FRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD-PAKRISIPEIRNH 274

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G +G+VY+G   K     A+K +                  
Sbjct: 4   DKWEMERTDI-TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 61
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 62  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 115
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 176 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 204

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 61  EVVGNGTYGQVYKGRHTKTG--QLAAIKVMXXXXXX--XXXXXXXXXXXXKYSNHRNIAT 116
           +V+G G +GQV K R  K G    AAIK M                    K  +H NI  
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWI 162
             GA   +        L+L +EY   G++ D ++ ++                +L  + +
Sbjct: 81  LLGACEHRG------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRN 218
                ++ RG+ YL + + IHRD+  +N+L+ +N   K+ DFG+S      + +T+GR  
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
                  WMA E +       + Y   SD+WS G+   E+      P C +
Sbjct: 195 V-----RWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 235

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 45/290 (15%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +EL++ +G+G +G     R  ++ +L A+K +                  +   H NI  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH-RSLRHPNIVR 79
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    +  +       L +VMEY   G + + +         E+   F  ++++ G+ Y 
Sbjct: 80  FKEVILTPT------HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYC 131
Query: 177 HENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H  +V HRD+K +N LL  +    +K+  FG S         ++T +GTP ++APEV+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 190
Query: 235 DENPDATYDNR-SDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
            E     YD + +D+WS G+T   M     P  D                     + PK 
Sbjct: 191 KE-----YDGKVADVWSCGVTLYVMLVGAYPFED--------------------PEEPKN 225
Query: 294 FQSFIETVL-----VKDY-HQRPYTDQLLKHPFIRDQPTERQARIQLKDH 337
           F+  I  +L     + DY H  P    L+   F+ D P +R +  ++++H
Sbjct: 226 FRKTIHRILNVQYAIPDYVHISPECRHLISRIFVAD-PAKRISIPEIRNH 274

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 2   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 59
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 60  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMNKGSLLDFLKGETGKYLRLP 111
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 112 QLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 172 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 205

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 18/235 (7%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKV-MXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           +E +G GTYG VYK ++      A  K+ +                  K   H NI   Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
                K       +L LV E+     +  L+   +G        +F+  ++L G+ Y H+
Sbjct: 67  DVIHTKK------RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLL-QLLNGIAYCHD 118
Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
            +V+HRD+K QN+L+    E+K+ DFG++      + +    I T ++ AP+V+   +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK- 177
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--NAPPRLKSKKWP 291
              Y    D+WS+G    EM    P    +     L  I R    P    SK WP
Sbjct: 178 ---YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP---NSKNWP 226

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 63  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD+   N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 171 TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 228
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 229 EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVGEYMSKGSLLDFLKGETGKYLRLP 280
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 281 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 341 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 374

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 111/270 (41%), Gaps = 29/270 (10%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY G   K     A+K +                  
Sbjct: 25  DKWEMERTDI-TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 82
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G    + P       ++V EY   G++ D ++    + +    + ++ 
Sbjct: 83  KEIKHPNLVQLLGVCTLEPP------FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMA 136
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAE---SQPPLCDLHPMRALFLI----- 277
           W APE +A +     T+  +SD+W+ G+   E+A    S  P  DL  +  L        
Sbjct: 197 WTAPESLAYN-----TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRME 251
Query: 278 -PRNAPPRL-----KSKKW-PKKFQSFIET 300
            P   PP++        KW P    SF ET
Sbjct: 252 QPEGCPPKVYELMRACWKWSPADRPSFAET 281

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A      +       L  E ++++ 
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 219

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A      +       L  E ++++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +A +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 218

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 8   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 65
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +             P  
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 179
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 180 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 208

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 7   DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 64
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 65  KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 118
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +             P  
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 178
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 179 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 207

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIG---TPYWMAPEVIACDENPDATYDNRS 246
            T    NA +KL DFG + +        N+      TPY++APEV+  ++     YD   
Sbjct: 148 YTSKRPNAILKLTDFGFAKE----TTSHNSLTEPCYTPYYVAPEVLGPEK-----YDKSC 198
Query: 247 DLWSLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIET 300
           D+WSLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 301 VLVKDYHQRPYTDQLLKHPFI 321
           +L  +  QR    + + HP+I
Sbjct: 259 LLKTEPTQRMTITEFMNHPWI 279

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 172 TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGNMSPEAFLQ 229
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+  
Sbjct: 230 EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGEMGKYLRLP 281
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG+   + D     R  
Sbjct: 282 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG 341
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 342 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 375

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           +V+GNG++G V++ +  ++ ++A  KV+                  +   H N+      
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIM-----RIVKHPNVVDLKAF 100
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHEN 179
           F        +  L LV+EY             K  Q++    I     ++LR L Y+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 180 KVIHRDIKGQNVLLTDNAEV-KLVDFGVSAQLDRTIGRRN-TFIGTPYWMAPEVIACDEN 237
            + HRDIK QN+LL   + V KL+DFG +  L    G  N + I + Y+ APE+I    N
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSXICSRYYRAPELIFGATN 218
Query: 238 PDATYDNRSDLWSLGITALEMAESQP 263
               Y    D+WS G    E+ + QP
Sbjct: 219 ----YTTNIDIWSTGCVMAELMQGQP 240

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 130/293 (44%), Gaps = 28/293 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX--KYSNHRNI 114
           +++ E +G G +  V +  H  TG   A K++                    +   H NI
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 66
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRGL 173
              + +  ++S        +LV +    G   +L +    +    E  A  C ++IL  +
Sbjct: 67  VRLHDSIQEESFH------YLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESI 117
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            Y H N ++HR++K +N+LL   A+   VKL DFG++ +++ +      F GTP +++PE
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPE 176
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+  D      Y    D+W+ G+    +    PP  D    R L+   +       S +W
Sbjct: 177 VLKKD-----PYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEW 230
Query: 291 PK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR-IQLKDHID 339
                + +S I+++L  +  +R   DQ LK P+I ++  ER A  I  +D +D
Sbjct: 231 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR--ERVASAIHRQDXVD 281

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 18/235 (7%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKV-MXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           +E +G GTYG VYK ++      A  K+ +                  K   H NI   Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
                K       +L LV E+     +  L+   +G        +F+  ++L G+ Y H+
Sbjct: 67  DVIHTKK------RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLL-QLLNGIAYCHD 118
Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
            +V+HRD+K QN+L+    E+K+ DFG++      + +    + T ++ AP+V+   +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK- 177
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--NAPPRLKSKKWP 291
              Y    D+WS+G    EM    P    +     L  I R    P    SK WP
Sbjct: 178 ---YSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTP---NSKNWP 226

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 18/235 (7%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKV-MXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           +E +G GTYG VYK ++      A  K+ +                  K   H NI   Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
                K       +L LV E+     +  L+   +G        +F+  ++L G+ Y H+
Sbjct: 67  DVIHTKK------RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLL-QLLNGIAYCHD 118
Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
            +V+HRD+K QN+L+    E+K+ DFG++      + +    + T ++ AP+V+   +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK- 177
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--NAPPRLKSKKWP 291
              Y    D+WS+G    EM    P    +     L  I R    P    SK WP
Sbjct: 178 ---YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP---NSKNWP 226

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A      +       L  E ++++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +A +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 218

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A ++  +++      L  E ++++ 
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLL 170
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 224
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 225 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 257

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P     L + +G G +GQV +        T T +  A+K++    
Sbjct: 12  HCERLPYDASKW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 70
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 71  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 125
Query: 151 STKGQ--------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDNA 197
           S + +         L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++  
Sbjct: 126 SKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 198 EVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITA 255
            VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+  
Sbjct: 186 VVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLL 240
Query: 256 LEM 258
            E+
Sbjct: 241 WEI 243

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 130/293 (44%), Gaps = 28/293 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX--XXXXXXXXXXKYSNHRNI 114
           +++ E +G G +  V +  H  TG   A K++                    +   H NI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRGL 173
              + +  ++S        +LV +    G   +L +    +    E  A  C ++IL  +
Sbjct: 68  VRLHDSIQEESFH------YLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESI 118
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            Y H N ++HR++K +N+LL   A+   VKL DFG++ +++ +      F GTP +++PE
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPE 177
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+  D      Y    D+W+ G+    +    PP  D    R L+   +       S +W
Sbjct: 178 VLKKD-----PYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEW 231
Query: 291 PK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR-IQLKDHID 339
                + +S I+++L  +  +R   DQ LK P+I ++  ER A  I  +D +D
Sbjct: 232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR--ERVASAIHRQDXVD 282

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
            +L++ +G G +G V  G +   G   A+K +                      H N+  
Sbjct: 14  LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL--RHSNLVQ 69
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G  +++        L++V EY   GS+ D ++S     L  + +     ++   ++YL
Sbjct: 70  LLGVIVEEK-----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 124
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
             N  +HRD+  +NVL++++   K+ DFG++ +   T   ++T      W APE +    
Sbjct: 125 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR--- 178
Query: 237 NPDATYDNRSDLWSLGITALEM 258
             +A +  +SD+WS GI   E+
Sbjct: 179 --EAAFSTKSDVWSFGILLWEI 198

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A    +L +  + + L  E ++++ 
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQME-LDHERMSYLL 170
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 224
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 225 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 257

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P     L + +G G +GQV +        T T +  A+K++    
Sbjct: 11  HCERLPYDASKW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA 69
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 124
Query: 151 STKGQ-----SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
           S + +      L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++   VK
Sbjct: 125 SKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVK 184
Query: 201 LVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+   E+
Sbjct: 185 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEI 239

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A    +L +  + + L  E ++++ 
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQME-LDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A      +       L  E ++++ 
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLL 125
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 179
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 180 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 212

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 11  HCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 124
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 125 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 239
Query: 255 ALEM 258
             E+
Sbjct: 240 LWEI 243

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A    +L +  + + L  E ++++ 
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQME-LDHERMSYLL 133
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 187
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 188 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 220

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 252 DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 309
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 310 KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 363
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHR++  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 364 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 423
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 424 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 452

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 11  HCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 124
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 125 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 239
Query: 255 ALEM 258
             E+
Sbjct: 240 LWEI 243

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A    +L +  + + L  E ++++ 
Sbjct: 77  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQME-LDHERMSYLL 131
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 132 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 185
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 186 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A      +       L  E ++++ 
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLL 126
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG++    RT G   +F+ TP  
Sbjct: 127 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAG--TSFMMTPYV 180
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 181 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 213

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A      +       L  E ++++ 
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLL 126
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 127 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 180
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 181 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 213

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 11  HCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 69
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 124
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 125 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 239
Query: 255 ALEM 258
             E+
Sbjct: 240 LWEI 243

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 113/285 (39%), Gaps = 47/285 (16%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +E+ E +G G+Y    +  H  T    A+K++                  +Y  H NI T
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILL---RYGQHPNIIT 80
Query: 117 YYGAFIKKSPPGKDD--QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               +        DD   +++V E    G + D  K  + +   E   + +   I + ++
Sbjct: 81  LKDVY--------DDGKYVYVVTELMKGGELLD--KILRQKFFSEREASAVLFTITKTVE 130
Query: 175 YLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           YLH   V+HRD+K  N+L  D +     +++ DFG + QL    G   T   T  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+         YD   D+WSLG+    M     P  +          P + P  + ++  
Sbjct: 191 VL-----ERQGYDAACDIWSLGVLLYTMLTGYTPFANG---------PDDTPEEILARIG 236
Query: 291 PKKF--------------QSFIETVLVKDYHQRPYTDQLLKHPFI 321
             KF              +  +  +L  D HQR     +L+HP+I
Sbjct: 237 SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 16/219 (7%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXX 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +            
Sbjct: 5   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 62
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 K  + + +  Y  A + + P      +++V EY   G + D +K   G+ L+  
Sbjct: 63  EAQVMKKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE           +  +SD+WS GI   E+
Sbjct: 175 AKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTEL 208

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A    +L +  + + L  E ++++ 
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQME-LDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 219

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G YG+V    +  T +  A+K++                      NH N+ 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 69  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 120
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 181 RRE----FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 38/240 (15%)
Query: 45  PED-RWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXX 95
           PED RW E P     L + +G G +GQV         K +  +  ++A   +        
Sbjct: 18  PEDPRW-ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 76
Query: 96  XXXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK- 153
                      K    H+NI    GA  +  P      L++++EY   G++ + +++ + 
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRP 130
Query: 154 -------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
                         + L  + +     ++ RG++YL   K IHRD+  +NVL+T++  +K
Sbjct: 131 PGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 201 LVDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + DFG++  +      + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 191 IADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 245

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A    +L +  + + L  E ++++ 
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQME-LDHERMSYLL 133
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 187
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 188 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 130/293 (44%), Gaps = 28/293 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX--KYSNHRNI 114
           +++ E +G G +  V +  H  TG   A K++                    +   H NI
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRGL 173
              + +  ++S        +LV +    G   +L +    +    E  A  C ++IL  +
Sbjct: 91  VRLHDSIQEESFH------YLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESI 141
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            Y H N ++HR++K +N+LL   A+   VKL DFG++ +++ +      F GTP +++PE
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPE 200
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+  D      Y    D+W+ G+    +    PP  D    R L+   +       S +W
Sbjct: 201 VLKKD-----PYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEW 254
Query: 291 PK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR-IQLKDHID 339
                + +S I+++L  +  +R   DQ LK P+I ++  ER A  I  +D +D
Sbjct: 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR--ERVASAIHRQDTVD 305

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D+W+ +   I  +   +G G YG+VY+G   K     A+K +                  
Sbjct: 213 DKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM- 270
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K   H N+    G   ++ P       +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 271 KEIKHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY- 225
            +I   ++YL +   IHR++  +N L+ +N  VK+ DFG+S  +       +     P  
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APE +A ++     +  +SD+W+ G+   E+A
Sbjct: 385 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIA 413

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 13  HCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 71
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 72  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 126
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 127 SKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 186
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 187 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 241
Query: 255 ALEM 258
             E+
Sbjct: 242 LWEI 245

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI +    F  +    +   ++LVME   A    +L +  + + L  E ++++ 
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQME-LDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 219

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 2   HAERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 115
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 116 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 230
Query: 255 ALEM 258
             E+
Sbjct: 231 LWEI 234

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 110/252 (43%), Gaps = 25/252 (9%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXX 103
           W +D W E P    +L + +G G +G+V+   + K  ++A +K M               
Sbjct: 178 WEKDAW-EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVA-VKTMKPGSMSVEAFLAEAN 235
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 + + +  +  A + K P      ++++ E+   GS+ D +KS +G       + 
Sbjct: 236 VMKTLQHDKLVKLH--AVVTKEP------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIG 222
               +I  G+ ++ +   IHRD++  N+L++ +   K+ DFG++  + D     R     
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347
Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE----SQPPLCDLHPMRAL---F 275
              W APE I        ++  +SD+WS GI  +E+        P + +   +RAL   +
Sbjct: 348 PIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402
Query: 276 LIPR--NAPPRL 285
            +PR  N P  L
Sbjct: 403 RMPRPENCPEEL 414

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 30/230 (13%)
Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--XXXXXXXXXXX 100
           +W E P     L + +G G +GQV +        T T +  A+K++              
Sbjct: 21  KW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 79
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL--K 158
                    +H N+    GA  K   P     L +++E+C  G+++  ++S + + +  K
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 159 EEWIAFICRE--------ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL 210
           + +  F+  E        + +G+++L   K IHRD+  +N+LL++   VK+ DFG++  +
Sbjct: 135 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDI 194
Query: 211 --DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             D    R+        WMAPE I      D  Y  +SD+WS G+   E+
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEI 239

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 53  PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
           P G  +L+E+   G +G V+K +        A+K+                       H 
Sbjct: 13  PRGSLQLLEIKARGRFGCVWKAQ--LMNDFVAVKIFPLQDKQSWQSEREIFSTPGM-KHE 69
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           N+  +  A  +K     + +LWL+  +   GS+TD +K   G  +    +  +   + RG
Sbjct: 70  NLLQFIAA--EKRGSNLEVELWLITAFHDKGSLTDYLK---GNIITWNELCHVAETMSRG 124
Query: 173 LKYLHEN-----------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD--RTIGRRNT 219
           L YLHE+            + HRD K +NVLL  +    L DFG++ + +  +  G  + 
Sbjct: 125 LSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHG 184
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            +GT  +MAPEV+    N       R D++++G+   E+ 
Sbjct: 185 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 110/252 (43%), Gaps = 25/252 (9%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXX 103
           W +D W E P    +L + +G G +G+V+   + K  ++A +K M               
Sbjct: 5   WEKDAW-EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVA-VKTMKPGSMSVEAFLAEAN 62
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 + + +  +  A + K P      ++++ E+   GS+ D +KS +G       + 
Sbjct: 63  VMKTLQHDKLVKLH--AVVTKEP------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 114
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIG 222
               +I  G+ ++ +   IHRD++  N+L++ +   K+ DFG++  + D     R     
Sbjct: 115 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 174
Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE----SQPPLCDLHPMRAL---F 275
              W APE I        ++  +SD+WS GI  +E+        P + +   +RAL   +
Sbjct: 175 PIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 229
Query: 276 LIPR--NAPPRL 285
            +PR  N P  L
Sbjct: 230 RMPRPENCPEEL 241

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 38/240 (15%)
Query: 45  PED-RWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXX 95
           PED RW E P     L + +G G +GQV         K +  +  ++A   +        
Sbjct: 11  PEDPRW-ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 69
Query: 96  XXXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
                      K    H+NI    GA  +  P      L++++EY   G++ + +++ + 
Sbjct: 70  LSDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRP 123
Query: 155 QSLKEEW--------------IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
             L+  +              +     ++ RG++YL   K IHRD+  +NVL+T++  +K
Sbjct: 124 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 183
Query: 201 LVDFGVSAQLDRTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + DFG++  +      + T  G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 184 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXXX 96
           PED   E P     L + +G G +GQV         K +  +  ++A   +         
Sbjct: 7   PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 66
Query: 97  XXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                     K    H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRPP 120
Query: 156 SLKEEW--------------IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            L+  +              +     ++ RG++YL   K IHRD+  +NVL+T++  +K+
Sbjct: 121 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 180
Query: 202 VDFGVSAQLDRTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  +      + T  G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 181 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 234

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--XXXXXXXXXXX 100
           +W E P    +L + +G G +GQV +        T T +  A+K++              
Sbjct: 23  KW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 81
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS---- 156
                    +H N+    GA  K   P     L +++E+C  G+++  ++S + +     
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 157 --------LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA 208
                   L  E +     ++ +G+++L   K IHRD+  +N+LL++   VK+ DFG++ 
Sbjct: 137 PEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 209 QL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +  D    R+        WMAPE I      D  Y  +SD+WS G+   E+
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEI 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 24/229 (10%)
Query: 41  TEGWPEDRWQEDPAGIFE----LIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXX 92
           + G  EDR   DP    E     ++ +G G +G V   R+      TG++ A+K +    
Sbjct: 2   SSGAFEDR---DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 58
Query: 93  XXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST 152
                         K   H NI  Y G        G+ + L L+MEY   GS+ D ++  
Sbjct: 59  EEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKH 114
Query: 153 KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-- 210
           K +    + + +   +I +G++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  
Sbjct: 115 KERIDHIKLLQYTS-QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 173
Query: 211 DRTIGRRNTFIGTP-YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           D+   +      +P +W APE +      ++ +   SD+WS G+   E+
Sbjct: 174 DKEXXKVKEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYEL 217

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 48  HCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 106
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L +++E+C  G+++  ++
Sbjct: 107 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLR 161
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 162 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 276
Query: 255 ALEM 258
             E+
Sbjct: 277 LWEI 280

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 70
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 71  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 186 ESLT-----ESKFSVASDVWSFGVVLYEL 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 75
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 76  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 130
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 191 ESLT-----ESKFSVASDVWSFGVVLYEL 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 61  EVVGNGTYGQVYKGRHTKTG--QLAAIKVMXXXXXX--XXXXXXXXXXXXKYSNHRNIAT 116
           +V+G G +GQV K R  K G    AAIK M                    K  +H NI  
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWI 162
             GA   +        L+L +EY   G++ D ++ ++                +L  + +
Sbjct: 88  LLGACEHRG------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRN 218
                ++ RG+ YL + + IHR++  +N+L+ +N   K+ DFG+S      + +T+GR  
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
                  WMA E +       + Y   SD+WS G+   E+      P C +
Sbjct: 202 V-----RWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 242

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 25/274 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX--KYSNHRNI 114
           +++ E +G G +  V +  H  TG   A K++                    +   H NI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRGL 173
              + +  ++S        +LV +    G   +L +    +    E  A  C ++IL  +
Sbjct: 68  VRLHDSIQEESFH------YLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESI 118
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            Y H N ++HR++K +N+LL   A+   VKL DFG++ +++ +      F GTP +++PE
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPE 177
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+  D      Y    D+W+ G+    +    PP  D    R L+   +       S +W
Sbjct: 178 VLKKD-----PYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEW 231
Query: 291 PK---KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                + +S I+++L  +  +R   DQ LK P+I
Sbjct: 232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 38/240 (15%)
Query: 45  PED-RWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXX 95
           PED RW E P     L + +G G +GQV         K +  +  ++A   +        
Sbjct: 10  PEDPRW-ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 68
Query: 96  XXXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
                      K    H+NI    GA  +  P      L++++EY   G++ + +++ + 
Sbjct: 69  LSDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRP 122
Query: 155 QSLKEEW--------------IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
             L+  +              +     ++ RG++YL   K IHRD+  +NVL+T++  +K
Sbjct: 123 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 182
Query: 201 LVDFGVSAQLDRTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + DFG++  +      + T  G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 183 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 237

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXXX 96
           PED   E P     L + +G G +GQV         K +  +  ++A   +         
Sbjct: 3   PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 62
Query: 97  XXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK-- 153
                     K    H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRPP 116
Query: 154 ------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
                        + L  + +     ++ RG++YL   K IHRD+  +NVL+T++  +K+
Sbjct: 117 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 176
Query: 202 VDFGVSAQLDRTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  +      + T  G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 230

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 2   HAERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L ++ E+C  G+++  ++
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVITEFCKFGNLSTYLR 115
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 116 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 230
Query: 255 ALEM 258
             E+
Sbjct: 231 LWEI 234

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 43  GWPEDRWQEDPAGIFE----LIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXX 94
           G  EDR   DP    E     ++ +G G +G V   R+      TG++ A+K +      
Sbjct: 2   GAFEDR---DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 58
Query: 95  XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
                       K   H NI  Y G        G+ + L L+MEY   GS+ D ++  K 
Sbjct: 59  HLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKE 114
Query: 155 QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DR 212
           +    + + +   +I +G++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+
Sbjct: 115 RIDHIKLLQYTS-QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 173
Query: 213 TIGRRNTFIGTP-YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              +      +P +W APE +      ++ +   SD+WS G+   E+
Sbjct: 174 EXXKVKEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYEL 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 69
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 70  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 124
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 185 ESLT-----ESKFSVASDVWSFGVVLYEL 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 75  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 129
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 190 ESLT-----ESKFSVASDVWSFGVVLYEL 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 72  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 126
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 187 ESLT-----ESKFSVASDVWSFGVVLYEL 210

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A ++  +++      L  E ++++ 
Sbjct: 83  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLL 137
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 138 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 191
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    DLWS+G    EM 
Sbjct: 192 VTRYYRAPEVIL-----GMGYKENVDLWSVGCIMGEMV 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 37/296 (12%)
Query: 56  IFELIE-VVGNGTYGQVYKGRHTKTGQLAAIKVMXXX-XXXXXXXXXXXXXXXKYSNHRN 113
           +++L E V+G G + +V    +  T Q  A+K++                   +   HRN
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +              ++D+ +LV E    GS+   +   K +   E   + + +++   L
Sbjct: 73  VLE------LIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASAL 124
Query: 174 KYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDR-------TIGRRNTFIGT 223
            +LH   + HRD+K +N+L       + VK+ DF + + +         +     T  G+
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-------CDLHPMRA--- 273
             +MAPEV+       + YD R DLWSLG+    +    PP        C      A   
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 274 ----LFLIPRNAPPRLKSKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
               LF   +        K W       +  I  +LV+D  QR    Q+L+HP+++
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 38/240 (15%)
Query: 45  PED-RWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXX 95
           PED RW E P     L + +G G +GQV         K +  +  ++A   +        
Sbjct: 18  PEDPRW-ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 76
Query: 96  XXXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
                      K    H+NI    GA  +  P      L++++EY   G++ + +++ + 
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRP 130
Query: 155 QSLKEEW--------------IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
             L+  +              +     ++ RG++YL   K IHRD+  +NVL+T++  +K
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 201 LVDFGVSAQLDRTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + DFG++  +      + T  G     WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 245

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 72  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 126
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 187 ESLT-----ESKFSVASDVWSFGVVLYEL 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 77
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 78  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 132
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 193 ESLT-----ESKFSVASDVWSFGVVLYEL 216

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 2   HAERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L ++ E+C  G+++  ++
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVITEFCKFGNLSTYLR 115
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 116 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 176 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 230
Query: 255 ALEM 258
             E+
Sbjct: 231 LWEI 234

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 102
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 103 NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 157
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 218 ESLT-----ESKFSVASDVWSFGVVLYEL 241

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXX-XXXXXXXXXXKYSNHRNIA 115
           ++L++ +G G  G+V    +  T +  A+K++                   K  NH N+ 
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
            +YG         + +  +L +EYC  G + D ++   G    +    F   +++ G+ Y
Sbjct: 68  KFYGH------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVVY 119
Query: 176 LHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVIA 233
           LH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++ 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPP 264
             E     +    D+WS GI    M   + P
Sbjct: 180 RRE----FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A    +L +  + + L  E ++++ 
Sbjct: 72  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQME-LDHERMSYLL 126
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 127 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 180
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    DLWS+G    EM 
Sbjct: 181 VTRYYRAPEVIL-----GMGYKENVDLWSVGCIMGEMV 213

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 40  YTEGWPED--RWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMX--X 90
           + E  P D  +W E P    +L + +G G +GQV +        T T +  A+K++    
Sbjct: 2   HCERLPYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 91  XXXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
                              +H N+    GA  K   P     L ++ E+C  G+++  ++
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVITEFCKFGNLSTYLR 115
Query: 151 STKGQ---------SLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDN 196
           S + +          L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++ 
Sbjct: 116 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 197 AEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGIT 254
             VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 176 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 230
Query: 255 ALEM 258
             E+
Sbjct: 231 LWEI 234

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/254 (22%), Positives = 110/254 (43%), Gaps = 39/254 (15%)
Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXX 103
           W +D W E P    +L + +G G +G+V+   + K  ++A +K M               
Sbjct: 172 WEKDAW-EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVA-VKTMKPGSMSVEAFLAEAN 229
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 + + +  +  A + K P      ++++ E+   GS+ D +KS +G       + 
Sbjct: 230 VMKTLQHDKLVKLH--AVVTKEP------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 281
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
               +I  G+ ++ +   IHRD++  N+L++ +   K+ DFG++             +G 
Sbjct: 282 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR------------VGA 329
Query: 224 PY---WMAPEVIACDENPDATYDNRSDLWSLGITALEMAE----SQPPLCDLHPMRAL-- 274
            +   W APE I        ++  +SD+WS GI  +E+        P + +   +RAL  
Sbjct: 330 KFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 384
Query: 275 -FLIPR--NAPPRL 285
            + +PR  N P  L
Sbjct: 385 GYRMPRPENCPEEL 398

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXXX 96
           PED   E P     L + +G G +GQV         K +  +  ++A   +         
Sbjct: 18  PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 77
Query: 97  XXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK-- 153
                     K    H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRPP 131
Query: 154 ------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
                        + L  + +     ++ RG++YL   K IHRD+  +NVL+T++  +K+
Sbjct: 132 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 191
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  +      + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 192 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXXX 96
           PED   E P     L + +G G +GQV         K +  +  ++A   +         
Sbjct: 59  PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 118
Query: 97  XXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
                     K    H+NI    GA  +  P      L++++EY   G++ + +++ +  
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRPP 172
Query: 156 SLKEEW--------------IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
            L+  +              +     ++ RG++YL   K IHRD+  +NVL+T++  +K+
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 232
Query: 202 VDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            DFG++  +      + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 286

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 72  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 126
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 187 ESLT-----ESKFSVASDVWSFGVVLYEL 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 89
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 90  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 144
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 205 ESLT-----ESKFSVASDVWSFGVVLYEL 228

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           +D W E P     L   +G G +G+V+ G    T ++A IK +                 
Sbjct: 1   KDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVM 58
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
            K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+   +  +
Sbjct: 59  KKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 110
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTP 224
             +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R       
Sbjct: 111 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 170
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            W APE           +  +SD+WS GI   E+
Sbjct: 171 KWTAPEAALY-----GRFTIKSDVWSFGILLTEL 199

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 38/240 (15%)
Query: 45  PED-RWQEDPAGIFELIEVVGNGTYGQVY--------KGRHTKTGQLAAIKVMXXXXXXX 95
           PED RW E P     L + +G G +GQV         K +  +  ++A   +        
Sbjct: 18  PEDPRW-ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 76
Query: 96  XXXXXXXXXXXKY-SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
                      K    H+NI    GA  +  P      L++++EY   G++ + +++ + 
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQAREP 130
Query: 155 QSLKEEW--------------IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
             L+  +              +     ++ RG++YL   K IHRD+  +NVL+T++  +K
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 201 LVDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + DFG++  +      + T  G  P  WMAPE +      D  Y ++SD+WS G+   E+
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEI 245

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 89
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 90  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 144
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 205 ESLT-----ESKFSVASDVWSFGVVLYEL 228

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXX 105
           +D W E P     L   +G G +G+V+ G    T ++A IK +                 
Sbjct: 3   KDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVM 60
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
            K  + + +  Y  A + + P      +++V EY   GS+ D +K   G+ L+   +  +
Sbjct: 61  KKLRHEKLVQLY--AVVSEEP------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 112
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTP 224
             +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R       
Sbjct: 113 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 172
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            W APE           +  +SD+WS GI   E+
Sbjct: 173 KWTAPEAALY-----GRFTIKSDVWSFGILLTEL 201

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A      +       L  E ++++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 218

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q   A    L+E VG G YG+V++G  +  G+  A+K+                      
Sbjct: 3   QRTVAHQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML- 59
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI  +  +    +      QLWL+  Y   GS+ D ++ T   ++       I   I
Sbjct: 60  RHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSI 114
Query: 170 LRGLKYLH--------ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR----R 217
             GL +LH        +  + HRD+K +N+L+  N +  + D G++    ++  +     
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 218 NTFIGTPYWMAPEVIACDENPDA-TYDN--RSDLWSLGITALEMA----------ESQPP 264
           N  +GT  +MAPEV+  DE      +D+  R D+W+ G+   E+A          + +PP
Sbjct: 175 NPRVGTKRYMAPEVL--DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 265 LCDLHP 270
             D+ P
Sbjct: 233 FYDVVP 238

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 13/206 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNI 114
           ++ ++ +G+G  G V     T  G   A+K +                    K  NH+NI
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
            +    F  +    +   ++LVME   A      +       L  E ++++  ++L G+K
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIK 138
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +LH   +IHRD+K  N+++  +  +K++DFG+ A+   T      ++ T Y+ APEVI  
Sbjct: 139 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTASTNFMMTPYVVTRYYRAPEVIL- 196
Query: 235 DENPDATYDNRSDLWSLGITALEMAE 260
                  Y    D+WS+G    E+ +
Sbjct: 197 ----GMGYKENVDIWSVGCIMGELVK 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F    V+G G +G+V   +   TG++ A K +                  +     N R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           + +   A+  K      D L LV+     G +   +         E    F   EI  GL
Sbjct: 246 VVSLAYAYETK------DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           + LH  ++++RD+K +N+LL D+  +++ D G++  +   +TI  R   +GT  +MAPEV
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 356
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      +  Y    D W+LG    EM   Q P 
Sbjct: 357 VK-----NERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q   A    L+E VG G YG+V++G  +  G+  A+K+                      
Sbjct: 3   QRTVARDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML- 59
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI  +  +    +      QLWL+  Y   GS+ D ++ T   ++       I   I
Sbjct: 60  RHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSI 114
Query: 170 LRGLKYLH--------ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR----R 217
             GL +LH        +  + HRD+K +N+L+  N +  + D G++    ++  +     
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 218 NTFIGTPYWMAPEVIACDENPDA-TYDN--RSDLWSLGITALEMA----------ESQPP 264
           N  +GT  +MAPEV+  DE      +D+  R D+W+ G+   E+A          + +PP
Sbjct: 175 NPRVGTKRYMAPEVL--DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 265 LCDLHP 270
             D+ P
Sbjct: 233 FYDVVP 238

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXX 99
           Y  GW  +  +       +L++ +G G +G V  G +   G   A+K +           
Sbjct: 184 YRSGWALNMKE------LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA 235
Query: 100 XXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
                      H N+    G  +++        L++V EY   GS+ D ++S     L  
Sbjct: 236 EASVMTQ--LRHSNLVQLLGVIVEEK-----GGLYIVTEYMAKGSLVDYLRSRGRSVLGG 288
Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
           + +     ++   ++YL  N  +HRD+  +NVL++++   K+ DFG++ +   T   ++T
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDT 345
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE +      +  +  +SD+WS GI   E+
Sbjct: 346 GKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEI 379

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A ++  +++      L  E ++++ 
Sbjct: 80  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLL 134
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT---FIGT 223
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G       F+ T
Sbjct: 135 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMVPFVVT 190
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            Y+ APEVI         Y    D+WS+G    EM
Sbjct: 191 RYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRN 113
           F    V+G G +G+V   +   TG++ A K +                  +     N R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           + +   A+  K      D L LV+     G +   +         E    F   EI  GL
Sbjct: 246 VVSLAYAYETK------DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEV 231
           + LH  ++++RD+K +N+LL D+  +++ D G++  +   +TI  R   +GT  +MAPEV
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 356
Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +      +  Y    D W+LG    EM   Q P 
Sbjct: 357 VK-----NERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 40/233 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXX---XXXXXKYSNHRN 113
           +EL++ +G G YG V+K    +TG++ A+K +                     + S H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I               D  ++LV +Y      TDL    +   L+     ++  ++++ +
Sbjct: 71  IVNLLNVL----RADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT-------------- 219
           KYLH   ++HRD+K  N+LL     VK+ DFG+S        RR T              
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI--RRVTNNIPLSINENTENF 180
Query: 220 ---------FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
                    ++ T ++ APE++         Y    D+WSLG    E+   +P
Sbjct: 181 DDDQPILTDYVATRWYRAPEILL----GSTKYTKGIDMWSLGCILGEILCGKP 229

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A ++  +++      L  E ++++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPEV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 218

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G G +G+V+ G    T ++A IK +                  K  + + +  Y  A +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY--AVV 71
Query: 123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVI 182
            + P      +++V EY   GS+ D +K   G+ L+   +  +  +I  G+ Y+     +
Sbjct: 72  SEEP------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 183 HRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVIACDENPDAT 241
           HRD++  N+L+ +N   K+ DFG++  + D     R        W APE           
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-----GR 180
Query: 242 YDNRSDLWSLGITALEM 258
           +  +SD+WS GI   E+
Sbjct: 181 FTIKSDVWSFGILLTEL 197

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A ++  +++      L  E ++++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A ++  +++      L  E ++++ 
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLL 133
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 187
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 188 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 219

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 47/273 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F +  ++G G +G+VY  R   TG++ A+K +                     N R + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL------NERIMLS 244
Query: 117 YYG----------AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
                        ++   +P    D+L  +++    G +      ++     E  + F  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTP----DKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYA 298
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            EI+ GL+++H   V++RD+K  N+LL ++  V++ D G++    +   + +  +GT  +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGY 356
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-----CDLHPMRALFL----- 276
           MAPEV+         YD+ +D +SLG    ++     P       D H +  + L     
Sbjct: 357 MAPEVL----QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
           +P +  P L+         S +E +L +D ++R
Sbjct: 413 LPDSFSPELR---------SLLEGLLQRDVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 47/273 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F +  ++G G +G+VY  R   TG++ A+K +                     N R + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL------NERIMLS 244
Query: 117 YYG----------AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
                        ++   +P    D+L  +++    G +      ++     E  + F  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTP----DKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYA 298
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            EI+ GL+++H   V++RD+K  N+LL ++  V++ D G++    +   + +  +GT  +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGY 356
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-----CDLHPMRALFL----- 276
           MAPEV+         YD+ +D +SLG    ++     P       D H +  + L     
Sbjct: 357 MAPEVL----QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
           +P +  P L+         S +E +L +D ++R
Sbjct: 413 LPDSFSPELR---------SLLEGLLQRDVNRR 436

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D +++   + +    +     +I +G
Sbjct: 75  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQA-HAERIDHIKLLQYTSQICKG 129
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 190 ESLT-----ESKFSVASDVWSFGVVLYEL 213

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXX 99
           Y  GW  +  +       +L++ +G G +G V  G +   G   A+K +           
Sbjct: 12  YRSGWALNMKE------LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA 63
Query: 100 XXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
                      H N+    G  +++        L++V EY   GS+ D ++S     L  
Sbjct: 64  EASVMTQ--LRHSNLVQLLGVIVEEK-----GGLYIVTEYMAKGSLVDYLRSRGRSVLGG 116
Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
           + +     ++   ++YL  N  +HRD+  +NVL++++   K+ DFG++ +   T   ++T
Sbjct: 117 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDT 173
Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                 W APE +      +  +  +SD+WS GI   E+
Sbjct: 174 GKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEI 207

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A ++  +++      L  E ++++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TP  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              Y+ APEVI         Y    D+WS+G    EM
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEM 218

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
            +L++ +G G +G V  G +   G   A+K +                      H N+  
Sbjct: 8   LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQ--LRHSNLVQ 63
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G  +++        L++V EY   GS+ D ++S     L  + +     ++   ++YL
Sbjct: 64  LLGVIVEEK-----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
             N  +HRD+  +NVL++++   K+ DFG++ +   T   ++T      W APE +    
Sbjct: 119 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR--- 172
Query: 237 NPDATYDNRSDLWSLGITALEM 258
             +  +  +SD+WS GI   E+
Sbjct: 173 --EKKFSTKSDVWSFGILLWEI 192

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 47/273 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F +  ++G G +G+VY  R   TG++ A+K +                     N R + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL------NERIMLS 244
Query: 117 YYG----------AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
                        ++   +P    D+L  +++    G +      ++     E  + F  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTP----DKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYA 298
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            EI+ GL+++H   V++RD+K  N+LL ++  V++ D G++    +   + +  +GT  +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGY 356
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-----CDLHPMRALFL----- 276
           MAPEV+         YD+ +D +SLG    ++     P       D H +  + L     
Sbjct: 357 MAPEVL----QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
           +P +  P L+         S +E +L +D ++R
Sbjct: 413 LPDSFSPELR---------SLLEGLLQRDVNRR 436

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 47/273 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           F +  ++G G +G+VY  R   TG++ A+K +                     N R + +
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL------NERIMLS 243
Query: 117 YYG----------AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
                        ++   +P    D+L  +++    G +      ++     E  + F  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTP----DKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYA 297
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            EI+ GL+++H   V++RD+K  N+LL ++  V++ D G++    +   + +  +GT  +
Sbjct: 298 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGY 355
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-----CDLHPMRALFL----- 276
           MAPEV+         YD+ +D +SLG    ++     P       D H +  + L     
Sbjct: 356 MAPEVL----QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 411
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQR 309
           +P +  P L+         S +E +L +D ++R
Sbjct: 412 LPDSFSPELR---------SLLEGLLQRDVNRR 435

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN 110
           E P    +L++ +G G +G+V+ G +  + ++A +K +                  K   
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVA-VKTLKPGTMSVQAFLEEANLM-KTLQ 65
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H  +   Y    K+ P      ++++ E+   GS+ D +KS +G  +    +     +I 
Sbjct: 66  HDKLVRLYAVVTKEEP------IYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 119
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAP 229
            G+ Y+     IHRD++  NVL++++   K+ DFG++  + D     R        W AP
Sbjct: 120 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 179
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         +  +S++WS GI   E+
Sbjct: 180 EAINF-----GCFTIKSNVWSFGILLYEI 203

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q   A    L+E VG G YG+V++G  +  G+  A+K+                      
Sbjct: 32  QRTVARQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML- 88
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI  +  +    +      QLWL+  Y   GS+ D ++ T   +L       I   I
Sbjct: 89  RHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSI 143
Query: 170 LRGLKYLH--------ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR----R 217
             GL +LH        +  + HRD+K +N+L+  N +  + D G++    ++  +     
Sbjct: 144 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 203
Query: 218 NTFIGTPYWMAPEVIACDENPDA-TYDN--RSDLWSLGITALEMA----------ESQPP 264
           N  +GT  +MAPEV+  DE      +D+  R D+W+ G+   E+A          + +PP
Sbjct: 204 NPRVGTKRYMAPEVL--DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 261
Query: 265 LCDLHP 270
             D+ P
Sbjct: 262 FYDVVP 267

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 49/280 (17%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-------NHRNIA 115
           +G G +G V+KGR  K   + AIK +                  +         NH NI 
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
             YG  +  +PP       +VME+   G +   +   K   +K      +  +I  G++Y
Sbjct: 87  KLYG--LMHNPP------RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEY 137
Query: 176 LHENK--VIHRDIKGQNVLLT---DNAEV--KLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
           +      ++HRD++  N+ L    +NA V  K+ DFG+S Q   ++   +  +G   WMA
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQWMA 194
Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-----------I 277
           PE I  +E    +Y  ++D +S  +    +   + P  +    +  F+           I
Sbjct: 195 PETIGAEEE---SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
           P + PPRL+         + IE     D  +RP+   ++K
Sbjct: 252 PEDCPPRLR---------NVIELCWSGDPKKRPHFSYIVK 282

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +V E    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG  A+   +     T   TPY++APEV+  ++     YD   D W
Sbjct: 194 YTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEK-----YDKSCDXW 247
Query: 250 SLGITALEMAESQPPLCDLHPMRALFLIP------RNAPPRLKSKKW---PKKFQSFIET 300
           SLG+    +    PP    H    L + P      R       + +W    ++ +  I  
Sbjct: 248 SLGVIXYILLCGYPPFYSNH---GLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRN 304
Query: 301 VLVKDYHQRPYTDQLLKHPFI 321
           +L  +  QR    +   HP+I
Sbjct: 305 LLKTEPTQRXTITEFXNHPWI 325

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           ++ ++ +G+G +G     R   T +L A+K +                      H NI  
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVR 80
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +    +  +       L ++MEY   G + + +         E+   F  +++L G+ Y 
Sbjct: 81  FKEVILTPT------HLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 177 HENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H  ++ HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 191
Query: 235 DENPDATYDNR-SDLWSLGITALEMAESQPPLCD 267
            E     YD + +D+WS G+T   M     P  D
Sbjct: 192 QE-----YDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 13/206 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXX--XXXXXXXXXXXXXXXXKYSNHRNI 114
           ++ ++ +G+G  G V     T  G   A+K +                    K  NH+NI
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
            +    F  +    +   ++LVME   A      +       L  E ++++  ++L G+K
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIK 140
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +LH   +IHRD+K  N+++  +  +K++DFG+ A+   T      ++ T Y+ APEVI  
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVIL- 198
Query: 235 DENPDATYDNRSDLWSLGITALEMAE 260
                  Y    D+WS+G    E+ +
Sbjct: 199 ----GMGYAANVDIWSVGCIMGELVK 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 111/285 (38%), Gaps = 47/285 (16%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +E+ E +G G+Y    +  H  T    A+K++                  +Y  H NI T
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILL---RYGQHPNIIT 80
Query: 117 YYGAFIKKSPPGKDD--QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               +        DD   +++V E    G + D  K  + +   E   + +   I + ++
Sbjct: 81  LKDVY--------DDGKYVYVVTELXKGGELLD--KILRQKFFSEREASAVLFTITKTVE 130
Query: 175 YLHENKVIHRDIKGQNVLLTDNA----EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           YLH   V+HRD+K  N+L  D +     +++ DFG + QL    G   T   T  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE 190
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+         YD   D+WSLG+          P  +          P + P  + ++  
Sbjct: 191 VLE-----RQGYDAACDIWSLGVLLYTXLTGYTPFANG---------PDDTPEEILARIG 236
Query: 291 PKKF--------------QSFIETVLVKDYHQRPYTDQLLKHPFI 321
             KF              +  +   L  D HQR     +L+HP+I
Sbjct: 237 SGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 21/210 (10%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRNIATYYG 119
           +G G +G VYKG +     +A  K+                   K      H N+    G
Sbjct: 39  MGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS-LKEEWIAFICREILRGLKYLHE 178
                S  G  D L LV  Y   GS+ D +    G   L       I +    G+ +LHE
Sbjct: 98  F----SSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGV---SAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           N  IHRDIK  N+LL +    K+ DFG+   S +  +T+   +  +GT  +MAPE +  +
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV-MXSRIVGTTAYMAPEALRGE 210
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
             P      +SD++S G+  LE+    P +
Sbjct: 211 ITP------KSDIYSFGVVLLEIITGLPAV 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 49/280 (17%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-------NHRNIA 115
           +G G +G V+KGR  K   + AIK +                  +         NH NI 
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
             YG  +  +PP       +VME+   G +   +   K   +K      +  +I  G++Y
Sbjct: 87  KLYG--LMHNPP------RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEY 137
Query: 176 LHENK--VIHRDIKGQNVLLT---DNAEV--KLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
           +      ++HRD++  N+ L    +NA V  K+ DFG S Q   ++   +  +G   WMA
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ---SVHSVSGLLGNFQWMA 194
Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-----------I 277
           PE I  +E    +Y  ++D +S  +    +   + P  +    +  F+           I
Sbjct: 195 PETIGAEEE---SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
           P + PPRL+         + IE     D  +RP+   ++K
Sbjct: 252 PEDCPPRLR---------NVIELCWSGDPKKRPHFSYIVK 282

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 19/217 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL---AAIKVMXXXXXXXXXX-XXXXXXX 105
           +E  A    +  V+G G +G+V  GR    G+     AIK +                  
Sbjct: 17  KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
               +H NI    G   K  P      + +V EY   GS+   +K   GQ    + +  +
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKP------VMIVTEYMENGSLDTFLKKNDGQFTVIQLVGML 130
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            R I  G+KYL +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G   
Sbjct: 131 -RGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              W APE IA  +     + + SD+WS GI   E+ 
Sbjct: 190 PIRWTAPEAIAFRK-----FTSASDVWSYGIVMWEVV 221

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX 106
           D W E P     L   +G G +G+V+ G    T ++A IK +                  
Sbjct: 1   DAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVMK 58
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  + + +  Y  A + + P      + +V EY   GS+ D +K   G+ L+   +  + 
Sbjct: 59  KLRHEKLVQLY--AVVSEEP------IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 110
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY 225
            +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R        
Sbjct: 111 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK 170
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           W APE           +  +SD+WS GI   E+
Sbjct: 171 WTAPEAALY-----GRFTIKSDVWSFGILLTEL 198

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A    +L +  + + L  E ++++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQME-LDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+  P  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMEPEV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    DLWS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDLWSVGCIMGEMV 219

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + ++ +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 72
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+MEY   GS+ D ++  K +    + + +   +I +G
Sbjct: 73  NIVKYKGVCYS---AGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKG 127
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHR++  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 187
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 188 ESLT-----ESKFSVASDVWSFGVVLYEL 211

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATY 117
           L++ +G+G +G V  G+    GQ   A+K++                  K S H  +  +
Sbjct: 12  LLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKF 68
Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
           YG   K+ P      +++V EY   G + + ++S  G+ L+   +  +C ++  G+ +L 
Sbjct: 69  YGVCSKEYP------IYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY---WMAPEVI 232
            ++ IHRD+  +N L+  +  VK+ DFG++  +  D+ +      +GT +   W APEV 
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVF 177
Query: 233 ACDENPDATYDNRSDLWSLGITALEM 258
                    Y ++SD+W+ GI   E+
Sbjct: 178 HY-----FKYSSKSDVWAFGILMWEV 198

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRNIATYYG 119
           +G G +G VYKG +     +A  K+                   K      H N+    G
Sbjct: 39  MGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS-LKEEWIAFICREILRGLKYLHE 178
                S  G  D L LV  Y   GS+ D +    G   L       I +    G+ +LHE
Sbjct: 98  F----SSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGV---SAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           N  IHRDIK  N+LL +    K+ DFG+   S +  +T+      +GT  +MAPE +  +
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV-MXXRIVGTTAYMAPEALRGE 210
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
             P      +SD++S G+  LE+    P +
Sbjct: 211 ITP------KSDIYSFGVVLLEIITGLPAV 234

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 122/287 (42%), Gaps = 28/287 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIA 115
           FE I+ +G G +G V++ ++       AIK +                       H  I 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 116 TYYGAFIKKS------PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF-ICRE 168
            Y+ A+++K+      P      L++ M+ C   ++ D +        +E  +   I  +
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR------------TIGR 216
           I   +++LH   ++HRD+K  N+  T +  VK+ DFG+   +D+               R
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL 276
               +GT  +M+PE I  +     +Y ++ D++SLG+   E+    P    +  +R L  
Sbjct: 187 HTGQVGTKLYMSPEQIHGN-----SYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTD 239
Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
           +     P L ++K+P ++   ++ +L     +RP    ++++    D
Sbjct: 240 VRNLKFPPLFTQKYPCEY-VMVQDMLSPSPMERPEAINIIENAVFED 285

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 108/273 (39%), Gaps = 16/273 (5%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +  I+ +G G +  V        G   A+K +                  +  NH NI  
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLK 174
                +++   G   + WL++ +   G++ + ++  K  G  L E+ I ++   I RGL+
Sbjct: 91  LVAYCLRER--GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI-GRRNTFI--------GTPY 225
            +H     HRD+K  N+LL D  +  L+D G   Q    + G R             T  
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-CDLHPMRALFLIPRNAPPR 284
           + APE+ +   +     D R+D+WSLG     M   + P         ++ L  +N    
Sbjct: 209 YRAPELFSVQSH--CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
            +S +        + +++  D HQRP+   LL 
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K  NH+NI      F  +    +   +++VME   A    +L +  + + L  E ++++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQME-LDHERMSYLL 132
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP-- 224
            ++L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+  P  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMEPEV 186
Query: 225 ---YWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              Y+ APEVI         Y    D+WS+G    EM 
Sbjct: 187 VTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMV 219

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 20/227 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXXXXXXXXXXXXXXXXXX 106
           +E  A   ++ +V+G G +G+V  GR    G+     AIK +                  
Sbjct: 24  KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 83
Query: 107 KYS-NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
               +H NI    G   K  P      + ++ EY   GS+   ++   G+    + +  +
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKP------VMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 137
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            R I  G+KYL +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G   
Sbjct: 138 -RGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 196
Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
              W APE IA  +     + + SD+WS GI   E M+  + P  D+
Sbjct: 197 PIRWTAPEAIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDM 238

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 34/289 (11%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
             L+E +G+G++G V +G     +G+  ++ V                   + +     +
Sbjct: 14  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRN+   YG  +  +PP K     +V E    GS+ D ++  +G  L    ++    ++ 
Sbjct: 74  HRNLIRLYGVVL--TPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVA 125
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPY- 225
            G+ YL   + IHRD+  +N+LL     VK+ DFG+   L    D  + + +  +  P+ 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFA 183
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPR 284
           W APE +        T+ + SD W  G+T  EM    Q P   L+  + L  I +     
Sbjct: 184 WCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 238
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPTERQA 330
            + +  P+     I  V+V+ +  +P    T   L+   +  QPT+ +A
Sbjct: 239 PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 283

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXX 99
           T G     W+ DP  +  L E+ G G +G V  G+    GQ   AIK++           
Sbjct: 11  TAGLGYGSWEIDPKDLTFLKEL-GTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFI 67
Query: 100 XXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
                    S H  +   YG   K+ P      ++++ EY   G + + ++  +    + 
Sbjct: 68  EEAKVMMNLS-HEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMR-HRFQT 119
Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRN 218
           + +  +C+++   ++YL   + +HRD+  +N L+ D   VK+ DFG+S   LD       
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEET 176
Query: 219 TFIGTPY---WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + +G+ +   W  PEV+       + + ++SD+W+ G+   E+
Sbjct: 177 SSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEI 214

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY-----SNH 111
           +E+++V+G G++GQV K    K  Q  A+K++                          N 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+      F  +      + + +  E     ++ +L+K  K Q      +      IL+
Sbjct: 159 MNVIHMLENFTFR------NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAE--VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
            L  LH+N++IH D+K +N+LL       +K++DFG S    +   R  T I + ++ AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTXIQSRFYRAP 268
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           EVI       A Y    D+WSLG    E+    P L
Sbjct: 269 EVIL-----GARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 26/222 (11%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY--SNHRN 113
            E+ E++G G +GQVY GR H +     AI+++                   Y  + H N
Sbjct: 35  LEIGELIGKGRFGQVYHGRWHGEV----AIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +  + GA +  SPP     L ++   C   ++  +V+  K   L       I +EI++G+
Sbjct: 91  VVLFMGACM--SPP----HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGM 143
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV-SAQLDRTIGRRNTFI----GTPYWMA 228
            YLH   ++H+D+K +NV   DN +V + DFG+ S       GRR   +    G    +A
Sbjct: 144 GYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 229 PEVIACDENPDATYD-----NRSDLWSLGITALEMAESQPPL 265
           PE+I    +PD   D       SD+++LG    E+   + P 
Sbjct: 203 PEIIR-QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 24/279 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX--KYSNHRNI 114
           ++L E +G G +  V +     TGQ  A K++                    +   H NI
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRGL 173
              + +        ++   +LV +    G   +L +    +    E  A  C ++IL  +
Sbjct: 66  VRLHDSI------SEEGFHYLVFDLVTGG---ELFEDIVAREYYSEADASHCIQQILESV 116
Query: 174 KYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            + H N ++HRD+K +N+LL   +  A VKL DFG++ ++         F GTP +++PE
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+  D      Y    D+W+ G+    +    PP  D    R L+   +       S +W
Sbjct: 177 VLRKD-----PYGKPVDMWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDFPSPEW 230
Query: 291 PK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT 326
                + +  I  +L  +  +R    + LKHP+I  + T
Sbjct: 231 DTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRST 269

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       +++ME    G +   ++ T+ +  +   +A
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLP------RFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 139 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 199 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 238

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 24/279 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX--KYSNHRNI 114
           ++L E +G G +  V +     TGQ  A K++                    +   H NI
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRGL 173
              + +        ++   +LV +    G   +L +    +    E  A  C ++IL  +
Sbjct: 66  VRLHDSI------SEEGFHYLVFDLVTGG---ELFEDIVAREYYSEADASHCIQQILESV 116
Query: 174 KYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            + H N ++HRD+K +N+LL   +  A VKL DFG++ ++         F GTP +++PE
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+  D      Y    D+W+ G+    +    PP  D    R L+   +       S +W
Sbjct: 177 VLRKD-----PYGKPVDMWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDFPSPEW 230
Query: 291 PK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT 326
                + +  I  +L  +  +R    + LKHP+I  + T
Sbjct: 231 DTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRST 269

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 34/289 (11%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
             L+E +G+G++G V +G     +G+  ++ V                   + +     +
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRN+   YG  +  +PP K     +V E    GS+ D ++  +G  L    ++    ++ 
Sbjct: 80  HRNLIRLYGVVL--TPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVA 131
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPY- 225
            G+ YL   + IHRD+  +N+LL     VK+ DFG+   L    D  + + +  +  P+ 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV--PFA 189
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPR 284
           W APE +        T+ + SD W  G+T  EM    Q P   L+  + L  I +     
Sbjct: 190 WCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPTERQA 330
            + +  P+     I  V+V+ +  +P    T   L+   +  QPT+ +A
Sbjct: 245 PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY-----SNH 111
           +E+++V+G G++GQV K    K  Q  A+K++                          N 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+      F  +      + + +  E     ++ +L+K  K Q      +      IL+
Sbjct: 159 MNVIHMLENFTFR------NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAE--VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
            L  LH+N++IH D+K +N+LL       +K++DFG S    +   R  T I + ++ AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTXIQSRFYRAP 268
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           EVI       A Y    D+WSLG    E+    P L
Sbjct: 269 EVIL-----GARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 12/165 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           +IL  + ++H++ ++HRD+K +N+LL      A VKL DFG++ ++         F GTP
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTP 197
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
            +++PEV+  D      Y    D+W+ G+    +    PP  D      L+   +     
Sbjct: 198 GYLSPEVLRKD-----PYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYD 251
Query: 285 LKSKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT 326
             S +W     + ++ I  +L  +  +R   DQ LKHP++  + T
Sbjct: 252 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRST 296

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 113/264 (42%), Gaps = 40/264 (15%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q   A   ++++ +G G YG+V+ G+    G+  A+KV                      
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTV-LM 88
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI  +  A IK +  G   QL+L+ +Y   GS+ D +KST   +L  + +  +    
Sbjct: 89  RHENILGFIAADIKGT--GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSS 143
Query: 170 LRGLKYLHEN--------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR---- 217
           + GL +LH           + HRD+K +N+L+  N    + D G++ +            
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 218 NTFIGTPYWMAPEVI--ACDENPDATYDNRSDLWSLGITALEMA----------ESQPPL 265
           NT +GT  +M PEV+  + + N   +Y   +D++S G+   E+A          E Q P 
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYI-MADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 266 CDLHP-------MRALFLIPRNAP 282
            DL P       MR +  I +  P
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRP 286

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 27/268 (10%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXX-XXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +V+G G +G+V  G     G+     AIK +                      +H N+  
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K +P      + ++ E+   GS+   ++   GQ    + +  + R I  G+KYL
Sbjct: 99  LEGVVTKSTP------VMIITEFMENGSLDSFLRQNDGQFTVIQLVGML-RGIAAGMKYL 151
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY---WMAPEV 231
            +   +HRD+  +N+L+  N   K+ DFG+S  L  D +     + +G      W APE 
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 232 IACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
           I   +     + + SD+WS GI   E M+  + P  D+     +  I ++   PP +   
Sbjct: 212 IQYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC- 265
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLL 316
             P      +     KD + RP   Q++
Sbjct: 266 --PSALHQLMLDCWQKDRNHRPKFGQIV 291

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHT----KTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
            + +  +G G +G V   R+      TG++ A+K +                  K   H 
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y G        G+ + L L+ME+   GS+ + ++  K +    + + +   +I +G
Sbjct: 75  NIVKYKGVCYS---AGRRN-LKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS-QICKG 129
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAP 229
           ++YL   + IHRD+  +N+L+ +   VK+ DFG++  L  D+   +      +P +W AP
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E +      ++ +   SD+WS G+   E+
Sbjct: 190 ESLT-----ESKFSVASDVWSFGVVLYEL 213

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +E+  ++G G++GQV K       +  AIK++                    + H     
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           YY   +K+    + + L LV E   + ++ DL+++T  + +         +++   L +L
Sbjct: 116 YYIVHLKRHFMFR-NHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 177 H--ENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
              E  +IH D+K +N+LL +   + +K+VDFG S QL + I +    I + ++ +PEV+
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVL 230
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQP 263
                    YD   D+WSLG   +EM   +P
Sbjct: 231 L-----GMPYDLAIDMWSLGCILVEMHTGEP 256

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +E+  ++G G++GQV K       +  AIK++                    + H     
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           YY   +K+    + + L LV E   + ++ DL+++T  + +         +++   L +L
Sbjct: 97  YYIVHLKRHFMFR-NHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 177 H--ENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
              E  +IH D+K +N+LL +   + +K+VDFG S QL + I +    I + ++ +PEV+
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVL 211
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQP 263
                    YD   D+WSLG   +EM   +P
Sbjct: 212 L-----GMPYDLAIDMWSLGCILVEMHTGEP 237

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       +++ME    G +   ++ T+ +  +   +A
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLP------RFILMELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 154 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 214 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 253

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +          AIK                     +  +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 72  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPES 183
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 184 INFRR-----FTSASDVWMFGVCMWEI 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXX 99
           T G     W+ DP  +  L E+ G G +G V  G+    GQ   AIK++           
Sbjct: 11  TAGLGYGSWEIDPKDLTFLKEL-GTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFI 67
Query: 100 XXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
                    S H  +   YG   K+ P      ++++ EY   G + + ++  +    + 
Sbjct: 68  EEAKVMMNLS-HEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMR-HRFQT 119
Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRN 218
           + +  +C+++   ++YL   + +HRD+  +N L+ D   VK+ DFG+S   LD       
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYT 176
Query: 219 TFIGTPY---WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + +G+ +   W  PEV+       + + ++SD+W+ G+   E+
Sbjct: 177 SSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEI 214

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQL----AAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNI 114
           ++V+G+G +G V+KG     G+       IKV+                    S +H +I
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               G       PG   QL  V +Y   GS+ D V+  +G +L  + +     +I +G+ 
Sbjct: 96  VRLLGLC-----PGSSLQL--VTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMY 147
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPY-WMAPE 230
           YL E+ ++HR++  +NVLL   ++V++ DFGV+  L   D+ +        TP  WMA E
Sbjct: 148 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA--KTPIKWMALE 205
Query: 231 VIACDENPDATYDNRSDLWSLGITALEM 258
            I         Y ++SD+WS G+T  E+
Sbjct: 206 SIHF-----GKYTHQSDVWSYGVTVWEL 228

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 116/280 (41%), Gaps = 24/280 (8%)
Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXX--KYSNHRN 113
           +++L E +G G +  V +      GQ  A K++                    +   H N
Sbjct: 23  MYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 82
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRG 172
           I   + +        ++   +L+ +    G   +L +    +    E  A  C ++IL  
Sbjct: 83  IVRLHDSI------SEEGHHYLIFDLVTGG---ELFEDIVAREYYSEADASHCIQQILEA 133
Query: 173 LKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           + + H+  V+HRD+K +N+LL      A VKL DFG++ +++        F GTP +++P
Sbjct: 134 VLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 193
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EV+  D      Y    DLW+ G+    +    PP  D    R L+   +       S +
Sbjct: 194 EVLRKD-----PYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDFPSPE 247
Query: 290 WPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT 326
           W     + +  I  +L  +  +R    + LKHP+I  + T
Sbjct: 248 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRST 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 114/280 (40%), Gaps = 49/280 (17%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-------NHRNIA 115
           +G G +G V+KGR  K   + AIK +                  +         NH NI 
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
             YG  +  +PP       +VME+   G +   +   K   +K      +  +I  G++Y
Sbjct: 87  KLYG--LMHNPP------RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEY 137
Query: 176 LHENK--VIHRDIKGQNVLLT---DNAEV--KLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
           +      ++HRD++  N+ L    +NA V  K+ DF +S Q   ++   +  +G   WMA
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ---SVHSVSGLLGNFQWMA 194
Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-----------I 277
           PE I  +E    +Y  ++D +S  +    +   + P  +    +  F+           I
Sbjct: 195 PETIGAEEE---SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
           P + PPRL+         + IE     D  +RP+   ++K
Sbjct: 252 PEDCPPRLR---------NVIELCWSGDPKKRPHFSYIVK 282

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 20/227 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXXXXXXXXXXX-XXXXXX 105
           +E  A   ++ +V+G G +G+V  GR    G+     AIK +                  
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
               +H NI    G   K  P      + ++ EY   GS+   ++   G+    + +  +
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKP------VMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 116
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            R I  G+KYL +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G   
Sbjct: 117 -RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 175
Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
              W APE IA  +     + + SD+WS GI   E M+  + P  D+
Sbjct: 176 PIRWTAPEAIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDM 217

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 34/289 (11%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
             L+E +G+G++G V +G     +G+  ++ V                   + +     +
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRN+   YG  +  +PP K     +V E    GS+ D ++  +G  L    ++    ++ 
Sbjct: 80  HRNLIRLYGVVL--TPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVA 131
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPY- 225
            G+ YL   + IHRD+  +N+LL     VK+ DFG+   L    D  + + +  +  P+ 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFA 189
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPR 284
           W APE +        T+ + SD W  G+T  EM    Q P   L+  + L  I +     
Sbjct: 190 WCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPTERQA 330
            + +  P+     I  V+V+ +  +P    T   L+   +  QPT+ +A
Sbjct: 245 PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 20/227 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXXXXXXXXXXXXXXXXXX 106
           +E  A   ++ +V+G G +G+V  GR    G+     AIK +                  
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 107 KYS-NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
               +H NI    G   K  P      + ++ EY   GS+   ++   G+    + +  +
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKP------VMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 122
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            R I  G+KYL +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G   
Sbjct: 123 -RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181
Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
              W APE IA  +     + + SD+WS GI   E M+  + P  D+
Sbjct: 182 PIRWTAPEAIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDM 223

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQL----AAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNI 114
           ++V+G+G +G V+KG     G+       IKV+                    S +H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               G       PG   QL  V +Y   GS+ D V+  +G +L  + +     +I +G+ 
Sbjct: 78  VRLLGLC-----PGSSLQL--VTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMY 129
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPY-WMAPE 230
           YL E+ ++HR++  +NVLL   ++V++ DFGV+  L   D+ +        TP  WMA E
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA--KTPIKWMALE 187
Query: 231 VIACDENPDATYDNRSDLWSLGITALEM 258
            I   +     Y ++SD+WS G+T  E+
Sbjct: 188 SIHFGK-----YTHQSDVWSYGVTVWEL 210

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY---SNHRNIATYYG 119
           +G G +G VYKG +     +A  K+                   K      H N+    G
Sbjct: 33  MGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS-LKEEWIAFICREILRGLKYLHE 178
                S  G  D L LV  Y   GS+ D +    G   L       I +    G+ +LHE
Sbjct: 92  F----SSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDE 236
           N  IHRDIK  N+LL +    K+ DFG++   ++          +GT  +MAPE +  + 
Sbjct: 146 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEI 205
Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPL 265
            P      +SD++S G+  LE+    P +
Sbjct: 206 TP------KSDIYSFGVVLLEIITGLPAV 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 129 KDDQL-WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIK 187
           KD Q  ++ +E C A ++ + V+      L  E I  + ++   GL +LH   ++HRD+K
Sbjct: 88  KDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLL-QQTTSGLAHLHSLNIVHRDLK 145
Query: 188 GQNVLLT-DNAEVK----LVDFGVSAQLD---RTIGRRNTFIGTPYWMAPEVIA--CDEN 237
             N+L++  NA  K    + DFG+  +L     +  RR+   GT  W+APE+++  C EN
Sbjct: 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKEN 205
Query: 238 PDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF-Q 295
           P  T     D++S G +    ++E   P       +A  L+   +   L  +K      +
Sbjct: 206 PTYTV----DIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIAR 261
Query: 296 SFIETVLVKDYHQRPYTDQLLKHPFI 321
             IE ++  D  +RP    +LKHPF 
Sbjct: 262 ELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 61  EVVGNGTYGQVYKGR-HTKTGQL---AAIKVMXXXXXXXXXX--XXXXXXXXKYSNHRNI 114
           +V+G G +G+VYKG   T +G+     AIK +                    ++S+H NI
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH-NI 108
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               G   K  P      + ++ EY   G++   ++   G+    + +  + R I  G+K
Sbjct: 109 IRLEGVISKYKP------MMIITEYMENGALDKFLREKDGEFSVLQLVGML-RGIAAGMK 161
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEV 231
           YL     +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W APE 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I+  +     + + SD+WS GI   E+
Sbjct: 222 ISYRK-----FTSASDVWSFGIVMWEV 243

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----NH 111
           +E ++ +G G +  VYK R   T Q+ AIK +                  +       +H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL--KEEWIAFICREI 169
            NI     AF      G    + LV ++      TDL    K  SL      I       
Sbjct: 72  PNIIGLLDAF------GHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+GL+YLH++ ++HRD+K  N+LL +N  +KL DFG++             + T ++ AP
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           E++         Y    D+W++G    E+    P L
Sbjct: 182 ELLFGAR----MYGVGVDMWAVGCILAELLLRVPFL 213

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXX 99
           T G     W+ DP  +  L E+ G G +G V  G+    GQ   AIK++           
Sbjct: 2   TAGLGYGSWEIDPKDLTFLKEL-GTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFI 58
Query: 100 XXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
                    S H  +   YG   K+ P      ++++ EY   G + + ++  +    + 
Sbjct: 59  EEAKVMMNLS-HEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMR-HRFQT 110
Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRN 218
           + +  +C+++   ++YL   + +HRD+  +N L+ D   VK+ DFG+S   LD       
Sbjct: 111 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYT 167
Query: 219 TFIGTPY---WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           + +G+ +   W  PEV+       + + ++SD+W+ G+   E+
Sbjct: 168 SSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEI 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNI 114
           ++V+G+G +G VYKG     G+      AIK++                    S +H ++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV---KSTKGQSLKEEWIAFICREILR 171
               G  +  +       + LV +    G + + V   K   G  L   W    C +I +
Sbjct: 80  VRLLGVCLSPT-------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW----CVQIAK 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL E +++HRD+  +NVL+     VK+ DFG++  L+      N   G  P  WMA 
Sbjct: 129 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I   +     + ++SD+WS G+T  E+
Sbjct: 189 ECIHYRK-----FTHQSDVWSYGVTIWEL 212

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +E+  ++G G++GQV K       +  AIK++                    + H     
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           YY   +K+    + + L LV E   + ++ DL+++T  + +         +++   L +L
Sbjct: 116 YYIVHLKRHFMFR-NHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 177 H--ENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
              E  +IH D+K +N+LL +     +K+VDFG S QL + I +    I + ++ +PEV+
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVL 230
Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQP 263
                    YD   D+WSLG   +EM   +P
Sbjct: 231 L-----GMPYDLAIDMWSLGCILVEMHTGEP 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +          AIK                     +  +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 72  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 184 INFRR-----FTSASDVWMFGVCMWEI 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 20/228 (8%)
Query: 36  EKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMXX-X 91
           E+ +YT   P  R  E      EL   +G G +G V++G +          AIK      
Sbjct: 373 EEDTYT--MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT 430
Query: 92  XXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS 151
                          +  +H +I    G  I ++P      +W++ME C  G +   ++ 
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENP------VWIIMELCTLGELRSFLQV 483
Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
            K  SL    +     ++   L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++
Sbjct: 484 RKF-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542
Query: 212 RTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +   + +    P  WMAPE I         + + SD+W  G+   E+
Sbjct: 543 DSTYYKASKGKLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEI 585

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNI 114
           ++V+G+G +G VYKG     G+      AIK++                    S +H ++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK---GQSLKEEWIAFICREILR 171
               G  +  +       + LV +    G + + V   K   G  L   W    C +I +
Sbjct: 103 VRLLGVCLSPT-------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW----CVQIAK 151
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL E +++HRD+  +NVL+     VK+ DFG++  L+      N   G  P  WMA 
Sbjct: 152 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I   +     + ++SD+WS G+T  E+
Sbjct: 212 ECIHYRK-----FTHQSDVWSYGVTIWEL 235

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXXXXXXXXXK 107
           W+ DP  +  L E+ G G +G V  G+    GQ   AIK++                   
Sbjct: 4   WEIDPKDLTFLKEL-GTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
            S H  +   YG   K+ P      ++++ EY   G + + ++  +    + + +  +C+
Sbjct: 61  LS-HEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCK 112
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTP 224
           ++   ++YL   + +HRD+  +N L+ D   VK+ DFG+S  +   + T  R + F    
Sbjct: 113 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKF--PV 170
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            W  PEV+       + + ++SD+W+ G+   E+
Sbjct: 171 RWSPPEVLMY-----SKFSSKSDIWAFGVLMWEI 199

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 81  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 132
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 193 ESIL-----HRIYTHQSDVWSYGVTVWEL 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXXXXXXXXXK 107
           W+ DP  +  L E+ G G +G V  G+    GQ   AIK++                   
Sbjct: 3   WEIDPKDLTFLKEL-GTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFIEEAKVMMN 59
Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
            S H  +   YG   K+ P      ++++ EY   G + + ++  + +   ++ +  +C+
Sbjct: 60  LS-HEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCK 111
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPY- 225
           ++   ++YL   + +HRD+  +N L+ D   VK+ DFG+S   LD       + +G+ + 
Sbjct: 112 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFP 168
Query: 226 --WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             W  PEV+       + + ++SD+W+ G+   E+
Sbjct: 169 VRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEI 198

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 139
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 140 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASY 199
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 200 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 239

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 79  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 191 ESIL-----HRIYTHQSDVWSYGVTVWEL 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +      A   AIK                     +  +H 
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 69  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 120
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 181 INFRR-----FTSASDVWMFGVCMWEI 202

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 78  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 129
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 190 ESIL-----HRIYTHQSDVWSYGVTVWEL 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 77  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 189 ESIL-----HRIYTHQSDVWSYGVTVWEL 212

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 52  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 111
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 165
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 166 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 225
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 226 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 265

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 80  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 192 ESIL-----HRIYTHQSDVWSYGVTVWEL 215

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 139 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 199 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 238

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +      A   AIK                     +  +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 72  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 184 INFRR-----FTSASDVWMFGVCMWEI 205

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +      A   AIK                     +  +H 
Sbjct: 14  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 74  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 125
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 186 INFRR-----FTSASDVWMFGVCMWEI 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXXXXXXXXXK 107
           W+ DP  +  L E+ G G +G V  G+    GQ   AIK++                   
Sbjct: 4   WEIDPKDLTFLKEL-GTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
            S H  +   YG   K+ P      ++++ EY   G + + ++  +    + + +  +C+
Sbjct: 61  LS-HEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCK 112
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPY- 225
           ++   ++YL   + +HRD+  +N L+ D   VK+ DFG+S   LD       + +G+ + 
Sbjct: 113 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFP 169
Query: 226 --WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             W  PEV+       + + ++SD+W+ G+   E+
Sbjct: 170 VRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEI 199

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 17  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 76
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 130
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 131 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 190
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 191 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 230

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 139
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 140 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 200 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 239

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 78  PHVCRLLGICLTST-------VQLIMQLMPFGXLLDYVREHK-DNIGSQYLLNWCVQIAK 129
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 190 ESIL-----HRIYTHQSDVWSYGVTVWEL 213

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +      A   AIK                     +  +H 
Sbjct: 15  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 75  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 126
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 187 INFRR-----FTSASDVWMFGVCMWEI 208

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 42  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 101
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 155
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 156 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 215
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 216 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 139
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 140 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 200 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 239

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +      A   AIK                     +  +H 
Sbjct: 40  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 100 HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 151
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 152 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 211
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 212 INFRR-----FTSASDVWMFGVCMWEI 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
             L+E +G+G++G V +G     +G+  ++ V                   + +     +
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRN+   YG  +  +PP K     +V E    GS+ D ++  +G  L    ++    ++ 
Sbjct: 70  HRNLIRLYGVVL--TPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVA 121
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPY- 225
            G+ YL   + IHRD+  +N+LL     VK+ DFG+   L    D  + + +  +  P+ 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV--PFA 179
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           W APE +        T+ + SD W  G+T  EM
Sbjct: 180 WCAPESLKT-----RTFSHASDTWMFGVTLWEM 207

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMXXXXXXXXXXX-XXXXXXXKYSNHRNI 114
           I  +G G +G+V    Y   +  TG++ A+K +                   +   H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y G             L LVMEY   GS+ D +      S+    +    ++I  G+ 
Sbjct: 96  IKYKGC----CEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMA 148
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEV 231
           YLH    IHRD+  +NVLL ++  VK+ DFG++  +         R       +W APE 
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           +      +  +   SD+WS G+T  E+
Sbjct: 209 LK-----EYKFYYASDVWSFGVTLYEL 230

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 154 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 214 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 253

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           EV+G G +G+V +GR    G+     AIK +                       H NI  
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G      P      + ++ E+   G++   ++   GQ    + +  + R I  G++YL
Sbjct: 82  LEGVVTNSMP------VMILTEFMENGALDSFLRLNDGQFTVIQLVGML-RGIASGMRYL 134
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPY---WMAPEV 231
            E   +HRD+  +N+L+  N   K+ DFG+S  L+         + +G      W APE 
Sbjct: 135 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 232 IACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
           IA  +     + + SD WS GI   E M+  + P  D+     +  I ++   PP     
Sbjct: 195 IAFRK-----FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPP---PP 246
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
             P      +     KD + RP   Q++ 
Sbjct: 247 DCPTSLHQLMLDCWQKDRNARPRFPQVVS 275

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 32  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 91
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 145
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 146 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 205
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 206 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 245

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEA 99
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDR-TI 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R + 
Sbjct: 154 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 214 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 253

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +      A   AIK                     +  +H 
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 77  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 128
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 189 INFRR-----FTSASDVWMFGVCMWEI 210

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 34/286 (11%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
             L+E +G+G++G V +G     +G+  ++ V                   + +     +
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRN+   YG  +  +PP K     +V E    GS+ D ++  +G  L    ++    ++ 
Sbjct: 70  HRNLIRLYGVVL--TPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVA 121
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPY- 225
            G+ YL   + IHRD+  +N+LL     VK+ DFG+   L    D  + + +  +  P+ 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFA 179
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPR 284
           W APE +        T+ + SD W  G+T  EM    Q P   L+  + L  I +     
Sbjct: 180 WCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234
Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPY---TDQLLKHPFIRDQPTE 327
            + +  P+     I  V+V+ +  +P    T   L+   +  QPT+
Sbjct: 235 PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 276

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 10/138 (7%)
Query: 131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQN 190
           + L LVME  G G +   +   K + +    +A +  ++  G+KYL E   +HRD+  +N
Sbjct: 82  EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 140
Query: 191 VLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSD 247
           VLL +    K+ DFG+S  L   D     R+       W APE I   +     + +RSD
Sbjct: 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-----FSSRSD 195
Query: 248 LWSLGITALE-MAESQPP 264
           +WS G+T  E ++  Q P
Sbjct: 196 VWSYGVTMWEALSYGQKP 213

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 125
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRT-I 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R   
Sbjct: 180 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 240 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 279

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
             L+E +G+G++G V +G     +G+  ++ V                   + +     +
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRN+   YG  +  +PP K     +V E    GS+ D ++  +G  L    ++    ++ 
Sbjct: 70  HRNLIRLYGVVL--TPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVA 121
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPY- 225
            G+ YL   + IHRD+  +N+LL     VK+ DFG+   L    D  + + +  +  P+ 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFA 179
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           W APE +        T+ + SD W  G+T  EM
Sbjct: 180 WCAPESLKT-----RTFSHASDTWMFGVTLWEM 207

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 111/264 (42%), Gaps = 47/264 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 79  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG +  L       +   G  P  WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAE------------------------SQPPL 265
           E I         Y ++SD+WS G+T  E+                           QPP+
Sbjct: 191 ESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 245
Query: 266 CDLHP---MRALFLIPRNAPPRLK 286
           C +     MR  ++I  ++ P+ +
Sbjct: 246 CTIDVYMIMRKCWMIDADSRPKFR 269

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 9/130 (6%)
Query: 131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQN 190
           + L LVME  G G +   +   K + +    +A +  ++  G+KYL E   +HR++  +N
Sbjct: 408 EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARN 466
Query: 191 VLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSD 247
           VLL +    K+ DFG+S  L   D     R+       W APE I   +     + +RSD
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-----FSSRSD 521
Query: 248 LWSLGITALE 257
           +WS G+T  E
Sbjct: 522 VWSYGVTMWE 531

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMXXXXXXXXXXX-XXXXXXXKYSNHRNI 114
           I  +G G +G+V    Y   +  TG++ A+K +                   +   H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y G    +     +  L LVMEY   GS+ D +      S+    +    ++I  G+ 
Sbjct: 79  IKYKGCCEDQG----EKSLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMA 131
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEV 231
           YLH    IHR++  +NVLL ++  VK+ DFG++  +         R       +W APE 
Sbjct: 132 YLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           +      +  +   SD+WS G+T  E+
Sbjct: 192 LK-----EYKFYYASDVWSFGVTLYEL 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 48  RWQEDPAGIFELIEVVGNGTYGQV-----YKGRHTKTGQLAAIKVMXXXXXXXX--XXXX 100
           +W E P    E  +V+G+G +G+V     Y    T      A+K++              
Sbjct: 39  KW-EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 97
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
                 +  +H NI    GA     P      ++L+ EYC  G + + ++S K +   E+
Sbjct: 98  ELKMMTQLGSHENIVNLLGACTLSGP------IYLIFEYCCYGDLLNYLRS-KREKFSED 150
Query: 161 WIAF--------------------IC--REILRGLKYLHENKVIHRDIKGQNVLLTDNAE 198
            I +                    +C   ++ +G+++L     +HRD+  +NVL+T    
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 199 VKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITA 255
           VK+ DFG++  +      + R N  +    WMAPE +      +  Y  +SD+WS GI  
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVK-WMAPESLF-----EGIYTIKSDVWSYGILL 264
Query: 256 LEM 258
            E+
Sbjct: 265 WEI 267

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTG------QLAAIKVMXXXXXXXXXXXXXXX 103
           +E P     LI  +G+G +G+VY+G+ +         Q+A   +                
Sbjct: 43  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 102
Query: 104 XXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
                 NH+NI    G  ++  P       ++++E    G +   ++ T+ +  +   +A
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLA 156
Query: 164 F-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDRT-I 214
                 + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  + R   
Sbjct: 157 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 216
Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            R+      P  WM PE        +  + +++D WS G+   E+
Sbjct: 217 YRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEI 256

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-----N 110
             L+E +G+G++G V +G     +G+  ++ V                   + +     +
Sbjct: 14  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           HRN+   YG  +  +PP K     +V E    GS+ D ++  +G  L    ++    ++ 
Sbjct: 74  HRNLIRLYGVVL--TPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGT-LSRYAVQVA 125
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFIGTPY- 225
            G+ YL   + IHRD+  +N+LL     VK+ DFG+   L    D  + + +  +  P+ 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFA 183
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           W APE +        T+ + SD W  G+T  EM
Sbjct: 184 WCAPESLKT-----RTFSHASDTWMFGVTLWEM 211

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXX-XXXXXKYSNHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 164 SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 34/224 (15%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G G++G+V++    +TG   A+K +                         I   YGA +
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSP-----RIVPLYGA-V 154
Query: 123 KKSPPGKDDQLW--LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           ++ P       W  + ME    GS+  LVK      L E+   +   + L GL+YLH  +
Sbjct: 155 REGP-------WVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHSRR 205
Query: 181 VIHRDIKGQNVLL-TDNAEVKLVDFGVSA-----QLDRTIGRRNTFIGTPYWMAPEVIAC 234
           ++H D+K  NVLL +D +   L DFG +       L +++   +   GT   MAPEV+  
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL- 264
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP 278
                 + D + D+WS     L M      L   HP    F  P
Sbjct: 265 ----GRSCDAKVDVWSSCCMMLHM------LNGCHPWTQFFRGP 298

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKY-----SNH 111
           +E+++V+G G +GQV K    K  Q  A+K++                          N 
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+      F  +      + + +  E     ++ +L+K  K Q      +      IL+
Sbjct: 159 MNVIHMLENFTFR------NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAE--VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
            L  LH+N++IH D+K +N+LL       +K++DFG S    +   R    I + ++ AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYXXIQSRFYRAP 268
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           EVI       A Y    D+WSLG    E+    P L
Sbjct: 269 EVIL-----GARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 81  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 132
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG +  L       +   G  P  WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 193 ESIL-----HRIYTHQSDVWSYGVTVWEL 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 79  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG +  L       +   G  P  WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 191 ESIL-----HRIYTHQSDVWSYGVTVWEL 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 22/218 (10%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXX-XXXXXXXXXXXXXXXXKYSNHRNIAT 116
           EV+G G +G+V +GR    G+     AIK +                       H NI  
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G      P      + ++ E+   G++   ++   GQ    + +  + R I  G++YL
Sbjct: 80  LEGVVTNSMP------VMILTEFMENGALDSFLRLNDGQFTVIQLVGML-RGIASGMRYL 132
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPY---WMAPEV 231
            E   +HRD+  +N+L+  N   K+ DFG+S  L+         + +G      W APE 
Sbjct: 133 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 232 IACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
           IA  +     + + SD WS GI   E M+  + P  D+
Sbjct: 193 IAFRK-----FTSASDAWSYGIVMWEVMSFGERPYWDM 225

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMXXXXXXXXXXX-XXXXXXXKYSNHRNI 114
           I  +G G +G+V    Y   +  TG++ A+K +                   +   H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y G    +     +  L LVMEY   GS+ D +      S+    +    ++I  G+ 
Sbjct: 79  IKYKGCCEDQG----EKSLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMA 131
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEV 231
           YLH    IHR++  +NVLL ++  VK+ DFG++  +         R       +W APE 
Sbjct: 132 YLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           +      +  +   SD+WS G+T  E+
Sbjct: 192 LK-----EYKFYYASDVWSFGVTLYEL 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           F+ I+V+G+G +G VYKG     G+     +A +++                      ++
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 111 PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 162
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 163 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 223 ESIL-----HRIYTHQSDVWSYGVTVWEL 246

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXX-XXXXXKYSNHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXX-XXXXXKYSNHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 109 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 161
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 162 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 222 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 273
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 274 PAALYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 33/236 (13%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           L+E VG G YG+V++G     G+  A+K+                       H NI  + 
Sbjct: 12  LVECVGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL-RHDNILGFI 68
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH- 177
            +    +      QLWL+  Y   GS+ D ++    Q+L+      +      GL +LH 
Sbjct: 69  AS--DMTSRNSSTQLWLITHYHEHGSLYDFLQR---QTLEPHLALRLAVSAACGLAHLHV 123
Query: 178 -------ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR-----TIGRRNTFIGTPY 225
                  +  + HRD K +NVL+  N +  + D G++    +      IG  N  +GT  
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIG-NNPRVGTKR 182
Query: 226 WMAPEVIACDENPDATYDNR-SDLWSLGITALEMA----------ESQPPLCDLHP 270
           +MAPEV+      D     + +D+W+ G+   E+A          + +PP  D+ P
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVP 238

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 36/237 (15%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMXXXXXX 94
           Y E W      E P    +  + +G G +G+V +      G+       A+K++      
Sbjct: 37  YNEKW------EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 95  --XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST 152
                             H NI    GA     P      + ++ EYC  G + + ++  
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRK 144
Query: 153 K--------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF 204
                    G+ L+   +     ++ +G+ +L     IHRD+  +NVLLT+    K+ DF
Sbjct: 145 AEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 204
Query: 205 GVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           G++  +      I + N  +    WMAPE I      D  Y  +SD+WS GI   E+
Sbjct: 205 GLARDIMNDSNYIVKGNARLPVK-WMAPESIF-----DCVYTVQSDVWSYGILLWEI 255

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 47/264 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 87  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 138
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 139 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAE------------------------SQPPL 265
           E I         Y ++SD+WS G+T  E+                           QPP+
Sbjct: 199 ESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 253
Query: 266 CDLHP---MRALFLIPRNAPPRLK 286
           C +     MR  ++I  ++ P+ +
Sbjct: 254 CTIDVYMIMRKCWMIDADSRPKFR 277

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 26/293 (8%)
Query: 34  GLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRH---TKTGQLAAIKVMXX 90
           GL  R  T+   E   + D   I  + +VVG G +G+V  GR    +K     AIK +  
Sbjct: 13  GLVPRGSTQTVHEFAKELDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 71
Query: 91  XXXXXXXXXXXXXXXXKYS-NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV 149
                               +H NI    G   K  P      + +V EY   GS+   +
Sbjct: 72  GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP------VMIVTEYMENGSLDSFL 125
Query: 150 KSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ 209
           +    Q    + +  + R I  G+KYL +   +HRD+  +N+L+  N   K+ DFG+S  
Sbjct: 126 RKHDAQFTVIQLVGML-RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 184
Query: 210 LDRTIGRRNTFIGTPY---WMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPL 265
           L+       T  G      W +PE IA  +     + + SD+WS GI   E M+  + P 
Sbjct: 185 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-----FTSASDVWSYGIVLWEVMSYGERPY 239
Query: 266 CDLHPMRALFLIPRN--APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLL 316
            ++     +  +      PP +     P      +     KD + RP  +Q++
Sbjct: 240 WEMSNQDVIKAVDEGYRLPPPMDC---PAALYQLMLDCWQKDRNNRPKFEQIV 289

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 36/237 (15%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMXXXXXX 94
           Y E W      E P    +  + +G G +G+V +      G+       A+K++      
Sbjct: 29  YNEKW------EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 82
Query: 95  --XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST 152
                             H NI    GA     P      + ++ EYC  G + + ++  
Sbjct: 83  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRK 136
Query: 153 K--------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF 204
                    G+ L+   +     ++ +G+ +L     IHRD+  +NVLLT+    K+ DF
Sbjct: 137 AEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 196
Query: 205 GVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           G++  +      I + N  +    WMAPE I      D  Y  +SD+WS GI   E+
Sbjct: 197 GLARDIMNDSNYIVKGNARLPVK-WMAPESIF-----DCVYTVQSDVWSYGILLWEI 247

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 109/268 (40%), Gaps = 27/268 (10%)
Query: 61  EVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXX-XXXXXXXXXXXXXXXXKYSNHRNIAT 116
           +V+G G +G+V  G     G+     AIK +                      +H N+  
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K +P      + ++ E+   GS+   ++   GQ    + +  + R I  G+KYL
Sbjct: 73  LEGVVTKSTP------VMIITEFMENGSLDSFLRQNDGQFTVIQLVGML-RGIAAGMKYL 125
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY---WMAPEV 231
            +   +HR +  +N+L+  N   K+ DFG+S  L  D +     + +G      W APE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 232 IACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSK 288
           I   +     + + SD+WS GI   E M+  + P  D+     +  I ++   PP +   
Sbjct: 186 IQYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC- 239
Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLL 316
             P      +     KD + RP   Q++
Sbjct: 240 --PSALHQLMLDCWQKDRNHRPKFGQIV 265

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 64  GNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRNIATYYGA 120
           G G +G VYKG +     +A  K+                   K      H N+    G 
Sbjct: 31  GEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS-LKEEWIAFICREILRGLKYLHEN 179
               S  G  D L LV  Y   GS+ D +    G   L       I +    G+ +LHEN
Sbjct: 90  ----SSDG--DDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN 143
Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDEN 237
             IHRDIK  N+LL +    K+ DFG++   ++       +  +GT  + APE +  +  
Sbjct: 144 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEIT 203
Query: 238 PDATYDNRSDLWSLGITALEMAESQPPL 265
           P      +SD++S G+  LE+    P +
Sbjct: 204 P------KSDIYSFGVVLLEIITGLPAV 225

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXX-XXXXXXXXKYSNHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 82  LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 134
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 195 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 246
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 247 PAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 47/264 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 80  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAE------------------------SQPPL 265
           E I         Y ++SD+WS G+T  E+                           QPP+
Sbjct: 192 ESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 246
Query: 266 CDLHP---MRALFLIPRNAPPRLK 286
           C +     MR  ++I  ++ P+ +
Sbjct: 247 CTIDVYMIMRKCWMIDADSRPKFR 270

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAF 121
           ++G G +G+VYKGR      +A  ++                     + HRN+    G  
Sbjct: 45  ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW--IAFICREILRGLKYLHEN 179
           +  +      +  LV  Y   GSV   ++         +W     I     RGL YLH++
Sbjct: 105 MTPT------ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 158
Query: 180 ---KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD-RTIGRRNTFIGTPYWMAPEVIACD 235
              K+IHRD+K  N+LL +  E  + DFG++  +D +         GT   +APE ++  
Sbjct: 159 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTG 218
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQ 262
           ++ + T     D++  G+  LE+   Q
Sbjct: 219 KSSEKT-----DVFGYGVMLLELITGQ 240

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 189 ESIL-----HRIYTHQSDVWSYGVTVWEL 212

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 47/264 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAE------------------------SQPPL 265
           E I         Y ++SD+WS G+T  E+                           QPP+
Sbjct: 189 ESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243
Query: 266 CDLHP---MRALFLIPRNAPPRLK 286
           C +     MR  ++I  ++ P+ +
Sbjct: 244 CTIDVYMIMRKCWMIDADSRPKFR 267

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 102 PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 153
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 154 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 214 ESIL-----HRIYTHQSDVWSYGVTVWEL 237

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+ +G +G VYKG     G+      AIK +                    S ++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+M+    G + D V+  K  ++  +++   C +I +
Sbjct: 84  PHVCRLLGICLTST-------VQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 196 ESIL-----HRIYTHQSDVWSYGVTVWEL 219

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 79  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 191 ESIL-----HRIYTHQSDVWSYGVTVWEL 214

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 20/228 (8%)
Query: 36  EKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMXX-X 91
           E+ +YT   P  R  E      EL   +G G +G V++G +          AIK      
Sbjct: 373 EEDTYT--MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT 430
Query: 92  XXXXXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS 151
                          +  +H +I    G  I ++P      +W++ME C  G +   ++ 
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENP------VWIIMELCTLGELRSFLQV 483
Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
            K  SL    +     ++   L YL   + +HRDI  +NVL++    VKL DFG+S  ++
Sbjct: 484 RKF-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME 542
Query: 212 RTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +   + +    P  WMAPE I         + + SD+W  G+   E+
Sbjct: 543 DSTYYKASKGKLPIKWMAPESINFRR-----FTSASDVWMFGVCMWEI 585

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
           ++IL  + + H+  V+HR++K +N+LL      A VKL DFG++ +++        F GT
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP 283
           P +++PEV+  D      Y    DLW+ G+    +    PP  D    R L+   +    
Sbjct: 177 PGYLSPEVLRKD-----PYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAY 230
Query: 284 RLKSKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT 326
              S +W     + +  I  +L  +  +R    + LKHP+I  + T
Sbjct: 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRST 276

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 80  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 192 ESIL-----HRIYTHQSDVWSYGVTVWEL 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 83  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 134
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 135 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 195 ESIL-----HRIYTHQSDVWSYGVTVWEL 218

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGXLLDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 189 ESIL-----HRIYTHQSDVWSYGVTVWEL 212

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 80  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 192 ESIL-----HRIYTHQSDVWSYGVTVWEL 215

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G G++G+V++    +TG   A+K +                         I   YGA +
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSP-----RIVPLYGA-V 135
Query: 123 KKSPPGKDDQLW--LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           ++ P       W  + ME    GS+  LVK      L E+   +   + L GL+YLH  +
Sbjct: 136 REGP-------WVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHSRR 186
Query: 181 VIHRDIKGQNVLL-TDNAEVKLVDFGVSA-----QLDRTIGRRNTFIGTPYWMAPEVIAC 234
           ++H D+K  NVLL +D +   L DFG +       L + +   +   GT   MAPEV+  
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL- 245
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP 278
                 + D + D+WS     L M      L   HP    F  P
Sbjct: 246 ----GRSCDAKVDVWSSCCMMLHM------LNGCHPWTQFFRGP 279

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYG 119
           ++V+G+G +G VYKG     G+   I V                   +      + + Y 
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
           + +         QL  V +    G + D V+  +G+   ++ + + C +I +G+ YL + 
Sbjct: 82  SRLLGICLTSTVQL--VTQLMPYGCLLDHVRENRGRLGSQDLLNW-CMQIAKGMSYLEDV 138
Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAPEVIACDEN 237
           +++HRD+  +NVL+     VK+ DFG++  LD      +   G  P  WMA E I     
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL---- 194
Query: 238 PDATYDNRSDLWSLGITALEM 258
               + ++SD+WS G+T  E+
Sbjct: 195 -RRRFTHQSDVWSYGVTVWEL 214

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG++  L+       T  G      W +PE IA
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 27/232 (11%)
Query: 34  GLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL---AAIKVMXX 90
           G   RS+T        +E  A    + +++G+G  G+V  GR    GQ     AIK +  
Sbjct: 36  GRAGRSFT--------REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA 87
Query: 91  XXXXXXXX-XXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV 149
                               +H NI    G   +           +V EY   GS+   +
Sbjct: 88  GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR------LAMIVTEYMENGSLDTFL 141
Query: 150 KSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ 209
           ++  GQ    + +  + R +  G++YL +   +HRD+  +NVL+  N   K+ DFG+S  
Sbjct: 142 RTHDGQFTIMQLVGML-RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 210 LDRTIGRRNTFIGTPY---WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           L+       T  G      W APE IA       T+ + SD+WS G+   E+
Sbjct: 201 LEDDPDAAXTTTGGKIPIRWTAPEAIAFR-----TFSSASDVWSFGVVMWEV 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMXXXXX-XXXXXXXXXXXXXKYSNHR 112
            EL   +G G +G V++G +          AIK                     +  +H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I    G  I ++P      +W++ME C  G +   ++  K  SL    +     ++   
Sbjct: 72  HIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTA 123
Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEV 231
           L YL   + +HRDI  +NVL++    VKL DFG+S  ++ +   + +    P  WMAPE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           I         + + SD+W  G+   E+
Sbjct: 184 INFRR-----FTSASDVWMFGVCMWEI 205

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 84  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 196 ESIL-----HRIYTHQSDVWSYGVTVWEL 219

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN 110
           E+    F+   ++G+G +G+VYKG   + G   A+K                     +  
Sbjct: 35  EEATNNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF--ICRE 168
           H ++ +  G   ++      +++ L+ +Y   G++   +  +   ++   W     IC  
Sbjct: 94  HPHLVSLIGFCDER------NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRTIGRRNTFIGTPY 225
             RGL YLH   +IHRD+K  N+LL +N   K+ DFG+S    +LD+T        GT  
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT-HLXXVVKGTLG 206
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL--------- 276
           ++ PE              +SD++S G+   E+  ++  +    P   + L         
Sbjct: 207 YIDPEYFI-----KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 277 ---IPRNAPPRLKSKKWPKKFQSFIETVL 302
              + +   P L  K  P+  + F +T +
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAV 290

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 46/284 (16%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           VG G++G+V++ +  +TG   A+K +                    S+ R I   YGA +
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACA----GLSSPR-IVPLYGA-V 135
Query: 123 KKSPPGKDDQLW--LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           ++ P       W  + ME    GS+  L+K      L E+   +   + L GL+YLH  +
Sbjct: 136 REGP-------WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR 186
Query: 181 VIHRDIKGQNVLL-TDNAEVKLVDFGVSA-----QLDRTIGRRNTFIGTPYWMAPEVIAC 234
           ++H D+K  NVLL +D +   L DFG +       L +++   +   GT   MAPEV+  
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM- 245
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
                   D + D+WS     L M      L   HP    F  P              K 
Sbjct: 246 ----GKPCDAKVDIWSSCCMMLHM------LNGCHPWTQYFRGPLCL-----------KI 284
Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHI 338
            S    +        P T Q ++   +R +P  R + ++L+  +
Sbjct: 285 ASEPPPIREIPPSCAPLTAQAIQEG-LRKEPVHRASAMELRRKV 327

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQL-AAIKVMXXXXXXXXXXXXXXXXXXKYSN 110
           DP  +  L E+ G G +G V  G+    GQ   AIK++                    S 
Sbjct: 2   DPKDLTFLKEL-GTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS- 57
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H  +   YG   K+ P      ++++ EY   G + + ++  + +   ++ +  +C+++ 
Sbjct: 58  HEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVC 110
Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDRTIGRRNTFIGTPY---W 226
             ++YL   + +HRD+  +N L+ D   VK+ DFG+S   LD       + +G+ +   W
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRW 167
Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             PEV+       + + ++SD+W+ G+   E+
Sbjct: 168 SPPEVLMY-----SKFSSKSDIWAFGVLMWEI 194

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 71  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 183 ESIL-----HRIYTHQSDVWSYGVTVWEL 206

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 46/284 (16%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           VG G++G+V++ +  +TG   A+K +                    S+ R I   YGA +
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACA----GLSSPR-IVPLYGA-V 119
Query: 123 KKSPPGKDDQLW--LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           ++ P       W  + ME    GS+  L+K      L E+   +   + L GL+YLH  +
Sbjct: 120 REGP-------WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR 170
Query: 181 VIHRDIKGQNVLL-TDNAEVKLVDFGVSA-----QLDRTIGRRNTFIGTPYWMAPEVIAC 234
           ++H D+K  NVLL +D +   L DFG +       L +++   +   GT   MAPEV+  
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM- 229
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
                   D + D+WS     L M      L   HP    F  P              K 
Sbjct: 230 ----GKPCDAKVDIWSSCCMMLHM------LNGCHPWTQYFRGPLCL-----------KI 268
Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHI 338
            S    +        P T Q ++   +R +P  R + ++L+  +
Sbjct: 269 ASEPPPIREIPPSCAPLTAQAIQEG-LRKEPVHRASAMELRRKV 311

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 27/232 (11%)
Query: 34  GLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQL---AAIKVMXX 90
           G   RS+T        +E  A    + +++G+G  G+V  GR    GQ     AIK +  
Sbjct: 36  GRAGRSFT--------REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA 87
Query: 91  XXXXXXXX-XXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV 149
                               +H NI    G   +           +V EY   GS+   +
Sbjct: 88  GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR------LAMIVTEYMENGSLDTFL 141
Query: 150 KSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ 209
           ++  GQ    + +  + R +  G++YL +   +HRD+  +NVL+  N   K+ DFG+S  
Sbjct: 142 RTHDGQFTIMQLVGML-RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 210 LDRTIGRRNTFIGTPY---WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           L+       T  G      W APE IA       T+ + SD+WS G+   E+
Sbjct: 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFR-----TFSSASDVWSFGVVMWEV 247

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 46/292 (15%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXX 100
           D W+     I  L+  +G G++G VY+G  R    G+    +A   V             
Sbjct: 7   DEWEVSREKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL 65
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-- 158
                 K     ++    G   K  P        +VME    G +   ++S + ++    
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNP 119
Query: 159 -------EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
                  +E I  +  EI  G+ YL+  K +HRD+  +N ++  +  VK+ DFG++  + 
Sbjct: 120 GRPPPTLQEMIQ-MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 178
Query: 212 RTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
            T   R    G     WMAPE +      D  +   SD+WS G+   E+   ++ P   L
Sbjct: 179 ETDXXRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 233
Query: 269 HPMRALFLI--------PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
              + L  +        P N P R   L    W   PK   +F+E V L+KD
Sbjct: 234 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 285

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 46/292 (15%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXX 100
           D W+     I  L+  +G G++G VY+G  R    G+    +A   V             
Sbjct: 10  DEWEVSREKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL 68
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-- 158
                 K     ++    G   K  P        +VME    G +   ++S + ++    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 159 -------EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
                  +E I  +  EI  G+ YL+  K +HRD+  +N ++  +  VK+ DFG++  + 
Sbjct: 123 GRPPPTLQEMIQ-MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 212 RTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
            T   R    G     WMAPE +      D  +   SD+WS G+   E+   ++ P   L
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 269 HPMRALFLI--------PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
              + L  +        P N P R   L    W   PK   +F+E V L+KD
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMX-XXXXXXXXXXXXXXXXXKYSNHRNI 114
           I  +G G +G+V    Y      TG+  A+K +                   +   H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRGL 173
             Y G   +    G    + L+ME+  +GS+ + +   K + +LK++    +  +I +G+
Sbjct: 86  VKYKGICTEDGGNG----IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGM 139
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAPE 230
            YL   + +HRD+  +NVL+    +VK+ DFG++  +  D+          +P +W APE
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 199
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL 276
            +       + +   SD+WS G+T  E+        D  PM ALFL
Sbjct: 200 CLM-----QSKFYIASDVWSFGVTLHELLTYCDS--DSSPM-ALFL 237

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 106/266 (39%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V EY   GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+   L+       T  G      W +PE IA
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 19/228 (8%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIK-VMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGA 120
           V+  G +  VY+ +   +G+  A+K ++                  K S H NI  +  A
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 121 --FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
               K+       +  L+ E C    V  L K      L  + +  I  +  R ++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 179 NK--VIHRDIKGQNVLLTDNAEVKLVDFGV------------SAQLDRTIGRRNTFIGTP 224
            K  +IHRD+K +N+LL++   +KL DFG             SAQ    +    T   TP
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
            +  PE+I  D   +     + D+W+LG     +   Q P  D   +R
Sbjct: 215 MYRTPEII--DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 110/264 (41%), Gaps = 47/264 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 79  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG +  L       +   G  P  WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAE------------------------SQPPL 265
           E I         Y ++SD+WS G+T  E+                           QPP+
Sbjct: 191 ESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 245
Query: 266 CDLHP---MRALFLIPRNAPPRLK 286
           C +     MR  ++I  ++ P+ +
Sbjct: 246 CTIDVYMIMRKCWMIDADSRPKFR 269

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMX-XXXXXXXXXXXXXXXXXKYSNHRNI 114
           I  +G G +G+V    Y      TG+  A+K +                   +   H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRGL 173
             Y G   +    G    + L+ME+  +GS+ + +   K + +LK++    +  +I +G+
Sbjct: 74  VKYKGICTEDGGNG----IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGM 127
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTP-YWMAPE 230
            YL   + +HRD+  +NVL+    +VK+ DFG++  +  D+          +P +W APE
Sbjct: 128 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL 276
            +       + +   SD+WS G+T  E+        D  PM ALFL
Sbjct: 188 CLM-----QSKFYIASDVWSFGVTLHELLTYCDS--DSSPM-ALFL 225

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 20/227 (8%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMXXXXXXXXXXXXX-XXXX 105
           +E  A   ++  V+G G +G+V  GR    G+     AIK +                  
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 106 XKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
               +H N+    G   +  P      + +V+E+   G++   ++   GQ    + +  +
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKP------VMIVIEFMENGALDAFLRKHDGQFTVIQLVGML 151
Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            R I  G++YL +   +HRD+  +N+L+  N   K+ DFG+S  ++       T  G   
Sbjct: 152 -RGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI 210
Query: 226 ---WMAPEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
              W APE I   +     + + SD+WS GI   E M+  + P  D+
Sbjct: 211 PVRWTAPEAIQYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDM 252

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQ---SLKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 81  DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 134
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE I    +  EN   
Sbjct: 135 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 253
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 254 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I  
Sbjct: 74  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAE 125
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 186 ESIL-----HRIYTHQSDVWSYGVTVWEL 209

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 93/243 (38%), Gaps = 42/243 (17%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMXXXXXX 94
           Y E W      E P    +  + +G G +G+V +      G+       A+K++      
Sbjct: 37  YNEKW------EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 95  --XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST 152
                             H NI    GA     P      + ++ EYC  G + + ++  
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRK 144
Query: 153 KGQSLKEEW--------------IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE 198
           +   L+  +              +     ++ +G+ +L     IHRD+  +NVLLT+   
Sbjct: 145 RPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 204
Query: 199 VKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITA 255
            K+ DFG++  +      I + N  +    WMAPE I      D  Y  +SD+WS GI  
Sbjct: 205 AKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIF-----DCVYTVQSDVWSYGILL 258
Query: 256 LEM 258
            E+
Sbjct: 259 WEI 261

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 84  DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 137
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE I    +  EN   
Sbjct: 138 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 196
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 197 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 256
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 257 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 292

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 80  DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 133
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE I    +  EN   
Sbjct: 134 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 192
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 193 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 252
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 253 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 288

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG +  L       +   G  P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 189 ESIL-----HRIYTHQSDVWSYGVTVWEL 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 92/241 (38%), Gaps = 40/241 (16%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMXXXXXX 94
           Y E W      E P    +  + +G G +G+V +      G+       A+K++      
Sbjct: 37  YNEKW------EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 95  --XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-- 150
                             H NI    GA     P      + ++ EYC  G + + ++  
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRK 144
Query: 151 ----------STKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
                     +    +L    +     ++ +G+ +L     IHRD+  +NVLLT+    K
Sbjct: 145 SRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204
Query: 201 LVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALE 257
           + DFG++  +      I + N  +    WMAPE I      D  Y  +SD+WS GI   E
Sbjct: 205 IGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIF-----DCVYTVQSDVWSYGILLWE 258
Query: 258 M 258
           +
Sbjct: 259 I 259

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT---IGRRNTFIGTP 224
           ++ RG+++L   K IHRD+  +N+LL++N  VK+ DFG++  + +    + + +T +   
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLK 266
Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            WMAPE I      D  Y  +SD+WS G+   E+
Sbjct: 267 -WMAPESIF-----DKIYSTKSDVWSYGVLLWEI 294

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 153
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE I    +  EN   
Sbjct: 154 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 272
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 273 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+G+G +G VYKG     G+      AIK +                    S ++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 84  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG +  L       +   G  P  WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 196 ESIL-----HRIYTHQSDVWSYGVTVWEL 219

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 20/232 (8%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G G  G V+        +  AIK +                  +  +H NI   +    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 123 KKSPPGKDD--------QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                  DD         +++V EY      TDL    +   L EE       ++LRGLK
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHARLFMYQLLRGLK 134
Query: 175 YLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLD---RTIGRRNTFIGTPYWMAPE 230
           Y+H   V+HRD+K  N+ + T++  +K+ DFG++  +D      G  +  + T ++ +P 
Sbjct: 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP 282
           ++    N    Y    D+W+ G    EM   +      H +  + LI  + P
Sbjct: 195 LLLSPNN----YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 181
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE I    +  EN   
Sbjct: 182 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 240
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 106/266 (39%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V E    GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 164 SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 46/284 (16%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           +G G++G+V++ +  +TG   A+K +                     +   I   YGA +
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL-----SSPRIVPLYGA-V 133
Query: 123 KKSPPGKDDQLW--LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           ++ P       W  + ME    GS+  L+K      L E+   +   + L GL+YLH  +
Sbjct: 134 REGP-------WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR 184
Query: 181 VIHRDIKGQNVLL-TDNAEVKLVDFGVSA-----QLDRTIGRRNTFIGTPYWMAPEVIAC 234
           ++H D+K  NVLL +D +   L DFG +       L +++   +   GT   MAPEV+  
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM- 243
Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
                   D + D+WS     L M      L   HP    F  P              K 
Sbjct: 244 ----GKPCDAKVDIWSSCCMMLHM------LNGCHPWTQYFRGPLCL-----------KI 282
Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHI 338
            S    +        P T Q ++   +R +P  R + ++L+  +
Sbjct: 283 ASEPPPIREIPPSCAPLTAQAIQEG-LRKEPVHRASAMELRRKV 325

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 22/215 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXX--XXXXXXXXXKYSNHRNI 114
           +  I  +G GTYG+VYK   T T +  AIK +                    K   HRNI
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST-KGQSLKEEWIAFICREILRGL 173
                    KS    + +L L+ EY       DL K   K   +    I     +++ G+
Sbjct: 96  IEL------KSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 174 KYLHENKVIHRDIKGQNVLL--TDNAE---VKLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
            + H  + +HRD+K QN+LL  +D +E   +K+ DFG++      I +    I T ++  
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           PE++    +    Y    D+WS+     EM    P
Sbjct: 206 PEILLGSRH----YSTSVDIWSIACIWAEMLMKTP 236

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 181
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE I    +  EN   
Sbjct: 182 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 240
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMXXXXXXXXXXX-XXXXXXXKYSNHRNI 114
           I  +G G +G+V    Y   +  TG++ A+K +                   +   H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y G    +     +  + LVMEY   GS+ D +       +    +    ++I  G+ 
Sbjct: 73  VKYKGCCEDQG----EKSVQLVMEYVPLGSLRDYLPR---HCVGLAQLLLFAQQICEGMA 125
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEV 231
           YLH    IHR +  +NVLL ++  VK+ DFG++  +         R       +W APE 
Sbjct: 126 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           +      +  +   SD+WS G+T  E+
Sbjct: 186 LK-----ECKFYYASDVWSFGVTLYEL 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 60  IEVVGNGTYGQV----YKGRHTKTGQLAAIKVMXXXXXXXXXXX-XXXXXXXKYSNHRNI 114
           I  +G G +G+V    Y   +  TG++ A+K +                   +   H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             Y G    +     +  + LVMEY   GS+ D +       +    +    ++I  G+ 
Sbjct: 74  VKYKGCCEDQG----EKSVQLVMEYVPLGSLRDYLPR---HCVGLAQLLLFAQQICEGMA 126
Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEV 231
           YLH    IHR +  +NVLL ++  VK+ DFG++  +         R       +W APE 
Sbjct: 127 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 232 IACDENPDATYDNRSDLWSLGITALEM 258
           +      +  +   SD+WS G+T  E+
Sbjct: 187 LK-----ECKFYYASDVWSFGVTLYEL 208

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 46/292 (15%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXX 100
           D W+     I  L+  +G G++G VY+G  R    G+    +A   V             
Sbjct: 10  DEWEVSREKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL 68
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-- 158
                 K     ++    G   K  P        +VME    G +   ++S + ++    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 159 -------EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
                  +E I  +  EI  G+ YL+  K +HRD+  +N ++  +  VK+ DFG++  + 
Sbjct: 123 GRPPPTLQEMIQ-MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 212 RTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
            T   R    G     WMAPE +      D  +   SD+WS G+   E+   ++ P   L
Sbjct: 182 ETAYYRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 269 HPMRALFLI--------PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
              + L  +        P N P R   L    W   PK   +F+E V L+KD
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 66/116 (56%), Gaps = 17/116 (14%)
Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-EEWIAFICREILRGLKYLHEN 179
           F++ +    D   ++VMEY G  S+    K +KGQ L   E IA++  EIL  L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL----KRSKGQKLPVAEAIAYLL-EILPALSYLHSI 201
Query: 180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF---IGTPYWMAPEVI 232
            +++ D+K +N++LT+  ++KL+D G        + R N+F    GTP + APE++
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLG-------AVSRINSFGYLYGTPGFQAPEIV 249

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+ +G +G VYKG     G+      AIK +                    S ++
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 77  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 189 ESIL-----HRIYTHQSDVWSYGVTVWEL 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 20/219 (9%)
Query: 62  VVGNGTYGQVYKGRHTKTGQ---LAAIKVMXXXXXXXXXXXXXXX-XXXKYSNHRNIATY 117
           V+G G +G VY G +    Q     AIK +                   +  NH N+   
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
            G  I   P G    L   + Y   G +   ++S +     ++ I+F   ++ RG++YL 
Sbjct: 88  IG--IMLPPEGLPHVL---LPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGMEYLA 141
Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ-LDR---TIGRRNTFIGTPYWMAPEVIA 233
           E K +HRD+  +N +L ++  VK+ DFG++   LDR   ++ +         W A E + 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPM 271
                   +  +SD+WS G+   E +    PP   + P 
Sbjct: 202 T-----YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 24/279 (8%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXX--XXXXXXXXXXXKYSNHRNI 114
           ++L E +G G +  V +     TG   A K++                    +   H NI
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNI 65
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC-REILRGL 173
              + +        ++   +LV +    G   +L +    +    E  A  C ++IL  +
Sbjct: 66  VRLHDSI------SEEGFHYLVFDLVTGG---ELFEDIVAREYYSEADASHCIQQILEAV 116
Query: 174 KYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            + H+  V+HRD+K +N+LL      A VKL DFG++ ++         F GTP +++PE
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+         Y    D+W+ G+    +    PP  D      L+   +       S +W
Sbjct: 177 VLR-----KEAYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEW 230
Query: 291 PK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT 326
                + ++ I  +L  +  +R    + LKHP++  + T
Sbjct: 231 DTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRST 269

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 37/230 (16%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRN--I 114
           +E+  ++G G+YG VY        +  AIK +                    +  ++  I
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRGL 173
              +   I +    K D+L++V+E   +    DL K  K    L E+ +  I   +L G 
Sbjct: 90  IRLHDLIIPEDLL-KFDELYIVLEIADS----DLKKLFKTPIFLTEQHVKTILYNLLLGE 144
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRN------------- 218
           K++HE+ +IHRD+K  N LL  +  VK+ DFG++  +  D+ I   N             
Sbjct: 145 KFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 219 ----------TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                     + + T ++ APE+I   EN    Y N  D+WS G    E+
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQEN----YTNSIDIWSTGCIFAEL 250

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 17/207 (8%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAF 121
           ++G G +G+VYKGR      +A  ++                     + HRN+    G  
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW--IAFICREILRGLKYLHEN 179
           +  +      +  LV  Y   GSV   ++         +W     I     RGL YLH++
Sbjct: 97  MTPT------ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150
Query: 180 ---KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD-RTIGRRNTFIGTPYWMAPEVIACD 235
              K+IHRD+K  N+LL +  E  + DFG++  +D +         G    +APE ++  
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTG 210
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQ 262
           ++ + T     D++  G+  LE+   Q
Sbjct: 211 KSSEKT-----DVFGYGVMLLELITGQ 232

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 106/266 (39%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V E    GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 111 LEGVVTKSKP------VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 163
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 224 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 275
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMXXXXXXXXXXXXXXXXXXKYS-NH 111
           F+ I+V+ +G +G VYKG     G+      AIK +                    S ++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            ++    G  +  +       + L+ +    G + D V+  K  ++  +++   C +I +
Sbjct: 84  PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMAP 229
           G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           E I         Y ++SD+WS G+T  E+
Sbjct: 196 ESIL-----HRIYTHQSDVWSYGVTVWEL 219

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 46/292 (15%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXX 100
           D W+     I  L+  +G G++G VY+G  R    G+    +A   V             
Sbjct: 10  DEWEVSREKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL 68
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-- 158
                 K     ++    G   K  P        +VME    G +   ++S + ++    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 159 -------EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
                  +E I  +  EI  G+ YL+  K +HRD+  +N ++  +  VK+ DFG++  + 
Sbjct: 123 GRPPPTLQEMIQ-MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 212 RTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
            T   R    G     WMAPE +      D  +   SD+WS G+   E+   ++ P   L
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 269 HPMRALFLI--------PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
              + L  +        P N P R   L    W   PK   +F+E V L+KD
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 47/247 (19%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQV-------YKGRHTKTGQLAAIKVMXXXXX-XXXX 97
           ED   E P     L + +G G +G+V        KGR   T    A+K++          
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT--TVAVKMLKENASPSELR 71
Query: 98  XXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--- 154
                    K  NH ++   YGA  +  P      L L++EY   GS+   ++ ++    
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGP------LLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 155 -------------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD 195
                              ++L    +     +I +G++YL E K++HRD+  +N+L+ +
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185
Query: 196 NAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
             ++K+ DFG+S  +   D  + R    I    WMA E +      D  Y  +SD+WS G
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLF-----DHIYTTQSDVWSFG 239
Query: 253 ITALEMA 259
           +   E+ 
Sbjct: 240 VLLWEIV 246

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 114/292 (39%), Gaps = 46/292 (15%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXX 100
           D W+     I  L+  +G G++G VY+G  R    G+    +A   V             
Sbjct: 10  DEWEVSREKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL 68
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-- 158
                 K     ++    G   K  P        +VME    G +   ++S + ++    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 159 -------EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
                  +E I  +  EI  G+ YL+  K +HRD+  +N ++  +  VK+ DFG++  + 
Sbjct: 123 GRPPPTLQEMIQ-MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 212 RTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
            T   R    G     WMAPE +      D  +   SD+WS G+   E+   ++ P   L
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 269 HPMRALFLI--------PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
              + L  +        P N P R   L    W   P    +F+E V L+KD
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 106/266 (39%), Gaps = 25/266 (9%)
Query: 61  EVVGNGTYGQVYKGRH---TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHRNIAT 116
           +VVG G +G+V  GR    +K     AIK +                      +H NI  
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G   K  P      + +V E    GS+   ++    Q    + +  + R I  G+KYL
Sbjct: 82  LEGVVTKSKP------VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYL 134
Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY---WMAPEVIA 233
            +   +HRD+  +N+L+  N   K+ DFG+S  L+       T  G      W +PE IA
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 234 CDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLHPMRALFLIPRN--APPRLKSKKW 290
             +     + + SD+WS GI   E M+  + P  ++     +  +      PP +     
Sbjct: 195 YRK-----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC--- 246
Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLL 316
           P      +     KD + RP  +Q++
Sbjct: 247 PAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSN 110
           E+    F+   ++G+G +G+VYKG   + G   A+K                     +  
Sbjct: 35  EEATNNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF--ICRE 168
           H ++ +  G   ++      +++ L+ +Y   G++   +  +   ++   W     IC  
Sbjct: 94  HPHLVSLIGFCDER------NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN---TFIGTPY 225
             RGL YLH   +IHRD+K  N+LL +N   K+ DFG+S +    +G+ +      GT  
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLG 206
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL--------- 276
           ++ PE              +SD++S G+   E+  ++  +    P   + L         
Sbjct: 207 YIDPEYFI-----KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 277 ---IPRNAPPRLKSKKWPKKFQSFIETVL 302
              + +   P L  K  P+  + F +T +
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAV 290

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 153
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D     +++ +GT  +M PE I    +  EN   
Sbjct: 154 KPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 272
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 273 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 447 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 504
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 505 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 559
Query: 252 GITALE 257
           G+   E
Sbjct: 560 GVLMWE 565

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 446 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 503
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 504 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 558
Query: 252 GITALE 257
           G+   E
Sbjct: 559 GVLMWE 564

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 30  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 90  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 143
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 144 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 204 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 32  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 92  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 145
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA-QLDRTIGRRNTFIGTPY---WM 227
           G+K+L   K +HRD+  +N +L +   VK+ DFG++   LD+     +   G      WM
Sbjct: 146 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 206 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 47/247 (19%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQV-------YKGRHTKTGQLAAIKVMXXXXX-XXXX 97
           ED   E P     L + +G G +G+V        KGR   T    A+K++          
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT--TVAVKMLKENASPSELR 71
Query: 98  XXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--- 154
                    K  NH ++   YGA  +  P      L L++EY   GS+   ++ ++    
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGP------LLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 155 -------------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD 195
                              ++L    +     +I +G++YL E K++HRD+  +N+L+ +
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185
Query: 196 NAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
             ++K+ DFG+S  +   D  + R    I    WMA E +      D  Y  +SD+WS G
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK-WMAIESLF-----DHIYTTQSDVWSFG 239
Query: 253 ITALEMA 259
           +   E+ 
Sbjct: 240 VLLWEIV 246

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
            +L+E++G G YG VYKG  +   +  A+KV                       H NIA 
Sbjct: 15  LKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINEKNIYRV-PLMEHDNIAR 71
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR---EILRGL 173
           +     + +  G+ + L LVMEY   GS+   +          +W++  CR    + RGL
Sbjct: 72  FIVGDERVTADGRMEYL-LVMEYYPNGSLXKYLSLHTS-----DWVSS-CRLAHSVTRGL 124
Query: 174 KYLHEN---------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTI--GRRN-- 218
            YLH            + HRD+  +NVL+ ++    + DFG+S +L  +R +  G  +  
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 219 --TFIGTPYWMAPEVI--ACDENPDATYDNRSDLWSLGITALEM 258
             + +GT  +MAPEV+  A +     +   + D+++LG+   E+
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 45/280 (16%)
Query: 59  LIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXXXXXXXXKYSNHR 112
           L+  +G G++G VY+G  R    G+    +A   V                   K     
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK---------EEWIA 163
           ++    G   K  P        +VME    G +   ++S + ++           +E I 
Sbjct: 80  HVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 133
Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
            +  EI  G+ YL+  K +HRD+  +N ++  +  VK+ DFG++  +  T   R    G 
Sbjct: 134 -MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 192
Query: 224 --PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLI--- 277
               WMAPE +      D  +   SD+WS G+   E+   ++ P   L   + L  +   
Sbjct: 193 LPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 247
Query: 278 -----PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
                P N P R   L    W   PK   +F+E V L+KD
Sbjct: 248 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 287

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 63  VGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYYGAFI 122
           VG GTYG VYK +           +                   +   H N+ +    F+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 123 KKSPPGKDDQLWLVMEYCGAG--SVTDLVKSTKGQS----LKEEWIAFICREILRGLKYL 176
             +    D ++WL+ +Y       +    +++K       L    +  +  +IL G+ YL
Sbjct: 89  SHA----DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 177 HENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLD---RTIGRRNTFIGTPYWMAP 229
           H N V+HRD+K  N+L+     +   VK+ D G +   +   + +   +  + T ++ AP
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           E++    +    Y    D+W++G    E+  S+P
Sbjct: 205 ELLLGARH----YTKAIDIWAIGCIFAELLTSEP 234

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 200 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 228

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 34/222 (15%)
Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRN--IATYYG 119
           ++G G+YG VY      T +  AIK +                    +  ++  I   Y 
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRGLKYLHE 178
             I      K D+L++V+E   +    DL K  K    L EE I  I   +L G  ++HE
Sbjct: 93  LIIPDDL-LKFDELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE 147
Query: 179 NKVIHRDIKGQNVLLTDNAEVKLVDFG----VSAQLDRTI----------GRRN------ 218
           + +IHRD+K  N LL  +  VK+ DFG    ++++ D  I          G  N      
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 219 --TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             + + T ++ APE+I   EN    Y    D+WS G    E+
Sbjct: 208 LTSHVVTRWYRAPELILLQEN----YTKSIDIWSTGCIFAEL 245

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 130 DDQLWLVMEYCGAGSVTDLVKSTKGQS---LKEEWIAFICREILRGLKYLHENKVIHRDI 186
           D  +++VME CG   +   +K  K       K  W     + +L  +  +H++ ++H D+
Sbjct: 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYW-----KNMLEAVHTIHQHGIVHSDL 181
Query: 187 KGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVI----ACDEN--P 238
           K  N L+ D   +KL+DFG++ Q+  D T   +++ +G   +M PE I    +  EN   
Sbjct: 182 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK-FQSF 297
            +    +SD+WSLG     M   + P   +    +      +    ++    P+K  Q  
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 298 IETVLVKDYHQRPYTDQLLKHPFIRDQ--PTERQAR 331
           ++  L +D  QR    +LL HP+++ Q  P  + A+
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 91/241 (37%), Gaps = 40/241 (16%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMXXXXXX 94
           Y E W      E P    +  + +G G +G+V +      G+       A+K++      
Sbjct: 37  YNEKW------EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 95  --XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-- 150
                             H NI    GA     P      + ++ EYC  G + + ++  
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRK 144
Query: 151 ----------STKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK 200
                     +    +     +     ++ +G+ +L     IHRD+  +NVLLT+    K
Sbjct: 145 SRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204
Query: 201 LVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALE 257
           + DFG++  +      I + N  +    WMAPE I      D  Y  +SD+WS GI   E
Sbjct: 205 IGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIF-----DCVYTVQSDVWSYGILLWE 258
Query: 258 M 258
           +
Sbjct: 259 I 259

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 191 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 219

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 104 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 161
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 162 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 216
Query: 252 GITALE 257
           G+   E
Sbjct: 217 GVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 104 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 161
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 162 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 216
Query: 252 GITALE 257
           G+   E
Sbjct: 217 GVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 102 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 159
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 160 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 214
Query: 252 GITALE 257
           G+   E
Sbjct: 215 GVLMWE 220

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL--KEEWIAFICR 167
           +H NI      F+    P    +L+LV E       TDL +    Q +    + I +   
Sbjct: 87  HHPNILGLRDIFVHFEEPAMH-KLYLVTELMR----TDLAQVIHDQRIVISPQHIQYFMY 141
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM 227
            IL GL  LHE  V+HRD+   N+LL DN ++ + DF + A+ D     +  ++   ++ 
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL-AREDTADANKTHYVTHRWYR 200
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM 258
           APE++   +     +    D+WS G    EM
Sbjct: 201 APELVMQFKG----FTKLVDMWSAGCVMAEM 227

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 91  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 144
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 145 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 205 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 91  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 144
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+K+L   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 145 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 205 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 29  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 89  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 142
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 143 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 203 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 26  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 86  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 139
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
           A E +   +     +  +SD+WS G+   E M    PP  D+
Sbjct: 200 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDV 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 50  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 110 PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 163
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 164 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 224 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 261

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 35/246 (14%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q   A    L E +G G +G+V++G+    G+  A+K+                      
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML- 93
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI  +  A  K +  G   QLWLV +Y   GS+ D +      ++  E +  +    
Sbjct: 94  RHENILGFIAADNKDN--GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALST 148
Query: 170 LRGLKYLHEN--------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR---- 217
             GL +LH           + HRD+K +N+L+  N    + D G++ + D          
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 218 NTFIGTPYWMAPEVIACDENPDATY---DNRSDLWSLGITALEMA----------ESQPP 264
           N  +GT  +MAPEV+  D++ +  +     R+D++++G+   E+A          + Q P
Sbjct: 209 NHRVGTKRYMAPEVL--DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 265 LCDLHP 270
             DL P
Sbjct: 267 YYDLVP 272

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL--KEEWIAFICR 167
           +H NI      F+    P    +L+LV E       TDL +    Q +    + I +   
Sbjct: 87  HHPNILGLRDIFVHFEEPAMH-KLYLVTELMR----TDLAQVIHDQRIVISPQHIQYFMY 141
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM 227
            IL GL  LHE  V+HRD+   N+LL DN ++ + DF + A+ D     +  ++   ++ 
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL-AREDTADANKTHYVTHRWYR 200
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM 258
           APE++   +     +    D+WS G    EM
Sbjct: 201 APELVMQFKG----FTKLVDMWSAGCVMAEM 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 23  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 83  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 136
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 137 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 197 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 49  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 109 PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 162
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 163 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 223 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 260

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 36  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 96  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 149
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+K+L   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 150 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
           A E +   +     +  +SD+WS G+   E M    PP  D+
Sbjct: 210 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDV 246

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 30  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 90  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 143
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 144 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 204 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 88  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 141
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 142 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 202 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 91  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 144
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+KYL   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 145 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 205 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           L E +G G +G+V++G+    G+  A+K+                       H NI  + 
Sbjct: 7   LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 63
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            A  K +  G   QLWLV +Y   GS+ D +      ++  E +  +      GL +LH 
Sbjct: 64  AADNKDN--GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHM 118
Query: 179 N--------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR----NTFIGTPYW 226
                     + HRD+K +N+L+  N    + D G++ + D          N  +GT  +
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 227 MAPEVIACDENPDATY---DNRSDLWSLGITALEMA----------ESQPPLCDLHP 270
           MAPEV+  D++ +  +     R+D++++G+   E+A          + Q P  DL P
Sbjct: 179 MAPEVL--DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 35/246 (14%)
Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS 109
           Q   A    L E +G G +G+V++G+    G+  A+K+                      
Sbjct: 24  QRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML- 80
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI  +  A  K +  G   QLWLV +Y   GS+ D +      ++  E +  +    
Sbjct: 81  RHENILGFIAADNKDN--GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALST 135
Query: 170 LRGLKYLHEN--------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR---- 217
             GL +LH           + HRD+K +N+L+  N    + D G++ + D          
Sbjct: 136 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 195
Query: 218 NTFIGTPYWMAPEVIACDENPDATY---DNRSDLWSLGITALEMA----------ESQPP 264
           N  +GT  +MAPEV+  D++ +  +     R+D++++G+   E+A          + Q P
Sbjct: 196 NHRVGTKRYMAPEVL--DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 253
Query: 265 LCDLHP 270
             DL P
Sbjct: 254 YYDLVP 259

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 88  LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 145
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 146 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 200
Query: 252 GITALE 257
           G+   E
Sbjct: 201 GVLMWE 206

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 97/250 (38%), Gaps = 49/250 (19%)
Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMXXXXXX 94
           Y E W      E P    +  + +G G +G+V +      G+       A+K++      
Sbjct: 22  YNEKW------EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 75
Query: 95  --XXXXXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-- 150
                             H NI    GA     P      + ++ EYC  G + + ++  
Sbjct: 76  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRK 129
Query: 151 --STKGQSL----------KEEWIAFICREIL-------RGLKYLHENKVIHRDIKGQNV 191
             +  G SL          KE+      R++L       +G+ +L     IHRD+  +NV
Sbjct: 130 AEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 189
Query: 192 LLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDL 248
           LLT+    K+ DFG++  +      I + N  +    WMAPE I      D  Y  +SD+
Sbjct: 190 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIF-----DCVYTVQSDV 243
Query: 249 WSLGITALEM 258
           WS GI   E+
Sbjct: 244 WSYGILLWEI 253

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           L E +G G +G+V++G+    G+  A+K+                       H NI  + 
Sbjct: 8   LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 64
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            A  K +  G   QLWLV +Y   GS+ D +      ++  E +  +      GL +LH 
Sbjct: 65  AADNKDN--GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHM 119
Query: 179 N--------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR----NTFIGTPYW 226
                     + HRD+K +N+L+  N    + D G++ + D          N  +GT  +
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 227 MAPEVIACDENPDATY---DNRSDLWSLGITALEMA----------ESQPPLCDLHP 270
           MAPEV+  D++ +  +     R+D++++G+   E+A          + Q P  DL P
Sbjct: 180 MAPEVL--DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 32  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 92  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 145
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+K+L   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 146 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 206 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 29  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 89  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 142
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+K+L   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 143 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDL 268
           A E +   +     +  +SD+WS G+   E M    PP  D+
Sbjct: 203 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDV 239

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 90  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 150 PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 203
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+K+L   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 264 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 301

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 20/223 (8%)
Query: 56  IFELIEVVGNGTYGQVYKG----RHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNH 111
           I    EV+G G +G VY G       K    A   +                   K  +H
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+ +  G  ++      +    +V+ Y   G + + +++       ++ I F   ++ +
Sbjct: 91  PNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 144
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPY---WM 227
           G+K+L   K +HRD+  +N +L +   VK+ DFG++  + D+     +   G      WM
Sbjct: 145 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 228 APEVIACDENPDATYDNRSDLWSLGITALE-MAESQPPLCDLH 269
           A E +   +     +  +SD+WS G+   E M    PP  D++
Sbjct: 205 ALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 94  LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 151
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 206
Query: 252 GITALE 257
           G+   E
Sbjct: 207 GVLMWE 212

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIAT 116
           ++L+  +G G Y +V++  +    +   +K++                  +     NI T
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLR--GGPNIIT 96
Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
              A I K P  +     LV E+        L      Q+L +  I F   EIL+ L Y 
Sbjct: 97  L--ADIVKDPVSRTPA--LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYC 147
Query: 177 HENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           H   ++HRD+K  NV++  ++ +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
           +     YD   D+WSLG     M   + P    H
Sbjct: 207 Q----MYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 88  LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 145
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 146 TQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 200
Query: 252 GITALE 257
           G+   E
Sbjct: 201 GVLMWE 206

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 84  LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 141
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 142 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 196
Query: 252 GITALE 257
           G+   E
Sbjct: 197 GVLMWE 202

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 44/231 (19%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXK----YSNHR 112
           F +I  +G+GT+G+V   +H    +  A+KV+                  K      N+ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y+G F+        D + L+ E  G  S+ +++          E I   C EIL+ 
Sbjct: 97  NIVKYHGKFMYY------DHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 173 LKYLHENKVIHRDIKGQNVLLTD-------------------------NAEVKLVDFGVS 207
           L YL +  + H D+K +N+LL D                         +  +KL+DFG +
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                  G   + I T  + APEVI      +  +D  SD+WS G    E+
Sbjct: 210 TFKSDYHG---SIINTRQYRAPEVIL-----NLGWDVSSDMWSFGCVLAEL 252

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT 194
           LVME    G +   ++  +   +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL 
Sbjct: 82  LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 139
Query: 195 DNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSL 251
                K+ DFG+S  L  D    +  T    P  W APE I         + ++SD+WS 
Sbjct: 140 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSF 194
Query: 252 GITALE 257
           G+   E
Sbjct: 195 GVLMWE 200

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 65/122 (53%), Gaps = 12/122 (9%)
Query: 144 SVTDLVKSTKGQSLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDNAE 198
           S++D+ +    + L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++   
Sbjct: 177 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 236
Query: 199 VKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL 256
           VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+   
Sbjct: 237 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLW 291
Query: 257 EM 258
           E+
Sbjct: 292 EI 293

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           L E +G G +G+V++G+    G+  A+K+                       H NI  + 
Sbjct: 10  LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 66
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            A  K +  G   QLWLV +Y   GS+ D +      ++  E +  +      GL +LH 
Sbjct: 67  AADNKDN--GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHM 121
Query: 179 N--------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR----NTFIGTPYW 226
                     + HRD+K +N+L+  N    + D G++ + D          N  +GT  +
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 227 MAPEVIACDENPDATY---DNRSDLWSLGITALEMA----------ESQPPLCDLHP 270
           MAPEV+  D++ +  +     R+D++++G+   E+A          + Q P  DL P
Sbjct: 182 MAPEVL--DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 236

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 65/122 (53%), Gaps = 12/122 (9%)
Query: 144 SVTDLVKSTKGQSLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDNAE 198
           S++D+ +    + L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++   
Sbjct: 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 231
Query: 199 VKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL 256
           VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+   
Sbjct: 232 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLW 286
Query: 257 EM 258
           E+
Sbjct: 287 EI 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 65/122 (53%), Gaps = 12/122 (9%)
Query: 144 SVTDLVKSTKGQSLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDNAE 198
           S++D+ +    + L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++   
Sbjct: 179 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 238
Query: 199 VKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL 256
           VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+   
Sbjct: 239 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLW 293
Query: 257 EM 258
           E+
Sbjct: 294 EI 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 65/122 (53%), Gaps = 12/122 (9%)
Query: 144 SVTDLVKSTKGQSLKEEWIAF---ICR--EILRGLKYLHENKVIHRDIKGQNVLLTDNAE 198
           S++D+ +    + L ++++     IC   ++ +G+++L   K IHRD+  +N+LL++   
Sbjct: 170 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 229
Query: 199 VKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITAL 256
           VK+ DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+   
Sbjct: 230 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLW 284
Query: 257 EM 258
           E+
Sbjct: 285 EI 286

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATYY 118
           L E +G G +G+V++G+    G+  A+K+                       H NI  + 
Sbjct: 13  LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 69
Query: 119 GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE 178
            A  K +  G   QLWLV +Y   GS+ D +      ++  E +  +      GL +LH 
Sbjct: 70  AADNKDN--GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHM 124
Query: 179 N--------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR----NTFIGTPYW 226
                     + HRD+K +N+L+  N    + D G++ + D          N  +GT  +
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 227 MAPEVIACDENPDATY---DNRSDLWSLGITALEMA----------ESQPPLCDLHP 270
           MAPEV+  D++ +  +     R+D++++G+   E+A          + Q P  DL P
Sbjct: 185 MAPEVL--DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 239

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 47/247 (19%)
Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQV-------YKGRHTKTGQLAAIKVMXXXXX-XXXX 97
           ED   E P     L + +G G +G+V        KGR   T    A+K++          
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT--TVAVKMLKENASPSELR 71
Query: 98  XXXXXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--- 154
                    K  NH ++   YGA  +  P      L L++EY   GS+   ++ ++    
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGP------LLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 155 -------------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD 195
                              ++L    +     +I +G++YL E  ++HRD+  +N+L+ +
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAE 185
Query: 196 NAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
             ++K+ DFG+S  +   D  + R    I    WMA E +      D  Y  +SD+WS G
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLF-----DHIYTTQSDVWSFG 239
Query: 253 ITALEMA 259
           +   E+ 
Sbjct: 240 VLLWEIV 246

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 121/294 (41%), Gaps = 52/294 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           F  +E +G+G +G V+K      G + AIK                     ++    H +
Sbjct: 9   FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 68
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           +  Y+ A+       +DD + +  EYC  GS+ D +          KE  +  +  ++ R
Sbjct: 69  VVRYFSAW------AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDN------AEVKLVDFGVSAQLDRTIGRRN--TFIGT 223
           GL+Y+H   ++H DIK  N+ ++        +E    D   S ++   IG     T I +
Sbjct: 123 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 182
Query: 224 PY-------WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL 276
           P        ++A EV+      + T+  ++D+++L +T +  A ++P             
Sbjct: 183 PQVEEGDSRFLANEVL----QENYTHLPKADIFALALTVVXAAGAEP------------- 225
Query: 277 IPRNAPP--RLKSKKWPK-------KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +PRN      ++  + P+       +F   ++ ++  D  +RP    L+KH  +
Sbjct: 226 LPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT- 223
           +  EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G  
Sbjct: 137 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 196
Query: 224 -PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 197 PVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 193 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 221

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 197 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT- 223
           +  EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G  
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 224 -PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 203 PVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 234

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT- 223
           +  EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G  
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 224 -PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
              WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 203 PVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 234

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 63  VGNGTYGQVYKGRH-----TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATY 117
           +G G +G+V+          +   L A+K +                      H +I  +
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVT--------DLVKSTKGQ---SLKEEWIAFIC 166
           YG  ++  P      L +V EY   G +         D V   +G     L +  +  I 
Sbjct: 81  YGVCVEGDP------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPY 225
           ++I  G+ YL     +HRD+  +N L+ +N  VK+ DFG+S  +  T   R       P 
Sbjct: 135 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 226 -WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            WM PE I   +     +   SD+WSLG+   E+
Sbjct: 195 RWMPPESIMYRK-----FTTESDVWSLGVVLWEI 223

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 196 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 224

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 199 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 227

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 199 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 227

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++  +  T   R    G     
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 228 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 256

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 84/187 (44%), Gaps = 28/187 (14%)
Query: 162 IAFICREILRGLKYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTI-GRRN 218
           I  I + +L    Y+H E  + HRD+K  N+L+  N  VKL DFG S  + D+ I G R 
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR- 211
Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP------LCDL---- 268
              GT  +M PE  + + + +     + D+WSLGI    M  +  P      L +L    
Sbjct: 212 ---GTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 269 ------HPM-RALFLIP-RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
                 +P+ R  FL P  N      +     +   F++  L K+  +R  ++  LKH +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 321 IRDQPTE 327
           + D   E
Sbjct: 326 LADTNIE 332

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 121/294 (41%), Gaps = 52/294 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           F  +E +G+G +G V+K      G + AIK                     ++    H +
Sbjct: 11  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           +  Y+ A+       +DD + +  EYC  GS+ D +          KE  +  +  ++ R
Sbjct: 71  VVRYFSAW------AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDN------AEVKLVDFGVSAQLDRTIGRRN--TFIGT 223
           GL+Y+H   ++H DIK  N+ ++        +E    D   S ++   IG     T I +
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 224 PY-------WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL 276
           P        ++A EV+      + T+  ++D+++L +T +  A ++P             
Sbjct: 185 PQVEEGDSRFLANEVL----QENYTHLPKADIFALALTVVCAAGAEP------------- 227
Query: 277 IPRNAPP--RLKSKKWPK-------KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +PRN      ++  + P+       +F   ++ ++  D  +RP    L+KH  +
Sbjct: 228 LPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 36/198 (18%)
Query: 133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
           L +VME    G +   ++    Q+  E   + I + I   ++YLH   + HRD+K +N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 193 LTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
            T    NA +KL DFG + +   T G +                        YD   D+W
Sbjct: 150 YTSKRPNAILKLTDFGFAKE---TTGEK------------------------YDKSCDMW 182
Query: 250 SLGITALEMAESQPPLCDLH------PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLV 303
           SLG+    +    PP    H       M+    + +   P  +  +  ++ +  I  +L 
Sbjct: 183 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 242
Query: 304 KDYHQRPYTDQLLKHPFI 321
            +  QR    + + HP+I
Sbjct: 243 TEPTQRMTITEFMNHPWI 260

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 6/125 (4%)
Query: 132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNV 191
           ++++VMEYC  G    L    + +    +   + C +++ GL+YLH   ++H+DIK  N+
Sbjct: 82  KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC-QLIDGLEYLHSQGIVHKDIKPGNL 140
Query: 192 LLTDNAEVKLVDFGVSAQLDRTIGRRN--TFIGTPYWMAPEVIACDENPDATYDNRSDLW 249
           LLT    +K+   GV+  L          T  G+P +  PE+       D     + D+W
Sbjct: 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA---NGLDTFSGFKVDIW 197
Query: 250 SLGIT 254
           S G+T
Sbjct: 198 SAGVT 202

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 121/294 (41%), Gaps = 52/294 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           F  +E +G+G +G V+K      G + AIK                     ++    H +
Sbjct: 11  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           +  Y+ A+       +DD + +  EYC  GS+ D +          KE  +  +  ++ R
Sbjct: 71  VVRYFSAW------AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDN------AEVKLVDFGVSAQLDRTIGRRN--TFIGT 223
           GL+Y+H   ++H DIK  N+ ++        +E    D   S ++   IG     T I +
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 224 PY-------WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL 276
           P        ++A EV+      + T+  ++D+++L +T +  A ++P             
Sbjct: 185 PQVEEGDSRFLANEVL----QENYTHLPKADIFALALTVVCAAGAEP------------- 227
Query: 277 IPRNAPP--RLKSKKWPK-------KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +PRN      ++  + P+       +F   ++ ++  D  +RP    L+KH  +
Sbjct: 228 LPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 39/258 (15%)
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST----KGQSLKEEWIAF- 164
           +H N+  YY +         D  L++ +E C   ++ DLV+S     +   L++E+    
Sbjct: 85  DHPNVIRYYCS------ETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLT-------------DNAEVKLVDFGVSAQLD 211
           + R+I  G+ +LH  K+IHRD+K QN+L++             +N  + + DFG+  +LD
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 212 --RTIGRRNTF--IGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLC 266
             +   R N     GT  W APE++  +E+         D++S+G +    +++ + P  
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELL--EESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 267 DLHP-----MRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           D +      +R +F +  +    L  +    +    I  ++  D  +RP   ++L+HP  
Sbjct: 256 DKYSRESNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313
Query: 322 RDQPTERQARIQLKDHID 339
             +  + +  +++ D ++
Sbjct: 314 WPKSKKLEFLLKVSDRLE 331

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK--VMXXXXXXXXXXXXXXXXXXKYSNHRNI 114
           F++  + G GT+G V  G+   TG   AIK  +                    + N   +
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE------WIAFICRE 168
            +Y+    ++    +D  L +VMEY     V D +        + +       I     +
Sbjct: 85  QSYFYTLGERD--RRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 169 ILRGLKYLH--ENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           ++R +  LH     V HRDIK  NVL+ + +  +KL DFG + +L  +      +I + Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRY 196
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
           + APE+I  +++    Y    D+WS+G    EM   +P
Sbjct: 197 YRAPELIFGNQH----YTTAVDIWSVGCIFAEMMLGEP 230

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 39/232 (16%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS--NHRNI 114
           +E+  ++G G+YG V +       ++ AIK +                    +  NH ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS-LKEEWIAFICREILRGL 173
                  I K    K D+L++V+E       +D  K  +    L E  I  +   +L G+
Sbjct: 115 VKVLDIVIPKDVE-KFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD---------------------- 211
           KY+H   ++HRD+K  N L+  +  VK+ DFG++  +D                      
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 212 ----RTIGRRNT-FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
               + + R+ T  + T ++ APE+I   EN    Y    D+WS+G    E+
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQEN----YTEAIDVWSIGCIFAEL 277

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 120/258 (46%), Gaps = 39/258 (15%)
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST----KGQSLKEEWIAF- 164
           +H N+  YY +         D  L++ +E C   ++ DLV+S     +   L++E+    
Sbjct: 85  DHPNVIRYYCS------ETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLT-------------DNAEVKLVDFGVSAQLD 211
           + R+I  G+ +LH  K+IHRD+K QN+L++             +N  + + DFG+  +LD
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 212 --RTIGRRNTF--IGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLC 266
             +   R N     GT  W APE++  +E+         D++S+G +    +++ + P  
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELL--EESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 267 DLHP-----MRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           D +      +R +F +  +    L  +    +    I  ++  D  +RP   ++L+HP  
Sbjct: 256 DKYSRESNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313
Query: 322 RDQPTERQARIQLKDHID 339
             +  + +  +++ D ++
Sbjct: 314 WPKSKKLEFLLKVSDRLE 331

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 121/294 (41%), Gaps = 52/294 (17%)
Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS---NHRN 113
           F  +E +G+G +G V+K      G + AIK                     ++    H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           +  Y+ A+       +DD + +  EYC  GS+ D +          KE  +  +  ++ R
Sbjct: 73  VVRYFSAW------AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 172 GLKYLHENKVIHRDIKGQNVLLTDN------AEVKLVDFGVSAQLDRTIGRRN--TFIGT 223
           GL+Y+H   ++H DIK  N+ ++        +E    D   S ++   IG     T I +
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 224 PY-------WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL 276
           P        ++A EV+      + T+  ++D+++L +T +  A ++P             
Sbjct: 187 PQVEEGDSRFLANEVL----QENYTHLPKADIFALALTVVCAAGAEP------------- 229
Query: 277 IPRNAPP--RLKSKKWPK-------KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
           +PRN      ++  + P+       +F   ++ ++  D  +RP    L+KH  +
Sbjct: 230 LPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 83/218 (38%), Gaps = 34/218 (15%)
Query: 63  VGNGTYGQV-----YKGRHTKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYSNHRNIATY 117
           +G G +G+V     Y    TK   L A+K +                      H +I  +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS---------------TKGQSLKEEWI 162
           YG        G  D L +V EY   G +   +++                KG+ L    +
Sbjct: 83  YGVC------GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQM 135
Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFI 221
             I  +I  G+ YL     +HRD+  +N L+  N  VK+ DFG+S  +  T   R     
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 222 GTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             P  WM PE I   +     +   SD+WS G+   E+
Sbjct: 196 MLPIRWMPPESIMYRK-----FTTESDVWSFGVILWEI 228

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 119/260 (45%), Gaps = 39/260 (15%)
Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST----KGQSLKEEWIAF- 164
           +H N+  YY +         D  L++ +E C   ++ DLV+S     +   L++E+    
Sbjct: 67  DHPNVIRYYCS------ETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLT-------------DNAEVKLVDFGVSAQLD 211
           + R+I  G+ +LH  K+IHRD+K QN+L++             +N  + + DFG+  +LD
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 212 RTIGRRNTFI----GTPYWMAPEVIACDENPDATYD-NRS-DLWSLG-ITALEMAESQPP 264
                  T +    GT  W APE++    N        RS D++S+G +    +++ + P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 265 LCDLHP-----MRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHP 319
             D +      +R +F +  +    L  +    +    I  ++  D  +RP   ++L+HP
Sbjct: 240 FGDKYSRESNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297
Query: 320 FIRDQPTERQARIQLKDHID 339
               +  + +  +++ D ++
Sbjct: 298 LFWPKSKKLEFLLKVSDRLE 317

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
           + HRNI   + +F         ++L ++ E+     + + + +T    L E  I     +
Sbjct: 58  ARHRNILHLHESF------ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQ 110
Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
           +   L++LH + + H DI+ +N++     ++ +K+++FG + QL      R  F    Y+
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170
Query: 227 MAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHP------MRALFLIPR 279
            APEV   D    AT     D+WSLG +  + ++   P L + +       M A +    
Sbjct: 171 -APEVHQHDVVSTAT-----DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
            A      K+   +   F++ +LVK+   R    + L+HP+++ Q  ER
Sbjct: 225 EA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK-QKIER 267

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 46/292 (15%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXX 100
           D W+     I  L+  +G G++G VY+G  R    G+    +A   V             
Sbjct: 10  DEWEVSREKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL 68
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-- 158
                 K     ++    G   K  P        +VME    G +   ++S + ++    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 159 -------EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
                  +E I  +  EI  G+ YL+  K +HR++  +N ++  +  VK+ DFG++  + 
Sbjct: 123 GRPPPTLQEMIQ-MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 212 RTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
            T   R    G     WMAPE +      D  +   SD+WS G+   E+   ++ P   L
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 269 HPMRALFLI--------PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
              + L  +        P N P R   L    W   P    +F+E V L+KD
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY 225
           EI  G+ YL+ NK +HRD+  +N  + ++  VK+ DFG++  +  T   R    G     
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 193 WMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 221

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 46/292 (15%)
Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKG--RHTKTGQ----LAAIKVMXXXXXXXXXXXX 100
           D W+     I  L+  +G G++G VY+G  R    G+    +A   V             
Sbjct: 11  DEWEVSREKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL 69
Query: 101 XXXXXXKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK-- 158
                 K     ++    G   K  P        +VME    G +   ++S + ++    
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPT------LVVMELMAHGDLKSYLRSLRPEAENNP 123
Query: 159 -------EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
                  +E I  +  EI  G+ YL+  K +HR++  +N ++  +  VK+ DFG++  + 
Sbjct: 124 GRPPPTLQEMIQ-MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY 182
Query: 212 RTIGRRNTFIGT--PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL 268
            T   R    G     WMAPE +      D  +   SD+WS G+   E+   ++ P   L
Sbjct: 183 ETDYYRKGGKGLLPVRWMAPESLK-----DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 237
Query: 269 HPMRALFLI--------PRNAPPR---LKSKKW---PKKFQSFIETV-LVKD 305
              + L  +        P N P R   L    W   P    +F+E V L+KD
Sbjct: 238 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 289

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 39/225 (17%)
Query: 59  LIEVVGNGTYGQVYKGRH-----TKTGQLAAIKVMXXXXXXXXXXXXXXXXXXKYS-NHR 112
            +E +G   +G+VYKG        +  Q  AIK +                  +    H 
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV--------------KSTKGQSLK 158
           N+    G   K  P      L ++  YC  G + + +                T   +L+
Sbjct: 90  NVVCLLGVVTKDQP------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 143
Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV-----SAQLDRT 213
                 +  +I  G++YL  + V+H+D+  +NVL+ D   VK+ D G+     +A   + 
Sbjct: 144 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 203
Query: 214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           +G  N+ +    WMAPE I         +   SD+WS G+   E+
Sbjct: 204 LG--NSLLPI-RWMAPEAIMY-----GKFSIDSDIWSYGVVLWEV 240

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 155 QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRT 213
           Q+L +  I F   EIL+ L Y H   ++HRD+K  NV++  ++ +++L+D+G+ A+    
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHP 184
Query: 214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH 269
               N  + + Y+  PE++   +     YD   D+WSLG     M   + P    H
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQ----MYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQL 210
           T+  +L+EE       ++L  +++ H   V+HRDIK +N+L+  N  E+KL+DFG  A L
Sbjct: 122 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 181
Query: 211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRS-DLWSLGITALEMAESQPPL-CDL 268
             T+     F GT  +  PE I         Y  RS  +WSLGI   +M     P   D 
Sbjct: 182 KDTV--YTDFDGTRVYSPPEWIRYHR-----YHGRSAAVWSLGILLYDMVCGDIPFEHDE 234
Query: 269 HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
             +R               ++   + Q  I   L      RP  +++  HP+++D
Sbjct: 235 EIIRGQVFF---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQL 210
           T+  +L+EE       ++L  +++ H   V+HRDIK +N+L+  N  E+KL+DFG  A L
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRS-DLWSLGITALEMAESQPPL-CDL 268
             T+     F GT  +  PE I         Y  RS  +WSLGI   +M     P   D 
Sbjct: 201 KDTV--YTDFDGTRVYSPPEWIRYHR-----YHGRSAAVWSLGILLYDMVCGDIPFEHDE 253
Query: 269 HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
             +R               ++   + Q  I   L      RP  +++  HP+++D
Sbjct: 254 EIIRGQVFF---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQL 210
           T+  +L+EE       ++L  +++ H   V+HRDIK +N+L+  N  E+KL+DFG  A L
Sbjct: 121 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 180
Query: 211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRS-DLWSLGITALEMAESQPPL-CDL 268
             T+     F GT  +  PE I         Y  RS  +WSLGI   +M     P   D 
Sbjct: 181 KDTV--YTDFDGTRVYSPPEWIRYHR-----YHGRSAAVWSLGILLYDMVCGDIPFEHDE 233
Query: 269 HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
             +R               ++   + Q  I   L      RP  +++  HP+++D
Sbjct: 234 EIIRGQVFF---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQL 210
           T+  +L+EE       ++L  +++ H   V+HRDIK +N+L+  N  E+KL+DFG  A L
Sbjct: 107 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 166
Query: 211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRS-DLWSLGITALEMAESQPPL-CDL 268
             T+     F GT  +  PE I         Y  RS  +WSLGI   +M     P   D 
Sbjct: 167 KDTV--YTDFDGTRVYSPPEWIRYHR-----YHGRSAAVWSLGILLYDMVCGDIPFEHDE 219
Query: 269 HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
             +R               ++   + Q  I   L      RP  +++  HP+++D
Sbjct: 220 EIIRGQVFF---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	463
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	0.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-163
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-156
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-156
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-153
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-148
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-147
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-140
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-139
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-131
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-130
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-129
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-126
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-106
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-106
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-100
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-92
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-92
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-90
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-89
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-79
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-77
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-74
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-72
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-71
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-69
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-68
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-62
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-57
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-56
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-55
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-55
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-55
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-54
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-54
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-53
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-53
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-53
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-51
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-51
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-51
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-51
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-50
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-50
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-49
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-48
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-48
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-48
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-48
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-48
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-48
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-48
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-48
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-48
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-48
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-48
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-47
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-47
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-47
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-47
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-46
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-46
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-46
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-46
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-46
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-45
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-45
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-45
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-44
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-44
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-44
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-44
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-44
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-44
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-44
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-44
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-44
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-43
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-43
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-42
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-42
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-42
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-42
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-40
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-40
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-40
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-40
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-40
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-39
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-39
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-39
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-39
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-39
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-38
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-38
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-38
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-38
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-38
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-38
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-37
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-37
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-37
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-37
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-37
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-36
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-36
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-36
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-36
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-36
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-36
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-36
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-35
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-35
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-34
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-34
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-34
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-33
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-33
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-33
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-33
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-33
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-33
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-32
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-32
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-31
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-31
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-31
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-31
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-31
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-30
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-30
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-29
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-29
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-28
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-24
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-22
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-21
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-19
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-17
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  546 bits (1409), Expect = 0.0
 Identities = 256/308 (83%), Positives = 283/308 (91%), Gaps = 2/308 (0%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS 109
             DPAGIFEL+E+VGNGTYGQVYKGRH KTGQLAAIKVMDVT DEEEEIK EIN+LKKYS
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 78

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +HRNIATYYGAFIKK+PPG DDQLWLVME+CGAGSVTDL+K+TKG +LKEEWIA+ICREI
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           LRGL +LH++KVIHRDIKGQNVLLT+NAEVKLVDFGVSAQLDRT+GRRNTFIGTPYWMAP
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EVIACDENPDATYD +SDLWSLGITA+EMAE  PPLCD+HPMRALFLIPRN  PRLKSKK
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERD 349
           W KKFQSFIE+ LVK++ QRP T+QL+KHPFIRDQP ERQ RIQLKDHID  KK++ E+D
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKD 318

Query: 350 --DYRYSG 355
             +Y YSG
Sbjct: 319 ETEYEYSG 326

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  462 bits (1190), Expect = e-163
 Identities = 115/304 (37%), Positives = 185/304 (60%), Gaps = 14/304 (4%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINV 104
             R   DP  ++E++  +G+G +G+VYK ++ +TG LAA KV++  +E+E E+  +EI +
Sbjct: 10  HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           L    +H  I    GA+        D +LW+++E+C  G+V  ++       L E  I  
Sbjct: 70  LAT-CDHPYIVKLLGAYYH------DGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQV 121

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           +CR++L  L +LH  ++IHRD+K  NVL+T   +++L DFGVSA+  +T+ +R++FIGTP
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
           YWMAPEV+ C+   D  YD ++D+WSLGIT +EMA+ +PP  +L+PMR L  I ++ PP 
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT 241

Query: 285 LKSK-KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKK 343
           L +  KW  +F+ F++  L K+   RP   QLL+HPF+    + +     L++ +   K 
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK----ALRELVAEAKA 297

Query: 344 RKKE 347
              E
Sbjct: 298 EVME 301

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  445 bits (1146), Expect = e-156
 Identities = 135/305 (44%), Positives = 191/305 (62%), Gaps = 21/305 (6%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINV 104
              + DP  +F  +E +G G++G+V+KG   +T ++ AIK++D+   EDE E+I+ EI V
Sbjct: 14  QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           L +  +   +  YYG+++K      D +LW++MEY G GS  DL++      L E  IA 
Sbjct: 74  LSQ-CDSPYVTKYYGSYLK------DTKLWIIMEYLGGGSALDLLEPGP---LDETQIAT 123

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           I REIL+GL YLH  K IHRDIK  NVLL+++ EVKL DFGV+ QL  T  +RNTF+GTP
Sbjct: 124 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP 183

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
           +WMAPEVI       + YD+++D+WSLGITA+E+A  +PP  +LHPM+ LFLIP+N PP 
Sbjct: 184 FWMAPEVIK-----QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT 238

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKR 344
           L+   + K  + F+E  L K+   RP   +LLKH FI     +      L + ID  K+ 
Sbjct: 239 LE-GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY---LTELIDRYKRW 294

Query: 345 KKERD 349
           K E+ 
Sbjct: 295 KAEQS 299

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  444 bits (1145), Expect = e-156
 Identities = 133/311 (42%), Positives = 191/311 (61%), Gaps = 17/311 (5%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVL 105
           ED   + P  +F+++E +G G+YG VYK  H +TGQ+ AIK + V E + +EI  EI+++
Sbjct: 20  EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-ESDLQEIIKEISIM 78

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
           ++  +  ++  YYG++ K      +  LW+VMEYCGAGSV+D+++      L E+ IA I
Sbjct: 79  QQ-CDSPHVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATI 130

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
            +  L+GL+YLH  + IHRDIK  N+LL      KL DFGV+ QL  T+ +RNT IGTP+
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           WMAPEVI      +  Y+  +D+WSLGITA+EMAE +PP  D+HPMRA+F+IP N PP  
Sbjct: 191 WMAPEVIQ-----EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF 245

Query: 286 K-SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKR 344
           +  + W   F  F++  LVK   QR    QLL+HPF+R        R  + + +D   K 
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMD--VKL 303

Query: 345 KKERDDYRYSG 355
           K++    R  G
Sbjct: 304 KRQESQQREEG 314

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  438 bits (1128), Expect = e-153
 Identities = 112/312 (35%), Positives = 179/312 (57%), Gaps = 23/312 (7%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLE 101
           E  +++DP  +F  +  +G+G++G VY  R  +  ++ AIK M  +     ++ ++I  E
Sbjct: 45  ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 104

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
           +  L+K   H N   Y G +++      +   WLVMEYC  GS +DL++  K   L+E  
Sbjct: 105 VRFLQK-LRHPNTIQYRGCYLR------EHTAWLVMEYCL-GSASDLLEVHKK-PLQEVE 155

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           IA +    L+GL YLH + +IHRD+K  N+LL++   VKL DFG ++ +       N+F+
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV 211

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           GTPYWMAPEVI   +  +  YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N 
Sbjct: 212 GTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTC 341
            P L+S  W + F++F+++ L K    RP ++ LLKH F+  +         + D I   
Sbjct: 270 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT----VIMDLIQRT 325

Query: 342 KKRKKERDDYRY 353
           K   +E D+ +Y
Sbjct: 326 KDAVRELDNLQY 337

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  424 bits (1093), Expect = e-148
 Identities = 100/298 (33%), Positives = 163/298 (54%), Gaps = 21/298 (7%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE-IKLEINVLKKY 108
           Q DP  + +    +G G+ G V   R   +G+  A+K+MD+ + +  E +  E+ +++ Y
Sbjct: 40  QGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
             H N+   Y +++        ++LW++ME+   G++TD+V   +   L EE IA +C  
Sbjct: 100 -QHFNVVEMYKSYLV------GEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEA 149

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
           +L+ L YLH   VIHRDIK  ++LLT +  VKL DFG  AQ+ + + +R + +GTPYWMA
Sbjct: 150 VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 209

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK 288
           PEVI+      + Y    D+WSLGI  +EM + +PP     P++A+  +  + PP+LK+ 
Sbjct: 210 PEVIS-----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS 264

Query: 289 -KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK 345
            K     + F+E +LV+D  +R    +LL HPF+            L   I   +K+ 
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE----CLVPLIQLYRKQT 318

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  422 bits (1086), Expect = e-147
 Identities = 113/301 (37%), Positives = 165/301 (54%), Gaps = 23/301 (7%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE-IKLEINVLKKY 108
             DP   +   E +G G  G VY      TGQ  AI+ M++ +  ++E I  EI V+++ 
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE- 73

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
           + + NI  Y  +++        D+LW+VMEY   GS+TD+V  T    + E  IA +CRE
Sbjct: 74  NKNPNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRE 124

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
            L+ L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+T +GTPYWMA
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK 288
           PEV+         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ 
Sbjct: 185 PEVVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239

Query: 289 -KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD-QPTERQARIQLKDHIDTCKKRKK 346
            K    F+ F+   L  D  +R    +LL+H F++  +P        L   I   K+  K
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS-----SLTPLIAAAKEATK 294

Query: 347 E 347
            
Sbjct: 295 N 295

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  404 bits (1039), Expect = e-140
 Identities = 107/292 (36%), Positives = 153/292 (52%), Gaps = 32/292 (10%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYS 109
                +EL EV+G+G    V         +  AIK +++   +   +E+  EI  + +  
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ-C 70

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST------KGQSLKEEWIA 163
           +H NI +YY +F+        D+LWLVM+    GSV D++K        K   L E  IA
Sbjct: 71  HHPNIVSYYTSFVV------KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG-----RRN 218
            I RE+L GL+YLH+N  IHRD+K  N+LL ++  V++ DFGVSA L           R 
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP 278
           TF+GTP WMAPEV+         YD ++D+WS GITA+E+A    P     PM+ L L  
Sbjct: 185 TFVGTPCWMAPEVM----EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240

Query: 279 RNAPPRLKS--------KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +N PP L++        KK+ K F+  I   L KD  +RP   +LL+H F +
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  403 bits (1036), Expect = e-139
 Identities = 79/371 (21%), Positives = 140/371 (37%), Gaps = 70/371 (18%)

Query: 51  EDPAGIFELIEVVGNG--TYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL---EINVL 105
               G +EL+ V+G G      V   R+  TG+   ++ +++     E +     E++V 
Sbjct: 21  LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVS 80

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFI 165
           K + NH NI  Y   FI       D++LW+V  +   GS  DL+ +     + E  IA+I
Sbjct: 81  KLF-NHPNIVPYRATFIA------DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT------ 219
            + +L+ L Y+H    +HR +K  ++L++ + +V L     +  +     R+        
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 220 -FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP 278
             +    W++PEV+  +      YD +SD++S+GITA E+A    P  D+   + L    
Sbjct: 194 YSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

Query: 279 RNAPPRLK--------------------------------------------SKKWPKKF 294
               P L                                              + +   F
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCK--KRKKERDDYR 352
             F+E  L ++   RP    LL H F +    +R+A   L + +         +      
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFK--QIKRRASEALPELLRPVTPITNFEGSQSQD 368

Query: 353 YSGSENEEEET 363
           +SG        
Sbjct: 369 HSGIFGLVTNL 379

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  380 bits (978), Expect = e-131
 Identities = 93/293 (31%), Positives = 144/293 (49%), Gaps = 18/293 (6%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE--EIKLEI 102
           PE  W        + +  +G G YG V K  H  +GQ+ A+K +  T DE+E  ++ +++
Sbjct: 13  PEQHWDFTAED-LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71

Query: 103 NVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEE 160
           +V+ + S+   I  +YGA  +      +   W+ ME            V S     + EE
Sbjct: 72  DVVMRSSDCPYIVQFYGALFR------EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125

Query: 161 WIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
            +  I    ++ L +L EN K+IHRDIK  N+LL  +  +KL DFG+S QL  +I +   
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD 185

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIP 278
             G   +MAPE I    +    YD RSD+WSLGIT  E+A  + P    + +   L  + 
Sbjct: 186 -AGCRPYMAPERIDPSASRQ-GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243

Query: 279 RNAPPRLKS---KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
           +  PP+L +   +++   F +F+   L KD  +RP   +LLKHPFI       
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  377 bits (970), Expect = e-130
 Identities = 86/284 (30%), Positives = 143/284 (50%), Gaps = 15/284 (5%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE--EIKLEINVLKKY 108
           E  A   E I  +G G YG V K RH  +GQ+ A+K +  T + +E   + +++++  + 
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFIC 166
            +     T+YGA  ++        +W+ ME     S+    K    KGQ++ E+ +  I 
Sbjct: 63  VDCPFTVTFYGALFREG------DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 167 REILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
             I++ L++LH    VIHRD+K  NVL+    +VK+ DFG+S  L   + + +   G   
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-DIDAGCKP 174

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPR 284
           +MAPE I  + N    Y  +SD+WSLGIT +E+A  + P      P + L  +     P+
Sbjct: 175 YMAPERINPELNQ-KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
           L + K+  +F  F    L K+  +RP   +L++HPF     ++ 
Sbjct: 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  377 bits (969), Expect = e-129
 Identities = 89/296 (30%), Positives = 151/296 (51%), Gaps = 15/296 (5%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE--EIKLEINVLKKYSNHRNI 114
            E +  +G+GT GQV+K R  KTG + A+K M  + ++EE   I ++++V+ K  +   I
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
              +G FI       +  +++ ME  G  +  + +K      + E  +  +   I++ L 
Sbjct: 87  VQCFGTFIT------NTDVFIAMELMGTCA--EKLKKRMQGPIPERILGKMTVAIVKALY 138

Query: 175 YLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YL  ++ VIHRD+K  N+LL +  ++KL DFG+S +L     + +   G   +MAPE I 
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERID 197

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIPRNAPPRLKSK-KWP 291
             +     YD R+D+WSLGI+ +E+A  Q P  +       L  + +  PP L     + 
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD-QPTERQARIQLKDHIDTCKKRKK 346
             FQSF++  L KD+ +RP  ++LL+H FI+  +  E       KD +   +  + 
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRS 313

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  317 bits (814), Expect = e-106
 Identities = 66/289 (22%), Positives = 109/289 (37%), Gaps = 25/289 (8%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINV 104
           P D    +          VG G++G+V++ +  +TG   A+K + +     EE+      
Sbjct: 48  PVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA---- 103

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
                +   I   YGA  +         + + ME    GS+  L+K  +   L E+   +
Sbjct: 104 CAGL-SSPRIVPLYGAVRE------GPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALY 154

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQLD-----RTIGRRN 218
              + L GL+YLH  +++H D+K  NVLL+ + +   L DFG +  L      +++   +
Sbjct: 155 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP 278
              GT   MAPEV+          D + D+WS     L M     P            I 
Sbjct: 215 YIPGTETHMAPEVVMGKP-----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269

Query: 279 RNAPPRLKSK-KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT 326
              PP  +            I+  L K+   R    +L +      Q  
Sbjct: 270 SEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  317 bits (815), Expect = e-106
 Identities = 97/352 (27%), Positives = 158/352 (44%), Gaps = 72/352 (20%)

Query: 16  ERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR 75
           E  EL E+  K L+ F+             + +  E     FE I  +G G  G V+K  
Sbjct: 5   EELELDEQQRKRLEAFLT-----------QKQKVGELKDDDFEKISELGAGNGGVVFKVS 53

Query: 76  HTKTGQLAAIKVMDVTEDEEE--EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL 133
           H  +G + A K++ +        +I  E+ VL +  N   I  +YGAF        D ++
Sbjct: 54  HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPYIVGFYGAFYS------DGEI 106

Query: 134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVL 192
            + ME+   GS+  ++K  K   + E+ +  +   +++GL YL E  K++HRD+K  N+L
Sbjct: 107 SICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164

Query: 193 LTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
           +    E+KL DFGVS QL  ++   N+F+GT  +M+PE +         Y  +SD+WS+G
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----GTHYSVQSDIWSMG 217

Query: 253 ITALEMAESQPPL--------------------------------------CDLHPMRAL 274
           ++ +EMA  + P+                                       D  P  A+
Sbjct: 218 LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

Query: 275 F----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           F     I    PP+L S  +  +FQ F+   L+K+  +R    QL+ H FI+
Sbjct: 278 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  301 bits (772), Expect = e-100
 Identities = 91/279 (32%), Positives = 143/279 (51%), Gaps = 16/279 (5%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYSNHRNIATYYG 119
            V+G GTYG VY GR        AIK +   +    + +  EI + K    H+NI  Y G
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLG 86

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILRGLKYLHE 178
           +F +      +  + + ME    GS++ L++S  G     E+ I F  ++IL GLKYLH+
Sbjct: 87  SFSE------NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 179 NKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           N+++HRDIKG NVL+ T +  +K+ DFG S +L        TF GT  +MAPE+I   + 
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII---DK 197

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPR-NAPPRLKSKKWPKKFQ 295
               Y   +D+WSLG T +EMA  +PP  +L  P  A+F +      P +  +    + +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI-PESMSAEAK 256

Query: 296 SFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQL 334
           +FI      D  +R   + LL   F++    +++ + +L
Sbjct: 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  289 bits (741), Expect = 2e-95
 Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 25/291 (8%)

Query: 35  LEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVT 91
           L+   Y    PE  +Q+     F+ +  +G+G+YG+V+K R  + G+L A+K        
Sbjct: 41  LQSPGYDPSRPESFFQQS----FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG 96

Query: 92  EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS 151
             +      E+   +K   H        A+ +         L+L  E CG  S+    ++
Sbjct: 97  PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE------GGILYLQTELCG-PSLQQHCEA 149

Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
             G SL E  +    R+ L  L +LH   ++H D+K  N+ L      KL DFG+  +L 
Sbjct: 150 -WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208

Query: 212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM 271
              G      G P +MAPE++   +     Y   +D++SLG+T LE+A +          
Sbjct: 209 TA-GAGEVQEGDPRYMAPELL---QGS---YGTAADVFSLGLTILEVACNMELPHGGEGW 261

Query: 272 RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           + L       PP   +     + +S +  +L  D   R   + LL  P +R
Sbjct: 262 QQLRQG--YLPPEF-TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  287 bits (737), Expect = 4e-95
 Identities = 59/290 (20%), Positives = 118/290 (40%), Gaps = 42/290 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           F  +E +G+G +G V+K      G + AIK          +E+    E+        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           +  Y+ A+ +      DD + +  EYC  GS+ D +          KE  +  +  ++ R
Sbjct: 73  VVRYFSAWAE------DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDN-------------------AEVKLVDFGVSAQLDR 212
           GL+Y+H   ++H DIK  N+ ++                        K+ D G   ++  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
                    G   ++A EV+      + T+  ++D+++L +T +  A ++P   +     
Sbjct: 187 P----QVEEGDSRFLANEVL----QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238

Query: 273 ALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
               I +   PR+  +   ++F   ++ ++  D  +RP    L+KH  + 
Sbjct: 239 E---IRQGRLPRI-PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  281 bits (720), Expect = 3e-92
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 20/289 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHR 112
           F + + +G G + +VY+      G   A+K + +          +   EI++LK+  NH 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 92

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREIL 170
           N+  YY +FI+      D++L +V+E   AG ++ ++K  K   + + E  +     ++ 
Sbjct: 93  NVIKYYASFIE------DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
             L+++H  +V+HRDIK  NV +T    VKL D G+           ++ +GTPY+M+PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPP-LCDLHPMRALFL-IPRNAPPRLKSK 288
                EN    Y+ +SD+WSLG    EMA  Q P   D   + +L   I +   P L S 
Sbjct: 207 R--IHENG---YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDH 337
            + ++ +  +   +  D  +RP    +          T          H
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH 310

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  279 bits (715), Expect = 9e-92
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 21/282 (7%)

Query: 51  EDPAGIFE-LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLK 106
               G F      +G G++  VYKG  T+T    A   +     T+ E +  K E  +LK
Sbjct: 21  MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 80

Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
               H NI  +Y ++           + LV E   +G++   +K  K   +K + +   C
Sbjct: 81  G-LQHPNIVRFYDSWESTVK--GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWC 135

Query: 167 REILRGLKYLHENK--VIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
           R+IL+GL++LH     +IHRD+K  N+ +T     VK+ D G++     +       IGT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGT 193

Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-AP 282
           P +MAPE+       +  YD   D+++ G+  LEMA S+ P  +      ++    +   
Sbjct: 194 PEFMAPEMY------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
           P    K    + +  IE  + ++  +R     LL H F +++
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  278 bits (714), Expect = 1e-90
 Identities = 81/328 (24%), Positives = 153/328 (46%), Gaps = 21/328 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           +  ++ +G G++G+    + T+ G+   IK +++   +  E EE + E+ VL     H N
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPN 84

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  Y  +F +      +  L++VM+YC  G +   + + KG   +E+ I     +I   L
Sbjct: 85  IVQYRESFEE------NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           K++H+ K++HRDIK QN+ LT +  V+L DFG++  L+ T+      IGTPY+++PE+  
Sbjct: 139 KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-- 196

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKK 293
           C+  P   Y+N+SD+W+LG    E+   +           +  I   + P + S  +   
Sbjct: 197 CENKP---YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV-SLHYSYD 252

Query: 294 FQSFIETVLVKDYHQRPYTDQLLKHPFIR---DQPTERQARIQLKDHIDTCKKRKKERDD 350
            +S +  +  ++   RP  + +L+  FI    ++    Q   +        K   +    
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPA 312

Query: 351 YRYSGSENEEEETGVGG--EPSSIIQAP 376
            R +  +N           +P++    P
Sbjct: 313 KRPASGQNSISVMPAQKITKPAAKYGIP 340

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  274 bits (702), Expect = 8e-90
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 26/285 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           F+ IE++G+G +GQV+K +H   G+   IK +       E+ + E+  L K  +H NI  
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---NNEKAEREVKALAKL-DHVNIVH 68

Query: 117 YYGAFI----------KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           Y G +           K S   K   L++ ME+C  G++   ++  +G+ L +     + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            +I +G+ Y+H  K+I+RD+K  N+ L D  +VK+ DFG+   L    G+R    GT  +
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGTLRY 187

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           M+PE I+        Y    DL++LG+   E+                          + 
Sbjct: 188 MSPEQIS-----SQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLRDGII- 236

Query: 287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQAR 331
           S  + KK ++ ++ +L K    RP T ++L+   +  +  E+  R
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  272 bits (697), Expect = 8e-89
 Identities = 79/301 (26%), Positives = 142/301 (47%), Gaps = 37/301 (12%)

Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK 107
           R+  D    FE I V+G G +GQV K R+    +  AIK +  TE++   I  E+ +L  
Sbjct: 3   RYASD----FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLAS 58

Query: 108 YSNHRNIATYYGAFIKKS-------PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
             NH+ +  YY A++++           K   L++ MEYC  G++ DL+ S +  + + +
Sbjct: 59  L-NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRD 116

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI------ 214
               + R+IL  L Y+H   +IHRD+K  N+ + ++  VK+ DFG++  + R++      
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 215 --------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP-- 264
                       + IGT  ++A EV+    +    Y+ + D++SLGI   EM    P   
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVL----DGTGHYNEKIDMYSLGIIFFEMI--YPFST 230

Query: 265 -LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
            +  ++ ++ L  +    PP        K  +  I  ++  D ++RP    LL   ++  
Sbjct: 231 GMERVNILKKLRSVSIEFPPDF-DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

Query: 324 Q 324
           +
Sbjct: 290 K 290

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  247 bits (634), Expect = 1e-79
 Identities = 80/279 (28%), Positives = 135/279 (48%), Gaps = 23/279 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           +E++  +G G+YG+  K R    G++   K +D    TE E++ +  E+N+L++   H N
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN 66

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILR 171
           I  YY   I +     +  L++VMEYC  G +  ++       Q L EE++  +  ++  
Sbjct: 67  IVRYYDRIIDR----TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 172 GLKYLHE-----NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            LK  H      + V+HRD+K  NV L     VKL DFG++  L+       TF+GTPY+
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRL 285
           M+PE    +      Y+ +SD+WSLG    E+    PP       + L   I      R+
Sbjct: 183 MSPEQ--MNRMS---YNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRI 236

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
              ++  +    I  +L    + RP  +++L++P I + 
Sbjct: 237 -PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  241 bits (618), Expect = 4e-77
 Identities = 66/301 (21%), Positives = 128/301 (42%), Gaps = 30/301 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNI 114
           FE I+ +G G +G V++ ++       AIK + +   E   E++  E+  L K   H  I
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGI 65

Query: 115 ATYYGAFI------KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE-WIAFICR 167
             Y+ A++      K  P      L++ M+ C   ++ D +        +E      I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT------------IG 215
           +I   +++LH   ++HRD+K  N+  T +  VK+ DFG+   +D+               
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF 275
           R    +GT  +M+PE      N    Y ++ D++SLG+   E+    P    +  +R L 
Sbjct: 186 RHTGQVGTKLYMSPEQ--IHGNS---YSHKVDIFSLGLILFELL--YPFSTQMERVRTLT 238

Query: 276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLK 335
            +     P L ++K+P      ++ +L     +RP    ++++    D     +  ++ +
Sbjct: 239 DVRNLKFPPLFTQKYP-CEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQR 297

Query: 336 D 336
            
Sbjct: 298 S 298

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  234 bits (600), Expect = 9e-74
 Identities = 69/347 (19%), Positives = 137/347 (39%), Gaps = 29/347 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYS-NHR 112
           + +++ +G+G   +V++  + +  Q+ AIK ++         +  + EI  L K   +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I   Y   I       D  +++VME      +   +K  K +S+         + +L  
Sbjct: 70  KIIRLYDYEIT------DQYIYMVMECGN-IDLNSWLK--KKKSIDPWERKSYWKNMLEA 120

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPE 230
           +  +H++ ++H D+K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 231 VI------ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPP 283
            I        +    +    +SD+WSLG     M   + P   + + +  L  I      
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKK 343
                   K  Q  ++  L +D  QR    +LL HP++  Q          K   +  K 
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--QIQTHPVNQMAKGTTEEMKY 297

Query: 344 RKKERDDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
              +        S N   +               +++  + F++ + 
Sbjct: 298 VLGQLVGLN---SPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 341

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  229 bits (586), Expect = 4e-72
 Identities = 64/282 (22%), Positives = 123/282 (43%), Gaps = 24/282 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYS-NHR 112
           + +++ +G+G   +V++  + +  Q+ AIK ++         +  + EI  L K   +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I   Y   I       D  +++VME      +   +K  K +S+         + +L  
Sbjct: 89  KIIRLYDYEIT------DQYIYMVMECGN-IDLNSWLK--KKKSIDPWERKSYWKNMLEA 139

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPE 230
           +  +H++ ++H D+K  N L+ D   +KL+DFG++ Q+  D T   +++ +GT  +M PE
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

Query: 231 VI------ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPP 283
            I        +    +    +SD+WSLG     M   + P   + + +  L  I      
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP 325
                   K  Q  ++  L +D  QR    +LL HP+++ Q 
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  229 bits (586), Expect = 3e-71
 Identities = 69/349 (19%), Positives = 137/349 (39%), Gaps = 29/349 (8%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYS-N 110
            I+ +++ +G+G   +V++  + +  Q+ AIK ++         +  + EI  L K   +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
              I   Y   I       D  +++VME      +   +K  K +S+         + +L
Sbjct: 115 SDKIIRLYDYEIT------DQYIYMVMECGN-IDLNSWLK--KKKSIDPWERKSYWKNML 165

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMA 228
             +  +H++ ++H D+K  N L+ D   +KL+DFG++ Q+  D T   +++ +G   +M 
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 229 PEVI------ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNA 281
           PE I        +    +    +SD+WSLG     M   + P   + + +  L  I    
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTC 341
                     K  Q  ++  L +D  QR    +LL HP++  Q          K   +  
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--QIQTHPVNQMAKGTTEEM 342

Query: 342 KKRKKERDDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNFQQIQK 390
           K    +        S N   +               +++  + F++ + 
Sbjct: 343 KYVLGQLVGLN---SPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  222 bits (568), Expect = 2e-69
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 18/286 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYSNHRNIA 115
           +  I+ +G G +  V        G   A+K +   E ++ EE + E ++ +   NH NI 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL-FNHPNIL 89

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREILRGL 173
                 +++       + WL++ +   G++ + ++    KG  L E+ I ++   I RGL
Sbjct: 90  RLVAYCLRERGAKH--EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI---------GTP 224
           + +H     HRD+K  N+LL D  +  L+D G   Q    +      +          T 
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP-LCDLHPMRALFLIPRNAPP 283
            + APE+           D R+D+WSLG     M   + P         ++ L  +N   
Sbjct: 208 SYRAPEL--FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQ 329
             +S +        + +++  D HQRP+   LL        P   Q
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  222 bits (568), Expect = 4e-68
 Identities = 68/305 (22%), Positives = 124/305 (40%), Gaps = 31/305 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           F   +V+G+G  G +   R     +  A+K +    +       E+ +L++   H N+  
Sbjct: 26  FCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82

Query: 117 YYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
           Y+          KD Q  ++ +E C   ++ + V+  K  +        + ++   GL +
Sbjct: 83  YFCTE-------KDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAH 133

Query: 176 LHENKVIHRDIKGQNVLLTDNAE-----VKLVDFGVSAQLD---RTIGRRNTFIGTPYWM 227
           LH   ++HRD+K  N+L++           + DFG+  +L     +  RR+   GT  W+
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPRLK 286
           APE++   E+         D++S G     + +E   P       +A  L+   +   L 
Sbjct: 194 APEML--SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251

Query: 287 -SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRK 345
             K      +  IE ++  D  +RP    +LKHPF      + Q    + D I      +
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRI------E 305

Query: 346 KERDD 350
           KE  D
Sbjct: 306 KESLD 310

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  203 bits (519), Expect = 7e-62
 Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 29/284 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIA 115
             +  V+  G +  VY+ +   +G+  A+K +    E++   I  E+  +KK S H NI 
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 116 TYYGAFI--KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
            +  A    K+       +  L+ E C    V  L K      L  + +  I  +  R +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 174 KYLHENK--VIHRDIKGQNVLLTDNAEVKLVDFG------------VSAQLDRTIGRRNT 219
           +++H  K  +IHRD+K +N+LL++   +KL DFG             SAQ    +    T
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---FL 276
              TP +  PE+I  D   +     + D+W+LG     +   Q P  D   +R +   + 
Sbjct: 210 RNTTPMYRTPEII--DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267

Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
           IP +             F S I  +L  +  +R    +++    
Sbjct: 268 IPPHDTQ-------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  192 bits (488), Expect = 2e-57
 Identities = 63/349 (18%), Positives = 127/349 (36%), Gaps = 93/349 (26%)

Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVL 105
           R+  D    FE I+ +G G +G V++ ++       AIK + +   E   E++  E+  L
Sbjct: 3   RYLTD----FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL 58

Query: 106 KKYSNHRNIATYYGAFIKKSPPG------------------------------------- 128
            K   H  I  Y+ A+++  P                                       
Sbjct: 59  AK-LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117

Query: 129 --------------KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA-FICREILRGL 173
                             L++ M+ C   ++ D +        +E  +   I  +I   +
Sbjct: 118 FSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF------------I 221
           ++LH   ++HRD+K  N+  T +  VK+ DFG+   +D+    +               +
Sbjct: 178 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-------L 274
           GT  +M+PE I         Y ++ D++SLG+   E+         L+           +
Sbjct: 238 GTKLYMSPEQIH-----GNNYSHKVDIFSLGLILFEL---------LYSFSTQMERVRII 283

Query: 275 FLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
             +     P L ++K+P +    ++ +L     +RP    ++++    +
Sbjct: 284 TDVRNLKFPLLFTQKYP-QEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  188 bits (480), Expect = 2e-56
 Identities = 70/307 (22%), Positives = 117/307 (38%), Gaps = 43/307 (14%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD--VTEDEEEEIKLEINVLKK 107
           Q     ++ L +++G G    V++GRH KTG L AIKV +        +    E  VLKK
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFIC 166
             NH+NI   +    + +         L+ME+C  GS+   L + +    L E     + 
Sbjct: 64  L-NHKNIVKLFAIEEETTT----RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLDRTIGRRNTFIG 222
           R+++ G+ +L EN ++HR+IK  N++        +  KL DFG + +L+    +  +  G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177

Query: 223 TPYWMAPEVIACDENPDAT---YDNRSDLWSLGITALEMAESQPPLCDLHPMRA----LF 275
           T  ++ P++             Y    DLWS+G+T    A    P       R     ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 276 LIPRNAPPRLK-----------------------SKKWPKKFQSFIETVLVKDYHQRPYT 312
            I    P                           S+         +  +L  D  +    
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 313 DQLLKHP 319
           DQ     
Sbjct: 298 DQFFAET 304

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  194 bits (493), Expect = 3e-55
 Identities = 87/414 (21%), Positives = 150/414 (36%), Gaps = 48/414 (11%)

Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD--VTEDEEEEIKLEINVL 105
                  G +E+ E +G G +G V +  H  TG+  AIK     ++    E   LEI ++
Sbjct: 7   SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM 66

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAF 164
           KK  NH N+ +             +D   L MEYC  G +   L +      LKE  I  
Sbjct: 67  KKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQLDRTIGRRNTFI 221
           +  +I   L+YLHEN++IHRD+K +N++L    +    K++D G + +LD+       F+
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 184

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA 281
           GT  ++APE++   +     Y    D WS G  A E      P              R  
Sbjct: 185 GTLQYLAPELLEQKK-----YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239

Query: 282 ----------------------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHP 319
                                  P   S     K + +++ +L+    QR    Q     
Sbjct: 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299

Query: 320 FIRDQPTERQARIQLKDHIDTCKKRKKERDDYRYSGS--ENEEEETGVGGEPSSIIQAPG 377
             +   +    ++    ++ + +       +     +     +++TG+  E   ++Q   
Sbjct: 300 CFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQ-AS 358

Query: 378 DNTLRRNFQQIQKLENCARSSSSSTST----------ATPTPRIQTPTHPTTAT 421
              L       Q + +C                        P+I  P HP + +
Sbjct: 359 GLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPESVS 412

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  184 bits (469), Expect = 3e-55
 Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 36/277 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE+   +G G +G VY  R  ++  + A+KV+          E +++ E+ +      H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHP 69

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   YG F   +      +++L++EY   G+V   ++  K     E+  A    E+   
Sbjct: 70  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANA 121

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S        RR    GT  ++ PE+I
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMI 179

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNAPPRL 285
                    +D + DLWSLG+   E    +PP              R  F  P       
Sbjct: 180 E-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +           I  +L  +  QRP   ++L+HP+I 
Sbjct: 235 R---------DLISRLLKHNPSQRPMLREVLEHPWIT 262

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  188 bits (479), Expect = 6e-55
 Identities = 67/320 (20%), Positives = 137/320 (42%), Gaps = 40/320 (12%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKY 108
           +++    +    +++G G+ G V   + +  G+  A+K M +  D  +   +EI +L + 
Sbjct: 9   FEQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLI--DFCDIALMEIKLLTES 65

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVK-----STKGQSLKEEWI 162
            +H N+  YY +          D+ L++ +E C   ++ DLV+         +  KE   
Sbjct: 66  DDHPNVIRYYCSE-------TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNP 117

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLT-------------DNAEVKLVDFGVSAQ 209
             + R+I  G+ +LH  K+IHRD+K QN+L++             +N  + + DFG+  +
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 210 LD----RTIGRRNTFIGTPYWMAPEVIACDENPDAT--YDNRSDLWSLGITALEM-AESQ 262
           LD          N   GT  W APE++    N           D++S+G     + ++ +
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 263 PPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHP 319
            P  D +   +  +    +   +K              I  ++  D  +RP   ++L+HP
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

Query: 320 FIRDQPTERQARIQLKDHID 339
               +  + +  +++ D ++
Sbjct: 298 LFWPKSKKLEFLLKVSDRLE 317

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  183 bits (467), Expect = 1e-54
 Identities = 68/279 (24%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSN 110
             +     +G G + + ++     T ++ A K++     +   + E++ +EI++ +    
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 73

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 74  HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 125

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+    GTP ++APE
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNAPP 283
           V++        +    D+WS+G     +   +PP              +  + IP++  P
Sbjct: 186 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                       S I+ +L  D   RP  ++LL   F  
Sbjct: 241 VAA---------SLIQKMLQTDPTARPTINELLNDEFFT 270

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  182 bits (464), Expect = 2e-54
 Identities = 66/284 (23%), Positives = 122/284 (42%), Gaps = 33/284 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F++  ++G G++  VY+     TG   AIK++D          + ++ E+ +  +   H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHP 71

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           +I   Y  F         + ++LV+E C  G +   +K+ + +   E        +I+ G
Sbjct: 72  SILELYNYF------EDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITG 124

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           + YLH + ++HRD+   N+LLT N  +K+ DFG++ QL     +  T  GTP +++PE+ 
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNAPPRL 285
                  + +   SD+WSLG     +   +PP               A + +P       
Sbjct: 185 T-----RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA 239

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQ 329
           K           I  +L ++   R     +L HPF+    + + 
Sbjct: 240 K---------DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKS 274

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  183 bits (467), Expect = 1e-53
 Identities = 71/314 (22%), Positives = 121/314 (38%), Gaps = 24/314 (7%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKK 107
           Q     ++ L +++G G    V++GRH KTG L AIKV +        +    E  VLKK
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFIC 166
             NH+NI   +    + +         L+ME+C  GS+   L + +    L E     + 
Sbjct: 64  L-NHKNIVKLFAIEEETTT----RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLDRTIGRRNTFIG 222
           R+++ G+ +L EN ++HR+IK  N++        +  KL DFG + +L+    +  +  G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177

Query: 223 TPYWMAPEVIACDENPDAT---YDNRSDLWSLGITALEMAESQPPLCDLHPMRA----LF 275
           T  ++ P++             Y    DLWS+G+T    A    P       R     ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD----QPTERQAR 331
            I    P    S     +      +  +          Q+L  P + +       +    
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 332 IQLKDHIDTCKKRK 345
            Q          R 
Sbjct: 298 DQFFAETSDILHRM 311

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  181 bits (462), Expect = 2e-53
 Identities = 68/279 (24%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSN 110
             +     +G G + + ++     T ++ A K++     +   + E++ +EI++ +    
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 99

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H+++  ++G F        +D +++V+E C   S+ +L K  K  +L E    +  R+I+
Sbjct: 100 HQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 151

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            G +YLH N+VIHRD+K  N+ L ++ EVK+ DFG++ +++    R+    GTP ++APE
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNAPP 283
           V++        +    D+WS+G     +   +PP              +  + IP++  P
Sbjct: 212 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                       S I+ +L  D   RP  ++LL   F  
Sbjct: 267 VAA---------SLIQKMLQTDPTARPTINELLNDEFFT 296

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  179 bits (457), Expect = 2e-53
 Identities = 71/277 (25%), Positives = 113/277 (40%), Gaps = 36/277 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F++   +G G +G VY  R  +   + A+KV+       E  E +++ EI +      H 
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHP 74

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   Y  F  +       +++L++E+   G +   ++  K     E+  A    E+   
Sbjct: 75  NILRMYNYFHDRK------RIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADA 126

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y HE KVIHRDIK +N+L+    E+K+ DFG S        RR T  GT  ++ PE+I
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMI 184

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNAPPRL 285
                   T+D + DLW  G+   E     PP                    P       
Sbjct: 185 E-----GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           K           I  +L     QR     +++HP+++
Sbjct: 240 K---------DLISKLLRYHPPQRLPLKGVMEHPWVK 267

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  184 bits (468), Expect = 7e-53
 Identities = 79/300 (26%), Positives = 141/300 (47%), Gaps = 26/300 (8%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHR 112
           +++ ++ +G+G YG+V   R   T    AIK++    V+     ++  E+ VLK    H 
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HP 96

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   Y  F            +LVME    G + D +         E   A I +++L G
Sbjct: 97  NIMKLYDFFED------KRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSG 148

Query: 173 LKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           + YLH++ ++HRD+K +N+LL     +A +K+VDFG+SA  +    +    +GT Y++AP
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAP 207

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EV+         YD + D+WS+G+    +    PP         L  +         S +
Sbjct: 208 EVL------RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-EKGKYTFDSPE 260

Query: 290 WPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKK 346
           W    +     I+ +L  D  +R    Q L+HP+I++  +++++ I+L    +  +  +K
Sbjct: 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  176 bits (448), Expect = 9e-52
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 30/274 (10%)

Query: 29  DDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM 88
           D  I   E   +      D        +  + E +G G++G V++      G   A+K++
Sbjct: 12  DYDIPTTENLYFQGAMDGDDMDIPWCDL-NIKEKIGAGSFGTVHRAEWH--GSDVAVKIL 68

Query: 89  ---DVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV 145
              D   +   E   E+ ++K+   H NI  + GA  +  PP     L +V EY   GS+
Sbjct: 69  MEQDFHAERVNEFLREVAIMKR-LRHPNIVLFMGAVTQ--PP----NLSIVTEYLSRGSL 121

Query: 146 TD-LVKSTKGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAEVKLV 202
              L KS   + L E     +  ++ +G+ YLH     ++HR++K  N+L+     VK+ 
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC 181

Query: 203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           DFG+S     T     +  GTP WMAPEV+  +       + +SD++S G+   E+A  Q
Sbjct: 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-----SNEKSDVYSFGVILWELATLQ 236

Query: 263 PPLCDLHPMRALFL---------IPRNAPPRLKS 287
            P  +L+P + +           IPRN  P++ +
Sbjct: 237 QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  180 bits (459), Expect = 1e-51
 Identities = 70/300 (23%), Positives = 127/300 (42%), Gaps = 26/300 (8%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHR 112
            + ++ ++G G++G+V K +   T Q  A+KV++       +   I  E+ +LKK   H 
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HP 81

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   +               ++V E    G + D +   K     E   A I +++  G
Sbjct: 82  NIMKLFEILED------SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSG 133

Query: 173 LKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           + Y+H++ ++HRD+K +N+LL     + ++K++DFG+S    +   +    IGT Y++AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAP 192

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EV+        TYD + D+WS G+    +    PP    +    L  +           +
Sbjct: 193 EVL------RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-ETGKYAFDLPQ 245

Query: 290 WPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKK 346
           W          I  +L      R    Q L+HP+I+   +E      L          ++
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQ 305

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  175 bits (446), Expect = 1e-51
 Identities = 67/262 (25%), Positives = 107/262 (40%), Gaps = 39/262 (14%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKV-MDVTEDEEEEIKLEINVLKK 107
               P+ +    EV+G G +GQ  K  H +TG++  +K  +   E+ +     E+ V++ 
Sbjct: 5   RIFRPSDLI-HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
              H N+  + G   K         L  + EY   G++  ++KS   Q           +
Sbjct: 64  LE-HPNVLKFIGVLYKDKR------LNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAK 115

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD--------------RT 213
           +I  G+ YLH   +IHRD+   N L+ +N  V + DFG++  +                 
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA 273
             +R T +G PYWMAPE+I        +YD + D++S GI   E+        D  P   
Sbjct: 176 RKKRYTVVGNPYWMAPEMIN-----GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230

Query: 274 LFL----------IPRNAPPRL 285
            F            P N PP  
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSF 252

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  179 bits (457), Expect = 2e-51
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 29/286 (10%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNH 111
            ++   V+G G++G+V   +   TGQ  A+KV+       + ++E +  E+ +LK+   H
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-H 85

Query: 112 RNIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
            NI   Y  F       +D    +LV E    G + D + S K     E   A I R++L
Sbjct: 86  PNIMKLYEFF-------EDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVL 136

Query: 171 RGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM 227
            G+ Y+H+NK++HRD+K +N+LL     +A ++++DFG+S   + +  +    IGT Y++
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYI 195

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS 287
           APEV+        TYD + D+WS G+    +    PP    +    L  +        + 
Sbjct: 196 APEVL------HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFEL 248

Query: 288 KKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQA 330
            +W K  +S    I  +L      R      L H +I+    E+ +
Sbjct: 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  173 bits (442), Expect = 5e-51
 Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 24/297 (8%)

Query: 42  EGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----------VT 91
              P           +E  E++G G    V +  H  T +  A+K++D            
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 92  EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS 151
           ++  E    E+++L+K S H NI      +        +   +LV +    G + D +  
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYET------NTFFFLVFDLMKKGELFDYLTE 117

Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
            K  +L E+    I R +L  +  LH+  ++HRD+K +N+LL D+  +KL DFG S QLD
Sbjct: 118 -KV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 212 RTIGRRNTFIGTPYWMAPEVIACDENPDAT-YDNRSDLWSLGITALEMAESQPPLCDLHP 270
               +     GTP ++APE+I C  N +   Y    D+WS G+    +    PP      
Sbjct: 176 PG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234

Query: 271 MRALFLIPRNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
           M  +  +  +   +  S +W     +    +   LV    +R   ++ L HPF +  
Sbjct: 235 ML-MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  173 bits (441), Expect = 5e-51
 Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 42/270 (15%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-------- 95
           +P+ R         E  + +G G +G V+KGR  K   + AIK + + + E         
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
           +E + E+ ++    NH NI   YG      PP       +VME+   G +   +   K  
Sbjct: 68  QEFQREVFIMSNL-NHPNIVKLYGLMHN--PP------RMVMEFVPCGDLYHRLLD-KAH 117

Query: 156 SLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAE-----VKLVDFGVSA 208
            +K      +  +I  G++Y+      ++HRD++  N+ L    E      K+ DFG+S 
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

Query: 209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL 268
           Q   ++      +G   WMAPE I  +E     Y  ++D +S  +    +   + P  + 
Sbjct: 178 QSVHSVS---GLLGNFQWMAPETIGAEEES---YTEKADTYSFAMILYTILTGEGPFDEY 231

Query: 269 HPMRALFL-----------IPRNAPPRLKS 287
              +  F+           IP + PPRL++
Sbjct: 232 SYGKIKFINMIREEGLRPTIPEDCPPRLRN 261

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  173 bits (442), Expect = 9e-51
 Identities = 64/304 (21%), Positives = 127/304 (41%), Gaps = 36/304 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           + + E +G G +G V++   T + +    K + V   ++  +K EI++L   + HRNI  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNI-ARHRNILH 65

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + +F         ++L ++ E+     + + + +T    L E  I     ++   L++L
Sbjct: 66  LHESFESM------EELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFL 118

Query: 177 HENKVIHRDIKGQNVLLT--DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H + + H DI+ +N++     ++ +K+++FG + QL             P + APEV   
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH 177

Query: 235 DENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA-----LFLIPRNAPPRLKS 287
           D          +D+WSLG     L        L  ++P  A     +     NA      
Sbjct: 178 D-----VVSTATDMWSLGTLVYVL--------LSGINPFLAETNQQIIENIMNAEYTFDE 224

Query: 288 KKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIR--DQPTERQARIQLKDHIDTCK 342
           + + +       F++ +LVK+   R    + L+HP+++   +    +    LK       
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284

Query: 343 KRKK 346
             KK
Sbjct: 285 LIKK 288

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  173 bits (439), Expect = 6e-50
 Identities = 37/314 (11%), Positives = 88/314 (28%), Gaps = 44/314 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHR 112
            +L+E +  G    V+  R  +  +  A+KV  +    +  E E +        +     
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL-GE 122

Query: 113 NIATYYGAF----------------IKKSPPGKDD----QLWLVMEYCGAGSVTDLVK-- 150
           +                          +  PG+DD       L+M    +  +  L    
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTL 181

Query: 151 ---STKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS 207
                         +  +  +++R    L    ++H      N+ +  +  + L D    
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP--- 264
            ++     R         +   E +         + +  + W LG++   +     P   
Sbjct: 242 WKVGT---RGPASSVPVTYAPREFLNASTAT---FTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 265 ----LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
               +       +L +   ++         P   ++ I   L  D  +R    + ++ P 
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355

Query: 321 IRDQPTERQARIQL 334
                 E  + +  
Sbjct: 356 FLQLQNEISSSLST 369

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  173 bits (441), Expect = 7e-50
 Identities = 68/365 (18%), Positives = 153/365 (41%), Gaps = 38/365 (10%)

Query: 1   MENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELI 60
             +     +KV    +  ++      D D F   + K+   +  P +  Q      ++++
Sbjct: 4   SHHHHHHGSKVRGKYDGPKI-----NDYDKFYEDIWKKYVPQ--PVEVKQGSVYDYYDIL 56

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYSNHRNIATYYG 119
           E +G+G +G V++     TG++   K ++     +   +K EI+++ +  +H  +   + 
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHD 115

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN 179
           AF  K       ++ L++E+   G + D + + +   + E  +    R+   GLK++HE+
Sbjct: 116 AFEDK------YEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 180 KVIHRDIKGQNVLLT--DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
            ++H DIK +N++      + VK++DFG++ +L+           T  + APE++  +  
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP- 226

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-----LFLIPRNAPPRLKSKKWPK 292
                   +D+W++G+    +      L  L P             +          +  
Sbjct: 227 ----VGFYTDMWAIGVLGYVL------LSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276

Query: 293 KFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERD 349
                  FI+ +L K+  +R      L+HP+++   +   +RI    +    +K K++  
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 336

Query: 350 DYRYS 354
           D+   
Sbjct: 337 DWPAP 341

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  171 bits (436), Expect = 9e-50
 Identities = 73/311 (23%), Positives = 132/311 (42%), Gaps = 43/311 (13%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRNIATY 117
           + +G G +  V +     TGQ  A K +      +D   EI  EI VL+   +   +   
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
           +  +          ++ L++EY   G +  L      + + E  +  + ++IL G+ YLH
Sbjct: 95  HEVYENT------SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 178 ENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           +N ++H D+K QN+LL       ++K+VDFG+S ++          +GTP ++APE++  
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNY 207

Query: 235 DENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA-----LFLIPRNAPPRLKS 287
           D          +D+W++GI A  L        L    P         +L           
Sbjct: 208 DP-----ITTATDMWNIGIIAYML--------LTHTSPFVGEDNQETYLNISQVNVDYSE 254

Query: 288 KKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIR-------DQPTERQARIQLKDH 337
           + +    Q    FI+++LVK+  +RP  +  L H +++         P E  +  Q +DH
Sbjct: 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDH 314

Query: 338 IDTCKKRKKER 348
                + K  +
Sbjct: 315 SVRSSEDKTSK 325

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  169 bits (430), Expect = 5e-49
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 25/284 (8%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVTEDEEEEIKLEIN 103
             W      + E+ E++G G +GQVY GR        AI+++      ED+ +  K E+ 
Sbjct: 26  QEWDIPFEQL-EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVM 81

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
             ++   H N+  + GA +   PP     L ++   C   ++  +V+  K   L      
Sbjct: 82  AYRQT-RHENVVLFMGACMS--PP----HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTR 133

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS-----AQLDRTIGRRN 218
            I +EI++G+ YLH   ++H+D+K +NV   DN +V + DFG+       Q  R   +  
Sbjct: 134 QIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLR 192

Query: 219 TFIGTPYWMAPEVI----ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL 274
              G    +APE+I       E     +   SD+++LG    E+   + P         +
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252

Query: 275 FLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
           + +     P L      K+    +      +  +RP   +L+  
Sbjct: 253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  169 bits (430), Expect = 1e-48
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 37/297 (12%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---------VTEDEE 95
           P+    ++    ++  +V+G G    V +  H  TG   A+K+M+           E+  
Sbjct: 84  PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR 143

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
           E  + E ++L++ + H +I T   ++           ++LV +    G + D +   K  
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYES------SSFMFLVFDLMRKGELFDYLTE-KV- 195

Query: 156 SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG 215
           +L E+    I R +L  + +LH N ++HRD+K +N+LL DN +++L DFG S  L+    
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-E 254

Query: 216 RRNTFIGTPYWMAPEVIACDENPDAT-YDNRSDLWSLG-IT-ALEMAESQPPLCDLHPMR 272
           +     GTP ++APE++ C  +     Y    DLW+ G I   L        L    P  
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL--------LAGSPPFW 306

Query: 273 A-----LFLIPRNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFI 321
                 +  +      +  S +W  +  +    I  +L  D   R   +Q L+HPF 
Sbjct: 307 HRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  168 bits (428), Expect = 1e-48
 Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 26/298 (8%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGA 120
           +V+G G  G+V +  H +TGQ  A+K++  +    +E+    +   + S   +I      
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV----DHHWQASGGPHIVCILDV 90

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           +  ++       L ++ME    G +   ++    Q+  E   A I R+I   +++LH + 
Sbjct: 91  Y--ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148

Query: 181 VIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           + HRD+K +N+L T    +A +KL DFG + +  +      T   TPY++APEV+  +  
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPE-- 204

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPL---CDLHPMRALFLIPRNAPPRLKSKKWPK-- 292
               YD   D+WSLG+    +    PP            +    R       + +W +  
Sbjct: 205 ---KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261

Query: 293 ---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKE 347
              K    I  +L  D  +R    Q + HP+I       Q  +     +   K    E
Sbjct: 262 EDAK--QLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDE 317

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  168 bits (427), Expect = 1e-48
 Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 32/293 (10%)

Query: 43  GWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEI 102
               +          +L+EV   G +G V+K +     +  A+K+  + + +  + + E+
Sbjct: 13  DLGTENLYFQSMP-LQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEV 69

Query: 103 NVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWI 162
             L     H NI  + GA  +      D  LWL+  +   GS++D +K      +    +
Sbjct: 70  YSLPG-MKHENILQFIGAEKR--GTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNEL 123

Query: 163 AFICREILRGLKYLHEN----------KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD- 211
             I   + RGL YLHE+           + HRDIK +NVLL +N    + DFG++ + + 
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 212 -RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP 270
            ++ G  +  +GT  +MAPEV+    N       R D++++G+   E+A           
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV- 242

Query: 271 MRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPY-TDQLLKHPFIR 322
                       P  +        +   E V+ K   +RP   D   KH  + 
Sbjct: 243 -------DEYMLPFEEEIGQHPSLEDMQEVVVHK--KKRPVLRDYWQKHAGMA 286

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  169 bits (429), Expect = 1e-48
 Identities = 63/334 (18%), Positives = 118/334 (35%), Gaps = 62/334 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD------------------VTEDEEEEI 98
           + +I  +  G + ++         +  A+K  +                    + + ++ 
Sbjct: 33  YRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 99  KLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL------VKST 152
           K E+ ++     +    T  G           D+++++ EY    S+         +   
Sbjct: 91  KNELQIITDI-KNEYCLTCEGII------TNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143

Query: 153 KGQSLKEEWIAFICREILRGLKYLHENK-VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
               +  + I  I + +L    Y+H  K + HRD+K  N+L+  N  VKL DFG S  + 
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM 271
               +     GT  +M PE      N  +    + D+WSLGI    M  +  P      +
Sbjct: 204 D--KKIKGSRGTYEFMPPEFF---SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258

Query: 272 RALFL--------IPRNAPPRLKSKKWPKKF----------QSFIETVLVKDYHQRPYTD 313
             LF          P +    L      K              F++  L K+  +R  ++
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 314 QLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKE 347
             LKH ++ D   E      L++      K++K+
Sbjct: 319 DALKHEWLADTNIED-----LREFSKELYKKRKK 347

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  167 bits (424), Expect = 2e-48
 Identities = 72/306 (23%), Positives = 130/306 (42%), Gaps = 40/306 (13%)

Query: 38  RSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDE 94
             ++ G     +Q   A  + ++ ++G G++G+V K +   T Q  A+KV++       +
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 95  EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
              I  E+ +LKK   H NI   +               ++V E    G + D +   K 
Sbjct: 65  TSTILREVELLKKLD-HPNIMKLFEILEDS------SSFYIVGELYTGGELFDEI--IKR 115

Query: 155 QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLD 211
           +   E   A I +++  G+ Y+H++ ++HRD+K +N+LL     + ++K++DFG+S    
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM 271
           +   +    IGT Y++APEV+        TYD + D+WS G+    +      L    P 
Sbjct: 176 QN-TKMKDRIGTAYYIAPEVL------RGTYDEKCDVWSAGVILYIL------LSGTPPF 222

Query: 272 RA-----LFLIPRNAPPRLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                  +              +W       K    I  +L      R    Q L+HP+I
Sbjct: 223 YGKNEYDILKRVETGKYAFDLPQWRTISDDAK--DLIRKMLTFHPSLRITATQCLEHPWI 280

Query: 322 RDQPTE 327
           +   +E
Sbjct: 281 QKYSSE 286

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  167 bits (426), Expect = 2e-48
 Identities = 82/323 (25%), Positives = 140/323 (43%), Gaps = 28/323 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---------VTEDEEEEIKLEINVLKK 107
           + + + +G+G  G+V      KT +  AIK++             D    ++ EI +LKK
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
             NH  I      F         +  ++V+E    G + D V     + LKE        
Sbjct: 72  L-NHPCIIKIKNFF-------DAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFY 121

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           ++L  ++YLHEN +IHRD+K +NVLL+   ++  +K+ DFG S  L  T     T  GTP
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTP 180

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
            ++APEV+       A Y+   D WSLG+         PP  +     +L     +    
Sbjct: 181 TYLAPEVLV--SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

Query: 285 LKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTC 341
              + W +  +     ++ +LV D   R  T++ L+HP+++D+  +R+ +  L +  ++ 
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 298

Query: 342 KKRKKERDDYRYSGSENEEEETG 364
              +             E E  G
Sbjct: 299 ALPQVLAQPSTSRKRPREGEAEG 321

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  167 bits (426), Expect = 2e-48
 Identities = 68/308 (22%), Positives = 123/308 (39%), Gaps = 33/308 (10%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIA 115
           +    + +G G++    K  H K+ Q  A+K++   +  E   + EI  LK    H NI 
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEGHPNIV 69

Query: 116 TYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +  F        D    +LVME    G + +  +  K +   E   ++I R+++  + 
Sbjct: 70  KLHEVF-------HDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVS 120

Query: 175 YLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           ++H+  V+HRD+K +N+L TD   N E+K++DFG +           T   T ++ APE+
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPP------LCDLHPMRALFLIPRNAPPRL 285
           +  +      YD   DLWSLG+    M   Q P               +    +      
Sbjct: 181 LNQNG-----YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

Query: 286 KSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDT 340
           + + W       K    I+ +L  D ++R     L  + +++D        +   D + +
Sbjct: 236 EGEAWKNVSQEAK--DLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGS 293

Query: 341 CKKRKKER 348
                   
Sbjct: 294 SGAAVHTC 301

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  170 bits (432), Expect = 2e-48
 Identities = 79/301 (26%), Positives = 134/301 (44%), Gaps = 28/301 (9%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---------VTEDEE 95
            +  + +     + + + +G+G  G+V      KT +  AI+++             D  
Sbjct: 125 DQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA 184

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
             ++ EI +LKK  NH  I      F         +  ++V+E    G + D V   K  
Sbjct: 185 LNVETEIEILKKL-NHPCIIKIKNFF-------DAEDYYIVLELMEGGELFDKVVGNK-- 234

Query: 156 SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDR 212
            LKE        ++L  ++YLHEN +IHRD+K +NVLL+   ++  +K+ DFG S  L  
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

Query: 213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
           T     T  GTP ++APEV+       A Y+   D WSLG+         PP  +     
Sbjct: 295 T-SLMRTLCGTPTYLAPEVLV--SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351

Query: 273 ALFLIPRNAPPRLKSKKWPK---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQ 329
           +L     +       + W +   K    ++ +LV D   R  T++ L+HP+++D+  +R+
Sbjct: 352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411

Query: 330 A 330
            
Sbjct: 412 F 412

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (426), Expect = 3e-48
 Identities = 75/316 (23%), Positives = 124/316 (39%), Gaps = 42/316 (13%)

Query: 28  LDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKV 87
           L D I   +      G P    +     I ++++ +G G YG+V+ G+    G+  A+KV
Sbjct: 11  LRDLIEQSQSSGSGSGLPLLVQRTIAKQI-QMVKQIGKGRYGEVWMGKWR--GEKVAVKV 67

Query: 88  MDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD 147
              TE+     + EI        H NI  +  A IK    G   QL+L+ +Y   GS+ D
Sbjct: 68  FFTTEEASWFRETEIYQTVL-MRHENILGFIAADIK--GTGSWTQLYLITDYHENGSLYD 124

Query: 148 LVKSTKGQSLKEEWIAFICREILRGLKYLHE--------NKVIHRDIKGQNVLLTDNAEV 199
            +KS    +L  + +  +    + GL +LH           + HRD+K +N+L+  N   
Sbjct: 125 YLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181

Query: 200 KLVDFGVSAQLDRTIGRR----NTFIGTPYWMAPEVIACDENP-DATYDNRSDLWSLGIT 254
            + D G++ +            NT +GT  +M PEV+    N         +D++S G+ 
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241

Query: 255 ALEMA----------ESQPPLCDLHPMRALFLIPRNA----------PPRLKSKKWPKKF 294
             E+A          E Q P  DL P    +   R            P R  S +  ++ 
Sbjct: 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301

Query: 295 QSFIETVLVKDYHQRP 310
              +      +   R 
Sbjct: 302 GKLMTECWAHNPASRL 317

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  166 bits (423), Expect = 3e-48
 Identities = 77/310 (24%), Positives = 128/310 (41%), Gaps = 43/310 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
            E+ EVVG G +G V K +     +  AIK ++ +E E +   +E+  L +  NH NI  
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIE-SESERKAFIVELRQLSRV-NHPNIVK 65

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREILRGLKY 175
            YGA +          + LVMEY   GS+ + L  +              C +  +G+ Y
Sbjct: 66  LYGACLNP--------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 176 LHENK---VIHRDIKGQNVLLTDNAEV-KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           LH  +   +IHRD+K  N+LL     V K+ DFG +  +   +       G+  WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMAPEV 174

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH--PMRALFL--------IPRNA 281
                     Y  + D++S GI   E+   + P  ++     R ++         + +N 
Sbjct: 175 FEGSN-----YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229

Query: 282 PPRLKS--KK-W---PKKFQSF--IETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQ 333
           P  ++S   + W   P +  S   I  ++       P  D+ L++P     P     R++
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVE 289

Query: 334 LKDHIDTCKK 343
                    +
Sbjct: 290 PYVDFAEFYR 299

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  167 bits (426), Expect = 4e-48
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 44/291 (15%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT------EDEEEEIKLEINVLKKYS 109
           ++EL EV+G G +  V +  + +TGQ  A+K++DV           E++K E ++     
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD--LVKSTKGQSLKEEWIAFICR 167
            H +I      +        D  L++V E+     +    + ++  G    E   +   R
Sbjct: 85  -HPHIVELLETY------SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           +IL  L+Y H+N +IHRD+K   VLL    ++A VKL  FGV+ QL  +       +GTP
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA----LFLIP 278
           ++MAPEV+  +      Y    D+W  G+    L        L    P       LF   
Sbjct: 198 HFMAPEVVKREP-----YGKPVDVWGCGVILFIL--------LSGCLPFYGTKERLFEGI 244

Query: 279 RNAPPRLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
                ++  ++W       K    +  +L+ D  +R    + L HP+++++
Sbjct: 245 IKGKYKMNPRQWSHISESAK--DLVRRMLMLDPAERITVYEALNHPWLKER 293

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  165 bits (419), Expect = 6e-48
 Identities = 45/244 (18%), Positives = 91/244 (37%), Gaps = 28/244 (11%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVTEDEEEEIKLEINVLKKYSNHRNI 114
             +  +     G+++KGR    G    +KV+   D +  +  +   E   L+ +S H N+
Sbjct: 13  NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNV 69

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               GA     PP       L+  +   GS+ +++       + +        ++ RG+ 
Sbjct: 70  LPVLGACQS--PPA--PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 175 YLH--ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           +LH  E  +    +  ++V++ ++   ++    V              +  P W+APE +
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEAL 180

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL---------IPRNAPP 283
              + P+ T    +D+WS  +   E+   + P  DL  M              IP    P
Sbjct: 181 --QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238

Query: 284 RLKS 287
            +  
Sbjct: 239 HVSK 242

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  171 bits (435), Expect = 6e-48
 Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 37/295 (12%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD--------------VTEDEEEEIKLE 101
            +  +  +G+G YG+V   +        AIKV+                 E   EEI  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
           I++LK    H NI   +  F            +LV E+   G + + + +       E  
Sbjct: 97  ISLLKSLD-HPNIIKLFDVFED------KKYFYLVTEFYEGGELFEQIINRH--KFDECD 147

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRN 218
            A I ++IL G+ YLH++ ++HRDIK +N+LL        +K+VDFG+S+   +   +  
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLR 206

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP 278
             +GT Y++APEV+         Y+ + D+WS G+    +    PP    +    +  + 
Sbjct: 207 DRLGTAYYIAPEVL------KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV- 259

Query: 279 RNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQA 330
                      W          I+ +L  DY++R   ++ L   +I+        
Sbjct: 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  165 bits (419), Expect = 7e-48
 Identities = 67/291 (23%), Positives = 123/291 (42%), Gaps = 40/291 (13%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD--VTEDEEEEIKLEINVLKK 107
           Q     +F     +G+G +G V+      +G    IK ++   ++   E+I+ EI VLK 
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTD--LVKSTKGQSLKEEWIAF 164
              H NI   +  F       +D   +++VME C  G + +  +    +G++L E ++A 
Sbjct: 77  LD-HPNIIKIFEVF-------EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           + ++++  L Y H   V+H+D+K +N+L      ++ +K++DFG++              
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA 187

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLG-IT-ALEMAESQPPLCDLHPMRA-----L 274
           GT  +MAPEV             + D+WS G +   L        L    P        +
Sbjct: 188 GTALYMAPEVF------KRDVTFKCDIWSAGVVMYFL--------LTGCLPFTGTSLEEV 233

Query: 275 FLIPRNAPPRLKSKKWP--KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
                   P    +  P   +    ++ +L KD  +RP   Q+L H + + 
Sbjct: 234 QQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (419), Expect = 1e-47
 Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 41/286 (14%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATY 117
            L+E VG G YG+V++G     G+  A+K+    +++    + E+        H NI  +
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVM-LRHENILGF 67

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
             + +         QLWL+  Y   GS+ D ++     +L       I   I  GL +LH
Sbjct: 68  IASDMT--SRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLH 122

Query: 178 E--------NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR----RNTFIGTPY 225
                      + HRD+K +N+L+  N +  + D G++    ++  +     N  +GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 226 WMAPEVIACDENPDA-TYDNRSDLWSLGITALEMA----------ESQPPLCDLHPMRAL 274
           +MAPEV+      D      R D+W+ G+   E+A          + +PP  D+ P    
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 275 FLIPRNA----------PPRLKSKKWPKKFQSFIETVLVKDYHQRP 310
           F   R            P R  S          ++    ++   R 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  164 bits (418), Expect = 2e-47
 Identities = 67/301 (22%), Positives = 118/301 (39%), Gaps = 46/301 (15%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE-IKLEINVLKKYSNHRNIATYYG 119
           +V+G G + +V    +  T Q  A+K+++         +  E+ +L +   HRN+     
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 120 AFIKKSPPGKDDQ--LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH 177
            F        +++   +LV E    GS+       K +   E   + + +++   L +LH
Sbjct: 79  FF--------EEEDRFYLVFEKMRGGSILS--HIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 178 ENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQL-------DRTIGRRNTFIGTPYWM 227
              + HRD+K +N+L       + VK+ DF + + +         +     T  G+  +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 228 APEVIACDENPDATYDNRSDLWSLGI---------------TALEMAESQPPLCDLHPMR 272
           APEV+       + YD R DLWSLG+                  +    +   C      
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 273 ALFLIPRNAPPRLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
            LF   +        K W       K    I  +LV+D  QR    Q+L+HP+++    E
Sbjct: 249 -LFESIQEGKYEFPDKDWAHISCAAK--DLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305

Query: 328 R 328
            
Sbjct: 306 N 306

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  163 bits (415), Expect = 4e-47
 Identities = 69/301 (22%), Positives = 135/301 (44%), Gaps = 44/301 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           +++ E +G G +  V +  H  TG   A K+++   ++  + ++++ E  + +K   H N
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPN 66

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   + +        ++   +LV +    G + + + + +     E   +   ++IL  +
Sbjct: 67  IVRLHDSI------QEESFHYLVFDLVTGGELFEDIVA-RE-FYSEADASHCIQQILESI 118

Query: 174 KYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            Y H N ++HR++K +N+LL      A VKL DFG++ +++ +    + F GTP +++PE
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE 177

Query: 231 VIACDENPDATYDNRSDLWSLG-IT-ALEMAESQPPLCDLHPMRA-----LFLIPRNAPP 283
           V+  D      Y    D+W+ G I   L        L    P        L+   +    
Sbjct: 178 VLKKDP-----YSKPVDIWACGVILYIL--------LVGYPPFWDEDQHRLYAQIKAGAY 224

Query: 284 RLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHI 338
              S +W       K  S I+++L  +  +R   DQ LK P+I ++     + I  +D +
Sbjct: 225 DYPSPEWDTVTPEAK--SLIDSMLTVNPKKRITADQALKVPWICNR-ERVASAIHRQDTV 281

Query: 339 D 339
           D
Sbjct: 282 D 282

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  163 bits (414), Expect = 5e-47
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 24/281 (8%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM---DVTEDEEEEIKLEIN 103
           D W+     I  + + +G+G++G VYKG+        A+K++     T  + +  K E+ 
Sbjct: 17  DDWEIPDGQI-TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVG 72

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           VL+K   H NI  + G      P      L +V ++C   S+   + +++ +  + + + 
Sbjct: 73  VLRKT-RHVNILLFMGYSTA--PQ-----LAIVTQWCEGSSLYHHLHASETK-FEMKKLI 123

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFI 221
            I R+  RG+ YLH   +IHRD+K  N+ L ++  VK+ DFG++ +  R  G        
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-LFLIPRN 280
           G+  WMAPEVI         Y  +SD+++ GI   E+   Q P  +++     + ++ R 
Sbjct: 184 GSILWMAPEVIR--MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 241

Query: 281 A--PPRLKSKKW-PKKFQSFIETVLVKDYHQRPYTDQLLKH 318
           +  P   K +   PK+ +  +   L K   +RP   ++L  
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  164 bits (416), Expect = 7e-47
 Identities = 75/325 (23%), Positives = 121/325 (37%), Gaps = 74/325 (22%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD------VTEDEEEEIKLEINVLKKYSN 110
           + L   +G G+YG V      +T  + AIK+M+      +   + E IK E+ ++KK   
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH- 86

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAG--------------------------- 143
           H NIA  Y  +        +  + LVME C  G                           
Sbjct: 87  HPNIARLYEVY------EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 144 -----------SVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVL 192
                            + +     +E+ I+ I R+I   L YLH   + HRDIK +N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200

Query: 193 LT--DNAEVKLVDFGVSAQLDRT----IGRRNTFIGTPYWMAPEVIACDENPDATYDNRS 246
            +   + E+KLVDFG+S +  +          T  GTPY++APEV+         Y  + 
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES---YGPKC 257

Query: 247 DLWSLGITALEMAESQPPLCDLHPMRA-----LFLIPRNAPPRLKSKKWPKKFQS---FI 298
           D WS G+    +      L    P              N     ++  +          +
Sbjct: 258 DAWSAGVLLHLL------LMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311

Query: 299 ETVLVKDYHQRPYTDQLLKHPFIRD 323
             +L ++  +R    + L+HP+I  
Sbjct: 312 SNLLNRNVDERFDAMRALQHPWISQ 336

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  162 bits (412), Expect = 8e-47
 Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 44/292 (15%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKY 108
           + D    + L   +G G++G+V       T    A K +     ++ +  K EI ++K  
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
             H NI   Y  F       +D+  ++LVME C  G + +  +    +  +E   A I +
Sbjct: 64  D-HPNIIRLYETF-------EDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMK 113

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           ++L  + Y H+  V HRD+K +N L      ++ +KL+DFG++A+         T +GTP
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTP 172

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLG-IT-ALEMAESQPPLCDLHPMRA-----LFLI 277
           Y+++P+V+      +  Y    D WS G +   L        LC   P  A     + L 
Sbjct: 173 YYVSPQVL------EGLYGPECDEWSAGVMMYVL--------LCGYPPFSAPTDSEVMLK 218

Query: 278 PRNAPPRLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
            R        K W       +  S I  +L K   QR  + Q L+H +   Q
Sbjct: 219 IREGTFTFPEKDWLNVSPQAE--SLIRRLLTKSPKQRITSLQALEHEWFEKQ 268

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  164 bits (416), Expect = 2e-46
 Identities = 76/305 (24%), Positives = 139/305 (45%), Gaps = 35/305 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYSNHRNIA 115
               E++G G +GQV+K   T TG   A K++      ++EE+K EI+V+ +  +H N+ 
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLI 149

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
             Y AF  K      + + LVMEY   G + D +   +  +L E       ++I  G+++
Sbjct: 150 QLYDAFESK------NDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRH 202

Query: 176 LHENKVIHRDIKGQNVLLT--DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +H+  ++H D+K +N+L    D  ++K++DFG++ +      +     GTP ++APEV+ 
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVN 261

Query: 234 CDENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA-----LFLIPRNAPPRLK 286
            D          +D+WS+G+ A  L        L  L P                   L+
Sbjct: 262 YDF-----VSFPTDMWSVGVIAYML--------LSGLSPFLGDNDAETLNNILACRWDLE 308

Query: 287 SKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKK 343
            +++    +    FI  +L+K+   R    + LKHP++ D     +   Q K +  +  +
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQ 368

Query: 344 RKKER 348
               +
Sbjct: 369 DFVTK 373

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  162 bits (412), Expect = 4e-46
 Identities = 53/359 (14%), Positives = 115/359 (32%), Gaps = 45/359 (12%)

Query: 1   MENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELI 60
           + NP D            +L   L K +  +    E +            +  + +  + 
Sbjct: 18  VGNPWDDKL-------IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVH 70

Query: 61  EVVGNGTYGQVYKGRH-----TKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIA 115
            ++G G + QVY+         K  Q   +KV       E  I  ++    K S      
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV---KSTKGQSLKEEWIAFICREILRG 172
            +Y A + +      +   LV E    G++ + +   K+T  + + +  +      +L  
Sbjct: 131 KFYSAHLFQ------NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184

Query: 173 LKYLHENKVIHRDIKGQNVLLTD-----------NAEVKLVDFGVSAQLD--RTIGRRNT 219
           ++ +H+ ++IH DIK  N +L +           +A + L+D G S  +           
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR 279
              T  +   E+++     +  ++ + D + +  T   M      L   +          
Sbjct: 245 KCETSGFQCVEMLS-----NKPWNYQIDYFGVAATVYCM------LFGTYMKVKNEGGEC 293

Query: 280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHI 338
                 +       +  F   +L         +  LL+    +        +I+   + 
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNR 352

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  163 bits (414), Expect = 5e-46
 Identities = 68/298 (22%), Positives = 123/298 (41%), Gaps = 25/298 (8%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGA 120
           +V+G G  G+V +  + +T +  A+K++        E+     +  + S   +I      
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV----ELHWRASQCPHIVRIVDV 123

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           +  ++       L +VME    G +   ++    Q+  E   + I + I   ++YLH   
Sbjct: 124 Y--ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181

Query: 181 VIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           + HRD+K +N+L T    NA +KL DFG + +         T   TPY++APEV+  +  
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPE-- 238

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---ALFLIPRNAPPRLKSKKWPK-- 292
               YD   D+WSLG+    +    PP    H +     +    R       + +W +  
Sbjct: 239 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 293 ---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKE 347
              K    I  +L  +  QR    + + HP+I       Q  +     +   K+R ++
Sbjct: 296 EEVK--MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  161 bits (410), Expect = 6e-46
 Identities = 73/319 (22%), Positives = 120/319 (37%), Gaps = 42/319 (13%)

Query: 25  DKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAA 84
              L D I  +       G P    +     I  L E +G G +G+V++G+    G+  A
Sbjct: 13  GTTLKDLIYDMTTSGSGSGLPLLVQRTIARTI-VLQESIGKGRFGEVWRGKWR--GEEVA 69

Query: 85  IKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS 144
           +K+    E+     + EI        H NI  +  A  K    G   QLWLV +Y   GS
Sbjct: 70  VKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNK--DNGTWTQLWLVSDYHEHGS 126

Query: 145 VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN--------KVIHRDIKGQNVLLTDN 196
           + D +      ++  E +  +      GL +LH           + HRD+K +N+L+  N
Sbjct: 127 LFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183

Query: 197 AEVKLVDFGVSAQLDRTIGRR----NTFIGTPYWMAPEVIACDENP-DATYDNRSDLWSL 251
               + D G++ + D          N  +GT  +MAPEV+    N        R+D++++
Sbjct: 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243

Query: 252 GITALEMA----------ESQPPLCDLHPMRALFLIPRNA----------PPRLKSKKWP 291
           G+   E+A          + Q P  DL P        R            P R +S +  
Sbjct: 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL 303

Query: 292 KKFQSFIETVLVKDYHQRP 310
           +     +      +   R 
Sbjct: 304 RVMAKIMRECWYANGAARL 322

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  160 bits (407), Expect = 7e-46
 Identities = 68/302 (22%), Positives = 126/302 (41%), Gaps = 51/302 (16%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD------------------------- 89
             + L + +G G+YG V    +       A+KV+                          
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 90  --VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIK-----KSPPGKDDQLWLVMEYCGA 142
                   E++  EI +LKK  +H N+       +K       P   +D L++V E    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKL-DHPNV-------VKLVEVLDDP--NEDHLYMVFELVNQ 122

Query: 143 GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV 202
           G V ++        L E+   F  +++++G++YLH  K+IHRDIK  N+L+ ++  +K+ 
Sbjct: 123 GPVMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA 179

Query: 203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNR-SDLWSLGITALEMAES 261
           DFGVS +   +    +  +GTP +MAPE ++        +  +  D+W++G+T       
Sbjct: 180 DFGVSNEFKGSDALLSNTVGTPAFMAPESLS---ETRKIFSGKALDVWAMGVTLYCFVFG 236

Query: 262 QPPLCDLHPMRALFLIPRNAPPRLKSKKW-PKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
           Q P  D   +  L    ++       +    +  +  I  +L K+   R    ++  HP+
Sbjct: 237 QCPFMDER-IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

Query: 321 IR 322
           + 
Sbjct: 296 VT 297

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  166 bits (422), Expect = 9e-46
 Identities = 67/360 (18%), Positives = 136/360 (37%), Gaps = 35/360 (9%)

Query: 2   ENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIE 61
            + +        DE+   +  K     +      +        P +   +     +++ E
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-EEIKLEINVLKKYSNHRNIATYYGA 120
            +G G +G V++     TG   A K +    + + E ++ EI  +     H  +   + A
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDA 222

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           F        D+++ ++ E+   G + + V       + E+      R++ +GL ++HEN 
Sbjct: 223 FED------DNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 181 VIHRDIKGQNVLLTDNAE--VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP 238
            +H D+K +N++ T      +KL+DFG++A LD          GT  + APEV       
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGK--- 331

Query: 239 DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-----LFLIPRNAPPRLKSKKWPKK 293
                  +D+WS+G+ +  +      L  L P             ++    +    +   
Sbjct: 332 --PVGYYTDMWSVGVLSYIL------LSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 383

Query: 294 FQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARI----QLKDHIDTCKKRKK 346
            +    FI  +L+ D + R    Q L+HP++       +       +     D+ K +  
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  158 bits (402), Expect = 1e-45
 Identities = 64/255 (25%), Positives = 106/255 (41%), Gaps = 44/255 (17%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-----EEIKLEINVLKKYSNHR 112
            L E++G G +G+VY+      G   A+K      DE+     E ++ E  +      H 
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI    G  +K+        L LVME+   G +  ++    G+ +  + +     +I RG
Sbjct: 67  NIIALRGVCLKEPN------LCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARG 117

Query: 173 LKYLHENK---VIHRDIKGQNVLLT--------DNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           + YLH+     +IHRD+K  N+L+          N  +K+ DFG++ +  RT   + +  
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAA 175

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL----- 276
           G   WMAPEVI         +   SD+WS G+   E+   + P   +  +   +      
Sbjct: 176 GAYAWMAPEVIRAS-----MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230

Query: 277 ----IPRNAPPRLKS 287
               IP   P     
Sbjct: 231 LALPIPSTCPEPFAK 245

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  160 bits (407), Expect = 2e-45
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 29/291 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +E+ E +G G+Y    +  H  T    A+K++D     + +   EI +L +Y  H NI T
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTEEIEILLRYGQHPNIIT 80

Query: 117 YYGAFIKKSPPGKDDQ--LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
               +        DD   +++V E    G + D  K  + +   E   + +   I + ++
Sbjct: 81  LKDVY--------DDGKYVYVVTELMKGGELLD--KILRQKFFSEREASAVLFTITKTVE 130

Query: 175 YLHENKVIHRDIKGQNVLLTDNAE----VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           YLH   V+HRD+K  N+L  D +     +++ DFG + QL    G   T   T  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM--RALFLIPRNAPPRLKSK 288
           V+         YD   D+WSLG+    M     P  +        +     +    L   
Sbjct: 191 VLERQG-----YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245

Query: 289 KWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKD 336
            W     +    +  +L  D HQR     +L+HP+I       Q ++  +D
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  161 bits (408), Expect = 2e-45
 Identities = 47/309 (15%), Positives = 97/309 (31%), Gaps = 46/309 (14%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIAT 116
            V+G        +    +TG+   + V   TE    +  +++K E+  L+     +N   
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 117 YYG-----------------AFIKKSPPGKDD---QLWLVMEYCGAGSVTDLV-----KS 151
                                 I+     +D      + +       ++          S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHS 197

Query: 152 TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
           +  +SL       +  +++R L  LH   ++H  ++  +++L     V L  F       
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---- 253

Query: 212 RTIGRRNTFIGTPYWMAPEVIAC------DENPDATYDNRSDLWSLGITALEMAESQPPL 265
              G R     +  +  PE+ A         +         D W+LG+    +  +  P+
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 266 CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP 325
                +     I R+    +     P+  ++ +E  L      R    Q ++ P      
Sbjct: 314 TKDAALGGSEWIFRS-CKNI-----PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367

Query: 326 TERQARIQL 334
           TE  A + L
Sbjct: 368 TELSAALPL 376

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  159 bits (404), Expect = 3e-45
 Identities = 69/311 (22%), Positives = 134/311 (43%), Gaps = 46/311 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-------TEDEEEEIKLEINVLKKYS 109
           +++ E +G+G +  V K R   TG   A K +              EEI+ E+++L++  
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H N+ T +  +  +        + L++E    G + D +   + +SL EE      ++I
Sbjct: 74  -HHNVITLHDVYENR------TDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQI 124

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           L G+ YLH  K+ H D+K +N++L         +KL+DFG++ +++          GTP 
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPE 183

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA-----LFLIP 278
           ++APE++  +          +D+WS+G+    L        L    P             
Sbjct: 184 FVAPEIVNYEP-----LGLEADMWSIGVITYIL--------LSGASPFLGDTKQETLANI 230

Query: 279 RNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLK 335
            +       + +    +    FI  +LVK+  +R    + L+HP+I   P + Q  +  +
Sbjct: 231 TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI--TPVDNQQAMVRR 288

Query: 336 DHIDTCKKRKK 346
           + +   +  +K
Sbjct: 289 ESVVNLENFRK 299

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (399), Expect = 2e-44
 Identities = 75/318 (23%), Positives = 134/318 (42%), Gaps = 46/318 (14%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD-------VTEDEEEEIKLEI 102
           QE+    ++  E +G+G +  V K R   TG   A K +              E+I+ E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 103 NVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWI 162
           ++LK+   H N+ T +  +  K        + L++E    G + D +   + +SL EE  
Sbjct: 66  SILKEIQ-HPNVITLHEVYENK------TDVILILELVAGGELFDFL--AEKESLTEEEA 116

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLDRTIGRRN 218
               ++IL G+ YLH  ++ H D+K +N++L         +K++DFG++ ++D       
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK 175

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA--- 273
              GTP ++APE++  +          +D+WS+G+    L        L    P      
Sbjct: 176 NIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYIL--------LSGASPFLGDTK 222

Query: 274 --LFLIPRNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
                         + + +         FI  +LVKD  +R      L+HP+I  +P + 
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI--KPKDT 280

Query: 329 QARIQLKDHIDTCKKRKK 346
           Q  +  K      +K KK
Sbjct: 281 QQALSRKASAVNMEKFKK 298

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  158 bits (401), Expect = 2e-44
 Identities = 66/286 (23%), Positives = 129/286 (45%), Gaps = 43/286 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           +++ E +G G +  V +  H  TG   A K+++   ++  + ++++ E  + +K   H N
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPN 89

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   + +        ++   +LV +    G + + + + +     E   +   ++IL  +
Sbjct: 90  IVRLHDSI------QEESFHYLVFDLVTGGELFEDIVA-RE-FYSEADASHCIQQILESI 141

Query: 174 KYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            Y H N ++HR++K +N+LL      A VKL DFG++ +++ +    + F GTP +++PE
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE 200

Query: 231 VIACDENPDATYDNRSDLWSLG-IT-ALEMAESQPPLCDLHPMRA-----LFLIPRNAPP 283
           V+  D      Y    D+W+ G I   L        L    P        L+   +    
Sbjct: 201 VLKKDP-----YSKPVDIWACGVILYIL--------LVGYPPFWDEDQHRLYAQIKAGAY 247

Query: 284 RLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
              S +W       K  S I+++L  +  +R   DQ LK P+I ++
Sbjct: 248 DYPSPEWDTVTPEAK--SLIDSMLTVNPKKRITADQALKVPWICNR 291

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  159 bits (403), Expect = 2e-44
 Identities = 42/307 (13%), Positives = 94/307 (30%), Gaps = 35/307 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
                V+G        +    +TG+   + V         +  +++K E+  L+     +
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 113 NIATYYGAFIKKSPP---------------GKDDQLWLVMEY----CGAGSVTDLVKS-- 151
           N            P                  +  +W++  +        ++    +   
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 152 ---TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA 208
              +  +SL       +  +++R L  LH   ++H  ++  +++L     V L  F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 209 QL-DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           +     +         P   A  ++   ++         D W+LG+    +  +  P  D
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 268 LHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
              +     I R+          P+  ++ +E  L      R    Q ++ P      TE
Sbjct: 320 DAALGGSEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373

Query: 328 RQARIQL 334
             A + L
Sbjct: 374 LSAALPL 380

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  157 bits (398), Expect = 3e-44
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
            +L+E++G G YG VYKG      +  A+KV      +    +  I  +     H NIA 
Sbjct: 15  LKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPL-MEHDNIAR 71

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
           +     + +  G+  +  LVMEY   GS+   +      +        +   + RGL YL
Sbjct: 72  FIVGDERVTADGRM-EYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYL 127

Query: 177 HE---------NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--------NT 219
           H            + HRD+  +NVL+ ++    + DFG+S +L      R         +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187

Query: 220 FIGTPYWMAPEVI--ACDENPDATYDNRSDLWSLGITALEMA---ESQPPLCDLHPMRAL 274
            +GT  +MAPEV+  A +     +   + D+++LG+   E+        P   +   +  
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247

Query: 275 F 275
           F
Sbjct: 248 F 248

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  157 bits (398), Expect = 4e-44
 Identities = 83/319 (26%), Positives = 140/319 (43%), Gaps = 33/319 (10%)

Query: 37  KRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE 96
                + W +   ++  +  FE+   +G G    VY+ +   T +  A+KV+  T D++ 
Sbjct: 35  ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI 94

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
            ++ EI VL + S H NI      F          ++ LV+E    G + D +   KG  
Sbjct: 95  -VRTEIGVLLRLS-HPNIIKLKEIFETP------TEISLVLELVTGGELFDRIVE-KG-Y 144

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRT 213
             E   A   ++IL  + YLHEN ++HRD+K +N+L      +A +K+ DFG+S  ++  
Sbjct: 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204

Query: 214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA 273
                T  GTP + APE++         Y    D+WS+GI    +     P  D    + 
Sbjct: 205 -VLMKTVCGTPGYCAPEILRGC-----AYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258

Query: 274 LFLIPRNAPPRLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
           +F    N      S  W +     K    +  ++V D  +R  T Q L+HP++  +    
Sbjct: 259 MFRRILNCEYYFISPWWDEVSLNAK--DLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316

Query: 329 QARIQLKDHIDTCKKRKKE 347
                   H+DT +K+ +E
Sbjct: 317 V-------HMDTAQKKLQE 328

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  155 bits (393), Expect = 5e-44
 Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 44/288 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD-------VTEDEEEEIKLEINVLKKYS 109
           +E+ E +G+G +  V K R   TG+  A K +              EEI+ E+N+L++  
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI T +  F  K        + L++E    G + D +   K  SL E+      ++I
Sbjct: 67  -HPNIITLHDIFENK------TDVVLILELVSGGELFDFLAE-KE-SLTEDEATQFLKQI 117

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           L G+ YLH  ++ H D+K +N++L      N  +KL+DFG++ +++          GTP 
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPE 176

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA-----LFLIP 278
           ++APE++  +          +D+WS+G+    L        L    P             
Sbjct: 177 FVAPEIVNYEP-----LGLEADMWSIGVITYIL--------LSGASPFLGETKQETLTNI 223

Query: 279 RNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRD 323
                    + +    +    FI  +LVKD  +R    Q L+H +I+ 
Sbjct: 224 SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  155 bits (394), Expect = 7e-44
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 40/285 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+  +++G G++  V   R   T +  AIK+++    + E++   +  E +V+ +  +H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR-LDHP 90

Query: 113 NIATYYGAFIKKSPPGKD-DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
                Y  F       +D ++L+  + Y   G +   ++  K  S  E    F   EI+ 
Sbjct: 91  FFVKLYFTF-------QDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVS 141

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAP 229
            L+YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N+F+GT  +++P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK- 288
           E++      + +    SDLW+LG    ++    PP    +       I       +K + 
Sbjct: 202 ELLT-----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-------IKLEY 249

Query: 289 KWPKKF----QSFIETVLVKDYHQRP------YTDQLLKHPFIRD 323
            +P+KF    +  +E +LV D  +R           L  HPF   
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  158 bits (402), Expect = 7e-44
 Identities = 60/285 (21%), Positives = 119/285 (41%), Gaps = 42/285 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           ++L E +G G +  V +      GQ  A  +++   ++  + ++++ E  + +    H N
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPN 71

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   + +        ++   +L+ +    G + + + + +     E   +   ++IL  +
Sbjct: 72  IVRLHDSI------SEEGHHYLIFDLVTGGELFEDIVA-RE-YYSEADASHCIQQILEAV 123

Query: 174 KYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            + H+  V+HR++K +N+LL      A VKL DFG++ +++        F GTP +++PE
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183

Query: 231 VIACDENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA-----LFLIPRNAPP 283
           V+  D      Y    DLW+ G+    L        L    P        L+   +    
Sbjct: 184 VLRKDP-----YGKPVDLWACGVILYIL--------LVGYPPFWDEDQHRLYQQIKAGAY 230

Query: 284 RLKSKKWPK-----KFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
              S +W       K    I  +L  +  +R    + LKHP+I  
Sbjct: 231 DFPSPEWDTVTPEAK--DLINKMLTINPSKRITAAEALKHPWISH 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  155 bits (393), Expect = 9e-44
 Identities = 64/308 (20%), Positives = 129/308 (41%), Gaps = 34/308 (11%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD-----VTEDEEEEIKLEINVLKKYS 109
           G + + +++G G+YG+V +   ++T    A+K++         + E  +K EI +L++  
Sbjct: 5   GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL- 63

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H+N+         +       ++++VMEYC  G    L    + +            ++
Sbjct: 64  RHKNVIQLVDVLYNEEK----QKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQL 118

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD--RTIGRRNTFIGTPYWM 227
           + GL+YLH   ++H+DIK  N+LLT    +K+   GV+  L          T  G+P + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 228 APEVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPR 279
            PE+    +    T+   + D+WS G+T   +     P    +         +  + IP 
Sbjct: 179 PPEIANGLD----TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234

Query: 280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHID 339
           +  P L            ++ +L  +  +R    Q+ +H + R +    +A + +    D
Sbjct: 235 DCGPPLS---------DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD 285

Query: 340 TCKKRKKE 347
           T  + +  
Sbjct: 286 TKDRWRSM 293

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  155 bits (394), Expect = 2e-43
 Identities = 70/311 (22%), Positives = 133/311 (42%), Gaps = 46/311 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-------TEDEEEEIKLEINVLKKYS 109
           +++ E +G+G +  V K R   TG   A K +              EEI+ E+++L++  
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI T +  +  +        + L++E    G + D +   + +SL EE      ++I
Sbjct: 74  -HPNIITLHDVYENR------TDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQI 124

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLT----DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           L G+ YLH  K+ H D+K +N++L         +KL+DFG++ +++          GTP 
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPE 183

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITA--LEMAESQPPLCDLHPMRA-----LFLIP 278
           ++APE++  +          +D+WS+G+    L        L    P             
Sbjct: 184 FVAPEIVNYEP-----LGLEADMWSIGVITYIL--------LSGASPFLGDTKQETLANI 230

Query: 279 RNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLK 335
                    + + +  +    FI  +LVK+  +R    + L+HP+I     + Q  +  +
Sbjct: 231 TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV--DTQQAMVRR 288

Query: 336 DHIDTCKKRKK 346
           + +   +  KK
Sbjct: 289 ESVVNLENFKK 299

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  152 bits (387), Expect = 5e-42
 Identities = 69/272 (25%), Positives = 127/272 (46%), Gaps = 25/272 (9%)

Query: 2   ENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQ-EDPAGIFELI 60
           +   D    +  D +   L +  +K++D+F++    +       + R + ED    +E++
Sbjct: 23  DCLLDGLDALVYDLDFPALRK--NKNIDNFLS--RYKDTINKIRDLRMKAED----YEVV 74

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +V+G G +G+V   RH  T ++ A+K++     +   +      E +++   +N   +  
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSPWVVQ 133

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + AF  +        L++VMEY   G   DLV       + E+W  F   E++  L  +
Sbjct: 134 LFYAF--QDD----RYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAI 184

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR-NTFIGTPYWMAPEVIACD 235
           H    IHRD+K  N+LL  +  +KL DFG   ++++    R +T +GTP +++PEV+   
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK-S 243

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           +  D  Y    D WS+G+   EM     P   
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  152 bits (387), Expect = 8e-42
 Identities = 74/333 (22%), Positives = 138/333 (41%), Gaps = 35/333 (10%)

Query: 6   DSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGI--FELIEVV 63
           D    +Y +   + L    +K++ +++   +  +        + ++       FE+++V+
Sbjct: 32  DILICLYDECNNSPLRR--EKNILEYLEWAKPFT-------SKVKQMRLHREDFEILKVI 82

Query: 64  GNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYYG 119
           G G +G+V   +     ++ A+K+++    +   E    + E +VL    + + I T + 
Sbjct: 83  GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLHY 141

Query: 120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREILRGLKYLH 177
           AF        D+ L+LVM+Y   G   DL+   S     L EE   F   E++  +  +H
Sbjct: 142 AF------QDDNNLYLVMDYYVGG---DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192

Query: 178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEVIACDE 236
           +   +HRDIK  N+L+  N  ++L DFG   +L      + +  +GTP +++PE++   E
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252

Query: 237 NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF-- 294
                Y    D WSLG+   EM   + P      +     I  N   R +          
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHKERFQFPTQVTDVSE 311

Query: 295 --QSFIETVLVKDYHQRPYTD--QLLKHPFIRD 323
             +  I  ++    H+          KHPF   
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  152 bits (386), Expect = 9e-42
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 30/278 (10%)

Query: 1   MENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGI--FE 58
           +E   D    V+ +   +ELA+  DK + DF+   E           R +E       FE
Sbjct: 14  LEPLLDLLLGVHQELGASELAQ--DKYVADFLQWAEPIV-------VRLKEVRLQRDDFE 64

Query: 59  LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNI 114
           +++V+G G + +V   +  +TGQ+ A+K+M+    +   E    + E +VL    + R I
Sbjct: 65  ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRRWI 123

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREILRG 172
              + AF  +      + L+LVMEY   G   DL+   S  G+ +  E   F   EI+  
Sbjct: 124 TQLHFAF--QDE----NYLYLVMEYYVGG---DLLTLLSKFGERIPAEMARFYLAEIVMA 174

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT-IGRRNTFIGTPYWMAPEV 231
           +  +H    +HRDIK  N+LL     ++L DFG   +L      R    +GTP +++PE+
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234

Query: 232 IAC--DENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
           +          +Y    D W+LG+ A EM   Q P   
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  149 bits (379), Expect = 9e-42
 Identities = 79/312 (25%), Positives = 119/312 (38%), Gaps = 61/312 (19%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL------EINVLK--KY 108
           +E +  +G G YG VYK R   +G   A+K + V         L      E+ +L+  + 
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK---STKGQSLKEEWIAFI 165
             H N+              ++ ++ LV E+       DL           L  E I  +
Sbjct: 71  FEHPNVVRLMDVCATSRT-DREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 125

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP- 224
            R+ LRGL +LH N ++HRD+K +N+L+T    VKL DFG    L R    +     TP 
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG----LARIYSYQMAL--TPV 179

Query: 225 -----YWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLI- 277
                Y  APEV+       +TY    D+WS+G I A EM   +P  C       L  I 
Sbjct: 180 VVTLWYR-APEVLLQ-----STYATPVDMWSVGCIFA-EMFRRKPLFCGNSEADQLGKIF 232

Query: 278 -----------------PRNAPPRLKSKKWPKKFQSF-------IETVLVKDYHQRPYTD 313
                            PR A P    +                +  +L  + H+R    
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292

Query: 314 QLLKHPFIRDQP 325
           + L+H ++    
Sbjct: 293 RALQHSYLHKDE 304

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  150 bits (380), Expect = 9e-42
 Identities = 72/332 (21%), Positives = 135/332 (40%), Gaps = 39/332 (11%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---------VTEDEEEEIKLEINVL 105
             +  +  +G+G +G V+     +  +   +K +          + + +  ++ LEI +L
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLV-KSTKGQSLKEEWIAF 164
                H NI      F  +          LVME  G+G   DL     +   L E   ++
Sbjct: 84  S-RVEHANIIKVLDIFENQG------FFQLVMEKHGSGL--DLFAFIDRHPRLDEPLASY 134

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           I R+++  + YL    +IHRDIK +N+++ ++  +KL+DFG +A L+R      TF GT 
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTI 193

Query: 225 YWMAPEVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIPRNAP 282
            + APEV+  +      Y     ++WSLG+T   +   + P C+L   + A    P    
Sbjct: 194 EYCAPEVLMGNP-----YRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVS 248

Query: 283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR---DQPTERQARIQLKDHID 339
             L          S +  +L     +R   ++L+  P++    +        +   +  +
Sbjct: 249 KELM---------SLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPE 299

Query: 340 TCKKRKKERDDYRYSGSENEEEETGVGGEPSS 371
           +        +    S S+  + +   GGE   
Sbjct: 300 SGVLSAASLEMGNRSLSDVAQAQELCGGEGHH 331

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  148 bits (377), Expect = 3e-41
 Identities = 75/344 (21%), Positives = 134/344 (38%), Gaps = 65/344 (18%)

Query: 37  KRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE 96
             S       +         +E + +VG G+YG V K R+  TG++ AIK   +  D+++
Sbjct: 7   HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65

Query: 97  EIKL----EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-- 150
            +K     EI +LK+   H N+        KK       + +LV E+        ++   
Sbjct: 66  MVKKIAMREIKLLKQL-RHENLVNLLEVCKKKK------RWYLVFEFVD----HTILDDL 114

Query: 151 STKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL 210
                 L  + +     +I+ G+ + H + +IHRDIK +N+L++ +  VKL DFG     
Sbjct: 115 ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG----F 170

Query: 211 DRTIG-RRNTFIGTPY----WM-APEVIACDENPDATYDNRSDLWSLG-ITALEMAESQP 263
            RT+      +         W  APE++  D      Y    D+W++G +   EM   +P
Sbjct: 171 ARTLAAPGEVY--DDEVATRWYRAPELLVGDVK----YGKAVDVWAIGCLVT-EMFMGEP 223

Query: 264 --------------------------PLCDLHPMRALFLIPRNAPPRLKSKKWPK---KF 294
                                      L + +P+ A   +P         +++PK     
Sbjct: 224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV 283

Query: 295 QSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHI 338
               +  L  D  +RP+  +LL H F +      +   +L+  +
Sbjct: 284 IDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKV 327

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  145 bits (369), Expect = 1e-40
 Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 24/276 (8%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHR 112
             ++L++ +G G YG+V    +  T +  A+K++D+    D  E IK EI + K   NH 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 65

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREILR 171
           N+  +YG   ++      +  +L +EYC  G + D +        + E        +++ 
Sbjct: 66  NVVKFYG--HRREG----NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA 116

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA--QLDRTIGRRNTFIGTPYWMAP 229
           G+ YLH   + HRDIK +N+LL +   +K+ DFG++   + +      N   GT  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 230 EVIACDENPDATYD-NRSDLWSLGIT--ALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           E++   E     +     D+WS GI   A+ +A   P        +              
Sbjct: 177 ELLKRRE-----FHAEPVDVWSCGIVLTAM-LAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
            KK      + +  +LV++   R     + K  +  
Sbjct: 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  146 bits (370), Expect = 2e-40
 Identities = 71/311 (22%), Positives = 125/311 (40%), Gaps = 65/311 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +E I  +G G+YG V+K R+  TGQ+ AIK   +  +++  IK     EI +LK+   H 
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQL-KHP 62

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREIL 170
           N+      F       +  +L LV EYC       ++       + + E  +  I  + L
Sbjct: 63  NLVNLLEVF------RRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTL 112

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTPY---- 225
           + + + H++  IHRD+K +N+L+T ++ +KL DFG      R +    + +         
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG----FARLLTGPSDYY--DDEVATR 166

Query: 226 WM-APEVIACDENPDATYDNRSDLWSLG-ITALEMAESQP-------------------- 263
           W  +PE++  D      Y    D+W++G + A E+    P                    
Sbjct: 167 WYRSPELLVGDTQ----YGPPVDVWAIGCVFA-ELLSGVPLWPGKSDVDQLYLIRKTLGD 221

Query: 264 ------PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS---FIETVLVKDYHQRPYTDQ 314
                  +   +   +   IP          K+P         ++  L  D  +R   +Q
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281

Query: 315 LLKHPFIRDQP 325
           LL HP+  +  
Sbjct: 282 LLHHPYFENIR 292

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  146 bits (372), Expect = 3e-40
 Identities = 86/346 (24%), Positives = 136/346 (39%), Gaps = 69/346 (19%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +E +  +G GT+G+V+K RH KTGQ  A+K + + E+E+E   +    EI +L+    H 
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQL-LKHE 76

Query: 113 NIATYYGAFIKKSPPGKDDQ--LWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICRE 168
           N+         K+ P    +  ++LV ++C      DL    S          I  + + 
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFC----EHDLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY--- 225
           +L GL Y+H NK++HRD+K  NVL+T +  +KL DFG    L R            Y   
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG----LARAFSLAKNSQPNRYTNR 188

Query: 226 ----WM-APEVIACDENPDATYDNRSDLWSLG-ITALEMAESQP---------------- 263
               W   PE++  + +    Y    DLW  G I A EM    P                
Sbjct: 189 VVTLWYRPPELLLGERD----YGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQLALISQ 243

Query: 264 ----------PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS-----FIETVLVKDYHQ 308
                     P  D + +     + +    ++K  +     +       I+ +LV D  Q
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVK-DRLKAYVRDPYALDLIDKLLVLDPAQ 302

Query: 309 RPYTDQLLKHPFIRDQPTERQARIQLKDHIDTC-----KKRKKERD 349
           R  +D  L H F    P     +  L  H+ +        R+K   
Sbjct: 303 RIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHH 348

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  145 bits (367), Expect = 3e-40
 Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 46/298 (15%)

Query: 61  EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGA 120
           +V+G G  G+V +  + +T +  A+K++        E+     +  + S   +I      
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV----ELHWRASQCPHIVRIVDV 79

Query: 121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK 180
           +  ++       L +VME    G +   ++    Q+  E   + I + I   ++YLH   
Sbjct: 80  Y--ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137

Query: 181 VIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           + HRD+K +N+L T    NA +KL DFG                      A E       
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAKETTGEK-- 174

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---ALFLIPRNAPPRLKSKKWPK-- 292
               YD   D+WSLG+    +    PP    H +     +    R       + +W +  
Sbjct: 175 ----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230

Query: 293 ---KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKE 347
              K    I  +L  +  QR    + + HP+I       Q  +     +   K+R ++
Sbjct: 231 EEVK--MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 286

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  145 bits (368), Expect = 5e-40
 Identities = 79/325 (24%), Positives = 146/325 (44%), Gaps = 45/325 (13%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNH 111
           G + L++ +G G + +V   RH  TG+  AIK++D   +     +++  E+ ++K   NH
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NH 73

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREIL 170
            NI   +     +        L+L+MEY   G V D LV   +   +KE+      R+I+
Sbjct: 74  PNIVKLFEVIETEK------TLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIV 124

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
             ++Y H+ +++HRD+K +N+LL  +  +K+ DFG S +     G+ + F G P + APE
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPE 183

Query: 231 VIACDENPDATYD-NRSDLWSLGITALEMAESQPP-----LCDLHP--MRALFLIPRNAP 282
           +    +     YD    D+WSLG+    +     P     L +L    +R  + IP    
Sbjct: 184 LFQGKK-----YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR--------DQPTERQARIQL 334
              +         + ++  LV +  +R   +Q++K  +I             E +  I  
Sbjct: 239 TDCE---------NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 289

Query: 335 KDHIDTCKKRKKERDDYRYSGSENE 359
           +  ID        +++ + S S+ +
Sbjct: 290 QKRIDIMVGMGYSQEEIQESLSKMK 314

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  144 bits (366), Expect = 9e-40
 Identities = 81/322 (25%), Positives = 128/322 (39%), Gaps = 61/322 (18%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTK-TGQLAAIKVMDVTEDEEEEIKL---- 100
           E          +E +  +G G YG+V+K R  K  G+  A+K + V +  EE + L    
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIR 60

Query: 101 EINVLK--KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK---STKGQ 155
           E+ VL+  +   H N+   +          ++ +L LV E+       DL          
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRT-DRETKLTLVFEHVD----QDLTTYLDKVPEP 115

Query: 156 SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG 215
            +  E I  +  ++LRGL +LH ++V+HRD+K QN+L+T + ++KL DFG    L R   
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG----LARIYS 171

Query: 216 RRNTFIGTP------YWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDL 268
            +     T       Y  APEV+       ++Y    DLWS+G I A EM   +P     
Sbjct: 172 FQMAL--TSVVVTLWYR-APEVLLQ-----SSYATPVDLWSVGCIFA-EMFRRKPLFRGS 222

Query: 269 HPMRALFLI------------------PRNAPPRLKSKKWPKKFQSF-------IETVLV 303
             +  L  I                  PR A     ++   K            +   L 
Sbjct: 223 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 282

Query: 304 KDYHQRPYTDQLLKHPFIRDQP 325
            +  +R      L HP+ +D  
Sbjct: 283 FNPAKRISAYSALSHPYFQDLE 304

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  149 bits (377), Expect = 1e-39
 Identities = 82/345 (23%), Positives = 137/345 (39%), Gaps = 42/345 (12%)

Query: 4   PKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDR-----WQED-PAGI- 56
             ++  +         L + L + +   +     + + +     R     W E  P G  
Sbjct: 127 DAETVARA-RAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGED 185

Query: 57  -FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNH 111
            F    V+G G +G+V+  +   TG+L A K ++          +   +E  +L K  + 
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK-VHS 244

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL-----VKSTKGQSLKEEWIAFIC 166
           R I +   AF  K        L LVM     G   D+              +E    F  
Sbjct: 245 RFIVSLAYAFETK------TDLCLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            +I+ GL++LH+  +I+RD+K +NVLL D+  V++ D G++ +L     +   + GTP +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD---LHPMRALFLIPRNAPP 283
           MAPE++         YD   D ++LG+T  EM  ++ P          + L         
Sbjct: 356 MAPELLL-----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
                K+    + F E +L KD  +R        D L  HP  RD
Sbjct: 411 TY-PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  144 bits (365), Expect = 1e-39
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 48/287 (16%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD-------VTEDEEEEIKLEINVLKK 107
             +++  ++G+G +G VY G         AIK ++               + +E+ +LKK
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 108 YSN-HRNIATYYGAFIKKSPPGKDDQLWLVMEYC-GAGSVTDLVKSTKGQSLKEEWIAFI 165
            S+    +      F +       D   L++E       + D +  T+  +L+EE     
Sbjct: 103 VSSGFSGVIRLLDWFERP------DSFVLILERPEPVQDLFDFI--TERGALQEELARSF 154

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
             ++L  +++ H   V+HRDIK +N+L+  +  E+KL+DFG  A L         F GT 
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTR 212

Query: 225 YWMAPEVIACDENPDATYDNRS-DLWSLGITALEMAESQPPLCDLHP-------MRALFL 276
            +  PE I         Y  RS  +WSLGI   +M      +C   P       +R    
Sbjct: 213 VYSPPEWIRYHR-----YHGRSAAVWSLGILLYDM------VCGDIPFEHDEEIIRGQVF 261

Query: 277 IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
             +               Q  I   L      RP  +++  HP+++D
Sbjct: 262 FRQRVSSEC---------QHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  143 bits (362), Expect = 4e-39
 Identities = 71/323 (21%), Positives = 130/323 (40%), Gaps = 27/323 (8%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHR 112
             ++L++ +G G YG+V    +  T +  A+K++D+    D  E IK EI + K   NH 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 65

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREILR 171
           N+  +YG   ++      +  +L +EYC  G + D +        + E        +++ 
Sbjct: 66  NVVKFYG--HRREG----NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA 116

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA--QLDRTIGRRNTFIGTPYWMAP 229
           G+ YLH   + HRDIK +N+LL +   +K+ DFG++   + +      N   GT  ++AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 230 EVIACDENPDATYD-NRSDLWSLGIT--ALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           E++   E     +     D+WS GI   A+ +A   P        +              
Sbjct: 177 ELLKRRE-----FHAEPVDVWSCGIVLTAM-LAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR---DQPTERQARIQLKDHIDTCKK 343
            KK      + +  +LV++   R     + K  +      +  +R               
Sbjct: 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGF 290

Query: 344 RKKERDDYRYSGSENEEEETGVG 366
            K  + +  +S   +     G G
Sbjct: 291 SKHIQSNLDFSPVNSASRTPGSG 313

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  144 bits (366), Expect = 4e-39
 Identities = 63/275 (22%), Positives = 125/275 (45%), Gaps = 22/275 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE++  +G G++G+V   +   T ++ A+K M+    V  +E   +  E+ +++    H 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG-LEHP 75

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILR 171
            +   + +F  +      + +++V++    G +   L ++      KEE +     E++ 
Sbjct: 76  FLVNLWYSF--QDE----EDMFMVVDLLLGGDLRYHLQQNVH---FKEETVKLFICELVM 126

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L YL   ++IHRD+K  N+LL ++  V + DF ++A L     +  T  GT  +MAPE+
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGTKPYMAPEM 185

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPP--LCDLHPMRALFLIPRNAPPRLKSKK 289
            +  +     Y    D WSLG+TA E+   + P  +      + +            S  
Sbjct: 186 FSSRKGAG--YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS-A 242

Query: 290 WPKKFQSFIETVLVKDYHQR-PYTDQLLKHPFIRD 323
           W ++  S ++ +L  +  QR      +   P++ D
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  141 bits (358), Expect = 9e-39
 Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 50/298 (16%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD-------VTEDEEEE 97
           P  + +E     + L  ++G G +G V+ G         AIKV+            +   
Sbjct: 21  PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80

Query: 98  IKLEINVLKK---YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL-VKSTK 153
             LE+ +L K      H  +      F         +   LV+E        DL    T+
Sbjct: 81  CPLEVALLWKVGAGGGHPGVIRLLDWF------ETQEGFMLVLERPLPAQ--DLFDYITE 132

Query: 154 GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDR 212
              L E        +++  +++ H   V+HRDIK +N+L+       KL+DFG  A L  
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192

Query: 213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRS-DLWSLGITALEMAESQPPLCDLHP- 270
                  F GT  +  PE I+  +     Y      +WSLGI   +M      +C   P 
Sbjct: 193 --EPYTDFDGTRVYSPPEWISRHQ-----YHALPATVWSLGILLYDM------VCGDIPF 239

Query: 271 ------MRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                 + A    P +  P            + I   L      RP  +++L  P+++
Sbjct: 240 ERDQEILEAELHFPAHVSPDC---------CALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  142 bits (360), Expect = 1e-38
 Identities = 81/288 (28%), Positives = 135/288 (46%), Gaps = 38/288 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+L+ V+G G+Y +V   R  KT ++ A+KV+       +++ + ++ E +V ++ SNH 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL---VKSTKGQSLKEEWIAFICREI 169
            +   +  F  ++      +L+ V+EY   G   DL   ++  + + L EE   F   EI
Sbjct: 71  FLVGLHSCF--QTE----SRLFFVIEYVNGG---DLMFHMQ--RQRKLPEEHARFYSAEI 119

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
              L YLHE  +I+RD+K  NVLL     +KL D+G+  +  R     +TF GTP ++AP
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA--------LFLIPRNA 281
           E++         Y    D W+LG+   EM   + P   +             LF +    
Sbjct: 180 EILR-----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQR----PYTDQ--LLKHPFIRD 323
             R+  +    K  S +++ L KD  +R    P T    +  HPF R+
Sbjct: 235 QIRIP-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  142 bits (359), Expect = 1e-38
 Identities = 76/306 (24%), Positives = 134/306 (43%), Gaps = 44/306 (14%)

Query: 14  DEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYK 73
             E+  + E L K  +DF+   E  S      +          F+ I+ +G G++G+V  
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ---------FDRIKTLGTGSFGRVML 59

Query: 74  GRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK 129
            +H ++G   A+K++D    V   + E    E  +L+   N   +     +F       K
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VNFPFLVKLEFSF-------K 111

Query: 130 DDQ-LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKG 188
           D+  L++VMEY   G +   ++  +     E    F   +I+   +YLH   +I+RD+K 
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169

Query: 189 QNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDL 248
           +N+L+     +++ DFG + ++    GR  T  GTP  +APE+I         Y+   D 
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIIL-----SKGYNKAVDW 221

Query: 249 WSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK-KWPKKF----QSFIETVLV 303
           W+LG+   EMA   PP     P++    I       +  K ++P  F    +  +  +L 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKI-------VSGKVRFPSHFSSDLKDLLRNLLQ 274

Query: 304 KDYHQR 309
            D  +R
Sbjct: 275 VDLTKR 280

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  140 bits (354), Expect = 2e-38
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 38/281 (13%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSN 110
           G + L + +G GT+G+V  G H  TG   A+K+++     + D   +IK EI  LK +  
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-R 69

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREI 169
           H +I   Y      +        ++VMEY   G + D + K  +   ++E     + ++I
Sbjct: 70  HPHIIKLYQVISTPT------DFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQI 120

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L  + Y H + V+HRD+K +NVLL  +   K+ DFG+S  +        T  G+P + AP
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAP 179

Query: 230 EVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNA 281
           EVI+        Y     D+WS G+    +     P  D H           +F IP   
Sbjct: 180 EVIS-----GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              +          + +  +L  D  +R     + +H + +
Sbjct: 235 NRSVA---------TLLMHMLQVDPLKRATIKDIREHEWFK 266

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  146 bits (370), Expect = 2e-38
 Identities = 78/349 (22%), Positives = 139/349 (39%), Gaps = 49/349 (14%)

Query: 4   PKDSTTKVYTDEERA---ELAEKLDKDLDDFIAGLEKRSYTEGWPEDR-----WQE-DPA 54
           P+   T      E+    +L ++L +   ++++      Y +    +R     W E  P 
Sbjct: 122 PRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPV 181

Query: 55  GI--FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKY 108
               F    V+G G +G+V   +   TG++ A K ++         E     E  +L+K 
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK- 240

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL---VKSTKGQSLKEEWIAFI 165
            N R + +   A+  K      D L LV+     G   DL   +         E    F 
Sbjct: 241 VNSRFVVSLAYAYETK------DALCLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFY 291

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIG 222
             EI  GL+ LH  ++++RD+K +N+LL D+  +++ D G++  +             +G
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----KGRVG 347

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL--CDLHPMRA-LFLIPR 279
           T  +MAPEV+      +  Y    D W+LG    EM   Q P         R  +  + +
Sbjct: 348 TVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402

Query: 280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
             P    S+++  + +S    +L KD  +R         ++ +HP  + 
Sbjct: 403 EVPEEY-SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  142 bits (360), Expect = 5e-38
 Identities = 84/316 (26%), Positives = 132/316 (41%), Gaps = 55/316 (17%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEEEIK 99
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK V+     +  E++
Sbjct: 43  TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 99

Query: 100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-----STKG 154
           +    ++K  +H NI      F        +  L LV++Y        + +     S   
Sbjct: 100 I----MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAK 150

Query: 155 QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRT 213
           Q+L   ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R 
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR- 209

Query: 214 IGRRNT-FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPM 271
            G  N  +I + Y+ APE+I    +    Y +  D+WS G + A E+   QP       +
Sbjct: 210 -GEPNVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLA-ELLLGQPIFPGDSGV 263

Query: 272 RALFLI----------------PRNAP---PRLKSKKWPKKFQS--------FIETVLVK 304
             L  I                P       P++K+  W K F+             +L  
Sbjct: 264 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323

Query: 305 DYHQRPYTDQLLKHPF 320
               R    +   H F
Sbjct: 324 TPTARLTPLEACAHSF 339

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  140 bits (354), Expect = 8e-38
 Identities = 76/278 (27%), Positives = 122/278 (43%), Gaps = 27/278 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE I V+G G++G+V   R  +TG L A+KV+     + +D+ E    E  +L    NH 
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST-KGQSLKEEWIAFICREILR 171
            +   +  F  ++P    D+L+ VME+   G   DL+    K +   E    F   EI+ 
Sbjct: 85  FLTQLFCCF--QTP----DRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIIS 135

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L +LH+  +I+RD+K  NVLL      KL DFG+  +         TF GTP ++APE+
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           +      +  Y    D W++G+   EM     P         LF    N           
Sbjct: 196 LQ-----EMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYP-TWLH 248

Query: 292 KKFQSFIETVLVKDYHQR------PYTDQLLKHPFIRD 323
           +     +++ + K+   R           +L+HPF ++
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  139 bits (353), Expect = 1e-37
 Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 34/279 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F L +++G G++G+V+     KT Q  AIK +     + +D+ E   +E  VL     H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL---VKSTKGQSLKEEWIAFICREI 169
            +   +  F  ++     + L+ VMEY   G   DL   ++             F   EI
Sbjct: 79  FLTHMFCTF--QTK----ENLFFVMEYLNGG---DLMYHIQ--SCHKFDLSRATFYAAEI 127

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRNTFIGTPY 225
           + GL++LH   +++RD+K  N+LL  +  +K+ DFG+         +T    NTF GTP 
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT----NTFCGTPD 183

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           ++APE++         Y++  D WS G+   EM   Q P         LF   R   P  
Sbjct: 184 YIAPEILL-----GQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFY 237

Query: 286 KSKKWPKKFQSFIETVLVKDYHQR-PYTDQLLKHPFIRD 323
             +   K+ +  +  + V++  +R      + +HP  R+
Sbjct: 238 P-RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  140 bits (355), Expect = 2e-37
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 34/286 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+L+ V+G G+Y +V   R  KT ++ A++V+       +++ + ++ E +V ++ SNH 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL-VKSTKGQSLKEEWIAFICREILR 171
            +   +  F  ++      +L+ V+EY   G   DL     + + L EE   F   EI  
Sbjct: 114 FLVGLHSCF--QTE----SRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISL 164

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L YLHE  +I+RD+K  NVLL     +KL D+G+  +  R     +TF GTP ++APE+
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA--------LFLIPRNAPP 283
           +         Y    D W+LG+   EM   + P   +             LF +      
Sbjct: 225 LR-----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQR----PYTDQ--LLKHPFIRD 323
           R+  +    K  S +++ L KD  +R    P T    +  HPF R+
Sbjct: 280 RIP-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (354), Expect = 2e-37
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 18/222 (8%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEI 98
               P+D+W  +   +  L E +G G +G+V+ GR      L A+K     +  D + + 
Sbjct: 101 HRAVPKDKWVLNHEDL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF 159

Query: 99  KLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK 158
             E  +LK+Y +H NI    G   +K P      +++VME    G     +++ +G  L+
Sbjct: 160 LQEARILKQY-SHPNIVRLIGVCTQKQP------IYIVMELVQGGDFLTFLRT-EGARLR 211

Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN 218
            + +  +  +   G++YL     IHRD+  +N L+T+   +K+ DFG+S +    +   +
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271

Query: 219 TFIGT-PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             +   P  W APE +         Y + SD+WS GI   E 
Sbjct: 272 GGLRQVPVKWTAPEALN-----YGRYSSESDVWSFGILLWET 308

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  144 bits (364), Expect = 2e-37
 Identities = 69/338 (20%), Positives = 133/338 (39%), Gaps = 37/338 (10%)

Query: 2   ENPKDSTTKVYTDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGI--FEL 59
           +       + Y +E    L   + +   +  +    R       E         +  F +
Sbjct: 139 KQVPPDLFQPYIEEICQNLRGDVFQKFIE--SDKFTRFCQWKNVE---LNIHLTMNDFSV 193

Query: 60  IEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSN--HRN 113
             ++G G +G+VY  R   TG++ A+K +D      +  E     E  +L   S      
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS-TKGQSLKEEWIAFICREILRG 172
           I     AF         D+L  +++    G   DL    ++     E  + F   EI+ G
Sbjct: 254 IVCMSYAFHTP------DKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILG 304

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L+++H   V++RD+K  N+LL ++  V++ D G++    +   + +  +GT  +MAPEV+
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 362

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM--RALFLIPRNAPPRLKSKKW 290
                    YD+ +D +SLG    ++     P           +  +       L    +
Sbjct: 363 QKGVA----YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL-PDSF 417

Query: 291 PKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
             + +S +E +L +D ++R         ++ + PF R 
Sbjct: 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  138 bits (351), Expect = 3e-37
 Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 37/282 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F  ++V+G G++G+V   RH       A+KV+     + + EE+ I  E NVL K   H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL---VKSTKGQSLKEEWIAFICREI 169
            +   + +F  ++     D+L+ V++Y   G   +L   ++  + +   E    F   EI
Sbjct: 100 FLVGLHFSF--QTA----DKLYFVLDYINGG---ELFYHLQ--RERCFLEPRARFYAAEI 148

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRNTFIGTPY 225
              L YLH   +++RD+K +N+LL     + L DFG+          T    +TF GTP 
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT----STFCGTPE 204

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           ++APEV+         YD   D W LG    EM    PP    +    ++    N P +L
Sbjct: 205 YLAPEVLH-----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPLQL 258

Query: 286 KSKKWPKKFQSFIETVLVKDYHQR----PYTDQLLKHPFIRD 323
           K        +  +E +L KD  +R        ++  H F   
Sbjct: 259 K-PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  137 bits (346), Expect = 8e-37
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 39/281 (13%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSN 110
           G + + E +G G++G+V    H KT Q  A+K +        D    ++ EI+ LK    
Sbjct: 9   GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-R 67

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREI 169
           H +I   Y      +       + +V+EY G G + D +V+  +   + E+      ++I
Sbjct: 68  HPHIIKLYDVITTPT------DIVMVIEYAG-GELFDYIVEKKR---MTEDEGRRFFQQI 117

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           +  ++Y H +K++HRD+K +N+LL DN  VK+ DFG+S  +        T  G+P + AP
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSCGSPNYAAP 176

Query: 230 EVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNA 281
           EVI         Y     D+WS GI    M   + P  D             ++++P   
Sbjct: 177 EVINGKL-----YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
            P  +         S I  ++V D  QR    ++ + P+  
Sbjct: 232 SPGAQ---------SLIRRMIVADPMQRITIQEIRRDPWFN 263

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  137 bits (347), Expect = 8e-37
 Identities = 86/336 (25%), Positives = 148/336 (44%), Gaps = 45/336 (13%)

Query: 14  DEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGI--FELIEVVGNGTYGQV 71
           +   +  A     D  D    L    +           +  GI  FEL++V+G G YG+V
Sbjct: 11  EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70

Query: 72  YKGRHT---KTGQLAAIKVMD----VTEDEEEE-IKLEINVLKKYSNHRNIATYYGAFIK 123
           +  R      TG+L A+KV+     V + +  E  + E  VL+       + T + AF  
Sbjct: 71  FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-- 128

Query: 124 KSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVI 182
           ++      +L L+++Y   G + T L +  +     E  +     EI+  L++LH+  +I
Sbjct: 129 QTE----TKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGII 181

Query: 183 HRDIKGQNVLLTDNAEVKLVDFG-----VSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN 237
           +RDIK +N+LL  N  V L DFG     V+ + +R       F GT  +MAP+++   ++
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA----YDFCGTIEYMAPDIVRGGDS 237

Query: 238 PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK-KWPKKF-- 294
               +D   D WSLG+   E+     P        +   I R     LKS+  +P++   
Sbjct: 238 G---HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---ILKSEPPYPQEMSA 291

Query: 295 --QSFIETVLVKDYHQR---PYTD--QLLKHPFIRD 323
             +  I+ +L+KD  +R      D  ++ +H F + 
Sbjct: 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  135 bits (343), Expect = 2e-36
 Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 44/284 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+++  +G G++G+V+  R    G+  A+KV+     V   + E    E  +L     H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI-VTHP 66

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREIL 170
            I   +G F       +D Q ++++M+Y   G + + L KS +          F   E+ 
Sbjct: 67  FIIRMWGTF-------QDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVC 116

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAP 229
             L+YLH   +I+RD+K +N+LL  N  +K+ DFG +  + D T     T  GTP ++AP
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAP 172

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK- 288
           EV++        Y+   D WS GI   EM     P  D + M+    I       L ++ 
Sbjct: 173 EVVS-----TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-------LNAEL 220

Query: 289 KWPKKF----QSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           ++P  F    +  +  ++ +D  QR       T+ +  HP+ ++
Sbjct: 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  136 bits (345), Expect = 2e-36
 Identities = 72/281 (25%), Positives = 114/281 (40%), Gaps = 34/281 (12%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F  + V+G G++G+V       T +L A+K++     + +D+ E   +E  VL       
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKST-KGQSLKEEWIAFICREILR 171
            +   +  F  ++     D+L+ VMEY   G   DL+    +    KE    F   EI  
Sbjct: 82  FLTQLHSCF--QTM----DRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAI 132

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS----AQLDRTIGRRNTFIGTPYWM 227
           GL +L    +I+RD+K  NV+L     +K+ DFG+          T     TF GTP ++
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT----KTFCGTPDYI 188

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS 287
           APE+IA        Y    D W+ G+   EM   Q P         LF            
Sbjct: 189 APEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYP- 241

Query: 288 KKWPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           K   K+  +  + ++ K   +R          + +H F R 
Sbjct: 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  135 bits (343), Expect = 2e-36
 Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 29/279 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVM---DVTEDEEEEIKLEINVLKKYSN 110
           FEL++V+G G++G+V+  +        QL A+KV+    +   +    K+E ++L +  N
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-VN 84

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICREI 169
           H  I   + AF  ++      +L+L++++   G + T L K        EE + F   E+
Sbjct: 85  HPFIVKLHYAF--QTE----GKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAEL 135

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
              L +LH   +I+RD+K +N+LL +   +KL DFG+S +      +  +F GT  +MAP
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
           EV+         +   +D WS G+   EM     P       +    +   A   +  + 
Sbjct: 196 EVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMP-QF 248

Query: 290 WPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
              + QS +  +  ++   R        +++ +H F   
Sbjct: 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  135 bits (342), Expect = 3e-36
 Identities = 77/277 (27%), Positives = 129/277 (46%), Gaps = 27/277 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+ ++++G GT+G+V   R   TG+  A+K++     + +DE      E  VL+  + H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL-VKSTKGQSLKEEWIAFICREILR 171
            +     AF  ++     D+L  VMEY   G   +L    ++ +   EE   F   EI+ 
Sbjct: 66  FLTALKYAF--QTH----DRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVS 116

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
            L+YLH   V++RDIK +N++L  +  +K+ DFG+  +         TF GTP ++APEV
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           +      D  Y    D W LG+   EM   + P  +      LF +      R   +   
Sbjct: 177 LE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFP-RTLS 229

Query: 292 KKFQSFIETVLVKDYHQR---PYTD--QLLKHPFIRD 323
            + +S +  +L KD  QR     +D  ++++H F   
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  140 bits (354), Expect = 3e-36
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 26/277 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F  + V+G G++G+V       T +L A+K++     + +D+ E   +E  VL       
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
            +   +  F  ++     D+L+ VMEY   G   DL+   +     KE    F   EI  
Sbjct: 403 FLTQLHSCF--QTM----DRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAI 453

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL +L    +I+RD+K  NV+L     +K+ DFG+  +         TF GTP ++APE+
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 513

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP 291
           IA        Y    D W+ G+   EM   Q P         LF            K   
Sbjct: 514 IA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYP-KSMS 566

Query: 292 KKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
           K+  +  + ++ K   +R          + +H F R 
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  134 bits (340), Expect = 9e-36
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNI 114
             ++ ++ +G+G +G     R   T +L A+K ++     +E ++ EI   +    H NI
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNI 78

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +    +  +       L ++MEY   G + + + +  G+   E+   F  +++L G+ 
Sbjct: 79  VRFKEVILTPT------HLAIIMEYASGGELYERICN-AGR-FSEDEARFFFQQLLSGVS 130

Query: 175 YLHENKVIHRDIKGQNVLLTDNAE--VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           Y H  ++ HRD+K +N LL  +    +K+ DFG S        +  + +GTP ++APEV+
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVL 189

Query: 233 ACDENPDATYD-NRSDLWSLGIT 254
              E     YD   +D+WS G+T
Sbjct: 190 LRQE-----YDGKIADVWSCGVT 207

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  132 bits (335), Expect = 1e-35
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 30/219 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +E +E +G GTYG V+K ++ +T ++ A+K + + +D++E +      EI +LK+   H+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKE-LKHK 61

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREIL 170
           NI   +             +L LV E+C      DL K   +    L  E +     ++L
Sbjct: 62  NIVRLHDVLHSDK------KLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTPYW 226
           +GL + H   V+HRD+K QN+L+  N E+KL +FG    L R  G   R  +  + T ++
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFG----LARAFGIPVRCYSAEVVTLWY 167

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
             P+V+   +     Y    D+WS G    E+A +  PL
Sbjct: 168 RPPDVLFGAK----LYSTSIDMWSAGCIFAELANAGRPL 202

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  133 bits (337), Expect = 2e-35
 Identities = 74/319 (23%), Positives = 117/319 (36%), Gaps = 64/319 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTED---EEEEIKLEINVLKKYSNHR 112
           F++  + G GT+G V  G+   TG   AIK V+        E + ++          +H 
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-----DLAVLHHP 79

Query: 113 NIATYYGAFIKKSPPGKDDQ-LWLVMEYCGAGSVTDLVK-----STKGQSLKEEWIAFIC 166
           NI      F       + D  L +VMEY        L +       +  +     I    
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 167 REILRGLKYLHEN--KVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNT-FIG 222
            +++R +  LH     V HRDIK  NVL+   +  +KL DFG + +L       N  +I 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVAYIC 193

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRALFLI---- 277
           + Y+ APE+I  +++    Y    D+WS+G I A EM   +P     +    L  I    
Sbjct: 194 SRYYRAPELIFGNQH----YTTAVDIWSVGCIFA-EMMLGEPIFRGDNSAGQLHEIVRVL 248

Query: 278 ------------PRNAP---PRLKSKKWPKKFQS-----------FIETVLVKDYHQRPY 311
                       P +        K   W   F              +  +L     +R  
Sbjct: 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308

Query: 312 TDQLLKHPF---IRDQPTE 327
             + L HP+   + D  T+
Sbjct: 309 PYEALCHPYFDELHDPATK 327

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (347), Expect = 4e-35
 Identities = 55/266 (20%), Positives = 100/266 (37%), Gaps = 40/266 (15%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTK-TGQLAAIKVMDVTEDE--------EEEIKLEINV 104
           AG +E+   + +G  G +Y        G+   +K +  + D         E +   E+  
Sbjct: 79  AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV- 137

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
                 H +I   +  F++ +    D   ++VMEY G  S+        GQ L       
Sbjct: 138 ------HPSIVQIF-NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIA 186

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
              EIL  L YLH   +++ D+K +N++LT+  ++KL+D G        I       GTP
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV----SRINSFGYLYGTP 241

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
            + APE++             +D++++G T   +    P     +      L   +   +
Sbjct: 242 GFQAPEIVRTGPTV------ATDIYTVGRTLAALTLDLPTRNGRYVDG---LPEDDPVLK 292

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRP 310
                    +   +   +  D  QR 
Sbjct: 293 T-----YDSYGRLLRRAIDPDPRQRF 313

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  135 bits (341), Expect = 4e-35
 Identities = 77/301 (25%), Positives = 131/301 (43%), Gaps = 41/301 (13%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSN 110
           G + L + +G GT+G+V  G+H  TG   A+K+++     + D   +I+ EI  LK +  
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-R 74

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIAFICREI 169
           H +I   Y      S       +++VMEY   G + D + K+ +   L E+    + ++I
Sbjct: 75  HPHIIKLYQVISTPS------DIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQI 125

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L G+ Y H + V+HRD+K +NVLL  +   K+ DFG+S  +        T  G+P + AP
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAP 184

Query: 230 EVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLHPM-------RALFLIPRNA 281
           EVI+        Y     D+WS G+    +     P  D H           +F  P+  
Sbjct: 185 EVIS-----GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

Query: 282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR---DQPTERQARIQLKDHI 338
            P +          S ++ +L  D  +R     + +H + +    +    +        I
Sbjct: 240 NPSVI---------SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMI 290

Query: 339 D 339
           D
Sbjct: 291 D 291

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  132 bits (335), Expect = 9e-35
 Identities = 69/301 (22%), Positives = 123/301 (40%), Gaps = 55/301 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           +   +V+GNG++G V++ +  ++ ++A  KV+     +  E+++    ++    H N+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQI----MRIV-KHPNVVD 96

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-----STKGQSLKEEWIAFICREILR 171
               F        +  L LV+EY        + +     +   Q++    I     ++LR
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 172 GLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNT-FIGTPYWMAP 229
            L Y+H   + HRDIK QN+LL   +  +KL+DFG +  L    G  N  +I + Y+ AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNVSYICSRYYRAP 210

Query: 230 EVIACDENPDATYDNRSDLWSLG-ITALEMAESQ---------------------PPLCD 267
           E+I    N    Y    D+WS G + A E+ + Q                     P    
Sbjct: 211 ELIFGATN----YTTNIDIWSTGCVMA-ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265

Query: 268 LHPMRALFLIPRNAPPRLKSKKWPKKFQS--------FIETVLVKDYHQRPYTDQLLKHP 319
           +  M   +    +  P+++   + K F+          I  +L      R    + L HP
Sbjct: 266 IKTMNPNY--MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323

Query: 320 F 320
           F
Sbjct: 324 F 324

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (326), Expect = 2e-34
 Identities = 48/219 (21%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL 100
            + +    W  +   + +L++ +G G +G V  G +   G   A+K +      +  +  
Sbjct: 8   QDEFYRSGWALNMKEL-KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA- 63

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           E +V+ +   H N+    G  +++        L++V EY   GS+ D ++S     L  +
Sbjct: 64  EASVMTQL-RHSNLVQLLGVIVEEKGG-----LYIVTEYMAKGSLVDYLRSRGRSVLGGD 117

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF 220
            +     ++   ++YL  N  +HRD+  +NVL++++   K+ DFG++         +   
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---------KEAS 168

Query: 221 IGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGI 253
                   P  W APE +      +  +  +SD+WS GI
Sbjct: 169 STQDTGKLPVKWTAPEALR-----EKKFSTKSDVWSFGI 202

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  133 bits (337), Expect = 2e-34
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 14/221 (6%)

Query: 40  YTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIK 99
           Y      D+W+ +   I  +   +G G YG+VY+G   K     A+K +     E EE  
Sbjct: 206 YGVSPNYDKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 264

Query: 100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
            E  V+K+   H N+    G   ++ P       +++ E+   G++ D ++    Q +  
Sbjct: 265 KEAAVMKEI-KHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSA 317

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
             + ++  +I   ++YL +   IHR++  +N L+ +N  VK+ DFG+S  +       + 
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377

Query: 220 FIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
               P  W APE +A        +  +SD+W+ G+   E+A
Sbjct: 378 GAKFPIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIA 413

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  129 bits (326), Expect = 4e-34
 Identities = 71/225 (31%), Positives = 106/225 (47%), Gaps = 42/225 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           F+ +E +GNGTY  VYKG +  TG   A+K + +  D EE        EI+++K+   H 
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL--DSEEGTPSTAIREISLMKE-LKHE 63

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-------STKGQSLKEEWIAFI 165
           NI   Y           +++L LV E+       DL K           + L+   + + 
Sbjct: 64  NIVRLYDVIHT------ENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RNTFIGTP 224
             ++L+GL + HENK++HRD+K QN+L+    ++KL DFG    L R  G   NTF  + 
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG----LARAFGIPVNTF--SS 167

Query: 225 ------YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
                 Y  AP+V+        TY    D+WS G    EM   +P
Sbjct: 168 EVVTLWYR-APDVLMGSR----TYSTSIDIWSCGCILAEMITGKP 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  128 bits (323), Expect = 9e-34
 Identities = 76/321 (23%), Positives = 130/321 (40%), Gaps = 65/321 (20%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----E 101
           E+ + +     ++ +E VG GTYG VYK +    G++ A+K + + + E+E I      E
Sbjct: 12  ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRL-DAEDEGIPSTAIRE 69

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKE 159
           I++LK+  +H NI +       +        L LV E+       DL K        L++
Sbjct: 70  ISLLKE-LHHPNIVSLIDVIHSER------CLTLVFEFME----KDLKKVLDENKTGLQD 118

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR-RN 218
             I     ++LRG+ + H+++++HRD+K QN+L+  +  +KL DFG    L R  G    
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG----LARAFGIPVR 174

Query: 219 TFIGTP------YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR 272
           ++  T       Y  AP+V+   +     Y    D+WS+G    EM   +P    +    
Sbjct: 175 SY--THEVVTLWYR-APDVLMGSK----KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227

Query: 273 ALFLIPR---------------------NAPPRLKSKKWPKKFQSF-------IETVLVK 304
            L  I                             + K W      F       +  +L  
Sbjct: 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCF 287

Query: 305 DYHQRPYTDQLLKHPFIRDQP 325
           D ++R      + HP+ +D  
Sbjct: 288 DPNKRISARDAMNHPYFKDLD 308

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  128 bits (325), Expect = 9e-34
 Identities = 84/337 (24%), Positives = 134/337 (39%), Gaps = 63/337 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           +     VG+G YG V      ++G+  AIK +    + E        E+ L    LK   
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL----LKHM- 80

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H N+      F   S        +LVM +      TDL K        EE I ++  ++
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMG-LKFSEEKIQYLVYQM 135

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT-FIGTPYWMA 228
           L+GLKY+H   V+HRD+K  N+ + ++ E+K++DFG    L R      T ++ T ++ A
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRA 191

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI------P---- 278
           PEVI    +    Y+   D+WS+G    EM   +        +  L  I      P    
Sbjct: 192 PEVILSWMH----YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247

Query: 279 -------------RNAPPRLKSKKWPKKFQS-------FIETVLVKDYHQRPYTDQLLKH 318
                        ++ P     K + + F          +E +L  D  +R    Q L H
Sbjct: 248 VQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

Query: 319 PFI---RDQPTERQARIQLKDHIDTCKKRKKERDDYR 352
           PF    RD   E +A+    D ++     K   D+++
Sbjct: 307 PFFEPFRDPEEETEAQQPFDDSLE---HEKLTVDEWK 340

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (323), Expect = 1e-33
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 27/219 (12%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEE--EEIKLEINV---LKK 107
           G + L  +VG G  G VY+   T   ++ A+K+M   ++ D      ++ E      L  
Sbjct: 34  GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-- 91

Query: 108 YSNHRNIATYYGAFIKKSPPGKDD-QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
                ++   +         G+ D QL++ M       +  +++  +   L       I 
Sbjct: 92  --QEPHVVPIHDF-------GEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIV 140

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG-VSAQLDRTIGRRNTFIGTPY 225
           R+I   L   H     HRD+K +N+L++ +    LVDFG  SA  D  + +    +GT Y
Sbjct: 141 RQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           +MAPE  +     ++    R+D+++L     E     PP
Sbjct: 201 YMAPERFS-----ESHATYRADIYALTCVLYECLTGSPP 234

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  128 bits (325), Expect = 1e-33
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 41/224 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKV--MDVTEDEEEEIKL----EINVLKKYSN 110
           +E ++ +G G +  VYK R   T Q+ AIK   +    + ++ I      EI +L++  +
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE-LS 70

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICRE 168
           H NI     AF  KS       + LV ++      TDL          L    I      
Sbjct: 71  HPNIIGLLDAFGHKS------NISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY--- 225
            L+GL+YLH++ ++HRD+K  N+LL +N  +KL DFG    L ++ G  N      Y   
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG----LAKSFGSPN----RAYTHQ 172

Query: 226 ----WM-APEVIACDENPDATYDNRSDLWSLG-ITALEMAESQP 263
               W  APE++         Y    D+W++G I A E+    P
Sbjct: 173 VVTRWYRAPELLFGAR----MYGVGVDMWAVGCILA-ELLLRVP 211

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  128 bits (325), Expect = 1e-33
 Identities = 77/317 (24%), Positives = 129/317 (40%), Gaps = 68/317 (21%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE------EIKLEINVLKKYSN 110
           F+L  ++G G YG V    H  TG++ AIK ++  +          EIK+    LK +  
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI----LKHF-K 67

Query: 111 HRNIATYYGAFIKKSPPGKDD--QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
           H NI T +       P   ++  +++++ E       TDL +    Q L ++ I +   +
Sbjct: 68  HENIITIFNIQR---PDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQ 120

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM- 227
            LR +K LH + VIHRD+K  N+L+  N ++K+ DFG++  +D +    +   G    M 
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 228 ---------APEVIACDENPDATYDNRSDLWSLGITALEMAESQP--------------- 263
                    APEV+         Y    D+WS G    E+   +P               
Sbjct: 181 EFVATRWYRAPEVMLTSAK----YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236

Query: 264 -----PLCD-----LHPMRALFLIPRNAPPRLKSKKWPKKFQS-------FIETVLVKDY 306
                P  D     +   RA   I ++ P         K F          ++ +LV D 
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYI-KSLPMYPA-APLEKMFPRVNPKGIDLLQRMLVFDP 294

Query: 307 HQRPYTDQLLKHPFIRD 323
            +R    + L+HP+++ 
Sbjct: 295 AKRITAKEALEHPYLQT 311

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  130 bits (329), Expect = 1e-33
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 16/224 (7%)

Query: 37  KRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE 96
            +  T+G  +D W+     +  L   +G G +G+V+ G    T +  AIK +       E
Sbjct: 167 SKPQTQGLAKDAWEIPRESL-RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE 224

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
               E  V+KK   H  +   Y   + + P      +++V EY   GS+ D +K   G+ 
Sbjct: 225 AFLQEAQVMKKL-RHEKLVQLYAV-VSEEP------IYIVTEYMSKGSLLDFLKGETGKY 276

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR 216
           L+   +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  ++     
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336

Query: 217 RNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                  P  W APE           +  +SD+WS GI   E+ 
Sbjct: 337 ARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELT 375

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  126 bits (320), Expect = 2e-33
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +  +E +G GTYG VYK ++   G+  A+K + + E E+E I      EI++LK+   H 
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL-EKEDEGIPSTTIREISILKE-LKHS 60

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREIL 170
           NI   Y     K       +L LV E+       DL K        L+         ++L
Sbjct: 61  NIVKLYDVIHTK------KRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLL 110

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTPYW 226
            G+ Y H+ +V+HRD+K QN+L+    E+K+ DFG    L R  G   R+ T  I T ++
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG----LARAFGIPVRKYTHEIVTLWY 166

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
            AP+V+   +     Y    D+WS+G    EM    P
Sbjct: 167 RAPDVLMGSK----KYSTTIDIWSVGCIFAEMVNGTP 199

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  127 bits (322), Expect = 2e-33
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 31/281 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMD-----VTEDEEEEIKLEINVLKKY 108
           FEL+ V+G G YG+V++ R      TG++ A+KV+          +    K E N+L++ 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE- 77

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV-TDLVKSTKGQSLKEEWIAFICR 167
             H  I     AF  ++      +L+L++EY   G +   L +        E+   F   
Sbjct: 78  VKHPFIVDLIYAF--QTG----GKLYLILEYLSGGELFMQLEREGI---FMEDTACFYLA 128

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM 227
           EI   L +LH+  +I+RD+K +N++L     VKL DFG+  +        +TF GT  +M
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS 287
           APE++       + ++   D WSLG    +M    PP       +            L  
Sbjct: 189 APEILM-----RSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNLP- 241

Query: 288 KKWPKKFQSFIETVLVKDYHQR-----PYTDQLLKHPFIRD 323
               ++ +  ++ +L ++   R         ++  HPF R 
Sbjct: 242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  129 bits (327), Expect = 3e-33
 Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 28/278 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE ++++G GT+G+V   +   TG+  A+K++     V +DE      E  VL+  S H 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 208

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL-VKSTKGQSLKEEWIAFICREILR 171
            +     +F         D+L  VMEY   G   +L    ++ +   E+   F   EI+ 
Sbjct: 209 FLTALKYSFQTH------DRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVS 259

Query: 172 GLKYLHENK-VIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            L YLH  K V++RD+K +N++L  +  +K+ DFG+  +  +      TF GTP ++APE
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           V+      D  Y    D W LG+   EM   + P  +      LF +      R   +  
Sbjct: 320 VLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFP-RTL 372

Query: 291 PKKFQSFIETVLVKDYHQR---PYTD--QLLKHPFIRD 323
             + +S +  +L KD  QR      D  ++++H F   
Sbjct: 373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  128 bits (323), Expect = 3e-33
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 56/305 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           ++ +  VG+G YG V     TKTG   A+K +    +          E++L    LK   
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL----LKHM- 85

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H N+      F       + + ++LV    G     DL    K Q L ++ + F+  +I
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQI 141

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT-FIGTPYWMA 228
           LRGLKY+H   +IHRD+K  N+ + ++ E+K++DFG    L R      T ++ T ++ A
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVATRWYRA 197

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI------P---- 278
           PE++    +    Y+   D+WS+G    E+   +        +  L LI      P    
Sbjct: 198 PEIMLNWMH----YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 279 -------------RNAPPRLKSKKWPKKFQS-------FIETVLVKDYHQRPYTDQLLKH 318
                        ++         +   F          +E +LV D  +R    Q L H
Sbjct: 254 LKKISSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 319 PFIRD 323
            +   
Sbjct: 313 AYFAQ 317

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  125 bits (317), Expect = 3e-33
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 16/217 (7%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEIN 103
           W ED W+     + +L+E +G G +G+V+ G +    ++A +K +       +    E N
Sbjct: 3   WWEDEWEVPRETL-KLVERLGAGQFGEVWMGYYNGHTKVA-VKSLKQGSMSPDAFLAEAN 60

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           ++K+   H+ +   Y   + + P      ++++ EY   GS+ D +K+  G  L    + 
Sbjct: 61  LMKQL-QHQRLVRLYAV-VTQEP------IYIITEYMENGSLVDFLKTPSGIKLTINKLL 112

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT 223
            +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  ++            
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172

Query: 224 PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           P  W APE I        T+  +SD+WS GI   E+ 
Sbjct: 173 PIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIV 204

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (315), Expect = 7e-33
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 19/221 (8%)

Query: 43  GWPE-DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLE 101
           G P  D+W+ +   I  +   +G G YG+VY+G   K     A+K +     E EE   E
Sbjct: 1   GSPNYDKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 59

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
             V+K+   H N+    G   ++ P       +++ E+   G++ D ++    Q +    
Sbjct: 60  AAVMKEI-KHPNLVQLLGVCTREPP------FYIITEFMTYGNLLDYLRECNRQEVSAVV 112

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS--AQLDRTIGRRNT 219
           + ++  +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S     D        
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172

Query: 220 FIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
               P  W APE +A        +  +SD+W+ G+   E+A
Sbjct: 173 KF--PIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIA 206

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (324), Expect = 7e-33
 Identities = 48/225 (21%), Positives = 97/225 (43%), Gaps = 30/225 (13%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL 100
            + +    W  +   + +L++ +G G +G V  G +   G   A+K +      +  +  
Sbjct: 180 QDEFYRSGWALNMKEL-KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA- 235

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           E +V+ +   H N+    G  +++        L++V EY   GS+ D ++S     L  +
Sbjct: 236 EASVMTQL-RHSNLVQLLGVIVEEKGG-----LYIVTEYMAKGSLVDYLRSRGRSVLGGD 289

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF 220
            +     ++   ++YL  N  +HRD+  +NVL++++   K+ DFG++         +   
Sbjct: 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---------KEAS 340

Query: 221 IGTPY------WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                      W APE +      +  +  +SD+WS GI   E+ 
Sbjct: 341 STQDTGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIY 380

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  126 bits (318), Expect = 1e-32
 Identities = 78/305 (25%), Positives = 123/305 (40%), Gaps = 56/305 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           +  ++ VG+G YG V      +TG   AIK +    + E        E++L    LK   
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL----LKHM- 81

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H N+      F            +LVM + G    TDL K  K + L E+ I F+  ++
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEKLGEDRIQFLVYQM 137

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT-FIGTPYWMA 228
           L+GL+Y+H   +IHRD+K  N+ + ++ E+K++DFG    L R      T ++ T ++ A
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMTGYVVTRWYRA 193

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI------P---- 278
           PEVI         Y    D+WS+G    EM   +        +  L  I      P    
Sbjct: 194 PEVILNWMR----YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 279 -------------RNAPPRLKSKKWPKKFQS-------FIETVLVKDYHQRPYTDQLLKH 318
                        +  P   + K +     +        +E +LV D  QR    + L H
Sbjct: 250 VQRLQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308

Query: 319 PFIRD 323
           P+   
Sbjct: 309 PYFES 313

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  125 bits (315), Expect = 2e-32
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 17/210 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           ++L+  +G G Y +V++  +    +   +K+  +   ++++IK EI +L+      NI T
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIKREIKILENLRGGPNIIT 95

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
                I K P  +     LV E+      TD  +    Q+L +  I F   EIL+ L Y 
Sbjct: 96  LAD--IVKDPVSRTP--ALVFEHVNN---TDFKQL--YQTLTDYDIRFYMYEILKALDYC 146

Query: 177 HENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD 235
           H   ++HRD+K  NV++  ++ +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDY 205

Query: 236 ENPDATYDNRSDLWSLGITALEMAESQPPL 265
           +     YD   D+WSLG     M   + P 
Sbjct: 206 QM----YDYSLDMWSLGCMLASMIFRKEPF 231

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  128 bits (322), Expect = 3e-32
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 16/224 (7%)

Query: 37  KRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE 96
            +  T+G  +D W+     +  L   +G G +G+V+ G    T +  AIK +       E
Sbjct: 250 SKPQTQGLAKDAWEIPRESL-RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE 307

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
               E  V+KK   H  +   Y   + + P      +++V EY   GS+ D +K   G+ 
Sbjct: 308 AFLQEAQVMKKL-RHEKLVQLYAV-VSEEP------IYIVTEYMSKGSLLDFLKGETGKY 359

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR 216
           L+   +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  ++     
Sbjct: 360 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419

Query: 217 RNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                  P  W APE           +  +SD+WS GI   E+ 
Sbjct: 420 ARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELT 458

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  123 bits (312), Expect = 4e-32
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +  ++ +G GTY  VYKG+   T  L A+K + +  + EE        E+++LK    H 
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL--EHEEGAPCTAIREVSLLKD-LKHA 60

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREIL 170
           NI T +     +        L LV EY       DL +     G  +    +     ++L
Sbjct: 61  NIVTLHDIIHTEK------SLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG---RRNTF-IGTPYW 226
           RGL Y H  KV+HRD+K QN+L+ +  E+KL DFG    L R      +     + T ++
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFG----LARAKSIPTKTYDNEVVTLWY 166

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
             P+++         Y  + D+W +G    EMA  +P
Sbjct: 167 RPPDILLGST----DYSTQIDMWGVGCIFYEMATGRP 199

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (317), Expect = 7e-32
 Identities = 52/224 (23%), Positives = 100/224 (44%), Gaps = 16/224 (7%)

Query: 37  KRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE 96
                + W +D W+     + +L + +G G +G+V+   + K  +  A+K M       E
Sbjct: 171 SSKPQKPWEKDAWEIPRESL-KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE 228

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
               E NV+K    H  +   +   + K P      ++++ E+   GS+ D +KS +G  
Sbjct: 229 AFLAEANVMKTL-QHDKLVKLHAV-VTKEP------IYIITEFMAKGSLLDFLKSDEGSK 280

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR 216
                +     +I  G+ ++ +   IHRD++  N+L++ +   K+ DFG++  ++     
Sbjct: 281 QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340

Query: 217 RNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                  P  W APE I        ++  +SD+WS GI  +E+ 
Sbjct: 341 AREGAKFPIKWTAPEAIN-----FGSFTIKSDVWSFGILLMEIV 379

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  124 bits (313), Expect = 1e-31
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 46/236 (19%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           +EL++ +G G YG V+K    +TG++ A+K + D  ++  +      EI +    L + S
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI----LTELS 66

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            H NI               D  ++LV +Y      TDL    +   L+     ++  ++
Sbjct: 67  GHENIVNLLNVL----RADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQYVVYQL 118

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG----------------VSAQLDRT 213
           ++ +KYLH   ++HRD+K  N+LL     VK+ DFG                +S   +  
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 214 IGRRNTFIGTPY----WM-APEVIACDENPDATYDNRSDLWSLG-ITALEMAESQP 263
               +  I T Y    W  APE++         Y    D+WSLG I   E+   +P
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTK----YTKGIDMWSLGCILG-EILCGKP 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  124 bits (312), Expect = 1e-31
 Identities = 72/351 (20%), Positives = 135/351 (38%), Gaps = 78/351 (22%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           ++ ++ +G+G  G V         +  AIK +    +++        E+ L    +K   
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL----MKCV- 81

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           NH+NI      F  +    +   +++VME        +L +  +   L  E ++++  ++
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQ-MELDHERMSYLLYQM 136

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM-- 227
           L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TPY +  
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYVVTR 190

Query: 228 ---APEVIACDENPDATYDNRSDLWSLGITALEMAESQP--------------------- 263
              APEVI         Y    D+WS+G    EM +                        
Sbjct: 191 YYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245

Query: 264 -------------------PLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVK 304
                              P    +    LF           +K    + +  +  +LV 
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305

Query: 305 DYHQRPYTDQLLKHPFI---RDQPTERQARIQLKDHIDTCKKRKKERDDYR 352
           D  +R   D+ L+HP+I    D         ++ D      +R+   ++++
Sbjct: 306 DASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQL--DEREHTIEEWK 354

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  122 bits (307), Expect = 1e-31
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 39/233 (16%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM--DVTEDEEEE 97
              D          + I  +G G +G+V   R       TG+  A+K +  +   +   +
Sbjct: 11  TEVDPT-HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD 69

Query: 98  IKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL 157
           +K EI +L+    H NI  Y G   +       + + L+ME+  +GS+ + +   K + +
Sbjct: 70  LKKEIEILRNL-YHENIVKYKGICTEDGG----NGIKLIMEFLPSGSLKEYLPKNKNK-I 123

Query: 158 KEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR 217
             +       +I +G+ YL   + +HRD+  +NVL+    +VK+ DFG++         +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT---------K 174

Query: 218 NTFIGTPY------------WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                  Y            W APE +       + +   SD+WS G+T  E+
Sbjct: 175 AIETDKEYYTVKDDRDSPVFWYAPECLM-----QSKFYIASDVWSFGVTLHEL 222

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  123 bits (311), Expect = 1e-31
 Identities = 65/339 (19%), Positives = 123/339 (36%), Gaps = 74/339 (21%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK--------- 107
           + L+  +G G +  V+  +        A+K++   +   E  + EI +L++         
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 108 -YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
                 +I      F  K P G    + +V E  G  ++  L+K  + + +   ++  I 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNG--VHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQIS 137

Query: 167 REILRGLKYLH-ENKVIHRDIKGQNVLL------TDNAEVKLVDFGVSAQLDRTIGRRNT 219
           +++L GL Y+H    +IH DIK +NVL+       +  ++K+ D G +   D        
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 194

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA---------ESQPPLCDLH- 269
            I T  + +PEV+       A +   +D+WS      E+          E      D   
Sbjct: 195 SIQTREYRSPEVL-----LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249

Query: 270 ---------PMRALFL------------------IPRNAPPRLK---------SKKWPKK 293
                     + +  L                  I +     L+         SK   K+
Sbjct: 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309

Query: 294 FQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARI 332
              F+  +L  D  +R     L+ HP+++D     + R+
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  122 bits (308), Expect = 2e-31
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVM--DVTEDEEEEIKLEINVLKKYSN 110
           F+ I+V+G+G +G VYKG     G+      AIK +    +    +EI  E  V+    +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 75

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           + ++    G     S       + L+ +    G + D V+  K   +  +++   C +I 
Sbjct: 76  NPHVCRLLGI-CLTST------VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIA 127

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMA 228
           +G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEM 258
            E I         Y ++SD+WS G+T  E+
Sbjct: 188 LESIL-----HRIYTHQSDVWSYGVTVWEL 212

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (306), Expect = 2e-31
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 35/224 (15%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYS-- 109
              +++++ +G G    VY    T      AIK +     E EE         LK++   
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEE--------TLKRFERE 61

Query: 110 -------NHRNIATYYGAFIKKSPPGKDDQL-WLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
                  +H+NI +            ++D   +LVMEY    ++++ ++      L  + 
Sbjct: 62  VHNSSQLSHQNIVSMIDV-------DEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDT 112

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG-VSAQLDRTIGRRNTF 220
                 +IL G+K+ H+ +++HRDIK QN+L+  N  +K+ DFG   A  + ++ + N  
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV 172

Query: 221 IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           +GT  + +PE  A  E  D      +D++S+GI   EM   +PP
Sbjct: 173 LGTVQYFSPE-QAKGEATDE----CTDIYSIGIVLYEMLVGEPP 211

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  121 bits (305), Expect = 2e-31
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM-DVTEDEEEEIKLE 101
           D  Q +   + + ++ +G G +G V   R       TG++ A+K +   TE+   + + E
Sbjct: 3   DPTQFEERHL-KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
           I +LK    H NI  Y G             L L+MEY   GS+ D ++  K + +    
Sbjct: 62  IEILKSL-QHDNIVKYKGVCYS----AGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIK 115

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           +     +I +G++YL   + IHRD+  +N+L+ +   VK+ DFG    L + + +   F 
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG----LTKVLPQDKEF- 170

Query: 222 GTPY-----------WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              +           W APE +      ++ +   SD+WS G+   E+
Sbjct: 171 ---FKVKEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYEL 210

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  122 bits (309), Expect = 2e-31
 Identities = 73/307 (23%), Positives = 125/307 (40%), Gaps = 56/307 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE------EIKLEINVLKKYSN 110
           +  +  +G G YG V            AIK +   E +        EIK+    L ++  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI----LLRF-R 83

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI          +     D +++V +       TDL K  K Q L  + I +   +IL
Sbjct: 84  HENIIGINDIIRAPTIEQMKD-VYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQIL 138

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT---FIGTPYWM 227
           RGLKY+H   V+HRD+K  N+LL    ++K+ DFG++   D           ++ T ++ 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQP--------------------P--- 264
           APE++   +     Y    D+WS+G    EM  ++P                    P   
Sbjct: 199 APEIMLNSKG----YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254

Query: 265 -LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQS-------FIETVLVKDYHQRPYTDQLL 316
            L  +  ++A   +  + P + K   W + F +        ++ +L  + H+R   +Q L
Sbjct: 255 DLNCIINLKARNYL-LSLPHKNK-VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

Query: 317 KHPFIRD 323
            HP++  
Sbjct: 313 AHPYLEQ 319

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (303), Expect = 3e-31
 Identities = 51/221 (23%), Positives = 103/221 (46%), Gaps = 20/221 (9%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL 100
           T G     W+ DP  +   ++ +G G +G V  G+        AIK++      E+E   
Sbjct: 11  TAGLGYGSWEIDPKDL-TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE 68

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           E  V+    +H  +   YG   K+ P      ++++ EY   G + + ++  + +  + +
Sbjct: 69  EAKVMMNL-SHEKLVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMRHR-FQTQ 120

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF 220
            +  +C+++   ++YL   + +HRD+  +N L+ D   VK+ DFG+S  +       +  
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV- 179

Query: 221 IGT--PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            G+  P  W  PEV+       + + ++SD+W+ G+   E+
Sbjct: 180 -GSKFPVRWSPPEVLM-----YSKFSSKSDIWAFGVLMWEI 214

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  121 bits (305), Expect = 3e-31
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 38/231 (16%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM-DVTEDEEEEIK 99
             D  Q +   + + ++ +G G +G V   R       TG++ A+K +   TE+   + +
Sbjct: 32  DRDPTQFEERHL-KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE 90

Query: 100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
            EI +LK    H NI  Y G             L L+MEY   GS+ D ++  K + +  
Sbjct: 91  REIEILKSL-QHDNIVKYKGV----CYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDH 144

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
             +     +I +G++YL   + IHRD+  +N+L+ +   VK+ DFG++         +  
Sbjct: 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT---------KVL 195

Query: 220 FIGTPY------------WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                Y            W APE +      ++ +   SD+WS G+   E+
Sbjct: 196 PQDKEYYKVKEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYEL 241

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  121 bits (305), Expect = 4e-31
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 39/231 (16%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM--DVTEDEEEEI 98
           P D        + + I  +G G +G+V        +  TG++ A+K +  D         
Sbjct: 22  PGDPTVFHKRYL-KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW 80

Query: 99  KLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK 158
           K EI++L+    H +I  Y G             L LVMEY   GS+ D +      S+ 
Sbjct: 81  KQEIDILRTL-YHEHIIKYKGCCEDAGAA----SLQLVMEYVPLGSLRDYLPR---HSIG 132

Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN 218
              +    ++I  G+ YLH    IHRD+  +NVLL ++  VK+ DFG    L + +   +
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG----LAKAVPEGH 188

Query: 219 TFIGTPY-----------WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +    Y           W APE +      +  +   SD+WS G+T  E+
Sbjct: 189 EY----YRVREDGDSPVFWYAPECLK-----EYKFYYASDVWSFGVTLYEL 230

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  121 bits (305), Expect = 5e-31
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 33/236 (13%)

Query: 38  RSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTG--QLAAIKVM--DVTED 93
                  P      D   I +  +V+G G +GQV K R  K G    AAIK M    ++D
Sbjct: 9   HGKNNPDPTIYPVLDWNDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 67

Query: 94  EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS--------- 144
           +  +   E+ VL K  +H NI    GA   +        L+L +EY   G+         
Sbjct: 68  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGY------LYLAIEYAPHGNLLDFLRKSR 121

Query: 145 -----VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEV 199
                    + ++   +L  + +     ++ RG+ YL + + IHRD+  +N+L+ +N   
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181

Query: 200 KLVDFGVSAQLDRTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGIT 254
           K+ DFG+S   +  + +    +  P  WMA E +       + Y   SD+WS G+ 
Sbjct: 182 KIADFGLSRGQEVYVKKTMGRL--PVRWMAIESLN-----YSVYTTNSDVWSYGVL 230

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  123 bits (309), Expect = 6e-31
 Identities = 64/256 (25%), Positives = 104/256 (40%), Gaps = 52/256 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           +E+  ++G G+YG V +       ++ AIK ++ V ED  +      EI +    L +  
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI----LNRL- 109

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICRE 168
           NH ++       I K     D+ L++V+E       +D  K  +    L E  I  +   
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDE-LYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYN 164

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM- 227
           +L G+KY+H   ++HRD+K  N L+  +  VK+ DFG++  +D      +    +P    
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 228 --------------------------APEVIACDENPDATYDNRSDLWSLG-ITALEMAE 260
                                     APE+I   EN    Y    D+WS+G I A E+  
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN----YTEAIDVWSIGCIFA-ELLN 279

Query: 261 SQPPLCDLHPMR-ALF 275
                   H  R  LF
Sbjct: 280 MIKENVAYHADRGPLF 295

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (303), Expect = 7e-31
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 36/229 (15%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM-DVTEDEEEEIKL 100
           +D    +   + + I  +G G +G V   R       TG L A+K +     D++ + + 
Sbjct: 15  QDPTIFEERHL-KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 73

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           EI +LK   +   I  Y G     S       L LVMEY  +G + D ++  + + L   
Sbjct: 74  EIQILKAL-HSDFIVKYRGV----SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDAS 127

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF 220
            +     +I +G++YL   + +HRD+  +N+L+   A VK+ DFG    L + +     +
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG----LAKLLPLDKDY 183

Query: 221 IGTPY-----------WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
               Y           W APE ++     D  +  +SD+WS G+   E+
Sbjct: 184 ----YVVREPGQSPIFWYAPESLS-----DNIFSRQSDVWSFGVVLYEL 223

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  120 bits (303), Expect = 8e-31
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 36/222 (16%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL----EINVLKKYSNHR 112
           +  I  +G GTYG+VYK   T T +  AIK + + E EEE +      E+++LK+   HR
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAIREVSLLKE-LQHR 93

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-STKGQSLKEEWIAFICREILR 171
           NI                 +L L+ EY       DL K   K   +    I     +++ 
Sbjct: 94  NIIELKSVIHHN------HRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNA-----EVKLVDFGVSAQLDRTIG---RRNTF-IG 222
           G+ + H  + +HRD+K QN+LL+ +       +K+ DFG    L R  G   R+ T  I 
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG----LARAFGIPIRQFTHEII 199

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAESQP 263
           T ++  PE++         Y    D+WS+  I A EM    P
Sbjct: 200 TLWYRPPEILLGSR----HYSTSVDIWSIACIWA-EMLMKTP 236

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  122 bits (308), Expect = 1e-30
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           ++ ++ +G+G  G V         +  AIK +    +++        E+ L    +K   
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL----MK-CV 118

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           NH+NI +    F  +    +   ++LVME        +L +  +   L  E ++++  ++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQ-MELDHERMSYLLYQM 173

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWM-- 227
           L G+K+LH   +IHRD+K  N+++  +  +K++DFG    L RT G   +F+ TPY +  
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYVVTR 227

Query: 228 ---APEVIACDENPDATYDNRSDLWSLGITALEMAESQP 263
              APEVI         Y    D+WS+G    EM   + 
Sbjct: 228 YYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKI 261

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  119 bits (301), Expect = 1e-30
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 23/227 (10%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVM--DVTEDE 94
            +   +   +  P+ +    +V+G G +G+VYKG       K     AIK +    TE +
Sbjct: 31  NQAVLKFTTEIHPSCV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ 89

Query: 95  EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG 154
             +   E  ++ ++ +H NI    G   K  P      + ++ EY   G++   ++   G
Sbjct: 90  RVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP------MMIITEYMENGALDKFLREKDG 142

Query: 155 QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI 214
           +      +  + R I  G+KYL     +HRD+  +N+L+  N   K+ DFG+S  L+   
Sbjct: 143 E-FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201

Query: 215 GRRNTFIGT--PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
               T  G   P  W APE I+        + + SD+WS GI   E+
Sbjct: 202 EATYTTSGGKIPIRWTAPEAIS-----YRKFTSASDVWSFGIVMWEV 243

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  117 bits (296), Expect = 3e-30
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVM--DVTEDEEEEIKLE 101
             ++     I EL   +G G +G V++G +      A   AIK      ++   E+   E
Sbjct: 8   RDYEIQRERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
              ++++ +H +I    G  I ++P      +W++ME C  G +   ++  K   L    
Sbjct: 67  ALTMRQF-DHPHIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRKYS-LDLAS 117

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           +     ++   L YL   + +HRDI  +NVL++ N  VKL DFG+S    R +     + 
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS----RYMEDSTYYK 173

Query: 222 GT----PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            +    P  WMAPE I         + + SD+W  G+   E+ 
Sbjct: 174 ASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEIL 211

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  116 bits (294), Expect = 4e-30
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 16/212 (7%)

Query: 48  RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK 107
           +W  DP+ +   ++ +G+G +G V+ G      +  AIK +      EE+   E  V+ K
Sbjct: 2   KWVIDPSEL-TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMK 59

Query: 108 YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICR 167
             +H  +   YG  ++++P      + LV E+   G ++D +++ +G     E +  +C 
Sbjct: 60  L-SHPKLVQLYGVCLEQAP------ICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCL 111

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-W 226
           ++  G+ YL E  VIHRD+  +N L+ +N  +K+ DFG++  +       +T    P  W
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 171

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +PEV +      + Y ++SD+WS G+   E+
Sbjct: 172 ASPEVFS-----FSRYSSKSDVWSFGVLMWEV 198

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  118 bits (297), Expect = 5e-30
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 22/225 (9%)

Query: 42  EGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVM--DVTEDEEE 96
                   + + + I  + +++G+G  G+V  GR    GQ     AIK +    TE +  
Sbjct: 37  RAGRSFTREIEASRI-HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
           +   E +++ ++ +H NI    G   +           +V EY   GS+   +++  GQ 
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRL------AMIVTEYMENGSLDTFLRTHDGQ- 147

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR 216
                +  + R +  G++YL +   +HRD+  +NVL+  N   K+ DFG+S  L+     
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207

Query: 217 RNTFIGT--PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
             T  G   P  W APE IA       T+ + SD+WS G+   E+
Sbjct: 208 AYTTTGGKIPIRWTAPEAIA-----FRTFSSASDVWSFGVVMWEV 247

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (294), Expect = 6e-30
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 29/222 (13%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVM--DVTEDEEEEIKLE 101
            ++      +  L  ++G G +G+VY+G +T         A+K    D T D +E+   E
Sbjct: 5   PQYGIAREDV-VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
             ++K   +H +I    G  I++ P       W++ME    G +   ++  K   LK   
Sbjct: 64  AVIMKNL-DHPHIVKLIGI-IEEEP------TWIIMELYPYGELGHYLERNKNS-LKVLT 114

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           +     +I + + YL     +HRDI  +N+L+     VKL DFG+S    R I   + + 
Sbjct: 115 LVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS----RYIEDEDYYK 170

Query: 222 GT----PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +    P  WM+PE I         +   SD+W   +   E+
Sbjct: 171 ASVTRLPIKWMSPESIN-----FRRFTTASDVWMFAVCMWEI 207

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  119 bits (299), Expect = 6e-30
 Identities = 64/337 (18%), Positives = 117/337 (34%), Gaps = 77/337 (22%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK--------------------------VMDV 90
           + L + +G G++G V +    ++G+  A+K                          ++D 
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 91  TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ--LWLVMEYCGAGSVTDL 148
                +E          ++             K           L ++MEY        L
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DTL 124

Query: 149 VK-----STKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLV 202
            K        G+S+    I+    ++ R + ++H   + HRDIK QN+L+ + +  +KL 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 203 DFGVSAQLDRTIGRRNT-FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG-ITALEMAE 260
           DFG + +L       +  +I + ++ APE++         Y    DLWS+G +   E+  
Sbjct: 185 DFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATE----YTPSIDLWSIGCVFG-ELIL 237

Query: 261 SQPPLCDLHPMRALFLI----------------PRNAP---PRLKSKKWPKKFQS----- 296
            +P       +  L  I                P       P LK+K W K         
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL 297

Query: 297 ---FIETVLVKDYHQRPYTDQLLKHPF---IRDQPTE 327
               +E +L  +   R    + + HPF   +R+    
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYES 334

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  119 bits (301), Expect = 7e-30
 Identities = 67/253 (26%), Positives = 100/253 (39%), Gaps = 51/253 (20%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIK-VMDVTEDEEE------EIKLEINVLKKYS 109
           + +  ++G G+YG VY      T +  AIK V  + ED  +      EI +    L +  
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI----LNRL- 82

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL---VKSTKGQSLKEEWIAFIC 166
               I   Y   I       D+ L++V+E       +DL    K+     L EE I  I 
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDE-LYIVLEIAD----SDLKKLFKT--PIFLTEEHIKTIL 135

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG---- 222
             +L G  ++HE+ +IHRD+K  N LL  +  VK+ DFG++  ++               
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 223 -------------TPY----WM-APEVIACDENPDATYDNRSDLWSLG-ITALEMAESQP 263
                        T +    W  APE+I   EN    Y    D+WS G I A E+     
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN----YTKSIDIWSTGCIFA-ELLNMLQ 250

Query: 264 PLCDLHPMR-ALF 275
              +    R  LF
Sbjct: 251 SHINDPTNRFPLF 263

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  118 bits (297), Expect = 1e-29
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 26/228 (11%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVM--DVTEDEE 95
           T+   E   + D   I  + +VVG G +G+V  GR    +K     AIK +    TE + 
Sbjct: 32  TQTVHEFAKELDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ 155
            +   E +++ ++ +H NI    G   K  P      + +V EY   GS+   ++    Q
Sbjct: 91  RDFLGEASIMGQF-DHPNIIRLEGVVTKSKP------VMIVTEYMENGSLDSFLRKHDAQ 143

Query: 156 SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----D 211
                 +  + R I  G+KYL +   +HRD+  +N+L+  N   K+ DFG+   L    +
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202

Query: 212 RTIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                R   I  P  W +PE IA        + + SD+WS GI   E+
Sbjct: 203 AAYTTRGGKI--PIRWTSPEAIA-----YRKFTSASDVWSYGIVLWEV 243

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  118 bits (297), Expect = 1e-29
 Identities = 74/345 (21%), Positives = 125/345 (36%), Gaps = 67/345 (19%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL------------EINV 104
           + +   + +G+YG V  G  +  G   AIK +  T  +   + +            EI +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL--VKSTKGQSLKEEWI 162
           L  + +H NI      F+    P     L+LV E       TDL  V   +   +  + I
Sbjct: 83  LNHF-HHPNILGLRDIFVHFEEPAMHK-LYLVTELMR----TDLAQVIHDQRIVISPQHI 136

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT--- 219
            +    IL GL  LHE  V+HRD+   N+LL DN ++ + DF     L R          
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN----LAREDTADANKTH 192

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-- 277
           ++   ++ APE++   +     +    D+WS G    EM   +           L  I  
Sbjct: 193 YVTHRWYRAPELVMQFKG----FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248

Query: 278 ----P-----------------RNAPPRLKSKKWPKKFQS-------FIETVLVKDYHQR 309
               P                 RN+   + ++ W     +        I  +L  +  +R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 310 PYTDQLLKHPFIRD--QPTERQARIQLKDHIDTCKKRKKERDDYR 352
             T+Q L+HP+      P +    +  + H D   +   +  D  
Sbjct: 309 ISTEQALRHPYFESLFDPLDLTEGLSERFHFD---ESVTDVYDMH 350

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  116 bits (293), Expect = 1e-29
 Identities = 48/226 (21%), Positives = 94/226 (41%), Gaps = 25/226 (11%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVM--DVTEDEEEEIK 99
            +       + I    EV+G G +G VY G    +       A+K +       E  +  
Sbjct: 15  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 74

Query: 100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
            E  ++K + +H N+ +  G  ++           +V+ Y   G + + +++       +
Sbjct: 75  TEGIIMKDF-SHPNVLSLLGICLRSEGS-----PLVVLPYMKHGDLRNFIRNETHNPTVK 128

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD-----RTI 214
           + I F   ++ +G+KYL   K +HRD+  +N +L +   VK+ DFG++  +         
Sbjct: 129 DLIGF-GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH 187

Query: 215 GRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            +    +  P  WMA E +         +  +SD+WS G+   E+ 
Sbjct: 188 NKTGAKL--PVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELM 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  117 bits (294), Expect = 1e-29
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVM--DVTEDEEEEIKLEINVLKKYSN 110
           F+ I+V+G+G +G VYKG     G+      AIK +    +    +EI  E  V+    +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 75

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           + ++    G     S       + L+ +    G + D V+  K   +  +++   C +I 
Sbjct: 76  NPHVCRLLGI-CLTST------VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIA 127

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMA 228
           +G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +   G  P  WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEM 258
            E I         Y ++SD+WS G+T  E+
Sbjct: 188 LESIL-----HRIYTHQSDVWSYGVTVWEL 212

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (292), Expect = 2e-29
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 42/238 (17%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEE 96
           +   +W E P    +L + +G G +GQV +        T T +  A+K++    T  E  
Sbjct: 17  YDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 75

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS------------ 144
            +  E+ +L    +H N+    GA  K   P     L +++E+C  G+            
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGP-----LMVIVEFCKFGNLSTYLRSKRNEF 130

Query: 145 --VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV 202
                  +      L  E +     ++ +G+++L   K IHRD+  +N+LL++   VK+ 
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190

Query: 203 DFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGIT 254
           DFG    L R I +   ++       P  WMAPE I      D  Y  +SD+WS G+ 
Sbjct: 191 DFG----LARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVL 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  115 bits (291), Expect = 3e-29
 Identities = 47/218 (21%), Positives = 95/218 (43%), Gaps = 26/218 (11%)

Query: 58  ELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVM---DVTEDEEEEIKLEINVLKKYSNH 111
            L  ++G G +G V + +      +    A+K++    +   + EE   E   +K++ +H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DH 84

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS----TKGQSLKEEWIAFICR 167
            ++A   G  ++    G+     +++ +   G +   + +        +L  + +     
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT---- 223
           +I  G++YL     IHRD+  +N +L ++  V + DFG+S    R I   + +       
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS----RKIYSGDYYRQGCASK 200

Query: 224 -PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            P  W+A E +A     D  Y   SD+W+ G+T  E+ 
Sbjct: 201 LPVKWLALESLA-----DNLYTVHSDVWAFGVTMWEIM 233

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  116 bits (292), Expect = 3e-29
 Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 41/238 (17%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKG-----RHTKTGQLAAIKVM--DVTED 93
           T+    ++W E P    +  + +G G +G+V +               A+K++      D
Sbjct: 33  TQLPYNEKW-EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91

Query: 94  EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS--------- 144
           E+E +  E+ ++     H NI    GA     P      + ++ EYC  G          
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRKS 145

Query: 145 ---VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
               TD   +    +     +     ++ +G+ +L     IHRD+  +NVLLT+    K+
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205

Query: 202 VDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGI 253
            DFG    L R I   + +I       P  WMAPE I      D  Y  +SD+WS GI
Sbjct: 206 GDFG----LARDIMNDSNYIVKGNARLPVKWMAPESIF-----DCVYTVQSDVWSYGI 254

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  114 bits (288), Expect = 3e-29
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKY 108
            +     I  L++ +G+G +G V  G+      +A +K++      E+E   E   + K 
Sbjct: 3   MELKREEI-TLLKELGSGQFGVVKLGKWKGQYDVA-VKMIKEGSMSEDEFFQEAQTMMKL 60

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
            +H  +  +YG   K+ P      +++V EY   G + + ++S  G+ L+   +  +C +
Sbjct: 61  -SHPKLVKFYGVCSKEYP------IYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYD 112

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT--PY- 225
           +  G+ +L  ++ IHRD+  +N L+  +  VK+ DFG++  +       +   GT  P  
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVK 170

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           W APEV          Y ++SD+W+ GI   E+ 
Sbjct: 171 WSAPEVFH-----YFKYSSKSDVWAFGILMWEVF 199

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  115 bits (289), Expect = 4e-29
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 25/231 (10%)

Query: 38  RSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVM--DVTE 92
            +                +  L+E +G+G++G V +G     +      A+K +  DV  
Sbjct: 2   SAGEGPLQSLTCLIGEKDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60

Query: 93  DEE--EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK 150
             E  ++   E+N +    +HRN+   YG  +  +PP     + +V E    GS+ D ++
Sbjct: 61  QPEAMDDFIREVNAMHSL-DHRNLIRLYG--VVLTPP-----MKMVTELAPLGSLLDRLR 112

Query: 151 STKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL 210
             +G       ++    ++  G+ YL   + IHRD+  +N+LL     VK+ DFG+   L
Sbjct: 113 KHQGH-FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

Query: 211 DRTIGRRNTFIGT--PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
            +             P+ W APE +        T+ + SD W  G+T  EM
Sbjct: 172 PQNDDHYVMQEHRKVPFAWCAPESLK-----TRTFSHASDTWMFGVTLWEM 217

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (290), Expect = 4e-29
 Identities = 59/242 (24%), Positives = 93/242 (38%), Gaps = 45/242 (18%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTED 93
           T+   + +W E P       + +G G +G+V +        +      A+K++       
Sbjct: 10  TQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68

Query: 94  EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS--------- 144
           E E +  E+ VL    NH NI    GA     P        ++ EYC  G          
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTIGGP------TLVITEYCCYGDLLNFLRRKR 122

Query: 145 -------VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA 197
                   +  +      +L  E +     ++ +G+ +L     IHRD+  +N+LLT   
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182

Query: 198 EVKLVDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSL 251
             K+ DFG    L R I   + ++       P  WMAPE I      +  Y   SD+WS 
Sbjct: 183 ITKICDFG----LARDIKNDSNYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSY 233

Query: 252 GI 253
           GI
Sbjct: 234 GI 235

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  117 bits (294), Expect = 5e-29
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK-----YSNH 111
           +E+++V+G G++GQV K    K  Q  A+K++   +    +   EI +L+        N 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            N+      F  ++       + +  E     ++ +L+K  K Q      +      IL+
Sbjct: 159 MNVIHMLENFTFRN------HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQ 211

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
            L  LH+N++IH D+K +N+LL     + +K++DFG S    + +    T+I + ++ AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTYIQSRFYRAP 268

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEM 258
           EVI       A Y    D+WSLG    E+
Sbjct: 269 EVIL-----GARYGMPIDMWSLGCILAEL 292

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  114 bits (288), Expect = 9e-29
 Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 45/238 (18%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-------HTKTGQLAAIKVM--DVTEDEE 95
            + +W E P     L + +G G +GQV             K     A+K++  D TE + 
Sbjct: 26  EDPKW-EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS----------- 144
            ++  E+ ++K    H+NI    GA  +  P      L++++EY   G+           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 138

Query: 145 ---VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
               +  +     + +  + +     ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198

Query: 202 VDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGI 253
            DFG    L R I   + +  T     P  WMAPE +      D  Y ++SD+WS G+
Sbjct: 199 ADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGV 247

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  114 bits (287), Expect = 1e-28
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVM--DVTEDEEEEIKLEINVLKKYSN 110
              ++V+G+G +G V+KG     G+       IKV+         + +   +  +    +
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-D 73

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H +I    G     S       L LV +Y   GS+ D V+  +G  L  + +     +I 
Sbjct: 74  HAHIVRLLGL-CPGSS------LQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIA 125

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG-TPY-WMA 228
           +G+ YL E+ ++HR++  +NVLL   ++V++ DFGV+  L     +       TP  WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEM 258
            E I         Y ++SD+WS G+T  E+
Sbjct: 186 LESIH-----FGKYTHQSDVWSYGVTVWEL 210

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (296), Expect = 2e-28
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 29/224 (12%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVM--DVTEDEEEEIKL 100
              ++     I EL   +G G +G V++G +      A   AIK      ++   E+   
Sbjct: 382 TRDYEIQRERI-ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           E   ++++ +H +I    G  I ++P      +W++ME C  G +   ++  K   L   
Sbjct: 441 EALTMRQF-DHPHIVKLIGV-ITENP------VWIIMELCTLGELRSFLQVRKFS-LDLA 491

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF 220
            +     ++   L YL   + +HRDI  +NVL++ N  VKL DFG+S    R +     +
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS----RYMEDSTYY 547

Query: 221 IGT----PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
             +    P  WMAPE I         + + SD+W  G+   E+ 
Sbjct: 548 KASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEIL 586

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  113 bits (284), Expect = 2e-28
 Identities = 52/229 (22%), Positives = 99/229 (43%), Gaps = 31/229 (13%)

Query: 42  EGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA--AIKVM--DVTE-DEEE 96
           E         D   +    + +G+G +G V KG +     +   A+K++  +  +   ++
Sbjct: 4   EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD 63

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
           E+  E NV+++  ++  I    G   +           LVME    G +   ++  + + 
Sbjct: 64  ELLAEANVMQQL-DNPYIVRMIGI-CEAES------WMLVMEMAELGPLNKYLQ--QNRH 113

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR 216
           +K++ I  +  ++  G+KYL E+  +HRD+  +NVLL      K+ DFG+S    + +  
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS----KALRA 169

Query: 217 RNTFIGT------PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
              +         P  W APE I         + ++SD+WS G+   E 
Sbjct: 170 DENYYKAQTHGKWPVKWYAPECIN-----YYKFSSKSDVWSFGVLMWEA 213

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  113 bits (285), Expect = 2e-28
 Identities = 71/317 (22%), Positives = 118/317 (37%), Gaps = 72/317 (22%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEE------EIKLEINVLKKYSN 110
           +  ++ +G G  G V+        +  AIK + V  D +       EIK+    +++  +
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVKHALREIKI----IRRL-D 66

Query: 111 HRNIATYYGAFIKKSPPGKDDQ--------LWLVMEYCGAGSVTDLVKSTKGQSLKEEWI 162
           H NI   +           DD         +++V EY      TDL    +   L EE  
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHA 122

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLL-TDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
                ++LRGLKY+H   V+HRD+K  N+ + T++  +K+ DFG    L R +    +  
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG----LARIMDPHYSHK 178

Query: 222 G--TPY----WM-APEVIACDENPDATYDNRSDLWSLG-ITALEMAESQPPLCDLHPMRA 273
           G  +      W  +P ++    N    Y    D+W+ G I A EM   +      H +  
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNN----YTKAIDMWAAGCIFA-EMLTGKTLFAGAHELEQ 233

Query: 274 LFLI------P----------------RNAPPRLKSKKWPKKFQS-------FIETVLVK 304
           + LI                       RN       K   +           F+E +L  
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTE-PHKPLTQLLPGISREAVDFLEQILTF 292

Query: 305 DYHQRPYTDQLLKHPFI 321
               R   ++ L HP++
Sbjct: 293 SPMDRLTAEEALSHPYM 309

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  114 bits (287), Expect = 2e-28
 Identities = 47/231 (20%), Positives = 92/231 (39%), Gaps = 35/231 (15%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVM--DVTEDEEEEIK 99
            +       + I    EV+G G +G VY G            A+K +       E  +  
Sbjct: 79  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 138

Query: 100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
            E  ++K + +H N+ +  G  ++           +V+ Y   G + + +++       +
Sbjct: 139 TEGIIMKDF-SHPNVLSLLGICLRSEGS-----PLVVLPYMKHGDLRNFIRNETHNPTVK 192

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT 219
           + I F   ++ +G+K+L   K +HRD+  +N +L +   VK+ DFG++    R +  +  
Sbjct: 193 DLIGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA----RDMYDKEF 247

Query: 220 FIGTPY-----------WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                            WMA E +         +  +SD+WS G+   E+ 
Sbjct: 248 D---SVHNKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELM 290

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  112 bits (283), Expect = 2e-28
 Identities = 50/225 (22%), Positives = 95/225 (42%), Gaps = 27/225 (12%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVM--DVTEDEEEEI 98
            P +R             V+G G +G VY G +    Q     AIK +       + E  
Sbjct: 16  IPHERVV------THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF 69

Query: 99  KLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLK 158
             E  +++   NH N+    G  +            +++ Y   G +   ++S +     
Sbjct: 70  LREGLLMRGL-NHPNVLALIGIMLPPEGL-----PHVLLPYMCHGDLLQFIRSPQRNPTV 123

Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIG 215
           ++ I+F   ++ RG++YL E K +HRD+  +N +L ++  VK+ DFG++  +   +    
Sbjct: 124 KDLISF-GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182

Query: 216 RRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           +++     P  W A E +         +  +SD+WS G+   E+ 
Sbjct: 183 QQHRHARLPVKWTALESLQ-----TYRFTTKSDVWSFGVLLWELL 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  112 bits (282), Expect = 3e-28
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 29/224 (12%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGR-HTKTGQLA-AIKVM--DVTEDEEEEIKLE 101
           + +       +      +G G +G V +G    +  Q+  AIKV+     + + EE+  E
Sbjct: 1   DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 60

Query: 102 INVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEW 161
             ++ +  ++  I    G   +         L LVME  G G +   +   + + +    
Sbjct: 61  AQIMHQL-DNPYIVRLIGV-CQAEA------LMLVMEMAGGGPLHKFLVGKREE-IPVSN 111

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI 221
           +A +  ++  G+KYL E   +HRD+  +NVLL +    K+ DFG+S    + +G  +++ 
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS----KALGADDSYY 167

Query: 222 GT------PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                   P  W APE I         + +RSD+WS G+T  E 
Sbjct: 168 TARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEA 206

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  112 bits (282), Expect = 3e-28
 Identities = 46/227 (20%), Positives = 90/227 (39%), Gaps = 35/227 (15%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLA-------AIKVM-DVTEDEEEEIKL 100
            +     +    E +G GT+ +++KG   + G           +KV+     +  E    
Sbjct: 3   HKIRNEDL-IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
             +++ K  +H+++   YG  +            LV E+   GS+   +K  K   +   
Sbjct: 62  AASMMSKL-SHKHLVLNYGVCVCGDE------NILVQEFVKFGSLDTYLKKNKNC-INIL 113

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLT--------DNAEVKLVDFGVSAQLDR 212
           W   + +++   + +L EN +IH ++  +N+LL         +   +KL D G+S  +  
Sbjct: 114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173

Query: 213 TIGRRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
               +         W+ PE I   +N     +  +D WS G T  E+
Sbjct: 174 KDILQ-----ERIPWVPPECIENPKN----LNLATDKWSFGTTLWEI 211

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  112 bits (282), Expect = 4e-28
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 35/224 (15%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYS----- 109
           +EL E++G G   +V+  R  +  +  A+KV+  D+  D             ++      
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPS--------FYLRFRREAQN 65

Query: 110 ----NHRNIATYY--GAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
               NH  I   Y  G    ++        ++VMEY    ++ D+V       +  +   
Sbjct: 66  AAALNHPAIVAVYDTG----EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAI 119

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV---SAQLDRTIGRRNTF 220
            +  +  + L + H+N +IHRD+K  N++++    VK++DFG+    A    ++ +    
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179

Query: 221 IGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP 264
           IGT  +++PE  A  ++ DA    RSD++SLG    E+   +PP
Sbjct: 180 IGTAQYLSPE-QARGDSVDA----RSDVYSLGCVLYEVLTGEPP 218

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  112 bits (283), Expect = 5e-28
 Identities = 51/240 (21%), Positives = 87/240 (36%), Gaps = 42/240 (17%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM-DVTEDEEEEI 98
                      I  L   +G G +G+V+          +   L A+K + + +E   ++ 
Sbjct: 32  DACVHHIKRRDI-VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF 90

Query: 99  KLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS-------------V 145
           + E  +L     H++I  ++G   +  P      L +V EY   G              +
Sbjct: 91  QREAELLTML-QHQHIVRFFGVCTEGRP------LLMVFEYMRHGDLNRFLRSHGPDAKL 143

Query: 146 TDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG 205
               +      L    +  +  ++  G+ YL     +HRD+  +N L+     VK+ DFG
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203

Query: 206 VSAQLDRTIG-----RRNTFIGTPY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
           +S    R I      R       P  WM PE I         +   SD+WS G+   E+ 
Sbjct: 204 MS----RDIYSTDYYRVGGRTMLPIRWMPPESIL-----YRKFTTESDVWSFGVVLWEIF 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (281), Expect = 6e-28
 Identities = 55/244 (22%), Positives = 105/244 (43%), Gaps = 29/244 (11%)

Query: 33  AGLEKRSYTEGWPE-DRWQEDPAGIFELIEVVGNGTYGQVYKGR---HTKTGQLAAIKVM 88
           +GL  R   E   + +    D   +  L +++G G +G V +G       T    A+K M
Sbjct: 12  SGLVPRGSEELQNKLEDVVIDRNLL-ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM 70

Query: 89  ---DVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSV 145
              + ++ E EE   E   +K + +H N+    G    +       +  +++ +   G +
Sbjct: 71  KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGV-CIEMSSQGIPKPMVILPFMKYGDL 128

Query: 146 TDLVKS----TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
              +      T  + +  + +     +I  G++YL     +HRD+  +N +L D+  V +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188

Query: 202 VDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGITA 255
            DFG+S    + I   + +        P  W+A E +A     D  Y ++SD+W+ G+T 
Sbjct: 189 ADFGLS----KKIYSGDYYRQGRIAKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTM 239

Query: 256 LEMA 259
            E+A
Sbjct: 240 WEIA 243

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  113 bits (284), Expect = 6e-28
 Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 45/238 (18%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-------HTKTGQLAAIKVM--DVTEDEE 95
            + +W E P     L + +G G +GQV             K     A+K++  D TE + 
Sbjct: 72  EDPKW-EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 130

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS----------- 144
            ++  E+ ++K    H+NI    GA  +  P      L++++EY   G+           
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPP 184

Query: 145 ---VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
               +  +     + +  + +     ++ RG++YL   K IHRD+  +NVL+T+N  +K+
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244

Query: 202 VDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGI 253
            DFG    L R I   + +  T     P  WMAPE +      D  Y ++SD+WS G+
Sbjct: 245 ADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGV 293

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  112 bits (283), Expect = 1e-27
 Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 44/249 (17%)

Query: 40  YTEGWPEDRWQEDPAGIFELI-EVVGNGTYGQVYKGR--HTKTGQLAAIKVMDVTEDEEE 96
           Y         +E    +FE     VG GTYG VYK +    K  +  A+K ++       
Sbjct: 5   YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISM 63

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK------ 150
               EI +L++   H N+ +    F+  +    D ++WL+ +Y       DL        
Sbjct: 64  SACREIALLRE-LKHPNVISLQKVFLSHA----DRKVWLLFDYAE----HDLWHIIKFHR 114

Query: 151 ----STKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT----DNAEVKLV 202
               + K   L    +  +  +IL G+ YLH N V+HRD+K  N+L+     +   VK+ 
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174

Query: 203 DFGVSAQLDRTIGR--RNTFIGTP----YWM-APEVIACDENPDATYDNRSDLWSLG-IT 254
           D G      R      +      P    +W  APE++         Y    D+W++G I 
Sbjct: 175 DMG----FARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIF 226

Query: 255 ALEMAESQP 263
           A E+  S+P
Sbjct: 227 A-ELLTSEP 234

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (281), Expect = 2e-27
 Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 45/238 (18%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-------HTKTGQLAAIKVM--DVTEDEE 95
            + RW+     +  L + +G G +GQV                   A+K++  D TE + 
Sbjct: 60  EDPRWELPRDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 118

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS----------- 144
            ++  E+ ++K    H+NI    GA  +  P      L++++EY   G+           
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRPP 172

Query: 145 ---VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
               +        + L  + +     ++ RG++YL   K IHRD+  +NVL+T++  +K+
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 232

Query: 202 VDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGI 253
            DFG    L R I   + +  T     P  WMAPE +      D  Y ++SD+WS G+
Sbjct: 233 ADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGV 281

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  110 bits (278), Expect = 2e-27
 Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 48/239 (20%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEEEIK 99
           D W+     I  +   +G G++G VY+G        +     AIK +    +  E  E  
Sbjct: 18  DEWEVAREKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL 76

Query: 100 LEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKE 159
            E +V+K++ N  ++    G   +  P        ++ME    G +   ++S +      
Sbjct: 77  NEASVMKEF-NCHHVVRLLGVVSQGQP------TLVIMELMTRGDLKSYLRSLRPAMANN 129

Query: 160 EWIA--------FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD 211
             +A         +  EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ DFG++    
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---- 185

Query: 212 RTIGRRNTFIGTPY-----------WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
                R+ +    Y           WM+PE +      D  +   SD+WS G+   E+A
Sbjct: 186 -----RDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIA 234

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  113 bits (284), Expect = 5e-27
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 29/225 (12%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-HTKTGQLA-AIKVM--DVTEDEEEEIKL 100
            + +       +      +G G +G V +G    +  Q+  AIKV+     + + EE+  
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           E  ++ +  ++  I    G   +         L LVME  G G +   +   + + +   
Sbjct: 386 EAQIMHQL-DNPYIVRLIG-VCQAEA------LMLVMEMAGGGPLHKFLVGKREE-IPVS 436

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTF 220
            +A +  ++  G+KYL E   +HR++  +NVLL +    K+ DFG+S    + +G  +++
Sbjct: 437 NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS----KALGADDSY 492

Query: 221 IGT------PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
                    P  W APE I         + +RSD+WS G+T  E 
Sbjct: 493 YTARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEA 532

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  110 bits (276), Expect = 5e-27
 Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 50/243 (20%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEEE 97
            + +W+     + E  +V+G+G +G+V          T      A+K++       E E 
Sbjct: 36  YDLKWEFPRENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA 94

Query: 98  IKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS------------- 144
           +  E+ ++ +  +H NI    GA     P      ++L+ EYC  G              
Sbjct: 95  LMSELKMMTQLGSHENIVNLLGACTLSGP------IYLIFEYCCYGDLLNYLRSKREKFS 148

Query: 145 --------VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN 196
                      L +      L  E +     ++ +G+++L     +HRD+  +NVL+T  
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 208

Query: 197 AEVKLVDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWS 250
             VK+ DFG    L R I   + ++       P  WMAPE +      +  Y  +SD+WS
Sbjct: 209 KVVKICDFG----LARDIMSDSNYVVRGNARLPVKWMAPESLF-----EGIYTIKSDVWS 259

Query: 251 LGI 253
            GI
Sbjct: 260 YGI 262

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  109 bits (274), Expect = 5e-27
 Identities = 58/245 (23%), Positives = 86/245 (35%), Gaps = 55/245 (22%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM-DVTEDEEEEIKL 100
                    I  L   +G G +G+V+         TK   L A+K + D T    ++ + 
Sbjct: 8   HVQHIKRRDI-VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR 66

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS--------------VT 146
           E  +L     H +I  +YG      P      L +V EY   G               + 
Sbjct: 67  EAELLTNL-QHEHIVKFYGVCGDGDP------LIMVFEYMKHGDLNKFLRAHGPDAMILV 119

Query: 147 DLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV 206
           D         L    +  I  +I  G+ YL     +HRD+  +N L+  N  VK+ DFG+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179

Query: 207 SAQLDRTIGRRNTFIGTPY------------WMAPEVIACDENPDATYDNRSDLWSLGIT 254
           S    R +        T Y            WM PE I         +   SD+WS G+ 
Sbjct: 180 S----RDVYS------TDYYRVGGHTMLPIRWMPPESIM-----YRKFTTESDVWSFGVI 224

Query: 255 ALEMA 259
             E+ 
Sbjct: 225 LWEIF 229

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  110 bits (276), Expect = 6e-27
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 38/236 (16%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEEE 97
             D  +     I  LI  +G+G +G+VY+G+     +  +    A+K +    +E +E +
Sbjct: 62  ISDLKEVPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120

Query: 98  IKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL 157
             +E  ++ K+ NH+NI    G  ++  P       ++++E    G +   ++ T+ +  
Sbjct: 121 FLMEALIISKF-NHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPS 173

Query: 158 KEEWIAF-----ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQ 209
           +   +A      + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  
Sbjct: 174 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-- 231

Query: 210 LDRTIGRRNTFIGTPY------WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
             R I R   +           WM PE        +  + +++D WS G+   E+ 
Sbjct: 232 --RDIYRAGYYRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIF 280

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  109 bits (274), Expect = 7e-27
 Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 52/251 (20%)

Query: 39  SYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVT 91
              +   + +W E P     L + +G G +G+V K               A+K++  + +
Sbjct: 8   DAFKILEDPKW-EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66

Query: 92  EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS------- 144
             E  ++  E NVLK+  NH ++   YGA  +  P      L L++EY   GS       
Sbjct: 67  PSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGP------LLLIVEYAKYGSLRGFLRE 119

Query: 145 ---------------VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ 189
                           +  +     ++L    +     +I +G++YL E K++HRD+  +
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179

Query: 190 NVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGT-----PY-WMAPEVIACDENPDATYD 243
           N+L+ +  ++K+ DFG    L R +   ++++       P  WMA E +      D  Y 
Sbjct: 180 NILVAEGRKMKISDFG----LSRDVYEEDSYVKRSQGRIPVKWMAIESLF-----DHIYT 230

Query: 244 NRSDLWSLGIT 254
            +SD+WS G+ 
Sbjct: 231 TQSDVWSFGVL 241

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  109 bits (274), Expect = 7e-27
 Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 38/236 (16%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEEE 97
             D  +     I  LI  +G+G +G+VY+G+     +  +    A+K +    +E +E +
Sbjct: 21  ISDLKEVPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79

Query: 98  IKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS-----T 152
             +E  ++ K+ NH+NI    G  ++  P       +++ME    G +   ++      +
Sbjct: 80  FLMEALIISKF-NHQNIVRCIGVSLQSLP------RFILMELMAGGDLKSFLRETRPRPS 132

Query: 153 KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVSAQ 209
           +  SL    +  + R+I  G +YL EN  IHRDI  +N LLT        K+ DFG++  
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-- 190

Query: 210 LDRTIGRRNTFIGTPY------WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
             R I R + +           WM PE        +  + +++D WS G+   E+ 
Sbjct: 191 --RDIYRASYYRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIF 239

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  108 bits (271), Expect = 8e-27
 Identities = 32/267 (11%), Positives = 71/267 (26%), Gaps = 54/267 (20%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYS 109
            G + L+   G     Q ++   T   +  A+  +D    + +D  +E       L +  
Sbjct: 30  NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI- 88

Query: 110 NHRNIATYYGAFIKKSPPGKDD-QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
           +   +A                    +V E+   GS+ ++  +    S          + 
Sbjct: 89  DKPGVARVLDV-------VHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQS 137

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMA 228
           +       H   V         V ++ + +V L                         M 
Sbjct: 138 LAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------------------MP 177

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-----PP 283
                         + + D+  +G +   +  ++ PL +      L    R+       P
Sbjct: 178 DA------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRP 310
               +  P +  +     +  D   R 
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRS 252

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  107 bits (270), Expect = 6e-26
 Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 24/214 (11%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-- 111
              +E+  ++G G++GQV K       +  AIK++   +    + ++E+ +L+  + H  
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 112 ---RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
                I      F+ ++       L LV E     ++ DL+++T  + +         ++
Sbjct: 113 EMKYYIVHLKRHFMFRN------HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 169 ILRGLKYLHENK--VIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           +   L +L   +  +IH D+K +N+LL +   + +K+VDFG S QL + I     +I + 
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSR 222

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEM 258
           ++ +PEV+         YD   D+WSLG   +EM
Sbjct: 223 FYRSPEVLL-----GMPYDLAIDMWSLGCILVEM 251

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  104 bits (263), Expect = 1e-25
 Identities = 54/234 (23%), Positives = 87/234 (37%), Gaps = 53/234 (22%)

Query: 58  ELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSN 110
             +E +G   +G+VYKG        +  Q  AIK +         EE + E  +  +   
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-Q 70

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS--------------VTDLVKSTKGQS 156
           H N+    G   K  P      L ++  YC  G                +     T   +
Sbjct: 71  HPNVVCLLGVVTKDQP------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 157 LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGR 216
           L+      +  +I  G++YL  + V+H+D+  +NVL+ D   VK+ D G+     R +  
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF----REVYA 180

Query: 217 RNTFIGTPY-----------WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            +      Y           WMAPE I         +   SD+WS G+   E+ 
Sbjct: 181 ADY-----YKLLGNSLLPIRWMAPEAIM-----YGKFSIDSDIWSYGVVLWEVF 224

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  105 bits (264), Expect = 3e-25
 Identities = 81/342 (23%), Positives = 124/342 (36%), Gaps = 96/342 (28%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH----R 112
           F +I  +G+GT+G+V   +H    +  A+KV+   +      K+E ++LKK  N      
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI  Y+G F+        D + L+ E  G  S+ +++          E I   C EIL+ 
Sbjct: 97  NIVKYHGKFMYY------DHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKA 149

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNA-------------------------EVKLVDFGVS 207
           L YL +  + H D+K +N+LL D                            +KL+DFG +
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD 267
                      + I T  + APEVI      +  +D  SD+WS G    E+         
Sbjct: 210 TFKSDYH---GSIINTRQYRAPEVIL-----NLGWDVSSDMWSFGCVLAELYTGSL---- 257

Query: 268 LHP-----------MRALFLIP----RNAPPRLKSK---------KWPKK---------- 293
           L                +  IP      A     SK          WP+           
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317

Query: 294 --------------FQSFIETVLVKDYHQRPYTDQLLKHPFI 321
                         F  F+ ++L  D   RP   +LLKH F+
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  105 bits (263), Expect = 3e-25
 Identities = 55/261 (21%), Positives = 95/261 (36%), Gaps = 62/261 (23%)

Query: 39  SYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVT 91
                      +     I E +  +G G +G+V++ R       +   + A+K++  + +
Sbjct: 32  PLLLNPKLLSLEYPRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS 90

Query: 92  EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS------- 144
            D + + + E  ++ ++ ++ NI    G      P      + L+ EY   G        
Sbjct: 91  ADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKP------MCLLFEYMAYGDLNEFLRS 143

Query: 145 ---------------VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ 189
                              V S     L       I R++  G+ YL E K +HRD+  +
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203

Query: 190 NVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY-----------WMAPEVIACDENP 238
           N L+ +N  VK+ DFG+S    R I   +      Y           WM PE I      
Sbjct: 204 NCLVGENMVVKIADFGLS----RNIYSADY-----YKADGNDAIPIRWMPPESIF----- 249

Query: 239 DATYDNRSDLWSLGITALEMA 259
              Y   SD+W+ G+   E+ 
Sbjct: 250 YNRYTTESDVWAYGVVLWEIF 270

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  103 bits (259), Expect = 1e-24
 Identities = 62/342 (18%), Positives = 110/342 (32%), Gaps = 90/342 (26%)

Query: 57  FELIEVVGNGTYGQVYKGR-HTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK-----YSN 110
           +E++  +G GT+G+V +   H +     A+K++       E  +LEINVLKK       N
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
                     F           + +  E  G  +  + +K    Q      +  +  ++ 
Sbjct: 81  KFLCVLMSDWFNFH------GHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLC 133

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDN-------------------AEVKLVDFGVSAQLD 211
             L++LHEN++ H D+K +N+L  ++                     +++ DFG +    
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP- 270
                  T + T ++  PEVI      +  +    D+WS+G    E          L   
Sbjct: 194 EHH---TTIVATRHYRPPEVIL-----ELGWAQPCDVWSIGCILFEYYRGFT----LFQT 241

Query: 271 ----------MRALFLIPR-----------------NAPPRLKSKKWPKK---------- 293
                      + L  IP                           ++ K+          
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301

Query: 294 --------FQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE 327
                       +  +L  D  QR    + L HPF      E
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  100 bits (251), Expect = 1e-23
 Identities = 63/340 (18%), Positives = 119/340 (35%), Gaps = 90/340 (26%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMDVTEDEEEEIKLEINVLKK-----YSN 110
           +E+++ +G G +G+V +    K G +  A+K++   +   E  + EI VL+       ++
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
                     F           + +V E  G  S  D +K       + + I  +  +I 
Sbjct: 76  TFRCVQMLEWFEHH------GHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQIC 128

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDN-------------------AEVKLVDFGVSAQLD 211
           + + +LH NK+ H D+K +N+L   +                    ++K+VDFG +   D
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP- 270
                 +T + T ++ APEVI         +    D+WS+G   +E          + P 
Sbjct: 189 EHH---STLVSTRHYRAPEVIL-----ALGWSQPCDVWSIGCILIEYYLGFT----VFPT 236

Query: 271 ----------MRALFLIPR-----------------NAPPRLKSKKWPKK---------- 293
                      R L  +P+                 +      + ++  +          
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296

Query: 294 --------FQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP 325
                       I+ +L  D  +R    + LKHPF     
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 51/283 (18%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE-EEEIKLEINVLKKYSNHRNIA 115
           F+   ++G+G +G+VYKG   + G   A+K       +  EE + EI  L     H ++ 
Sbjct: 41  FDHKFLIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLV 98

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA--FICREILRGL 173
           +  G   +       +++ L+ +Y   G++   +  +   ++   W     IC    RGL
Sbjct: 99  SLIGFCDE------RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS---AQLDRT-IGRRNTFI-GTPYWMA 228
            YLH   +IHRD+K  N+LL +N   K+ DFG+S    +LD+T +   +T + GT  ++ 
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL---STVVKGTLGYID 209

Query: 229 PEVIACDENPDATYDNR------SDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP 282
           PE           Y  +      SD++S G+   E+  ++  +    P   + L      
Sbjct: 210 PE-----------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258

Query: 283 ------------PRLKSKKWPKKFQSFIETVL--VKDY-HQRP 310
                       P L  K  P+  + F +T +  +      RP
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 45/217 (20%)

Query: 62  VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSN--HRNIATY 117
           ++G G +G+VYKGR    G L A+K +        E + + E+ ++   S   HRN+   
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMI---SMAVHRNLLRL 92

Query: 118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA--FICREILRGLKY 175
            G  +         +  LV  Y   GSV   ++         +W     I     RGL Y
Sbjct: 93  RGFCMT------PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146

Query: 176 LHEN---KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI-----GTPYWM 227
           LH++   K+IHRD+K  N+LL +  E  + DFG    L + +  ++T +     GT   +
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHI 202

Query: 228 APEVIACDENPDATYDNR------SDLWSLGITALEM 258
           APE           Y +       +D++  G+  LE+
Sbjct: 203 APE-----------YLSTGKSSEKTDVFGYGVMLLEL 228

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 92.2 bits (230), Expect = 5e-21
 Identities = 62/222 (27%), Positives = 89/222 (40%), Gaps = 37/222 (16%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE-----EEEIKLEINVLK 106
           D   I      +G G +G VYKG         A+K +    D      +++   EI V+ 
Sbjct: 28  DERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85

Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD-LVKSTKGQSLKEEWIA-- 163
           K   H N+    G           D L LV  Y   GS+ D L        L   W    
Sbjct: 86  KCQ-HENLVELLGFSSD------GDDLCLVYVYMPNGSLLDRLSCLDGTPPL--SWHMRC 136

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT--FI 221
            I +    G+ +LHEN  IHRDIK  N+LL +    K+ DFG++   ++      T   +
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV 196

Query: 222 GTPYWMAPEVIACDENPDATY-----DNRSDLWSLGITALEM 258
           GT  +MAPE                   +SD++S G+  LE+
Sbjct: 197 GTTAYMAPE-----------ALRGEITPKSDIYSFGVVLLEI 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 37/290 (12%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
              + L   +G+G++G +Y G     G+  AIK+  V + +  ++ +E  + K       
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVG 66

Query: 114 IATYYGAFIKKSPPGKDDQL-WLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
           I T           G +     +VME  G  S+ DL      + SLK   +  +  +++ 
Sbjct: 67  IPTIRWC-------GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKT--VLLLADQMIS 116

Query: 172 GLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQ-LDRTIGR------RNTFI 221
            ++Y+H    IHRD+K  N L+        V ++DFG++ +  D    +           
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP------LCDLHPMRALF 275
           GT  + +   I      + +   R DL SLG   +       P               + 
Sbjct: 177 GTARYAS---INTHLGIEQSR--RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231

Query: 276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKHPFIR 322
               + P  +  K +P +F +++       +  +P   Y  QL ++ F R
Sbjct: 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 54/292 (18%), Positives = 110/292 (37%), Gaps = 39/292 (13%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
              +++   +G G++G +++G +    Q  AIK       +  +++ E    K  +    
Sbjct: 9   GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTG 67

Query: 114 IATYYGAFIKKSPPGKDDQL-WLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
           I   Y         G++     LV++  G  S+ DL+     + S+K   +A   +++L 
Sbjct: 68  IPNVYYF-------GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT--VAMAAKQMLA 117

Query: 172 GLKYLHENKVIHRDIKGQNVLL-----TDNAEVKLVDFGVSAQ-LDRTIGR------RNT 219
            ++ +HE  +++RDIK  N L+      +   + +VDFG+     D    +      +  
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP------LCDLHPMRA 273
             GT  +M+   I      + +   R DL +LG   +       P        +      
Sbjct: 178 LSGTARYMS---INTHLGREQSR--RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232

Query: 274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKHPFIR 322
           +    ++ P R     +P++F  ++       +   P   Y   L      R
Sbjct: 233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 51/265 (19%), Positives = 92/265 (34%), Gaps = 68/265 (25%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK-------YS 109
           + +I  +G G +  V+     +  +  A+KV+   E   E    EI +LK          
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           N   +      F      G    + +V E  G   +   +  +  Q L    +  I +++
Sbjct: 99  NREMVVQLLDDFKISGVNGT--HICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 170 LRGLKYLH-ENKVIHRDIKGQNVLLT---------------------------------- 194
           L+GL YLH + ++IH DIK +N+LL+                                  
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 195 ---------------DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPD 239
                          +  +VK+ D G +  + +        I T  + + EV+       
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLI-----G 267

Query: 240 ATYDNRSDLWSLGITALEMAESQPP 264
           + Y+  +D+WS    A E+A     
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYL 292

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 88.1 bits (218), Expect = 6e-19
 Identities = 64/419 (15%), Positives = 134/419 (31%), Gaps = 53/419 (12%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
              F L   +G+G++G++Y G + +T +  AIK+ +V + +  ++  E  + +       
Sbjct: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTG 64

Query: 114 IATYYGAFIKKSPPGKDDQL-WLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
           I             G +     LVM+  G  S+ DL      + SLK   +  +  +++ 
Sbjct: 65  IPNVRWF-------GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKT--VLMLADQMIN 114

Query: 172 GLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQ-LDRTIGR------RNTFI 221
            ++++H    +HRDIK  N L+       +V ++DFG++ +  D +  +           
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP------LCDLHPMRALF 275
           GT  + +   +      + +   R DL SLG   +       P               + 
Sbjct: 175 GTARYAS---VNTHLGIEQSR--RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229

Query: 276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK--------------HPF- 320
                       + +P +F S+        +  +P    L +              + F 
Sbjct: 230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFD 289

Query: 321 --IRDQPTERQARIQLKDHIDTCKKRKKERDDYRYSGSENEEEETGVGGEPSSIIQAPGD 378
             I      + A    +                +       +E    G       +AP  
Sbjct: 290 WTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPP 349

Query: 379 NTLRRNFQQIQKLENCARSSSSSTSTATPTPRIQTPTHPTTATPTSTENFPCVPTHDSD 437
                   + +        +S S             +  ++  P  + +   +P   S+
Sbjct: 350 IASVGTLAKQKA--PVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSE 406

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 53/302 (17%), Positives = 98/302 (32%), Gaps = 41/302 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           + L + +G+G +G +Y    T   +  A  V+ V   E   +  E+   ++ +    I  
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 117 YYGAFIKKSP------------PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           +                            ++VME  G   +  +             +  
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKST--VLQ 155

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLL--TDNAEVKLVDFGVSAQ-------LDRTIG 215
           +   +L  L+Y+HEN+ +H DIK  N+LL   +  +V L D+G+S +             
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215

Query: 216 RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF 275
            R    GT  +      + D +       RSD+  LG   L     + P           
Sbjct: 216 PRKGHNGTIEFT-----SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270

Query: 276 L---------IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKHPFIRD 323
                     +P++      S     +   F+       Y ++P      ++L    I  
Sbjct: 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330

Query: 324 QP 325
            P
Sbjct: 331 GP 332

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 30/213 (14%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
              F + + +G G +G++  G++  T +  AIK+  + +    ++ LE    K+  +   
Sbjct: 8   GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDG 66

Query: 114 IATYYGAFIKKSPPGKDDQL-WLVMEYCGAGSVTDLVKSTKGQ-SLKEEWIAFICREILR 171
           I   Y         G   +   +V+E  G  S+ DL        SLK   +  I  +++ 
Sbjct: 67  IPQVYYF-------GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKT--VLMIAIQLIS 116

Query: 172 GLKYLHENKVIHRDIKGQNVLL-----TDNAEVKLVDFGVSAQ-LDRTIGR------RNT 219
            ++Y+H   +I+RD+K +N L+          + ++DF ++ + +D    +        +
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
             GT  +M+   I      + +   R DL +LG
Sbjct: 177 LTGTARYMS---INTHLGKEQSR--RDDLEALG 204

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 82.2 bits (202), Expect = 2e-17
 Identities = 41/231 (17%), Positives = 69/231 (29%), Gaps = 58/231 (25%)

Query: 53  PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---------EEIKLEIN 103
           P    +  E +G G +G+V++     T    AIK++ +   +          EEI  EI 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 104 VLKKYS--------NHRNIATYYGAFIKKSPPGK------------------------DD 131
           + K+ S                      +                             DD
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQN 190
           QL++V+E+   G   DL +     S      + I  ++   L     + +  HRD+   N
Sbjct: 136 QLFIVLEFEFGG--IDLEQMRTKLSSLATAKS-ILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 191 VLLTDNAEVKLVD-----------FGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           VLL   +  KL              G+   +      R    G   +    
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 39/222 (17%), Positives = 84/222 (37%), Gaps = 36/222 (16%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA--------AIKVMDVTEDEEEEIKLEINVLKKY 108
           ++L         G +Y+   T T            ++K+    + ++  +  E N  ++ 
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL----DAKDGRLFNEQNFFQRA 99

Query: 109 SNHRNIATYYGAFIKKSP--P-----GKDDQLW--LVMEYCGAGSVTDLVKSTKGQSLKE 159
           +    +  +   +       P     G     +  LV+   G  S+   +  +    L E
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSE 158

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLL--TDNAEVKLVDFGVSAQ-------L 210
             +  +   +L  L++LHEN+ +H ++  +N+ +   D ++V L  +G + +       +
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
               G R+   G   ++     + D +       RSDL SLG
Sbjct: 219 AYVEGSRSPHEGDLEFI-----SMDLHKGCGPSRRSDLQSLG 255

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 61/288 (21%), Positives = 103/288 (35%), Gaps = 82/288 (28%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEE 96
           +   +W E P    +L + +G G +GQV +        T T +  A+K++    T  E  
Sbjct: 12  YDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 70

Query: 97  EIKLEINVLKK------------------------------------YSNHRNIATYYGA 120
            +  E+ +L                                        + RN    Y  
Sbjct: 71  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130

Query: 121 FIKKSPPGKDDQ----------LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
              +   GKD            L  +     + S   + + +     +EE    + ++ L
Sbjct: 131 KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFL 190

Query: 171 -------------RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR 217
                        +G+++L   K IHRD+  +N+LL++   VK+ DFG    L R I + 
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKD 246

Query: 218 NTFIGT-----PY-WMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
             ++       P  WMAPE I      D  Y  +SD+WS G+   E+ 
Sbjct: 247 PDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIF 289

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 40/220 (18%), Positives = 84/220 (38%), Gaps = 32/220 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA--AIKVMDVTEDEEEEIKLEINVLKKYSNHRNI 114
           +++   +G G +G +Y      +  +   A  V+ V   +   +  E+   ++ +    I
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 115 ATYYGAFIKKSP------------PGKDDQLWLVMEYCGAGSVTDLVKSTKGQ-SLKEEW 161
             +      K                     +++M+  G+  +  + ++   + S K   
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKT-- 153

Query: 162 IAFICREILRGLKYLHENKVIHRDIKGQNVLL--TDNAEVKLVDFGVSAQ-------LDR 212
           +  +   IL  L+Y+HE++ +H DIK  N+LL   +  +V LVD+G++ +          
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

Query: 213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLG 252
               +    GT  +      + D +       R DL  LG
Sbjct: 214 AADPKRCHDGTIEFT-----SIDAHNGVAPSRRGDLEILG 248

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	463
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.81
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.21
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.79
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.49
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.48
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.4
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.37
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.97
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.82
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.81
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.73
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.72
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.72
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.67
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.65
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.61
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.29
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.24
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.82
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.46
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.48
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.78

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-67  Score=514.97  Aligned_cols=258  Identities=28%  Similarity=0.547  Sum_probs=226.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...   ....+.+.+|+.+|+++ +|||||+++++|      ++.
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~------~~~   95 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESF------EEN   95 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE------EET
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEE------EEC
Confidence            35899999999999999999999999999999999743   33456788999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|||||||+||+|.+++...++..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus        96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            79999999999999999998777677899999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ..........+||+.|||||++.     +..|+.++||||||||||||++|++||.+.+..+.+..+.....+. ....+
T Consensus       176 ~~~~~~~~~~~GT~~YmAPE~l~-----~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-~~~~~  249 (350)
T 4b9d_A          176 NSTVELARACIGTPYYLSPEICE-----NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-VSLHY  249 (350)
T ss_dssp             CHHHHHHHHHHSCCTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-CCTTS
T ss_pred             cCCcccccccCCCccccCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-CCccC
Confidence            65544456678999999999997     5679999999999999999999999999998888888777665543 34578


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++++++||.+||.+||.+|||++|+|+||||+..
T Consensus       250 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.2e-66  Score=505.10  Aligned_cols=257  Identities=39%  Similarity=0.745  Sum_probs=230.3

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +...|+++++||+|+||+||+|+++.+|+.||||++... ....+.+.+|+.+|+.+ +|||||+++++|      .+.+
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~------~~~~  144 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSY------LVGD  144 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEE------EETT
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEE------EECC
Confidence            445799999999999999999999999999999999743 23345678999999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|||||||+||+|.+++...   .+++..++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            999999999999999999753   59999999999999999999999999999999999999999999999999999887


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-CCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKKW  290 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~  290 (463)
                      .........+||+.|||||++.     ...|+.++||||||||+|||++|.+||.+.+..+.+..+.....+... ...+
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~-----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  296 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV  296 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGS
T ss_pred             CCCCcccccccCcCcCCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccC
Confidence            6656667789999999999997     667999999999999999999999999999888888777665544433 3568


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++++++||.+||.+||.+|||++|+|+||||++.
T Consensus       297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            9999999999999999999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.1e-65  Score=492.33  Aligned_cols=257  Identities=26%  Similarity=0.480  Sum_probs=228.4

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+|+++|+++ +|||||+++++|      ++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~------~~~  104 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTF------QDD  104 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEE------ECS
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------EeC
Confidence            5699999999999999999999999999999999742    34457789999999999 899999999999      556


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|||||||+||+|.+++...+  .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            89999999999999999998765  6999999999999999999999999999999999999999999999999999987


Q ss_pred             ccc--cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         211 DRT--IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       211 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ...  .....+.+||+.|||||++.     +..|+.++|||||||++|+|++|++||.+.+....+..|.......  +.
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~-----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--p~  255 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLT-----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF--PE  255 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHH-----HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CT
T ss_pred             CCCCCcccccCcccCcccCCHHHHc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--Cc
Confidence            532  23446779999999999998     5679999999999999999999999999988888777776654422  34


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHH------HhcCccccCCchh
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQ------LLKHPFIRDQPTE  327 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e------~l~hp~~~~~~~~  327 (463)
                      .+++++++||.+||.+||.+|||++|      +++||||++..++
T Consensus       256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          256 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence            68999999999999999999999988      5899999876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-64  Score=508.62  Aligned_cols=258  Identities=39%  Similarity=0.754  Sum_probs=231.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++.+.|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.+ +|||||+++++|.      ..
T Consensus       148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~------~~  220 (423)
T 4fie_A          148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYL------VG  220 (423)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEE------ET
T ss_pred             ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEE------EC
Confidence            44567999999999999999999999999999999997543 3445688999999999 8999999999994      45


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|||||||+||+|.+++...   .+++..++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus       221 ~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          221 DELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence            7999999999999999999753   5999999999999999999999999999999999999999999999999999988


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~  289 (463)
                      ..........+||+.|||||++.     ...|+.++||||||||+|||++|++||.+.+....+..+.....+.. ....
T Consensus       298 ~~~~~~~~~~~GTp~YmAPEvl~-----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  372 (423)
T 4fie_A          298 SKEVPRRKSLVGTPYWMAPELIS-----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK  372 (423)
T ss_dssp             CSSCCCBCCCEECTTTCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred             CCCCccccccccCcCcCCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc
Confidence            76656667789999999999997     67799999999999999999999999999988888887766654443 3357


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      +++++++||.+||..||.+|||++|+|+||||++.
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            89999999999999999999999999999999854

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.8e-63  Score=474.42  Aligned_cols=256  Identities=29%  Similarity=0.488  Sum_probs=218.1

Q ss_pred             Cce-EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIF-ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++| ++.++||+|+||+||+|++..++..||+|++...   ....+.+.+|+.+|+++ +|||||+++++|....  ...
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~--~~~  101 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTV--KGK  101 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEE--TTE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeecc--CCC
Confidence            455 7888999999999999999999999999998633   33456788999999999 8999999999985321  223


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEcc-CCcEEEEecccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTD-NAEVKLVDFGVS  207 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~~-~~~vkL~DFGla  207 (463)
                      +.+|||||||+||+|.+++....  .+++..++.|++||+.||+|||++|  ||||||||+||||+. ++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            57899999999999999998654  6999999999999999999999998  999999999999974 799999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc-ccCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRLK  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~-i~~~~~~~~~  286 (463)
                      +....  ....+.+||+.|||||++.      ..|+.++|||||||+||||+||++||.+......+.. +.....+...
T Consensus       180 ~~~~~--~~~~~~~GTp~YmAPE~~~------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~  251 (290)
T 3fpq_A          180 TLKRA--SFAKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF  251 (290)
T ss_dssp             GGCCT--TSBEESCSSCCCCCGGGGG------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred             EeCCC--CccCCcccCccccCHHHcC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC
Confidence            86543  2345678999999999885      3599999999999999999999999987766555443 4444444344


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ...+++++++||.+||..||.+|||++|+|+||||++
T Consensus       252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            5567889999999999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-63  Score=474.16  Aligned_cols=251  Identities=25%  Similarity=0.440  Sum_probs=206.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+|+.+|+++ +|||||+++++|      ++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~------~~~   85 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVI------KSK   85 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEE------ECS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEE------EEC
Confidence            5799999999999999999999999999999999643    23356788999999999 899999999999      556


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+||||||| +|+|.+++....  .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        86 ~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           86 DEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             SEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             CEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence            8999999999 679999997654  6999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDAT-YDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ... ....+.+||+.|||||++.     +.. ++.++|||||||++|+|++|++||.+.+....+..+......  .+..
T Consensus       163 ~~~-~~~~~~~GT~~Y~APE~~~-----~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~--~p~~  234 (275)
T 3hyh_A          163 TDG-NFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT--LPKF  234 (275)
T ss_dssp             -------------CTTSCHHHHS-----SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTT
T ss_pred             CCC-CccCCeeECcccCChhhhc-----CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCCC
Confidence            543 2335678999999999997     344 468999999999999999999999988777766666555433  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +++++++||.+||+.||.+|||++|+|+||||+.
T Consensus       235 ~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          235 LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            8999999999999999999999999999999964

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.5e-64  Score=485.45  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=219.4

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+|++++.||+|+||+||+|++.   .+++.||||++...   ......+.+|+.+|+++ +|||||+++++|      +
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~------~   96 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAF------Q   96 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEE------E
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEE------E
Confidence            57999999999999999999984   46889999999643   22344678899999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +++.+|||||||+||+|.+++...+  .+++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence            5589999999999999999998755  69999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ..........+.+||+.|||||++.     +..|+.++|||||||++|||++|++||.+.+..+.+..+.......  +.
T Consensus       175 ~~~~~~~~~~~~~GT~~YmAPE~~~-----~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--p~  247 (304)
T 3ubd_A          175 ESIDHEKKAYSFCGTVEYMAPEVVN-----RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--PQ  247 (304)
T ss_dssp             C-----CCCCSCCCCGGGCCHHHHH-----TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CT
T ss_pred             eccCCCccccccccCcccCCHHHhc-----cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CC
Confidence            7655545556789999999999997     6779999999999999999999999999998888877776654432  34


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchh
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~  327 (463)
                      .+++++++||.+||++||.+|||     ++|+++||||++..++
T Consensus       248 ~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            68999999999999999999998     5899999999986654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.7e-62  Score=476.40  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=218.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .+.|++.++||+|+||+||+|+++.+|+.||||+++....    ..+|+.+|+.+ +|||||+++++|      .+.+.+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-~HpnIV~l~~~~------~~~~~~  125 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-SSPRIVPLYGAV------REGPWV  125 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-CCTTBCCEEEEE------EETTEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-CCCCCCcEEEEE------EECCEE
Confidence            3569999999999999999999999999999999975432    24699999999 899999999999      455799


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~~~~~  212 (463)
                      |||||||+||+|.++++..+  .+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+..
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            99999999999999998765  699999999999999999999999999999999999999887 699999999987753


Q ss_pred             ccC-----ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CC
Q psy7384         213 TIG-----RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LK  286 (463)
Q Consensus       213 ~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~  286 (463)
                      ...     .....+||+.|||||++.     +..|+.++|||||||++|||++|++||.+.+....+..+....++. ..
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~-----~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  278 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVM-----GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI  278 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGS
T ss_pred             CCcccceecCCccccCccccCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhc
Confidence            221     123468999999999997     5679999999999999999999999999888777777666554432 23


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHH-------------hcCccccCC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQL-------------LKHPFIRDQ  324 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~-------------l~hp~~~~~  324 (463)
                      .+.+++++++||.+||.+||.+|||+.|+             |+|||+.+.
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            56789999999999999999999999997             579998753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-60  Score=478.02  Aligned_cols=264  Identities=28%  Similarity=0.453  Sum_probs=221.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++....   .....+.+|+.+|+.+ +|||||++++++.......+
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTT
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccccc
Confidence            4568999999999999999999999999999999996432   3345678999999999 89999999999865443345


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|||||||+ |+|.+++...  ..+++..++.|++||+.||.|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            678999999996 5799999654  4799999999999999999999999999999999999999999999999999987


Q ss_pred             cccc----cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--C-
Q psy7384         210 LDRT----IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--P-  282 (463)
Q Consensus       210 ~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~-  282 (463)
                      +...    .....+.+||++|||||++.+    ...|+.++||||+|||+|||++|++||.+.+....+..|....  + 
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~----~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLS----LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccCccccccccccceeChHhcCHHHhcC----CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            6432    223456799999999999873    3457999999999999999999999999988777665542210  0 


Q ss_pred             -------------------CCC-------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         283 -------------------PRL-------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       283 -------------------~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                         +..       ..+.+++++++||.+||..||.+|||++|+|+||||++.
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                               000       013568899999999999999999999999999999853

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.5e-59  Score=461.41  Aligned_cols=255  Identities=24%  Similarity=0.367  Sum_probs=207.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++++.||+|+||+||+|+++   .+++.||+|++.... ....+.+|+++|+.+.+|||||+++++|      +..+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~------~~~~   93 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCF------RKND   93 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEE------EETT
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEE------EECC
Confidence            46999999999999999999875   457899999986543 3456789999999987899999999999      4558


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-CcEEEEeccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQL  210 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-~~vkL~DFGla~~~  210 (463)
                      ++|||||||+||+|.+++.     .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            9999999999999999984     48999999999999999999999999999999999999876 89999999999765


Q ss_pred             cccc----------------------------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy7384         211 DRTI----------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ  262 (463)
Q Consensus       211 ~~~~----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~  262 (463)
                      ....                            ......+||++|||||++.+    ...|+.++||||+|||+|||++|+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK----CPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC----CCCCCCccchhhhHHHHHHHHHCC
Confidence            3221                            11234689999999999973    346899999999999999999999


Q ss_pred             CCCCCCC-chhhhhcccC----------------------------------------C------------CCCCCCCCC
Q psy7384         263 PPLCDLH-PMRALFLIPR----------------------------------------N------------APPRLKSKK  289 (463)
Q Consensus       263 ~Pf~~~~-~~~~~~~i~~----------------------------------------~------------~~~~~~~~~  289 (463)
                      +||...+ +..++..|..                                        .            .........
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            9995543 3332221100                                        0            000111245


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      +++++++||++||..||.+|+|++|+|+||||++.+
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            789999999999999999999999999999998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-59  Score=455.37  Aligned_cols=261  Identities=23%  Similarity=0.409  Sum_probs=200.7

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCC------
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP------  127 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~------  127 (463)
                      .|++++.||+|+||+||+|+++.+|+.||||++.....  ..+.+.+|+.+|+++ +|||||+++++|......      
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC--------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCcccccccc
Confidence            49999999999999999999999999999999975433  346788999999999 899999999998654211      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKG-QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                      .....+|||||||.||+|.+++..... ....+..++.|+.||++||+|||++||+||||||+||||+.++.+||+|||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence            123358999999999999999976442 2345667899999999999999999999999999999999999999999999


Q ss_pred             ccccccccC------------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hh
Q psy7384         207 SAQLDRTIG------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RA  273 (463)
Q Consensus       207 a~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~  273 (463)
                      |+.+.....            .....+||+.|||||++.     +..|+.++||||||||+|||++   ||....+. ..
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-----~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-----GNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHT-----TCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHc-----CCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            987754321            224468999999999997     5679999999999999999996   78654322 22


Q ss_pred             hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       274 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      +..+.....+.. ....++.+++||.+||+.||.+|||+.|+|+||||++..+
T Consensus       237 ~~~~~~~~~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          237 LTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHTTCCCHH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHhcCCCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            333322222211 1234567889999999999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-57  Score=441.30  Aligned_cols=253  Identities=23%  Similarity=0.430  Sum_probs=215.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...|.+.+.||+|+||+||+|++.     .++..||||+++.. ....+.+.+|+++|+++ +|||||++++++      
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~------   84 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVC------   84 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE------
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEE------
Confidence            457999999999999999999875     35789999999744 33457789999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTK-----------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      .+.+.+|||||||++|+|.+++....           ...+++..+..|+.||+.||.|||+++||||||||+||||+.+
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence            45578999999999999999997642           3469999999999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q psy7384         197 AEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRA  273 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~  273 (463)
                      +.+||+|||+|+.......  .....+||+.|||||++.     ...|+.++|||||||+||||+| |++||.+.+..+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-----~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~  239 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-----YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  239 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999987644322  123356999999999998     5679999999999999999998 8999999888887


Q ss_pred             hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       274 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      +..+..+..+. .+..+++++.+||.+||+.||++|||++++  |+|+
T Consensus       240 ~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L  284 (299)
T 4asz_A          240 IECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLL  284 (299)
T ss_dssp             HHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHH
T ss_pred             HHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHH
Confidence            77776655433 345789999999999999999999999999  4455

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-57  Score=477.92  Aligned_cols=259  Identities=24%  Similarity=0.397  Sum_probs=228.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++.... ...+.+.+|+.+|+.+ +|||||+++++|      ++.+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~------~~~~  227 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAF------EDDN  227 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEE------ECSS
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEE------EECC
Confidence            3468999999999999999999999999999999997543 3456788999999999 899999999999      5568


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC--CcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN--AEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~--~~vkL~DFGla~~  209 (463)
                      .+|||||||+||+|.+++.... ..+++.+++.|++||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+.
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            9999999999999999996433 369999999999999999999999999999999999999854  8999999999998


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLKS  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~  287 (463)
                      +... ......+||+.|||||++.     +..|+.++||||||||+|+|++|.+||.+.+....+..+.....  +....
T Consensus       307 ~~~~-~~~~~~~GT~~y~APEv~~-----~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  380 (573)
T 3uto_A          307 LDPK-QSVKVTTGTAEFAAPEVAE-----GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF  380 (573)
T ss_dssp             CCTT-SEEEEECSSGGGCCHHHHT-----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred             ccCC-CceeeeEECccccCHHHhC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence            7654 3345678999999999997     66799999999999999999999999999998888877765543  22334


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ..+++++++||.+||..||.+|||++|+|+||||+...
T Consensus       381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            57899999999999999999999999999999998643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-57  Score=476.65  Aligned_cols=259  Identities=23%  Similarity=0.405  Sum_probs=216.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHH---HHHHHHhcCCCceeeecccccccCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLE---INVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E---i~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      -+.|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+|   +.++..+ +|||||+++++|     
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f-----  261 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAF-----  261 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEE-----
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEE-----
Confidence            35799999999999999999999999999999999632    1223334444   3444455 799999999999     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                       ++.+.+|||||||.||+|.+++....  .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+
T Consensus       262 -~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          262 -HTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             -EECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence             56689999999999999999998654  699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh---hhhcccCCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---ALFLIPRNAPP  283 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~~~  283 (463)
                      |+.+...  ...+.+||+.|||||++..    +..|+.++||||||||||||++|.+||.+.+...   ....+..... 
T Consensus       339 A~~~~~~--~~~t~~GTp~YmAPEvl~~----~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-  411 (689)
T 3v5w_A          339 ACDFSKK--KPHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-  411 (689)
T ss_dssp             CEECSSC--CCCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-
T ss_pred             eeecCCC--CCCCccCCcCccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-
Confidence            9877543  3456799999999999962    4579999999999999999999999997654322   1222222222 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchhHH
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTERQ  329 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~~~  329 (463)
                       ..+..+++++++||.+||.+||.+|++     ++||++||||++..+...
T Consensus       412 -~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          412 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             -CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence             223468999999999999999999998     799999999998877654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-57  Score=440.68  Aligned_cols=254  Identities=27%  Similarity=0.491  Sum_probs=206.9

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +...+.|++.+.||+|+||+||+|++.   ..||||+++..   ....+.+.+|+.+|+++ +|||||++++++.     
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~-----  102 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMT-----  102 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-----
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE-----
Confidence            445567999999999999999999864   35899998643   33456789999999999 8999999999873     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                        ++.+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||++++.+||+|||+|
T Consensus       103 --~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          103 --KDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             --SSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             --CCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence              246899999999999999997544 36999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CC
Q psy7384         208 AQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PP  283 (463)
Q Consensus       208 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~  283 (463)
                      +......  ......+||+.|||||++.+..  ...|+.++|||||||+||||+||++||.+.+....+..+....  .+
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~--~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p  257 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD--NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP  257 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccC--CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            8765322  2235568999999999997422  3468999999999999999999999998877665544332221  12


Q ss_pred             --CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 --RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 --~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                        ......+++++.+||.+||+.||.+|||+.|++++
T Consensus       258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence              12345789999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.2e-57  Score=441.93  Aligned_cols=252  Identities=21%  Similarity=0.383  Sum_probs=210.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...|.+.++||+|+||+||+|++.     .++..||||+++.. ....+.+.+|+.+|.++ +|||||+++++|      
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~------  112 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVC------  112 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE------
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE------
Confidence            457899999999999999999875     35889999999743 34457889999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTK-------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT  194 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~  194 (463)
                      .+.+.+|||||||++|+|.+++....             ...+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            45578999999999999999997643             23589999999999999999999999999999999999999


Q ss_pred             cCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCch
Q psy7384         195 DNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPM  271 (463)
Q Consensus       195 ~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~  271 (463)
                      .++.+||+|||+++......  ......+||+.|||||++.     ...|+.++|||||||+||||+| |+.||.+.+..
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-----~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-----YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhc-----CCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999998764332  2224467999999999997     6789999999999999999999 89999998888


Q ss_pred             hhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         272 RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       272 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.+..+..+..+. .+..+++++.+||.+||+.||++|||++|++++
T Consensus       268 ~~~~~i~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          268 EAIDCITQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8777776654433 345789999999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5e-57  Score=438.61  Aligned_cols=255  Identities=23%  Similarity=0.389  Sum_probs=217.5

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +.....++++++||+|+||+||+|++.     .+++.||||++...  ....+.+.+|+.+|.++ +|||||++++++  
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~--   98 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVV--   98 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEE--
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEE--
Confidence            344567999999999999999999864     45789999999643  33457899999999999 899999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCC
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ  189 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~  189 (463)
                          ...+.+|||||||++|+|.+++....              ...+++..+..|+.||+.||.|||+++||||||||+
T Consensus        99 ----~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~  174 (308)
T 4gt4_A           99 ----TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR  174 (308)
T ss_dssp             ----CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ----EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence                44578999999999999999997542              235899999999999999999999999999999999


Q ss_pred             ceEEccCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy7384         190 NVLLTDNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLC  266 (463)
Q Consensus       190 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~  266 (463)
                      ||||++++.+||+|||+++.+....  ......+||+.|||||++.     ...|+.++|||||||+||||+| |.+||.
T Consensus       175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-----~~~~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-----YGKFSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh-----CCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999998764332  2234568999999999998     5679999999999999999998 899999


Q ss_pred             CCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         267 DLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       267 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.+..+.+..+.....+. .+..+++++.+|+.+||+.||.+|||+.||+++
T Consensus       250 ~~~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          250 GYSNQDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TCCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            998887777766554432 345789999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.1e-57  Score=444.35  Aligned_cols=258  Identities=23%  Similarity=0.406  Sum_probs=215.8

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +.+.++|++.+.||+|+||+||+|++..+     ++.||||++....  .....+.+|+.+|.++.+|||||+++++|. 
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~-  138 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-  138 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE-
Confidence            45567899999999999999999998754     3689999997543  345678899999999965699999999984 


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCC
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ  189 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~  189 (463)
                          ...+.+|||||||++|+|.++|+...              ...+++..+..|+.||+.||.|||+++||||||||+
T Consensus       139 ----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~  214 (353)
T 4ase_A          139 ----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  214 (353)
T ss_dssp             ----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence                23457899999999999999997643              235899999999999999999999999999999999


Q ss_pred             ceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy7384         190 NVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLC  266 (463)
Q Consensus       190 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~  266 (463)
                      |||+++++.+||+|||+|+.+.....  .....+||+.|||||++.     ...|+.++|||||||+||||+| |.+||.
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-----~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh-----cCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999987644322  234567999999999998     5679999999999999999998 999998


Q ss_pred             CCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         267 DLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       267 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.+....+..+.........+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8765554443322222223345789999999999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-54  Score=423.09  Aligned_cols=300  Identities=84%  Similarity=1.348  Sum_probs=248.1

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++.........+.+|+.+++++.+||||+++++++.........
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            35678899999999999999999999999999999999877667788999999999997899999999999765433345


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            78999999999999999998765567999999999999999999999999999999999999999999999999999877


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...........||+.|+|||++.........++.++|||||||++|+|++|..||.+.........+.....+......+
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  259 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCS
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcccc
Confidence            65444445668999999999987543335678899999999999999999999999888777777666666666666789


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhHHHHHHhHHhHHHHHHhhhcccc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDD  350 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~  350 (463)
                      +..+.+||.+||..||.+|||++++++||||++.+.+.+...+++.++...++++.++.+
T Consensus       260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (326)
T 2x7f_A          260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDE  319 (326)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHHHHHHHHHHHHHHHHHCC-----
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccccceeehhhhhhhhhccccccCch
Confidence            999999999999999999999999999999999999888888899988888877766543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=423.94  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=222.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++...    ......+..|+.+|..+.+||||++++++|      ..
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~------~~   95 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF------QT   95 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE------EC
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE------Ee
Confidence            46799999999999999999999999999999999742    234566788999999887899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+||||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            578999999999999999997664  699999999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ...........+||+.|+|||++.     ...|+.++|||||||++|+|++|.+||.+.+.......+.......  +..
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~  246 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQ-----EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW  246 (353)
T ss_dssp             SCC---------CCGGGCCHHHHH-----HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTT
T ss_pred             cccCCccccccCCCcCeEChhhcC-----CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCC
Confidence            544444456678999999999997     4568999999999999999999999999988877777665554322  345


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCH------HHHhcCccccCCchh
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYT------DQLLKHPFIRDQPTE  327 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~------~e~l~hp~~~~~~~~  327 (463)
                      ++..+++||++||..||.+||++      +++++||||++..+.
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            88999999999999999999998      899999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-52  Score=414.53  Aligned_cols=257  Identities=29%  Similarity=0.465  Sum_probs=225.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++...    ......+.+|+.+|+.+ +||||++++++|      ...
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~------~~~   77 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAF------QTH   77 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEE------ECS
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEE------EeC
Confidence            5799999999999999999999999999999999642    33456788999999998 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            79999999999999999997654  6899999999999999999999999999999999999999999999999999865


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ..........+||+.|+|||++.     +..|+.++|||||||++|||++|.+||.+.+.......+......  .+..+
T Consensus       156 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~  228 (337)
T 1o6l_A          156 ISDGATMKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTL  228 (337)
T ss_dssp             CCTTCCBCCCEECGGGCCGGGGS-----SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTS
T ss_pred             ccCCCcccccccChhhCChhhhc-----CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Confidence            44444456678999999999997     567899999999999999999999999888776666555443322  23468


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      ++++++||.+||..||.+||     +++++++||||....+.
T Consensus       229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            99999999999999999999     99999999999876554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.2e-53  Score=409.00  Aligned_cols=258  Identities=41%  Similarity=0.752  Sum_probs=225.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +..++|++++.||+|+||.||+|++..+|+.||+|++... ......+.+|+.+++.+ +||||++++++|.      ..
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~------~~   89 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYL------VG   89 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEE------ET
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEE------EC
Confidence            4456899999999999999999999999999999998643 33456788999999999 8999999999994      45


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.||+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            7899999999999999999754   5899999999999999999999999999999999999999999999999999877


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC-CCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP-RLKSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~  289 (463)
                      ..........+||+.|+|||++.     ...|+.++|||||||++|+|++|..||.+.+.......+.....+ ......
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK  241 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHH-----CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGG
T ss_pred             CCcccccCCccCCcCccChhhhc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence            65555556678999999999997     567899999999999999999999999888776666554333322 223456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++..+++||.+||..||.+|||++|+|+||||+..
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            88999999999999999999999999999999854

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-52  Score=417.43  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=226.5

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------hHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------EEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      ....+.|++.+.||+|+||.||+|+++.+|+.||+|++.....       ....+.+|+.+|+.+ +||||++++++|  
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~--   84 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVY--   84 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEE--
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEE--
Confidence            4556789999999999999999999999999999999974322       356789999999999 799999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC----cE
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EV  199 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~----~v  199 (463)
                          ...+.+|+||||+.||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++    .+
T Consensus        85 ----~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~v  158 (361)
T 2yab_A           85 ----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI  158 (361)
T ss_dssp             ----ECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             ----EeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCE
Confidence                4557999999999999999999654  3799999999999999999999999999999999999998776    79


Q ss_pred             EEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         200 KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       200 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      ||+|||++...... ......+||+.|+|||++.     ...|+.++||||||||+|+|++|.+||.+.+....+..+..
T Consensus       159 kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~  232 (361)
T 2yab_A          159 KLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA  232 (361)
T ss_dssp             EECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred             EEEecCCceEcCCC-CccccCCCCccEECchHHc-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999876543 2335568999999999997     56789999999999999999999999999887777766655


Q ss_pred             CCCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         280 NAPPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       280 ~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      ......  ....+++.+++||.+||..||.+|||++|+|+||||+....
T Consensus       233 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          233 VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            433221  12567899999999999999999999999999999986544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-52  Score=412.58  Aligned_cols=253  Identities=26%  Similarity=0.496  Sum_probs=221.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||.||+|++..+|+.||||++...   ......+.+|+.+|+.+ +||||+++++++      ...
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~------~~~   86 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVI------ETE   86 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE------ECS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE------EEC
Confidence            46799999999999999999999999999999999643   23456778999999999 799999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             CEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            78999999999999999997664  6999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATY-DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ... ......+||+.|+|||++.     +..+ +.++|||||||++|+|++|.+||.+.+.......+......  .+..
T Consensus       165 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~p~~  236 (328)
T 3fe3_A          165 TVG-GKLDAFCGAPPYAAPELFQ-----GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFY  236 (328)
T ss_dssp             SSS-CGGGTTSSSGGGCCHHHHH-----TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTT
T ss_pred             CCC-CccccccCCcceeCccccc-----CCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCC
Confidence            543 2345678999999999997     3344 57899999999999999999999988877766665554332  2235


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ++.++.+||++||..||.+|||++|+++||||..
T Consensus       237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence            7899999999999999999999999999999974

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.4e-54  Score=416.17  Aligned_cols=256  Identities=24%  Similarity=0.346  Sum_probs=194.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|.+.+.||+|+||+||+|++  +|+.||||++............|+..+.++ +|||||++++++....  .....+
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~--~~~~~~   76 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDN--GTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEEC--SSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecC--CCceEE
Confidence            35699999999999999999987  489999999976544444444566666677 8999999999996532  122468


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC--------CceecCCCCCceEEccCCcEEEEecc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN--------KVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                      |||||||++|+|.++++..   .+++..+..++.|++.||+|||++        +||||||||+||||+.++.+||+|||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            9999999999999999754   589999999999999999999987        99999999999999999999999999


Q ss_pred             cccccccccC----ccccccCCccccccceeccCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh-------
Q psy7384         206 VSAQLDRTIG----RRNTFIGTPYWMAPEVIACDEN-PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-------  273 (463)
Q Consensus       206 la~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-------  273 (463)
                      +|+.......    .....+||+.|||||++..... ....|+.++|||||||+||||+||.+||........       
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            9987654322    1234689999999999964211 122477899999999999999999887743322111       


Q ss_pred             -------hhc-cc-CCCCCCCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         274 -------LFL-IP-RNAPPRLKS----KKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       274 -------~~~-i~-~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                             +.. +. ....+....    ...+..+.+|+.+||..||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                   111 11 111122111    122357889999999999999999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-52  Score=415.61  Aligned_cols=260  Identities=27%  Similarity=0.476  Sum_probs=227.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++...    ......+..|..+|..+.+||||++++++|      ..
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~------~~   89 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF------QT   89 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE------EC
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE------Ee
Confidence            45799999999999999999999999999999999743    234566788999998877899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            578999999999999999998654  699999999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ...........+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+.......+......  ....
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~  240 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILL-----GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRW  240 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTT
T ss_pred             cccCCCcccCCCCCcccCChhhhc-----CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC--CCcc
Confidence            544334456678999999999997     567899999999999999999999999988877766665544332  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHH-HHhcCccccCCchhH
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTD-QLLKHPFIRDQPTER  328 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~-e~l~hp~~~~~~~~~  328 (463)
                      ++.++++||.+||..||.+||++. ++++||||+...+..
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~  280 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  280 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHH
Confidence            889999999999999999999998 999999999876653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.4e-52  Score=420.26  Aligned_cols=259  Identities=29%  Similarity=0.477  Sum_probs=219.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||+||+|+++.+++.||+|++....    .....+..|..+|.++.+||||++++++|      ..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~------~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF------QT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE------EC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE------EE
Confidence            457999999999999999999999999999999997432    22345778999999887899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+||||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            579999999999999999998654  699999999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--------hhhh-hcccCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--------MRAL-FLIPRN  280 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--------~~~~-~~i~~~  280 (463)
                      ...........+||+.|+|||++.     +..|+.++|||||||++|||++|.+||.....        ...+ ..+...
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~  277 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILR-----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  277 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred             cccCCCccccccCCcccCCchhhc-----CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence            544444456779999999999997     56789999999999999999999999964321        1112 222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHhcCccccCCchh
Q psy7384         281 APPRLKSKKWPKKFQSFIETVLVKDYHQRPYT------DQLLKHPFIRDQPTE  327 (463)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~e~l~hp~~~~~~~~  327 (463)
                      .. . .+..++.++++||++||+.||.+||++      +|+++||||++..+.
T Consensus       278 ~~-~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          278 QI-R-IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             CC-C-CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             cc-C-CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            21 1 234689999999999999999999985      899999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-52  Score=410.56  Aligned_cols=258  Identities=21%  Similarity=0.361  Sum_probs=225.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+|+.+ +||||+++++++      ...+.
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~------~~~~~   75 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESF------ESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEE------EETTE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEE------ecCCE
Confidence            45689999999999999999999999999999999987766777889999999999 899999999999      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc--CCcEEEEeccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQL  210 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~--~~~vkL~DFGla~~~  210 (463)
                      +|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            999999999999999996533 36999999999999999999999999999999999999987  789999999999877


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC--CCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL--KSK  288 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~  288 (463)
                      ... ......+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+....+..+........  ...
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T 1tki_A          155 KPG-DNFRLLFTAPEYYAPEVHQ-----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHT-----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             CCC-CccccccCChhhcCcHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence            543 2234567999999999997     55688999999999999999999999998887776666554433221  124


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      .++.++++||.+||..||.+|||+.|+|+||||++.
T Consensus       229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            688999999999999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-52  Score=413.44  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=226.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++...    ......+..|..+|..+.+||||++++++|      +.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~------~~   92 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF------QT   92 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE------EC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE------Ec
Confidence            45799999999999999999999999999999999743    234567788999998876899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            579999999999999999998654  699999999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ...........+||+.|+|||++.     ...|+.++|||||||++|||++|.+||.+.+.......+......  .+..
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~  243 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKS  243 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHT-----TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTT
T ss_pred             cccCCcccccccCCccccChhhhc-----CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--CCCC
Confidence            544334456678999999999997     567899999999999999999999999988877766666554332  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchh
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~  327 (463)
                      ++.++++||.+||..||.+||+     ++++++||||+...+.
T Consensus       244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            8999999999999999999994     7999999999876654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-52  Score=405.33  Aligned_cols=254  Identities=26%  Similarity=0.491  Sum_probs=223.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+++.+ +||||+++++++      ...
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~------~~~   78 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTF------QDA   78 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEE------ECS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEE------EeC
Confidence            5699999999999999999999999999999999643    23456778899999998 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            79999999999999999997654  6999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...   ....+||+.|+|||++.     ...|+.++|||||||++|+|++|.+||.+.+.......+......  .+..+
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~p~~~  226 (318)
T 1fot_A          157 PDV---TYTLCGTPDYIAPEVVS-----TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFF  226 (318)
T ss_dssp             SSC---BCCCCSCTTTCCHHHHT-----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC--CCTTS
T ss_pred             CCc---cccccCCccccCHhHhc-----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCC
Confidence            532   24568999999999987     567899999999999999999999999988877776666554332  23468


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      +.++++||.+||..||.+||     +++++++||||++..+.
T Consensus       227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence            89999999999999999999     99999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.1e-52  Score=422.95  Aligned_cols=257  Identities=23%  Similarity=0.390  Sum_probs=223.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|++....   .....+.+|+.+++.+ +||||+++++++      ..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~------~~   81 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSI------SE   81 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEE------EC
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEE------EE
Confidence            3457999999999999999999999999999999997543   3345688999999999 899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc---cCCcEEEEeccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGV  206 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~---~~~~vkL~DFGl  206 (463)
                      .+..|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            679999999999999999997654  699999999999999999999999999999999999998   467899999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC--C
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--R  284 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~  284 (463)
                      +.............+||+.|+|||++.     ...|+.++||||||||+|+|++|.+||.+.+.......+......  .
T Consensus       160 a~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  234 (444)
T 3soa_A          160 AIEVEGEQQAWFGFAGTPGYLSPEVLR-----KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS  234 (444)
T ss_dssp             CBCCCTTCCBCCCSCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eEEecCCCceeecccCCcccCCHHHhc-----CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc
Confidence            988766555556678999999999997     567899999999999999999999999988877776665554332  2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .....+++++++||.+||..||.+|||+.|+|+||||+.
T Consensus       235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            233578999999999999999999999999999999964

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-51  Score=407.82  Aligned_cols=259  Identities=29%  Similarity=0.484  Sum_probs=219.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++...    ......+.+|+.++.++.+||||++++++|      ..
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~------~~   81 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF------QT   81 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE------EC
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE------Ee
Confidence            35799999999999999999999999999999999743    233456788999999887899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            579999999999999999997654  699999999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--------hh-hhhcccCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP--------MR-ALFLIPRN  280 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--------~~-~~~~i~~~  280 (463)
                      ...........+||+.|+|||++.     +..|+.++|||||||++|||++|.+||.....        .. ....+...
T Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          160 GLRPGDTTSTFCGTPNYIAPEILR-----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             SCCTTCCBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             ccCCCCcccccCCCccccCccccC-----CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence            544334456678999999999997     56789999999999999999999999965211        11 12222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHhcCccccCCchh
Q psy7384         281 APPRLKSKKWPKKFQSFIETVLVKDYHQRPYT------DQLLKHPFIRDQPTE  327 (463)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~e~l~hp~~~~~~~~  327 (463)
                      .. . .+..++.++++||.+||..||.+||++      +++++||||.+..+.
T Consensus       235 ~~-~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          235 QI-R-IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             CC-C-CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             CC-C-CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence            21 1 234688999999999999999999995      899999999876654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-51  Score=401.79  Aligned_cols=263  Identities=25%  Similarity=0.442  Sum_probs=216.7

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ......++|++++.||+|+||+||+|++. +|+.||+|++....   .....+.+|+.+++++ +||||+++++++    
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~----   88 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVI----   88 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEE----
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEE----
Confidence            34556789999999999999999999985 58999999986432   2346788999999999 899999999999    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                        ...+.+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        89 --~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           89 --HSERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             --CCSSCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             --ccCCEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCc
Confidence              556789999999985 8888886543 469999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC---CCC
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR---NAP  282 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~~  282 (463)
                      +++............+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+......+..+..   ...
T Consensus       165 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          165 LARAFGIPVRSYTHEVVTLWYRAPDVLMG----SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN  240 (311)
T ss_dssp             TCEETTSCCC---CCCCCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred             CceecCCCcccccCCcccCCcCCHHHhcC----CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence            99887655444556689999999999863    35689999999999999999999999987766554433211   000


Q ss_pred             CC-------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         283 PR-------------------------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       283 ~~-------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      +.                         ...+.+++++.+||.+||..||.+|||++|+|+||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            00                         01134678999999999999999999999999999998643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-51  Score=406.08  Aligned_cols=256  Identities=24%  Similarity=0.431  Sum_probs=225.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+|+.+ +||||+++++++      .
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~------~  111 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF------K  111 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEE------E
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------E
Confidence            346799999999999999999999999999999998643    23456788899999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccce
Confidence            5579999999999999999998654  69999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .....   ....+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+.......+......  .+.
T Consensus       190 ~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~  259 (350)
T 1rdq_E          190 RVKGR---TWTLCGTPEALAPEIIL-----SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPS  259 (350)
T ss_dssp             ECSSC---BCCCEECGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCT
T ss_pred             eccCC---cccccCCccccCHHHhc-----CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--CCC
Confidence            76543   24568999999999997     567899999999999999999999999988877776666554332  234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchh
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~  327 (463)
                      .++.++++||.+||..||.+||+     ++++++||||....+.
T Consensus       260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence            68999999999999999999998     9999999999876654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=404.17  Aligned_cols=262  Identities=26%  Similarity=0.439  Sum_probs=224.3

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------hHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------EEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      ....++|++.+.||+|+||.||+|++..+|..||+|++.....       ....+.+|+.+|+.+ +||||+++++++  
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~--   83 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY--   83 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE--
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEE--
Confidence            3455689999999999999999999999999999999964321       357889999999999 799999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC----cE
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EV  199 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~----~v  199 (463)
                          .....+|+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++    .+
T Consensus        84 ----~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  157 (326)
T 2y0a_A           84 ----ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI  157 (326)
T ss_dssp             ----ECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCE
T ss_pred             ----EeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCE
Confidence                4557899999999999999999654  3699999999999999999999999999999999999998877    89


Q ss_pred             EEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         200 KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       200 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      ||+|||++....... .....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+......+..+..
T Consensus       158 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  231 (326)
T 2y0a_A          158 KIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA  231 (326)
T ss_dssp             EECCCTTCEECCTTS-CCCCCCSCTTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred             EEEECCCCeECCCCC-ccccccCCcCcCCceeec-----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence            999999998775432 234567999999999986     56789999999999999999999999988877666555443


Q ss_pred             CCCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         280 NAPPR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       280 ~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      .....  .....++..+++||.+||..||.+|||++++|+||||+.....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  281 (326)
T 2y0a_A          232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  281 (326)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHH
T ss_pred             cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcch
Confidence            32211  1124678999999999999999999999999999999876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-52  Score=400.91  Aligned_cols=259  Identities=26%  Similarity=0.444  Sum_probs=215.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---------------------------hHHHHHHHHHHHH
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---------------------------EEEEIKLEINVLK  106 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~Ei~~l~  106 (463)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++.....                           ..+.+.+|+.+|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4679999999999999999999999999999999864321                           1246789999999


Q ss_pred             HhcCCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCC
Q psy7384         107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDI  186 (463)
Q Consensus       107 ~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDL  186 (463)
                      .+ +||||+++++++..    ...+.+|+||||+++++|.+++.   ...+++..++.++.||+.||.|||++||+||||
T Consensus        92 ~l-~h~~iv~~~~~~~~----~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           92 KL-DHPNVVKLVEVLDD----PNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             TC-CCTTBCCEEEEEEC----SSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             hC-CCCCCCeEEEEEEc----CCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99 89999999999853    23468999999999999988653   236999999999999999999999999999999


Q ss_pred             CCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy7384         187 KGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLC  266 (463)
Q Consensus       187 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~  266 (463)
                      ||+|||++.++.+||+|||++.............+||+.|+|||++....  ...++.++|||||||++|+|++|..||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR--KIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC--CCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC--CCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999987765444445568999999999986321  1124788999999999999999999998


Q ss_pred             CCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         267 DLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       267 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      +.........+............+++.+++||.+||..||.+|||++|+|+||||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            87765555444444333333457899999999999999999999999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.1e-52  Score=420.00  Aligned_cols=263  Identities=25%  Similarity=0.443  Sum_probs=222.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++...    ......+.+|+.++..+ +||||++++++|      .
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~------~  139 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAF------Q  139 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEE------E
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------E
Confidence            345799999999999999999999999999999998642    12234577899999998 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +.+.+||||||+.||+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            567999999999999999999753   58999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CCCC
Q psy7384         209 QLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRL  285 (463)
Q Consensus       209 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~  285 (463)
                      ....... .....+||+.|+|||++..... ...|+.++|||||||++|||++|.+||.+.+.......+....  ....
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTT-TCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCC-CcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence            7654321 2346789999999999974211 1238899999999999999999999999988877776665432  1222


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCCch
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~  326 (463)
                      ....++.++++||.+||..+|.+  |++++|+++||||++..+
T Consensus       296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            33478999999999999999988  999999999999987544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.4e-51  Score=409.41  Aligned_cols=256  Identities=25%  Similarity=0.433  Sum_probs=220.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++....   .....+.+|+.+++.+ +||||+++++++      ..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~------~~   99 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI------QE   99 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE------EC
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------Ee
Confidence            3467999999999999999999999999999999997532   3446788999999999 899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC---CcEEEEeccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN---AEVKLVDFGV  206 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~---~~vkL~DFGl  206 (463)
                      .+..|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            578999999999999999996543  68999999999999999999999999999999999999764   4599999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC--C
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--R  284 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~  284 (463)
                      +...... ......+||+.|+|||++.     ...|+.++|||||||++|+|++|.+||.+.+.......+......  .
T Consensus       178 a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (362)
T 2bdw_A          178 AIEVNDS-EAWHGFAGTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS  251 (362)
T ss_dssp             CBCCTTC-CSCCCSCSCTTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             ceEecCC-cccccCCCCccccCHHHHc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            9877543 2334568999999999997     567899999999999999999999999988777666655444332  2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .....+++++++||.+||..||.+|||+.++|+||||..
T Consensus       252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            222467899999999999999999999999999999974

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.2e-51  Score=405.25  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=214.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.++|++++.||+|+||.||+|++..+++.||+|++....  ...+.+.+|+.+++.+ +||||+++++++      ...
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~------~~~   77 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHR------REG   77 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEE------ECS
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEE------ecC
Confidence            4567999999999999999999999999999999986443  2346678999999999 899999999998      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            7899999999999999998644  36999999999999999999999999999999999999999999999999999865


Q ss_pred             ccc--cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc-ccCCCCCCCCC
Q psy7384         211 DRT--IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRLKS  287 (463)
Q Consensus       211 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~  287 (463)
                      ...  .......+||+.|+|||++..    ...++.++|||||||++|+|++|..||.+......... ...........
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW  231 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHC----SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTG
T ss_pred             ccCCcccccCCCccCcCccCcHHhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcc
Confidence            422  222345689999999999973    22347789999999999999999999977655433222 11222222223


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..++..+.+||.+||..||.+|||++|+++||||..
T Consensus       232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence            567899999999999999999999999999999974

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-51  Score=407.78  Aligned_cols=258  Identities=27%  Similarity=0.442  Sum_probs=217.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC------cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT------EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      +.++|++.+.||+|+||.||+|++..+|+.||||++...      ......+.+|+.+++.+ +||||+++++++     
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~-----   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETY-----   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEE-----
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEE-----
Confidence            456899999999999999999999999999999998632      12457789999999999 899999999999     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc---EEE
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKL  201 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~---vkL  201 (463)
                       ...+.+|+|||||+|++|.+++....  +..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||
T Consensus        96 -~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           96 -SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             -EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             -EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence             44578999999999999998876532  346899999999999999999999999999999999999986554   999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      +|||++.............+||+.|+|||++.     ...|+.++||||||||+|+|++|.+||.+... .....+....
T Consensus       175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~  248 (351)
T 3c0i_A          175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK-----REPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGK  248 (351)
T ss_dssp             CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTC
T ss_pred             ecCcceeEecCCCeeecCCcCCcCccCHHHHc-----CCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCC
Confidence            99999988765444445668999999999997     56789999999999999999999999987543 2333332222


Q ss_pred             CCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 PPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 ~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ....  ....+++++++||.+||..||.+|||+.++|+||||++
T Consensus       249 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            2111  12467899999999999999999999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.2e-51  Score=419.19  Aligned_cols=258  Identities=23%  Similarity=0.401  Sum_probs=208.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||+||+|++..+|+.||||++...   ......+.+|+.+|+.+ +||||++++++|......+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccC
Confidence            47899999999999999999999999999999999743   34456788999999999 899999999999655433445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+||||||+.+ +|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            688999999986 46666642    4899999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---------  281 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  281 (463)
                      ... ......+||++|+|||++.     +..|+.++||||||||+|+|++|++||.+.+....+..+....         
T Consensus       215 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          215 GTS-FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             --C-CCC----CCCTTCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             CCC-cccCCCcccccccCHHHHc-----CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            543 2345578999999999997     5679999999999999999999999999887665554432110         


Q ss_pred             ------------CCCCCCCC-------------------CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 ------------PPRLKSKK-------------------WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 ------------~~~~~~~~-------------------~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                  .+......                   .++++++||.+||..||.+|||++|+|+||||+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                        00000000                   1457999999999999999999999999999974

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.4e-51  Score=407.38  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=207.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...++|++++.||+|+||+||+|++..+++.||+|++.........+.+|+.+++.+ +||||+++++++.      ..+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~------~~~   89 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVIL------TPT   89 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEE------CSS
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEe------eCC
Confidence            456789999999999999999999999999999999987666667788999999999 8999999999994      457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc--EEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE--VKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~--vkL~DFGla~~  209 (463)
                      .+|+||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        90 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           90 HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            8999999999999999997655  6999999999999999999999999999999999999987665  99999999875


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCchhhh----hcccCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYD-NRSDLWSLGITALEMAESQPPLCDLHPMRAL----FLIPRNAPPR  284 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~  284 (463)
                      .... ......+||+.|+|||++.     +..++ .++|||||||++|+|++|.+||.+.......    ..+.......
T Consensus       168 ~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  241 (361)
T 3uc3_A          168 SVLH-SQPKSTVGTPAYIAPEVLL-----RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI  241 (361)
T ss_dssp             --------------CTTSCHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC
T ss_pred             cccc-CCCCCCcCCCCcCChhhhc-----CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC
Confidence            4322 2234567999999999997     34454 4489999999999999999999876543322    2222332222


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .....+++++++||.+||..||.+|||++|+++||||..
T Consensus       242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          242 PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            333468899999999999999999999999999999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-51  Score=404.95  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=216.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+++.+ +||||+++++++      ..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~------~~   80 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVI------TT   80 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEE------EC
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEE------Ee
Confidence            467999999999999999999999999999999986321    2235788999999999 899999999999      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+ +|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           81 PTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             SSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             CCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence            57899999999 679999887654  699999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATY-DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .... ......+||+.|+|||++.     +..+ +.++|||||||++|+|++|..||.+.........+.....  ..+.
T Consensus       158 ~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~p~  229 (336)
T 3h4j_B          158 MTDG-NFLKTSCGSPNYAAPEVIN-----GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY--VMPD  229 (336)
T ss_dssp             TTTS-BTTCCCTTSTTTSCGGGSC-----CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCC--CCCT
T ss_pred             ccCC-cccccccCCcCcCCHHHHc-----CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC--CCcc
Confidence            6543 2335568999999999997     3344 6899999999999999999999987665555444433322  2234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .+++++++||.+||..||.+|||++|+++||||+.
T Consensus       230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            68899999999999999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.7e-51  Score=394.79  Aligned_cols=257  Identities=27%  Similarity=0.435  Sum_probs=211.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++++.||+|+||+||+|++..+|+.||+|++....   .....+.+|+.+++++ +||||+++++++      ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVL------HSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEE------EETT
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEE------EeCC
Confidence            46999999999999999999999999999999997432   3346788999999999 899999999999      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        75 ~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           75 KLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            89999999986 6666655433 469999999999999999999999999999999999999999999999999998776


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCchhhhhcccCC----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL-CDLHPMRALFLIPRN----------  280 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf-~~~~~~~~~~~i~~~----------  280 (463)
                      .........+||+.|+|||++.+    ...++.++|||||||++|+|++|..|| .+.+....+..+...          
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          153 IPVRCYSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred             CccccccCCccccCCcChHHHcC----CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence            55455566789999999999863    344899999999999999999887775 444433333221110          


Q ss_pred             -----------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         281 -----------------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       281 -----------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                       .......+.++..+++||.+||+.||.+|||++|+|+||||++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                             00001123578899999999999999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-50  Score=408.66  Aligned_cols=263  Identities=27%  Similarity=0.494  Sum_probs=218.1

Q ss_pred             CCCCceEEEeeeeee--CCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          52 DPAGIFELIEVVGNG--TYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ...++|++++.||+|  +||.||+|++..+|+.||||++....   .....+.+|+.+++.+ +|||||+++++|.    
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~----   96 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFI----   96 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEE----
Confidence            345789999999999  99999999999999999999997442   3346778899999999 8999999999994    


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                        ..+.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        97 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           97 --ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             --ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             --ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence              457899999999999999999877556799999999999999999999999999999999999999999999999998


Q ss_pred             cccccccc-------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         207 SAQLDRTI-------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       207 a~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      +.......       ......+||+.|+|||++...   ...|+.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT---SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhcc---CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            86543211       112334799999999999732   25689999999999999999999999988766655544332


Q ss_pred             CCCC--------------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q psy7384         280 NAPP--------------------------------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQL  315 (463)
Q Consensus       280 ~~~~--------------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  315 (463)
                      ...+                                            ......+++.+++||.+||..||.+|||++|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            2211                                            01224578899999999999999999999999


Q ss_pred             hcCccccCC
Q psy7384         316 LKHPFIRDQ  324 (463)
Q Consensus       316 l~hp~~~~~  324 (463)
                      |+||||+..
T Consensus       332 l~hp~f~~~  340 (389)
T 3gni_B          332 LNHSFFKQI  340 (389)
T ss_dssp             TTSGGGGGC
T ss_pred             hcCHHHHHH
Confidence            999999754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.9e-51  Score=409.96  Aligned_cols=260  Identities=27%  Similarity=0.433  Sum_probs=216.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++....    .....+..|..++.+..+||||++++++|      .
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~------~  109 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF------Q  109 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE------E
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE------E
Confidence            3468999999999999999999999999999999996432    23345566777643333899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            5579999999999999999998654  68999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ............+||+.|+|||++.     +..|+.++|||||||++|||++|.+||.+.+.......+......  ...
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~  260 (373)
T 2r5t_A          188 ENIEHNSTTSTFCGTPEYLAPEVLH-----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKP  260 (373)
T ss_dssp             GGBCCCCCCCSBSCCCCCCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC--CCS
T ss_pred             ccccCCCccccccCCccccCHHHhC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC--CCC
Confidence            7544444456678999999999997     567899999999999999999999999988877766666544322  234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCH----HHHhcCccccCCchh
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYT----DQLLKHPFIRDQPTE  327 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~----~e~l~hp~~~~~~~~  327 (463)
                      .++..+++||.+||..||.+||++    +++++||||+...+.
T Consensus       261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            689999999999999999999986    699999999877654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.9e-51  Score=400.09  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=213.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecCc-----chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVTE-----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ..++|++++.||+|+||.||+|++.   .+|+.||+|++....     .....+.+|+.+|+.+ +||||+++++++   
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~---   90 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAF---   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEE---
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEE---
Confidence            3467999999999999999999985   689999999987432     2345677899999999 899999999999   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                         ...+.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           91 ---QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             ---ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             ---EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeC
Confidence               44578999999999999999997654  6899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      |+++............+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+....+..+...... 
T Consensus       166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-  239 (327)
T 3a62_A          166 GLCKESIHDGTVTHTFCGTIEYMAPEILM-----RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN-  239 (327)
T ss_dssp             SCC----------CTTSSCCTTSCHHHHT-----TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-
T ss_pred             CcccccccCCccccccCCCcCccCHhhCc-----CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-
Confidence            99986544433445668999999999997     566889999999999999999999999988777666655444322 


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                       ....++.++++||.+||..||.+||     +++++++||||.+..++
T Consensus       240 -~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          240 -LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             -CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             -CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence             2346889999999999999999999     89999999999876544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.9e-52  Score=421.06  Aligned_cols=266  Identities=25%  Similarity=0.423  Sum_probs=223.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||+||+|+++.+++.||+|++....    .....+..|+.++..+ +||||++++++|      ..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~------~~  145 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAF------QD  145 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEE------EC
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE------ee
Confidence            457999999999999999999999999999999996421    2223477899999998 899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+||||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            679999999999999999997632 3699999999999999999999999999999999999999999999999999977


Q ss_pred             cccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---CCCC
Q psy7384         210 LDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---PPRL  285 (463)
Q Consensus       210 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~~  285 (463)
                      ...... .....+||+.|+|||++.........|+.++|||||||++|||++|++||.+.+..+.+..+....   ....
T Consensus       225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  304 (437)
T 4aw2_A          225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT  304 (437)
T ss_dssp             CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred             cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence            644322 234468999999999986322224568999999999999999999999999988777766654321   1111


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHhcCccccCCchh
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQ--RPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~~  327 (463)
                      ....+++++++||++||..+|++  |++++|+++||||++..++
T Consensus       305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            12468999999999999988888  9999999999999876654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.8e-51  Score=394.07  Aligned_cols=255  Identities=27%  Similarity=0.445  Sum_probs=209.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++++.||+|+||.||+|++ .+|+.||+|++.....   ....+.+|+.+++.+ +||||+++++++      ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~   73 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVI------HTKK   73 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEE------ECSS
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEE------ccCC
Confidence            4699999999999999999998 6789999999864432   236778999999999 899999999999      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        74 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           74 RLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             CEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             eEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            89999999986 9999887543 368999999999999999999999999999999999999999999999999998765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---C-------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---A-------  281 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---~-------  281 (463)
                      .........+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+....+..+...   .       
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          152 IPVRKYTHEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             C---------CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccccccccCchheeC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence            44344455679999999999863    345889999999999999999999999887665544332110   0       


Q ss_pred             -------CC----------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -------PP----------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -------~~----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                             .+          ......+++++++||.+||..||.+|||++|+|+||||++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                   00          0112357899999999999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.2e-51  Score=405.00  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=204.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+|+++ +||||+++++++      ...
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~------~~~  120 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-SHPNIIKLKEIF------ETP  120 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-CCTTBCCEEEEE------ECS
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-CCCCCcceeeeE------ecC
Confidence            445678999999999999999999999999999999997543 345678899999999 799999999999      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEecccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVS  207 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGla  207 (463)
                      +.+|+||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            78999999999999999997543  6899999999999999999999999999999999999975   889999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh-hhcccCCCCC--C
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-LFLIPRNAPP--R  284 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~--~  284 (463)
                      +..... ......+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+...... ...+......  .
T Consensus       199 ~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~  272 (349)
T 2w4o_A          199 KIVEHQ-VLMKTVCGTPGYCAPEILR-----GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS  272 (349)
T ss_dssp             ---------------CGGGSCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT
T ss_pred             cccCcc-cccccccCCCCccCHHHhc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC
Confidence            876543 2234567999999999997     56789999999999999999999999987665542 2333232221  2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .....++.++++||.+||..||.+|||+.|+|+||||....
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            22356889999999999999999999999999999998654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4e-51  Score=400.35  Aligned_cols=258  Identities=28%  Similarity=0.480  Sum_probs=204.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|++++.||+|+||.||+|++..+|+.||+|++....  .....+.+|+.+++.+ +||||+++++++      ...+.
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~------~~~~~   77 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVI------HTENK   77 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEE------CCTTE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEE------EECCe
Confidence            47999999999999999999999999999999997432  2346788999999999 899999999999      55679


Q ss_pred             EEEEEecCCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTK----GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +|+||||+. |+|.+++....    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            999999998 59999987643    2358999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---C----
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---A----  281 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---~----  281 (463)
                      ............+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+....+..+...   .    
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMG----SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             ecCCCcccCCCCcccccccCchHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            77654444455689999999999863    346899999999999999999999999887765544332110   0    


Q ss_pred             ----------CC---------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 ----------PP---------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 ----------~~---------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                .+               ......++.++++||.+||..||.+|||++|+|+||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence                      00               00112578899999999999999999999999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.9e-51  Score=404.65  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=214.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      +.++|++.+.||+|+||.||+|+++.+|+.||+|++.....   ...+|+.++.++.+||||+++++++      ...+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~------~~~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVY------DDGKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEE------ECSSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEE------EcCCE
Confidence            45679999999999999999999999999999999975432   2457888898887899999999999      45579


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC----CcEEEEeccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN----AEVKLVDFGVSA  208 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~----~~vkL~DFGla~  208 (463)
                      +|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+.+.    +.+||+|||++.
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999999999997543  69999999999999999999999999999999999998543    359999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---chhhhhcccCCCCC--
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH---PMRALFLIPRNAPP--  283 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~--  283 (463)
                      ............+||+.|+|||++.     ...|+.++|||||||++|+|++|.+||.+..   ....+..+......  
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  243 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLE-----RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS  243 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHH-----HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred             cCcCCCCceeccCCCccccCHHHhc-----CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence            7765544556678999999999997     4558899999999999999999999997632   22333333333222  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ......+++++++||.+||..||.+|||+.++++||||.+
T Consensus       244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            1123568999999999999999999999999999999954

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-51  Score=412.03  Aligned_cols=258  Identities=25%  Similarity=0.455  Sum_probs=206.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...   ......+.+|+.+|+.+.+||||+++++++..    ...
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~   83 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA----DND   83 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----TTS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec----CCC
Confidence            35799999999999999999999999999999998532   33456677899999999669999999999853    233


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+. ++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             CEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            57999999998 5899998753   5899999999999999999999999999999999999999999999999999865


Q ss_pred             ccc---------------------cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7384         211 DRT---------------------IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH  269 (463)
Q Consensus       211 ~~~---------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  269 (463)
                      ...                     .......+||++|+|||++.+    ...|+.++||||||||+|+|++|++||.+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG----STKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            321                     112344689999999999873    3578999999999999999999999999888


Q ss_pred             chhhhhcccCCCC-C-------------------------------C-------------CCCCCCCHHHHHHHHHhhhc
Q psy7384         270 PMRALFLIPRNAP-P-------------------------------R-------------LKSKKWPKKFQSFIETVLVK  304 (463)
Q Consensus       270 ~~~~~~~i~~~~~-~-------------------------------~-------------~~~~~~~~~~~~li~~~L~~  304 (463)
                      ....+..+..... +                               .             .....+++++.+||.+||..
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            7666554421100 0                               0             01126688999999999999


Q ss_pred             CCCCCCCHHHHhcCccccC
Q psy7384         305 DYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       305 dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ||.+|||++|+|+||||+.
T Consensus       316 dP~~R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          316 NPNKRISANDALKHPFVSI  334 (388)
T ss_dssp             SGGGSCCHHHHTTSTTTTT
T ss_pred             CcccCCCHHHHhCCHHHHH
Confidence            9999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=405.52  Aligned_cols=263  Identities=24%  Similarity=0.456  Sum_probs=221.8

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++++.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+|+.+ +||||++++++|      .
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~------~   85 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSF------Q   85 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE------E
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE------E
Confidence            346899999999999999999999999999999998632    23456788999999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+||||+.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence            5578999999999999999997543  69999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh---hhhcccCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---ALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~~~~~  285 (463)
                      .+... ......+||+.|+|||++....  +..|+.++|||||||++|+|++|.+||.......   ....+.....  .
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~  238 (384)
T 4fr4_A          164 MLPRE-TQITTMAGTKPYMAPEMFSSRK--GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--T  238 (384)
T ss_dssp             ECCTT-CCBCCCCSCGGGCCGGGTCCCS--SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--C
T ss_pred             eccCC-CceeccCCCccccCCeeeccCC--CCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--C
Confidence            76543 3345678999999999986321  3468999999999999999999999997543322   1222222211  2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHhcCccccCCchhHH
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPY-TDQLLKHPFIRDQPTERQ  329 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt-~~e~l~hp~~~~~~~~~~  329 (463)
                      .+..++..+.+||.+||..||.+||+ ++++++||||.+..+...
T Consensus       239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~  283 (384)
T 4fr4_A          239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV  283 (384)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred             CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence            23468999999999999999999998 999999999998776543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=395.23  Aligned_cols=264  Identities=26%  Similarity=0.430  Sum_probs=214.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc------chHHHHHHHHHHHHHhc--CCCceeeeccccccc
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE------DEEEEIKLEINVLKKYS--NHRNIATYYGAFIKK  124 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~  124 (463)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++....      .....+.+|+.+++.+.  +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3568999999999999999999999999999999986322      12346677888777763  599999999998643


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                      .. .....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        87 ~~-~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           87 RT-DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CS-SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             CC-CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            21 11226899999997 59999998776666999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--C
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--P  282 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~  282 (463)
                      |++...... ......+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+....+..+....  +
T Consensus       165 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          165 GLARIYSYQ-MALTPVVVTLWYRAPEVLL-----QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             SCTTTSTTC-CCSGGGGCCCSSCCHHHHH-----TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccCCC-cccCCccccccccCchHHc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999876543 2335568999999999997     5668999999999999999999999998887766554432110  0


Q ss_pred             C-C----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         283 P-R----------------------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       283 ~-~----------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      + .                      ...+.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            0 0                      0113578899999999999999999999999999999753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-50  Score=389.01  Aligned_cols=266  Identities=24%  Similarity=0.469  Sum_probs=219.3

Q ss_pred             CCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccc
Q psy7384          44 WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAF  121 (463)
Q Consensus        44 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~  121 (463)
                      .+...|+....++|.+.+.||+|+||.||+|++..++..||+|++...  ......+.+|+.+|+.+ +||||+++++++
T Consensus        11 ~~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   89 (285)
T 3is5_A           11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVF   89 (285)
T ss_dssp             --CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             cccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHhe
Confidence            345567778889999999999999999999999999999999998643  33467889999999999 899999999999


Q ss_pred             cccCCCCCCCeEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE---ccC
Q psy7384         122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL---TDN  196 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl---~~~  196 (463)
                            ......|+||||+.+|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||+   +.+
T Consensus        90 ------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~  163 (285)
T 3is5_A           90 ------EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPH  163 (285)
T ss_dssp             ------ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTT
T ss_pred             ------ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCC
Confidence                  4557899999999999999988653  23579999999999999999999999999999999999999   456


Q ss_pred             CcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc
Q psy7384         197 AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL  276 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~  276 (463)
                      +.+||+|||++...... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.........
T Consensus       164 ~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~  236 (285)
T 3is5_A          164 SPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK  236 (285)
T ss_dssp             CCEEECCCCCCCC-----------CTTGGGCCHHHHT------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCEEEEeeecceecCCc-ccCcCcccccCcCChHHhc------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence            78999999999766543 2234567999999999984      4588999999999999999999999988776555444


Q ss_pred             ccCCCC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         277 IPRNAP-PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       277 i~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +..... .......+++++.+||.+||..||.+|||+.|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          237 ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             hccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            332222 22223457899999999999999999999999999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.6e-51  Score=416.65  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=215.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++..    .......+.+|+.+|+.+ +||||++++++|      .
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~------~  218 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSF------Q  218 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEE------E
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEE------e
Confidence            34689999999999999999999999999999999963    233345677899999988 799999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ..+.+||||||+.+|+|.+++....  .+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||++
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence            4578999999999999999997654  69999999999999999999998 99999999999999999999999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      +............+||+.|+|||++.     ...|+.++|||||||++|+|++|.+||.+.+.......+......  ..
T Consensus       297 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~p  369 (446)
T 4ejn_A          297 KEGIKDGATMKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FP  369 (446)
T ss_dssp             CTTCC-----CCSSSCGGGCCHHHHH-----TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CC
T ss_pred             eeccCCCcccccccCCccccCHhhcC-----CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC--CC
Confidence            87554444456678999999999997     567899999999999999999999999888777666655444332  23


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      ..+++++++||.+||..||.+||     +++|+++||||.+..+.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence            46889999999999999999999     99999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.9e-50  Score=400.71  Aligned_cols=262  Identities=40%  Similarity=0.781  Sum_probs=226.3

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      .++.++|++++.||+|+||.||+|++..+|+.||||++....    .....+.+|+.+|+++ +||||+++++++.    
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~----  124 (348)
T 1u5q_A           50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYL----  124 (348)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE----
T ss_pred             cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE----
Confidence            345567999999999999999999999999999999997432    2235678999999999 8999999999994    


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                        ..+..||||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       125 --~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          125 --REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             --ETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             --ECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence              4478999999997 58888886543 4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      +......    ...+||+.|+|||++....  ...++.++|||||||++|+|++|.+||.+.+....+..+.....+...
T Consensus       201 a~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  274 (348)
T 1u5q_A          201 ASIMAPA----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ  274 (348)
T ss_dssp             CBSSSSB----CCCCSCGGGCCHHHHHTTS--SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred             ceecCCC----CcccCCcceeCHhhhcccc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence            9876432    4568999999999985321  456889999999999999999999999988877777666666666666


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      ...+++.+++||.+||..||.+|||++++++||||......
T Consensus       275 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence            67899999999999999999999999999999999865443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.5e-51  Score=410.71  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=208.1

Q ss_pred             CCCceEEE-eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELI-EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..+.|.+. +.||+|+||+||+|++..+|+.||||++...    ..+.+|+.++.++.+||||++++++|....  ....
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~--~~~~  132 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLY--AGRK  132 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE--TTEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecc--cCCc
Confidence            34568877 7999999999999999999999999999632    456788988877778999999999884311  2246


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEeccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSA  208 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGla~  208 (463)
                      .+|||||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            7899999999999999998765557999999999999999999999999999999999999987   7899999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh----hhcccCC--CC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA----LFLIPRN--AP  282 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~----~~~i~~~--~~  282 (463)
                      ..... ......+||+.|+|||++.     ...|+.++||||||||+|+|++|.+||.+......    ...+...  ..
T Consensus       213 ~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          213 ETTSH-NSLTTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             ECC------------CTTCCGGGSC-----CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccCCC-CccccCCCCCCccCHhhcC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            76533 2235568999999999986     56799999999999999999999999977654321    1122111  12


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      +......++.++++||.+||..||.+|||++++|+||||...
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            222335689999999999999999999999999999999753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.9e-50  Score=395.01  Aligned_cols=256  Identities=37%  Similarity=0.733  Sum_probs=223.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..|+..+.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.+ +||||+++++++.      ..+..
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~------~~~~~  117 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYL------VGEEL  117 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEE------ETTEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE------ECCEE
Confidence            3588899999999999999999999999999999744 34456788999999999 8999999999994      44789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+++++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       118 ~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence            999999999999999864   25999999999999999999999999999999999999999999999999999877655


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-CCCCCH
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKKWPK  292 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  292 (463)
                      .......+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+.....+... ...+++
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2c30_A          195 VPKRKSLVGTPYWMAPEVIS-----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSP  269 (321)
T ss_dssp             SCCBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCH
T ss_pred             ccccccccCCccccCHhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCH
Confidence            44455678999999999997     567899999999999999999999999888776666555444433322 346789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .+++||.+||..||.+|||++++++||||....
T Consensus       270 ~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          270 VLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999999999999998543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-50  Score=397.97  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=195.7

Q ss_pred             CceEEE---eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELI---EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~---~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++.   +.||+|+||.||+|++..+|+.||+|++...  ....+.+|+.+++.+.+||||+++++++      ....
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~------~~~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVF------HDQL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEE------ECSS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEE------EcCC
Confidence            357765   7899999999999999999999999999643  4567789999999996699999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC---cEEEEeccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA---EVKLVDFGVSA  208 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~---~vkL~DFGla~  208 (463)
                      ..|+||||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            8999999999999999997654  699999999999999999999999999999999999997665   89999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-------hhhhhcccCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-------MRALFLIPRNA  281 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~  281 (463)
                      ............+||+.|+|||++.     ...|+.++|||||||++|+|++|.+||.+...       ...+..+....
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~  232 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLN-----QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD  232 (325)
T ss_dssp             ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred             ecCCCCCcccccCCCcCccCHHHhc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence            7665544456678999999999997     56789999999999999999999999976443       22333333332


Q ss_pred             CCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 PPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 ~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ....  ....+++++++||.+||..||.+|||++++++||||++.
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            2111  113578999999999999999999999999999999854

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-50  Score=405.29  Aligned_cols=259  Identities=21%  Similarity=0.402  Sum_probs=222.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+|+.+ +||||+++++++      ...
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~------~~~  120 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAF------EDK  120 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEE------ECS
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEE------EeC
Confidence            34568999999999999999999999999999999997543 3455788999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc--CCcEEEEeccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSA  208 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~--~~~vkL~DFGla~  208 (463)
                      ..+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccce
Confidence            78999999999999999986533 36899999999999999999999999999999999999974  5779999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLK  286 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~  286 (463)
                      ...... .....+||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+.+....+..+.....  +...
T Consensus       200 ~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  273 (387)
T 1kob_A          200 KLNPDE-IVKVTTATAEFAAPEIVD-----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA  273 (387)
T ss_dssp             ECCTTS-CEEEECSSGGGCCHHHHT-----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred             ecCCCc-ceeeeccCCCccCchhcc-----CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            775432 234457999999999997     56789999999999999999999999998887766665544332  2222


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ...+++++++||.+||..||.+|||++|+|+||||...
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            35689999999999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-50  Score=402.38  Aligned_cols=256  Identities=29%  Similarity=0.462  Sum_probs=216.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc----CCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS----NHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~----~h~nIv~l~~~~~~~~~~  127 (463)
                      ...++|++++.||+|+||.||+|++..+++.||||++.........+..|+.+++.+.    +||||+++++++.     
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~-----  106 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM-----  106 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE-----
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceee-----
Confidence            3467899999999999999999999999999999999866666777888999999984    4999999999994     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc------------
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD------------  195 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~------------  195 (463)
                       ..+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.            
T Consensus       107 -~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          107 -YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             -ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             -ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence             447899999999 889999998776667999999999999999999999999999999999999975            


Q ss_pred             -------------CCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy7384         196 -------------NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ  262 (463)
Q Consensus       196 -------------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~  262 (463)
                                   ++.+||+|||+++.....   ....+||+.|+|||++.     +..|+.++|||||||++|+|++|.
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVIL-----NLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHc-----CCCCCCccchHHHHHHHHHHHHCC
Confidence                         789999999999865433   24567999999999997     567899999999999999999999


Q ss_pred             CCCCCCCchhhhhcccCCCCCCC-------------------------C-------------------CCCCCHHHHHHH
Q psy7384         263 PPLCDLHPMRALFLIPRNAPPRL-------------------------K-------------------SKKWPKKFQSFI  298 (463)
Q Consensus       263 ~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~-------------------~~~~~~~~~~li  298 (463)
                      +||.+.+....+..+.....+..                         .                   ....++.+.+||
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            99988766554432211100000                         0                   011236788999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         299 ETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       299 ~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      .+||+.||.+|||++|+|+||||+
T Consensus       337 ~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          337 YSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHhcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999999995

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=413.20  Aligned_cols=265  Identities=27%  Similarity=0.417  Sum_probs=220.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++....    .....+.+|+.+|..+ +||||++++++|      .+
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~------~~  132 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAF------QD  132 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEE------EC
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEE------ee
Confidence            457999999999999999999999999999999996421    2234577899999998 899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+||||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            579999999999999999997653 3699999999999999999999999999999999999999999999999999987


Q ss_pred             cccccC-ccccccCCccccccceeccC--CCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---CC
Q psy7384         210 LDRTIG-RRNTFIGTPYWMAPEVIACD--ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---PP  283 (463)
Q Consensus       210 ~~~~~~-~~~~~~gt~~y~aPE~l~~~--~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---~~  283 (463)
                      ...... .....+||+.|+|||++...  ......|+.++|||||||++|||++|++||.+.+....+..+....   ..
T Consensus       212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  291 (412)
T 2vd5_A          212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL  291 (412)
T ss_dssp             CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence            654322 22346899999999998631  1113468999999999999999999999999988777666554321   11


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHhcCccccCCchh
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQR---PYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~hp~~~~~~~~  327 (463)
                      ......++.++++||++||. +|.+|   ++++|+++||||++..+.
T Consensus       292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            11234789999999999999 99998   599999999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-50  Score=418.97  Aligned_cols=267  Identities=26%  Similarity=0.491  Sum_probs=225.1

Q ss_pred             cCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeee
Q psy7384          41 TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATY  117 (463)
Q Consensus        41 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l  117 (463)
                      .+++++...+..+.++|++++.||+|+||+||+|++..+|+.||+|++..   .......+.+|+.+|+++ +||||+++
T Consensus         8 ~~~~~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~   86 (486)
T 3mwu_A            8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKL   86 (486)
T ss_dssp             ------CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCE
T ss_pred             CCCCccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeE
Confidence            34555566666778899999999999999999999999999999999853   234567888999999999 89999999


Q ss_pred             cccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc---
Q psy7384         118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT---  194 (463)
Q Consensus       118 ~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~---  194 (463)
                      ++++      .....+|+|||||.+|+|.+++....  .+++..++.+++||+.||.|||++||+||||||+|||++   
T Consensus        87 ~~~~------~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~  158 (486)
T 3mwu_A           87 FEIL------EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE  158 (486)
T ss_dssp             EEEE------ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS
T ss_pred             EEEE------EcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC
Confidence            9999      45579999999999999999987654  699999999999999999999999999999999999995   


Q ss_pred             cCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh
Q psy7384         195 DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL  274 (463)
Q Consensus       195 ~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  274 (463)
                      .++.+||+|||+++..... ......+||+.|+|||++.      ..|+.++||||||||+|+|++|.+||.+.+....+
T Consensus       159 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  231 (486)
T 3mwu_A          159 KDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL  231 (486)
T ss_dssp             TTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGG------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            4567999999999876543 2334568999999999986      34899999999999999999999999998887777


Q ss_pred             hcccCCCCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         275 FLIPRNAPPR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       275 ~~i~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..+.......  .....+++++++||.+||..||.+|||+.++|+||||+.
T Consensus       232 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            6665543322  223467899999999999999999999999999999974

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=393.71  Aligned_cols=259  Identities=28%  Similarity=0.480  Sum_probs=211.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.....   ....+.+|+.+++++ +||||+++++++      ...+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~   75 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVF------RRKR   75 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEE------EETT
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhhee------ecCC
Confidence            579999999999999999999999999999999864433   245677899999999 799999999999      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..++||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            8999999999999999886543  69999999999999999999999999999999999999999999999999998776


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC------------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR------------  279 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~------------  279 (463)
                      .........+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.........+..            
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPELLVG----DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             ------------GGGCCHHHHHT----CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             CcccccCCCcCCccccChHHHhc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            54444456689999999999873    35688999999999999999999999988776554432211            


Q ss_pred             ---------CCCCCC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         280 ---------NAPPRL--------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       280 ---------~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                               ...+..        ..+.++..+.+||.+||..||.+|||++|+|+||||++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                     000000        11467889999999999999999999999999999987543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-50  Score=413.79  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||+||+|++..+|+.||||++...   ....+.+.+|+.+|+.+ +|||||++++++..... +.
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~  128 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDV-EK  128 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT-TT
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCc-cc
Confidence            457899999999999999999999999999999998643   23456788999999999 89999999999865422 33


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       129 ~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          129 FDELYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             CceEEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            467999999985 6999998654  3699999999999999999999999999999999999999999999999999987


Q ss_pred             ccccc---------------------------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh--
Q psy7384         210 LDRTI---------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE--  260 (463)
Q Consensus       210 ~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~--  260 (463)
                      .....                           ......+||++|+|||++..    ...|+.++||||||||+|||++  
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL----QENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC----CCCCCcHhHHHHHHHHHHHHHHhc
Confidence            64221                           12345689999999998753    4569999999999999999999  


Q ss_pred             ---------CCCCCCCCCch--------------------hhhhcc---------------------------cCC--CC
Q psy7384         261 ---------SQPPLCDLHPM--------------------RALFLI---------------------------PRN--AP  282 (463)
Q Consensus       261 ---------g~~Pf~~~~~~--------------------~~~~~i---------------------------~~~--~~  282 (463)
                               |.++|.+.+..                    ..+..+                           ...  ..
T Consensus       282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (458)
T 3rp9_A          282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD  361 (458)
T ss_dssp             TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred             cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence                     77888665421                    111000                           000  00


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .....+.++.++.+||++||..||.+|||++|+|+||||++..
T Consensus       362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            0111245689999999999999999999999999999998643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-49  Score=382.57  Aligned_cols=258  Identities=25%  Similarity=0.444  Sum_probs=222.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+.++|++.+.||+|+||.||+|.+..+|..||+|++....   .....+.+|+.+++++ +||||+++++++      .
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~   75 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI------Q   75 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE------E
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEE------E
Confidence            45678999999999999999999999999999999996432   3446778999999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc---EEEEecc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFG  205 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~---vkL~DFG  205 (463)
                      ..+..|+||||+.+++|.+.+....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        76 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           76 EESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            5578999999999999999887654  6999999999999999999999999999999999999976655   9999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--C
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--P  283 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~  283 (463)
                      ++...... .......||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+.....  +
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  227 (284)
T 3kk8_A          154 LAIEVNDS-EAWHGFAGTPGYLSPEVLK-----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP  227 (284)
T ss_dssp             TCEECCSS-CBCCCSCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             eeEEcccC-ccccCCCCCcCCcCchhhc-----CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC
Confidence            99776543 2234567999999999997     56789999999999999999999999988877666655444332  2


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ......+++++.+||.+||..||.+|||++|+|+||||.+.
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            22335788999999999999999999999999999999754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-50  Score=401.15  Aligned_cols=261  Identities=26%  Similarity=0.435  Sum_probs=213.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++...   ......+.+|+.+|+.+ +||||+++++++.......
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccc
Confidence            3467899999999999999999999999999999998543   22346778999999999 7999999999996543223


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||||+ +++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            335679999999 78999999752   58999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC--------
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--------  280 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------  280 (463)
                      .....   ....+||++|+|||++..    ...|+.++||||||||+|+|++|++||.+.+....+..+...        
T Consensus       177 ~~~~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          177 QADSE---MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             ECCSS---CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccc---cCcCcCCCCcCCHHHHhC----CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            76543   355689999999999873    356899999999999999999999999987766554433210        


Q ss_pred             -------------------CCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         281 -------------------APP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       281 -------------------~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                         ...  .......++.+.+||.+||..||.+|||++++|+||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                               000  01124568899999999999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.1e-51  Score=399.89  Aligned_cols=260  Identities=24%  Similarity=0.421  Sum_probs=207.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.....   ....+.+|+.+|+.+ +||||+++++++      .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~  103 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVI------H  103 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEE------E
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEE------e
Confidence            345689999999999999999999999999999999964432   234567899999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc-----cCCcEEEEe
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-----DNAEVKLVD  203 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~-----~~~~vkL~D  203 (463)
                      ..+.+||||||+.+ +|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|
T Consensus       104 ~~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          104 HNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             cCCEEEEEEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            55789999999985 9999997654  599999999999999999999999999999999999994     455699999


Q ss_pred             cccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--  281 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--  281 (463)
                      ||++.............+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+......+..+....  
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  256 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLG----SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL  256 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence            9999877654444556678999999999873    3458999999999999999999999998887766554432110  


Q ss_pred             C------------------CCCC--------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         282 P------------------PRLK--------SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       282 ~------------------~~~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      +                  +...        ...+++++++||.+||..||.+|||++|+|+||||++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            0                  0000        012678999999999999999999999999999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.2e-50  Score=430.42  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=229.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++++.||+|+||.||+|+++.+++.||||++...    ......+..|..+|..+.+||||++++++|      +.
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~------~~  413 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF------QT  413 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC------BC
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE------Ee
Confidence            46799999999999999999999999999999999642    234466778999998887899999999999      55


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+||||||+.||+|.+++....  .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            679999999999999999998765  699999999999999999999999999999999999999999999999999986


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ...........+||+.|+|||++.     ...|+.++|||||||++|||++|.+||.+.+....+..|......  .+..
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~  564 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKS  564 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHT-----CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC--CCTT
T ss_pred             cccCCcccccccCCCcccCHhhhc-----CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--CCcc
Confidence            544444456678999999999997     677999999999999999999999999998888777777665432  2347


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCH-----HHHhcCccccCCchhH
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYT-----DQLLKHPFIRDQPTER  328 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~~~~~  328 (463)
                      ++.++++||++||..||.+||++     ++|++||||....++.
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence            89999999999999999999997     9999999999876653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9e-50  Score=391.30  Aligned_cols=262  Identities=26%  Similarity=0.457  Sum_probs=224.6

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------hHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------EEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      ....++|++.+.||+|+||.||+|++..+|+.||+|++.....       ....+.+|+.+++.+ +||||+++++++  
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~--   84 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVY--   84 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE--
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEE--
Confidence            3455789999999999999999999999999999999964321       357789999999999 799999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC----cE
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EV  199 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~----~v  199 (463)
                          ...+.+|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++    .+
T Consensus        85 ----~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           85 ----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             ----ECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             ----ecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCE
Confidence                4457899999999999999999754  3689999999999999999999999999999999999999887    79


Q ss_pred             EEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         200 KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       200 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      ||+|||++....... ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.+......+..+..
T Consensus       159 kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  232 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS  232 (321)
T ss_dssp             EECCCTTCEECCTTC-CCCCCCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred             EEccCccceecCccc-cccccCCCCCccCccccc-----CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            999999998765432 234557999999999987     56789999999999999999999999988877766665544


Q ss_pred             CCCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         280 NAPPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       280 ~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      ......  ....++..+++||.+||..||.+|||++++++||||+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          233 VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence            332211  124678899999999999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.5e-50  Score=388.73  Aligned_cols=272  Identities=41%  Similarity=0.845  Sum_probs=224.7

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++.++|++++.||+|+||.||+|++..+|..||+|++... ......+.+|+.+++.+ +||||+++++++.      
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------   86 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYY------   86 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEE------
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeee------
Confidence            346778999999999999999999999999999999998643 34467888999999999 8999999999984      


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           87 HDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             CC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             eCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            4468999999999999999987643 369999999999999999999999999999999999999999999999999986


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-CCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-LKS  287 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~  287 (463)
                      .............||+.|+|||++.........++.++|||||||++|+|++|..||...+.......+.....+. ...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP  245 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence            5433323334567999999999985322225668899999999999999999999998887766655544443332 234


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhHH
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQ  329 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  329 (463)
                      ..++..+.+||.+||..||.+|||++++++||||........
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  287 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA  287 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHH
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchh
Confidence            578899999999999999999999999999999997665443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.5e-50  Score=419.14  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=221.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+|+.+ +||||++++++|      .
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~------~  254 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAY------E  254 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEE------E
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEE------e
Confidence            356799999999999999999999999999999999642    23356678999999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+||||||+.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence            55799999999999999999987665569999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch---hhhhcccCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM---RALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~~  285 (463)
                      ...... .....+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+....   ..+.......... 
T Consensus       335 ~~~~~~-~~~~~~GT~~Y~APEvl~-----~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~-  407 (576)
T 2acx_A          335 HVPEGQ-TIKGRVGTVGYMAPEVVK-----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE-  407 (576)
T ss_dssp             ECCTTC-CEECCCSCGGGCCHHHHT-----TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC-
T ss_pred             ecccCc-cccccCCCccccCHHHHc-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc-
Confidence            765432 234568999999999997     567899999999999999999999999876432   1222211111212 


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      ....++.++++||.+||..||.+||     +++|+++||||++..+.
T Consensus       408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            2357899999999999999999999     89999999999987654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.4e-50  Score=390.29  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=208.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|+++++||+|+||+||+|++..+|+.||||++....   ........|+..+.++.+|+||+++++++      ..
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~------~~  128 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW------EE  128 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE------EE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE------Ee
Confidence            3478999999999999999999999999999999986432   23345566777777776899999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             CCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            57899999999 669999887654 4699999999999999999999999999999999999999999999999999887


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      .... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+......+.   ....+......
T Consensus       207 ~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~~  276 (311)
T 3p1a_A          207 LGTA-GAGEVQEGDPRYMAPELLQ------GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---QGYLPPEFTAG  276 (311)
T ss_dssp             CC-------CCCCCGGGCCGGGGG------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHT---TTCCCHHHHTT
T ss_pred             cccC-CCCcccCCCccccCHhHhc------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHh---ccCCCcccccC
Confidence            6543 2234457999999999986      258899999999999999999977775544333222   22222222346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +++++.+||.+||..||.+|||++|+|+||||++
T Consensus       277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            7899999999999999999999999999999975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.4e-50  Score=390.15  Aligned_cols=264  Identities=47%  Similarity=0.911  Sum_probs=221.2

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.+ +||||+++++++.      ..
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~~   96 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-DSPHVVKYYGSYF------KN   96 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-CCTTBCCEEEEEE------ET
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-CCCCCccEEEEEE------eC
Confidence            345668999999999999999999999999999999997643 346788999999999 8999999999984      44


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            78999999999999999997433 46999999999999999999999999999999999999999999999999999877


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~  289 (463)
                      ...........||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+.....+.. ....
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQ-----EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL  250 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHS-----SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred             hhhccccCccCCCCCccChhhcC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCccc
Confidence            65544455668999999999987     55688999999999999999999999988777666555444433322 2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhH
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER  328 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  328 (463)
                      ++..+.+||.+||..||.+|||++++++||||+......
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~  289 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS  289 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence            789999999999999999999999999999998765443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.6e-50  Score=416.16  Aligned_cols=261  Identities=28%  Similarity=0.429  Sum_probs=222.0

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..+.|++++.||+|+||.||+|+++.+|+.||+|++....    .....+.+|+.+|+.+ +||||++++++|      .
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~------~  255 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAF------E  255 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEE------E
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEE------e
Confidence            3467999999999999999999999999999999996432    3346788999999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                      ..+.+|+||||+.||+|.+++....  ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecce
Confidence            5578999999999999999997643  34699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc----hhhhhcccCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP----MRALFLIPRNAP  282 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~  282 (463)
                      ++.+..........+||+.|+|||++.     +..|+.++|||||||++|||++|.+||.+...    ......+.....
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~  410 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLL-----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV  410 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred             eeeccCCCcccccccCCccccChhhhc-----CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence            987765444445568999999999997     56799999999999999999999999987543    222222222221


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchh
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~  327 (463)
                        ..+..++.++++||.+||..||.+||+     ++++++||||++..+.
T Consensus       411 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          411 --TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             --CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence              123578999999999999999999996     5899999999987654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.1e-50  Score=415.64  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=222.2

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--------------chHHHHHHHHHHHHHhcCCCce
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--------------DEEEEIKLEINVLKKYSNHRNI  114 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~Ei~~l~~l~~h~nI  114 (463)
                      ......++|++++.||+|+||+||+|++..++..||+|++....              .....+.+|+.+|+.+ +||||
T Consensus        30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  108 (504)
T 3q5i_A           30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNI  108 (504)
T ss_dssp             ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTB
T ss_pred             cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCC
Confidence            34456788999999999999999999999999999999997432              3356788999999999 89999


Q ss_pred             eeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc
Q psy7384         115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT  194 (463)
Q Consensus       115 v~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~  194 (463)
                      +++++++      .....+|||||||.||+|.+++....  .+++..++.+++||+.||.|||++||+||||||+|||++
T Consensus       109 v~~~~~~------~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          109 IKLFDVF------EDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE  180 (504)
T ss_dssp             CCEEEEE------ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred             CeEEEEE------EcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEe
Confidence            9999999      45579999999999999999997654  699999999999999999999999999999999999998


Q ss_pred             cCC---cEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch
Q psy7384         195 DNA---EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM  271 (463)
Q Consensus       195 ~~~---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  271 (463)
                      .++   .+||+|||++...... ......+||+.|+|||++.      ..|+.++|||||||++|+|++|.+||.+.+..
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  253 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ  253 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            775   6999999999877543 2334568999999999984      45899999999999999999999999998887


Q ss_pred             hhhhcccCCCCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         272 RALFLIPRNAPPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       272 ~~~~~i~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..+..+........  ....+++++++||.+||..||.+|||++|+|+||||+.
T Consensus       254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          254 DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            77766655543221  12568899999999999999999999999999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.9e-50  Score=406.91  Aligned_cols=257  Identities=28%  Similarity=0.411  Sum_probs=216.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc-----CCCceeeecccccccCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS-----NHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~-----~h~nIv~l~~~~~~~~~~  127 (463)
                      ..++|++++.||+|+||.||+|++..+++.||||++.........+.+|+.+++.+.     +|+||+++++++.     
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-----  169 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-----  169 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence            457899999999999999999999999999999999876666678888999998874     5779999999994     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc--EEEEecc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE--VKLVDFG  205 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~--vkL~DFG  205 (463)
                       ..+.+|+||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|||
T Consensus       170 -~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          170 -FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             -ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             -cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence             4478999999996 59999998877667999999999999999999999999999999999999999887  9999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-----
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-----  280 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----  280 (463)
                      +++.....   ....+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+....+..+...     
T Consensus       248 ~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          248 SSCYEHQR---VYTYIQSRFYRAPEVIL-----GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHHH-----TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cceecCCc---ccccCCCCCccChHHHh-----CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99765433   24568999999999998     567899999999999999999999999887765544322100     


Q ss_pred             -----------------CCCC-----------------------------------CCCCCCCHHHHHHHHHhhhcCCCC
Q psy7384         281 -----------------APPR-----------------------------------LKSKKWPKKFQSFIETVLVKDYHQ  308 (463)
Q Consensus       281 -----------------~~~~-----------------------------------~~~~~~~~~~~~li~~~L~~dp~~  308 (463)
                                       ..+.                                   ......++.+.+||.+||.+||.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence                             0000                                   001234788999999999999999


Q ss_pred             CCCHHHHhcCccccCC
Q psy7384         309 RPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       309 Rpt~~e~l~hp~~~~~  324 (463)
                      |||++|+|+||||+..
T Consensus       400 Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          400 RMTPGQALRHPWLRRR  415 (429)
T ss_dssp             SCCHHHHHTSTTTC--
T ss_pred             CCCHHHHhCChhhccC
Confidence            9999999999999853

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=397.10  Aligned_cols=256  Identities=25%  Similarity=0.443  Sum_probs=206.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchH--HHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|++++.||+|+||.||+|++..+++.||+|++.......  ..+.+|+.+|+.+ +||||+++++++      ...+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDII------HTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEE------ECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEE------eeCCE
Confidence            46999999999999999999999999999999986443221  1345799999999 799999999999      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           75 LTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             EEEEeccccc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9999999975 8999887643 3699999999999999999999999999999999999999999999999999987665


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---CCC------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---APP------  283 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---~~~------  283 (463)
                      ........+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+....+..+...   ...      
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ----------CGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             CccccccccCcccccChhhhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence            4444455689999999999863    356899999999999999999999999887766554332110   000      


Q ss_pred             ------------C-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         284 ------------R-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       284 ------------~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                  .       .....+++++++||.+||..||.+|||++|+|+||||.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  287 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS  287 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence                        0       011356889999999999999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-49  Score=395.18  Aligned_cols=260  Identities=27%  Similarity=0.501  Sum_probs=220.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---------hHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---------EEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....         ....+.+|+.+++.+.+||||+++++++   
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---  169 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---  169 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE---
Confidence            3679999999999999999999999999999999975431         1356778999999997799999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                         ......|+||||+.|++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       170 ---~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ---ESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             ---EBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ---eeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEec
Confidence               44578999999999999999997654  6999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDEN-PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      |++..+.... .....+||+.|+|||++.+... ....++.++|||||||++|+|++|..||.+......+..+......
T Consensus       245 G~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          245 GFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             TTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9998775432 2345689999999999864321 1345889999999999999999999999887766665554443322


Q ss_pred             CC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         284 RL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       284 ~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ..  ....++..+.+||.+||..||.+|||++++|+||||+
T Consensus       324 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            11  1246788999999999999999999999999999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.5e-50  Score=392.62  Aligned_cols=263  Identities=24%  Similarity=0.435  Sum_probs=221.6

Q ss_pred             CCCCceEEE-eeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELI-EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .+.++|.+. +.||+|+||.||+|++..+|+.||+|++...   ......+.+|+.+++.+.+||||+++++++      
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~------   98 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY------   98 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE------
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE------
Confidence            456789988 8999999999999999999999999998643   334678889999999997789999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEec
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDF  204 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DF  204 (463)
                      ...+.+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            45578999999999999999987655567999999999999999999999999999999999999987   789999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--C
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--P  282 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~  282 (463)
                      |++....... .....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+....  .
T Consensus       179 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  252 (327)
T 3lm5_A          179 GMSRKIGHAC-ELREIMGTPEYLAPEILN-----YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY  252 (327)
T ss_dssp             GGCEEC----------CCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ccccccCCcc-ccccccCCcCccCCeeec-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc
Confidence            9998765432 234467999999999997     5678999999999999999999999998887766655443322  2


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      +......+++.+.+||.+||..||.+|||++++|+||||++...
T Consensus       253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            22333578899999999999999999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=402.35  Aligned_cols=257  Identities=27%  Similarity=0.479  Sum_probs=214.8

Q ss_pred             CceEE--EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFEL--IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~--~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..|.+  .+.||+|+||.||+|++..+|..||+|++.... .....+.+|+.+|+++ +||||+++++++      ...+
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~------~~~~  159 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAF------ESKN  159 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE------ECSS
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEE------EECC
Confidence            44555  678999999999999999999999999997543 4556788999999999 899999999999      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE--ccCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL--TDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl--~~~~~vkL~DFGla~~  209 (463)
                      .+||||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++.
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            8999999999999999887543 358999999999999999999999999999999999999  5667899999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC--CCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--RLKS  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~  287 (463)
                      ..... .....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.+....+..+......  ....
T Consensus       239 ~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  312 (373)
T 2x4f_A          239 YKPRE-KLKVNFGTPEFLAPEVVN-----YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF  312 (373)
T ss_dssp             CCTTC-BCCCCCSSCTTCCHHHHT-----TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred             cCCcc-ccccccCCCcEeChhhcc-----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhh
Confidence            65432 234457999999999986     567889999999999999999999999988877766655444322  1223


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ..+++++++||.+||..||.+|||++|+|+||||.+..
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            56899999999999999999999999999999998643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5e-50  Score=391.76  Aligned_cols=268  Identities=24%  Similarity=0.395  Sum_probs=212.2

Q ss_pred             cCCCCCCceEEE-eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          49 WQEDPAGIFELI-EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        49 ~~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      +...+.++|++. +.||+|+||.||+|++..+++.||||++.... .....+.+|+.+|.++.+||||+++++++.    
T Consensus         6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~----   81 (316)
T 2ac3_A            6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE----   81 (316)
T ss_dssp             SCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred             cCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe----
Confidence            345567789996 78999999999999999999999999997543 346788899999999768999999999994    


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc---EEEEe
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVD  203 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~---vkL~D  203 (463)
                        ..+.+|+||||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|
T Consensus        82 --~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           82 --EEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             --ETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             --eCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence              4579999999999999999998754  6899999999999999999999999999999999999987765   99999


Q ss_pred             ccccccccccc-------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh----
Q psy7384         204 FGVSAQLDRTI-------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR----  272 (463)
Q Consensus       204 FGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~----  272 (463)
                      ||++.......       ......+||+.|+|||++.........++.++|||||||++|+|++|.+||.+.....    
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            99987653211       1123456999999999986311111457889999999999999999999997754321    


Q ss_pred             -----------hhhcccCCCCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         273 -----------ALFLIPRNAPPR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       273 -----------~~~~i~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                 ....+.......  .....++..+++||.+||..||.+|||++|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             ccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                       112222221111  1114678999999999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.3e-50  Score=411.35  Aligned_cols=255  Identities=27%  Similarity=0.441  Sum_probs=220.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....    .....+.+|+.+|+.+ +||||+++++++      .
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~------~   86 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVI------S   86 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEE------E
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE------E
Confidence            3468999999999999999999999999999999996432    2346788999999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+||||+.||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence            457899999999999999999653  369999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ..... ......+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+.......+......  .+.
T Consensus       165 ~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~  237 (476)
T 2y94_A          165 MMSDG-EFLRTSCGSPNYAAPEVISG----RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY--TPQ  237 (476)
T ss_dssp             ECCTT-CCBCCCCSCSTTCCHHHHTT----CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC--CCT
T ss_pred             hcccc-ccccccCCCcCeEChhhccC----CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC--CCc
Confidence            76543 23345689999999999973    223368999999999999999999999888776666665544332  234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .+++++++||.+||..||.+|||++++++||||+.
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            67899999999999999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-49  Score=403.66  Aligned_cols=265  Identities=27%  Similarity=0.417  Sum_probs=209.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...++|++++.||+|+||.||+|++..+|+.||||++...   ......+.+|+.+|+.+ +||||+++++++..... .
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~  100 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDL-L  100 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT-T
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCC-C
Confidence            3567899999999999999999999999999999999643   23456788999999999 79999999999864321 2


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||||+. |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus       101 ~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          101 KFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            2267999999997 4999999754  369999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC----------------------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-----
Q psy7384         209 QLDRTIG----------------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-----  261 (463)
Q Consensus       209 ~~~~~~~----------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-----  261 (463)
                      .......                      .....+||++|+|||++..    ...|+.++||||||||+|||++|     
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL----QENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc----CCCCCcccccchHHHHHHHHHhcccccc
Confidence            7653321                      2356789999999998753    45689999999999999999984     


Q ss_pred             ------CCCCCCCCc-----------------hhhhhcc-----------------------cCCCCCC------CCCCC
Q psy7384         262 ------QPPLCDLHP-----------------MRALFLI-----------------------PRNAPPR------LKSKK  289 (463)
Q Consensus       262 ------~~Pf~~~~~-----------------~~~~~~i-----------------------~~~~~~~------~~~~~  289 (463)
                            .++|.+.+.                 ..++..+                       .......      ...+.
T Consensus       254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (432)
T 3n9x_A          254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS  333 (432)
T ss_dssp             SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred             cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence                  455544331                 0111000                       0000000      01146


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      +++++.+||.+||..||.+|||++|+|+||||++..
T Consensus       334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            789999999999999999999999999999998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.7e-50  Score=414.42  Aligned_cols=256  Identities=29%  Similarity=0.522  Sum_probs=218.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...++|++++.||+|+||+||+|++..++..||+|++...   ......+.+|+.+|+.+ +||||++++++|      .
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~------~  106 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFF------E  106 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEE------E
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEE------E
Confidence            4456899999999999999999999999999999999743   23456788999999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEecc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFG  205 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFG  205 (463)
                      ....+|+|||||.+|+|.+++....  .+++..++.+++||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            5578999999999999999987654  6999999999999999999999999999999999999976   4559999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC-
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR-  284 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-  284 (463)
                      ++...... ......+||+.|+|||++.      ..|+.++|||||||++|+|++|.+||.+.+....+..+....... 
T Consensus       185 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  257 (494)
T 3lij_A          185 LSAVFENQ-KKMKERLGTAYYIAPEVLR------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD  257 (494)
T ss_dssp             TCEECBTT-BCBCCCCSCTTTCCHHHHT------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             CCeECCCC-ccccccCCCcCeeCHHHHc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            99876543 2335568999999999984      458999999999999999999999999988877776665544322 


Q ss_pred             -CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         285 -LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       285 -~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                       .....+++.+++||.+||..||.+|||+.|+|+||||+.
T Consensus       258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence             223568999999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=380.25  Aligned_cols=255  Identities=25%  Similarity=0.460  Sum_probs=194.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+++.+ +||||+++++++      ...
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~   83 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYF------EDS   83 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEE------ECS
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEE------ccC
Confidence            46999999999999999999999999999999996432    2246788999999999 899999999998      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            78999999999999999997543 46899999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...........||+.|+|||++.     ...++.++|||||||++|+|++|.+||........+..+.....  .....+
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~  235 (278)
T 3cok_A          163 KMPHEKHYTLCGTPNYISPEIAT-----RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY--EMPSFL  235 (278)
T ss_dssp             C---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC--CCCTTS
T ss_pred             cCCCCcceeccCCCCcCCcchhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc--CCcccc
Confidence            54433344567999999999987     55678899999999999999999999987665554444332221  123467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      +.++.+||.+||..||.+|||++++++||||...
T Consensus       236 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            8999999999999999999999999999999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.7e-50  Score=416.15  Aligned_cols=258  Identities=29%  Similarity=0.500  Sum_probs=224.5

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ...+.++|++.+.||+|+||.||+|++..+|+.||||++...    ......+.+|+.+|+.+ +||||+++++++    
T Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~----   95 (484)
T 3nyv_A           21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFF----   95 (484)
T ss_dssp             CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEE----
T ss_pred             CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEE----
Confidence            345667899999999999999999999999999999998643    34567889999999999 899999999999    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE---ccCCcEEEE
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL---TDNAEVKLV  202 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl---~~~~~vkL~  202 (463)
                        ...+.+|+||||+.+|+|.+++....  .+++..++.+++||+.||.|||++||+||||||+|||+   +.++.+||+
T Consensus        96 --~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  171 (484)
T 3nyv_A           96 --EDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII  171 (484)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             --EeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEE
Confidence              45579999999999999999997544  69999999999999999999999999999999999999   567899999


Q ss_pred             ecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC
Q psy7384         203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       203 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      |||+++..... ......+||+.|+|||++.      ..|+.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus       172 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  244 (484)
T 3nyv_A          172 DFGLSTHFEAS-KKMKDKIGTAYYIAPEVLH------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY  244 (484)
T ss_dssp             CTTHHHHBCCC-CSHHHHTTGGGTCCHHHHH------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             eeeeeEEcccc-cccccCCCCccccCceeec------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999876543 2334567999999999986      3588999999999999999999999999888777766655443


Q ss_pred             CC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         283 PR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       283 ~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..  .....+++++++||.+||..||.+|||++|+|+||||+.
T Consensus       245 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          245 TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            22  222467899999999999999999999999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.7e-50  Score=395.75  Aligned_cols=263  Identities=27%  Similarity=0.443  Sum_probs=213.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.....   ....+.+|+.+++.+ +||||+++++++      ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~   95 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVC------KK   95 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE------EE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEe------ec
Confidence            35689999999999999999999999999999999864332   245577899999999 799999999999      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            578999999999999988875433  699999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---------  280 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------  280 (463)
                      ............||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+......+..+...         
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVG----DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccC----CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            7654444456689999999999863    346889999999999999999999999887765544332110         


Q ss_pred             ------------CCCCC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhH
Q psy7384         281 ------------APPRL--------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER  328 (463)
Q Consensus       281 ------------~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  328 (463)
                                  ..+..        ..+.+++.+.+||.+||..||.+|||++|+|+||||+......
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  317 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE  317 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHH
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhh
Confidence                        00000        1135789999999999999999999999999999998654433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.8e-49  Score=385.68  Aligned_cols=259  Identities=49%  Similarity=0.915  Sum_probs=225.9

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .....+|++++.||+|+||.||+|++..+++.||+|++...  ......+.+|+.+++.+ +||||+++++++.      
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------   90 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYL------   90 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEE------
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEe------
Confidence            35567899999999999999999999999999999999744  34567889999999999 8999999999984      


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||||+.+++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           91 KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccce
Confidence            44789999999999999999864   368999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .............||+.|+|||++.     ...++.++|||||||++|+|++|.+||...........+.....+. ...
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~  241 (303)
T 3a7i_A          168 QLTDTQIKRNTFVGTPFWMAPEVIK-----QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT-LEG  241 (303)
T ss_dssp             ECBTTBCCBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CCS
T ss_pred             ecCccccccCccCCCcCccCHHHHh-----cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC-Ccc
Confidence            7765444445668999999999997     5678899999999999999999999998877766665554444332 345


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .++..+.+||.+||..||.+|||++++++||||....
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            7889999999999999999999999999999997543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-49  Score=380.68  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=221.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +..++|++.+.||+|+||.||+|++..++..||+|++... ......+.+|+.+++.+ +||||+++++++      ...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~   78 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETF------EDN   78 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEE------ECS
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEE------ecC
Confidence            3456899999999999999999999999999999998643 34467888999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE---ccCCcEEEEecccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVS  207 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl---~~~~~vkL~DFGla  207 (463)
                      +..|+||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             CeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            78999999999999999987654  68999999999999999999999999999999999999   78899999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC-
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-  286 (463)
                      ...... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.........+......... 
T Consensus       157 ~~~~~~-~~~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (277)
T 3f3z_A          157 ARFKPG-KMMRTKVGTPYYVSPQVLE------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK  229 (277)
T ss_dssp             EECCTT-SCBCCCCSCTTTCCHHHHT------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             eeccCc-cchhccCCCCCccChHHhc------ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch
Confidence            876543 2334567999999999985      34889999999999999999999999888777666655444332221 


Q ss_pred             -CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         287 -SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       287 -~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                       ...+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence             2367899999999999999999999999999999963

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.9e-49  Score=379.58  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=217.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ....|++.+.||+|+||.||+|.+..++..||+|++...   ......+.+|+.+|+.+ +||||+++++++....  ..
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~--~~  100 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTV--KG  100 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEES--SS
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecccc--CC
Confidence            345699999999999999999999999999999998643   34456788999999999 8999999999885432  33


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEc-cCCcEEEEeccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLT-DNAEVKLVDFGV  206 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~-~~~~vkL~DFGl  206 (463)
                      ...+|+||||+++++|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            467899999999999999998654  6899999999999999999999999  99999999999997 789999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc-ccCCCCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRNAPPRL  285 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~-i~~~~~~~~  285 (463)
                      +......  ......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+......... +.....+..
T Consensus       179 ~~~~~~~--~~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (290)
T 1t4h_A          179 ATLKRAS--FAKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS  250 (290)
T ss_dssp             GGGCCTT--SBEESCSSCCCCCGGGGG------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred             ccccccc--ccccccCCcCcCCHHHHh------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence            9765433  234567999999999885      3488999999999999999999999987655544433 333333334


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ....+++++.+||.+||..||.+|||++++|+||||++.
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            445677899999999999999999999999999999763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-50  Score=395.56  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=212.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch------HHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE------EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .++|++++.||+|+||.||+|++..+|+.||+|++......      ...+.+|+.+++.+ +||||+++++++      
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------   81 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAF------   81 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEE------
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEE------
Confidence            46799999999999999999999999999999998643211      23677899999999 799999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           82 GHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            455789999999986 8888886533 46889999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC--CC---
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--AP---  282 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~---  282 (463)
                      +............+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+....+..+...  .+   
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  235 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeccCCcccCCcccccccccCchHhhC----CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence            887655445556789999999999863    345889999999999999999999999888776555433211  00   


Q ss_pred             --CCC-------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         283 --PRL-------------------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       283 --~~~-------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                        +..                   ....+++++++||.+||..||.+|||++|+|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence              000                   013567899999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.7e-50  Score=405.83  Aligned_cols=260  Identities=30%  Similarity=0.462  Sum_probs=206.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---------chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....         .....+.+|+.+|+++ +||||+++++++.  
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~--  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD--  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE--
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe--
Confidence            467999999999999999999999999999999986432         1123477899999999 8999999999973  


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC---cEEE
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA---EVKL  201 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~---~vkL  201 (463)
                           .+.+|+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       211 -----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -----AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -----SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -----cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence                 24689999999999999988644  3699999999999999999999999999999999999997544   5999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc-ccCC
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRN  280 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~-i~~~  280 (463)
                      +|||+++..... ......+||+.|+|||++....  ...|+.++|||||||++|+|++|.+||.+......+.. +...
T Consensus       284 ~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~  360 (419)
T 3i6u_A          284 TDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  360 (419)
T ss_dssp             CCSSTTTSCC------------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred             eecccceecCCC-ccccccCCCCCccCceeeecCC--CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence            999999877543 2334568999999999985311  35688999999999999999999999987654433322 2222


Q ss_pred             CCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         281 APPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       281 ~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      .....  ....+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus       361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  408 (419)
T 3i6u_A          361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  408 (419)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred             CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence            22111  12467899999999999999999999999999999987443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.8e-50  Score=395.21  Aligned_cols=262  Identities=29%  Similarity=0.477  Sum_probs=216.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec------CcchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV------TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ..++|++.+.||+|+||.||+|++..++..||+|++..      .......+.+|+.+++.+ +||||+++++++     
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~-----   97 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVY-----   97 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEE-----
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhh-----
Confidence            45689999999999999999999999999999999863      234567889999999999 799999999999     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhC--------------------------------------CCCCCHHHHHHHHHH
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTK--------------------------------------GQSLKEEWIAFICRE  168 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~q  168 (463)
                       ...+..|+||||++||+|.+++....                                      ...+++..++.++.|
T Consensus        98 -~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           98 -EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             -ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence             45578999999999999999985210                                      112467788999999


Q ss_pred             HHHHHhhhhcCCceecCCCCCceEEccCC--cEEEEecccccccccccC----ccccccCCccccccceeccCCCCCCCC
Q psy7384         169 ILRGLKYLHENKVIHRDIKGQNVLLTDNA--EVKLVDFGVSAQLDRTIG----RRNTFIGTPYWMAPEVIACDENPDATY  242 (463)
Q Consensus       169 il~aL~~LH~~givHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~  242 (463)
                      |+.||.|||++||+||||||+|||++.++  .+||+|||++..+.....    ......||+.|+|||++...   ...+
T Consensus       177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~  253 (345)
T 3hko_A          177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT---NESY  253 (345)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS---SSCC
T ss_pred             HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC---CCCC
Confidence            99999999999999999999999998766  899999999986643211    23456799999999998632   3568


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy7384         243 DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF  320 (463)
Q Consensus       243 ~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  320 (463)
                      +.++|||||||++|+|++|..||.+.........+.......  .....+++.+++||.+||..||.+|||+.++|+|||
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~  333 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW  333 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence            899999999999999999999999888777666554443322  222347899999999999999999999999999999


Q ss_pred             ccCC
Q psy7384         321 IRDQ  324 (463)
Q Consensus       321 ~~~~  324 (463)
                      |++.
T Consensus       334 ~~~~  337 (345)
T 3hko_A          334 ISQF  337 (345)
T ss_dssp             HHTT
T ss_pred             hccC
Confidence            9764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.5e-49  Score=392.62  Aligned_cols=263  Identities=25%  Similarity=0.418  Sum_probs=217.8

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +..++|++++.||+|+||.||+|++..++..||+|++....  .....+.+|+.+|+++ +||||+++++++..... ..
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~  101 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTI-EQ  101 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSST-TT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCc-cc
Confidence            34578999999999999999999999999999999997433  3346788999999999 89999999999854321 23


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ....|+||||+.+ +|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       102 ~~~~~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          102 MKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             CCCEEEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            3578999999975 999998753   599999999999999999999999999999999999999999999999999987


Q ss_pred             cccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-----
Q psy7384         210 LDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-----  281 (463)
Q Consensus       210 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-----  281 (463)
                      ......   .....+||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+....+..+....     
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHT----BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcC----CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            654322   1244589999999998763    3458899999999999999999999998877665554332100     


Q ss_pred             ------------------C-C-----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 ------------------P-P-----RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 ------------------~-~-----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                        + .     ......++.++.+||.+||..||.+|||++|+|+||||++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                              0 0     00124578899999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-48  Score=378.69  Aligned_cols=266  Identities=27%  Similarity=0.460  Sum_probs=223.0

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----------chHHHHHHHHHHHHHhcCCCceeeeccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----------DEEEEIKLEINVLKKYSNHRNIATYYGA  120 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~  120 (463)
                      ....++|++.+.||+|+||.||+|++..+|+.||+|++....          .....+.+|+.+++++.+||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            445678999999999999999999999999999999997542          2235677899999999669999999999


Q ss_pred             ccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEE
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK  200 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vk  200 (463)
                      +      ...+..|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        93 ~------~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           93 Y------ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             E------ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             e------ccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEE
Confidence            9      45578999999999999999998654  689999999999999999999999999999999999999999999


Q ss_pred             EEecccccccccccCccccccCCccccccceeccCC-CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         201 LVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE-NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       201 L~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      |+|||++...... .......|++.|+|||++.... .....++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       165 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          165 LTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            9999999876543 2234567999999999985321 1145688999999999999999999999988776665554433


Q ss_pred             CCCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         280 NAPPR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       280 ~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .....  .....++..+.+||.+||..||.+|||++++|+||||++..
T Consensus       244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            33221  12246789999999999999999999999999999998654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.2e-49  Score=378.96  Aligned_cols=257  Identities=26%  Similarity=0.476  Sum_probs=223.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+++.+ +||||+++++++      
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------   84 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFF------   84 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE------
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeee------
Confidence            4457899999999999999999999999999999998643    23456788899999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+..|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  162 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA  162 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence            44578999999999999999987654  6899999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      ..............||+.|+|||++.     ...++.++|||||||++|+|++|..||...........+......  ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~  235 (294)
T 2rku_A          163 TKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IP  235 (294)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHT-----TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CC
T ss_pred             eecccCccccccccCCCCcCCcchhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC--Cc
Confidence            87654444445567999999999987     566889999999999999999999999887766555544433221  23


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ..++..+.+||.+||..||.+|||++++++||||+..
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          236 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            4678999999999999999999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8e-49  Score=381.37  Aligned_cols=256  Identities=28%  Similarity=0.472  Sum_probs=218.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++      ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~   79 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIY------ESTT   79 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEE------ECSS
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhc------ccCC
Confidence            4567999999999999999999999999999999997543 2345688999999999 899999999998      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE---ccCCcEEEEeccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSA  208 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl---~~~~~vkL~DFGla~  208 (463)
                      .+|+||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            8999999999999999997654  68999999999999999999999999999999999999   778899999999987


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLK  286 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~  286 (463)
                      .....  .....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+.....  +...
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEVLA-----QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF  230 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTTBS-----SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred             ecCCC--ccccccCCCCccChHHhc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            65432  234457999999999987     56789999999999999999999999988777665555444332  2223


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ...++..+.+||.+||..||.+|||++++|+||||...
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            35788999999999999999999999999999999754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.6e-49  Score=378.94  Aligned_cols=252  Identities=29%  Similarity=0.498  Sum_probs=215.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++.+.||+|+||.||+|++..++..||+|++....    .....+.+|+.+++.+ +||||+++++++      ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~   80 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYF------HD   80 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEE------EC
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheE------ec
Confidence            467999999999999999999999999999999986432    2245688899999999 799999999999      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..|+||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence            578999999999999999997664  689999999999999999999999999999999999999999999999999865


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ....  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+......  ....
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  229 (279)
T 3fdn_A          159 APSS--RRTDLCGTLDYLPPEMIE-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDF  229 (279)
T ss_dssp             C----------CCCCTTCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCTT
T ss_pred             CCcc--cccccCCCCCccCHhHhc-----cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC--CCCc
Confidence            5432  224557999999999987     567788999999999999999999999887766665554443322  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +++.+++||.+||..||.+|||++|+++||||+.
T Consensus       230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence            7899999999999999999999999999999964

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6e-49  Score=387.88  Aligned_cols=257  Identities=26%  Similarity=0.476  Sum_probs=223.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+++.+ +||||+++++++      
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------  110 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFF------  110 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE------
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------
Confidence            3467899999999999999999999999999999998643    23456788999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence            44578999999999999999987654  6899999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      .............+||+.|+|||++.     ...++.++|||||||++|+|++|..||...........+......  ..
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~  261 (335)
T 2owb_A          189 TKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IP  261 (335)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHH-----TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CC
T ss_pred             eecccCcccccccCCCccccCHHHhc-----cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC--CC
Confidence            87754444445668999999999997     566889999999999999999999999887766555444333221  23


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ..++..+.+||.+||..||.+|||++|+|+||||+..
T Consensus       262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          262 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            4678999999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.8e-49  Score=376.76  Aligned_cols=253  Identities=23%  Similarity=0.395  Sum_probs=210.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||.||+|++..+++.||+|++...   ......+.+|+..+..+.+||||+++++++.      ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~------~~   83 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA------ED   83 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE------ET
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee------cC
Confidence            45799999999999999999999999999999999743   3445677889999999878999999999994      45


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC------------
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN------------  196 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~------------  196 (463)
                      +.+|+||||+++++|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++.+            
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            79999999999999999997643  2468999999999999999999999999999999999999844            


Q ss_pred             -------CcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7384         197 -------AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH  269 (463)
Q Consensus       197 -------~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  269 (463)
                             ..+||+|||++......    ....||+.|+|||++..    ...++.++|||||||++|+|++|.+||....
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQE----NYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTT----CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             ccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcC----CCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                   47999999999876543    33469999999999863    3456789999999999999999998876554


Q ss_pred             chhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         270 PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       270 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ....+.   ....+ .....+++.+.+||.+||..||.+|||+.++++||||.+.
T Consensus       236 ~~~~~~---~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          236 QWHEIR---QGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHH---TTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHH---cCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            333222   22222 2234688999999999999999999999999999999753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.9e-49  Score=391.05  Aligned_cols=256  Identities=33%  Similarity=0.578  Sum_probs=216.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...++|++++.||+|+||.||+|++..+|..||+|++...  ......+.+|+.+|+.+ +||||+++++++.      .
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~------~  102 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFY------S  102 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE------E
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEE------E
Confidence            3456899999999999999999999999999999999754  33456788999999999 8999999999994      4


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .+.+|+||||+++++|.+++....  .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             CCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            578999999999999999998765  689999999999999999999996 99999999999999999999999999987


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh-------------
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-------------  275 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~-------------  275 (463)
                      .....  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||..........             
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3eqc_A          181 QLIDS--MANSFVGTRSYMSPERLQ-----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  253 (360)
T ss_dssp             HHHHH--C----CCCCTTCCHHHHT-----TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred             ccccc--cccCCCCCCCeECHHHHc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence            66432  224567999999999997     5678999999999999999999999997655432211             


Q ss_pred             -----------------------------cccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         276 -----------------------------LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       276 -----------------------------~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                                   .+.....+......++.++.+||.+||..||.+|||++|+|+||||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                                         111222333344567899999999999999999999999999999964

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-49  Score=389.26  Aligned_cols=260  Identities=23%  Similarity=0.411  Sum_probs=207.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCC------
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP------  126 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~------  126 (463)
                      ++|++++.||+|+||.||+|++..+|+.||||++...  ....+.+.+|+.+|+++ +||||++++++|.....      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence            4699999999999999999999999999999999743  34567889999999999 89999999998854321      


Q ss_pred             ---------------------------------------------CCCCCeEEEEEecCCCCCHHHHHHhhCC-CCCCHH
Q psy7384         127 ---------------------------------------------PGKDDQLWLVMEYCGAGSVTDLVKSTKG-QSLKEE  160 (463)
Q Consensus       127 ---------------------------------------------~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~  160 (463)
                                                                   ......+|+|||||++|+|.+++..... ....+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                         0122358999999999999999986442 235666


Q ss_pred             HHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc------------CccccccCCccccc
Q psy7384         161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI------------GRRNTFIGTPYWMA  228 (463)
Q Consensus       161 ~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~------------~~~~~~~gt~~y~a  228 (463)
                      .++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......            ......+||+.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            789999999999999999999999999999999999999999999998775432            12234579999999


Q ss_pred             cceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC
Q psy7384         229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQ  308 (463)
Q Consensus       229 PE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  308 (463)
                      ||++.     +..++.++|||||||++|+|++|..|+....  .....+.....+ ......++.+.+||.+||..||.+
T Consensus       245 PE~~~-----~~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~  316 (332)
T 3qd2_B          245 PEQIH-----GNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTE  316 (332)
T ss_dssp             HHHHH-----CCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred             hHHhc-----CCCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhccCCC-cccccCChhHHHHHHHHccCCCCc
Confidence            99997     5678999999999999999999987753211  111111111111 112244678899999999999999


Q ss_pred             CCCHHHHhcCccccC
Q psy7384         309 RPYTDQLLKHPFIRD  323 (463)
Q Consensus       309 Rpt~~e~l~hp~~~~  323 (463)
                      |||++|+|+||||++
T Consensus       317 Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          317 RPEATDIIENAIFEN  331 (332)
T ss_dssp             SCCHHHHHHSTTCCC
T ss_pred             CCCHHHHhhchhhhc
Confidence            999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-49  Score=399.70  Aligned_cols=268  Identities=23%  Similarity=0.349  Sum_probs=215.6

Q ss_pred             CCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc-------CCCceee
Q psy7384          44 WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS-------NHRNIAT  116 (463)
Q Consensus        44 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~-------~h~nIv~  116 (463)
                      +..........++|++++.||+|+||+||+|++..+++.||||++.........+.+|+.+|+.+.       +|+||++
T Consensus        26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            344445555678999999999999999999999999999999999876666778899999999984       2888999


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEcc
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTD  195 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~  195 (463)
                      ++++|....  .....+||||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+||||+.
T Consensus       106 ~~~~~~~~~--~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~  182 (397)
T 1wak_A          106 LLDDFKISG--VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             EEEEEEEEE--TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred             eecceeecC--CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence            999985321  1346899999999 56777777665555799999999999999999999998 9999999999999987


Q ss_pred             CC-------------------------------------------------cEEEEecccccccccccCccccccCCccc
Q psy7384         196 NA-------------------------------------------------EVKLVDFGVSAQLDRTIGRRNTFIGTPYW  226 (463)
Q Consensus       196 ~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~gt~~y  226 (463)
                      ++                                                 .+||+|||++......   ....+||+.|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y  259 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQY  259 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcc
Confidence            65                                                 7999999999876543   3455799999


Q ss_pred             cccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh------hhhcc---cCCCC---------------
Q psy7384         227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR------ALFLI---PRNAP---------------  282 (463)
Q Consensus       227 ~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~------~~~~i---~~~~~---------------  282 (463)
                      +|||++.     +..|+.++|||||||++|+|++|.+||.+.+...      .+..+   ....+               
T Consensus       260 ~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  334 (397)
T 1wak_A          260 RSLEVLI-----GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT  334 (397)
T ss_dssp             CCHHHHH-----TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred             cCChhhc-----CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence            9999998     5668999999999999999999999997654321      11100   00000               


Q ss_pred             --------CC--------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         283 --------PR--------------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       283 --------~~--------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                              ..              ......+..+.+||.+||..||.+|||++|+|+||||+
T Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                    00              00112245788999999999999999999999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-48  Score=394.24  Aligned_cols=262  Identities=25%  Similarity=0.413  Sum_probs=209.3

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcC-CCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSN-HRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~-h~nIv~l~~~~~~~~~~~  128 (463)
                      ...+|++++.||+|+||.||+|.+.. ++.||||++....   .....+.+|+.+|..+.. ||||+++++++.      
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~------  126 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI------  126 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE------
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe------
Confidence            34579999999999999999999765 8999999997542   345678899999999953 699999999984      


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+||||| +.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            4468999999 56789999998654  689999999999999999999999999999999999995 5889999999998


Q ss_pred             ccccccC--ccccccCCccccccceeccCCC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhcccC
Q psy7384         209 QLDRTIG--RRNTFIGTPYWMAPEVIACDEN------PDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPR  279 (463)
Q Consensus       209 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~------~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~  279 (463)
                      .+.....  .....+||+.|+|||++.....      ....|+.++||||||||+|+|++|.+||.+.... ..+..+..
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            7653321  2345679999999999864211      1246899999999999999999999999775432 33333333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       280 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ...........+.++++||.+||..||.+|||+.|+|+||||+...
T Consensus       283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            3222223345578999999999999999999999999999997543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-49  Score=397.15  Aligned_cols=260  Identities=25%  Similarity=0.432  Sum_probs=198.8

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...   ......+.+|+.+|+.+ +||||+++++++........
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence            357899999999999999999999999999999998643   23456778999999999 79999999999854322223


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             CCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            46789999999 6799998865   3699999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--------  281 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  281 (463)
                      ....   ....+||++|+|||++..    ...|+.++||||||||+|+|++|++||.+.+....+..+....        
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          182 TADE---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ------------CCCTTCCHHHHTT----CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccc---CCCcCcCcCccChHHHcC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6533   345689999999999873    3578899999999999999999999999887665544322100        


Q ss_pred             --------------CCCC-------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         282 --------------PPRL-------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       282 --------------~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                    .+..       .....++.+.+||.+||..||.+|||++|+|+||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                          0000       013567899999999999999999999999999999753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-49  Score=400.86  Aligned_cols=260  Identities=27%  Similarity=0.398  Sum_probs=211.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..+|++++.||+|+||.||+|++..+|+.||||++.....   ...+|+.+|+.+ +|||||+++++|...........+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeE
Confidence            4479999999999999999999999999999999864322   234799999999 899999999998654322333457


Q ss_pred             EEEEecCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-CcEEEEeccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKS--TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-AEVKLVDFGVSAQL  210 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-~~vkL~DFGla~~~  210 (463)
                      ++||||+.+ +|.+++..  .....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.+
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            899999986 67666653  234579999999999999999999999999999999999999954 67899999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC----------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN----------  280 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------  280 (463)
                      .... .....+||+.|+|||++.+    ...|+.++||||||||+|||++|++||.+.+..+.+..+...          
T Consensus       208 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          208 VRGE-PNVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CTTC-CCCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCC-CceeeeeCCCcCCHHHHcC----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4432 2345689999999999863    346899999999999999999999999988766555433210          


Q ss_pred             ---------CCCCC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 ---------APPRL--------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 ---------~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                               ..+..        ....++.++++||.+||..||.+|||+.|+|+||||.+
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence                     01111        12356889999999999999999999999999999964

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=390.40  Aligned_cols=248  Identities=26%  Similarity=0.486  Sum_probs=211.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---------hHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---------EEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.....         ....+.+|+.+|+.+ +||||++++++|   
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~---   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIF---   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEE---
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEE---
Confidence            3579999999999999999999999999999999975421         234567899999999 899999999999   


Q ss_pred             CCCCCCCeEEEEEecCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEe
Q psy7384         125 SPPGKDDQLWLVMEYCGAG-SVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~D  203 (463)
                         ...+.+++||||+.+| +|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        99 ---~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A           99 ---ENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             ---ECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             ---eeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEee
Confidence               4557999999999776 9999997544  699999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccCccccccCCccccccceeccCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATY-DNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      ||++...... ......+||+.|+|||++.     +..+ +.++|||||||++|+|++|..||.......      ... 
T Consensus       174 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~-  240 (335)
T 3dls_A          174 FGSAAYLERG-KLFYTFCGTIEYCAPEVLM-----GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------EAA-  240 (335)
T ss_dssp             CTTCEECCTT-CCBCEECSCGGGCCHHHHT-----TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------TTC-
T ss_pred             cccceECCCC-CceeccCCCccccChhhhc-----CCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------hhc-
Confidence            9999876543 2234567999999999987     3444 789999999999999999999997633211      111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                       ......+++++.+||.+||..||.+|||++++++||||++.
T Consensus       241 -~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          241 -IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence             11233578999999999999999999999999999999764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-49  Score=396.94  Aligned_cols=261  Identities=24%  Similarity=0.396  Sum_probs=211.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC-----
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP-----  127 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~-----  127 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||||++.....   ...+|+.+|+.+ +||||++++++|......     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTC-CCTTBCCEEEEEEEC--------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHc-CCCCccchhheeeecCccccccc
Confidence            45689999999999999999999999999999999864422   234799999999 899999999998653211     


Q ss_pred             ---------------------------CCCCeEEEEEecCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHhhhhc
Q psy7384         128 ---------------------------GKDDQLWLVMEYCGAGSVTDLVKS--TKGQSLKEEWIAFICREILRGLKYLHE  178 (463)
Q Consensus       128 ---------------------------~~~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~  178 (463)
                                                 .....+++||||+.+ +|.+.+..  .....+++..++.++.||+.||.|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                       234568999999985 88887764  334579999999999999999999999


Q ss_pred             CCceecCCCCCceEEc-cCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHH
Q psy7384         179 NKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALE  257 (463)
Q Consensus       179 ~givHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~e  257 (463)
                      +||+||||||+|||++ .++.+||+|||+++..... ......+||+.|+|||++.+    ...|+.++|||||||++|+
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLG----ATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTT----CSSCCTHHHHHHHHHHHHH
T ss_pred             CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcC----CCCCCcchhhhhHHHHHHH
Confidence            9999999999999997 6889999999999876543 23345679999999999863    3458999999999999999


Q ss_pred             HHhCCCCCCCCCchhhhhcccCC-------------------CCCCC--------CCCCCCHHHHHHHHHhhhcCCCCCC
Q psy7384         258 MAESQPPLCDLHPMRALFLIPRN-------------------APPRL--------KSKKWPKKFQSFIETVLVKDYHQRP  310 (463)
Q Consensus       258 ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rp  310 (463)
                      |++|.+||.+.+..+.+..+...                   ..+..        ....+++++.+||.+||..||.+||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999988776655443210                   01111        1235788999999999999999999


Q ss_pred             CHHHHhcCccccC
Q psy7384         311 YTDQLLKHPFIRD  323 (463)
Q Consensus       311 t~~e~l~hp~~~~  323 (463)
                      |+.|+|+||||.+
T Consensus       315 t~~e~l~hp~f~~  327 (383)
T 3eb0_A          315 NPYEAMAHPFFDH  327 (383)
T ss_dssp             CHHHHHTSGGGHH
T ss_pred             CHHHHhcCHHHHH
Confidence            9999999999964

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-48  Score=374.38  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=215.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++|++++.||+|+||.||+|++..+++.||+|++...  ......+.+|+.+++.+ +||||+++++++      ...+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHR------REGNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEE------EETTE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEE------EcCCE
Confidence            4699999999999999999999999999999998643  24457888999999999 899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            99999999999999988643  3689999999999999999999999999999999999999999999999999976543


Q ss_pred             cc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh-cccCCCCCCCCCCC
Q psy7384         213 TI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNAPPRLKSKK  289 (463)
Q Consensus       213 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~  289 (463)
                      ..  .......||+.|+|||++..    ...++.++|||||||++|+|++|..||.......... .+............
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK  233 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTC----SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGG
T ss_pred             CcchhcccCCccccCccChHHHhc----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhh
Confidence            21  22345679999999999863    2224778999999999999999999997765433222 22222221222346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ++..+.+||.+||..||.+|||++++++||||++..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             cCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            789999999999999999999999999999998654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.7e-49  Score=388.65  Aligned_cols=268  Identities=27%  Similarity=0.446  Sum_probs=214.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCC--C
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP--P  127 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~--~  127 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++....   .....+.+|+.+|+.+ +||||+++++++.....  .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence            3468999999999999999999999999999999985432   2345677899999999 79999999999865321  1


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+|+||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            124679999999986 7777776543 36999999999999999999999999999999999999999999999999999


Q ss_pred             cccccc----cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC---C
Q psy7384         208 AQLDRT----IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR---N  280 (463)
Q Consensus       208 ~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~---~  280 (463)
                      ..+...    .......+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+......+..+..   .
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccccccccccCCcccccCccCchhhcC----CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            876421    222345678999999999863    35688999999999999999999999988776555433211   1


Q ss_pred             CCCCCCCC---------------------------CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         281 APPRLKSK---------------------------KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       281 ~~~~~~~~---------------------------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      ..+.....                           ..++.+++||.+||..||.+|||++|+|+||||...+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            11110000                           026779999999999999999999999999999865543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-49  Score=387.61  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCC-CceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNH-RNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~~~~~~~  127 (463)
                      ...++|++++.||+|+||.||+|.+ .+++.||+|++....   .....+.+|+.+|..+..| +||+++++++      
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~------   78 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE------   78 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE------
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE------
Confidence            3467899999999999999999987 468899999997543   2346778999999999422 9999999998      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+||||| +.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus        79 ~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           79 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             eeCCEEEEEEe-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            44579999999 56789999998654  689999999999999999999999999999999999996 678999999999


Q ss_pred             cccccccC--ccccccCCccccccceeccCCC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhccc
Q psy7384         208 AQLDRTIG--RRNTFIGTPYWMAPEVIACDEN------PDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIP  278 (463)
Q Consensus       208 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~------~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~  278 (463)
                      +.......  .....+||+.|+|||++.....      ....++.++|||||||++|+|++|..||.+.... ..+..+.
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  234 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  234 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence            87654322  2245679999999999863110      1256889999999999999999999999765432 3333333


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ............+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            3222233345667899999999999999999999999999999754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-48  Score=392.97  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=213.9

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCc-----eeeecccccccC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN-----IATYYGAFIKKS  125 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~n-----Iv~l~~~~~~~~  125 (463)
                      +...++|++.+.||+|+||+||+|++..+++.||||++.........+..|+.+++.+..|++     |+++++++.   
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~---  126 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM---  126 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---
Confidence            344678999999999999999999999999999999998766666778889999998865664     899999884   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh--cCCceecCCCCCceEEc--cCCcEEE
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH--ENKVIHRDIKGQNVLLT--DNAEVKL  201 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--~~givHrDLkp~NILl~--~~~~vkL  201 (463)
                         ..+.+||||||+.+ +|.+++.......+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||
T Consensus       127 ---~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          127 ---FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             ---ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             ---cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence               44799999999965 9999998776567999999999999999999999  57999999999999995  4788999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      +|||+++.....   ....+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus       203 ~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~  274 (382)
T 2vx3_A          203 VDFGSSCQLGQR---IYQYIQSRFYRSPEVLL-----GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL  274 (382)
T ss_dssp             CCCTTCEETTCC---CCSSCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EeccCceecccc---cccccCCccccChHHHc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999877543   24568999999999997     5578999999999999999999999998877655443321100


Q ss_pred             --CC--------------------------------CCCCCC----------------------------CCHHHHHHHH
Q psy7384         282 --PP--------------------------------RLKSKK----------------------------WPKKFQSFIE  299 (463)
Q Consensus       282 --~~--------------------------------~~~~~~----------------------------~~~~~~~li~  299 (463)
                        ++                                ....+.                            ..+++++||.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  354 (382)
T 2vx3_A          275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL  354 (382)
T ss_dssp             CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence              00                                000000                            0137899999


Q ss_pred             HhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         300 TVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       300 ~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      +||+.||.+|||++|+|+||||++.
T Consensus       355 ~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          355 RMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             HhcCCChhhCCCHHHHhcCcccccC
Confidence            9999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.5e-48  Score=380.76  Aligned_cols=253  Identities=26%  Similarity=0.474  Sum_probs=205.5

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +...++|++.+.||+|+||.||+|++  +|..||+|++....   .....+.+|+.+|+++ +||||+++++++      
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~------  103 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAV------  103 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE------
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE------
Confidence            44567899999999999999999987  47889999986443   3345788999999999 799999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEccCCcEEEEec
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKG-QSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~~~~~vkL~DF  204 (463)
                      ...+.+|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            455789999999999999999975431 23899999999999999999999999  999999999999999999999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      |+++.............||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  258 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLR-----DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL  258 (309)
T ss_dssp             C-----------------CCTTSCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             CCCccccccccccccCCCCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            99986655444445668999999999997     5668899999999999999999999999887776665543333333


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....+++.+.+||.+||..||.+|||++++++
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            344578999999999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.9e-48  Score=374.91  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=218.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++.+.||+|+||.||+|++..++..||+|++...    ......+.+|+.+++.+ +||||+++++++      ..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~   85 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYF------HD   85 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE------EC
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEE------Ec
Confidence            35799999999999999999999999999999998643    22346788999999999 899999999998      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+.+|+||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            578999999999999999998654  689999999999999999999999999999999999999999999999999876


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ....  ......|++.|+|||++.     +..++.++|||||||++|+|++|..||...........+......  ....
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~  234 (284)
T 2vgo_A          164 APSL--RRRTMCGTLDYLPPEMIE-----GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPF  234 (284)
T ss_dssp             CSSS--CBCCCCSCGGGCCHHHHT-----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTT
T ss_pred             Cccc--ccccccCCCCcCCHHHhc-----cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--CCCc
Confidence            5432  224567999999999987     566889999999999999999999999887766655544433221  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ++..+++||.+||..||.+|||++++++||||+
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            789999999999999999999999999999995

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-48  Score=390.84  Aligned_cols=259  Identities=22%  Similarity=0.383  Sum_probs=205.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||.||+|++..+|+.||||++...   ......+.+|+.+++.+ +||||+++++++.........
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence            46899999999999999999999999999999999743   23346678999999999 899999999999654333344


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+.+ +|.+++..    .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             cceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            589999999975 78888852    5899999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC-------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP-------  283 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------  283 (463)
                      ... ......+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+....+..+......       
T Consensus       178 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          178 GTS-FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -------------CTTCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             ccc-cccCCceecCCccCHHHhc-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            543 2234568999999999997     567899999999999999999999999988776555443322110       


Q ss_pred             --------------CCCC------------C-------CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         284 --------------RLKS------------K-------KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       284 --------------~~~~------------~-------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                    ....            +       ..+.++++||.+||..||.+|||++|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                          0000            0       014678999999999999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-48  Score=374.51  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=215.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-------chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ++|++++.||+|+||.||+|++..+|+.||+|++....       .....+.+|+.+++.+ +||||+++++++      
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------   77 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIF------   77 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE------
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhhee------
Confidence            57999999999999999999999999999999986432       1367889999999999 799999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC----cEEEEe
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EVKLVD  203 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~----~vkL~D  203 (463)
                      ...+..|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence            44578999999999999999997654  689999999999999999999999999999999999998876    899999


Q ss_pred             cccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ||++....... ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+......
T Consensus       156 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  229 (283)
T 3bhy_A          156 FGIAHKIEAGN-EFKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD  229 (283)
T ss_dssp             CTTCEECC---------CCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             cccceeccCCC-cccccCCCcCccCcceec-----CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence            99998765432 234457999999999986     567889999999999999999999999888776655544333221


Q ss_pred             C--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         284 R--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       284 ~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .  .....++..+.+||.+||..||.+|||+.++++||||+.
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            1  112467889999999999999999999999999999953

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.7e-50  Score=400.33  Aligned_cols=261  Identities=15%  Similarity=0.160  Sum_probs=201.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----CcchHHHHHHHHHHHHHhc--CCCceeeecccccc--
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----TEDEEEEIKLEINVLKKYS--NHRNIATYYGAFIK--  123 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~--  123 (463)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++..    .....+.+.+|+.+++.+.  +|||||++++.+..  
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            346789999999999999999999999999999999963    3345678889995554443  79999999954431  


Q ss_pred             -----cCC------CCCCC-----eEEEEEecCCCCCHHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHhhhhcCCce
Q psy7384         124 -----KSP------PGKDD-----QLWLVMEYCGAGSVTDLVKSTKGQ-----SLKEEWIAFICREILRGLKYLHENKVI  182 (463)
Q Consensus       124 -----~~~------~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~giv  182 (463)
                           ...      ...++     ..||||||+ +|+|.+++......     .+++..+..|+.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence                 100      00111     378999999 67999999865321     122477888999999999999999999


Q ss_pred             ecCCCCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccC------CCCCCCCCcchhHHHHHHHHH
Q psy7384         183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACD------ENPDATYDNRSDLWSLGITAL  256 (463)
Q Consensus       183 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~~~~~DiwSlG~il~  256 (463)
                      ||||||+||||+.++.+||+|||+++....   .....+| +.|+|||++...      ......|+.++|||||||++|
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999999999999999999986543   2345678 999999999732      000126899999999999999


Q ss_pred             HHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         257 EMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       257 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +|++|..||.+.........+....      ..+++++++||.+||..||.+|||+.++++||||+.
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHSSCCC------CCSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999998776655554443322      467899999999999999999999999999999964

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-48  Score=376.76  Aligned_cols=263  Identities=32%  Similarity=0.557  Sum_probs=202.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.....  .......|+..+.+..+||||+++++++.      .
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------~   77 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF------R   77 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE------C
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee------c
Confidence            345689999999999999999999999999999999975432  23334444444344448999999999994      4


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEeccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                      .+..|+||||+++ +|.+++...  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           78 EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            5789999999975 888877642  345799999999999999999999998 999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CchhhhhcccCCCCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRL  285 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~  285 (463)
                      +....... ......||+.|+|||++.... ....++.++|||||||++|+|++|..||... .....+........+..
T Consensus       157 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (290)
T 3fme_A          157 SGYLVDDV-AKDIDAGCKPYMAPERINPEL-NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL  234 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCT-TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred             cccccccc-cccccCCCccccChhhcChhh-cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence            98765432 223447999999999973211 1566889999999999999999999999763 33344444444444555


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ....+++++.+||.+||..||.+|||++|+++||||+.
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            55678999999999999999999999999999999963

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-48  Score=381.51  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=211.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|++++.||+|+||.||+|++..+++.||+|++...  ....+.+|+.+|+.+..||||+++++++..    ......
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKD----PVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC----TTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeecc----CCCCce
Confidence            46799999999999999999999999999999998643  356788999999999669999999999853    224688


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~~~~~  212 (463)
                      ++||||+.+++|.+++.     .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       109 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999999885     388999999999999999999999999999999999999776 899999999987654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hhhhhccc-------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIP-------------  278 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~-------------  278 (463)
                      .. .....+||+.|+|||++..    ...++.++|||||||++|+|++|..||..... ...+..+.             
T Consensus       184 ~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          184 GQ-EYNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             TC-CCCSCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CC-ccccccccccccChhhhcC----CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            32 2345679999999999863    35689999999999999999999999954322 11111100             


Q ss_pred             CCC----------------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         279 RNA----------------------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       279 ~~~----------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ...                      ........+++++++||.+||..||.+|||++|+|+||||++..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            000                      00111123689999999999999999999999999999998654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-48  Score=383.10  Aligned_cols=259  Identities=31%  Similarity=0.471  Sum_probs=210.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---------chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .++|++.+.||+|+||.||+|++..+++.||||++....         .....+.+|+.+|+.+ +||||+++++++.. 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEES-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcC-
Confidence            357999999999999999999999999999999986432         1234577899999999 89999999999832 


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc---EEE
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKL  201 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~---vkL  201 (463)
                            +..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||
T Consensus        87 ------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           87 ------EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             ------SSEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             ------CceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEE
Confidence                  2489999999999999998654  37999999999999999999999999999999999999987654   999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc-ccCC
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL-IPRN  280 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~-i~~~  280 (463)
                      +|||++....... ......||+.|+|||++....  ...++.++|||||||++|+|++|..||........+.. +...
T Consensus       159 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (322)
T 2ycf_A          159 TDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  235 (322)
T ss_dssp             CCCTTCEECCCCH-HHHHHHSCCTTCCHHHHHHTT--TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred             ccCccceeccccc-ccccccCCcCccCchhhccCC--CCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence            9999998765331 223457999999999975311  45688999999999999999999999976554332222 2222


Q ss_pred             CCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         281 APPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       281 ~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .....  ....+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            11111  1246789999999999999999999999999999998643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-48  Score=384.60  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=213.8

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEE-cCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC------ceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRH-TKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR------NIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~------nIv~l~~~~~~  123 (463)
                      +...++|++++.||+|+||.||+|.+ ..+|+.||+|++.........+.+|+.+++.+ +|+      +|+++++++  
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~--   86 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWF--   86 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEE--
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeeccc--
Confidence            34567899999999999999999998 56789999999987666677888999999988 455      499999998  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc--------
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD--------  195 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~--------  195 (463)
                          ...+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.        
T Consensus        87 ----~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           87 ----EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             ----EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ----ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence                4457999999999 889999998776667999999999999999999999999999999999999987        


Q ss_pred             -----------CCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7384         196 -----------NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP  264 (463)
Q Consensus       196 -----------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~P  264 (463)
                                 ++.+||+|||++......   ....+||+.|+|||++.     +..++.++|||||||++|+|++|..|
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVIL-----ALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHT-----TSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhh-----CCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                       668999999999875432   24567999999999997     56789999999999999999999999


Q ss_pred             CCCCCchhhhhcccCC---CC---------------------------------------CCCCCCCCCHHHHHHHHHhh
Q psy7384         265 LCDLHPMRALFLIPRN---AP---------------------------------------PRLKSKKWPKKFQSFIETVL  302 (463)
Q Consensus       265 f~~~~~~~~~~~i~~~---~~---------------------------------------~~~~~~~~~~~~~~li~~~L  302 (463)
                      |...+.......+...   .+                                       ........++.+.+||.+||
T Consensus       234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence            9877654433221100   00                                       00011223567899999999


Q ss_pred             hcCCCCCCCHHHHhcCccccC
Q psy7384         303 VKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       303 ~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..||.+|||++|+|+||||+.
T Consensus       314 ~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          314 EYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             CSSTTTSCCHHHHTTSGGGGG
T ss_pred             CcCcccccCHHHHhcCHHHHH
Confidence            999999999999999999974

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.9e-49  Score=391.77  Aligned_cols=263  Identities=14%  Similarity=0.104  Sum_probs=195.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhc-CCCceeeeccccc------
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYS-NHRNIATYYGAFI------  122 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~-~h~nIv~l~~~~~------  122 (463)
                      ...|++.+.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+++.+. +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999998643    34456778877666664 4999888664332      


Q ss_pred             -ccCCC-----------CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHH------HHHHHHHHHHHhhhhcCCceec
Q psy7384         123 -KKSPP-----------GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWI------AFICREILRGLKYLHENKVIHR  184 (463)
Q Consensus       123 -~~~~~-----------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qil~aL~~LH~~givHr  184 (463)
                       ....+           .....+||||||+. |+|.+++..... .+.+...      ..++.||+.||+|||++||+||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence             11100           00145899999999 799999986532 3444444      5677999999999999999999


Q ss_pred             CCCCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7384         185 DIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP  264 (463)
Q Consensus       185 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~P  264 (463)
                      ||||+||||+.++.+||+|||+++......   ....+|+.|+|||++...   ...|+.++|||||||++|+|++|..|
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNAS---TATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCS---EEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCC---CCCcCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998765432   245677999999999621   25789999999999999999999999


Q ss_pred             CCCCCchhhh--hc-----ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         265 LCDLHPMRAL--FL-----IPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       265 f~~~~~~~~~--~~-----i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      |.+.......  ..     .............+++.+++||.+||..||.+|||++++|+||||++.
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            9776432211  11     001111122234789999999999999999999999999999999753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-48  Score=388.77  Aligned_cols=260  Identities=28%  Similarity=0.445  Sum_probs=213.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      .++|++++.||+|+||.||+|++.   .+|+.||||++...     ......+.+|+.+|+.+.+||||+++++++    
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  128 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----  128 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence            468999999999999999999984   57999999998632     123456678999999997799999999998    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                        ...+.+||||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       129 --~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          129 --QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             --EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             --eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence              44578999999999999999998654  69999999999999999999999999999999999999999999999999


Q ss_pred             cccccccc-cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh----hcccCC
Q psy7384         206 VSAQLDRT-IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL----FLIPRN  280 (463)
Q Consensus       206 la~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~----~~i~~~  280 (463)
                      +++..... .......+||+.|+|||++.+.   ...++.++|||||||++|+|++|..||.........    ..+...
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  281 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  281 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence            99865432 2223456899999999998732   245788999999999999999999999754432221    112112


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCch
Q psy7384         281 APPRLKSKKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPT  326 (463)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  326 (463)
                      .+  .....++..+++||.+||..||.+||     |++++++||||....+
T Consensus       282 ~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          282 EP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             CC--CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence            11  22346889999999999999999999     9999999999987544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-48  Score=376.70  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=211.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...++|++++.||+|+||.||+|++..++..||+|++...    ......+.+|+.++..+ +||||+++++++      
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~------   80 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVD------   80 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEE------
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEee------
Confidence            4567899999999999999999999999999999998532    23346788999999999 899999999998      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+|+||||++|++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           81 EEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             eeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            45578999999999999999998664  6999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-
Q psy7384         208 AQLDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-  285 (463)
Q Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-  285 (463)
                      ....... ......+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+...............+.. 
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAK-----GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT  233 (294)
T ss_dssp             TTC-------------CCSSCCHHHHH-----TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHH
T ss_pred             cccccccccccCccccCccccCHhHhc-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcc
Confidence            8765432 2234457999999999997     56688999999999999999999999988877665544434333322 


Q ss_pred             --CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         286 --KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       286 --~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                        ....+++.+.++|.+||..||.+||+..+.+.+.|.
T Consensus       234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence              245789999999999999999999966666555554

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-48  Score=374.37  Aligned_cols=260  Identities=30%  Similarity=0.571  Sum_probs=219.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||.||+|++..+|+.||+|++...   ......+.+|+.+++++ +||||+++++++..    ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~   79 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIID----RTN   79 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE----GGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEec----CCC
Confidence            45799999999999999999999999999999999743   33456788999999999 89999999998753    234


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCC-----ceecCCCCCceEEccCCcEEEEe
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENK-----VIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDLkp~NILl~~~~~vkL~D  203 (463)
                      ..+|+||||+++++|.+++....  ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            68999999999999999997643  345999999999999999999999999     99999999999999999999999


Q ss_pred             cccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ||++..............||+.|+|||++.     ...++.++|||||||++|+|++|..||...+.......+.....+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  234 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMN-----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR  234 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHH-----CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CchheeeccccccccccCCCccccChHHhc-----cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence            999987654433334557999999999997     567889999999999999999999999888766555555444332


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      . ....++.++.+||.+||..||.+|||++++++|+|+...
T Consensus       235 ~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          235 R-IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             C-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             c-CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            2 234688999999999999999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-48  Score=393.77  Aligned_cols=262  Identities=25%  Similarity=0.368  Sum_probs=209.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ...+|++++.||+|+||+||+|++..++. +|+|++.....   ...+|+.+|+.+ +||||++++++|...........
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---FKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---SCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---hHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceE
Confidence            45689999999999999999999987776 77776643221   223699999999 89999999999976543344456


Q ss_pred             EEEEEecCCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc-cCCcEEEEeccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKS-TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQL  210 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~-~~~~vkL~DFGla~~~  210 (463)
                      +|+||||+.++.+..+... .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++..
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            8899999987544433322 2245799999999999999999999999999999999999998 7999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-----------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-----------  279 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-----------  279 (463)
                      .... .....+||+.|+|||++.+    ...|+.++|||||||++|+|++|++||.+.+....+..+..           
T Consensus       193 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          193 IAGE-PNVSYICSRYYRAPELIFG----ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CTTC-CCCSSCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cCCC-CCcccccCcCccCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4432 2345689999999999863    34589999999999999999999999998876655443321           


Q ss_pred             --------CCCCC--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 --------NAPPR--------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 --------~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                              ...+.        .....+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence                    01111        1123478899999999999999999999999999999753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.5e-48  Score=370.38  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=209.6

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+++.+ +||||+++++++      ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~   82 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVI------ST   82 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE------EC
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEE------ec
Confidence            467999999999999999999999999999999986432    2345788999999999 799999999998      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            578999999999999999997654  689999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ..... ......||+.|+|||++..    ....+.++|||||||++|+|++|..||.+.........+......  ....
T Consensus       161 ~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  233 (276)
T 2h6d_A          161 MSDGE-FLRTSCGSPNYAAPEVISG----RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--IPEY  233 (276)
T ss_dssp             CCC--------------CCTGGGTT----SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTT
T ss_pred             cCCCc-ceecccCCccccCHHHHcC----CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--Cchh
Confidence            65432 2234579999999999873    223368899999999999999999999887665555544333221  2346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ++..+.+||.+||..||.+|||++++++||||++.
T Consensus       234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            78999999999999999999999999999999754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.6e-48  Score=383.27  Aligned_cols=263  Identities=22%  Similarity=0.368  Sum_probs=215.0

Q ss_pred             CcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCC-cEEEEEEeecCcchHHHHHHHHHHHHHhcCCCc------eeeeccc
Q psy7384          48 RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTG-QLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN------IATYYGA  120 (463)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~n------Iv~l~~~  120 (463)
                      .......++|++++.||+|+||.||+|++..++ ..||+|++.........+.+|+.+++.+ .|++      |+.++++
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeee
Confidence            334445689999999999999999999998777 6899999987666677888999999998 4655      8888888


Q ss_pred             ccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE-------
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL-------  193 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl-------  193 (463)
                      +      ...+.+||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+       
T Consensus        91 ~------~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           91 F------NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             E------EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred             e------eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence            8      4457999999999 6678888776665679999999999999999999999999999999999999       


Q ss_pred             ------------ccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy7384         194 ------------TDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES  261 (463)
Q Consensus       194 ------------~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g  261 (463)
                                  +.++.+||+|||+++.....   ....+||+.|+|||++.     +..++.++|||||||++|+|++|
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVIL-----ELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeee-----cCCCCCccchHHHHHHHHHHHhC
Confidence                        56789999999999865433   24568999999999997     56789999999999999999999


Q ss_pred             CCCCCCCCchhhhhcccCC--CCC----------------------------------------CCCCCCCCHHHHHHHH
Q psy7384         262 QPPLCDLHPMRALFLIPRN--APP----------------------------------------RLKSKKWPKKFQSFIE  299 (463)
Q Consensus       262 ~~Pf~~~~~~~~~~~i~~~--~~~----------------------------------------~~~~~~~~~~~~~li~  299 (463)
                      .+||.+......+..+...  ..+                                        .......+.++.+||.
T Consensus       236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            9999877654433221110  000                                        0011122457899999


Q ss_pred             HhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         300 TVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       300 ~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      +||..||.+|||++|+|+||||++...
T Consensus       316 ~~L~~dP~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred             HHhcCChhhCcCHHHHhcChhhcCCCh
Confidence            999999999999999999999987543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.4e-49  Score=385.48  Aligned_cols=261  Identities=22%  Similarity=0.374  Sum_probs=213.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....    .....+.+|+.+++.+ +||||+++++++....  
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~--   85 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAET--   85 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEE--
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccC--
Confidence            45678999999999999999999999999999999997532    2345678899999999 8999999999985432  


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ......|+||||++|++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            11235699999999999999998654  6999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC-
Q psy7384         208 AQLDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP-  283 (463)
Q Consensus       208 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-  283 (463)
                      .......   ......+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.........+...... 
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  238 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQAR-----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP  238 (311)
T ss_dssp             ------------------CCTTCCHHHHH-----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhc-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence            8764322   1223457999999999997     567899999999999999999999999888776665544333222 


Q ss_pred             -CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         284 -RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       284 -~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                       ......++.++.+||.+||..||.+||++.+++.|+|++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence             122356889999999999999999999999999999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.4e-48  Score=383.90  Aligned_cols=261  Identities=21%  Similarity=0.356  Sum_probs=217.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch------------------HHHHHHHHHHHHHhcCCCce
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE------------------EEEIKLEINVLKKYSNHRNI  114 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~Ei~~l~~l~~h~nI  114 (463)
                      ..++|++++.||+|+||.||+|++  +|+.||+|++......                  ...+.+|+.+++.+ +||||
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i  105 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYC  105 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTB
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCc
Confidence            356899999999999999999998  8999999998632111                  17889999999999 79999


Q ss_pred             eeecccccccCCCCCCCeEEEEEecCCCCCHHHH------HHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCC
Q psy7384         115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDL------VKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIK  187 (463)
Q Consensus       115 v~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLk  187 (463)
                      +++++++      ...+.+|+||||+++|+|.++      +.......+++..++.++.||+.||.|||+ +||+|||||
T Consensus       106 ~~~~~~~------~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~  179 (348)
T 2pml_X          106 LTCEGII------TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK  179 (348)
T ss_dssp             CCCSEEE------ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred             ceEEEEE------eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence            9999999      445799999999999999998      654435679999999999999999999999 999999999


Q ss_pred             CCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCc-chhHHHHHHHHHHHHhCCCCCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDN-RSDLWSLGITALEMAESQPPLC  266 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~-~~DiwSlG~il~ell~g~~Pf~  266 (463)
                      |+|||++.++.+||+|||++......  ......||+.|+|||++..    ...++. ++|||||||++|+|++|..||.
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSN----ESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSS----CCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             hHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcC----CCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999876443  3345679999999999873    225665 8999999999999999999998


Q ss_pred             CCCc-hhhhhcccCCCCCCCC-----------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchhH
Q psy7384         267 DLHP-MRALFLIPRNAPPRLK-----------------SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER  328 (463)
Q Consensus       267 ~~~~-~~~~~~i~~~~~~~~~-----------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  328 (463)
                      .... ......+.........                 ...++..+.+||.+||..||.+|||++++++||||++.....
T Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~  333 (348)
T 2pml_X          254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED  333 (348)
T ss_dssp             CSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHH
T ss_pred             CCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHH
Confidence            8766 3444333333221111                 156889999999999999999999999999999999876543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-47  Score=380.78  Aligned_cols=265  Identities=27%  Similarity=0.446  Sum_probs=215.1

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .....++|++.+.||+|+||.||+|++..+|+.||||++....  .....+.+|+.+++.+ +||||+++++++..... 
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-   83 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSF-   83 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCS-
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeeccccc-
Confidence            3456678999999999999999999999999999999996433  2345677999999999 89999999998754321 


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ......|+||||+. ++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            23468999999997 5899988753   5999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC----------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcc
Q psy7384         208 AQLDRTIG----------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI  277 (463)
Q Consensus       208 ~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i  277 (463)
                      ........          .....+||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+....+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHS----CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeecc----CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            87643211          1223578999999998863    466899999999999999999999999887654433221


Q ss_pred             cC---C---------------------CC--C----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         278 PR---N---------------------AP--P----RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       278 ~~---~---------------------~~--~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ..   .                     ..  +    ......+++++.+||.+||..||.+|||++++|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            10   0                     00  0    00113678999999999999999999999999999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=378.49  Aligned_cols=263  Identities=26%  Similarity=0.440  Sum_probs=211.6

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++....  .....+.+|+.+|+.+ +||||+++++++..    ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~   80 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEE----TT   80 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC----TT
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeec----CC
Confidence            45678999999999999999999999999999999996432  3456778999999999 79999999999853    23


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE----ccCCcEEEEec
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKG-QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL----TDNAEVKLVDF  204 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl----~~~~~vkL~DF  204 (463)
                      ....|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence            3588999999999999999986542 349999999999999999999999999999999999999    77788999999


Q ss_pred             ccccccccccCccccccCCccccccceeccC---CCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh----hhhcc
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACD---ENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR----ALFLI  277 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~----~~~~i  277 (463)
                      |+++...... .....+||+.|+|||++...   ......++.++|||||||++|+|++|..||.......    .+..+
T Consensus       161 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          161 GAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            9998775442 23456799999999998531   1113678899999999999999999999996543321    22222


Q ss_pred             cCCCCC-----------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy7384         278 PRNAPP-----------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF  320 (463)
Q Consensus       278 ~~~~~~-----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  320 (463)
                      ....+.                       ......++..+.+||.+||..||.+|||++|+|+||=
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            111110                       0111234568899999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-47  Score=376.04  Aligned_cols=264  Identities=25%  Similarity=0.418  Sum_probs=215.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEc-CCCcEEEEEEeecCcc---hHHHHHHHHHHHHHhc--CCCceeeecccccccCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHT-KTGQLAAIKVMDVTED---EEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSP  126 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~  126 (463)
                      ..++|++++.||+|+||.||+|++. .+|+.||+|++.....   ....+.+|+.+++.+.  +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3468999999999999999999995 6789999999864321   2235667887777664  79999999999852210


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                       .....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        89 -~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           89 -DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             -SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             -CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence             24468899999998 5999999876656799999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC------
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN------  280 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~------  280 (463)
                      +....... ......||+.|+|||++.     ...++.++|||||||++|+|++|.+||.+......+..+...      
T Consensus       167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          167 ARIYSFQM-ALTSVVVTLWYRAPEVLL-----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCCCCGGG-GGCCCCCCCTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cccccCCC-CccccccccceeCHHHHh-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            98765432 234567999999999997     566899999999999999999999999887765544332110      


Q ss_pred             -------------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         281 -------------------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       281 -------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                         .........++..+++||.+||..||.+|||+.++|+||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                               00011124678999999999999999999999999999999754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.6e-48  Score=375.15  Aligned_cols=259  Identities=22%  Similarity=0.397  Sum_probs=216.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...     ......+.+|+.+++.+ +||||+++++++..    .
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYN----E   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC----C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEc----C
Confidence            46799999999999999999999999999999999643     24457888999999999 79999999999853    2


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .....|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            346899999999886 8888877666689999999999999999999999999999999999999999999999999998


Q ss_pred             ccccc--cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         209 QLDRT--IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       209 ~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      .....  ........||+.|+|||++.+.   ...++.++|||||||++|+|++|..||.+.+.......+......  .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~  232 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGL---DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--I  232 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCC---SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--C
T ss_pred             ccCccccccccccCCCCCCCcChhhccCc---ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC--C
Confidence            76432  1222345799999999998631   223477899999999999999999999887766655554443322  2


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ...++..+.+||.+||..||.+|||++++++||||+.
T Consensus       233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             CCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence            3467899999999999999999999999999999965

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.1e-48  Score=385.61  Aligned_cols=259  Identities=25%  Similarity=0.410  Sum_probs=209.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++...   ......+.+|+.+++.+ +||||+++++++........
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCccc
Confidence            346899999999999999999999999999999999753   22356778999999999 79999999999964432222


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+|+||||+. ++|.+++.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             ceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            234599999997 58877763    2599999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---------  280 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------  280 (463)
                      ....   ....+||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+....+..+...         
T Consensus       194 ~~~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          194 ADAE---MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccC---cCCcccCccccCHHHhcC----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            6543   245679999999999863    357889999999999999999999999887765544332110         


Q ss_pred             ------------------CCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         281 ------------------APPR--LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       281 ------------------~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                        ....  .....+++.+++||.+||+.||.+|||++|+|+||||+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                              0000  0123568999999999999999999999999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-47  Score=382.68  Aligned_cols=255  Identities=24%  Similarity=0.424  Sum_probs=215.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEc-------CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFI  122 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~  122 (463)
                      ...++|++.+.||+|+||.||+|++.       .++..||+|++....  .....+.+|+.+|+.+.+||||+++++++ 
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-  156 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-  156 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE-
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-
Confidence            34578999999999999999999975       345679999997543  34467889999999997799999999999 


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCC
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKG  188 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp  188 (463)
                           ...+.+|+||||+.+|+|.+++.....              ..+++..+..++.||+.||.|||++||+||||||
T Consensus       157 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp  231 (370)
T 2psq_A          157 -----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  231 (370)
T ss_dssp             -----CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             -----ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence                 455789999999999999999986542              3588999999999999999999999999999999


Q ss_pred             CceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPL  265 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf  265 (463)
                      +||||+.++.+||+|||+++.......  ......+|+.|+|||++.     ...|+.++|||||||++|||++ |..||
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-----TCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc-----CCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999986653321  223345788999999997     5679999999999999999999 99999


Q ss_pred             CCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         266 CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       266 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+.........+.....+ .....++.++.+||.+||..||.+|||+.|++++
T Consensus       307 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          307 PGIPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TTCCGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            887766665555444332 2345788999999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.1e-48  Score=373.70  Aligned_cols=265  Identities=29%  Similarity=0.480  Sum_probs=209.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCC-------
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP-------  126 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~-------  126 (463)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.........+.+|+.+++.+ +||||+++++++.....       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence            3579999999999999999999999999999999976666677888999999999 89999999998754210       


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                      ....+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence            123468899999999999999997533 4678899999999999999999999999999999999999999999999999


Q ss_pred             ccccccc--------------cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-h
Q psy7384         207 SAQLDRT--------------IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-M  271 (463)
Q Consensus       207 a~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~  271 (463)
                      +......              ........||+.|+|||++.+    ...++.++|||||||++|+|++   ||..... .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~  235 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG----TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV  235 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTS----CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccC----CCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence            8766422              112244579999999999863    3468899999999999999998   5543222 2


Q ss_pred             hhhhcccCC--CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         272 RALFLIPRN--APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       272 ~~~~~i~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                      .....+...  ..+.......+..+++||.+||..||.+|||++++++||||+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (303)
T 1zy4_A          236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD  293 (303)
T ss_dssp             HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred             HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence            222222111  12222345667889999999999999999999999999999876544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-48  Score=379.00  Aligned_cols=261  Identities=41%  Similarity=0.683  Sum_probs=196.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  ......+.+|+.+++.+ +||||+++++++.      ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~~   85 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFV------VK   85 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEE------SS
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEe------ec
Confidence            356799999999999999999999889999999998643  23456778899999998 8999999999994      44


Q ss_pred             CeEEEEEecCCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKST------KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                      +..|+||||+++++|.+++...      ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence            6899999999999999998752      2346899999999999999999999999999999999999999999999999


Q ss_pred             cccccccccc-----CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         205 GVSAQLDRTI-----GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       205 Gla~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      |++.......     .......||+.|+|||++..    ...++.++|||||||++|+|++|..||..............
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ----VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHH----HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhcc----ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            9987654321     11234579999999999863    24578899999999999999999999988766554433322


Q ss_pred             CCCCC--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 NAPPR--------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 ~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ...+.        .....++.++.+||.+||..||.+|||+.++++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            22111        1224678999999999999999999999999999999753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.8e-48  Score=385.22  Aligned_cols=257  Identities=24%  Similarity=0.419  Sum_probs=213.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEE-----EcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|++.+.||+|+||.||+|+     +..+++.||||++....  .....+.+|+.++.++.+||||+++++++.. 
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-   97 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-   97 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec-
Confidence            456789999999999999999999     44567899999997543  3346788999999999789999999999843 


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------------------------------------------
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------------------------------------------  154 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------  154 (463)
                          ....+++||||+.+|+|.+++.....                                                  
T Consensus        98 ----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           98 ----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             ----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             ----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence                23568999999999999999986542                                                  


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc--Cccc
Q psy7384         155 --------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI--GRRN  218 (463)
Q Consensus       155 --------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~  218 (463)
                                    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  ....
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                          128899999999999999999999999999999999999999999999999998664322  1234


Q ss_pred             cccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHH
Q psy7384         219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSF  297 (463)
Q Consensus       219 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  297 (463)
                      ...||+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+......+...............+++++.+|
T Consensus       254 ~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  328 (359)
T 3vhe_A          254 DARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT  328 (359)
T ss_dssp             -CEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred             ccCCCceeEChhhhc-----CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            456899999999997     5678999999999999999998 9999988765544433333322233345688999999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q psy7384         298 IETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       298 i~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      |.+||..||.+|||+.|+++|
T Consensus       329 i~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          329 MLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.6e-48  Score=379.84  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=189.3

Q ss_pred             CCCCCceEEEe-eeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          51 EDPAGIFELIE-VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        51 ~~~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ....++|++++ .||+|+||.||+|++..+|+.||||++....    ....|+..+.++.+||||+++++++....  ..
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~--~~   97 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH--HG   97 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE--TT
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc--CC
Confidence            35667899965 6999999999999999999999999996542    23344444444458999999999985421  12


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEeccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGV  206 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGl  206 (463)
                      ...+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            356899999999999999998776667999999999999999999999999999999999999976   45599999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh----cccC--C
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF----LIPR--N  280 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~----~i~~--~  280 (463)
                      +......  .....+||+.|+|||++.     ...++.++|||||||++|+|++|..||.+........    .+..  .
T Consensus       178 ~~~~~~~--~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (336)
T 3fhr_A          178 AKETTQN--ALQTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY  250 (336)
T ss_dssp             CEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             ceecccc--ccccCCCCcCccChhhhC-----CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence            9866532  234567899999999986     5678899999999999999999999997665433211    1111  1


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         281 APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..+......+++++++||.+||..||.+|||++|+|+||||++
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            1122233568999999999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-47  Score=368.59  Aligned_cols=255  Identities=27%  Similarity=0.504  Sum_probs=217.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++++.||+|+||.||+|++..+++.||+|++...   ......+.+|+.+++++ +||||+++++++      ..
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~   92 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEIL------ED   92 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEE------EC
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEE------eC
Confidence            345799999999999999999999999999999998643   33567888999999999 899999999998      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC---CcEEEEeccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN---AEVKLVDFGV  206 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~---~~vkL~DFGl  206 (463)
                      .+.+|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            578999999999999999987654  68999999999999999999999999999999999999754   4699999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC--
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR--  284 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--  284 (463)
                      +....... ......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.+.......+.......  
T Consensus       171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  243 (287)
T 2wei_A          171 STCFQQNT-KMKDRIGTAYYIAPEVLR------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL  243 (287)
T ss_dssp             GGTBCCCS-SCSCHHHHHTTCCHHHHT------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred             ceeecCCC-ccccccCcccccChHHhc------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            88765432 223456899999999985      348899999999999999999999999887766655554433221  


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .....++.++.+||.+||..||.+|||++++|+||||++
T Consensus       244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            222567899999999999999999999999999999964

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.4e-48  Score=382.48  Aligned_cols=263  Identities=25%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC-CCCCeE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP-GKDDQL  133 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~-~~~~~~  133 (463)
                      ++|++.+.||+|+||.||+|++..+|+.||||++............++..+..+ +||||++++++|...... .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeE
Confidence            469999999999999999999999999999999876555455666788888888 899999999998654321 223347


Q ss_pred             EEEEecCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHhhhh--cCCceecCCCCCceEEcc-CCcEEEEeccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKS--TKGQSLKEEWIAFICREILRGLKYLH--ENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSA  208 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH--~~givHrDLkp~NILl~~-~~~vkL~DFGla~  208 (463)
                      ++||||+.+ +|.+.+..  .....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||++.
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            899999987 55544432  23457899999999999999999999  999999999999999996 8999999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC------
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP------  282 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------  282 (463)
                      ...... .....+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+....+..+.+...      
T Consensus       181 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          181 KLSPSE-PNVAYICSRYYRAPELIFG----NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             CCCTTS-CCCSTTSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ecCCCC-CcccccCCcceeCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            765432 2345679999999999863    34589999999999999999999999988776655443321000      


Q ss_pred             ------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         283 ------------------------PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       283 ------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                              ........++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                                    001112356789999999999999999999999999999753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8e-48  Score=384.67  Aligned_cols=258  Identities=24%  Similarity=0.414  Sum_probs=216.6

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEE-----EcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +...++|++++.||+|+||.||+|+     +..++..||||++...  ......+.+|+.+++.+ +||||+++++++  
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~--  143 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVS--  143 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE--
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEE--
Confidence            4556789999999999999999999     4456789999998643  34455788999999999 899999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG-----QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-  197 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-  197 (463)
                          ......|+||||+.+|+|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       144 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~  219 (367)
T 3l9p_A          144 ----LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  219 (367)
T ss_dssp             ----CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             ----ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence                445678999999999999999987542     3589999999999999999999999999999999999998554 


Q ss_pred             --cEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q psy7384         198 --EVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMR  272 (463)
Q Consensus       198 --~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~  272 (463)
                        .+||+|||+++......  .......||+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.....
T Consensus       220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~  294 (367)
T 3l9p_A          220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE  294 (367)
T ss_dssp             TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             CceEEECCCccccccccccccccCCCcCCcccEECHHHhc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence              59999999998653321  2234456899999999997     5678999999999999999998 999999888777


Q ss_pred             hhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         273 ALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       273 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ....+....... ....++..+.+||.+||+.||.+|||++++++|.|+
T Consensus       295 ~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          295 VLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            766665544332 345788999999999999999999999999998765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-47  Score=363.25  Aligned_cols=251  Identities=23%  Similarity=0.386  Sum_probs=216.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++++.||+|+||.||+|++. ++..||+|++.......+.+.+|+.+++++ +||||+++++++      ...+.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~~   79 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC------LEQAP   79 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEE------CSSSS
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEE------ecCCc
Confidence            3457999999999999999999986 467899999987766778899999999999 799999999999      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999999999999997544 3689999999999999999999999999999999999999999999999999986643


Q ss_pred             cc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         213 TI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       213 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      .. .......+|+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+..... ......+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  232 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFS-----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLA  232 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTS
T ss_pred             cccccccCcccccccCCHHHhc-----CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-CCCCCcC
Confidence            22 1223345788999999997     4668999999999999999999 9999998877766666554433 2334567


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ++.+.+||.+||..||.+|||+.++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            8999999999999999999999999886

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=370.40  Aligned_cols=257  Identities=33%  Similarity=0.536  Sum_probs=207.8

Q ss_pred             EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEE
Q psy7384          58 ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      .....||+|+||.||+|++..++..||+|++.... .....+.+|+.+++.+ +||||+++++++.      ..+.+++|
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~~~~~~lv   97 (295)
T 2clq_A           25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFS------ENGFIKIF   97 (295)
T ss_dssp             SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEE------ETTEEEEE
T ss_pred             CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEE------eCCcEEEE
Confidence            33459999999999999999999999999987543 3456788999999999 8999999999994      45789999


Q ss_pred             EecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEeccccccccccc
Q psy7384         137 MEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       137 ~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~  214 (463)
                      |||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999999998653 235678999999999999999999999999999999999987 8999999999998765443


Q ss_pred             CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh-hhcccCCCCCCCCCCCCCHH
Q psy7384         215 GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-LFLIPRNAPPRLKSKKWPKK  293 (463)
Q Consensus       215 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  293 (463)
                      .......||+.|+|||++...   ...++.++|||||||++|+|++|..||........ ................++.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE  254 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHG---GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred             CcccccCCCccccChhhhcCC---CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence            334556799999999998632   13478899999999999999999999976443322 11111111111223568899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         294 FQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       294 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      +.+||.+||..||.+|||++++|+||||+..
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=374.97  Aligned_cols=265  Identities=22%  Similarity=0.400  Sum_probs=210.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCC-----
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP-----  126 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~-----  126 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++.....     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC-
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccccc
Confidence            4578999999999999999999999999999999987543 3456788999999999 89999999998743211     


Q ss_pred             ---CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc-cCCcEEEE
Q psy7384         127 ---PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLV  202 (463)
Q Consensus       127 ---~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~-~~~~vkL~  202 (463)
                         ......+|+||||+. |+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               134478999999998 599999864   3689999999999999999999999999999999999997 56799999


Q ss_pred             eccccccccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         203 DFGVSAQLDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       203 DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      |||++.......   .......+|+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHC----TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcC----cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999998764321   12234568999999999863    35688999999999999999999999988776555443322


Q ss_pred             CCCC----------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         280 NAPP----------------------------RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       280 ~~~~----------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      ..+.                            ......++.++++||.+||..||.+|||++++|+||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            1110                            0012457899999999999999999999999999999986543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=391.29  Aligned_cols=261  Identities=26%  Similarity=0.442  Sum_probs=193.6

Q ss_pred             CCceEE-EeeeeeeCCeEEEEEEEc--CCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFEL-IEVVGNGTYGQVYKGRHT--KTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~-~~~LG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .+.|++ .++||+|+||.||+|+++  .+++.||+|++..... ...+.+|+.+|+.+ +||||++++++|..    ...
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~   92 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLS----HAD   92 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHC-CCTTBCCCCEEEEE----TTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhc-CCCCeeeEeeEEec----CCC
Confidence            345777 458999999999999976  5688999999975432 34678999999999 79999999999864    234


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE----ccCCcE
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK-------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL----TDNAEV  199 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl----~~~~~v  199 (463)
                      ..+||||||+.+ +|.+++....       ...+++..++.++.||+.||.|||++||+||||||+||||    +.++.+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            689999999975 8888876432       2249999999999999999999999999999999999999    677899


Q ss_pred             EEEeccccccccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-----
Q psy7384         200 KLVDFGVSAQLDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-----  271 (463)
Q Consensus       200 kL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-----  271 (463)
                      ||+|||+++......   ......+||+.|+|||++.+    ...|+.++||||||||+|+|++|.+||.+....     
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTT----CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcC----CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            999999998765322   22345689999999999873    345899999999999999999999999765431     


Q ss_pred             ----hhhhcccC--CCCCC----------------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCC
Q psy7384         272 ----RALFLIPR--NAPPR----------------------------------LKSKKWPKKFQSFIETVLVKDYHQRPY  311 (463)
Q Consensus       272 ----~~~~~i~~--~~~~~----------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt  311 (463)
                          ..+..+..  +.+..                                  ......+..+.+||.+||..||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence                11111100  00000                                  001122678999999999999999999


Q ss_pred             HHHHhcCccccCCc
Q psy7384         312 TDQLLKHPFIRDQP  325 (463)
Q Consensus       312 ~~e~l~hp~~~~~~  325 (463)
                      ++|+|+||||.+.+
T Consensus       328 a~e~L~hp~f~~~~  341 (405)
T 3rgf_A          328 SEQAMQDPYFLEDP  341 (405)
T ss_dssp             HHHHHTSGGGTSSS
T ss_pred             HHHHhcChhhccCC
Confidence            99999999998654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-47  Score=373.98  Aligned_cols=266  Identities=20%  Similarity=0.355  Sum_probs=200.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCc---EEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ...++|++.+.||+|+||.||+|++..++.   .||+|++...   ......+.+|+.+++.+ +||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence            445689999999999999999999887765   8999998643   34567888999999999 8999999999986542


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEE
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKG----QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL  201 (463)
                      ........++||||+.+|+|.+++.....    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            22222345999999999999999975432    25899999999999999999999999999999999999999999999


Q ss_pred             EecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhccc
Q psy7384         202 VDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       202 ~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~  278 (463)
                      +|||+++.......  ......+++.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+.
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA-----DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             eeccccccccccccccccccccCcccccCchhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            99999987643321  122345788999999997     5568999999999999999999 999999887777666554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-------HHHHhcCccccCC
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPY-------TDQLLKHPFIRDQ  324 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~e~l~hp~~~~~  324 (463)
                      ..... .....+++++.+||.+||..||.+|||       ++++++|+|+...
T Consensus       254 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          254 GGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             TTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             cCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            44332 234578899999999999999999999       7888999999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=379.05  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=207.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++....   .....+.+|+.+++.+ +||||+++++++.........
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence            467999999999999999999999999999999996432   2346778999999999 799999999998543211112


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+. ++|.+++.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            34699999997 48887763    25899999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-----------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-----------  279 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-----------  279 (463)
                      ...   ....+||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+....+..+..           
T Consensus       177 ~~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          177 DAE---MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             ----------CCSBCCSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             CCC---ccccccCcCcCCHHHHhC----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            533   245679999999999863    35688999999999999999999999988765443332211           


Q ss_pred             ----------------CCCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 ----------------NAPP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 ----------------~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                      ....  ......++.++.+||.+||..||.+|||++++|+||||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  311 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  311 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                            0011  1122467899999999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.2e-47  Score=366.74  Aligned_cols=254  Identities=22%  Similarity=0.400  Sum_probs=221.0

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +...++|++.+.||+|+||.||+|.+..++..||+|++.........+.+|+.+++.+ +||||+++++++      ...
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~   81 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC------TRE   81 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEE------CSS
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE------ccC
Confidence            3456789999999999999999999999999999999987777788899999999999 799999999998      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            78999999999999999998766667999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         211 DRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       211 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ..... ......+|+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+..... .....
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~  235 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERPE  235 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-CCCCT
T ss_pred             cCCccccccCCccccCcCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-CCCCC
Confidence            54322 223345788999999997     4568999999999999999999 9999988776655554443332 23345


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+++.+.+||.+||..||.+|||++++++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            78999999999999999999999999976

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=372.76  Aligned_cols=251  Identities=28%  Similarity=0.464  Sum_probs=208.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec-CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.. .......+.+|+.+++.+ +||||+++++++.      ..+.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~------~~~~   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLY------KDKR   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEE------ETTE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEe------cCCe
Confidence            3579999999999999999999999999999998754 344567788999999999 7999999999994      4578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999999999999998643 4699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccCc--------------cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc
Q psy7384         213 TIGR--------------RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       213 ~~~~--------------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  278 (463)
                      ....              ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~  235 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-----GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN  235 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhc-----CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence            2211              11457999999999997     5678999999999999999999999997654332211110


Q ss_pred             -CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         279 -RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       279 -~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                       ...........+++.+.+||.+||..||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             000011123467889999999999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.7e-47  Score=379.75  Aligned_cols=261  Identities=23%  Similarity=0.367  Sum_probs=204.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc------------hHHHHHHHHHHHHHhcCCCceeeecccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED------------EEEEIKLEINVLKKYSNHRNIATYYGAF  121 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~  121 (463)
                      .++|++.+.||+|+||.||+|.+.. |..||||++.....            ....+.+|+.+|+.+ +||||+++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   98 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIF   98 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeE
Confidence            3469999999999999999999765 89999999853211            136788999999999 799999999998


Q ss_pred             cccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEE
Q psy7384         122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL  201 (463)
                      ..... .....+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        99 ~~~~~-~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A           99 VHFEE-PAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             EECCT-TTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EeccC-CCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence            65421 23457899999998 5888888743 346999999999999999999999999999999999999999999999


Q ss_pred             EecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC--
Q psy7384         202 VDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--  279 (463)
Q Consensus       202 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~--  279 (463)
                      +|||++...... .......||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+......+..+..  
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (362)
T 3pg1_A          176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQ----FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV  250 (362)
T ss_dssp             CCTTC----------------CGGGCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EecCcccccccc-cccceecccceecCcHHhcC----CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            999999765433 22345679999999999863    35688999999999999999999999988765444332211  


Q ss_pred             ---------------------CCCCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 ---------------------NAPPR-------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 ---------------------~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                           .....       .....+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                                 00000       0123567899999999999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.1e-48  Score=385.56  Aligned_cols=260  Identities=22%  Similarity=0.351  Sum_probs=209.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc----------CCCceeeecccccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS----------NHRNIATYYGAFIK  123 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~----------~h~nIv~l~~~~~~  123 (463)
                      .++|++++.||+|+||.||+|++..+++.||||++.........+.+|+.+++.+.          .|+||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            46899999999999999999999999999999999876666778889999999874          28999999999864


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEcc------C
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTD------N  196 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~------~  196 (463)
                      ..  .....+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.      .
T Consensus        98 ~~--~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           98 KG--PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EE--TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             cC--CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence            32  1223789999999 88999999876666799999999999999999999998 9999999999999953      3


Q ss_pred             CcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-----
Q psy7384         197 AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-----  271 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-----  271 (463)
                      +.+||+|||++......   ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+....     
T Consensus       175 ~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLL-----GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHH-----TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             ceEEEcccccccccCCC---CCCCCCCccccCcHHHh-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence            47999999999876543   24457999999999997     566899999999999999999999999765421     


Q ss_pred             -hhhhccc---CCCC--------------------C-----------------CCCCCCCCHHHHHHHHHhhhcCCCCCC
Q psy7384         272 -RALFLIP---RNAP--------------------P-----------------RLKSKKWPKKFQSFIETVLVKDYHQRP  310 (463)
Q Consensus       272 -~~~~~i~---~~~~--------------------~-----------------~~~~~~~~~~~~~li~~~L~~dp~~Rp  310 (463)
                       ..+..+.   ...+                    .                 ......++.++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence             1111000   0000                    0                 001123456889999999999999999


Q ss_pred             CHHHHhcCccccCC
Q psy7384         311 YTDQLLKHPFIRDQ  324 (463)
Q Consensus       311 t~~e~l~hp~~~~~  324 (463)
                      |++|+|+||||++.
T Consensus       327 t~~ell~hp~f~~~  340 (373)
T 1q8y_A          327 DAGGLVNHPWLKDT  340 (373)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHhhChhhhcc
Confidence            99999999999763

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=373.84  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=212.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCc---EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ...++|++.+.||+|+||.||+|++..++.   .||||++...  ......+.+|+.+|+.+ +||||+++++++     
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-----  119 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVV-----  119 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-----
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE-----
Confidence            446789999999999999999999986654   5999999753  33456788999999999 899999999999     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                       ...+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       120 -~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          120 -TRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             -CGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             -EeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence             45578999999999999999997543 3699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCC
Q psy7384         207 SAQLDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       207 a~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      ++........   .....+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+.....
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  272 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIA-----FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR  272 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhc-----CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC
Confidence            9876543221   12234678899999997     4668999999999999999999 9999988887776666554433


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      . .....+++.+.+||.+||..||.+|||+.++++
T Consensus       273 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 L-PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C-CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2 234578999999999999999999999999976

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=376.54  Aligned_cols=256  Identities=24%  Similarity=0.425  Sum_probs=217.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCC-------CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKT-------GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAF  121 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~  121 (463)
                      +...++|++.+.||+|+||.||+|++..+       +..||+|++....  .....+.+|+.+++.+.+||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            55678999999999999999999997643       3579999997543  33467889999999997899999999999


Q ss_pred             cccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                            ...+.+|+||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||++||+|||||
T Consensus       145 ------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  218 (382)
T 3tt0_A          145 ------TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  218 (382)
T ss_dssp             ------CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ------ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence                  455789999999999999999987542              359999999999999999999999999999999


Q ss_pred             CCceEEccCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPP  264 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~P  264 (463)
                      |+||||+.++.+||+|||+++......  .......+|+.|+|||++.     +..++.++|||||||++|+|++ |..|
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-----CCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999998765332  2223446789999999997     5678999999999999999999 9999


Q ss_pred             CCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         265 LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       265 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      |.+.........+....... ....+++++.+||.+||..||.+|||+++++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          294 YPGVPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             STTCCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            98887766665554443322 345788999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.7e-47  Score=359.69  Aligned_cols=251  Identities=22%  Similarity=0.374  Sum_probs=215.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++.........+.+|+.+++++ +||||+++++++      ...+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~~   77 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVC------SKEYP   77 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEE------CSSSS
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEE------ccCCc
Confidence            4568999999999999999999876 567899999987766778899999999999 799999999999      55578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      .|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             eEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999999999999999997653 3589999999999999999999999999999999999999999999999999986643


Q ss_pred             ccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         213 TIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ... ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||...........+..... ......+
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  230 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFH-----YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-LYRPHLA  230 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHH-----HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTS
T ss_pred             hhhhcccCCCcCcccCCHHHHh-----ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-CCCCCcC
Confidence            321 123345677899999997     4568899999999999999999 9999988877766655544433 2334467


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ++.+.+||.+||..||.+|||+.+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999886

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-47  Score=373.80  Aligned_cols=257  Identities=23%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +...++|++.+.||+|+||.||+|++.     .++..||+|++...  ......+.+|+.+|.++.+||||+++++++  
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence            345678999999999999999999973     35678999999643  233467889999999997799999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHhhhhcCCce
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG---------------------QSLKEEWIAFICREILRGLKYLHENKVI  182 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~~LH~~giv  182 (463)
                          ...+.+|+||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||++||+
T Consensus       119 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  194 (344)
T 1rjb_A          119 ----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV  194 (344)
T ss_dssp             ----CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             ----eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                445789999999999999999986542                     2378999999999999999999999999


Q ss_pred             ecCCCCCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh
Q psy7384         183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE  260 (463)
Q Consensus       183 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~  260 (463)
                      ||||||+|||++.++.+||+|||++........  ......||+.|+|||++.     ...++.++|||||||++|+|++
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-----EGIYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHTT
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-----cCCCChhHhHHHHHHHHHHHHc
Confidence            999999999999999999999999987654322  123345788999999987     4568999999999999999998


Q ss_pred             -CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         261 -SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       261 -g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       |..||.+......+..+............+++++.+||.+||..||.+|||+.++++|
T Consensus       270 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence             9999988776555444333333333345678999999999999999999999999886

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.3e-47  Score=373.02  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=213.7

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------hHHHHHHHHHHHHHhc-CCCceeeeccc
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------EEEEIKLEINVLKKYS-NHRNIATYYGA  120 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~Ei~~l~~l~-~h~nIv~l~~~  120 (463)
                      ..+...++|++.+.||+|+||.||+|++..+|+.||||++.....       ....+.+|+.+++.+. .|+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            345567889999999999999999999999999999999964321       2245668999999995 36999999999


Q ss_pred             ccccCCCCCCCeEEEEEecCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc-cCCc
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGA-GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAE  198 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~-~~~~  198 (463)
                      +      ...+..++|||++.+ ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++ +++.
T Consensus       117 ~------~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          117 F------ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             E------ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE
T ss_pred             E------ecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC
Confidence            9      445789999999986 89999997654  689999999999999999999999999999999999998 7899


Q ss_pred             EEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc
Q psy7384         199 VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       199 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  278 (463)
                      +||+|||++......  ......||+.|+|||++..    ...++.++|||||||++|+|++|..||.......  .   
T Consensus       189 ~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~---  257 (320)
T 3a99_A          189 LKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRY----HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--R---  257 (320)
T ss_dssp             EEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--H---
T ss_pred             EEEeeCccccccccc--cccCCCCCccCCChHHhcc----CCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--c---
Confidence            999999999876543  2344579999999999873    2334788999999999999999999996543211  1   


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCchh
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  327 (463)
                       ..  ......+++++.+||.+||..||.+|||++++++||||++....
T Consensus       258 -~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          258 -GQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             -CC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             -cc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence             11  11234688999999999999999999999999999999976544

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.6e-47  Score=368.31  Aligned_cols=257  Identities=24%  Similarity=0.422  Sum_probs=215.7

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEE-----cCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRH-----TKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +...++|++.+.||+|+||.||+|++     ..+++.||+|++....  .....+.+|+.+++++.+||||+++++++  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE--
Confidence            44567899999999999999999985     3567899999997543  34567889999999997799999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG----------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                          ...+..|+||||+++|+|.+++.....                ..+++..++.++.||+.||.|||++||+|||||
T Consensus        97 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  172 (313)
T 1t46_A           97 ----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (313)
T ss_dssp             ----CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence                455788999999999999999986542                248999999999999999999999999999999


Q ss_pred             CCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPP  264 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~P  264 (463)
                      |+|||++.++.+||+|||++........  ......||+.|+|||++.     ...++.++|||||||++|+|++ |..|
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc-----CCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999987654322  123345788999999987     4568999999999999999999 9999


Q ss_pred             CCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         265 LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       265 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      |.+......................++..+.+||.+||..||.+|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             STTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            988765554444333333333445788999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-46  Score=361.73  Aligned_cols=252  Identities=20%  Similarity=0.383  Sum_probs=213.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++.........+.+|+.+++.+ +||||+++++++      ...+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~~   92 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC------TKQR   92 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEE------CSSS
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEE------ecCC
Confidence            44568999999999999999999876 577899999987766678899999999999 799999999999      5557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            8999999999999999997633 369999999999999999999999999999999999999999999999999998664


Q ss_pred             ccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         212 RTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       212 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ... .......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||...........+..... ......
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~  245 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLM-----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LYRPHL  245 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHH-----HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTT
T ss_pred             ccccccccCCccCcccCCHHHhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC-CCCCCc
Confidence            321 1123345788999999997     4568999999999999999998 9999988877766666554433 233456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +++.+.+||.+||..||.+|||++++++|
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            78999999999999999999999999886

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=372.33  Aligned_cols=255  Identities=22%  Similarity=0.409  Sum_probs=215.1

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      ....++|++++.||+|+||.||+|++.     .+++.||+|++....  .....+.+|+.+++.+ +||||+++++++  
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~--  119 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVC--  119 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE--
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE--
Confidence            345678999999999999999999987     355899999997543  3356788999999999 899999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHhhhhcCCc
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTK----------------------GQSLKEEWIAFICREILRGLKYLHENKV  181 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~gi  181 (463)
                          ...+.+|+||||+.+|+|.+++....                      ...+++..++.++.||+.||.|||++||
T Consensus       120 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i  195 (343)
T 1luf_A          120 ----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  195 (343)
T ss_dssp             ----CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             ----ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence                45578999999999999999998643                      1468999999999999999999999999


Q ss_pred             eecCCCCCceEEccCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHH
Q psy7384         182 IHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA  259 (463)
Q Consensus       182 vHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell  259 (463)
                      +||||||+|||++.++.+||+|||++.......  .......+|+.|+|||++.     ...++.++|||||||++|+|+
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~  270 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIF  270 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-----cCCcCcccccHHHHHHHHHHH
Confidence            999999999999999999999999998664322  1223456899999999987     456899999999999999999


Q ss_pred             h-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         260 E-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       260 ~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      + |..||.+.........+....... ....++..+.+||.+||..||.+|||+.+++++
T Consensus       271 t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          271 SYGLQPYYGMAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTTCCTTTTSCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCcCCCCChHHHHHHHhCCCcCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9 999999887776666555444322 345788999999999999999999999999764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.8e-46  Score=360.11  Aligned_cols=253  Identities=24%  Similarity=0.436  Sum_probs=209.1

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch---H-----HHHHHHHHHHHHhcCCCceeeeccc
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE---E-----EEIKLEINVLKKYSNHRNIATYYGA  120 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~-----~~~~~Ei~~l~~l~~h~nIv~l~~~  120 (463)
                      ......++|++.+.||+|+||.||+|++..+++.||+|++......   .     ..+.+|+.+++.+ +||||++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   91 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGL   91 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhhee
Confidence            3345567899999999999999999999999999999998643211   1     6788999999999 89999999999


Q ss_pred             ccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEccCCc
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAE  198 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~~~~~  198 (463)
                      +..      ..  ++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.
T Consensus        92 ~~~------~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           92 MHN------PP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             ETT------TT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred             ecC------CC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence            842      22  79999999999999887543 46999999999999999999999999  999999999999987776


Q ss_pred             -----EEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q psy7384         199 -----VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA  273 (463)
Q Consensus       199 -----vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  273 (463)
                           +||+|||+++.....   .....||+.|+|||++...   ...++.++|||||||++|+|++|..||........
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  236 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVHS---VSGLLGNFQWMAPETIGAE---EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI  236 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSSC---EECCCCCCTTSCGGGSSCS---SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred             CCceeEEeCCCCcccccccc---ccccCCCccccCchhhccC---CCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence                 999999999765432   3456799999999998432   45678899999999999999999999977654433


Q ss_pred             --hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         274 --LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       274 --~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                        ...+............+++.+.+||.+||..||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              22222222233344578999999999999999999999999976

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.5e-47  Score=372.40  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|++++.||+|+||.||+|++.  ++.||||++............|+.+|.++ +||||+++++++....  .....+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~--~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGT--SVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEEC--SSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCC--CCCceE
Confidence            468999999999999999999875  78999999987666666777899999998 8999999999986532  123568


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC----------CceecCCCCCceEEccCCcEEEEe
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN----------KVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----------givHrDLkp~NILl~~~~~vkL~D  203 (463)
                      |+||||+++|+|.+++...   .+++..++.++.||+.||.|||+.          ||+||||||+|||++.++.+||+|
T Consensus        98 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            9999999999999999763   489999999999999999999999          999999999999999999999999


Q ss_pred             cccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh-------
Q psy7384         204 FGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL-------  274 (463)
Q Consensus       204 FGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~-------  274 (463)
                      ||+++.......  .....+||+.|+|||++.+.......++.++|||||||++|+|++|+.||.+.......       
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            999987654322  23346799999999999743222245677899999999999999999999764332111       


Q ss_pred             --------h-cccC-CCCCCCC----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         275 --------F-LIPR-NAPPRLK----SKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       275 --------~-~i~~-~~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                              . .+.. ...+...    ....++++.+||.+||..||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    0 0111 1111111    1122356999999999999999999999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-46  Score=358.23  Aligned_cols=246  Identities=27%  Similarity=0.507  Sum_probs=201.1

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .++|++.+.||+|+||.||+|.+.  |..||+|++....     ...+.+.+|+.+++.+ +||||+++++++      .
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~   76 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVC------L   76 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEE------C
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEE------e
Confidence            457999999999999999999875  8899999986432     2246788999999999 799999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC---ceecCCCCCceEEcc--------CC
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK---VIHRDIKGQNVLLTD--------NA  197 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDLkp~NILl~~--------~~  197 (463)
                      ..+..|+||||+++++|.+++..   ..+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             cCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence            55788999999999999999853   36999999999999999999999999   999999999999985        77


Q ss_pred             cEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcc
Q psy7384         198 EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI  277 (463)
Q Consensus       198 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i  277 (463)
                      .+||+|||++.......  .....||+.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+
T Consensus       154 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  226 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIR-----ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV  226 (271)
T ss_dssp             CEEECCCCC---------------CCGGGSCHHHHH-----HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred             ceEEccCCccccccccc--ccCCCCccceeCHHHhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Confidence            89999999998665432  23457999999999997     456899999999999999999999999988777666655


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ............+++.+.+||.+||..||.+|||+.|+++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            55444444456789999999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.9e-46  Score=364.82  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=206.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcC-CCceeeecccccccCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSN-HRNIATYYGAFIKKSPP  127 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~-h~nIv~l~~~~~~~~~~  127 (463)
                      ...++|++++.||+|+||.||+|.+. +++.||+|++....   .....+.+|+.++.++.. |+||+++++++.     
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----   98 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----   98 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----
Confidence            34568999999999999999999975 58899999996432   345678899999999953 699999999984     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                       ..+.+|+||| +.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus        99 -~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~  173 (313)
T 3cek_A           99 -TDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  173 (313)
T ss_dssp             -CSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             -cCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence             4578999999 56789999997654  689999999999999999999999999999999999996 589999999999


Q ss_pred             cccccccC--ccccccCCccccccceeccCCC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhccc
Q psy7384         208 AQLDRTIG--RRNTFIGTPYWMAPEVIACDEN------PDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIP  278 (463)
Q Consensus       208 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~------~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~  278 (463)
                      ........  .....+||+.|+|||++.....      ....++.++|||||||++|+|++|..||...... ..+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            87643321  1234579999999999864211      1246888999999999999999999999765432 2222222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ............+..+.+||.+||..||.+|||++++|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            22222223345688999999999999999999999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6e-47  Score=372.64  Aligned_cols=250  Identities=20%  Similarity=0.319  Sum_probs=206.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.+.+||||+++++++      ...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~------~~~~~   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFG------PCGKY   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEE------EETTE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEE------ecCCc
Confidence            3567999999999999999999999999999999987543 2346789999999997899999999998      44578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc-----EEEEecccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE-----VKLVDFGVS  207 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~-----vkL~DFGla  207 (463)
                      .|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            99999999 89999999865 347999999999999999999999999999999999999998887     999999999


Q ss_pred             cccccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh---hhcc
Q psy7384         208 AQLDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA---LFLI  277 (463)
Q Consensus       208 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~---~~~i  277 (463)
                      +.+.....       .....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+......   +..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i  232 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHL-----GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI  232 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHc-----CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence            87643322       124568999999999997     56789999999999999999999999987543322   2222


Q ss_pred             cCC---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         278 PRN---APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       278 ~~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...   .+.......++ ++.+||..||..||.+||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          233 GDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111   11111123455 9999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-46  Score=365.13  Aligned_cols=254  Identities=25%  Similarity=0.437  Sum_probs=214.2

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|++.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+|+.+++.+ +||||+++++++   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~---   95 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGAC---   95 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE---
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEE---
Confidence            34578999999999999999999984     456899999997543  3446788999999999 899999999998   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHhhhhcCCce
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG----------------------QSLKEEWIAFICREILRGLKYLHENKVI  182 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~qil~aL~~LH~~giv  182 (463)
                         ...+..|+||||+.+++|.+++.....                      ..+++..++.++.||+.||.|||++||+
T Consensus        96 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  172 (314)
T 2ivs_A           96 ---SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV  172 (314)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             ---ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence               455789999999999999999986542                      2488999999999999999999999999


Q ss_pred             ecCCCCCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh
Q psy7384         183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE  260 (463)
Q Consensus       183 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~  260 (463)
                      ||||||+|||++.++.+||+|||++........  ......+|+.|+|||++.     ...++.++|||||||++|+|++
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-----DHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHT
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-----CCCcCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999986643322  123345788999999997     4568899999999999999999


Q ss_pred             -CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         261 -SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       261 -g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       |..||.+.........+...... .....+++.+.+||.+||..||.+|||+.+++++
T Consensus       248 ~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          248 LGGNPYPGIPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TSCCSSTTCCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             99999887776655554443332 2345789999999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.9e-46  Score=367.09  Aligned_cols=263  Identities=34%  Similarity=0.567  Sum_probs=191.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++....  .....+..|+..+.+..+||||+++++++.      .
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~------~   92 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF------R   92 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE------C
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE------e
Confidence            34568999999999999999999999999999999997543  234456667774544448999999999994      4


Q ss_pred             CCeEEEEEecCCCCCHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEecc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKS---TKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                      .+..|+||||+.+ +|.+++..   .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            5789999999986 88887763   2245799999999999999999999999 99999999999999999999999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhcccCCCCCC
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPRNAPPR  284 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~  284 (463)
                      ++....... ......||+.|+|||++.... ....++.++|||||||++|+|++|..||.+.... ..+..+.....+.
T Consensus       172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3aln_A          172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSA-SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ  249 (327)
T ss_dssp             SSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred             Cceeccccc-ccccCCCCccccCceeecccc-CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence            998765432 223347999999999984211 1456889999999999999999999999775432 3333333333332


Q ss_pred             CC---CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         285 LK---SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       285 ~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..   ...++..+.+||.+||..||.+|||+.++++||||..
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            22   2467899999999999999999999999999999963

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-46  Score=388.34  Aligned_cols=254  Identities=22%  Similarity=0.395  Sum_probs=219.1

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .....|++.+.||+|+||.||+|++..++..||||++.........+.+|+.+|+++ +||||+++++++      ...+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~------~~~~  289 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC------TREP  289 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE------CSSS
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEE------ecCC
Confidence            345679999999999999999999999999999999987666778899999999999 899999999999      4457


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            89999999999999999987666679999999999999999999999999999999999999999999999999998764


Q ss_pred             ccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCC
Q psy7384         212 RTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKK  289 (463)
Q Consensus       212 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  289 (463)
                      ... .......+++.|+|||++.     ...++.++|||||||++|||++ |..||.+.+.......+..... ......
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~  443 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERPEG  443 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-CCCCTT
T ss_pred             CCceeecCCCcCCcceeCHhHHh-----cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Confidence            321 1122345678999999997     4568999999999999999999 9999988776655554443332 223457


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +++.+.+||.+||..||.+|||+.++++.
T Consensus       444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          444 CPEKVYELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            88999999999999999999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.1e-46  Score=358.95  Aligned_cols=253  Identities=24%  Similarity=0.400  Sum_probs=202.5

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      +...++|++.+.||+|+||.||+|++..+   +..||+|++....  .....+.+|+.+++++ +||||+++++++.   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~---   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT---   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC---
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc---
Confidence            34567899999999999999999998654   4579999986432  3356788999999999 8999999999973   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                          ++..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           87 ----ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             ----SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ----cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence                246899999999999999997543 468999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         206 VSAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       206 la~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ++........ ......+|+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~  236 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL  236 (281)
T ss_dssp             -----------------CCGGGCCHHHHH-----HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred             cccccCcccccccccCCCcccccChhhcc-----cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC
Confidence            9987654321 122345788999999997     4568899999999999999996 99999888777666655444332


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       .....+++.+.+||.+||..||.+|||+.+++++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             2345789999999999999999999999999764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-46  Score=367.83  Aligned_cols=257  Identities=23%  Similarity=0.430  Sum_probs=214.0

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCc-----EEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +...++|++.+.||+|+||.||+|.+..++.     .||+|++....  .....+.+|+.+++.+.+||||+++++++  
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC--  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence            3456789999999999999999999987664     79999997543  34567889999999997799999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCce
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTK------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNV  191 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NI  191 (463)
                          ...+.+|+||||+++|+|.+++....            ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus       120 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          120 ----THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV  195 (333)
T ss_dssp             ----CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred             ----ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence                45578999999999999999997643            34689999999999999999999999999999999999


Q ss_pred             EEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy7384         192 LLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDL  268 (463)
Q Consensus       192 Ll~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~  268 (463)
                      |++.++.+||+|||++........  ......||+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-----DCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc-----cCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999986643322  123345788999999987     4568999999999999999998 99999887


Q ss_pred             CchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         269 HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       269 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ........+............+++.+.+||.+||..||.+|||+.+++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            65554444333333333345678999999999999999999999999873

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-46  Score=355.72  Aligned_cols=251  Identities=16%  Similarity=0.322  Sum_probs=210.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..++|++.+.||+|+||.||+|++.  |..||+|++....   .....+.+|+.+++.+ +||||+++++++..    ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~   80 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQS----PP   80 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECT----TT
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEcc----CC
Confidence            3457999999999999999999985  8889999997543   3456788999999999 89999999999843    22


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEccCCcEEEEecccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .+..++||||+++|+|.+++.......+++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence            368899999999999999998766557999999999999999999999999  999999999999999999999999987


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS  287 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  287 (463)
                      .....     ....||+.|+|||++.+..  ...++.++|||||||++|+|++|..||.+.+.......+..........
T Consensus       161 ~~~~~-----~~~~~t~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          161 FSFQS-----PGRMYAPAWVAPEALQKKP--EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP  233 (271)
T ss_dssp             CTTSC-----TTCBSCGGGSCHHHHHSCG--GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred             eeecc-----cCccCCccccChhhhccCC--CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence            54332     3457899999999997321  1223447999999999999999999998887776655544443333445


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..+++.+.+||.+||..||.+|||++++++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            678999999999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.5e-46  Score=361.05  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=208.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+|+.+++.+.+|+||+++++++      .....
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~------~~~~~   80 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFG------QEGLH   80 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEE------EETTE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeec------CCCce
Confidence            4568999999999999999999999999999999986442 3346788999999998899999999998      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc-----EEEEecccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE-----VKLVDFGVS  207 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~-----vkL~DFGla  207 (463)
                      .|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||++
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            99999999 999999998643 36999999999999999999999999999999999999987765     999999999


Q ss_pred             cccccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh---hhhcc
Q psy7384         208 AQLDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---ALFLI  277 (463)
Q Consensus       208 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---~~~~i  277 (463)
                      ........       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.....   .+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  233 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhc-----CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence            87654322       234567999999999987     5668999999999999999999999998754322   12111


Q ss_pred             cCC---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         278 PRN---APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       278 ~~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...   .........+++++.+||.+||..||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            111   1111112467899999999999999999999999865

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=363.91  Aligned_cols=260  Identities=33%  Similarity=0.568  Sum_probs=191.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch--HHHHHHHHH-HHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE--EEEIKLEIN-VLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~Ei~-~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||.||+|++..+|+.||||++......  ...+..|+. +++.+ +||||+++++++.      ..
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~------~~   96 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFI------TN   96 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEE------CS
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEe------cC
Confidence            46799999999999999999999999999999999754332  233444444 45555 8999999999994      45


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-CceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      +.+|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            7899999999 55665555433 34799999999999999999999995 999999999999999999999999999976


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-chhhhhcccCCCCCCC-CC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLH-PMRALFLIPRNAPPRL-KS  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~-~~  287 (463)
                      ..... ......||+.|+|||++.........++.++|||||||++|+|++|..||.... ....+..+.....+.. ..
T Consensus       175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (318)
T 2dyl_A          175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH  253 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred             ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence            64432 223457999999999985432225668899999999999999999999997743 3333433333333322 23


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..++.++.+||.+||..||.+|||++++++||||++
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            468899999999999999999999999999999963

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.4e-46  Score=353.48  Aligned_cols=250  Identities=23%  Similarity=0.385  Sum_probs=214.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.......+.+.+|+.+++.+ +||||+++++++      ...+..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~~~~~~   78 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC------LEQAPI   78 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEE------CSSSSC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEE------ccCCCe
Confidence            457999999999999999999986 577899999987766678899999999999 899999999999      445789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT  213 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  213 (463)
                      |+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999999997643 36899999999999999999999999999999999999999999999999999866432


Q ss_pred             c-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         214 I-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       214 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      . .......+++.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+...... .....++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~  231 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFS-----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLAS  231 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-CCCTTSC
T ss_pred             cccccccccccccccChhhhc-----CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-CCCccCc
Confidence            1 1123345788999999997     4568899999999999999999 89999887776666555444332 2344678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..+.+||.+||..||.+|||+.+++++
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-46  Score=376.41  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=213.6

Q ss_pred             CCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          47 DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        47 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ..|. ...++|++.+.||+|+||.||+|++..+++.||+|++....  .....+.+|+.+|+.+ +||||+++++++   
T Consensus       107 ~~~~-~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~---  181 (377)
T 3cbl_A          107 DKWV-LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVC---  181 (377)
T ss_dssp             CTTB-CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEE---
T ss_pred             cccE-EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE---
Confidence            3442 34568999999999999999999999999999999987442  2335678899999999 899999999999   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                         ...+.+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       182 ---~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          182 ---TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred             ---ecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcC
Confidence               44568999999999999999997643 35899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCC
Q psy7384         205 GVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       205 Gla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      |+++........  .....+++.|+|||++.     ...++.++|||||||++|||++ |..||.+.........+....
T Consensus       258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  332 (377)
T 3cbl_A          258 GMSREEADGVYAASGGLRQVPVKWTAPEALN-----YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG  332 (377)
T ss_dssp             GGCEECTTSEEECCSSCCEEEGGGSCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC
T ss_pred             CCceecCCCceeecCCCCCCCcCcCCHhHhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999865432111  11223577899999997     4568999999999999999998 999998887766555544433


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .. .....+++.+.+||.+||..||.+|||++++++
T Consensus       333 ~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          333 RL-PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            22 234568899999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-46  Score=366.36  Aligned_cols=257  Identities=24%  Similarity=0.415  Sum_probs=211.6

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|++.+.||+|+||.||+|++.     .+++.||+|++.....  ....+.+|+.++.++.+||||+++++++.. 
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  102 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-  102 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-
Confidence            34568999999999999999999863     4678999999975433  345788999999999779999999999842 


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCc
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQN  190 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~N  190 (463)
                          ....+|+||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus       103 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A          103 ----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             ----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             ----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence                33568999999999999999986542              128899999999999999999999999999999999


Q ss_pred             eEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy7384         191 VLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCD  267 (463)
Q Consensus       191 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~  267 (463)
                      ||++.++.+||+|||++........  ......||+.|+|||++.     ...++.++|||||||++|+|++ |..||.+
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc-----cccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999986643221  223456889999999997     5668999999999999999998 9999987


Q ss_pred             CCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         268 LHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       268 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ......+...............+++.+.++|.+||..||.+|||+.++++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            665444332222222222334678999999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.1e-46  Score=361.44  Aligned_cols=254  Identities=28%  Similarity=0.486  Sum_probs=200.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...    ......+.+|+.+++.+ +||||+++++++.      
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~------  102 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFI------  102 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE------
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE------
Confidence            446899999999999999999999999999999998742    23456788999999999 8999999999994      


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                      ..+..++||||+.+++|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            447899999999999999998753  345689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch--hhhhcccCCCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM--RALFLIPRNAPPR  284 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~  284 (463)
                      +..............|++.|+|||++.     ...++.++|||||||++|+|++|..||.+....  .....+.....+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  257 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIH-----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP  257 (310)
T ss_dssp             ----------------CCSSCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred             eeeecCCCccccccCCCeeEeChHHhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence            987655444445567999999999987     567889999999999999999999999765322  2223333333334


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .....++.++.+||.+||..||.+|||+++++++
T Consensus       258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            4446789999999999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.6e-46  Score=356.55  Aligned_cols=256  Identities=24%  Similarity=0.472  Sum_probs=215.8

Q ss_pred             CCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          46 EDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        46 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ...| +...++|++++.||+|+||.||+|.+. ++..||+|++.........+.+|+.+++.+ +||||+++++++.   
T Consensus         5 ~~~~-~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~---   78 (279)
T 1qpc_A            5 EDEW-EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT---   78 (279)
T ss_dssp             TCTT-BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC---
T ss_pred             hhhc-ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEc---
Confidence            3444 345678999999999999999999975 567899999987666678899999999999 8999999999873   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                          .+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        79 ----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           79 ----QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ----CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence                2458999999999999999976543469999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         206 VSAQLDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       206 la~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ++....... .......+++.|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+..... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  228 (279)
T 1qpc_A          155 LARLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-  228 (279)
T ss_dssp             TCEECSSSCEECCTTCCCCTTTSCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-
T ss_pred             ccccccCcccccccCCCCccCccChhhhc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-
Confidence            998765322 1123345788999999997     4568899999999999999999 9999988777666555544332 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ......+++.+.+||.+||..||.+|||++++++
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2234578899999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.8e-46  Score=364.91  Aligned_cols=256  Identities=24%  Similarity=0.428  Sum_probs=213.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEc-------CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHT-------KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAF  121 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~  121 (463)
                      +...++|++.+.||+|+||.||+|++.       .++..||+|++....  .....+.+|+.+++.+.+||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            455678999999999999999999986       457789999997543  34567889999999997899999999998


Q ss_pred             cccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG--------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                            ...+.+|+||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||++||+|||||
T Consensus       111 ------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  184 (334)
T 2pvf_A          111 ------TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA  184 (334)
T ss_dssp             ------CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ------ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence                  455789999999999999999986542              248899999999999999999999999999999


Q ss_pred             CCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPP  264 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~P  264 (463)
                      |+|||++.++.+||+|||++........  ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..|
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc-----CCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999987654321  123345788999999987     4568899999999999999999 9999


Q ss_pred             CCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         265 LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       265 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      |.+.........+...... .....++..+.+||.+||..||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          260 YPGIPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             STTCCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCcCCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9887766655544443322 2335688999999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=365.71  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------hHHHHHHHHHHHHHhc---CCCceeeeccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------EEEEIKLEINVLKKYS---NHRNIATYYGA  120 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~Ei~~l~~l~---~h~nIv~l~~~  120 (463)
                      +...++|++.+.||+|+||.||+|++..+|+.||+|++.....       ....+.+|+.++.++.   +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4556789999999999999999999999999999999964432       2234457899998885   69999999999


Q ss_pred             ccccCCCCCCCeEEEEEec-CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc-cCCc
Q psy7384         121 FIKKSPPGKDDQLWLVMEY-CGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAE  198 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~-~~~~  198 (463)
                      +      ...+..++|||| +.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus       107 ~------~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          107 F------ETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             C-----------CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred             E------ecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence            8      445788999999 78999999998754  689999999999999999999999999999999999998 8899


Q ss_pred             EEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc
Q psy7384         199 VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       199 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  278 (463)
                      +||+|||++......  ......||+.|+|||++..    ...++.++|||||||++|+|++|+.||........  .  
T Consensus       179 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~--  248 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISR----HQYHALPATVWSLGILLYDMVCGDIPFERDQEILE--A--  248 (312)
T ss_dssp             EEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH--T--
T ss_pred             EEEEEcchhhhcccC--cccccCCcccccCceeeec----CCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh--h--
Confidence            999999999876543  2345679999999999873    22335689999999999999999999965432111  1  


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                        .  ......++..+.+||.+||..||.+|||++|+++||||+..
T Consensus       249 --~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          249 --E--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             --C--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             --c--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence              1  11234678999999999999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.3e-46  Score=362.32  Aligned_cols=253  Identities=24%  Similarity=0.426  Sum_probs=202.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEE----EcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ..++|++++.||+|+||.||+|+    +..+++.||+|++.... .....+.+|+.+|+++ +||||+++++++...   
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~---   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSA---   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHH---
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---
Confidence            45689999999999999999998    56789999999987543 3446788999999999 799999999988432   


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                       ....+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           84 -GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             -HHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             -CCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence             2246899999999999999997654 25899999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-------------
Q psy7384         208 AQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------------  271 (463)
Q Consensus       208 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-------------  271 (463)
                      ........   ......+++.|+|||++.     ...++.++|||||||++|+|++|..||......             
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhc-----CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            87643321   122345778899999997     556899999999999999999999998543211             


Q ss_pred             ---hhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         272 ---RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       272 ---~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                         .....+... ........+++++.+||.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IVFHLIELLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhcc-CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               001111111 122234578999999999999999999999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.7e-46  Score=363.43  Aligned_cols=260  Identities=23%  Similarity=0.408  Sum_probs=216.7

Q ss_pred             CCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeee
Q psy7384          45 PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATY  117 (463)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l  117 (463)
                      ....| +...++|++.+.||+|+||.||+|++.     .++..||+|++.....  ....+.+|+.+++.+ +||||+++
T Consensus        16 ~~~~~-~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~   93 (322)
T 1p4o_A           16 VPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRL   93 (322)
T ss_dssp             CCCTT-BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCE
T ss_pred             Chhhh-cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeee
Confidence            34444 355678999999999999999999887     3578899999975433  345688999999999 89999999


Q ss_pred             cccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCC
Q psy7384         118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQ  189 (463)
Q Consensus       118 ~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~  189 (463)
                      ++++      ...+..|+||||+.+|+|.+++....        ...+++..+..++.||+.||.|||++||+||||||+
T Consensus        94 ~~~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~  167 (322)
T 1p4o_A           94 LGVV------SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR  167 (322)
T ss_dssp             EEEE------CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred             EEEE------ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccc
Confidence            9998      45578899999999999999997543        135789999999999999999999999999999999


Q ss_pred             ceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy7384         190 NVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLC  266 (463)
Q Consensus       190 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~  266 (463)
                      |||++.++.+||+|||++........  ......+|+.|+|||++.     +..++.++|||||||++|+|++ |..||.
T Consensus       168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~  242 (322)
T 1p4o_A          168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLAEQPYQ  242 (322)
T ss_dssp             GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc-----cCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence            99999999999999999986643321  123345789999999987     4568899999999999999999 899998


Q ss_pred             CCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         267 DLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       267 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +.........+...... .....++..+.+||.+||..||.+|||+.++++|
T Consensus       243 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          243 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TSCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            87776665555444332 2345788999999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.2e-46  Score=359.93  Aligned_cols=249  Identities=22%  Similarity=0.400  Sum_probs=205.3

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCC-------cEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeeccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTG-------QLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFI  122 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~  122 (463)
                      +...++|++.+.||+|+||.||+|++..++       ..||+|++... ......+.+|+.+++.+ +||||+++++++ 
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVC-   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEE-
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEE-
Confidence            345678999999999999999999998877       46999998643 34567788999999999 799999999999 


Q ss_pred             ccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc----
Q psy7384         123 KKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE----  198 (463)
Q Consensus       123 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~----  198 (463)
                           ...+..|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.    
T Consensus        82 -----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  155 (289)
T 4fvq_A           82 -----VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG  155 (289)
T ss_dssp             -----CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred             -----EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc
Confidence                 44567899999999999999997643 34899999999999999999999999999999999999998887    


Q ss_pred             ----EEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchhh
Q psy7384         199 ----VKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRA  273 (463)
Q Consensus       199 ----vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~  273 (463)
                          +||+|||++......    ....||+.|+|||++..    ...++.++|||||||++|+|++| .+||........
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~  227 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLPK----DILQERIPWVPPECIEN----PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK  227 (289)
T ss_dssp             BCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHC----GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ccceeeeccCcccccccCc----cccCCcCcccCHHHhCC----CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence                999999998765432    34468999999999973    25688999999999999999995 555555444333


Q ss_pred             hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       274 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .......   ......++.++.+||.+||..||.+|||++++++|
T Consensus       228 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          228 LQFYEDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHHTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3222111   11223457789999999999999999999999886

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.7e-46  Score=366.47  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=212.3

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEE-----EcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccc
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAF  121 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~  121 (463)
                      ..+...++|++++.||+|+||.||+|+     +..++..||+|++...  ......+.+|+.+++++ +||||+++++++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  102 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVS  102 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEE
Confidence            334567899999999999999999999     5567889999999643  34456788999999999 899999999999


Q ss_pred             cccCCCCCCCeEEEEEecCCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-
Q psy7384         122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG-----QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-  195 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-  195 (463)
                            ...+..|+||||+++++|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++. 
T Consensus       103 ------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          103 ------LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             ------CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred             ------cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC
Confidence                  445678999999999999999987542     35899999999999999999999999999999999999984 


Q ss_pred             --CCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy7384         196 --NAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHP  270 (463)
Q Consensus       196 --~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~  270 (463)
                        +..+||+|||++.......  .......||+.|+|||++.     ...++.++|||||||++|+|++ |..||.+...
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  251 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN  251 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence              4569999999987654322  1223456899999999997     4568999999999999999998 9999988776


Q ss_pred             hhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         271 MRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       271 ~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ......+....... ....++..+.+||.+||..||.+|||+.++++|.|+
T Consensus       252 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          252 QEVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            66655554443322 345688999999999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.8e-46  Score=364.79  Aligned_cols=250  Identities=24%  Similarity=0.416  Sum_probs=204.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcE----EEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQL----AAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .++|++++.||+|+||.||+|++..+++.    ||+|.+...  ......+.+|+.+++++ +||||+++++++..    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT----   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEES----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEec----
Confidence            46799999999999999999999888765    477776532  24457788999999999 89999999999853    


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                         +..++|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ---~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           89 ---STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             ---CCeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence               35789999999999999997644 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         208 AQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       208 ~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      +........  .....+|+.|+|||++.     +..++.++|||||||++|+|++ |..||.+.........+..... .
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~  238 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-L  238 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-C
T ss_pred             eEccCCcccccccCCCccccccChHHhc-----cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-C
Confidence            876543222  22345688999999998     5678999999999999999999 9999988776655544433332 2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .....++..+.+||.+||..||.+|||+.+++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            3345688999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-45  Score=377.56  Aligned_cols=248  Identities=23%  Similarity=0.407  Sum_probs=211.6

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...+.|++.+.||+|+||.||+|.+.  |+.||||++.... ....+.+|+.+|+++ +||||+++++++..     ...
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~~  260 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVE-----EKG  260 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC-CCTTBCCEEEEEEC-----TTS
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc-cCCCEEEEEEEEEc-----CCC
Confidence            34568999999999999999999875  7799999997553 456788999999999 89999999999752     335


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            79999999999999999987765568999999999999999999999999999999999999999999999999998654


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...   ....+++.|+|||++.     ...++.++|||||||++|||++ |..||.+.+..+....+..+... .....+
T Consensus       341 ~~~---~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~p~~~  411 (450)
T 1k9a_A          341 STQ---DTGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGC  411 (450)
T ss_dssp             ---------CCCTTTSCHHHHH-----SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-CCCTTC
T ss_pred             ccc---cCCCCCcceeCHHHhc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCcC
Confidence            321   2336788999999997     5678999999999999999998 99999887776666555444332 234578


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ++.+.+||.+||..||.+|||+.++++
T Consensus       412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          412 PPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.8e-46  Score=382.18  Aligned_cols=252  Identities=21%  Similarity=0.390  Sum_probs=215.6

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +...++|++.+.||+|+||.||+|.+. .+..||||++.......+.+.+|+.+|+.+ +||||+++++++.       .
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-------~  254 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT-------K  254 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-------S
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-------C
Confidence            455678999999999999999999985 467899999987666778899999999999 8999999999983       2


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+||||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            56899999999999999998654446889999999999999999999999999999999999999999999999999876


Q ss_pred             cccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         211 DRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       211 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .... .......+++.|+|||++.     ...++.++|||||||++|||++ |..||.+.+..+....+...... ....
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~~~  408 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAIN-----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-PRPE  408 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-CCCT
T ss_pred             CCCceeccCCCcccccccCHHHhc-----cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCC
Confidence            4321 1123345678899999997     4568999999999999999999 99999988877666655444322 2345


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+++++.+||.+||..||.+|||++++++
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            78999999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.3e-45  Score=356.26  Aligned_cols=240  Identities=23%  Similarity=0.354  Sum_probs=195.1

Q ss_pred             CCCCceEEE-eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELI-EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ...++|.++ +.||+|+||.||+|.+..+++.||+|++...    ..+.+|+.++.++.+||||+++++++....  ...
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~--~~~   87 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLY--AGR   87 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE--TTE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhc--CCC
Confidence            345678887 7899999999999999999999999998642    456788998877769999999999985311  224


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEecccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVS  207 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGla  207 (463)
                      ..+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            67899999999999999998876667999999999999999999999999999999999999987   788999999987


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---CCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---PPR  284 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~  284 (463)
                      ....                           ...++.++|||||||++|+|++|.+||.+..............   ...
T Consensus       168 ~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  220 (299)
T 3m2w_A          168 KETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  220 (299)
T ss_dssp             EECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred             cccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence            5432                           2346778999999999999999999997765544322211111   111


Q ss_pred             CC---CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         285 LK---SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       285 ~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ..   ...+++++++||.+||..||.+|||++|+|+||||.+.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            11   14678999999999999999999999999999999753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.4e-46  Score=367.61  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=205.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcE----EEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQL----AAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .++|++++.||+|+||.||+|++..++..    ||+|.+...  ......+.+|+.++..+ +||||+++++++.     
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-----   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-----
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-----
Confidence            45799999999999999999999888876    677776432  22234567899999999 8999999999883     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                        .+..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        86 --~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           86 --GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             --BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             --CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence              256899999999999999997543 36889999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         208 AQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       208 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      +.......  ......||+.|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+...... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  236 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIH-----FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL-  236 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC-
T ss_pred             cccCcccccccccCCCCcccccChHHhc-----cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-
Confidence            87643322  224456888999999997     4568999999999999999999 99999887666555544443322 


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .....++.++.+||.+||..||.+|||+.++++|
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2234577889999999999999999999999886

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=367.69  Aligned_cols=248  Identities=16%  Similarity=0.211  Sum_probs=197.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEE-----EEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc--CCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKG-----RHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS--NHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~  124 (463)
                      ...++|++.+.||+|+||.||+|     .+..+++.||+|++...  ....+..|+.++..+.  .|+||+++++++.  
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~--  137 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL--  137 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE--
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeee--
Confidence            44678999999999999999999     46778999999998654  3456778888888772  2899999999984  


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc------
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKST---KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD------  195 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~------  195 (463)
                          ..+..||||||+++|+|.+++...   ....+++..++.|+.||+.||+|||++||+||||||+||||+.      
T Consensus       138 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          138 ----FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ----CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             ----cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence                457889999999999999999753   2346999999999999999999999999999999999999988      


Q ss_pred             -----CCcEEEEeccccccccc--ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy7384         196 -----NAEVKLVDFGVSAQLDR--TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL  268 (463)
Q Consensus       196 -----~~~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  268 (463)
                           ++.+||+|||+++.+..  ........+||+.|+|||++.     +..|+.++|||||||++|||++|+.||...
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-----NKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-----TCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-----CCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                 89999999999976532  222345568999999999997     566999999999999999999999999543


Q ss_pred             CchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         269 HPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       269 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .....  .+..    .......++.+.+++..||+.+|.+|++..+.+.+
T Consensus       289 ~~~~~--~~~~----~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          289 EGGEC--KPEG----LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ETTEE--EECS----CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             CCCce--eech----hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            32111  1111    11111346789999999999999999665444443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-45  Score=375.64  Aligned_cols=266  Identities=25%  Similarity=0.366  Sum_probs=199.7

Q ss_pred             cCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          49 WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      +.....+.|.+.+.||+|+||+||.+ ...+|+.||||++...  ....+.+|+.+|+.+.+||||+++++++      .
T Consensus         9 ~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~------~   79 (434)
T 2rio_A            9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSE------T   79 (434)
T ss_dssp             CSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEE------E
T ss_pred             hhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEE------e
Confidence            44556677888999999999999875 4567999999998653  3456788999999876899999999998      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCC-----CCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC-------
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQS-----LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN-------  196 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~-----l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~-------  196 (463)
                      ..+.+|||||||. |+|.+++.......     .++..++.++.||+.||.|||++||+||||||+|||++.+       
T Consensus        80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence            5578999999996 59999997643211     1233457899999999999999999999999999999754       


Q ss_pred             ------CcEEEEecccccccccccC----ccccccCCccccccceeccCCC--CCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy7384         197 ------AEVKLVDFGVSAQLDRTIG----RRNTFIGTPYWMAPEVIACDEN--PDATYDNRSDLWSLGITALEMAE-SQP  263 (463)
Q Consensus       197 ------~~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~~~DiwSlG~il~ell~-g~~  263 (463)
                            +.+||+|||+++.......    .....+||+.|+|||++.+...  ....++.++|||||||++|+|++ |.+
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence                  4899999999987754322    1234579999999999964211  13568999999999999999999 999


Q ss_pred             CCCCCCchhhh--hcccCC-CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         264 PLCDLHPMRAL--FLIPRN-APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       264 Pf~~~~~~~~~--~~i~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ||.+.......  ...... .........++.++++||.+||..||.+|||+.++++||||...
T Consensus       239 Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             TTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             CCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            99765433211  111110 01111122346789999999999999999999999999999753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.6e-46  Score=363.83  Aligned_cols=252  Identities=26%  Similarity=0.450  Sum_probs=210.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEE--EEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLA--AIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v--aiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++|++.+.||+|+||.||+|++..+|..+  |+|.+...  ......+.+|+.+++++.+||||+++++++      ..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~------~~   97 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC------EH   97 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE------EE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee------ee
Confidence            367999999999999999999999888865  88988642  334557889999999997799999999999      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD  195 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~  195 (463)
                      .+.+|+||||+++|+|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            578999999999999999997643              246899999999999999999999999999999999999999


Q ss_pred             CCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q psy7384         196 NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRAL  274 (463)
Q Consensus       196 ~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~  274 (463)
                      ++.+||+|||+++..... .......+++.|+|||++.     ...++.++|||||||++|+|++ |..||.+.......
T Consensus       178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~  251 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  251 (327)
T ss_dssp             GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             CCeEEEcccCcCcccccc-ccccCCCCCccccChhhhc-----cccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence            999999999998754332 1223345788999999987     4568899999999999999998 99999988777666


Q ss_pred             hcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         275 FLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       275 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..+...... .....+++.+.+||.+||..||.+|||+++++++
T Consensus       252 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 EKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            655544332 2334788999999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.1e-46  Score=357.85  Aligned_cols=253  Identities=28%  Similarity=0.495  Sum_probs=211.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCC-------
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP-------  126 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~-------  126 (463)
                      .++|++++.||+|+||.||+|++..+|+.||+|++....   ..+.+|+.+++.+ +||||+++++++.....       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccc
Confidence            457999999999999999999999999999999997543   3567899999999 89999999998743100       


Q ss_pred             ---CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEe
Q psy7384         127 ---PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       127 ---~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~D  203 (463)
                         ......+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  165 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD  165 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence               01235689999999999999999876656799999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ||++....... ......||+.|+|||++.     ...++.++|||||||++|+|++|..||......  ...+....  
T Consensus       166 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~--  235 (284)
T 2a19_B          166 FGLVTSLKNDG-KRTRSKGTLRYMSPEQIS-----SQDYGKEVDLYALGLILAELLHVCDTAFETSKF--FTDLRDGI--  235 (284)
T ss_dssp             CTTCEESSCCS-CCCCCCSCCTTSCHHHHH-----CSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH--HHHHHTTC--
T ss_pred             chhheeccccc-cccccCCcccccChhhhc-----cCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH--HHHhhccc--
Confidence            99998765432 234457999999999997     567889999999999999999999988533221  11111111  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                        ....++..+++||.+||..||.+|||+.++++|.|..
T Consensus       236 --~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          236 --ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              2346789999999999999999999999999997764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-45  Score=359.37  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....    .....+.+|+.+++.+ +||||+++++++.      
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~------  104 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGE------  104 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEE------
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEe------
Confidence            3467999999999999999999999999999999996432    2246788999999999 8999999999984      


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             eCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            4578999999999999999998654  68999999999999999999999999999999999999999999999999987


Q ss_pred             cccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC-CCCC
Q psy7384         209 QLDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP-PRLK  286 (463)
Q Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~  286 (463)
                      ...... .......|++.|+|||++.     ...++.++|||||||++|+|++|..||.+.........+..... +...
T Consensus       183 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (309)
T 2h34_A          183 ATTDEKLTQLGNTVGTLYYMAPERFS-----ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTV  257 (309)
T ss_dssp             --------------CCGGGCCGGGTC-----C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGT
T ss_pred             cccccccccccccCCCcCccCHHHHc-----CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCcccc
Confidence            664332 2233557999999999987     56788899999999999999999999987665433322222221 2233


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCC-CHHHHhc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRP-YTDQLLK  317 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rp-t~~e~l~  317 (463)
                      ...++.++.+||.+||..||.+|| +++++++
T Consensus       258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            457889999999999999999999 8888765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.3e-45  Score=355.12  Aligned_cols=254  Identities=22%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEE----EcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ..++|++++.||+|+||.||+|+    +..+++.||+|++...  ......+.+|+.+++.+ +||||+++++++...  
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--   95 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTED--   95 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecC--
Confidence            34679999999999999999999    5678999999998643  23457788999999999 799999999998542  


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                        ....+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        96 --~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           96 --GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             ----CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             --CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence              2367899999999999999996554 3699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------------C
Q psy7384         207 SAQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL--------------H  269 (463)
Q Consensus       207 a~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~--------------~  269 (463)
                      +........   ......||..|+|||++.     ...++.++|||||||++|+|++|..||...              .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLM-----QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM  247 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeec-----CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence            987654321   223456888999999997     456889999999999999999999886322              1


Q ss_pred             chhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         270 PMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       270 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....+...............+++.+.+||.+||..||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            111111111122222334578899999999999999999999999976

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-45  Score=358.28  Aligned_cols=257  Identities=25%  Similarity=0.438  Sum_probs=199.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHh-cCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKY-SNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l-~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ...++|++++.||+|+||.||+|++  +|+.||+|++...  ....+..|.+++... .+||||+++++++....  ...
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~--~~~   78 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSR--HSS   78 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE--TTE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeecccc--CCC
Confidence            4567899999999999999999987  5889999998653  344556677776662 28999999999875431  334


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh--------cCCceecCCCCCceEEccCCcEEEE
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH--------ENKVIHRDIKGQNVLLTDNAEVKLV  202 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givHrDLkp~NILl~~~~~vkL~  202 (463)
                      ..+|+||||+++|+|.++++.   ..+++..+..++.||+.||.|||        ++||+||||||+|||++.++.+||+
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             ceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence            678999999999999999954   36999999999999999999999        9999999999999999999999999


Q ss_pred             ecccccccccccCc----cccccCCccccccceeccCCCCC-CCCCcchhHHHHHHHHHHHHhC----------CCCCCC
Q psy7384         203 DFGVSAQLDRTIGR----RNTFIGTPYWMAPEVIACDENPD-ATYDNRSDLWSLGITALEMAES----------QPPLCD  267 (463)
Q Consensus       203 DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~-~~~~~~~DiwSlG~il~ell~g----------~~Pf~~  267 (463)
                      |||+++........    ....+||+.|+|||++....... ..++.++|||||||++|+|++|          .+||.+
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999766443221    23347999999999997421100 0455789999999999999999          888865


Q ss_pred             CCchh----hhhcc--cCCCCCCCC----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         268 LHPMR----ALFLI--PRNAPPRLK----SKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       268 ~~~~~----~~~~i--~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....    .+...  .....+...    ...+++.+.+||.+||..||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            43221    11111  111111111    1234578999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=360.36  Aligned_cols=261  Identities=24%  Similarity=0.387  Sum_probs=206.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++... ......+.+|+.+++.+ +||||+++++++....  ....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~--~~~~  103 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRER--GAKH  103 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEE--TTEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEecc--CCCc
Confidence            456899999999999999999999999999999988643 34556788999999999 8999999999986321  2345


Q ss_pred             eEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ..|+||||+.+|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            889999999999999999763  245799999999999999999999999999999999999999999999999999876


Q ss_pred             cccccC---------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-hhhhcccC
Q psy7384         210 LDRTIG---------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-RALFLIPR  279 (463)
Q Consensus       210 ~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~  279 (463)
                      ......         ......||+.|+|||++....  ...++.++|||||||++|+|++|..||...... ........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS--HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS--EEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCC--CcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            532111         112346899999999986321  123688999999999999999999999542111 01111111


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       280 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..........++..+.+||.+||..||.+|||+++++++
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            111222335688999999999999999999999999886

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=360.47  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=203.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEE----EEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLA----AIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----aiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .++|++++.||+|+||.||+|++..+++.+    |+|.+..  .......+.+|+.+++.+ +||||+++++++..    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEES----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEec----
Confidence            467999999999999999999998888765    6666642  334567889999999999 89999999999853    


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                         +..++|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ---~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           89 ---STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             ---SSEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ---CCceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence               35889999999999999998654 36999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         208 AQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       208 ~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      +........  .....+|+.|+|||++.     +..++.++|||||||++|+|++ |.+||.+.........+..... .
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~  238 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-L  238 (327)
T ss_dssp             ---------------CCCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-C
T ss_pred             eEccCccccccccCCCccccccCHHHHc-----CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C
Confidence            876433221  22345788999999998     5678999999999999999999 9999988776665554444332 2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .....++.++.+||.+||..||.+|||+.|+++
T Consensus       239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            334568899999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-45  Score=378.30  Aligned_cols=252  Identities=24%  Similarity=0.408  Sum_probs=210.3

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +...++|++.+.||+|+||.||+|.+.. +..||||++.......+.+.+|+.+|+++ +||||+++++++.      . 
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~------~-  250 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS------E-  250 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC------S-
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEc------C-
Confidence            3456789999999999999999999875 46799999986655667899999999999 8999999999983      2 


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+||||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            56899999999999999997654456999999999999999999999999999999999999999999999999999876


Q ss_pred             cccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         211 DRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       211 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .... .......+++.|+|||++.     ...++.++|||||||++|||++ |..||.+....+....+...... ....
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~~~  404 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPP  404 (452)
T ss_dssp             ------------CCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CCCT
T ss_pred             CCCceecccCCcccccccCHhHHh-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCC
Confidence            4321 1123345778999999997     4568999999999999999999 99999988877666655444332 2345


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+++.+.+||.+||..||.+|||++++++
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            78999999999999999999999999876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-45  Score=362.86  Aligned_cols=254  Identities=24%  Similarity=0.443  Sum_probs=209.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEE----EcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGR----HTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .++|++++.||+|+||.||+|+    +..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..    .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYG----P   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC----S
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEec----C
Confidence            4689999999999999999999    46788999999997543 3446688999999999 89999999998853    3


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            44679999999999999999986442 58999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh-------------
Q psy7384         209 QLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR-------------  272 (463)
Q Consensus       209 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~-------------  272 (463)
                      .......   ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.......             
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLS-----DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL  250 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhc-----cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence            7643321   223346888999999987     4568899999999999999999999986543211             


Q ss_pred             -hhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         273 -ALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       273 -~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       .+...............+++.+.+||.+||..||.+|||+++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1111111122223345789999999999999999999999999765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-45  Score=355.55  Aligned_cols=252  Identities=20%  Similarity=0.328  Sum_probs=200.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+ .|++++..+..+.     ...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~-----~~~~   78 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCG-----AEGD   78 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHH-TTSTTCCCEEEEE-----EETT
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHh-cCCCCCCeeeeec-----CCCC
Confidence            34578999999999999999999999999999999876432 224578899999999 6777666666553     3447


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE---ccCCcEEEEeccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSA  208 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl---~~~~~vkL~DFGla~  208 (463)
                      ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             ceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            889999999 899999997543 369999999999999999999999999999999999999   789999999999998


Q ss_pred             ccccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh---hccc
Q psy7384         209 QLDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---FLIP  278 (463)
Q Consensus       209 ~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~---~~i~  278 (463)
                      .......       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.......   ..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHL-----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhc-----CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            7654322       223567999999999997     566899999999999999999999999775433221   1111


Q ss_pred             CC---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         279 RN---APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       279 ~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..   .+.......+++++.+||.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11   1111112467899999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.2e-46  Score=370.05  Aligned_cols=254  Identities=19%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecCcchHHHHHHHHH---------------HHHHhcC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVTEDEEEEIKLEIN---------------VLKKYSN  110 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~Ei~---------------~l~~l~~  110 (463)
                      +...++|++.+.||+|+||.||+|.+..+     ++.||+|++.....   .+..|+.               .+..+ +
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l-~  106 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKL-K  106 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH---HHHHHHHHHHHHCCHHHHHHHHHHTTC-S
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch---hHHHHHHHHHhhhhhHHHHHHHHHhhc-c
Confidence            34567899999999999999999998765     57899999875432   2333443               34444 5


Q ss_pred             CCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCc
Q psy7384         111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQN  190 (463)
Q Consensus       111 h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~N  190 (463)
                      |+||+++++++....  ......||||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus       107 h~~iv~~~~~~~~~~--~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~N  182 (364)
T 3op5_A          107 YLGVPKYWGSGLHDK--NGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASN  182 (364)
T ss_dssp             CCCSCCEEEEEEEEE--TTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCeEEeeeeecc--CCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHH
Confidence            999999999986431  1235689999999 99999999764 3469999999999999999999999999999999999


Q ss_pred             eEEc--cCCcEEEEecccccccccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy7384         191 VLLT--DNAEVKLVDFGVSAQLDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES  261 (463)
Q Consensus       191 ILl~--~~~~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g  261 (463)
                      ||++  .++.+||+|||+++.+.....       .....+||+.|+|||++.     +..++.++|||||||++|+|++|
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g  257 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-----GVAPSRRGDLEILGYCMIQWLTG  257 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-----CCCCCchhhHHHHHHHHHHHHhC
Confidence            9999  889999999999987643321       123456999999999997     56689999999999999999999


Q ss_pred             CCCCCCCCchhhhhcccC---------CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         262 QPPLCDLHPMRALFLIPR---------NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       262 ~~Pf~~~~~~~~~~~i~~---------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ..||.+............         .....+....+++++.+||..||..||.+||+++++++
T Consensus       258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            999976432222111000         00011122467899999999999999999999999865

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.3e-46  Score=370.82  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=199.8

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ..++|++.+.||+|+||.||+|++.   .++..||||++...  ......+.+|+.+|.++ +||||+++++++      
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~------  115 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVV------  115 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE------
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------
Confidence            3568999999999999999999887   45778999999754  33456788999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          116 TKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             eeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            45578999999999999999997543 46899999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcc---ccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         208 AQLDRTIGRR---NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       208 ~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      +.........   ....+++.|+|||++.     ...++.++|||||||++|||++ |..||.+.........+......
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~  269 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIA-----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL  269 (373)
T ss_dssp             -------------------CTTSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC
T ss_pred             cccccCCccceeccCCCcCCCccChhhhc-----cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            8765432211   1223577899999997     4678999999999999999998 99999888776665554433221


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                       .....++..+.+||.+||..||.+||+++++++
T Consensus       270 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 -PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             -CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence             223467899999999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.6e-46  Score=364.22  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=207.0

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ....++|++.+.||+|+||.||+|++ .+|+.||+|++... ......+.+|+.+++.+ +||||+++++++      ..
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~------~~  106 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFC------DE  106 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEEC------CC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEE------cC
Confidence            34567899999999999999999996 46889999998644 34567888999999999 899999999998      45


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTK--GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .+..|+||||+++|+|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            578999999999999999986543  235899999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc---------
Q psy7384         208 AQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL---------  276 (463)
Q Consensus       208 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~---------  276 (463)
                      .......  .......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+..+......         
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFI-----KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHH-----HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             cccccccccccccccCCCccccCHHHhc-----CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            7654321  1223456899999999987     45688999999999999999999999976544322110         


Q ss_pred             ---ccC---CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         277 ---IPR---NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       277 ---i~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                         +..   ...........+..+.+||.+||..||.+|||+.++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               000   011111122345678999999999999999999999876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=376.38  Aligned_cols=260  Identities=26%  Similarity=0.435  Sum_probs=207.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++....  .....+.+|+.+|+.+ +||||+++++++..    ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~   80 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEE----TT   80 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC----TT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeecc----CC
Confidence            45678999999999999999999999999999999996432  3456778999999999 79999999999853    23


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE----ccCCcEEEEec
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKG-QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL----TDNAEVKLVDF  204 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl----~~~~~vkL~DF  204 (463)
                      ....|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence            3478999999999999999976442 349999999999999999999999999999999999999    77788999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc----hhhhhcc
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENP---DATYDNRSDLWSLGITALEMAESQPPLCDLHP----MRALFLI  277 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~----~~~~~~i  277 (463)
                      |+++...... .....+||+.|+|||++......   ...++.++|||||||++|+|++|..||.....    ...+..+
T Consensus       161 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          161 GAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            9998765432 23456799999999998631100   14577899999999999999999999964322    2222222


Q ss_pred             cCCCCCC-----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         278 PRNAPPR-----------------------LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       278 ~~~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....+..                       .....++..+.+||.+||..||.+|||++++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            2222110                       011234567889999999999999999999865

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-45  Score=351.39  Aligned_cols=249  Identities=21%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCc---EEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .|++.+.||+|+||.||+|++..++.   .||+|++....  ...+.+.+|+.+++.+ +||||+++++++..     .+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-----~~   95 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLP-----PE   95 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECC-----SS
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEec-----CC
Confidence            58888999999999999999766554   79999987433  3456788999999999 89999999999842     23


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             CCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            4459999999999999999753 346899999999999999999999999999999999999999999999999999765


Q ss_pred             cccc----CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         211 DRTI----GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       211 ~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ....    .......+|+.|+|||++.     ...++.++|||||||++|+|++ |.+||...+.......+..... ..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~  248 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQ-----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-LP  248 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-CC
T ss_pred             cCCcccccccCcCCCCCccccChhhhc-----cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-CC
Confidence            4321    2223456889999999997     5678999999999999999999 5555665555554444433332 33


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....+++.+.+||.+||..||.+|||++++++
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            34568899999999999999999999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.9e-45  Score=352.80  Aligned_cols=247  Identities=23%  Similarity=0.410  Sum_probs=202.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++.+.||+|+||.||+|.+.  |+.||+|++... ...+.+.+|+.+++.+ +||||+++++++.     ...+.
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~   89 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIV-----EEKGG   89 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEEC-----CC--C
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-hHHHHHHHHHHHHHhC-CCCCEeeEEEEEE-----cCCCc
Confidence            3467999999999999999999874  889999999754 3556788999999999 8999999999874     23357


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            89999999999999999865543488999999999999999999999999999999999999999999999999876543


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      ..   ....+++.|+|||++.     ...++.++|||||||++|+|++ |.+||...........+...... .....++
T Consensus       170 ~~---~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  240 (278)
T 1byg_A          170 TQ---DTGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGCP  240 (278)
T ss_dssp             ---------CCTTTSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-CCCTTCC
T ss_pred             cc---cCCCccccccCHHHhC-----CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCcccCC
Confidence            32   3346789999999997     4568899999999999999998 99999887766655555444332 2345788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +.+.++|.+||..||.+|||+.++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          241 PAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-45  Score=358.22  Aligned_cols=253  Identities=22%  Similarity=0.378  Sum_probs=205.6

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCC----cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTG----QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ....+|++.+.||+|+||.||+|.+..++    ..||+|++....  .....+.+|+.+++.+ +||||+++++++    
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~----  115 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVI----  115 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE----
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE----
Confidence            34568999999999999999999987653    359999997543  3345788999999999 899999999998    


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                        ...+..||||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       116 --~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          116 --SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             --CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             --ecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence              45578999999999999999997543 469999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCC
Q psy7384         206 VSAQLDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       206 la~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      ++.........   .....+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  267 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF  267 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             cchhhccccccccccCCCCccccccCchhcc-----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC
Confidence            99876543211   12234678999999997     5678999999999999999998 999998887766665554443


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .. .....++..+.+||.+||..||.+||++.+++++
T Consensus       268 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          268 RL-PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CC-CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22 2234688999999999999999999999999764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=376.12  Aligned_cols=259  Identities=22%  Similarity=0.316  Sum_probs=197.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..+|++.+.||+|+||+|+. ....+|+.||||++.....  ..+.+|+.+|+.+.+|||||++++++      .....+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~------~~~~~~   93 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTE------KDRQFQ   93 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEE------EETTEE
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEE------ecCCEE
Confidence            45799999999999999764 3456789999999864322  23568999999987799999999998      455789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-----CCcEEEEeccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-----NAEVKLVDFGVSA  208 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-----~~~vkL~DFGla~  208 (463)
                      |||||||. |+|.+++..... .+.+..++.++.||+.||.|||++||+||||||+|||++.     ...+||+|||+++
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            99999996 599999976542 4555567889999999999999999999999999999953     2358899999998


Q ss_pred             cccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         209 QLDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       209 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      ......   ......+||+.|+|||++....  ...++.++|||||||++|+|++ |.+||...........+.......
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  249 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC--KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC  249 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhccc--ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence            765332   2234567999999999986321  3456789999999999999999 999996554433332222221111


Q ss_pred             C-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         285 L-KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       285 ~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      . .....+..+++||.+||..||.+|||++++++||||....
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            1 1223456789999999999999999999999999997643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.3e-45  Score=349.27  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=207.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ...++|++.+.||+|+||.||+|++...   +..||+|++...  ......+.+|+.+++.+ +||||+++++++..   
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---   84 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---   84 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---
Confidence            3456899999999999999999997643   346999998754  23457788999999999 89999999999832   


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                          +..|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        85 ----~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           85 ----EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             ----CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence                35689999999999999997654 3689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         207 SAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       207 a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      +........ ......+++.|+|||++.     ...++.++|||||||++|+|++ |..||...........+...... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-  233 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESIN-----FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-  233 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-
T ss_pred             CcccccccccccccCCCCcceeCchhhc-----cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-
Confidence            987654321 123345788999999997     4568899999999999999998 99999877666555444333222 


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .....+++.+.+||.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            2234678999999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.6e-45  Score=353.64  Aligned_cols=251  Identities=20%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.+ .|++++..+..+.     ...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l-~~~~~i~~~~~~~-----~~~~~   79 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMM-QGGVGIPTIRWCG-----AEGDY   79 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHH-TTSTTCCCEEEEE-----EETTE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHh-hcCCCCCcccccc-----CCCCc
Confidence            45689999999999999999999999999999999875432 34688999999999 6777666666553     34468


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE---ccCCcEEEEecccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl---~~~~~vkL~DFGla~~  209 (463)
                      .|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            89999999 899999997543 369999999999999999999999999999999999999   4889999999999987


Q ss_pred             cccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh---hhhcccC
Q psy7384         210 LDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR---ALFLIPR  279 (463)
Q Consensus       210 ~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---~~~~i~~  279 (463)
                      ......       ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.....   .+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHL-----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            654322       124567999999999987     5668999999999999999999999997744321   1111111


Q ss_pred             C---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         280 N---APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       280 ~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .   .+.......+++++.+||.+||+.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1   1111112467899999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=351.88  Aligned_cols=252  Identities=24%  Similarity=0.400  Sum_probs=211.1

Q ss_pred             CCCceEEEe-eeeeeCCeEEEEEEEc--CCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          53 PAGIFELIE-VVGNGTYGQVYKGRHT--KTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        53 ~~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ..++|.+.+ .||+|+||.||+|.+.  .++..||+|++...  ......+.+|+.+++.+ +||||+++++++.     
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----   80 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ-----   80 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE-----
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEec-----
Confidence            345688877 9999999999999864  46788999999753  33456788999999999 8999999999983     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                        .+..|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           81 --AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             --SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             --CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccce
Confidence              24689999999999999999643 346999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         208 AQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       208 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ........   ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+.....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~  232 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM  232 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred             eeeccCcceeeccccccccccccCHHHhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC
Confidence            87643321   122345789999999997     4568899999999999999998 99999887776666555444333


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHP  319 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  319 (463)
                      . ....+++.+.+||.+||..||.+||++.++++|.
T Consensus       233 ~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          233 E-CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             C-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             C-CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            2 3457899999999999999999999999999873

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.1e-45  Score=354.78  Aligned_cols=254  Identities=28%  Similarity=0.520  Sum_probs=197.5

Q ss_pred             CCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          50 QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      .+...++|++.+.||+|+||.||+|++.   ..||+|++....   .....+.+|+.+|+.+ +||||+++++++     
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-----   89 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-----   89 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-----
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-----
Confidence            3567789999999999999999999864   359999986433   3346788999999999 899999999965     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                        .....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        90 --~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 --TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             --CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             --cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence              2356899999999999999996543 4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc--cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc-CC---
Q psy7384         207 SAQLDRT--IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP-RN---  280 (463)
Q Consensus       207 a~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~-~~---  280 (463)
                      +......  ........||+.|+|||++....  ...++.++|||||||++|+|++|..||.+......+.... ..   
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD--SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS  244 (289)
T ss_dssp             -----------------CCCTTCCHHHHC------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccC--CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence            9765432  12233457999999999985321  4567889999999999999999999998866554443322 11   


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         281 APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       281 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .........+++.+.+||.+||..||.+|||++++++
T Consensus       245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1112233578899999999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.4e-45  Score=355.18  Aligned_cols=258  Identities=21%  Similarity=0.356  Sum_probs=202.9

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcC---CCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|++...   ......+.+|+.+++++ +||||+++++++.....
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence            34679999999999999999998765   4568999998743   23346788999999999 79999999999864321


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEE
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKST----KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV  202 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~  202 (463)
                       ......|+||||+.+|+|.+++...    ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       111 -~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          111 -QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             -cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence             1123569999999999999998542    23469999999999999999999999999999999999999999999999


Q ss_pred             eccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccC
Q psy7384         203 DFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       203 DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~  279 (463)
                      |||++.......  .......+++.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  264 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH  264 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHH-----SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhc-----CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence            999998664322  1123345788999999997     5678999999999999999999 9999988777666555544


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         280 NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       280 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...+. ....+++.+.+||.+||..||.+|||+.+++++
T Consensus       265 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          265 GHRLK-QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCCC-CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCC-CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43322 235688999999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.3e-45  Score=351.38  Aligned_cols=251  Identities=21%  Similarity=0.405  Sum_probs=205.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCC---cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTG---QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..+|++.+.||+|+||.||+|++..++   ..+|+|.+....  .....+.+|+.+++++ +||||+++++++.     .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~   97 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICL-----R   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEC-----C
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEE-----c
Confidence            347999999999999999999976443   468999986433  3456788999999999 7999999999864     3


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .++..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence            4468899999999999999997533 468999999999999999999999999999999999999999999999999998


Q ss_pred             cccccc----CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         209 QLDRTI----GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       209 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ......    .......||+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.........+..... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-  250 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-  250 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-
T ss_pred             cccccchhccccccCCCCCccccChHHhc-----CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-
Confidence            664322    1223456788999999997     4568899999999999999999 6778877666555554444333 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ......+++.+.+||.+||..||.+|||+.++++
T Consensus       251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2334568899999999999999999999999976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=356.50  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=192.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCC--CC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP--PG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~--~~  128 (463)
                      ....+|++.+.||+|+||.||+|++..+|+.||+|++... ......+.+|+.+++++.+||||+++++++.....  ..
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3456899999999999999999999999999999988543 34456788999999999669999999998853221  13


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEccCCcEEEEecc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKST-KGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                      ....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            4467899999996 6999988753 3346999999999999999999999999  9999999999999999999999999


Q ss_pred             cccccccccC------------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q psy7384         206 VSAQLDRTIG------------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA  273 (463)
Q Consensus       206 la~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  273 (463)
                      ++........            .....+||+.|+|||++...  ....++.++|||||||++|+|++|..||.+......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY--SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             TCBCCSSCC-------------------------------CC--TTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhcc--ccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            9987653221            11245699999999998421  156688999999999999999999999976554433


Q ss_pred             hhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         274 LFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       274 ~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...    .........++..+.+||.+||..||.+|||++|+++|
T Consensus       262 ~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          262 VNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hcC----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            322    12222344667889999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.9e-46  Score=364.10  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=202.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ...++|++.+.||+|+||.||+|++ .+|+.||+|++.....  ....+.+|+.+++.+ +||||+++++++      ..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~   98 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC------MT   98 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEE------CC
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEE------ec
Confidence            3456799999999999999999985 4688999999864322  223678999999999 799999999999      44


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHhhhhcC---CceecCCCCCceEEccCCcEEEEec
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKG--QSLKEEWIAFICREILRGLKYLHEN---KVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                      .+..++||||+.+|+|.+++.....  ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            5688999999999999999986542  3599999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----Cchhh---hh
Q psy7384         205 GVSAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-----HPMRA---LF  275 (463)
Q Consensus       205 Gla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-----~~~~~---~~  275 (463)
                      |++........ ......||+.|+|||++.     ...++.++|||||||++|+|++|..||...     .....   ..
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHH-----HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             ccccccCcccccccccccCCcCccCHHHhc-----cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99987653322 233456999999999997     456899999999999999999999999521     11000   00


Q ss_pred             cccCC-C--------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcc
Q psy7384         276 LIPRN-A--------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF  320 (463)
Q Consensus       276 ~i~~~-~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  320 (463)
                      ..... .        .........+..+.+||.+||..||.+|||+.++++|-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            00000 0        000111122467999999999999999999999998743

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-45  Score=365.57  Aligned_cols=252  Identities=21%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCC---cEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTG---QLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...|++.+.||+|+||.||+|++..++   ..||+|.+...  ......+.+|+.+++++ +||||+++++++.     .
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~-----~  161 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICL-----R  161 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEEC-----C
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----c
Confidence            446899999999999999999976443   46899998643  34457788999999999 8999999999864     3


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       162 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          162 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccc
Confidence            3467899999999999999997543 468899999999999999999999999999999999999999999999999998


Q ss_pred             ccccccC----ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         209 QLDRTIG----RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       209 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      .......    ......+|+.|+|||++.     ...++.++|||||||++|+|++ |.+||.+.+..+....+..... 
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-  314 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-  314 (373)
T ss_dssp             -----------------CCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-
T ss_pred             cccccccccccccCCCCCcccccChHHhc-----CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-
Confidence            6543211    123345788999999997     5678999999999999999999 7889987766655554444333 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ......++..+.+||.+||..||.+|||+.+++++
T Consensus       315 ~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            23345788999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-44  Score=350.23  Aligned_cols=249  Identities=23%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             CCCceEEEe-eeeeeCCeEEEEEEE--cCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          53 PAGIFELIE-VVGNGTYGQVYKGRH--TKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        53 ~~~~y~~~~-~LG~G~fg~V~~~~~--~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ..++|++.+ .||+|+||.||+|.+  ..+++.||+|++....   .....+.+|+.+++.+ +||||+++++++.    
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----   88 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE----   88 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE----
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEC----
Confidence            346799998 999999999999954  5667899999996432   2356788999999999 8999999999982    


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                         .+..|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        89 ---~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           89 ---AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             ---SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ---CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence               257899999999999999997643  699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCC
Q psy7384         207 SAQLDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       207 a~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      +.........   .....+++.|+|||++.     ...++.++|||||||++|+|++ |..||.+.........+.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~  238 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECIN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER  238 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhc-----cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            9876443221   12234678999999997     4568889999999999999999 9999988877666555544433


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      +. ....+++.+.+||.+||..||.+|||+.++++
T Consensus       239 ~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 MG-CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            32 34578999999999999999999999999976

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=366.38  Aligned_cols=255  Identities=20%  Similarity=0.231  Sum_probs=197.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcC---CCcEEEEEEeecCcch------------HHHHHHHHHHHHHhcCCCceee
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMDVTEDE------------EEEIKLEINVLKKYSNHRNIAT  116 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~------------~~~~~~Ei~~l~~l~~h~nIv~  116 (463)
                      ...++|++.+.||+|+||.||+|++..   ++..+|+|++......            ...+.+|+..+..+ +||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcce
Confidence            346789999999999999999999987   7889999998754321            12345677778887 8999999


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +++++....  .....+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       113 ~~~~~~~~~--~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEF--KGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEES--SSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred             eeccccccc--CCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence            999986521  2357899999999 999999997655  79999999999999999999999999999999999999887


Q ss_pred             C--cEEEEecccccccccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy7384         197 A--EVKLVDFGVSAQLDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCD  267 (463)
Q Consensus       197 ~--~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  267 (463)
                      +  .+||+|||+++.+.....       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-----GVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-----TCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc-----CCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            7  999999999987643211       124457999999999997     56789999999999999999999999965


Q ss_pred             CCch-hhhhcc----cCCCCC----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         268 LHPM-RALFLI----PRNAPP----RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       268 ~~~~-~~~~~i----~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .... ......    ....+.    ......+++++.+||.+||..||.+|||++++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            3221 111110    001110    0112268899999999999999999999999876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=361.77  Aligned_cols=255  Identities=17%  Similarity=0.243  Sum_probs=202.5

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC--------CcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT--------GQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      ...++|++.+.||+|+||.||+|++..+        ++.||+|++...    ..+.+|+.+++++ +||||+++++.+..
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~  113 (352)
T 2jii_A           39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-AKPLQVNKWKKLYS  113 (352)
T ss_dssp             TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-CCHHHHHHHHHHTT
T ss_pred             ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-cccchhhhhhhhcc
Confidence            3467999999999999999999999874        889999998754    4678999999999 79999985543321


Q ss_pred             cCC----------CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE
Q psy7384         124 KSP----------PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL  193 (463)
Q Consensus       124 ~~~----------~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl  193 (463)
                      ...          .......|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence            100          01247899999999 9999999987644579999999999999999999999999999999999999


Q ss_pred             ccCC--cEEEEecccccccccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy7384         194 TDNA--EVKLVDFGVSAQLDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP  264 (463)
Q Consensus       194 ~~~~--~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~P  264 (463)
                      +.++  .+||+|||+++.+.....       ......||+.|+|||++.     +..++.++|||||||++|+|++|..|
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-----GCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-----cCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9988  899999999987653321       123457999999999987     56789999999999999999999999


Q ss_pred             CCCCC-chhhhhccc---CCCCCCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         265 LCDLH-PMRALFLIP---RNAPPRL-----KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       265 f~~~~-~~~~~~~i~---~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      |.+.. ....+....   .......     ....++.++.+||.+||..||.+|||++++++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            97754 222221111   1111111     11356899999999999999999999999876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.2e-45  Score=382.44  Aligned_cols=253  Identities=24%  Similarity=0.407  Sum_probs=215.3

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +...++|++.+.||+|+||.||+|.+.. +..||||++.......+.+.+|+.+|+++ +|+||+++++++.      . 
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~------~-  333 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS------E-  333 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC------S-
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEe------e-
Confidence            3456789999999999999999999865 46799999986656667899999999999 8999999999983      2 


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+||||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            56899999999999999997654456999999999999999999999999999999999999999999999999999876


Q ss_pred             cccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         211 DRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       211 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .... .......++..|+|||++.     ...++.++|||||||+||||++ |..||.+....+.+..+...... ....
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~~~  487 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPP  487 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-CCCT
T ss_pred             CCCceecccCCcCcccccCHHHhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCC
Confidence            4321 1122345778999999997     4568999999999999999999 99999988777666655444332 2345


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+++.+.+||.+||..||.+|||++++++.
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            789999999999999999999999999763

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=352.08  Aligned_cols=244  Identities=30%  Similarity=0.534  Sum_probs=196.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|++.+.||+|+||.||+|++.  ++.||+|++... .....+.+|+.+|+++ +||||+++++++.        +..
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--------~~~   74 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRV-NHPNIVKLYGACL--------NPV   74 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHC-CCTTBCCEEEBCT--------TTT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcC-CCCCcCeEEEEEc--------CCc
Confidence            357999999999999999999875  788999998643 4567788999999999 8999999999883        247


Q ss_pred             EEEEecCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHhhhhc---CCceecCCCCCceEEccCCc-EEEEeccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKG-QSLKEEWIAFICREILRGLKYLHE---NKVIHRDIKGQNVLLTDNAE-VKLVDFGVSA  208 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~---~givHrDLkp~NILl~~~~~-vkL~DFGla~  208 (463)
                      |+||||+++|+|.+++..... ..+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            999999999999999976442 247889999999999999999999   89999999999999988886 7999999997


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch--hhhhcccCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM--RALFLIPRNAPPRLK  286 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~~~  286 (463)
                      ......   ....||+.|+|||++.     +..++.++|||||||++|+|++|+.||......  .....+.....+ ..
T Consensus       155 ~~~~~~---~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~  225 (307)
T 2eva_A          155 DIQTHM---TNNKGSAAWMAPEVFE-----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PL  225 (307)
T ss_dssp             -------------CCTTSSCHHHHT-----CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CC
T ss_pred             cccccc---ccCCCCCceEChhhhC-----CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-Cc
Confidence            664322   3446999999999997     567899999999999999999999999764332  222222222222 22


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...++..+.+||.+||..||.+|||+++++++
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            34688999999999999999999999999764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.1e-45  Score=351.15  Aligned_cols=252  Identities=23%  Similarity=0.410  Sum_probs=203.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcC-CCc--EEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTK-TGQ--LAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~--~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      ..++|++++.||+|+||.||+|++.. ++.  .||+|++...    ......+.+|+.+++.+ +||||+++++++..  
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--   92 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT--   92 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcc--
Confidence            45689999999999999999998653 333  6899998643    23456788999999999 89999999999842  


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                           ...++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        93 -----~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           93 -----PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             -----CCceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence                 24899999999999999997653 358999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCC
Q psy7384         206 VSAQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNA  281 (463)
Q Consensus       206 la~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~  281 (463)
                      ++........   ......+|+.|+|||++.     ...++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~  241 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLK-----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG  241 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence            9987644322   123346788999999997     4568899999999999999999 999999888777666665544


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         282 PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       282 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ........++..+.++|.+||..||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            4444456789999999999999999999999999873

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=358.15  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=190.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++++.||+|+||.||+|++  +++.||||++............|+..+..+ +|+||+++++.+..... .....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~-~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTA-DGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECT-TSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheeccccccc-CCCce
Confidence            346799999999999999999976  589999999975443333333344334445 89999999975533211 34457


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC---------CceecCCCCCceEEccCCcEEEEe
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN---------KVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------givHrDLkp~NILl~~~~~vkL~D  203 (463)
                      +|+||||+++|+|.+++....   .++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            899999999999999997543   58899999999999999999999         999999999999999999999999


Q ss_pred             cccccccccc--------cCccccccCCccccccceeccCCCC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q psy7384         204 FGVSAQLDRT--------IGRRNTFIGTPYWMAPEVIACDENP--DATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA  273 (463)
Q Consensus       204 FGla~~~~~~--------~~~~~~~~gt~~y~aPE~l~~~~~~--~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  273 (463)
                      ||++..+...        .......+||+.|+|||++.+....  ...++.++|||||||++|||++|..||........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            9999876432        1122345799999999998631110  03466789999999999999999776643222111


Q ss_pred             hhc------------------cc-CCCCCCCC-----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         274 LFL------------------IP-RNAPPRLK-----SKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       274 ~~~------------------i~-~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...                  +. ....+...     ...+++.+.+||.+||..||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            100                  00 11111111     1123457999999999999999999999964

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-45  Score=357.11  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=194.1

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHh-cCCCceeeecccccccCCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKY-SNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l-~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ....++|++++.||+|+||.||+|++.  |+.||+|++.....  .....|.+++..+ .+||||+++++++....  ..
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~--~~  106 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGT--GS  106 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC--GG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCC--CC
Confidence            345578999999999999999999875  88999999865433  3444455554433 28999999999986432  22


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC--------CceecCCCCCceEEccCCcEEE
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN--------KVIHRDIKGQNVLLTDNAEVKL  201 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDLkp~NILl~~~~~vkL  201 (463)
                      ...+|+||||+++|+|.+++...   .+++..++.++.||+.||.|||++        ||+||||||+|||++.++.+||
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            26899999999999999999754   589999999999999999999999        9999999999999999999999


Q ss_pred             EecccccccccccCc----cccccCCccccccceeccCCCCCCCCCc------chhHHHHHHHHHHHHhC----------
Q psy7384         202 VDFGVSAQLDRTIGR----RNTFIGTPYWMAPEVIACDENPDATYDN------RSDLWSLGITALEMAES----------  261 (463)
Q Consensus       202 ~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~------~~DiwSlG~il~ell~g----------  261 (463)
                      +|||++.........    ....+||+.|+|||++..     ..+..      ++|||||||++|||++|          
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-----SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTT-----CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhccc-----ccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999766433221    124579999999999973     33333      49999999999999999          


Q ss_pred             CCCCCCCCchhh----hhcc--cCCCCCCC----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         262 QPPLCDLHPMRA----LFLI--PRNAPPRL----KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       262 ~~Pf~~~~~~~~----~~~i--~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ..||........    ....  .....+..    ....+++++.+||.+||..||.+|||+.++++|
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            667754322111    1111  11111111    122456779999999999999999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.7e-45  Score=368.72  Aligned_cols=258  Identities=16%  Similarity=0.136  Sum_probs=198.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCC-Cceeeeccc--------
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNH-RNIATYYGA--------  120 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~--------  120 (463)
                      ...|.+.+.||+|+||+||+|++..+|+.||||++....    ...+.+.+|+.+++.+ .| .|+......        
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence            345889999999999999999999999999999987322    2246788999998887 45 332211111        


Q ss_pred             -ccccC--------C---CCCCCeEEEEEecCCCCCHHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHhhhhcCCcee
Q psy7384         121 -FIKKS--------P---PGKDDQLWLVMEYCGAGSVTDLVKST-----KGQSLKEEWIAFICREILRGLKYLHENKVIH  183 (463)
Q Consensus       121 -~~~~~--------~---~~~~~~~~lV~E~~~ggsL~~~l~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~givH  183 (463)
                       .....        .   ......++++|+++ +++|.+++...     ....+++..+..++.||+.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence             00000        0   00123467888876 56999998522     2335778888999999999999999999999


Q ss_pred             cCCCCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCC-----CCCCCCCcchhHHHHHHHHHHH
Q psy7384         184 RDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE-----NPDATYDNRSDLWSLGITALEM  258 (463)
Q Consensus       184 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~~~~~DiwSlG~il~el  258 (463)
                      |||||+||||+.++.+||+|||+++.....   ....+| +.|+|||++....     .....|+.++|||||||++|+|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999998876544   345678 9999999994211     0145688899999999999999


Q ss_pred             HhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         259 AESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       259 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ++|+.||.+.........+...      ...+++.+++||.+||..||.+|||+.++++||||++
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHCCCCCCCcchhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            9999999887665554444322      2367899999999999999999999999999999953

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.4e-45  Score=355.20  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=203.9

Q ss_pred             CCCce-EEEeeeeeeCCeEEEEEEE----cCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          53 PAGIF-ELIEVVGNGTYGQVYKGRH----TKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        53 ~~~~y-~~~~~LG~G~fg~V~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      +.++| ++++.||+|+||.||+|..    ..+|+.||+|++....  .....+.+|+.+|+.+ +||||+++++++... 
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDA-  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET-
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecC-
Confidence            45556 9999999999999988764    4578899999997543  3356788999999999 799999999998642 


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                         ....+|+||||+++|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       106 ---~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          106 ---GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             ---TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             ---CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcc
Confidence               246899999999999999999754   48999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh----------
Q psy7384         206 VSAQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR----------  272 (463)
Q Consensus       206 la~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~----------  272 (463)
                      ++........   ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.......          
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  254 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLK-----EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ  254 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhc-----CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence            9987654321   123446888999999997     4568899999999999999999999996532210          


Q ss_pred             ----hhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         273 ----ALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       273 ----~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                          .+...............++.++.+||.+||..||.+|||++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          255 MTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                011111112222334578899999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.3e-45  Score=386.33  Aligned_cols=263  Identities=28%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...  ......+.+|+.+++++ +||||+++++++.........+
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence            46899999999999999999999999999999998643  33456788999999999 8999999999975433223467


Q ss_pred             eEEEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCc---EEEEecccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAE---VKLVDFGVS  207 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~---vkL~DFGla  207 (463)
                      ..|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            8899999999999999998643 235889999999999999999999999999999999999987664   999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh------------
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF------------  275 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~------------  275 (463)
                      ...... .......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+........            
T Consensus       172 ~~~~~~-~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          172 KELDQG-ELCTEFVGTLQYLAPELLE-----QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CBTTSC-CCCCCCCSCCTTCSSCSSC-----CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccc-cccccccCCcccCChHHhc-----cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            876543 2334568999999999987     5678999999999999999999999996542221110            


Q ss_pred             --cccCC--------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         276 --LIPRN--------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       276 --~i~~~--------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                        .....        ..+......+++.+.+||.+||..||.+|||+.++++||||..
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence              00000        0011122346789999999999999999999999999999963

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.3e-44  Score=378.76  Aligned_cols=245  Identities=24%  Similarity=0.392  Sum_probs=203.2

Q ss_pred             eEEE-eeeeeeCCeEEEEEEE--cCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          57 FELI-EVVGNGTYGQVYKGRH--TKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        57 y~~~-~~LG~G~fg~V~~~~~--~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.+. +.||+|+||.||+|.+  ..+++.||||++...   ......+.+|+.+|+++ +|||||++++++.       .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-------~  441 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-------A  441 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEE-------S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-------c
Confidence            4443 4899999999999965  456789999999743   23357889999999999 7999999999983       2


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.++|||||+.+|+|.+++....  .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             CCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            45899999999999999997543  6899999999999999999999999999999999999999999999999999876


Q ss_pred             ccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         211 DRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       211 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      .....   ......+|+.|+|||++.     ...++.++|||||||++|||++ |..||.+.........+...... ..
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~-----~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-~~  593 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECIN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GC  593 (635)
T ss_dssp             TC-------------CGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CC
T ss_pred             ccCccccccccCCCCceeeeChhhhc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC
Confidence            43321   122335678999999997     5678999999999999999998 99999988877766665554433 23


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...+++++.+||..||..||.+|||++++++
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            4578999999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4e-44  Score=369.31  Aligned_cols=251  Identities=20%  Similarity=0.331  Sum_probs=202.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..++|++++.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+..|++|..+..++      ...+.
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~------~~~~~   77 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFG------VEGDY   77 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEE------EETTE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEE------eeCCE
Confidence            45689999999999999999999999999999999875432 345788999999995445555555544      34478


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEE---ccCCcEEEEecccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL---TDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl---~~~~~vkL~DFGla~~  209 (463)
                      .||||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            89999999 899999997543 369999999999999999999999999999999999999   6889999999999987


Q ss_pred             cccccC-------ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh---hhcccC
Q psy7384         210 LDRTIG-------RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA---LFLIPR  279 (463)
Q Consensus       210 ~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~---~~~i~~  279 (463)
                      +.....       .....+||+.|+|||++.     +..++.++||||||||||+|++|..||.+......   +..+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhc-----CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            654322       122567999999999997     56789999999999999999999999987554221   111111


Q ss_pred             C---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         280 N---APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       280 ~---~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .   .........++.++.+||..||..+|.+||++++|++
T Consensus       231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          231 KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1   0001111467899999999999999999999988764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=377.25  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=205.9

Q ss_pred             CCceEEEe-eeeeeCCeEEEEEEEcC--CCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIE-VVGNGTYGQVYKGRHTK--TGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~-~LG~G~fg~V~~~~~~~--~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      .+.|.+.+ .||+|+||.||+|.+..  ++..||||++...  ....+.+.+|+.+|+++ +|||||++++++..     
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-----  407 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-----  407 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-----
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-----
Confidence            34566666 89999999999998763  4567999999753  34567899999999999 89999999999842     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        +.+||||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       408 --~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          408 --EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             --SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             --CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence              4689999999999999999653 3469999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         209 QLDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       209 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      .+......   .....+++.|+|||++.     ...++.++|||||||++|||++ |..||.+....+....+..+....
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~-----~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~  559 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME  559 (613)
T ss_dssp             TCC--------------CCTTSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhc-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            76432211   12234568999999997     5678999999999999999998 999999888777666665554332


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                       ....+++++.+||.+||..||.+||+++++++
T Consensus       560 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          560 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             -CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             34578999999999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.3e-44  Score=345.85  Aligned_cols=248  Identities=26%  Similarity=0.399  Sum_probs=200.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .|...+.||+|+||.||+|.+  ++..||+|++...     ......+.+|+.+++.+ +||||+++++++      ...
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~------~~~  102 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFS------SDG  102 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEE------CSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEE------ecC
Confidence            355668999999999999975  5789999998632     23457788999999999 899999999998      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTK-GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      +..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence            78999999999999999997543 34699999999999999999999999999999999999999999999999999886


Q ss_pred             cccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC----CC--
Q psy7384         210 LDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----NA--  281 (463)
Q Consensus       210 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~--  281 (463)
                      ......  ......||+.|+|||++.      ..++.++|||||||++|+|++|.+||.+......+..+..    ..  
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALR------GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT  256 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHT------TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC
T ss_pred             cccccccccccccCCCcCcCChHHhc------CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh
Confidence            643221  123457999999999885      3478899999999999999999999977654332221110    00  


Q ss_pred             -------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         282 -------PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       282 -------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                             .........+..+.++|.+||..||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          257 IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                   0011112345678999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=350.28  Aligned_cols=253  Identities=24%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEE----cCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRH----TKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ..++|++++.||+|+||.||+|++    ..+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++..    
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----  113 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYS----  113 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe----
Confidence            356799999999999999999984    5679999999997543 3456788999999999 89999999998853    


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .....+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            22347899999999999999997653 36899999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCch-------------
Q psy7384         208 AQLDRTIGR---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPM-------------  271 (463)
Q Consensus       208 ~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-------------  271 (463)
                      .........   .....++..|+|||++.     ...++.++|||||||++|+|++|..||......             
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLT-----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  267 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred             hhccccccccccccCCCCceeEECchhhc-----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence            876543221   22345788899999997     456889999999999999999999998532110             


Q ss_pred             ---hhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         272 ---RALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       272 ---~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                         .....+.... .......++.++.+||.+||..||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 IVFHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHhhcCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               0001111111 12234578899999999999999999999999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.2e-45  Score=362.41  Aligned_cols=248  Identities=20%  Similarity=0.240  Sum_probs=190.2

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---------chHHHHHHHHHHHHHhc--------CC-----
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---------DEEEEIKLEINVLKKYS--------NH-----  111 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~Ei~~l~~l~--------~h-----  111 (463)
                      .++|++++.||+|+||+||+|++  +|+.||||++....         .....+.+|+.+|+.+.        .|     
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  68999999997432         23477889999999884        24     


Q ss_pred             ------------CceeeecccccccCC-------CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy7384         112 ------------RNIATYYGAFIKKSP-------PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG  172 (463)
Q Consensus       112 ------------~nIv~l~~~~~~~~~-------~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~a  172 (463)
                                  |||++++++|.....       ....+.+||||||+.+|++.+.+..   ..+++..++.+++||+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence                        555555555532100       0125789999999999977666643   368999999999999999


Q ss_pred             Hhhhh-cCCceecCCCCCceEEccCC--------------------cEEEEecccccccccccCccccccCCccccccce
Q psy7384         173 LKYLH-ENKVIHRDIKGQNVLLTDNA--------------------EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV  231 (463)
Q Consensus       173 L~~LH-~~givHrDLkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~  231 (463)
                      |.||| ++||+||||||+||||+.++                    .+||+|||+++.....     ..+||+.|+|||+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~  248 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhh
Confidence            99999 99999999999999999887                    8999999999876542     3489999999999


Q ss_pred             eccCCCCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCchh----hhh-cccCC-CCCCCCCCCCCHHHHHHHHHhhhc
Q psy7384         232 IACDENPDATYDNRSDLWSLGIT-ALEMAESQPPLCDLHPMR----ALF-LIPRN-APPRLKSKKWPKKFQSFIETVLVK  304 (463)
Q Consensus       232 l~~~~~~~~~~~~~~DiwSlG~i-l~ell~g~~Pf~~~~~~~----~~~-~i~~~-~~~~~~~~~~~~~~~~li~~~L~~  304 (463)
                      +.+     . .+.++||||||++ .+++++|..||.+.....    .+. .+... .........+++++++||++||+.
T Consensus       249 ~~g-----~-~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~  322 (336)
T 2vuw_A          249 FTG-----D-GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF  322 (336)
T ss_dssp             GCC-----C-SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred             hcC-----C-CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence            963     2 2789999998777 788999999995422111    111 11111 111111234678999999999998


Q ss_pred             CCCCCCCHHHHh-cCcccc
Q psy7384         305 DYHQRPYTDQLL-KHPFIR  322 (463)
Q Consensus       305 dp~~Rpt~~e~l-~hp~~~  322 (463)
                      |     |++|+| +||||+
T Consensus       323 d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          323 S-----SATDLLCQHSLFK  336 (336)
T ss_dssp             S-----SHHHHHHHCGGGC
T ss_pred             C-----CHHHHHhcCCCcC
Confidence            7     999999 999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=350.76  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=207.9

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +...++|++.+.||+|+||.||+|++..   .+|+|++....   .....+.+|+.+++.+ +||||+++++++.     
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----   99 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACM-----   99 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEE-----
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEe-----
Confidence            3445789999999999999999998864   49999986432   2334567899999999 8999999999994     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                       ..+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus       100 -~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          100 -SPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             -CSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             -cCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence             4468999999999999999997533 4689999999999999999999999999999999999997 679999999998


Q ss_pred             cccccc-----cCccccccCCccccccceeccCCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc
Q psy7384         208 AQLDRT-----IGRRNTFIGTPYWMAPEVIACDEN----PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP  278 (463)
Q Consensus       208 ~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  278 (463)
                      ......     ........||+.|+|||++.....    ....++.++|||||||++|+|++|..||...........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            755321     122234568999999999864211    13457899999999999999999999998887777666666


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ....+......++.++.+||.+||..||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            665555555678899999999999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.6e-43  Score=346.77  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=200.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHh-cCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKY-SNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l-~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..++|++.+.||+|+||.||+|++  +|+.||+|++...  ....+.+|++++..+ .+||||+++++++....  ....
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~--~~~~  113 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDN--GTWT  113 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC--SSCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC--Cccc
Confidence            356899999999999999999987  4899999998643  345677888888873 38999999999985431  1223


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh--------cCCceecCCCCCceEEccCCcEEEEe
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH--------ENKVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givHrDLkp~NILl~~~~~vkL~D  203 (463)
                      .+|+||||+.+|+|.+++...   .+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+|
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence            899999999999999999753   5899999999999999999999        89999999999999999999999999


Q ss_pred             cccccccccccC----ccccccCCccccccceeccCCCCC-CCCCcchhHHHHHHHHHHHHhC----------CCCCCCC
Q psy7384         204 FGVSAQLDRTIG----RRNTFIGTPYWMAPEVIACDENPD-ATYDNRSDLWSLGITALEMAES----------QPPLCDL  268 (463)
Q Consensus       204 FGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~-~~~~~~~DiwSlG~il~ell~g----------~~Pf~~~  268 (463)
                      ||++........    ......||+.|+|||++....... ..++.++|||||||++|+|++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            999987654322    124457999999999987421100 0234789999999999999999          7888665


Q ss_pred             Cch----hhhh-cccCC-CCCCCC----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         269 HPM----RALF-LIPRN-APPRLK----SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       269 ~~~----~~~~-~i~~~-~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ...    ..+. .+... ..+...    ....++.+.+||.+||..||.+|||+.++++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            321    1111 11111 111111    12334678999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-42  Score=371.84  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=209.2

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKS  125 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~  125 (463)
                      +...++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+|+.+++.+ +||||+++++++.   
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~---  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT---  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC---
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe---
Confidence            34457899999999999999999998654   4579999986432  3346788999999999 8999999999983   


Q ss_pred             CCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecc
Q psy7384         126 PPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                          ++.+|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       462 ----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          462 ----ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             ----cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence                246899999999999999997543 468999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         206 VSAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       206 la~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      +++....... ......+|+.|+|||++.     ...++.++|||||||++|||++ |.+||.+......+..+......
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~  611 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL  611 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhc-----CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9987644321 122345788999999997     4578999999999999999997 99999988877766665544333


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      . ....+++.+.+||.+||..||.+|||+.++++
T Consensus       612 ~-~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 P-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C-CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            2 34578899999999999999999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.2e-42  Score=332.34  Aligned_cols=221  Identities=15%  Similarity=0.113  Sum_probs=185.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....    .....+.+|+.++..+ +||||+++++++.      
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~------  101 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVH------  101 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE------
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEE------
Confidence            4578999999999999999999999999999999997542    2336788999999999 8999999999994      


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+..|+||||++|++|.+++..    .....++..++.||+.||.|||++||+||||||+|||++.++.+||+++|   
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---
Confidence            45789999999999999999953    24566788999999999999999999999999999999999999998544   


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc---ccCCCCCC-
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL---IPRNAPPR-  284 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~---i~~~~~~~-  284 (463)
                                       |++            .++.++|||||||++|+|++|+.||.+.+....+..   ......+. 
T Consensus       175 -----------------~~~------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T 3uqc_A          175 -----------------TMP------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP  225 (286)
T ss_dssp             -----------------CCT------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred             -----------------ccC------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence                             222            267789999999999999999999988776553322   11221111 


Q ss_pred             -CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         285 -LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       285 -~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                       .....+++++.+||.+||..||.+| |+.|+++
T Consensus       226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence             1235789999999999999999999 9999876

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-42  Score=373.59  Aligned_cols=246  Identities=21%  Similarity=0.293  Sum_probs=199.3

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcC-CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTK-TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...++|++.+.||+|+||.||+|++.. +|+.||||++....  .....+.+|+.+|..+ +||||+++++++..... .
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~-~  154 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDR-H  154 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECT-T
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCC-C
Confidence            345789999999999999999999976 78999999986432  3345678999999999 79999999999865421 1


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      .....||||||++|++|.+++..    .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence            11237999999999999988753    68999999999999999999999999999999999999875 89999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      .....    ...+||+.|+|||++..      .++.++|||||||++|+|++|.+||.+....        .........
T Consensus       230 ~~~~~----~~~~gt~~y~aPE~~~~------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~  291 (681)
T 2pzi_A          230 RINSF----GYLYGTPGFQAPEIVRT------GPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVL  291 (681)
T ss_dssp             ETTCC----SCCCCCTTTSCTTHHHH------CSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHH
T ss_pred             hcccC----CccCCCccccCHHHHcC------CCCCceehhhhHHHHHHHHhCCCCCcccccc--------ccccccccc
Confidence            76543    45679999999999863      2488999999999999999999998653211        111111111


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ..++.+.+||.+||..||.+||+..+++.|+|+.
T Consensus       292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            2357899999999999999999999999998873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4.3e-37  Score=323.02  Aligned_cols=227  Identities=16%  Similarity=0.198  Sum_probs=159.6

Q ss_pred             eeeeCCeEEEEEEEcCCCcEEEEEEeecCc-----------chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          63 VGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-----------DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        63 LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++.|++|.+..++..-.|+.||+|++....           ...+++.+|+++|+++..|+||+++++++      ++++
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~------ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG------ENAQ  315 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE------ECSS
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE------EECC
Confidence            456777777777777789999999996431           23456889999999998899999999999      6678


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+||||||++|++|.++|....  .+++.   .|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999999999997644  56654   588999999999999999999999999999999999999999999887


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .......+.+||+.|||||++.      +.+..++|+||+|+++|+|+++..+|.     ..+...    +.    ..+ 
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~------g~~~~~~d~~s~g~~~~~l~~~~~~~~-----~~l~~~----~~----~~~-  450 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFA------ENKSWNGFWRSAPVHPFNLPQPWSNWL-----YAVWQE----PV----ERW-  450 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC-----------------------CCCCTTHHHHH-----HHHHTS----CG----GGC-
T ss_pred             CCCccccCceechhhccHHHhC------CCCCCcccccccccchhhhccccchhH-----HHhhcC----CC----CCC-
Confidence            6655667789999999999996      346678999999999999877755541     111111    00    011 


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                       .+..++..++..+|..|+.......|+|.
T Consensus       451 -~~~~l~~~l~~~~~~~~~~~~~~~~~~~~  479 (569)
T 4azs_A          451 -NFVLLLALFEKKAKLPSAEQQRGATEQWI  479 (569)
T ss_dssp             -SHHHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred             -cHHHHHHHHhCCCCCCCCChhhhccchhH
Confidence             25677778888888888877776666665

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.8e-29  Score=262.16  Aligned_cols=183  Identities=17%  Similarity=0.191  Sum_probs=139.9

Q ss_pred             EEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---------hHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---------EEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      ..+.||+|+||.||+|.  ..+..+++|.......         ..+.+.+|+.+|+++ +||||+++..++..      
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~------  410 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVD------  410 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEE------
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEe------
Confidence            45689999999999994  4577889988643211         134578999999999 79999944444322      


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      .+..||||||++|++|.+++..          +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++.
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            2456999999999999999864          5689999999999999999999999999999988  999999999988


Q ss_pred             cccccCc-------cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7384         210 LDRTIGR-------RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL  265 (463)
Q Consensus       210 ~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  265 (463)
                      .......       ....+||+.|||||++...   ...|+..+|+||..+-..+...++.+|
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~---~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF---LEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH---HHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHH---HHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            7543221       2356899999999999631   145778899999998888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=9.8e-27  Score=223.29  Aligned_cols=143  Identities=17%  Similarity=0.192  Sum_probs=116.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------------------hHHHHHHHHHHHHHhcCCCceee
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------------------EEEEIKLEINVLKKYSNHRNIAT  116 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~Ei~~l~~l~~h~nIv~  116 (463)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|++.....                   ....+.+|+.+|+++ +  | ++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~  165 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LA  165 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CC
Confidence            345559999999999999999 8899999999964321                   345688999999999 4  4 66


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +++++..       +..|+||||++|++|.+ +.      .  .....++.||+.||.|||++||+||||||+|||++ +
T Consensus       166 v~~~~~~-------~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          166 VPKVYAW-------EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             SCCEEEE-------ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T
T ss_pred             cCeEEec-------cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C
Confidence            6665521       45699999999999988 42      1  23457999999999999999999999999999999 9


Q ss_pred             CcEEEEecccccccccccCccccccCCccccccceec
Q psy7384         197 AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA  233 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~  233 (463)
                      +.+||+|||+++.             +..|+|||++.
T Consensus       229 ~~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             CcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            9999999999853             34578899875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=9.2e-23  Score=193.10  Aligned_cols=137  Identities=23%  Similarity=0.343  Sum_probs=108.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcE--EEEEEeecCcch-------------------------HHHHHHHHHHHHHh
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQL--AAIKVMDVTEDE-------------------------EEEIKLEINVLKKY  108 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~Ei~~l~~l  108 (463)
                      .|++.+.||+|+||.||+|.+..+|+.  ||||++......                         ...+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            489999999999999999998778988  999997543111                         13578899999999


Q ss_pred             cCCCce--eeecccccccCCCCCCCeEEEEEecCCC-C----CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh-cCC
Q psy7384         109 SNHRNI--ATYYGAFIKKSPPGKDDQLWLVMEYCGA-G----SVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH-ENK  180 (463)
Q Consensus       109 ~~h~nI--v~l~~~~~~~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~g  180 (463)
                       .|++|  ..+++.          +..+|||||+.+ |    +|.++...     .++..+..++.||+.||.||| ++|
T Consensus       128 -~~~~i~~p~~~~~----------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g  191 (258)
T 1zth_A          128 -KEAGVSVPQPYTY----------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE  191 (258)
T ss_dssp             -HHTTCCCCCEEEE----------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred             -HhCCCCCCeEEEc----------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence             57754  333322          245899999942 3    67766432     234567889999999999999 999


Q ss_pred             ceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         181 VIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       181 ivHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      |+||||||+|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999988  8999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.81  E-value=9.5e-21  Score=187.09  Aligned_cols=145  Identities=12%  Similarity=0.139  Sum_probs=98.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc---------------hHHHHHHHHHHHHHhcCCCceeeecc
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED---------------EEEEIKLEINVLKKYSNHRNIATYYG  119 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~Ei~~l~~l~~h~nIv~l~~  119 (463)
                      ..|++.+.||.|+||.||+|.+. +|+.||||+++....               .......+.++.... .|+|+++++.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~k-E~~nL~rL~~  172 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIK-EFAFMKALYE  172 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHH-HHHHHHHHHH
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHH-HHHHHHHHHh
Confidence            35999999999999999999874 699999999753210               111222222222222 3444444443


Q ss_pred             cccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC--
Q psy7384         120 AFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA--  197 (463)
Q Consensus       120 ~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~--  197 (463)
                      .......+-.....+|||||++|++|.++..        ......++.||+.+|.+||++|||||||||.||||++++  
T Consensus       173 ~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          173 EGFPVPEPIAQSRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             TTCSCCCEEEEETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             cCCCCCeeeeccCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence            3321100000122379999999988865431        123567889999999999999999999999999998876  


Q ss_pred             --------cEEEEecccccc
Q psy7384         198 --------EVKLVDFGVSAQ  209 (463)
Q Consensus       198 --------~vkL~DFGla~~  209 (463)
                              .+.|+||+-+..
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEE
T ss_pred             ccccccccceEEEEeCCccc
Confidence                    389999997644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=5.2e-14  Score=132.80  Aligned_cols=137  Identities=14%  Similarity=0.132  Sum_probs=108.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      |++...++.|+++.||++...  +..+++|+..... .....+.+|+.+|+.+..+..+.++++++      ...+..|+
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~------~~~~~~~l   87 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE------RHDGWSNL   87 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE------EETTEEEE
T ss_pred             ceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE------ecCCceEE
Confidence            888899999999999999743  6789999986421 22346889999999996677788888877      33468899


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-------------------------------------
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-------------------------------------  178 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------  178 (463)
                      ||||++|.+|.+.+.       +......++.++..+|..||+                                     
T Consensus        88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999877631       112234678899999999998                                     


Q ss_pred             ----------------------CCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         179 ----------------------NKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       179 ----------------------~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                                            ..++|+|++|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876666799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=4e-12  Score=119.20  Aligned_cols=133  Identities=14%  Similarity=0.119  Sum_probs=96.1

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCc--eeeecccccccCCCCCCCeE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN--IATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~n--Iv~l~~~~~~~~~~~~~~~~  133 (463)
                      .|.+....+.|..+.||++.. .+|..+++|+....  ....+..|+.+++.+..+ +  +.+++++.      ...+..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~-~~~vP~~~~~~------~~~~~~   90 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATT-GVPCAAVLDVV------TEAGRD   90 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTT-TCCBCCEEEEE------ECSSCE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhC-CCCCCeEEEec------cCCCCC
Confidence            366655445666799999964 56778999997643  234677899999998655 4  44577766      233578


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC---------------------------------
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK---------------------------------  180 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---------------------------------  180 (463)
                      |+||||++|.+|.  ..     ...   ...++.+++..|..||+..                                 
T Consensus        91 ~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            9999999998874  21     122   1256677777777777643                                 


Q ss_pred             -------------------------ceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         181 -------------------------VIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       181 -------------------------ivHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                                               ++|+|++|.|||+++++.+.|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                     9999999999999877667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.21  E-value=4e-11  Score=118.39  Aligned_cols=141  Identities=16%  Similarity=0.248  Sum_probs=102.7

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEee--cCc--chHHHHHHHHHHHHHhcC-CCceeeecccccccCCCCCCCeEE
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMD--VTE--DEEEEIKLEINVLKKYSN-HRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~Ei~~l~~l~~-h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      ++.|+.|.++.||++...  +..+++|+..  ...  .....+.+|+.+++.+.. +..+.+++..+...   ...+..|
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~---~~~g~~~  117 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE---SVIGRAF  117 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT---TTTSSCE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC---CccCCeE
Confidence            578999999999999754  4578888765  322  224577889999999843 34467777776322   1124679


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc------------------------------------
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE------------------------------------  178 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------------  178 (463)
                      +||||++|..+.+..    ...++......++.+++.+|..||+                                    
T Consensus       118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            999999998775421    1246788888899999999999996                                    


Q ss_pred             ----------------------CCceecCCCCCceEEccCCc--EEEEecccccc
Q psy7384         179 ----------------------NKVIHRDIKGQNVLLTDNAE--VKLVDFGVSAQ  209 (463)
Q Consensus       179 ----------------------~givHrDLkp~NILl~~~~~--vkL~DFGla~~  209 (463)
                                            ..++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  46999999999999987653  69999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.20  E-value=1.4e-11  Score=118.83  Aligned_cols=188  Identities=18%  Similarity=0.178  Sum_probs=120.0

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCce--eeecccccccCCCCCCCeEEEEEe
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNI--ATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nI--v~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      +.++.|.+..||++.     ..+++|+.... .....+.+|..+|+.+..+..|  .+++.....   .......|+|||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~---~~~~~~~~~vm~   96 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP---SETYQMSFAGFT   96 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC---CSSCSCSCEEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC---CCCCCcceEEEc
Confidence            568999999999973     45888885432 3456788999999988544333  233332211   011124589999


Q ss_pred             cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc----------------------------------------
Q psy7384         139 YCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE----------------------------------------  178 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------------------  178 (463)
                      +++|.+|.+....    .++..+...++.|++..|..||+                                        
T Consensus        97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9999888754321    46777777888888888888885                                        


Q ss_pred             ------------------CCceecCCCCCceEEcc--CCcEEEEecccccccccccCccccccCCccc---ccccee---
Q psy7384         179 ------------------NKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW---MAPEVI---  232 (463)
Q Consensus       179 ------------------~givHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y---~aPE~l---  232 (463)
                                        ..++|+|++|.|||++.  ++.+.|+||+.+...+.....    .....+   ..|+..   
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl----~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF----ISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH----HTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH----HHHHhhccccCHHHHHHH
Confidence                              24799999999999988  566899999987654321100    000001   112211   


Q ss_pred             -ccCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCC
Q psy7384         233 -ACDENPD-----ATYDNRSDLWSLGITALEMAESQPPL  265 (463)
Q Consensus       233 -~~~~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf  265 (463)
                       .......     .......+.|++|.++|.+.+|.++|
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             0000000     00112358999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.79  E-value=6.9e-08  Score=92.98  Aligned_cols=136  Identities=15%  Similarity=0.158  Sum_probs=90.5

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC--ceeeecccccccCCCCCCCeEEEEE
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR--NIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~--nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      ++.++.|....||+.     |..+++|+-. .......+.+|..+|+.+..|-  .|.+.+.+..     ...+..|+||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-----~~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-----RSDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-----CTTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-----cCCCceEEEE
Confidence            366888999999998     4568888743 2234567889999999995432  2334444332     1235678999


Q ss_pred             ecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc---------------------------------------
Q psy7384         138 EYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE---------------------------------------  178 (463)
Q Consensus       138 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------------------  178 (463)
                      ||++|.+|.+..-.    .++......++.++...|..||+                                       
T Consensus        93 e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           93 RKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             ECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             eccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            99999888763211    23444444455555555554443                                       


Q ss_pred             ---------------------CCceecCCCCCceEEcc---CCc-EEEEeccccccc
Q psy7384         179 ---------------------NKVIHRDIKGQNVLLTD---NAE-VKLVDFGVSAQL  210 (463)
Q Consensus       179 ---------------------~givHrDLkp~NILl~~---~~~-vkL~DFGla~~~  210 (463)
                                           ..++|+|++|.|||++.   ++. +.|+||+.+..-
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                 24699999999999987   355 589999987543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.68  E-value=1.2e-07  Score=89.29  Aligned_cols=133  Identities=15%  Similarity=0.148  Sum_probs=93.3

Q ss_pred             eeeeeCCe-EEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecC
Q psy7384          62 VVGNGTYG-QVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYC  140 (463)
Q Consensus        62 ~LG~G~fg-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~  140 (463)
                      .+..|..| .||+......+..+++|+-..  .....+.+|..+|+.+..+--+.+++.++      ...+..|+|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--~~~~~~~~E~~~l~~l~~~vPVP~v~~~~------~~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG--SVANDVTDEMVRLNWLTAFMPLPTIKHFI------RTPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET--HHHHHHHHHHHHHHHHTTTSCCCCEEEEE------EETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC--CCHhHHHHHHHHHHHhccCCCcCeEEEEE------EECCeEEEEEEee
Confidence            44445554 699988777777888998653  24557888999999886554455666665      3446889999999


Q ss_pred             CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC-----------------------------------------
Q psy7384         141 GAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN-----------------------------------------  179 (463)
Q Consensus       141 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-----------------------------------------  179 (463)
                      +|.++.+......      .....++.++...|.-||..                                         
T Consensus       103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            9988877654211      12233445555555555531                                         


Q ss_pred             -----------------CceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         180 -----------------KVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       180 -----------------givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                                       .++|+|+++.|||+++++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                             26999999999999987777899999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.48  E-value=4.8e-07  Score=90.24  Aligned_cols=76  Identities=14%  Similarity=0.133  Sum_probs=48.7

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--------chHHHHHHHHHHHHHhcCC-Cce-eeecccccccCCCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--------DEEEEIKLEINVLKKYSNH-RNI-ATYYGAFIKKSPPGK  129 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~Ei~~l~~l~~h-~nI-v~l~~~~~~~~~~~~  129 (463)
                      ++.||.|.++.||++....+++.+++|......        .....+..|.++|+.+..+ +.+ .+++.+.        
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--------  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--------  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--------
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--------
Confidence            478999999999999766567889999764211        1224567788898887543 333 3444332        


Q ss_pred             CCeEEEEEecCCCC
Q psy7384         130 DDQLWLVMEYCGAG  143 (463)
Q Consensus       130 ~~~~~lV~E~~~gg  143 (463)
                      .+..++|||+++|.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            12358999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.40  E-value=3.3e-06  Score=81.92  Aligned_cols=144  Identities=17%  Similarity=0.216  Sum_probs=79.4

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC-CceeeecccccccCCCCCCCeEEEEEe
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH-RNIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h-~nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      ++.|+.|..+.||++... +| .+++|+....   ...+..|..+++.+..+ -.+.+++............+..++|||
T Consensus        37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET-TE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC-CC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            356777788999999753 33 5889988753   23444566666665321 123333331100000012357899999


Q ss_pred             cCCCCCHH---------------HHHHhhCCC--C--------C-CHH--------H-----------------------
Q psy7384         139 YCGAGSVT---------------DLVKSTKGQ--S--------L-KEE--------W-----------------------  161 (463)
Q Consensus       139 ~~~ggsL~---------------~~l~~~~~~--~--------l-~~~--------~-----------------------  161 (463)
                      |++|.++.               .+.......  +        + ...        .                       
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542               111111110  0        0 000        0                       


Q ss_pred             HHHHHHHHHHHHhhhh-------------cCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         162 IAFICREILRGLKYLH-------------ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       162 ~~~i~~qil~aL~~LH-------------~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +..+..++..++.+|+             ..+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1112223444566665             3689999999999999878889999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.37  E-value=4.7e-07  Score=88.89  Aligned_cols=86  Identities=9%  Similarity=0.022  Sum_probs=55.3

Q ss_pred             EEEeee-eeeCCeEEEEEEEc--C----CCcEEEEEEeecCc---c-hHHHHHHHHHHHHHhcCC--Cceeeeccccccc
Q psy7384          58 ELIEVV-GNGTYGQVYKGRHT--K----TGQLAAIKVMDVTE---D-EEEEIKLEINVLKKYSNH--RNIATYYGAFIKK  124 (463)
Q Consensus        58 ~~~~~L-G~G~fg~V~~~~~~--~----~~~~vaiK~~~~~~---~-~~~~~~~Ei~~l~~l~~h--~nIv~l~~~~~~~  124 (463)
                      ..++.| +.|..+.+|++...  .    ++..+++|+.....   . ....+.+|..+++.+..+  -.+.+++.+....
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            445788 88989999998653  1    15678888865322   0 124677889988888554  2455666655221


Q ss_pred             CCCCCCCeEEEEEecCCCCCHH
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVT  146 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~  146 (463)
                         ...+..|+||||++|..+.
T Consensus       103 ---~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 ---DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             ---TTTSSCEEEEECCCCBCCC
T ss_pred             ---CccCCceEEEEecCCCChh
Confidence               1114568999999986653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.03  E-value=1.4e-05  Score=76.36  Aligned_cols=72  Identities=11%  Similarity=0.002  Sum_probs=44.6

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEec
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEY  139 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~  139 (463)
                      ++.|+.|....+|++      ..+++|+............+|..+++.+..+.-..+++...      .  +.-++|+||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~------~--~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD------P--ATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC------T--TTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE------C--CCCEEEEee
Confidence            588999999999999      34788887543221123356888887775442223455443      1  234789999


Q ss_pred             C-CCCCH
Q psy7384         140 C-GAGSV  145 (463)
Q Consensus       140 ~-~ggsL  145 (463)
                      + +|.+|
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 66544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.00  E-value=2.7e-05  Score=74.84  Aligned_cols=76  Identities=14%  Similarity=0.178  Sum_probs=57.2

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCC--CceeeecccccccCCCCCCCeEEEEE
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNH--RNIATYYGAFIKKSPPGKDDQLWLVM  137 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h--~nIv~l~~~~~~~~~~~~~~~~~lV~  137 (463)
                      ++.|+.|.+..+|+...  .+..+++|+....  ....+..|...|+.|..+  ..+.+++.+.      ...+..|+||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~------~~~g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIG------NSQGHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE------ECSSEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEe------ecCCceEEEE
Confidence            47889999999999974  4667888987643  356788899999888543  4566777665      2336789999


Q ss_pred             ecCCCCCH
Q psy7384         138 EYCGAGSV  145 (463)
Q Consensus       138 E~~~ggsL  145 (463)
                      ||++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.97  E-value=3e-05  Score=77.79  Aligned_cols=81  Identities=14%  Similarity=0.186  Sum_probs=48.0

Q ss_pred             hcCCceecCCCCCceEEccCCcEEEEecccccccccccCccccccC--CccccccceeccCCCCCCCCCcchhHHHHHHH
Q psy7384         177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIG--TPYWMAPEVIACDENPDATYDNRSDLWSLGIT  254 (463)
Q Consensus       177 H~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~i  254 (463)
                      +...++|+|++|.|||++.++ ++|+||+.+..-...... .....  ...|++|+......  ...-....++..+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  305 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQE--NDRKEYKQWILRTIEQ  305 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSS--CCSHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccc--cchHHHHHHHHHHHHH
Confidence            567899999999999998776 999999987654321100 01111  13456665543110  0111223455577777


Q ss_pred             HHHHHhC
Q psy7384         255 ALEMAES  261 (463)
Q Consensus       255 l~ell~g  261 (463)
                      +|+++++
T Consensus       306 ~~~~y~~  312 (420)
T 2pyw_A          306 TWNLFNK  312 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            7877654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.82  E-value=0.00015  Score=69.85  Aligned_cols=143  Identities=12%  Similarity=0.106  Sum_probs=81.4

Q ss_pred             eeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCCeEEEEEec
Q psy7384          61 EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDDQLWLVMEY  139 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~~~~lV~E~  139 (463)
                      ..|+ |....||++.. .+|+.+++|+..........+..|..+++.+..+. .+.+++.. .........+..++||+|
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence            4566 88889998854 34667889998643334567778888888875331 13444432 100000123577899999


Q ss_pred             CCCCCHH-----H------H---HHhh-CC------CCCCHHH----------------------HHHHHHHHHHHHhhh
Q psy7384         140 CGAGSVT-----D------L---VKST-KG------QSLKEEW----------------------IAFICREILRGLKYL  176 (463)
Q Consensus       140 ~~ggsL~-----~------~---l~~~-~~------~~l~~~~----------------------~~~i~~qil~aL~~L  176 (463)
                      ++|..+.     .      .   ++.. ..      ..+....                      ....+.+++..+.-+
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9885431     1      1   1110 00      0111111                      011222222222222


Q ss_pred             ----hcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         177 ----HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       177 ----H~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                          ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                245689999999999998 4 89999999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.81  E-value=0.00024  Score=63.62  Aligned_cols=123  Identities=15%  Similarity=0.164  Sum_probs=82.4

Q ss_pred             CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhh-cCCceecCCCCCceEEccCCcEEEEecccccccccccCcccccc
Q psy7384         143 GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLH-ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI  221 (463)
Q Consensus       143 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  221 (463)
                      -+|.++|...+ .+++|++++.++.|.+.+|.-+- ...-..+=+.|..|++..+|.|.+.+ +.+.            .
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~   98 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------A   98 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------c
Confidence            37999998655 58999999999999999988762 11212444567999999999887764 2110            1


Q ss_pred             CCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHh
Q psy7384         222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETV  301 (463)
Q Consensus       222 gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  301 (463)
                      ....+.+||...      ...+.+.=|||||+++|..+--..|                   ......+++.+.+||..|
T Consensus        99 ~~~~~~~pe~~~------~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           99 GEPPPVAGKLGY------SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHM  153 (229)
T ss_dssp             --------CCSS------SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHH
T ss_pred             cccCCCChhhcc------ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHH
Confidence            223467888762      2345778999999999998753322                   122346889999999999


Q ss_pred             hhc
Q psy7384         302 LVK  304 (463)
Q Consensus       302 L~~  304 (463)
                      ...
T Consensus       154 t~~  156 (229)
T 2yle_A          154 ANT  156 (229)
T ss_dssp             TTC
T ss_pred             Hhc
Confidence            866

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.73  E-value=6.3e-05  Score=74.22  Aligned_cols=138  Identities=15%  Similarity=0.182  Sum_probs=83.1

Q ss_pred             eeeeeeCCeEEEEEEEcC-------CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          61 EVVGNGTYGQVYKGRHTK-------TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      +.|..|-...+|++....       .+..+++|+..........+.+|..+++.+..+.-..++++.+      .+    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~------~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF------PE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE------TT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc------CC----
Confidence            567778888999997642       3467889886432233556678999999886554445666665      22    


Q ss_pred             EEEEecCCCCCHH--------------HHHHh---hC---CCCC--CHHHHHHHHHHHHH-------------------H
Q psy7384         134 WLVMEYCGAGSVT--------------DLVKS---TK---GQSL--KEEWIAFICREILR-------------------G  172 (463)
Q Consensus       134 ~lV~E~~~ggsL~--------------~~l~~---~~---~~~l--~~~~~~~i~~qil~-------------------a  172 (463)
                      .+||||++|.+|.              +.+..   ..   ....  -...+..+..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            2999999986542              11111   11   1111  13455555554422                   1


Q ss_pred             Hhhhh--------cCCceecCCCCCceEEccC----CcEEEEeccccc
Q psy7384         173 LKYLH--------ENKVIHRDIKGQNVLLTDN----AEVKLVDFGVSA  208 (463)
Q Consensus       173 L~~LH--------~~givHrDLkp~NILl~~~----~~vkL~DFGla~  208 (463)
                      +..|.        ...++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            22222        1369999999999999876    789999999774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.72  E-value=0.00011  Score=74.04  Aligned_cols=74  Identities=16%  Similarity=0.198  Sum_probs=50.5

Q ss_pred             EeeeeeeCCeEEEEEEEcC-------CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          60 IEVVGNGTYGQVYKGRHTK-------TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ++.|+.|....||++....       .+..+++|+.... .....+..|..+++.+..+.-..++++.+      .+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~------~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIF------SG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEE------TT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEe------CC---
Confidence            4678889999999998643       2567889987432 12245567999999886554345666655      11   


Q ss_pred             EEEEEecCCCCC
Q psy7384         133 LWLVMEYCGAGS  144 (463)
Q Consensus       133 ~~lV~E~~~ggs  144 (463)
                       .+|+||++|.+
T Consensus       148 -g~v~e~l~G~~  158 (429)
T 1nw1_A          148 -GRLEEYIPSRP  158 (429)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEeCCcc
Confidence             38999998744

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.72  E-value=0.00014  Score=69.78  Aligned_cols=148  Identities=12%  Similarity=0.132  Sum_probs=78.7

Q ss_pred             EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCCeEEEE
Q psy7384          58 ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDDQLWLV  136 (463)
Q Consensus        58 ~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~~~~lV  136 (463)
                      .-++.|+.|....+|++... .| .+++|+.... .....+..|+.++..+..+. .+.+++............+..++|
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            34577888999999999753 34 5788988642 12235567888888775431 123333221000000112567999


Q ss_pred             EecCCCCCHHH-----------H---HHhh-CCC--C----CCHHHHHHH---------------HHHHHHHHhhhh---
Q psy7384         137 MEYCGAGSVTD-----------L---VKST-KGQ--S----LKEEWIAFI---------------CREILRGLKYLH---  177 (463)
Q Consensus       137 ~E~~~ggsL~~-----------~---l~~~-~~~--~----l~~~~~~~i---------------~~qil~aL~~LH---  177 (463)
                      |+|++|..+..           .   ++.. ...  .    .....-...               ...+...+.+++   
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99999865310           0   1111 000  0    111000000               011333344443   


Q ss_pred             ----cCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         178 ----ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       178 ----~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                          ..+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                2479999999999999877666899999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.67  E-value=0.00037  Score=65.90  Aligned_cols=78  Identities=13%  Similarity=0.072  Sum_probs=54.5

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCc--eeeecccccccCCCCCCCeE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRN--IATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~n--Iv~l~~~~~~~~~~~~~~~~  133 (463)
                      ..-++.+|.|..+.||++.. .+|+.|.+|+-.... .....+..|...|+.|.....  +.+++.+.          .-
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----------~~   85 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----------DR   85 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----------TT
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----------Cc
Confidence            45678999999999999975 568889999865332 223467889999998854322  33344332          23


Q ss_pred             EEEEecCCCCCH
Q psy7384         134 WLVMEYCGAGSV  145 (463)
Q Consensus       134 ~lV~E~~~ggsL  145 (463)
                      ++||||+.++..
T Consensus        86 ~lv~e~l~~~~~   97 (288)
T 3f7w_A           86 TLAMEWVDERPP   97 (288)
T ss_dssp             EEEEECCCCCCC
T ss_pred             eEEEEeecccCC
Confidence            799999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.65  E-value=6e-05  Score=74.13  Aligned_cols=76  Identities=13%  Similarity=0.112  Sum_probs=45.9

Q ss_pred             EeeeeeeCCeEEEEEEEcC--------CCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTK--------TGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++.|+.|....+|++....        .+..+++|+.............|..+++.+..+.-+.++++.+      .   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~------~---  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF------N---  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE------T---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec------C---
Confidence            4677888889999998653        1267888987543222223467888888885443234555543      1   


Q ss_pred             eEEEEEecCCCCCH
Q psy7384         132 QLWLVMEYCGAGSV  145 (463)
Q Consensus       132 ~~~lV~E~~~ggsL  145 (463)
                       -++||||++|.++
T Consensus       109 -~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 -GGRIEEWLYGDPL  121 (369)
T ss_dssp             -TEEEEECCCSEEC
T ss_pred             -CcEEEEEecCCcC
Confidence             2689999988543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.64  E-value=0.00014  Score=70.27  Aligned_cols=138  Identities=17%  Similarity=0.202  Sum_probs=71.1

Q ss_pred             eeeeeeCCeE-EEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCCeEEEEEe
Q psy7384          61 EVVGNGTYGQ-VYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDDQLWLVME  138 (463)
Q Consensus        61 ~~LG~G~fg~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~~~~lV~E  138 (463)
                      +.|+.|+... +|+... .+|..+++|......  ...+..|+.+++.+..+. .+.+++.+.      ...+  ++|||
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d------~~~g--~ll~e   92 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEE------HARG--LLLIE   92 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEE------TTTT--EEEEC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeec------CCCC--EEEEe
Confidence            5666565544 667653 235667777654321  134456777777775432 234455432      1122  78999


Q ss_pred             cCCCCCHHHHHHhhC------------------------CCCCCHHHHHH--------HH------------HHHHHHHh
Q psy7384         139 YCGAGSVTDLVKSTK------------------------GQSLKEEWIAF--------IC------------REILRGLK  174 (463)
Q Consensus       139 ~~~ggsL~~~l~~~~------------------------~~~l~~~~~~~--------i~------------~qil~aL~  174 (463)
                      ++.+..+.+.+....                        ...+.......        +.            ..+...+.
T Consensus        93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~  172 (333)
T 3csv_A           93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA  172 (333)
T ss_dssp             CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred             eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            998777655442110                        00122211100        00            01111122


Q ss_pred             hh------hcCCceecCCCCCceEEccC----CcEEEEecccccc
Q psy7384         175 YL------HENKVIHRDIKGQNVLLTDN----AEVKLVDFGVSAQ  209 (463)
Q Consensus       175 ~L------H~~givHrDLkp~NILl~~~----~~vkL~DFGla~~  209 (463)
                      .|      +...++|+|+++.|||++.+    +.+.|+||+.+..
T Consensus       173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            22      34579999999999999874    6799999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.61  E-value=0.00023  Score=72.04  Aligned_cols=76  Identities=13%  Similarity=0.114  Sum_probs=48.7

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEec
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEY  139 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~  139 (463)
                      ++.|+.|-...+|++.....+..+++|+........-...+|..+++.|..+.-..++++.+      .  +  .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~------~--~--G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF------T--N--GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE------T--T--EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe------C--C--eEEEEe
Confidence            46788899999999987544577889987432221112358999999985444335666665      1  1  259999


Q ss_pred             CCCCCH
Q psy7384         140 CGAGSV  145 (463)
Q Consensus       140 ~~ggsL  145 (463)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.29  E-value=0.0015  Score=63.37  Aligned_cols=32  Identities=22%  Similarity=0.394  Sum_probs=27.9

Q ss_pred             CCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         179 NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       179 ~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.82  E-value=0.002  Score=64.33  Aligned_cols=79  Identities=13%  Similarity=0.130  Sum_probs=51.0

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCC-------CcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKT-------GQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++ +.|..|-...+|++.....       +..+++++........-...+|..+++.+..+.-..++++.+      .
T Consensus        72 ~~~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~------~  144 (424)
T 3mes_A           72 YIEV-KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF------P  144 (424)
T ss_dssp             GEEE-EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE------T
T ss_pred             ceEE-EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc------C
Confidence            3444 5667788899999986521       577888886433222223467888888886544345555543      1


Q ss_pred             CCCeEEEEEecCCCCCH
Q psy7384         129 KDDQLWLVMEYCGAGSV  145 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL  145 (463)
                          -++||||++|.+|
T Consensus       145 ----~~~I~efI~G~~l  157 (424)
T 3mes_A          145 ----EGRIEEFIDGEPL  157 (424)
T ss_dssp             ----TEEEEECCCSEEC
T ss_pred             ----CCEEEEEeCCccC
Confidence                2789999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.46  E-value=0.0075  Score=59.83  Aligned_cols=30  Identities=30%  Similarity=0.520  Sum_probs=25.2

Q ss_pred             CceecCCCCCceEE------ccCCcEEEEecccccc
Q psy7384         180 KVIHRDIKGQNVLL------TDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       180 givHrDLkp~NILl------~~~~~vkL~DFGla~~  209 (463)
                      .++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      3467799999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.48  E-value=1.6  Score=38.76  Aligned_cols=120  Identities=7%  Similarity=0.013  Sum_probs=78.5

Q ss_pred             HHHHHHHhcCCCceeeecccccccCCCCCCCeEEEEEecCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcC
Q psy7384         101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGA-GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHEN  179 (463)
Q Consensus       101 Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~  179 (463)
                      |+.+|..  .||+.+.. .+-      ..++.+.+.++.-+. .++.. ++     .++....++++.+|+....++++ 
T Consensus        36 el~LL~~--~~~~Fl~~-~I~------e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~-   99 (215)
T 4ann_A           36 LMYLLEQ--HSPYFIDA-ELT------ELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRT-   99 (215)
T ss_dssp             GGGGGGS--CCTTBCCE-EEE------ECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGS-
T ss_pred             HHHHHhc--cCCcccce-EEE------EcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcC-
Confidence            4445544  58888865 232      344666676665542 22222 22     37788888899999887755543 


Q ss_pred             CceecCCCCCceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHH-HHHHHHHHH
Q psy7384         180 KVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW-SLGITALEM  258 (463)
Q Consensus       180 givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~Diw-SlG~il~el  258 (463)
                       =+|--|+|+||+++.++.++++-.|+-..                 ++|.-+          +. -|.| .+=|++..+
T Consensus       100 -r~tf~L~P~NL~f~~~~~p~i~~RGik~~-----------------l~P~~~----------~e-e~fL~qyKAliial  150 (215)
T 4ann_A          100 -RYTFVLAPDELFFTRDGLPIAKTRGLQNV-----------------VDPLPV----------SE-AEFLTRYKALVICA  150 (215)
T ss_dssp             -SEECCCSGGGEEECTTSCEEESCCEETTT-----------------BSCCCC----------CH-HHHHHHHHHHHHHH
T ss_pred             -ceEEEEecceEEEcCCCCEEEEEccCccC-----------------CCCCCC----------CH-HHHHHHHHHHHHHH
Confidence             47788999999999999999998775321                 223211          11 2333 577899999


Q ss_pred             HhCCCCC
Q psy7384         259 AESQPPL  265 (463)
Q Consensus       259 l~g~~Pf  265 (463)
                      +.++..|
T Consensus       151 l~~K~~F  157 (215)
T 4ann_A          151 FNEKQSF  157 (215)
T ss_dssp             HCTTCCH
T ss_pred             HcCCCCH
Confidence            9998877

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.78  E-value=2.9  Score=37.19  Aligned_cols=113  Identities=12%  Similarity=0.060  Sum_probs=74.5

Q ss_pred             CCCceeeecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHh-hhhcCCceecCCCC
Q psy7384         110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK-YLHENKVIHRDIKG  188 (463)
Q Consensus       110 ~h~nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~-~LH~~givHrDLkp  188 (463)
                      .||+. .. .+-      ..++.+.+.++.-+++.=+..++     .++..+.++++.+|+.... +++  .-+|--|+|
T Consensus        48 ~~~~f-~~-~I~------~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI-VR-DID------VSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCP  112 (219)
T ss_dssp             SCSSS-EE-EEE------ECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCG
T ss_pred             cCCCC-Ce-EEE------EeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeC
Confidence            58877 22 222      34467777777664433333443     4778888899999888776 554  457778999


Q ss_pred             CceEEccCCcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHH-HHHHHHHHHHhCCCCC
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLW-SLGITALEMAESQPPL  265 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~Diw-SlG~il~ell~g~~Pf  265 (463)
                      +||+++.++.++|.-.|+-.                 -++|.-+.           .-|.| .+=|++..++.++.-|
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~-----------------~lpP~e~~-----------ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKE-----------------SLPPDEWD-----------DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GGEEECTTCCEEESCCEETT-----------------TBSSCSCC-----------HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             ceEEEeCCCcEEEEEcCCcc-----------------cCCCCCCC-----------HHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999999887532                 23333221           12444 5778888887776655

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	463
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-84
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-83
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-76
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-75
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-71
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-70
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-70
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-70
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-70
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-69
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-68
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-67
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-67
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-66
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-63
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-62
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-60
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-60
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-58
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-57
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-57
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-56
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-55
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-54
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-54
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-53
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-52
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-52
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-51
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-50
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-49
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-47
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-46
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-34
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-22

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (664), Expect = 1e-84
 Identities = 116/273 (42%), Positives = 176/273 (64%), Gaps = 10/273 (3%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYSN 110
           +P   +E+I  +G+G +G+VYK ++ +T  LAA KV+D  +E+E E+  +EI++L    +
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS-CD 67

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI     AF        ++ LW+++E+C  G+V  ++     + L E  I  +C++ L
Sbjct: 68  HPNIVKLLDAFYY------ENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTL 120

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
             L YLH+NK+IHRD+K  N+L T + ++KL DFGVSA+  RTI RR++FIGTPYWMAPE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KK 289
           V+ C+ + D  YD ++D+WSLGIT +EMAE +PP  +L+PMR L  I ++ PP L    +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           W   F+ F++  L K+   R  T QLL+HPF+ 
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  256 bits (655), Expect = 4e-83
 Identities = 107/309 (34%), Positives = 172/309 (55%), Gaps = 23/309 (7%)

Query: 49  WQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINV 104
           +++DP  +F  +  +G+G++G VY  R  +  ++ AIK M  +     ++ ++I  E+  
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           L+K   H N   Y G +++      +   WLVMEYC   +   L      + L+E  IA 
Sbjct: 69  LQKL-RHPNTIQYRGCYLR------EHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAA 119

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           +    L+GL YLH + +IHRD+K  N+LL++   VKL DFG ++ +       N+F+GTP
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTP 175

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR 284
           YWMAPEVI      +  YD + D+WSLGIT +E+AE +PPL +++ M AL+ I +N  P 
Sbjct: 176 YWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233

Query: 285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKR 344
           L+S  W + F++F+++ L K    RP ++ LLKH F+       +    + D I   K  
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV----LRERPPTVIMDLIQRTKDA 289

Query: 345 KKERDDYRY 353
            +E D+ +Y
Sbjct: 290 VRELDNLQY 298

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (608), Expect = 3e-76
 Identities = 108/275 (39%), Positives = 158/275 (57%), Gaps = 17/275 (6%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV-TEDEEEEIKLEINVLKKYS 109
            DP   +   E +G G  G VY      TGQ  AI+ M++  + ++E I  EI V+++ +
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-N 74

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
            + NI  Y  +++        D+LW+VMEY   GS+TD+V  T      E  IA +CRE 
Sbjct: 75  KNPNIVNYLDSYLV------GDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCREC 125

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP 229
           L+ L++LH N+VIHRDIK  N+LL  +  VKL DFG  AQ+     +R+T +GTPYWMAP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-K 288
           EV+         Y  + D+WSLGI A+EM E +PP  + +P+RAL+LI  N  P L++ +
Sbjct: 186 EVVTRKA-----YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
           K    F+ F+   L  D  +R    +LL+H F++ 
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 6e-75
 Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 21/275 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           +E++  +G G+YG+  K R    G++   K +D   +TE E++ +  E+N+L++   H N
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-LKHPN 64

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--STKGQSLKEEWIAFICREILR 171
           I  YY   I ++    +  L++VMEYC  G +  ++   + + Q L EE++  +  ++  
Sbjct: 65  IVRYYDRIIDRT----NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 172 GLKYLHE-----NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
            LK  H      + V+HRD+K  NV L     VKL DFG++  L+        F+GTPY+
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
           M+PE +         Y+ +SD+WSLG    E+    PP            I      R+ 
Sbjct: 181 MSPEQMNRMS-----YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI- 234

Query: 287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI 321
             ++  +    I  +L    + RP  +++L++P I
Sbjct: 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 1e-71
 Identities = 76/270 (28%), Positives = 120/270 (44%), Gaps = 22/270 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           FE+   +G G +G VY  R  ++  + A+KV+          E +++ E+ +      H 
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHP 66

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
           NI   YG F          +++L++EY   G+V   ++  K     E+  A    E+   
Sbjct: 67  NILRLYGYFHD------ATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANA 118

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L Y H  +VIHRDIK +N+LL    E+K+ DFG S     +  RR T  GT  ++ PE+I
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 176

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK 292
                    +D + DLWSLG+   E    +PP            I R            +
Sbjct: 177 EGRM-----HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDFVTE 229

Query: 293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
             +  I  +L  +  QRP   ++L+HP+I 
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 1e-70
 Identities = 90/316 (28%), Positives = 147/316 (46%), Gaps = 61/316 (19%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNHRNI 114
           FE I  +G G  G V+K  H  +G + A K++  ++      +I  E+ VL +  N   I
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYI 66

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +YGAF        D ++ + ME+   GS+  ++K  K   + E+ +  +   +++GL 
Sbjct: 67  VGFYGAFY------SDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118

Query: 175 YLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           YL E +K++HRD+K  N+L+    E+KL DFGVS QL  +    N+F+GT  +M+PE + 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 176

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPL---------------------------- 265
                   Y  +SD+WS+G++ +EMA  + P+                            
Sbjct: 177 GTH-----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 266 ----------CDLHPMRALF----LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPY 311
                      D  P  A+F     I    PP+L S  +  +FQ F+   L+K+  +R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 312 TDQLLKHPFIRDQPTE 327
             QL+ H FI+    E
Sbjct: 292 LKQLMVHAFIKRSDAE 307

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 2e-70
 Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 19/279 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNI 114
           ++L++ +G G YG+V    +  T +  A+K++D+    D  E IK EI + K   NH N+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-LNHENV 65

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
             +YG   +       +  +L +EYC  G + D ++   G  + E        +++ G+ 
Sbjct: 66  VKFYGHRRE------GNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVV 117

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRR--NTFIGTPYWMAPEVI 232
           YLH   + HRDIK +N+LL +   +K+ DFG++         R  N   GT  ++APE++
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS-KKWP 291
              E     +    D+WS GI    M   + P          +   +     L   KK  
Sbjct: 178 KRREF----HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQA 330
               + +  +LV++   R     + K  +   +P ++ A
Sbjct: 234 SAPLALLHKILVENPSARITIPDIKKDRWYN-KPLKKGA 271

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 3e-70
 Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 20/273 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
            +    +G G++  VYKG  T+T    A   +    +T+ E +  K E  +LK    H N
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPN 69

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  +Y ++   S       + LV E   +G++   +K  + + +K + +   CR+IL+GL
Sbjct: 70  IVRFYDSWE--STVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGL 125

Query: 174 KYLHENK--VIHRDIKGQNVLLTD-NAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           ++LH     +IHRD+K  N+ +T     VK+ D G++     +       IGTP +MAPE
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPE 183

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNAPPRLKSKK 289
           +       +  YD   D+++ G+  LEMA S+ P  +      ++  +     P    K 
Sbjct: 184 MY------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
              + +  IE  + ++  +R     LL H F +
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  221 bits (565), Expect = 5e-70
 Identities = 76/280 (27%), Positives = 127/280 (45%), Gaps = 24/280 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----------EDEEEEIKLEINVLK 106
           +E  E++G G    V +  H  T +  A+K++DVT          ++  E    E+++L+
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K S H NI      +        +   +LV +    G + D +   +  +L E+    I 
Sbjct: 65  KVSGHPNIIQLKDTYET------NTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIM 116

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
           R +L  +  LH+  ++HRD+K +N+LL D+  +KL DFG S QLD    +     GTP +
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSY 175

Query: 227 MAPEVIACDENPDA-TYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           +APE+I C  N +   Y    D+WS G+    +    PP      M  L +I  +   + 
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-MSGNYQF 234

Query: 286 KSKKW---PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
            S +W       +  +   LV    +R   ++ L HPF +
Sbjct: 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  222 bits (567), Expect = 2e-69
 Identities = 65/331 (19%), Positives = 148/331 (44%), Gaps = 21/331 (6%)

Query: 26  KDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAI 85
            D D F   + K+   +  P +  Q      ++++E +G+G +G V++     TG++   
Sbjct: 2   NDYDKFYEDIWKKYVPQ--PVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 59

Query: 86  KVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS 144
           K ++     ++  +K EI+++ +  +H  +   + AF          ++ L++E+   G 
Sbjct: 60  KFINTPYPLDKYTVKNEISIMNQ-LHHPKLINLHDAFED------KYEMVLILEFLSGGE 112

Query: 145 VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLL--TDNAEVKLV 202
           + D + + +   + E  +    R+   GLK++HE+ ++H DIK +N++      + VK++
Sbjct: 113 LFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 171

Query: 203 DFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQ 262
           DFG++ +L+           T  + APE++  +          +D+W++G+    +    
Sbjct: 172 DFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP-----VGFYTDMWAIGVLGYVLLSGL 225

Query: 263 PPLCDLHPMRALFLIPRNA--PPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPF 320
            P      +  L  + R               + + FI+ +L K+  +R      L+HP+
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285

Query: 321 IRDQPTERQARIQLKDHIDTCKKRKKERDDY 351
           ++   +   +RI    +    +K K++  D+
Sbjct: 286 LKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  217 bits (554), Expect = 5e-68
 Identities = 77/307 (25%), Positives = 137/307 (44%), Gaps = 27/307 (8%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKY 108
           ED   I++  +V+G G + +V      +T +L AIK +     E +E  ++ EI VL K 
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK- 63

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
             H NI      +           L+L+M+    G + D +   +     E   + +  +
Sbjct: 64  IKHPNIVALDDIYE------SGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQ 115

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPY 225
           +L  +KYLH+  ++HRD+K +N+L     +++++ + DFG+S   D      +T  GTP 
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPG 174

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APP 283
           ++APEV+A        Y    D WS+G+ A  +    PP  D +  +    I +      
Sbjct: 175 YVAPEVLAQKP-----YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229

Query: 284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR-----DQPTERQARIQLKDHI 338
                      + FI  ++ KD  +R   +Q L+HP+I      D+   +    Q+K + 
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF 289

Query: 339 DTCKKRK 345
              K ++
Sbjct: 290 AKSKWKQ 296

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 2e-67
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 18/278 (6%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK 106
           D W E P G   + + +G+G++G VYKG+      +  + V   T  + +  K E+ VL+
Sbjct: 1   DDW-EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           K + H NI  + G            QL +V ++C   S+   +   + +  +   +  I 
Sbjct: 60  K-TRHVNILLFMGY-------STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIA 110

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTP 224
           R+  +G+ YLH   +IHRD+K  N+ L ++  VK+ DFG++    R  G  +     G+ 
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

Query: 225 YWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI----PRN 280
            WMAPEVI   +     Y  +SD+++ GI   E+   Q P  +++    +  +      +
Sbjct: 171 LWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228

Query: 281 APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
                     PK  +  +   L K   +RP   Q+L  
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  216 bits (552), Expect = 3e-67
 Identities = 70/330 (21%), Positives = 141/330 (42%), Gaps = 22/330 (6%)

Query: 29  DDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM 88
           D+++  + K+ Y +  P +   +     +++ E +G G +G V++     TG   A K +
Sbjct: 2   DNYVFDIWKQYYPQ--PVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 59

Query: 89  DVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTD 147
               E ++E ++ EI  +     H  +   + AF        D+++ ++ E+   G + +
Sbjct: 60  MTPHESDKETVRKEIQTMSV-LRHPTLVNLHDAFED------DNEMVMIYEFMSGGELFE 112

Query: 148 LVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT--DNAEVKLVDFG 205
            V     + + E+      R++ +GL ++HEN  +H D+K +N++ T   + E+KL+DFG
Sbjct: 113 KVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171

Query: 206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL 265
           ++A LD          GT  + APEV              +D+WS+G+ +  +     P 
Sbjct: 172 LTAHLDPK-QSVKVTTGTAEFAAPEVAEGKP-----VGYYTDMWSVGVLSYILLSGLSPF 225

Query: 266 CDLHPMRALFLIPRN--APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
              +    L  +                +  + FI  +L+ D + R    Q L+HP++  
Sbjct: 226 GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285

Query: 324 QPT-ERQARIQLKDHIDTCKKRKKERDDYR 352
                R ++I    +       K + D + 
Sbjct: 286 GNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 5e-67
 Identities = 68/316 (21%), Positives = 135/316 (42%), Gaps = 22/316 (6%)

Query: 57  FELI-EVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIA 115
           +++  +V+G G  G+V +  + +T +  A+K++     +  + + E+ +  + S   +I 
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIV 68

Query: 116 TYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKY 175
                +  ++       L +VME    G +   ++    Q+  E   + I + I   ++Y
Sbjct: 69  RIVDVY--ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 176 LHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           LH   + HRD+K +N+L T    NA +KL DFG + +         T   TPY++APEV+
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVL 185

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP------MRALFLIPRNAPPRLK 286
             ++     YD   D+WSLG+    +    PP    H       M+    + +   P  +
Sbjct: 186 GPEK-----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKK 346
             +  ++ +  I  +L  +  QR    + + HP+I       Q  +     +   K+R +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 300

Query: 347 ERDDYRYSGSENEEEE 362
           +  +   S       +
Sbjct: 301 DVKEEMTSALATMRVD 316

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-66
 Identities = 63/296 (21%), Positives = 124/296 (41%), Gaps = 23/296 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           + + E +G G +G V++   T + +    K + V   ++  +K EI++L   + HRNI  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNI-ARHRNILH 65

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            + +F         ++L ++ E+     + + + +     L E  I     ++   L++L
Sbjct: 66  LHESFE------SMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFL 118

Query: 177 HENKVIHRDIKGQNVLLT--DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIAC 234
           H + + H DI+ +N++     ++ +K+++FG + QL             P + APEV   
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH 177

Query: 235 DENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRLKSKKWPK 292
           D          +D+WSLG     +     P       + +  I            K+   
Sbjct: 178 D-----VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 293 KFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKER 348
           +   F++ +LVK+   R    + L+HP+++ Q  ER         I T K R+   
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLK-QKIER----VSTKVIRTLKHRRYYH 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 2e-63
 Identities = 65/275 (23%), Positives = 127/275 (46%), Gaps = 22/275 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+  +++G G++  V   R   T +  AIK+++    + E++   +  E +V+ +  +H 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
                Y  F        D++L+  + Y   G +   ++  K  S  E    F   EI+  
Sbjct: 69  FFVKLYFTFQD------DEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSA 120

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGTPYWMAPE 230
           L+YLH   +IHRD+K +N+LL ++  +++ DFG +  L  +    R N+F+GT  +++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW 290
           ++             SDLW+LG    ++    PP    +       I +        +K+
Sbjct: 181 LLTEKS-----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKF 233

Query: 291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP 325
             K +  +E +LV D  +R   +++  +  ++  P
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 4e-63
 Identities = 79/334 (23%), Positives = 142/334 (42%), Gaps = 24/334 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F L +++G G++G+V+     KT Q  AIK +     + +D+ E   +E  VL     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +   +  F         + L+ VMEY   G +   ++             F   EI+ G
Sbjct: 64  FLTHMFCTFQT------KENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILG 115

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L++LH   +++RD+K  N+LL  +  +K+ DFG+  +      + NTF GTP ++APE++
Sbjct: 116 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK 292
              +     Y++  D WS G+   EM   Q P            I  + P     +   K
Sbjct: 176 LGQK-----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRWLEK 228

Query: 293 KFQSFIETVLVKDYHQRP-YTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKERDDY 351
           + +  +  + V++  +R      + +HP  R+   E   R ++       + + K   D 
Sbjct: 229 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPF---RPKVKSPFDC 285

Query: 352 RYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNF 385
                E   E+  +     ++I +  D  + RNF
Sbjct: 286 SNFDKEFLNEKPRLSFADRALINS-MDQNMFRNF 318

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 9e-62
 Identities = 56/263 (21%), Positives = 111/263 (42%), Gaps = 19/263 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
            +L++ +G G +G V  G +   G   A+K +   +   +    E +V+ +   H N+  
Sbjct: 9   LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-NDATAQAFLAEASVMTQL-RHSNLVQ 64

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G  +++        L++V EY   GS+ D ++S     L  + +     ++   ++YL
Sbjct: 65  LLGVIVEE-----KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE 236
             N  +HRD+  +NVL++++   K+ DFG++ +   T   ++T      W APE +    
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR--- 173

Query: 237 NPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQ 295
             +  +  +SD+WS GI   E+    + P   +     +  + +           P    
Sbjct: 174 --EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPAVY 230

Query: 296 SFIETVLVKDYHQRPYTDQLLKH 318
             ++     D   RP   QL + 
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQ 253

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  198 bits (504), Expect = 5e-61
 Identities = 61/275 (22%), Positives = 118/275 (42%), Gaps = 19/275 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHR 112
           +EL E++G G   +V+  R  +  +  A+KV+              + E        NH 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 67

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I   Y     ++P G     ++VMEY    ++ D+V +     +  +    +  +  + 
Sbjct: 68  AIVAVYDTGEAETPAG--PLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMAP 229
           L + H+N +IHRD+K  N++++    VK++DFG++  +     ++ +    IGT  +++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 230 EVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PPRLKS 287
           E          + D RSD++SLG    E+   +PP     P+   +   R    PP  + 
Sbjct: 184 EQAR-----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
           +       + +   L K+   R  T   ++   +R
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-60
 Identities = 63/281 (22%), Positives = 113/281 (40%), Gaps = 19/281 (6%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEIN 103
           W ED W E P    +L+E +G G +G+V+ G +       A+K +       +    E N
Sbjct: 3   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEAN 60

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIA 163
           ++K+   H+ +   Y            + ++++ EY   GS+ D +K+  G  L    + 
Sbjct: 61  LMKQL-QHQRLVRLYAVVT-------QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL 112

Query: 164 FICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIG 222
            +  +I  G+ ++ E   IHRD++  N+L++D    K+ DFG++  + D     R     
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP 282
              W APE I         +  +SD+WS GI   E+               +        
Sbjct: 173 PIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227

Query: 283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQL---LKHPF 320
             ++    P++    +     +    RP  D L   L+  F
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 7e-60
 Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 28/292 (9%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE-------EEIKLEI 102
           QE+    ++  E +G+G +  V K R   TG   A K +     +        E+I+ E+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 103 NVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWI 162
           ++LK+   H N+ T +  +           + L++E    G + D     + +SL EE  
Sbjct: 65  SILKEI-QHPNVITLHEVYE------NKTDVILILELVAGGELFD--FLAEKESLTEEEA 115

Query: 163 AFICREILRGLKYLHENKVIHRDIKGQNVLLTDN----AEVKLVDFGVSAQLDRTIGRRN 218
               ++IL G+ YLH  ++ H D+K +N++L D       +K++DFG++ ++D       
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK 174

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP 278
              GTP ++APE++  +          +D+WS+G+    +     P         L  + 
Sbjct: 175 NIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

Query: 279 RN--APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTER 328
                             + FI  +LVKD  +R      L+HP+I+ + T++
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  193 bits (490), Expect = 7e-58
 Identities = 71/341 (20%), Positives = 139/341 (40%), Gaps = 34/341 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYS--N 110
           F +  ++G G +G+VY  R   TG++ A+K +D      +  E     E  +L   S  +
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
              I     AF         D+L  +++    G +   +   +     E  + F   EI+
Sbjct: 66  CPFIVCMSYAFHT------PDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEII 117

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
            GL+++H   V++RD+K  N+LL ++  V++ D G++    +   + +  +GT  +MAPE
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPE 175

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK-SKK 289
           V+         YD+ +D +SLG    ++     P           +        ++    
Sbjct: 176 VLQKGVA----YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231

Query: 290 WPKKFQSFIETVLVKDYHQRPYT-----DQLLKHPFIRDQPTERQARIQLKDHIDTCKKR 344
           +  + +S +E +L +D ++R         ++ + PF R    +    + L+ +       
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ---MVFLQKYPPPLIPP 288

Query: 345 KKERDDYRYSGSENEEEETGVGGEPSSIIQAPGDNTLRRNF 385
           + E +        + +EE     +   I     D  L RNF
Sbjct: 289 RGEVNAADAFDIGSFDEE-----DTKGIKLLDSDQELYRNF 324

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 8e-58
 Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 45/300 (15%)

Query: 58  ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT------EDEEEEIKLEINVLKKYSNH 111
           E ++ +G G +  VYK R   T Q+ AIK + +       +        EI +L++  +H
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SH 59

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            NI     AF           + LV ++        +        L    I       L+
Sbjct: 60  PNIIGLLDAFGH------KSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 111

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEV 231
           GL+YLH++ ++HRD+K  N+LL +N  +KL DFG++             + T ++ APE+
Sbjct: 112 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------------- 277
           +         Y    D+W++G    E+    P L     +  L  I              
Sbjct: 172 LFGARM----YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227

Query: 278 ------------PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP 325
                           P               I+ + + +   R    Q LK  +  ++P
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 8e-58
 Identities = 67/293 (22%), Positives = 118/293 (40%), Gaps = 20/293 (6%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL 100
           T+G  +D W E P     L   +G G +G+V+ G    T ++A IK +       E    
Sbjct: 4   TQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQ 61

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEE 160
           E  V+KK   H  +   Y           ++ +++V EY   GS+ D +K   G+ L+  
Sbjct: 62  EAQVMKKL-RHEKLVQLYAVVS-------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 113

Query: 161 WIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNT 219
            +  +  +I  G+ Y+     +HRD++  N+L+ +N   K+ DFG++  + D     R  
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA-ESQPPLCDLHPMRALFLIP 278
                 W APE           +  +SD+WS GI   E+  + + P   +     L  + 
Sbjct: 174 AKFPIKWTAPEAALYGR-----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228

Query: 279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK--HPFIRDQPTERQ 329
           R         + P+     +     K+  +RP  + L      +      + Q
Sbjct: 229 RGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-57
 Identities = 79/313 (25%), Positives = 120/313 (38%), Gaps = 46/313 (14%)

Query: 52  DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKY 108
           D    +E +  +G GT+G+V+K RH KTGQ  A+K + +    E        EI +L+  
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 109 SNHRNIATYYGAFIKKSPPG--KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
             H N+         K+ P       ++LV ++C       L             I  + 
Sbjct: 67  -KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVM 123

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRT----IGRRNTFIG 222
           + +L GL Y+H NK++HRD+K  NVL+T +  +KL DFG++            R    + 
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 223 TPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI----- 277
           T ++  PE++  + +    Y    DLW  G    EM    P +        L LI     
Sbjct: 184 TLWYRPPELLLGERD----YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 278 -------------------------PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYT 312
                                     R    RLK+          I+ +LV D  QR  +
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 313 DQLLKHPFIRDQP 325
           D  L H F    P
Sbjct: 300 DDALNHDFFWSDP 312

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 51/264 (19%), Positives = 109/264 (41%), Gaps = 17/264 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
              ++ +G G +G V  G+  +     AIK++      E+E   E  V+    +H  +  
Sbjct: 6   LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQ 63

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            YG   K         ++++ EY   G + + ++  + +  + + +  +C+++   ++YL
Sbjct: 64  LYGVCTK------QRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL 116

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVIACD 235
              + +HRD+  +N L+ D   VK+ DFG+S  + D              W  PEV+   
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL--- 173

Query: 236 ENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
               + + ++SD+W+ G+   E+    + P            I +      +     +K 
Sbjct: 174 --MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKV 230

Query: 295 QSFIETVLVKDYHQRPYTDQLLKH 318
            + + +   +   +RP    LL +
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 4e-57
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 32/283 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-------DEEEEIKLEINVLKKYS 109
           +++  ++G+G +G VY G         AIK ++               + +E+ +LKK S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 110 -NHRNIATYYGAFIKKSPPGKDDQLWLVMEYC-GAGSVTDLVKSTKGQSLKEEWIAFICR 167
                +      F +       D   L++E       + D +   +  +L+EE       
Sbjct: 66  SGFSGVIRLLDWFER------PDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFW 117

Query: 168 EILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYW 226
           ++L  +++ H   V+HRDIK +N+L+  +  E+KL+DFG  A L  T      F GT  +
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 175

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK 286
             PE I         +   + +WSLGI   +M     P      +    +  R       
Sbjct: 176 SPPEWIRYHRY----HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------- 224

Query: 287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQ 329
            ++   + Q  I   L      RP  +++  HP+++D    ++
Sbjct: 225 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 4e-57
 Identities = 59/264 (22%), Positives = 111/264 (42%), Gaps = 17/264 (6%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
              ++ +G+G +G V+ G         AIK +      EE+   E  V+ K  +H  +  
Sbjct: 7   LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQ 64

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
            YG  ++         + LV E+   G ++D +++ +      E +  +C ++  G+ YL
Sbjct: 65  LYGVCLE------QAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYL 117

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWMAPEVIACD 235
            E  VIHRD+  +N L+ +N  +K+ DFG++  + D              W +PEV +  
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-- 175

Query: 236 ENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKF 294
               + Y ++SD+WS G+   E+ +E + P  +      +  I        K +      
Sbjct: 176 ---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHV 231

Query: 295 QSFIETVLVKDYHQRPYTDQLLKH 318
              +     +    RP   +LL+ 
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 6e-57
 Identities = 63/336 (18%), Positives = 127/336 (37%), Gaps = 49/336 (14%)

Query: 15  EERAELAEKLDKDLDDFIA-GLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYK 73
           E + ++ +      +++      +  Y   W   R         E  +V+G+G +G+V  
Sbjct: 2   ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPREN------LEFGKVLGSGAFGKVMN 55

Query: 74  GRHTKTGQLA-----AIKVM--DVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP 126
                  +       A+K++       E E +  E+ ++ +  +H NI    GA      
Sbjct: 56  ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--- 112

Query: 127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQ---------------------SLKEEWIAFI 165
                 ++L+ EYC  G + + ++S + +                      L  E +   
Sbjct: 113 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 169

Query: 166 CREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL--DRTIGRRNTFIGT 223
             ++ +G+++L     +HRD+  +NVL+T    VK+ DFG++  +  D     R      
Sbjct: 170 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229

Query: 224 PYWMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAP 282
             WMAPE +      +  Y  +SD+WS GI   E+ +    P   +      + + +N  
Sbjct: 230 VKWMAPESLF-----EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284

Query: 283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
              +     ++    +++    D  +RP    L   
Sbjct: 285 KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-56
 Identities = 79/312 (25%), Positives = 127/312 (40%), Gaps = 41/312 (13%)

Query: 41  TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKL 100
           T G   DR QE     +   +V+GNG++G VY+ +   +G+L AIK +     ++     
Sbjct: 9   TPGQGPDRPQEVS---YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNR 62

Query: 101 EINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK-STKGQSLKE 159
           E+ +++K  +H NI      F        +  L LV++Y            S   Q+L  
Sbjct: 63  ELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 160 EWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGRRN 218
            ++     ++ R L Y+H   + HRDIK QN+LL  D A +KL DFG + QL R      
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNV 180

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI- 277
           ++I + Y+ APE+I    +    Y +  D+WS G    E+   QP       +  L  I 
Sbjct: 181 SYICSRYYRAPELIFGATD----YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236

Query: 278 ------------------PRNAPPRLKSKKWPKKFQ--------SFIETVLVKDYHQRPY 311
                                  P++K+  W K F+        +    +L      R  
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296

Query: 312 TDQLLKHPFIRD 323
             +   H F  +
Sbjct: 297 PLEACAHSFFDE 308

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  187 bits (475), Expect = 3e-56
 Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 28/276 (10%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+++  +G G++G+V+  R    G+  A+KV+     V   + E    E  +L     H 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 64

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            I   +G F          Q++++M+Y   G +  L++ ++          F   E+   
Sbjct: 65  FIIRMWGTFQD------AQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVCLA 116

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L+YLH   +I+RD+K +N+LL  N  +K+ DFG +  +        T  GTP ++APEV+
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVV 173

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK 292
           +        Y+   D WS GI   EM     P  D + M+    I            + +
Sbjct: 174 STKP-----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNE 226

Query: 293 KFQSFIETVLVKDYHQRPYT-----DQLLKHPFIRD 323
             +  +  ++ +D  QR        + +  HP+ ++
Sbjct: 227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-56
 Identities = 62/277 (22%), Positives = 115/277 (41%), Gaps = 27/277 (9%)

Query: 57  FELIEVV-GNGTYGQVYKGRH--TKTGQLAAIKVM--DVTEDEEEEIKLEINVLKKYSNH 111
             + ++  G G +G V +G +   K     AIKV+     + + EE+  E  ++ +  ++
Sbjct: 10  LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ-LDN 68

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
             I    G         + + L LVME  G G +   +   + + +    +A +  ++  
Sbjct: 69  PYIVRLIGVC-------QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSM 120

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYWMA 228
           G+KYL E   +HRD+  +NVLL +    K+ DFG+S  L   D     R+       W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPRLKS 287
           PE I   +     + +RSD+WS G+T  E  +  Q P   +     +  I +        
Sbjct: 181 PECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-P 234

Query: 288 KKWPKKFQSFIETVLVKDYHQRPYTDQL---LKHPFI 321
            + P +  + +    +  +  RP    +   ++  + 
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (470), Expect = 1e-55
 Identities = 55/286 (19%), Positives = 105/286 (36%), Gaps = 33/286 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIAT 116
           + L   +G+G++G +Y G     G+  AIK+  V + +  ++ +E  + K       I T
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPT 67

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
                       + D   +VME  G     + + +   +    + +  +  +++  ++Y+
Sbjct: 68  IRWCGA------EGDYNVMVMELLGPS--LEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 177 HENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSAQLD-------RTIGRRNTFIGTPYW 226
           H    IHRD+K  N L+        V ++DFG++ +                   GT  +
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA----- 281
            +       E        R DL SLG   +       P   L          R +     
Sbjct: 180 ASINTHLGIE-----QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 282 -PPRLKSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKHPFIRD 323
            P  +  K +P +F +++       +  +P   Y  QL ++ F R 
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-55
 Identities = 70/298 (23%), Positives = 119/298 (39%), Gaps = 39/298 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKT-GQLAAIKVMDV---TEDEEEEIKLEINVLKKYS--N 110
           +E +  +G G YG+V+K R  K  G+  A+K + V    E        E+ VL+      
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H N+   +          ++ +L LV E+     +T  +       +  E I  +  ++L
Sbjct: 69  HPNVVRLFDVCTVSRTD-RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPE 230
           RGL +LH ++V+HRD+K QN+L+T + ++KL DFG  A++        + + T ++ APE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG-LARIYSFQMALTSVVVTLWYRAPE 185

Query: 231 VIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI------------- 277
           V+         Y    DLWS+G    EM   +P       +  L  I             
Sbjct: 186 VLLQSS-----YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 278 ------------PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
                           P         +  +  +   L  +  +R      L HP+ +D
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 7e-55
 Identities = 68/330 (20%), Positives = 123/330 (37%), Gaps = 44/330 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE--EEIKLEINVLKKYSNHRNI 114
           +  +  +G G YG V            AIK +   E +   +    EI +L ++  H NI
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENI 68

Query: 115 ATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLK 174
                    ++P  +  +   ++ +     +  L+K+   Q L  + I +   +ILRGLK
Sbjct: 69  IGINDII--RAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123

Query: 175 YLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD---RTIGRRNTFIGTPYWMAPEV 231
           Y+H   V+HRD+K  N+LL    ++K+ DFG++   D      G    ++ T ++ APE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 232 IACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI-------------- 277
           +   +     Y    D+WS+G    EM  ++P     H +  L  I              
Sbjct: 184 MLNSKG----YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 278 ---------------PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR 322
                              P          K    ++ +L  + H+R   +Q L HP++ 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299

Query: 323 DQPTERQARIQLKDHIDTCKKRKKERDDYR 352
                    I         +     ++  +
Sbjct: 300 QYYDPSDEPIAEAPFKFDMELDDLPKEKLK 329

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 9e-55
 Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 32/281 (11%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQL--AAIKVMD--VTEDEEEEIKLEINVLKKYSNHR 112
            +  +V+G G +GQV K R  K G    AAIK M    ++D+  +   E+ VL K  +H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVK--------------STKGQSLK 158
           NI    GA            L+L +EY   G++ D ++              ++   +L 
Sbjct: 72  NIINLLGACEH------RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 159 EEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRN 218
            + +     ++ RG+ YL + + IHRD+  +N+L+ +N   K+ DFG+ ++      ++ 
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKT 184

Query: 219 TFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLI 277
                  WMA E +       + Y   SD+WS G+   E+      P C +        +
Sbjct: 185 MGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239

Query: 278 PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
           P+      K      +    +     +  ++RP   Q+L  
Sbjct: 240 PQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  181 bits (461), Expect = 2e-54
 Identities = 52/295 (17%), Positives = 100/295 (33%), Gaps = 35/295 (11%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
              +++   +G G++G +++G +    Q  AIK       +  +++ E    K  +    
Sbjct: 4   GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTG 62

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y          +     LV++  G      L     G+    + +A   +++L  +
Sbjct: 63  IPNVYYFGQ------EGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARV 114

Query: 174 KYLHENKVIHRDIKGQNVLLTD-----NAEVKLVDFGVSAQLDRTIG-------RRNTFI 221
           + +HE  +++RDIK  N L+          + +VDFG+       +         +    
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 222 GTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI---- 277
           GT  +M+       E        R DL +LG   +       P   L             
Sbjct: 175 GTARYMSINTHLGRE-----QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229

Query: 278 --PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRP---YTDQLLKHPFIRDQPTE 327
              ++ P R     +P++F  ++       +   P   Y   L      R   TE
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 2e-54
 Identities = 60/273 (21%), Positives = 107/273 (39%), Gaps = 25/273 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRH---TKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYS 109
             L+E +G+G++G V +G     +      A+K +        +  ++   E+N +    
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL- 68

Query: 110 NHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREI 169
           +HRN+   YG  +          + +V E    GS+ D ++  +G       ++    ++
Sbjct: 69  DHRNLIRLYGVVL-------TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQV 120

Query: 170 LRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL---DRTIGRRNTFIGTPYW 226
             G+ YL   + IHRD+  +N+LL     VK+ DFG+   L   D     +        W
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPRL 285
            APE +        T+ + SD W  G+T  EM    Q P   L+  + L  I +      
Sbjct: 181 CAPESLK-----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
           + +  P+   + +          RP    L   
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-54
 Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 25/276 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHR 112
           F+ ++++G GT+G+V   R   TG+  A+K++     + +DE      E  VL+  + H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65

Query: 113 NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRG 172
            +     AF         D+L  VMEY   G +   +   + +   EE   F   EI+  
Sbjct: 66  FLTALKYAFQT------HDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSA 117

Query: 173 LKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVI 232
           L+YLH   V++RDIK +N++L  +  +K+ DFG+  +         TF GTP ++APEV+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 233 ACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK 292
             ++     Y    D W LG+   EM   + P  +    R   LI          +    
Sbjct: 178 EDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSP 230

Query: 293 KFQSFIETVLVKDYHQRPYT-----DQLLKHPFIRD 323
           + +S +  +L KD  QR         ++++H F   
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 7e-54
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 42/297 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           F+ +E +G GTYG VYK R+  TG++ A+K + +   TE        EI++LK+  NH N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPN 62

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I               +++L+LV E+         + ++    +    I     ++L+GL
Sbjct: 63  IVKLLDVIHT------ENKLYLVFEFLHQDL-KKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            + H ++V+HRD+K QN+L+     +KL DFG++      +      + T ++ APE++ 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP----------- 282
             +     Y    D+WSLG    EM   +        +  LF I R              
Sbjct: 176 GCKY----YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query: 283 ---------PRLKSKKWPKKF-------QSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
                    P+   + + K         +S +  +L  D ++R      L HPF +D
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 58/271 (21%), Positives = 113/271 (41%), Gaps = 28/271 (10%)

Query: 62  VVGNGTYGQVYKGRH--TKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRNIAT 116
            +G+G +G V KG +   K  +  A+K++         ++E+  E NV+++  ++  I  
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 72

Query: 117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYL 176
             G         + +   LVME    G +   ++  + + +K++ I  +  ++  G+KYL
Sbjct: 73  MIGIC-------EAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYL 123

Query: 177 HENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD---RTIGRRNTFIGTPYWMAPEVIA 233
            E+  +HRD+  +NVLL      K+ DFG+S  L         +        W APE I 
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 234 CDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK 292
             +     + ++SD+WS G+   E  +  Q P   +       ++ +           P+
Sbjct: 184 YYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPR 237

Query: 293 KFQSFIETVLVKDYHQRPYTDQL---LKHPF 320
           +    +      D   RP    +   L++ +
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-53
 Identities = 66/315 (20%), Positives = 122/315 (38%), Gaps = 24/315 (7%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVM------DVTEDEEEEIKLEINVLKKYSN 110
           F+ I+V+G+G +G VYKG     G+   I V         +    +EI  E  V+    +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           + ++    G  +          + L+ +    G + D V+  K      +++   C +I 
Sbjct: 70  NPHVCRLLGICL-------TSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIA 121

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNT--FIGTPYWMA 228
           +G+ YL + +++HRD+  +NVL+     VK+ DFG++  L       +         WMA
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 229 PEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK 288
            E I         Y ++SD+WS G+T  E+        D  P   +  I        +  
Sbjct: 182 LESILHRI-----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 236

Query: 289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARIQLKDHIDTCKKRKKER 348
                    +    + D   RP   +L+       +  +R   IQ  + +        + 
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL--PSPTDS 294

Query: 349 DDYRYSGSENEEEET 363
           + YR    E + ++ 
Sbjct: 295 NFYRALMDEEDMDDV 309

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (456), Expect = 4e-53
 Identities = 82/367 (22%), Positives = 145/367 (39%), Gaps = 45/367 (12%)

Query: 13  TDEERAELAEKLDKDLDDFIAGLEKRSYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVY 72
              E+  + E L K  +DF+   E  S      +          F+ I+ +G G++G+V 
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ---------FDRIKTLGTGSFGRVM 58

Query: 73  KGRHTKTGQLAAIKVMD----VTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG 128
             +H ++G   A+K++D    V   + E    E  +L+   N   +     +F       
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD----- 112

Query: 129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKG 188
            +  L++VMEY   G +   ++  +     E    F   +I+   +YLH   +I+RD+K 
Sbjct: 113 -NSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169

Query: 189 QNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDL 248
           +N+L+     +++ DFG +    R  GR  T  GTP  +APE+I         Y+   D 
Sbjct: 170 ENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKG-----YNKAVDW 221

Query: 249 WSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQ 308
           W+LG+   EMA   PP     P++    I            +    +  +  +L  D  +
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKDLLRNLLQVDLTK 279

Query: 309 RPYT-----DQLLKHPFIRD--------QPTERQARIQLKDHIDTCKKRKKERDDYRYSG 355
           R        + +  H +           +  E     + K   DT      E ++ R S 
Sbjct: 280 RFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSI 339

Query: 356 SENEEEE 362
           +E   +E
Sbjct: 340 NEKCGKE 346

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (450), Expect = 7e-53
 Identities = 56/272 (20%), Positives = 115/272 (42%), Gaps = 14/272 (5%)

Query: 47  DRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLK 106
           D+W+ +      +   +G G YG+VY+G   K     A+K +     E EE   E  V+K
Sbjct: 10  DKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 68

Query: 107 KYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFIC 166
           +   H N+    G   +      +   +++ E+   G++ D ++    Q +    + ++ 
Sbjct: 69  EI-KHPNLVQLLGVCTR------EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 167 REILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI-GTPY 225
            +I   ++YL +   IHRD+  +N L+ +N  VK+ DFG+S  +       +        
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181

Query: 226 WMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL 285
           W APE +A ++     +  +SD+W+ G+   E+A           +  ++ +        
Sbjct: 182 WTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
           + +  P+K    +      +   RP   ++ +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (449), Expect = 1e-52
 Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 25/280 (8%)

Query: 50  QEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVM--DVTEDEEEEIKLEINV 104
           +E      ++ +V+G G +G+V  G     G+     AIK +    TE +  +   E ++
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80

Query: 105 LKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
           + ++ +H N+    G   K         + ++ E+   GS+   ++   GQ      +  
Sbjct: 81  MGQF-DHPNVIHLEGVVTK------STPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVG 132

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-----DRTIGRRNT 219
           + R I  G+KYL +   +HRD+  +N+L+  N   K+ DFG+S  L     D T      
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192

Query: 220 FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIP 278
                 W APE I   +     + + SD+WS GI   E+ +  + P  D+     +  I 
Sbjct: 193 GKIPIRWTAPEAIQYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247

Query: 279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
           ++          P      +     KD + RP   Q++  
Sbjct: 248 QDYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  176 bits (447), Expect = 1e-52
 Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 44/297 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRN 113
           +  +E +G GTYG VYK ++   G+  A+K + +    E        EI++LK+   H N
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSN 61

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   Y             +L LV E+        L     G  L+         ++L G+
Sbjct: 62  IVKLYDVIHT------KKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGI 113

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            Y H+ +V+HRD+K QN+L+    E+K+ DFG++      + +    I T ++ AP+V+ 
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLI---------------- 277
             +     Y    D+WS+G    EM    P    +     L  I                
Sbjct: 174 GSKK----YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 278 -----------PRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
                          P     K   +     +  +L  D +QR    Q L+H + ++
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-52
 Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 38/298 (12%)

Query: 46  EDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVMDVT--EDEEEEI 98
           + +W E P       + +G G +G+V +        +      A+K++  +    E E +
Sbjct: 15  DHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73

Query: 99  KLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQ--- 155
             E+ VL    NH NI    GA              ++ EYC  G + + ++  +     
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTI------GGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 156 -------------SLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV 202
                        +L  E +     ++ +G+ +L     IHRD+  +N+LLT     K+ 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 203 DFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM-A 259
           DFG++  +  D     +        WMAPE I      +  Y   SD+WS GI   E+ +
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESI-----FNCVYTFESDVWSYGIFLWELFS 242

Query: 260 ESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
               P   +      + + +     L  +  P +    ++T    D  +RP   Q+++
Sbjct: 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-52
 Identities = 61/269 (22%), Positives = 107/269 (39%), Gaps = 22/269 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLA---AIKVMDVTEDEE--EEIKLEINVLKKYSNH 111
            EL   +G G +G V++G +      A   AIK       +   E+   E   ++++ +H
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DH 67

Query: 112 RNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILR 171
            +I    G          ++ +W++ME C  G +   ++  K  SL    +     ++  
Sbjct: 68  PHIVKLIGVIT-------ENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLST 119

Query: 172 GLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI-GTPYWMAPE 230
            L YL   + +HRDI  +NVL++ N  VKL DFG+S  ++ +   + +       WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 231 VIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPRLKSKK 289
            I         + + SD+W  G+   E+      P   +     +  I       +    
Sbjct: 180 SINFRR-----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPN 233

Query: 290 WPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
            P    S +      D  +RP   +L   
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 1e-51
 Identities = 68/297 (22%), Positives = 117/297 (39%), Gaps = 41/297 (13%)

Query: 54  AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN 113
           A    L E +G G +G+V++G+    G+  A+K+    E+     + EI        H N
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML-RHEN 58

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I  +  A  K +      QLWLV +Y   GS+ D +      ++  E +  +      GL
Sbjct: 59  ILGFIAADNKDNGTWT--QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGL 113

Query: 174 KYLHE--------NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL----DRTIGRRNTFI 221
            +LH           + HRD+K +N+L+  N    + D G++ +     D      N  +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 222 GTPYWMAPEVIACDENPDA-TYDNRSDLWSLGITALEMA----------ESQPPLCDLHP 270
           GT  +MAPEV+    N        R+D++++G+   E+A          + Q P  DL P
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 271 MRALF----------LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
                           +  N P R +S +  +     +      +   R    ++ K
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-51
 Identities = 77/328 (23%), Positives = 134/328 (40%), Gaps = 45/328 (13%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           +  ++ VG+G YG V      +TG   AIK +     +E   +    E+ +LK    H N
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHEN 78

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +      F            +LVM + G   +  L+K  K   L E+ I F+  ++L+GL
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEK---LGEDRIQFLVYQMLKGL 134

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           +Y+H   +IHRD+K  N+ + ++ E+K++DFG++ Q D        ++ T ++ APEVI 
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVIL 191

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-------------- 279
                   Y    D+WS+G    EM   +        +  L  I +              
Sbjct: 192 NWMR----YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 280 --------NAPPRLKSKKWPKKF-------QSFIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
                      P L+ K +            + +E +LV D  QR    + L HP+    
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

Query: 325 PTERQARIQLKDHIDTCKKRKKERDDYR 352
                   Q++ + D+     +  D+++
Sbjct: 308 HDTEDEP-QVQKYDDSFDDVDRTLDEWK 334

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  175 bits (443), Expect = 2e-51
 Identities = 66/323 (20%), Positives = 125/323 (38%), Gaps = 60/323 (18%)

Query: 45  PEDRWQEDPAGI-------FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEE 97
           P + W  +   +       ++L+  +G G Y +V++  +    +   +K++     ++++
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKK 75

Query: 98  IKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSL 157
           IK EI +L+      NI T                  LV E+        L      Q+L
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPV----SRTPALVFEHVNNTDFKQLY-----QTL 126

Query: 158 KEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT-DNAEVKLVDFGVSAQLDRTIGR 216
            +  I F   EIL+ L Y H   ++HRD+K  NV++  ++ +++L+D+G++         
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QE 185

Query: 217 RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPL----------- 265
            N  + + Y+  PE++   +     YD   D+WSLG     M   + P            
Sbjct: 186 YNVRVASRYFKGPELLVDYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 266 -----------CDLHPMRALFLIPR--NAPPRLKSKKWPKKFQS------------FIET 300
                       D      + L PR  +   R   K+W +   S            F++ 
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 301 VLVKDYHQRPYTDQLLKHPFIRD 323
           +L  D+  R    + ++HP+   
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYT 324

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-51
 Identities = 69/299 (23%), Positives = 125/299 (41%), Gaps = 36/299 (12%)

Query: 45  PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKT-------GQLAAIKVM--DVTEDEE 95
           PED   E P     L + +G G +GQV                   A+K++  D TE + 
Sbjct: 3   PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 62

Query: 96  EEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG- 154
            ++  E+ ++K    H+NI    GA  +      D  L++++EY   G++ + +++ +  
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQ------DGPLYVIVEYASKGNLREYLQARRPP 116

Query: 155 -------------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
                        + L  + +     ++ RG++YL   K IHRD+  +NVL+T++  +K+
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 176

Query: 202 VDFGVSAQLDRTIGRRNT--FIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            DFG++  +      + T        WMAPE +      D  Y ++SD+WS G+   E+ 
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIF 231

Query: 260 ESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
                     P+  LF + +      K      +    +         QRP   QL++ 
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 1e-50
 Identities = 56/299 (18%), Positives = 110/299 (36%), Gaps = 45/299 (15%)

Query: 51  EDPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVM--DVTEDEEEEIKLEIN 103
           E P    E +  +G G +G+V++ R       +   + A+K++  + + D + + + E  
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68

Query: 104 VLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS------- 156
           ++ ++ ++ NI    G             + L+ EY   G + + ++S    +       
Sbjct: 69  LMAEF-DNPNIVKLLGVCAV------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 157 ---------------LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKL 201
                          L       I R++  G+ YL E K +HRD+  +N L+ +N  VK+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181

Query: 202 VDFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMA 259
            DFG+S  +                 WM PE I         Y   SD+W+ G+   E+ 
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIF 236

Query: 260 ESQ-PPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
                P   +     ++ +          +  P +  + +     K    RP    + +
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 9e-50
 Identities = 66/299 (22%), Positives = 123/299 (41%), Gaps = 35/299 (11%)

Query: 44  WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGR-----HTKTGQLAAIKVM--DVTEDEEE 96
           +   +W E P    +L + +G G +GQV +        T T +  A+K++    T  E  
Sbjct: 3   YDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61

Query: 97  EIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQS 156
            +  E+ +L    +H N+    GA  K         L +++E+C  G+++  ++S + + 
Sbjct: 62  ALMSELKILIHIGHHLNVVNLLGACTKP-----GGPLMVIVEFCKFGNLSTYLRSKRNEF 116

Query: 157 --------------LKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLV 202
                         L  E +     ++ +G+++L   K IHRD+  +N+LL++   VK+ 
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 176

Query: 203 DFGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEM-A 259
           DFG++  +  D    R+        WMAPE I      D  Y  +SD+WS G+   E+ +
Sbjct: 177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFS 231

Query: 260 ESQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
               P   +          +             +    +      +  QRP   +L++H
Sbjct: 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 3e-49
 Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 44/298 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEE---EEIKLEINVLKKYSNHRN 113
           +E +E +G GTYG V+K ++ +T ++ A+K + + +D+E        EI +LK+   H+N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKN 62

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I   +           D +L LV E+C                   E +     ++L+GL
Sbjct: 63  IVRLHDVLHS------DKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGL 114

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
            + H   V+HRD+K QN+L+  N E+KL +FG++      +   +  + T ++  P+V+ 
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF------------------ 275
             +     Y    D+WS G    E+A +  PL   + +                      
Sbjct: 175 GAKL----YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 276 ----------LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD 323
                     + P          K     +  ++ +L  +  QR   ++ L+HP+  D
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-48
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 27/283 (9%)

Query: 57  FELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKY 108
           FEL++V+G G YG+V+  R      TG+L A+KV+            E  + E  VL+  
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 109 SNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICRE 168
                + T + AF        + +L L+++Y   G +   +   + +   E  +     E
Sbjct: 86  RQSPFLVTLHYAFQT------ETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGE 137

Query: 169 ILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL-DRTIGRRNTFIGTPYWM 227
           I+  L++LH+  +I+RDIK +N+LL  N  V L DFG+S +       R   F GT  +M
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN--APPRL 285
           AP+++   ++    +D   D WSLG+   E+     P        +   I R        
Sbjct: 198 APDIVRGGDSG---HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYT-----DQLLKHPFIRD 323
             ++     +  I+ +L+KD  +R        D++ +H F + 
Sbjct: 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 4e-48
 Identities = 52/273 (19%), Positives = 110/273 (40%), Gaps = 23/273 (8%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTK---TGQLAAIKVMD--VTEDEEEEIKLEINVLKKYSN 110
           I    EV+G G +G VY G            A+K ++      E  +   E  ++K + +
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-S 86

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H N+ +  G  ++      +    +V+ Y   G + + ++  +  +   + +     ++ 
Sbjct: 87  HPNVLSLLGICLRS-----EGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVA 140

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD----RTIGRRNTFIGTPYW 226
           +G+K+L   K +HRD+  +N +L +   VK+ DFG++  +      ++  +        W
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200

Query: 227 MAPEVIACDENPDATYDNRSDLWSLGITALEM-AESQPPLCDLHPMRALFLIPRNAPPRL 285
           MA E +   +     +  +SD+WS G+   E+     PP  D++       + +     L
Sbjct: 201 MALESLQTQK-----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-L 254

Query: 286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH 318
           + +  P      +          RP   +L+  
Sbjct: 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 7e-47
 Identities = 58/270 (21%), Positives = 102/270 (37%), Gaps = 22/270 (8%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVM--DVTEDEEEEIKLEINVLKKYSN 110
               +V+G G +G+VYKG    +        AIK +    TE +  +   E  ++ ++ +
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-S 67

Query: 111 HRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREIL 170
           H NI    G   K         + ++ EY   G++   ++   G+      +  + R I 
Sbjct: 68  HHNIIRLEGVISK------YKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIA 120

Query: 171 RGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFI---GTPYWM 227
            G+KYL     +HRD+  +N+L+  N   K+ DFG+S  L+       T         W 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 228 APEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKS 287
           APE I+  +   A     SD+WS GI   E+               +     +       
Sbjct: 181 APEAISYRKFTSA-----SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235

Query: 288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLK 317
              P      +     ++  +RP    ++ 
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (409), Expect = 3e-46
 Identities = 64/340 (18%), Positives = 127/340 (37%), Gaps = 56/340 (16%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           ++ ++ +G+G  G V         +  AIK +      +   +    E+ ++K   NH+N
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC-VNHKN 77

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           I +    F  +    +   ++LVME   A     +           E ++++  ++L G+
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGI 132

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           K+LH   +IHRD+K  N+++  +  +K++DFG++     +      ++ T Y+ APEVI 
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL 191

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP----------- 282
                   Y    D+WS+G    EM   +        +     +                
Sbjct: 192 GMG-----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 283 ----------PRLKSKKWPKKF-------------------QSFIETVLVKDYHQRPYTD 313
                     P+     +PK F                   +  +  +LV D  +R   D
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 314 QLLKHPFIRDQPTERQARIQLKDHID-TCKKRKKERDDYR 352
             L+HP+I       +         D    +R+   ++++
Sbjct: 307 DALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 1e-45
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 44/301 (14%)

Query: 57  FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMD---VTEDEEEEIKLEINVLKKYSNHRN 113
           ++ +  VG+G YG V     TKTG   A+K +     +    +    E+ +LK    H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHEN 78

Query: 114 IATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGL 173
           +      F       + + ++LV    G     DL    K Q L ++ + F+  +ILRGL
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGL 134

Query: 174 KYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIA 233
           KY+H   +IHRD+K  N+ + ++ E+K++DFG++   D        ++ T ++ APE++ 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIML 191

Query: 234 CDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-------------- 279
              +    Y+   D+WS+G    E+   +        +  L LI R              
Sbjct: 192 NWMH----YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 280 --------NAPPRLKSKKWPKKFQS-------FIETVLVKDYHQRPYTDQLLKHPFIRDQ 324
                    +  ++    +   F          +E +LV D  +R    Q L H +    
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 325 P 325
            
Sbjct: 308 H 308

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-45
 Identities = 61/309 (19%), Positives = 118/309 (38%), Gaps = 38/309 (12%)

Query: 39  SYTEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMD--VT 91
           S  + +  D W E       +   +G G++G VY+G        +     AIK ++   +
Sbjct: 5   SAADVYVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 92  EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKS 151
             E  E   E +V+K++ N  ++    G   +           ++ME    G +   ++S
Sbjct: 64  MRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ------GQPTLVIMELMTRGDLKSYLRS 116

Query: 152 TKG--------QSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVD 203
            +                +  +  EI  G+ YL+ NK +HRD+  +N ++ ++  VK+ D
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176

Query: 204 FGVSAQL--DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE- 260
           FG++  +       +    +    WM+PE +      D  +   SD+WS G+   E+A  
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATL 231

Query: 261 SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK--- 317
           ++ P   L   + L  +        K    P      +      +   RP   +++    
Sbjct: 232 AEQPYQGLSNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

Query: 318 ---HPFIRD 323
               P  R+
Sbjct: 291 EEMEPGFRE 299

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (324), Expect = 4e-34
 Identities = 62/341 (18%), Positives = 118/341 (34%), Gaps = 74/341 (21%)

Query: 55  GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKK------- 107
             + L+  +G G +  V+  +        A+K++   +   E  + EI +L++       
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72

Query: 108 ---YSNHRNIATYYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
                   +I      F  K P G    + +V E  G  ++  L+K  + + +   ++  
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGV--HVVMVFEVLG-ENLLALIKKYEHRGIPLIYVKQ 129

Query: 165 ICREILRGLKYLHEN-KVIHRDIKGQNVLLTDN------AEVKLVDFGVSAQLDRTIGRR 217
           I +++L GL Y+H    +IH DIK +NVL+          ++K+ D G +   D      
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HY 186

Query: 218 NTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPP------------- 264
              I T  + +PEV+         +   +D+WS      E+                   
Sbjct: 187 TNSIQTREYRSPEVLLGAP-----WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

Query: 265 ------------------------LCDLHPMRALFLIPRNAPPRLK---------SKKWP 291
                                       +    L  I +     L+         SK   
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

Query: 292 KKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPTERQARI 332
           K+   F+  +L  D  +R     L+ HP+++D     + R+
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.0 bits (225), Expect = 5e-22
 Identities = 31/218 (14%), Positives = 72/218 (33%), Gaps = 43/218 (19%)

Query: 56  IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIK----------LEINVL 105
           +  + +++G G    V+     +      +K   V     +++K            + + 
Sbjct: 1   VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 106 KKYSNHRNIATYYGAFIKKSPPGKD-DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAF 164
              +  R +    G  +   P     +   ++ME   A          +   ++ E    
Sbjct: 60  SARNEFRALQKLQGLAV---PKVYAWEGNAVLMELIDAK---------ELYRVRVENPDE 107

Query: 165 ICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIGRRNTFIGTP 224
           +   IL  +   +   ++H D+   NVL+++   + ++DF  S ++              
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEE----------- 155

Query: 225 YWMAPEVIACDENPDATYDNR-----SDLWSLGITALE 257
                E++  D     TY +R      D+ S     L+
Sbjct: 156 --GWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	463
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.6
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.63
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.41
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.95

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-63  Score=474.02  Aligned_cols=257  Identities=42%  Similarity=0.755  Sum_probs=227.7

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++.++|++++.||+|+||+||+|+++.+|+.||||++... ....+.+.+|+.+|+.+ +|||||+++++|      ...
T Consensus        17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~------~~~   89 (293)
T d1yhwa1          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSY------LVG   89 (293)
T ss_dssp             CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEE------EET
T ss_pred             CcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEE------EEC
Confidence            3456799999999999999999999999999999999743 33457789999999999 899999999999      445


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|||||||+||+|.+++...   .+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus        90 ~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1          90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence            7899999999999999988653   5999999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKK  289 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~  289 (463)
                      ..........+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+....+..+.....+.. ....
T Consensus       167 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T d1yhwa1         167 TPEQSKRSTMVGTPYWMAPEVVT-----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK  241 (293)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHS-----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred             ccccccccccccCCCccChhhhc-----CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence            65555556778999999999997     56789999999999999999999999998888777766554443332 3456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         290 WPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       290 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +++++++||.+||..||.+|||++|+|+||||+.
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            8999999999999999999999999999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-62  Score=471.83  Aligned_cols=265  Identities=44%  Similarity=0.863  Sum_probs=233.2

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.+.|++++.||+|+||+||+|+++.+|..||+|++... ....+.+.+|+++|+++ +|||||++++++      ...+
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~------~~~~   82 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAF------YYEN   82 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEE------EETT
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE------eeCC
Confidence            445799999999999999999999999999999999753 34456788999999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|||||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC
Confidence            9999999999999999987543 369999999999999999999999999999999999999999999999999998776


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCC-CCCCC
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRL-KSKKW  290 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~  290 (463)
                      .........+||+.|+|||++.........|+.++|||||||++|+|++|++||.+.+..+.+..+.....+.. ....+
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW  241 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGS
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccC
Confidence            54444456789999999999976554467799999999999999999999999999888888777766654443 34578


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ++++++||.+||+.||.+|||++|+|+||||+...
T Consensus       242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999999998543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-62  Score=465.54  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=216.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....  ...+.+.+|+.+|+++ +|||||++++++      .+.+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~------~~~~   76 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHR------REGN   76 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEE------EETT
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeee------ccCc
Confidence            457999999999999999999999999999999997543  2345688999999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|||||||+||+|.+++...  ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             eeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            999999999999999998643  379999999999999999999999999999999999999999999999999998764


Q ss_pred             cc--cCccccccCCccccccceeccCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc-CCCCCCCCC
Q psy7384         212 RT--IGRRNTFIGTPYWMAPEVIACDENPDAT-YDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP-RNAPPRLKS  287 (463)
Q Consensus       212 ~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~  287 (463)
                      ..  .......+||+.|||||++.     +.. ++.++|||||||++|+|++|++||............. .........
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~  229 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLK-----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW  229 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHH-----CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred             cCCccccccceeeCcCccCHhHhc-----CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence            32  22345678999999999997     344 4678999999999999999999997766544433322 222222333


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ..+++++++||.+||+.||.+|||++|+|+||||++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            578999999999999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-62  Score=460.81  Aligned_cols=251  Identities=30%  Similarity=0.502  Sum_probs=223.2

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++...    ......+.+|+.+|+.+ +|||||++++++      .+.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~------~~~   78 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYF------HDA   78 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEE------ECS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEE------EEC
Confidence            4699999999999999999999999999999998632    23456788999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|||||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             CEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence            79999999999999999998655  6999999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...  .....+||+.|+|||++.     +..|+.++|||||||++|+|++|++||.+.+....+..+.+....  .+..+
T Consensus       157 ~~~--~~~~~~Gt~~Y~APE~~~-----~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~  227 (263)
T d2j4za1         157 PSS--RRTTLCGTLDYLPPEMIE-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFV  227 (263)
T ss_dssp             CCC--CCEETTEEGGGCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTS
T ss_pred             CCC--cccccCCCCcccCHHHHc-----CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCccC
Confidence            543  235568999999999997     567899999999999999999999999988887777766555432  23468


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      ++++++||.+||+.||.+|||++|+|+||||+.
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999999999999963

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-62  Score=471.44  Aligned_cols=260  Identities=39%  Similarity=0.755  Sum_probs=229.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      +++..+|++++.||+|+||+||+|++..+|+.||||++....    ...+.+.+|+.+|+++ +|||||+++++|.    
T Consensus        11 ~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~----   85 (309)
T d1u5ra_          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYL----   85 (309)
T ss_dssp             SCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEE----
T ss_pred             cCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEE----
Confidence            455667999999999999999999999999999999997543    2335688999999999 8999999999994    


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                        +.+.+|||||||.+|+|..++...+  .+++..++.+++||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus        86 --~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          86 --REHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             --ETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             --ECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccc
Confidence              4578999999999999977665443  699999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         207 SAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      |......    ...+||+.|||||++.+..  ...|+.++|||||||++|||++|.+||.+.+....+..+.....+...
T Consensus       162 a~~~~~~----~~~~GT~~Y~APE~~~~~~--~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~  235 (309)
T d1u5ra_         162 ASIMAPA----NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ  235 (309)
T ss_dssp             CBSSSSB----CCCCSCGGGCCHHHHTTTT--SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred             ccccCCC----CccccCccccCHHHHhccC--CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            9876543    4568999999999996432  356899999999999999999999999998888888877777777777


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      ...+++++++||.+||..||.+|||++|+|+||||....
T Consensus       236 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            778999999999999999999999999999999997543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-61  Score=459.57  Aligned_cols=256  Identities=30%  Similarity=0.574  Sum_probs=211.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.|++++.||+|+||+||+|+++.+|+.||+|++...   ....+.+.+|+++|+++ +|||||++++++..    +.++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~----~~~~   78 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIID----RTNT   78 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC--------
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEe----CCCC
Confidence            4699999999999999999999999999999998643   33456688999999999 89999999999854    2346


Q ss_pred             eEEEEEecCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHhhhhcCC-----ceecCCCCCceEEccCCcEEEEec
Q psy7384         132 QLWLVMEYCGAGSVTDLVKST--KGQSLKEEWIAFICREILRGLKYLHENK-----VIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDLkp~NILl~~~~~vkL~DF  204 (463)
                      .+|||||||+||+|.+++...  ....+++..++.++.||+.||.|||++|     |+||||||+||||+.++.+||+||
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            789999999999999998653  2457999999999999999999999976     999999999999999999999999


Q ss_pred             ccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC
Q psy7384         205 GVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       205 Gla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      |+++.+..........+||+.|+|||++.     +..|+.++|||||||++|||++|.+||.+.+..+....+.....+.
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~  233 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMN-----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR  233 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHc-----CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99998766555556678999999999997     5679999999999999999999999999888877776665554433


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                       .+..+++++++||.+||+.||.+|||++|+|+|||+
T Consensus       234 -~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 -IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence             345789999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-61  Score=467.83  Aligned_cols=259  Identities=28%  Similarity=0.465  Sum_probs=210.3

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ++..++|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+|+.+|+.+ +|||||+++++|      .
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~------~   77 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIY------E   77 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEE------E
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEE------E
Confidence            456678999999999999999999999999999999997432  3345677999999999 899999999999      5


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc---cCCcEEEEecc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFG  205 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~---~~~~vkL~DFG  205 (463)
                      +++.+|||||||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||+.   .++.+||+|||
T Consensus        78 ~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          78 SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             ECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence            5689999999999999999997543  799999999999999999999999999999999999995   47899999999


Q ss_pred             cccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC--
Q psy7384         206 VSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--  283 (463)
Q Consensus       206 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--  283 (463)
                      +++..... ......+||+.|||||++.     +..|+.++|||||||++|+|++|.+||.+.........+......  
T Consensus       156 ~a~~~~~~-~~~~~~~GT~~y~APE~~~-----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~  229 (307)
T d1a06a_         156 LSKMEDPG-SVLSTACGTPGYVAPEVLA-----QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD  229 (307)
T ss_dssp             ------------------CTTSCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC
T ss_pred             eeEEccCC-CeeeeeeeCccccCcHHHc-----CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC
Confidence            99876543 2334568999999999997     567899999999999999999999999998887777666554432  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ......+++++++||.+||..||.+|||++|+|+||||+..
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            22345789999999999999999999999999999999853

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-61  Score=468.70  Aligned_cols=255  Identities=33%  Similarity=0.582  Sum_probs=216.8

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++...  ......+.+|+.+|+.+ +|||||+++++|      .+.
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~------~~~   76 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAF------YSD   76 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEE------ECS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE------EEC
Confidence            456799999999999999999999999999999999743  34457888999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      +.+|||||||+||+|.+++...+  .+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|+.
T Consensus        77 ~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          77 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             SEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             CEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            78999999999999999998655  69999999999999999999997 5999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh--------------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF--------------  275 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~--------------  275 (463)
                      ....  .....+||+.|+|||++.     +..|+.++||||+||++|||++|+.||.+.+......              
T Consensus       155 ~~~~--~~~~~~GT~~Y~APEvl~-----~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  227 (322)
T d1s9ja_         155 LIDS--MANSFVGTRSYMSPERLQ-----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  227 (322)
T ss_dssp             HHHH--TC---CCSSCCCCHHHHH-----CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred             cCCC--ccccccCCccccCchHHc-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence            6543  235678999999999998     5679999999999999999999999997654322110              


Q ss_pred             ----------------------------cccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         276 ----------------------------LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       276 ----------------------------~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                                  .+....++......++.++++||.+||..||.+|||++|+|+||||++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                                        011122233334457899999999999999999999999999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-60  Score=450.52  Aligned_cols=255  Identities=29%  Similarity=0.487  Sum_probs=217.4

Q ss_pred             Cce-EEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIF-ELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++| ++.++||+|+||+||+|++..++..||+|++...   ....+.+.+|+++|+++ +|||||+++++|....  ...
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~--~~~   84 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTV--KGK   84 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEES--SSC
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeecc--ccC
Confidence            345 7888999999999999999999999999998643   33456788999999999 7999999999985432  334


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCC--ceecCCCCCceEEc-cCCcEEEEecccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENK--VIHRDIKGQNVLLT-DNAEVKLVDFGVS  207 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDLkp~NILl~-~~~~vkL~DFGla  207 (463)
                      ..+|||||||++|+|.+++....  .+++..++.+++||+.||+|||++|  |+||||||+||||+ .++.+||+|||++
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            67899999999999999997654  6999999999999999999999998  99999999999996 5789999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh-cccCCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF-LIPRNAPPRLK  286 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~-~i~~~~~~~~~  286 (463)
                      +.....  .....+||+.|||||++.      ..|+.++|||||||++|||++|++||.+......+. .+.....+...
T Consensus       163 ~~~~~~--~~~~~~GT~~Y~aPE~~~------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~  234 (270)
T d1t4ha_         163 TLKRAS--FAKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF  234 (270)
T ss_dssp             GGCCTT--SBEESCSSCCCCCGGGGG------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred             eeccCC--ccCCcccCccccCHHHhC------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc
Confidence            865432  235678999999999985      358999999999999999999999998776555443 34444444444


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCcccc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIR  322 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  322 (463)
                      ...+++++++||.+||+.||++|||++|+|+||||+
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            556789999999999999999999999999999995

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-61  Score=459.02  Aligned_cols=256  Identities=26%  Similarity=0.481  Sum_probs=222.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+|+.+|+++ +|||||+++++|      .+.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~------~~~   80 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTF------QDD   80 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEE------ECS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEE------EEC
Confidence            4699999999999999999999999999999999632    33456788999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|||||||+||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceec
Confidence            89999999999999999988665  6999999999999999999999999999999999999999999999999999877


Q ss_pred             ccc--cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCC
Q psy7384         211 DRT--IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSK  288 (463)
Q Consensus       211 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  288 (463)
                      ...  .......+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+....+..+......  .+.
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~p~  231 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLT-----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--FPE  231 (288)
T ss_dssp             C----------CCCCGGGCCHHHHH-----TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--CCT
T ss_pred             ccCCcccccccccCCccccCceeec-----cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC--CCc
Confidence            532  22334568999999999997     567999999999999999999999999998887777776655432  234


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHH------HhcCccccCCch
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQ------LLKHPFIRDQPT  326 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e------~l~hp~~~~~~~  326 (463)
                      .+++++++||.+||+.||.+|||++|      +++||||.+..+
T Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w  275 (288)
T d1uu3a_         232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  275 (288)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence            68999999999999999999999988      578999976543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-60  Score=463.27  Aligned_cols=257  Identities=29%  Similarity=0.465  Sum_probs=228.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+|+.+|+++ +|||||+++++|      ++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~------~~~   77 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAF------QTH   77 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEE------ECS
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeee------ccc
Confidence            4699999999999999999999999999999999742    33457788999999999 899999999999      556


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+|||||+||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus        78 ~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          78 DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             cccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence            89999999999999999998765  6899999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ..........+||+.|+|||++.     +..|+.++|||||||++|||++|++||.+.+.......+......  .+..+
T Consensus       156 ~~~~~~~~~~~GT~~Y~aPE~~~-----~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~--~p~~~  228 (337)
T d1o6la_         156 ISDGATMKTFCGTPEYLAPEVLE-----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTL  228 (337)
T ss_dssp             CCTTCCBCCCEECGGGCCGGGGS-----SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTS
T ss_pred             ccCCcccccceeCHHHhhhhhcc-----CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC--CCccC
Confidence            65555566789999999999997     677999999999999999999999999998887776666555432  23468


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      ++++++||++||++||.+|+     +++|+++||||.+..+.
T Consensus       229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence            99999999999999999999     49999999999876543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-59  Score=453.05  Aligned_cols=259  Identities=26%  Similarity=0.440  Sum_probs=226.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-------chHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-------DEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      .+..++|++++.||+|+||+||+|+++.+|+.||||++....       ...+.+.+|+.+|+++ +|||||+++++|  
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~--   82 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY--   82 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE--
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEE--
Confidence            345678999999999999999999999999999999986321       2357889999999999 899999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC----cE
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA----EV  199 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~----~v  199 (463)
                          .+.+.+|||||||+||+|.+++...+  .+++..++.+++||+.||+|||++||+||||||+|||++.++    .+
T Consensus        83 ----~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~v  156 (293)
T d1jksa_          83 ----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI  156 (293)
T ss_dssp             ----ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred             ----EECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccce
Confidence                55689999999999999999998765  699999999999999999999999999999999999998766    59


Q ss_pred             EEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC
Q psy7384         200 KLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR  279 (463)
Q Consensus       200 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  279 (463)
                      ||+|||++...... ......+||+.|+|||++.     ...|+.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus       157 kl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~-----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  230 (293)
T d1jksa_         157 KIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA  230 (293)
T ss_dssp             EECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred             EecchhhhhhcCCC-ccccccCCCCcccCHHHHc-----CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            99999999877543 2335568999999999997     56789999999999999999999999999888887776655


Q ss_pred             CCCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 NAPPRL--KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 ~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ......  ....+++++++||++||+.||.+|||++|+|+||||+..
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            543222  235789999999999999999999999999999999854

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-59  Score=462.69  Aligned_cols=258  Identities=21%  Similarity=0.406  Sum_probs=226.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..+.|++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+|+++ +|||||+++++|      .+++
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~------~~~~   99 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAF------EDKY   99 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEE------ECSS
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEE------EECC
Confidence            3467999999999999999999999999999999997543 3456778999999999 899999999999      4568


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc--cCCcEEEEecccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT--DNAEVKLVDFGVSAQ  209 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~--~~~~vkL~DFGla~~  209 (463)
                      .+|||||||+||+|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+||||+  .++.+||+|||+|+.
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence            999999999999999987643 34699999999999999999999999999999999999997  578999999999988


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC--CCCCC
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP--PRLKS  287 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~  287 (463)
                      +... ......+||+.|+|||++.     +..|+.++|||||||++|+|++|.+||.+.+....+..+.....  +....
T Consensus       179 ~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  252 (352)
T d1koba_         179 LNPD-EIVKVTTATAEFAAPEIVD-----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF  252 (352)
T ss_dssp             CCTT-SCEEEECSSGGGCCHHHHT-----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred             cCCC-CceeeccCcccccCHHHHc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence            7653 2335568999999999997     66799999999999999999999999999888887777655443  23334


Q ss_pred             CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         288 KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       288 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ..+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            5789999999999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-59  Score=462.40  Aligned_cols=259  Identities=24%  Similarity=0.398  Sum_probs=225.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ..-++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+++ +|||||+++++|      .+.
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~------~~~   95 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAF------EDD   95 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEE------EET
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEE------EEC
Confidence            34568999999999999999999999999999999996543 3456788999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc--CCcEEEEeccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSA  208 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~--~~~vkL~DFGla~  208 (463)
                      +.+|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+|||++.  ++.+||+|||+++
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            79999999999999999986433 36999999999999999999999999999999999999964  6789999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC--CCC
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--RLK  286 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~  286 (463)
                      .+... ......+||+.|||||++.     +..|+.++|||||||++|+|++|++||.+.+..+.+..+......  ...
T Consensus       175 ~~~~~-~~~~~~~gT~~Y~aPEv~~-----~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         175 HLDPK-QSVKVTTGTAEFAAPEVAE-----GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             ECCTT-SCEEEECSCTTTCCHHHHH-----TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG
T ss_pred             ecccc-cccceecCcccccCHHHHc-----CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            87654 2335578999999999997     567899999999999999999999999998887777766544332  222


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                      ...+++++++||.+||..||.+|||++|+|+||||+..
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            34688999999999999999999999999999999854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-59  Score=452.93  Aligned_cols=254  Identities=26%  Similarity=0.491  Sum_probs=225.5

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.|++++.||+|+||+||+|+++.+|+.||||++...    ....+.+.+|+.+|+.+ +|||||++++++      ...
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~------~~~   76 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTF------QDA   76 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEE------ECS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeE------eeC
Confidence            3599999999999999999999999999999999632    23456788999999999 899999999999      456


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|+|||||.||+|..++....  .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus        77 ~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          77 QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             CeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence            89999999999999999987655  6889999999999999999999999999999999999999999999999999887


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...   ....+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||.+.+....+..+......  .+..+
T Consensus       155 ~~~---~~~~~Gt~~Y~APE~l~-----~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~  224 (316)
T d1fota_         155 PDV---TYTLCGTPDYIAPEVVS-----TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFF  224 (316)
T ss_dssp             SSC---BCCCCSCTTTCCHHHHT-----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC--CCTTS
T ss_pred             ccc---cccccCcccccCHHHHc-----CCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC--CCCCC
Confidence            543   24578999999999997     567999999999999999999999999998888777776555432  23468


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      +++++++|.+||..||.+|+     |++++|+||||++..++
T Consensus       225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            99999999999999999996     99999999999986654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.7e-59  Score=442.87  Aligned_cols=261  Identities=28%  Similarity=0.473  Sum_probs=226.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc----------hHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED----------EEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      .++|++++.||+|+||+||+|++..+|+.||||++.....          ..+.+.+|+.+|+++..|||||+++++|  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            4679999999999999999999999999999999964321          2245778999999996699999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEe
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVD  203 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~D  203 (463)
                          .+.+.+|||||||+||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        80 ----~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~D  153 (277)
T d1phka_          80 ----ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD  153 (277)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             ----ccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEcc
Confidence                55689999999999999999998655  699999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccCccccccCCccccccceeccCC-CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCC
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDE-NPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      ||+++.+.... .....+||+.|+|||++.+.. .....++.++||||+||++|+|++|++||.+.+.......+.....
T Consensus       154 FG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~  232 (277)
T d1phka_         154 FGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  232 (277)
T ss_dssp             CTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             chheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence            99998876543 335568999999999987422 1245688999999999999999999999999888777766655432


Q ss_pred             --CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         283 --PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       283 --~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                        +......+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         233 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence              22333578999999999999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-59  Score=458.30  Aligned_cols=254  Identities=24%  Similarity=0.437  Sum_probs=226.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...    ....+.+.+|+.+|+.+ +|||||+++++|      ...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~------~~~  113 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF------KDN  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEE------ECS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccc------ccc
Confidence            5799999999999999999999999999999998632    23456788999999999 899999999999      455


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+|+||||+.||+|.+++...+  .+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            78999999999999999997665  6999999999999999999999999999999999999999999999999999887


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ...   ....+||+.|||||++.     +..|+.++|||||||++|+|++|.+||.+.+....+..+.......  ...+
T Consensus       192 ~~~---~~~~~Gt~~Y~APE~~~-----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~  261 (350)
T d1rdqe_         192 KGR---TWTLCGTPEALAPEIIL-----SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHF  261 (350)
T ss_dssp             SSC---BCCCEECGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTC
T ss_pred             ccc---cccccCccccCCHHHHc-----CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--CccC
Confidence            643   34568999999999997     5678999999999999999999999999988877777766554332  3478


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      ++++.+||++||..||.+|+     |++++++||||++..+.
T Consensus       262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence            99999999999999999994     99999999999876654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-59  Score=453.39  Aligned_cols=257  Identities=21%  Similarity=0.362  Sum_probs=226.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .-++|++++.||+|+||+||+|+++.+|+.||+|++.........+.+|+.+|+.+ +|||||+++++|      ++.+.
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~------~~~~~   75 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESF------ESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEE------EETTE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEE------EECCE
Confidence            34679999999999999999999999999999999987777777888999999999 899999999999      45579


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc--CCcEEEEeccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD--NAEVKLVDFGVSAQL  210 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~--~~~vkL~DFGla~~~  210 (463)
                      +|||||||+||+|.+++...+ ..+++.+++.|+.||+.||.|||++||+||||||+|||++.  ...+||+|||+++..
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            999999999999999997543 36999999999999999999999999999999999999975  458999999999877


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCC--CCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPR--LKSK  288 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~  288 (463)
                      ... ......+||+.|+|||.+.     +..|+.++|||||||++|+|++|.+||.+.+..+.+..+.......  ....
T Consensus       155 ~~~-~~~~~~~~t~~y~ape~~~-----~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T d1tkia_         155 KPG-DNFRLLFTAPEYYAPEVHQ-----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHT-----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             ccC-Ccccccccccccccchhcc-----CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence            543 2335567999999999987     6678999999999999999999999999998887777766554322  1224


Q ss_pred             CCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         289 KWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       289 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      .+++++++||.+||..||.+|||++|+|+||||+.
T Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            68999999999999999999999999999999964

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=450.06  Aligned_cols=258  Identities=27%  Similarity=0.480  Sum_probs=226.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.|++++.||+|+||+||+|+++.+|+.||||++...    ......+..|+.++.+..+|||||++++++      .+.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~------~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF------QTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE------ECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE------ccC
Confidence            3599999999999999999999999999999999632    334456777888777544899999999999      456


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      +.+|||||||+||+|.+++....  .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhc
Confidence            79999999999999999998655  6899999999999999999999999999999999999999999999999999877


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCCCCCC
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLKSKKW  290 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  290 (463)
                      ..........+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||.+.+.......+....+.  .+..+
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~  226 (320)
T d1xjda_         154 MLGDAKTNTFCGTPDYIAPEILL-----GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWL  226 (320)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHT-----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTS
T ss_pred             ccccccccccCCCCCcCCHHHHc-----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCccC
Confidence            66555566678999999999998     667999999999999999999999999998887777776555432  23468


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHH-HHhcCccccCCchh
Q psy7384         291 PKKFQSFIETVLVKDYHQRPYTD-QLLKHPFIRDQPTE  327 (463)
Q Consensus       291 ~~~~~~li~~~L~~dp~~Rpt~~-e~l~hp~~~~~~~~  327 (463)
                      ++++++||.+||..||.+|||+. ++++||||++..++
T Consensus       227 s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~  264 (320)
T d1xjda_         227 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  264 (320)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             CHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence            99999999999999999999995 89999999876543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=447.63  Aligned_cols=254  Identities=25%  Similarity=0.389  Sum_probs=212.6

Q ss_pred             EEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcch------HHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          59 LIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDE------EEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        59 ~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .+++||+|+||+||+|+++.+|+.||||++......      ...+.+|+.+|+.+ +|||||+++++|      ...+.
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~------~~~~~   74 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAF------GHKSN   74 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEE------CCTTC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeee------ccCCc
Confidence            568999999999999999999999999998643221      24678999999999 899999999999      55678


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +||||||+.++++..+..  ....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          75 ISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             CEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             eeehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC
Confidence            999999999887766654  334689999999999999999999999999999999999999999999999999988776


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC-----------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA-----------  281 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-----------  281 (463)
                      ........+||+.|+|||++..    ...|+.++|||||||++|||++|.+||.+.++.+.+..+....           
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         153 PNRAYTHQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             CcccccceecChhhccHHHHcc----CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence            5555566789999999999863    4568999999999999999999999999888776654432100           


Q ss_pred             -----------CCC----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         282 -----------PPR----LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       282 -----------~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                                 .+.    .....+++++++||.+||+.||++|||++|+|+||||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                       000    00135678999999999999999999999999999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-57  Score=451.63  Aligned_cols=257  Identities=23%  Similarity=0.412  Sum_probs=213.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc----chHHHHHHH---HHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE----DEEEEIKLE---INVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E---i~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +.|++++.||+|+||.||+|+++.+|+.||||++....    .....+.+|   +.+++.+ +|||||+++++|      
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~------   76 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAF------   76 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEE------
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEE------
Confidence            46999999999999999999999999999999986321    222334444   4455555 799999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+|||||||+||+|.+++....  .+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence            45579999999999999999997654  6899999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhh--cccCCCCCCC
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALF--LIPRNAPPRL  285 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~--~i~~~~~~~~  285 (463)
                      +.+...  .....+||+.|+|||++..    +..|+.++|||||||++|+|++|++||.+.+......  ...... +..
T Consensus       155 ~~~~~~--~~~~~~GT~~y~APE~~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~  227 (364)
T d1omwa3         155 CDFSKK--KPHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVE  227 (364)
T ss_dssp             EECSSS--CCCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-CCC
T ss_pred             eecCCC--cccccccccccchhHHhhc----CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCC
Confidence            877543  2355689999999999863    4568999999999999999999999998765433322  211111 222


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHhcCccccCCchh
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPY-----TDQLLKHPFIRDQPTE  327 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~  327 (463)
                      ....+++++++||.+||..||.+|||     ++|+++||||++..+.
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         228 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence            34578999999999999999999999     7999999999987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=450.60  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=214.9

Q ss_pred             CCCceEEEe-eeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          53 PAGIFELIE-VVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        53 ~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ..+.|++++ .||+|+||+||+|++..+|+.||||++...    ..+.+|+.++.++.+|||||+++++|....  ..+.
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~--~~~~   82 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLY--AGRK   82 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE--TTEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecc--cCCC
Confidence            345799885 599999999999999999999999998643    457789999887768999999999985321  2246


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc---CCcEEEEeccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD---NAEVKLVDFGVSA  208 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~---~~~vkL~DFGla~  208 (463)
                      .+|||||||+||+|.+++.......+++.+++.|++||+.||+|||++||+||||||+|||++.   ++.+||+|||+|+
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence            7999999999999999998766667999999999999999999999999999999999999975   5679999999998


Q ss_pred             ccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc----ccCCCC--
Q psy7384         209 QLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL----IPRNAP--  282 (463)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~----i~~~~~--  282 (463)
                      ..... ......+||+.|+|||++.     +..|+.++||||||||+|+|++|++||.+.+.......    +.....  
T Consensus       163 ~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         163 ETTSH-NSLTTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             ECCCC-CCCCCCSCCCSSCCCCCCC-----GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             eccCC-CccccccCCcccCCcHHHc-----CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            77543 2335668999999999997     56799999999999999999999999987665444322    222211  


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                      +......+++++++||.+||+.||.+|||++|+|+||||.+
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            11112357899999999999999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-57  Score=436.60  Aligned_cols=257  Identities=22%  Similarity=0.389  Sum_probs=219.6

Q ss_pred             CcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          48 RWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      .| +...++|++.+.||+|+||+||+|+++.+|+.||||++.......+.+.+|+.+|+++ +|||||+++++|      
T Consensus        11 ~w-ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~------   82 (287)
T d1opja_          11 KW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC------   82 (287)
T ss_dssp             TT-BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEE------
T ss_pred             cc-EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccE------
Confidence            35 4455789999999999999999999999999999999987777778899999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .+.+.+|||||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence            45578999999999999999998776678999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCCCCC
Q psy7384         208 AQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       208 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  286 (463)
                      +....... ......||+.|+|||++.     ...|+.++|||||||++|||++|..||........+..+.........
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~  237 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER  237 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHH-----HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             eecCCCCceeeccccccccccChHHHc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            87754322 223345889999999998     567999999999999999999976665444444444333333222333


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ...+++++++||.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            4578999999999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=437.29  Aligned_cols=259  Identities=27%  Similarity=0.456  Sum_probs=216.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++++.||+|+||+||+|++..+|+.||||++....   .....+.+|+.+|+++ +|||||+++++|      ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~------~~~~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVI------HTEN   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEE------EETT
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccc------cccc
Confidence            36999999999999999999999999999999996432   2346788999999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+||||+.+ .+.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus        75 ~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          75 KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             ceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence            99999999976 55666655555679999999999999999999999999999999999999999999999999998876


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-----------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-----------  280 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  280 (463)
                      .........+||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+....+..+...           
T Consensus       154 ~~~~~~~~~~gt~~y~apE~~~~----~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         154 VPVRTYTHEVVTLWYRAPEILLG----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG  229 (298)
T ss_dssp             CCSBCTTCCBCCCTTCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             CCcccceeecccceeeehhhhcc----ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence            65555666789999999999863    344688999999999999999999999887766554432110           


Q ss_pred             ------C---CCCC-------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         281 ------A---PPRL-------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       281 ------~---~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                            .   .+..       ....+++++++||++||..||.+|||++|+|+||||++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                  0   0000       0135678999999999999999999999999999998643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-57  Score=429.85  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=210.7

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc-------chHHHHHHHHHHHHHhc-CCCceeeecccccccC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE-------DEEEEIKLEINVLKKYS-NHRNIATYYGAFIKKS  125 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~Ei~~l~~l~-~h~nIv~l~~~~~~~~  125 (463)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....       .....+.+|+.+|+++. .|||||+++++|    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            468999999999999999999999999999999986321       11234568999999984 389999999999    


Q ss_pred             CCCCCCeEEEEEecCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-CCcEEEEe
Q psy7384         126 PPGKDDQLWLVMEYCGA-GSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-NAEVKLVD  203 (463)
Q Consensus       126 ~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-~~~vkL~D  203 (463)
                        ...+.+|+||||+.+ +++.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus        79 --~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          79 --ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             --ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             --eeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence              556799999999976 68888887654  6999999999999999999999999999999999999985 57999999


Q ss_pred             cccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC
Q psy7384         204 FGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       204 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      ||+|+.....  .....+||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+...      ...  
T Consensus       155 FG~a~~~~~~--~~~~~~GT~~y~aPE~~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~------~~~--  220 (273)
T d1xwsa_         155 FGSGALLKDT--VYTDFDGTRVYSPPEWIRY----HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------RGQ--  220 (273)
T ss_dssp             CTTCEECCSS--CBCCCCSCGGGSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------HCC--
T ss_pred             cccceecccc--cccccccCCCcCCHHHHcC----CCCCCcccccccceeeehhHhhCCCCCCCchHHh------hcc--
Confidence            9999876443  3356789999999999974    2345678999999999999999999997643211      111  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCch
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQPT  326 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  326 (463)
                      ......+|+++++||++||..||.+|||++|+|+||||++...
T Consensus       221 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         221 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            1123468999999999999999999999999999999987644

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-57  Score=428.10  Aligned_cols=262  Identities=24%  Similarity=0.463  Sum_probs=221.5

Q ss_pred             CCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          45 PEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ..+.| +.+.++|++++.||+|+||.||+|+++ ++..||||++.......+.+.+|+.+|+++ +|||||++++++.. 
T Consensus         4 ~~~~w-ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-   79 (272)
T d1qpca_           4 WEDEW-EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             TTCTT-BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred             CCCCe-ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-
Confidence            34455 345678999999999999999999975 577899999987766778899999999999 89999999998732 


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEec
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDF  204 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DF  204 (463)
                            +.+|||||||++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus        80 ------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          80 ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             ------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ------CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence                  45799999999999999887655556999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchhhhhcccCCCC
Q psy7384         205 GVSAQLDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       205 Gla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      |+|+.+.... .......||+.|+|||++.     ...|+.++|||||||++|||+|| .+||...+....+..+.....
T Consensus       154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~  228 (272)
T d1qpca_         154 GLARLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR  228 (272)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             cceEEccCCccccccccCCcccccChHHHh-----CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence            9998775432 2234457899999999997     46789999999999999999995 566666666555555544433


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc--Ccccc
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK--HPFIR  322 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~  322 (463)
                      + ..+..+++++.+||.+||+.||++|||++++++  |+||+
T Consensus       229 ~-~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 M-VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            3 334578999999999999999999999999998  78885

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-56  Score=430.34  Aligned_cols=263  Identities=27%  Similarity=0.412  Sum_probs=213.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCC-CcEEEEEEeecC---cchHHHHHHHHHHHHHhc--CCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKT-GQLAAIKVMDVT---EDEEEEIKLEINVLKKYS--NHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~--~h~nIv~l~~~~~~~~~~  127 (463)
                      .++|++++.||+|+||+||+|++..+ ++.||||++...   ......+.+|+.+|+.+.  +||||++++++|..... 
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~-   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC-
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc-
Confidence            35799999999999999999999766 678999998632   222335667888877664  79999999999854321 


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      .....+|++|||+.++.+.... ......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             ccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence            2346889999999887665443 344557999999999999999999999999999999999999999999999999998


Q ss_pred             cccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC-------
Q psy7384         208 AQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN-------  280 (463)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------  280 (463)
                      +..... ......+||+.|+|||++.     +..|+.++|||||||++|||++|++||.+.+..+.+..+...       
T Consensus       164 ~~~~~~-~~~~~~~gT~~Y~APE~~~-----~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         164 RIYSFQ-MALTSVVVTLWYRAPEVLL-----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CCCCGG-GGGCCCCCCCTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhccc-ccCCCcccChhhcCcchhc-----CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            766543 3345678999999999997     677999999999999999999999999988776554432110       


Q ss_pred             ------------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         281 ------------------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       281 ------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                        .........+++.+++||.+||..||.+|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                              00011224578899999999999999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-56  Score=433.72  Aligned_cols=257  Identities=23%  Similarity=0.410  Sum_probs=216.4

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCc-----EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQ-----LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIK  123 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~  123 (463)
                      +...++|++.+.||+|+||+||+|++..+++     .||+|++...  ......+.+|+.+|.++.+|||||++++++  
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~--  110 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--  110 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE--
Confidence            3455689999999999999999999876553     6999988533  334457889999999987899999999999  


Q ss_pred             cCCCCCCCeEEEEEecCCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHhhhhcCCce
Q psy7384         124 KSPPGKDDQLWLVMEYCGAGSVTDLVKSTKG---------------------QSLKEEWIAFICREILRGLKYLHENKVI  182 (463)
Q Consensus       124 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~~LH~~giv  182 (463)
                          ...+.+|||||||++|+|.+++.....                     ..+++..++.|+.||+.||+|||++|||
T Consensus       111 ----~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~Ii  186 (325)
T d1rjba_         111 ----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV  186 (325)
T ss_dssp             ----CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             ----eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence                555789999999999999999976432                     3588999999999999999999999999


Q ss_pred             ecCCCCCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh
Q psy7384         183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE  260 (463)
Q Consensus       183 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~  260 (463)
                      ||||||+|||++.++.+||+|||+|+.......  ......||+.|||||++.     ...|+.++|||||||++|||++
T Consensus       187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-----EGIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHTT
T ss_pred             eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-----CCCCCcceeccchhHHHHHHHh
Confidence            999999999999999999999999987654332  223456899999999997     5679999999999999999997


Q ss_pred             -CCCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         261 -SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       261 -g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       |.+||.+.+....+..+.........+..+++++++||.+||+.||++|||++||++|
T Consensus       262 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             8999998877766666555544334456789999999999999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.2e-56  Score=426.50  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=210.1

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|+++++||+|+||+||+|+++ +|+.||||++....   .....+.+|+.+|+++ +|||||+++++|      ...+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~------~~~~   73 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVI------HTKK   73 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEE------ECSS
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeec------ccCC
Confidence            47999999999999999999985 78999999996542   2356888999999999 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..|++|||+.++.+..+....  ..+++..++.+++||+.||+|||++|||||||||+|||++.++.+||+|||++....
T Consensus        74 ~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          74 RLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             CEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             ceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence            899999999887766665433  479999999999999999999999999999999999999999999999999998876


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC------------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR------------  279 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~------------  279 (463)
                      ..........|++.|+|||.+..    ...++.++|||||||++|||++|++||.+.+..+.+..+..            
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~----~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         152 IPVRKYTHEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             C---------CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cCccccceecccchhhhHHHHhC----CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence            55444566679999999999873    45678999999999999999999999988776555433210            


Q ss_pred             ---------------CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 ---------------NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 ---------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                     ..+.......+++.+++||++||+.||++|||++|+|+||||++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                           00001112457889999999999999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=433.06  Aligned_cols=260  Identities=27%  Similarity=0.428  Sum_probs=212.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++...   ....+.+.+|+.+|+.+ +|||||+++++|........
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccc
Confidence            567999999999999999999999999999999999743   23356788999999999 89999999999976544344


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                      ...+||||||+ +.+|..+++..   .+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence            56789999999 56788777543   599999999999999999999999999999999999999999999999999987


Q ss_pred             cccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC----------
Q psy7384         210 LDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----------  279 (463)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~----------  279 (463)
                      .+..   .+..+||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+....+..+..          
T Consensus       171 ~~~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         171 ADSE---MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             CCSS---CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cCCc---cccccccccccCHHHHcC----CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            7643   356789999999999873    35578999999999999999999999988766554322110          


Q ss_pred             -----------------C--CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 -----------------N--APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 -----------------~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                       .  .........+++++++||.+||..||.+|||++|+|+||||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                             0  00111224678899999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=424.19  Aligned_cols=254  Identities=28%  Similarity=0.510  Sum_probs=207.6

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeec---CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV---TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      +...++|++.+.||+|+||+||+|++.   ..||||+++.   .....+.+.+|+.+|+++ +|||||++++++.     
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-----   74 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-----   74 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-----
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-----
Confidence            445678999999999999999999753   3599999863   344567888999999999 8999999999863     


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                        .+.+|||||||++|+|.+++...+ ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|
T Consensus        75 --~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          75 --APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             --SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             --ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccce
Confidence              246899999999999999997544 36999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC-CC-CC
Q psy7384         208 AQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR-NA-PP  283 (463)
Q Consensus       208 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~-~~  283 (463)
                      +......  .......||+.|||||++....  ...|+.++|||||||++|||+||+.||.+.+....+..+.. .. .+
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p  229 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP  229 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC
T ss_pred             eeccccCCcccccccccCcccCCHHHHhccc--CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            8765322  2334568999999999986422  34689999999999999999999999998776655443322 21 11


Q ss_pred             --CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         284 --RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       284 --~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                        ......+++++++||.+||..||.+|||++|++++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence              12345788999999999999999999999999876

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=431.86  Aligned_cols=259  Identities=25%  Similarity=0.370  Sum_probs=212.5

Q ss_pred             ceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          56 IFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        56 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      +|+.+++||+|+||+||+|++..+|+.||||++.....   ...+|+.+|+++ +||||++++++|.......+..++||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEE
Confidence            69999999999999999999999999999999975432   234799999999 89999999999876544345567899


Q ss_pred             EEecCCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEecccccccccc
Q psy7384         136 VMEYCGAGSVTDLVKS-TKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSAQLDRT  213 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~  213 (463)
                      |||||+++.+..+... .....+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            9999987654444332 2345799999999999999999999999999999999999998765 8999999999877543


Q ss_pred             cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC--------------
Q psy7384         214 IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR--------------  279 (463)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~--------------  279 (463)
                       ......+||+.|+|||++.+    ...|+.++|||||||++|||++|++||...+..+.+..+..              
T Consensus       177 -~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         177 -EPNVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             -SCCCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             -cccccccccccccChHHhhc----ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence             23355689999999999863    45689999999999999999999999988776655443311              


Q ss_pred             -----CCC--------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         280 -----NAP--------PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       280 -----~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                           ...        .......+++++.+||.+||..||.+|||+.|+|+||||++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                 000        11223467899999999999999999999999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.2e-55  Score=419.05  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=211.4

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++...    ......+.+|+.+|+.+ +|||||++++++....  .
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~--~   81 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAET--P   81 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEC--S
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeecc--C
Confidence            356899999999999999999999999999999999643    22345788999999998 8999999999986542  2


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ....+|||||||+||+|.+++...+  .+++.+++.+++||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             CCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhh
Confidence            2346899999999999999987665  69999999999999999999999999999999999999999999999999987


Q ss_pred             cccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCCCC--
Q psy7384         209 QLDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNAPP--  283 (463)
Q Consensus       209 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--  283 (463)
                      ......   ......+||+.|+|||++.     +..|+.++|||||||++|+|+||++||.+.+..+.+..+......  
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQAR-----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  234 (277)
T ss_dssp             ECC----------------TTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred             hhccccccccccccccCcccccCHHHHc-----CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence            653322   2334568999999999997     567899999999999999999999999998887777665554432  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFI  321 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  321 (463)
                      ......+|+++++||.+||..||.+||+..+.|.|+|+
T Consensus       235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            23446789999999999999999999954444456665

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=414.87  Aligned_cols=249  Identities=23%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      ..|++++.||+|+||+||+|++. ++..||||++.......+.+.+|+.+++++ +|||||++++++      ...+.+|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~------~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC------LEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEE------CSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCccccccee------ccCCceE
Confidence            46999999999999999999976 567899999987777778899999999999 899999999999      4457899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      ||||||++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus        77 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             EEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999999999987543 468899999999999999999999999999999999999999999999999998765432


Q ss_pred             C-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         215 G-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      . ......||+.|+|||++.     ...|+.++|||||||++|||+| |.+||...+....+..+.....+ ..+..+++
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~  229 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFS-----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLAST  229 (263)
T ss_dssp             ---------CTTSCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCH
T ss_pred             ceeecceecCcccCChHHhc-----CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCH
Confidence            2 223457899999999997     5679999999999999999999 57777776666666655544332 23456789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ++.+||.+||+.||.+|||++|+++|
T Consensus       230 ~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         230 HVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999999886

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.7e-55  Score=419.67  Aligned_cols=251  Identities=23%  Similarity=0.425  Sum_probs=203.4

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCc---EEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQ---LAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ...|++.+.||+|+||+||+|+++.+|+   .||||.+...  ....+.+.+|+.+|+++ +|||||++++++      .
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~------~   97 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVV------T   97 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE------C
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEE------e
Confidence            3469999999999999999999987764   5889988643  33456789999999999 899999999999      4


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence            5578999999999999999887543 368999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc-----cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCC
Q psy7384         209 QLDRTIGR-----RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAP  282 (463)
Q Consensus       209 ~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  282 (463)
                      .+......     .....||+.|||||++.     ...|+.++|||||||++|||+| |.+||.+.+..+.+..+.....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~  251 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR  251 (299)
T ss_dssp             -------------------CGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHh-----cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            76543221     12245799999999997     5679999999999999999998 8999999888777776655543


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         283 PRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       283 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +. ....+++++.+||.+||+.||.+|||+.|++++
T Consensus       252 ~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 LP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            32 345789999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=410.40  Aligned_cols=249  Identities=20%  Similarity=0.390  Sum_probs=218.9

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEE
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLW  134 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~  134 (463)
                      +.|+++++||+|+||+||+|+++ ++..||||+++......+.+.+|+.++.++ +|||||++++++      .+.+.+|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~------~~~~~~~   75 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC------TKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEE------CCSSSEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEE------eeCCceE
Confidence            46899999999999999999985 778999999988777778999999999999 899999999999      4557899


Q ss_pred             EEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccccc
Q psy7384         135 LVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI  214 (463)
Q Consensus       135 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  214 (463)
                      +||||+++|+|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        76 iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             EEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999999999987544 368899999999999999999999999999999999999999999999999998765432


Q ss_pred             C-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCCH
Q psy7384         215 G-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWPK  292 (463)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  292 (463)
                      . ......||+.|+|||++.     ...|+.++|||||||++|||+| |+.||.+.+..+....+.....+ ..+..+++
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-~~p~~~~~  228 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLM-----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASE  228 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred             ceeecccCCCCCcCCcHHhc-----CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-CCcccccH
Confidence            2 223467899999999998     5678999999999999999998 89999998888777766655433 34457889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         293 KFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       293 ~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ++++||.+||+.||.+|||++++++|
T Consensus       229 ~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         229 KVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.9e-54  Score=423.79  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=211.5

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++..  ..+.+.+|+.+|+.+..||||++++++|..    .....+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~----~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKD----PVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC----TTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEe----cCCCce
Confidence            35799999999999999999999999999999998653  356788999999999679999999999853    234679


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC-cEEEEeccccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA-EVKLVDFGVSAQLDR  212 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~-~vkL~DFGla~~~~~  212 (463)
                      |+|||||.+++|..+.     ..+++..++.+++||+.||+|||++||+||||||+||||+.++ .+||+|||+|+....
T Consensus       108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999999997764     2599999999999999999999999999999999999998654 699999999987754


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhh-hhcc--------------
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRA-LFLI--------------  277 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i--------------  277 (463)
                      . ......+||+.|+|||++..    ...|+.++||||+||++|+|++|..||........ ...+              
T Consensus       183 ~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         183 G-QEYNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             T-CCCCSCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             C-CcccccccCccccCcccccC----CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            3 23456689999999999874    34578999999999999999999999976543221 1000              


Q ss_pred             -------------c-CC-------CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         278 -------------P-RN-------APPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       278 -------------~-~~-------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                                   . ..       .........+++++++||++||..||.+|||++|+|+||||++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                         0 00       011112234688999999999999999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=415.86  Aligned_cols=267  Identities=24%  Similarity=0.435  Sum_probs=219.5

Q ss_pred             cCCCCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeeccc
Q psy7384          41 TEGWPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGA  120 (463)
Q Consensus        41 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~  120 (463)
                      +.|...+.|.. ..++|++.+.||+|+||+||+|++..+ ..||||++.......+.+.+|+.+|+++ +|||||+++++
T Consensus         4 ~~~~~~~~~~i-~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~   80 (285)
T d1fmka3           4 TQGLAKDAWEI-PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAV   80 (285)
T ss_dssp             CSSSSTTCSBC-CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             CCCCCCcceEc-CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEE
Confidence            34555666754 456899999999999999999998755 5699999987777778899999999999 89999999999


Q ss_pred             ccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEE
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVK  200 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vk  200 (463)
                      +.      + +.+|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus        81 ~~------~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~k  153 (285)
T d1fmka3          81 VS------E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK  153 (285)
T ss_dssp             EC------S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             Ee------c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEE
Confidence            83      2 4579999999999999998765555799999999999999999999999999999999999999999999


Q ss_pred             EEeccccccccccc-CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchhhhhccc
Q psy7384         201 LVDFGVSAQLDRTI-GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIP  278 (463)
Q Consensus       201 L~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~  278 (463)
                      |+|||+++...... .......||+.|+|||++.     ...++.++|||||||++|||++| .+||.+....+.+..+.
T Consensus       154 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~  228 (285)
T d1fmka3         154 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  228 (285)
T ss_dssp             ECCCCTTC--------------CCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             EcccchhhhccCCCceeeccccccccccChHHHh-----CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999998764322 2233457999999999997     56789999999999999999995 55566666666666555


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc--CccccC
Q psy7384         279 RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK--HPFIRD  323 (463)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~  323 (463)
                      ....+. ....+++++++||.+||+.||++|||++++++  ++||+.
T Consensus       229 ~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         229 RGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             TTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             hcCCCC-CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            544332 45678999999999999999999999999988  788864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=415.52  Aligned_cols=252  Identities=24%  Similarity=0.419  Sum_probs=212.1

Q ss_pred             CceEEEee-eeeeCCeEEEEEEEcCC--CcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          55 GIFELIEV-VGNGTYGQVYKGRHTKT--GQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        55 ~~y~~~~~-LG~G~fg~V~~~~~~~~--~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      +.|.+.+. ||+|+||+||+|.++.+  +..||||++...  ....+.+.+|+.+|+++ +|||||++++++..      
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------   80 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA------   80 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES------
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc------
Confidence            46888885 99999999999987643  557999999643  33457789999999999 89999999999832      


Q ss_pred             CCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccc
Q psy7384         130 DDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQ  209 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~  209 (463)
                       +.+|||||||++|+|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence             46899999999999999986433 4699999999999999999999999999999999999999999999999999987


Q ss_pred             ccccc---CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         210 LDRTI---GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       210 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      +....   .......||+.|+|||++.     ...|+.++|||||||++|||+| |.+||.+.+..+....+..+..+..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~  233 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECIN-----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC  233 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred             ccccccccccccccccCccccChHHHh-----CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            75432   1223456899999999997     5678999999999999999998 9999998887777666665554433


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHH---hcCccc
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQL---LKHPFI  321 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~  321 (463)
                       +..+++++.+||.+||..||++|||+.++   |+|+|+
T Consensus       234 -p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         234 -PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             45789999999999999999999999888   456665

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=423.74  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=209.8

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .+.+|++++.||+|+||+||+|+++.+|+.||||++....  ...+.+.+|+.+|+++ +||||+++++++..... ...
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~-~~~   83 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTI-EQM   83 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSST-TTC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccc-ccc
Confidence            4567999999999999999999999999999999997543  3346788999999999 89999999999854321 122


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ..+||+ +|+.+|+|.+++...   .+++..++.+++||+.||+|||++|||||||||+||||++++.+||+|||++...
T Consensus        84 ~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          84 KDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             CCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            345555 556689999999753   5999999999999999999999999999999999999999999999999999866


Q ss_pred             ccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhccc---------
Q psy7384         211 DRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIP---------  278 (463)
Q Consensus       211 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~---------  278 (463)
                      .....   .....+||+.|+|||++..    ...|+.++||||+||++|+|++|++||.+.+.........         
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTT----BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             cCCCccceeeccccccceechHHHhhc----CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            44322   2345679999999999863    4567899999999999999999999998776543332210         


Q ss_pred             ------------------CCCCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         279 ------------------RNAPP--RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       279 ------------------~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                        .....  ......++.++++||.+||+.||.+|||++|+|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                              00000  01124677899999999999999999999999999999843

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=420.82  Aligned_cols=265  Identities=28%  Similarity=0.427  Sum_probs=209.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCC--CC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP--PG  128 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~--~~  128 (463)
                      .++|++++.||+|+||+||+|++..+|+.||||++...   ......+.+|+.+|+++ +||||+++++++.....  ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence            57899999999999999999999999999999998543   23346788999999999 89999999999865321  12


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..+.+|+||||+.++.+..+..  ....+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence            2457899999998876554433  33479999999999999999999999999999999999999999999999999997


Q ss_pred             ccccc----cCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCC---C
Q psy7384         209 QLDRT----IGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRN---A  281 (463)
Q Consensus       209 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~---~  281 (463)
                      .....    .......+||+.|+|||++.+    ...|+.++|||||||++|||++|++||.+.++......+...   .
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~----~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcC----CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            66432    122344579999999999874    346899999999999999999999999887766554332110   0


Q ss_pred             CCCCC------------------C---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCCc
Q psy7384         282 PPRLK------------------S---------KKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQP  325 (463)
Q Consensus       282 ~~~~~------------------~---------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  325 (463)
                      .+...                  .         ...++++++||.+||+.||++|||++|+|+||||++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p  312 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  312 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence            00000                  0         01356788999999999999999999999999998654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=411.09  Aligned_cols=256  Identities=26%  Similarity=0.424  Sum_probs=215.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|++++.||+|+||+||+|++..+|+.||||+++...   .....+.+|+.+|+.+ +||||++++++|      ....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~------~~~~   74 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVL------HSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEE------ECSS
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccc------cccc
Confidence            47999999999999999999999999999999996432   3467888999999998 899999999999      4557


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      ..++|||++.+++|..++...  ..+++..++.+++|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        75 ~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          75 KLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence            899999999999988887654  478999999999999999999999999999999999999999999999999998876


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-hhhhhccc------------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHP-MRALFLIP------------  278 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~------------  278 (463)
                      ..........+++.|+|||++..    ...++.++|||||||++|||++|..||....+ .+.+..+.            
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         153 IPVRCYSAEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred             CCCccceeeccccchhhhhHhcc----CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence            65555556678899999999863    34478999999999999999999988644333 32222110            


Q ss_pred             ---------------CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         279 ---------------RNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       279 ---------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                     ...........+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                           001111123466889999999999999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=413.54  Aligned_cols=245  Identities=23%  Similarity=0.400  Sum_probs=205.4

Q ss_pred             eeeeeeCCeEEEEEEEc--CCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          61 EVVGNGTYGQVYKGRHT--KTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        61 ~~LG~G~fg~V~~~~~~--~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      ++||+|+||+||+|.+.  .+++.||||++...   ....+.+.+|+.+|+++ +|||||++++++..       +..||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-------~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-------ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-------SSEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-------CCEEE
Confidence            47999999999999865  34678999998632   23356789999999999 89999999999832       35789


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccccccC
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG  215 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~  215 (463)
                      |||||++|+|.+++....  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus        85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            999999999999997644  699999999999999999999999999999999999999999999999999987643322


Q ss_pred             c---cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         216 R---RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       216 ~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .   .....||+.|+|||++.     ...|+.++|||||||++|||++ |.+||.+.+..+....+..+..+. .+..+|
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-~p~~~~  236 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECIN-----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-CPAGCP  236 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred             ccccccccCCCceecCchhhc-----CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-CCcccC
Confidence            1   23356899999999997     5678999999999999999998 899999988777666665554433 345789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHh---cCccc
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLL---KHPFI  321 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l---~hp~~  321 (463)
                      +++++||.+||+.||.+|||+++++   +|+|+
T Consensus       237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            9999999999999999999999984   55554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=412.56  Aligned_cols=257  Identities=23%  Similarity=0.401  Sum_probs=205.4

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC-----CcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT-----GQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      ...++|++++.||+|+||.||+|++...     ++.||||++...  ......+.+|+.++.++.+|+||+.+++++.  
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--   87 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT--   87 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec--
Confidence            3446799999999999999999997643     468999998643  3345677889999999878999999999874  


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCc
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQN  190 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~N  190 (463)
                         .....+++|||||++|+|.+++....              ...+++..++.++.||+.||.|||++|||||||||+|
T Consensus        88 ---~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          88 ---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             ---STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             ---cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence               33467899999999999999997543              2358899999999999999999999999999999999


Q ss_pred             eEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q psy7384         191 VLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCD  267 (463)
Q Consensus       191 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~  267 (463)
                      |||+.++.+||+|||+|+.......  .....+||+.|+|||++.     ...|+.++|||||||++|||++| .+||.+
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999987643322  234567999999999998     56789999999999999999986 678887


Q ss_pred             CCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         268 LHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       268 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      ......+..+............+++++++||.+||+.||.+|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            765555444333222223345789999999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=407.06  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=204.9

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcCC---CcEEEEEEeecC--cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTKT---GQLAAIKVMDVT--EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ...++|++.+.||+|+||.||+|++..+   +..||||.+...  ......+.+|+.+|+++ +|||||++++++.    
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~----   78 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT----   78 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC----
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe----
Confidence            3446899999999999999999998754   346889988643  33356788999999999 8999999999983    


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                         ++.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        79 ---~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          79 ---ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             ---cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence               257899999999999999876543 4689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC-ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCC
Q psy7384         207 SAQLDRTIG-RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPR  284 (463)
Q Consensus       207 a~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  284 (463)
                      ++.+..... ......||+.|+|||++.     ...|+.++|||||||++|||++ |.+||.+.+..+....+..+..+.
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~-----~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~  229 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESIN-----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP  229 (273)
T ss_dssp             ----------------CCGGGCCHHHHH-----HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred             heeccCCcceeccceecCcccchhhHhc-----cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            987654322 234456899999999997     5679999999999999999998 899999988887777766655433


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         285 LKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       285 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                       .+..+++++++||.+||..||.+|||++|+++|
T Consensus       230 -~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         230 -MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             345789999999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=417.90  Aligned_cols=262  Identities=28%  Similarity=0.439  Sum_probs=216.7

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEc---CCCcEEEEEEeecC-----cchHHHHHHHHHHHHHhcCCCceeeecccccccCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHT---KTGQLAAIKVMDVT-----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSP  126 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~  126 (463)
                      ++|++++.||+|+||+||+|++.   .+|+.||||++...     ....+.+.+|+.+|+++.+||||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            57999999999999999999974   46899999998532     223456789999999996558999999999     


Q ss_pred             CCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccc
Q psy7384         127 PGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGV  206 (463)
Q Consensus       127 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGl  206 (463)
                       .....+|+||||+.+|+|.+++....  .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        99 -~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_          99 -QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             -ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence             45579999999999999999998765  578999999999999999999999999999999999999999999999999


Q ss_pred             cccccc-ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC--CC
Q psy7384         207 SAQLDR-TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA--PP  283 (463)
Q Consensus       207 a~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~  283 (463)
                      ++.+.. .........|++.|+|||.+...   ...++.++|||||||+||+|++|..||.+.+.......+....  ..
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~---~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~  252 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE  252 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred             hhhhcccccccccccccccccchhHHhhcC---CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence            987643 23334567899999999999742   3457889999999999999999999998876655444332211  11


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHhcCccccCCchh
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRP-----YTDQLLKHPFIRDQPTE  327 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  327 (463)
                      ......+++++++||++||..||.+||     |++|+|+||||++..+.
T Consensus       253 ~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence            112346899999999999999999999     58999999999875543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-53  Score=403.62  Aligned_cols=250  Identities=22%  Similarity=0.389  Sum_probs=201.0

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCC----cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTG----QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ...|++.++||+|+||.||+|.++.++    ..||||++....  .....+.+|+.+|+++ +|||||++++++      
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~------   78 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVI------   78 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE------
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEE------
Confidence            346999999999999999999987654    479999986433  3345788999999999 899999999999      


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                      ...+.+++|||||.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus        79 ~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          79 SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchh
Confidence            45578999999999999999887543 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchhhhhcccCCCCC
Q psy7384         208 AQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       208 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      +.+.....   ......||+.|+|||++.     ...|+.++|||||||++|||++| .+||.+.+..+.+..+.....+
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~  232 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAIS-----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL  232 (283)
T ss_dssp             ----------------CCCGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHc-----cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence            87654322   123346899999999997     56799999999999999999996 5555555555555554444333


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                       ..+..+++.+.+||.+||..||.+|||+.|+++
T Consensus       233 -~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 -PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence             234578999999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-54  Score=422.04  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=209.8

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCc---chHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTE---DEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      .++|++++.||+|+||+||+|++..+|+.||||++....   .....+.+|+.+|+.+ +|||||+++++|......+. 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~-   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE-   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT-
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc-
Confidence            468999999999999999999999999999999997442   3345678999999999 89999999999865432222 


Q ss_pred             CeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccc
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQL  210 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~  210 (463)
                      ...++||+|+.||+|.+++..   ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             CceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence            344556677789999999854   35999999999999999999999999999999999999999999999999999776


Q ss_pred             ccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccCCC---------
Q psy7384         211 DRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPRNA---------  281 (463)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  281 (463)
                      ...   .....||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+.......+....         
T Consensus       172 ~~~---~~~~~g~~~y~apE~~~~----~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         172 DDE---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             TGG---GSSSCHHHHTSCHHHHTT----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             Ccc---cccccccccccCchhhcC----CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            543   255679999999999763    3457889999999999999999999998877655443321110         


Q ss_pred             -------------CCCC-------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccC
Q psy7384         282 -------------PPRL-------KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRD  323 (463)
Q Consensus       282 -------------~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  323 (463)
                                   ....       ....+++++++||.+||..||.+|||++|+|+||||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                         0000       01357889999999999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=420.06  Aligned_cols=258  Identities=24%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC---cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT---EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      ++|+++++||+|+||+||+|+++.+|+.||||++...   ......+.+|+.+|+.+ +|||||+++++|......+...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence            5799999999999999999999999999999999744   23345688999999999 8999999999997665445668


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+|+|||||.++.+ +.+.    ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            99999999977544 4442    258999999999999999999999999999999999999999999999999988765


Q ss_pred             cccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC------------
Q psy7384         212 RTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR------------  279 (463)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~------------  279 (463)
                      .. ......+||+.|+|||++.     +..++.++||||+||++|+|++|++||.+.+.......+..            
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~l~-----~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         171 TS-FMMTPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             -----------CCTTCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cc-cccccccccccccChhhhc-----CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            43 2335568999999999997     56789999999999999999999999988776554332210            


Q ss_pred             ----------CCCCC------------CC------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcCccccCC
Q psy7384         280 ----------NAPPR------------LK------SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKHPFIRDQ  324 (463)
Q Consensus       280 ----------~~~~~------------~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  324 (463)
                                .....            ..      ....++++++||++||..||++|||++|+|+||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                      00000            00      01235678999999999999999999999999999853

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-53  Score=399.36  Aligned_cols=248  Identities=23%  Similarity=0.421  Sum_probs=206.6

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      ..+.|++++.||+|+||.||+|+++  |..||||+++.. ...+.+.+|+++|+++ +|||||++++++..     ..+.
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-----~~~~   75 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVE-----EKGG   75 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEECC-----C--C
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEe-----cCCc
Confidence            3457999999999999999999984  778999999754 4557889999999999 89999999998852     3356


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccccccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLDR  212 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~~  212 (463)
                      +|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence            89999999999999999765544689999999999999999999999999999999999999999999999999987654


Q ss_pred             ccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCCCCCCCC
Q psy7384         213 TIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRLKSKKWP  291 (463)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  291 (463)
                      .   .....+|+.|+|||++.     +..++.++|||||||++|||+| |++||...+..+....+..+..+.. ...++
T Consensus       156 ~---~~~~~~~~~y~aPE~l~-----~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~  226 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALR-----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCP  226 (262)
T ss_dssp             ---------CCTTTSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC-CTTCC
T ss_pred             C---CccccccccCCChHHHh-----CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-CccCC
Confidence            3   24457899999999997     4678999999999999999998 7999988877777777666555443 45788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         292 KKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       292 ~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +++++||.+||..||.+|||+.+++++
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999999999773

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=406.90  Aligned_cols=249  Identities=24%  Similarity=0.418  Sum_probs=207.0

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCc----EEEEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQ----LAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPG  128 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vaiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~  128 (463)
                      ..|++++.||+|+||+||+|++..+|+    .||+|.+..  .....+.+.+|+.+|+++ +|||||++++++..     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~-----   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT-----   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEES-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-----
Confidence            359999999999999999999988876    578888753  234567899999999999 89999999999853     


Q ss_pred             CCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         129 KDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       129 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                        +..+++|||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus        83 --~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          83 --STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             --SSEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             --CCeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence              46789999999999999887643 479999999999999999999999999999999999999999999999999998


Q ss_pred             ccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCCCC
Q psy7384         209 QLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPPRL  285 (463)
Q Consensus       209 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  285 (463)
                      ........  .....||+.|+|||++.     ...|+.++|||||||++|||+| |.+||.+.+..+....+..+..+ .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~  233 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESIL-----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-P  233 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-C
T ss_pred             ecccccccccccccccCccccChHHHh-----cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-C
Confidence            77543222  23346899999999998     5679999999999999999998 89999887766655555444332 2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         286 KSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       286 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+..+++++.+||.+||..||.+|||+.|+++|
T Consensus       234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            345789999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=398.38  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=204.6

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCC-C--cEEEEEEeecC----cchHHHHHHHHHHHHHhcCCCceeeecccccccCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKT-G--QLAAIKVMDVT----EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPP  127 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~-~--~~vaiK~~~~~----~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~  127 (463)
                      ++|++++.||+|+||.||+|++... +  ..||||++...    ....+.+.+|+.+|+++ +|||||++++++..    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee----
Confidence            5699999999999999999986533 3  36899988632    33456789999999999 89999999999942    


Q ss_pred             CCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccc
Q psy7384         128 GKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVS  207 (463)
Q Consensus       128 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla  207 (463)
                         +.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus        83 ---~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          83 ---PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ---cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence               36789999999999999887654 36999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC---ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCchhhhhcccCCCCC
Q psy7384         208 AQLDRTIG---RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPPLCDLHPMRALFLIPRNAPP  283 (463)
Q Consensus       208 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  283 (463)
                      +.......   ......|+..|+|||++.     ...++.++|||||||++|||+| |.+||.+.+..+....+.+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~  233 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLK-----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER  233 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHH-----HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHh-----CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence            98754322   123346788999999998     5678999999999999999998 89999999988888777666544


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         284 RLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       284 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      ......+++++++||.+||..||++|||++++++
T Consensus       234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4455688999999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-52  Score=399.37  Aligned_cols=255  Identities=24%  Similarity=0.423  Sum_probs=212.0

Q ss_pred             CCCCCceEEEeeeeeeCCeEEEEEEEcCCC-------cEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeecccc
Q psy7384          51 EDPAGIFELIEVVGNGTYGQVYKGRHTKTG-------QLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAF  121 (463)
Q Consensus        51 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~  121 (463)
                      +...++|++++.||+|+||.||+|++..++       ..||||++....  .....+.+|+..+.++.+|||||+++++|
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            455678999999999999999999976554       479999996543  34577888999999997899999999999


Q ss_pred             cccCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCC
Q psy7384         122 IKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIK  187 (463)
Q Consensus       122 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLk  187 (463)
                            .+++.+|+|||||++|+|.+++....              ...+++..++.+++||+.||+|||++||||||||
T Consensus        89 ------~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK  162 (299)
T d1fgka_          89 ------TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  162 (299)
T ss_dssp             ------CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ------ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence                  44578999999999999999997654              2358999999999999999999999999999999


Q ss_pred             CCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy7384         188 GQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-SQPP  264 (463)
Q Consensus       188 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g~~P  264 (463)
                      |+|||++.++.+||+|||+++.......  ......||+.|+|||++.     ...|+.++|||||||++|||++ |.+|
T Consensus       163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-----~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-----CCCCCchhhhHHhHHHHHHhccCCCCC
Confidence            9999999999999999999987754322  234457899999999997     5679999999999999999998 7999


Q ss_pred             CCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         265 LCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       265 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      |.+.+.......+.....+ ..+..+++++++||.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         238 YPGVPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             STTCCHHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            9887776665555444333 334578999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-51  Score=399.15  Aligned_cols=253  Identities=22%  Similarity=0.405  Sum_probs=214.0

Q ss_pred             CCCCceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccccccc
Q psy7384          52 DPAGIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGAFIKK  124 (463)
Q Consensus        52 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~  124 (463)
                      .+.++|++++.||+|+||+||+|+++.     ++..||||++....  ...+.+.+|+.+|+++ +||||+++++++   
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~---   85 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVC---   85 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE---
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeee---
Confidence            345679999999999999999999753     46789999997543  3356789999999999 899999999999   


Q ss_pred             CCCCCCCeEEEEEecCCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHhhhhcCCce
Q psy7384         125 SPPGKDDQLWLVMEYCGAGSVTDLVKSTK----------------------GQSLKEEWIAFICREILRGLKYLHENKVI  182 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~giv  182 (463)
                         ...+..++||||+.+|+|.+++....                      ...+++..+..|++||+.||+|||++|||
T Consensus        86 ---~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv  162 (301)
T d1lufa_          86 ---AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV  162 (301)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             ---ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence               45578999999999999999997532                      12488999999999999999999999999


Q ss_pred             ecCCCCCceEEccCCcEEEEeccccccccccc--CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh
Q psy7384         183 HRDIKGQNVLLTDNAEVKLVDFGVSAQLDRTI--GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE  260 (463)
Q Consensus       183 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~  260 (463)
                      ||||||+||||+.++.+||+|||+++.+....  .......||+.|+|||++.     ...|+.++|||||||++|||++
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-----YNRYTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-----cCCCChhhhhccchhhHHHHHc
Confidence            99999999999999999999999998664332  2233567899999999998     5679999999999999999999


Q ss_pred             CC-CCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         261 SQ-PPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       261 g~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      |. +||.+.+..+.+..+.....+. .+..+++++.+||.+||+.||.+|||+.||++
T Consensus       238 ~~~~p~~~~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         238 YGLQPYYGMAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTCCTTTTSCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            84 7898888887777766655433 34578999999999999999999999999854

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=399.24  Aligned_cols=258  Identities=24%  Similarity=0.439  Sum_probs=217.6

Q ss_pred             CcCCCCCCceEEEeeeeeeCCeEEEEEEEc-----CCCcEEEEEEeecCc--chHHHHHHHHHHHHHhcCCCceeeeccc
Q psy7384          48 RWQEDPAGIFELIEVVGNGTYGQVYKGRHT-----KTGQLAAIKVMDVTE--DEEEEIKLEINVLKKYSNHRNIATYYGA  120 (463)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~Ei~~l~~l~~h~nIv~l~~~  120 (463)
                      .| +...++|++.+.||+|+||.||+|++.     .+++.||||++....  .....+.+|+.++.++.+|||||+++++
T Consensus        17 ~~-~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          17 KW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GG-BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cc-cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            45 556679999999999999999999864     456789999997543  3445788999999999779999999999


Q ss_pred             ccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC----------------CCCCCHHHHHHHHHHHHHHHhhhhcCCceec
Q psy7384         121 FIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK----------------GQSLKEEWIAFICREILRGLKYLHENKVIHR  184 (463)
Q Consensus       121 ~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givHr  184 (463)
                      +      ...+.+|||||||++|+|.+++....                ...+++..+..++.||+.||+|||++|||||
T Consensus        96 ~------~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr  169 (311)
T d1t46a_          96 C------TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR  169 (311)
T ss_dssp             E------CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             E------eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9      45578999999999999999997643                2258899999999999999999999999999


Q ss_pred             CCCCCceEEccCCcEEEEecccccccccccC--ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy7384         185 DIKGQNVLLTDNAEVKLVDFGVSAQLDRTIG--RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAE-S  261 (463)
Q Consensus       185 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~-g  261 (463)
                      ||||+|||++.++.+||+|||+++.......  .....+||+.|+|||++.     ...++.++|||||||++|||+| |
T Consensus       170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwS~G~~l~ellt~g  244 (311)
T d1t46a_         170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-----NCVYTFESDVWSYGIFLWELFSLG  244 (311)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc-----CCCCCCcccccchHHHHHHHHhCC
Confidence            9999999999999999999999987654322  223457899999999997     5678999999999999999998 6


Q ss_pred             CCCCCCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         262 QPPLCDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       262 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+||.+.+....+..+............+++++.+||.+||+.||.+|||++||++
T Consensus       245 ~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            77777777666665554444444445678999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=402.33  Aligned_cols=251  Identities=26%  Similarity=0.462  Sum_probs=211.3

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcE--EEEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCC
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQL--AAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKD  130 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vaiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~  130 (463)
                      +.|++.+.||+|+||.||+|+++.+|..  ||||.+..  .....+.+.+|+++|.++.+|||||++++++.      ..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~------~~   83 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE------HR   83 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE------ET
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe------cC
Confidence            5799999999999999999999988864  67777753  23345678999999999867999999999994      45


Q ss_pred             CeEEEEEecCCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccC
Q psy7384         131 DQLWLVMEYCGAGSVTDLVKST--------------KGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDN  196 (463)
Q Consensus       131 ~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~  196 (463)
                      +.+|+||||+++|+|.+++...              ....+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            7899999999999999999753              23579999999999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCchhhhh
Q psy7384         197 AEVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPLCDLHPMRALF  275 (463)
Q Consensus       197 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~  275 (463)
                      +.+||+|||+++...... ......||..|+|||.+.     ...|+.++|||||||++|||++| .+||.+.+..+.+.
T Consensus       164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~-----~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~  237 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  237 (309)
T ss_dssp             GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHH-----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CceEEccccccccccccc-cccceecCCcccchHHhc-----cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999998665432 223457999999999997     56789999999999999999996 56788888777777


Q ss_pred             cccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         276 LIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       276 ~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      .+..+..+.. ...+++++++||.+||+.||++|||++|+++|
T Consensus       238 ~i~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         238 KLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HGGGTCCCCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCC-CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7666544433 45789999999999999999999999999876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=391.94  Aligned_cols=260  Identities=23%  Similarity=0.405  Sum_probs=218.2

Q ss_pred             CCCCCcCCCCCCceEEEeeeeeeCCeEEEEEEEcC-----CCcEEEEEEeecCcc--hHHHHHHHHHHHHHhcCCCceee
Q psy7384          44 WPEDRWQEDPAGIFELIEVVGNGTYGQVYKGRHTK-----TGQLAAIKVMDVTED--EEEEIKLEINVLKKYSNHRNIAT  116 (463)
Q Consensus        44 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~Ei~~l~~l~~h~nIv~  116 (463)
                      +-++.| +...++|++.+.||+|+||.||+|.+..     ++..||||+++....  ....+.+|+.+++++ +|||||+
T Consensus        10 ~~~~~~-ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~   87 (308)
T d1p4oa_          10 YVPDEW-EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVR   87 (308)
T ss_dssp             CCCCTT-BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCC
T ss_pred             cCccce-eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEee
Confidence            344566 4446789999999999999999998853     357899999975433  335678999999999 8999999


Q ss_pred             ecccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCC
Q psy7384         117 YYGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTK--------GQSLKEEWIAFICREILRGLKYLHENKVIHRDIKG  188 (463)
Q Consensus       117 l~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp  188 (463)
                      +++++      ...+..++||||+.+|+|.+++....        ...+++..+..++.||+.||.|||+++|+||||||
T Consensus        88 ~~~~~------~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~  161 (308)
T d1p4oa_          88 LLGVV------SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA  161 (308)
T ss_dssp             EEEEE------CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSG
T ss_pred             eeeEE------ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcC
Confidence            99999      44578999999999999999986532        13478899999999999999999999999999999


Q ss_pred             CceEEccCCcEEEEecccccccccccCc--cccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCC
Q psy7384         189 QNVLLTDNAEVKLVDFGVSAQLDRTIGR--RNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAES-QPPL  265 (463)
Q Consensus       189 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf  265 (463)
                      +|||++.++++||+|||+++.+......  .....||+.|+|||.+.     ...++.++|||||||++|||++| .+||
T Consensus       162 ~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~-----~~~~~~~~Dv~S~G~il~El~t~~~~p~  236 (308)
T d1p4oa_         162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLAEQPY  236 (308)
T ss_dssp             GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-----HCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             CceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHc-----cCCCCcccccccHHHHHHHHHhCCCCCC
Confidence            9999999999999999999876543222  23346899999999997     56789999999999999999998 5889


Q ss_pred             CCCCchhhhhcccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHhc
Q psy7384         266 CDLHPMRALFLIPRNAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLLK  317 (463)
Q Consensus       266 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  317 (463)
                      .+.+..+.+..+.....+. ....+++.+.+||.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         237 QGLSNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TTSCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888877777666554433 34578899999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=388.71  Aligned_cols=249  Identities=20%  Similarity=0.375  Sum_probs=201.8

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCC---cEEEEEEeec--CcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTG---QLAAIKVMDV--TEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDD  131 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~---~~vaiK~~~~--~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~  131 (463)
                      +.+.++||+|+||+||+|++..++   ..||||+++.  .....+.+.+|+++|.++ +|||||++++++..     .++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-----~~~  102 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLR-----SEG  102 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEE-----TTT
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEe-----cCC
Confidence            345689999999999999987653   3689999863  333457799999999999 89999999998753     346


Q ss_pred             eEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCCcEEEEecccccccc
Q psy7384         132 QLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNAEVKLVDFGVSAQLD  211 (463)
Q Consensus       132 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~~vkL~DFGla~~~~  211 (463)
                      .+++|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||++++.+||+|||+++...
T Consensus       103 ~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         103 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             ceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            8999999999999999987543 467888899999999999999999999999999999999999999999999998764


Q ss_pred             cccC----ccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CchhhhhcccCCCCCCCC
Q psy7384         212 RTIG----RRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDL-HPMRALFLIPRNAPPRLK  286 (463)
Q Consensus       212 ~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~  286 (463)
                      ....    ......||+.|+|||++.     ...++.++|||||||++|||++|..||... +..+....+..+..+ ..
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-~~  255 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQ-----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQ  255 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHH-----HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-CC
T ss_pred             ccccccceecccccccccccChHHHh-----cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CC
Confidence            3321    123356899999999987     567899999999999999999977766543 333344444444333 33


Q ss_pred             CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         287 SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       287 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                      +..+++++.+||.+||..||++||++.|+++|
T Consensus       256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            45788999999999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=383.55  Aligned_cols=254  Identities=20%  Similarity=0.347  Sum_probs=197.3

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      +++|++++.||+|+||.||+|++..+|+.||||++.... ....+..|+++++.+ .|+|++.++..+.     ...+..
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l-~~~~~i~~~~~~~-----~~~~~~   78 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCG-----AEGDYN   78 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHS-TTSTTCCCEEEEE-----EETTEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHc-cCCCcccEEEEEE-----ecCCEE
Confidence            468999999999999999999999999999999987543 234578899999999 5665544444432     345789


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEc---cCCcEEEEeccccccc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLT---DNAEVKLVDFGVSAQL  210 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~---~~~~vkL~DFGla~~~  210 (463)
                      ++||||+. ++|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++   .+..+||+|||+|+.+
T Consensus        79 ~ivme~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEcC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999995 56766665433 4799999999999999999999999999999999999985   3567999999999876


Q ss_pred             cccc-------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhcccC----
Q psy7384         211 DRTI-------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFLIPR----  279 (463)
Q Consensus       211 ~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~----  279 (463)
                      ....       ......+||+.|+|||++.     +..|+.++|||||||++|||++|.+||.+.........+..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHL-----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHT-----TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cccccccceeccccCCcCCCccccCHHHHh-----CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            5322       1234567999999999987     56799999999999999999999999977655443322111    


Q ss_pred             --CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH---hcCccc
Q psy7384         280 --NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQL---LKHPFI  321 (463)
Q Consensus       280 --~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~  321 (463)
                        ..+.......+|+++.+||..||..||.+||+++++   |+|+|.
T Consensus       232 ~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence              111112234788999999999999999999998765   445443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=384.03  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=194.9

Q ss_pred             CCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeE
Q psy7384          54 AGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQL  133 (463)
Q Consensus        54 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~  133 (463)
                      .+.|.+.+.||+|+||.||+|++  +|+.||||++............|+..+..+ +|||||++++++....  .....+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~--~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDN--GTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEEC--SSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCC--CcceEE
Confidence            35699999999999999999986  588999999975544433344455555566 7999999999997542  223478


Q ss_pred             EEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc--------CCceecCCCCCceEEccCCcEEEEecc
Q psy7384         134 WLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE--------NKVIHRDIKGQNVLLTDNAEVKLVDFG  205 (463)
Q Consensus       134 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~--------~givHrDLkp~NILl~~~~~vkL~DFG  205 (463)
                      |+|||||++|+|.++++..   .+++.....++.|++.||.|||+        +||+||||||+||||+.++.+||+|||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            9999999999999999764   58899999999999999999996        699999999999999999999999999


Q ss_pred             cccccccccC----ccccccCCccccccceeccCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhhhc----
Q psy7384         206 VSAQLDRTIG----RRNTFIGTPYWMAPEVIACDEN-PDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRALFL----  276 (463)
Q Consensus       206 la~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~----  276 (463)
                      +++.......    .....+||+.|+|||++..... ....++.++|||||||+||||+||.+||.........+.    
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            9987654321    2345689999999999864211 112367889999999999999999988754332211110    


Q ss_pred             -----------cc-CCCCCCCC----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHhcC
Q psy7384         277 -----------IP-RNAPPRLK----SKKWPKKFQSFIETVLVKDYHQRPYTDQLLKH  318 (463)
Q Consensus       277 -----------i~-~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  318 (463)
                                 +. ....+...    .......+.+|+.+||..||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                       00 11111111    11123468899999999999999999999763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.3e-49  Score=377.21  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             CCCceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCe
Q psy7384          53 PAGIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQ  132 (463)
Q Consensus        53 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~  132 (463)
                      .+++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.+|+||+.+++++      .....
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~------~~~~~   75 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFG------QEGLH   75 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEE------EETTE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEe------ecCCc
Confidence            3578999999999999999999999999999999986542 3345778999999997679999999988      45578


Q ss_pred             EEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEcc-----CCcEEEEecccc
Q psy7384         133 LWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTD-----NAEVKLVDFGVS  207 (463)
Q Consensus       133 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~-----~~~vkL~DFGla  207 (463)
                      .|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             cEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence            99999999 679999887544 46999999999999999999999999999999999999964     578999999999


Q ss_pred             ccccccc-------CccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchhhh---hcc
Q psy7384         208 AQLDRTI-------GRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMRAL---FLI  277 (463)
Q Consensus       208 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~---~~i  277 (463)
                      +......       ......+||+.|||||++.     +..++.++|||||||++|||++|..||.+.......   ..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhc-----CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            8764321       1234568999999999997     567999999999999999999999999765443221   111


Q ss_pred             cC---CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHh
Q psy7384         278 PR---NAPPRLKSKKWPKKFQSFIETVLVKDYHQRPYTDQLL  316 (463)
Q Consensus       278 ~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  316 (463)
                      ..   ..+.......+|+++.+++..|+..+|.+||+++.+.
T Consensus       229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            11   1111112346889999999999999999999987764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-47  Score=378.48  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             CceEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhc----------CCCceeeeccccccc
Q psy7384          55 GIFELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYS----------NHRNIATYYGAFIKK  124 (463)
Q Consensus        55 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~----------~h~nIv~l~~~~~~~  124 (463)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++........+.+|+.+|+.+.          .|+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5799999999999999999999999999999999876656677888999988873          368899999888542


Q ss_pred             CCCCCCCeEEEEEecCCCCC-HHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-CCceecCCCCCceEEccCC-----
Q psy7384         125 SPPGKDDQLWLVMEYCGAGS-VTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-NKVIHRDIKGQNVLLTDNA-----  197 (463)
Q Consensus       125 ~~~~~~~~~~lV~E~~~ggs-L~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDLkp~NILl~~~~-----  197 (463)
                          .....+++|+++..+. ............+++..++.+++||+.||.|||+ +||+||||||+||||+.++     
T Consensus        93 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          93 ----GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             ----ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ----cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence                2356677777665544 3444444555689999999999999999999997 8999999999999998655     


Q ss_pred             -cEEEEecccccccccccCccccccCCccccccceeccCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCchh----
Q psy7384         198 -EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAPEVIACDENPDATYDNRSDLWSLGITALEMAESQPPLCDLHPMR----  272 (463)
Q Consensus       198 -~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~----  272 (463)
                       .++|+|||.+......   ....+||+.|+|||++.     ...|+.++||||+||++++|++|+.||.......    
T Consensus       169 ~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLL-----GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHH-----TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             ceeeEeecccccccccc---cccccccccccChhhcc-----ccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence             4999999998866533   25568999999999998     5678999999999999999999999996543211    


Q ss_pred             --hhhc---------------------------ccCCCCC-------------CCCCCCCCHHHHHHHHHhhhcCCCCCC
Q psy7384         273 --ALFL---------------------------IPRNAPP-------------RLKSKKWPKKFQSFIETVLVKDYHQRP  310 (463)
Q Consensus       273 --~~~~---------------------------i~~~~~~-------------~~~~~~~~~~~~~li~~~L~~dp~~Rp  310 (463)
                        .+..                           .......             .......++++++||.+||..||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence              0000                           0000000             000112356899999999999999999


Q ss_pred             CHHHHhcCccccCC
Q psy7384         311 YTDQLLKHPFIRDQ  324 (463)
Q Consensus       311 t~~e~l~hp~~~~~  324 (463)
                      |++|+|+||||++.
T Consensus       321 ta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         321 DAGGLVNHPWLKDT  334 (362)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHhcCcccCCC
Confidence            99999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=5.6e-27  Score=209.74  Aligned_cols=162  Identities=17%  Similarity=0.169  Sum_probs=120.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcc-------------------hHHHHHHHHHHHHHhcCCCceeee
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTED-------------------EEEEIKLEINVLKKYSNHRNIATY  117 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~Ei~~l~~l~~h~nIv~l  117 (463)
                      |.+.++||+|+||+||+|++. +|+.||||+++....                   .......|...+.++ .|.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            568899999999999999985 689999998753211                   112345678888888 79999988


Q ss_pred             cccccccCCCCCCCeEEEEEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhcCCceecCCCCCceEEccCC
Q psy7384         118 YGAFIKKSPPGKDDQLWLVMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHENKVIHRDIKGQNVLLTDNA  197 (463)
Q Consensus       118 ~~~~~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDLkp~NILl~~~~  197 (463)
                      ++..          ..++||||+++..+.+         ++...+..++.||+.+|.|||++||+||||||+|||+++++
T Consensus        80 ~~~~----------~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~  140 (191)
T d1zara2          80 YAWE----------GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG  140 (191)
T ss_dssp             EEEE----------TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE
T ss_pred             EEec----------CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC
Confidence            7664          2379999999865432         44555678999999999999999999999999999998655


Q ss_pred             cEEEEecccccccccccCccccccCCcccccc------ceeccCCCCCCCCCcchhHHHHHHH
Q psy7384         198 EVKLVDFGVSAQLDRTIGRRNTFIGTPYWMAP------EVIACDENPDATYDNRSDLWSLGIT  254 (463)
Q Consensus       198 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~~~~~~~~~~DiwSlG~i  254 (463)
                       ++|+|||+|........        ..|...      +.+      ...|+.++|+||+.--
T Consensus       141 -~~liDFG~a~~~~~~~~--------~~~l~rd~~~~~~~f------~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         141 -IWIIDFPQSVEVGEEGW--------REILERDVRNIITYF------SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             -EEECCCTTCEETTSTTH--------HHHHHHHHHHHHHHH------HHHHCCCCCHHHHHHH
T ss_pred             -EEEEECCCcccCCCCCc--------HHHHHHHHHHHHHHH------cCCCCCcccHHHHHHH
Confidence             89999999876643211        111111      122      2457778999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.60  E-value=6.5e-08  Score=88.33  Aligned_cols=137  Identities=13%  Similarity=0.133  Sum_probs=88.0

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecC-cchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCCCCeEEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVT-EDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      |++.+..+-++.+.||+..  ..+..+.+|+.... ......+.+|..++..+..+--+.+++.+.      +.++..|+
T Consensus        16 ~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~------~~~~~~~l   87 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE------RHDGWSNL   87 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE------EETTEEEE
T ss_pred             eEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE------ecCCceEE
Confidence            5666665556667899985  34556777877532 223445678888888885554455666555      34478899


Q ss_pred             EEecCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHhhhhc-------------------------------------
Q psy7384         136 VMEYCGAGSVTDLVKSTKGQSLKEEWIAFICREILRGLKYLHE-------------------------------------  178 (463)
Q Consensus       136 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------  178 (463)
                      ||++++|.++.+.....    ..   ...++.++...|..||+                                     
T Consensus        88 v~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            99999998875543210    11   11122333333333332                                     


Q ss_pred             ----------------------CCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         179 ----------------------NKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       179 ----------------------~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                                            ..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  137999999999999877767799999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.22  E-value=2.1e-06  Score=83.15  Aligned_cols=78  Identities=14%  Similarity=0.139  Sum_probs=49.2

Q ss_pred             EeeeeeeCCeEEEEEEEcCCCcEEEEEEeec----C----cchHHHHHHHHHHHHHhcCC--CceeeecccccccCCCCC
Q psy7384          60 IEVVGNGTYGQVYKGRHTKTGQLAAIKVMDV----T----EDEEEEIKLEINVLKKYSNH--RNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        60 ~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~----~----~~~~~~~~~Ei~~l~~l~~h--~nIv~l~~~~~~~~~~~~  129 (463)
                      .+.||.|....||++.+..+++.+++|.-..    .    .....+...|.+.|+.+..+  ..+.+++.+.        
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--------  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--------  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--------
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--------
Confidence            3678999999999998877788899986431    1    11234556788888877544  2344455432        


Q ss_pred             CCeEEEEEecCCCCCH
Q psy7384         130 DDQLWLVMEYCGAGSV  145 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL  145 (463)
                      .+..++|||++.+..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            1345799999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.02  E-value=8.7e-06  Score=73.29  Aligned_cols=75  Identities=12%  Similarity=0.081  Sum_probs=48.6

Q ss_pred             eeeeeC-CeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCCeEEEEEec
Q psy7384          62 VVGNGT-YGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDDQLWLVMEY  139 (463)
Q Consensus        62 ~LG~G~-fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~~~~lV~E~  139 (463)
                      .+..|. -+.||+... .++..+++|......  ...+..|...|+.+..+. .+.+++.+.      .+.+..++||++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~------~~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVV------TEAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEE------ECSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeec------ccccceEEEEEe
Confidence            445555 368999874 456668888865432  335678888888775432 234455554      334678999999


Q ss_pred             CCCCCH
Q psy7384         140 CGAGSV  145 (463)
Q Consensus       140 ~~ggsL  145 (463)
                      ++|.++
T Consensus        88 i~G~~~   93 (255)
T d1nd4a_          88 VPGQDL   93 (255)
T ss_dssp             CSSEET
T ss_pred             eecccc
Confidence            988655

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.63  E-value=6.8e-05  Score=72.19  Aligned_cols=77  Identities=14%  Similarity=0.190  Sum_probs=54.0

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCC-------CcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCceeeecccccccCCCCC
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKT-------GQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRNIATYYGAFIKKSPPGK  129 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~nIv~l~~~~~~~~~~~~  129 (463)
                      .++ +.|+.|-.-.+|++.....       ...|.+++.... .......+|..+++.+..+.-..++++++      . 
T Consensus        45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~------~-  115 (395)
T d1nw1a_          45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIF------S-  115 (395)
T ss_dssp             EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEE------T-
T ss_pred             eEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEc------C-
Confidence            444 6788888899999986532       356777776533 33456778999999987664445777776      1 


Q ss_pred             CCeEEEEEecCCCCCH
Q psy7384         130 DDQLWLVMEYCGAGSV  145 (463)
Q Consensus       130 ~~~~~lV~E~~~ggsL  145 (463)
                         -++||||++|..|
T Consensus       116 ---~g~I~efi~g~~l  128 (395)
T d1nw1a_         116 ---GGRLEEYIPSRPL  128 (395)
T ss_dssp             ---TEEEECCCCEEEC
T ss_pred             ---CceEEEEeccccC
Confidence               1689999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.41  E-value=0.00054  Score=63.77  Aligned_cols=139  Identities=12%  Similarity=0.122  Sum_probs=79.5

Q ss_pred             eCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCC-ceeeecccccccCCCCCCCeEEEEEecCCCCC
Q psy7384          66 GTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHR-NIATYYGAFIKKSPPGKDDQLWLVMEYCGAGS  144 (463)
Q Consensus        66 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~-nIv~l~~~~~~~~~~~~~~~~~lV~E~~~ggs  144 (463)
                      +.--.||++.. .+|..|++|+.+......+.+..|+..+..|..+. -++..+..- ........+..+.+++++.|..
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~-g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFN-GQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBT-TBSCEEETTEEEEEEECCCCEE
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecC-CCeeeeeeeEEEEEEeecCCcC
Confidence            33468999975 56888999998766666778888999998885331 112221111 0111123467899999998744


Q ss_pred             HH-----HH------H---Hh-hCC------CC-------------------CCH---HHHHHHHHHHHHHHhhhh----
Q psy7384         145 VT-----DL------V---KS-TKG------QS-------------------LKE---EWIAFICREILRGLKYLH----  177 (463)
Q Consensus       145 L~-----~~------l---~~-~~~------~~-------------------l~~---~~~~~i~~qil~aL~~LH----  177 (463)
                      +.     .+      +   .. ...      ..                   ++.   ......+.+++..+.-+-    
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~  190 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF  190 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence            31     11      1   00 000      01                   111   112223333333333221    


Q ss_pred             cCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         178 ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       178 ~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      ..++||+|+++.|||+++ + ..++||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            247999999999999974 3 4589999764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.95  E-value=0.002  Score=59.25  Aligned_cols=149  Identities=11%  Similarity=0.088  Sum_probs=75.3

Q ss_pred             eEEEeeeeeeCCeEEEEEEEcCCCcEEEEEEeecCcchHHHHHHHHHHHHHhcCCCc-eeeecccccccCCCCCCCeEEE
Q psy7384          57 FELIEVVGNGTYGQVYKGRHTKTGQLAAIKVMDVTEDEEEEIKLEINVLKKYSNHRN-IATYYGAFIKKSPPGKDDQLWL  135 (463)
Q Consensus        57 y~~~~~LG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~Ei~~l~~l~~h~n-Iv~l~~~~~~~~~~~~~~~~~l  135 (463)
                      ..-++.|..|---+.|+.... .| .+++|++... .....+..|++++..|..+-- +...+...............+.
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~   96 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA   96 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             ceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence            444567778888899998754 34 4889988542 233455667777777742211 1111110000000011245666


Q ss_pred             EEecCCCCCHHH-----------H---HHhh-CC------CCC------------------CHHHHHHHHHHHHHHHhhh
Q psy7384         136 VMEYCGAGSVTD-----------L---VKST-KG------QSL------------------KEEWIAFICREILRGLKYL  176 (463)
Q Consensus       136 V~E~~~ggsL~~-----------~---l~~~-~~------~~l------------------~~~~~~~i~~qil~aL~~L  176 (463)
                      ++.++.|.....           .   +... ..      ...                  ........+..+...+.-.
T Consensus        97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  176 (316)
T d2ppqa1          97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  176 (316)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence            777776643210           0   0000 00      000                  0111122222333333333


Q ss_pred             h----cCCceecCCCCCceEEccCCcEEEEeccccc
Q psy7384         177 H----ENKVIHRDIKGQNVLLTDNAEVKLVDFGVSA  208 (463)
Q Consensus       177 H----~~givHrDLkp~NILl~~~~~vkL~DFGla~  208 (463)
                      +    ..|+||+|+.++||+++.+...-|+||+.+.
T Consensus       177 ~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         177 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccccccccccCCcchhhhhcccccceeEecccccc
Confidence            3    2589999999999999988777899999764